Citrus Sinensis ID: 013682

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------44
Protein Sequence
MLKLMLCIFLSRSYKILTIVCRVGIICLGICARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRRL
Secondary Structure (PSIPRED)
cHHHHHHHHcccccccccccccHHHHHHHHccccccccccccHHHcccHHHHHHccccccccccccccccccccEEccccccccccccHHHHcccccccccccccccccEEEcccccccccccHHHHcccccccEEccccccccccHHHHHccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccHHHHHHHHcccccccEEEEccccEEEEEEcccccEEEEEEEcccccccccHHHHHHHHHHHcccccccccEEEEEEcccccEEEEcccccccHHHHHcccccccccccHHHHHHHHHHHHHHHHccccccccccEEccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cHHHHHHHHHHcccHHHHHHcccccEEEEccccccccccccccHcccccEEEccccccccccccccHcccccEEEEEcccccccccccHHHcccccccEEEcccccccEEEEcccccccccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEcccccccccccccHHHHccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccHHHccccccccccccccccccEEcHHHHHHHHcccccccEEccccccEEEEEEcccccEEEEEEcccccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEccccccHHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEccccHHHHHHHHHcc
Coil and Loop (DISEMBL)
MLKLMLCIFLSRSYKILTIVCRVGIICLGICARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFVYLISDLgnaalsgelapelgqlKNLELLALGnliklksldlysnlfngtipDTLANLKQLKYLRLnnnslsgliptslttitslnildlsnnrlsgpvpdngsfsqftpisfennlnlcgpntkkpcsgsppfsppppfgptsspgrnksnaaiPVGVALGAALLFAVPvigfaywrrtrphefffdvpaeddselqlgqlkRFSLRELQVAtdgfsnknilgrggfgkvykgrladgKLVAVKRLKEertsggelqfqTEVKIISMAVHRNLLRLYGFCTTVTEKLLVypymtngsvASRLRerqsslppldwptrkkiALGSARGlsylhehcdpkiihRDVKAANIlldedadqsskTILRRL
Flexible Loop (DISEMBL)
MLKLMLCIFLSRSYKILTIVCRVGIICLGICARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVAtdgfsnknilgrggfgkvykgrlaDGKLVAVKrlkeertsggelqfqteVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRlrerqsslppldwptrkKIALGSARGLSYLHEHCDPKIIHRDVKAANilldedadqssktilrrl
Low Complexity Region (SEG)
MLKLMLCIFLSRSYKILTIVCRVGIICLGICARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPelgqlknlellalgnliklkslDLYSNLFNGTIPDTLANLKQLKYLRLNNNslsgliptslttitslnildlsNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKpcsgsppfsppppfgptsspgRNKSNaaipvgvalgaallfavpvIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRRL
Disordered region (IsUnstruct)
**KLMLCIFLSRSYKILTIVCRVGIICLGICARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSN****************TPISFE*NL************************************AIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV**************DWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL***************
Disordered Region (DISOPRED)
MLKLMLCIFLSRSYKILTIVCRVGIICLGICARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTK*****************************IPVGVALGAALLFAVPVIGFAYW***********************QLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKE*R******QFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRRL
Disordered Region (DISEMBL)
MLKLMLCIFLSRSYKILTIVCRVGIICLGICARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNT************************NKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRRL
Disordered Region (DISPRO)
MLKLMLCIFLSRSYKILTIVCRVGIICLGICARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSG******************NKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRP***FFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRRL
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLKLMLCIFLSRSYKILTIVCRVGIICLGICARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRRL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	438	2.2.26 [Sep-21-2011]
Q94AG2	625	Somatic embryogenesis rec	yes	no	0.799	0.56	0.734	1e-129
Q94F62	615	BRASSINOSTEROID INSENSITI	no	no	0.778	0.554	0.672	1e-123
Q9SKG5	620	Somatic embryogenesis rec	no	no	0.773	0.546	0.652	1e-120
Q8LPS5	601	Somatic embryogenesis rec	no	no	0.742	0.540	0.595	3e-99
Q9XIC7	628	Somatic embryogenesis rec	no	no	0.716	0.5	0.532	1e-94
Q8RY65	635	Protein NSP-INTERACTING K	no	no	0.748	0.516	0.513	1e-93
Q9LFS4	638	Protein NSP-INTERACTING K	no	no	0.764	0.525	0.512	6e-92
Q0WVM4	634	Probable LRR receptor-lik	no	no	0.783	0.541	0.496	3e-85
Q93ZS4	632	Protein NSP-INTERACTING K	no	no	0.789	0.547	0.516	8e-82
Q8VYT3	648	Probable LRR receptor-lik	no	no	0.760	0.513	0.488	2e-80

>sp|Q94AG2|SERK1_ARATH Somatic embryogenesis receptor kinase 1 OS=Arabidopsis thaliana GN=SERK1 PE=1 SV=2

 Score =  460 bits (1184), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 269/366 (73%), Positives = 293/366 (80%), Gaps = 16/366 (4%)

Query: 77  DLGNAALSGELAPELGQLKNLELLAL-------------GNLIKLKSLDLYSNLFNGTIP 123
           DLGNA LSG L PELG LKNL+ L L             GNL  L SLDLY N F+G IP
Sbjct: 75  DLGNAELSGHLVPELGVLKNLQYLELYSNNITGPIPSNLGNLTNLVSLDLYLNSFSGPIP 134

Query: 124 DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 183
           ++L  L +L++LRLNNNSL+G IP SLT IT+L +LDLSNNRLSG VPDNGSFS FTPIS
Sbjct: 135 ESLGKLSKLRFLRLNNNSLTGSIPMSLTNITTLQVLDLSNNRLSGSVPDNGSFSLFTPIS 194

Query: 184 FENNLNLCGPNTKKPCSGSPPFSPPPPFGP---TSSPGRNKSNAAIPVGVALGAALLFAV 240
           F NNL+LCGP T  PC GSPPFSPPPPF      S+P       AI  GVA GAALLFA 
Sbjct: 195 FANNLDLCGPVTSHPCPGSPPFSPPPPFIQPPPVSTPSGYGITGAIAGGVAAGAALLFAA 254

Query: 241 PVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFG 300
           P I FA+WRR +P + FFDVPAE+D E+ LGQLKRFSLRELQVA+DGFSNKNILGRGGFG
Sbjct: 255 PAIAFAWWRRRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFG 314

Query: 301 KVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL 360
           KVYKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LL
Sbjct: 315 KVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 374

Query: 361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN 420
           VYPYM NGSVAS LRER  S PPLDWPTRK+IALGSARGLSYLH+HCDPKIIHRDVKAAN
Sbjct: 375 VYPYMANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAAN 434

Query: 421 ILLDED 426
           ILLDE+
Sbjct: 435 ILLDEE 440

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Phosphorylates BRI1 on 'Ser-887' and CDC48 on at least one threonine residue and on 'Ser-41'. Confers embryogenic competence. Acts redundantly with SERK2 as a control point for sporophytic development controlling male gametophyte production. Involved in the brassinolide signaling pathway.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2

 Score =  443 bits (1139), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 244/363 (67%), Positives = 272/363 (74%), Gaps = 22/363 (6%)

Query: 77  DLGNAALSGELAPELGQLKNLELLAL-------------GNLIKLKSLDLYSNLFNGTIP 123
           DLGNA LSG+L  +LGQL NL+ L L             GNL +L SLDLY N  +G IP
Sbjct: 74  DLGNANLSGQLVMQLGQLPNLQYLELYSNNITGTIPEQLGNLTELVSLDLYLNNLSGPIP 133

Query: 124 DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 183
            TL  LK+L++LRLNNNSLSG IP SLT + +L +LDLSNN L+G +P NGSFS FTPIS
Sbjct: 134 STLGRLKKLRFLRLNNNSLSGEIPRSLTAVLTLQVLDLSNNPLTGDIPVNGSFSLFTPIS 193

Query: 184 FENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVI 243
           F N          K         PP    P S  G N+   AI  GVA GAALLFAVP I
Sbjct: 194 FANT---------KLTPLPASPPPPISPTPPSPAGSNRITGAIAGGVAAGAALLFAVPAI 244

Query: 244 GFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVY 303
             A+WRR +P + FFDVPAE+D E+ LGQLKRFSLRELQVA+D FSNKNILGRGGFGKVY
Sbjct: 245 ALAWWRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVY 304

Query: 304 KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP 363
           KGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYP
Sbjct: 305 KGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 364

Query: 364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 423
           YM NGSVAS LRER  S PPLDWP R++IALGSARGL+YLH+HCDPKIIHRDVKAANILL
Sbjct: 365 YMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL 424

Query: 424 DED 426
           DE+
Sbjct: 425 DEE 427

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2

 Score =  431 bits (1107), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 237/363 (65%), Positives = 269/363 (74%), Gaps = 24/363 (6%)

Query: 77  DLGNAALSGELAPELGQLKNLELLAL-------------GNLIKLKSLDLYSNLFNGTIP 123
           DLGNA LSG+L PELGQL NL+ L L             G+L++L SLDLY+N  +G IP
Sbjct: 81  DLGNAKLSGKLVPELGQLLNLQYLELYSNNITGEIPEELGDLVELVSLDLYANSISGPIP 140

Query: 124 DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 183
            +L  L +L++LRLNNNSLSG IP +LT++  L +LD+SNNRLSG +P NGSFS FTPIS
Sbjct: 141 SSLGKLGKLRFLRLNNNSLSGEIPMTLTSV-QLQVLDISNNRLSGDIPVNGSFSLFTPIS 199

Query: 184 FENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVI 243
           F NN            +  P   P         P   +  AAI  GVA GAALLFAVP I
Sbjct: 200 FANN----------SLTDLPEPPPTSTSPTPPPPSGGQMTAAIAGGVAAGAALLFAVPAI 249

Query: 244 GFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVY 303
            FA+W R +P + FFDVPAE+D E+ LGQLKRF+LREL VATD FSNKN+LGRGGFGKVY
Sbjct: 250 AFAWWLRRKPQDHFFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVY 309

Query: 304 KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP 363
           KGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYP
Sbjct: 310 KGRLADGNLVAVKRLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 369

Query: 364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 423
           YM NGSVAS LRER    P LDWP RK IALGSARGL+YLH+HCD KIIHRDVKAANILL
Sbjct: 370 YMANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILL 429

Query: 424 DED 426
           DE+
Sbjct: 430 DEE 432

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8LPS5|SERK5_ARATH Somatic embryogenesis receptor kinase 5 OS=Arabidopsis thaliana GN=SERK5 PE=1 SV=2

 Score =  362 bits (929), Expect = 3e-99,   Method: Compositional matrix adjust.
 Identities = 216/363 (59%), Positives = 254/363 (69%), Gaps = 38/363 (10%)

Query: 77  DLGNAALSGELAPELGQLKNLELLAL-------------GNLIKLKSLDLYSNLFNGTIP 123
           DLG+A LSGEL P+L QL NL+ L L             G+L++L SLDL++N  +G IP
Sbjct: 76  DLGSANLSGELVPQLAQLPNLQYLELFNNNITGEIPEELGDLMELVSLDLFANNISGPIP 135

Query: 124 DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 183
            +L  L +L++LRL NNSLSG IP SLT +  L++LD+SNNRLSG +P NGSFSQFT +S
Sbjct: 136 SSLGKLGKLRFLRLYNNSLSGEIPRSLTAL-PLDVLDISNNRLSGDIPVNGSFSQFTSMS 194

Query: 184 FENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVI 243
           F NN                      P   + SP  + ++AAI VGVA GAALLFA+   
Sbjct: 195 FANN-------------------KLRPRPASPSPSPSGTSAAIVVGVAAGAALLFALAWW 235

Query: 244 GFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVY 303
                 R +    F DVPAE+D E+ LGQ KRFSLREL VAT+ FS +N+LG+G FG +Y
Sbjct: 236 -----LRRKLQGHFLDVPAEEDPEVYLGQFKRFSLRELLVATEKFSKRNVLGKGRFGILY 290

Query: 304 KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP 363
           KGRLAD  LVAVKRL EERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYP
Sbjct: 291 KGRLADDTLVAVKRLNEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 350

Query: 364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 423
           YM NGSVAS LRER    P LDWP RK IALGSARGL+YLH+HCD KIIH DVKAANILL
Sbjct: 351 YMANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHLDVKAANILL 410

Query: 424 DED 426
           DE+
Sbjct: 411 DEE 413

Serine/threonine-kinase of unknown function.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XIC7|SERK2_ARATH Somatic embryogenesis receptor kinase 2 OS=Arabidopsis thaliana GN=SERK2 PE=1 SV=1

 Score =  347 bits (890), Expect = 1e-94,   Method: Compositional matrix adjust.
 Identities = 214/402 (53%), Positives = 243/402 (60%), Gaps = 88/402 (21%)

Query: 77  DLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLR 136
           DLGNA LSG+L P+LGQLKN                                   L+YL 
Sbjct: 78  DLGNADLSGQLVPQLGQLKN-----------------------------------LQYLE 102

Query: 137 LNNNSLSGLIPTSLTTITSLNILDLSNNRLSGP--------------------------- 169
           L +N+++G +P+ L  +T+L  LDL  N  +GP                           
Sbjct: 103 LYSNNITGPVPSDLGNLTNLVSLDLYLNSFTGPIPDSLGKLFKLRFLRLNNNSLTGPIPM 162

Query: 170 ---------------------VPDNGSFSQFTPISFENNLNLCGPNTKK----PCSGSPP 204
                                VPDNGSFS FTPISF NNL+LCGP T +        SPP
Sbjct: 163 SLTNIMTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGPVTSRPCPGSPPFSPP 222

Query: 205 FSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAED 264
               PP    +  G + + A      A  A L  A  +    + RR +P EFFFDVPAE+
Sbjct: 223 PPFIPPPIVPTPGGYSATGAIAGGVAAGAALLFAAPALAFAWWRRR-KPQEFFFDVPAEE 281

Query: 265 DSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS 324
           D E+ LGQLKRFSLRELQVATD FSNKNILGRGGFGKVYKGRLADG LVAVKRLKEERT 
Sbjct: 282 DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTP 341

Query: 325 GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPL 384
           GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NGSVAS LRER  S  PL
Sbjct: 342 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPL 401

Query: 385 DWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            W  R++IALGSARGLSYLH+HCDPKIIHRDVKAANILLDE+
Sbjct: 402 AWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 443

Serine/threonine-kinase involved in brassinosteroid-dependent and -independent signaling pathways. Acts redundantly with SERK1 as a control point for sporophytic development controlling male gametophyte production.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1

 Score =  343 bits (881), Expect = 1e-93,   Method: Compositional matrix adjust.
 Identities = 189/368 (51%), Positives = 242/368 (65%), Gaps = 40/368 (10%)

Query: 83  LSGELAPELGQLKNLELLAL-------------GNLIKLKSLDLYSNLFNGTIPDTLANL 129
           LSG L+  +G L NL+ + L             G L+KLK+LDL +N F G IP TL+  
Sbjct: 93  LSGTLSSSIGNLTNLQTVLLQNNYITGNIPHEIGKLMKLKTLDLSTNNFTGQIPFTLSYS 152

Query: 130 KQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLN 189
           K L+YLR+NNNSL+G IP+SL  +T L  LDLS N LSGPVP     S     +   N  
Sbjct: 153 KNLQYLRVNNNSLTGTIPSSLANMTQLTFLDLSYNNLSGPVPR----SLAKTFNVMGNSQ 208

Query: 190 LCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNA--------AIPVGVALGAALLFAVP 241
           +C   T+K C+G+ P     P   T +  +NKS+         A+  GV+L    L    
Sbjct: 209 ICPTGTEKDCNGTQP----KPMSITLNSSQNKSSDGGTKNRKIAVVFGVSLTCVCLL--- 261

Query: 242 VIGFA---YWRRTRPHE-FFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRG 297
           +IGF    +WRR    +  FFD+  ++  E+ LG L+RF+ +ELQ AT  FS+KN++G+G
Sbjct: 262 IIGFGFLLWWRRRHNKQVLFFDINEQNKEEMCLGNLRRFNFKELQSATSNFSSKNLVGKG 321

Query: 298 GFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE 357
           GFG VYKG L DG ++AVKRLK+    GGE+QFQTE+++IS+AVHRNLLRLYGFCTT +E
Sbjct: 322 GFGNVYKGCLHDGSIIAVKRLKDINNGGGEVQFQTELEMISLAVHRNLLRLYGFCTTSSE 381

Query: 358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVK 417
           +LLVYPYM+NGSVASRL+ +    P LDW TRK+IALG+ RGL YLHE CDPKIIHRDVK
Sbjct: 382 RLLVYPYMSNGSVASRLKAK----PVLDWGTRKRIALGAGRGLLYLHEQCDPKIIHRDVK 437

Query: 418 AANILLDE 425
           AANILLD+
Sbjct: 438 AANILLDD 445

Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1

 Score =  338 bits (866), Expect = 6e-92,   Method: Compositional matrix adjust.
 Identities = 185/361 (51%), Positives = 232/361 (64%), Gaps = 26/361 (7%)

Query: 83  LSGELAPELGQLKNLELLAL-------------GNLIKLKSLDLYSNLFNGTIPDTLANL 129
           LSG L+P +  L NL ++ L             G L +L++LDL  N F+G IP ++  L
Sbjct: 93  LSGTLSPSITNLTNLRIVLLQNNNIKGKIPAEIGRLTRLETLDLSDNFFHGEIPFSVGYL 152

Query: 130 KQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLN 189
           + L+YLRLNNNSLSG+ P SL+ +T L  LDLS N LSGPVP    F+  T  S   N  
Sbjct: 153 QSLQYLRLNNNSLSGVFPLSLSNMTQLAFLDLSYNNLSGPVP---RFAAKT-FSIVGNPL 208

Query: 190 LCGPNTKKPCSGSPPFSPPPPFGPTSSP----GRNKSNAAIPVGVALGAALLFAVPVIGF 245
           +C   T+  C+G+           T  P    G      AI VG ++G   L  + V  F
Sbjct: 209 ICPTGTEPDCNGTTLIPMSMNLNQTGVPLYAGGSRNHKMAIAVGSSVGTVSLIFIAVGLF 268

Query: 246 AYWRRTRPHEFFFDVP-AEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYK 304
            +WR+      FFDV       E+ LG L+RF  RELQ+AT+ FS+KN+LG+GG+G VYK
Sbjct: 269 LWWRQRHNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYK 328

Query: 305 GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY 364
           G L D  +VAVKRLK+    GGE+QFQTEV++IS+AVHRNLLRLYGFC T TEKLLVYPY
Sbjct: 329 GILGDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPY 388

Query: 365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 424
           M+NGSVASR++ +    P LDW  RK+IA+G+ARGL YLHE CDPKIIHRDVKAANILLD
Sbjct: 389 MSNGSVASRMKAK----PVLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLD 444

Query: 425 E 425
           +
Sbjct: 445 D 445

Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q0WVM4|Y2239_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g23950 OS=Arabidopsis thaliana GN=At2g23950 PE=2 SV=1

 Score =  316 bits (809), Expect = 3e-85,   Method: Compositional matrix adjust.
 Identities = 188/379 (49%), Positives = 245/379 (64%), Gaps = 36/379 (9%)

Query: 66  SSSNLFVYLISDLGNAALSGELAPELGQLKNLELLALGN-------------LIKLKSLD 112
           SS NL + L +   + +LSG L+  +G L NL  ++L N             L KL++LD
Sbjct: 71  SSDNLVIGLGAP--SQSLSGTLSGSIGNLTNLRQVSLQNNNISGKIPPEICSLPKLQTLD 128

Query: 113 LYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD 172
           L +N F+G IP ++  L  L+YLRLNNNSLSG  P SL+ I  L+ LDLS N L GPVP 
Sbjct: 129 LSNNRFSGEIPGSVNQLSNLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLRGPVP- 187

Query: 173 NGSFSQFTPISFE--NNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGV 230
                +F   +F    N  +C  +  + CSGS   SP       SS GR  +  A+ +GV
Sbjct: 188 -----KFPARTFNVAGNPLICKNSLPEICSGSISASPLS-VSLRSSSGRRTNILAVALGV 241

Query: 231 ALGAALLFAVPVI---GFAYWRRTRPHEFFFDVP-AEDDSELQLGQLKRFSLRELQVATD 286
           +LG    FAV VI   GF ++R+ +       +   +++  L LG L+ F+ REL VATD
Sbjct: 242 SLG----FAVSVILSLGFIWYRKKQRRLTMLRISDKQEEGLLGLGNLRSFTFRELHVATD 297

Query: 287 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           GFS+K+ILG GGFG VY+G+  DG +VAVKRLK+   + G  QF+TE+++IS+AVHRNLL
Sbjct: 298 GFSSKSILGAGGFGNVYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTELEMISLAVHRNLL 357

Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
           RL G+C + +E+LLVYPYM+NGSVASRL+ +    P LDW TRKKIA+G+ARGL YLHE 
Sbjct: 358 RLIGYCASSSERLLVYPYMSNGSVASRLKAK----PALDWNTRKKIAIGAARGLFYLHEQ 413

Query: 407 CDPKIIHRDVKAANILLDE 425
           CDPKIIHRDVKAANILLDE
Sbjct: 414 CDPKIIHRDVKAANILLDE 432

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1

 Score =  304 bits (779), Expect = 8e-82,   Method: Compositional matrix adjust.
 Identities = 188/364 (51%), Positives = 231/364 (63%), Gaps = 18/364 (4%)

Query: 77  DLGNAALSGELAPELGQLKNLELLAL-------------GNLIKLKSLDLYSNLFNGTIP 123
           DL + +LSG L+P +G L  L+ + L             G L KL+SLDL +N F G IP
Sbjct: 80  DLPSQSLSGTLSPRIGNLTYLQSVVLQNNAITGPIPETIGRLEKLQSLDLSNNSFTGEIP 139

Query: 124 DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 183
            +L  LK L YLRLNNNSL G  P SL+ I  L ++D+S N LSG +P   S   F  I 
Sbjct: 140 ASLGELKNLNYLRLNNNSLIGTCPESLSKIEGLTLVDISYNNLSGSLP-KVSARTFKVIG 198

Query: 184 FENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVI 243
              N  +CGP     CS  P     P  GP  S  R   +       A  +A  F     
Sbjct: 199 ---NALICGPKAVSNCSAVPEPLTLPQDGPDESGTRTNGHHVALAFAASFSAAFFVFFTS 255

Query: 244 G-FAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKV 302
           G F +WR  R  + FFDV  + D E+ LG LKR++ +EL+ AT+ F++KNILGRGG+G V
Sbjct: 256 GMFLWWRYRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNSKNILGRGGYGIV 315

Query: 303 YKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY 362
           YKG L DG LVAVKRLK+   +GGE+QFQTEV+ IS+A+HRNLLRL GFC++  E++LVY
Sbjct: 316 YKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSNQERILVY 375

Query: 363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL 422
           PYM NGSVASRL++     P LDW  RKKIA+G+ARGL YLHE CDPKIIHRDVKAANIL
Sbjct: 376 PYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANIL 435

Query: 423 LDED 426
           LDED
Sbjct: 436 LDED 439

Involved in defense response to geminivirus infection.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VYT3|Y4052_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g30520 OS=Arabidopsis thaliana GN=At4g30520 PE=2 SV=1

 Score =  300 bits (767), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 176/360 (48%), Positives = 235/360 (65%), Gaps = 27/360 (7%)

Query: 82  ALSGELAPELGQLKNLELLALGN-------------LIKLKSLDLYSNLFNGTIPDTLAN 128
           +LSG L+  +G L NL  ++L N             L KL++LDL +N F+G IP ++  
Sbjct: 88  SLSGGLSESIGNLTNLRQVSLQNNNISGKIPPELGFLPKLQTLDLSNNRFSGDIPVSIDQ 147

Query: 129 LKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFE--N 186
           L  L+YLRLNNNSLSG  P SL+ I  L+ LDLS N LSGPVP      +F   +F    
Sbjct: 148 LSSLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLSGPVP------KFPARTFNVAG 201

Query: 187 NLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVIGFA 246
           N  +C  N  + CSGS   + P     +SS GR  +  AI + V+LG+ ++  + +  F 
Sbjct: 202 NPLICRSNPPEICSGSIN-ASPLSVSLSSSSGRRSNRLAIALSVSLGSVVILVLALGSFC 260

Query: 247 YWRRTRPHEFFFDVPAEDDSELQ-LGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKG 305
           ++R+ +      ++  + +  LQ LG L+ F+ REL V TDGFS+KNILG GGFG VY+G
Sbjct: 261 WYRKKQRRLLILNLNDKQEEGLQGLGNLRSFTFRELHVYTDGFSSKNILGAGGFGNVYRG 320

Query: 306 RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM 365
           +L DG +VAVKRLK+   + G+ QF+ E+++IS+AVH+NLLRL G+C T  E+LLVYPYM
Sbjct: 321 KLGDGTMVAVKRLKDINGTSGDSQFRMELEMISLAVHKNLLRLIGYCATSGERLLVYPYM 380

Query: 366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 425
            NGSVAS+L+ +    P LDW  RK+IA+G+ARGL YLHE CDPKIIHRDVKAANILLDE
Sbjct: 381 PNGSVASKLKSK----PALDWNMRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANILLDE 436

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	438
115475023	624	Os08g0174700 [Oryza sativa Japonica Grou	0.799	0.560	0.743	1e-136
218200553	624	hypothetical protein OsI_28003 [Oryza sa	0.799	0.560	0.743	1e-136
357139703	615	PREDICTED: somatic embryogenesis recepto	0.799	0.569	0.746	1e-135
418204460	624	somatic embryogenesis receptor-like kina	0.799	0.560	0.756	1e-134
38679443	624	benzothiadiazole-induced somatic embryog	0.799	0.560	0.737	1e-134
242065530	626	hypothetical protein SORBIDRAFT_04g02381	0.796	0.557	0.732	1e-133
449462838	626	PREDICTED: somatic embryogenesis recepto	0.799	0.559	0.713	1e-133
219886135	626	unknown [Zea mays] gi|413937424|gb|AFW71	0.796	0.557	0.730	1e-133
162463139	626	somatic embryogenesis receptor-like kina	0.796	0.557	0.730	1e-133
326497495	622	predicted protein [Hordeum vulgare subsp	0.799	0.562	0.732	1e-133

>gi|115475023|ref|NP_001061108.1| Os08g0174700 [Oryza sativa Japonica Group] gi|40253600|dbj|BAD05545.1| putative somatic embryogenesis receptor kinase 1 [Oryza sativa Japonica Group] gi|57753893|dbj|BAD86793.1| SERK-family receptor-like protein kinase [Oryza sativa Japonica Group] gi|113623077|dbj|BAF23022.1| Os08g0174700 [Oryza sativa Japonica Group] gi|215736920|dbj|BAG95849.1| unnamed protein product [Oryza sativa Japonica Group] gi|222639998|gb|EEE68130.1| hypothetical protein OsJ_26221 [Oryza sativa Japonica Group]

 Score =  490 bits (1262), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 272/366 (74%), Positives = 296/366 (80%), Gaps = 16/366 (4%)

Query: 77  DLGNAALSGELAPELGQLKNLELLAL-------------GNLIKLKSLDLYSNLFNGTIP 123
           DLGNAALSG L P+LGQLKNL+ L L             GNL  L SLDLY N F G IP
Sbjct: 74  DLGNAALSGTLVPQLGQLKNLQYLELYSNNISGTIPSELGNLTNLVSLDLYLNNFTGPIP 133

Query: 124 DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 183
           D+L NL +L++LRLNNNSLSG IP SLT IT+L +LDLSNN LSG VP  GSFS FTPIS
Sbjct: 134 DSLGNLLKLRFLRLNNNSLSGSIPKSLTAITALQVLDLSNNNLSGEVPSTGSFSLFTPIS 193

Query: 184 FENNLNLCGPNTKKPCSGSPPFSPPPPFGP---TSSPGRNKSNAAIPVGVALGAALLFAV 240
           F NN +LCGP T KPC G+PPFSPPPP+ P     SPG + S  AI  GVA GAALLFA+
Sbjct: 194 FANNPSLCGPGTTKPCPGAPPFSPPPPYNPPTPVQSPGSSSSTGAIAGGVAAGAALLFAI 253

Query: 241 PVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFG 300
           P IGFA++RR +P E FFDVPAE+D E+ LGQLKRFSLRELQVATD FSNKNILGRGGFG
Sbjct: 254 PAIGFAWYRRRKPQEHFFDVPAEEDPEVHLGQLKRFSLRELQVATDTFSNKNILGRGGFG 313

Query: 301 KVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL 360
           KVYKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LL
Sbjct: 314 KVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 373

Query: 361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN 420
           VYPYM NGSVASRLRER  S PPLDW TR++IALGSARGLSYLH+HCDPKIIHRDVKAAN
Sbjct: 374 VYPYMANGSVASRLRERPPSEPPLDWRTRRRIALGSARGLSYLHDHCDPKIIHRDVKAAN 433

Query: 421 ILLDED 426
           ILLDED
Sbjct: 434 ILLDED 439

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|218200553|gb|EEC82980.1| hypothetical protein OsI_28003 [Oryza sativa Indica Group]

 Score =  490 bits (1261), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 272/366 (74%), Positives = 296/366 (80%), Gaps = 16/366 (4%)

Query: 77  DLGNAALSGELAPELGQLKNLELLAL-------------GNLIKLKSLDLYSNLFNGTIP 123
           DLGNAALSG L P+LGQLKNL+ L L             GNL  L SLDLY N F G IP
Sbjct: 74  DLGNAALSGTLVPQLGQLKNLQYLELYSNNISGTIPSELGNLTNLVSLDLYLNNFTGPIP 133

Query: 124 DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 183
           D+L NL +L++LRLNNNSLSG IP SLT IT+L +LDLSNN LSG VP  GSFS FTPIS
Sbjct: 134 DSLGNLLKLRFLRLNNNSLSGSIPKSLTAITALQVLDLSNNNLSGEVPSTGSFSLFTPIS 193

Query: 184 FENNLNLCGPNTKKPCSGSPPFSPPPPFGP---TSSPGRNKSNAAIPVGVALGAALLFAV 240
           F NN +LCGP T KPC G+PPFSPPPP+ P     SPG + S  AI  GVA GAALLFA+
Sbjct: 194 FANNPSLCGPGTTKPCPGAPPFSPPPPYNPPTPVQSPGSSSSTGAIAGGVAAGAALLFAI 253

Query: 241 PVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFG 300
           P IGFA++RR +P E FFDVPAE+D E+ LGQLKRFSLRELQVATD FSNKNILGRGGFG
Sbjct: 254 PAIGFAWYRRRKPQEHFFDVPAEEDPEVHLGQLKRFSLRELQVATDTFSNKNILGRGGFG 313

Query: 301 KVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL 360
           KVYKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LL
Sbjct: 314 KVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 373

Query: 361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN 420
           VYPYM NGSVASRLRER  S PPLDW TR++IALGSARGLSYLH+HCDPKIIHRDVKAAN
Sbjct: 374 VYPYMANGSVASRLRERPPSEPPLDWRTRRRIALGSARGLSYLHDHCDPKIIHRDVKAAN 433

Query: 421 ILLDED 426
           ILLDED
Sbjct: 434 ILLDED 439

Source: Oryza sativa Indica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357139703|ref|XP_003571417.1| PREDICTED: somatic embryogenesis receptor kinase 1-like, partial [Brachypodium distachyon]

 Score =  487 bits (1254), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 274/367 (74%), Positives = 295/367 (80%), Gaps = 17/367 (4%)

Query: 77  DLGNAALSGELAPELGQLKNLELLAL-------------GNLIKLKSLDLYSNLFNGTIP 123
           DLGNAALSG L P+LGQLKNL+ L L             GNL  L SLDLY N F G IP
Sbjct: 64  DLGNAALSGTLVPQLGQLKNLQYLELYSNNISGTIPSELGNLTNLVSLDLYLNNFTGPIP 123

Query: 124 DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 183
           D+L NL +L++LRLNNNSLSG IP SLT IT+L +LDLSNN+LSG VP  GSFS FTPIS
Sbjct: 124 DSLGNLLKLRFLRLNNNSLSGTIPKSLTAITALQVLDLSNNKLSGEVPSTGSFSSFTPIS 183

Query: 184 FENNLNLCGPNTKKPCSGSPPFSPPPPFGP---TSSPGRNKS-NAAIPVGVALGAALLFA 239
           F NN  LCGP T KPC G+PPFSPPPP+ P     SPG + S   AI  GVA GAALLFA
Sbjct: 184 FGNNPALCGPGTSKPCPGAPPFSPPPPYNPPTPVQSPGSSSSSTGAIAGGVAAGAALLFA 243

Query: 240 VPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGF 299
           VP IGFAYWRR +P E FFDVPAE+D E+ LGQLKRFSLRELQVATD FSNKNILGRGGF
Sbjct: 244 VPAIGFAYWRRRKPEEHFFDVPAEEDPEVHLGQLKRFSLRELQVATDTFSNKNILGRGGF 303

Query: 300 GKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL 359
           GKVYKGRL DG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+L
Sbjct: 304 GKVYKGRLTDGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 363

Query: 360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAA 419
           LVYPYM NGSVASRLRER  S PPLDW TR++IALGSARGLSYLH+HCDPKIIHRDVKAA
Sbjct: 364 LVYPYMANGSVASRLRERGPSEPPLDWQTRRRIALGSARGLSYLHDHCDPKIIHRDVKAA 423

Query: 420 NILLDED 426
           NILLDED
Sbjct: 424 NILLDED 430

Source: Brachypodium distachyon

Species: Brachypodium distachyon

Genus: Brachypodium

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|418204460|gb|AFX61784.1| somatic embryogenesis receptor-like kinase [Camellia nitidissima]

 Score =  486 bits (1250), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 277/366 (75%), Positives = 297/366 (81%), Gaps = 16/366 (4%)

Query: 77  DLGNAALSGELAPELGQLKNLELLAL-------------GNLIKLKSLDLYSNLFNGTIP 123
           DLGNAALSG+L P+LGQLKNL+ L L             GNL  L SLDLY N F G IP
Sbjct: 74  DLGNAALSGQLVPQLGQLKNLQYLELYSNNMSGPIPSDLGNLTNLVSLDLYLNGFTGPIP 133

Query: 124 DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 183
           DTL  L +L++ RLNNNSLSG IP SL  IT+L +LDLSNNRLSGPVPDNGSFS FTPIS
Sbjct: 134 DTLGKLTKLRFFRLNNNSLSGSIPMSLINITALQVLDLSNNRLSGPVPDNGSFSLFTPIS 193

Query: 184 FENNLNLCGPNTKKPCSGSPPFSPPPPFGPT---SSPGRNKSNAAIPVGVALGAALLFAV 240
           F NN NLCGP T KPC GSPPF+PPPPF P    SSP  N +  AI  GVA GAALLFA 
Sbjct: 194 FANNFNLCGPVTGKPCPGSPPFAPPPPFVPPSTISSPSGNSATGAIAGGVAAGAALLFAA 253

Query: 241 PVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFG 300
           P IGFA+WRR +PHE FFDVPAE+D E+ LGQLKRFSLRELQVATD FSNKNILGRGGFG
Sbjct: 254 PAIGFAWWRRRKPHEHFFDVPAEEDPEVHLGQLKRFSLRELQVATDTFSNKNILGRGGFG 313

Query: 301 KVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL 360
           KVYKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LL
Sbjct: 314 KVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 373

Query: 361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN 420
           VYPYM NGSVAS LRER  S  PLDWPTRK+IALGSARGLSYLH+HCDPKIIHRDVKAAN
Sbjct: 374 VYPYMANGSVASCLRERPPSEQPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAAN 433

Query: 421 ILLDED 426
           ILLDE+
Sbjct: 434 ILLDEE 439

Source: Camellia nitidissima

Species: Camellia nitidissima

Genus: Camellia

Family: Theaceae

Order: Ericales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|38679443|gb|AAR26543.1| benzothiadiazole-induced somatic embryogenesis receptor kinase 1 [Oryza sativa Indica Group]

 Score =  484 bits (1246), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 270/366 (73%), Positives = 294/366 (80%), Gaps = 16/366 (4%)

Query: 77  DLGNAALSGELAPELGQLKNLELLAL-------------GNLIKLKSLDLYSNLFNGTIP 123
           DLGNAALSG L P+LGQLKNL+ L L             GNL  L SLDLY N F G IP
Sbjct: 74  DLGNAALSGTLVPQLGQLKNLQYLELYSNNISGTIPSELGNLTNLVSLDLYLNNFTGPIP 133

Query: 124 DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 183
           D+L NL +L++LRLNNNSLSG IP SLT IT+L +LDLSNN LSG VP    FS FTPIS
Sbjct: 134 DSLGNLLKLRFLRLNNNSLSGSIPKSLTAITALQVLDLSNNNLSGEVPYKHGFSLFTPIS 193

Query: 184 FENNLNLCGPNTKKPCSGSPPFSPPPPFGP---TSSPGRNKSNAAIPVGVALGAALLFAV 240
           F NN +LCGP T KPC G+PPFSPPPP+ P     SPG + S  AI  GVA GAALLFA+
Sbjct: 194 FANNPSLCGPGTTKPCPGAPPFSPPPPYNPPTPVQSPGSSSSTGAIAGGVAAGAALLFAI 253

Query: 241 PVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFG 300
           P IGFA++RR +P E FFDVPAE+D E+ LGQLKRFSLRELQVATD FSNKNILGRGGFG
Sbjct: 254 PAIGFAWYRRRKPQEHFFDVPAEEDPEVHLGQLKRFSLRELQVATDTFSNKNILGRGGFG 313

Query: 301 KVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL 360
           KVYKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LL
Sbjct: 314 KVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 373

Query: 361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN 420
           VYPYM NGSVASRLRER  S PPLDW TR++IALGSARGLSYLH+HCDPKIIHRDVKAAN
Sbjct: 374 VYPYMANGSVASRLRERPPSEPPLDWRTRRRIALGSARGLSYLHDHCDPKIIHRDVKAAN 433

Query: 421 ILLDED 426
           ILLDED
Sbjct: 434 ILLDED 439

Source: Oryza sativa Indica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|242065530|ref|XP_002454054.1| hypothetical protein SORBIDRAFT_04g023810 [Sorghum bicolor] gi|241933885|gb|EES07030.1| hypothetical protein SORBIDRAFT_04g023810 [Sorghum bicolor]

 Score =  482 bits (1241), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 269/367 (73%), Positives = 293/367 (79%), Gaps = 18/367 (4%)

Query: 77  DLGNAALSGELAPELGQLKNLELLAL-------------GNLIKLKSLDLYSNLFNGTIP 123
           DLGNA LSG L P+LGQLKNL+ L L             GNL  L SLDLY N F+G+IP
Sbjct: 77  DLGNAQLSGVLVPQLGQLKNLQYLELYSNNISGTIPPELGNLTNLVSLDLYMNNFSGSIP 136

Query: 124 DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 183
           D+L NL +L++LRLNNNSL G IP SLT I++L +LDLSNN LSG VP  GSFS FTPIS
Sbjct: 137 DSLGNLLKLRFLRLNNNSLVGQIPVSLTNISTLQVLDLSNNNLSGQVPSTGSFSLFTPIS 196

Query: 184 FENNLNLCGPNTKKPCSGSPPFSPPPPFGP----TSSPGRNKSNAAIPVGVALGAALLFA 239
           F NN  LCGP T KPC G+PPFSPPPPF P    T S G + S  AI  GVA GAAL+FA
Sbjct: 197 FANNPGLCGPGTTKPCPGAPPFSPPPPFNPPSPPTQSTGAS-STGAIAGGVAAGAALVFA 255

Query: 240 VPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGF 299
           VP I FA WRR +P E FFDVPAE+D E+ LGQLK+FSLRELQVATD FSNKNILGRGGF
Sbjct: 256 VPAIAFAMWRRRKPEEHFFDVPAEEDPEVHLGQLKKFSLRELQVATDNFSNKNILGRGGF 315

Query: 300 GKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL 359
           GKVYKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+L
Sbjct: 316 GKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 375

Query: 360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAA 419
           LVYPYM NGSVASRLRERQ S PPL W TR++IALGSARGLSYLH+HCDPKIIHRDVKAA
Sbjct: 376 LVYPYMANGSVASRLRERQQSEPPLKWETRRRIALGSARGLSYLHDHCDPKIIHRDVKAA 435

Query: 420 NILLDED 426
           NILLDED
Sbjct: 436 NILLDED 442

Source: Sorghum bicolor

Species: Sorghum bicolor

Genus: Sorghum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449462838|ref|XP_004149147.1| PREDICTED: somatic embryogenesis receptor kinase 2-like [Cucumis sativus] gi|449521625|ref|XP_004167830.1| PREDICTED: somatic embryogenesis receptor kinase 2-like [Cucumis sativus]

 Score =  482 bits (1241), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 261/366 (71%), Positives = 286/366 (78%), Gaps = 16/366 (4%)

Query: 77  DLGNAALSGELAPELGQLKNLELLAL-------------GNLIKLKSLDLYSNLFNGTIP 123
           DLGNA LSG+L P+LGQLK+L+ L L             GNL  L SLDLY N   G IP
Sbjct: 76  DLGNAGLSGKLVPQLGQLKSLQYLELYGNNISGEIPDDLGNLENLVSLDLYLNGLTGPIP 135

Query: 124 DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 183
           DT   L QL++LRLN+N LSGLIP SL  I++L +LDLSNN LSG VP+NGSFS FTPIS
Sbjct: 136 DTFGKLTQLRFLRLNDNKLSGLIPISLINISTLQVLDLSNNLLSGKVPNNGSFSLFTPIS 195

Query: 184 FENNLNLCGPNTKKPCSGSPPFSPPPPF---GPTSSPGRNKSNAAIPVGVALGAALLFAV 240
           F NNL+LCG  T KPC G PPFSPPPPF      SS   N  N AI  GVA GAALLFA 
Sbjct: 196 FANNLDLCGLVTGKPCPGDPPFSPPPPFVPQSTVSSHELNNPNGAIVGGVAAGAALLFAT 255

Query: 241 PVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFG 300
           P I F YW R +  E FFDVPAE+DSE+ LGQLKRFSLR+LQVATD F NKNILGRGGFG
Sbjct: 256 PAIIFVYWHRRKSREIFFDVPAEEDSEINLGQLKRFSLRDLQVATDNFCNKNILGRGGFG 315

Query: 301 KVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL 360
           KVY+GRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL+GFCTT +E+LL
Sbjct: 316 KVYRGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLHGFCTTSSERLL 375

Query: 361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN 420
           VYPYM NGSVAS LRER  S  PLDWPTRKK+ALGSARGLSYLH+ CDPKIIHRDVKAAN
Sbjct: 376 VYPYMANGSVASCLRERPQSEAPLDWPTRKKVALGSARGLSYLHDGCDPKIIHRDVKAAN 435

Query: 421 ILLDED 426
           ILLDE+
Sbjct: 436 ILLDEE 441

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|219886135|gb|ACL53442.1| unknown [Zea mays] gi|413937424|gb|AFW71975.1| putative leucine-rich repeat receptor-like protein kinase family protein [Zea mays]

 Score =  480 bits (1236), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 268/367 (73%), Positives = 292/367 (79%), Gaps = 18/367 (4%)

Query: 77  DLGNAALSGELAPELGQLKNLELLAL-------------GNLIKLKSLDLYSNLFNGTIP 123
           DLGNA LSG L P+LGQLKNL+ L L             GNL  L SLDLY N F+G IP
Sbjct: 77  DLGNAQLSGVLVPQLGQLKNLQYLELYSNNISGTIPPELGNLTNLVSLDLYMNNFSGNIP 136

Query: 124 DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 183
           D+L NL +L++LRLNNNSL G IP SLT I++L +LDLSNN LSG VP  GSFS FTPIS
Sbjct: 137 DSLGNLVKLRFLRLNNNSLVGPIPVSLTNISTLQVLDLSNNNLSGQVPSTGSFSLFTPIS 196

Query: 184 FENNLNLCGPNTKKPCSGSPPFSPPPPFGP----TSSPGRNKSNAAIPVGVALGAALLFA 239
           F NN NLCGP T KPC G+PPFSPPPPF P    T S G + S  AI  GVA GAAL+FA
Sbjct: 197 FANNPNLCGPGTSKPCPGAPPFSPPPPFNPPSPPTQSTGAS-STGAIAGGVAAGAALVFA 255

Query: 240 VPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGF 299
           VP I FA WRR +P E FFDVPAE+D E+ LGQLK+FSLRELQVATD FSNKNILGRGGF
Sbjct: 256 VPAIAFAMWRRRKPEEHFFDVPAEEDPEVHLGQLKKFSLRELQVATDNFSNKNILGRGGF 315

Query: 300 GKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL 359
           GKVYKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVH+NLLRL GFC T TE+L
Sbjct: 316 GKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHKNLLRLRGFCMTPTERL 375

Query: 360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAA 419
           LVYPYM NGSVASRLRERQ S PPL W  R++IALGSARGLSYLH+HCDPKIIHRDVKAA
Sbjct: 376 LVYPYMANGSVASRLRERQPSEPPLSWEPRRRIALGSARGLSYLHDHCDPKIIHRDVKAA 435

Query: 420 NILLDED 426
           NILLDED
Sbjct: 436 NILLDED 442

Source: Zea mays

Species: Zea mays

Genus: Zea

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|162463139|ref|NP_001105133.1| somatic embryogenesis receptor-like kinase2 precursor [Zea mays] gi|13897310|emb|CAC37639.1| SERK2 protein [Zea mays]

 Score =  480 bits (1236), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 268/367 (73%), Positives = 292/367 (79%), Gaps = 18/367 (4%)

Query: 77  DLGNAALSGELAPELGQLKNLELLAL-------------GNLIKLKSLDLYSNLFNGTIP 123
           DLGNA LSG L P+LGQLKNL+ L L             GNL  L SLDLY N F+G IP
Sbjct: 77  DLGNAQLSGVLVPQLGQLKNLQYLELYSNNISGTIPPELGNLTNLVSLDLYMNNFSGNIP 136

Query: 124 DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 183
           D+L NL +L++LRLNNNSL G IP SLT I++L +LDLSNN LSG VP  GSFS FTPIS
Sbjct: 137 DSLGNLVKLRFLRLNNNSLVGPIPVSLTNISTLQVLDLSNNNLSGQVPSTGSFSLFTPIS 196

Query: 184 FENNLNLCGPNTKKPCSGSPPFSPPPPFGP----TSSPGRNKSNAAIPVGVALGAALLFA 239
           F NN NLCGP T KPC G+PPFSPPPPF P    T S G + S  AI  GVA GAAL+FA
Sbjct: 197 FANNPNLCGPGTSKPCPGAPPFSPPPPFNPPSPPTQSTGAS-STGAIAGGVAAGAALVFA 255

Query: 240 VPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGF 299
           VP I FA WRR +P E FFDVPAE+D E+ LGQLK+FSLRELQVATD FSNKNILGRGGF
Sbjct: 256 VPAIAFAMWRRRKPEEHFFDVPAEEDPEVHLGQLKKFSLRELQVATDNFSNKNILGRGGF 315

Query: 300 GKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL 359
           GKVYKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVH+NLLRL GFC T TE+L
Sbjct: 316 GKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHKNLLRLRGFCMTPTERL 375

Query: 360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAA 419
           LVYPYM NGSVASRLRERQ S PPL W  R++IALGSARGLSYLH+HCDPKIIHRDVKAA
Sbjct: 376 LVYPYMANGSVASRLRERQPSEPPLSWEPRRRIALGSARGLSYLHDHCDPKIIHRDVKAA 435

Query: 420 NILLDED 426
           NILLDED
Sbjct: 436 NILLDED 442

Source: Zea mays

Species: Zea mays

Genus: Zea

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|326497495|dbj|BAK05837.1| predicted protein [Hordeum vulgare subsp. vulgare] gi|332330747|gb|AEE44134.1| BRI1-associated kinase 1 [Hordeum vulgare subsp. vulgare]

 Score =  480 bits (1236), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 269/367 (73%), Positives = 294/367 (80%), Gaps = 17/367 (4%)

Query: 77  DLGNAALSGELAPELGQLKNLELLAL-------------GNLIKLKSLDLYSNLFNGTIP 123
           DLGNAAL G L P+LGQL+NL+ L L             GNL  L SLDLY N F G IP
Sbjct: 71  DLGNAALFGTLVPQLGQLRNLQYLELYSNNISGTIPSELGNLTNLVSLDLYLNNFTGPIP 130

Query: 124 DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 183
           D+L NL +L++LRLNNNSLSG IP SLT IT+L +LDLSNN+LSG VP  GSFS FTPIS
Sbjct: 131 DSLGNLLKLRFLRLNNNSLSGTIPKSLTAITALQVLDLSNNKLSGEVPSTGSFSLFTPIS 190

Query: 184 FENNLNLCGPNTKKPCSGSPPFSPPPPFGPT---SSPGRNKS-NAAIPVGVALGAALLFA 239
           F NN  LCGP T KPC G+PPFSPPPP+ P     SPG + S   AI  GVA GAALLFA
Sbjct: 191 FGNNPALCGPGTSKPCPGAPPFSPPPPYNPPTPEQSPGSSSSSTGAIAGGVAAGAALLFA 250

Query: 240 VPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGF 299
           +P IGFAYWRR +P E FFDVPAE+D E+ LGQLKRFSLRELQVATD FSN+NILGRGGF
Sbjct: 251 IPAIGFAYWRRRKPQEHFFDVPAEEDPEVHLGQLKRFSLRELQVATDTFSNRNILGRGGF 310

Query: 300 GKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL 359
           GKVYKGRL DG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+L
Sbjct: 311 GKVYKGRLTDGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 370

Query: 360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAA 419
           LVYPYM NGSVASRLRER  + PPLDW TR++IALGSARGLSYLH+HCDPKIIHRDVKAA
Sbjct: 371 LVYPYMANGSVASRLRERGPAEPPLDWQTRRRIALGSARGLSYLHDHCDPKIIHRDVKAA 430

Query: 420 NILLDED 426
           NILLDED
Sbjct: 431 NILLDED 437

Source: Hordeum vulgare subsp. vulgare

Species: Hordeum vulgare

Genus: Hordeum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	438
TAIR|locus:2013021	625	SERK1 "somatic embryogenesis r	0.420	0.294	0.847	4.6e-103
TAIR|locus:2026097	628	SERK2 "somatic embryogenesis r	0.420	0.292	0.826	1.1e-99
TAIR|locus:2040461	620	SERK4 "somatic embryogenesis r	0.420	0.296	0.798	1.9e-91
TAIR|locus:2040471	601	SERK5 "somatic embryogenesis r	0.413	0.301	0.734	3.6e-80
TAIR|locus:2036636	632	NIK3 "NSP-interacting kinase 3	0.710	0.492	0.477	5.6e-68
TAIR|locus:2146102	638	NIK1 "NSP-interacting kinase 1	0.698	0.479	0.463	3.6e-66
TAIR|locus:2145407	613	AT5G10290 [Arabidopsis thalian	0.392	0.280	0.668	6.1e-66
TAIR|locus:2160644	614	AT5G63710 [Arabidopsis thalian	0.404	0.288	0.629	3.7e-64
TAIR|locus:2061466	634	AT2G23950 [Arabidopsis thalian	0.694	0.479	0.441	3.4e-61
TAIR|locus:2118811	648	SARK "SENESCENCE-ASSOCIATED RE	0.694	0.469	0.439	1.9e-60

TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 813 (291.2 bits), Expect = 4.6e-103, Sum P(2) = 4.6e-103
 Identities = 156/184 (84%), Positives = 168/184 (91%)

Query:   243 IGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKV 302
             I FA+WRR +P + FFDVPAE+D E+ LGQLKRFSLRELQVA+DGFSNKNILGRGGFGKV
Sbjct:   257 IAFAWWRRRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKV 316

Query:   303 YKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY 362
             YKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVY
Sbjct:   317 YKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 376

Query:   363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL 422
             PYM NGSVAS LRER  S PPLDWPTRK+IALGSARGLSYLH+HCDPKIIHRDVKAANIL
Sbjct:   377 PYMANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANIL 436

Query:   423 LDED 426
             LDE+
Sbjct:   437 LDEE 440

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0042802 "identical protein binding" evidence=IPI

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=IDA

GO:0009793 "embryo development ending in seed dormancy" evidence=RCA;IMP

GO:0005515 "protein binding" evidence=IPI

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=TAS

GO:0009556 "microsporogenesis" evidence=IGI;IMP

GO:0010152 "pollen maturation" evidence=IMP

GO:0043234 "protein complex" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI;IMP

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0007030 "Golgi organization" evidence=IGI

GO:0010227 "floral organ abscission" evidence=IGI

GO:0000226 "microtubule cytoskeleton organization" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0007062 "sister chromatid cohesion" evidence=RCA

GO:0009880 "embryonic pattern specification" evidence=RCA

GO:0010072 "primary shoot apical meristem specification" evidence=RCA

GO:0010228 "vegetative to reproductive phase transition of meristem" evidence=RCA

GO:0010431 "seed maturation" evidence=RCA

GO:0016310 "phosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0045595 "regulation of cell differentiation" evidence=RCA

GO:0051301 "cell division" evidence=RCA

TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 784 (281.0 bits), Expect = 1.1e-99, Sum P(2) = 1.1e-99
 Identities = 152/184 (82%), Positives = 164/184 (89%)

Query:   243 IGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKV 302
             + FA+WRR +P EFFFDVPAE+D E+ LGQLKRFSLRELQVATD FSNKNILGRGGFGKV
Sbjct:   260 LAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKV 319

Query:   303 YKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY 362
             YKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVY
Sbjct:   320 YKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 379

Query:   363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL 422
             PYM NGSVAS LRER  S  PL W  R++IALGSARGLSYLH+HCDPKIIHRDVKAANIL
Sbjct:   380 PYMANGSVASCLRERPPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANIL 439

Query:   423 LDED 426
             LDE+
Sbjct:   440 LDEE 443

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009556 "microsporogenesis" evidence=IGI;IMP

GO:0010152 "pollen maturation" evidence=IMP

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 765 (274.4 bits), Expect = 1.9e-91, Sum P(2) = 1.9e-91
 Identities = 147/184 (79%), Positives = 160/184 (86%)

Query:   243 IGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKV 302
             I FA+W R +P + FFDVPAE+D E+ LGQLKRF+LREL VATD FSNKN+LGRGGFGKV
Sbjct:   249 IAFAWWLRRKPQDHFFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKV 308

Query:   303 YKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY 362
             YKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVY
Sbjct:   309 YKGRLADGNLVAVKRLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 368

Query:   363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL 422
             PYM NGSVAS LRER    P LDWP RK IALGSARGL+YLH+HCD KIIHRDVKAANIL
Sbjct:   369 PYMANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANIL 428

Query:   423 LDED 426
             LDE+
Sbjct:   429 LDEE 432

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0060548 "negative regulation of cell death" evidence=IMP

GO:1900140 "regulation of seedling development" evidence=IMP

GO:0010200 "response to chitin" evidence=IEP;RCA

GO:0008219 "cell death" evidence=IGI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI

GO:0010150 "leaf senescence" evidence=IGI

GO:0000165 "MAPK cascade" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2040471 SERK5 "somatic embryogenesis receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 676 (243.0 bits), Expect = 3.6e-80, Sum P(2) = 3.6e-80
 Identities = 133/181 (73%), Positives = 148/181 (81%)

Query:   246 AYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKG 305
             A+W R +    F DVPAE+D E+ LGQ KRFSLREL VAT+ FS +N+LG+G FG +YKG
Sbjct:   233 AWWLRRKLQGHFLDVPAEEDPEVYLGQFKRFSLRELLVATEKFSKRNVLGKGRFGILYKG 292

Query:   306 RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM 365
             RLAD  LVAVKRL EERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM
Sbjct:   293 RLADDTLVAVKRLNEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 352

Query:   366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 425
              NGSVAS LRER    P LDWP RK IALGSARGL+YLH+HCD KIIH DVKAANILLDE
Sbjct:   353 ANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHLDVKAANILLDE 412

Query:   426 D 426
             +
Sbjct:   413 E 413

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 690 (248.0 bits), Expect = 5.6e-68, P = 5.6e-68
 Identities = 151/316 (47%), Positives = 182/316 (57%)

Query:   112 DLYSNLFNGTIPDTLANLKQLKYLRLNNNXXXXXXXXXXXXXXXXXXXXXXNNRLSGPVP 171
             DL +N F G IP +L  LK L YLRLNNN                       N LSG +P
Sbjct:   128 DLSNNSFTGEIPASLGELKNLNYLRLNNNSLIGTCPESLSKIEGLTLVDISYNNLSGSLP 187

Query:   172 DNGSFSQFTPISFENNLNLCGPNTKKXXXXXXXXXXXXXXXXXXXXXRNKSNXXXXXXXX 231
                S   F  I    N  +CGP                         R   +        
Sbjct:   188 -KVSARTFKVIG---NALICGPKAVSNCSAVPEPLTLPQDGPDESGTRTNGHHVALAFAA 243

Query:   232 XXXXXXXXXXXIG-FAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSN 290
                         G F +WR  R  + FFDV  + D E+ LG LKR++ +EL+ AT+ F++
Sbjct:   244 SFSAAFFVFFTSGMFLWWRYRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNS 303

Query:   291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 350
             KNILGRGG+G VYKG L DG LVAVKRLK+   +GGE+QFQTEV+ IS+A+HRNLLRL G
Sbjct:   304 KNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRG 363

Query:   351 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 410
             FC++  E++LVYPYM NGSVASRL++     P LDW  RKKIA+G+ARGL YLHE CDPK
Sbjct:   364 FCSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPK 423

Query:   411 IIHRDVKAANILLDED 426
             IIHRDVKAANILLDED
Sbjct:   424 IIHRDVKAANILLDED 439

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0048653 "anther development" evidence=RCA

TAIR|locus:2146102 NIK1 "NSP-interacting kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 673 (242.0 bits), Expect = 3.6e-66, P = 3.6e-66
 Identities = 148/319 (46%), Positives = 185/319 (57%)

Query:   112 DLYSNLFNGTIPDTLANLKQLKYLRLNNNXXXXXXXXXXXXXXXXXXXXXXNNRLSGPVP 171
             DL  N F+G IP ++  L+ L+YLRLNNN                       N LSGPVP
Sbjct:   135 DLSDNFFHGEIPFSVGYLQSLQYLRLNNNSLSGVFPLSLSNMTQLAFLDLSYNNLSGPVP 194

Query:   172 DNGSFSQFTPISFENNLNLCGPNTK---KXXXXXXXXXXXXXXXXXXXXXRNKSNXXXXX 228
                 F+  T  S   N  +C   T+                          ++++     
Sbjct:   195 ---RFAAKT-FSIVGNPLICPTGTEPDCNGTTLIPMSMNLNQTGVPLYAGGSRNHKMAIA 250

Query:   229 XXXXXXXXXXXXXXIG-FAYWRRTRPHEFFFDVP-AEDDSELQLGQLKRFSLRELQVATD 286
                           +G F +WR+      FFDV       E+ LG L+RF  RELQ+AT+
Sbjct:   251 VGSSVGTVSLIFIAVGLFLWWRQRHNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATN 310

Query:   287 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
              FS+KN+LG+GG+G VYKG L D  +VAVKRLK+    GGE+QFQTEV++IS+AVHRNLL
Sbjct:   311 NFSSKNLLGKGGYGNVYKGILGDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLL 370

Query:   347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
             RLYGFC T TEKLLVYPYM+NGSVASR++ +    P LDW  RK+IA+G+ARGL YLHE 
Sbjct:   371 RLYGFCITQTEKLLVYPYMSNGSVASRMKAK----PVLDWSIRKRIAIGAARGLVYLHEQ 426

Query:   407 CDPKIIHRDVKAANILLDE 425
             CDPKIIHRDVKAANILLD+
Sbjct:   427 CDPKIIHRDVKAANILLDD 445

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0051607 "defense response to virus" evidence=IMP

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0009736 "cytokinin mediated signaling pathway" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2145407 AT5G10290 [Arabidopsis thaliana (taxid:3702)]

 Score = 592 (213.5 bits), Expect = 6.1e-66, Sum P(2) = 6.1e-66
 Identities = 115/172 (66%), Positives = 136/172 (79%)

Query:   255 EFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVA 314
             + F DV  E D  +  GQLKRF+ RELQ+ATD FS KN+LG+GGFGKVYKG L D   VA
Sbjct:   257 DVFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVA 316

Query:   315 VKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL 374
             VKRL +  + GG+  FQ EV++IS+AVHRNLLRL GFCTT TE+LLVYP+M N S+A RL
Sbjct:   317 VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRL 376

Query:   375 RERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
             RE ++  P LDW TRK+IALG+ARG  YLHEHC+PKIIHRDVKAAN+LLDED
Sbjct:   377 REIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLLDED 428

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2160644 AT5G63710 [Arabidopsis thaliana (taxid:3702)]

 Score = 595 (214.5 bits), Expect = 3.7e-64, Sum P(2) = 3.7e-64
 Identities = 112/178 (62%), Positives = 142/178 (79%)

Query:   249 RRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLA 308
             RRT+ ++ FFDV  EDD ++  GQLKRFSLRE+Q+ATD F+  N++G+GGFGKVY+G L 
Sbjct:   251 RRTK-YDIFFDVAGEDDRKISFGQLKRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLP 309

Query:   309 DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG 368
             D   VAVKRL +  + GGE  FQ E+++IS+AVH+NLLRL GFCTT +E++LVYPYM N 
Sbjct:   310 DKTKVAVKRLADYFSPGGEAAFQREIQLISVAVHKNLLRLIGFCTTSSERILVYPYMENL 369

Query:   369 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
             SVA RLR+ ++    LDWPTRK++A GSA GL YLHEHC+PKIIHRD+KAANILLD +
Sbjct:   370 SVAYRLRDLKAGEEGLDWPTRKRVAFGSAHGLEYLHEHCNPKIIHRDLKAANILLDNN 427

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

TAIR|locus:2061466 AT2G23950 [Arabidopsis thaliana (taxid:3702)]

 Score = 626 (225.4 bits), Expect = 3.4e-61, P = 3.4e-61
 Identities = 139/315 (44%), Positives = 181/315 (57%)

Query:   112 DLYSNLFNGTIPDTLANLKQLKYLRLNNNXXXXXXXXXXXXXXXXXXXXXXNNRLSGPVP 171
             DL +N F+G IP ++  L  L+YLRLNNN                       N L GPVP
Sbjct:   128 DLSNNRFSGEIPGSVNQLSNLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLRGPVP 187

Query:   172 DNGSFSQFTPISFENNLNLCGPNTKKXXXXXXXXXXXXXXXXXXXXXRNKSNXXXXXXXX 231
                 F   T  +   N  +C  N+                       R ++N        
Sbjct:   188 ---KFPART-FNVAGNPLIC-KNSLPEICSGSISASPLSVSLRSSSGR-RTNILAVALGV 241

Query:   232 XXXXXXXXXXXIGFAYWRRTRPHEFFFDVP-AEDDSELQLGQLKRFSLRELQVATDGFSN 290
                        +GF ++R+ +       +   +++  L LG L+ F+ REL VATDGFS+
Sbjct:   242 SLGFAVSVILSLGFIWYRKKQRRLTMLRISDKQEEGLLGLGNLRSFTFRELHVATDGFSS 301

Query:   291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 350
             K+ILG GGFG VY+G+  DG +VAVKRLK+   + G  QF+TE+++IS+AVHRNLLRL G
Sbjct:   302 KSILGAGGFGNVYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTELEMISLAVHRNLLRLIG 361

Query:   351 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 410
             +C + +E+LLVYPYM+NGSVASRL+ +    P LDW TRKKIA+G+ARGL YLHE CDPK
Sbjct:   362 YCASSSERLLVYPYMSNGSVASRLKAK----PALDWNTRKKIAIGAARGLFYLHEQCDPK 417

Query:   411 IIHRDVKAANILLDE 425
             IIHRDVKAANILLDE
Sbjct:   418 IIHRDVKAANILLDE 432

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2118811 SARK "SENESCENCE-ASSOCIATED RECEPTOR-LIKE KINASE" [Arabidopsis thaliana (taxid:3702)]

 Score = 619 (223.0 bits), Expect = 1.9e-60, P = 1.9e-60
 Identities = 139/316 (43%), Positives = 179/316 (56%)

Query:   112 DLYSNLFNGTIPDTLANLKQLKYLRLNNNXXXXXXXXXXXXXXXXXXXXXXNNRLSGPVP 171
             DL +N F+G IP ++  L  L+YLRLNNN                       N LSGPVP
Sbjct:   131 DLSNNRFSGDIPVSIDQLSSLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLSGPVP 190

Query:   172 DNGSFSQFTPISFENNLNLCGPNTKKXXXXXXXXXXXXXXXXXXXXXRNKSNXXXXXXXX 231
                 F   T  +   N  +C  N  +                     R  SN        
Sbjct:   191 ---KFPART-FNVAGNPLICRSNPPEICSGSINASPLSVSLSSSSGRR--SNRLAIALSV 244

Query:   232 XXXXXXXXXXXIG-FAYWRRTRPHEFFFDVPAEDDSELQ-LGQLKRFSLRELQVATDGFS 289
                        +G F ++R+ +      ++  + +  LQ LG L+ F+ REL V TDGFS
Sbjct:   245 SLGSVVILVLALGSFCWYRKKQRRLLILNLNDKQEEGLQGLGNLRSFTFRELHVYTDGFS 304

Query:   290 NKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
             +KNILG GGFG VY+G+L DG +VAVKRLK+   + G+ QF+ E+++IS+AVH+NLLRL 
Sbjct:   305 SKNILGAGGFGNVYRGKLGDGTMVAVKRLKDINGTSGDSQFRMELEMISLAVHKNLLRLI 364

Query:   350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
             G+C T  E+LLVYPYM NGSVAS+L+ +    P LDW  RK+IA+G+ARGL YLHE CDP
Sbjct:   365 GYCATSGERLLVYPYMPNGSVASKLKSK----PALDWNMRKRIAIGAARGLLYLHEQCDP 420

Query:   410 KIIHRDVKAANILLDE 425
             KIIHRDVKAANILLDE
Sbjct:   421 KIIHRDVKAANILLDE 436

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010150 "leaf senescence" evidence=IMP

GO:0007267 "cell-cell signaling" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0009616 "virus induced gene silencing" evidence=RCA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009887 "organ morphogenesis" evidence=RCA

GO:0009944 "polarity specification of adaxial/abaxial axis" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010051 "xylem and phloem pattern formation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010267 "production of ta-siRNAs involved in RNA interference" evidence=RCA

GO:0035196 "production of miRNAs involved in gene silencing by miRNA" evidence=RCA

GO:0048438 "floral whorl development" evidence=RCA

GO:0048439 "flower morphogenesis" evidence=RCA

GO:0048519 "negative regulation of biological process" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q94AG2	SERK1_ARATH	2, ., 7, ., 1, 1, ., 1	0.7349	0.7990	0.56	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.914
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	438
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-33
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	6e-33
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-32
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-30
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-30
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-30
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	9e-30
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-27
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-24
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-19
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-18
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-18
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-17
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-17
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-17
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-17
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	8e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	8e-17
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-16
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-16
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-16
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	9e-16
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-15
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-15
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-15
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-15
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-15
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	9e-15
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-14
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-14
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-14
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-14
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-14
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-14
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-14
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-14
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-14
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-13
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-13
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-13
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-13
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-13
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-13
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-13
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-13
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	9e-13
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-12
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-12
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-12
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-12
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-12
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-12
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-12
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-11
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-11
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-11
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-11
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-11
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-11
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-11
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-11
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-11
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	9e-11
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-10
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-10
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-10
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-10
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-10
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-10
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-10
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-10
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-10
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-10
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-10
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-10
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-10
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-10
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-10
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-09
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-09
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-09
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-09
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-09
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-09
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-09
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-09
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-09
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-09
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-09
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-09
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-09
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-09
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-09
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-09
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-09
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-09
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	8e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	8e-09
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	9e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-08
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-08
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-08
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-08
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-08
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-08
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-08
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-08
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-08
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	6e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-08
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-08
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-08
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	7e-08
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	9e-08
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	9e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-07
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-07
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-07
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-07
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-07
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-07
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-07
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-07
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-07
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-07
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-07
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-07
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-07
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-07
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-07
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-07
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	8e-07
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	8e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	9e-07
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-06
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-06
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-06
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-06
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-06
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-06
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-06
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	7e-06
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	8e-06
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	8e-06
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	9e-06
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-05
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-05
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-05
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-05
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-05
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-05
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-05
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-05
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-05
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-05
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-05
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-05
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-05
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-05
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	5e-05
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-05
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	8e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	8e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	9e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	9e-05
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	9e-05
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	9e-05
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-04
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-04
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-04
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-04
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-04
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-04
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-04
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-04
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-04
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-04
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-04
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-04
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-04
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-04
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-04
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.001
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.001
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	0.001
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	0.001
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	0.001
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	0.001
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	0.001
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	0.001
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	0.002
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	0.002
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	0.002
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	0.003
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	0.003
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	0.003
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	0.003
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	0.003
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	0.003
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.003
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	0.004
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.004

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  125 bits (316), Expect = 3e-33
 Identities = 49/143 (34%), Positives = 68/143 (47%), Gaps = 11/143 (7%)

Query: 289 SNKNILGRGGFGKVYKGRLADGK-----LVAVKRLKEERTSGGELQFQTEVKIISMAVHR 343
           +    LG G FG+VYKG+L          VAVK LKE+ +     +F  E +I+    H 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           N+++L G CT      +V  YM  G + S LR+ +  L           AL  ARG+ YL
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLS---LSDLLSFALQIARGMEYL 118

Query: 404 HEHCDPKIIHRDVKAANILLDED 426
                   IHRD+ A N L+ E+
Sbjct: 119 ESK---NFIHRDLAARNCLVGEN 138

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  123 bits (311), Expect = 6e-33
 Identities = 51/137 (37%), Positives = 69/137 (50%), Gaps = 7/137 (5%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 352
           LG GGFG VY  R    GK VA+K +K+E +S    +   E++I+    H N+++LYG  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 412
                  LV  Y   GS+   L+E +     L      +I L    GL YLH +    II
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHSN---GII 114

Query: 413 HRDVKAANILLDEDADQ 429
           HRD+K  NILLD D  +
Sbjct: 115 HRDLKPENILLDSDNGK 131

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  123 bits (312), Expect = 1e-32
 Identities = 48/143 (33%), Positives = 67/143 (46%), Gaps = 10/143 (6%)

Query: 289 SNKNILGRGGFGKVYKGRLADGK-----LVAVKRLKEERTSGGELQFQTEVKIISMAVHR 343
           +    LG G FG+VYKG L          VAVK LKE+ +     +F  E +I+    H 
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           N+++L G CT     ++V  YM  G +   LR+ +     L        AL  ARG+ YL
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYL 119

Query: 404 HEHCDPKIIHRDVKAANILLDED 426
                   IHRD+ A N L+ E+
Sbjct: 120 ESK---NFIHRDLAARNCLVGEN 139

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  118 bits (298), Expect = 1e-30
 Identities = 49/144 (34%), Positives = 67/144 (46%), Gaps = 12/144 (8%)

Query: 292 NILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
             LG G FG+VYKG+L         VAVK LKE+ +      F  E +++    H N++R
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP-----PLDWPTRKKIALGSARGLSY 402
           L G CT      LV  YM  G +   LR+ +   P      L        A+  A+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 403 LHEHCDPKIIHRDVKAANILLDED 426
           L      K +HRD+ A N L+ ED
Sbjct: 121 LASK---KFVHRDLAARNCLVGED 141

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  117 bits (296), Expect = 2e-30
 Identities = 47/140 (33%), Positives = 65/140 (46%), Gaps = 8/140 (5%)

Query: 288 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           +     LG G FGKVY  R    GKLVA+K +K+++      +   E+KI+    H N++
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
           RLY       +  LV  Y   G +   L++R      L     +         L YLH  
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR----GRLSEDEARFYLRQILSALEYLHSK 116

Query: 407 CDPKIIHRDVKAANILLDED 426
               I+HRD+K  NILLDED
Sbjct: 117 ---GIVHRDLKPENILLDED 133

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  117 bits (296), Expect = 2e-30
 Identities = 47/138 (34%), Positives = 64/138 (46%), Gaps = 11/138 (7%)

Query: 294 LGRGGFGKVYKGRLADGK-----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           LG G FG+VYKG L          VAVK LKE  +     +F  E  I+    H N++RL
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 349 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 408
            G CT      +V  YM  G +   LR+       L      ++AL  A+G+ YL     
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHG---EKLTLKDLLQMALQIAKGMEYLESK-- 121

Query: 409 PKIIHRDVKAANILLDED 426
              +HRD+ A N L+ E+
Sbjct: 122 -NFVHRDLAARNCLVTEN 138

Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  115 bits (291), Expect = 9e-30
 Identities = 53/136 (38%), Positives = 66/136 (48%), Gaps = 9/136 (6%)

Query: 293 ILGRGGFGKVYKGR-LADGKLVAVKRL-KEERTSGGELQFQTEVKIISMAVHRNLLRLYG 350
            LG G FG VYK +    GK+VAVK L K    S  +   + E++I+    H N++RL  
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 351 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 410
                    LV  Y   G +   L        PL     KKIAL   RGL YLH +    
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSRGG----PLSEDEAKKIALQILRGLEYLHSN---G 118

Query: 411 IIHRDVKAANILLDED 426
           IIHRD+K  NILLDE+
Sbjct: 119 IIHRDLKPENILLDEN 134

Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  115 bits (289), Expect = 2e-27
 Identities = 101/357 (28%), Positives = 155/357 (43%), Gaps = 53/357 (14%)

Query: 77  DLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLR 136
            L    LSGE+  EL   K           KL SLDL  N  +G IP + + +  L  L 
Sbjct: 505 KLSENKLSGEIPDELSSCK-----------KLVSLDLSHNQLSGQIPASFSEMPVLSQLD 553

Query: 137 LNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTK 196
           L+ N LSG IP +L  + SL  +++S+N L G +P  G+F      +   N++LCG +T 
Sbjct: 554 LSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTT 613

Query: 197 KPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEF 256
              SG P         P     +  S     +   LGA L+ A+   GF + R     E 
Sbjct: 614 ---SGLP---------PCKRVRKTPSWWFY-ITCTLGAFLVLALVAFGFVFIRGRNNLE- 659

Query: 257 FFDVPAEDDS-ELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVA 314
              V  ED + ELQ    K      +         +N++ RG  G  YKG+ + +G    
Sbjct: 660 LKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFV 719

Query: 315 VKRLKE-------ERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN 367
           VK + +       E    G+LQ            H N+++L G C +     L++ Y+  
Sbjct: 720 VKEINDVNSIPSSEIADMGKLQ------------HPNIVKLIGLCRSEKGAYLIHEYIEG 767

Query: 368 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 424
            +++  LR        L W  R+KIA+G A+ L +LH  C P ++  ++    I++D
Sbjct: 768 KNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID 817

Length = 968

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  100 bits (252), Expect = 3e-24
 Identities = 51/139 (36%), Positives = 77/139 (55%), Gaps = 11/139 (7%)

Query: 292 NILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVHRNLLRLY 349
            +LGRG FG VY     D G+L+AVK ++    S  EL   + E++I+S   H N++R Y
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 350 GFCTTVTEK-LLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           G      +  L ++  Y++ GS++S L ++   LP    P  +K       GL+YLH + 
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSS-LLKKFGKLPE---PVIRKYTRQILEGLAYLHSN- 120

Query: 408 DPKIIHRDVKAANILLDED 426
              I+HRD+K ANIL+D D
Sbjct: 121 --GIVHRDIKGANILVDSD 137

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 51/145 (35%), Positives = 74/145 (51%), Gaps = 16/145 (11%)

Query: 288 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           F     +G+GGFG+VYK R    GK VA+K +K E     E     E++I+    H N++
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN-EIQILKKCKHPNIV 60

Query: 347 RLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA---LGSARGLSY 402
           + YG      ++L +V  + + GS+   L+    +L      T  +IA       +GL Y
Sbjct: 61  KYYG-SYLKKDELWIVMEFCSGGSLKDLLKSTNQTL------TESQIAYVCKELLKGLEY 113

Query: 403 LHEHCDPKIIHRDVKAANILLDEDA 427
           LH +    IIHRD+KAANILL  D 
Sbjct: 114 LHSN---GIIHRDIKAANILLTSDG 135

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 84.6 bits (210), Expect = 1e-18
 Identities = 44/141 (31%), Positives = 70/141 (49%), Gaps = 9/141 (6%)

Query: 288 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNL 345
           +   +++GRG FG VYKG  L  G  VA+K++  E+     L+    E+ ++    H N+
Sbjct: 2   YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61

Query: 346 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 405
           ++  G   T     ++  Y  NGS+   + ++    P           L   +GL+YLHE
Sbjct: 62  VKYIGSIETSDSLYIILEYAENGSLRQII-KKFGPFPESLVAVYVYQVL---QGLAYLHE 117

Query: 406 HCDPKIIHRDVKAANILLDED 426
                +IHRD+KAANIL  +D
Sbjct: 118 Q---GVIHRDIKAANILTTKD 135

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 83.2 bits (206), Expect = 5e-18
 Identities = 45/139 (32%), Positives = 65/139 (46%), Gaps = 10/139 (7%)

Query: 292 NILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
            ++G G FG+V +GRL         VA+K LK   +    L F TE  I+    H N++R
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           L G  T     +++  YM NGS+   LRE               +  G A G+ YL E  
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQL---VGMLRGIASGMKYLSEMN 126

Query: 408 DPKIIHRDVKAANILLDED 426
               +HRD+ A NIL++ +
Sbjct: 127 ---YVHRDLAARNILVNSN 142

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 83.0 bits (206), Expect = 8e-18
 Identities = 42/146 (28%), Positives = 68/146 (46%), Gaps = 17/146 (11%)

Query: 288 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNL 345
           +     +G G +G+VYK R    G+LVA+K+++ E    G  +    E+K++    H N+
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60

Query: 346 LRLYGFCTTVTEKL-----LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 400
           +RL      VT K      +V+ YM +  +   L   +           K        GL
Sbjct: 61  VRLKE---IVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTE---SQIKCYMKQLLEGL 113

Query: 401 SYLHEHCDPKIIHRDVKAANILLDED 426
            YLH +    I+HRD+K +NIL++ D
Sbjct: 114 QYLHSN---GILHRDIKGSNILINND 136

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 81.3 bits (201), Expect = 3e-17
 Identities = 45/152 (29%), Positives = 68/152 (44%), Gaps = 19/152 (12%)

Query: 291 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 344
           K  LG G FGKV+ G     +      LVAVK LKE  ++     F+ E ++++   H N
Sbjct: 10  KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK----------KIAL 394
           +++ YG CT     ++V+ YM +G +   LR        L  P             +IA+
Sbjct: 70  IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 395 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
             A G+ YL        +HRD+   N L+  D
Sbjct: 130 QIASGMVYLASQ---HFVHRDLATRNCLVGYD 158

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 83.7 bits (207), Expect = 3e-17
 Identities = 55/186 (29%), Positives = 79/186 (42%), Gaps = 37/186 (19%)

Query: 77  DLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLR 136
            L N  L G +  ++ +L+            L+S++L  N   G IP +L ++  L+ L 
Sbjct: 424 GLDNQGLRGFIPNDISKLR-----------HLQSINLSGNSIRGNIPPSLGSITSLEVLD 472

Query: 137 LNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD--NGSFSQFTPISFENNLNLCGPN 194
           L+ NS +G IP SL  +TSL IL+L+ N LSG VP    G        +F +N  LCG  
Sbjct: 473 LSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532

Query: 195 TKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYW--RR-- 250
             + C            GP  S           +G+A G ++ F   VI    W  RR  
Sbjct: 533 GLRAC------------GPHLS-------VGAKIGIAFGVSVAFLFLVICAMCWWKRRQN 573

Query: 251 -TRPHE 255
             R   
Sbjct: 574 ILRAQR 579

Length = 623

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 80.1 bits (198), Expect = 4e-17
 Identities = 44/136 (32%), Positives = 64/136 (47%), Gaps = 8/136 (5%)

Query: 291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 350
              +G+G FG V  G    G+ VAVK LK++  S     F  E  +++   H NL++L G
Sbjct: 11  GATIGKGEFGDVMLGDYR-GQKVAVKCLKDD--STAAQAFLAEASVMTTLRHPNLVQLLG 67

Query: 351 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 410
                    +V  YM  GS+   LR R  ++  L    +   AL    G+ YL E     
Sbjct: 68  VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLA--QQLGFALDVCEGMEYLEEK---N 122

Query: 411 IIHRDVKAANILLDED 426
            +HRD+ A N+L+ ED
Sbjct: 123 FVHRDLAARNVLVSED 138

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 79.6 bits (197), Expect = 7e-17
 Identities = 43/145 (29%), Positives = 68/145 (46%), Gaps = 16/145 (11%)

Query: 288 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           F     LG G +G VYK      G++VA+K +          +   E+ I+       ++
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PVEEDLQEIIKEISILKQCDSPYIV 61

Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL---GSARGLSYL 403
           + YG     T+  +V  Y   GSV+  ++    +L      T ++IA     + +GL YL
Sbjct: 62  KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTL------TEEEIAAILYQTLKGLEYL 115

Query: 404 HEHCDPKIIHRDVKAANILLDEDAD 428
           H +   K IHRD+KA NILL+E+  
Sbjct: 116 HSN---KKIHRDIKAGNILLNEEGQ 137

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 79.4 bits (196), Expect = 8e-17
 Identities = 41/135 (30%), Positives = 68/135 (50%), Gaps = 10/135 (7%)

Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           +G+G FG VYKG L     VAVK  +       + +F  E +I+    H N+++L G C 
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62

Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK--KIALGSARGLSYLHEHCDPKI 411
                 +V   +  GS+ + LR++++ L       +K  +++L +A G+ YL        
Sbjct: 63  QKQPIYIVMELVPGGSLLTFLRKKKNRL-----TVKKLLQMSLDAAAGMEYLESKN---C 114

Query: 412 IHRDVKAANILLDED 426
           IHRD+ A N L+ E+
Sbjct: 115 IHRDLAARNCLVGEN 129

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 79.6 bits (197), Expect = 8e-17
 Identities = 57/180 (31%), Positives = 83/180 (46%), Gaps = 39/180 (21%)

Query: 284 ATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVK--RLKEERTSGGELQFQTEVKII-SM 339
            T  F    ++G G +GKVYK R    G+LVA+K   + E+     E + + E  I+   
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE----EEEIKEEYNILRKY 59

Query: 340 AVHRNLLRLYGF-----CTTVTEKL-LVYPYMTNGSV---ASRLRERQSSLPPLDWPTRK 390
           + H N+   YG           ++L LV      GSV      LR++   L   +W    
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKE-EW---- 114

Query: 391 KIAL---GSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 437
            IA     + RGL+YLHE+   K+IHRD+K  NILL ++A+          Q   T+ RR
Sbjct: 115 -IAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR 170

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 80.6 bits (197), Expect = 2e-16
 Identities = 49/146 (33%), Positives = 68/146 (46%), Gaps = 9/146 (6%)

Query: 287 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGEL--QFQTEVKII-SMAVHR 343
            +     LG G FG+VY  R  D KLVA+K L ++  S  +   +F  E++I+ S+    
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           N+++LY F        LV  Y+  GS+   L++     P L       I       L YL
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGP-LSESEALFILAQILSALEYL 117

Query: 404 HEHCDPKIIHRDVKAANILLDEDADQ 429
           H      IIHRD+K  NILLD D   
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRV 140

Length = 384

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 78.2 bits (193), Expect = 3e-16
 Identities = 47/146 (32%), Positives = 72/146 (49%), Gaps = 17/146 (11%)

Query: 294 LGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           LG+G FG VY+G LA G +       VA+K + E  +    ++F  E  ++      +++
Sbjct: 14  LGQGSFGMVYEG-LAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72

Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---SLPPLDWPTRKKI---ALGSARGL 400
           RL G  +T    L+V   M  G + S LR R+    + P L  PT +K    A   A G+
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 401 SYLHEHCDPKIIHRDVKAANILLDED 426
           +YL      K +HRD+ A N ++ ED
Sbjct: 133 AYLAAK---KFVHRDLAARNCMVAED 155

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 77.5 bits (191), Expect = 4e-16
 Identities = 45/141 (31%), Positives = 71/141 (50%), Gaps = 10/141 (7%)

Query: 288 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
           F+ +  LG G FG+V++G   +   VA+K LK +     +  FQ EV+ +    H++L+ 
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQ-DFQKEVQALKRLRHKHLIS 66

Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLR--ERQSSLPPLDWPTRKKIALGSARGLSYLHE 405
           L+  C+      ++   M  GS+ + LR  E Q     L   +   +A   A G++YL E
Sbjct: 67  LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV----LPVASLIDMACQVAEGMAYLEE 122

Query: 406 HCDPKIIHRDVKAANILLDED 426
                 IHRD+ A NIL+ ED
Sbjct: 123 Q---NSIHRDLAARNILVGED 140

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 76.7 bits (189), Expect = 9e-16
 Identities = 51/151 (33%), Positives = 67/151 (44%), Gaps = 12/151 (7%)

Query: 282 QVATDGFSNKNILGRGGFGKVYKG--RLADGKL----VAVKRLKEERTSGGELQFQTEVK 335
           +V  D  +    LG G FG+VY+G  R  DG      VAVK L E  +   E  F  E  
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 336 IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE---RQSSLPPLDWPTRKKI 392
           I+S   H+N++RL G       + ++   M  G + S LRE   R      L        
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121

Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 423
           A   A+G  YL E+     IHRD+ A N LL
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLL 149

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 48/137 (35%), Positives = 77/137 (56%), Gaps = 12/137 (8%)

Query: 293 ILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 352
           +LG+G FG+V+KG L D   VAVK  KE+     +++F +E +I+    H N+++L G C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK--KIALGSARGLSYLH-EHCDP 409
           T      +V   +  G   S LR+++  L      T++  K AL +A G++YL  ++C  
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDEL-----KTKQLVKFALDAAAGMAYLESKNC-- 114

Query: 410 KIIHRDVKAANILLDED 426
             IHRD+ A N L+ E+
Sbjct: 115 --IHRDLAARNCLVGEN 129

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 78.4 bits (193), Expect = 2e-15
 Identities = 45/108 (41%), Positives = 60/108 (55%), Gaps = 13/108 (12%)

Query: 77  DLGNAALSGELAPELGQLKNLELLALG-------------NLIKLKSLDLYSNLFNGTIP 123
           DL N  LSGE+  ++G   +L++L LG             NL  L+ L L SN   G IP
Sbjct: 146 DLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIP 205

Query: 124 DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 171
             L  +K LK++ L  N+LSG IP  +  +TSLN LDL  N L+GP+P
Sbjct: 206 RELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIP 253

Length = 968

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 42/134 (31%), Positives = 65/134 (48%), Gaps = 13/134 (9%)

Query: 294 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG-F 351
           LG+G  G VYK R    GK+ A+K++  +       Q   E+K +       +++ YG F
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68

Query: 352 CT--TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
                ++   +V  YM  GS+A  L+ +   +P    P    IA    +GL YLH     
Sbjct: 69  YKEGEIS---IVLEYMDGGSLADLLK-KVGKIPE---PVLAYIARQILKGLDYLHT--KR 119

Query: 410 KIIHRDVKAANILL 423
            IIHRD+K +N+L+
Sbjct: 120 HIIHRDIKPSNLLI 133

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 45/139 (32%), Positives = 71/139 (51%), Gaps = 14/139 (10%)

Query: 294 LGRGGFGKVYKG-RLADGKLVAVKRLK---EERTSGGEL-QFQTEVKIISMAVHRNLLRL 348
           LG G FG VY+G  L DG   AVK +    + +T    + Q + E+ ++S   H N+++ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 349 YGFCTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
            G      + L ++   +  GS+A  L++  S   P+     ++I LG    L YLH   
Sbjct: 68  LG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLH--- 119

Query: 408 DPKIIHRDVKAANILLDED 426
           D   +HRD+K ANIL+D +
Sbjct: 120 DRNTVHRDIKGANILVDTN 138

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 74.5 bits (184), Expect = 4e-15
 Identities = 44/143 (30%), Positives = 69/143 (48%), Gaps = 21/143 (14%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QTEVKIISMAVHRNLLRLYGF 351
           +G+G FGKVY  R  +DGKL  +K +     S  E +    EVKI+    H N+++ Y  
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE- 66

Query: 352 CTTVTEKLL--VYPYMTNGSVASRLRERQSSLPP------LDWPTRKKIALGSARGLSYL 403
            +   +  L  V  Y   G ++ ++++++    P      LDW    ++ L     L YL
Sbjct: 67  -SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV--QLCLA----LKYL 119

Query: 404 HEHCDPKIIHRDVKAANILLDED 426
           H     KI+HRD+K  NI L  +
Sbjct: 120 HSR---KILHRDIKPQNIFLTSN 139

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 48/162 (29%), Positives = 69/162 (42%), Gaps = 21/162 (12%)

Query: 288 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           F+    +G+G FG+VYK       ++VA+K +  E         Q E++ +S      + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 347 RLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 405
           + YG       KL ++  Y   GS    L+        LD      I      GL YLHE
Sbjct: 63  KYYG-SFLKGSKLWIIMEYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHE 116

Query: 406 HCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 437
                 IHRD+KAANILL E+ D          Q + T+ +R
Sbjct: 117 E---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 73.4 bits (180), Expect = 9e-15
 Identities = 40/133 (30%), Positives = 67/133 (50%), Gaps = 8/133 (6%)

Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           +G G FG V+ G   + + VA+K ++E   S  E  F  E +++    H  L++LYG CT
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 413
             +   LV+ +M +G ++  LR ++         T   + L    G++YL       +IH
Sbjct: 70  ERSPICLVFEFMEHGCLSDYLRAQRGKFSQ---ETLLGMCLDVCEGMAYLESSN---VIH 123

Query: 414 RDVKAANILLDED 426
           RD+ A N L+ E+
Sbjct: 124 RDLAARNCLVGEN 136

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 73.7 bits (182), Expect = 1e-14
 Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 15/144 (10%)

Query: 288 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT----EVKIISMAVH 342
           +     LG G +G VYK R    G++VA+K+++ +    G     +    E+ ++    H
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG---IPSTALREISLLKELKH 57

Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 402
            N+++L     T  +  LV+ Y     +   L +R   L P      K I     RGL+Y
Sbjct: 58  PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSP---NLIKSIMYQLLRGLAY 113

Query: 403 LHEHCDPKIIHRDVKAANILLDED 426
            H H   +I+HRD+K  NIL++ D
Sbjct: 114 CHSH---RILHRDLKPQNILINRD 134

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 40/146 (27%), Positives = 65/146 (44%), Gaps = 19/146 (13%)

Query: 292 NILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQ---FQTEVKIISMAVHR 343
             LG G FGKV   R        G+ VAVK L     SG E     F+ E++I+    H 
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLN---HSGEEQHRSDFEREIEILRTLDHE 66

Query: 344 NLLRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           N+++  G C     +   L+  Y+ +GS+   L+  +     ++       +    +G+ 
Sbjct: 67  NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMD 123

Query: 402 YLHEHCDPKIIHRDVKAANILLDEDA 427
           YL      + IHRD+ A NIL++ + 
Sbjct: 124 YLGSQ---RYIHRDLAARNILVESED 146

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 46/137 (33%), Positives = 71/137 (51%), Gaps = 13/137 (9%)

Query: 292 NILGRGGFGKVYKG-RLADGKLVAVK--RLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           N +G G FGKVY    L  G+L+AVK  R+++      + +   E+K++ +  H NL++ 
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIK-EIADEMKVLELLKHPNLVKY 64

Query: 349 YGFCTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           YG      EK+ ++  Y + G++   L   +     LD    +   L    GL+YLH H 
Sbjct: 65  YGV-EVHREKVYIFMEYCSGGTLEELLEHGRI----LDEHVIRVYTLQLLEGLAYLHSH- 118

Query: 408 DPKIIHRDVKAANILLD 424
              I+HRD+K ANI LD
Sbjct: 119 --GIVHRDIKPANIFLD 133

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 75.7 bits (186), Expect = 2e-14
 Identities = 45/108 (41%), Positives = 60/108 (55%), Gaps = 13/108 (12%)

Query: 78  LGNAALSGELAPELGQLKNLELLALG-------------NLIKLKSLDLYSNLFNGTIPD 124
           L +  L G++  ELGQ+K+L+ + LG              L  L  LDL  N   G IP 
Sbjct: 195 LASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPS 254

Query: 125 TLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD 172
           +L NLK L+YL L  N LSG IP S+ ++  L  LDLS+N LSG +P+
Sbjct: 255 SLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPE 302

Length = 968

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 46/137 (33%), Positives = 64/137 (46%), Gaps = 16/137 (11%)

Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG V+ G+      VA+K ++E   S  E  F  E K++    H NL++LYG CT
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS--EDDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA----RGLSYLHEHCDP 409
                 +V  YM NG + + LRER+  L         +  L         + YL  +   
Sbjct: 70  KQRPIFIVTEYMANGCLLNYLRERKGKL-------GTEWLLDMCSDVCEAMEYLESNG-- 120

Query: 410 KIIHRDVKAANILLDED 426
             IHRD+ A N L+ ED
Sbjct: 121 -FIHRDLAARNCLVGED 136

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 72.2 bits (178), Expect = 2e-14
 Identities = 51/139 (36%), Positives = 67/139 (48%), Gaps = 16/139 (11%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRL-Y 349
           LG+G FGKV   R    GKL A+K LK+++           TE  I+S   H  +++L Y
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 350 GFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-LGSARGLSYLHEHC 407
            F T   EKL LV  Y   G + S L  ++      +   R   A +  A  L YLH   
Sbjct: 61  AFQTE--EKLYLVLEYAPGGELFSHLS-KEGRFS--EERARFYAAEIVLA--LEYLHSL- 112

Query: 408 DPKIIHRDVKAANILLDED 426
              II+RD+K  NILLD D
Sbjct: 113 --GIIYRDLKPENILLDAD 129

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 41/139 (29%), Positives = 72/139 (51%), Gaps = 18/139 (12%)

Query: 293 ILGRGGFGKVYKGR-LADG---KL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
           +LG G FG VYKG  + +G   K+ VA+K L+EE +     +   E  +++   H +++R
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYLH 404
           L G C +     L+   M  G +   +R  + ++     L+W       +  A+G+SYL 
Sbjct: 74  LLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYLE 126

Query: 405 EHCDPKIIHRDVKAANILL 423
           E    +++HRD+ A N+L+
Sbjct: 127 EK---RLVHRDLAARNVLV 142

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 72.2 bits (177), Expect = 4e-14
 Identities = 48/158 (30%), Positives = 73/158 (46%), Gaps = 27/158 (17%)

Query: 294 LGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
           +G+G FG+V++ R           +VAVK LKEE ++  +  FQ E  +++   H N+++
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRER----QSSL--------------PPLDWPTR 389
           L G C       L++ YM  G +   LR R    Q SL               PL    +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 390 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA 427
             IA   A G++YL E    K +HRD+   N L+ E+ 
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENM 167

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 46/141 (32%), Positives = 66/141 (46%), Gaps = 6/141 (4%)

Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 344
           D       LG G  G V K      GK++AVK ++ E     + Q   E+ I+       
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
           ++  YG      +  +   YM  GS+   L+E Q  +P        KIA+   +GL+YLH
Sbjct: 61  IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPE---RILGKIAVAVLKGLTYLH 117

Query: 405 EHCDPKIIHRDVKAANILLDE 425
           E    KIIHRDVK +NIL++ 
Sbjct: 118 E--KHKIIHRDVKPSNILVNS 136

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 73.7 bits (181), Expect = 6e-14
 Identities = 49/138 (35%), Positives = 71/138 (51%), Gaps = 15/138 (10%)

Query: 77  DLGNAALSGELAPELGQLKNLELLALG-------------NLIKLKSLDLYSNLFNGTIP 123
           DL    L+G +   LG LKNL+ L L              +L KL SLDL  N  +G IP
Sbjct: 242 DLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301

Query: 124 DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPI 182
           + +  L+ L+ L L +N+ +G IP +LT++  L +L L +N+ SG +P N G  +  T +
Sbjct: 302 ELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVL 361

Query: 183 SFENNLNLCGPNTKKPCS 200
               N NL G   +  CS
Sbjct: 362 DLSTN-NLTGEIPEGLCS 378

Length = 968

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 70.8 bits (174), Expect = 8e-14
 Identities = 44/132 (33%), Positives = 61/132 (46%), Gaps = 7/132 (5%)

Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG+V+ G       VAVK LK    S     F  E +I+    H  L++LY  C+
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA--FLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 413
                 +V  YM+ GS+   L+  +     L  P    +A   A G++YL        IH
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYLESR---NYIH 126

Query: 414 RDVKAANILLDE 425
           RD+ A NIL+ E
Sbjct: 127 RDLAARNILVGE 138

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 70.7 bits (173), Expect = 1e-13
 Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 13/138 (9%)

Query: 293 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-----FQTEVKIISMAVHRNLL 346
            LG G F   Y+ R +  G L+AVK++   R +  E +      + E+++++   H +++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
           R+ G     +   L   +M  GSV+  L    S                  RGLSYLHE+
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLL----SKYGAFKEAVIINYTEQLLRGLSYLHEN 122

Query: 407 CDPKIIHRDVKAANILLD 424
              +IIHRDVK AN+L+D
Sbjct: 123 ---QIIHRDVKGANLLID 137

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 69.9 bits (171), Expect = 2e-13
 Identities = 42/137 (30%), Positives = 65/137 (47%), Gaps = 10/137 (7%)

Query: 291 KNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           K+ LG G +G+VY+G        VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 68

Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRE-RQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 408
           G CT      ++  +MT G++   LRE  +  +  +       +A   +  + YL +   
Sbjct: 69  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKK-- 123

Query: 409 PKIIHRDVKAANILLDE 425
              IHRD+ A N L+ E
Sbjct: 124 -NFIHRDLAARNCLVGE 139

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 38/135 (28%), Positives = 65/135 (48%), Gaps = 9/135 (6%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGF 351
           +G G  G V+K +    G+ VA+K++   R  GG   Q   E+K +    H  +++L   
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 352 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
               +  +LV  YM    ++  LR+ +  LP       K       +G++Y+H +    I
Sbjct: 68  FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPE---AQVKSYMRMLLKGVAYMHAN---GI 120

Query: 412 IHRDVKAANILLDED 426
           +HRD+K AN+L+  D
Sbjct: 121 MHRDLKPANLLISAD 135

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 69.6 bits (170), Expect = 3e-13
 Identities = 44/150 (29%), Positives = 65/150 (43%), Gaps = 21/150 (14%)

Query: 294 LGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
           LG G FGKV+           D  LVAVK LKE  +      FQ E +++++  H++++R
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVR 71

Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRE-----------RQSSLPPLDWPTRKKIALGS 396
            YG CT     L+V+ YM +G +   LR               +   L       IA   
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           A G+ YL        +HRD+   N L+ + 
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQG 158

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 49/134 (36%), Positives = 63/134 (47%), Gaps = 10/134 (7%)

Query: 294 LGRGGFGKVYKGRL--ADGKL--VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           LG G FG V +G    + GK+  VAVK LK ++ S     F  E  I+    H NL+RLY
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
           G   T     +V      GS+  RLR+    L      T    A+  A G+ YL      
Sbjct: 63  GVVLTHPLM-MVTELAPLGSLLDRLRKDA--LGHFLISTLCDYAVQIANGMRYLESK--- 116

Query: 410 KIIHRDVKAANILL 423
           + IHRD+ A NILL
Sbjct: 117 RFIHRDLAARNILL 130

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 68.9 bits (168), Expect = 4e-13
 Identities = 46/134 (34%), Positives = 67/134 (50%), Gaps = 9/134 (6%)

Query: 294 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 352
           +GRG FG+V+ GRL AD   VAVK  +E      + +F  E +I+    H N++RL G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH-EHCDPKI 411
           T      +V   +  G   + LR   +  P L      ++   +A G+ YL  +HC    
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYLESKHC---- 115

Query: 412 IHRDVKAANILLDE 425
           IHRD+ A N L+ E
Sbjct: 116 IHRDLAARNCLVTE 129

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 68.9 bits (169), Expect = 4e-13
 Identities = 45/140 (32%), Positives = 68/140 (48%), Gaps = 9/140 (6%)

Query: 292 NILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 350
            ++G G    VY    L + + VA+KR+  E+      + + EV+ +S   H N+++ Y 
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 351 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP--LDWPTRKKIALGSARGLSYLHEHCD 408
                 E  LV PY++ GS+   ++   SS P   LD      +     +GL YLH +  
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLDIMK---SSYPRGGLDEAIIATVLKEVLKGLEYLHSN-- 121

Query: 409 PKIIHRDVKAANILLDEDAD 428
              IHRD+KA NILL ED  
Sbjct: 122 -GQIHRDIKAGNILLGEDGS 140

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 4e-13
 Identities = 52/158 (32%), Positives = 76/158 (48%), Gaps = 24/158 (15%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 352
           +G G +G VYK R +A G+LVA+K +K E     E   Q E+ ++    H N++  +G  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFE-IIQQEISMLKECRHPNIVAYFGSY 69

Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL---GSARGLSYLHEHCDP 409
               +  +V  Y   GS+    +  +  L  L      +IA     + +GL+YLHE    
Sbjct: 70  LRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL------QIAYVCRETLKGLAYLHET--- 120

Query: 410 KIIHRDVKAANILLDEDAD----------QSSKTILRR 437
             IHRD+K ANILL ED D          Q + TI +R
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR 158

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 68.7 bits (168), Expect = 5e-13
 Identities = 45/147 (30%), Positives = 71/147 (48%), Gaps = 16/147 (10%)

Query: 293 ILGRGGFGKVYKGRLA--DGKL--VAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLR 347
           ILG G FG V +G+L+  DG    VAVK +K +  +  E++ F +E   +    H N+++
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 348 LYGFCTTVTEK------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRK--KIALGSARG 399
           L G C   +        +++ P+M +G + S L   +    P   P +   K  +  A G
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 400 LSYLHEHCDPKIIHRDVKAANILLDED 426
           + YL        IHRD+ A N +L ED
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLRED 149

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 68.5 bits (167), Expect = 5e-13
 Identities = 42/140 (30%), Positives = 67/140 (47%), Gaps = 10/140 (7%)

Query: 289 SNKNILGRGGFGKVYKGRL-ADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 344
           + + ++G G FG+V++G L   G+    VA+K LK   T      F +E  I+    H N
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
           ++RL G  T     +++  YM NG++   LR+              +   G A G+ YL 
Sbjct: 68  IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYL- 123

Query: 405 EHCDPKIIHRDVKAANILLD 424
              D   +HRD+ A NIL++
Sbjct: 124 --SDMNYVHRDLAARNILVN 141

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 68.4 bits (167), Expect = 5e-13
 Identities = 44/133 (33%), Positives = 64/133 (48%), Gaps = 8/133 (6%)

Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 413
                 +V  YM+NG + + LRE      P       ++      G++YL      + IH
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL---LEMCKDVCEGMAYLESK---QFIH 123

Query: 414 RDVKAANILLDED 426
           RD+ A N L+D+ 
Sbjct: 124 RDLAARNCLVDDQ 136

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 68.0 bits (166), Expect = 9e-13
 Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 10/138 (7%)

Query: 293 ILGRGGFGKVYKGRL-ADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           ++G G FG+V +GRL   GK    VA+K LK   T      F +E  I+    H N++ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 349 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 408
            G  T     +++  +M NG++ S LR+       +       +  G A G+ YL E   
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYLSEM-- 125

Query: 409 PKIIHRDVKAANILLDED 426
              +HRD+ A NIL++ +
Sbjct: 126 -NYVHRDLAARNILVNSN 142

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 27/153 (17%)

Query: 294 LGRGGFGKVYKGRL---ADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
           LG G FGKVYKG L    +      VA+K LKE      + +F+ E +++S   H N++ 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 348 LYGFCTTVTEKLLVYPYMTNGSV---------------ASRLRERQSSLPPLDWPTRKKI 392
           L G CT      +++ Y+ +G +                S     +SSL   D+     I
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF---LHI 129

Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 425
           A+  A G+ YL  H     +HRD+ A N L+ E
Sbjct: 130 AIQIAAGMEYLSSH---HFVHRDLAARNCLVGE 159

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 42/138 (30%), Positives = 68/138 (49%), Gaps = 14/138 (10%)

Query: 293 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEER----TSGGELQFQTEVKIISMAVHRNLLR 347
           +LG+G FG+VY     D G+ +AVK++  +     T       + E++++    H  +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 348 LYGFCTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
            YG C    E L ++  YM  GSV  +L+    +   L     +K       G+ YLH +
Sbjct: 69  YYG-CLRDDETLSIFMEYMPGGSVKDQLK----AYGALTETVTRKYTRQILEGVEYLHSN 123

Query: 407 CDPKIIHRDVKAANILLD 424
               I+HRD+K ANIL D
Sbjct: 124 ---MIVHRDIKGANILRD 138

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 42/132 (31%), Positives = 60/132 (45%), Gaps = 7/132 (5%)

Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG+V++G   +   VAVK LK       +  F  E +I+    H  L++LY  CT
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKD--FLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 413
                 +V   M  GS+   L+        L  P    +A   A G++YL        IH
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRA--LKLPQLIDMAAQVASGMAYLEAQ---NYIH 126

Query: 414 RDVKAANILLDE 425
           RD+ A N+L+ E
Sbjct: 127 RDLAARNVLVGE 138

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 66.5 bits (162), Expect = 3e-12
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 12/137 (8%)

Query: 292 NILGRGGFGKVYKGRLADGKLVAVKR--LKEERTSGGELQF---QTEVKIISMAVHRNLL 346
            +LG+G +G VY G    G+L+AVK+  L        E ++   Q EV ++    H N++
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
           +  G C       +   ++  GS++S L        PL  P   K       G++YLH +
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN 121

Query: 407 CDPKIIHRDVKAANILL 423
           C   ++HRD+K  N++L
Sbjct: 122 C---VVHRDIKGNNVML 135

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 49/139 (35%), Positives = 70/139 (50%), Gaps = 14/139 (10%)

Query: 294 LGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 351
           LG G FGKVYK +  + G   A K ++ E  S  EL+ F  E+ I+S   H N++ LY  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYE- 69

Query: 352 CTTVTE-KLLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
                E KL +   +   G++ S + E +     L  P  + +       L++LH H   
Sbjct: 70  -AYFYENKLWILIEFCDGGALDSIMLELER---GLTEPQIRYVCRQMLEALNFLHSH--- 122

Query: 410 KIIHRDVKAANILLDEDAD 428
           K+IHRD+KA NILL  D D
Sbjct: 123 KVIHRDLKAGNILLTLDGD 141

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 66.1 bits (162), Expect = 5e-12
 Identities = 43/150 (28%), Positives = 69/150 (46%), Gaps = 25/150 (16%)

Query: 288 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           + N   +G G  G+VYK    A GK VA+K+++  + +  +     E+ I+    H N++
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQN--KELIINEILIMKDCKHPNIV 78

Query: 347 RLYGFCTTVTEKL-LVYPYMTNGSVA-------SRLRERQSSLPPLDWPTRKKIALGSAR 398
             Y     V ++L +V  YM  GS+         R+ E Q +           +     +
Sbjct: 79  DYYD-SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA----------YVCREVLQ 127

Query: 399 GLSYLHEHCDPKIIHRDVKAANILLDEDAD 428
           GL YLH      +IHRD+K+ NILL +D  
Sbjct: 128 GLEYLHSQ---NVIHRDIKSDNILLSKDGS 154

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 65.4 bits (159), Expect = 7e-12
 Identities = 50/159 (31%), Positives = 72/159 (45%), Gaps = 29/159 (18%)

Query: 293 ILGRGGFGKVYKGR------LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
            LG G FGKV K         A    VAVK LKE  +S       +E  ++    H +++
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP------------PLDWPTRKKIAL 394
           +LYG C+     LL+  Y   GS+ S LRE +   P             LD P  + + +
Sbjct: 67  KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 395 GS--------ARGLSYLHEHCDPKIIHRDVKAANILLDE 425
           G         +RG+ YL E    K++HRD+ A N+L+ E
Sbjct: 127 GDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAE 162

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 65.1 bits (159), Expect = 8e-12
 Identities = 46/156 (29%), Positives = 69/156 (44%), Gaps = 28/156 (17%)

Query: 293 ILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRNL 345
            LG G FG+V K              VAVK LK++ T        +E++++ M   H+N+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 346 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP-------LDWPTRKKI------ 392
           + L G CT      +V  Y  +G++   LR R+   PP          P  + +      
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARR---PPGEYASPDDPRPPEETLTQKDLV 135

Query: 393 --ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
             A   ARG+ +L      K IHRD+ A N+L+ ED
Sbjct: 136 SFAYQVARGMEFLASK---KCIHRDLAARNVLVTED 168

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 13/153 (8%)

Query: 292 NILGRGGFGKVYKGRLAD------GKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRN 344
           N LG G FG+VY+G   D      G + VAVK L++  T   + +F  E  ++S   H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE-RQSSLPP--LDWPTRKKIALGSARGLS 401
           +++L G C     + ++   M  G + S LR+ R     P  L       I L  A+G  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 402 YLHEHCDPKIIHRDVKAANILLDEDADQSSKTI 434
           YL        IHRD+ A N L+ E    + + +
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVV 150

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 41/137 (29%), Positives = 62/137 (45%), Gaps = 13/137 (9%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---EVKIISMAVHRNLLRLY 349
           +G G +G V K R  A G++VA+K+ KE      E   +T   EVK++    H N++ L 
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLRHENIVNLK 66

Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
                     LV+ Y+   ++   L      LPP      +       + ++Y H H   
Sbjct: 67  EAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPD---AVRSYIWQLLQAIAYCHSH--- 119

Query: 410 KIIHRDVKAANILLDED 426
            IIHRD+K  NIL+ E 
Sbjct: 120 NIIHRDIKPENILVSES 136

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 35/142 (24%), Positives = 64/142 (45%), Gaps = 14/142 (9%)

Query: 293 ILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
            LGRG FG+V+  +           LV VK L++ +    + +F+ E+ +     H+N++
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 347 RLYGFCTTVTEKLLVYPYMTNGS-----VASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           RL G C       ++  Y   G       A++ ++ +   PPL    +  +    A G+ 
Sbjct: 72  RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131

Query: 402 YLHEHCDPKIIHRDVKAANILL 423
           +L      + +HRD+ A N L+
Sbjct: 132 HLSNA---RFVHRDLAARNCLV 150

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 25/163 (15%)

Query: 293 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLLRLYG 350
           ++G G +G+VYKGR +  G+L A+K +  + T   E + + E+ ++   + HRN+   YG
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTEDEEEEIKLEINMLKKYSHHRNIATYYG 80

Query: 351 FCTTVT------EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
                +      +  LV  +   GSV   ++  + +    DW     I     RGL++LH
Sbjct: 81  AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLH 138

Query: 405 EHCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 437
            H   K+IHRD+K  N+LL E+A+          Q  +T+ RR
Sbjct: 139 AH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 178

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 40/144 (27%), Positives = 69/144 (47%), Gaps = 17/144 (11%)

Query: 293 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGG---ELQ------FQTEVKIISMAVH 342
           ++G+G +G+VY       G+++AVK+++   T  G     Q       ++E++ +    H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 402
            N+++  GF TT     +   Y+  GS+ S LR         +    +        GL+Y
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAY 123

Query: 403 LHEHCDPKIIHRDVKAANILLDED 426
           LH      I+HRD+KA N+L+D D
Sbjct: 124 LHSK---GILHRDLKADNLLVDAD 144

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 64.0 bits (155), Expect = 2e-11
 Identities = 46/144 (31%), Positives = 78/144 (54%), Gaps = 15/144 (10%)

Query: 293 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLLRLYG 350
           ++G G +G+VYKGR +  G+L A+K +  + T   E + + E+ ++   + HRN+   YG
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70

Query: 351 FCTT-----VTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
                    + ++L LV  +   GSV   ++  + +    +W     I     RGLS+LH
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLH 128

Query: 405 EHCDPKIIHRDVKAANILLDEDAD 428
           +H   K+IHRD+K  N+LL E+A+
Sbjct: 129 QH---KVIHRDIKGQNVLLTENAE 149

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 50/150 (33%), Positives = 71/150 (47%), Gaps = 35/150 (23%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRL-- 348
           LG G FG+VYK R +  G++VA+K++    E+  G  +    E+KI+    H N++ L  
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKHPNVVPLID 74

Query: 349 --YGFCTTVTEKL----LVYPYM--------TNGSVASRLRERQSSLPPLDWPTRKKIAL 394
                      K     +V PYM         N SV  +L E Q           K   L
Sbjct: 75  MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV--KLTESQI----------KCYML 122

Query: 395 GSARGLSYLHEHCDPKIIHRDVKAANILLD 424
               G++YLHE+    I+HRD+KAANIL+D
Sbjct: 123 QLLEGINYLHEN---HILHRDIKAANILID 149

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 16/154 (10%)

Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FGKVYK +  +  ++A  ++ + ++      +  E+ I++   H N+++L     
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 413
                 ++  +   G+V + + E +    PL  P  + +   +   L+YLHE+   KIIH
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELER---PLTEPQIRVVCKQTLEALNYLHEN---KIIH 126

Query: 414 RDVKAANILLDEDAD----------QSSKTILRR 437
           RD+KA NIL   D D          ++++TI RR
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 160

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 62.9 bits (153), Expect = 4e-11
 Identities = 47/142 (33%), Positives = 65/142 (45%), Gaps = 17/142 (11%)

Query: 292 NILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
            ++G+G FG VY G L D        AVK L          QF  E  I+    H N+L 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 348 LYGFC-TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYL 403
           L G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHN------PTVKDLIGFGLQVAKGMEYL 114

Query: 404 HEHCDPKIIHRDVKAANILLDE 425
                 K +HRD+ A N +LDE
Sbjct: 115 ASK---KFVHRDLAARNCMLDE 133

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 62.6 bits (152), Expect = 4e-11
 Identities = 44/136 (32%), Positives = 63/136 (46%), Gaps = 16/136 (11%)

Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG V+ G+      VA+K + E   S  E  F  E K++    H  L++LYG CT
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMS--EEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR----GLSYLHEHCDP 409
                 +V  +M NG + + LR+RQ  L        K + L   +    G+ YL  +   
Sbjct: 70  QQKPLYIVTEFMENGCLLNYLRQRQGKL-------SKDMLLSMCQDVCEGMEYLERN--- 119

Query: 410 KIIHRDVKAANILLDE 425
             IHRD+ A N L+  
Sbjct: 120 SFIHRDLAARNCLVSS 135

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 45/135 (33%), Positives = 71/135 (52%), Gaps = 12/135 (8%)

Query: 293 ILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 352
           I+G G FG V +G    G+ VAVK +K + T+     F  E  +++   H+NL+RL G  
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLG-- 66

Query: 353 TTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
             +   L +V   M+ G++ + LR R  +L  +      + +L  A G+ YL      K+
Sbjct: 67  VILHNGLYIVMELMSKGNLVNFLRTRGRALVSV--IQLLQFSLDVAEGMEYLESK---KL 121

Query: 412 IHRDVKAANILLDED 426
           +HRD+ A NIL+ ED
Sbjct: 122 VHRDLAARNILVSED 136

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 64.1 bits (156), Expect = 7e-11
 Identities = 44/112 (39%), Positives = 62/112 (55%), Gaps = 14/112 (12%)

Query: 74  LIS-DLGNAALSGELAPELGQLKNLELL-------------ALGNLIKLKSLDLYSNLFN 119
           LIS DL + +LSGE+   + QL+NLE+L             AL +L +L+ L L+SN F+
Sbjct: 286 LISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFS 345

Query: 120 GTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 171
           G IP  L     L  L L+ N+L+G IP  L +  +L  L L +N L G +P
Sbjct: 346 GEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIP 397

Length = 968

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 61.6 bits (150), Expect = 9e-11
 Identities = 47/135 (34%), Positives = 69/135 (51%), Gaps = 14/135 (10%)

Query: 294 LGRGGFGKVYKG--RLADGKL--VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           LG G FG V KG   +  GK   VAVK LK+E  + G+ +F  E  +++   H  ++RL 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 350 GFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 408
           G C    E L LV      G +   L++R+  +P  D    K++A   A G++YL     
Sbjct: 63  GVC--KGEPLMLVMELAPLGPLLKYLKKRR-EIPVSDL---KELAHQVAMGMAYLESK-- 114

Query: 409 PKIIHRDVKAANILL 423
              +HRD+ A N+LL
Sbjct: 115 -HFVHRDLAARNVLL 128

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 62.6 bits (152), Expect = 2e-10
 Identities = 51/155 (32%), Positives = 69/155 (44%), Gaps = 42/155 (27%)

Query: 41  LKAVLQECEQLHLL-----------ISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAP 89
           L   LQ  E LHL            ++ L  ++VLQ  SN F            SGE+  
Sbjct: 303 LVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKF------------SGEIPK 350

Query: 90  ELGQLKNLELLAL----------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLK 133
            LG+  NL +L L                GNL KL    L+SN   G IP +L   + L+
Sbjct: 351 NLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLI---LFSNSLEGEIPKSLGACRSLR 407

Query: 134 YLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 168
            +RL +NS SG +P+  T +  +  LD+SNN L G
Sbjct: 408 RVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQG 442

Length = 968

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 37/137 (27%), Positives = 68/137 (49%), Gaps = 9/137 (6%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKE-ERTSGGELQFQTEVKIISMAVHRNLLRLYGF 351
           +G G +G VYK R    G++VA+K++K    + G       E+K++    H N+++L   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 352 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
                +  LV+ +M +  +   +++RQ  LP       K       +GL++ H H    I
Sbjct: 67  FRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPE---SLIKSYLYQLLQGLAFCHSH---GI 119

Query: 412 IHRDVKAANILLDEDAD 428
           +HRD+K  N+L++ +  
Sbjct: 120 LHRDLKPENLLINTEGV 136

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 44/140 (31%), Positives = 64/140 (45%), Gaps = 15/140 (10%)

Query: 294 LGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           LG G FGKV            G++VAVK LK E        ++ E+ I+    H N+++ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 349 YGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
            G C+    K   L+  Y+  GS+   L + + +L  L        A     G++YLH  
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL-----LLFAQQICEGMAYLHSQ 126

Query: 407 CDPKIIHRDVKAANILLDED 426
                IHRD+ A N+LLD D
Sbjct: 127 ---HYIHRDLAARNVLLDND 143

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 41/149 (27%), Positives = 64/149 (42%), Gaps = 18/149 (12%)

Query: 286 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVHR 343
           +     + LG G  G V K RL +  ++   +         +LQ Q   E++I       
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTIT-TDPNPDLQKQILRELEINKSCKSP 59

Query: 344 NLLRLYGFCTTVTEKLL--VYPYMTNGSVAS---RLRER--QSSLPPLDWPTRKKIALGS 396
            +++ YG     +   +     Y   GS+ S   ++++R  +     L      KIA   
Sbjct: 60  YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESV 114

Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLDE 425
            +GLSYLH     KIIHRD+K +NILL  
Sbjct: 115 LKGLSYLHSR---KIIHRDIKPSNILLTR 140

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 44/140 (31%), Positives = 68/140 (48%), Gaps = 7/140 (5%)

Query: 287 GFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGE-LQFQTEVKIISMAVHRN 344
            F     LG+G +G VYK  RL+D +  A+K +     S  E      E++I++   H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 345 LLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           ++  Y        KL +V  Y   G ++  + +R+     +      +I +   RGL  L
Sbjct: 61  IIS-YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119

Query: 404 HEHCDPKIIHRDVKAANILL 423
           HE    KI+HRD+K+ANILL
Sbjct: 120 HEQ---KILHRDLKSANILL 136

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 60.7 bits (148), Expect = 2e-10
 Identities = 42/144 (29%), Positives = 61/144 (42%), Gaps = 23/144 (15%)

Query: 293 ILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISM--------AVHR 343
           I+G G F  V   +     K  A+K L + +     L  + +VK + +          H 
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQ-----LIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 344 NLLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 402
            +++LY +     E L  V  Y  NG +   +R+  S    LD    +  A      L Y
Sbjct: 63  GIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGS----LDEKCTRFYAAEILLALEY 117

Query: 403 LHEHCDPKIIHRDVKAANILLDED 426
           LH      IIHRD+K  NILLD+D
Sbjct: 118 LHSK---GIIHRDLKPENILLDKD 138

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 45/138 (32%), Positives = 66/138 (47%), Gaps = 10/138 (7%)

Query: 293 ILGRGGFGKVYKGRLA-DGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           ++G G FG+V  GRL   GK    VA+K LK   T      F +E  I+    H N++ L
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 349 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 408
            G  T     ++V  YM NGS+ + LR+       +       +  G A G+ YL    D
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL---VGMLRGIASGMKYL---SD 124

Query: 409 PKIIHRDVKAANILLDED 426
              +HRD+ A NIL++ +
Sbjct: 125 MGYVHRDLAARNILVNSN 142

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 60.2 bits (147), Expect = 3e-10
 Identities = 40/135 (29%), Positives = 67/135 (49%), Gaps = 14/135 (10%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVK-IISMAVHRNLLRLYGF 351
           LG G FG VY  R    G+LVA+K++K++  S  E     EVK +  +  H N+++L   
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK-- 64

Query: 352 CTTVTEK---LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 408
                E      V+ YM  G++   +++R+    P      + I     +GL+++H+H  
Sbjct: 65  -EVFRENDELYFVFEYM-EGNLYQLMKDRKGK--PFSESVIRSIIYQILQGLAHIHKH-- 118

Query: 409 PKIIHRDVKAANILL 423
               HRD+K  N+L+
Sbjct: 119 -GFFHRDLKPENLLV 132

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 60.4 bits (147), Expect = 4e-10
 Identities = 35/121 (28%), Positives = 53/121 (43%), Gaps = 10/121 (8%)

Query: 312 LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVA 371
           LVAVK L+ + +      F  EVKI+S     N+ RL G CT      ++  YM NG + 
Sbjct: 48  LVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107

Query: 372 SRLRERQ-------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 424
             L++          +   L + T   +A   A G+ YL        +HRD+   N L+ 
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVG 164

Query: 425 E 425
           +
Sbjct: 165 K 165

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 59.9 bits (145), Expect = 4e-10
 Identities = 40/138 (28%), Positives = 58/138 (42%), Gaps = 7/138 (5%)

Query: 294 LGRGGFGKVYKGRLADGKLVA---VKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 350
           +G G FGKV  G    G   A   VK L+   T   +L F  EV+      H N+L+  G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 351 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWP-TRKKIALGSARGLSYLHEHCDP 409
            C      LLV  +   G + + LR  +  +  +      +++A   A GL +LH+    
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119

Query: 410 KIIHRDVKAANILLDEDA 427
             IH D+   N  L  D 
Sbjct: 120 DFIHSDLALRNCQLTADL 137

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 59.6 bits (144), Expect = 4e-10
 Identities = 45/137 (32%), Positives = 65/137 (47%), Gaps = 14/137 (10%)

Query: 293 ILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 352
            +G+G FG V  G    G  VAVK +K + T+     F  E  +++   H NL++L G  
Sbjct: 13  TIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLG-- 66

Query: 353 TTVTEK---LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
             V EK    +V  YM  GS+   LR R  S+  L      K +L     + YL  +   
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEAN--- 121

Query: 410 KIIHRDVKAANILLDED 426
             +HRD+ A N+L+ ED
Sbjct: 122 NFVHRDLAARNVLVSED 138

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 60.1 bits (145), Expect = 4e-10
 Identities = 45/142 (31%), Positives = 66/142 (46%), Gaps = 9/142 (6%)

Query: 288 FSNKNILGRGGFGKVYKGRLADGK-LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           F+    +G+G FG+VYKG     K +VA+K +  E         Q E+ ++S      + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
           R YG     T+  ++  Y+  GS    L+       PL+      I     +GL YLH  
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE 120

Query: 407 CDPKIIHRDVKAANILLDEDAD 428
              + IHRD+KAAN+LL E  D
Sbjct: 121 ---RKIHRDIKAANVLLSEQGD 139

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 59.8 bits (145), Expect = 4e-10
 Identities = 40/144 (27%), Positives = 70/144 (48%), Gaps = 13/144 (9%)

Query: 288 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQT-EVKIISMAVHRNL 345
           F   N +G+G FG V+K  R AD ++ A+K++   + +  E +    E ++++      +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 346 LRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLD--WPTRKKIALGSARGLSY 402
           +R Y        KL +V  Y  NG +   L+ ++    P D  W    +  +    GL++
Sbjct: 62  IRYYE-SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAH 116

Query: 403 LHEHCDPKIIHRDVKAANILLDED 426
           LH     KI+HRD+K+ N+ LD  
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAY 137

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 59.9 bits (145), Expect = 5e-10
 Identities = 46/137 (33%), Positives = 66/137 (48%), Gaps = 7/137 (5%)

Query: 294 LGRGGFGKVYKGRLADG---KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 350
           +G G FGKV  G +  G     V VK L+   +   +++F  E +      H NLL+  G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 351 FCTTVTEKLLVYPYMTNGSVASRLRE-RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
            CT VT  LLV  +   G +   LR  R++ L   D  T +++A   A GL +LH++   
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119

Query: 410 KIIHRDVKAANILLDED 426
             IH D+   N LL  D
Sbjct: 120 NFIHSDLALRNCLLTAD 136

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 60.2 bits (146), Expect = 5e-10
 Identities = 47/144 (32%), Positives = 66/144 (45%), Gaps = 12/144 (8%)

Query: 288 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQ---TEVKIISMAVHR 343
           F++   +G G FG VY  R +   ++VA+K++        E ++Q    EV+ +    H 
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQQLRHP 75

Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           N +   G         LV  Y   GS AS + E      PL       I  G+ +GL+YL
Sbjct: 76  NTIEYKGCYLREHTAWLVMEYCL-GS-ASDILEVHKK--PLQEVEIAAICHGALQGLAYL 131

Query: 404 HEHCDPKIIHRDVKAANILLDEDA 427
           H H     IHRD+KA NILL E  
Sbjct: 132 HSHE---RIHRDIKAGNILLTEPG 152

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 59.7 bits (145), Expect = 5e-10
 Identities = 45/161 (27%), Positives = 79/161 (49%), Gaps = 23/161 (14%)

Query: 281 LQVATDGFSNKNILGRGGFGKVYKGRLADGKL-----VAVKRLKEERTSGGELQ---FQT 332
           + ++ D  +  ++L  G FG+++ G L D K      V VK +K+  +   E+Q      
Sbjct: 1   IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS---EIQVTLLLQ 57

Query: 333 EVKIISMAVHRNLLRLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPLDWP---- 387
           E  ++    H+N+L +   C    E   V YPYM  G++   L+  Q  L   + P    
Sbjct: 58  ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQ--QCRLGEANNPQALS 115

Query: 388 TRKKIALGS--ARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           T++ + +    A G+SYLH+     +IH+D+ A N ++DE+
Sbjct: 116 TQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEE 153

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 59.5 bits (145), Expect = 6e-10
 Identities = 40/144 (27%), Positives = 65/144 (45%), Gaps = 24/144 (16%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG----------ELQFQTEVKIISMAVH 342
           LG G +  VYK R    G++VA+K++K                 E++   E+K      H
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK------H 61

Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 402
            N++ L       +   LV+ +M    +   ++++   L P D    K   L + RGL Y
Sbjct: 62  PNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPAD---IKSYMLMTLRGLEY 117

Query: 403 LHEHCDPKIIHRDVKAANILLDED 426
           LH +    I+HRD+K  N+L+  D
Sbjct: 118 LHSN---WILHRDLKPNNLLIASD 138

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 59.1 bits (143), Expect = 7e-10
 Identities = 42/134 (31%), Positives = 64/134 (47%), Gaps = 12/134 (8%)

Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG+V+ G       VA+K LK+   S     F  E  ++    H  L+RLY    
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE--AFLAEANLMKQLQHPRLVRLYA--- 68

Query: 354 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
            VT++   ++  YM NGS+   L+  +     L       +A   A G++++        
Sbjct: 69  VVTQEPIYIITEYMENGSLVDFLKTPEGI--KLTINKLIDMAAQIAEGMAFIERK---NY 123

Query: 412 IHRDVKAANILLDE 425
           IHRD++AANIL+ E
Sbjct: 124 IHRDLRAANILVSE 137

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 59.2 bits (144), Expect = 7e-10
 Identities = 35/146 (23%), Positives = 58/146 (39%), Gaps = 16/146 (10%)

Query: 292 NILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGE-LQFQTEVKIISMAVHRNLLRLY 349
             +G+G FG V K  R +DGK++  K +     +  E  Q  +EV I+    H N++R Y
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 350 GFCTTVTEKLLVYPYMTN------GSVASRLRERQSSLP-PLDWPTRKKIALGSARGLSY 402
                      +Y  M          +  + ++ +  +     W    +I       L  
Sbjct: 66  DR-IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW----RILTQLLLALYE 120

Query: 403 LH--EHCDPKIIHRDVKAANILLDED 426
            H        ++HRD+K ANI LD +
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDAN 146

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 44/145 (30%), Positives = 67/145 (46%), Gaps = 15/145 (10%)

Query: 294 LGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLY 349
           LG G FG V +G+L        VAVK +K    +  E++ F +E   +    H N++RL 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 350 GFCTTVTEK------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRK--KIALGSARGLS 401
           G C    E       +++ P+M +G + S L   +    P   PT+   K     A G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 402 YLHEHCDPKIIHRDVKAANILLDED 426
           YL        IHRD+ A N +L+E+
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNEN 148

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 43/139 (30%), Positives = 70/139 (50%), Gaps = 14/139 (10%)

Query: 293 ILGRGGFGKVYKGRLAD-GKLVAVKRLK----EERTSGGELQFQTEVKIISMAVHRNLLR 347
           +LG+G FG+VY    AD G+ +AVK+++       TS      + E++++   +H  +++
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 348 LYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 405
            YG      E+ L     +M  GS+  +L+    S   L     +K       G+SYLH 
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLHS 124

Query: 406 HCDPKIIHRDVKAANILLD 424
           +    I+HRD+K ANIL D
Sbjct: 125 N---MIVHRDIKGANILRD 140

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 58.4 bits (142), Expect = 1e-09
 Identities = 42/146 (28%), Positives = 62/146 (42%), Gaps = 26/146 (17%)

Query: 292 NILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-------ELQFQTEVKIISMAVHR 343
             +G G +G VYK R L  G+ VA+K+++   +  G       E+     +K +    H 
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIAL---LKQLESFEHP 61

Query: 344 NLLRLYGFCTTVTEK-----LLVYPYMTNGSVASRLRERQSSLPP--LDWPTRKKIALGS 396
           N++RL   C            LV+ +     V   L    S  P   L   T K +    
Sbjct: 62  NIVRLLDVCHGPRTDRELKLTLVFEH-----VDQDLATYLSKCPKPGLPPETIKDLMRQL 116

Query: 397 ARGLSYLHEHCDPKIIHRDVKAANIL 422
            RG+ +LH H    I+HRD+K  NIL
Sbjct: 117 LRGVDFLHSHR---IVHRDLKPQNIL 139

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 40/132 (30%), Positives = 60/132 (45%), Gaps = 7/132 (5%)

Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG+V+ G   +   VAVK LK    S     F  E  ++    H  L+RLY   T
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS--VQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 413
                 ++  YM  GS+   L+  +     +  P     +   A G++Y+        IH
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGG--KVLLPKLIDFSAQIAEGMAYIERK---NYIH 126

Query: 414 RDVKAANILLDE 425
           RD++AAN+L+ E
Sbjct: 127 RDLRAANVLVSE 138

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 19/152 (12%)

Query: 291 KNILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLL 346
           ++++G G FG+V K R+    L    A+KR+KE  +      F  E++++  +  H N++
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ--SSLPPLDWPTRKKIALGS-------- 396
            L G C       L   Y  +G++   LR+ +   + P           L S        
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 397 --ARGLSYLHEHCDPKIIHRDVKAANILLDED 426
             ARG+ YL +    + IHRD+ A NIL+ E+
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGEN 160

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 44/139 (31%), Positives = 70/139 (50%), Gaps = 14/139 (10%)

Query: 293 ILGRGGFGKVYKGRLAD-GKLVAVKRL----KEERTSGGELQFQTEVKIISMAVHRNLLR 347
           +LGRG FG+VY    AD G+ +AVK++      + TS      + E++++    H  +++
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 348 LYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 405
            YG      EK L     YM  GS+  +L+    +   L     ++      +G+SYLH 
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHS 124

Query: 406 HCDPKIIHRDVKAANILLD 424
           +    I+HRD+K ANIL D
Sbjct: 125 N---MIVHRDIKGANILRD 140

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 41/137 (29%), Positives = 63/137 (45%), Gaps = 10/137 (7%)

Query: 294 LGRGGFGKVYKGRLAD-GKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRL-Y 349
           LG+GGFG+V   ++   GK+ A K+L ++R     GE     E KI+     R ++ L Y
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
            F  T  +  LV   M  G +  +        P          A     GL +LH+    
Sbjct: 61  AF-ETKDDLCLVMTLMNGGDL--KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR--- 114

Query: 410 KIIHRDVKAANILLDED 426
           +I++RD+K  N+LLD+ 
Sbjct: 115 RIVYRDLKPENVLLDDH 131

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 42/140 (30%), Positives = 66/140 (47%), Gaps = 11/140 (7%)

Query: 288 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNL 345
           F   N +G G +G VY+ R    G++VA+K+++ +    G  +    E+ ++    H N+
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68

Query: 346 LRLYGFCT--TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           + L        +    LV  Y     +AS L    +   P      K + L   RGL YL
Sbjct: 69  VELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPT---PFSESQVKCLMLQLLRGLQYL 124

Query: 404 HEHCDPKIIHRDVKAANILL 423
           HE+    IIHRD+K +N+LL
Sbjct: 125 HENF---IIHRDLKVSNLLL 141

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 57.8 bits (139), Expect = 2e-09
 Identities = 44/142 (30%), Positives = 65/142 (45%), Gaps = 9/142 (6%)

Query: 288 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           F+    +G+G FG+V+KG      K+VA+K +  E         Q E+ ++S      + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
           + YG     T+  ++  Y+  GS    L        PLD      I     +GL YLH  
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE 120

Query: 407 CDPKIIHRDVKAANILLDEDAD 428
              K IHRD+KAAN+LL E  +
Sbjct: 121 ---KKIHRDIKAANVLLSEHGE 139

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 57.8 bits (139), Expect = 2e-09
 Identities = 43/139 (30%), Positives = 72/139 (51%), Gaps = 18/139 (12%)

Query: 293 ILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
           +LG G FG VYKG  + +G+ V    A+K L E       ++F  E  I++   H +L+R
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYLH 404
           L G C + T + LV   M +G +   + E + ++     L+W       +  A+G+ YL 
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 126

Query: 405 EHCDPKIIHRDVKAANILL 423
           E    +++HRD+ A N+L+
Sbjct: 127 ER---RLVHRDLAARNVLV 142

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 36/134 (26%), Positives = 66/134 (49%), Gaps = 6/134 (4%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 352
           LG G +  VYKGR    G++VA+K +  +   G       E+ ++    H N++RL+   
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 412
            T  + +LV+ YM       +  +       LD  T K       +G+++ HE+   +++
Sbjct: 68  HTENKLMLVFEYMDKD--LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVL 122

Query: 413 HRDVKAANILLDED 426
           HRD+K  N+L+++ 
Sbjct: 123 HRDLKPQNLLINKR 136

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 57.4 bits (138), Expect = 3e-09
 Identities = 44/144 (30%), Positives = 66/144 (45%), Gaps = 13/144 (9%)

Query: 288 FSNKNILGRGGFGKVYKGRLADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 344
           F+    +G+G FG+V+KG   D +   +VA+K +  E         Q E+ ++S      
Sbjct: 6   FTKLERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
           + + YG     T+  ++  Y+  GS    LR       P D      +     +GL YLH
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLH 118

Query: 405 EHCDPKIIHRDVKAANILLDEDAD 428
                K IHRD+KAAN+LL E  D
Sbjct: 119 SE---KKIHRDIKAANVLLSEQGD 139

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 39/146 (26%), Positives = 69/146 (47%), Gaps = 6/146 (4%)

Query: 280 ELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS 338
           E +   D    + +LG+G +G VY  R L+    +A+K +  ER S        E+ + S
Sbjct: 2   EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEI-PERDSRYVQPLHEEIALHS 60

Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              HRN+++  G  +      +    +  GS+++ LR +   L   +  T          
Sbjct: 61  YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE-QTIIFYTKQILE 119

Query: 399 GLSYLHEHCDPKIIHRDVKAANILLD 424
           GL YLH++   +I+HRD+K  N+L++
Sbjct: 120 GLKYLHDN---QIVHRDIKGDNVLVN 142

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)

Query: 288 FSNKNILGRGGFGKVYKGR-LADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 399
            ++ RL G C T T + L+   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 69  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 121

Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           ++YL E    +++HRD+ A N+L+
Sbjct: 122 MNYLEER---RLVHRDLAARNVLV 142

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 44/139 (31%), Positives = 66/139 (47%), Gaps = 8/139 (5%)

Query: 294 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRL-Y 349
           LG+GGFG+V   ++ A GKL A K+L ++R     G      E +I++    R ++ L Y
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
            F  T T+  LV   M  G +   +       P    P           GL +LH+    
Sbjct: 61  AF-QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116

Query: 410 KIIHRDVKAANILLDEDAD 428
           +II+RD+K  N+LLD D +
Sbjct: 117 RIIYRDLKPENVLLDNDGN 135

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 57.4 bits (138), Expect = 4e-09
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 17/158 (10%)

Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEV 334
           +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  E 
Sbjct: 2   EVAREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60

Query: 335 KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTRKK 391
            ++      +++RL G  +     L++   MT G + S LR  +  +   P    P+ KK
Sbjct: 61  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120

Query: 392 ---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
              +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 121 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 155

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 56.4 bits (136), Expect = 6e-09
 Identities = 42/138 (30%), Positives = 70/138 (50%), Gaps = 15/138 (10%)

Query: 293 ILGRGGFGKVYK-GRLADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHRNLLRLYG 350
           ++GRG FG V+   R AD KLV +K++  E+ T    L  Q E +++ +  H N++  Y 
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 351 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP----LDWPTRKKIALGSARGLSYLHEH 406
                   ++V  Y   G++A  +++R +SL      L +  +  +AL       ++H  
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL------HHVHTK 120

Query: 407 CDPKIIHRDVKAANILLD 424
               I+HRD+K  NILLD
Sbjct: 121 ---LILHRDLKTQNILLD 135

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 56.7 bits (137), Expect = 6e-09
 Identities = 37/135 (27%), Positives = 63/135 (46%), Gaps = 12/135 (8%)

Query: 293 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH---RNLLRL 348
           ++GRG +G VY+G+ +  G++VA+K +  +         Q EV ++S        N+ + 
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 349 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 408
           YG         ++  Y   GSV + ++       P+       I       L Y+H+   
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV-- 120

Query: 409 PKIIHRDVKAANILL 423
             +IHRD+KAANIL+
Sbjct: 121 -GVIHRDIKAANILV 134

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 56.6 bits (137), Expect = 6e-09
 Identities = 40/146 (27%), Positives = 64/146 (43%), Gaps = 30/146 (20%)

Query: 294 LGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVH-RNLLRLYG- 350
           +GRG FG V K      G ++AVKR++       + +   ++ ++  +     +++ YG 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 351 --------FC----TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
                    C        +K   Y Y     + S + E              KIA+ + +
Sbjct: 72  LFREGDCWICMELMDISLDKFYKYVYE---VLKSVIPEEILG----------KIAVATVK 118

Query: 399 GLSYLHEHCDPKIIHRDVKAANILLD 424
            L+YL E  + KIIHRDVK +NILLD
Sbjct: 119 ALNYLKE--ELKIIHRDVKPSNILLD 142

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 16/154 (10%)

Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FGKVYK +  +   +A  ++ E ++      +  E++I++   H  +++L G   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 413
              +  ++  +   G+V + + E    L     P  + I       L YLH     KIIH
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGLTE---PQIQVICRQMLEALQYLHSM---KIIH 133

Query: 414 RDVKAANILLDEDAD----------QSSKTILRR 437
           RD+KA N+LL  D D          ++ KT+ RR
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR 167

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 56.9 bits (137), Expect = 6e-09
 Identities = 44/154 (28%), Positives = 66/154 (42%), Gaps = 24/154 (15%)

Query: 294 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRN 344
           LG G FG+V         K R      VAVK LK+  T        +E++++  +  H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP------------PLDWPTRKKI 392
           ++ L G CT      ++  Y   G++   LR R+   P             L +      
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           A   ARG+ YL      + IHRD+ A N+L+ ED
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTED 170

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 56.1 bits (135), Expect = 8e-09
 Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 21/148 (14%)

Query: 294 LGRGGFGKVYKGRLAD---GKL---VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
           LG+G FG VY+G   D   G+    VAVK + E  +    ++F  E  ++      +++R
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWPTRKKI---ALGSAR 398
           L G  +     L+V   M +G + S LR      E     PP   PT +++   A   A 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP---PTLQEMIQMAAEIAD 130

Query: 399 GLSYLHEHCDPKIIHRDVKAANILLDED 426
           G++YL+     K +HRD+ A N ++  D
Sbjct: 131 GMAYLNAK---KFVHRDLAARNCMVAHD 155

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 56.4 bits (136), Expect = 8e-09
 Identities = 40/154 (25%), Positives = 68/154 (44%), Gaps = 21/154 (13%)

Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKR----LKEERTSGGELQFQTEVKIISMA 340
           D +     +G G +GKVYK R    GKLVA+K+    + EE      L+   E+ ++ M 
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR---EISLLQML 57

Query: 341 VHRN-LLRLYGFCTTVTEK-------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI 392
                ++RL        E+        LV+ Y+ +          +    PL   T K  
Sbjct: 58  SESIYIVRL--LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF 115

Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
                +G+++ H+H    ++HRD+K  N+L+D+ 
Sbjct: 116 MYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQ 146

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 56.1 bits (135), Expect = 9e-09
 Identities = 45/144 (31%), Positives = 74/144 (51%), Gaps = 22/144 (15%)

Query: 293 ILGRGGFGKVYKG-RLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAV--HRNL 345
           +LG G FG V+KG  + +G      VA+K + ++R+     Q  T+  +++M    H  +
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI-QDRSGRQTFQEITD-HMLAMGSLDHAYI 71

Query: 346 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSY 402
           +RL G C   + +L V      GS+   +R+ + SL P   L+W       +  A+G+ Y
Sbjct: 72  VRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYY 124

Query: 403 LHEHCDPKIIHRDVKAANILLDED 426
           L EH    ++HR++ A NILL  D
Sbjct: 125 LEEHR---MVHRNLAARNILLKSD 145

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 41/141 (29%), Positives = 68/141 (48%), Gaps = 17/141 (12%)

Query: 294 LGRGGFGKVYKGR--LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMA---VHRNLLR 347
           +G G +GKV+K R     G+ VA+KR++ +    G  L    EV ++       H N++R
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 348 LYGFCTTV-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 402
           L+  CT       T+  LV+ ++         +  +  +P     T K +     RGL +
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT---ETIKDMMFQLLRGLDF 125

Query: 403 LHEHCDPKIIHRDVKAANILL 423
           LH H   +++HRD+K  NIL+
Sbjct: 126 LHSH---RVVHRDLKPQNILV 143

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 48/152 (31%), Positives = 69/152 (45%), Gaps = 10/152 (6%)

Query: 278 LRELQVATDGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKI 336
           L  L   TD +     +G+G +GKVYK     DG L AVK L        E++ +  + +
Sbjct: 14  LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI-L 72

Query: 337 ISMAVHRNLLRLYGFCTTVTEKL-----LVYPYMTNGSVASRLRERQSSLPPLDWPTRKK 391
            S+  H N+++ YG      + +     LV      GSV   ++        LD      
Sbjct: 73  QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132

Query: 392 IALGSARGLSYLHEHCDPKIIHRDVKAANILL 423
           I  G+  GL +LH +   +IIHRDVK  NILL
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILL 161

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 45/142 (31%), Positives = 69/142 (48%), Gaps = 12/142 (8%)

Query: 288 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQ---TEVKIISMAVHR 343
           FS+   +G G FG VY  R + + ++VA+K++        E ++Q    EV+ +    H 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKLRHP 75

Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           N ++  G         LV  Y   GS +  L   +  L  ++      +  G+ +GL+YL
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA---VTHGALQGLAYL 131

Query: 404 HEHCDPKIIHRDVKAANILLDE 425
           H H    +IHRDVKA NILL E
Sbjct: 132 HSH---NMIHRDVKAGNILLSE 150

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 47/156 (30%), Positives = 72/156 (46%), Gaps = 28/156 (17%)

Query: 294 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 344
           LG G FG+V         K +      VAVK LK++ T        +E++++ M   H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWP-----------TRKKI- 392
           ++ L G CT      ++  Y + G++   LR R+   P +D+            T K + 
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRP--PGMDYSFDTCKLPEEQLTFKDLV 137

Query: 393 --ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
             A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 138 SCAYQVARGMEYLASQ---KCIHRDLAARNVLVTED 170

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 43/158 (27%), Positives = 69/158 (43%), Gaps = 28/158 (17%)

Query: 291 KNILGRGGFGKVYKGRLADG----------------KLVAVKRLKEERTSGGELQFQTEV 334
           K  LG G FG+V+    A+G                 LVAVK L+ + T      F  E+
Sbjct: 10  KEKLGEGQFGEVHLCE-AEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68

Query: 335 KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ--------SSLPPLDW 386
           KI+S   + N++RL G C +     ++  YM NG +   L +R+        +++P +  
Sbjct: 69  KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128

Query: 387 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 424
                +A+  A G+ YL        +HRD+   N L+ 
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVG 163

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 42/150 (28%), Positives = 64/150 (42%), Gaps = 27/150 (18%)

Query: 292 NILGRGGFGKVYKGR-LADGKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
             +G+G FG+V+K R     ++VA+K+ L E    G  +    E+KI+ +  H N++ L 
Sbjct: 18  AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77

Query: 350 GFCTTVTEKLLVYPYMTNGSVAS-------------RLRERQSSLPPLDWPTRKKIALGS 396
             C T            N    S              L    +          KK+    
Sbjct: 78  EICRTK-------ATPYNRYKGSFYLVFEFCEHDLAGLL--SNKNVKFTLSEIKKVMKML 128

Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLDED 426
             GL Y+H +   KI+HRD+KAANIL+ +D
Sbjct: 129 LNGLYYIHRN---KILHRDMKAANILITKD 155

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 45/139 (32%), Positives = 68/139 (48%), Gaps = 18/139 (12%)

Query: 293 ILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
           +LG G FG VYKG    DG+     VA+K L+E  +     +   E  +++      + R
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRE---RQSSLPPLDWPTRKKIALGSARGLSYLH 404
           L G C T T + LV   M  G +   +RE   R  S   L+W       +  A+G+SYL 
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLE 126

Query: 405 EHCDPKIIHRDVKAANILL 423
           E    +++HRD+ A N+L+
Sbjct: 127 E---VRLVHRDLAARNVLV 142

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 45/153 (29%), Positives = 68/153 (44%), Gaps = 27/153 (17%)

Query: 294 LGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           LG   FGK+YKG L        +LVA+K LK+        +FQ E  +++   H N++ L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 349 YGFCTTVTEKLLVYPYMTNGSVASRLRER----------------QSSLPPLDWPTRKKI 392
            G  T      +++ Y+  G +   L  R                +SSL   D+     I
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF---LHI 129

Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 425
           A+  A G+ YL  H     +H+D+ A NIL+ E
Sbjct: 130 AIQIAAGMEYLSSHF---FVHKDLAARNILIGE 159

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 40/161 (24%), Positives = 70/161 (43%), Gaps = 41/161 (25%)

Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEV------------------- 334
           LG+G F K++KG            ++ E    GEL  +TEV                   
Sbjct: 3   LGQGTFTKIFKG------------IRREVGDYGELH-KTEVLLKVLDKSHRNYSESFFEA 49

Query: 335 -KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA 393
             ++S   H++L+  YG C    E ++V  Y+  GS+ + L++ ++ +    W       
Sbjct: 50  ASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINIS-W------K 102

Query: 394 LGSARGLSY-LHEHCDPKIIHRDVKAANILLDEDADQSSKT 433
           L  A+ L++ LH   D  + H +V A N+LL  + D+ +  
Sbjct: 103 LEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGN 143

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 54.2 bits (131), Expect = 3e-08
 Identities = 44/145 (30%), Positives = 61/145 (42%), Gaps = 14/145 (9%)

Query: 287 GFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL-KEERTSGGELQ-FQTEVKIISMAVHR 343
            F    ++G+G FGKV   +  D K + A+K + K++    G ++    E +I+    H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 344 NLLRL-YGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
            L+ L Y F     E + LV   +  G     LR   S          K         L 
Sbjct: 61  FLVNLWYSFQDE--ENMYLVVDLLLGGD----LRYHLSQKVKFSEEQVKFWICEIVLALE 114

Query: 402 YLHEHCDPKIIHRDVKAANILLDED 426
           YLH      IIHRD+K  NILLDE 
Sbjct: 115 YLHSK---GIIHRDIKPDNILLDEQ 136

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 44/144 (30%), Positives = 69/144 (47%), Gaps = 22/144 (15%)

Query: 293 ILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQ----------FQTEVKIISMAV 341
           ++G G FG VY G  A  G+L+AVK++  E  S                  E+ ++    
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQV--ELPSVSASSKDRKRSMLDALAREIALLKELQ 64

Query: 342 HRNLLRLYGFCTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 400
           H N+++  G  +   + L ++  Y+  GSVA+ L    +    L     ++I     +GL
Sbjct: 65  HENIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGL 119

Query: 401 SYLHEHCDPKIIHRDVKAANILLD 424
           +YLH      IIHRD+K ANIL+D
Sbjct: 120 NYLHNR---GIIHRDIKGANILVD 140

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 41/151 (27%), Positives = 64/151 (42%), Gaps = 19/151 (12%)

Query: 291 KNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 344
           K  LG G FGKV+           D  LVAVK LK+  +      F  E ++++   H +
Sbjct: 10  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEH 68

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL-------PPLDWPTRK--KIALG 395
           +++ YG C      ++V+ YM +G +   LR              P +    +   IA  
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 396 SARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            A G+ YL        +HRD+   N L+ E+
Sbjct: 129 IAAGMVYLASQ---HFVHRDLATRNCLVGEN 156

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 55/162 (33%), Positives = 73/162 (45%), Gaps = 15/162 (9%)

Query: 271 GQLKRFSLRELQVATDG---FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG 326
           G LK   + EL    D    F++   +G G FG VY  R     ++VA+K++        
Sbjct: 7   GSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN 66

Query: 327 ELQFQ---TEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP 383
           E ++Q    EVK +    H N +   G         LV  Y   GS AS L E      P
Sbjct: 67  E-KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GS-ASDLLEVHKK--P 121

Query: 384 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 425
           L       I  G+ +GL+YLH H    +IHRD+KA NILL E
Sbjct: 122 LQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTE 160

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 43/139 (30%), Positives = 67/139 (48%), Gaps = 14/139 (10%)

Query: 293 ILGRGGFGKVYKGRLAD-GKLVAVKRLK----EERTSGGELQFQTEVKIISMAVHRNLLR 347
           +LG+G FG+VY     D G+ +A K+++       TS      + E++++    H  +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 348 LYGFCTTVTEKLLV--YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 405
            YG      EK L     YM  GSV  +L+    +   L     +K       G+SYLH 
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLK----AYGALTESVTRKYTRQILEGMSYLHS 124

Query: 406 HCDPKIIHRDVKAANILLD 424
           +    I+HRD+K ANIL D
Sbjct: 125 N---MIVHRDIKGANILRD 140

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 53.1 bits (127), Expect = 6e-08
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)

Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYA--- 68

Query: 354 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 69  VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 123

Query: 412 IHRDVKAANILLDED 426
           +HRD++AANIL+ E+
Sbjct: 124 VHRDLRAANILVGEN 138

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 54.5 bits (131), Expect = 6e-08
 Identities = 43/131 (32%), Positives = 58/131 (44%), Gaps = 10/131 (7%)

Query: 296 RGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRLYGFC 352
           RG FGKVY GR   + KL AVK +K+       +  Q Q E   ++++    ++ LY   
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73

Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 412
            +     LV  Y+  G V S L          D     K     A  L YLH H    II
Sbjct: 74  QSANNVYLVMEYLIGGDVKSLL----HIYGYFDEEMAVKYISEVALALDYLHRH---GII 126

Query: 413 HRDVKAANILL 423
           HRD+K  N+L+
Sbjct: 127 HRDLKPDNMLI 137

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 53.5 bits (128), Expect = 6e-08
 Identities = 45/136 (33%), Positives = 62/136 (45%), Gaps = 12/136 (8%)

Query: 294 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQ---TEVKIISMAVHRNLLRLY 349
           +G G FG VY    +   ++VAVK++        E ++Q    EVK +    H N +   
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE-KWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
           G         LV  Y   GS +  L   +    PL       I  G+ +GL+YLH H   
Sbjct: 88  GCYLKEHTAWLVMEYCL-GSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSHN-- 141

Query: 410 KIIHRDVKAANILLDE 425
            +IHRD+KA NILL E
Sbjct: 142 -MIHRDIKAGNILLTE 156

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 53.2 bits (128), Expect = 7e-08
 Identities = 31/142 (21%), Positives = 62/142 (43%), Gaps = 6/142 (4%)

Query: 285 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK--EERTSGGELQFQTEVKIISMAV 341
              F  +  +G+G F  VYK   L DG++VA+K+++  E   +        E+ ++    
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           H N+++         E  +V      G ++  ++  +     +   T  K  +     L 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 402 YLHEHCDPKIIHRDVKAANILL 423
           ++H     +I+HRD+K AN+ +
Sbjct: 121 HMHSK---RIMHRDIKPANVFI 139

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 48.7 bits (117), Expect = 7e-08
 Identities = 23/60 (38%), Positives = 31/60 (51%)

Query: 107 KLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 166
            LKSLDL +N            L  LK L L+ N+L+ + P + + + SL  LDLS N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 24/154 (15%)

Query: 294 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 344
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ----------SSLP--PLDWPTRKKI 392
           ++ L G CT      ++  Y + G++   LR R+          + +P   + +      
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
               ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTEN 173

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 52.9 bits (127), Expect = 9e-08
 Identities = 44/141 (31%), Positives = 68/141 (48%), Gaps = 14/141 (9%)

Query: 293 ILGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNL 345
            LG G FGKV +        +D  + VAVK LK    S       +E+KI+S +  H N+
Sbjct: 42  TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101

Query: 346 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL-H 404
           + L G CT     L++  Y   G + + LR ++ S   L        +   A+G+++L  
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF--LTLEDLLSFSYQVAKGMAFLAS 159

Query: 405 EHCDPKIIHRDVKAANILLDE 425
           ++C    IHRD+ A N+LL  
Sbjct: 160 KNC----IHRDLAARNVLLTH 176

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 53.2 bits (127), Expect = 1e-07
 Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 10/145 (6%)

Query: 286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 344
           D +     LG G +  VYKG+   +GKLVA+K ++ +   G       E  ++    H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS-ARGLSYL 403
           ++ L+    T     LV+ Y     V + L +     P    P   K+ L    RGLSY+
Sbjct: 65  IVLLHDIIHTKETLTLVFEY-----VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYI 119

Query: 404 HEHCDPKIIHRDVKAANILLDEDAD 428
           H+     I+HRD+K  N+L+ +  +
Sbjct: 120 HQR---YILHRDLKPQNLLISDTGE 141

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 39/138 (28%), Positives = 63/138 (45%), Gaps = 10/138 (7%)

Query: 293 ILGRGGFGKVYKGRLA-DGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           ILG G FG++ +G L    K    VA+  L+   +      F  E   +    H N++RL
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 349 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 408
            G  T     ++V  YM+NG++ S LR+ +  L          +  G A G+ YL E   
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL---MGMLPGLASGMKYLSEM-- 126

Query: 409 PKIIHRDVKAANILLDED 426
              +H+ + A  +L++ D
Sbjct: 127 -GYVHKGLAAHKVLVNSD 143

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 42/136 (30%), Positives = 65/136 (47%), Gaps = 9/136 (6%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 352
           +G G +G VYK R L  G+L AVK +K E      L  Q E+ ++    H N++  +G  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-IQQEIFMVKECKHCNIVAYFGSY 75

Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 412
            +  +  +   Y   GS    L++      PL       +   + +GL+YLH       +
Sbjct: 76  LSREKLWICMEYCGGGS----LQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK---M 128

Query: 413 HRDVKAANILLDEDAD 428
           HRD+K ANILL ++ D
Sbjct: 129 HRDIKGANILLTDNGD 144

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 50/155 (32%), Positives = 70/155 (45%), Gaps = 27/155 (17%)

Query: 286 DGFSNKNILGRGGFGKVYKGRLAD-GKLVAVK--RLKEERTSGGELQFQTEVKIISMAVH 342
           D F     +G G +G+VYK R  D G+LVA+K  RL  E+  G  +    E+KI+    H
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNH 65

Query: 343 RNLLRLYGFCTTVTEK-------------LLVYPYMTNGSVASRLRERQSSLPPLDWPTR 389
           RN++ L      VT+K              LV+ YM +  +   L E  S L        
Sbjct: 66  RNIVNL---KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMG--LLE--SGLVHFSEDHI 118

Query: 390 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 424
           K        GL+Y H       +HRD+K +NILL+
Sbjct: 119 KSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLN 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 44/145 (30%), Positives = 69/145 (47%), Gaps = 22/145 (15%)

Query: 294 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLR 347
           LG+G FG V   R   L D  G++VAVK+L+        L+ F+ E++I+    H N+++
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAE--HLRDFEREIEILKSLQHDNIVK 69

Query: 348 LYGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSY 402
             G C +   +   LV  Y+  GS+   L   RER      LD       A    +G+ Y
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER------LDHRKLLLYASQICKGMEY 123

Query: 403 LHEHCDPKIIHRDVKAANILLDEDA 427
           L      + +HRD+   NIL++ + 
Sbjct: 124 LGSK---RYVHRDLATRNILVESEN 145

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 39/143 (27%), Positives = 68/143 (47%), Gaps = 24/143 (16%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-------ELQFQTEVKIISMAVHRNL 345
           +G G +G VYK R    G++VA+K+++ E    G       E+    E+       H N+
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN------HPNI 60

Query: 346 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP--PLDWPTRKKIALGSARGLSYL 403
           +RL     +  +  LV+ ++        L++   S P   LD P  K       +G++Y 
Sbjct: 61  VRLLDVVHSENKLYLVFEFLD-----LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115

Query: 404 HEHCDPKIIHRDVKAANILLDED 426
           H H   +++HRD+K  N+L+D +
Sbjct: 116 HSH---RVLHRDLKPQNLLIDRE 135

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 39/135 (28%), Positives = 61/135 (45%), Gaps = 10/135 (7%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---EVKIISMAVHRNLLRLY 349
           LG+G +G VYK      G  +A   +KE R    E +F     E+ I+  AV   ++  Y
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMA---MKEIRLELDESKFNQIIMELDILHKAVSPYIVDFY 65

Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
           G         +   YM  GS+  +L     +   +     ++I     +GL +L E  + 
Sbjct: 66  GAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EH 122

Query: 410 KIIHRDVKAANILLD 424
            IIHRDVK  N+L++
Sbjct: 123 NIIHRDVKPTNVLVN 137

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 36/125 (28%), Positives = 60/125 (48%), Gaps = 25/125 (20%)

Query: 310 GKLVAVKRL---KEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT 366
           G+ VAVK++   K++R    EL F  EV I+    H N++ +Y       E  +V  ++ 
Sbjct: 44  GRQVAVKKMDLRKQQRR---ELLFN-EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99

Query: 367 NGSV-----ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANI 421
            G++      +R+ E Q +           + L   + LS+LH      +IHRD+K+ +I
Sbjct: 100 GGALTDIVTHTRMNEEQIA----------TVCLAVLKALSFLHAQ---GVIHRDIKSDSI 146

Query: 422 LLDED 426
           LL  D
Sbjct: 147 LLTSD 151

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 38/143 (26%), Positives = 64/143 (44%), Gaps = 23/143 (16%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH-RNLLRLYG- 350
           LGRG +G V K R +  G ++AVKR++    S  + +   ++ I   +V     +  YG 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68

Query: 351 --------FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 402
                    C  V +  L   Y        ++ ++  ++P        KIA+   + L Y
Sbjct: 69  LFREGDVWICMEVMDTSLDKFY-------KKVYDKGLTIPE---DILGKIAVSIVKALEY 118

Query: 403 LHEHCDPKIIHRDVKAANILLDE 425
           LH      +IHRDVK +N+L++ 
Sbjct: 119 LHSKL--SVIHRDVKPSNVLINR 139

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 43/132 (32%), Positives = 65/132 (49%), Gaps = 12/132 (9%)

Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG+V+ G       VAVK LK    S     F  E +I+    H  L++LY    
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS--PESFLEEAQIMKKLRHDKLVQLYA--- 68

Query: 354 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
            V+E+   +V  YM+ GS+   L++ +     L  P    +A   A G++Y+        
Sbjct: 69  VVSEEPIYIVTEYMSKGSLLDFLKDGEGR--ALKLPNLVDMAAQVAAGMAYIERM---NY 123

Query: 412 IHRDVKAANILL 423
           IHRD+++ANIL+
Sbjct: 124 IHRDLRSANILV 135

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 33/184 (17%)

Query: 266 SELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVY--------KGRLADGKLVAVKR 317
           SE +L +  R+     +V  D       LG G FG+V         K +      VAVK 
Sbjct: 3   SEYELPEDPRW-----EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKM 57

Query: 318 LKEERTSGGELQFQTEVKIISM-AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE 376
           LK + T        +E++++ M   H+N++ L G CT      ++  Y + G++   LR 
Sbjct: 58  LKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA 117

Query: 377 RQSSLPPLDW---PTRKKIALGS-----------ARGLSYLHEHCDPKIIHRDVKAANIL 422
           R+   P +++   PT+      S           ARG+ YL      K IHRD+ A N+L
Sbjct: 118 RRP--PGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVL 172

Query: 423 LDED 426
           + ED
Sbjct: 173 VTED 176

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 51.1 bits (123), Expect = 3e-07
 Identities = 39/137 (28%), Positives = 65/137 (47%), Gaps = 12/137 (8%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRLYG 350
           + +G +G+V+  +  + G + A+K +K+          Q  TE  I+S A    +++LY 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 351 FCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
           +     + L LV  Y+  G +AS L     ++  LD    +         L YLH +   
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLE----NVGSLDEDVARIYIAEIVLALEYLHSN--- 112

Query: 410 KIIHRDVKAANILLDED 426
            IIHRD+K  NIL+D +
Sbjct: 113 GIIHRDLKPDNILIDSN 129

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 45/149 (30%), Positives = 64/149 (42%), Gaps = 32/149 (21%)

Query: 293 ILGRGGFGKV----YKGRLADGKLVAVKRLKEERTSGGELQFQTEVK----------IIS 338
           +LGRG FGKV    YK     G+L A+K LK+     G++  + EV+            +
Sbjct: 6   VLGRGHFGKVLLAEYKK---TGELYAIKALKK-----GDIIARDEVESLMCEKRIFETAN 57

Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI-ALGSA 397
              H  L+ L+    T      V  Y   G +   +     S P      R    A    
Sbjct: 58  SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP------RAVFYAACVV 111

Query: 398 RGLSYLHEHCDPKIIHRDVKAANILLDED 426
            GL YLHE+   KI++RD+K  N+LLD +
Sbjct: 112 LGLQYLHEN---KIVYRDLKLDNLLLDTE 137

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 39/147 (26%), Positives = 62/147 (42%), Gaps = 16/147 (10%)

Query: 294 LGRGGFGKVYKGRL-------ADGKLVAVKRLKEERTSGGE--LQFQTEVKIISMAVHRN 344
           LG+G F  +YKG L         G    V  + +   S     L F     ++S   H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
           L++LYG C    E ++V  Y+  G +   L  R+ +   L W  +  +A   A  L YL 
Sbjct: 63  LVKLYGVCVR-DENIMVEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQLASALHYLE 118

Query: 405 EHCDPKIIHRDVKAANILLDEDADQSS 431
           +    K++H +V   NIL+        
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEG 142

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 43/152 (28%), Positives = 65/152 (42%), Gaps = 24/152 (15%)

Query: 291 KNILGRGGFGKVYKGR------LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 344
           K  LG G FGKV+           D  LVAVK LK+   +  +  FQ E ++++   H +
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK-DFQREAELLTNLQHEH 68

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE-------------RQSSLPPLDWPTRKK 391
           +++ YG C      ++V+ YM +G +   LR              RQ+    L       
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK-GELGLSQMLH 127

Query: 392 IALGSARGLSYLHEHCDPKIIHRDVKAANILL 423
           IA   A G+ YL        +HRD+   N L+
Sbjct: 128 IASQIASGMVYLASQ---HFVHRDLATRNCLV 156

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 37/137 (27%), Positives = 64/137 (46%), Gaps = 9/137 (6%)

Query: 293 ILGRGGFGK--VYKGRLADGKLVAVKRLKEERTSGGELQF-QTEVKIISMAVHRNLLRLY 349
           +LG+G FG+  +Y+ R  D  LV  K +   R S  E +    E+ I+S+  H N++  Y
Sbjct: 7   VLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
                    L+   Y   G++  ++  ++  L   +        + SA  +SY+H+    
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA--VSYIHKA--- 120

Query: 410 KIIHRDVKAANILLDED 426
            I+HRD+K  NI L + 
Sbjct: 121 GILHRDIKTLNIFLTKA 137

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 33/138 (23%), Positives = 68/138 (49%), Gaps = 11/138 (7%)

Query: 294 LGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT-EVKIISMAVHRNLLRLYGF 351
           +G G +G V+K +  +  ++VA+KR++ +    G       E+ ++    H+N++RLY  
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 352 CTTVTEKLLVYPYMTNGSVASRLRERQSSLP-PLDWPTRKKIALGSARGLSYLHEHCDPK 410
             +  +  LV+ Y         L++   S    +D    K       +GL++ H H    
Sbjct: 68  LHSDKKLTLVFEYCDQD-----LKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---N 119

Query: 411 IIHRDVKAANILLDEDAD 428
           ++HRD+K  N+L++++ +
Sbjct: 120 VLHRDLKPQNLLINKNGE 137

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 51.1 bits (122), Expect = 4e-07
 Identities = 47/142 (33%), Positives = 66/142 (46%), Gaps = 20/142 (14%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-ELQFQTEV---KIISMAVHRNLLRL 348
           +G G +G VYK R    G  VA+K ++ +    G  L    EV   K +    H N++RL
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 349 YGFCTTV-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWP--TRKKIALGSARGLS 401
              C T      T+  LV+ +     V   LR     +PP   P  T K +     RGL 
Sbjct: 68  MDVCATSRTDRETKVTLVFEH-----VDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122

Query: 402 YLHEHCDPKIIHRDVKAANILL 423
           +LH +C   I+HRD+K  NIL+
Sbjct: 123 FLHANC---IVHRDLKPENILV 141

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 42/137 (30%), Positives = 65/137 (47%), Gaps = 10/137 (7%)

Query: 294 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 352
           LG G +  V+KGR      LVA+K ++ E   G       EV ++    H N++ L+   
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS-ARGLSYLHEHCDPKI 411
            T     LV+ Y+      S L++   +   L      KI +    RGLSY H+    KI
Sbjct: 73  HTERCLTLVFEYLD-----SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KI 124

Query: 412 IHRDVKAANILLDEDAD 428
           +HRD+K  N+L++E  +
Sbjct: 125 LHRDLKPQNLLINEKGE 141

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 50.5 bits (121), Expect = 5e-07
 Identities = 37/141 (26%), Positives = 60/141 (42%), Gaps = 21/141 (14%)

Query: 291 KNILGRGGFGKVYKG---RLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
              +G G FG VY+G      + K+ VAVK  K   +     +F  E  I+    H +++
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 347 RLYGFCT-----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           +L G  T      V E   + P    G + S L+  + SL      +    +   +  L+
Sbjct: 71  KLIGVITENPVWIVME---LAPL---GELRSYLQVNKYSLDLA---SLILYSYQLSTALA 121

Query: 402 YLHEHCDPKIIHRDVKAANIL 422
           YL      + +HRD+ A N+L
Sbjct: 122 YLESK---RFVHRDIAARNVL 139

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 50.9 bits (122), Expect = 5e-07
 Identities = 35/139 (25%), Positives = 66/139 (47%), Gaps = 11/139 (7%)

Query: 288 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRN 344
           + N  ++G G +G V K +  + G++VA+K+    E+     ++  + E++++    H N
Sbjct: 3   YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHEN 61

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
           L+ L           LV+ ++ +    + L + +     LD    +K      RG+ + H
Sbjct: 62  LVNLIEVFRRKKRLYLVFEFVDH----TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH 117

Query: 405 EHCDPKIIHRDVKAANILL 423
            H    IIHRD+K  NIL+
Sbjct: 118 SH---NIIHRDIKPENILV 133

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 50.3 bits (120), Expect = 5e-07
 Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 22/155 (14%)

Query: 288 FSNKNILGRGGFGKVYKGRL----ADGKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVH 342
           F+   +LG+G FG V + +L       + VAVK LK +  S  ++ +F  E   +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 343 RNLLRLYGFCTTVTEK------LLVYPYMTNGSV-----ASRLRERQSSLPPLDWPTRKK 391
            N+++L G       K      +++ P+M +G +      SR+ E   +LP     T  +
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLP---LQTLVR 117

Query: 392 IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
             +  A G+ YL        IHRD+ A N +L+E+
Sbjct: 118 FMIDIASGMEYLSSK---NFIHRDLAARNCMLNEN 149

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 50.7 bits (121), Expect = 6e-07
 Identities = 46/171 (26%), Positives = 65/171 (38%), Gaps = 41/171 (23%)

Query: 291 KNILGRGGFGKVY--------------------KGRLADGKLVAVKRLKEERTSGGELQF 330
           K  LG G FG+V+                    KGR     LVAVK L+ +        F
Sbjct: 10  KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGR---PLLVAVKILRPDANKNARNDF 66

Query: 331 QTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ------------ 378
             EVKI+S     N++RL G C       ++  YM NG +   L                
Sbjct: 67  LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126

Query: 379 ---SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
                LP + + +   +AL  A G+ YL        +HRD+   N L+ E+
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGEN 174

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 50.6 bits (121), Expect = 8e-07
 Identities = 51/147 (34%), Positives = 69/147 (46%), Gaps = 29/147 (19%)

Query: 293 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL----- 346
           ++G+G FGKV   +  ADGK  AVK L+++      +  + E K I MA  RN+L     
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKK-----AILKKKEQKHI-MA-ERNVLLKNVK 54

Query: 347 ------RLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 399
                   Y F T   +KL  V  Y+  G +   L +R+ S P    P  +  A   A  
Sbjct: 55  HPFLVGLHYSFQTA--DKLYFVLDYVNGGELFFHL-QRERSFPE---PRARFYAAEIASA 108

Query: 400 LSYLHEHCDPKIIHRDVKAANILLDED 426
           L YLH      II+RD+K  NILLD  
Sbjct: 109 LGYLHSL---NIIYRDLKPENILLDSQ 132

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 50.3 bits (120), Expect = 8e-07
 Identities = 46/143 (32%), Positives = 70/143 (48%), Gaps = 21/143 (14%)

Query: 293 ILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQ------FQTEVKIISMAV-HRN 344
           +LG+G FGKV   RL   G+L AVK LK++      LQ        TE +I+S+A  H  
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVI----LQDDDVECTMTEKRILSLARNHPF 57

Query: 345 LLRLYGFCTTVTEKLL-VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           L +LY  C    ++L  V  ++  G +   +++ +      D    +  A      L +L
Sbjct: 58  LTQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRR----FDEARARFYAAEITSALMFL 112

Query: 404 HEHCDPKIIHRDVKAANILLDED 426
           H   D  II+RD+K  N+LLD +
Sbjct: 113 H---DKGIIYRDLKLDNVLLDHE 132

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 51.0 bits (122), Expect = 9e-07
 Identities = 30/86 (34%), Positives = 46/86 (53%), Gaps = 2/86 (2%)

Query: 104 NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSL-TTITSLNILDLS 162
           N  ++ S+DL     +G I   +  L  ++ + L+NN LSG IP  + TT +SL  L+LS
Sbjct: 67  NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126

Query: 163 NNRLSGPVPDNGSFSQFTPISFENNL 188
           NN  +G +P  GS      +   NN+
Sbjct: 127 NNNFTGSIP-RGSIPNLETLDLSNNM 151

Length = 968

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 50.0 bits (120), Expect = 9e-07
 Identities = 40/141 (28%), Positives = 56/141 (39%), Gaps = 19/141 (13%)

Query: 293 ILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQF-QTEVKIISMAVHRNLLRLYGF 351
                    + K +     LVAVK++  +  S  +L+  Q E+       H N+L  Y  
Sbjct: 9   CFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP-YVT 66

Query: 352 CTTVTEKL-LVYPYMTNGSVASRLRER-QSSLPPLDWPTRKKIAL---GSARGLSYLH-E 405
              V  +L +V P M  GS    L+      LP L       IA         L Y+H +
Sbjct: 67  SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPEL------AIAFILKDVLNALDYIHSK 120

Query: 406 HCDPKIIHRDVKAANILLDED 426
                 IHR VKA++ILL  D
Sbjct: 121 GF----IHRSVKASHILLSGD 137

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 34/137 (24%), Positives = 67/137 (48%), Gaps = 12/137 (8%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHRNLLRLYGF 351
           +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H N+++L   
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 352 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR--KKIALGSARGLSYLHEHCDP 409
             T  +  LV+ ++        L++   + P    P    K       +GL++ H H   
Sbjct: 68  IHTENKLYLVFEFLHQD-----LKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH--- 119

Query: 410 KIIHRDVKAANILLDED 426
           +++HRD+K  N+L++ +
Sbjct: 120 RVLHRDLKPQNLLINTE 136

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 49.7 bits (118), Expect = 1e-06
 Identities = 42/135 (31%), Positives = 64/135 (47%), Gaps = 12/135 (8%)

Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG+G FG+V+ G       VA+K LK          F  E +I+    H  L+ LY    
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM--PEAFLQEAQIMKKLRHDKLVPLYA--- 68

Query: 354 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
            V+E+   +V  +M  GS+   L+E       L  P    +A   A G++Y+        
Sbjct: 69  VVSEEPIYIVTEFMGKGSLLDFLKEGDGKY--LKLPQLVDMAAQIADGMAYIERM---NY 123

Query: 412 IHRDVKAANILLDED 426
           IHRD++AANIL+ ++
Sbjct: 124 IHRDLRAANILVGDN 138

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 41/142 (28%), Positives = 69/142 (48%), Gaps = 17/142 (11%)

Query: 294 LGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGE--LQFQTEVKIISMAVHRNLL 346
           LG G FGKV   R        G+ VAVK LK E  SGG      + E++I+    H N++
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIV 69

Query: 347 RLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
           +  G CT        L+  ++ +GS+   L   ++    ++   + K A+   +G+ YL 
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMDYLG 126

Query: 405 EHCDPKIIHRDVKAANILLDED 426
                + +HRD+ A N+L++ +
Sbjct: 127 SR---QYVHRDLAARNVLVESE 145

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 47/168 (27%), Positives = 74/168 (44%), Gaps = 31/168 (18%)

Query: 271 GQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ 329
           GQ     L +L+   +       +G G  G+VYK R    G ++AVK+++  RT   E  
Sbjct: 7   GQKYPADLNDLENLGE-------IGSGTCGQVYKMRFKKTGHVMAVKQMR--RTGNKE-- 55

Query: 330 FQTEVKIISMAVH--------RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL 381
              E K I M +           +++ YG+  T ++  +    M   +   +L +R    
Sbjct: 56  ---ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGP 110

Query: 382 PPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDAD 428
            P D     K+ +   + L YL E H    +IHRDVK +NILLD   +
Sbjct: 111 IPED--ILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGN 153

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 43/157 (27%), Positives = 65/157 (41%), Gaps = 27/157 (17%)

Query: 291 KNILGRGGFGKVY------------KGRLADGK-----LVAVKRLKEERTSGGELQFQTE 333
           K  LG G FG+V+            K    D       LVAVK L+E+        F  E
Sbjct: 10  KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKE 69

Query: 334 VKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV---ASRLRER----QSSLPPLDW 386
           +KI+S     N++RL   C T     ++  YM NG +    SR   +    ++ +  + +
Sbjct: 70  IKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129

Query: 387 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 423
            T   +A   A G+ YL        +HRD+   N L+
Sbjct: 130 STLIFMATQIASGMKYLSSL---NFVHRDLATRNCLV 163

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 48.4 bits (116), Expect = 3e-06
 Identities = 36/144 (25%), Positives = 65/144 (45%), Gaps = 12/144 (8%)

Query: 295 GRGGFGKVYKGRL---ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA---VHRNLLRL 348
           GRG +G+VYK +     DGK  A+K+ K ++     +  Q+  + I++     H N++ L
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGIS-QSACREIALLRELKHENVVSL 67

Query: 349 YGFCTTVTEKL--LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
                   +K   L++ Y  +         RQ+    +     K +      G+ YLH +
Sbjct: 68  VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN 127

Query: 407 CDPKIIHRDVKAANILLDEDADQS 430
               ++HRD+K ANIL+  +  + 
Sbjct: 128 W---VLHRDLKPANILVMGEGPER 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 40/138 (28%), Positives = 64/138 (46%), Gaps = 12/138 (8%)

Query: 294 LGRGGFGKVYKGR--LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 351
           LG G +  V+KGR  L +  LVA+K ++ E   G       EV ++    H N++ L+  
Sbjct: 14  LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 352 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA-RGLSYLHEHCDPK 410
             T     LV+ Y+        L++       +      KI L    RGL+Y H     K
Sbjct: 73  VHTDKSLTLVFEYLDKD-----LKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---K 124

Query: 411 IIHRDVKAANILLDEDAD 428
           ++HRD+K  N+L++E  +
Sbjct: 125 VLHRDLKPQNLLINERGE 142

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 41/137 (29%), Positives = 66/137 (48%), Gaps = 10/137 (7%)

Query: 294 LGRGGFGKVYKGR--LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 351
           LG G +  VYKGR  L D  LVA+K ++ E   G       EV ++    H N++ L+  
Sbjct: 14  LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 352 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
             T     LV+ Y+ +  +   L +  +S   ++    K       RGL+Y H     K+
Sbjct: 73  IHTEKSLTLVFEYL-DKDLKQYLDDCGNS---INMHNVKLFLFQLLRGLNYCHRR---KV 125

Query: 412 IHRDVKAANILLDEDAD 428
           +HRD+K  N+L++E  +
Sbjct: 126 LHRDLKPQNLLINERGE 142

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 47.5 bits (114), Expect = 5e-06
 Identities = 41/143 (28%), Positives = 62/143 (43%), Gaps = 21/143 (14%)

Query: 291 KNILGRGGFGKVY----KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           K I G+  FGKV     K      KL   K +K +  +  E      V  + M  + N +
Sbjct: 23  KLIDGK--FGKVSVLKHKP---TQKLFVQKIIKAKNFNAIEPM----VHQL-MKDNPNFI 72

Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
           +LY   TT+   +L+  Y+ +G +   L++       L     KKI       L+ LH+H
Sbjct: 73  KLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH 128

Query: 407 CDPKIIHRDVKAANILLDEDADQ 429
               IIH D+K  N+L D   D+
Sbjct: 129 ---NIIHNDIKLENVLYDRAKDR 148

Length = 267

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 47.2 bits (113), Expect = 5e-06
 Identities = 38/138 (27%), Positives = 60/138 (43%), Gaps = 16/138 (11%)

Query: 294 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRLYG 350
           LG GGFG+V   ++    +  A+K +K+        Q    +E +I+    H  +++LY 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59

Query: 351 FCTTVTEKLLVY---PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
              T  +K  +Y    Y   G + + LR+R       D  T +           YLH   
Sbjct: 60  --RTFKDKKYIYMLMEYCLGGELWTILRDRGL----FDEYTARFYIACVVLAFEYLHNR- 112

Query: 408 DPKIIHRDVKAANILLDE 425
              II+RD+K  N+LLD 
Sbjct: 113 --GIIYRDLKPENLLLDS 128

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 47.9 bits (114), Expect = 5e-06
 Identities = 35/98 (35%), Positives = 50/98 (51%), Gaps = 8/98 (8%)

Query: 294 LGRGGFGKVYK------GRLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 346
           LGRG FGKV +       + A  + VAVK LKE  T+       TE+KI I +  H N++
Sbjct: 15  LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74

Query: 347 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPP 383
            L G CT     L+V   Y   G++++ LR ++    P
Sbjct: 75  NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSP 112

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 47.4 bits (113), Expect = 6e-06
 Identities = 37/134 (27%), Positives = 62/134 (46%), Gaps = 10/134 (7%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 352
           LG G +  VYKGR    G+LVA+K ++ E   G       E  ++    H N++ L+   
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72

Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS-ARGLSYLHEHCDPKI 411
            T     LV+ Y+      + L++              ++ L    RGL+Y H+    ++
Sbjct: 73  HTKKTLTLVFEYLD-----TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RV 124

Query: 412 IHRDVKAANILLDE 425
           +HRD+K  N+L+ E
Sbjct: 125 LHRDLKPQNLLISE 138

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 47.4 bits (113), Expect = 6e-06
 Identities = 43/141 (30%), Positives = 66/141 (46%), Gaps = 17/141 (12%)

Query: 293 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEE---RTSGGELQFQTEVKIISMA-VHRNLLR 347
           +LG+G FGKV    L    +L AVK LK++   +    E    TE +++++A  H  L +
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECT-MTEKRVLALAGKHPFLTQ 60

Query: 348 LYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 405
           L       T+  L  V  Y+  G +   ++         D P  +  A     GL +LHE
Sbjct: 61  L--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR----FDEPRARFYAAEIVLGLQFLHE 114

Query: 406 HCDPKIIHRDVKAANILLDED 426
                II+RD+K  N+LLD +
Sbjct: 115 R---GIIYRDLKLDNVLLDSE 132

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 47.2 bits (112), Expect = 7e-06
 Identities = 37/136 (27%), Positives = 59/136 (43%), Gaps = 6/136 (4%)

Query: 294 LGRGGFGKVYKGRLADGKLVA---VKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 350
           +G G FGKV    +     VA   VK LK   +S  + +F  +     +  H N+L+  G
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 351 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 410
            C      LLV+ Y   G + S L + Q           +++A   A G++++H+H    
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---N 119

Query: 411 IIHRDVKAANILLDED 426
            +H D+   N  L  D
Sbjct: 120 FLHSDLALRNCFLTSD 135

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 47.2 bits (113), Expect = 8e-06
 Identities = 37/146 (25%), Positives = 71/146 (48%), Gaps = 19/146 (13%)

Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 343
           D +   N +  G +G VY+ R    G++VA+K+LK E+   G  +    E+ I+    H 
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64

Query: 344 NLLRL----YGFCTTVTEKLLVYPYMTNG--SVASRLRERQSSLPPLDWPTRKKIALGSA 397
           N++ +     G  + + +  +V  Y+ +   S+   ++       P      K + L   
Sbjct: 65  NIVTVKEVVVG--SNLDKIYMVMEYVEHDLKSLMETMK------QPFLQSEVKCLMLQLL 116

Query: 398 RGLSYLHEHCDPKIIHRDVKAANILL 423
            G+++LH++    I+HRD+K +N+LL
Sbjct: 117 SGVAHLHDN---WILHRDLKTSNLLL 139

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 29/165 (17%)

Query: 280 ELQVATDGFSNKNILGRGGFGKVYKGRL---ADG---KLVAVKRLKEERTSGGELQFQTE 333
           E+ ++T  F  +  LG   FGKVYKG L   A G   + VA+K LK++       +F+ E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 334 VKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER---------------Q 378
             + S   H N++ L G  T      +++ Y ++  +   L  R               +
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 379 SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 423
           S+L P D+     I    A G+ +L  H    ++H+D+   N+L+
Sbjct: 119 STLEPADF---VHIVTQIAAGMEFLSSH---HVVHKDLATRNVLV 157

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 47.0 bits (112), Expect = 9e-06
 Identities = 37/135 (27%), Positives = 66/135 (48%), Gaps = 15/135 (11%)

Query: 294 LGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT----EVKIISMAVHRNLLRL 348
           +G G +G V+K R  + G++VA+K+  E   S  +   +     E++++    H NL+ L
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVE---SEDDPVIKKIALREIRMLKQLKHPNLVNL 65

Query: 349 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 408
                   +  LV+ Y  + +V + L +    +P       KKI   + + +++ H+H  
Sbjct: 66  IEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEH---LIKKIIWQTLQAVNFCHKH-- 119

Query: 409 PKIIHRDVKAANILL 423
              IHRDVK  NIL+
Sbjct: 120 -NCIHRDVKPENILI 133

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 37/141 (26%), Positives = 64/141 (45%), Gaps = 24/141 (17%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-------ELQFQTEVKIISMAVHRNL 345
           +G G +G VYK R     + +A+K+++ E+   G       E+    E++      H N+
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ------HGNI 63

Query: 346 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR--KKIALGSARGLSYL 403
           +RL     +     LV+ Y+        L++   S P      R  K       RG++Y 
Sbjct: 64  VRLQDVVHSEKRLYLVFEYLD-----LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118

Query: 404 HEHCDPKIIHRDVKAANILLD 424
           H H   +++HRD+K  N+L+D
Sbjct: 119 HSH---RVLHRDLKPQNLLID 136

Length = 294

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 37/130 (28%), Positives = 60/130 (46%), Gaps = 8/130 (6%)

Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG+V+         VAVK +K    S     F  E  ++    H  L++L+   T
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE--AFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 413
                 ++  +M  GS+   L+  + S  PL  P     +   A G++++ +      IH
Sbjct: 72  K-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NYIH 125

Query: 414 RDVKAANILL 423
           RD++AANIL+
Sbjct: 126 RDLRAANILV 135

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 33/134 (24%), Positives = 58/134 (43%), Gaps = 12/134 (8%)

Query: 292 NILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 350
           N +G G  G VYK      G+L A+K +          Q   E++I+    H N+++ + 
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139

Query: 351 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 410
                 E  ++  +M  GS+       +  L          +A     G++YLH      
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFL--------ADVARQILSGIAYLHRR---H 188

Query: 411 IIHRDVKAANILLD 424
           I+HRD+K +N+L++
Sbjct: 189 IVHRDIKPSNLLIN 202

Length = 353

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 46.4 bits (111), Expect = 1e-05
 Identities = 39/163 (23%), Positives = 62/163 (38%), Gaps = 45/163 (27%)

Query: 288 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EVKII 337
           +     +G G +G V        G+ VA+K++           F           E+K++
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNV------FDDLIDAKRILREIKLL 53

Query: 338 SMAVHRNLLRLYGFCT-TVTEKL----LVYPYM-TNGSVASRLRERQSSLPPLDWPTRKK 391
               H N++ L         E      +V   M T+  +   ++  Q    PL   T   
Sbjct: 54  RHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETD--LHKVIKSPQ----PL---TDDH 104

Query: 392 I------ALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 428
           I       L   RGL YLH      +IHRD+K +NIL++ + D
Sbjct: 105 IQYFLYQIL---RGLKYLHS---ANVIHRDLKPSNILVNSNCD 141

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 42/149 (28%), Positives = 74/149 (49%), Gaps = 29/149 (19%)

Query: 293 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL---QFQTEVKIISMAVHRNLLRL 348
           ++G+GG G+VY        + VA+K+++E+  S   L   +F  E KI +  +H  ++ +
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIRED-LSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 349 YGFCTTVTEKLLVY---PYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARG--LS 401
           Y  C+   +   VY   PY+   ++ S L+   ++ SL        K++A  ++ G  LS
Sbjct: 68  YSICS---DGDPVYYTMPYIEGYTLKSLLKSVWQKESLS-------KELAEKTSVGAFLS 117

Query: 402 YLHEHC-------DPKIIHRDVKAANILL 423
             H+ C          ++HRD+K  NILL
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILL 146

Length = 932

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 37/135 (27%), Positives = 64/135 (47%), Gaps = 12/135 (8%)

Query: 291 KNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           + ILG G  G VYK   L   +++AVK +  + T   + Q  +E++I+       ++  Y
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
           G         +   +M  GS+     +    +P        +IA+   +GL+YL      
Sbjct: 66  GAFFVENRISICTEFMDGGSL-----DVYRKIPE---HVLGRIAVAVVKGLTYL---WSL 114

Query: 410 KIIHRDVKAANILLD 424
           KI+HRDVK +N+L++
Sbjct: 115 KILHRDVKPSNMLVN 129

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 42/151 (27%), Positives = 68/151 (45%), Gaps = 19/151 (12%)

Query: 292 NILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLR 347
           +++G G FG+V K R+    L    A+KR+KE  +      F  E++++  +  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------------RQSSLPPLDWPTRKKIALG 395
           L G C       L   Y  +G++   LR+              S+   L        A  
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 396 SARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            ARG+ YL +    + IHRD+ A NIL+ E+
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGEN 148

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 32/98 (32%), Positives = 49/98 (50%), Gaps = 8/98 (8%)

Query: 294 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 346
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 15  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74

Query: 347 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPP 383
            L G CT     L+V   +   G++++ LR ++    P
Sbjct: 75  NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVP 112

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 48/139 (34%), Positives = 68/139 (48%), Gaps = 17/139 (12%)

Query: 293 ILGRGGFGKVY-KGRLADGKLVAVKRLKEE----RTSGGELQFQTEVKIISMAVHRNLLR 347
           ++G+G FGKV    R  DGK  AVK L+++    R     +  +  V ++    H  L+ 
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVG 60

Query: 348 L-YGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 405
           L Y F TT  EKL  V  ++  G +   L +R+ S P    P  +  A   A  L YLH 
Sbjct: 61  LHYSFQTT--EKLYFVLDFVNGGELFFHL-QRERSFPE---PRARFYAAEIASALGYLHS 114

Query: 406 HCDPKIIHRDVKAANILLD 424
                I++RD+K  NILLD
Sbjct: 115 ---INIVYRDLKPENILLD 130

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 37/123 (30%), Positives = 57/123 (46%), Gaps = 19/123 (15%)

Query: 310 GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS 369
           GK VAVK++   +    EL F  EV I+    H N++ +Y       E  +V  ++  G+
Sbjct: 47  GKQVAVKKMDLRKQQRRELLFN-EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105

Query: 370 VA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 424
           +      +R+ E Q +           + L   R LSYLH      +IHRD+K+ +ILL 
Sbjct: 106 LTDIVTHTRMNEEQIA----------TVCLSVLRALSYLHNQ---GVIHRDIKSDSILLT 152

Query: 425 EDA 427
            D 
Sbjct: 153 SDG 155

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 37/135 (27%), Positives = 63/135 (46%), Gaps = 9/135 (6%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 352
           +G G +G VYK R +  G+L A+K +K E      +  Q E+ ++    H N++  +G  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIMMKDCKHSNIVAYFGSY 75

Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 412
               +  +   +   GS    L++      PL       ++  + +GL YLH       +
Sbjct: 76  LRRDKLWICMEFCGGGS----LQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK---M 128

Query: 413 HRDVKAANILLDEDA 427
           HRD+K ANILL ++ 
Sbjct: 129 HRDIKGANILLTDNG 143

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 36/141 (25%), Positives = 66/141 (46%), Gaps = 17/141 (12%)

Query: 293 ILGRGGFGKVY--KGRLADGKLVAVKRLKEERTSGGELQF-QTEVKIISMAVHRNLLRLY 349
            +G G FGK+Y  K + +D +   +K +   +    E +  + EV +++   H N++  +
Sbjct: 7   KIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSL----PPLDWPTRKKIALGSARGLSYLHE 405
                     +V  Y   G +  R+  ++  L      L W    +I+LG    L ++H 
Sbjct: 66  ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV--QISLG----LKHIH- 118

Query: 406 HCDPKIIHRDVKAANILLDED 426
             D KI+HRD+K+ NI L ++
Sbjct: 119 --DRKILHRDIKSQNIFLSKN 137

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 30/160 (18%)

Query: 294 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 352
           +G G  G V    + + GKLVAVK++   +    EL F  EV I+    H N++ +Y   
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHENVVEMYNSY 86

Query: 353 TTVTEKLLVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
               E  +V  ++  G++      +R+ E Q +           + L   + LS LH   
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----------AVCLAVLKALSVLHAQ- 135

Query: 408 DPKIIHRDVKAANILLDEDAD----------QSSKTILRR 437
              +IHRD+K+ +ILL  D            Q SK + RR
Sbjct: 136 --GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 173

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 39/147 (26%), Positives = 69/147 (46%), Gaps = 12/147 (8%)

Query: 285 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRL-KEERTSGGELQFQTEVKIISMAVH 342
           T+ + +   +G G FG V   R    G+ VA+K++ K   T     +   E+K++    H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 343 RNLLRLYG-FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
            N++ L   F + + +   V   +  G+   RL   +    PL+    +       RGL 
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSR----PLEKQFIQYFLYQILRGLK 122

Query: 402 YLHEHCDPKIIHRDVKAANILLDEDAD 428
           Y+H      ++HRD+K +NIL++E+ D
Sbjct: 123 YVHS---AGVVHRDLKPSNILINENCD 146

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 35/136 (25%), Positives = 65/136 (47%), Gaps = 9/136 (6%)

Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           +GRG +G VYK +  DGK      LK+   +G  +    E+ ++    H N++ L     
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 354 TVTEK--LLVYPYMTNG--SVASRLRERQSSLPPLDWPTR--KKIALGSARGLSYLHEHC 407
           + +++   L++ Y  +    +    R  +++  P+  P    K +      G+ YLH + 
Sbjct: 69  SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128

Query: 408 DPKIIHRDVKAANILL 423
              ++HRD+K ANIL+
Sbjct: 129 ---VLHRDLKPANILV 141

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 44/144 (30%), Positives = 69/144 (47%), Gaps = 23/144 (15%)

Query: 293 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRN----L 345
           I+GRGGFG+VY  R AD GK+ A+K L ++R     GE     E  ++S+    +    +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 346 LRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR---GLS 401
              Y F T   +KL  +   M  G +   L +           +  ++   +A    GL 
Sbjct: 61  CMSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGVF-------SEAEMRFYAAEIILGLE 111

Query: 402 YLHEHCDPKIIHRDVKAANILLDE 425
           ++H      +++RD+K ANILLDE
Sbjct: 112 HMHNRF---VVYRDLKPANILLDE 132

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 42/138 (30%), Positives = 66/138 (47%), Gaps = 11/138 (7%)

Query: 294 LGRG--GFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLY 349
           +GRG      VY  R    G LV V+    E  +   L+  Q EV +     H N++  +
Sbjct: 6   IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65

Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP-LDWPTRKKIALGSARGLSYLHEHCD 408
              TT +   ++ P+M  GS  S L+   +  P  +       I  G+ RGL+YLH++  
Sbjct: 66  TVFTTGSWLWVISPFMAYGSANSLLK---TYFPEGMSEALIGNILFGALRGLNYLHQN-- 120

Query: 409 PKIIHRDVKAANILLDED 426
              IHR++KA++IL+  D
Sbjct: 121 -GYIHRNIKASHILISGD 137

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 37/152 (24%), Positives = 67/152 (44%), Gaps = 19/152 (12%)

Query: 291 KNILGRGGFGKVYKGRLA-DGKLV--AVKRLKEERTSGGELQFQTEVKII-SMAVHRNLL 346
           ++++G G FG+V +  +  DG  +  A+K LKE  +      F  E++++  +  H N++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRE------------RQSSLPPLDWPTRKKIAL 394
            L G C       +   Y   G++   LR+               +   L      + A 
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 395 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
             A G+ YL    + + IHRD+ A N+L+ E+
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGEN 155

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 44.8 bits (107), Expect = 4e-05
 Identities = 44/139 (31%), Positives = 61/139 (43%), Gaps = 16/139 (11%)

Query: 294 LGRGGFGKVYKGRLAD-GKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYG 350
           LG G FG+V   R    GK  A+K L + +            E +I+    H  L+ LYG
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 351 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR---KKIALGSARGLSYLHEHC 407
                +   LV  Y+  G + S LR  +S   P     R    ++ L     L YLH   
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFSHLR--KSGRFPEPV-ARFYAAQVVLA----LEYLH-SL 120

Query: 408 DPKIIHRDVKAANILLDED 426
           D  I++RD+K  N+LLD D
Sbjct: 121 D--IVYRDLKPENLLLDSD 137

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 16/147 (10%)

Query: 288 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRN 344
           F    +LG+GGFG+V   ++ A GK+ A K+L+++R     GE     E +I+     R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-QSSLPPLDWPTRKKIALGSAR---GL 400
           ++ L     T     LV   M  G +   +    ++           +    +A    GL
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE------EGRAVFYAAEICCGL 115

Query: 401 SYLHEHCDPKIIHRDVKAANILLDEDA 427
             LH+    +I++RD+K  NILLD+  
Sbjct: 116 EDLHQE---RIVYRDLKPENILLDDHG 139

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 45.2 bits (107), Expect = 4e-05
 Identities = 39/124 (31%), Positives = 54/124 (43%), Gaps = 20/124 (16%)

Query: 308 ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL---YGFCTTVTEKLLVYPY 364
              K V VK +   +T G E+     +K IS   HR ++ L   Y + +TV   +  Y  
Sbjct: 117 EQRKKVIVKAVTGGKTPGREIDI---LKTIS---HRAIINLIHAYRWKSTVCMVMPKYKC 170

Query: 365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 424
                V     +R   LP     T ++  L +   L+YLH      IIHRDVK  NI LD
Sbjct: 171 DLFTYV-----DRSGPLPLEQAITIQRRLLEA---LAYLHGR---GIIHRDVKTENIFLD 219

Query: 425 EDAD 428
           E  +
Sbjct: 220 EPEN 223

Length = 392

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 33/94 (35%), Positives = 47/94 (50%), Gaps = 14/94 (14%)

Query: 86  ELAPELGQLKNLELLALGN------------LIKLKSLDLYSNLFNGTIPDTLANLKQLK 133
           +L   L  L NL  L L              L  L+ LDL +N     +  +L+NLK L 
Sbjct: 177 DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLS 235

Query: 134 YLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
            L L+NN L   +P S+  +++L  LDLSNN++S
Sbjct: 236 GLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS 268

Length = 394

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 44.4 bits (105), Expect = 7e-05
 Identities = 42/147 (28%), Positives = 61/147 (41%), Gaps = 22/147 (14%)

Query: 292 NILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE-----------LQFQT--EVKII 337
             LG G +GKV K      GK+VA+K++K    S              + F T  E+KI+
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 338 SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 397
           +   H N++ L           LV   M     AS L++       L     K I L   
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIM-----ASDLKKVVDRKIRLTESQVKCILLQIL 129

Query: 398 RGLSYLHEHCDPKIIHRDVKAANILLD 424
            GL+ LH+      +HRD+  ANI ++
Sbjct: 130 NGLNVLHKW---YFMHRDLSPANIFIN 153

Length = 335

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 44.3 bits (104), Expect = 8e-05
 Identities = 43/139 (30%), Positives = 64/139 (46%), Gaps = 11/139 (7%)

Query: 293 ILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRLY 349
           ++GRG + KV   RL  + ++ A+K +K+E     E     QTE  +   A     L   
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 350 GFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 408
             C   T +L LV  Y+  G +   + +RQ  LP       +  A      L++LHE   
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDLMFHM-QRQRKLPE---EHARFYAAEICIALNFLHER-- 115

Query: 409 PKIIHRDVKAANILLDEDA 427
             II+RD+K  N+LLD D 
Sbjct: 116 -GIIYRDLKLDNVLLDADG 133

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 44.1 bits (104), Expect = 8e-05
 Identities = 42/143 (29%), Positives = 65/143 (45%), Gaps = 21/143 (14%)

Query: 293 ILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQ------FQTEVKIISMAV-HRN 344
           +LG+G FGKV         ++ A+K LK++      LQ        TE +I+++A  H  
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI----LQDDDVDCTMTEKRILALAAKHPF 57

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRL-RERQSSLPPLDWPTRKKIALGSARGLSYL 403
           L  L+    T      V  Y+  G +  ++ R R+      D P  +  A      L +L
Sbjct: 58  LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK-----FDEPRSRFYAAEVTLALMFL 112

Query: 404 HEHCDPKIIHRDVKAANILLDED 426
           H H    +I+RD+K  NILLD +
Sbjct: 113 HRH---GVIYRDLKLDNILLDAE 132

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 44.2 bits (104), Expect = 9e-05
 Identities = 34/106 (32%), Positives = 50/106 (47%), Gaps = 6/106 (5%)

Query: 89  PELGQLKNL---ELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGL 145
            EL    N     L +L NL  L  L+L +N     +P+++ NL  L+ L L+NN +S  
Sbjct: 212 EELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-- 268

Query: 146 IPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLC 191
             +SL ++T+L  LDLS N LS  +P          +     L L 
Sbjct: 269 SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLK 314

Length = 394

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 43.8 bits (103), Expect = 9e-05
 Identities = 40/151 (26%), Positives = 65/151 (43%), Gaps = 30/151 (19%)

Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKI-------ISMAV----- 341
           LGRG   ++Y G L        K   E+     E + +  +K+       IS+A      
Sbjct: 3   LGRGTRTQIYAGILNY------KDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETAS 56

Query: 342 ------HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALG 395
                 H++++ LYG C    E ++V  ++  G +   +  R+S    L  P + K+A  
Sbjct: 57  MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH-RKSD--VLTTPWKFKVAKQ 113

Query: 396 SARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            A  LSYL    D  ++H +V   NILL  +
Sbjct: 114 LASALSYLE---DKDLVHGNVCTKNILLARE 141

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 43.8 bits (103), Expect = 9e-05
 Identities = 40/146 (27%), Positives = 65/146 (44%), Gaps = 14/146 (9%)

Query: 288 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRN 344
           F    +LG+GGFG+V   ++ A GK+ A KRL+++R     GE     E +I+     + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR---GLS 401
           ++ L     T     LV   M  G +   +    +  P  +    ++    +A    GL 
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN--PGFE---EERALFYAAEILCGLE 116

Query: 402 YLHEHCDPKIIHRDVKAANILLDEDA 427
            LH       ++RD+K  NILLD+  
Sbjct: 117 DLHRE---NTVYRDLKPENILLDDYG 139

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 43.8 bits (103), Expect = 9e-05
 Identities = 44/144 (30%), Positives = 69/144 (47%), Gaps = 23/144 (15%)

Query: 293 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRN----L 345
           I+GRGGFG+VY  R AD GK+ A+K L ++R     GE     E  ++S+    +    +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 346 LRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR---GLS 401
              Y F T   +KL  +   M  G +   L +           + K++   +     GL 
Sbjct: 61  CMTYAFHT--PDKLCFILDLMNGGDLHYHLSQHGVF-------SEKEMRFYATEIILGLE 111

Query: 402 YLHEHCDPKIIHRDVKAANILLDE 425
           ++H      +++RD+K ANILLDE
Sbjct: 112 HMHNRF---VVYRDLKPANILLDE 132

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 43.8 bits (104), Expect = 1e-04
 Identities = 35/140 (25%), Positives = 66/140 (47%), Gaps = 17/140 (12%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLRLYGF 351
           +G G F +V K +    GK  A+K +K+   S  ++    E++ +  ++ H N+LRL   
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRL--- 63

Query: 352 CTTVTEKL-----LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
              + ++      LV+  M + ++   ++ R+  LP       K       + L ++H +
Sbjct: 64  IEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEK---RVKSYMYQLLKSLDHMHRN 119

Query: 407 CDPKIIHRDVKAANILLDED 426
               I HRD+K  NIL+ +D
Sbjct: 120 ---GIFHRDIKPENILIKDD 136

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 38/141 (26%), Positives = 63/141 (44%), Gaps = 8/141 (5%)

Query: 284 ATDGFSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           A   + N   LG G +  VYKG    +G+LVA+K +  +   G       E  ++    H
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62

Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 402
            N++ L+    T      V+ YM +  +A  + +    L P +    +       RGL+Y
Sbjct: 63  ANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYN---VRLFMFQLLRGLAY 118

Query: 403 LHEHCDPKIIHRDVKAANILL 423
           +H      I+HRD+K  N+L+
Sbjct: 119 IHGQ---HILHRDLKPQNLLI 136

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 37/136 (27%), Positives = 65/136 (47%), Gaps = 9/136 (6%)

Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG-FC 352
           +GRG +G VYK +  DGK      LK+   +G  +    E+ ++    H N++ L   F 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 353 TTVTEKL-LVYPYMTNG--SVASRLRERQSSLPPLDWP--TRKKIALGSARGLSYLHEHC 407
           +    K+ L++ Y  +    +    R  +++  P+  P    K +      G+ YLH + 
Sbjct: 69  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128

Query: 408 DPKIIHRDVKAANILL 423
              ++HRD+K ANIL+
Sbjct: 129 ---VLHRDLKPANILV 141

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 45/153 (29%), Positives = 66/153 (43%), Gaps = 30/153 (19%)

Query: 294 LGRGGFGKVYKGRLADG--KLVAVKRL----------KEERTSGGELQFQTEVKIISMAV 341
           LG G FG VYK R  +    L+A+K +          K ER         +EV II   +
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIG-DIVSEVTIIKEQL 66

Query: 342 -HRNLLRLYGFCTTVTEKLLVYPYM------TNGSVASRLRERQSSLPPLD-WPTRKKIA 393
            H N++R Y    T  E   +Y  M        G   + L+E++        W    ++ 
Sbjct: 67  RHPNIVRYY---KTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123

Query: 394 LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           L     L YLH+  + +I+HRD+   NI+L ED
Sbjct: 124 LA----LRYLHK--EKRIVHRDLTPNNIMLGED 150

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 38/136 (27%), Positives = 62/136 (45%), Gaps = 10/136 (7%)

Query: 294 LGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF- 351
           +G+G +GKV+K     +G   AVK L        E++ +  + + +++ H N+++ YG  
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNI-LKALSDHPNVVKFYGMY 84

Query: 352 ----CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
                    +  LV      GSV   ++        ++ P    I   +  GL +LH + 
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143

Query: 408 DPKIIHRDVKAANILL 423
             K IHRDVK  NILL
Sbjct: 144 --KTIHRDVKGNNILL 157

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 45/140 (32%), Positives = 67/140 (47%), Gaps = 15/140 (10%)

Query: 293 ILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQT--EVKIISMA-VHRNLLRL 348
           +LG+G FGKV+   L    +  A+K LK++     +    T  E +++S+A  H  L  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 349 YGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
           Y  CT  T++ L  V  Y+  G +   ++    S    D P     A     GL +LH  
Sbjct: 62  Y--CTFQTKENLFFVMEYLNGGDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLHSK 115

Query: 407 CDPKIIHRDVKAANILLDED 426
               I++RD+K  NILLD D
Sbjct: 116 ---GIVYRDLKLDNILLDTD 132

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 43/142 (30%), Positives = 66/142 (46%), Gaps = 17/142 (11%)

Query: 293 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV-HRNLLRL 348
           ++GRG + KV   RL    ++ A+K +K+E  +  E     QTE  +   A  H  L+ L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 349 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR---GLSYLHE 405
           +    T +    V  Y+  G +   + +RQ  LP       +     SA     L+YLHE
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLP------EEHARFYSAEISLALNYLHE 114

Query: 406 HCDPKIIHRDVKAANILLDEDA 427
                II+RD+K  N+LLD + 
Sbjct: 115 R---GIIYRDLKLDNVLLDSEG 133

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 37/138 (26%), Positives = 68/138 (49%), Gaps = 17/138 (12%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV---HRNLLRLY 349
           +G G +G VYKGR    G++VA+K+++ E  S  E    T ++ IS+     H N++ L 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLE--SEEEGVPSTAIREISLLKELQHPNIVCLQ 65

Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYLHEH 406
                 +   L++ +++       L++   SLP    +D    K       +G+ + H  
Sbjct: 66  DVLMQESRLYLIFEFLS-----MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120

Query: 407 CDPKIIHRDVKAANILLD 424
              +++HRD+K  N+L+D
Sbjct: 121 ---RVLHRDLKPQNLLID 135

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 46/140 (32%), Positives = 68/140 (48%), Gaps = 16/140 (11%)

Query: 293 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE--LQFQTEVKIISMAVHRNLLRL- 348
           +LG+G FGKV   R  A GK  A+K LK+E     +      TE +++    H  L  L 
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 349 YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
           Y F T   ++L  V  Y   G +   L RER  S     +   + ++      L YLH  
Sbjct: 62  YSFQTH--DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS-----ALGYLHS- 113

Query: 407 CDPKIIHRDVKAANILLDED 426
           CD  +++RD+K  N++LD+D
Sbjct: 114 CD--VVYRDLKLENLMLDKD 131

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 32/101 (31%), Positives = 48/101 (47%), Gaps = 12/101 (11%)

Query: 293 ILGRGGFGKV--------YKGRLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHR 343
           +LG G FGKV         K    +   VAVK LKE  T+       +E+KI I +  H 
Sbjct: 14  VLGHGAFGKVVEASAFGIDKKSSCN--TVAVKMLKEGATASEHKALMSELKILIHIGNHL 71

Query: 344 NLLRLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPP 383
           N++ L G CT     L+V   +   G++++ LR ++    P
Sbjct: 72  NVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSP 112

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 17/32 (53%), Positives = 20/32 (62%), Gaps = 4/32 (12%)

Query: 398 RGLSYLHEHCDPKIIHRDVKAANILLDEDADQ 429
            GL YLH     +IIHRDVK  NI ++ D DQ
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFIN-DVDQ 195

Length = 357

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 40/140 (28%), Positives = 65/140 (46%), Gaps = 17/140 (12%)

Query: 294 LGRGGFGK--VYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYG 350
           +G G FGK  + K +  DGK   +K +   + S  E +  + EV ++S   H N+++   
Sbjct: 8   IGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66

Query: 351 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP----LDWPTRKKIALGSARGLSYLHEH 406
                    +V  Y   G +  ++  ++  L P    LDW  +  +AL         H H
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK--------HVH 118

Query: 407 CDPKIIHRDVKAANILLDED 426
            D KI+HRD+K+ NI L +D
Sbjct: 119 -DRKILHRDIKSQNIFLTKD 137

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 48/144 (33%), Positives = 66/144 (45%), Gaps = 24/144 (16%)

Query: 294 LGRGGFGKVYKGRLAD-GKLVAVKRL-KEERTSGGEL-QFQTEVKIISMAVHRNLLRLYG 350
           LG+G  G+V+  RL   GKL A+K L K+E     ++ +  TE +I++   H  L  LY 
Sbjct: 9   LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68

Query: 351 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR--------GLSY 402
              T T   LV  Y   G +  RL +RQ           K ++   AR         L Y
Sbjct: 69  SFQTETYLCLVMDYCPGGEL-FRLLQRQP---------GKCLSEEVARFYAAEVLLALEY 118

Query: 403 LHEHCDPKIIHRDVKAANILLDED 426
           LH      I++RD+K  NILL E 
Sbjct: 119 LHLL---GIVYRDLKPENILLHES 139

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 41/136 (30%), Positives = 60/136 (44%), Gaps = 11/136 (8%)

Query: 293 ILGRGGFGKVYKGR-LADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLY 349
           ++G+G FGKV   R  A+ K  AVK L+++       E    +E  ++   V    L   
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 350 GFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 408
            F     +KL  V  Y+  G +   L+  +  L P      +  A   A  L YLH    
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP----RARFYAAEIASALGYLHSL-- 115

Query: 409 PKIIHRDVKAANILLD 424
             I++RD+K  NILLD
Sbjct: 116 -NIVYRDLKPENILLD 130

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 41/141 (29%), Positives = 64/141 (45%), Gaps = 8/141 (5%)

Query: 288 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRN 344
           F +  +LG+GGFG+V   ++ A GK+ A K+L+++R     GE     E +I+     R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
           ++ L     T     LV   M  G +   +    +  P  D       A     GL  L 
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQ 119

Query: 405 EHCDPKIIHRDVKAANILLDE 425
                +I++RD+K  NILLD+
Sbjct: 120 RE---RIVYRDLKPENILLDD 137

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 42.2 bits (99), Expect = 4e-04
 Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 7/96 (7%)

Query: 293 ILGRGGFGKV-----YKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNL 345
            LG G FGKV     Y    +D  + VAVK LK            +E+K++S +  H N+
Sbjct: 42  TLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINI 101

Query: 346 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL 381
           + L G CT     L++  Y   G + + LR ++ S 
Sbjct: 102 VNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSF 137

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 41.9 bits (98), Expect = 4e-04
 Identities = 48/140 (34%), Positives = 66/140 (47%), Gaps = 19/140 (13%)

Query: 293 ILGRGGFGKVY-KGRLADGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAV-HRNLLRL 348
           ++G+G FGKV    R +DG   AVK L+++     + Q     E  ++   + H  L+ L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 349 -YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKKI-ALGSARGLSYLH 404
            Y F T   EKL  V  Y+  G +   L RER    P      R +  A   A  + YLH
Sbjct: 62  HYSFQTA--EKLYFVLDYVNGGELFFHLQRERCFLEP------RARFYAAEVASAIGYLH 113

Query: 405 EHCDPKIIHRDVKAANILLD 424
                 II+RD+K  NILLD
Sbjct: 114 SL---NIIYRDLKPENILLD 130

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 41.1 bits (96), Expect = 5e-04
 Identities = 38/151 (25%), Positives = 67/151 (44%), Gaps = 42/151 (27%)

Query: 293 ILGRGGFGKVYKGR-LADGKLVAVKRL-------KEERTSGGELQFQTEVKIISMAVHRN 344
           ++G+G +G+V   R   DGK   +K+L       +E + +  E Q  +++K  ++  +R 
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 345 --------LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP----LDWPTRKKI 392
                   L  + GFC               G +  +L+E++  L P    ++W  +  +
Sbjct: 67  SWEGEDGLLYIVMGFCE-------------GGDLYHKLKEQKGKLLPENQVVEWFVQIAM 113

Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 423
           AL       YLHE     I+HRD+K  N+ L
Sbjct: 114 AL------QYLHEK---HILHRDLKTQNVFL 135

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 41.3 bits (97), Expect = 7e-04
 Identities = 41/141 (29%), Positives = 69/141 (48%), Gaps = 17/141 (12%)

Query: 293 ILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV-HRNLLRL 348
           ++GRG + KV    L    ++ A+K +K+E  +  E     QTE  +   A  H  L+ L
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61

Query: 349 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR---KKIALGSARGLSYLHE 405
           +    T +    V  +++ G +   + +RQ  LP  +   R    +I+L     L++LHE
Sbjct: 62  HSCFQTESRLFFVIEFVSGGDLMFHM-QRQRKLP--EEHARFYSAEISLA----LNFLHE 114

Query: 406 HCDPKIIHRDVKAANILLDED 426
                II+RD+K  N+LLD +
Sbjct: 115 R---GIIYRDLKLDNVLLDAE 132

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 40.9 bits (96), Expect = 7e-04
 Identities = 39/136 (28%), Positives = 58/136 (42%), Gaps = 15/136 (11%)

Query: 296 RGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVK-----IISMAVHRNLLRLY 349
           +G FG VY  +  + G   A+K LK  ++        T VK     ++       + +LY
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLK--KSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
               +     LV  Y+  G  AS L +    LP  DW   K+       G+  LH     
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCAS-LIKTLGGLP-EDWA--KQYIAEVVLGVEDLH---QR 116

Query: 410 KIIHRDVKAANILLDE 425
            IIHRD+K  N+L+D+
Sbjct: 117 GIIHRDIKPENLLIDQ 132

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 41.4 bits (97), Expect = 7e-04
 Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 7/93 (7%)

Query: 293 ILGRGGFGKVYK------GRLADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNL 345
            LG G FGKV +      G+  +   VAVK LK    +       +E+KI+S +  H+N+
Sbjct: 45  TLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNI 104

Query: 346 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ 378
           + L G CT     L++  Y   G + + LR++ 
Sbjct: 105 VNLLGACTHGGPVLVITEYCCYGDLLNFLRKKA 137

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.4 bits (85), Expect = 0.001
 Identities = 16/49 (32%), Positives = 22/49 (44%)

Query: 94  LKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSL 142
           L  +   A   L  LK LDL  N      P+  + L  L+ L L+ N+L
Sbjct: 12  LTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 33/106 (31%), Positives = 48/106 (45%), Gaps = 8/106 (7%)

Query: 286 DGFSNKNILGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKIIS- 338
           DG     ILG G FGKV +G      R      VAVK LK    S  +    +E+KI++ 
Sbjct: 37  DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTH 96

Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL-RERQSSLPP 383
           +  H N++ L G CT      ++  Y   G + + L + R + L  
Sbjct: 97  LGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSR 142

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 34/141 (24%), Positives = 67/141 (47%), Gaps = 10/141 (7%)

Query: 288 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK--EERTSGGELQFQTEVKIISMAVHRN 344
           F  +  +GRG F +VY+   L DG  VA+K+++  +   +        E+ ++    H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLR--ERQSSLPPLDWPTRKKIALGSARGLSY 402
           +++ Y       E  +V      G ++  ++  ++Q  L P     +  + L SA  L +
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA--LEH 121

Query: 403 LHEHCDPKIIHRDVKAANILL 423
           +H     +++HRD+K AN+ +
Sbjct: 122 MHSR---RVMHRDIKPANVFI 139

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 40.9 bits (96), Expect = 0.001
 Identities = 46/155 (29%), Positives = 66/155 (42%), Gaps = 19/155 (12%)

Query: 277 SLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL-KEERTSGGELQFQTEV 334
            + +L++  + F    ++GRG FG+V   R    K V A+K L K E     +  F  E 
Sbjct: 34  KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE 93

Query: 335 KIISMAVHRN---LLRLYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTR 389
           + I MA H N   +++L        +K L  V  YM  G + + +        P  W  R
Sbjct: 94  RDI-MA-HANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDI---PEKW-AR 145

Query: 390 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 424
              A      L  +H       IHRDVK  N+LLD
Sbjct: 146 FYTA-EVVLALDAIHSM---GFIHRDVKPDNMLLD 176

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 40.5 bits (95), Expect = 0.001
 Identities = 18/38 (47%), Positives = 26/38 (68%), Gaps = 2/38 (5%)

Query: 391 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 428
           KI++   RGL+YL E    KI+HRDVK +NIL++   +
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGE 138

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 41/143 (28%), Positives = 67/143 (46%), Gaps = 12/143 (8%)

Query: 288 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRN 344
           F +  +LG+GGFG+V   ++ A GK+ A K+L+++R     GE     E +I+     R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI--ALGSARGLSY 402
           ++ L     T     LV   M  G     L+    ++    +   + +  A     GL  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGD----LKFHIYNMGNPGFDEERAVFYAAEITCGLED 117

Query: 403 LHEHCDPKIIHRDVKAANILLDE 425
           LH     +I++RD+K  NILLD+
Sbjct: 118 LHRE---RIVYRDLKPENILLDD 137

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 45/140 (32%), Positives = 65/140 (46%), Gaps = 14/140 (10%)

Query: 293 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE--LQFQTEVKIISMAVHRNLLRL- 348
           +LG+G FGKV   R  A GK  A+K LK+E     +      TE +++    H  L  L 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 349 YGFCTTVTEKLLVYPYMTNGSVASRL-RERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           Y F  T      V  Y+  G +   L RER  S     +   + ++      L YLH   
Sbjct: 62  YSF-QTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVS-----ALDYLHSG- 114

Query: 408 DPKIIHRDVKAANILLDEDA 427
             KI++RD+K  N++LD+D 
Sbjct: 115 --KIVYRDLKLENLMLDKDG 132

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 40/142 (28%), Positives = 68/142 (47%), Gaps = 22/142 (15%)

Query: 294 LGRGGFGKVYKGRLAD-GKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRL-Y 349
           LG+GGFG+V   ++ + GK+ A K+L ++R     GE     E +I+       ++ L Y
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLR---ERQSSLPPLDWPTRKKIALGSAR---GLSYL 403
            F  + T   LV   M  G +   +    ER   +        +++   SA+   G+ +L
Sbjct: 61  AF-ESKTHLCLVMSLMNGGDLKYHIYNVGERGLEM--------ERVIHYSAQITCGILHL 111

Query: 404 HEHCDPKIIHRDVKAANILLDE 425
           H      I++RD+K  N+LLD+
Sbjct: 112 HSM---DIVYRDMKPENVLLDD 130

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 38/144 (26%), Positives = 67/144 (46%), Gaps = 7/144 (4%)

Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKE-ERTSGGELQFQTEVKIISMA 340
           ++  D F   + LG G  G V K +     L+  ++L   E       Q   E++++   
Sbjct: 1   ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 341 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 400
               ++  YG   +  E  +   +M  GS+   L+E +  +P        K+++   RGL
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR-IPE---EILGKVSIAVLRGL 116

Query: 401 SYLHEHCDPKIIHRDVKAANILLD 424
           +YL E    +I+HRDVK +NIL++
Sbjct: 117 AYLRE--KHQIMHRDVKPSNILVN 138

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 40.0 bits (94), Expect = 0.002
 Identities = 43/151 (28%), Positives = 67/151 (44%), Gaps = 24/151 (15%)

Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVH 342
           D F    ++GRG FG+V+  R    G++ A+K L++            + E  I++ A  
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 343 RNLLRLYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKI-----ALG 395
             +++LY   +   E+ L  V  YM  G + + L  R+   P  +   R  I     AL 
Sbjct: 61  PWIVKLY--YSFQDEEHLYLVMEYMPGGDLMNLL-IRKDVFPE-ET-ARFYIAELVLALD 115

Query: 396 SARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           S   L +         IHRD+K  NIL+D D
Sbjct: 116 SVHKLGF---------IHRDIKPDNILIDAD 137

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 40/154 (25%), Positives = 66/154 (42%), Gaps = 30/154 (19%)

Query: 294 LGRGGFGKVYKGRL--------ADGKLVAVKRLKEERTSGGELQ---------------- 329
           LG+G    +Y GRL         + ++     L E   +G EL+                
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 330 FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR 389
           F     ++S   H +L  ++G C   +E ++V  ++ +G +   LR+ +  + P+ W   
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRV-PVAWKIT 121

Query: 390 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 423
               L SA  LSYL    D  ++H +V A NILL
Sbjct: 122 VAQQLASA--LSYLE---DKNLVHGNVCAKNILL 150

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 39.6 bits (92), Expect = 0.003
 Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 10/98 (10%)

Query: 332 TEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP-YMTNGSVASRLRERQSSLPPLDWPTRK 390
           TE  I+    H ++++L G  T      L+ P Y T+  +   L  +++ +   D    +
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD--LYCYLAAKRN-IAICDILAIE 188

Query: 391 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 428
           +  L   R + YLHE+   +IIHRD+KA NI ++   D
Sbjct: 189 RSVL---RAIQYLHEN---RIIHRDIKAENIFINHPGD 220

Length = 391

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 39.0 bits (91), Expect = 0.003
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 35/152 (23%)

Query: 293 ILGRGGFGKVY----KGRLADGKLVAVKRLKE----ERTSGGELQFQTEVKIISMAVHRN 344
           +LG G +GKV+     G    GKL A+K LK+    ++    E   +TE +++  AV R 
Sbjct: 7   VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAE-HTRTERQVLE-AVRRC 64

Query: 345 --LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR---- 398
             L+ L+    T T+  L+  Y+  G + + L +R+                   R    
Sbjct: 65  PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE------------HFTESEVRVYIA 112

Query: 399 ----GLSYLHEHCDPKIIHRDVKAANILLDED 426
                L +LH+     II+RD+K  NILLD +
Sbjct: 113 EIVLALDHLHQL---GIIYRDIKLENILLDSE 141

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 38/140 (27%), Positives = 60/140 (42%), Gaps = 20/140 (14%)

Query: 294 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 352
           +G G  G V   R    G+ VAVK +   +    EL F  EV I+    H+N++ +Y   
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN-EVVIMRDYQHQNVVEMYKSY 87

Query: 353 TTVTEKLLVYPYMTNGSVAS-----RLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
               E  ++  ++  G++       RL E Q +           +     + L YLH   
Sbjct: 88  LVGEELWVLMEFLQGGALTDIVSQTRLNEEQIA----------TVCESVLQALCYLHSQ- 136

Query: 408 DPKIIHRDVKAANILLDEDA 427
              +IHRD+K+ +ILL  D 
Sbjct: 137 --GVIHRDIKSDSILLTLDG 154

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 39.0 bits (91), Expect = 0.003
 Identities = 36/152 (23%), Positives = 62/152 (40%), Gaps = 42/152 (27%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVK--------RLKEERTSGGELQFQTEVKIISMAVHRN 344
           +G G FG+V+  R        A+K        RLK+E+          E +++    H  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQ------HVHNEKRVLKEVSHPF 62

Query: 345 LLRLYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR---- 398
           ++RL+   T   ++ L  +  Y+  G + S LR               + +  +      
Sbjct: 63  IIRLF--WTEHDQRFLYMLMEYVPGGELFSYLR------------NSGRFSNSTGLFYAS 108

Query: 399 ----GLSYLHEHCDPKIIHRDVKAANILLDED 426
                L YLH     +I++RD+K  NILLD++
Sbjct: 109 EIVCALEYLHSK---EIVYRDLKPENILLDKE 137

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 38.8 bits (90), Expect = 0.003
 Identities = 41/144 (28%), Positives = 65/144 (45%), Gaps = 26/144 (18%)

Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKE-ERTSGGEL------QFQTEVKIISMAVHRNLL 346
           LG+G FG VY   + D K VA +RLK  +    GEL      Q   E +++S   H  ++
Sbjct: 8   LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 347 RLYG-------FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 399
           + +        FC  +TE      Y     +  +L E + +   L      +  +    G
Sbjct: 66  KFHASFLERDAFCI-ITE------YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118

Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           + Y+H+    +I+HRD+KA NI L
Sbjct: 119 VHYMHQR---RILHRDLKAKNIFL 139

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 43/153 (28%), Positives = 67/153 (43%), Gaps = 15/153 (9%)

Query: 278 LRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK--EERTSGGELQFQTEV 334
           +R+LQ+  + +    ++GRG FG+V   R  +  K+ A+K L   E         F  E 
Sbjct: 35  IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 335 KIISMAVHRNLLRLYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKI 392
            I++ A    +++L  FC    +K L  V  YM  G + + +        P  W   K  
Sbjct: 95  DIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV---PEKWA--KFY 147

Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 425
                  L  +H      +IHRDVK  N+LLD+
Sbjct: 148 TAEVVLALDAIHSM---GLIHRDVKPDNMLLDK 177

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 39.3 bits (91), Expect = 0.003
 Identities = 37/140 (26%), Positives = 61/140 (43%), Gaps = 24/140 (17%)

Query: 296 RGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL------- 348
           R G     +G+    +L+A KR+K    S   +Q + E+  +    H N+L++       
Sbjct: 179 RRGVNSTNQGKPKCERLIA-KRVKA--GSRAAIQLENEILALGRLNHENILKIEEILRSE 235

Query: 349 -YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-LGSARGLSYLHEH 406
              +  T      +Y +M + +   + R       PL   TR  +  L  A  + Y+H  
Sbjct: 236 ANTYMITQKYDFDLYSFMYDEAFDWKDR-------PLLKQTRAIMKQLLCA--VEYIH-- 284

Query: 407 CDPKIIHRDVKAANILLDED 426
            D K+IHRD+K  NI L+ D
Sbjct: 285 -DKKLIHRDIKLENIFLNCD 303

Length = 501

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 38/140 (27%), Positives = 65/140 (46%), Gaps = 15/140 (10%)

Query: 294 LGRGGFGKVYKGRLAD-GKLVAVKRL-KEERTSGGELQFQT-EVKIISMAVHRNLLRLYG 350
           +G+G FG+VY+ R  D  ++ A+K L K+E  +  E+     E  I+   +      + G
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 351 F---CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS-ARGLSYLHEH 406
                 T ++  LV  YM+ G +   L +++          R K  +      L +LH++
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHL-QKEGRFSE----DRAKFYIAELVLALEHLHKY 115

Query: 407 CDPKIIHRDVKAANILLDED 426
               I++RD+K  NILLD  
Sbjct: 116 ---DIVYRDLKPENILLDAT 132

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 39.0 bits (91), Expect = 0.004
 Identities = 50/231 (21%), Positives = 75/231 (32%), Gaps = 61/231 (26%)

Query: 227 PVGVALGAALLF---AVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQV 283
             G AL         A P +   +       + F   P E            F       
Sbjct: 89  APGAALALLAATYLWATPGVAPGFV------DMFVLAPLEGLFR------PSFKK----- 131

Query: 284 ATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKII 337
             D F     LG G FG VYK  L       +GK V +K+  E     G ++     ++ 
Sbjct: 132 --DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYV-LKKATEY----GAVEIWMNERVR 184

Query: 338 SMAVHRNLLRLYGFCTTVTEK-----LLVYPYMTNGSVASRLRERQ-------------S 379
               +     +YGF   V+ K      LV+ Y    ++A  ++ ++              
Sbjct: 185 RACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQ 244

Query: 380 SLPPLDWPTRKKIALGSARG-----LSYLHEHCDPKIIHRDVKAANILLDE 425
            LP      R+   + +        L  LH      I+HRDVK  NI+  E
Sbjct: 245 DLPK--GLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQNIIFSE 290

Length = 566

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	438
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	99.97
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.96
KOG0581	364	consensus Mitogen-activated protein kinase kinase	99.95
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.95
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.95
KOG0575	592	consensus Polo-like serine/threonine protein kinas	99.95
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.95
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.94
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.94
KOG3653	534	consensus Transforming growth factor beta/activin	99.94
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.94
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.94
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.94
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.93
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.93
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.93
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.93
KOG0605	550	consensus NDR and related serine/threonine kinases	99.93
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.93
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.93
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.93
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.92
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.92
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.92
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.92
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.92
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.92
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.92
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.92
KOG0198	313	consensus MEKK and related serine/threonine protei	99.92
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.92
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.91
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.91
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.91
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.91
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.91
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.91
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.91
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.91
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.91
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.91
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.91
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.91
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.91
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.91
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.91
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.91
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.91
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.91
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.91
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.9
KOG0610	459	consensus Putative serine/threonine protein kinase	99.9
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.9
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.9
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.9
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.9
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.9
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.9
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.9
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.9
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.9
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.9
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.9
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.9
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.9
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.9
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.9
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.9
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.9
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.9
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.9
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.9
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.9
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.9
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.89
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.89
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.89
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.89
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.89
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.89
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.89
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.89
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.89
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.89
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.89
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.89
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.89
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.89
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.89
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.89
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.89
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.89
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.89
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.89
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.89
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.89
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.89
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.89
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.89
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.89
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.89
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.89
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.89
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.89
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.89
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.89
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.89
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.89
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.89
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.89
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.89
PTZ00267	478	NIMA-related protein kinase; Provisional	99.89
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.89
PHA02988	283	hypothetical protein; Provisional	99.89
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.89
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.89
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.89
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.89
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.89
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.89
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.89
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.88
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.88
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.88
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.88
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.88
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.88
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.88
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.88
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.88
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.88
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.88
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.88
PHA03212	391	serine/threonine kinase US3; Provisional	99.88
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.88
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.88
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.88
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.88
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.88
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.88
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.88
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.88
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.88
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.88
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.88
KOG0578	550	consensus p21-activated serine/threonine protein k	99.88
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.88
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.88
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.88
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.88
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.88
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.88
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.88
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.88
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.88
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.88
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.88
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.88
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.88
KOG0586	596	consensus Serine/threonine protein kinase [General	99.88
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.88
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.88
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.88
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.88
PTZ00283	496	serine/threonine protein kinase; Provisional	99.88
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.88
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.88
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.88
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.88
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.88
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.88
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.88
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.88
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.87
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.87
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.87
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.87
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.87
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.87
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.87
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.87
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.87
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.87
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.87
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.87
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.87
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.87
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.87
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.87
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.87
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.87
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.87
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.87
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.87
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.87
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.87
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.87
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.87
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.87
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.87
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.87
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.87
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.87
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.87
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.87
PHA03209	357	serine/threonine kinase US3; Provisional	99.87
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.87
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.86
PTZ00036	440	glycogen synthase kinase; Provisional	99.86
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.86
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.86
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.86
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.86
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.86
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.86
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.86
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.86
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.86
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.86
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.86
PHA03211	461	serine/threonine kinase US3; Provisional	99.86
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.86
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.86
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.86
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.86
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.86
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.86
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.86
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.86
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.86
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.86
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.86
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.86
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.86
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.86
KOG0589	426	consensus Serine/threonine protein kinase [General	99.86
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.86
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.86
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.86
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.86
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.86
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.86
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.86
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.86
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.86
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.86
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.86
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.86
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.86
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.86
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.86
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.86
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.86
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.86
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.86
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.85
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.85
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.85
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.85
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.85
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.85
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.85
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.85
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.85
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.85
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.85
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.85
KOG0584	632	consensus Serine/threonine protein kinase [General	99.85
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.85
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.85
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.85
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.85
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.85
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.85
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.85
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.85
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.85
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.85
PHA03207	392	serine/threonine kinase US3; Provisional	99.85
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.85
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.85
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.85
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.85
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.85
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.85
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.85
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.85
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.85
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.84
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.84
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.84
PRK09188	365	serine/threonine protein kinase; Provisional	99.84
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.84
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.84
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.84
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.84
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.84
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.84
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.84
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.84
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.84
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.84
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.84
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.84
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.84
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.84
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.84
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.84
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.84
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.84
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.84
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.84
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.83
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.83
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.83
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.83
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.83
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.83
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.83
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.83
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.83
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.83
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.83
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.83
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.83
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.83
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.83
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.83
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.83
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.83
PLN00009	294	cyclin-dependent kinase A; Provisional	99.83
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.83
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.83
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.83
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.82
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.82
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.82
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.82
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.82
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.82
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.82
PTZ00284	467	protein kinase; Provisional	99.82
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.82
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.82
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.82
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.82
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.82
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.82
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.82
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.82
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.82
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.82
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.82
PHA03210	501	serine/threonine kinase US3; Provisional	99.81
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.81
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.81
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.81
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.81
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.81
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.81
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.81
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.81
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.8
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.8
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.8
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.8
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.8
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.8
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.8
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.8
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.8
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.8
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.79
PRK10345	210	hypothetical protein; Provisional	99.79
KOG1152	772	consensus Signal transduction serine/threonine kin	99.79
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.79
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.78
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.78
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.78
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.78
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.77
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.77
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.77
PHA02882	294	putative serine/threonine kinase; Provisional	99.76
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.76
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.75
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.75
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.74
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.73
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.73
PRK14879	211	serine/threonine protein kinase; Provisional	99.72
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.72
smart00090	237	RIO RIO-like kinase.	99.71
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.71
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.71
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.7
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.7
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.7
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.7
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.7
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.69
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.68
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.67
PRK12274	218	serine/threonine protein kinase; Provisional	99.67
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.67
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.64
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.64
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.6
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.6
PLN03150	623	hypothetical protein; Provisional	99.6
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.6
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.6
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.59
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.56
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.55
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.53
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.53
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.52
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.46
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.46
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.43
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.42
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.4
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.34
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.27
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.24
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.23
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.22
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.21
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.18
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.15
PLN00181	793	protein SPA1-RELATED; Provisional	99.15
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.11
PLN03150	623	hypothetical protein; Provisional	99.1
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.1
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.08
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.07
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.06
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.05
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.02
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	98.98
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.91
KOG0472	565	consensus Leucine-rich repeat protein [Function un	98.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	98.87
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	98.87
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.78
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.78
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.73
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.72
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.69
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.69
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.69
KOG3087	229	consensus Serine/threonine protein kinase [General	98.69
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.68
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.67
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	98.66
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	98.59
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.59
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.57
KOG1243	690	consensus Protein kinase [General function predict	98.49
PRK09902	216	hypothetical protein; Provisional	98.48
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.46
KOG0590	601	consensus Checkpoint kinase and related serine/thr	98.46
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.42
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	98.38
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.37
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	98.36
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.32
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	98.32
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.3
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.25
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.14
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.14
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.14
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	98.11
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.09
KOG4237	498	consensus Extracellular matrix protein slit, conta	98.07
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.06
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.04
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.04
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.03
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	97.99
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.97
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	97.94
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.94
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	97.92
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	97.9
PLN02876	822	acyl-CoA dehydrogenase	97.89
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.86
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	97.84
PRK10593	297	hypothetical protein; Provisional	97.84
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.79
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	97.76
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.73
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	97.71
PF01636	239	APH: Phosphotransferase enzyme family This family	97.7
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	97.67
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	97.6

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.4e-45  Score=408.05  Aligned_cols=368  Identities=28%  Similarity=0.487  Sum_probs=266.0

Q ss_pred             cceeeehhHHHHHHHhhh-hhhhhhhcchheeecccCCcc-----------ceeeeecCCCccccccchhhccCCCCCee
Q 013682           33 RGFTLLVTLKAVLQECEQ-LHLLISFLIFIRVLQSSSNLF-----------VYLISDLGNAALSGELAPELGQLKNLELL  100 (438)
Q Consensus        33 ~~~~~~~~l~~~~~~~~~-l~~~~~~~~~~~~l~~~~n~~-----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l  100 (438)
                      .+++.|+.|+++.|.+.. .|..+..+.+++.|++++|.+           .+..++|++|+++|.+|..+.++++|+.|
T Consensus       425 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L  504 (968)
T PLN00113        425 TKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQL  504 (968)
T ss_pred             hcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEE
Confidence            344444445555444443 222344556666666666643           36778999999999999999999999988


Q ss_pred             cc-------------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCC
Q 013682          101 AL-------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS  167 (438)
Q Consensus       101 ~l-------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~  167 (438)
                      ++             +++++|++|+|++|.++|.+|..++++++|+.|+|++|+++|.+|..+.++++|+.+++++|+++
T Consensus       505 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~  584 (968)
T PLN00113        505 KLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLH  584 (968)
T ss_pred             ECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcce
Confidence            64             45788999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccccccCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCcccceeehhhHHHHHhhheee
Q 013682          168 GPVPDNGSFSQFTPISFENNLNLCGPNTKK---PCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVIG  244 (438)
Q Consensus       168 g~ip~~~~~~~~~~~~~~~N~~lcg~~~~~---~C~~s~~~s~~~~~~~~~~~~~~~~~~~i~v~vv~g~~~~~~~~l~~  244 (438)
                      |.+|..+.+..+...++.||+.+||+.+..   +|..                .+......+.++++++++++++++++.
T Consensus       585 ~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~  648 (968)
T PLN00113        585 GSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKR----------------VRKTPSWWFYITCTLGAFLVLALVAFG  648 (968)
T ss_pred             eeCCCcchhcccChhhhcCCccccCCccccCCCCCcc----------------ccccceeeeehhHHHHHHHHHHHHHHH
Confidence            999998888888888899999999864321   1210                001111122222222222222222222


Q ss_pred             eEEeeccCCCCcccCCCCCCc-hhhhc---CccccccHHHHHHHhCCCCCCCccccccceEEEEEEe-CCCCEEEEEEcc
Q 013682          245 FAYWRRTRPHEFFFDVPAEDD-SELQL---GQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLK  319 (438)
Q Consensus       245 ~~~~rr~r~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~  319 (438)
                      ++++++++..+. ...+.+.. .+...   .....+++++   ....+...+.||+|+||.||+|+. .++..||||+++
T Consensus       649 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~  724 (968)
T PLN00113        649 FVFIRGRNNLEL-KRVENEDGTWELQFFDSKVSKSITIND---ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN  724 (968)
T ss_pred             HHHHHhhhcccc-cccccccccccccccccccchhhhHHH---HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEcc
Confidence            223333221111 00111000 00000   0011223333   234577788999999999999987 478999999986


Q ss_pred             ccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHH
Q 013682          320 EERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG  399 (438)
Q Consensus       320 ~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~g  399 (438)
                      ....     ...+|++.+++++|||||+++|+|.+.+..++||||+++|+|.++++.       ++|.++..++.|+|+|
T Consensus       725 ~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~  792 (968)
T PLN00113        725 DVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKA  792 (968)
T ss_pred             CCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHH
Confidence            4321     124568889999999999999999999999999999999999999953       7899999999999999


Q ss_pred             HHHHhcCCCCCceecCCCCCCeeeCCCCCcchh
Q 013682          400 LSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  432 (438)
Q Consensus       400 L~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~  432 (438)
                      |+|||+.+.++|+|||+||+||++|+++.+++.
T Consensus       793 L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~  825 (968)
T PLN00113        793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR  825 (968)
T ss_pred             HHHhccCCCCCeecCCCCHHhEEECCCCceEEE
Confidence            999998878899999999999999998887664

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-36  Score=297.61  Aligned_cols=161  Identities=53%  Similarity=0.900  Sum_probs=148.5

Q ss_pred             ccccccHHHHHHHhCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEE
Q 013682          272 QLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF  351 (438)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~  351 (438)
                      ..+.|+++++..+|++|...+.||+|+||.||+|...+++.||||++....... ..+|..|+.++++++|||+|+++||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence            456799999999999999999999999999999999988999999886644332 4579999999999999999999999


Q ss_pred             EeeCC-eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcc
Q 013682          352 CTTVT-EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  430 (438)
Q Consensus       352 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~  430 (438)
                      |.+.+ +.+||||||++|+|.++|+.....  +++|.+|++||.++|+||+|||+.+.|+||||||||+|||+|+|+++|
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence            99988 599999999999999999986543  689999999999999999999999999999999999999999999999


Q ss_pred             hhhhh
Q 013682          431 SKTIL  435 (438)
Q Consensus       431 l~Df~  435 (438)
                      ++||+
T Consensus       218 lsDFG  222 (361)
T KOG1187|consen  218 LSDFG  222 (361)
T ss_pred             ccCcc
Confidence            99996

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=4.4e-30  Score=244.42  Aligned_cols=144  Identities=29%  Similarity=0.413  Sum_probs=127.6

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccc-cccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ..+|...+.||+|+||+||+|+++ ++..||||.+.... .....+....|+.+++.++|||||+++++++.++..++||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            356777888999999999999975 57899999986553 2233445789999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC------CCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED------ADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~------~~~~l~Df~  435 (438)
                      |||.+|||.++++.+.    .+++..+..++.|+|.||++||++   +||||||||.|||++..      ...||+||+
T Consensus        89 EyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG  160 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFG  160 (429)
T ss_pred             EeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence            9999999999999875    389999999999999999999999   99999999999999975      346999996

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.96  E-value=5.8e-29  Score=244.39  Aligned_cols=143  Identities=34%  Similarity=0.567  Sum_probs=125.2

Q ss_pred             CCCCCccccccceEEEEEEeCCCCEEEEEEccccccccc-hHHHHHHHHHHhcCCCCCceeeEEEEeeCC-eeEEEEecC
Q 013682          288 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVT-EKLLVYPYM  365 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~e~~  365 (438)
                      +...+.+|+|+||+||+|.|.....||||++........ ..+|.+|+.+|.+++|||||+++|+|.++. ...+|||||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            344566999999999999997544599999975432222 458999999999999999999999999987 789999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-ceecCCCCCCeeeCCCC-Ccchhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK-IIHRDVKAANILLDEDA-DQSSKTIL  435 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivHrDLK~~NILld~~~-~~~l~Df~  435 (438)
                      ++|+|.++++..  ....+++..++.+|.|||+||.|||++   + ||||||||+|||++.++ .+||+||+
T Consensus       123 ~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFG  189 (362)
T KOG0192|consen  123 PGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFG  189 (362)
T ss_pred             CCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCc
Confidence            999999999874  233599999999999999999999999   6 99999999999999998 99999997

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-28  Score=230.47  Aligned_cols=143  Identities=31%  Similarity=0.429  Sum_probs=127.3

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCC-eeEEEEec
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-EKLLVYPY  364 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~e~  364 (438)
                      +++..+.||+|..|+|||++++ +++.+|+|.+.........+++.+|++++...+||+||+++|.|.... +..++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            3444678999999999999985 688999999965544445568999999999999999999999999988 59999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |++|||+..+...+    ++++...-.|+.+|.+||.|||+ +   +||||||||+|||++..|++||+||+=
T Consensus       160 MDgGSLd~~~k~~g----~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGV  225 (364)
T KOG0581|consen  160 MDGGSLDDILKRVG----RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGV  225 (364)
T ss_pred             cCCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccc
Confidence            99999999997653    48889999999999999999996 6   999999999999999999999999973

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1e-28  Score=243.05  Aligned_cols=141  Identities=35%  Similarity=0.511  Sum_probs=127.4

Q ss_pred             CCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCC
Q 013682          288 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  367 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  367 (438)
                      +...+.||+|.||+||.|.|.....||+|.++..  ......|.+|+.+|++++|+|||+++|+|..++.++||||||+.
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~--~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~  285 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG--SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK  285 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEecc--ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence            4445789999999999999987779999999765  23345799999999999999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          368 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+|.++|+...  ...+...+.+.++.|||+||+||+++   ++|||||.++||||+++..+||+||+
T Consensus       286 GsLl~yLr~~~--~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFG  348 (468)
T KOG0197|consen  286 GSLLDYLRTRE--GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFG  348 (468)
T ss_pred             CcHHHHhhhcC--CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccc
Confidence            99999999732  23578899999999999999999999   99999999999999999999999996

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=7.6e-28  Score=229.02  Aligned_cols=145  Identities=27%  Similarity=0.396  Sum_probs=125.6

Q ss_pred             hCCCCCCCccccccceEEEEEEe-CCCCEEEEEEcccccccc------chHHHHHHHHHHhcCCCCCceeeEEEEeeCCe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG------GELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  357 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  357 (438)
                      .+.|...+.||+|+||.|-+|.- ++|+.||||+++......      .....++|+++|++++|||||++++++..++.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            45567778999999999999975 579999999996543222      12245799999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC---CCcchhhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED---ADQSSKTI  434 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~---~~~~l~Df  434 (438)
                      .||||||++||+|.+++....    .+.+.....++.|++.|+.|||++   ||+||||||+|||+..+   --.||+||
T Consensus       251 ~YmVlE~v~GGeLfd~vv~nk----~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVANK----YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             eEEEEEEecCccHHHHHHhcc----ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence            999999999999999998754    377788899999999999999999   99999999999999877   56799999


Q ss_pred             hh
Q 013682          435 LR  436 (438)
Q Consensus       435 ~~  436 (438)
                      +=
T Consensus       324 Gl  325 (475)
T KOG0615|consen  324 GL  325 (475)
T ss_pred             ch
Confidence            73

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1.5e-27  Score=237.36  Aligned_cols=143  Identities=28%  Similarity=0.483  Sum_probs=130.2

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccc--cccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ..|...+.||+|||+.||+++. .+|+.||+|++.+..  .........+|+++.+.++|||||+++++|++.+..|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4578889999999999999997 789999999996543  2333457899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+|++++|.++++.++    ++++++++.+..||+.||.|||++   +|+|||||..|+++++++++|||||+
T Consensus        98 ELC~~~sL~el~Krrk----~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFG  163 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRK----PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFG  163 (592)
T ss_pred             EecCCccHHHHHHhcC----CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccc
Confidence            9999999999998543    499999999999999999999999   99999999999999999999999996

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.95  E-value=7.1e-28  Score=248.13  Aligned_cols=150  Identities=31%  Similarity=0.512  Sum_probs=133.3

Q ss_pred             HHhCCCCCCCccccccceEEEEEEeC------CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCC
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT  356 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  356 (438)
                      ..+.+....+.||+|+||+||+|+..      +.+.||||.+|.....+...+|++|+++++.++|||||+++|+|...+
T Consensus       483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD  562 (774)
T ss_pred             echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence            34455666788999999999999853      356899999988776667779999999999999999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhccCCC----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC
Q 013682          357 EKLLVYPYMTNGSVASRLRERQSS----------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED  426 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~  426 (438)
                      ..+||+|||..|||.++|+.....          ..+++..+.+.||.|||.||+||.++   .+|||||..+|+||.++
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGEN  639 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccc
Confidence            999999999999999999964321          22488899999999999999999999   99999999999999999


Q ss_pred             CCcchhhhh
Q 013682          427 ADQSSKTIL  435 (438)
Q Consensus       427 ~~~~l~Df~  435 (438)
                      ..+||+||+
T Consensus       640 l~VKIsDfG  648 (774)
T KOG1026|consen  640 LVVKISDFG  648 (774)
T ss_pred             eEEEecccc
Confidence            999999997

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.94  E-value=1.8e-27  Score=224.52  Aligned_cols=145  Identities=28%  Similarity=0.389  Sum_probs=130.5

Q ss_pred             HhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc--cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      ..++|+..++||+|+||+||+++.. +++.+|+|++++..-.  .......+|..++..++||.||+++-.|++.+..|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            3567899999999999999999864 5899999999765422  234468899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+||+.||.|..+|.+..    .+++..+..++.+|+.||.|||+.   +||||||||+|||+|++|.++++||+
T Consensus       103 Vld~~~GGeLf~hL~~eg----~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFg  170 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREG----RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFG  170 (357)
T ss_pred             EEeccCCccHHHHHHhcC----CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccc
Confidence            999999999999998654    388999999999999999999999   99999999999999999999999996

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=2.9e-27  Score=230.20  Aligned_cols=143  Identities=29%  Similarity=0.467  Sum_probs=125.0

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccch-HHHHHHHHHHhcCCCCCceeeEEEEeeC--CeeEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGE-LQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLLV  361 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~-~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv  361 (438)
                      +.|+..+.||+|.||.||+|+. .+|+.||+|+++-+....+. ....+|+.+|++++|||||++.+...+.  ...|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            4466668899999999999985 57999999999766543333 3568999999999999999999998876  689999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +|||++ ||..++....   ..++..+...++.|++.||+|+|++   +|+|||||.+|||||.+|..||+||+
T Consensus       197 FeYMdh-DL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFG  263 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFG  263 (560)
T ss_pred             Eecccc-hhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEecccc
Confidence            999986 8888886532   3589999999999999999999999   99999999999999999999999996

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.94  E-value=4.4e-27  Score=227.28  Aligned_cols=140  Identities=36%  Similarity=0.531  Sum_probs=121.4

Q ss_pred             CCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHh--cCCCCCceeeEEEEeeCC----eeE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIIS--MAVHRNLLRLYGFCTTVT----EKL  359 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~--~l~H~niv~l~g~~~~~~----~~~  359 (438)
                      +..+..+++|+|+||.||||++. ++.||||++...    ..+.|..|-++.+  .++|+||++++++-...+    +.+
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            34455678999999999999984 689999999643    3346777777665  568999999999876655    789


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCCceecCCCCCCeeeCCCCCcchhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH------CDPKIIHRDVKAANILLDEDADQSSKT  433 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivHrDLK~~NILld~~~~~~l~D  433 (438)
                      ||+||.+.|+|.++|..+     ..+|....+|+..+++||+|||+.      .+|+|+|||||++|||+.+|+++.|+|
T Consensus       285 LVt~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             EEeeeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence            999999999999999875     389999999999999999999983      578999999999999999999999999


Q ss_pred             hh
Q 013682          434 IL  435 (438)
Q Consensus       434 f~  435 (438)
                      |+
T Consensus       360 FG  361 (534)
T KOG3653|consen  360 FG  361 (534)
T ss_pred             cc
Confidence            97

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=5e-27  Score=234.30  Aligned_cols=152  Identities=28%  Similarity=0.448  Sum_probs=132.4

Q ss_pred             HHHHHHhCCCCCCCccccccceEEEEEEeCC--C--CE-EEEEEcccc--ccccchHHHHHHHHHHhcCCCCCceeeEEE
Q 013682          279 RELQVATDGFSNKNILGRGGFGKVYKGRLAD--G--KL-VAVKRLKEE--RTSGGELQFQTEVKIISMAVHRNLLRLYGF  351 (438)
Q Consensus       279 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~--~--~~-vAvK~l~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~  351 (438)
                      +.++...++....+.||+|+||+||+|++..  +  .. ||||..+..  .......+|..|+++|+.++|||||+++|+
T Consensus       150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV  229 (474)
T KOG0194|consen  150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV  229 (474)
T ss_pred             cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            3445556667777999999999999998742  2  23 899998752  333445589999999999999999999999


Q ss_pred             EeeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcch
Q 013682          352 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS  431 (438)
Q Consensus       352 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l  431 (438)
                      +....+.++|||+|.||+|.++|++...   .++..+...++.++|+||+|||+.   +++||||.++|+|++.+..+||
T Consensus       230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKI  303 (474)
T KOG0194|consen  230 AVLEEPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKI  303 (474)
T ss_pred             EcCCCccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEe
Confidence            9999999999999999999999998653   489999999999999999999999   9999999999999999999999


Q ss_pred             hhhhh
Q 013682          432 KTILR  436 (438)
Q Consensus       432 ~Df~~  436 (438)
                      +||+=
T Consensus       304 SDFGL  308 (474)
T KOG0194|consen  304 SDFGL  308 (474)
T ss_pred             Ccccc
Confidence            99973

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.94  E-value=1.4e-26  Score=209.09  Aligned_cols=143  Identities=27%  Similarity=0.452  Sum_probs=128.0

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccc-hHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      ++|...+.+|+|.||.||+|+. .+|+.||||+++.....++ .....||+..++.++|+||+.++++|-..+..-+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            3466678899999999999985 5799999999976554444 3468999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+. +|+..+++...   .++..+...++.++.+|++|+|++   .|+|||+||.|+|++++|..|++||+
T Consensus        82 fm~t-dLe~vIkd~~i---~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFG  146 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNI---ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFG  146 (318)
T ss_pred             eccc-cHHHHhccccc---ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeeccc
Confidence            9985 99999987643   588899999999999999999999   99999999999999999999999997

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.94  E-value=2.8e-27  Score=239.91  Aligned_cols=143  Identities=30%  Similarity=0.437  Sum_probs=132.6

Q ss_pred             CCCCCCccccccceEEEEEEeCC----CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          287 GFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~~----~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ...+.++||.|.||+||+|+++-    ...||||.+|...+...+.+|..|+.+|.+++||||++|.|+.......++++
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            34567899999999999999752    45799999998888878889999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |||++|+|+++||.+.+   .+++.+...+.++||.||.||.+.   +.|||||.++|||++.+..+|++||+
T Consensus       710 EyMENGsLDsFLR~~DG---qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFG  776 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQNDG---QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFG  776 (996)
T ss_pred             hhhhCCcHHHHHhhcCC---ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEecccc
Confidence            99999999999998764   388999999999999999999999   99999999999999999999999997

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=1.1e-26  Score=220.31  Aligned_cols=142  Identities=23%  Similarity=0.437  Sum_probs=128.6

Q ss_pred             CCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccc--hHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          287 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      +|+..+.||+|.||+|-+|.. ..|+.||||.+++..-.+.  ...+.+|+++|+.++||||+.++.+|+..+...+|||
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME  133 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME  133 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence            455567899999999999974 5799999999977654333  2368999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |..+|.|++++.+++    .+++.++.++++||.+|+.|+|.+   +++|||||.+|||+|+++++||+||+
T Consensus       134 YaS~GeLYDYiSer~----~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFG  198 (668)
T KOG0611|consen  134 YASGGELYDYISERG----SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFG  198 (668)
T ss_pred             ecCCccHHHHHHHhc----cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccc
Confidence            999999999998765    389999999999999999999999   99999999999999999999999997

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.93  E-value=3.8e-26  Score=224.13  Aligned_cols=148  Identities=26%  Similarity=0.345  Sum_probs=128.6

Q ss_pred             HHhCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccc--hHHHHHHHHHHhcC-CCCCceeeEEEEeeCCee
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGG--ELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEK  358 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~--~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  358 (438)
                      ....+|..++.||+|+|++|++|+. .+++.||||++.+..--.+  ..-..+|-..|..+ .||.||+|+..|.+...+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            3456788899999999999999986 4689999999855332111  12356677778888 899999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhhc
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRR  437 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~~  437 (438)
                      |+|+||+++|+|.+++++.+    .++...++.+|.+|..|++|||++   |||||||||+|||+|+||..+|.||+.-
T Consensus       150 YFvLe~A~nGdll~~i~K~G----sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA  221 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKYG----SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA  221 (604)
T ss_pred             EEEEEecCCCcHHHHHHHhC----cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence            99999999999999998764    489999999999999999999999   9999999999999999999999999853

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.93  E-value=6.2e-26  Score=207.82  Aligned_cols=145  Identities=27%  Similarity=0.400  Sum_probs=129.1

Q ss_pred             HhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      ..++|+..+.||.|+||+|..++.+ +|..+|+|+++....  ....+...+|..+++.+.||+++++.+.+.+.+..+|
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym  121 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM  121 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence            3467888899999999999999875 588999999965421  1222346789999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||||++||.|.+++++.+    +++.+.++.+|.||+.|++|||+.   .|++|||||+|||+|.+|-.||.||+
T Consensus       122 vmeyv~GGElFS~Lrk~~----rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFG  189 (355)
T KOG0616|consen  122 VMEYVPGGELFSYLRKSG----RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFG  189 (355)
T ss_pred             EEeccCCccHHHHHHhcC----CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEecc
Confidence            999999999999999864    489999999999999999999999   99999999999999999999999996

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.93  E-value=2.1e-26  Score=211.42  Aligned_cols=142  Identities=22%  Similarity=0.334  Sum_probs=120.7

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccc-hHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      .|+....+|+|+||+|||++.+ +|+.||||++.....+.. .+-..||+.+++.++|+|+|.++.+|......++|+||
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~   82 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY   82 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence            4556678999999999999976 599999999976533222 23478999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+.--| +.|.....   .++......+..|++.|+.|+|++   ++|||||||+|||+..++.+|++||+
T Consensus        83 ~dhTvL-~eLe~~p~---G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFG  146 (396)
T KOG0593|consen   83 CDHTVL-HELERYPN---GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFG  146 (396)
T ss_pred             cchHHH-HHHHhccC---CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccch
Confidence            987444 44443222   277888999999999999999999   99999999999999999999999996

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.93  E-value=1.3e-25  Score=220.35  Aligned_cols=147  Identities=21%  Similarity=0.326  Sum_probs=131.9

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCee
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  358 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  358 (438)
                      ....++|+...+||+|+||.||.|+-+ +|..+|+|++++...  .........|-.+|...++|+||+++-.|++.+.+
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            345688999999999999999999865 699999999976532  22233578899999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||||||++|||+..+|....    .++...+..++.+++.|++-+|..   |+|||||||+|+|||..|..|++||+
T Consensus       217 YLiMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFG  286 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFG  286 (550)
T ss_pred             EEEEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeecccc
Confidence            99999999999999998764    388999999999999999999999   99999999999999999999999997

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=2.7e-26  Score=204.46  Aligned_cols=149  Identities=30%  Similarity=0.430  Sum_probs=131.2

Q ss_pred             HhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccc--cccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      +.++|+.++.||+|.||.||.|+.+ ++-.||+|++.+..  ......++.+|+++-+.++||||+++++++.+....|+
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            4578899999999999999999875 57789999985432  12234479999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhhc
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRR  437 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~~  437 (438)
                      ++||...|++...|++..  ...++...+..+..|+|.|+.|+|..   +|+|||+||+|+|++.+++.+++||+=+
T Consensus       100 ilEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGws  171 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWS  171 (281)
T ss_pred             EEEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCce
Confidence            999999999999998643  33588888999999999999999998   9999999999999999999999999744

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.93  E-value=4.8e-26  Score=224.49  Aligned_cols=147  Identities=26%  Similarity=0.381  Sum_probs=132.3

Q ss_pred             HhCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      +.+.....+.||+|.||+|..++...+..||||.++.........+|.+|+++|.+++|||||+++|+|..++...+++|
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            34456667899999999999999877899999999988777777799999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||++|+|.+++..+....  ..-....+|+.|||.||+||.+.   ++||||+.++|+|+|.++++||+||+
T Consensus       616 YmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfg  682 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFG  682 (807)
T ss_pred             HHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcc
Confidence            999999999998764332  34456678999999999999999   99999999999999999999999995

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=1.7e-25  Score=216.33  Aligned_cols=148  Identities=28%  Similarity=0.365  Sum_probs=124.2

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-------------cchHHHHHHHHHHhcCCCCCcee
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-------------GGELQFQTEVKIISMAVHRNLLR  347 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~  347 (438)
                      .+..+.|.+.+.||+|.||+|-+|+.. +++.||||++.+....             ...+...+|+++|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            345678889999999999999999864 6899999998543210             11236789999999999999999


Q ss_pred             eEEEEee--CCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC
Q 013682          348 LYGFCTT--VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE  425 (438)
Q Consensus       348 l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~  425 (438)
                      ++.+..+  .+..|||+|||..|.+...=.    ....++..+++.|..++..||+|||.+   +||||||||+|+|+++
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSS  245 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcC
Confidence            9999876  456899999999998753322    122389999999999999999999999   9999999999999999


Q ss_pred             CCCcchhhhhh
Q 013682          426 DADQSSKTILR  436 (438)
Q Consensus       426 ~~~~~l~Df~~  436 (438)
                      +|.+||+||+-
T Consensus       246 ~g~VKIsDFGV  256 (576)
T KOG0585|consen  246 DGTVKISDFGV  256 (576)
T ss_pred             CCcEEeeccce
Confidence            99999999974

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.92  E-value=4e-26  Score=226.47  Aligned_cols=149  Identities=30%  Similarity=0.480  Sum_probs=132.0

Q ss_pred             HHHHHHHhCCCCCCCccccccceEEEEEEeCCCCEEEEEEcccccccc-chHHHHHHHHHHhcCCCCCceeeEEEEeeCC
Q 013682          278 LRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVT  356 (438)
Q Consensus       278 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  356 (438)
                      .+++.+..+.+.....||+|+||+||+|+|..  .||||.++.....+ ..+.|..|+..+++-+|.||+-+.|+|..+.
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            35666666677788999999999999999953  59999997654333 3447999999999999999999999998887


Q ss_pred             eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          357 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      . .+|+.+|++-+|+.+++....   .++..+.+.||.|||+||.|||.+   +|||||||..||++++++.++|+||+
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~et---kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFG  533 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQET---KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFG  533 (678)
T ss_pred             e-eeeehhccCchhhhhccchhh---hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccc
Confidence            7 999999999999999997643   488899999999999999999999   99999999999999999999999996

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.92  E-value=1.7e-25  Score=220.56  Aligned_cols=151  Identities=30%  Similarity=0.434  Sum_probs=126.7

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEe------CCCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEee
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  354 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~------~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  354 (438)
                      .+..++|+..+.||+|+||.||+|.+      .+++.||||.++..........+.+|+.++..+ +|||||+++++|..
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            34567788899999999999999974      135689999987543333345689999999999 89999999999876


Q ss_pred             CC-eeEEEEecCCCCCHHHHhhccCCC-----------------------------------------------------
Q 013682          355 VT-EKLLVYPYMTNGSVASRLRERQSS-----------------------------------------------------  380 (438)
Q Consensus       355 ~~-~~~lv~e~~~~gsL~~~l~~~~~~-----------------------------------------------------  380 (438)
                      .+ ..+++|||+++|+|.++++.....                                                     
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            44 578999999999999998753210                                                     


Q ss_pred             -----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          381 -----LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       381 -----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                           ..++++.+...++.|++.||+|||+.   +|+||||||+|||+++++.++++||+
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG  219 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFG  219 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecc
Confidence                 12478889999999999999999998   99999999999999999999999996

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.6e-26  Score=223.62  Aligned_cols=145  Identities=26%  Similarity=0.371  Sum_probs=127.9

Q ss_pred             HhCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCC-CCCceeeEEEEeeCC-eeEE
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVT-EKLL  360 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~l  360 (438)
                      ..++|...+.||.|.||.||+|+. .++..||||++|.....-++..-.||+..+++++ |||||++..++.+.+ ..++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            345677788999999999999985 4688999999987654433334679999999999 999999999998877 8999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |||||+. +|++.++++.   ..+++.++..|+.||.+||+|+|.+   |+.|||+||+|||+.....+||+||+
T Consensus        88 VfE~Md~-NLYqLmK~R~---r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFG  155 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFG  155 (538)
T ss_pred             eHHhhhh-hHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccc
Confidence            9999975 9999998763   3699999999999999999999999   99999999999999999999999997

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=4e-25  Score=218.90  Aligned_cols=147  Identities=25%  Similarity=0.376  Sum_probs=129.0

Q ss_pred             HHhCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccc----cchHHHHHHHHHHhcCC-CCCceeeEEEEeeCC
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS----GGELQFQTEVKIISMAV-HRNLLRLYGFCTTVT  356 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~----~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~  356 (438)
                      .....|...+.||+|+||+|+.|+. .++..||+|.+......    .......+|+.+++.++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3456788899999999999999986 46899999977553111    22345778999999999 999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC-CCcchhhhh
Q 013682          357 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTIL  435 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~-~~~~l~Df~  435 (438)
                      ..++||||+.+|+|.+++.+..    ++.+.++..++.|+++|++|+|++   +|+||||||+|+|+|.+ +++|++||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG  166 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG  166 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence            9999999999999999998742    478899999999999999999999   99999999999999999 999999997


Q ss_pred             h
Q 013682          436 R  436 (438)
Q Consensus       436 ~  436 (438)
                      -
T Consensus       167 ~  167 (370)
T KOG0583|consen  167 L  167 (370)
T ss_pred             c
Confidence            4

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=1e-26  Score=211.51  Aligned_cols=149  Identities=24%  Similarity=0.344  Sum_probs=127.1

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEcccccc-ccchHHHHHHHHHHhcCCCCCceeeEE-EEeeCCe-eEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYG-FCTTVTE-KLLV  361 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g-~~~~~~~-~~lv  361 (438)
                      .+|++.+.||+|.||+|||+.. .+|..+|.|.++-... .....+...|+.+++.++|||||++++ -+.+..+ .++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            3466678899999999999975 6899999999873222 223346889999999999999999998 4555555 7899


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeeeCCCCCcchhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK--IIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||||..|||.+.++..+.....+++....++..|++.||.++|+. -|+  |+||||||.||+++.+|.+|+|||+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccch
Confidence            999999999999987666667799999999999999999999994 224  9999999999999999999999996

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.92  E-value=2.2e-25  Score=207.23  Aligned_cols=143  Identities=27%  Similarity=0.410  Sum_probs=124.2

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccch-HHHHHHHHHHhcCCCCCceeeEEEEee--CCeeEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGE-LQFQTEVKIISMAVHRNLLRLYGFCTT--VTEKLLV  361 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~-~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv  361 (438)
                      ++|+..+.|++|.||.||+|+. ++++.||+|+++.+....+. ..-.+|+.++.+++|||||.+..+...  -+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            4566678899999999999996 46889999999866543332 256899999999999999999988764  4679999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||||+. ||.+.+....   .++...+..-++.|+.+|++|||.+   .|+|||||++|+|+.+.|..||+||+
T Consensus       156 Me~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFG  222 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFG  222 (419)
T ss_pred             HHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccc
Confidence            999986 8999887654   3588899999999999999999999   99999999999999999999999996

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.92  E-value=7.7e-25  Score=212.62  Aligned_cols=147  Identities=29%  Similarity=0.456  Sum_probs=126.4

Q ss_pred             CCCCCCCccccccceEEEEEEeCC-----------------CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceee
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLAD-----------------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL  348 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~~-----------------~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l  348 (438)
                      ++|...+.||+|+||.||+|.+.+                 +..||+|.++.........+|.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            467778899999999999997532                 336999998765433344579999999999999999999


Q ss_pred             EEEEeeCCeeEEEEecCCCCCHHHHhhccCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcee
Q 013682          349 YGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH  413 (438)
Q Consensus       349 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH  413 (438)
                      ++++.+.+..+++|||+++|+|.+++.....               ....++|.....++.|++.||+|||+.   +|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence            9999999999999999999999998865321               113478899999999999999999999   9999


Q ss_pred             cCCCCCCeeeCCCCCcchhhhh
Q 013682          414 RDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       414 rDLK~~NILld~~~~~~l~Df~  435 (438)
                      |||||+|||+++++.++++||+
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG  183 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFG  183 (304)
T ss_pred             cCcchhheEEcCCccEEECCCc
Confidence            9999999999999999999996

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=6.8e-25  Score=210.87  Aligned_cols=146  Identities=26%  Similarity=0.381  Sum_probs=132.5

Q ss_pred             hCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .++|+....||.|..+.||+|+. +.+..||||++.-+........+.+|+..|+.++||||++++..|..+.+.|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            45688889999999999999986 56899999999766555555678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||.+||+.+.++......  +++..+..|.+++.+||.|||.+   |-||||+|+.|||||+||.++++||.
T Consensus       105 fMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFg  171 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFG  171 (516)
T ss_pred             hhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCce
Confidence            999999999998865443  88899999999999999999999   99999999999999999999999995

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.92  E-value=1.2e-24  Score=208.18  Aligned_cols=143  Identities=31%  Similarity=0.504  Sum_probs=124.0

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCC--eeEEEEe
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT--EKLLVYP  363 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv~e  363 (438)
                      ++...+.||+|+||.||.+... +|...|||.+....... ...+.+|+.++.+++|||||+.+|......  ..++.||
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            4556788999999999999875 48899999986542222 446899999999999999999999855544  5889999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC-CCCcchhhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTILR  436 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~-~~~~~l~Df~~  436 (438)
                      |+++|+|.+++.....   .++++....+..||++||+|||++   +||||||||+|||++. ++++||+||+.
T Consensus        97 y~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~  164 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGL  164 (313)
T ss_pred             ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcc
Confidence            9999999999987643   489999999999999999999999   9999999999999999 79999999983

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.92  E-value=1.4e-24  Score=204.80  Aligned_cols=145  Identities=26%  Similarity=0.407  Sum_probs=123.0

Q ss_pred             CCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCC-ceeeEEEEeeCC------e
Q 013682          287 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRN-LLRLYGFCTTVT------E  357 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~------~  357 (438)
                      .|...+.||+|+||+||+|+. .+|+.||+|+++-.... .......+|+.++..++|+| ||++++++.+.+      .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            344456799999999999986 47899999998765432 22235789999999999999 999999998877      7


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      .++|+||++. +|..++.........++......++.|+..|++|||++   +|+||||||.|||++++|..|++||+
T Consensus        92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence            8899999975 89999987543212356678899999999999999999   99999999999999999999999996

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.6e-24  Score=208.24  Aligned_cols=140  Identities=31%  Similarity=0.440  Sum_probs=119.7

Q ss_pred             CCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHh--cCCCCCceeeEEEEeeC----CeeE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIIS--MAVHRNLLRLYGFCTTV----TEKL  359 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~--~l~H~niv~l~g~~~~~----~~~~  359 (438)
                      ....+.+.||+|.||+||+|+|+ |+.||||+|..    .++..+.+|.++.+  .++|+||..+++.-..+    .+.|
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             heeEEEEEecCccccceeecccc-CCceEEEEecc----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            34666789999999999999995 78999999943    23345667777665  67999999999875443    4679


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-----CCCCCceecCCCCCCeeeCCCCCcchhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-----HCDPKIIHRDVKAANILLDEDADQSSKTI  434 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~ivHrDLK~~NILld~~~~~~l~Df  434 (438)
                      ||++|.+.|||+++|...     .++-...++++..+|.||+|||.     +.+|.|.|||||+.|||+..++.+.|+|+
T Consensus       286 LvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             EeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            999999999999999764     38889999999999999999997     46899999999999999999999999998


Q ss_pred             h
Q 013682          435 L  435 (438)
Q Consensus       435 ~  435 (438)
                      +
T Consensus       361 G  361 (513)
T KOG2052|consen  361 G  361 (513)
T ss_pred             e
Confidence            6

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.91  E-value=1.5e-24  Score=206.41  Aligned_cols=145  Identities=27%  Similarity=0.385  Sum_probs=127.9

Q ss_pred             CCCCCCCccccccceEEEEEEeC----CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~----~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      ++|+..+.||+|+||.||+|.+.    .+..||+|.++..........+.+|+..+..++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            45777889999999999999753    35689999997654433345789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |||+++|+|.+++....   ..++|.+...++.|++.|++|||++   +++||||||+||++++++.++++||..
T Consensus        85 ~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~  153 (266)
T cd05064          85 TEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRR  153 (266)
T ss_pred             EEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcc
Confidence            99999999999997643   2488999999999999999999999   999999999999999999999999963

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.91  E-value=7e-25  Score=233.65  Aligned_cols=148  Identities=32%  Similarity=0.497  Sum_probs=131.4

Q ss_pred             hCCCCCCCccccccceEEEEEEeCC--CC----EEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCee
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLAD--GK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  358 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~~--~~----~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  358 (438)
                      .+..+..+.||+|+||.||+|.+.+  +.    .||||.++...+.....+|.+|+.+|+.++|||||+++|+|.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            4455667889999999999998743  33    49999998776666667899999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQS---SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++++|||++|+|.++|++.+.   ....++..+.+.++.|||+|+.||+++   ++|||||.++|+|+++...+||+||+
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence            999999999999999998632   234588899999999999999999999   99999999999999999999999996

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.91  E-value=2e-24  Score=215.21  Aligned_cols=143  Identities=20%  Similarity=0.314  Sum_probs=126.7

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|+..+.||+|+||+||+|+.. +++.||+|+++....  ......+.+|+.++..++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888899999999999999864 588999999865321  122235788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.++|+||+
T Consensus        81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFG  146 (363)
T cd05628          81 EFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFG  146 (363)
T ss_pred             cCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeecc
Confidence            9999999999997643    488999999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.91  E-value=1.3e-24  Score=217.65  Aligned_cols=150  Identities=29%  Similarity=0.379  Sum_probs=128.2

Q ss_pred             HHhCCCCCCCccccccceEEEEEEe------CCCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEeeC
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  355 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~------~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  355 (438)
                      ...++|+..+.||+|+||.||+|++      .++..||||+++..........+.+|+.++..+ +|||||+++++|...
T Consensus        32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            3455688889999999999999974      235689999997544333445688999999999 899999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhccCC--------------------------------------------------------
Q 013682          356 TEKLLVYPYMTNGSVASRLRERQS--------------------------------------------------------  379 (438)
Q Consensus       356 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------  379 (438)
                      +..++||||+++|+|.++++....                                                        
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            999999999999999999975321                                                        


Q ss_pred             ---------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          380 ---------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       380 ---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                                     ....++|.....++.|++.||+|||+.   +|+||||||+|||+++++.++++||.
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG  259 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFG  259 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCc
Confidence                           012478899999999999999999998   99999999999999999999999996

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=2.7e-24  Score=215.37  Aligned_cols=143  Identities=19%  Similarity=0.302  Sum_probs=126.0

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|...+.||+|+||.||+++.. +++.||||.+.....  ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            36778899999999999999864 688999999854321  222346788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++++||+
T Consensus        81 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfG  146 (377)
T cd05629          81 EFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFG  146 (377)
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecc
Confidence            9999999999987542    478889999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=2.3e-24  Score=214.70  Aligned_cols=143  Identities=22%  Similarity=0.352  Sum_probs=127.0

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|+..+.||+|+||.||+|+.. +++.||||+++....  ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46888899999999999999874 688999999865321  122335788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++++||+
T Consensus        81 E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  146 (364)
T cd05599          81 EYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFG  146 (364)
T ss_pred             CCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecc
Confidence            9999999999987643    388999999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.91  E-value=3.3e-25  Score=208.93  Aligned_cols=142  Identities=29%  Similarity=0.448  Sum_probs=116.8

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCe-----eEE
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE-----KLL  360 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----~~l  360 (438)
                      .|...+++|.|+||.||+|... +++.||||+.-.+..     --.+|..+|++++|||||++.-+|....+     .-+
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            3455689999999999999975 578999998754321     23578899999999999999988865322     248


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC-CCcchhhhhhc
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTILRR  437 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~-~~~~l~Df~~~  437 (438)
                      |||||+. +|.+.++........++.-...-+..|+.+||+|||+.   +|+||||||.|+|+|.+ |..||+||+..
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcc
Confidence            9999985 99999986433334577778889999999999999998   99999999999999988 89999999864

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.91  E-value=3.8e-24  Score=214.67  Aligned_cols=142  Identities=23%  Similarity=0.272  Sum_probs=125.5

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc--cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .|+..+.||+|+||+||+|+.. +++.||+|+++.....  .....+.+|+.++..++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            4677889999999999999864 6889999998653221  223468899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++++||+
T Consensus        82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFG  146 (381)
T cd05626          82 YIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFG  146 (381)
T ss_pred             cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCc
Confidence            999999999987643    378888999999999999999998   99999999999999999999999997

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.91  E-value=5.5e-24  Score=205.12  Aligned_cols=143  Identities=27%  Similarity=0.432  Sum_probs=125.6

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      ++|...+.||+|+||.||+|+.. +++.||+|.++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46788899999999999999864 68899999986544333344678999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++ |+|.+++....   ..+++.....++.|++.||+|||++   +|+||||||+|||+++++.++++||+
T Consensus        85 ~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG  148 (288)
T cd07871          85 LD-SDLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFG  148 (288)
T ss_pred             CC-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCc
Confidence            97 48998886543   2378889999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.91  E-value=3.2e-24  Score=210.91  Aligned_cols=143  Identities=22%  Similarity=0.310  Sum_probs=126.9

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|...+.||+|+||.||+|+.. +++.||+|.++....  ......+.+|+.++..++||||+++++++...+..+++|
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56778899999999999999975 588999999865321  122346889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++|+|.++++...    .+++..+..++.|++.||+|||++   +|+||||||+|||+++++.++++||.
T Consensus        98 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg  163 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFG  163 (329)
T ss_pred             cCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeecc
Confidence            9999999999997643    378888999999999999999999   99999999999999999999999996

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=2.5e-24  Score=207.93  Aligned_cols=143  Identities=24%  Similarity=0.302  Sum_probs=126.5

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|+..+.||+|+||.||+|... +++.||+|.++....  ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36788899999999999999875 688999999864321  122346889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++|+|.++++...    .+++.....++.|++.||+|||++   +|+||||||+|||+++++.++++||.
T Consensus        81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg  146 (291)
T cd05612          81 EYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFG  146 (291)
T ss_pred             eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecC
Confidence            9999999999997643    378899999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.91  E-value=1.2e-24  Score=214.06  Aligned_cols=142  Identities=26%  Similarity=0.410  Sum_probs=126.8

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccc-cccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      ++|...+.||+|+||.||||+.+ +.+.||+|.+.+.. ...+.....+|+++++.++|||||.+++.|++..+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            45666788999999999999865 68899999985543 33344578999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+.+ +|..++.+..    .+++.....++.++..||.|||+.   +|+|||+||.|||++..|.+|++||.
T Consensus        82 ~a~g-~L~~il~~d~----~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg  145 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG----KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFG  145 (808)
T ss_pred             hhhh-hHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhh
Confidence            9987 9999998654    389999999999999999999999   99999999999999999999999985

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.91  E-value=3.7e-24  Score=213.84  Aligned_cols=147  Identities=23%  Similarity=0.301  Sum_probs=128.6

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCee
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  358 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  358 (438)
                      ....++|+..+.||+|+||.||+++.. +++.||+|.++....  ......+.+|+.+++.++||||+++++++......
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            444578888999999999999999975 588999999864321  12233578999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ++||||+++|+|.+++...     .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.++|+||+-
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~  188 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGT  188 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccc
Confidence            9999999999999998653     378889999999999999999999   999999999999999999999999963

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.91  E-value=6.8e-24  Score=208.02  Aligned_cols=137  Identities=26%  Similarity=0.320  Sum_probs=121.4

Q ss_pred             CccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCC
Q 013682          292 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  368 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g  368 (438)
                      +.||+|+||.||+|+.. +++.||+|+++....  ......+.+|+.++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            36899999999999864 688999999875422  122345788999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          369 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       369 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.++|+||+
T Consensus        81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG  140 (323)
T cd05571          81 ELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFG  140 (323)
T ss_pred             cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCC
Confidence            9999987643    478999999999999999999999   99999999999999999999999997

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.91  E-value=6.7e-24  Score=212.46  Aligned_cols=142  Identities=23%  Similarity=0.295  Sum_probs=125.6

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      +|+..+.||+|+||.||+|+.. +++.||+|.+.....  ......+.+|+.++..++||||+++++.+.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            5778899999999999999864 588999999864321  1223468899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||+
T Consensus        82 ~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG  146 (376)
T cd05598          82 YIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG  146 (376)
T ss_pred             CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCC
Confidence            999999999997643    378888899999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.91  E-value=5.7e-24  Score=210.12  Aligned_cols=146  Identities=24%  Similarity=0.279  Sum_probs=127.0

Q ss_pred             HhCCCCCCCccccccceEEEEEEeCC--CCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeE
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLAD--GKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  359 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~~--~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  359 (438)
                      ..++|+..+.||+|+||.||+|.+..  +..||+|.+.....  ......+.+|+.++..++||||+++++++.+.+..+
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            34568888999999999999998643  36899999854321  222346889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      +||||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++++||+-
T Consensus       108 lv~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~  177 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGF  177 (340)
T ss_pred             EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCC
Confidence            9999999999999997643    378999999999999999999999   999999999999999999999999963

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.91  E-value=6.8e-24  Score=212.86  Aligned_cols=142  Identities=24%  Similarity=0.297  Sum_probs=125.2

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .|+..+.||+|+||.||+|+.. +++.||+|.++....  ......+.+|+.+++.++|||||++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            4677889999999999999864 688999999865321  1223468899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.++++||+
T Consensus        82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFG  146 (382)
T cd05625          82 YIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG  146 (382)
T ss_pred             CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECC
Confidence            999999999987642    378888999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.91  E-value=1.3e-23  Score=203.94  Aligned_cols=144  Identities=26%  Similarity=0.444  Sum_probs=125.9

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .++|+..+.||+|+||.||+|+.. +++.||+|.++..........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            357888899999999999999975 6889999998654333333467889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+. +++.+++....   ..+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.++++||.
T Consensus        84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg  148 (303)
T cd07869          84 YVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFG  148 (303)
T ss_pred             CCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCC
Confidence            996 68888876542   2478889999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.90  E-value=9.9e-24  Score=206.93  Aligned_cols=137  Identities=25%  Similarity=0.326  Sum_probs=121.2

Q ss_pred             CccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCC
Q 013682          292 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  368 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g  368 (438)
                      +.||+|+||.||+++.. +++.||+|.++....  ......+.+|+.++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            36899999999999864 689999999865432  122335778999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          369 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       369 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +|..++....    .+++.....++.|++.||+|||++   +|+||||||+|||+++++.++++||.
T Consensus        81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg  140 (323)
T cd05595          81 ELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFG  140 (323)
T ss_pred             cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccH
Confidence            9998886543    478999999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.90  E-value=3.6e-24  Score=204.29  Aligned_cols=145  Identities=28%  Similarity=0.307  Sum_probs=127.1

Q ss_pred             hCCCCCCCccccccceEEEEEEeCC-CCEEEEEEcccccccc--chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~~-~~~vAvK~l~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      .+.|+..+.||+|.-|+||.++.++ +..+|+|++.+.....  ...+.+.|.++++.++||.++.+|+.++++...+++
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            3445667889999999999999864 6899999996543222  223678899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  434 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df  434 (438)
                      ||||+||+|....++...  ..++...+..+|.+|..||+|||..   |||+|||||+||||-+||.+-++||
T Consensus       156 meyCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDF  223 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDF  223 (459)
T ss_pred             EecCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeec
Confidence            999999999998876533  4589999999999999999999999   9999999999999999999999998

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.90  E-value=3.9e-24  Score=214.02  Aligned_cols=150  Identities=29%  Similarity=0.409  Sum_probs=127.6

Q ss_pred             HHhCCCCCCCccccccceEEEEEEeC------CCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEeeC
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  355 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  355 (438)
                      ...++|+..+.||+|+||.||+|++.      ++..||+|.++.....+....+.+|+.+++.+ +|+|||+++++|...
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            44557888899999999999999742      23579999997544333344688999999999 899999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhccCC--------------------------------------------------------
Q 013682          356 TEKLLVYPYMTNGSVASRLRERQS--------------------------------------------------------  379 (438)
Q Consensus       356 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------  379 (438)
                      +..++||||+++|+|.++++....                                                        
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            999999999999999999865321                                                        


Q ss_pred             ----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          380 ----------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       380 ----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                                ...++++.+...++.|++.||+|||++   +|+||||||+|||+++++.++++||.
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfG  257 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFG  257 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeece
Confidence                      012478889999999999999999998   99999999999999999999999996

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=8.9e-24  Score=208.01  Aligned_cols=142  Identities=23%  Similarity=0.303  Sum_probs=126.5

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc--cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      +|+..+.||+|+||.||+|+.. +++.||+|+++.....  .....+.+|+.++..++||||+++++++...+..++|||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            5778899999999999999975 5889999998654321  223468899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||+
T Consensus        82 ~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg  146 (333)
T cd05600          82 YVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFG  146 (333)
T ss_pred             CCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCc
Confidence            999999999997543    478899999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.90  E-value=1.2e-23  Score=202.44  Aligned_cols=143  Identities=29%  Similarity=0.392  Sum_probs=124.6

Q ss_pred             CCCCCccccccceEEEEEEe-CCCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          288 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      |+..+.||+|+||.||+|.. .+++.||+|.+.....  ......+.+|+.++..++|+|++++.+++.+.+..+++|||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            56678899999999999986 4789999999864322  12233578899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++|+|.+.+.....  ..+++..+..++.|++.|++|||+.   +|+||||||+|||+++++.++++||+
T Consensus        82 ~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg  147 (285)
T cd05631          82 MNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLG  147 (285)
T ss_pred             cCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCC
Confidence            999999988765322  2488999999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.90  E-value=1.5e-23  Score=206.05  Aligned_cols=137  Identities=28%  Similarity=0.338  Sum_probs=121.4

Q ss_pred             CccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCC
Q 013682          292 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  368 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g  368 (438)
                      +.||+|+||.||+++.. +++.||+|+++....  ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            36899999999999864 688999999865432  222346888999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          369 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       369 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +|..++....    .+++.++..++.|++.||+|||+.   +|+||||||+|||+++++.++++||.
T Consensus        81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG  140 (328)
T cd05593          81 ELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFG  140 (328)
T ss_pred             CHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCc
Confidence            9998886542    488999999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.90  E-value=1.4e-23  Score=205.11  Aligned_cols=144  Identities=26%  Similarity=0.461  Sum_probs=123.9

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCC----EEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~----~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      .+|+..+.||+|+||.||+|++. ++.    .||+|.++.........++.+|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46888899999999999999864 333    48999987543333445788999999999999999999998764 5679


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ++||+++|+|.++++....   .+++.....++.|++.||+|||+.   +|+||||||+|||+++++.++++||+-
T Consensus        86 v~e~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~  155 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGL  155 (316)
T ss_pred             eeecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccc
Confidence            9999999999999986432   478899999999999999999999   999999999999999999999999963

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.90  E-value=7.1e-24  Score=211.86  Aligned_cols=146  Identities=22%  Similarity=0.271  Sum_probs=127.2

Q ss_pred             HHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeE
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  359 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  359 (438)
                      ...++|+..+.||+|+||.||+++.. +++.||+|.++....  ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            34567888899999999999999875 688999999864321  122335788999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      +||||+++|+|.++++..     .++...+..++.|++.||+|||+.   +|+||||||+|||+++++.++|+||+-
T Consensus       120 lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~  188 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT  188 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccc
Confidence            999999999999998653     267788889999999999999999   999999999999999999999999963

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=1.7e-23  Score=204.17  Aligned_cols=135  Identities=21%  Similarity=0.295  Sum_probs=120.0

Q ss_pred             cccccceEEEEEEeC-CCCEEEEEEccccc--cccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCCCH
Q 013682          294 LGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  370 (438)
Q Consensus       294 LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  370 (438)
                      ||+|+||.||+|+.. +++.||+|.++...  .......+.+|+.++..++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999875 57899999986432  122234678899999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          371 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       371 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      .+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++++||.
T Consensus        81 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg  138 (312)
T cd05585          81 FHHLQREG----RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFG  138 (312)
T ss_pred             HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECc
Confidence            99987642    488999999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.90  E-value=1.8e-23  Score=208.08  Aligned_cols=143  Identities=20%  Similarity=0.334  Sum_probs=126.4

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|+..+.||+|+||.||+++.. +++.||+|.++....  ......+.+|+.++..++||||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46778899999999999999875 688999999864321  222346788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++++||.
T Consensus        81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG  146 (360)
T cd05627          81 EFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFG  146 (360)
T ss_pred             eCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeecc
Confidence            9999999999987643    378899999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.90  E-value=3.5e-23  Score=203.16  Aligned_cols=137  Identities=26%  Similarity=0.322  Sum_probs=120.4

Q ss_pred             CccccccceEEEEEEe-CCCCEEEEEEccccccc--cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCC
Q 013682          292 NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  368 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g  368 (438)
                      +.||+|+||.||+++. .+++.||+|.++.....  .....+.+|+.++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999986 46889999998754321  22345778999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          369 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       369 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +|..++....    .+++..+..++.|++.||+|||+ .   +|+||||||+|||+++++.++|+||+
T Consensus        81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg  141 (325)
T cd05594          81 ELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFG  141 (325)
T ss_pred             cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCC
Confidence            9998886543    48899999999999999999997 6   89999999999999999999999997

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.90  E-value=2e-23  Score=205.22  Aligned_cols=144  Identities=23%  Similarity=0.294  Sum_probs=127.3

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|+..+.||+|+||.||+++.. +++.||+|.++....  ......+.+|+.++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36778899999999999999864 688999999875432  122346889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++|+|.++++....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||.
T Consensus        81 e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg  147 (330)
T cd05601          81 EYQPGGDLLSLLNRYED---QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFG  147 (330)
T ss_pred             CCCCCCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCC
Confidence            99999999999976522   488999999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.90  E-value=2.9e-23  Score=204.29  Aligned_cols=145  Identities=26%  Similarity=0.345  Sum_probs=127.8

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .++|+..+.||+|+||.||+++.. ++..||+|.++..........+.+|+.++..++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            467888899999999999999875 6889999998654333334468999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+++|+|.+++....    .+++..+..++.|++.|+.|||+.+  +|+||||||+|||+++++.++++||.
T Consensus        84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg  149 (331)
T cd06649          84 HMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFG  149 (331)
T ss_pred             cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCc
Confidence            999999999987643    3788999999999999999999851  59999999999999999999999996

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.90  E-value=1.4e-23  Score=209.76  Aligned_cols=151  Identities=23%  Similarity=0.310  Sum_probs=130.7

Q ss_pred             HHHHHHHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEee
Q 013682          278 LRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTT  354 (438)
Q Consensus       278 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~  354 (438)
                      +.+.....++|+..+.||+|+||.||+++.. +++.||+|.++....  ......+.+|+.+++.++||||+++++++..
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            3445566688999999999999999999875 588999999854221  1223357889999999999999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhh
Q 013682          355 VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  434 (438)
Q Consensus       355 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df  434 (438)
                      .+..++||||+++|+|.++++..     .++...+..++.|++.||+|||++   +|+||||||+|||++.++.++|+||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence            99999999999999999998653     267888899999999999999999   9999999999999999999999999


Q ss_pred             hh
Q 013682          435 LR  436 (438)
Q Consensus       435 ~~  436 (438)
                      +-
T Consensus       187 G~  188 (371)
T cd05622         187 GT  188 (371)
T ss_pred             Cc
Confidence            63

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.90  E-value=1.2e-23  Score=212.05  Aligned_cols=151  Identities=28%  Similarity=0.380  Sum_probs=128.2

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEeC------CCCEEEEEEccccccccchHHHHHHHHHHhcCC-CCCceeeEEEEee
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTT  354 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~  354 (438)
                      ....++|...+.||+|+||.||+|+..      .+..||||+++..........+.+|+.+++.+. |||||+++++|..
T Consensus        33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            344667888899999999999999852      134699999975443333457899999999996 9999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHhhccCC-------------------------------------------------------
Q 013682          355 VTEKLLVYPYMTNGSVASRLRERQS-------------------------------------------------------  379 (438)
Q Consensus       355 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------  379 (438)
                      .+..++||||+++|+|.+++.....                                                       
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            9999999999999999998875321                                                       


Q ss_pred             -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCee
Q 013682          380 -------------------------------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL  422 (438)
Q Consensus       380 -------------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NIL  422 (438)
                                                           ....+++.++..++.|++.|++|||+.   +|+||||||+|||
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil  269 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence                                                 012478888999999999999999998   9999999999999


Q ss_pred             eCCCCCcchhhhh
Q 013682          423 LDEDADQSSKTIL  435 (438)
Q Consensus       423 ld~~~~~~l~Df~  435 (438)
                      +++++.++++||.
T Consensus       270 l~~~~~~kL~DfG  282 (400)
T cd05105         270 LAQGKIVKICDFG  282 (400)
T ss_pred             EeCCCEEEEEeCC
Confidence            9999999999996

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.90  E-value=2.3e-23  Score=205.08  Aligned_cols=144  Identities=20%  Similarity=0.263  Sum_probs=126.1

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|...+.||+|+||.||+++.. +++.||+|.++....  ......+.+|..++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46788899999999999999875 578999999864321  122335788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++|+|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++++||+
T Consensus        81 Ey~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG  147 (331)
T cd05624          81 DYYVGGDLLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFG  147 (331)
T ss_pred             eCCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEecc
Confidence            99999999999976322   478899999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=2.2e-23  Score=205.16  Aligned_cols=145  Identities=21%  Similarity=0.292  Sum_probs=126.6

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|+..+.||+|+||.||+++.. +++.||+|.++....  ......+.+|..++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46788899999999999999874 588999999864221  122345888999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||+++|+|.+++....   ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++++||.-
T Consensus        81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~  148 (331)
T cd05597          81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGS  148 (331)
T ss_pred             ecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCc
Confidence            9999999999997532   2378899999999999999999999   999999999999999999999999973

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.90  E-value=2.7e-23  Score=199.45  Aligned_cols=139  Identities=29%  Similarity=0.400  Sum_probs=121.0

Q ss_pred             cccccceEEEEEEeC-CCCEEEEEEcccccccc--chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCCCH
Q 013682          294 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  370 (438)
Q Consensus       294 LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  370 (438)
                      ||+|+||+||++... +++.||+|.+.......  ....+..|+.+++.++||||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999864 68899999986432221  223577899999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          371 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       371 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ...+.........+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++++||.
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg  142 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLG  142 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCc
Confidence            988765433344689999999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=6.8e-24  Score=213.79  Aligned_cols=146  Identities=28%  Similarity=0.423  Sum_probs=127.2

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccc--cccchHHHHHHHHHHhcC-CCCCceeeEEEEeeCCe
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTE  357 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  357 (438)
                      ....++|...++||+|.||+|+.++.+ +++.+|||.+|+..  ..++....+.|..++... +||.++.++.+|++.++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            455678999999999999999999975 57899999998764  234445678888888766 59999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      .+.||||+.||++..+.+..     .++.+.+..+|+.|+.||.|||++   +|||||||-+|||+|.+|.+||+||+
T Consensus       444 l~fvmey~~Ggdm~~~~~~~-----~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFG  513 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIHTD-----VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFG  513 (694)
T ss_pred             EEEEEEecCCCcEEEEEecc-----cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccc
Confidence            99999999999954443322     489999999999999999999999   99999999999999999999999997

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.90  E-value=3.7e-23  Score=203.75  Aligned_cols=145  Identities=26%  Similarity=0.349  Sum_probs=127.6

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .++|+..+.||+|+||.||++... ++..+|+|.++..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            467888899999999999999875 5888999988654333334468999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+++|+|.++++...    .+++.....++.|++.|++|||+..  +|+||||||+|||+++++.++++||.
T Consensus        84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg  149 (333)
T cd06650          84 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFG  149 (333)
T ss_pred             cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCC
Confidence            999999999997643    3788899999999999999999741  69999999999999999999999996

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.90  E-value=4e-23  Score=196.40  Aligned_cols=145  Identities=31%  Similarity=0.450  Sum_probs=128.0

Q ss_pred             hCCCCCCCccccccceEEEEEEeCC----CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~~----~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      .++|+..+.||+|+||.||+|++..    ...||||.++..........|.+|+.++..++||||+++++.+...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            3567888999999999999998742    457999998765433344578999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +|||+++++|.+++.....   .+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++++||.
T Consensus        83 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg  151 (266)
T cd05033          83 ITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFG  151 (266)
T ss_pred             EEEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccc
Confidence            9999999999999976432   589999999999999999999998   99999999999999999999999995

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=8.2e-24  Score=211.90  Aligned_cols=142  Identities=27%  Similarity=0.392  Sum_probs=128.2

Q ss_pred             CCCCCCccccccceEEEEEEe-CCCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          287 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      -|+.++.||+|+-|.|..|++ .+|+.+|||++.+...  +.....+++|+.+|+.+.|||++++++++++..+.|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            467788999999999999986 5799999999966522  2223468999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+++|.|++++..++    ++...++.+++.||..|+.|+|+.   +|+||||||+|+|+|...+.||+||+
T Consensus        93 yv~gGELFdylv~kG----~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFG  157 (786)
T KOG0588|consen   93 YVPGGELFDYLVRKG----PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFG  157 (786)
T ss_pred             ecCCchhHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccc
Confidence            999999999998765    388899999999999999999999   99999999999999999999999997

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.90  E-value=4.2e-23  Score=195.12  Aligned_cols=142  Identities=29%  Similarity=0.429  Sum_probs=126.5

Q ss_pred             CCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecC
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      ++|+..+.||+|+||.||++++.++..+|+|.++...  ....++.+|+.++++++||||+++++++...+..+++|||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            3466778899999999999998877889999886432  23457889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++|+|.++++....   .++|..+..++.|++.||+|||+.   +|+||||||+||++++++.++++||.
T Consensus        82 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g  145 (256)
T cd05114          82 ENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFG  145 (256)
T ss_pred             CCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCC
Confidence            99999999875432   478999999999999999999998   99999999999999999999999996

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=1.9e-23  Score=206.74  Aligned_cols=144  Identities=26%  Similarity=0.342  Sum_probs=127.8

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc--cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|...+.||+|+||.||+|+.. +++.||+|+++.....  .....+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36778899999999999999975 6899999998654321  23346889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++++||.-
T Consensus        81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~  147 (350)
T cd05573          81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGL  147 (350)
T ss_pred             cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCC
Confidence            999999999999765    2488999999999999999999998   999999999999999999999999963

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.89  E-value=4.6e-23  Score=196.27  Aligned_cols=141  Identities=28%  Similarity=0.346  Sum_probs=119.7

Q ss_pred             ccccccceEEEEEEeCC---CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCCC
Q 013682          293 ILGRGGFGKVYKGRLAD---GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS  369 (438)
Q Consensus       293 ~LG~G~fG~Vy~~~~~~---~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs  369 (438)
                      .||+|+||.||+|...+   ...+|+|.++..........+.+|+..++.++||||+++++.+......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997533   347888887644333334468899999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          370 VASRLRERQSS-LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       370 L~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |.++++..... ....++.....++.|++.|++|||+.   +|+||||||+||+++++++++++||.-
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~  146 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGL  146 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEecccc
Confidence            99999875432 12356788899999999999999999   999999999999999999999999963

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.89  E-value=4.1e-23  Score=202.51  Aligned_cols=137  Identities=27%  Similarity=0.353  Sum_probs=119.8

Q ss_pred             CccccccceEEEEEEeC----CCCEEEEEEcccccc---ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          292 NILGRGGFGKVYKGRLA----DGKLVAVKRLKEERT---SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~----~~~~vAvK~l~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      +.||+|+||.||+++..    +++.||+|.++....   ......+.+|+.+++.++||||+++++++...+..+++|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            57999999999999752    478999999865321   12223578899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++|+|.+++....    .+.+..+..++.|++.||+|||+.   +|+||||||+|||+++++.++|+||+
T Consensus        82 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  145 (323)
T cd05584          82 LSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFG  145 (323)
T ss_pred             CCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCc
Confidence            99999999987543    377888899999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.89  E-value=4.3e-23  Score=201.85  Aligned_cols=137  Identities=28%  Similarity=0.359  Sum_probs=120.7

Q ss_pred             CccccccceEEEEEEe----CCCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCC
Q 013682          292 NILGRGGFGKVYKGRL----ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  366 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~----~~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  366 (438)
                      +.||+|+||.||+++.    .+++.||+|+++..... .....+.+|+.++..++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5699999999999874    35789999998654322 223357789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          367 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       367 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+||++++++.++++||.
T Consensus        82 ~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg  143 (318)
T cd05582          82 GGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFG  143 (318)
T ss_pred             CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeecc
Confidence            999999986542    489999999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.89  E-value=1.8e-23  Score=207.52  Aligned_cols=138  Identities=24%  Similarity=0.342  Sum_probs=119.6

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecC
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      +|+..+.||+|+||.||+|+.. +++.||||.+...........+.+|+++++.++|+||+++++++...+..++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            4555688999999999999874 689999999865433333446899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++|+|....        ...+.....++.|++.||+|||++   +|+||||||+|||+++++.++|+||.
T Consensus       155 ~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG  213 (353)
T PLN00034        155 DGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFG  213 (353)
T ss_pred             CCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccc
Confidence            999985421        245677888999999999999999   99999999999999999999999996

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.89  E-value=3e-23  Score=209.09  Aligned_cols=152  Identities=26%  Similarity=0.370  Sum_probs=128.2

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEeC------CCCEEEEEEccccccccchHHHHHHHHHHhcCC-CCCceeeEEEEee
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTT  354 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~  354 (438)
                      ....++|...+.||+|+||.||+|++.      .++.||+|+++..........+.+|+.++..+. |||||+++++|..
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            344556777899999999999999863      245899999976433333346889999999997 9999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHhhccCC-------------------------------------------------------
Q 013682          355 VTEKLLVYPYMTNGSVASRLRERQS-------------------------------------------------------  379 (438)
Q Consensus       355 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------  379 (438)
                      .+..++||||+++|+|.++++....                                                       
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            9999999999999999999975321                                                       


Q ss_pred             ---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCC
Q 013682          380 ---------------------------------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN  420 (438)
Q Consensus       380 ---------------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~N  420 (438)
                                                             ....++|.....++.|++.||+|||+.   +|+||||||+|
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~N  269 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARN  269 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcce
Confidence                                                   112467888999999999999999998   99999999999


Q ss_pred             eeeCCCCCcchhhhhh
Q 013682          421 ILLDEDADQSSKTILR  436 (438)
Q Consensus       421 ILld~~~~~~l~Df~~  436 (438)
                      ||+++++.++++||.-
T Consensus       270 iLl~~~~~~kL~DfGl  285 (401)
T cd05107         270 VLICEGKLVKICDFGL  285 (401)
T ss_pred             EEEeCCCEEEEEecCc
Confidence            9999999999999963

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.89  E-value=5.4e-23  Score=202.23  Aligned_cols=137  Identities=25%  Similarity=0.342  Sum_probs=120.3

Q ss_pred             CccccccceEEEEEEeC-CCCEEEEEEccccccc--cchHHHHHHHHHHhcC-CCCCceeeEEEEeeCCeeEEEEecCCC
Q 013682          292 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  367 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~  367 (438)
                      +.||+|+||.||+|+.. +++.||+|.++.....  .....+.+|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999874 6889999999754322  1223578899999888 799999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          368 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+|..++....    .+++..+..++.|++.||+|||++   +|+||||||+|||+++++.++|+||.
T Consensus        81 g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg  141 (329)
T cd05588          81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYG  141 (329)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCc
Confidence            99998886542    489999999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.89  E-value=6.2e-23  Score=199.75  Aligned_cols=143  Identities=25%  Similarity=0.422  Sum_probs=125.3

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      ++|...+.||+|+||.||+|+.. +++.||+|.++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            46777889999999999999875 57899999987554343444678999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++ ++.+++....   ..+++.....++.|++.||+|||+.   +|+||||||+||++++++.++++||.
T Consensus        86 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg  149 (309)
T cd07872          86 LDK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFG  149 (309)
T ss_pred             CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccc
Confidence            985 8888876543   2478889999999999999999998   99999999999999999999999996

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.89  E-value=6.7e-23  Score=193.15  Aligned_cols=138  Identities=31%  Similarity=0.486  Sum_probs=122.6

Q ss_pred             CccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCCCH
Q 013682          292 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  370 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  370 (438)
                      +.||+|+||.||+|+.. +++.||+|.++.....+....+.+|+++++.++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            35899999999999874 68899999886543333345789999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          371 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       371 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      .++++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||++++++.++++||.
T Consensus        81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg  139 (252)
T cd05084          81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFG  139 (252)
T ss_pred             HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccc
Confidence            99987542   2478999999999999999999999   99999999999999999999999995

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.89  E-value=3.7e-23  Score=197.87  Aligned_cols=149  Identities=26%  Similarity=0.407  Sum_probs=127.3

Q ss_pred             HhCCCCCCCccccccceEEEEEEeC------CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCe
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  357 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  357 (438)
                      ..++|+..+.||+|+||.||+|.+.      ++..||+|.++.........++.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567888899999999999999753      2467999998653322234468899999999999999999999999899


Q ss_pred             eEEEEecCCCCCHHHHhhccCCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcch
Q 013682          358 KLLVYPYMTNGSVASRLRERQSS------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS  431 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l  431 (438)
                      .++||||+++|+|.++++.....      ...++|.....++.|++.|++|||+.   +++||||||+||++++++.+++
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence            99999999999999998764321      23468889999999999999999998   9999999999999999999999


Q ss_pred             hhhh
Q 013682          432 KTIL  435 (438)
Q Consensus       432 ~Df~  435 (438)
                      +||.
T Consensus       161 ~dfg  164 (277)
T cd05062         161 GDFG  164 (277)
T ss_pred             CCCC
Confidence            9996

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.89  E-value=5.1e-23  Score=201.86  Aligned_cols=142  Identities=25%  Similarity=0.337  Sum_probs=122.6

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCC-CceeeEEEEeeCCeeEEEE
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHR-NLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lv~  362 (438)
                      +|+..+.||+|+||.||+|+.. +++.||+|+++....  ......+..|..++..++|+ +|+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4677889999999999999875 578999999865422  22334678899999888765 5888999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.++++||+
T Consensus        81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg  146 (324)
T cd05587          81 EYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFG  146 (324)
T ss_pred             cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecC
Confidence            9999999999987543    378999999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.89  E-value=2.6e-23  Score=197.34  Aligned_cols=140  Identities=35%  Similarity=0.577  Sum_probs=120.7

Q ss_pred             CCccccccceEEEEEEeC-----CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecC
Q 013682          291 KNILGRGGFGKVYKGRLA-----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       291 ~~~LG~G~fG~Vy~~~~~-----~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      .+.||+|+||.||+|.+.     .+..|+||.++..........|.+|+..+.+++||||++++|++...+..++||||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            467999999999999876     256899999966443334568999999999999999999999999888899999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++|+|.++++...  ...+++..+..++.|+|.||+|||+.   +++|+||+++||++++++.+|++||.
T Consensus        84 ~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~  148 (259)
T PF07714_consen   84 PGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFG  148 (259)
T ss_dssp             TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTT
T ss_pred             ccccccccccccc--cccccccccccccccccccccccccc---cccccccccccccccccccccccccc
Confidence            9999999998862  23489999999999999999999999   99999999999999999999999995

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.89  E-value=5.4e-23  Score=197.38  Aligned_cols=147  Identities=29%  Similarity=0.441  Sum_probs=126.1

Q ss_pred             CCCCCCCccccccceEEEEEEe-----CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-----~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      ++|+..+.||+|+||.||+|.+     .++..||+|.++..........+.+|++++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4577778999999999999974     24578999999754333333578899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC
Q 013682          361 VYPYMTNGSVASRLRERQS-------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  427 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~  427 (438)
                      +|||+++++|.+++.....             ....+++.+...++.|++.||+|||++   +|+||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence            9999999999999864321             112478899999999999999999999   999999999999999999


Q ss_pred             Ccchhhhh
Q 013682          428 DQSSKTIL  435 (438)
Q Consensus       428 ~~~l~Df~  435 (438)
                      .++++||.
T Consensus       162 ~~kl~dfg  169 (283)
T cd05090         162 HVKISDLG  169 (283)
T ss_pred             cEEecccc
Confidence            99999996

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.89  E-value=5.6e-23  Score=201.35  Aligned_cols=137  Identities=28%  Similarity=0.404  Sum_probs=119.2

Q ss_pred             CccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcC-CCCCceeeEEEEeeCCeeEEEEecCCC
Q 013682          292 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  367 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~  367 (438)
                      +.||+|+||.||+|+.. +++.||+|.++....  .+....+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36899999999999875 578999999865432  22233577788888765 799999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          368 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+|...+....    .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.++++||.
T Consensus        81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg  141 (321)
T cd05591          81 GDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFG  141 (321)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecc
Confidence            99998887543    378999999999999999999999   99999999999999999999999997

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.89  E-value=5.3e-23  Score=202.34  Aligned_cols=142  Identities=25%  Similarity=0.309  Sum_probs=123.1

Q ss_pred             CCCCCCccccccceEEEEEEeC----CCCEEEEEEcccccc---ccchHHHHHHHHHHhcC-CCCCceeeEEEEeeCCee
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERT---SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEK  358 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~----~~~~vAvK~l~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  358 (438)
                      +|+..+.||+|+||.||+++..    +++.||+|.++....   ......+.+|+.++..+ +||||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4677789999999999999752    578999999864321   11223578899999999 599999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++|||+++|+|.+++....    .+++.+...++.|++.||+|||+.   +|+||||||+|||++.++.++|+||+
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG  150 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFG  150 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCc
Confidence            99999999999999987643    378999999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.89  E-value=4.5e-23  Score=198.62  Aligned_cols=150  Identities=27%  Similarity=0.422  Sum_probs=127.3

Q ss_pred             HHhCCCCCCCccccccceEEEEEEeC------CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCC
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT  356 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  356 (438)
                      +..++|+..+.||+|+||.||+|...      .+..||+|.++..........+.+|+.+++.++||||+++++++...+
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            34567888999999999999999753      245799998865433233346888999999999999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhccCC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcc
Q 013682          357 EKLLVYPYMTNGSVASRLRERQS------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  430 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~  430 (438)
                      ..+++|||+++|+|.++++....      .....++.....++.|++.||.|||+.   +|+||||||+||++++++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence            99999999999999999975321      123457788899999999999999998   999999999999999999999


Q ss_pred             hhhhh
Q 013682          431 SKTIL  435 (438)
Q Consensus       431 l~Df~  435 (438)
                      ++||.
T Consensus       160 L~Dfg  164 (288)
T cd05061         160 IGDFG  164 (288)
T ss_pred             ECcCC
Confidence            99995

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.89  E-value=5.8e-23  Score=202.21  Aligned_cols=144  Identities=21%  Similarity=0.275  Sum_probs=125.8

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|+..+.||+|+||.||+++.. +++.+|+|.+.....  ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            36778899999999999999975 478899999854221  122335888999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++|+|.++++....   .+++..+..++.|++.|++|||+.   +|+||||||+|||++.++.++++||.
T Consensus        81 ey~~~g~L~~~l~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG  147 (332)
T cd05623          81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG  147 (332)
T ss_pred             eccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecc
Confidence            99999999999976322   478899999999999999999999   99999999999999999999999997

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.89  E-value=7.4e-23  Score=201.25  Aligned_cols=137  Identities=27%  Similarity=0.362  Sum_probs=119.1

Q ss_pred             CccccccceEEEEEEeC-CCCEEEEEEcccccccc--chHHHHHHHHHHhcC-CCCCceeeEEEEeeCCeeEEEEecCCC
Q 013682          292 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  367 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~  367 (438)
                      +.||+|+||.||+|+.. +++.||+|.++......  ....+.+|+.++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46899999999999874 57899999987543222  223577888887766 899999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          368 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+|..++....    .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+||.
T Consensus        81 ~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG  141 (329)
T cd05618          81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYG  141 (329)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCC
Confidence            99998886542    488999999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.89  E-value=9e-23  Score=194.38  Aligned_cols=141  Identities=31%  Similarity=0.394  Sum_probs=121.1

Q ss_pred             CccccccceEEEEEEeCC---CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCC
Q 013682          292 NILGRGGFGKVYKGRLAD---GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  368 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~---~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g  368 (438)
                      +.||+|+||.||+|.+.+   +..+|+|.++..........+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999998643   45799998866543333447889999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          369 SVASRLRERQS-SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       369 sL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +|.++++.... .....++..+..++.|++.|++|||+.   +++||||||+||++++++.++++||.
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg  145 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYG  145 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcc
Confidence            99999976432 223467788889999999999999998   99999999999999999999999996

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.89  E-value=5.7e-23  Score=201.54  Aligned_cols=140  Identities=29%  Similarity=0.402  Sum_probs=119.7

Q ss_pred             CCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHH---hcCCCCCceeeEEEEeeCCeeEEE
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKII---SMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      |...+.||+|+||.||+|+.. +++.||||.++....  ......+.+|+.++   +.++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            455688999999999999874 688999999865421  12223466666554   567899999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |||+++|+|...++..     .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++++||.
T Consensus        81 ~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg  146 (324)
T cd05589          81 MEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFG  146 (324)
T ss_pred             EcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCccc
Confidence            9999999999887542     489999999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.89  E-value=7.2e-23  Score=198.89  Aligned_cols=148  Identities=28%  Similarity=0.466  Sum_probs=126.8

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCC--EEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEeeCCeeEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGK--LVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~--~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  360 (438)
                      +++|+..+.||+|+||.||+|++. ++.  .+|+|.++..........+.+|++++.++ +||||+++++++...+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            457788899999999999999874 343  46888876543333445788999999999 89999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC
Q 013682          361 VYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  428 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~  428 (438)
                      +|||+++|+|.++++....            ....+++.++..++.|++.|++|||+.   +|+||||||+|||+++++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence            9999999999999975431            123578999999999999999999998   9999999999999999999


Q ss_pred             cchhhhh
Q 013682          429 QSSKTIL  435 (438)
Q Consensus       429 ~~l~Df~  435 (438)
                      ++++||.
T Consensus       163 ~kl~dfg  169 (303)
T cd05088         163 AKIADFG  169 (303)
T ss_pred             EEeCccc
Confidence            9999996

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.89  E-value=7.4e-23  Score=200.47  Aligned_cols=137  Identities=31%  Similarity=0.443  Sum_probs=119.1

Q ss_pred             CccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcC-CCCCceeeEEEEeeCCeeEEEEecCCC
Q 013682          292 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  367 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~  367 (438)
                      +.||+|+||.||+|+.. +++.||+|.++....  ......+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999875 588999999865321  22334567788888765 699999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          368 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.++++||+
T Consensus        81 g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG  141 (320)
T cd05590          81 GDLMFHIQKSR----RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFG  141 (320)
T ss_pred             chHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCC
Confidence            99999887643    388999999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.89  E-value=1.1e-22  Score=193.97  Aligned_cols=140  Identities=26%  Similarity=0.350  Sum_probs=118.7

Q ss_pred             ccccccceEEEEEEeCCC---CEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCCC
Q 013682          293 ILGRGGFGKVYKGRLADG---KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS  369 (438)
Q Consensus       293 ~LG~G~fG~Vy~~~~~~~---~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs  369 (438)
                      .||+|+||.||+|+..++   ..+++|.++..........+.+|+.+++.++||||+++++.|......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999975433   34667766544333344579999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          370 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       370 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |.++++.........++.....++.|++.||+|||+.   +++||||||+|||+++++.++++||.
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg  144 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYG  144 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccc
Confidence            9999986533333467777889999999999999998   99999999999999999999999996

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=8e-23  Score=196.74  Aligned_cols=144  Identities=28%  Similarity=0.377  Sum_probs=125.0

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc--cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      +|+..+.||+|+||.||++... +++.||+|.+......  .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3667789999999999999864 6889999998653222  122357789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+++|+|.+++....  ...+++..+..++.|++.|+.|||+.   +|+||||||+||++++++.++++||.
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg  147 (285)
T cd05605          81 LMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLG  147 (285)
T ss_pred             ccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCC
Confidence            999999998886532  23489999999999999999999998   99999999999999999999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.89  E-value=8.5e-23  Score=194.32  Aligned_cols=144  Identities=29%  Similarity=0.421  Sum_probs=125.9

Q ss_pred             CCCCCCCccccccceEEEEEEeC-C---CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-D---GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~---~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      ++|+..+.||+|+||.||+|+.. +   +..+|+|.++..........+.+|+.++..++||||+++++++...+..+++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            45677889999999999999863 2   3379999987544333345789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |||+++++|.+++....   ..+++.+...++.|++.|++|||+.   +++||||||+|||+++++.++++||.
T Consensus        84 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg  151 (267)
T cd05066          84 TEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFG  151 (267)
T ss_pred             EEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCC
Confidence            99999999999997643   2479999999999999999999999   99999999999999999999999995

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.89  E-value=2.2e-23  Score=215.84  Aligned_cols=146  Identities=26%  Similarity=0.378  Sum_probs=123.5

Q ss_pred             CCCCCCccccccceEEEEEEeCCC-CEEEEEEccccccccchHHHHHHHHHHhcCC-CCCceeeEEE-Eee------CCe
Q 013682          287 GFSNKNILGRGGFGKVYKGRLADG-KLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGF-CTT------VTE  357 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~~~-~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~-~~~------~~~  357 (438)
                      ++++.++|.+|||+.||.|+...+ ..||+|++-.. .........+|+.+|+.++ |+|||.+++. ...      .-+
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            345568899999999999997654 99999997443 2334456899999999997 9999999993 221      235


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      .+|.||||.+|+|-+++..+..  ..|++.++++|+.|+++|+++||.. +|+|||||||.+||||+.+++-|++||+.
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS  192 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS  192 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence            7899999999999999987543  2399999999999999999999996 88999999999999999999999999985

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.89  E-value=9.7e-23  Score=199.27  Aligned_cols=137  Identities=26%  Similarity=0.395  Sum_probs=116.7

Q ss_pred             CccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhc-CCCCCceeeEEEEeeCCeeEEEEecCCC
Q 013682          292 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISM-AVHRNLLRLYGFCTTVTEKLLVYPYMTN  367 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~e~~~~  367 (438)
                      +.||+|+||+||+|+.. +++.||+|.++....  ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999874 578999999875432  1222345556666654 5899999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          368 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+|..++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.++++||+
T Consensus        81 g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg  141 (316)
T cd05592          81 GDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFG  141 (316)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCc
Confidence            99999887543    378899999999999999999998   99999999999999999999999996

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.89  E-value=3.1e-23  Score=205.94  Aligned_cols=148  Identities=26%  Similarity=0.401  Sum_probs=130.5

Q ss_pred             HHHHhCCCCCCCccccccceEEEEEEeCC-----CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeC
Q 013682          281 LQVATDGFSNKNILGRGGFGKVYKGRLAD-----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV  355 (438)
Q Consensus       281 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-----~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  355 (438)
                      .+...+.....+.||+|.||.||+|.+.+     ...||||..|.+.+.+..+.|..|+.+|+.++|||||+++|+|.+ 
T Consensus       384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-  462 (974)
T KOG4257|consen  384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-  462 (974)
T ss_pred             ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-
Confidence            34444555667899999999999998632     236999999988877778889999999999999999999999965 


Q ss_pred             CeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          356 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       356 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ...|+|||+++.|.|.++|+....   .++......++.|++.||+|||+.   ++|||||.++|||+.+...+|++||+
T Consensus       463 ~P~WivmEL~~~GELr~yLq~nk~---sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFG  536 (974)
T KOG4257|consen  463 QPMWIVMELAPLGELREYLQQNKD---SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFG  536 (974)
T ss_pred             cceeEEEecccchhHHHHHHhccc---cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccc
Confidence            468999999999999999987654   478888999999999999999999   99999999999999999999999997

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.89  E-value=9.5e-23  Score=199.65  Aligned_cols=137  Identities=27%  Similarity=0.373  Sum_probs=116.5

Q ss_pred             CccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHH-HHhcCCCCCceeeEEEEeeCCeeEEEEecCCC
Q 013682          292 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVK-IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  367 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  367 (438)
                      +.||+|+||.||+|+.. +++.||+|.+.....  ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999975 588999999864321  112234555544 67889999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          368 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+|...+....    .+++.+...++.|++.||+|||+.   +|+||||||+||+++.++.++|+||.
T Consensus        81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg  141 (321)
T cd05603          81 GELFFHLQRER----CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFG  141 (321)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCC
Confidence            99998886542    378888899999999999999998   99999999999999999999999996

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.89  E-value=5.4e-23  Score=203.40  Aligned_cols=149  Identities=30%  Similarity=0.410  Sum_probs=124.6

Q ss_pred             HhCCCCCCCccccccceEEEEEEe------CCCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEeeC-
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV-  355 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~------~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-  355 (438)
                      ..++|+..+.||+|+||.||+|.+      .+++.||||.++..........+.+|+.++..+ +||||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            346788899999999999999974      246789999997543333344688999999999 689999999988654 


Q ss_pred             CeeEEEEecCCCCCHHHHhhccCCC-------------------------------------------------------
Q 013682          356 TEKLLVYPYMTNGSVASRLRERQSS-------------------------------------------------------  380 (438)
Q Consensus       356 ~~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------  380 (438)
                      ...+++|||+++|+|.++++.....                                                       
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            4578999999999999998753210                                                       


Q ss_pred             --------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          381 --------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       381 --------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                              ...++|.+...++.|++.|++|||+.   +|+||||||+|||++++++++++||.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg  224 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFG  224 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecc
Confidence                    12368888999999999999999999   99999999999999999999999996

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.89  E-value=1.1e-22  Score=192.76  Aligned_cols=145  Identities=29%  Similarity=0.403  Sum_probs=129.3

Q ss_pred             HhCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      ..++|+..+.||+|+||.||+|...+++.||+|.++...  ....++.+|+.++++++||||+++++++...+..+++||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            345688889999999999999998777889999986532  234578999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+++++|.++++...  ...++|.....++.|++.|+.|||+.   +|+||||||+||++++++.++++||.
T Consensus        82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg  148 (261)
T cd05068          82 LMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFG  148 (261)
T ss_pred             cccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcc
Confidence            999999999997643  23589999999999999999999998   99999999999999999999999996

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.89  E-value=1.2e-22  Score=198.61  Aligned_cols=137  Identities=28%  Similarity=0.434  Sum_probs=118.4

Q ss_pred             CccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhc-CCCCCceeeEEEEeeCCeeEEEEecCCC
Q 013682          292 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISM-AVHRNLLRLYGFCTTVTEKLLVYPYMTN  367 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~e~~~~  367 (438)
                      +.||+|+||+||+|+.. +++.||+|.++....  ......+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36899999999999975 578999999875421  2223346667777765 5899999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          368 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+|.++++...    .+++.+...++.|++.||+|||+.   +|+||||||+|||++.++.++++||.
T Consensus        81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg  141 (316)
T cd05619          81 GDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFG  141 (316)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCC
Confidence            99999987642    378999999999999999999999   99999999999999999999999997

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.89  E-value=1.1e-22  Score=199.45  Aligned_cols=137  Identities=28%  Similarity=0.403  Sum_probs=117.0

Q ss_pred             CccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHH-HHhcCCCCCceeeEEEEeeCCeeEEEEecCCC
Q 013682          292 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVK-IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  367 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  367 (438)
                      +.||+|+||+||+|+.. +++.||+|.+.....  ......+.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36899999999999974 689999999864321  112234445544 56789999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          368 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+|..++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.++++||.
T Consensus        81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg  141 (323)
T cd05575          81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFG  141 (323)
T ss_pred             CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccC
Confidence            99999887543    478899999999999999999999   99999999999999999999999997

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.89  E-value=7.2e-23  Score=196.84  Aligned_cols=143  Identities=18%  Similarity=0.290  Sum_probs=123.3

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      ++|+..+.||+|+||.||+|+.. +++.||+|+++..... .....+.+|+.++..++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            35778899999999999999985 5789999998654322 223468899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |++++.+....+..    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++||.
T Consensus        81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg  145 (287)
T cd07848          81 YVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFG  145 (287)
T ss_pred             cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeecc
Confidence            99988776554322    2478899999999999999999998   99999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.89  E-value=1.4e-22  Score=197.36  Aligned_cols=143  Identities=29%  Similarity=0.355  Sum_probs=126.1

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      ++|+..+.||+|+||.||+++.. ++..+|+|.++.........++.+|++++..++||||+++++++...+..+++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36788899999999999999874 57889999886543322334688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++++|.++++...    .+++.....++.|++.||+|||+ .   +++||||||+||++++++.++++||.
T Consensus        81 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg  145 (308)
T cd06615          81 MDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFG  145 (308)
T ss_pred             cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCC
Confidence            99999999997642    47889999999999999999997 4   89999999999999999999999995

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.89  E-value=1.2e-22  Score=198.54  Aligned_cols=137  Identities=26%  Similarity=0.399  Sum_probs=118.2

Q ss_pred             CccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhc-CCCCCceeeEEEEeeCCeeEEEEecCCC
Q 013682          292 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISM-AVHRNLLRLYGFCTTVTEKLLVYPYMTN  367 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~e~~~~  367 (438)
                      +.||+|+||.||+|+.. +++.||+|.++....  ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46899999999999975 588999999875432  2223346667777764 5899999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          368 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+|..++....    .+++.++..++.|++.||+|||++   +|+||||||+|||++.++.++++||.
T Consensus        81 g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg  141 (316)
T cd05620          81 GDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFG  141 (316)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccC
Confidence            99999887642    378899999999999999999999   99999999999999999999999997

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.89  E-value=7.7e-23  Score=197.69  Aligned_cols=148  Identities=28%  Similarity=0.421  Sum_probs=126.3

Q ss_pred             hCCCCCCCccccccceEEEEEEeCC---------------CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLAD---------------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY  349 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~~---------------~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~  349 (438)
                      .++|+..+.||+|+||.||+++...               ...||+|.++..........+.+|++++.+++|||+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3567888999999999999987532               2358999987654333445689999999999999999999


Q ss_pred             EEEeeCCeeEEEEecCCCCCHHHHhhccCC--------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCe
Q 013682          350 GFCTTVTEKLLVYPYMTNGSVASRLRERQS--------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANI  421 (438)
Q Consensus       350 g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NI  421 (438)
                      +++...+..++||||+++++|.+++.....        ....++|.+...++.|++.|++|||+.   +++||||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence            999999999999999999999999865321        112478899999999999999999999   999999999999


Q ss_pred             eeCCCCCcchhhhh
Q 013682          422 LLDEDADQSSKTIL  435 (438)
Q Consensus       422 Lld~~~~~~l~Df~  435 (438)
                      ++++++.++++||.
T Consensus       161 ll~~~~~~kl~dfg  174 (295)
T cd05097         161 LVGNHYTIKIADFG  174 (295)
T ss_pred             EEcCCCcEEecccc
Confidence            99999999999996

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.89  E-value=1.2e-22  Score=199.18  Aligned_cols=142  Identities=25%  Similarity=0.342  Sum_probs=121.7

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcC-CCCCceeeEEEEeeCCeeEEEE
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      +|...+.||+|+||.||+|+.. +++.||+|.++....  ......+..|..++... +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4677889999999999999875 578999999865432  12223466777777766 5899999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++|+|...+....    .+++.++..++.|++.||+|||++   +|+||||||+|||+++++.++++||+
T Consensus        81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG  146 (323)
T cd05616          81 EYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCC
Confidence            9999999999886543    378999999999999999999999   99999999999999999999999997

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.89  E-value=7.3e-23  Score=211.28  Aligned_cols=144  Identities=17%  Similarity=0.223  Sum_probs=124.4

Q ss_pred             CCCCCccccccceEEEEEEeC-C-CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecC
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-D-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-~-~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      |...+.||+|+||.||+|... + ++.||+|.+.... ......+.+|+.+++.++|||||++++++...+..++||||+
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            677789999999999999753 3 5778888764322 222335788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++|+|.++++.......++++.++..++.|++.||+|||++   +|+||||||+|||+++++.++++||.
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFg  214 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFG  214 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCc
Confidence            99999998875433344688999999999999999999999   99999999999999999999999996

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.89  E-value=5.6e-23  Score=202.79  Aligned_cols=150  Identities=32%  Similarity=0.438  Sum_probs=125.4

Q ss_pred             HHhCCCCCCCccccccceEEEEEEeC------CCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEeeC
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  355 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  355 (438)
                      ...++|+..+.||+|+||.||+|...      +++.||+|+++..........+.+|+.++.++ +|+||++++++|...
T Consensus         4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            34567888899999999999999642      24789999987544333344678899999999 899999999988654


Q ss_pred             -CeeEEEEecCCCCCHHHHhhccCCC------------------------------------------------------
Q 013682          356 -TEKLLVYPYMTNGSVASRLRERQSS------------------------------------------------------  380 (438)
Q Consensus       356 -~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------  380 (438)
                       ...+++|||+++|+|.+++......                                                      
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence             5678999999999999998653211                                                      


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          381 ---LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       381 ---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                         ..+++|..+..++.|++.||+|||+.   +|+||||||+|||+++++.++++||+
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG  218 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFG  218 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccc
Confidence               12589999999999999999999999   99999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>PHA02988 hypothetical protein; Provisional

Probab=99.89  E-value=2.7e-22  Score=193.04  Aligned_cols=137  Identities=19%  Similarity=0.296  Sum_probs=118.9

Q ss_pred             CccccccceEEEEEEeCCCCEEEEEEccccccccc--hHHHHHHHHHHhcCCCCCceeeEEEEee----CCeeEEEEecC
Q 013682          292 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTT----VTEKLLVYPYM  365 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~e~~  365 (438)
                      ..+|+|++|.||+|.+ +|+.||||.++.......  ...|.+|+.++.+++|||||+++|++.+    ....+++|||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            6799999999999998 688999999975432221  2467899999999999999999999876    34678999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++|+|.++++...    .++|.....++.+++.|+.|||+..  +++||||||+|||+++++.++++||+
T Consensus       105 ~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg  168 (283)
T PHA02988        105 TRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHG  168 (283)
T ss_pred             CCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccc
Confidence            9999999997643    4889999999999999999999731  67899999999999999999999996

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.89  E-value=1.6e-22  Score=191.42  Aligned_cols=141  Identities=30%  Similarity=0.448  Sum_probs=125.5

Q ss_pred             CCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCC
Q 013682          287 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  366 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  366 (438)
                      +|...+.||+|+||.||+|++.++..+|+|.++...  ....++.+|+.++.+++||||+++++++...+..+++|||+.
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            466678899999999999998777779999986432  223468999999999999999999999998888999999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          367 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       367 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +|+|.++++....   .+++.++..++.|++.|++|||+.   +++|+||||+||++++++.++++||.
T Consensus        83 ~~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g  145 (256)
T cd05113          83 NGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFG  145 (256)
T ss_pred             CCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCc
Confidence            9999999876432   489999999999999999999998   99999999999999999999999996

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.89  E-value=1.4e-22  Score=198.96  Aligned_cols=137  Identities=27%  Similarity=0.376  Sum_probs=117.2

Q ss_pred             CccccccceEEEEEEeC-CCCEEEEEEccccccc--cchHHHHHHHH-HHhcCCCCCceeeEEEEeeCCeeEEEEecCCC
Q 013682          292 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVK-IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  367 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  367 (438)
                      +.||+|+||+||+|+.. +++.||+|+++.....  .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            36899999999999864 6889999998653221  12234555554 56789999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          368 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+|...+....    .+++.++..++.|++.||+|||+.   +|+||||||+|||+++++.++++||+
T Consensus        81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG  141 (325)
T cd05604          81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFG  141 (325)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecC
Confidence            99998886542    488999999999999999999999   99999999999999999999999997

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.89  E-value=1.1e-22  Score=200.14  Aligned_cols=142  Identities=18%  Similarity=0.351  Sum_probs=120.8

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeC-----CeeE
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TEKL  359 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~  359 (438)
                      +|+..+.||+|+||.||+|+.. +++.||||+++..... .....+.+|+.+++.++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            3667789999999999999864 6899999998643222 2234688999999999999999999988643     2479


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      +||||+. ++|.+++....    .+++.....++.|++.||+|||++   +|+||||||+|||+++++.++|+||.-
T Consensus        81 lv~e~~~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~  149 (338)
T cd07859          81 VVFELME-SDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGL  149 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcc
Confidence            9999995 68998886543    389999999999999999999999   999999999999999999999999973

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.89  E-value=9e-23  Score=196.75  Aligned_cols=152  Identities=30%  Similarity=0.446  Sum_probs=129.6

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEeCC------CCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEee
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  354 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~------~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  354 (438)
                      ....++|+..+.||+|+||.||++.+.+      ...+|+|.++..........+.+|+.++.++ +|+||+++++++..
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            4455678888999999999999998632      3579999987543333334688999999999 79999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHhhccC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCee
Q 013682          355 VTEKLLVYPYMTNGSVASRLRERQ------------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL  422 (438)
Q Consensus       355 ~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NIL  422 (438)
                      .+..+++|||+++|+|.++++...            .....+++..+..++.|++.|++|||+.   +|+||||||+||+
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil  164 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVL  164 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEE
Confidence            999999999999999999997532            2234589999999999999999999998   9999999999999


Q ss_pred             eCCCCCcchhhhhh
Q 013682          423 LDEDADQSSKTILR  436 (438)
Q Consensus       423 ld~~~~~~l~Df~~  436 (438)
                      +++++.++++||..
T Consensus       165 ~~~~~~~kL~Dfg~  178 (293)
T cd05053         165 VTEDHVMKIADFGL  178 (293)
T ss_pred             EcCCCeEEeCcccc
Confidence            99999999999963

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.89  E-value=2.2e-22  Score=189.32  Aligned_cols=138  Identities=33%  Similarity=0.523  Sum_probs=123.0

Q ss_pred             CccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCCCHH
Q 013682          292 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVA  371 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~  371 (438)
                      ++||+|+||.||+|...+++.+|+|.++..........+.+|+.+++.++||||+++++++...+..+++|||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999987888999999875443333446889999999999999999999999999999999999999999


Q ss_pred             HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          372 SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       372 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++....   ..+++.....++.|++.|+.|+|+.   +++||||||+||++++++.++++||.
T Consensus        81 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g  138 (250)
T cd05085          81 SFLRKKK---DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFG  138 (250)
T ss_pred             HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCc
Confidence            9987543   2478999999999999999999998   99999999999999999999999995

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.89  E-value=1e-22  Score=192.95  Aligned_cols=145  Identities=27%  Similarity=0.401  Sum_probs=128.2

Q ss_pred             HhCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      ..++|+..+.||+|+||.||+|...++..||+|.++...  .....+.+|+.+++.++|+||+++++.+...+..+++||
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE   81 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence            345788889999999999999998778889999886432  224578999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+++|+|.++++...  ...+++.++..++.|++.|++|||+.   +++||||||+||++++++.++++||.
T Consensus        82 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg  148 (261)
T cd05072          82 YMAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFG  148 (261)
T ss_pred             cCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCc
Confidence            999999999987642  23478899999999999999999998   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.89  E-value=1.4e-22  Score=196.07  Aligned_cols=148  Identities=25%  Similarity=0.422  Sum_probs=126.2

Q ss_pred             hCCCCCCCccccccceEEEEEEeCC-C--CEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEeeCCeeEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLAD-G--KLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~~-~--~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  360 (438)
                      +++|+..+.||+|+||.||+|...+ +  ..+|+|.++..........+.+|+.++.++ +||||+++++++......++
T Consensus         1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence            3578888999999999999998753 3  357999887543333345688999999988 79999999999999889999


Q ss_pred             EEecCCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC
Q 013682          361 VYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  428 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~  428 (438)
                      +|||+++|+|.++++....            ....+++.....++.|++.|++|||+.   +|+||||||+|||+++++.
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLA  157 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCe
Confidence            9999999999999975321            112478999999999999999999998   9999999999999999999


Q ss_pred             cchhhhh
Q 013682          429 QSSKTIL  435 (438)
Q Consensus       429 ~~l~Df~  435 (438)
                      ++++||.
T Consensus       158 ~kl~dfg  164 (297)
T cd05089         158 SKIADFG  164 (297)
T ss_pred             EEECCcC
Confidence            9999996

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.88  E-value=1.4e-22  Score=196.05  Aligned_cols=149  Identities=27%  Similarity=0.403  Sum_probs=127.1

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-----------------CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCcee
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-----------------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR  347 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-----------------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~  347 (438)
                      .++|+..+.||+|+||.||+++..                 ++..||+|.++.........++.+|+.++..++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            346888899999999999998532                 234699999875543334457899999999999999999


Q ss_pred             eEEEEeeCCeeEEEEecCCCCCHHHHhhccCCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCC
Q 013682          348 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSS-------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN  420 (438)
Q Consensus       348 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~N  420 (438)
                      +++++...+..+++|||+++|+|.+++......       ...+++.+...++.|++.|++|||+.   +|+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence            999999999999999999999999998764321       12478889999999999999999999   99999999999


Q ss_pred             eeeCCCCCcchhhhhh
Q 013682          421 ILLDEDADQSSKTILR  436 (438)
Q Consensus       421 ILld~~~~~~l~Df~~  436 (438)
                      |++++++.++++||.-
T Consensus       161 ili~~~~~~~l~dfg~  176 (296)
T cd05095         161 CLVGKNYTIKIADFGM  176 (296)
T ss_pred             EEEcCCCCEEeccCcc
Confidence            9999999999999964

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.88  E-value=2.1e-22  Score=190.40  Aligned_cols=141  Identities=31%  Similarity=0.437  Sum_probs=125.5

Q ss_pred             CCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCC
Q 013682          287 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  366 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  366 (438)
                      +|+..+.||+|+||.||+|.+.++..+|+|.++...  ....++.+|+.+++.++||||+++++++...+..+++|||++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA--MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            466778899999999999998777789999985432  223468899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          367 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       367 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++|.++++....   .++|.....++.|++.|++|||+.   +|+||||||+||++++++.++++||.
T Consensus        83 ~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg  145 (256)
T cd05059          83 NGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFG  145 (256)
T ss_pred             CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcc
Confidence            9999999976432   479999999999999999999999   99999999999999999999999996

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.88  E-value=1.2e-22  Score=199.18  Aligned_cols=142  Identities=25%  Similarity=0.338  Sum_probs=121.8

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCC-CCCceeeEEEEeeCCeeEEEE
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~  362 (438)
                      +|+..+.||+|+||.||+|+.. +++.||+|.++....  ......+..|..++..+. |++|+++.+++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3566789999999999999864 688999999865421  222345778888888775 577888999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++|+|.+++....    .+++.++..++.|++.||+|||++   +|+||||||+|||+++++.++++||.
T Consensus        81 Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg  146 (323)
T cd05615          81 EYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccc
Confidence            9999999999987543    489999999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.88  E-value=1.2e-22  Score=194.27  Aligned_cols=147  Identities=31%  Similarity=0.511  Sum_probs=127.8

Q ss_pred             CCCCCCCccccccceEEEEEEeCC------CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  359 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~~------~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  359 (438)
                      ++|...+.||+|+||.||+|...+      ++.||||.++..........+.+|++++..++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            456777899999999999998632      47899999876543334457999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCc
Q 013682          360 LVYPYMTNGSVASRLRERQS----------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  429 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~  429 (438)
                      ++|||+++++|.++++....          ....+++.+...++.|++.|++|||+.   +++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence            99999999999999976421          223578999999999999999999999   99999999999999999999


Q ss_pred             chhhhh
Q 013682          430 SSKTIL  435 (438)
Q Consensus       430 ~l~Df~  435 (438)
                      +++||.
T Consensus       162 kl~d~g  167 (280)
T cd05049         162 KIGDFG  167 (280)
T ss_pred             EECCcc
Confidence            999996

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.88  E-value=2e-22  Score=191.38  Aligned_cols=147  Identities=18%  Similarity=0.271  Sum_probs=127.4

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc--cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|+..+.||+|+||.||+|+.. +++.||||.++.....  .....+.+|+.+++.++||||+++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            46888899999999999999864 6889999987543222  22346889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++|+|.+++.........+++.....++.|++.||+|||++   +++||||||+||+++.++.++++||.
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g  151 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccc
Confidence            99999999998865433334578889999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.88  E-value=1.5e-22  Score=196.43  Aligned_cols=150  Identities=27%  Similarity=0.435  Sum_probs=127.8

Q ss_pred             HHhCCCCCCCccccccceEEEEEEeC--------CCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEe
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRLA--------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCT  353 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~~--------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~  353 (438)
                      ...++|...+.||+|+||.||+|++.        ++..||+|.++.........++.+|+.++..+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            34566778899999999999999741        24479999987543333445789999999999 8999999999999


Q ss_pred             eCCeeEEEEecCCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCe
Q 013682          354 TVTEKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANI  421 (438)
Q Consensus       354 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NI  421 (438)
                      .....+++|||+++|+|.+++.....            ....++|.+...++.|++.||+|||+.   +|+||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence            99999999999999999999976432            123478899999999999999999999   999999999999


Q ss_pred             eeCCCCCcchhhhh
Q 013682          422 LLDEDADQSSKTIL  435 (438)
Q Consensus       422 Lld~~~~~~l~Df~  435 (438)
                      ++++++.++++||.
T Consensus       169 li~~~~~~kl~D~g  182 (304)
T cd05101         169 LVTENNVMKIADFG  182 (304)
T ss_pred             EEcCCCcEEECCCc
Confidence            99999999999995

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.88  E-value=1.9e-22  Score=198.15  Aligned_cols=137  Identities=28%  Similarity=0.362  Sum_probs=119.8

Q ss_pred             CccccccceEEEEEEeC-CCCEEEEEEccccccc--cchHHHHHHHHHHhcC-CCCCceeeEEEEeeCCeeEEEEecCCC
Q 013682          292 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  367 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~  367 (438)
                      +.||+|+||+||+|+.. +++.||+|+++.....  .....+.+|+.++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46899999999999874 5789999999754322  2223578899888877 699999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          368 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+|...+....    .+++..+..++.|++.|++|||+.   +|+||||||+|||+++++.++|+||.
T Consensus        81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg  141 (327)
T cd05617          81 GDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYG  141 (327)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccc
Confidence            99998886542    489999999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.88  E-value=3.2e-22  Score=189.74  Aligned_cols=147  Identities=20%  Similarity=0.295  Sum_probs=129.7

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc--cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|+..+.||+|+||.||+|... +++.||+|.++.....  .....+.+|+.++++++|+|++++++++...+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888899999999999999975 7899999988643222  22446889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++|+|.+++.........+++.+...++.+++.|++|||+.   +|+||||||+||++++++.++++||.
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~  151 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccc
Confidence            99999999999876444344588999999999999999999999   99999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.88  E-value=2.1e-22  Score=197.65  Aligned_cols=137  Identities=28%  Similarity=0.368  Sum_probs=115.8

Q ss_pred             CccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHH-HHHhcCCCCCceeeEEEEeeCCeeEEEEecCCC
Q 013682          292 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEV-KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  367 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~-~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  367 (438)
                      +.||+|+||.||+|+.. +++.||+|+++....  ......+.+|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36899999999999875 578899999864321  11222344444 456788999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          368 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+|.+++....    .+.+.....++.|++.||+|||+.   +|+||||||+|||++.++.++++||+
T Consensus        81 ~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG  141 (325)
T cd05602          81 GELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFG  141 (325)
T ss_pred             CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCC
Confidence            99999987643    367888889999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.88  E-value=1.8e-22  Score=196.39  Aligned_cols=150  Identities=29%  Similarity=0.419  Sum_probs=127.8

Q ss_pred             HhCCCCCCCccccccceEEEEEEeC--------CCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEee
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLA--------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  354 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~--------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  354 (438)
                      ..++|...+.||+|+||.||+|+..        +...+|+|.++.........++.+|+.++.++ +||||+++++++..
T Consensus        16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (307)
T cd05098          16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   95 (307)
T ss_pred             ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            3467888899999999999999752        13469999987543333344688899999999 79999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCee
Q 013682          355 VTEKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL  422 (438)
Q Consensus       355 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NIL  422 (438)
                      .+..+++|||+++|+|.++++....            ....++|.+...++.|++.||+|||+.   +++||||||+||+
T Consensus        96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil  172 (307)
T cd05098          96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL  172 (307)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheE
Confidence            9999999999999999999986432            113488999999999999999999998   9999999999999


Q ss_pred             eCCCCCcchhhhhh
Q 013682          423 LDEDADQSSKTILR  436 (438)
Q Consensus       423 ld~~~~~~l~Df~~  436 (438)
                      +++++.++++||..
T Consensus       173 l~~~~~~kL~dfg~  186 (307)
T cd05098         173 VTEDNVMKIADFGL  186 (307)
T ss_pred             EcCCCcEEECCCcc
Confidence            99999999999963

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.88  E-value=2.7e-22  Score=192.69  Aligned_cols=142  Identities=27%  Similarity=0.447  Sum_probs=123.4

Q ss_pred             CCCCCccccccceEEEEEEe-----CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeC--CeeEE
Q 013682          288 FSNKNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLL  360 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~-----~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l  360 (438)
                      |+..+.||+|+||.||++++     .++..||+|.++..........+.+|+.+++.++|||++++.+++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL   85 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence            56678899999999999974     247789999987543333345789999999999999999999998775  56789


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +|||+++++|.+++....   ..++|.++..++.|++.||+|||+.   +|+||||||+||++++++.++++||.
T Consensus        86 v~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg  154 (284)
T cd05079          86 IMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFG  154 (284)
T ss_pred             EEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCc
Confidence            999999999999986542   2479999999999999999999999   99999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.9e-23  Score=207.16  Aligned_cols=150  Identities=27%  Similarity=0.395  Sum_probs=132.5

Q ss_pred             HHHHHHhCCCCCCCccccccceEEEEEEeCC-CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCe
Q 013682          279 RELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  357 (438)
Q Consensus       279 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  357 (438)
                      ++++....+....+.||-|.||.||.|.|+. .-.||||.++.+.  ....+|..|+++|+.++|||+|+++|+|..+..
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt--MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP  337 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP  337 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc--hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence            4455556667778899999999999999964 6689999998753  345589999999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      .|+|+|||.+|+|.++|++....  .+.--..+.+|.||+.||+||...   ++|||||.++|+|+.++--+|++||+
T Consensus       338 FYIiTEfM~yGNLLdYLRecnr~--ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFG  410 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLRECNRS--EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFG  410 (1157)
T ss_pred             eEEEEecccCccHHHHHHHhchh--hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccc
Confidence            99999999999999999987543  355667789999999999999999   99999999999999999999999996

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.88  E-value=2e-22  Score=202.79  Aligned_cols=136  Identities=24%  Similarity=0.291  Sum_probs=121.6

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      ..+|+..+.||+|+||.||+|... +++.||+|....       ..+.+|+.+++.++|||||++++++......++++|
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e  163 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP  163 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence            457999999999999999999864 688999996532       246789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++. ++|..++....    .+++.++..++.|++.||+|||++   +|+||||||+|||++.++.++|+||+
T Consensus       164 ~~~-~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG  227 (391)
T PHA03212        164 RYK-TDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG  227 (391)
T ss_pred             cCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCC
Confidence            995 78888886543    378999999999999999999999   99999999999999999999999996

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.88  E-value=1.1e-22  Score=192.69  Aligned_cols=145  Identities=30%  Similarity=0.445  Sum_probs=128.8

Q ss_pred             hCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      ..+|+..+.||+|+||.||+|...+++.+|+|.++.... .....+.+|+.+++.++||||+++++++...+..+++|||
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            345777899999999999999987789999999865432 2234688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++|+|.+++++...  ..+++.+...++.|++.|++|||+.   +|+||||||+||++++++.++++||.
T Consensus        84 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g  149 (261)
T cd05148          84 MEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFG  149 (261)
T ss_pred             cccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEcccc
Confidence            999999999986432  3489999999999999999999998   99999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.88  E-value=2.7e-22  Score=193.27  Aligned_cols=146  Identities=32%  Similarity=0.442  Sum_probs=124.4

Q ss_pred             CCCCCCccccccceEEEEEEeC------CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      +|+..+.||+|+||.||+|...      ....+|+|.++..........+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            3667789999999999999752      2357999988654433334468899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCC
Q 013682          361 VYPYMTNGSVASRLRERQS--------------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN  420 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~N  420 (438)
                      ++||+.+|+|.+++.....                    ....+++.....++.|++.|++|||+.   +|+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence            9999999999999865321                    113578999999999999999999998   99999999999


Q ss_pred             eeeCCCCCcchhhhh
Q 013682          421 ILLDEDADQSSKTIL  435 (438)
Q Consensus       421 ILld~~~~~~l~Df~  435 (438)
                      ||+++++.++++||.
T Consensus       158 ill~~~~~~kl~dfg  172 (290)
T cd05045         158 VLVAEGRKMKISDFG  172 (290)
T ss_pred             EEEcCCCcEEecccc
Confidence            999999999999995

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.88  E-value=1.5e-22  Score=194.76  Aligned_cols=149  Identities=30%  Similarity=0.479  Sum_probs=128.6

Q ss_pred             hCCCCCCCccccccceEEEEEEeC------CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCee
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  358 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  358 (438)
                      .++|+..+.||+|+||.||+|+..      ++..||+|.++.........++.+|+.+++.++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467888899999999999999853      46789999987544333345689999999999999999999999998899


Q ss_pred             EEEEecCCCCCHHHHhhccCC------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCC
Q 013682          359 LLVYPYMTNGSVASRLRERQS------------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN  420 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~N  420 (438)
                      +++|||+++|+|.++++....                  ....+++.....++.|++.||+|||+.   +++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence            999999999999999975321                  113478889999999999999999998   99999999999


Q ss_pred             eeeCCCCCcchhhhhh
Q 013682          421 ILLDEDADQSSKTILR  436 (438)
Q Consensus       421 ILld~~~~~~l~Df~~  436 (438)
                      |++++++.++++||.-
T Consensus       161 il~~~~~~~~l~dfg~  176 (288)
T cd05050         161 CLVGENMVVKIADFGL  176 (288)
T ss_pred             eEecCCCceEECcccc
Confidence            9999999999999963

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.88  E-value=2.4e-22  Score=215.49  Aligned_cols=147  Identities=22%  Similarity=0.340  Sum_probs=126.7

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc--chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|+..+.||+|+||.||+|+.. +++.||+|+++......  ....+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            46788899999999999999875 58899999987543222  2346899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQS-------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++|+|.+++.....       .....++.....++.|++.||+|||+.   +|+||||||+|||++.++.++++||+
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            99999999998864211       112456788899999999999999999   99999999999999999999999996

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.88  E-value=2.1e-22  Score=191.80  Aligned_cols=143  Identities=29%  Similarity=0.446  Sum_probs=125.3

Q ss_pred             CCCCCCccccccceEEEEEEeCC-C---CEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          287 GFSNKNILGRGGFGKVYKGRLAD-G---KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~~-~---~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      +|+..+.||+|+||.||+|+... +   ..||+|.++.........+|..|+.+++.++||||+++++++......+++|
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            45667899999999999998742 3   3699999875433334457999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++|+|.++++...   ..+++.++..++.|++.|++|||++   +++||||||+||++++++.++++||.
T Consensus        85 e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg  151 (269)
T cd05065          85 EFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFG  151 (269)
T ss_pred             ecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCc
Confidence            9999999999987643   2478999999999999999999998   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.88  E-value=2.7e-22  Score=192.34  Aligned_cols=147  Identities=31%  Similarity=0.493  Sum_probs=126.2

Q ss_pred             CCCCCCCccccccceEEEEEEeCC------CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  359 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~~------~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  359 (438)
                      ++|+..+.||+|+||.||+|....      ...||+|.++..........+.+|+..+..++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            357778899999999999998632      25799999875443333446899999999999999999999999888999


Q ss_pred             EEEecCCCCCHHHHhhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC
Q 013682          360 LVYPYMTNGSVASRLRERQSS------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  427 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~  427 (438)
                      ++|||+++|+|.+++......            ...+++.+...++.|++.||+|||+.   +++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence            999999999999999764211            13578899999999999999999999   999999999999999999


Q ss_pred             Ccchhhhh
Q 013682          428 DQSSKTIL  435 (438)
Q Consensus       428 ~~~l~Df~  435 (438)
                      .++++||.
T Consensus       162 ~~~L~dfg  169 (283)
T cd05048         162 TVKISDFG  169 (283)
T ss_pred             cEEECCCc
Confidence            99999996

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.88  E-value=2.6e-22  Score=196.43  Aligned_cols=137  Identities=30%  Similarity=0.425  Sum_probs=119.7

Q ss_pred             CccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcC-CCCCceeeEEEEeeCCeeEEEEecCCC
Q 013682          292 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  367 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~  367 (438)
                      +.||+|+||+||+|+.. +++.||+|.++....  ......+.+|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999875 578999999875431  22233567888888777 799999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          368 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+|...+....    .+++.++..++.|++.||+|||+.   +|+||||||+||++++++.++++||.
T Consensus        81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg  141 (318)
T cd05570          81 GDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFG  141 (318)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccC
Confidence            99998887543    489999999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.88  E-value=3.1e-22  Score=193.16  Aligned_cols=148  Identities=28%  Similarity=0.398  Sum_probs=127.9

Q ss_pred             hCCCCCCCccccccceEEEEEEeCC-----------------CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCcee
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLAD-----------------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR  347 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~~-----------------~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~  347 (438)
                      .++|...+.||+|+||.||+|...+                 +..||+|.+...........+.+|+.++++++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4567888999999999999987532                 24689999876543334457899999999999999999


Q ss_pred             eEEEEeeCCeeEEEEecCCCCCHHHHhhccCC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCC
Q 013682          348 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQS-------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN  420 (438)
Q Consensus       348 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~N  420 (438)
                      +++++...+..+++|||+++++|.+++.....       ....+++.....++.|++.||+|||+.   +|+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence            99999999999999999999999999976531       122589999999999999999999998   99999999999


Q ss_pred             eeeCCCCCcchhhhh
Q 013682          421 ILLDEDADQSSKTIL  435 (438)
Q Consensus       421 ILld~~~~~~l~Df~  435 (438)
                      |++++++.++++||.
T Consensus       161 ili~~~~~~~l~dfg  175 (296)
T cd05051         161 CLVGKNYTIKIADFG  175 (296)
T ss_pred             eeecCCCceEEcccc
Confidence            999999999999996

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.88  E-value=2.9e-22  Score=192.30  Aligned_cols=143  Identities=27%  Similarity=0.437  Sum_probs=122.8

Q ss_pred             CCCCCCCccccccceEEEEEEeC-----CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEee--CCee
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEK  358 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-----~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~  358 (438)
                      .+|+..+.||+|+||.||++.+.     +++.||+|.++... ......+.+|+++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            35677889999999999999752     47799999986532 2233478999999999999999999998754  3467


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++||||+++|+|.+++....   ..++|..+..++.|++.||+|||+.   +|+||||||+||++++++.++++||.
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg  153 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFG  153 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCc
Confidence            89999999999999987542   2479999999999999999999999   99999999999999999999999996

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.88  E-value=2.2e-22  Score=192.59  Aligned_cols=136  Identities=26%  Similarity=0.346  Sum_probs=114.2

Q ss_pred             ccccccceEEEEEEeCC-------------------------CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCcee
Q 013682          293 ILGRGGFGKVYKGRLAD-------------------------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR  347 (438)
Q Consensus       293 ~LG~G~fG~Vy~~~~~~-------------------------~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~  347 (438)
                      .||+|+||.||+|.+..                         ...||+|.++.... .....+.+|+.+++.++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence            58999999999997421                         13589998864322 22346888999999999999999


Q ss_pred             eEEEEeeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC
Q 013682          348 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  427 (438)
Q Consensus       348 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~  427 (438)
                      ++++|.+....++||||+++|+|..+++....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~  154 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG---RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG  154 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence            99999999999999999999999999875322   478999999999999999999998   999999999999998654


Q ss_pred             C-------cchhhhh
Q 013682          428 D-------QSSKTIL  435 (438)
Q Consensus       428 ~-------~~l~Df~  435 (438)
                      .       .+++||.
T Consensus       155 ~~~~~~~~~kl~d~g  169 (274)
T cd05076         155 LAEGTSPFIKLSDPG  169 (274)
T ss_pred             cccCccceeeecCCc
Confidence            3       5888885

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.88  E-value=4.1e-22  Score=191.88  Aligned_cols=143  Identities=29%  Similarity=0.491  Sum_probs=118.0

Q ss_pred             CCCCCCccccccceEEEEEEeC--CCCEEEEEEcccccccc-chHHHHHHHHHHhcC---CCCCceeeEEEEee-----C
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA--DGKLVAVKRLKEERTSG-GELQFQTEVKIISMA---VHRNLLRLYGFCTT-----V  355 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~--~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----~  355 (438)
                      +|+..+.||+|+||.||+|+..  +++.||+|.++...... ....+.+|+.++..+   +||||++++++|..     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            5778899999999999999863  46789999986543222 223566777776655   69999999999853     3


Q ss_pred             CeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          356 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       356 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ...+++|||+. ++|.+++.....  ..+++.++..++.|++.||+|||+.   +|+||||||+|||+++++.++++||.
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence            45789999996 689998875432  2478999999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=5.8e-23  Score=203.25  Aligned_cols=141  Identities=25%  Similarity=0.368  Sum_probs=125.1

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      ..|.....||+|+.|.||.|+. .+++.||||++.... ....+-..+|+.+|+..+|+|||.++..|...++.|.||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~-Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK-QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEecc-CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            3466678899999999999974 578899999985443 22333578999999999999999999999889999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |++|+|.+.+...     .+++.+...|+.+++.||+|||.+   +|+|||||.+|||++.+|++||+||+
T Consensus       352 m~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFG  414 (550)
T KOG0578|consen  352 MEGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFG  414 (550)
T ss_pred             cCCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeee
Confidence            9999999888654     389999999999999999999999   99999999999999999999999996

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.88  E-value=2.7e-22  Score=192.09  Aligned_cols=144  Identities=28%  Similarity=0.449  Sum_probs=123.7

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCC----EEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  359 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~----~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  359 (438)
                      .++|+..+.||+|+||.||+|++. +++    .||+|.++..........+.+|+..+..++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            356777899999999999999863 444    4899998754443344578899999999999999999999875 4578


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++||+++|+|.++++...   ..+++.....++.|++.||+|||+.   +|+||||||+|||+++++.++++||+
T Consensus        85 l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG  154 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFG  154 (279)
T ss_pred             EEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCC
Confidence            9999999999999997643   2488999999999999999999999   99999999999999999999999996

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.88  E-value=3e-22  Score=191.20  Aligned_cols=147  Identities=25%  Similarity=0.473  Sum_probs=126.0

Q ss_pred             CCCCCCCccccccceEEEEEEeC------CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  359 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  359 (438)
                      ++|+..+.||+|+||.||+|+..      +.+.||+|.+...........+.+|+.++++++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            46777889999999999999863      245799998854322223347899999999999999999999999888999


Q ss_pred             EEEecCCCCCHHHHhhccCCCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSL-----PPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  434 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df  434 (438)
                      +||||+++|+|.+++.......     ..+++..+..++.|++.|++|||+.   +|+||||||+||++++++..+++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999997654221     2589999999999999999999999   9999999999999999999999997


Q ss_pred             h
Q 013682          435 L  435 (438)
Q Consensus       435 ~  435 (438)
                      .
T Consensus       162 ~  162 (275)
T cd05046         162 S  162 (275)
T ss_pred             c
Confidence            5

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.88  E-value=3.5e-22  Score=193.66  Aligned_cols=143  Identities=27%  Similarity=0.450  Sum_probs=125.6

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      ++|...+.||+|+||.||+|+.. +++.||+|.++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            46777899999999999999875 57899999986544333444678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++ ++|.+++.....   .+++.....++.|++.||+|||+.   +|+||||||+||++++++.++++||.
T Consensus        86 ~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg  149 (301)
T cd07873          86 LD-KDLKQYLDDCGN---SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFG  149 (301)
T ss_pred             cc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCc
Confidence            97 589888876432   478899999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.88  E-value=4.2e-22  Score=188.73  Aligned_cols=135  Identities=24%  Similarity=0.368  Sum_probs=117.5

Q ss_pred             cccccceEEEEEEeC---CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCCCH
Q 013682          294 LGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  370 (438)
Q Consensus       294 LG~G~fG~Vy~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  370 (438)
                      ||+|+||.||+|.+.   ++..||+|.++..........+.+|+.++++++||||+++++++. .+..++||||+++|+|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L   81 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL   81 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence            899999999999764   355799999876543333456899999999999999999999885 4578999999999999


Q ss_pred             HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          371 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       371 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      .+++....   ..+++.++..++.|++.|++|||++   +++||||||+||+++.++.++++||.
T Consensus        82 ~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg  140 (257)
T cd05115          82 NKFLSGKK---DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFG  140 (257)
T ss_pred             HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCC
Confidence            99987532   2489999999999999999999998   99999999999999999999999996

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.88  E-value=4.9e-22  Score=188.90  Aligned_cols=143  Identities=27%  Similarity=0.404  Sum_probs=126.2

Q ss_pred             hCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .++|+..+.||+|+||.||+|+. .+++.||+|+++.... .....+.+|+.++..++||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e   86 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME   86 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence            34688889999999999999986 4688999999864322 223457889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+++++|.++++...    .+++.+...++.|++.|++|||+.   +|+|||+||+||++++++.++++||.
T Consensus        87 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg  151 (267)
T cd06646          87 YCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFG  151 (267)
T ss_pred             CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCc
Confidence            999999999886542    478999999999999999999998   99999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.88  E-value=1.9e-22  Score=192.61  Aligned_cols=149  Identities=28%  Similarity=0.427  Sum_probs=127.5

Q ss_pred             HhCCCCCCCccccccceEEEEEEeCC------CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCe
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  357 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~~------~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  357 (438)
                      ..++|...+.||+|+||.||+|...+      +..||+|.+...........+.+|+.++..++||||+++++++.....
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            34567788999999999999998642      368999998654333334468899999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhccCCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcch
Q 013682          358 KLLVYPYMTNGSVASRLRERQSS------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS  431 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l  431 (438)
                      .+++|||+++|+|.+++......      ...++|..+..++.|++.|+.|||+.   +|+||||||+||++++++.+++
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEE
Confidence            99999999999999999754321      22478899999999999999999998   9999999999999999999999


Q ss_pred             hhhh
Q 013682          432 KTIL  435 (438)
Q Consensus       432 ~Df~  435 (438)
                      +||.
T Consensus       161 ~dfg  164 (277)
T cd05032         161 GDFG  164 (277)
T ss_pred             CCcc
Confidence            9996

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.88  E-value=4.2e-22  Score=188.59  Aligned_cols=145  Identities=30%  Similarity=0.450  Sum_probs=129.4

Q ss_pred             HhCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      ..++|...+.||+|+||.||+|...+++.||||.++...  ....++.+|+.+++.++|+|++++++++......+++||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            456788889999999999999998777889999986532  234578999999999999999999999998889999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+++++|.+++.....  ..+++.+...++.|++.|++|||+.   +++|+||||+||++++++.++++||.
T Consensus        82 ~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g  148 (261)
T cd05034          82 YMSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFG  148 (261)
T ss_pred             ccCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccc
Confidence            9999999999976432  3489999999999999999999999   99999999999999999999999995

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.88  E-value=2.4e-22  Score=196.10  Aligned_cols=151  Identities=28%  Similarity=0.433  Sum_probs=127.9

Q ss_pred             HHhCCCCCCCccccccceEEEEEEeC--------CCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEe
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRLA--------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCT  353 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~~--------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~  353 (438)
                      ...++|...+.||+|+||.||+|+..        ....+|+|.++..........+..|+.++..+ +||||+++++++.
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            34567788899999999999999742        24579999987543333344688999999998 6999999999999


Q ss_pred             eCCeeEEEEecCCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCe
Q 013682          354 TVTEKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANI  421 (438)
Q Consensus       354 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NI  421 (438)
                      .....+++|||+++|+|.+++.....            ....++|.+...++.|++.||.|||+.   +|+||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni  165 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNV  165 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeE
Confidence            88899999999999999999976421            123588999999999999999999998   999999999999


Q ss_pred             eeCCCCCcchhhhhh
Q 013682          422 LLDEDADQSSKTILR  436 (438)
Q Consensus       422 Lld~~~~~~l~Df~~  436 (438)
                      |+++++.++++||.-
T Consensus       166 ll~~~~~~kL~Dfg~  180 (314)
T cd05099         166 LVTEDNVMKIADFGL  180 (314)
T ss_pred             EEcCCCcEEEccccc
Confidence            999999999999974

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.88  E-value=5.1e-22  Score=190.63  Aligned_cols=139  Identities=30%  Similarity=0.459  Sum_probs=120.9

Q ss_pred             CCCCccccccceEEEEEEe-----CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeC--CeeEEE
Q 013682          289 SNKNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLLV  361 (438)
Q Consensus       289 ~~~~~LG~G~fG~Vy~~~~-----~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv  361 (438)
                      +..+.||+|+||+||++.+     .+++.||+|.++..........+.+|+.+++.++||||+++++++...  ...+++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            6678899999999988653     357789999987654333445788999999999999999999988653  357899


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |||+++|+|.+++...     .+++.++..++.|++.|++|||+.   +|+||||||+||++++++.++++||.
T Consensus        87 ~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg  152 (283)
T cd05080          87 MEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFG  152 (283)
T ss_pred             ecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecc
Confidence            9999999999998653     389999999999999999999999   99999999999999999999999996

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.88  E-value=4.6e-22  Score=195.29  Aligned_cols=140  Identities=23%  Similarity=0.315  Sum_probs=121.4

Q ss_pred             CCccccc--cceEEEEEEe-CCCCEEEEEEccccccccc-hHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCC
Q 013682          291 KNILGRG--GFGKVYKGRL-ADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  366 (438)
Q Consensus       291 ~~~LG~G--~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  366 (438)
                      .++||+|  +||+||+++. .+++.||+|+++....... ...+.+|+.+++.++||||+++++++..++..++||||++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            4679999  6889999987 4689999999865433222 3357789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          367 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       367 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +|+|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+++.||.
T Consensus        83 ~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~  146 (327)
T cd08227          83 YGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLR  146 (327)
T ss_pred             CCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccc
Confidence            9999999875422  2478999999999999999999998   99999999999999999999999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.88  E-value=5.3e-23  Score=176.04  Aligned_cols=141  Identities=23%  Similarity=0.431  Sum_probs=122.2

Q ss_pred             CCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccch-HHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecC
Q 013682          288 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGE-LQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~-~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      |...+.||+|.||+||+|+. .+++.||+|+++-+..+++. ....+|+.+++.++|.|||+++++...+...-+|+|||
T Consensus         4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c   83 (292)
T KOG0662|consen    4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC   83 (292)
T ss_pred             hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence            44457899999999999985 46889999998765444432 36889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      .. +|..+.....+   .++......++.|+.+||.|+|++   ++.|||+||.|.|++.+|+.|++||+
T Consensus        84 dq-dlkkyfdslng---~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfg  146 (292)
T KOG0662|consen   84 DQ-DLKKYFDSLNG---DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFG  146 (292)
T ss_pred             hH-HHHHHHHhcCC---cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccc
Confidence            75 77777655432   478888999999999999999999   99999999999999999999999996

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.88  E-value=3.5e-22  Score=189.24  Aligned_cols=145  Identities=28%  Similarity=0.411  Sum_probs=126.8

Q ss_pred             HHhCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      +..++|+..+.||+|+||.||+|...+++.||+|.++...  ....++.+|+.+++.++|+|++++++++ ..+..+++|
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~   79 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS--MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIIT   79 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC--CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEE
Confidence            3456788889999999999999998888999999986533  2334789999999999999999999986 456789999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++++|.+++.....  ..+++.+...++.|++.||+|||+.   +++||||||+||++++++.++++||.
T Consensus        80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg  147 (260)
T cd05067          80 EYMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFG  147 (260)
T ss_pred             EcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCc
Confidence            99999999999876432  3588999999999999999999998   99999999999999999999999995

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.88  E-value=3.9e-22  Score=191.31  Aligned_cols=143  Identities=27%  Similarity=0.410  Sum_probs=119.7

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCC----EEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~----~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      ++|+..+.||+|+||+||+|.+. +++    .+|+|.+..........++..|+..++.++||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            45677789999999999999874 344    478887754322222346778888899999999999999875 455789


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++||+++|+|.+++.....   .++|.....++.|++.||+|||+.   +++||||||+||++++++.++++||.
T Consensus        86 i~e~~~~gsL~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg  154 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRD---SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFG  154 (279)
T ss_pred             EEEeCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCc
Confidence            9999999999999976432   489999999999999999999998   99999999999999999999999996

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.88  E-value=2.1e-22  Score=200.97  Aligned_cols=145  Identities=25%  Similarity=0.369  Sum_probs=128.5

Q ss_pred             HhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccc-hHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      ....|.+...||+|.|++|..|+.. ++..||+|.+.+...... ...+.+|+++|..++|||||+++++.......|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            3456788899999999999999874 688999999876543322 23588999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |||+.+|.+++++.....    .....+..+..|+.+|++|+|++   .|||||||++|||+|.+++.+|+||.
T Consensus       134 ~eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfg  200 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFG  200 (596)
T ss_pred             EEeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccc
Confidence            999999999999987643    55588899999999999999999   99999999999999999999999996

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.88  E-value=2.3e-22  Score=195.30  Aligned_cols=149  Identities=28%  Similarity=0.366  Sum_probs=128.2

Q ss_pred             HHhCCCCCCCccccccceEEEEEEeC------CCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEeeC
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  355 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  355 (438)
                      ...++|...+.||+|+||.||+|...      ++..||+|.++..........+.+|+.+++++ +||||+++++++...
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            34567888899999999999999741      24579999987543333344689999999999 799999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          356 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       356 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +..+++|||+++|+|.++++....  ..+++.+...++.|++.|++|||+.   +|+|+||||+|||+++++.++++||.
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence            999999999999999999976432  2379999999999999999999998   99999999999999999999999996


Q ss_pred             h
Q 013682          436 R  436 (438)
Q Consensus       436 ~  436 (438)
                      -
T Consensus       187 ~  187 (302)
T cd05055         187 L  187 (302)
T ss_pred             c
Confidence            3

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.88  E-value=6.1e-22  Score=188.86  Aligned_cols=141  Identities=29%  Similarity=0.483  Sum_probs=120.9

Q ss_pred             CccccccceEEEEEEeCC-CC--EEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEeeCCeeEEEEecCCC
Q 013682          292 NILGRGGFGKVYKGRLAD-GK--LVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  367 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~-~~--~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~  367 (438)
                      +.||+|+||.||+|+..+ +.  .+|+|.++..........+.+|+.++.++ +||||+++++++......+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            358999999999998753 43  57889887543333445788999999999 799999999999999999999999999


Q ss_pred             CCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          368 GSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       368 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+|.++++....            ....+++.+...++.|++.|++|||+.   +++||||||+||++++++.++++||.
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            999999976431            123478999999999999999999998   99999999999999999999999996

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.88  E-value=5.6e-22  Score=188.87  Aligned_cols=145  Identities=28%  Similarity=0.405  Sum_probs=119.2

Q ss_pred             CCCCccccccceEEEEEEeCC-CC--EEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeC------Cee
Q 013682          289 SNKNILGRGGFGKVYKGRLAD-GK--LVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV------TEK  358 (438)
Q Consensus       289 ~~~~~LG~G~fG~Vy~~~~~~-~~--~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~  358 (438)
                      ...+.||+|+||.||+|++.+ +.  .||+|.++..... .....+.+|+.+++.++||||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456789999999999998754 33  6899988654322 2234688999999999999999999987542      246


Q ss_pred             EEEEecCCCCCHHHHhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQ--SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      +++|||+++|+|.+++....  .....+++.....++.|++.|++|||+.   +|+||||||+|||+++++.++++||.-
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence            89999999999998875332  1223478999999999999999999998   999999999999999999999999963

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.88  E-value=3.3e-22  Score=199.96  Aligned_cols=141  Identities=26%  Similarity=0.338  Sum_probs=121.7

Q ss_pred             CCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCC-----eeE
Q 013682          287 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-----EKL  359 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~  359 (438)
                      +|+..+.||+|+||.||+|.. .+++.||+|.+...... .....+.+|+.+++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            467789999999999999986 46899999998643221 22346889999999999999999999998776     789


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +||||+. ++|.+.+....    .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.++++||.
T Consensus        81 lv~e~~~-~~l~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg  148 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ----PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFG  148 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEecccc
Confidence            9999997 57887775432    489999999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=1.8e-22  Score=208.96  Aligned_cols=150  Identities=20%  Similarity=0.223  Sum_probs=127.2

Q ss_pred             HHhCCCCCCCccccccceEEEEEEe-CCCCEEEEEEcccccc-ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCC----
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT----  356 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----  356 (438)
                      ...++|...+.||+|+||.||+|+. .+++.||||.++.... ......+.+|+.++..++|+|+++++..+...+    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            3456888899999999999999986 4689999999865432 222346889999999999999999988765432    


Q ss_pred             ----eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchh
Q 013682          357 ----EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  432 (438)
Q Consensus       357 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~  432 (438)
                          ..++||||+++|+|.++++........+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.++|+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence                25799999999999999976544445689999999999999999999999   99999999999999999999999


Q ss_pred             hhh
Q 013682          433 TIL  435 (438)
Q Consensus       433 Df~  435 (438)
                      ||+
T Consensus       186 DFG  188 (496)
T PTZ00283        186 DFG  188 (496)
T ss_pred             ecc
Confidence            996

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.88  E-value=6.2e-22  Score=189.72  Aligned_cols=137  Identities=26%  Similarity=0.350  Sum_probs=118.7

Q ss_pred             cccccceEEEEEEeC-CCCEEEEEEccccccc--cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCCCH
Q 013682          294 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  370 (438)
Q Consensus       294 LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  370 (438)
                      ||+|+||.||+++.. +++.||+|.+......  .....+..|++++..++||||+++.+++......+++|||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999874 5899999998643221  1223456799999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          371 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       371 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      .+.+.....  ..+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++++||.
T Consensus        81 ~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg  140 (277)
T cd05607          81 KYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLG  140 (277)
T ss_pred             HHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeece
Confidence            988865422  2478999999999999999999998   99999999999999999999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.88  E-value=3.6e-22  Score=189.91  Aligned_cols=145  Identities=28%  Similarity=0.493  Sum_probs=126.5

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CC---CEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DG---KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~---~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      .++|+..+.||+|+||.||+|+.. ++   ..+|+|.++..........+..|++++..++|||++++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            346777889999999999999874 33   37999998654333334578899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +|||+++++|.++++...   ..+++.++..++.|++.|++|||+.   +++||||||+||++++++.++++||.
T Consensus        84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg  152 (268)
T cd05063          84 ITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFG  152 (268)
T ss_pred             EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCc
Confidence            999999999999987643   2489999999999999999999999   99999999999999999999999996

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.88  E-value=8.9e-23  Score=206.31  Aligned_cols=142  Identities=30%  Similarity=0.447  Sum_probs=120.8

Q ss_pred             CCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeC------CeeEEEE
Q 013682          290 NKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV------TEKLLVY  362 (438)
Q Consensus       290 ~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lv~  362 (438)
                      ..+.||+||||.||+|+. .+|+.||||.++............+|++++++++|||||++++.=.+.      ....++|
T Consensus        17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm   96 (732)
T KOG4250|consen   17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM   96 (732)
T ss_pred             ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence            346799999999999995 579999999998765555566789999999999999999999875443      3467999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC--CCCC--cchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD--EDAD--QSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld--~~~~--~~l~Df~  435 (438)
                      |||.+|||...|++..+. ..++..+.+.+..+++.||.|||++   +|+||||||.||++-  +||.  -|++||+
T Consensus        97 EyC~gGsL~~~L~~PEN~-~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   97 EYCSGGSLRKVLNSPENA-YGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             eecCCCcHHHHhcCcccc-cCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            999999999999876443 3589999999999999999999999   999999999999985  3343  3899996

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.88  E-value=5.9e-22  Score=187.13  Aligned_cols=143  Identities=30%  Similarity=0.487  Sum_probs=127.8

Q ss_pred             hCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      .++|+..+.||+|+||.||+|... ++.||+|.++....  ...++.+|+.++..++|+|++++++++...+..+++|||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            356777899999999999999874 78899999876532  345789999999999999999999999988999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++++|.++++....  ..++|.....++.|++.|+.|||+.   +++||||||+||++++++.++++||.
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g  147 (256)
T cd05039          82 MAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFG  147 (256)
T ss_pred             cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccc
Confidence            999999999976532  2489999999999999999999999   99999999999999999999999996

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.88  E-value=5.2e-23  Score=202.50  Aligned_cols=133  Identities=32%  Similarity=0.488  Sum_probs=118.6

Q ss_pred             CCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCC
Q 013682          289 SNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  368 (438)
Q Consensus       289 ~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g  368 (438)
                      ...+-||.|+-|.||+|++. ++.||||+++..        -+.++..+++++|||||.+.|+|.+....++|||||+.|
T Consensus       127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G  197 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG  197 (904)
T ss_pred             hhhhhhccCcccceeeeecc-CceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence            33466999999999999995 678999988542        245788899999999999999999999999999999999


Q ss_pred             CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhhc
Q 013682          369 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRR  437 (438)
Q Consensus       369 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~~  437 (438)
                      -|+..|+...    .+..........+||.||.|||.+   .|||||||+-||||..+..+||+||+-+
T Consensus       198 qL~~VLka~~----~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS  259 (904)
T KOG4721|consen  198 QLYEVLKAGR----PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTS  259 (904)
T ss_pred             cHHHHHhccC----ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccch
Confidence            9999998764    367778888999999999999999   9999999999999999999999999853

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.88  E-value=3e-22  Score=191.80  Aligned_cols=150  Identities=25%  Similarity=0.405  Sum_probs=128.4

Q ss_pred             HhCCCCCCCccccccceEEEEEEeCC-----CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEee-CCe
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLAD-----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTE  357 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~~-----~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~  357 (438)
                      ..++|+..+.||+|+||.||+|.+.+     +..||+|.++..........+.+|+.++++++||||+++++++.. ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            45678888999999999999998754     678999998754333334568899999999999999999998776 467


Q ss_pred             eEEEEecCCCCCHHHHhhccCCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSS----LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKT  433 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~D  433 (438)
                      .++++||+++|+|.+++......    ...+++.++..++.|++.||+|||+.   +++||||||+||++++++.++++|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence            88999999999999998764322    14589999999999999999999998   999999999999999999999999


Q ss_pred             hhh
Q 013682          434 ILR  436 (438)
Q Consensus       434 f~~  436 (438)
                      |.-
T Consensus       161 ~g~  163 (280)
T cd05043         161 NAL  163 (280)
T ss_pred             CCC
Confidence            863

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.88  E-value=3.6e-22  Score=197.92  Aligned_cols=145  Identities=25%  Similarity=0.340  Sum_probs=128.1

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc--chHHHHHHHHHHhcCC-CCCceeeEEEEeeCCeeEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l  360 (438)
                      .+.|+..+.||+|.||.||+++.+ +|+.+|+|.+++.....  ....+.+|+.+|+.+. |||||.+.+.+++....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            445777789999999999999975 59999999997654332  2347899999999998 9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC----CCcchhhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED----ADQSSKTILR  436 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~----~~~~l~Df~~  436 (438)
                      |||++.+|.|.+.+...     .+++.++..++.|++.|+.|||+.   +|+|||+||+|+|+...    +..+++||+.
T Consensus       114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            99999999999999876     289999999999999999999998   99999999999999865    3689999985


Q ss_pred             c
Q 013682          437 R  437 (438)
Q Consensus       437 ~  437 (438)
                      .
T Consensus       186 a  186 (382)
T KOG0032|consen  186 A  186 (382)
T ss_pred             c
Confidence            4

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.88  E-value=3.3e-22  Score=191.42  Aligned_cols=150  Identities=31%  Similarity=0.394  Sum_probs=127.5

Q ss_pred             HhCCCCCCCccccccceEEEEEEeC------CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCe
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  357 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  357 (438)
                      .+++|+..+.||+|+||.||+|.+.      .+..||+|.++..........|.+|+.+++.++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            3567888899999999999999874      3567999988654433334568999999999999999999999999889


Q ss_pred             eEEEEecCCCCCHHHHhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC---Ccch
Q 013682          358 KLLVYPYMTNGSVASRLRERQS---SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSS  431 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~---~~~l  431 (438)
                      .+++|||+++++|.+++.....   ....++|.++..++.|++.|++|||+.   +++||||||+||++++++   .+++
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence            9999999999999999876532   123589999999999999999999999   999999999999998765   4899


Q ss_pred             hhhhh
Q 013682          432 KTILR  436 (438)
Q Consensus       432 ~Df~~  436 (438)
                      +||..
T Consensus       161 ~dfg~  165 (277)
T cd05036         161 ADFGM  165 (277)
T ss_pred             ccCcc
Confidence            99863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.87  E-value=5e-22  Score=191.32  Aligned_cols=148  Identities=28%  Similarity=0.451  Sum_probs=126.7

Q ss_pred             hCCCCCCCccccccceEEEEEEeC------CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCee
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  358 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  358 (438)
                      .++|...+.||+|+||.||++...      ++..+|+|.++... ......+.+|+.++.+++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            356778899999999999999742      24568999886532 22334689999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhccCC---------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCc
Q 013682          359 LLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  429 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~  429 (438)
                      +++|||+++++|.++++....         ....+++.+...++.|++.||+|||+.   +++||||||+||++++++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence            999999999999999975431         223489999999999999999999998   99999999999999999999


Q ss_pred             chhhhhh
Q 013682          430 SSKTILR  436 (438)
Q Consensus       430 ~l~Df~~  436 (438)
                      +++||.-
T Consensus       160 kl~dfg~  166 (288)
T cd05093         160 KIGDFGM  166 (288)
T ss_pred             EeccCCc
Confidence            9999963

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.87  E-value=4.7e-22  Score=190.52  Aligned_cols=148  Identities=24%  Similarity=0.324  Sum_probs=123.7

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHH-HhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      ++|+..+.||+|+||.||+|+.. +++.||+|+++.........++..|... ++..+|||++++++++...+..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36777889999999999999875 6899999998754333333455556654 667789999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |++ |+|.++++........+++..+..++.|++.||+|||+++  +++||||||+||++++++.++++||.-
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~  150 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGI  150 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccc
Confidence            997 6888888764433456899999999999999999999742  799999999999999999999999963

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.87  E-value=5.7e-22  Score=188.20  Aligned_cols=143  Identities=29%  Similarity=0.411  Sum_probs=126.1

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      .+|...+.||+|+||.||+|.+. +++.||+|.++..  .....++.+|+.++..++||||+++++++...+..+++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            35667788999999999999875 5889999998643  22344688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++++|.+++.....  ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.++++||.
T Consensus        84 ~~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~  149 (263)
T cd05052          84 MTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFG  149 (263)
T ss_pred             CCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCc
Confidence            999999999876432  3478999999999999999999998   99999999999999999999999996

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.87  E-value=7.3e-22  Score=187.94  Aligned_cols=146  Identities=29%  Similarity=0.423  Sum_probs=122.4

Q ss_pred             CCCCCccccccceEEEEEEeC-C---CCEEEEEEcccccccc-chHHHHHHHHHHhcCCCCCceeeEEEEeeCCe-----
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-D---GKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTE-----  357 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-~---~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----  357 (438)
                      |+..+.||+|+||.||+|... +   +..||+|.++...... ....+.+|+..++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            456788999999999999864 2   3679999987543222 23468999999999999999999998876554     


Q ss_pred             -eEEEEecCCCCCHHHHhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhh
Q 013682          358 -KLLVYPYMTNGSVASRLRERQS--SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  434 (438)
Q Consensus       358 -~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df  434 (438)
                       .+++|||+++|+|.+++.....  ....+++.....++.|++.||+|||+.   +|+||||||+||++++++.++++||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             6899999999999999865421  223588999999999999999999998   9999999999999999999999999


Q ss_pred             hh
Q 013682          435 LR  436 (438)
Q Consensus       435 ~~  436 (438)
                      .-
T Consensus       158 g~  159 (273)
T cd05035         158 GL  159 (273)
T ss_pred             cc
Confidence            63

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=4.4e-22  Score=195.72  Aligned_cols=135  Identities=24%  Similarity=0.271  Sum_probs=114.8

Q ss_pred             cccccceEEEEEEeC-CCCEEEEEEccccccc--cchHHHHHHHHHHhcC---CCCCceeeEEEEeeCCeeEEEEecCCC
Q 013682          294 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMA---VHRNLLRLYGFCTTVTEKLLVYPYMTN  367 (438)
Q Consensus       294 LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lv~e~~~~  367 (438)
                      ||+|+||+||+|+.. +++.||+|++......  .....+..|..++...   +||||+++++++...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999874 5889999998543211  1122355566666544   699999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          368 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||+++++.++++||+
T Consensus        81 g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg  141 (330)
T cd05586          81 GELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFG  141 (330)
T ss_pred             ChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCC
Confidence            99999887543    478999999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.87  E-value=5.7e-22  Score=190.81  Aligned_cols=143  Identities=27%  Similarity=0.360  Sum_probs=124.0

Q ss_pred             CCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc--cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      |+..+.||+|+||+||+|... +++.||+|.+......  .....+.+|+.++..++|+|++++.+++...+..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            455678999999999999874 6889999998643221  1223578899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++++|.+++.....  ..+++.....++.|++.||.|||+.   +|+||||||+||++++++.++++||.
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg  147 (285)
T cd05632          82 MNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLG  147 (285)
T ss_pred             ccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCC
Confidence            999999988865422  2489999999999999999999998   99999999999999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.87  E-value=5.5e-22  Score=187.30  Aligned_cols=136  Identities=26%  Similarity=0.422  Sum_probs=117.0

Q ss_pred             CccccccceEEEEEEeCC-C----------CEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          292 NILGRGGFGKVYKGRLAD-G----------KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~-~----------~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      +.||+|+||.||+|...+ +          ..+++|.++.....  ...+.+|+.+++.++||||+++++++.. ...++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence            368999999999998753 3          25788877543222  4578999999999999999999999988 77899


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC-------Ccchhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-------DQSSKT  433 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~-------~~~l~D  433 (438)
                      +|||+++|+|.++++....   .+++..+..++.|++.||+|||++   +|+||||||+||+++.++       .++++|
T Consensus        78 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          78 VEEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             EEEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence            9999999999999986532   478999999999999999999998   999999999999999888       689999


Q ss_pred             hhh
Q 013682          434 ILR  436 (438)
Q Consensus       434 f~~  436 (438)
                      |.-
T Consensus       152 fg~  154 (259)
T cd05037         152 PGI  154 (259)
T ss_pred             CCc
Confidence            863

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.87  E-value=5.3e-22  Score=188.02  Aligned_cols=144  Identities=28%  Similarity=0.424  Sum_probs=125.6

Q ss_pred             hCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      .++|+..+.||+|+||.||+|...++..+|+|.++....  ....+.+|+.++++++|+|++++++++. ....+++|||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY   81 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence            456777899999999999999987788899999865332  2346899999999999999999999875 4568999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      +++++|.++++...  ...+++.++..++.|++.|++|||+.   +|+||||||+||++++++.++++||.-
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~  148 (260)
T cd05070          82 MSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGL  148 (260)
T ss_pred             cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCcee
Confidence            99999999987642  23478999999999999999999999   999999999999999999999999963

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.87  E-value=4.5e-22  Score=189.03  Aligned_cols=147  Identities=20%  Similarity=0.304  Sum_probs=127.7

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccc--cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|+..+.||+|+||.||+|+. .+++.+|||.++.....  ....++.+|+.+++.++||||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4677788999999999999986 47889999987643222  12346889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++++|.+++.........+++.....++.|++.|++|||++   +++|+||||+||+++.++.++++||.
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg  151 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcch
Confidence            99999999999875333334589999999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.87  E-value=3.3e-22  Score=191.83  Aligned_cols=145  Identities=25%  Similarity=0.377  Sum_probs=123.0

Q ss_pred             CCCCCccccccceEEEEEEeC------CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          288 FSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      |...+.||+|+||.||+|...      +++.||+|.++..........+.+|+.++..++||||+++++++......+++
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~   86 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI   86 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence            455678999999999999863      24689999997543222234688999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCc
Q 013682          362 YPYMTNGSVASRLRERQ------------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  429 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~  429 (438)
                      +||+.+++|.+++....            .....+++..+..++.|++.||+|+|+.   +|+||||||+||++++++.+
T Consensus        87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~  163 (283)
T cd05091          87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNV  163 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCce
Confidence            99999999999985321            1123478889999999999999999998   99999999999999999999


Q ss_pred             chhhhh
Q 013682          430 SSKTIL  435 (438)
Q Consensus       430 ~l~Df~  435 (438)
                      +++||.
T Consensus       164 kl~Dfg  169 (283)
T cd05091         164 KISDLG  169 (283)
T ss_pred             Eecccc
Confidence            999997

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.87  E-value=6.4e-22  Score=189.52  Aligned_cols=143  Identities=27%  Similarity=0.484  Sum_probs=123.9

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCC----EEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~----~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      ++|+..+.||+|+||.||+|.+. ++.    .+|+|.++..........+.+|+..++.++|||++++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            45677789999999999999864 232    6899988655433334578899999999999999999999987 78899


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +|||+++|+|.+++.....   .+++.....++.|++.|++|||+.   +|+||||||+||++++++.++++||.
T Consensus        86 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg  154 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFG  154 (279)
T ss_pred             EEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCc
Confidence            9999999999999976432   388999999999999999999998   99999999999999999999999996

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.87  E-value=4.4e-22  Score=196.03  Aligned_cols=149  Identities=29%  Similarity=0.430  Sum_probs=126.6

Q ss_pred             HhCCCCCCCccccccceEEEEEEeCC--------CCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEee
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLAD--------GKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  354 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~~--------~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  354 (438)
                      ...+|...+.||+|+||.||+|+...        +..||+|.++.........++.+|+.++.++ +||||++++++|..
T Consensus        10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            33467888999999999999997421        2368999887543333345789999999999 79999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCee
Q 013682          355 VTEKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL  422 (438)
Q Consensus       355 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NIL  422 (438)
                      .+..+++|||+++|+|.+++.....            ....++|.+...++.|++.||+|||+.   +|+||||||+||+
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil  166 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVL  166 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEE
Confidence            9999999999999999999976421            123578999999999999999999998   9999999999999


Q ss_pred             eCCCCCcchhhhh
Q 013682          423 LDEDADQSSKTIL  435 (438)
Q Consensus       423 ld~~~~~~l~Df~  435 (438)
                      +++++.++++||.
T Consensus       167 l~~~~~~kL~Dfg  179 (334)
T cd05100         167 VTEDNVMKIADFG  179 (334)
T ss_pred             EcCCCcEEECCcc
Confidence            9999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.87  E-value=1.2e-21  Score=184.93  Aligned_cols=145  Identities=17%  Similarity=0.294  Sum_probs=126.5

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecC
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      +|+..+.||+|+||.||+++.. +++.+|+|.++..........+.+|+.+++.++|||++++++.+.+.+..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            3666789999999999999874 688999999864433334456888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ++|++.+++.....  ..+++.....++.|++.|+.|||++   +|+|+||||+||++++++.++++||..
T Consensus        81 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~  146 (255)
T cd08219          81 DGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGS  146 (255)
T ss_pred             CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCc
Confidence            99999998875322  3478899999999999999999999   999999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.87  E-value=8.5e-22  Score=188.87  Aligned_cols=139  Identities=25%  Similarity=0.348  Sum_probs=122.0

Q ss_pred             CCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecC
Q 013682          287 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      +|+..+.||+|+||.||+|.. .+++.||+|.+...........+.+|+.++.+++||||+++++++...+..+++|||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            567778999999999999986 4688999999865433333446889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ++++|..+.        .+++.....++.|++.|++|||+.   +|+|+||||+||+++.++.++++||.-
T Consensus        82 ~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~  141 (279)
T cd06619          82 DGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGV  141 (279)
T ss_pred             CCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCc
Confidence            999986542        267888899999999999999999   999999999999999999999999963

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.87  E-value=8.5e-22  Score=187.09  Aligned_cols=143  Identities=27%  Similarity=0.416  Sum_probs=123.9

Q ss_pred             hCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      .++|...+.||+|+||.||+|++.+...||+|.++...  .....+.+|+.++..++||||+++++.+. ....+++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY   81 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc--cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence            34577889999999999999998766779999987532  22346899999999999999999999874 4567999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++|+|.++++....  ..+++..+..++.|++.||+|+|+.   +|+||||||+||++++++.++++||.
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg  147 (262)
T cd05071          82 MSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFG  147 (262)
T ss_pred             CCCCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCC
Confidence            999999999976422  2478999999999999999999998   99999999999999999999999995

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.87  E-value=8.4e-22  Score=189.77  Aligned_cols=143  Identities=25%  Similarity=0.466  Sum_probs=125.6

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      ++|+..+.||+|+||.||+|... +++.||+|.++..........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            56777889999999999999875 68899999986543333334577899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +.+ +|.+++.....   .+++.....++.|++.||.|||+.   +|+||||||+||++++++.++++||.
T Consensus        85 ~~~-~L~~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg  148 (291)
T cd07844          85 LDT-DLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFG  148 (291)
T ss_pred             CCC-CHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccc
Confidence            984 99998875432   478999999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.87  E-value=9.7e-22  Score=186.62  Aligned_cols=142  Identities=26%  Similarity=0.452  Sum_probs=125.0

Q ss_pred             CCCCCCccccccceEEEEEEeCCCCEEEEEEcccccccc-----chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          287 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG-----GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      +|...+.||+|+||.||+|...+++.+|+|.++......     ....+.+|+.+++.++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            366778999999999999988788999999886432211     123588999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |||+++++|.+++.+..    .+++.....++.|++.|++|||+.   +|+|+||||+||++++++.++++||.
T Consensus        81 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  147 (265)
T cd06631          81 MEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFG  147 (265)
T ss_pred             EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccch
Confidence            99999999999997642    378899999999999999999998   99999999999999999999999995

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.87  E-value=6.1e-22  Score=211.82  Aligned_cols=144  Identities=31%  Similarity=0.391  Sum_probs=127.1

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc--chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|...+.||+|+||.||+|... +++.||+|+++......  ....+.+|+.++..++||||+++++++......++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            56788899999999999999975 68899999986533221  1246888999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||+.+++|.++++...    .+++..+..++.|++.||+|||..   +|+||||||+|||++.++.++|+||+-
T Consensus        84 Ey~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGl  150 (669)
T cd05610          84 EYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGL  150 (669)
T ss_pred             eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCC
Confidence            9999999999987542    378899999999999999999998   999999999999999999999999973

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.87  E-value=2e-22  Score=205.53  Aligned_cols=139  Identities=30%  Similarity=0.470  Sum_probs=124.2

Q ss_pred             CCCccccccceEEEEEEe-CCC----CEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          290 NKNILGRGGFGKVYKGRL-ADG----KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       290 ~~~~LG~G~fG~Vy~~~~-~~~----~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      ..++||+|+||+||+|.| +.|    .+||+|++..........++.+|+-.|+.++|||+++++|+|.... ..||++|
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~  778 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL  778 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence            347899999999999987 333    4799999977666666678999999999999999999999998776 8899999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+.|.|.++++.++.   .+.-...+.+..|||+||.|||.+   ++|||||.++|||+.+-..+|+.||+
T Consensus       779 mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfg  843 (1177)
T KOG1025|consen  779 MPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFG  843 (1177)
T ss_pred             cccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecc
Confidence            999999999998654   366788899999999999999999   99999999999999999999999996

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.87  E-value=1e-21  Score=189.29  Aligned_cols=144  Identities=25%  Similarity=0.380  Sum_probs=124.6

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      +++|...+.||+|+||.||+|... +++.||+|.++..........+.+|+.+++.++|+||+++++++...+..+++||
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            467888899999999999999864 6889999998655433334467899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+. +++.+++....   ..+.+.....++.|++.||+|||+.   +|+||||||+||+++.+++++++||.
T Consensus        84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg  148 (291)
T cd07870          84 YMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFG  148 (291)
T ss_pred             ccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccc
Confidence            996 67877765432   2367888999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.87  E-value=1.1e-21  Score=188.97  Aligned_cols=143  Identities=27%  Similarity=0.353  Sum_probs=123.8

Q ss_pred             CCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccc--hHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      |+..+.||+|+||.||++... +++.||+|.+........  ...+..|+.++..++|+|++++++.+.+.+..+++|||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            556688999999999999874 688999999864332221  23577899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++++|.+++.....  ..+++..+..++.|++.|+.|||+.   +|+||||||+||++++++.++++||.
T Consensus        82 ~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg  147 (285)
T cd05630          82 MNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLG  147 (285)
T ss_pred             cCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeecc
Confidence            999999998865322  2488899999999999999999998   99999999999999999999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.87  E-value=5.2e-22  Score=190.62  Aligned_cols=153  Identities=26%  Similarity=0.347  Sum_probs=128.8

Q ss_pred             HHHHHHHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEe--
Q 013682          278 LRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCT--  353 (438)
Q Consensus       278 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~--  353 (438)
                      ++.+...+++|+..+.||+|+||.||++... +++.+|+|.++...  .....+.+|+.++..+ +||||+++++++.  
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            3445667888999999999999999999874 57899999875432  2234678899999998 6999999999874  


Q ss_pred             ---eCCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcc
Q 013682          354 ---TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  430 (438)
Q Consensus       354 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~  430 (438)
                         ..+..+++|||+++++|.++++........+++..+..++.|++.|+.|||+.   +|+||||||+||++++++.++
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~k  164 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVK  164 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEE
Confidence               34568999999999999998865433334578899999999999999999998   999999999999999999999


Q ss_pred             hhhhh
Q 013682          431 SKTIL  435 (438)
Q Consensus       431 l~Df~  435 (438)
                      ++||.
T Consensus       165 l~dfg  169 (286)
T cd06638         165 LVDFG  169 (286)
T ss_pred             EccCC
Confidence            99996

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.87  E-value=5e-22  Score=190.87  Aligned_cols=147  Identities=25%  Similarity=0.364  Sum_probs=127.2

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      ++|+..+.||+|+||.||+++.. +++.||+|.++..........+.+|+.++..++||||+++++.+...+..+++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            35677889999999999999975 68899999886543333344788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++++|.++++... ....+++.....++.|++.|+.|||+.+  +|+||||||+||+++.++.++++||.
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg  148 (286)
T cd06622          81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFG  148 (286)
T ss_pred             cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecC
Confidence            99999999887632 1235899999999999999999999631  89999999999999999999999996

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.87  E-value=9e-22  Score=187.27  Aligned_cols=149  Identities=23%  Similarity=0.316  Sum_probs=126.1

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      +.+++.+.....||+|+||.||+|+.. ++..||+|.++.... .....+.+|+.+++.++|+||+++++++...+..++
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            455666766788999999999999864 577899998865432 233478999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC-CCCcchhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTIL  435 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~-~~~~~l~Df~  435 (438)
                      ++||+++++|.++++..... ...++..+..++.|++.|++|||+.   +|+||||||+||+++. ++.++++||.
T Consensus        83 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg  154 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGP-LKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFG  154 (268)
T ss_pred             EEecCCCCCHHHHHHHhccc-CCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecch
Confidence            99999999999999864221 1127788889999999999999998   9999999999999987 6789999996

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.87  E-value=1.2e-21  Score=186.14  Aligned_cols=137  Identities=26%  Similarity=0.380  Sum_probs=115.5

Q ss_pred             CccccccceEEEEEEeCC-------------CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCee
Q 013682          292 NILGRGGFGKVYKGRLAD-------------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  358 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~-------------~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  358 (438)
                      +.||+|+||.||+|.+.+             ...||+|.+.... .+....+.+|+.++..++||||+++++++......
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            358999999999998532             2258899875532 22334688899999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC-------cch
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD-------QSS  431 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~-------~~l  431 (438)
                      +++|||+++|+|..+++...   ..+++.....++.|++.|++|||+.   +|+||||||+|||++.++.       +++
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l  153 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL  153 (262)
T ss_pred             EEEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence            99999999999998886542   2488999999999999999999998   9999999999999987764       688


Q ss_pred             hhhh
Q 013682          432 KTIL  435 (438)
Q Consensus       432 ~Df~  435 (438)
                      +||.
T Consensus       154 ~d~g  157 (262)
T cd05077         154 SDPG  157 (262)
T ss_pred             CCCC
Confidence            8876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.87  E-value=9.4e-23  Score=182.77  Aligned_cols=150  Identities=27%  Similarity=0.339  Sum_probs=131.2

Q ss_pred             hCCCCCCCccccccceEEEEEE-eCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEee-----CCee
Q 013682          285 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-----VTEK  358 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~~  358 (438)
                      .++|.+.+.||+|||..||.++ ..++..+|+|++.... .++....++|++..++++|||+++++++...     ..+.
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            4567778999999999999998 4678999999986653 3445578999999999999999999987643     3458


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |++++|...|+|.+.+.........+++.+.+.|+.++++||++||+. .|+.+||||||.|||+.+++++.+.||+.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence            999999999999999988766666799999999999999999999998 55799999999999999999999999975

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.87  E-value=1.7e-21  Score=183.69  Aligned_cols=142  Identities=34%  Similarity=0.522  Sum_probs=125.2

Q ss_pred             CccccccceEEEEEEeCC----CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCC
Q 013682          292 NILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  367 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~----~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  367 (438)
                      +.||+|+||.||+|....    +..||+|.++..........+.+|+..+..++|+|++++++++......+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            468999999999998753    7789999997654443355789999999999999999999999999999999999999


Q ss_pred             CCHHHHhhccCCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          368 GSVASRLRERQSS-----LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       368 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ++|.+++......     ...+++.+...++.|++.|++|||+.   +++||||||+||++++++.++++||..
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~  151 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGL  151 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccc
Confidence            9999999875211     24589999999999999999999998   999999999999999999999999963

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=1.6e-21  Score=184.62  Aligned_cols=144  Identities=26%  Similarity=0.428  Sum_probs=126.2

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc----chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG----GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      ++|+..+.||+|+||.||+|... +++.||+|.++......    ....+.+|+.++++++||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46888899999999999999864 68899999886432211    12368889999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ++||+++++|.+.+....    .+++.....++.|++.|++|||+.   +|+||||||+||++++++.++++||.-
T Consensus        82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~  150 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGA  150 (263)
T ss_pred             EEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence            999999999999987643    378889999999999999999999   999999999999999999999999963

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.87  E-value=1.8e-21  Score=186.58  Aligned_cols=143  Identities=23%  Similarity=0.359  Sum_probs=124.8

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      ++|+..+.||+|+||.||+|+.. +++.||+|++...... .....+.+|+.+++.++|||++++++++......+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            35777889999999999999975 5889999998644322 223457899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |++++++....+...    .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||.
T Consensus        81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  145 (286)
T cd07847          81 YCDHTVLNELEKNPR----GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFG  145 (286)
T ss_pred             ccCccHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccc
Confidence            999988887765432    389999999999999999999998   99999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.87  E-value=1.6e-21  Score=183.73  Aligned_cols=144  Identities=24%  Similarity=0.346  Sum_probs=126.3

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEccccc-cccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      +|+..+.||+|+||.||+|... +++.||+|.+.... .......+.+|+.+++.++|||++++++++.+.+..+++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4666788999999999999874 68899999986432 222344688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++++|.++++...  ...+++.....++.|++.|+.|||+.   +++||||||+||++++++.++++||.
T Consensus        81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~  146 (256)
T cd08529          81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLG  146 (256)
T ss_pred             CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccc
Confidence            99999999998642  23588999999999999999999998   99999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.87  E-value=2e-21  Score=186.33  Aligned_cols=144  Identities=21%  Similarity=0.361  Sum_probs=124.5

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc-chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      +|+..+.||+|+||.||+|+.. +++.||+|.++...... ....+.+|+.++..++|||++++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4667788999999999999874 68899999986543222 234688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++ ++|.+++..... ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++++||.
T Consensus        81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  146 (285)
T cd07861          81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFG  146 (285)
T ss_pred             CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECccc
Confidence            97 688888865422 23588999999999999999999998   99999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.87  E-value=1.2e-21  Score=185.63  Aligned_cols=144  Identities=23%  Similarity=0.357  Sum_probs=126.0

Q ss_pred             HhCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      ..++|...+.||+|+||.||+|...++..+|+|.++...  .....+.+|+.+++.++|+|++++++.+.. ...+++||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE   80 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence            456788889999999999999997777789999886432  233468899999999999999999999877 77899999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+++|+|.+++....  ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++||.
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~  147 (260)
T cd05073          81 FMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFG  147 (260)
T ss_pred             eCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCc
Confidence            999999999997643  23478999999999999999999998   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.87  E-value=1.3e-21  Score=194.61  Aligned_cols=140  Identities=24%  Similarity=0.323  Sum_probs=122.3

Q ss_pred             HHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      ....+|...+.||+|+||.||+|+.. +++.||+|.....       ....|+.+++.++||||+++++++......++|
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence            34567999999999999999999875 5778999975322       235689999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |||+. ++|.+++....   ..++|..+..++.|++.||+|||+.   +|+||||||+|||+++++.++++||.-
T Consensus       136 ~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~  203 (357)
T PHA03209        136 LPHYS-SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGA  203 (357)
T ss_pred             EEccC-CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcc
Confidence            99995 68888886542   2589999999999999999999999   999999999999999999999999973

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.87  E-value=1.3e-21  Score=188.56  Aligned_cols=143  Identities=30%  Similarity=0.402  Sum_probs=126.3

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc--cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|+..+.||+|+||.||++... +++.||+|.++.....  .....+.+|++++++++||||+++++++...+..+++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            35777899999999999999875 5889999998653221  22346889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++++|.++++...    .+++.....++.|++.||+|||+.   +|+||||+|+||++++++.++++||.
T Consensus        81 e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg  146 (290)
T cd05580          81 EYVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFG  146 (290)
T ss_pred             ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCC
Confidence            9999999999987652    478899999999999999999998   99999999999999999999999996

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.86  E-value=1.8e-21  Score=184.46  Aligned_cols=143  Identities=28%  Similarity=0.386  Sum_probs=123.3

Q ss_pred             CCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecC
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      ++|...+.||+|+||.||+|...++..+|+|.+....  .....+.+|+.+++.++|||++++++++. .+..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            4567778899999999999998776789999876432  23346889999999999999999999875 45688999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ++|+|.++++...  ...++|..+..++.|++.|++|||+.   +++||||||+||++++++.++++||.-
T Consensus        83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~  148 (260)
T cd05069          83 GKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGL  148 (260)
T ss_pred             CCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCcc
Confidence            9999999997642  23478999999999999999999998   999999999999999999999999963

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.86  E-value=1.1e-21  Score=200.49  Aligned_cols=143  Identities=23%  Similarity=0.321  Sum_probs=117.4

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeC--------
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--------  355 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------  355 (438)
                      ..+|...+.||+|+||.||+|... +++.||||++....     ....+|+.+++.++|||||++++++...        
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            457888999999999999999874 68899999874321     2346799999999999999999876432        


Q ss_pred             CeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC-Ccchhhh
Q 013682          356 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTI  434 (438)
Q Consensus       356 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~-~~~l~Df  434 (438)
                      ...++||||+++ ++.+++.........+++.....++.|++.||+|||+.   +|+||||||+|||++.++ .++|+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence            235689999985 77777654333334588999999999999999999999   999999999999999765 6999999


Q ss_pred             hh
Q 013682          435 LR  436 (438)
Q Consensus       435 ~~  436 (438)
                      +-
T Consensus       216 Gl  217 (440)
T PTZ00036        216 GS  217 (440)
T ss_pred             cc
Confidence            73

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.86  E-value=4.2e-22  Score=188.09  Aligned_cols=142  Identities=32%  Similarity=0.476  Sum_probs=123.2

Q ss_pred             CCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccch-HHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecC
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGE-LQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~-~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      |+..+.||+|+||.||+++.. +++.||+|.+......... ....+|+..+..++||||+++++++......+++|||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            345678999999999999975 4678999998665332222 23456999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ++++|.+++....    .+++..+..++.|+++||+|||+.   +|+||||||+||+++++++++++||.-
T Consensus        81 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~  144 (260)
T PF00069_consen   81 PGGSLQDYLQKNK----PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGS  144 (260)
T ss_dssp             TTEBHHHHHHHHS----SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTT
T ss_pred             ccccccccccccc----cccccccccccccccccccccccc---ccccccccccccccccccccccccccc
Confidence            9999999998332    379999999999999999999999   999999999999999999999999974

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=9.7e-22  Score=188.28  Aligned_cols=144  Identities=31%  Similarity=0.429  Sum_probs=127.0

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .++|+..+.||+|+||.||+|... ++..||+|.++... ......+.+|+.+++.++|||++++++.+......++|||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            356777888999999999999874 58899999986432 2233468899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+++++|.+++....   ..+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++..+++||.
T Consensus        83 ~~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g  148 (280)
T cd06611          83 FCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFG  148 (280)
T ss_pred             ccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCc
Confidence            999999999987643   2488999999999999999999999   99999999999999999999999995

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=8e-23  Score=214.99  Aligned_cols=152  Identities=24%  Similarity=0.298  Sum_probs=135.1

Q ss_pred             HHHHHHHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEee
Q 013682          278 LRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTT  354 (438)
Q Consensus       278 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~  354 (438)
                      ..+++...++|.+.++||+|+||.|..++++ +++.||+|++.+...  .....-|.+|-.+|...+.+.||.++-.|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            4556667789999999999999999999975 688999999976322  2233469999999999999999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhh
Q 013682          355 VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  434 (438)
Q Consensus       355 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df  434 (438)
                      +.+.|+|||||+||+|...+.+..    +++...+..+...|..||.-+|+.   |+|||||||+|||+|..|..+++||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF  219 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF  219 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence            999999999999999999998753    488899999999999999999999   9999999999999999999999999


Q ss_pred             hh
Q 013682          435 LR  436 (438)
Q Consensus       435 ~~  436 (438)
                      +.
T Consensus       220 Gs  221 (1317)
T KOG0612|consen  220 GS  221 (1317)
T ss_pred             hh
Confidence            85

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.86  E-value=2e-21  Score=182.80  Aligned_cols=138  Identities=29%  Similarity=0.466  Sum_probs=123.2

Q ss_pred             CccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCCCHH
Q 013682          292 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVA  371 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~  371 (438)
                      +.||+|+||.||++...+++.||+|.++..........+.+|+.+++.++||||+++++++......+++|||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            36899999999999986689999999876543333457899999999999999999999999999999999999999999


Q ss_pred             HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          372 SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       372 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++++....   .+++.....++.+++.|++|||++   +++||||||+||++++++.++++||.
T Consensus        81 ~~l~~~~~---~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g  138 (251)
T cd05041          81 TFLRKKKN---RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFG  138 (251)
T ss_pred             HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeecc
Confidence            99976432   478899999999999999999999   99999999999999999999999996

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.86  E-value=2e-21  Score=188.21  Aligned_cols=141  Identities=23%  Similarity=0.353  Sum_probs=125.8

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      .+|+..+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.++|||++++++++...+..++||||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            5688889999999999999986 4689999999864322 2334688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++++|.+++.+.     .+++.+...++.|++.||.|||+.   +|+||||||+||+++.++.++++||.
T Consensus        98 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg  160 (297)
T cd06656          98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG  160 (297)
T ss_pred             cCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCc
Confidence            9999999998653     378899999999999999999998   99999999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.86  E-value=1.7e-21  Score=184.01  Aligned_cols=138  Identities=35%  Similarity=0.450  Sum_probs=121.0

Q ss_pred             CccccccceEEEEEEeCC--C--CEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCC
Q 013682          292 NILGRGGFGKVYKGRLAD--G--KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  367 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~--~--~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  367 (438)
                      +.||+|+||.||+|.+.+  +  ..||+|.++..........+.+|+.++++++||||+++++.+.. ...+++|||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            368999999999998743  3  36999998765443334578999999999999999999999888 889999999999


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          368 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+|.+++.....  ..++|.....++.|++.||+|||+.   +++||||||+||+++.++.++++||.
T Consensus        80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg  142 (257)
T cd05040          80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFG  142 (257)
T ss_pred             CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccc
Confidence            999999987532  3589999999999999999999999   99999999999999999999999996

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.86  E-value=2.3e-21  Score=184.12  Aligned_cols=143  Identities=27%  Similarity=0.418  Sum_probs=122.2

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc----chHHHHHHHHHHhcCCCCCceeeEEEEeeC--Cee
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG----GELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEK  358 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~  358 (438)
                      .+|+..+.||+|+||.||+|... +++.||+|.++......    ....+.+|+.++.+++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46778899999999999999874 58899999875432111    123678899999999999999999988763  457


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++|||+++++|.+++....    .+++.....++.|++.||+|||+.   +|+|+||||+||++++++.++++||.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg  151 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFG  151 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCc
Confidence            79999999999999987542    378888999999999999999999   99999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.86  E-value=2.1e-21  Score=188.64  Aligned_cols=143  Identities=21%  Similarity=0.325  Sum_probs=125.9

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|+..+.||+|+||.||+++.. +++.||+|.++....  ......+.+|+.+++.++||||+++++.+...+..+++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36778899999999999999875 578999999865432  122346789999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++++|.+++....    .+++.....++.|++.|++|||+.   +++||||||+||++++++.++++||.
T Consensus        81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg  146 (305)
T cd05609          81 EYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFG  146 (305)
T ss_pred             ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCC
Confidence            9999999999997642    478999999999999999999998   99999999999999999999999996

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.86  E-value=2.1e-21  Score=185.89  Aligned_cols=143  Identities=26%  Similarity=0.420  Sum_probs=124.3

Q ss_pred             CCCCCCccccccceEEEEEEeC-----CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEee--CCeeE
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEKL  359 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-----~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~  359 (438)
                      .|+..+.||+|+||.||+|++.     +++.+|||.++..........+.+|+.+++.++||||+++++++..  ....+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            4566788999999999999863     3678999998754332234579999999999999999999999877  55789


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++|||+++++|.+++.....   .+++.....++.|++.||+|||+.   +++||||||+||+++.++.++++||.
T Consensus        85 lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  154 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFG  154 (284)
T ss_pred             EEEecCCCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccc
Confidence            99999999999999976432   489999999999999999999998   99999999999999999999999995

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=5e-22  Score=187.23  Aligned_cols=141  Identities=24%  Similarity=0.389  Sum_probs=120.3

Q ss_pred             CCCCCCccccccceEEEEEEe-CCCCEEEEEEcccc-ccccchHHHHHHHHHHhcCCCCCceeeEEEEee-----CCeeE
Q 013682          287 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEE-RTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-----VTEKL  359 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~~~  359 (438)
                      .|...+.||+|+||.|..|.. .+|+.||||++... ......++..+|+.+++.++|+|||.+.+.+..     ....|
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY  102 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY  102 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence            445568899999999999986 46899999998532 222234468899999999999999999998865     45789


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +|+|+|+ -+|...++...    .++......+..|+.+||.|+|+.   +|+||||||+|+|++.+.+.||+||+
T Consensus       103 iV~elMe-tDL~~iik~~~----~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFG  170 (359)
T KOG0660|consen  103 LVFELME-TDLHQIIKSQQ----DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFG  170 (359)
T ss_pred             EehhHHh-hHHHHHHHcCc----cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccc
Confidence            9999994 58988887653    378889999999999999999999   99999999999999999999999996

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.86  E-value=1.4e-21  Score=187.84  Aligned_cols=144  Identities=24%  Similarity=0.331  Sum_probs=125.9

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      ++|+..+.||+|+||.||++... +++.||+|.+...........+.+|++++..++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            45666788999999999999874 58899999886543333345789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++++|.++++...    .+++.....++.+++.|+.|||+..  +++||||||+||++++++.++++||.
T Consensus        85 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~g  149 (284)
T cd06620          85 MDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFG  149 (284)
T ss_pred             CCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCC
Confidence            99999999887642    4789999999999999999999731  79999999999999999999999996

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.86  E-value=1.6e-21  Score=199.26  Aligned_cols=138  Identities=23%  Similarity=0.262  Sum_probs=121.4

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      ..+|...+.||+|+||.||+|... +++.||||....       ..+.+|+.++++++|+|||++++++...+..+++||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            346888899999999999999875 578899996321       246789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ++. ++|.+++....   ..++|.++..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||.-
T Consensus       241 ~~~-~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGl  306 (461)
T PHA03211        241 KYR-SDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGA  306 (461)
T ss_pred             ccC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCC
Confidence            995 78888886532   2589999999999999999999999   999999999999999999999999973

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.86  E-value=3e-21  Score=182.21  Aligned_cols=144  Identities=22%  Similarity=0.316  Sum_probs=126.3

Q ss_pred             CCCCCCccccccceEEEEEEe-CCCCEEEEEEccccc-cccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          287 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      +|+..+.||+|+||.||.++. .+++.+++|.+.... ......++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            367788999999999999886 468899999875432 223345688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++|+|.+++....  ...+++.++..++.|++.|++|||+.   +++||||||+||++++++.++++||.
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~  146 (256)
T cd08221          81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFG  146 (256)
T ss_pred             cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCc
Confidence            99999999997643  23578999999999999999999998   99999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.86  E-value=3e-21  Score=182.44  Aligned_cols=141  Identities=28%  Similarity=0.445  Sum_probs=123.0

Q ss_pred             CCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEe-eCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT-TVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lv~e~  364 (438)
                      ++|+..+.||+|+||.||++... +..||+|.++..   .....+.+|+.+++.++|+|++++++++. ..+..+++|||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC---chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            46777899999999999999874 778999988543   22346889999999999999999999765 45568999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++++|.++++....  ..+++.....++.|++.||+|||++   +|+||||||+||++++++.++++||.
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg  147 (256)
T cd05082          82 MAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFG  147 (256)
T ss_pred             CCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCc
Confidence            999999999976432  3478999999999999999999999   99999999999999999999999996

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.86  E-value=1.9e-22  Score=202.71  Aligned_cols=140  Identities=29%  Similarity=0.413  Sum_probs=123.3

Q ss_pred             CCCccccccceEEEEEEeC--CCC--EEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecC
Q 013682          290 NKNILGRGGFGKVYKGRLA--DGK--LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       290 ~~~~LG~G~fG~Vy~~~~~--~~~--~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      ..+.||+|.||+|++|.|.  .|+  .||||.++.........+|.+|+..|.+++|||+|++||++.+ ....||+|++
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            3477999999999999985  344  6899999876544445589999999999999999999999987 6788999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +.|+|.++|++.  ....+-......++.|||.||.||.++   ++|||||.++|+|+.....+||+||+
T Consensus       193 plGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFG  257 (1039)
T KOG0199|consen  193 PLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFG  257 (1039)
T ss_pred             ccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeeccc
Confidence            999999999983  233577788889999999999999999   99999999999999999999999996

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.86  E-value=2.6e-21  Score=183.31  Aligned_cols=138  Identities=31%  Similarity=0.458  Sum_probs=116.2

Q ss_pred             CccccccceEEEEEEeC----CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEee-CCeeEEEEecCC
Q 013682          292 NILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTEKLLVYPYMT  366 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~----~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e~~~  366 (438)
                      +.||+|+||.||+|.+.    +...||+|.+...........+.+|+.+++.++|||++++++++.. ++..+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999863    2357999988543222233468899999999999999999998764 556789999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          367 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       367 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +|+|.++++....   ..++.....++.|++.|++|||+.   +++||||||+|||+++++.++++||.
T Consensus        81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg  143 (262)
T cd05058          81 HGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFG  143 (262)
T ss_pred             CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCcc
Confidence            9999999976432   357788899999999999999998   99999999999999999999999996

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.86  E-value=2.7e-21  Score=182.96  Aligned_cols=136  Identities=25%  Similarity=0.371  Sum_probs=117.2

Q ss_pred             ccccccceEEEEEEeC---CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCC
Q 013682          293 ILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  368 (438)
Q Consensus       293 ~LG~G~fG~Vy~~~~~---~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g  368 (438)
                      .||+|+||.||+|.++   ++..+|+|+++..... ....++.+|+.+++.++||||+++++++. .+..+++|||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            4899999999999753   5778999998654322 22346889999999999999999999875 45678999999999


Q ss_pred             CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          369 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       369 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      +|.+++....    .+++.....++.|++.|++|||++   +|+||||||+||++++++.++++||.-
T Consensus        81 ~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~  141 (257)
T cd05116          81 PLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGL  141 (257)
T ss_pred             cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCcc
Confidence            9999987542    478999999999999999999998   999999999999999999999999963

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.86  E-value=1.8e-21  Score=185.39  Aligned_cols=143  Identities=24%  Similarity=0.335  Sum_probs=122.7

Q ss_pred             CCCCCCCccccccceEEEEEEeCC----CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~~----~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      ++|...+.||+|+||.||+|.+.+    ...||+|..+..........+.+|+.+++.++||||+++++++.. +..+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457777899999999999998643    346999988654333334578999999999999999999998865 557899


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |||+++|+|.+++....   ..+++..+..++.+++.|++|||+.   +++||||||+||+++.++.++++||.
T Consensus        85 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g  152 (270)
T cd05056          85 MELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFG  152 (270)
T ss_pred             EEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCc
Confidence            99999999999997643   2479999999999999999999998   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.86  E-value=1.4e-21  Score=185.75  Aligned_cols=142  Identities=26%  Similarity=0.404  Sum_probs=124.8

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      ++|...+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|+.+++.++||||+++++.+...+..+++|||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            35666688999999999999864 688999999865422 2233578899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++++|.+++....    .+++.+...++.|++.|++|||+.   +|+||||||+||+++.++.++++||.
T Consensus        88 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg  151 (267)
T cd06645          88 CGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFG  151 (267)
T ss_pred             cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcce
Confidence            99999999986543    488999999999999999999999   99999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.86  E-value=2.2e-21  Score=187.13  Aligned_cols=146  Identities=28%  Similarity=0.450  Sum_probs=124.7

Q ss_pred             CCCCCCCccccccceEEEEEEeC------CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  359 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  359 (438)
                      .+|...+.||+|+||.||+|+..      ++..+|+|.++... ......+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            34667789999999999999742      34568999886432 222346889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC
Q 013682          360 LVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  427 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~  427 (438)
                      +||||+++++|.++++....            ....++|..+..++.|++.|++|||++   +|+||||||+||++++++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence            99999999999999975421            123478999999999999999999999   999999999999999999


Q ss_pred             Ccchhhhh
Q 013682          428 DQSSKTIL  435 (438)
Q Consensus       428 ~~~l~Df~  435 (438)
                      .++++||.
T Consensus       161 ~~~l~dfg  168 (291)
T cd05094         161 LVKIGDFG  168 (291)
T ss_pred             cEEECCCC
Confidence            99999996

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.86  E-value=2.6e-21  Score=187.02  Aligned_cols=142  Identities=26%  Similarity=0.418  Sum_probs=124.5

Q ss_pred             CCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc---c-chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS---G-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~---~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      |+..+.||+|+||.||+|... +++.||+|.++.....   . ....+..|+.+++.++|+||+++++++.+.+..++||
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF   81 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence            666788999999999999874 6889999998754322   1 1235678999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||+ +|+|.++++...   ..+++.....++.|+++||+|||+.   +|+||||||+||+++.++.++++||.-
T Consensus        82 e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~  148 (298)
T cd07841          82 EFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGL  148 (298)
T ss_pred             ccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEcccee
Confidence            999 899999997643   2489999999999999999999999   999999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.86  E-value=1.7e-21  Score=193.83  Aligned_cols=142  Identities=23%  Similarity=0.280  Sum_probs=119.9

Q ss_pred             HhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCC-----
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-----  356 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----  356 (438)
                      ..++|+..+.||+|+||.||+++.. +++.||+|.++..... .....+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3467888999999999999999864 5889999998654322 22346789999999999999999999986543     


Q ss_pred             -eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          357 -EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       357 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                       ..++||||+++ ++.+.+..      .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||.
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence             46899999975 56665543      267888999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.86  E-value=1.9e-21  Score=185.20  Aligned_cols=146  Identities=31%  Similarity=0.477  Sum_probs=124.4

Q ss_pred             HhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEeeC------
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV------  355 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~------  355 (438)
                      +.+.|+..+.||+|+||.||+|... +++.||+|.++..  ......+..|+.++.++ +|||++++++++...      
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC--CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            3456777788999999999999874 5889999998543  23344688899999888 699999999998753      


Q ss_pred             CeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          356 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       356 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ...+++|||+.+|+|.+++.....  ..++|..+..++.|++.|++|||++   +|+||||||+||++++++.++++||.
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg  156 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG  156 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence            457899999999999999876432  3488999999999999999999999   99999999999999999999999996


Q ss_pred             h
Q 013682          436 R  436 (438)
Q Consensus       436 ~  436 (438)
                      -
T Consensus       157 ~  157 (272)
T cd06637         157 V  157 (272)
T ss_pred             C
Confidence            3

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.86  E-value=2.7e-21  Score=187.21  Aligned_cols=141  Identities=22%  Similarity=0.357  Sum_probs=125.3

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      .+|+..+.||+|+||.||+|.. .+++.||+|.+...... ....+.+|+.+++.++|||++++++.+......++||||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            4677788999999999999986 46889999988653322 334688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++++|.+++...     .+++.+...++.|++.|++|||+.   +|+||||||+||+++.++.++++||.
T Consensus        99 ~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg  161 (296)
T cd06654          99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG  161 (296)
T ss_pred             cCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccc
Confidence            9999999998643     378899999999999999999999   99999999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.86  E-value=3.7e-21  Score=181.93  Aligned_cols=136  Identities=30%  Similarity=0.459  Sum_probs=118.6

Q ss_pred             CccccccceEEEEEEeCC----CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCC
Q 013682          292 NILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  367 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~----~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  367 (438)
                      +.||+|+||.||+|.+..    +..+|+|.++.........++.+|+.+++.+.|||++++++++. .+..+++|||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            468999999999997632    26899999876543334457899999999999999999999876 4567999999999


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          368 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+|.+++....    .+++..+..++.|++.|++|||+.   +++||||||+||++++++.++++||.
T Consensus        80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~  140 (257)
T cd05060          80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFG  140 (257)
T ss_pred             CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEecccc
Confidence            99999997653    478999999999999999999998   99999999999999999999999995

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.86  E-value=3.8e-21  Score=181.31  Aligned_cols=141  Identities=27%  Similarity=0.435  Sum_probs=124.4

Q ss_pred             CCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc----ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT----SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      |+..+.||+|+||+||+|... +++.||+|.+.....    ......+.+|+.+++.++|+|++++++++......+++|
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            566788999999999999875 788999998854321    112346889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++++|.++++...    .+++.....++.|++.|++|||+.   +|+|+||+|+||++++++.++++||.
T Consensus        82 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~  147 (258)
T cd06632          82 ELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFG  147 (258)
T ss_pred             EecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCc
Confidence            9999999999997642    478999999999999999999999   99999999999999999999999995

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.86  E-value=5.4e-22  Score=194.89  Aligned_cols=147  Identities=24%  Similarity=0.346  Sum_probs=128.9

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccc-hHHHHHHHHHHhcCCCCCceeeEEEEeeCCe-eEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTE-KLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lv~  362 (438)
                      ++|...+++|+|+||.++..+.+ +++.+++|.+........ ......|+.++++++|||||.+.+.|...+. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            56777899999999999988764 577999999876543333 3367899999999999999999999999888 89999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhhc
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRR  437 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~~  437 (438)
                      +|++||++.+.+.+.++  ..+++.+...++.|++.|+.|||+.   +|+|||||+.||++..+..++++||+-.
T Consensus        84 ~Y~eGg~l~~~i~~~k~--~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGla  153 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKG--VLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLA  153 (426)
T ss_pred             eecCCCCHHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhh
Confidence            99999999999987653  3588899999999999999999988   9999999999999999999999999853

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.86  E-value=3.5e-21  Score=184.62  Aligned_cols=144  Identities=26%  Similarity=0.460  Sum_probs=125.8

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecC
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      +|+..+.||+|++|.||+|+.. +++.||+|.++..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4677889999999999999975 588999999876544334456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++ +|.+++..... ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.++++||.
T Consensus        81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g  145 (284)
T cd07836          81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFG  145 (284)
T ss_pred             Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecc
Confidence            85 88888865432 23589999999999999999999998   99999999999999999999999984

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.86  E-value=2.3e-22  Score=185.40  Aligned_cols=148  Identities=26%  Similarity=0.382  Sum_probs=123.7

Q ss_pred             HhCCCCCCCccccccceEEEEEEeC---C--CCEEEEEEccccccccc-hHHHHHHHHHHhcCCCCCceeeEEEEee-CC
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLA---D--GKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTT-VT  356 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~---~--~~~vAvK~l~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~  356 (438)
                      ....|+....||+|.||.||+|.-.   +  .+.+|+|.++......+ .....+|+.+++.++|||+|.+..++.. +.
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            3456778888999999999999542   2  34799999987643333 3468899999999999999999999877 78


Q ss_pred             eeEEEEecCCCCCHHHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC----CCcch
Q 013682          357 EKLLVYPYMTNGSVASRLRERQSS-LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED----ADQSS  431 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~----~~~~l  431 (438)
                      ..++++||.+. +|.+.++-++.. ...++-.....|..||..|+.|||++   -|+||||||.|||+..|    |.+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEe
Confidence            89999999986 888888754332 23577788899999999999999999   89999999999999988    88999


Q ss_pred             hhhh
Q 013682          432 KTIL  435 (438)
Q Consensus       432 ~Df~  435 (438)
                      +||+
T Consensus       178 aDlG  181 (438)
T KOG0666|consen  178 ADLG  181 (438)
T ss_pred             eccc
Confidence            9985

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=1.8e-22  Score=199.47  Aligned_cols=142  Identities=31%  Similarity=0.439  Sum_probs=121.3

Q ss_pred             CCCCCccccccceEEEEEEe-CCCCEEEEEEccccccc--cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          288 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      |...+-||.|+||.||-|+. .+.+.||||++.-....  ..+.++..|+..+..++|||.|.+.|||..+...||||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            45567799999999999986 46889999998543322  2234789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |- ||-.+.+.-.+.   ++...++..|..++..||+|||++   +.||||||+.|||+.+.|.+|++||+.
T Consensus       108 Cl-GSAsDlleVhkK---plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGS  172 (948)
T KOG0577|consen  108 CL-GSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGS  172 (948)
T ss_pred             Hh-ccHHHHHHHHhc---cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccc
Confidence            96 466666654332   477888999999999999999999   999999999999999999999999985

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.86  E-value=4.2e-21  Score=183.73  Aligned_cols=140  Identities=31%  Similarity=0.473  Sum_probs=123.9

Q ss_pred             CCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCC
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  366 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  366 (438)
                      |+..+.||+|+||.||+|... ++..||+|.+...........+.+|+..+..++||||+++++++...+..++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            556688999999999999864 6789999987544333334468899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          367 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       367 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++|.+++...     .+++.....++.|++.|+.|||+.   +++|+||||+||+++.++.++++||.
T Consensus        86 ~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg  146 (277)
T cd06641          86 GGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFG  146 (277)
T ss_pred             CCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecc
Confidence            99999988642     378999999999999999999998   99999999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.86  E-value=2.3e-21  Score=188.31  Aligned_cols=143  Identities=28%  Similarity=0.481  Sum_probs=121.1

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCC----EEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~----~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      ++|+..+.||+|+||.||+|.+. ++.    .||+|.++..........+.+|+.+++.++||||++++++|... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            45677789999999999999863 343    57999886543333334688999999999999999999998754 4679


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++||+++|+|.+++.....   .+++..+..++.|++.||+|||++   +|+||||||+||++++++.++++||.
T Consensus        86 v~e~~~~g~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg  154 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKD---NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFG  154 (303)
T ss_pred             eehhcCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccc
Confidence            9999999999999876432   478899999999999999999999   99999999999999999999999996

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.86  E-value=3.4e-21  Score=183.58  Aligned_cols=141  Identities=27%  Similarity=0.421  Sum_probs=122.6

Q ss_pred             CCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc---------chHHHHHHHHHHhcCCCCCceeeEEEEeeCCe
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG---------GELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  357 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  357 (438)
                      |...+.||+|+||.||+|... +++.||+|.++......         ....+.+|+.+++.++|||++++++++...+.
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   82 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY   82 (272)
T ss_pred             eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence            556788999999999999864 68899999875321111         01247789999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      .++||||+++++|.++++...    .+++..+..++.|++.|+.|||+.   +++||||||+||++++++.++++||.
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~  153 (272)
T cd06629          83 LSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFG  153 (272)
T ss_pred             eEEEEecCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecc
Confidence            999999999999999997652    488899999999999999999998   99999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.86  E-value=4.4e-21  Score=181.06  Aligned_cols=142  Identities=27%  Similarity=0.479  Sum_probs=125.7

Q ss_pred             CCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecC
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      .+|+..+.||+|+||.||+|.+.+++.+|+|.++...  ....++.+|+++++.++|||++++++++......+++|||+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA--MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC--CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            3566678899999999999988777899999886432  23346899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++++|.++++....   .+++.....++.|++.|++|||+.   +++||||||+||+++.++.++++||.
T Consensus        82 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g  145 (256)
T cd05112          82 EHGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFG  145 (256)
T ss_pred             CCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCc
Confidence            99999999876432   478999999999999999999998   99999999999999999999999996

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.86  E-value=2.6e-21  Score=185.57  Aligned_cols=146  Identities=31%  Similarity=0.466  Sum_probs=125.3

Q ss_pred             CCCCCCCccccccceEEEEEEeC------CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  359 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  359 (438)
                      .+|...+.||+|+||.||+++..      ++..+|+|.++... ......+.+|+++++.++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            45667789999999999999642      35689999886432 233447999999999999999999999999989999


Q ss_pred             EEEecCCCCCHHHHhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC
Q 013682          360 LVYPYMTNGSVASRLRERQS-----------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  428 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~  428 (438)
                      ++|||+++|+|.++++....           ....+++..+..++.|++.|++|||+.   +++||||||+||++++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence            99999999999999976431           113478999999999999999999998   9999999999999999999


Q ss_pred             cchhhhh
Q 013682          429 QSSKTIL  435 (438)
Q Consensus       429 ~~l~Df~  435 (438)
                      ++++||.
T Consensus       161 ~kL~dfg  167 (280)
T cd05092         161 VKIGDFG  167 (280)
T ss_pred             EEECCCC
Confidence            9999996

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.86  E-value=4.9e-21  Score=181.89  Aligned_cols=141  Identities=28%  Similarity=0.457  Sum_probs=123.3

Q ss_pred             CCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccc--------hHHHHHHHHHHhcCCCCCceeeEEEEeeCCee
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG--------ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  358 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~--------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  358 (438)
                      |.....||+|+||.||+|... +++.||+|.+........        ...+.+|+.+++.++||||+++++++...+..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            556788999999999999864 578999998864332211        13578899999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++|||+++++|.+++....    .+++..+..++.|++.|++|||+.   +++||||||+||++++++.++++||.
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg  151 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFG  151 (267)
T ss_pred             EEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccC
Confidence            99999999999999997642    378899999999999999999998   99999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.86  E-value=4e-21  Score=185.34  Aligned_cols=143  Identities=29%  Similarity=0.407  Sum_probs=125.9

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      +.|+..+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.+++.++|||++++++.+......++||||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            45777889999999999999875 58899999986432 22344688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++++|...+.+..   ..+++..+..++.|++.|++|||+.   +++||||||+||+++.+++++++||.
T Consensus        91 ~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg  155 (292)
T cd06644          91 CPGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFG  155 (292)
T ss_pred             CCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCc
Confidence            99999988876532   2488999999999999999999998   99999999999999999999999996

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.86  E-value=1.3e-21  Score=187.69  Aligned_cols=143  Identities=24%  Similarity=0.397  Sum_probs=125.2

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc-chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      ++|+..+.||+|+||.||+|.+. +++.||+|.+....... ....+.+|+++++.++||||+++++++...+..+++||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            35777889999999999999985 58899999986543222 23468899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |++++++.++.....    .++|.+...++.|++.|++|||+.   +|+||||+|+||++++++.++++||.
T Consensus        81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg  145 (286)
T cd07846          81 FVDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFG  145 (286)
T ss_pred             cCCccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeee
Confidence            999999888765432    389999999999999999999998   99999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=3.4e-21  Score=187.94  Aligned_cols=146  Identities=29%  Similarity=0.328  Sum_probs=127.4

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc--chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|+..+.||+|+||.||+|... +++.||+|.+.......  ....+.+|++++..++||||+++++.+...+..+++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            35777889999999999999875 48899999986543222  3346889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||+.+++|.+++....  ...+++.....++.|++.||+|||+.   +++||||||+||+++.++.++++||.-
T Consensus        81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~  149 (316)
T cd05574          81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDL  149 (316)
T ss_pred             EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecch
Confidence            9999999999987532  23588999999999999999999999   999999999999999999999999863

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.86  E-value=2.2e-21  Score=186.93  Aligned_cols=154  Identities=31%  Similarity=0.409  Sum_probs=129.2

Q ss_pred             HHHHHHHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEeeC
Q 013682          278 LRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  355 (438)
Q Consensus       278 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  355 (438)
                      +.++..++++|+..+.||+|+||.||++... +++.+|+|.+....  .....+.+|+.++.++ +|||++++++++...
T Consensus        14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            3444556788999999999999999999874 68899999985432  2234677899999888 799999999998754


Q ss_pred             -----CeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcc
Q 013682          356 -----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  430 (438)
Q Consensus       356 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~  430 (438)
                           +..++||||+++|+|.++++........+++.....++.|++.||+|||+.   +|+||||||+||++++++.++
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~k  168 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVK  168 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEE
Confidence                 357999999999999998875333334589999999999999999999998   999999999999999999999


Q ss_pred             hhhhhh
Q 013682          431 SKTILR  436 (438)
Q Consensus       431 l~Df~~  436 (438)
                      ++||..
T Consensus       169 l~dfg~  174 (291)
T cd06639         169 LVDFGV  174 (291)
T ss_pred             Eeeccc
Confidence            999963

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.86  E-value=1.4e-21  Score=187.05  Aligned_cols=140  Identities=31%  Similarity=0.481  Sum_probs=122.9

Q ss_pred             CCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCC
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  366 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  366 (438)
                      |+..+.||+|+||.||+|... +++.||+|.++..........+.+|+.+++.++||||+++++++...+..++||||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            344567999999999999864 5789999998654333334468899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          367 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       367 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++|.+++...     .+++.....++.|++.|+.|||+.   +++|+||+|+||++++++.++++||.
T Consensus        86 ~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg  146 (277)
T cd06642          86 GGSALDLLKPG-----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFG  146 (277)
T ss_pred             CCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEcccc
Confidence            99999988642     378999999999999999999998   99999999999999999999999995

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.86  E-value=4.4e-21  Score=180.72  Aligned_cols=142  Identities=34%  Similarity=0.512  Sum_probs=124.8

Q ss_pred             CCCCccccccceEEEEEEeCC-----CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          289 SNKNILGRGGFGKVYKGRLAD-----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       289 ~~~~~LG~G~fG~Vy~~~~~~-----~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      +..+.||+|+||.||+++..+     +..||+|.++..........+..|+..+..++|+||+++++++...+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            456789999999999998753     378999999665433345578999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+++++|.+++......  .+++.+...++.|++.|++|||+.   +++||||||+||++++++.++++||.
T Consensus        82 ~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg  148 (258)
T smart00219       82 YMEGGDLLDYLRKNRPK--ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFG  148 (258)
T ss_pred             ccCCCCHHHHHHhhhhc--cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccC
Confidence            99999999998764321  179999999999999999999999   99999999999999999999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.86  E-value=2.2e-21  Score=191.68  Aligned_cols=143  Identities=24%  Similarity=0.334  Sum_probs=121.1

Q ss_pred             HhCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeC------
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV------  355 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------  355 (438)
                      ..++|+..+.||+|+||.||+|.. .+++.||||.++..... .....+.+|+.+++.++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            456788899999999999999986 46889999998653222 2234577899999999999999999887543      


Q ss_pred             CeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          356 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       356 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ...++++|++ +++|.+.+...     .+++..+..++.|++.||+|||++   +|+||||||+|||+++++.++++||.
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKCQ-----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence            3468999988 78998877532     388999999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.86  E-value=4.7e-21  Score=183.41  Aligned_cols=142  Identities=30%  Similarity=0.446  Sum_probs=125.0

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecC
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      .|+..+.||+|+||.||+|... +++.||+|.++..........+.+|+.+++.+.||||+++++++.+....++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            3556688999999999999875 588999999865433333457889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ++|+|.++++..     .+++.+...++.|++.|++|+|+.   +++|+||+|+||+++.++.++++||.-
T Consensus        85 ~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~  147 (277)
T cd06640          85 GGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGV  147 (277)
T ss_pred             CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEccccc
Confidence            999999988643     378889999999999999999998   999999999999999999999999963

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=4.3e-21  Score=183.17  Aligned_cols=142  Identities=30%  Similarity=0.400  Sum_probs=126.9

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecC
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      +|+..+.||.|+||.||+|+.. +++.||+|.+...........+.+|+.+++.++|+|++++++++.+....++++||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            5677788999999999999875 588999999865433334456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ++++|.++++..     ++++.....++.|++.|+.|||+.   +++||||+|+||+++++++++++||.-
T Consensus        82 ~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~  144 (274)
T cd06609          82 GGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGV  144 (274)
T ss_pred             CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccccc
Confidence            999999998753     489999999999999999999998   999999999999999999999999963

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.86  E-value=2.2e-21  Score=184.55  Aligned_cols=141  Identities=32%  Similarity=0.492  Sum_probs=120.6

Q ss_pred             CccccccceEEEEEEeCC-------CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          292 NILGRGGFGKVYKGRLAD-------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~-------~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      +.||+|+||.||+|+..+       ++.+|+|.+...........+.+|+.+++.++||||+++++++...+..+++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998642       2579999886543333445789999999999999999999999998999999999


Q ss_pred             CCCCCHHHHhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC-----Ccchhhhh
Q 013682          365 MTNGSVASRLRERQS---SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-----DQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~-----~~~l~Df~  435 (438)
                      +++++|.++++....   ....++|.++..++.|++.|++|||+.   +++|+||||+||+++.++     .++++||.
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            999999999976422   123478999999999999999999998   999999999999999887     88999986

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.85  E-value=6.8e-21  Score=179.52  Aligned_cols=142  Identities=30%  Similarity=0.454  Sum_probs=127.7

Q ss_pred             hCCCCCCCccccccceEEEEEEeCC-CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~~-~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .++|+..+.||+|+||.||+|...+ ++.+|+|.++....   ..++.+|+.+++.++|||++++++++......++++|
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e   78 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME   78 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence            3578888999999999999999864 78999999865422   4579999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+.+++|.+++....   ..+++.....++.|++.|+.|||+.   +++||||+|+||++++++.++++||.
T Consensus        79 ~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg  144 (256)
T cd06612          79 YCGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFG  144 (256)
T ss_pred             cCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccc
Confidence            999999999987543   2489999999999999999999999   99999999999999999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.85  E-value=8.1e-21  Score=180.00  Aligned_cols=146  Identities=29%  Similarity=0.421  Sum_probs=128.7

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      ++|+..+.||+|+||.||+|... ++..+|+|++...........+.+|+..++.++|+|++++++.+...+..+++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46788899999999999999864 57899999986544333445789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++++|.+.++.... ...+++.....++.|++.|++|||+.   +|+||||||+||++++++..+++||.
T Consensus        81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~  147 (267)
T cd06610          81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFG  147 (267)
T ss_pred             cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccc
Confidence            999999999976432 13478999999999999999999999   99999999999999999999999996

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=7.1e-21  Score=180.03  Aligned_cols=144  Identities=31%  Similarity=0.451  Sum_probs=127.5

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .++|+..+.||+|+||.||+|... +++.+|+|.++..... ....+.+|+.+++.++||||+++++++...+..+++||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e   80 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME   80 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence            356788899999999999999874 5788999998654322 34578999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+++++|.+++....   ..+++.+...++.|++.|++|||++   +|+|+||||+||++++++.++++||.
T Consensus        81 ~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g  146 (262)
T cd06613          81 YCGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFG  146 (262)
T ss_pred             CCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccc
Confidence            999999999887642   2478999999999999999999998   99999999999999999999999995

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.85  E-value=5.1e-21  Score=183.57  Aligned_cols=141  Identities=30%  Similarity=0.454  Sum_probs=122.7

Q ss_pred             CCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCC
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  366 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  366 (438)
                      |+..+.||+|+||.||+|+.. ++..+|+|.+.... ......+.+|+.+++.++|||++++++++...+..+++|||++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            345577999999999999875 47788999885432 2233468899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          367 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       367 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++|...+....   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++||.
T Consensus        86 ~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg  148 (282)
T cd06643          86 GGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFG  148 (282)
T ss_pred             CCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccc
Confidence            999998876532   2489999999999999999999998   99999999999999999999999996

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=6.1e-21  Score=182.32  Aligned_cols=141  Identities=26%  Similarity=0.439  Sum_probs=124.9

Q ss_pred             CCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCC---CCCceeeEEEEeeCCeeEEEE
Q 013682          287 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV---HRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv~  362 (438)
                      .|+..+.||+|+||.||+|.. .+++.||+|.++.........++.+|+.+++.++   |||++++++++......+++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            356678899999999999997 4688999999865433344457889999998886   999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++++|.++++..     .+++.....++.|++.|+.|||+.   +|+||||+|+||++++++.++++||.
T Consensus        82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg  146 (277)
T cd06917          82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFG  146 (277)
T ss_pred             ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCC
Confidence            999999999988653     488999999999999999999999   99999999999999999999999996

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.85  E-value=4.1e-21  Score=181.24  Aligned_cols=140  Identities=30%  Similarity=0.480  Sum_probs=121.9

Q ss_pred             CCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecC
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      ++|+..+.||+|+||.||++.. +++.||+|.++...   ....+.+|+.++..++|||++++++++.. +..+++|||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECC
Confidence            3577788999999999999975 57789999986532   23468899999999999999999999865 4579999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++++|.++++....  ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++++||.
T Consensus        81 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg  145 (254)
T cd05083          81 SKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFG  145 (254)
T ss_pred             CCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCc
Confidence            99999999976432  2478999999999999999999998   99999999999999999999999996

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.85  E-value=2.5e-21  Score=192.26  Aligned_cols=143  Identities=22%  Similarity=0.284  Sum_probs=120.4

Q ss_pred             HhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeC------
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV------  355 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------  355 (438)
                      ..++|+..+.||+|+||.||++... .++.||||.++..... .....+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4568888999999999999999864 5889999998654322 2234678899999999999999999988643      


Q ss_pred             CeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          356 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       356 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ...+++|||+++ ++.+.+..      .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++++||.
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence            346899999975 66666643      278889999999999999999999   99999999999999999999999996


Q ss_pred             h
Q 013682          436 R  436 (438)
Q Consensus       436 ~  436 (438)
                      -
T Consensus       165 ~  165 (355)
T cd07874         165 L  165 (355)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.85  E-value=4.1e-21  Score=184.84  Aligned_cols=147  Identities=27%  Similarity=0.349  Sum_probs=125.4

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeC--CeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~  362 (438)
                      ++|...+.||+|++|.||++... +++.+|+|.+...........+.+|+++++.++||||+++++++...  ...+++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            35777789999999999999974 57899999986543333345789999999999999999999988653  4679999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++++|.+++.........+++.....++.|++.||+|||+.   +++|+||+|+||++++++.++++||.
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg  150 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFG  150 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecc
Confidence            99999999988765333334578889999999999999999998   99999999999999999999999995

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.85  E-value=1.6e-21  Score=184.68  Aligned_cols=137  Identities=25%  Similarity=0.395  Sum_probs=115.7

Q ss_pred             CccccccceEEEEEEeCC--------CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          292 NILGRGGFGKVYKGRLAD--------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~--------~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      +.||+|+||.||+|....        ...||+|.+.... ......+.+|+.+++.++|||++++++++...+..++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence            358999999999998632        2348888875432 2223468889999999999999999999999899999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCc--------chhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ--------SSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~--------~l~Df~  435 (438)
                      |+++|+|.++++....   .+++.....++.|++.|++|||+.   +|+||||||+||+++.+++.        +++||.
T Consensus        80 ~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          80 YVKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             cCCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence            9999999999976532   478999999999999999999998   99999999999999988764        777775

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.85  E-value=5.9e-21  Score=183.49  Aligned_cols=143  Identities=29%  Similarity=0.464  Sum_probs=117.5

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccc-hHHHHHHHHHHhcC---CCCCceeeEEEEee-----CC
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG-ELQFQTEVKIISMA---VHRNLLRLYGFCTT-----VT  356 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~-~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----~~  356 (438)
                      +|+..+.||+|+||.||+|+.. +++.||+|.++....... ...+.+|+.++..+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            3667788999999999999875 688999999865432222 23466777776655   79999999998864     24


Q ss_pred             eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          357 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ..+++|||+. ++|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++++||.
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg  153 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFG  153 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccC
Confidence            4789999998 488888875422  3488999999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.85  E-value=6.1e-21  Score=184.05  Aligned_cols=146  Identities=25%  Similarity=0.388  Sum_probs=122.8

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc-chHHHHHHHHHHhcCC-CCCceeeEEEEeeCCe-----
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAV-HRNLLRLYGFCTTVTE-----  357 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~-----  357 (438)
                      ++|+..+.||+|+||.||+|... +++.||+|.++...... ....+.+|+.+++.+. ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            35778899999999999999875 68899999886543222 2346888999999995 6999999999887665     


Q ss_pred             eEEEEecCCCCCHHHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC-CCCcchhhhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSS-LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTIL  435 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~-~~~~~l~Df~  435 (438)
                      .+++|||+++ ++.+++...... ...+++.....++.|++.||+|||+.   +|+||||||+||+++. ++.++++||.
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999985 888887654322 34589999999999999999999999   9999999999999999 8899999986

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.85  E-value=5.7e-21  Score=181.41  Aligned_cols=143  Identities=29%  Similarity=0.423  Sum_probs=124.1

Q ss_pred             CCCCCCccccccceEEEEEEe-CCCCEEEEEEcccccccc-----chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          287 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-----GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      +|+..+.||+|+||.||+|.. .+++.||+|.++......     ....+.+|+.++++++|+||+++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            467778999999999999986 468899999986432111     12468899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC-Ccchhhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTILR  436 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~-~~~l~Df~~  436 (438)
                      +|||+++++|.+++.+..    ++++.....++.|++.|++|||+.   +++||||||+||+++.++ .++++||..
T Consensus        81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~  150 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGA  150 (268)
T ss_pred             EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccc
Confidence            999999999999987642    478999999999999999999999   999999999999999876 589999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.85  E-value=1.1e-21  Score=196.12  Aligned_cols=140  Identities=26%  Similarity=0.429  Sum_probs=119.7

Q ss_pred             CCccccccceEEEEEEeC-CCCEEEEEEccccc---cccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCe--eEEEEec
Q 013682          291 KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER---TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE--KLLVYPY  364 (438)
Q Consensus       291 ~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lv~e~  364 (438)
                      ..+||+|+|-+||||... +|..||.-.++-..   .+.....|..|+++++.++|||||+++..+.+...  .-+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            467999999999999864 57788866554322   22233579999999999999999999999988655  6789999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC-CCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~-~~~~l~Df~  435 (438)
                      +..|+|..+.++.+.    ++......+++||.+||.|||++ .|+|||||||.+||+|+.+ |++||||++
T Consensus       125 ~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLG  191 (632)
T KOG0584|consen  125 FTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLG  191 (632)
T ss_pred             ccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchh
Confidence            999999999987653    77788999999999999999998 8899999999999999987 899999985

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.85  E-value=4.4e-21  Score=181.90  Aligned_cols=144  Identities=31%  Similarity=0.396  Sum_probs=127.5

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecC
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      +|+..+.||+|+||.||++... +++.+|+|.+..........++.+|+..++.++||||+++++.+...+..++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5666788999999999999875 688999999876543344457899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ++++|.+++....   ..+++.....++.|++.|++|||+ .   +++||||||+||++++++.++++||..
T Consensus        82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~  147 (265)
T cd06605          82 DGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGV  147 (265)
T ss_pred             CCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence            9999999987643   357888999999999999999999 7   999999999999999999999999963

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.85  E-value=6.1e-21  Score=182.98  Aligned_cols=142  Identities=26%  Similarity=0.392  Sum_probs=125.7

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc-ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      +|+..+.||+|+||.||+|+.. +++.||+|+++.... ......+.+|+.+++.++|||++++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            3667788999999999999874 688999999865432 22234789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      + +++|.+++....   ..+++.++..++.|++.||+|||+.   +++|+||||+||++++++.++++||.
T Consensus        81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg  144 (286)
T cd07832          81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFG  144 (286)
T ss_pred             c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeee
Confidence            9 999999987643   3489999999999999999999998   99999999999999999999999996

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.85  E-value=9.8e-22  Score=181.85  Aligned_cols=144  Identities=25%  Similarity=0.393  Sum_probs=123.3

Q ss_pred             HHHHHHHhCCCCCCCccccccceEEEEEE-eCCCCEEEEEEccccccccchHHHHHHHHHHhcCC-CCCceeeEEEEeeC
Q 013682          278 LRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTV  355 (438)
Q Consensus       278 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~  355 (438)
                      +++.-..++     +.||+|+|+.|--+. ..++..+|||++.+. ......+..+|++++...+ |+||+.++.+|+++
T Consensus        75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            445444444     679999999999886 468999999999654 2333457889999988775 99999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC---Ccchh
Q 013682          356 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSK  432 (438)
Q Consensus       356 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~---~~~l~  432 (438)
                      +..|||||-|.||+|.+.+.++..    +++.++.++..+||.||.|||.+   +|.||||||+|||..+-.   .+||+
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~~~----F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiC  221 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKRKH----FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKIC  221 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHhhh----ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeee
Confidence            999999999999999999987653    89999999999999999999999   999999999999997643   56899


Q ss_pred             hh
Q 013682          433 TI  434 (438)
Q Consensus       433 Df  434 (438)
                      ||
T Consensus       222 Df  223 (463)
T KOG0607|consen  222 DF  223 (463)
T ss_pred             cc
Confidence            88

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.85  E-value=1.2e-20  Score=179.30  Aligned_cols=143  Identities=27%  Similarity=0.436  Sum_probs=122.6

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc----cchHHHHHHHHHHhcCCCCCceeeEEEEee--CCee
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS----GGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEK  358 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~  358 (438)
                      .+|+..+.||+|+||.||+|... +++.||+|.++.....    .....+.+|+.+++.++||||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36788899999999999999864 5889999988543211    112358889999999999999999998865  3567


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++++||+++++|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+||++++++.++++||.
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg  151 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG  151 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCC
Confidence            89999999999999987643    378899999999999999999998   99999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.85  E-value=9.5e-21  Score=179.22  Aligned_cols=143  Identities=29%  Similarity=0.436  Sum_probs=128.1

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      ++|+..+.||+|++|.||+|+.. +++.||+|.+...........+.+|+..+..++|+|++++++++...+..+++|||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            35777899999999999999875 58999999986654333345799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++++|.+++...    ..+++.....++.|+++|++|||+ .   +++||||+|+||+++.++.++++||.
T Consensus        81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~  145 (264)
T cd06623          81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFG  145 (264)
T ss_pred             cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCc
Confidence            9999999999764    248899999999999999999999 8   99999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.85  E-value=7.5e-21  Score=180.07  Aligned_cols=142  Identities=30%  Similarity=0.479  Sum_probs=125.8

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      +|+..+.||+|+||.||+|... +++.||+|.++..... .....+.+|+.+++.++|+||+++++.+...+..++++||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            3667789999999999999864 6889999998654332 2344789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++++|.+++....    .+++..+..++.+++.|++|||+.   +|+|+||||+||++++++.++++||.
T Consensus        81 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g  144 (264)
T cd06626          81 CSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFG  144 (264)
T ss_pred             CCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccc
Confidence            99999999987642    378889999999999999999999   99999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.85  E-value=4.9e-21  Score=190.90  Aligned_cols=142  Identities=22%  Similarity=0.279  Sum_probs=120.0

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeC------C
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV------T  356 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~  356 (438)
                      .++|+..+.||+|+||.||+|... .++.||||+++..... .....+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            467888899999999999999864 5889999998654322 2234678899999999999999999987543      3


Q ss_pred             eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          357 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ..++||||+++ ++.+.+..      .+++..+..++.|++.||+|||++   +|+||||||+|||+++++.++++||.-
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence            56999999975 67777643      278889999999999999999999   999999999999999999999999963

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.85  E-value=6.2e-21  Score=184.04  Aligned_cols=143  Identities=25%  Similarity=0.400  Sum_probs=123.8

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccc-hHHHHHHHHHHhcCCCCCceeeEEEEeeC--CeeEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLLV  361 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv  361 (438)
                      ++|+..+.||+|+||.||+|... +++.+|+|.++....... ...+.+|+.++..++||||+++++++...  ...+++
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46777889999999999999975 588999999875432222 23577899999999999999999998877  889999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |||+. ++|.+.+.....   .+++.+...++.|++.||+|||+.   +++||||||+||++++++.++++||.
T Consensus        85 ~e~~~-~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g  151 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQ---PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFG  151 (293)
T ss_pred             ehhcC-cCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecC
Confidence            99997 599888875432   489999999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.85  E-value=8.2e-21  Score=185.35  Aligned_cols=138  Identities=22%  Similarity=0.339  Sum_probs=113.5

Q ss_pred             CCccccccceEEEEEEeC---CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEee--CCeeEEEEecC
Q 013682          291 KNILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEKLLVYPYM  365 (438)
Q Consensus       291 ~~~LG~G~fG~Vy~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~e~~  365 (438)
                      .+.||+|+||.||+|+..   +++.||+|.++...   ....+.+|+.+++.++||||+++++++..  ....+++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            467999999999999864   46789999986432   22357899999999999999999998854  45678999998


Q ss_pred             CCCCHHHHhhccCC-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee----CCCCCcchhhhh
Q 013682          366 TNGSVASRLRERQS-----SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL----DEDADQSSKTIL  435 (438)
Q Consensus       366 ~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILl----d~~~~~~l~Df~  435 (438)
                      . ++|.+++.....     ....+++.....++.|++.||+|||++   +|+||||||+|||+    +.++.++++||+
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            6 588887754321     122478899999999999999999999   99999999999999    456789999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.85  E-value=3.2e-21  Score=207.73  Aligned_cols=154  Identities=16%  Similarity=0.265  Sum_probs=126.2

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEee--CCe
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTE  357 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~  357 (438)
                      ....++|...+.||+|+||.||+|+.. ++..||+|.++..... .....+..|+.++..++|||||++++++..  ...
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            445678888999999999999999875 5778999988643222 223468899999999999999999998855  356


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC----CCceecCCCCCCeeeCCC-------
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD----PKIIHRDVKAANILLDED-------  426 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivHrDLK~~NILld~~-------  426 (438)
                      .++||||+++|+|.+++.........+++..+..|+.||+.||+|||+...    .+||||||||+|||++.+       
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            899999999999999997643333458999999999999999999998521    259999999999999653       


Q ss_pred             ----------CCcchhhhh
Q 013682          427 ----------ADQSSKTIL  435 (438)
Q Consensus       427 ----------~~~~l~Df~  435 (438)
                                +.++|+||+
T Consensus       169 ~~~~~n~ng~~iVKLsDFG  187 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFG  187 (1021)
T ss_pred             cccccccCCCCceEEccCC
Confidence                      347999996

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.85  E-value=4.4e-21  Score=193.21  Aligned_cols=137  Identities=25%  Similarity=0.283  Sum_probs=120.4

Q ss_pred             hCCCCCCCccccccceEEEEEEeC---CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      ..+|...+.||+|+||.||++...   .++.||+|.+...      ....+|+.+++.++|||||++++++......+++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            457888899999999999999753   3578999987542      2356899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |||+. ++|.+++...    ..+++.++..++.|++.||+|||++   +|+||||||+|||++.++.++|+||+
T Consensus       165 ~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG  230 (392)
T PHA03207        165 MPKYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFG  230 (392)
T ss_pred             ehhcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCc
Confidence            99996 6888888433    2489999999999999999999999   99999999999999999999999996

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.85  E-value=8.1e-21  Score=179.50  Aligned_cols=149  Identities=23%  Similarity=0.336  Sum_probs=124.3

Q ss_pred             CCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEee--CCeeEEEE
Q 013682          287 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEKLLVY  362 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~  362 (438)
                      +|+..+.||+|+||.||++.. .+++.||+|.++..... .....+..|+.+++.++|||++++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            366778899999999999986 46789999998653322 223468889999999999999999998764  44578999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC--DPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++++|.+++.........+++.....++.|++.|++|||..+  ..+++|+||||+||++++++.++++||.
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g  155 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFG  155 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccc
Confidence            999999999999765444456899999999999999999999322  2399999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.85  E-value=2.2e-22  Score=184.72  Aligned_cols=139  Identities=28%  Similarity=0.467  Sum_probs=124.9

Q ss_pred             CCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCC
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  366 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  366 (438)
                      |.....||+|+||.||+|.++ .|+.+|+|.+..+   ...+++..|+.+|+.++.|++|++||.|......|+|||||-
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~---sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD---TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc---chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            444578999999999999875 6999999998653   344578999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          367 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       367 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      .|+..+.++.+..   ++++.+...+......||+|||..   .-||||||+.|||++.+|.+|++||+
T Consensus       112 AGSiSDI~R~R~K---~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFG  174 (502)
T KOG0574|consen  112 AGSISDIMRARRK---PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFG  174 (502)
T ss_pred             CCcHHHHHHHhcC---CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhcc
Confidence            9999999987543   589999999999999999999998   78999999999999999999999996

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.85  E-value=8e-21  Score=182.97  Aligned_cols=142  Identities=27%  Similarity=0.332  Sum_probs=122.7

Q ss_pred             CCCCCCccccccceEEEEEEe----CCCCEEEEEEcccccc---ccchHHHHHHHHHHhcC-CCCCceeeEEEEeeCCee
Q 013682          287 GFSNKNILGRGGFGKVYKGRL----ADGKLVAVKRLKEERT---SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEK  358 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~----~~~~~vAvK~l~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  358 (438)
                      +|+..+.||+|+||.||+++.    .+|+.||+|+++....   ......+.+|+.++..+ +|+||+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            366778899999999999985    3688999999865322   11234578899999999 599999999999988899


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++||||+++++|.+++....    .+++.....++.|++.||+|||+.   +++||||||+|||+++++.++++||.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg  150 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG  150 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCc
Confidence            99999999999999987643    378889999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=1e-20  Score=179.68  Aligned_cols=143  Identities=27%  Similarity=0.433  Sum_probs=122.3

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc----ccchHHHHHHHHHHhcCCCCCceeeEEEEeeC--Cee
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT----SGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEK  358 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~  358 (438)
                      .+|...+.||+|+||.||+|+.. +++.||+|.+.....    ......+.+|+++++.++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46778899999999999999864 688999998743211    12223688999999999999999999998764  457


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++++||+++++|.+++....    .+++.....++.|++.|+.|||+.   +++||||||+||++++++.++++||.
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg  151 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG  151 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccc
Confidence            89999999999999987542    378889999999999999999999   99999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.85  E-value=1.3e-20  Score=179.48  Aligned_cols=145  Identities=27%  Similarity=0.400  Sum_probs=119.4

Q ss_pred             CCCCCccccccceEEEEEEeC----CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCC------
Q 013682          288 FSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT------  356 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~----~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  356 (438)
                      |...+.||+|+||.||+|.+.    +++.||||.++..... ....++.+|+.++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            455678999999999999853    3678999998654322 22346889999999999999999999886532      


Q ss_pred             eeEEEEecCCCCCHHHHhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhh
Q 013682          357 EKLLVYPYMTNGSVASRLRERQ--SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  434 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df  434 (438)
                      ..++++||+.+|+|..++....  .....+++.....++.|++.|++|||+.   +|+||||||+||++++++.++++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            2478899999999998875422  1123478899999999999999999998   9999999999999999999999999


Q ss_pred             h
Q 013682          435 L  435 (438)
Q Consensus       435 ~  435 (438)
                      .
T Consensus       158 g  158 (273)
T cd05074         158 G  158 (273)
T ss_pred             c
Confidence            6

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.85  E-value=1.2e-20  Score=180.59  Aligned_cols=137  Identities=28%  Similarity=0.395  Sum_probs=119.9

Q ss_pred             cccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCCCH
Q 013682          294 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  370 (438)
Q Consensus       294 LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  370 (438)
                      ||+|+||+||++... +++.||+|.+.....  ......+.+|+++++.++|||++++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999864 688999999864321  22234577899999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          371 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       371 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      .+++.....  ..+++.++..++.|++.|+.|||+.   +++||||||+||++++++.++++||.
T Consensus        81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg  140 (277)
T cd05577          81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLG  140 (277)
T ss_pred             HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCc
Confidence            999876532  3488999999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.85  E-value=8.4e-21  Score=183.78  Aligned_cols=141  Identities=21%  Similarity=0.363  Sum_probs=125.7

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      .+|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+..++.++|||++++++++...+..++|+||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            4577788999999999999986 468899999886432 22344688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++++|.+++...     .+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++++||.
T Consensus        98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg  160 (296)
T cd06655          98 LAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFG  160 (296)
T ss_pred             cCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCc
Confidence            9999999988653     378999999999999999999999   99999999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.85  E-value=3.6e-21  Score=181.99  Aligned_cols=142  Identities=26%  Similarity=0.350  Sum_probs=125.9

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc--cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      +|+..+.||+|+||.||+|+.. +++.||+|.+......  .....+.+|+++++.++||||+++++.+.+....++++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4667789999999999999875 5889999998654322  234578999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+.+++|..++...    ..+++.....++.|+++||.|||+.   +++|+||||+||++++++.++++||.
T Consensus        81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~  145 (258)
T cd05578          81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFN  145 (258)
T ss_pred             CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecc
Confidence            99999999998764    2488999999999999999999998   99999999999999999999999985

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.85  E-value=1e-21  Score=178.29  Aligned_cols=145  Identities=26%  Similarity=0.351  Sum_probs=124.0

Q ss_pred             HhCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccc---h----HHHHHHHHHHhcC-CCCCceeeEEEEee
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGG---E----LQFQTEVKIISMA-VHRNLLRLYGFCTT  354 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~---~----~~~~~E~~~l~~l-~H~niv~l~g~~~~  354 (438)
                      .-+.|...+.+|.|..+.|.++.. .+++.+|+|++....+...   .    +.-.+|+.+++++ .||+|+.+.+++++
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            345677788999999999988865 4688999998854332111   1    1345788999877 59999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhh
Q 013682          355 VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  434 (438)
Q Consensus       355 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df  434 (438)
                      +...++|+|.|+.|.|.++|....    .+++.+..+|+.|+.+|++|||..   +||||||||+|||+|++.+.+|+||
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~V----tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKV----TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhhe----eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence            999999999999999999997654    489999999999999999999999   9999999999999999999999999


Q ss_pred             h
Q 013682          435 L  435 (438)
Q Consensus       435 ~  435 (438)
                      +
T Consensus       168 G  168 (411)
T KOG0599|consen  168 G  168 (411)
T ss_pred             c
Confidence            6

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.84  E-value=1.3e-20  Score=177.72  Aligned_cols=145  Identities=20%  Similarity=0.293  Sum_probs=125.9

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc-ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      +|+..+.||+|+||.||+++.. +++.||+|.+..... .....++.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            3677789999999999999864 688999999864322 22334788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      +++++|.+.+.....  ..+++.+...++.|++.|++|||+.   +++|+||+|+||+++.+++++++||..
T Consensus        81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~  147 (256)
T cd08218          81 CEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGI  147 (256)
T ss_pred             CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccc
Confidence            999999999875422  2478899999999999999999998   999999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.84  E-value=5.1e-21  Score=183.55  Aligned_cols=141  Identities=21%  Similarity=0.416  Sum_probs=122.2

Q ss_pred             CCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc-chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecC
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      |+..+.||+|+||.||+|+.. +|+.||+|.++...... ....+.+|+++++.++|||++++++++.+....++++||+
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC   81 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence            666788999999999999875 68899999986543222 2235788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      + ++|.+++....   ..+++..+..++.|+++||.|||+.   +|+||||||+||+++.+++++++||.
T Consensus        82 ~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg  144 (284)
T cd07839          82 D-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFG  144 (284)
T ss_pred             C-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccc
Confidence            7 57888776532   2489999999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.84  E-value=1.3e-20  Score=179.29  Aligned_cols=147  Identities=32%  Similarity=0.440  Sum_probs=127.3

Q ss_pred             HhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEeeCC-----
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVT-----  356 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~-----  356 (438)
                      ++++|+..+.||+|+||.||+|... +++.+|+|.++...  .....+.+|+.+++++ +|+||+++++++....     
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            4678999999999999999999975 57899999886532  2334689999999998 6999999999997644     


Q ss_pred             -eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          357 -EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       357 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                       ..+++|||+++++|.++++........+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++++||.
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence             47999999999999999876432334689999999999999999999999   99999999999999999999999995

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=7.1e-21  Score=187.23  Aligned_cols=136  Identities=20%  Similarity=0.198  Sum_probs=107.8

Q ss_pred             HHhCCCCCCCccccccceEEEEEEeC--CCCEEEEEEcccccc----ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCC
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRLA--DGKLVAVKRLKEERT----SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT  356 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~~--~~~~vAvK~l~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  356 (438)
                      ...++|...+.||+|+||+||+|++.  +++.||||++.....    ......|.+|+.++..++|+|+++.+..   .+
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence            34567999999999999999999864  577789998643211    1123468999999999999999853322   24


Q ss_pred             eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCC-CCCCeeeCCCCCcchhhhh
Q 013682          357 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV-KAANILLDEDADQSSKTIL  435 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDL-K~~NILld~~~~~~l~Df~  435 (438)
                      ..++||||+++++|.. ...       ..   ...++.++++||+|||++   +|+|||| ||+|||++.++.++|+||+
T Consensus        92 ~~~LVmE~~~G~~L~~-~~~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG  157 (365)
T PRK09188         92 KDGLVRGWTEGVPLHL-ARP-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ  157 (365)
T ss_pred             CcEEEEEccCCCCHHH-hCc-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence            5799999999999962 211       01   145678999999999999   9999999 9999999999999999996

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.84  E-value=1.4e-20  Score=180.58  Aligned_cols=136  Identities=28%  Similarity=0.343  Sum_probs=113.9

Q ss_pred             ccccccceEEEEEEeC-CCCEEEEEEccccccccc--hHHHHHHHHHH---hcCCCCCceeeEEEEeeCCeeEEEEecCC
Q 013682          293 ILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG--ELQFQTEVKII---SMAVHRNLLRLYGFCTTVTEKLLVYPYMT  366 (438)
Q Consensus       293 ~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~--~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lv~e~~~  366 (438)
                      .||+|+||.||++... +++.+|+|.+........  ...+.+|..++   ...+|||++.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999874 588999998865432211  22344454333   34579999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          367 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       367 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +|+|.+++....    .+++.....++.|++.|++|||+.   +|+||||||+|||+++++.++++||.
T Consensus        81 ~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg  142 (279)
T cd05633          81 GGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLG  142 (279)
T ss_pred             CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCC
Confidence            999999887543    489999999999999999999999   99999999999999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.84  E-value=8e-21  Score=182.20  Aligned_cols=143  Identities=22%  Similarity=0.424  Sum_probs=124.4

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc-chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      +|+..+.||+|+||.||+|+.. +++.||||.++...... ....+.+|++++++++||||+++++++...+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4677889999999999999874 68899999986543222 234688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +. ++|.+++.....  ..+++.....++.|++.|++|||+.   +++||||+|+||++++++.++++||.
T Consensus        81 ~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg  145 (284)
T cd07860          81 LH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFG  145 (284)
T ss_pred             cc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence            96 689888865432  3488999999999999999999998   99999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.84  E-value=7.2e-23  Score=183.11  Aligned_cols=145  Identities=23%  Similarity=0.315  Sum_probs=123.8

Q ss_pred             HhCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccc-cccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      ..+.|+..+.||+|+|+.||++.. .+|+.+|+|.+.... +..+.+++.+|+.+.+.++|||||++...+.+....|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            356677778999999999999875 468889999875332 233556799999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC---CCcchhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED---ADQSSKTIL  435 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~---~~~~l~Df~  435 (438)
                      +|+|+|++|..-+-.+.    .+++..+-.+.+||.+||.|+|.+   +|||||+||+|+|+.+.   .-+|++||+
T Consensus        89 Fe~m~G~dl~~eIV~R~----~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FG  158 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVARE----FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFG  158 (355)
T ss_pred             EecccchHHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccc
Confidence            99999999987776542    378888999999999999999999   99999999999999754   356999996

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=4.2e-22  Score=191.55  Aligned_cols=142  Identities=33%  Similarity=0.447  Sum_probs=127.6

Q ss_pred             CCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecC
Q 013682          287 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      .|...+.||+|+||.||+|.. .+++.||+|++.-+...+...+.++|+.++..++++||.+++|.+......+++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            456668899999999999986 4688999999987766666678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      .+|++.+.++...    .+++....-+..++..|+.|||++   +.+|||||+.|||+..+|+++++||+
T Consensus        94 ~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~Dfg  156 (467)
T KOG0201|consen   94 GGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFG  156 (467)
T ss_pred             cCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecc
Confidence            9999999997643    246667777889999999999999   99999999999999999999999996

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.84  E-value=2.1e-20  Score=179.62  Aligned_cols=144  Identities=27%  Similarity=0.433  Sum_probs=128.9

Q ss_pred             HhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      .++.|+..+.+|+|+||.||+|... +++.||+|.++....  ....+.+|+..++.++|+|++++++++...+..++++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            4556777789999999999999976 688999999865432  3456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++++|.+++....   ..+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.++++||.
T Consensus        95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~  161 (286)
T cd06614          95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFG  161 (286)
T ss_pred             eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccc
Confidence            9999999999998753   2589999999999999999999998   99999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.84  E-value=1.6e-20  Score=178.64  Aligned_cols=147  Identities=24%  Similarity=0.340  Sum_probs=122.1

Q ss_pred             CCCCCCccccccceEEEEEEeCC--CCEEEEEEcccccc---------ccchHHHHHHHHHHhc-CCCCCceeeEEEEee
Q 013682          287 GFSNKNILGRGGFGKVYKGRLAD--GKLVAVKRLKEERT---------SGGELQFQTEVKIISM-AVHRNLLRLYGFCTT  354 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~~--~~~vAvK~l~~~~~---------~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~  354 (438)
                      +|+..+.||+|+||.||+|....  ++.+|+|.+.....         .....++.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            46677889999999999999754  67899998753221         1112346778887764 799999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceecCCCCCCeeeCCCCCcchhh
Q 013682          355 VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKT  433 (438)
Q Consensus       355 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDLK~~NILld~~~~~~l~D  433 (438)
                      .+..+++|||+++++|.+++.........+++.....++.|++.|+.|||+ .   +++||||||+||++++++.++++|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence            999999999999999999886533333458899999999999999999996 5   799999999999999999999999


Q ss_pred             hhh
Q 013682          434 ILR  436 (438)
Q Consensus       434 f~~  436 (438)
                      |.-
T Consensus       158 fg~  160 (269)
T cd08528         158 FGL  160 (269)
T ss_pred             ccc
Confidence            973

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=3.4e-21  Score=187.87  Aligned_cols=142  Identities=25%  Similarity=0.338  Sum_probs=125.1

Q ss_pred             CCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccc-hHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecC
Q 013682          288 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      |...+.||+|.|++|-.|++ -+|..||||++.+...+.. ...+..|+.+|+.++|||||++|.+..+....|||+|+=
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG   99 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG   99 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence            66678899999999999985 4799999999966543322 236789999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC-CCcchhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTIL  435 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~-~~~~l~Df~  435 (438)
                      .+|+|++++-++..   .+.+..+.+++.||..|+.|+|..   ++|||||||+||.+-+. |-+|+.||+
T Consensus       100 D~GDl~DyImKHe~---Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFG  164 (864)
T KOG4717|consen  100 DGGDLFDYIMKHEE---GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFG  164 (864)
T ss_pred             CCchHHHHHHhhhc---cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeecc
Confidence            99999999987644   378899999999999999999998   99999999999988765 789999996

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.84  E-value=1.5e-20  Score=181.89  Aligned_cols=146  Identities=29%  Similarity=0.449  Sum_probs=124.3

Q ss_pred             HHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCC----
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT----  356 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----  356 (438)
                      ...++|+..+.||+|+||.||+|... +++.||+|.++..... .....+.+|+.+++.++|||++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45677888999999999999999975 5889999998654322 22346788999999999999999999987654    


Q ss_pred             ------eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcc
Q 013682          357 ------EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  430 (438)
Q Consensus       357 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~  430 (438)
                            ..++++||+++ ++...+...   ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence                  68999999986 777776543   22489999999999999999999999   999999999999999999999


Q ss_pred             hhhhh
Q 013682          431 SKTIL  435 (438)
Q Consensus       431 l~Df~  435 (438)
                      ++||.
T Consensus       157 l~dfg  161 (302)
T cd07864         157 LADFG  161 (302)
T ss_pred             eCccc
Confidence            99996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.84  E-value=1.7e-20  Score=184.33  Aligned_cols=139  Identities=29%  Similarity=0.408  Sum_probs=119.5

Q ss_pred             Cccccc--cceEEEEEEeC-CCCEEEEEEcccccccc-chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCC
Q 013682          292 NILGRG--GFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  367 (438)
Q Consensus       292 ~~LG~G--~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  367 (438)
                      ..||+|  +||+||+|+.. +++.||+|.++...... ....+.+|+.+++.++||||+++++++...+..++++||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  99999999874 68999999986543222 234688999999999999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          368 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++.++++....  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..+++||.
T Consensus        84 ~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~  146 (328)
T cd08226          84 GSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLS  146 (328)
T ss_pred             CCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechH
Confidence            999999876432  2478899999999999999999998   99999999999999999999999884

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.84  E-value=2.4e-20  Score=175.98  Aligned_cols=144  Identities=23%  Similarity=0.325  Sum_probs=123.1

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEee-CCeeEEEEe
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTEKLLVYP  363 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e  363 (438)
                      +|+..+.||+|+||.||++... +++.||+|.++..... .....+.+|+.++++++|+|++++++.+.. ....+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4677889999999999999864 5789999998643322 223468899999999999999999988764 445789999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+++++|.++++....  ..+++.++..++.+++.|++|||+.   +|+||||||+||++++++..+++||.
T Consensus        81 ~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~  147 (257)
T cd08223          81 FCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLG  147 (257)
T ss_pred             ccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEeccc
Confidence            9999999999976422  3479999999999999999999999   99999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.84  E-value=1.1e-20  Score=181.30  Aligned_cols=142  Identities=25%  Similarity=0.338  Sum_probs=123.6

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc-chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      +|+..+.||+|+||.||+|... +++.||+|.++...... ....+.+|+++++.++|+||+++++++...+..+++|||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            5777889999999999999875 58899999986543222 234689999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++++.+..+.+..    ..+++.+...++.|++.|++|||+.   +++||||+|+||++++++.++++||.
T Consensus        82 ~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g  145 (288)
T cd07833          82 VERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFG  145 (288)
T ss_pred             CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeee
Confidence            9987776655432    2378999999999999999999999   99999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.84  E-value=1.1e-20  Score=183.08  Aligned_cols=136  Identities=24%  Similarity=0.333  Sum_probs=120.7

Q ss_pred             CCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCCC
Q 013682          291 KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS  369 (438)
Q Consensus       291 ~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs  369 (438)
                      ...||+|+||.||+|... +++.||+|.++... ......+.+|+..+..++|||++++++++...+..+++|||+++++
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            457999999999999864 68899999985432 2334468899999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          370 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       370 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |.+++...     .+++.....++.|++.|++|||+.   +++||||||+||+++.++.++++||.
T Consensus       105 L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg  162 (297)
T cd06659         105 LTDIVSQT-----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFG  162 (297)
T ss_pred             HHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeech
Confidence            99877542     378999999999999999999999   99999999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.84  E-value=7.2e-21  Score=183.87  Aligned_cols=136  Identities=26%  Similarity=0.362  Sum_probs=120.2

Q ss_pred             CCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCCC
Q 013682          291 KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS  369 (438)
Q Consensus       291 ~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs  369 (438)
                      ...||+|+||.||++... ++..||||.++... ......+.+|+..+..++|||++++++.+...+..+++|||+++++
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~  105 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA  105 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence            356999999999999864 68899999885432 2233468899999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          370 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       370 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |.+++...     .+++.+...++.|++.|++|||+.   +|+||||||+||++++++.++++||.
T Consensus       106 L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg  163 (292)
T cd06658         106 LTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFG  163 (292)
T ss_pred             HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCc
Confidence            99987542     378999999999999999999999   99999999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.84  E-value=1.6e-20  Score=181.45  Aligned_cols=141  Identities=23%  Similarity=0.364  Sum_probs=125.1

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      ++|...+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.+++.++|||++++++.+...+..++|+||
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            5677889999999999999986 367899999985432 22234688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++++|.+++.+.     .+++.++..++.|++.|+.|||+.   +++||||||+||+++.++.++++||.
T Consensus        98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg  160 (293)
T cd06647          98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG  160 (293)
T ss_pred             CCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCc
Confidence            9999999998753     378899999999999999999999   99999999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.84  E-value=3e-20  Score=180.68  Aligned_cols=143  Identities=30%  Similarity=0.431  Sum_probs=122.6

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc--cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ..|+..+.||+|+||.||+|... +++.||+|.++.....  .....+.+|+.+++.++|||++++.+++...+..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45777889999999999999874 6889999988543222  22246889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+. |++.+.+.....   .+++..+..++.|++.||.|||+.   +|+||||+|+||++++++.++++||.
T Consensus        95 e~~~-g~l~~~~~~~~~---~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg  160 (307)
T cd06607          95 EYCL-GSASDILEVHKK---PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFG  160 (307)
T ss_pred             HhhC-CCHHHHHHHccc---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecC
Confidence            9997 577776654322   489999999999999999999998   99999999999999999999999996

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.84  E-value=8.3e-21  Score=171.61  Aligned_cols=137  Identities=17%  Similarity=0.236  Sum_probs=104.4

Q ss_pred             CCccccccceEEEEEEeCCCCEEEEEEcccccccc-c-------hHH-----------------HHHHHHHHhcCCCCCc
Q 013682          291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG-G-------ELQ-----------------FQTEVKIISMAVHRNL  345 (438)
Q Consensus       291 ~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~-~-------~~~-----------------~~~E~~~l~~l~H~ni  345 (438)
                      ...||+|+||.||+|...+|+.||||+++...... .       ...                 ...|+..+..+.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            35799999999999998789999999997543211 1       012                 2348899999988776


Q ss_pred             eeeEEEEeeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCceecCCCCCCeeeC
Q 013682          346 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL-HEHCDPKIIHRDVKAANILLD  424 (438)
Q Consensus       346 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDLK~~NILld  424 (438)
                      .....+.  ....++||||++++++.......    ..+++.+...++.|++.+|.|+ |+.   +|+||||||+|||++
T Consensus        82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~  152 (190)
T cd05147          82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH  152 (190)
T ss_pred             CCCcEEE--ecCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence            4433322  22348999999988775543221    2478899999999999999999 677   999999999999998


Q ss_pred             CCCCcchhhhhhc
Q 013682          425 EDADQSSKTILRR  437 (438)
Q Consensus       425 ~~~~~~l~Df~~~  437 (438)
                       ++.++++||+..
T Consensus       153 -~~~v~LiDFG~a  164 (190)
T cd05147         153 -DGKLYIIDVSQS  164 (190)
T ss_pred             -CCcEEEEEcccc
Confidence             478999999753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.84  E-value=2.8e-20  Score=181.44  Aligned_cols=138  Identities=23%  Similarity=0.347  Sum_probs=112.9

Q ss_pred             CCccccccceEEEEEEeC---CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEee--CCeeEEEEecC
Q 013682          291 KNILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEKLLVYPYM  365 (438)
Q Consensus       291 ~~~LG~G~fG~Vy~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~e~~  365 (438)
                      ...||+|+||.||+|+..   ++..||+|.++...   ....+.+|+.+++.++||||+++++++..  ....+++|||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence            357999999999999864   35789999886432   22357899999999999999999998854  45678999998


Q ss_pred             CCCCHHHHhhccC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee----CCCCCcchhhhh
Q 013682          366 TNGSVASRLRERQ-----SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL----DEDADQSSKTIL  435 (438)
Q Consensus       366 ~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILl----d~~~~~~l~Df~  435 (438)
                      .+ +|.+++....     .....+++..+..++.|++.||+|||+.   +|+||||||+|||+    ++++.++|+||+
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            74 7777765321     1123478889999999999999999999   99999999999999    456789999996

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.84  E-value=1.2e-20  Score=178.32  Aligned_cols=135  Identities=28%  Similarity=0.401  Sum_probs=120.1

Q ss_pred             cccccceEEEEEEeC-CCCEEEEEEccccccc--cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCCCH
Q 013682          294 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  370 (438)
Q Consensus       294 LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  370 (438)
                      ||+|+||.||+++.. +++.+|+|.++.....  .....+.+|+.++..++|||++++++.+......+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999986 4899999998654321  2334688999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          371 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       371 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      .+++....    .+++..+..++.|++.||+|||+.   +++||||+|+||++++++.++++||.
T Consensus        81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg  138 (265)
T cd05579          81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFG  138 (265)
T ss_pred             HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecc
Confidence            99997643    489999999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.84  E-value=2.4e-21  Score=205.35  Aligned_cols=148  Identities=25%  Similarity=0.363  Sum_probs=119.5

Q ss_pred             HHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeC------
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV------  355 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------  355 (438)
                      ....+|+..+.||+||||.||+++.+ ||+.||||++.-...........+|+.++++++|||||+++..+.+.      
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            34567888899999999999999865 89999999997655333445788999999999999999984433100      


Q ss_pred             --------------------------------------------------------------------------------
Q 013682          356 --------------------------------------------------------------------------------  355 (438)
Q Consensus       356 --------------------------------------------------------------------------------  355 (438)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------------CeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHH
Q 013682          356 ---------------------------------TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY  402 (438)
Q Consensus       356 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~y  402 (438)
                                                       ...|+.||||+.-.+.+.+++.....   .-....+++++|++||+|
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHH
Confidence                                             12467889998877777776643210   345678999999999999


Q ss_pred             HhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          403 LHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       403 LH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      +|++   +||||||||.||++|++..+||+||+.
T Consensus       713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFGL  743 (1351)
T KOG1035|consen  713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGL  743 (1351)
T ss_pred             HHhC---ceeeccCCcceeEEcCCCCeeeccccc
Confidence            9999   999999999999999999999999974

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.84  E-value=3.8e-20  Score=174.02  Aligned_cols=146  Identities=26%  Similarity=0.393  Sum_probs=128.1

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      +|+..+.||+|+||.||++... +++.+|+|++...... .....+.+|+++++.++|||++++.+.+...+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            3666788999999999999975 5889999998654322 2334688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++++|.+.++........+++.....++.+++.|++|||+.   +++|+||+|+||++++++.++++||.
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~  148 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFG  148 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCcc
Confidence            999999999987543335689999999999999999999999   99999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.83  E-value=2.9e-20  Score=175.19  Aligned_cols=144  Identities=27%  Similarity=0.382  Sum_probs=123.8

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc-ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      +|+..+.||+|+||.||++... +++.+|+|.+..... ......+.+|+.+++.++|||++++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            3667789999999999999864 688999999864322 22344688999999999999999999999989999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC-Ccchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~-~~~l~Df~  435 (438)
                      +++++|.++++...  ...+++..+..++.+++.|++|||++   +|+||||||+||++++++ .++++||.
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~  147 (256)
T cd08220          81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFG  147 (256)
T ss_pred             CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCC
Confidence            99999999997643  23478999999999999999999999   999999999999998654 57999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.83  E-value=2.3e-21  Score=186.73  Aligned_cols=149  Identities=28%  Similarity=0.392  Sum_probs=130.3

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccc--cccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCee
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  358 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  358 (438)
                      .+..+.|..-++||+|+||.||-++.+ +|+.+|.|.+.+..  ...++.-...|-.++.+++.+.||.+--.|++.+..
T Consensus       181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L  260 (591)
T KOG0986|consen  181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL  260 (591)
T ss_pred             hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence            344567888899999999999999864 69999999885432  223344567889999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++|+..|.||+|.-++.....  +.+++.+++.+|.+|+.||++||+.   +||+|||||+|||+|+.|.++|+|++
T Consensus       261 ClVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLG  332 (591)
T KOG0986|consen  261 CLVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLG  332 (591)
T ss_pred             EEEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccc
Confidence            999999999999988877654  4599999999999999999999999   99999999999999999999999975

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.83  E-value=3.3e-20  Score=175.82  Aligned_cols=136  Identities=26%  Similarity=0.350  Sum_probs=120.4

Q ss_pred             cccccceEEEEEEeC-CCCEEEEEEccccccc--cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCCCH
Q 013682          294 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  370 (438)
Q Consensus       294 LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  370 (438)
                      ||+|+||.||+|+.. +++.||+|.+......  .....+.+|+.+++.++||||+++++.+.+....+++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999975 4889999998654322  2334688999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          371 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       371 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      .+++....    .+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++++||.-
T Consensus        81 ~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~  139 (262)
T cd05572          81 WTILRDRG----LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGF  139 (262)
T ss_pred             HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCc
Confidence            99997643    378899999999999999999998   999999999999999999999999863

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.83  E-value=3.2e-20  Score=180.62  Aligned_cols=144  Identities=29%  Similarity=0.458  Sum_probs=123.0

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccc-hHHHHHHHHHHhcCCCCCceeeEEEEeeC--CeeEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLL  360 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l  360 (438)
                      .++|+..+.||+|+||.||+|... +++.||+|.++....... ...+.+|+.++.+++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467888899999999999999874 689999999865432222 23567899999999999999999998754  46899


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||||+. ++|.+++....   ..+++.+...++.|++.|++|||+.   +++||||||+||++++++.++++||.
T Consensus        86 v~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg  153 (309)
T cd07845          86 VMEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFG  153 (309)
T ss_pred             EEecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccc
Confidence            999997 48888876532   3589999999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.83  E-value=1.6e-20  Score=185.05  Aligned_cols=142  Identities=21%  Similarity=0.336  Sum_probs=121.3

Q ss_pred             hCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeC-----Cee
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TEK  358 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~  358 (438)
                      .++|+..+.||+|+||.||+|.. .+++.||+|.++..........+.+|+.+++.++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46788889999999999999986 468899999986433333334688899999999999999999887653     347


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++++||+. +++.+.+...     .+++.....++.|++.||+|||+.   +|+||||||+||+++.++.++++||.
T Consensus        84 ~lv~e~~~-~~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg  151 (336)
T cd07849          84 YIVQELME-TDLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFG  151 (336)
T ss_pred             EEEehhcc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccc
Confidence            89999997 4888777543     388999999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.83  E-value=2.7e-20  Score=178.45  Aligned_cols=151  Identities=30%  Similarity=0.466  Sum_probs=126.4

Q ss_pred             HHHHHHHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEee-
Q 013682          278 LRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT-  354 (438)
Q Consensus       278 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-  354 (438)
                      ..++..+.+.|+..+.||+|+||.||+|+.. +++.+|+|.+....  .....+..|+.++.++ +|||++++++++.. 
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            3444456677888899999999999999874 68899999875432  2234678888888888 69999999999853 


Q ss_pred             -----CCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCc
Q 013682          355 -----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  429 (438)
Q Consensus       355 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~  429 (438)
                           ....+++|||+++|+|.+++.....  ..+++..+..++.|++.|++|||+.   +|+|||+||+||++++++.+
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~  160 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEV  160 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence                 4567999999999999999876432  2477888899999999999999999   99999999999999999999


Q ss_pred             chhhhh
Q 013682          430 SSKTIL  435 (438)
Q Consensus       430 ~l~Df~  435 (438)
                      +++||.
T Consensus       161 ~l~dfg  166 (282)
T cd06636         161 KLVDFG  166 (282)
T ss_pred             EEeeCc
Confidence            999995

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.83  E-value=3.4e-20  Score=180.51  Aligned_cols=145  Identities=23%  Similarity=0.376  Sum_probs=121.1

Q ss_pred             CCCCCCccccccceEEEEEEeC---CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeC--CeeE
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA---DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKL  359 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~---~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~  359 (438)
                      +|+..+.||+|+||.||+|...   +++.||+|.++....  ......+.+|+.++..++||||+++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            3666788999999999999874   478999999876321  12234678899999999999999999999887  7899


Q ss_pred             EEEecCCCCCHHHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC----CCCcchhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSS-LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE----DADQSSKTI  434 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~----~~~~~l~Df  434 (438)
                      +||||+++ ++.+.+...... ...+++.....++.|++.|++|||+.   +|+||||||+||+++.    ++.++++||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 677766543222 23578899999999999999999999   9999999999999999    899999999


Q ss_pred             h
Q 013682          435 L  435 (438)
Q Consensus       435 ~  435 (438)
                      .
T Consensus       157 g  157 (316)
T cd07842         157 G  157 (316)
T ss_pred             c
Confidence            6

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.83  E-value=4e-20  Score=176.97  Aligned_cols=140  Identities=24%  Similarity=0.322  Sum_probs=119.0

Q ss_pred             CCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCC-CCCceeeEEEEeeC--CeeEEEEe
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTV--TEKLLVYP  363 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lv~e  363 (438)
                      |+..+.||+|+||.||+|+.. +++.||+|.++............+|+..+.++. |+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            445678999999999999864 688999999876433333334567888888885 99999999999887  88999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |++ |++.+.+....   ..++|.++..++.|++.||+|||+.   +++||||||+||++++ +.++++||.
T Consensus        81 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg  144 (282)
T cd07831          81 LMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFG  144 (282)
T ss_pred             cCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecc
Confidence            997 58888887543   2489999999999999999999999   9999999999999999 999999995

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.83  E-value=3.3e-20  Score=179.96  Aligned_cols=144  Identities=28%  Similarity=0.453  Sum_probs=121.5

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc-chHHHHHHHHHHhcCCCCCceeeEEEEeeCCe-----
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTE-----  357 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----  357 (438)
                      .++|+..+.||+|+||.||+|+.. +++.||||.+....... ....+.+|+.+++.++||||+++++++...+.     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            456888899999999999999874 68899999886433222 22356789999999999999999999876543     


Q ss_pred             ---eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhh
Q 013682          358 ---KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  434 (438)
Q Consensus       358 ---~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df  434 (438)
                         .++||||+. +++.+.+....   ..+++.+...++.|++.||+|||++   +++||||||+||+++.++.++++||
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence               499999997 48888876532   2478999999999999999999999   9999999999999999999999999


Q ss_pred             h
Q 013682          435 L  435 (438)
Q Consensus       435 ~  435 (438)
                      .
T Consensus       164 g  164 (310)
T cd07865         164 G  164 (310)
T ss_pred             C
Confidence            6

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.83  E-value=2.7e-20  Score=175.54  Aligned_cols=144  Identities=19%  Similarity=0.350  Sum_probs=123.9

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      +|+..+.||+|+||.||+|... ++..||+|.+...... .....+.+|+.+++.++|+|++++++.+......++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            3666788999999999999875 5789999998653222 2334688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC-cchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD-QSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~-~~l~Df~  435 (438)
                      +++++|.+++.....  ..+++..+..++.|++.|++|||+.   +++|+||||+||++++++. .+++||.
T Consensus        81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~  147 (257)
T cd08225          81 CDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFG  147 (257)
T ss_pred             CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccc
Confidence            999999999876432  3479999999999999999999998   9999999999999998864 5999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.83  E-value=6.5e-20  Score=175.81  Aligned_cols=137  Identities=28%  Similarity=0.360  Sum_probs=113.9

Q ss_pred             ccccccceEEEEEEeC-CCCEEEEEEcccccccc--chHHHHHHH---HHHhcCCCCCceeeEEEEeeCCeeEEEEecCC
Q 013682          293 ILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEV---KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  366 (438)
Q Consensus       293 ~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~--~~~~~~~E~---~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  366 (438)
                      .||+|+||.||+|+.. +++.||+|.+.......  ....+..|.   ..+....||||+++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999864 58899999886532221  112233443   34455689999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          367 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       367 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      +|+|.+++...    ..+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++++||..
T Consensus        81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~  143 (278)
T cd05606          81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGL  143 (278)
T ss_pred             CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcC
Confidence            99999888653    2489999999999999999999998   999999999999999999999999963

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.83  E-value=8.5e-20  Score=171.53  Aligned_cols=142  Identities=29%  Similarity=0.471  Sum_probs=125.4

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      +|+..+.||+|++|.||+++.. +++.||+|.+...... .....+.+|++++.+++|||++++++++......+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            3667789999999999999875 5789999998654322 2234689999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++++|.+++...    ..+++..+..++.|++.|+.|||+.   +|+||||||+||++++++.++++||.
T Consensus        81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~  144 (254)
T cd06627          81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFG  144 (254)
T ss_pred             CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccc
Confidence            9999999998764    2489999999999999999999999   99999999999999999999999985

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.83  E-value=3.7e-20  Score=183.13  Aligned_cols=143  Identities=24%  Similarity=0.373  Sum_probs=121.8

Q ss_pred             HhCCCCCCCccccccceEEEEEEe-CCCCEEEEEEcccccccc-chHHHHHHHHHHhcCCCCCceeeEEEEeeCC-----
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVT-----  356 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----  356 (438)
                      ..++|+..+.||+|+||.||+|.. .++..||||+++...... ....+.+|+.+++.++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            456788889999999999999985 468899999985432221 2335789999999999999999999987643     


Q ss_pred             -eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          357 -EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       357 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                       ..++||||+ +++|.+++...     .+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++++||.
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence             358999998 67898887542     488999999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.83  E-value=3.3e-20  Score=181.40  Aligned_cols=139  Identities=27%  Similarity=0.343  Sum_probs=117.2

Q ss_pred             CCccccccceEEEEEEe-CCCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCC
Q 013682          291 KNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  368 (438)
Q Consensus       291 ~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g  368 (438)
                      .++||.|.||+||-|++ ++|+.||||++.+...+ ..+.++..|++++..++||.||.+.-.|++++..+.|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            37899999999999986 47999999999665433 34457899999999999999999999999999999999999654


Q ss_pred             CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC---CCcchhhhh
Q 013682          369 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED---ADQSSKTIL  435 (438)
Q Consensus       369 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~---~~~~l~Df~  435 (438)
                      -|+-.|....   .+++...-..+..||..||.|||.+   +|+|+||||+|||+.+.   ..+|++||+
T Consensus       649 MLEMILSsEk---gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFG  712 (888)
T KOG4236|consen  649 MLEMILSSEK---GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFG  712 (888)
T ss_pred             HHHHHHHhhc---ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeecccc
Confidence            4444444433   2477777888899999999999999   99999999999999865   368999996

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=1.1e-20  Score=189.94  Aligned_cols=140  Identities=27%  Similarity=0.392  Sum_probs=121.4

Q ss_pred             ccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCCCHH
Q 013682          293 ILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVA  371 (438)
Q Consensus       293 ~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~  371 (438)
                      +||+|.||+||.|+.. +...+|||.+.... +...+.+.+|+.+.+.++|.|||+++|.|.+.+..-+.||-++||+|.
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd-sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD-SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccccc-chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            6999999999999965 45578999996543 334457899999999999999999999999999999999999999999


Q ss_pred             HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC-CCCcchhhhhhc
Q 013682          372 SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTILRR  437 (438)
Q Consensus       372 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~-~~~~~l~Df~~~  437 (438)
                      +.|+.+.+... =.+...-.+..||.+||.|||++   .|||||||-+|||++. .|..||+||+-+
T Consensus       661 sLLrskWGPlK-DNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTs  723 (1226)
T KOG4279|consen  661 SLLRSKWGPLK-DNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTS  723 (1226)
T ss_pred             HHHHhccCCCc-cchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccc
Confidence            99998655321 15677788999999999999999   9999999999999996 588999999854

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.83  E-value=9.1e-20  Score=178.23  Aligned_cols=141  Identities=31%  Similarity=0.457  Sum_probs=121.1

Q ss_pred             CCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc--cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      |+..+.||+|+||.||+|+.. ++..||+|.+......  .....+.+|+.+++.++|||++++++++...+..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            556688999999999999864 6889999998643222  2233688899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +. |++.+.+....   ..++|.++..++.|++.|+.|||+.   +|+||||+|+||+++.++.++++||.
T Consensus       107 ~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg  170 (317)
T cd06635         107 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFG  170 (317)
T ss_pred             CC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCC
Confidence            97 57777765432   2489999999999999999999999   99999999999999999999999995

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.83  E-value=2.5e-20  Score=175.46  Aligned_cols=146  Identities=26%  Similarity=0.353  Sum_probs=126.9

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      +|+..+.||+|+||.||+++.. +++.+|+|.++..... .....+.+|+.+++.++|+||+++.+++......+++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            3667788999999999999864 6789999998654322 2234678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++++|.+++.+.......+++.....++.|++.|++|||+.   +++|+||+|+||+++++++++++||.
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g  148 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLG  148 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeecc
Confidence            999999999877443344689999999999999999999999   99999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.83  E-value=4.9e-20  Score=176.51  Aligned_cols=141  Identities=28%  Similarity=0.467  Sum_probs=122.3

Q ss_pred             CCCCCccccccceEEEEEEeC-CCCEEEEEEccccc-cccchHHHHHHHHHHhcCCCCCceeeEEEEeeC--CeeEEEEe
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLLVYP  363 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e  363 (438)
                      |+..+.||+|+||.||+|+.. +++.+|+|.++... .......+.+|+.+++.++|||++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            455678999999999999875 47899999997653 122234688999999999999999999999887  78999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+++ +|.+++....   ..+++..+..++.|++.|++|||+.   +++|+||||+||++++++.++++||.
T Consensus        81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g  145 (287)
T cd07840          81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFG  145 (287)
T ss_pred             cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEcccc
Confidence            9974 8888886542   3589999999999999999999998   99999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.83  E-value=7.7e-20  Score=176.46  Aligned_cols=144  Identities=23%  Similarity=0.401  Sum_probs=121.2

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      ++|+..+.||+|+||.||+|+.. +++.||+|.++..... .....+.+|+.+++.++||||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46778889999999999999875 6889999998654322 223468899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC-CCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~-~~~~l~Df~  435 (438)
                      |++ +++.+.+.....  ..+++.....++.|++.||+|||++   +++||||||+||+++.+ +.++++||.
T Consensus        82 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg  148 (294)
T PLN00009         82 YLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFG  148 (294)
T ss_pred             ccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccc
Confidence            996 578887754322  2357888889999999999999998   99999999999999964 567999986

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.83  E-value=3e-20  Score=178.04  Aligned_cols=142  Identities=28%  Similarity=0.421  Sum_probs=123.2

Q ss_pred             CCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCC-CCCceeeEEEEeeCCeeEEEEecC
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      |+..+.||+|+||.||+|+.. +++.||+|++.............+|+..+.+++ |||++++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            455688999999999999975 478999999865433333334567899999999 999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                       +|++.+.+....  ...+++.++..++.|++.||.|||+.   +++|+||+|+||++++++.++++||.
T Consensus        81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~  144 (283)
T cd07830          81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFG  144 (283)
T ss_pred             -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecc
Confidence             889999887653  23479999999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.83  E-value=9.9e-20  Score=170.33  Aligned_cols=143  Identities=33%  Similarity=0.495  Sum_probs=127.0

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecC
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      +|...+.||+|++|.||++... +++.+++|+++.... .....+.+|++.++.++|+|++++++++......++++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence            3666788999999999999975 688999999866433 23457899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ++++|.+++....   ..+++.....++.|++.|++|||..   +++||||+|+||++++++.++|+||..
T Consensus        80 ~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~  144 (253)
T cd05122          80 SGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGL  144 (253)
T ss_pred             CCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccc
Confidence            9999999987642   3489999999999999999999998   999999999999999999999999863

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.83  E-value=2.2e-20  Score=178.24  Aligned_cols=144  Identities=27%  Similarity=0.368  Sum_probs=126.9

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCC-CCCceeeEEEEeeCCeeEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv  361 (438)
                      ++|...+.||+|+||.||+|+.. +++.||+|.+.....  ......+.+|+.++..++ ||||+++++++...+..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36777889999999999999875 688999999865321  122346888999999998 99999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |||+++++|.++++...    .+++.....++.|++.||+|||+.   +++|+|+||+||+++.++.++++||.-
T Consensus        81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~  148 (280)
T cd05581          81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGT  148 (280)
T ss_pred             EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCcc
Confidence            99999999999997653    489999999999999999999998   999999999999999999999999974

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.82  E-value=5.2e-20  Score=182.22  Aligned_cols=149  Identities=23%  Similarity=0.330  Sum_probs=125.2

Q ss_pred             HHHHHHHhCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeC
Q 013682          278 LRELQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV  355 (438)
Q Consensus       278 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  355 (438)
                      .+++...+++|...+.||+|+||.||+|.. .+++.||+|+++..... .....+.+|+.++..++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            455667788999999999999999999985 46889999998653222 2234678899999999999999999988643


Q ss_pred             ------CeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCc
Q 013682          356 ------TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  429 (438)
Q Consensus       356 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~  429 (438)
                            ...+++++++ +++|.+.++..     .+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~  159 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL  159 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence                  3367888876 78998877542     378999999999999999999999   99999999999999999999


Q ss_pred             chhhhh
Q 013682          430 SSKTIL  435 (438)
Q Consensus       430 ~l~Df~  435 (438)
                      +++||.
T Consensus       160 kl~dfg  165 (345)
T cd07877         160 KILDFG  165 (345)
T ss_pred             EEeccc
Confidence            999996

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.82  E-value=1.9e-20  Score=188.68  Aligned_cols=143  Identities=27%  Similarity=0.405  Sum_probs=123.3

Q ss_pred             CCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCC-C-----CCceeeEEEEeeCCeeE
Q 013682          287 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-H-----RNLLRLYGFCTTVTEKL  359 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~  359 (438)
                      +|...++||+|+||.|-||.. .+++.||||+++....  -..+...|+.++..++ |     -|+|++++++.-.++.+
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~--f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR--FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH--HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            577789999999999999985 5799999999986532  2335678899998886 4     48999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC--CCcchhhhhhc
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED--ADQSSKTILRR  437 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~--~~~~l~Df~~~  437 (438)
                      +|+|.+. -+|+++++.....  .++......++.||+.||.+||..   +|||+||||+|||+.+-  ..+||+||+.+
T Consensus       265 iVfELL~-~NLYellK~n~f~--Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  265 IVFELLS-TNLYELLKNNKFR--GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             eeehhhh-hhHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccc
Confidence            9999986 4999999886543  488899999999999999999999   99999999999999875  47899999864

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.82  E-value=8.7e-20  Score=175.60  Aligned_cols=139  Identities=24%  Similarity=0.361  Sum_probs=122.3

Q ss_pred             CCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCC
Q 013682          288 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  366 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  366 (438)
                      |...+.||+|++|.||++.. .+++.+|+|+++... ......+.+|+.+++.++|||++++++++...+..++++||++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            44457899999999999986 468899999875432 2233468899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          367 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       367 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++|.+++...     .+++.....++.|++.|++|||++   +|+||||||+||++++++.++++||.
T Consensus       100 ~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g  160 (285)
T cd06648         100 GGALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG  160 (285)
T ss_pred             CCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccc
Confidence            99999998762     378899999999999999999999   99999999999999999999999995

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.82  E-value=4.8e-20  Score=179.62  Aligned_cols=138  Identities=24%  Similarity=0.231  Sum_probs=115.7

Q ss_pred             ccccccceEEEEEEeCCCCEEEEEEccccc-cccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCCCHH
Q 013682          293 ILGRGGFGKVYKGRLADGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVA  371 (438)
Q Consensus       293 ~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~  371 (438)
                      .+|.|+++.||++.. +++.||+|+++... .......+.+|+.+++.++||||+++++++...+..+++|||+++|++.
T Consensus         9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   87 (314)
T cd08216           9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE   87 (314)
T ss_pred             hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence            344455555555544 68899999986542 2233457899999999999999999999999999999999999999999


Q ss_pred             HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          372 SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       372 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ++++....  ..+++.....++.|++.||+|||+.   +|+||||||+||++++++.++++||..
T Consensus        88 ~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~  147 (314)
T cd08216          88 DLLKTHFP--EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRY  147 (314)
T ss_pred             HHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCcc
Confidence            99986432  2378889999999999999999999   999999999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.82  E-value=9.3e-21  Score=165.76  Aligned_cols=152  Identities=26%  Similarity=0.350  Sum_probs=127.5

Q ss_pred             HHHHhCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHH-hcCCCCCceeeEEEEeeCCee
Q 013682          281 LQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLRLYGFCTTVTEK  358 (438)
Q Consensus       281 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~~~~~  358 (438)
                      +++..++......||+|++|.|-+-++ .+|+..|+|+++.....+...+..+|+.+. +....|.+|.++|........
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            345555666677899999999887776 479999999998766665666778888754 556799999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++.||.|+. ||..+-++........++...-+||..|..||.|||++-  .+||||+||+|||+|.+|.+|++||+
T Consensus       121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFG  194 (282)
T KOG0984|consen  121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFG  194 (282)
T ss_pred             EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccc
Confidence            999999975 888777765555556788888899999999999999974  79999999999999999999999996

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.82  E-value=8.4e-20  Score=172.81  Aligned_cols=137  Identities=25%  Similarity=0.338  Sum_probs=114.7

Q ss_pred             CccccccceEEEEEEeC-CCCEEEEEEccccccc--cchHHHHHHHHH-HhcCCCCCceeeEEEEeeCCeeEEEEecCCC
Q 013682          292 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKI-ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  367 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  367 (438)
                      +.||+|+||.||+|... +++.||+|.++.....  .....+..|... ....+|+|++++++++...+..+++|||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46899999999999874 5889999998643211  111234445443 4456899999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          368 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++|.++++...    .+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++++||.
T Consensus        82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  142 (260)
T cd05611          82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFG  142 (260)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecc
Confidence            99999987543    378899999999999999999998   99999999999999999999999996

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.82  E-value=1.1e-19  Score=170.73  Aligned_cols=143  Identities=32%  Similarity=0.481  Sum_probs=126.2

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeC--CeeEEEE
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLLVY  362 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~  362 (438)
                      +|+..+.||+|++|.||+|... +++.|++|.++..... .....+.+|+..+++++||||+++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            3666788999999999999975 6889999998654321 2344789999999999999999999999888  8899999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||+++++|.+++....    .+++.++..++.|++.|++|||+.   +++|+|++|+||++++++.++++||..
T Consensus        81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~  147 (260)
T cd06606          81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGC  147 (260)
T ss_pred             EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccccc
Confidence            9999999999987653    589999999999999999999998   999999999999999999999999963

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>PTZ00284 protein kinase; Provisional

Probab=99.82  E-value=3.3e-20  Score=191.15  Aligned_cols=145  Identities=19%  Similarity=0.312  Sum_probs=115.1

Q ss_pred             HHHHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCC------CCCceeeEEEEe
Q 013682          281 LQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV------HRNLLRLYGFCT  353 (438)
Q Consensus       281 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~g~~~  353 (438)
                      +....++|+..+.||+|+||+||+|... +++.||||+++...  .....+..|+.++..++      |.+++++++++.
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            3445678999999999999999999864 57899999986431  11224455666665554      456889998887


Q ss_pred             eC-CeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceecCCCCCCeeeCCCC----
Q 013682          354 TV-TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDA----  427 (438)
Q Consensus       354 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDLK~~NILld~~~----  427 (438)
                      .. ...++|||++ +++|.+++.+..    .+++..+..++.|++.||+|||+ .   +||||||||+|||++.++    
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccc
Confidence            64 4678899987 678888887542    48999999999999999999997 5   899999999999999776    


Q ss_pred             ------------Ccchhhhh
Q 013682          428 ------------DQSSKTIL  435 (438)
Q Consensus       428 ------------~~~l~Df~  435 (438)
                                  .+||+||+
T Consensus       274 ~~~~~~~~~~~~~vkl~DfG  293 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDLG  293 (467)
T ss_pred             cccccccCCCCceEEECCCC
Confidence                        38999997

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=1.6e-20  Score=187.01  Aligned_cols=142  Identities=23%  Similarity=0.289  Sum_probs=123.9

Q ss_pred             CCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccc--cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          287 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      -|...+.||-|+||+|..++. ++...||+|.+++...-  ........|-.+|+..+.+.||+|+-.|.+.+.+|+|||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            466678899999999999975 45678999998654321  122346788899999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |++||++.++|.+..    .|.+..++.++.++++|+++.|..   |+|||||||+|||||.||..|+.||+
T Consensus       710 YIPGGDmMSLLIrmg----IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFG  774 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMG----IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG  774 (1034)
T ss_pred             ccCCccHHHHHHHhc----cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecc
Confidence            999999999998754    378888999999999999999999   99999999999999999999999996

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.82  E-value=8e-20  Score=175.18  Aligned_cols=142  Identities=24%  Similarity=0.434  Sum_probs=123.1

Q ss_pred             CCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc-chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecC
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      |+..+.||+|++|.||+|... +++.||+|+++...... ....+.+|+..++.++|||++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            456688999999999999874 68999999986543222 2346888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      + ++|.+++.....  ..+++..+..++.|++.||+|||+.   +++||||+|+||++++++.++++||.
T Consensus        81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~  144 (283)
T cd07835          81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFG  144 (283)
T ss_pred             C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecc
Confidence            5 689998875432  3489999999999999999999998   99999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.82  E-value=6.3e-20  Score=177.39  Aligned_cols=145  Identities=25%  Similarity=0.436  Sum_probs=121.0

Q ss_pred             HhCCCCCCCccccccceEEEEEEeCC-CCEEEEEEccccccccchHHHHHHHHHHhcCC-CCCceeeEEEEeeCCeeEEE
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~~-~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv  361 (438)
                      ..++|+..+.||+|+||.||+|.+.+ ++.||||.++..........+.+|+..+.+.. ||||+++++++.+....+++
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            34567788999999999999999864 88999999865433333445677777666664 99999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |||+. +++.+......   ..+++..+..++.|++.|++|||+ .   +|+||||+|+||++++++.++|+||.
T Consensus        93 ~e~~~-~~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg  160 (296)
T cd06618          93 MELMS-TCLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFG  160 (296)
T ss_pred             eeccC-cCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccc
Confidence            99985 47776665432   258999999999999999999997 4   89999999999999999999999996

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.82  E-value=4.5e-20  Score=177.54  Aligned_cols=141  Identities=28%  Similarity=0.335  Sum_probs=121.5

Q ss_pred             CCCCCccccccceEEEEEEeC----CCCEEEEEEcccccc---ccchHHHHHHHHHHhcC-CCCCceeeEEEEeeCCeeE
Q 013682          288 FSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERT---SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKL  359 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~----~~~~vAvK~l~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  359 (438)
                      |+..+.||+|+||.||+++..    +++.||||.++....   ......+.+|+.++..+ +||||+++++.+......+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            566788999999999999752    467899999864321   11233578899999999 5999999999999889999


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +||||+++|+|.+++....    .+++.....++.|++.||+|||+.   +++||||||+||++++++.++++||.
T Consensus        82 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg  150 (288)
T cd05583          82 LILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFG  150 (288)
T ss_pred             EEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECc
Confidence            9999999999999987542    378899999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.82  E-value=4.4e-20  Score=189.14  Aligned_cols=149  Identities=22%  Similarity=0.355  Sum_probs=115.9

Q ss_pred             HhCCCCCCCccccccceEEEEEEe-----------------CCCCEEEEEEccccccc-------------cchHHHHHH
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRL-----------------ADGKLVAVKRLKEERTS-------------GGELQFQTE  333 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~-----------------~~~~~vAvK~l~~~~~~-------------~~~~~~~~E  333 (438)
                      ..++|+..++||+|+||.||+|.+                 ..++.||||+++.....             .....+..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999964                 13467999998643211             011124457


Q ss_pred             HHHHhcCCCCCc-----eeeEEEEee--------CCeeEEEEecCCCCCHHHHhhccCCC--------------------
Q 013682          334 VKIISMAVHRNL-----LRLYGFCTT--------VTEKLLVYPYMTNGSVASRLRERQSS--------------------  380 (438)
Q Consensus       334 ~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------  380 (438)
                      +.++.+++|.++     ++++++|..        .+..++||||+++|+|.++++.....                    
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777776654     677777753        35689999999999999998753211                    


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          381 LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       381 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ...++|..+..++.|++.||+|+|+.   +|+||||||+|||++.++.++++||.
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFG  354 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFG  354 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCc
Confidence            12357888999999999999999998   99999999999999999999999996

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.82  E-value=3.8e-20  Score=182.27  Aligned_cols=143  Identities=23%  Similarity=0.357  Sum_probs=121.8

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEee----CCeeE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT----VTEKL  359 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~  359 (438)
                      ++|+..+.||+|+||.||+|... +++.||+|++...... .....+.+|+.++..++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            67888899999999999999864 6889999998654322 223467789999999999999999988753    34679


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      +||||+. |+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+||++++++.++++||.-
T Consensus        85 lv~e~~~-~~l~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~  153 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQ----PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGM  153 (334)
T ss_pred             EEEehhh-hhHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccc
Confidence            9999996 68988886432    389999999999999999999998   999999999999999999999999963

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=1.9e-21  Score=193.46  Aligned_cols=140  Identities=26%  Similarity=0.337  Sum_probs=120.0

Q ss_pred             CCCccccccceEEEEEEeCC-CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCC
Q 013682          290 NKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  368 (438)
Q Consensus       290 ~~~~LG~G~fG~Vy~~~~~~-~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g  368 (438)
                      +..-||.|+||+||+|..++ +-..|-|.+... ......++.-|+++++.++||+||++++.|.-.+.+|+..|||.||
T Consensus        36 IiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GG  114 (1187)
T KOG0579|consen   36 IIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGG  114 (1187)
T ss_pred             HHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCc
Confidence            34558999999999998764 445677776332 2333457899999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          369 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       369 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      -....+-.-.   ..++..+...++.|++.||.|||++   +|||||||+.|||+.-||+++++||+=
T Consensus       115 AVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGV  176 (1187)
T KOG0579|consen  115 AVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGV  176 (1187)
T ss_pred             hHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccc
Confidence            9888776543   3589999999999999999999999   999999999999999999999999973

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.82  E-value=6.3e-20  Score=180.87  Aligned_cols=142  Identities=23%  Similarity=0.380  Sum_probs=120.9

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccc-cccchHHHHHHHHHHhcC-CCCCceeeEEEEeeC--CeeE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER-TSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV--TEKL  359 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~--~~~~  359 (438)
                      .++|+..+.||+|+||.||+|... +++.+|+|++.... .......+.+|+.++..+ +||||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            456777889999999999999875 57899999885422 122234577899999999 999999999998654  3579


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +||||++ ++|..++...     .++|.....++.|++.||+|||+.   +|+||||||+||++++++.++++||.
T Consensus        86 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g  152 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFG  152 (337)
T ss_pred             EEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeecc
Confidence            9999997 5998888653     478999999999999999999998   99999999999999999999999996

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.82  E-value=8.9e-20  Score=176.28  Aligned_cols=135  Identities=25%  Similarity=0.374  Sum_probs=119.8

Q ss_pred             CccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCCCH
Q 013682          292 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  370 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  370 (438)
                      ..||+|+||.||++... +++.||+|.+.... ......+.+|+.+++.++|+|++++++.+...+..+++|||+++++|
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            56999999999999874 68899999875432 22344688999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          371 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       371 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      .+++...     .+++.....++.|++.|++|||+.   +++||||||+||++++++.++++||.
T Consensus       105 ~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg  161 (292)
T cd06657         105 TDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFG  161 (292)
T ss_pred             HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccc
Confidence            9887542     378999999999999999999999   99999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.82  E-value=1.1e-19  Score=180.47  Aligned_cols=143  Identities=22%  Similarity=0.306  Sum_probs=120.7

Q ss_pred             HhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc-ccchHHHHHHHHHHhcCCCCCceeeEEEEeeC------
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTV------  355 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------  355 (438)
                      ..++|+..+.||+|+||.||+|+.. +++.||+|.++.... ......+.+|+.++..++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            3467888899999999999999864 688999999864322 22234677899999999999999999988643      


Q ss_pred             CeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          356 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       356 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ...++||||+. ++|.+.+...      +++.....++.|++.||+|||+.   +|+||||||+||++++++.++++||.
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence            34689999996 5888777532      78889999999999999999999   99999999999999999999999996


Q ss_pred             h
Q 013682          436 R  436 (438)
Q Consensus       436 ~  436 (438)
                      -
T Consensus       164 ~  164 (353)
T cd07850         164 L  164 (353)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.82  E-value=9.5e-20  Score=179.09  Aligned_cols=146  Identities=24%  Similarity=0.359  Sum_probs=123.9

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc-ccchHHHHHHHHHHhcCCCCCceeeEEEEee-CCee
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTEK  358 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~  358 (438)
                      ...+++|+..+.||+|+||.||+|... +++.||+|++..... ......+.+|+.++..++|||++++.+++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            345778999999999999999999864 688999998754322 2233467899999999999999999998865 5578


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ++++||+ +++|.+.++..     .+++.....++.|++.||+|||+.   +|+||||||+||++++++.++++||..
T Consensus        86 ~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~  154 (328)
T cd07856          86 YFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGL  154 (328)
T ss_pred             EEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccc
Confidence            8999998 56898887642     367888889999999999999999   999999999999999999999999963

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.81  E-value=3.1e-20  Score=192.63  Aligned_cols=150  Identities=19%  Similarity=0.233  Sum_probs=114.7

Q ss_pred             HHhCCCCCCCccccccceEEEEEEeCC--CCEEEEEEc--------------ccc--ccccchHHHHHHHHHHhcCCCCC
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRLAD--GKLVAVKRL--------------KEE--RTSGGELQFQTEVKIISMAVHRN  344 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~--~~~vAvK~l--------------~~~--~~~~~~~~~~~E~~~l~~l~H~n  344 (438)
                      ...++|+..+.||+|+||+||++.++.  +..++.|.+              ...  ........+.+|+.++..++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            345789999999999999999987532  222222211              000  01112235789999999999999


Q ss_pred             ceeeEEEEeeCCeeEEEEecCCCCCHHHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee
Q 013682          345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSS-LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  423 (438)
Q Consensus       345 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILl  423 (438)
                      ||++++++...+..++++|++. +++.+++...... .......+...++.|++.||+|||++   +|+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            9999999999999999999985 5777776543211 11233556778999999999999999   99999999999999


Q ss_pred             CCCCCcchhhhhh
Q 013682          424 DEDADQSSKTILR  436 (438)
Q Consensus       424 d~~~~~~l~Df~~  436 (438)
                      ++++.++|+||+-
T Consensus       301 ~~~~~vkL~DFGl  313 (501)
T PHA03210        301 NCDGKIVLGDFGT  313 (501)
T ss_pred             CCCCCEEEEeCCC
Confidence            9999999999963

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.81  E-value=7.8e-20  Score=175.78  Aligned_cols=146  Identities=25%  Similarity=0.358  Sum_probs=118.3

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCC-CCCceeeEEEEeeCCeeEEEEec
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      +|...+.||+|+||.||++... +++.||+|.+...........+.+|+.++.++. ||||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4455678999999999999874 588999999865433333456889999999886 99999999999999999999999


Q ss_pred             CCCCCHHHHhhcc-CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRER-QSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +.. ++.++.... ......+++.....++.+++.||+|||+..  +|+||||||+||++++++.++++||.
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg  153 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFG  153 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecc
Confidence            864 555443211 011235889999999999999999999632  89999999999999999999999995

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.81  E-value=1.6e-19  Score=177.86  Aligned_cols=137  Identities=27%  Similarity=0.324  Sum_probs=118.7

Q ss_pred             CCccccccceEEEEEEeC-CCCEEEEEEccccccccc-------------hHHHHHHHHHHhcCCCCCceeeEEEEeeCC
Q 013682          291 KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG-------------ELQFQTEVKIISMAVHRNLLRLYGFCTTVT  356 (438)
Q Consensus       291 ~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~-------------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  356 (438)
                      .+.||+|+||.||+|... +++.||+|.++.......             ...+.+|+.++..++||||+++++++...+
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   93 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD   93 (335)
T ss_pred             hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence            467999999999999864 688999999864322210             124678999999999999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          357 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ..+++|||+. |+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+||+++.++.++++||.
T Consensus        94 ~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg  164 (335)
T PTZ00024         94 FINLVMDIMA-SDLKKVVDRKI----RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFG  164 (335)
T ss_pred             cEEEEEeccc-cCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCcc
Confidence            9999999997 68998886532    378899999999999999999998   99999999999999999999999996

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.81  E-value=2.9e-19  Score=170.39  Aligned_cols=141  Identities=26%  Similarity=0.299  Sum_probs=115.9

Q ss_pred             HHHhCCCCCCCcc--ccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHh-cCCCCCceeeEEEEeeCCe
Q 013682          282 QVATDGFSNKNIL--GRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLLRLYGFCTTVTE  357 (438)
Q Consensus       282 ~~~~~~~~~~~~L--G~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~  357 (438)
                      ....++|...+.+  |+|+||.||+++.. ++..+|+|.++......    .  |+.... ..+|||++++++.+...+.
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~--e~~~~~~~~~h~~iv~~~~~~~~~~~   83 (267)
T PHA03390         10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----I--EPMVHQLMKDNPNFIKLYYSVTTLKG   83 (267)
T ss_pred             HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----h--hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence            3444566666665  99999999999864 68889999986432111    1  222222 1279999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC-Ccchhhhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTIL  435 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~-~~~l~Df~  435 (438)
                      .++||||+++|+|.+++....    .++|.++..++.|++.|++|||+.   +++||||||+||+++.++ .++++||.
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg  155 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYG  155 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence            999999999999999997653    489999999999999999999999   999999999999999998 99999996

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.81  E-value=1.2e-19  Score=164.29  Aligned_cols=135  Identities=18%  Similarity=0.220  Sum_probs=105.2

Q ss_pred             CCccccccceEEEEEEeCCCCEEEEEEcccccccc--------------------c-----hHHHHHHHHHHhcCCCCCc
Q 013682          291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG--------------------G-----ELQFQTEVKIISMAVHRNL  345 (438)
Q Consensus       291 ~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~--------------------~-----~~~~~~E~~~l~~l~H~ni  345 (438)
                      ...||+|+||.||+|+..+|+.||||+++......                    .     ...+.+|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            36799999999999997789999999987542110                    0     1124578899999999987


Q ss_pred             eeeEEEEeeCCeeEEEEecCCCCCHHHH-hhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceecCCCCCCeee
Q 013682          346 LRLYGFCTTVTEKLLVYPYMTNGSVASR-LRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILL  423 (438)
Q Consensus       346 v~l~g~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDLK~~NILl  423 (438)
                      .....+...  ..++||||++++++... +..     ..++..+...++.|++.++.|+|+ .   +|+||||||+|||+
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll  151 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY  151 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence            554444332  34899999998855433 332     136778889999999999999999 8   99999999999999


Q ss_pred             CCCCCcchhhhhh
Q 013682          424 DEDADQSSKTILR  436 (438)
Q Consensus       424 d~~~~~~l~Df~~  436 (438)
                      + ++.++++||+-
T Consensus       152 ~-~~~~~liDFG~  163 (190)
T cd05145         152 H-DGKPYIIDVSQ  163 (190)
T ss_pred             E-CCCEEEEEccc
Confidence            9 89999999973

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.81  E-value=6.7e-21  Score=176.65  Aligned_cols=146  Identities=29%  Similarity=0.348  Sum_probs=128.1

Q ss_pred             HHhCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccc--cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeE
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  359 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  359 (438)
                      +..++|...++||+|.||+|..++- .+++.+|+|+++++..-  +....-..|-+++...+||.+..+.-.++..+..+
T Consensus       165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC  244 (516)
T KOG0690|consen  165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC  244 (516)
T ss_pred             eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence            3457788899999999999999985 47999999999876432  22234567889999999999999998899999999


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      .||||+.||.|.-+|...+    .+++.....+-..|..||.|||++   +||+||+|.+|.|+|.||..||+||+
T Consensus       245 FVMeyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFG  313 (516)
T KOG0690|consen  245 FVMEYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFG  313 (516)
T ss_pred             EEEEEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecc
Confidence            9999999999998887643    388889999999999999999999   99999999999999999999999996

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.81  E-value=4.5e-19  Score=173.04  Aligned_cols=141  Identities=31%  Similarity=0.446  Sum_probs=120.6

Q ss_pred             CCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc--cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      |...+.||+|+||.||+|+.. +++.||+|.+......  .....+.+|+.+++.++|||++++++++.+....+++|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            455677999999999999864 6889999998543222  1223678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +. |++.+.+....   ..+++.++..++.|++.|++|||+.   +++||||||+||++++++.++++||.
T Consensus       103 ~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg  166 (313)
T cd06633         103 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFG  166 (313)
T ss_pred             CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecC
Confidence            96 57877776432   2488999999999999999999999   99999999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.81  E-value=8.6e-20  Score=172.73  Aligned_cols=145  Identities=21%  Similarity=0.273  Sum_probs=120.1

Q ss_pred             CCCCCCccccccceEEEEEEeCC-CCEEEEEEcccccc----ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          287 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERT----SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~~-~~~vAvK~l~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      +|...+.||+|+||.||+++... +..+++|.++....    .....++.+|+.+++.++||||+++++++.+.+..+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            36677889999999999998643 44566666543221    12233577899999999999999999999988899999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |||+++++|.++++........+++.++..++.|++.|+.|||+.   +++|+||||+||++++ +.++++||.
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g  150 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFG  150 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccC
Confidence            999999999999876433344689999999999999999999998   9999999999999985 568999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.81  E-value=3.1e-19  Score=171.06  Aligned_cols=142  Identities=29%  Similarity=0.493  Sum_probs=118.4

Q ss_pred             CCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccc-hHHHHHHHHHHhcC---CCCCceeeEEEEeeCCe-----
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG-ELQFQTEVKIISMA---VHRNLLRLYGFCTTVTE-----  357 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~-~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~-----  357 (438)
                      |+..+.||+|+||.||+|+.. +++.||+|.++....... ...+.+|+.++.++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            455688999999999999986 488999999875433222 23466777766554   69999999999988776     


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      .+++|||+. ++|.+++.....  ..+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++++||.
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg  152 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFG  152 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccC
Confidence            899999997 489888865432  2489999999999999999999998   99999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.80  E-value=1.5e-19  Score=178.19  Aligned_cols=142  Identities=22%  Similarity=0.366  Sum_probs=120.8

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc-ccchHHHHHHHHHHhcCCCCCceeeEEEEeeC-----Cee
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TEK  358 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~  358 (438)
                      ++|...+.||+|+||.||+|+.. +++.||||.++.... ......+.+|+.+++.++|+||+++++++...     ...
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            46778889999999999999864 688999999865321 22234677899999999999999999987653     347


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++|||+. ++|.+++....    .+++.....++.|++.||.|||+.   +++||||||+||+++.++.++++||.
T Consensus        85 ~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg  153 (337)
T cd07858          85 YIVYELMD-TDLHQIIRSSQ----TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFG  153 (337)
T ss_pred             EEEEeCCC-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCc
Confidence            99999996 68888886532    488999999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.80  E-value=1.9e-19  Score=177.91  Aligned_cols=141  Identities=25%  Similarity=0.397  Sum_probs=118.8

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc-chHHHHHHHHHHhcCCCCCceeeEEEEeeCC------
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVT------  356 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  356 (438)
                      .++|...+.||+|+||.||+|... +++.||+|.++...... ....+.+|+.+++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            367888899999999999999864 68999999986533222 2346889999999999999999999986542      


Q ss_pred             eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          357 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ..++++||+.. ++.+...      ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++||.
T Consensus        94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg  162 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFG  162 (342)
T ss_pred             eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCC
Confidence            45899999964 7766542      1378899999999999999999999   99999999999999999999999996

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.80  E-value=1.2e-19  Score=178.06  Aligned_cols=142  Identities=23%  Similarity=0.353  Sum_probs=123.0

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc-ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCC-----eeE
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-----EKL  359 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~  359 (438)
                      +|+..+.||+|+||.||+|+.. +++.||+|.+..... ......+.+|+.+++.++||||+++.+++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            3667789999999999999975 488999999865432 233447899999999999999999999988765     789


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ++|||++ ++|.+.+....    .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++++||.-
T Consensus        81 lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~  149 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGL  149 (330)
T ss_pred             EEecchh-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCc
Confidence            9999998 58888886542    589999999999999999999999   999999999999999999999999963

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.80  E-value=1.1e-19  Score=192.03  Aligned_cols=152  Identities=26%  Similarity=0.380  Sum_probs=131.5

Q ss_pred             HHHHhCCCCCCCccccccceEEEEEEeC----C----CCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEE
Q 013682          281 LQVATDGFSNKNILGRGGFGKVYKGRLA----D----GKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGF  351 (438)
Q Consensus       281 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~----~----~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~  351 (438)
                      +++..+++...+.+|+|+||.|++|...    .    ...||||.++......+...+..|+.+|..+ +|+||+.++|+
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            4555566666679999999999999742    1    3479999998877666666899999999877 69999999999


Q ss_pred             EeeCCeeEEEEecCCCCCHHHHhhccC---CC-------C--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCC
Q 013682          352 CTTVTEKLLVYPYMTNGSVASRLRERQ---SS-------L--PPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAA  419 (438)
Q Consensus       352 ~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~-------~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~  419 (438)
                      |...+..++|+||+..|+|.++++..+   .-       .  ..++..+.+.++.|||.||+||++.   ++|||||.++
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR  447 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR  447 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence            999999999999999999999999876   00       0  1378889999999999999999999   9999999999


Q ss_pred             CeeeCCCCCcchhhhh
Q 013682          420 NILLDEDADQSSKTIL  435 (438)
Q Consensus       420 NILld~~~~~~l~Df~  435 (438)
                      |||+.++..+||+||+
T Consensus       448 NVLi~~~~~~kIaDFG  463 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFG  463 (609)
T ss_pred             hEEecCCCEEEEcccc
Confidence            9999999999999997

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.80  E-value=1.4e-19  Score=175.69  Aligned_cols=144  Identities=30%  Similarity=0.446  Sum_probs=120.8

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc-chHHHHHHHHHHhcCCCCCceeeEEEEeeCC------
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVT------  356 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  356 (438)
                      .++|+..+.||+|+||.||+|+.. +++.+|+|.+......+ ....+.+|+++++.++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            467888899999999999999875 58899999986543222 2235788999999999999999999875533      


Q ss_pred             --eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhh
Q 013682          357 --EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  434 (438)
Q Consensus       357 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df  434 (438)
                        ..+++|||+.+ ++...+....   ..+++.++..++.|+++||+|||+.   +|+||||||+||++++++.++++||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence              35899999975 6777665432   2489999999999999999999999   9999999999999999999999998


Q ss_pred             h
Q 013682          435 L  435 (438)
Q Consensus       435 ~  435 (438)
                      .
T Consensus       160 g  160 (311)
T cd07866         160 G  160 (311)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.80  E-value=2.4e-19  Score=171.44  Aligned_cols=141  Identities=30%  Similarity=0.476  Sum_probs=123.0

Q ss_pred             CCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecC
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      |+..+.||+|+||.||+|+.. +++.||+|.++..... .....+..|+.+++.++|+|++++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            445678999999999999975 5889999998764322 22346788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      + ++|.+++....   ..+++..+..++.|++.|++|||++   +|+||||+|+||++++++.++++||.
T Consensus        81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g  143 (282)
T cd07829          81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFG  143 (282)
T ss_pred             C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCC
Confidence            8 58999987642   2489999999999999999999999   99999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.80  E-value=3.5e-19  Score=167.17  Aligned_cols=136  Identities=32%  Similarity=0.356  Sum_probs=120.5

Q ss_pred             cccccceEEEEEEeC-CCCEEEEEEcccccccc--chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCCCH
Q 013682          294 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  370 (438)
Q Consensus       294 LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  370 (438)
                      ||+|+||.||++... +++.+|+|.++......  ....+.+|+.+++.++|||++++++.+...+..+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999875 58899999986543322  234688999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          371 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       371 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      .+++....    .+++.....++.|++.|+.|+|+.   +++|+||||+||++++++.++++||..
T Consensus        81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~  139 (250)
T cd05123          81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGL  139 (250)
T ss_pred             HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCc
Confidence            99997643    478999999999999999999998   999999999999999999999999863

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.80  E-value=2.5e-19  Score=171.33  Aligned_cols=141  Identities=26%  Similarity=0.436  Sum_probs=122.7

Q ss_pred             CCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecC
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      |+..+.||+|++|.||+|... +++.+|+|.++..... .....+.+|+.+++.++|+||+++++++...+..++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            445678999999999999874 6889999998654332 22346888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++ ++.+.+....   ..+++..+..++.|++.|++|||+.   +|+|+||||+||++++++.++++||.
T Consensus        81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~  143 (283)
T cd05118          81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFG  143 (283)
T ss_pred             CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeee
Confidence            75 8888887643   2589999999999999999999999   99999999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.80  E-value=4.6e-19  Score=172.56  Aligned_cols=141  Identities=31%  Similarity=0.455  Sum_probs=120.2

Q ss_pred             CCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      |+..+.||+|+||.||+|+.. +++.+|+|.+.....  .....++.+|+.+++.++|+|++++.+++......++||||
T Consensus        17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   96 (308)
T cd06634          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (308)
T ss_pred             HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence            555678999999999999974 578899998854221  12234678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +. |++.+.+....   ..+++.++..++.|++.|+.|||+.   +++||||||+||+++.++.++++||.
T Consensus        97 ~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg  160 (308)
T cd06634          97 CL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG  160 (308)
T ss_pred             cC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcc
Confidence            96 68877775432   2478899999999999999999998   99999999999999999999999996

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.80  E-value=4e-19  Score=174.83  Aligned_cols=142  Identities=24%  Similarity=0.343  Sum_probs=117.3

Q ss_pred             CCCCCCccccccceEEEEEEeC-C--CCEEEEEEcccccccc-chHHHHHHHHHHhcC-CCCCceeeEEEEeeC----Ce
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-D--GKLVAVKRLKEERTSG-GELQFQTEVKIISMA-VHRNLLRLYGFCTTV----TE  357 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~--~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~  357 (438)
                      +|...+.||+|+||.||+++.. +  +..||+|.++...... ....+.+|+.++..+ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            3566788999999999999874 3  6789999986532222 234678899999988 599999999875432    45


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      .++++||+. ++|.+.+....    .+++.....++.|++.||+|||+.   +|+||||||+||++++++.++|+||..
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~  151 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGL  151 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence            688889886 68988886532    488999999999999999999999   999999999999999999999999963

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.79  E-value=3.1e-20  Score=197.96  Aligned_cols=144  Identities=33%  Similarity=0.445  Sum_probs=124.5

Q ss_pred             CCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          287 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      +++....||.|.||.||-|.. .+|...|||.++..... .......+|..++..++|||+|+++|+=...+..++.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            456678899999999999974 57899999988654322 2234688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhhc
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRR  437 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~~  437 (438)
                      |++|+|.+.++..+.    .++.....+..|++.|++|||++   +|||||+||+||++|.+|-.|.+||+..
T Consensus      1316 C~~GsLa~ll~~gri----~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRI----EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred             hccCcHHHHHHhcch----hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccce
Confidence            999999999976532    45666677889999999999999   9999999999999999999999999864

>PRK10345 hypothetical protein; Provisional

Probab=99.79  E-value=6.4e-19  Score=161.08  Aligned_cols=133  Identities=18%  Similarity=0.240  Sum_probs=102.3

Q ss_pred             CCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcC-----CCCCceeeEEEEeeCC---eeE
Q 013682          289 SNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-----VHRNLLRLYGFCTTVT---EKL  359 (438)
Q Consensus       289 ~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~~~  359 (438)
                      ...+.||+|+||.||.  ++ ++.. +||++.... ......+.+|+..+..+     .||||++++|++.+..   ..+
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            4457899999999996  43 3444 688875432 22345789999999999     5799999999998864   333


Q ss_pred             -EEEec--CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCceecCCCCCCeeeCC----CCCcch
Q 013682          360 -LVYPY--MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL-SYLHEHCDPKIIHRDVKAANILLDE----DADQSS  431 (438)
Q Consensus       360 -lv~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivHrDLK~~NILld~----~~~~~l  431 (438)
                       +|+||  +.+|+|.+++.+.     .+++.  ..++.++..++ +|||++   +|+||||||+|||++.    ++.++|
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~L  150 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVV  150 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEE
Confidence             78999  6689999999653     14444  35567777777 999999   9999999999999974    347899


Q ss_pred             hhhh
Q 013682          432 KTIL  435 (438)
Q Consensus       432 ~Df~  435 (438)
                      +||+
T Consensus       151 iDg~  154 (210)
T PRK10345        151 CDNI  154 (210)
T ss_pred             EECC
Confidence            9943

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.79  E-value=1.3e-19  Score=179.20  Aligned_cols=145  Identities=23%  Similarity=0.296  Sum_probs=122.7

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc----ccc---hHHHHHHHHHHhcCC---CCCceeeEEEEee
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT----SGG---ELQFQTEVKIISMAV---HRNLLRLYGFCTT  354 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~----~~~---~~~~~~E~~~l~~l~---H~niv~l~g~~~~  354 (438)
                      .+|...+.+|+|+||.|+.|.++ +...|.||.+.+++-    +-.   .-..-.|+.+|+.++   |+||++++.+|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            35777889999999999999875 466899998865431    111   113557999999997   9999999999999


Q ss_pred             CCeeEEEEecC-CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhh
Q 013682          355 VTEKLLVYPYM-TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKT  433 (438)
Q Consensus       355 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~D  433 (438)
                      .+..|++||-. ++-+|++++..+    +.+++.++..|+.||+.|.++||++   +|||||||-+||.+|.+|-+|+.|
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~k----p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFK----PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhcc----CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence            99999999965 445899998654    3589999999999999999999999   999999999999999999999999


Q ss_pred             hhhc
Q 013682          434 ILRR  437 (438)
Q Consensus       434 f~~~  437 (438)
                      |+..
T Consensus       714 fgsa  717 (772)
T KOG1152|consen  714 FGSA  717 (772)
T ss_pred             ccch
Confidence            9853

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.79  E-value=4.7e-19  Score=182.86  Aligned_cols=148  Identities=30%  Similarity=0.436  Sum_probs=128.1

Q ss_pred             HHHHhCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEee----
Q 013682          281 LQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT----  354 (438)
Q Consensus       281 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----  354 (438)
                      +...++-|.+.+++|+|.+|+||+++. ++++.+|+|++....  +...+.+.|.++++.. +|||++.++|++.-    
T Consensus        14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~--d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~   91 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE--DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG   91 (953)
T ss_pred             CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc--cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence            344567788889999999999999985 578899999886543  3344677888888766 69999999999864    


Q ss_pred             -CCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhh
Q 013682          355 -VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKT  433 (438)
Q Consensus       355 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~D  433 (438)
                       ++++|||||||.+||..+.+....  ..+++|.....|...++.|+.|||..   .++|||+|-.|||++.++.+|+.|
T Consensus        92 ~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvD  166 (953)
T KOG0587|consen   92 NGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVD  166 (953)
T ss_pred             CCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEee
Confidence             678999999999999999998765  45699999999999999999999999   999999999999999999999999


Q ss_pred             hh
Q 013682          434 IL  435 (438)
Q Consensus       434 f~  435 (438)
                      |+
T Consensus       167 FG  168 (953)
T KOG0587|consen  167 FG  168 (953)
T ss_pred             ee
Confidence            96

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.78  E-value=6.9e-19  Score=164.68  Aligned_cols=127  Identities=21%  Similarity=0.218  Sum_probs=110.1

Q ss_pred             ccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCCCHHHHhh
Q 013682          297 GGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR  375 (438)
Q Consensus       297 G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~  375 (438)
                      |.||.||+++.. +++.||+|.++...      .+.+|...+....|||++++++++...+..+++|||+++|+|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            889999999874 68899999986532      23344555556679999999999999999999999999999999987


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          376 ERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       376 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ...    .+++.....++.|++.||+|||+.   +|+||||||+||++++++.++++||..
T Consensus        78 ~~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~  131 (237)
T cd05576          78 KFL----NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSR  131 (237)
T ss_pred             Hhc----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccc
Confidence            643    388999999999999999999998   999999999999999999999999863

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.78  E-value=3.9e-19  Score=175.79  Aligned_cols=143  Identities=25%  Similarity=0.367  Sum_probs=122.3

Q ss_pred             HhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCe----
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE----  357 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----  357 (438)
                      ..++|+..+.||+|+||.||+|+.. +++.||+|.+...... .....+.+|+.+++.++|||++++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4567888899999999999999975 5789999998643222 223457789999999999999999988766554    


Q ss_pred             --eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          358 --KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       358 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                        .++|+||+ +++|.+++...     .+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++++||.
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKCQ-----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence              89999998 56998888652     489999999999999999999998   99999999999999999999999996

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.78  E-value=1.2e-19  Score=166.91  Aligned_cols=140  Identities=25%  Similarity=0.317  Sum_probs=117.1

Q ss_pred             hCCCCCC-CccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEee----CCe
Q 013682          285 TDGFSNK-NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT----VTE  357 (438)
Q Consensus       285 ~~~~~~~-~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~  357 (438)
                      +++|+.. ++||-|-.|+|-.+..+ +++.+|+|++...      ....+|++..-+. .|||||+++++|+.    ...
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            4556543 68999999999998764 6889999988432      2467888876655 59999999998865    455


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC---CCcchhhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED---ADQSSKTI  434 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~---~~~~l~Df  434 (438)
                      ..+|||+|+||.|++.+.++..  ..+++.++-.|+.||+.|+.|||+.   +|.||||||+|+|..+.   ...|++||
T Consensus       134 LLiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             eEeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccc
Confidence            7899999999999999988643  4589999999999999999999999   99999999999999864   45699998


Q ss_pred             h
Q 013682          435 L  435 (438)
Q Consensus       435 ~  435 (438)
                      +
T Consensus       209 G  209 (400)
T KOG0604|consen  209 G  209 (400)
T ss_pred             c
Confidence            6

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.78  E-value=7.4e-19  Score=173.73  Aligned_cols=140  Identities=25%  Similarity=0.361  Sum_probs=117.5

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeC---------
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV---------  355 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~---------  355 (438)
                      .+|...+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.++||||+++++++...         
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            56778899999999999999864 688999999865432 3344688999999999999999999776543         


Q ss_pred             -----CeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC-CCc
Q 013682          356 -----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQ  429 (438)
Q Consensus       356 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~-~~~  429 (438)
                           ...+++|||+. ++|.+.+...     .+++.....++.|++.||+|||+.   +|+||||||+||+++.+ +.+
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence                 35789999997 5888887542     378999999999999999999999   99999999999999854 567


Q ss_pred             chhhhh
Q 013682          430 SSKTIL  435 (438)
Q Consensus       430 ~l~Df~  435 (438)
                      +++||.
T Consensus       155 kl~dfg  160 (342)
T cd07854         155 KIGDFG  160 (342)
T ss_pred             EECCcc
Confidence            999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.77  E-value=1.5e-19  Score=173.69  Aligned_cols=146  Identities=25%  Similarity=0.351  Sum_probs=121.1

Q ss_pred             CCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccch------HHHHHHHHHHhcCCCCCceeeEEEEee-CCee
Q 013682          287 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGE------LQFQTEVKIISMAVHRNLLRLYGFCTT-VTEK  358 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~  358 (438)
                      +|-..++||+|+|++||+|.. ...+.||||+-.....+..+      +...+|-.+.+.++||.||++|+++.- .+..
T Consensus       464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF  543 (775)
T KOG1151|consen  464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF  543 (775)
T ss_pred             HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence            355567899999999999974 45788999975433333222      246789999999999999999999875 4567


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC---CCCcchhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTIL  435 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~---~~~~~l~Df~  435 (438)
                      +-|+|||+|.+|+-+|+..+    .+++.++..|+.||+.||.||.+. +|+|||-||||.|||+-+   -|+.||.||+
T Consensus       544 CTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  544 CTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             eeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            89999999999999998764    388999999999999999999997 789999999999999965   3788999997


Q ss_pred             hc
Q 013682          436 RR  437 (438)
Q Consensus       436 ~~  437 (438)
                      =+
T Consensus       619 LS  620 (775)
T KOG1151|consen  619 LS  620 (775)
T ss_pred             hh
Confidence            43

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.77  E-value=2.3e-20  Score=168.96  Aligned_cols=145  Identities=26%  Similarity=0.361  Sum_probs=115.9

Q ss_pred             CCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHH-hcCCCCCceeeEEEEeeCCeeEEEEecC
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      .+....||.|+||+|+|-.++ .|+..|||+++......++.++..|.+.. +.-+-||||+++|.+..++..|+-||+|
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM  145 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM  145 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence            344567999999999998874 69999999998766555566788888755 4457899999999999999999999999


Q ss_pred             CCCCHHHHhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          366 TNGSVASRLRERQ-SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       366 ~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      .- |+..+-.... .....+++.-.-.|......||.||-...  .|||||+||+|||+|..|++|++||+
T Consensus       146 d~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFG  213 (361)
T KOG1006|consen  146 DI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFG  213 (361)
T ss_pred             hh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeeccc
Confidence            64 6554433211 11234677777788888899999998753  89999999999999999999999996

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.77  E-value=1.2e-19  Score=172.99  Aligned_cols=145  Identities=24%  Similarity=0.330  Sum_probs=123.2

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc--cchHHHHHHHHHHhcC-CCCCceeeEEEEeeCCeeEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  360 (438)
                      ..+|....+||+|+||+|..|+.+ +.+.+|||+++++..-  +..+--+.|-++++.. +-|.++++..++++.+.+|.
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            446888899999999999999865 4678999999876532  2222234566666655 57889999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||||+.+|+|.-.+++..    .+.++.+..+|..||-||-|||++   +||+||||..|||+|.+|.+||+||+-
T Consensus       428 VMEyvnGGDLMyhiQQ~G----kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGm  496 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVG----KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGM  496 (683)
T ss_pred             EEEEecCchhhhHHHHhc----ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccc
Confidence            999999999999988754    378889999999999999999999   999999999999999999999999973

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.76  E-value=3.9e-18  Score=164.95  Aligned_cols=143  Identities=21%  Similarity=0.256  Sum_probs=104.9

Q ss_pred             hCCCCCCCccccccceEEEEEEeCC----CCEEEEEEccccccccc-h---------HHHHHHHHHHhcCCCCCceeeEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGG-E---------LQFQTEVKIISMAVHRNLLRLYG  350 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~~----~~~vAvK~l~~~~~~~~-~---------~~~~~E~~~l~~l~H~niv~l~g  350 (438)
                      .++|+..+.||+|+||.||+|++.+    +..+|+|.......... +         .....+...+..+.|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3578888999999999999998753    34566665322211100 0         01223334556778999999999


Q ss_pred             EEeeCC----eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC
Q 013682          351 FCTTVT----EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED  426 (438)
Q Consensus       351 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~  426 (438)
                      ++....    ..++++|++.. ++.+.+....    ..++.....++.|++.||+|||+.   +|+||||||+|||++++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~  162 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN  162 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence            776543    34677887643 5665554321    256788899999999999999998   99999999999999999


Q ss_pred             CCcchhhhh
Q 013682          427 ADQSSKTIL  435 (438)
Q Consensus       427 ~~~~l~Df~  435 (438)
                      +.++++||+
T Consensus       163 ~~~~l~DFG  171 (294)
T PHA02882        163 NRGYIIDYG  171 (294)
T ss_pred             CcEEEEEcC
Confidence            999999996

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.76  E-value=1.4e-20  Score=169.08  Aligned_cols=141  Identities=32%  Similarity=0.537  Sum_probs=116.6

Q ss_pred             CCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccc-hHHHHHHHHHHhcCCCCCceeeEEEEee--------CCe
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTT--------VTE  357 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~~~  357 (438)
                      |.....+|+|.||+||+|+.+ +++.||+|+.--+....+ -....+|+.++..++|+|++.++..|..        ...
T Consensus        19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t   98 (376)
T KOG0669|consen   19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT   98 (376)
T ss_pred             HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence            334467999999999999875 577899987532222222 2357899999999999999999988864        234


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      .|+|+++|+. +|...|.+..   .+++..+...++.++..||.|+|+.   .|+|||+||+|+||+.++..+++||+
T Consensus        99 ~ylVf~~ceh-DLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   99 FYLVFDFCEH-DLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             eeeeHHHhhh-hHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence            7899999986 8888887643   3588899999999999999999999   99999999999999999999999997

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.75  E-value=1.2e-17  Score=153.57  Aligned_cols=143  Identities=34%  Similarity=0.473  Sum_probs=124.6

Q ss_pred             CCCCCccccccceEEEEEEeCC-CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCC
Q 013682          288 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  366 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~~-~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  366 (438)
                      |...+.||+|++|.||++...+ ++.+|+|.+...........+.+|+..+..++|+|++++++++...+..++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            3456789999999999999864 889999998654332134578899999999999999999999999899999999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          367 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       367 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      +++|.+++.....   .+++.....++.+++.++.|||..   +++|+|++|+||+++.++.++++||..
T Consensus        81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~  144 (225)
T smart00221       81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGL  144 (225)
T ss_pred             CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCce
Confidence            9999999876432   178899999999999999999999   999999999999999999999999863

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.75  E-value=2e-17  Score=149.44  Aligned_cols=136  Identities=37%  Similarity=0.541  Sum_probs=120.3

Q ss_pred             cccccceEEEEEEeCC-CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCCCHHH
Q 013682          294 LGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVAS  372 (438)
Q Consensus       294 LG~G~fG~Vy~~~~~~-~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~  372 (438)
                      ||+|++|.||++...+ ++.+++|.++..........+.+|+..+..++|++++++++++......++++||+.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999854 889999998654332223578999999999999999999999999899999999999999999


Q ss_pred             HhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC-CCCcchhhhh
Q 013682          373 RLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTIL  435 (438)
Q Consensus       373 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~-~~~~~l~Df~  435 (438)
                      ++....   ..+++..+..++.+++++++|||+.   +++|+||+|.||++++ ++.++++||.
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~  138 (215)
T cd00180          81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFG  138 (215)
T ss_pred             HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCC
Confidence            987642   2478999999999999999999999   9999999999999999 8999999985

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.74  E-value=2.7e-19  Score=179.53  Aligned_cols=145  Identities=28%  Similarity=0.407  Sum_probs=127.8

Q ss_pred             HhCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ..++|.....+|.|.||.||||+. ..++..|+|.++-...+ ...-.+.|+-+++..+|||||.++|.+...+..|+.|
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d-d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD-DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc-cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            346788889999999999999986 46889999999876543 3335788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |||.+|+|++.-+-.    .++++.+...+++...+|++|||+.   +-+|||+|-.|||+.++|+++++||..
T Consensus        92 EycgggslQdiy~~T----gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgv  158 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGV  158 (829)
T ss_pred             EecCCCcccceeeec----ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCc
Confidence            999999998876543    3588889999999999999999999   889999999999999999999999975

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.73  E-value=1.6e-18  Score=157.59  Aligned_cols=140  Identities=25%  Similarity=0.423  Sum_probs=114.0

Q ss_pred             CCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCC-CCCceeeEEEEeeCCeeEEEEecCCC
Q 013682          290 NKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPYMTN  367 (438)
Q Consensus       290 ~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~  367 (438)
                      ....||.|.-|.|++++++ +|..+|||.+.......+.+++...+.++.+-+ .|.||+.+|+|......++.||.|..
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~  175 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST  175 (391)
T ss_pred             hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence            3456999999999999975 588999999976544444456777777666554 89999999999999999999999853


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          368 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                       -.+..++.-+.   ++++.-.-++...+..||.||.+.+  +|+|||+||+|||+|+.|++|++||+
T Consensus       176 -C~ekLlkrik~---piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFG  237 (391)
T KOG0983|consen  176 -CAEKLLKRIKG---PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFG  237 (391)
T ss_pred             -HHHHHHHHhcC---CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccc
Confidence             44555554332   4667677788889999999998865  89999999999999999999999996

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.73  E-value=2.9e-18  Score=159.77  Aligned_cols=147  Identities=25%  Similarity=0.340  Sum_probs=126.1

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccch--HHHHHHHHHHhcC-CCCCceeeEEEEeeCCe
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGE--LQFQTEVKIISMA-VHRNLLRLYGFCTTVTE  357 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~--~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  357 (438)
                      ....++|...++||+|+|++|..+++ ++.+.+|+|++|++...+.+  ...+.|-.+.... +||.+|.+..++.++..
T Consensus       246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr  325 (593)
T KOG0695|consen  246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR  325 (593)
T ss_pred             ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence            34567899999999999999999987 46889999999875433222  2456677777655 79999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      .+.|.||+++|+|.-+++..+    .+++..+..+...|..||.|||++   +||+||||..|||+|.+|..|+.|++
T Consensus       326 lffvieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdyg  396 (593)
T KOG0695|consen  326 LFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYG  396 (593)
T ss_pred             EEEEEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccc
Confidence            999999999999988776654    388899999999999999999999   99999999999999999999999975

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.72  E-value=3.1e-17  Score=150.72  Aligned_cols=131  Identities=17%  Similarity=0.220  Sum_probs=109.7

Q ss_pred             CccccccceEEEEEEeCCCCEEEEEEccccccccc-------hHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          292 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG-------ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      +.||+|++|.||+|.+ ++..|++|..........       ...+.+|+..+..+.|+++.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5689999999999987 677899998654322111       12577899999999999998877777777888999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++++|.+.+...       .+ .+..++.+++.++.++|+.   +++|||++|+|||++ ++.++++||.
T Consensus        81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~  139 (211)
T PRK14879         81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFG  139 (211)
T ss_pred             eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECC
Confidence            9999999988542       22 7788999999999999999   999999999999999 7889999995

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.72  E-value=2e-18  Score=153.30  Aligned_cols=137  Identities=21%  Similarity=0.347  Sum_probs=114.3

Q ss_pred             hCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCC-CCCceeeEEEEeeCC--eeEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVT--EKLL  360 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~l  360 (438)
                      .++|+..+.+|+|.|++||.|.. .+++.+.||.++...    .+.+.+|+.++..+. |||||++++...++.  ...+
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            35677789999999999999974 567889999997542    346899999999997 999999999988754  4579


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC-CCcchhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTIL  435 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~-~~~~l~Df~  435 (438)
                      ++||+.+-+....-..       ++-.+...+..++..||.|+|+.   ||+|||+||+|+++|.+ -..++.|.+
T Consensus       113 iFE~v~n~Dfk~ly~t-------l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWG  178 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLYPT-------LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWG  178 (338)
T ss_pred             HhhhhccccHHHHhhh-------hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecc
Confidence            9999999887655432       56678889999999999999999   99999999999999975 456777753

>smart00090 RIO RIO-like kinase

Probab=99.71  E-value=2.1e-17  Score=154.45  Aligned_cols=138  Identities=14%  Similarity=0.117  Sum_probs=105.1

Q ss_pred             CCCCCCccccccceEEEEEE--eCCCCEEEEEEcccccccc-----------------------chHHHHHHHHHHhcCC
Q 013682          287 GFSNKNILGRGGFGKVYKGR--LADGKLVAVKRLKEERTSG-----------------------GELQFQTEVKIISMAV  341 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~--~~~~~~vAvK~l~~~~~~~-----------------------~~~~~~~E~~~l~~l~  341 (438)
                      .|...+.||+|+||.||+|.  ..+|+.||+|.++......                       ....+.+|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            36777899999999999998  4679999999986432110                       0113568999999887


Q ss_pred             CCC--ceeeEEEEeeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-ceecCCCC
Q 013682          342 HRN--LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK-IIHRDVKA  418 (438)
Q Consensus       342 H~n--iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivHrDLK~  418 (438)
                      +..  +.++++.    ...++||||++++++.......    ......+...++.|++.+++|||+.   + |+|||+||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp  177 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE  177 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence            633  3344432    2358999999998876654221    1245566788999999999999999   8 99999999


Q ss_pred             CCeeeCCCCCcchhhhhh
Q 013682          419 ANILLDEDADQSSKTILR  436 (438)
Q Consensus       419 ~NILld~~~~~~l~Df~~  436 (438)
                      +||+++ +++.++.||..
T Consensus       178 ~NIli~-~~~i~LiDFg~  194 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQ  194 (237)
T ss_pred             hhEEEE-CCCEEEEEChh
Confidence            999999 88999999974

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.71  E-value=1.3e-17  Score=174.70  Aligned_cols=145  Identities=23%  Similarity=0.239  Sum_probs=101.6

Q ss_pred             HhCCCCCCCccccccceEEEEEEeC-C----CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEE------E
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLA-D----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF------C  352 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~----~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------~  352 (438)
                      ..++|+..+.||+|+||.||+|++. +    +..||+|+++...   ....+..|.  +....+.++..+...      +
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~---~~e~~~~e~--l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG---AVEIWMNER--VRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc---hhHHHHHHH--HHhhchhhHHHHHHhhhccccc
Confidence            4678999999999999999999874 4    6899999875421   111111111  112222222222211      2


Q ss_pred             eeCCeeEEEEecCCCCCHHHHhhccCCC----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCC
Q 013682          353 TTVTEKLLVYPYMTNGSVASRLRERQSS----------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV  416 (438)
Q Consensus       353 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDL  416 (438)
                      ......++||||+.+++|.+++......                ...........++.|++.||+|||++   +|+||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL  281 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV  281 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence            4566789999999999999998754210                00112234557899999999999998   9999999


Q ss_pred             CCCCeeeCC-CCCcchhhhhh
Q 013682          417 KAANILLDE-DADQSSKTILR  436 (438)
Q Consensus       417 K~~NILld~-~~~~~l~Df~~  436 (438)
                      ||+|||+++ ++.++|+||+-
T Consensus       282 KP~NILl~~~~~~~KL~DFGl  302 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGA  302 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCC
Confidence            999999996 57899999973

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.71  E-value=5.3e-17  Score=150.64  Aligned_cols=132  Identities=35%  Similarity=0.484  Sum_probs=117.2

Q ss_pred             cceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCCCHHHHhhc
Q 013682          298 GFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE  376 (438)
Q Consensus       298 ~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~  376 (438)
                      +||.||+|... +++.+|+|++...........+.+|+..++.++|+|++++++.+......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999986 48899999986544332245799999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          377 RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       377 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ...    +++.....++.+++.++.|||..   +++|+|++|+||++++++.++++||..
T Consensus        81 ~~~----~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~  133 (244)
T smart00220       81 RGR----LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGL  133 (244)
T ss_pred             ccC----CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccc
Confidence            432    78899999999999999999999   999999999999999999999999864

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.70  E-value=1.2e-18  Score=170.16  Aligned_cols=144  Identities=24%  Similarity=0.290  Sum_probs=124.7

Q ss_pred             hCCCCCCCccccccceEEEEEEeCCC-CEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLADG-KLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~~~-~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      ..+++....||-|+||.|=..+.... ..+|+|.+++..-  ...+.....|-.+|...+.|.||++|..|.+....|+.
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            34566667899999999998886543 3589999876432  22334577889999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||-|-||.+...|+++..    ++...+..++..+.+|++|||++   +||+|||||+|.++|.+|-+|+.||+
T Consensus       499 mEaClGGElWTiLrdRg~----Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFG  565 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRGS----FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFG  565 (732)
T ss_pred             HHhhcCchhhhhhhhcCC----cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehh
Confidence            999999999999998753    88889999999999999999999   99999999999999999999999996

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.70  E-value=5.3e-17  Score=147.87  Aligned_cols=133  Identities=22%  Similarity=0.162  Sum_probs=103.6

Q ss_pred             CCCCCCccccccceEEEEEEeCCCCEEEEEEcccccccc---------------------chHHHHHHHHHHhcCCCCC-
Q 013682          287 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG---------------------GELQFQTEVKIISMAVHRN-  344 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~---------------------~~~~~~~E~~~l~~l~H~n-  344 (438)
                      -|...+.||+|+||.||++..++|+.||||+++......                     ....+.+|...+..+.|++ 
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            366778999999999999998889999999875422100                     0112567888888888874 


Q ss_pred             -ceeeEEEEeeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee
Q 013682          345 -LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  423 (438)
Q Consensus       345 -iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILl  423 (438)
                       +...++    ....+++|||+++++|......          .....++.+++.++.++|+.   +|+||||||+||++
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill  158 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILV  158 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEE
Confidence             444443    2456899999999998754321          23467888999999999998   99999999999999


Q ss_pred             CCCCCcchhhhhh
Q 013682          424 DEDADQSSKTILR  436 (438)
Q Consensus       424 d~~~~~~l~Df~~  436 (438)
                      ++++.++++||+.
T Consensus       159 ~~~~~~~liDfg~  171 (198)
T cd05144         159 DDDEKIYIIDWPQ  171 (198)
T ss_pred             cCCCcEEEEECCc
Confidence            9999999999975

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.70  E-value=5.9e-17  Score=147.47  Aligned_cols=127  Identities=17%  Similarity=0.233  Sum_probs=102.8

Q ss_pred             ccccccceEEEEEEeCCCCEEEEEEccccccccc-------hHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecC
Q 013682          293 ILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG-------ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       293 ~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      .||+|+||.||+|.+ ++..|++|..........       ...+.+|+.++..++|+++.....++...+..+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            379999999999996 577899998644321111       135778999999999988766555666677789999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++++|.+.+....           ..++.+++.++.++|+.   +++|||+||+||+++ ++.+++.||.
T Consensus        80 ~g~~l~~~~~~~~-----------~~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg  134 (199)
T TIGR03724        80 EGKPLKDVIEEGN-----------DELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFG  134 (199)
T ss_pred             CCccHHHHHhhcH-----------HHHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECC
Confidence            9999998875421           07889999999999999   999999999999999 7899999985

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.70  E-value=1.5e-17  Score=151.23  Aligned_cols=141  Identities=20%  Similarity=0.314  Sum_probs=116.0

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEE-EeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGF-CTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~lv~  362 (438)
                      +.|.+.+.+|+|.||++-.++++ ..+.+++|.++...+  ...+|.+|-.---.+ .|.||+.-+.+ |++.+....++
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t--t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT--TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh--hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            56778899999999999999986 467899999865432  345799998654344 59999988764 66777788999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC--CCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE--DADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~--~~~~~l~Df~~  436 (438)
                      ||++.|+|.+-+...     .+.+....+++.|+++|++|||+.   ++||||||.+||||-+  ...+|++||+-
T Consensus       102 E~aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~  169 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGL  169 (378)
T ss_pred             ccCccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccc
Confidence            999999999887653     267788899999999999999999   9999999999999953  35789999973

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.70  E-value=2e-17  Score=170.09  Aligned_cols=141  Identities=29%  Similarity=0.331  Sum_probs=111.4

Q ss_pred             CCCCCccccccce-EEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEeeCCeeEEEEecC
Q 013682          288 FSNKNILGRGGFG-KVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       288 ~~~~~~LG~G~fG-~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      |...+++|.|+.| .||+|.+ +++.||||++-...    ..-..+|+.+++.- +|||||++++.-.++...|+..|.|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            4556789999998 5899998 58899999984322    22467999998877 5999999998888888899999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC---C--CCcchhhhhhc
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---D--ADQSSKTILRR  437 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~---~--~~~~l~Df~~~  437 (438)
                      . -+|.+++...........-.....+..|++.|++|||+.   +||||||||.||||+.   +  ..|+|+||...
T Consensus       586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls  658 (903)
T KOG1027|consen  586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLS  658 (903)
T ss_pred             h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccc
Confidence            6 599999976411111111134577888999999999998   9999999999999986   3  47899999854

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.69  E-value=1.2e-16  Score=167.01  Aligned_cols=134  Identities=15%  Similarity=0.194  Sum_probs=106.8

Q ss_pred             CCCCCCCccccccceEEEEEEeCCCCEEEEEE-ccccccc------cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCee
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKR-LKEERTS------GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  358 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~-l~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  358 (438)
                      ..|...+.||+|+||.||+|.+.+.. +++|+ .......      .....+.+|+.++..++|++++....++......
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            34456789999999999999885443 34443 2211111      1123588999999999999999888888777788


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ++||||+++++|.+++.            ....++.+++.++.|||+.   +++|||+||+|||+ +++.++++||.-
T Consensus       412 ~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGl  473 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGL  473 (535)
T ss_pred             EEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcc
Confidence            99999999999998875            3467899999999999999   99999999999999 578899999963

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.68  E-value=1e-16  Score=147.33  Aligned_cols=137  Identities=9%  Similarity=0.088  Sum_probs=110.2

Q ss_pred             HHhCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccch--HH------HHHHHHHHhcCCCCCceeeEEEEee
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGE--LQ------FQTEVKIISMAVHRNLLRLYGFCTT  354 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~--~~------~~~E~~~l~~l~H~niv~l~g~~~~  354 (438)
                      ....+|...+++|+|+||.||.+.. ++..+|+|.++........  ..      +++|+..+.++.||+|..+..++..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            3457889999999999999999765 5678999999765432221  12      6899999999999999999888653


Q ss_pred             C--------CeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC
Q 013682          355 V--------TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED  426 (438)
Q Consensus       355 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~  426 (438)
                      .        ...+++|||++|.+|.++..        ++.    ....+++.++..+|+.   +++|||+||+|++++++
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~  171 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN  171 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence            3        35789999999999977631        222    2455899999999999   99999999999999998


Q ss_pred             CCcchhhhhh
Q 013682          427 ADQSSKTILR  436 (438)
Q Consensus       427 ~~~~l~Df~~  436 (438)
                      + +++.||..
T Consensus       172 g-i~liDfg~  180 (232)
T PRK10359        172 G-LRIIDLSG  180 (232)
T ss_pred             C-EEEEECCC
Confidence            8 99999963

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.67  E-value=6.5e-18  Score=153.62  Aligned_cols=139  Identities=25%  Similarity=0.338  Sum_probs=112.8

Q ss_pred             CCCCccccccceEEEEEEe-CCCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeC-----CeeEEE
Q 013682          289 SNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TEKLLV  361 (438)
Q Consensus       289 ~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lv  361 (438)
                      +..+.||-|+||+||.... ++|+.||.|++...... ...+.+.+|..++.-.+|.|+...++....+     .+.|.+
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            3457899999999999886 47999999998543211 1234688999999999999999998876543     346778


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +|+|. .+|...+-...    .++-.....+..||.+||.|||+.   +|.||||||.|.|++++...||+||+
T Consensus       136 TELmQ-SDLHKIIVSPQ----~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFG  201 (449)
T KOG0664|consen  136 TELMQ-SDLHKIIVSPQ----ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFG  201 (449)
T ss_pred             HHHHH-hhhhheeccCC----CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccc
Confidence            88885 47766665432    477778888899999999999999   99999999999999999999999996

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.67  E-value=3.7e-16  Score=140.93  Aligned_cols=128  Identities=18%  Similarity=0.134  Sum_probs=100.7

Q ss_pred             CCCccccccceEEEEEEeCCCCEEEEEEccccccccc---hHHHHHHHHHHhcCC-CCCceeeEEEEeeCCeeEEEEecC
Q 013682          290 NKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG---ELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       290 ~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~---~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      ....|++|+||+||.+.. ++..++.+.+........   ...+.+|++++.++. |+++++++++    +..+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            346799999999997765 577788777755432211   124789999999995 5789998885    4579999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCC-CCCCeeeCCCCCcchhhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV-KAANILLDEDADQSSKTILR  436 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDL-K~~NILld~~~~~~l~Df~~  436 (438)
                      ++.+|.+....           ....+..|++.+++|+|++   +|+|||| ||+|||+++++.++|+||..
T Consensus        81 ~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~  138 (218)
T PRK12274         81 AGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQL  138 (218)
T ss_pred             cCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCC
Confidence            99998654321           1134678899999999999   9999999 79999999999999999974

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.67  E-value=6.8e-17  Score=162.55  Aligned_cols=139  Identities=24%  Similarity=0.319  Sum_probs=115.7

Q ss_pred             hCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHh-cCCCCCceeeEEEEeeCCeeEEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++.|.....+|+|+|+.|.++.. .+++..|||++....     .+-.+|+.++. .-+||||+++.+.+.+..+.|+||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            56677777899999999999876 468889999986541     12345664444 447999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee-CCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL-DEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILl-d~~~~~~l~Df~~  436 (438)
                      |++.++-+.+.++....    .. .++..++.+++.|+.|||++   +||||||||+|||+ ++.++.+++||++
T Consensus       396 e~l~g~ell~ri~~~~~----~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~  462 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKPE----FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGF  462 (612)
T ss_pred             hhccccHHHHHHHhcch----hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEech
Confidence            99999988877766432    23 67888999999999999999   99999999999999 5889999999985

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.64  E-value=1.5e-16  Score=151.16  Aligned_cols=154  Identities=24%  Similarity=0.320  Sum_probs=128.2

Q ss_pred             HHHHHHHhCCCCCCCccccccceEEEEEEeCC------CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEE
Q 013682          278 LRELQVATDGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF  351 (438)
Q Consensus       278 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~------~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~  351 (438)
                      .+++.+..++++....+-+|.||.||+|.|.+      .+.|-||.++...++-....+..|...+..+.|||+.++.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            45666777788888899999999999997753      346788888776655555568899999999999999999999


Q ss_pred             EeeC-CeeEEEEecCCCCCHHHHhhccCCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC
Q 013682          352 CTTV-TEKLLVYPYMTNGSVASRLRERQSS----LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED  426 (438)
Q Consensus       352 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~  426 (438)
                      +.+. +..+..|.++.-|+|..+|+..+..    ...++-.+...+|.|++.|++|||.+   +|||.||.++|++||+.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence            8764 4568889999999999999943322    22466778899999999999999999   99999999999999999


Q ss_pred             CCcchhhh
Q 013682          427 ADQSSKTI  434 (438)
Q Consensus       427 ~~~~l~Df  434 (438)
                      ..+|++|=
T Consensus       433 LqVkltDs  440 (563)
T KOG1024|consen  433 LQVKLTDS  440 (563)
T ss_pred             eeEEeccc
Confidence            99999883

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.64  E-value=4.1e-16  Score=154.09  Aligned_cols=142  Identities=21%  Similarity=0.281  Sum_probs=120.1

Q ss_pred             CCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccc-hHHHHHHHHHHhcCC-CCCceeeEEEEeeCCeeEEEEe
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~-~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      ..|+..+.||+||.++||++...+.+.||+|++.....+.. ...|..|++.+.+++ |.+||++++|-..++..|||||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            34777889999999999999988888999998754433322 336999999999995 9999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |=+ -+|.++|+.+...  ..+| ....+-.|+..|+.+.|.+   +|||.||||.|.|+-. |-.|++||+
T Consensus       441 ~Gd-~DL~kiL~k~~~~--~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFG  504 (677)
T KOG0596|consen  441 CGD-IDLNKILKKKKSI--DPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFG  504 (677)
T ss_pred             ccc-ccHHHHHHhccCC--CchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeec
Confidence            765 5999999886543  2345 6778889999999999999   9999999999999974 889999996

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.60  E-value=3.5e-15  Score=128.25  Aligned_cols=130  Identities=17%  Similarity=0.123  Sum_probs=108.6

Q ss_pred             CCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCC--CCceeeEEEEeeCCeeEEEEecCCCC
Q 013682          291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH--RNLLRLYGFCTTVTEKLLVYPYMTNG  368 (438)
Q Consensus       291 ~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lv~e~~~~g  368 (438)
                      .+.+|+|.++.||++...+ ..+++|..+....   ...+.+|+..+..++|  .++.+++++....+..+++|||++++
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            4679999999999999854 7899998855432   3468899999999976  58899988888778899999999987


Q ss_pred             CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          369 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       369 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++...           ++.....++.+++++++++|....++++|+|+||+||++++++.+++.||.
T Consensus        79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~  134 (155)
T cd05120          79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWE  134 (155)
T ss_pred             ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecc
Confidence            76533           445667789999999999999755679999999999999998999999985

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.60  E-value=2.5e-15  Score=146.64  Aligned_cols=134  Identities=22%  Similarity=0.344  Sum_probs=110.0

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCC-----C---CCceeeEEEEee--
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-----H---RNLLRLYGFCTT--  354 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~g~~~~--  354 (438)
                      .+|...+.||=|.|++||.|.. .+.+.||+|+.|...  .-.+....|+.++++++     |   .+||+|++.|..  
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            5677889999999999999975 467899999987542  12235778999988763     3   369999999875  


Q ss_pred             --CCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC
Q 013682          355 --VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED  426 (438)
Q Consensus       355 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~  426 (438)
                        ..+.+||+|++ |.+|..++.....+  .++......|+.||..||.|||+.|  +|||-||||+|||+..+
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~Yr--Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYR--GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST  224 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCC--CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence              45688999988 66899998876544  3778899999999999999999988  99999999999999754

>PLN03150 hypothetical protein; Provisional

Probab=99.60  E-value=2e-15  Score=160.04  Aligned_cols=117  Identities=35%  Similarity=0.572  Sum_probs=101.8

Q ss_pred             ceeeeecCCCccccccchhhccCCCCCeeccccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhc
Q 013682           72 VYLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLT  151 (438)
Q Consensus        72 ~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~  151 (438)
                      .+..++|++|.++|.+|.++++|++           |+.|+|++|++.|.+|+.++++++|+.|+|++|+++|.+|..++
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~-----------L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~  487 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRH-----------LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLG  487 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCC-----------CCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHh
Confidence            4778999999999999998877765           56689999999999999999999999999999999999999999


Q ss_pred             cCCCCCeEeccCCCCCCCCCCCCC--CCcccccccccccccCCCCCCCCC
Q 013682          152 TITSLNILDLSNNRLSGPVPDNGS--FSQFTPISFENNLNLCGPNTKKPC  199 (438)
Q Consensus       152 ~~~~L~~l~ls~N~l~g~ip~~~~--~~~~~~~~~~~N~~lcg~~~~~~C  199 (438)
                      ++++|+.|+|++|+++|.+|....  ...+..+.+.+|..+|+.+....|
T Consensus       488 ~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C  537 (623)
T PLN03150        488 QLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC  537 (623)
T ss_pred             cCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCCCCCCC
Confidence            999999999999999999997532  123456778899999986554555

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.60  E-value=1.4e-15  Score=146.20  Aligned_cols=141  Identities=21%  Similarity=0.343  Sum_probs=120.2

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEeC----CCCEEEEEEccccccccchHHHHHHHHHHhcCC-CCCceeeEEEEeeCC
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVT  356 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~----~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~  356 (438)
                      ....+.|...+.||+|.|+.||+|...    .++.||+|.+......   .....|++++..+. +.||+++.+++...+
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            344556888899999999999999753    3678999998654322   25789999998874 999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC-CCcchhhhh
Q 013682          357 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTIL  435 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~-~~~~l~Df~  435 (438)
                      ...+|+||+++-+..++.+.       ++..+...+...+..||+|+|.+   +|||||+||+|+|.+.. +.-.+.||.
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             eeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEech
Confidence            99999999999998888865       56788999999999999999999   99999999999999976 456888886

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.60  E-value=1.5e-15  Score=136.70  Aligned_cols=132  Identities=20%  Similarity=0.259  Sum_probs=92.6

Q ss_pred             CCccccccceEEEEEEeCCCCEEEEEEccccccccch-HH----------------------HHHHHHHHhcCCCCC--c
Q 013682          291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGE-LQ----------------------FQTEVKIISMAVHRN--L  345 (438)
Q Consensus       291 ~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~-~~----------------------~~~E~~~l~~l~H~n--i  345 (438)
                      .+.||+|+||.||+|...+++.||||+++........ ..                      ...|...+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            3679999999999999878999999988653221110 01                      134555555554332  3


Q ss_pred             eeeEEEEeeCCeeEEEEecCCCCCHHH-HhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceecCCCCCCeee
Q 013682          346 LRLYGFCTTVTEKLLVYPYMTNGSVAS-RLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILL  423 (438)
Q Consensus       346 v~l~g~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDLK~~NILl  423 (438)
                      .+.+++    ...+++|||++++++.. .+....     .. .+...++.+++.++.++|. .   +|+|||+||+||++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili  148 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV  148 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence            344432    24689999999965321 121110     11 5678899999999999999 7   99999999999999


Q ss_pred             CCCCCcchhhhhh
Q 013682          424 DEDADQSSKTILR  436 (438)
Q Consensus       424 d~~~~~~l~Df~~  436 (438)
                      + ++.+++.||..
T Consensus       149 ~-~~~~~liDfg~  160 (187)
T cd05119         149 D-DGKVYIIDVPQ  160 (187)
T ss_pred             E-CCcEEEEECcc
Confidence            9 89999999964

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.59  E-value=7.4e-16  Score=143.33  Aligned_cols=138  Identities=25%  Similarity=0.321  Sum_probs=111.7

Q ss_pred             CCCCCCccccccceEEEEEEe-CCCCEEEEEEcccc-ccccchHHHHHHHHHHhcCCCCCceeeEEEEeeC------Cee
Q 013682          287 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEE-RTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV------TEK  358 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~  358 (438)
                      +|...+.+|.|+- .|..|.. -.++.||+|++... ......+...+|..++..++|+|+++++.++...      .+.
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~   96 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV   96 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence            4555677888876 4554543 25789999987432 2233345688999999999999999999998653      357


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+|||||. ++|...+...      ++..+...+..|+++|+.|||+.   +|+||||||+||++..+...||.||+
T Consensus        97 y~v~e~m~-~nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg  163 (369)
T KOG0665|consen   97 YLVMELMD-ANLCQVILME------LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFG  163 (369)
T ss_pred             HHHHHhhh-hHHHHHHHHh------cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccch
Confidence            99999996 5888877632      67788899999999999999999   99999999999999999999999997

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.56  E-value=1.3e-14  Score=142.23  Aligned_cols=142  Identities=21%  Similarity=0.267  Sum_probs=114.1

Q ss_pred             CCCCCCccccccceEEEEEEeCC--CCEEEEEEccccccccchHHHHHHHHHHhcCCC----CCceeeEEEE-eeCCeeE
Q 013682          287 GFSNKNILGRGGFGKVYKGRLAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVH----RNLLRLYGFC-TTVTEKL  359 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~~--~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~  359 (438)
                      +|...+.||+|+||.||.+....  ...+|+|........... .+..|+.++..+.+    +++..+++.. ......+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            68888999999999999998654  347898886554333322 57778888887763    5888888888 4777889


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC-----Ccchhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-----DQSSKTI  434 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~-----~~~l~Df  434 (438)
                      +||+.+ +.+|.++.+...  ...++..+..+|+.|+..+|+++|+.   +++||||||.|++++...     ...+.||
T Consensus        98 iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             EEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            999977 679998765443  34589999999999999999999999   999999999999999653     5788888


Q ss_pred             h
Q 013682          435 L  435 (438)
Q Consensus       435 ~  435 (438)
                      +
T Consensus       172 G  172 (322)
T KOG1164|consen  172 G  172 (322)
T ss_pred             C
Confidence            5

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.55  E-value=5.8e-14  Score=134.83  Aligned_cols=143  Identities=34%  Similarity=0.459  Sum_probs=121.9

Q ss_pred             CCCCCccccccceEEEEEEeCCCCEEEEEEccccccccc--hHHHHHHHHHHhcCCCC-CceeeEEEEeeCCeeEEEEec
Q 013682          288 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHR-NLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~--~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lv~e~  364 (438)
                      |...+.||.|+||.||++...  ..+|+|.+........  ...+.+|+..+..+.|+ +++++...+......++++||
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            455678999999999999976  7899999876554443  55799999999999988 799999999777778999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC-Ccchhhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTILR  436 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~-~~~l~Df~~  436 (438)
                      +.++++.+.+...... ..+.......+..|++.++.|+|+.   +++|||+||+||+++.++ .+++.||+.
T Consensus        80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~  148 (384)
T COG0515          80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGL  148 (384)
T ss_pred             CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCc
Confidence            9999999776654311 2478889999999999999999999   899999999999999998 699999974

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.53  E-value=5.5e-14  Score=131.66  Aligned_cols=132  Identities=17%  Similarity=0.184  Sum_probs=100.2

Q ss_pred             Cccc-cccceEEEEEEeCCCCEEEEEEccccc------c------ccchHHHHHHHHHHhcCCCCCc--eeeEEEEeeCC
Q 013682          292 NILG-RGGFGKVYKGRLADGKLVAVKRLKEER------T------SGGELQFQTEVKIISMAVHRNL--LRLYGFCTTVT  356 (438)
Q Consensus       292 ~~LG-~G~fG~Vy~~~~~~~~~vAvK~l~~~~------~------~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~~  356 (438)
                      ..|| .|+.|.||..... +..++||.+....      .      ......+.+|++++..++|+++  ++.+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            5687 7889999998874 6788999874311      0      0112357889999999998885  66776644322


Q ss_pred             e----eEEEEecCCC-CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcch
Q 013682          357 E----KLLVYPYMTN-GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS  431 (438)
Q Consensus       357 ~----~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l  431 (438)
                      .    .++||||+++ .+|.+++...     +++..    ...+++.++.+||+.   +|+||||||+|||++.++.+++
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence            2    2599999997 6898887542     23332    356889999999999   9999999999999999999999


Q ss_pred             hhhhh
Q 013682          432 KTILR  436 (438)
Q Consensus       432 ~Df~~  436 (438)
                      +||..
T Consensus       184 IDfg~  188 (239)
T PRK01723        184 IDFDR  188 (239)
T ss_pred             EECCC
Confidence            99975

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.53  E-value=2.3e-14  Score=128.57  Aligned_cols=142  Identities=20%  Similarity=0.240  Sum_probs=113.8

Q ss_pred             HhCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCC-CceeeEEEEeeCCeeEEE
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR-NLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lv  361 (438)
                      ....|...+.||.|+||.+|.|.. .+|..||||.-....   ...++..|..+...++|. .|..+..+..+...-.+|
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a---~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA---KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC---CCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            345688889999999999999985 579999999754332   223577888888888764 466666677778888999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC---Ccchhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSKTIL  435 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~---~~~l~Df~  435 (438)
                      ||.. +.||++...-...   .++..+.+-.|-|+..-++|+|.+   ++|||||||+|.|+.-+.   ...+.||+
T Consensus        90 MdLL-GPsLEdLfnfC~R---~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFG  159 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNFCSR---RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFG  159 (341)
T ss_pred             eecc-CccHHHHHHHHhh---hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEecc
Confidence            9987 6788887654322   478889999999999999999999   999999999999998654   45788886

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.52  E-value=6e-15  Score=165.24  Aligned_cols=140  Identities=36%  Similarity=0.492  Sum_probs=114.8

Q ss_pred             cceeeehhHHHHHHHhh-hhhhhhh-hcchheeecccCCcc----------ceeeeecCCCccccccchhhccCCCCCee
Q 013682           33 RGFTLLVTLKAVLQECE-QLHLLIS-FLIFIRVLQSSSNLF----------VYLISDLGNAALSGELAPELGQLKNLELL  100 (438)
Q Consensus        33 ~~~~~~~~l~~~~~~~~-~l~~~~~-~~~~~~~l~~~~n~~----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l  100 (438)
                      .+++.|++|+++.|.++ ++|..+. .+.+|+.|++++|.+          .|..++|++|.++|.+|..++++++|+.|
T Consensus        90 ~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L  169 (968)
T PLN00113         90 FRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVL  169 (968)
T ss_pred             hCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEE
Confidence            45778889999999887 7887765 889999999888754          47788999999999999999999999988


Q ss_pred             cc-------------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCC
Q 013682          101 AL-------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS  167 (438)
Q Consensus       101 ~l-------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~  167 (438)
                      ++             +++++|++|+|++|++.|.+|..++++++|+.|+|++|++++.+|..++++++|+.|++++|+++
T Consensus       170 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~  249 (968)
T PLN00113        170 DLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLT  249 (968)
T ss_pred             ECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceec
Confidence            65             34667888888888888888888888888888888888888888888888888888888888887


Q ss_pred             CCCCC
Q 013682          168 GPVPD  172 (438)
Q Consensus       168 g~ip~  172 (438)
                      |.+|.
T Consensus       250 ~~~p~  254 (968)
T PLN00113        250 GPIPS  254 (968)
T ss_pred             cccCh
Confidence            77774

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.46  E-value=9.8e-14  Score=132.07  Aligned_cols=134  Identities=20%  Similarity=0.290  Sum_probs=109.6

Q ss_pred             HhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCC--C----CceeeEEEEeeCC
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH--R----NLLRLYGFCTTVT  356 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H--~----niv~l~g~~~~~~  356 (438)
                      .+.+|.....+|+|.||+|-++... .+..||+|+++.-.  .-.....-|++++.++.+  |    -+|.+.+++.-.+
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg  164 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD--KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG  164 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH--HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence            3677888899999999999998753 47899999997542  222345678888888842  2    2678888888899


Q ss_pred             eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC
Q 013682          357 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE  425 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~  425 (438)
                      +.++|+|.+ |-|+.+++....  ..+++......|+.|++.+++|||+.   .++|-||||+|||+-+
T Consensus       165 hiCivfell-G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvs  227 (415)
T KOG0671|consen  165 HICIVFELL-GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVS  227 (415)
T ss_pred             ceEEEEecc-ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEec
Confidence            999999988 559999998753  34688899999999999999999999   9999999999999853

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.46  E-value=4e-14  Score=151.87  Aligned_cols=146  Identities=22%  Similarity=0.277  Sum_probs=113.3

Q ss_pred             HHHHhCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCC---CCCceeeEEEEeeCCe
Q 013682          281 LQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV---HRNLLRLYGFCTTVTE  357 (438)
Q Consensus       281 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~  357 (438)
                      .++..+.|.+.+.+|+|+||+||+|...+|+.||+|+-+....++    |.--..++.+++   -+-|..+..++.-.+.
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            344556677788999999999999998889999999877655543    222223344444   2334444455555777


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC-------CCCcc
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-------DADQS  430 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~-------~~~~~  430 (438)
                      .++|+||.+.|+|.+++...    ..++|.-...++.|++.-+++||..   +|||+||||+|.|+..       ..-.+
T Consensus       769 S~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~  841 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLY  841 (974)
T ss_pred             ceeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceE
Confidence            89999999999999999743    3489999999999999999999999   9999999999999953       23468


Q ss_pred             hhhhhhc
Q 013682          431 SKTILRR  437 (438)
Q Consensus       431 l~Df~~~  437 (438)
                      |+||++.
T Consensus       842 lIDfG~s  848 (974)
T KOG1166|consen  842 LIDFGRS  848 (974)
T ss_pred             EEecccc
Confidence            9999875

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.43  E-value=3.4e-13  Score=137.08  Aligned_cols=136  Identities=22%  Similarity=0.235  Sum_probs=96.3

Q ss_pred             CCccccccceEEEEEEeCCCCEEEEEEcccccccc---------------------------------------chHHHH
Q 013682          291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG---------------------------------------GELQFQ  331 (438)
Q Consensus       291 ~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~---------------------------------------~~~~~~  331 (438)
                      .+.||.|++|.||+|++++|+.||||+.+......                                       .+.+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            36899999999999999999999999986532100                                       011355


Q ss_pred             HHHHHHhcC----CCCCceeeEEEEe-eCCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHH-HHHHHhc
Q 013682          332 TEVKIISMA----VHRNLLRLYGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR-GLSYLHE  405 (438)
Q Consensus       332 ~E~~~l~~l----~H~niv~l~g~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~  405 (438)
                      +|+..+.++    +|.+-+.+-.++. ..+..++||||++|+++.+........   .   .+..++..++. .+..+|.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~---~---~~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG---L---DRKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC---C---CHHHHHHHHHHHHHHHHHh
Confidence            566655544    2333344333333 245579999999999998876532111   2   23456666655 4678888


Q ss_pred             CCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          406 HCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       406 ~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      .   +++|+|+||.||++++++.+++.||+
T Consensus       276 ~---g~~H~D~hPgNilv~~~g~i~liDfG  302 (437)
T TIGR01982       276 D---GFFHADLHPGNIFVLKDGKIIALDFG  302 (437)
T ss_pred             C---CceeCCCCcccEEECCCCcEEEEeCC
Confidence            8   99999999999999999999999996

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.42  E-value=8.3e-13  Score=123.73  Aligned_cols=140  Identities=20%  Similarity=0.273  Sum_probs=111.4

Q ss_pred             CCCCCCCccccccceEEEEEE-eCCCCEEEEEEccccccccchHHHHHHHHHHhcCC-CCCceeeEEEEeeCCeeEEEEe
Q 013682          286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      -.|...+.||+|+||+.+.|+ +-++++||||.-... +  ...++..|-...+.+. -+.|..++-+..+..+-.||+|
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-S--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-S--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEecccc-C--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            357888999999999999997 457999999975332 1  1225777877777664 5788888777777777889999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC-----Ccchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-----DQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~-----~~~l~Df~  435 (438)
                      +. |.||+++..-..   ..++..+...+|.|+..-++|+|++   ..|.|||||+|.||..-+     .+++.||+
T Consensus       105 LL-GPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG  174 (449)
T KOG1165|consen  105 LL-GPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFG  174 (449)
T ss_pred             hh-CcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEecc
Confidence            87 668887765433   2488899999999999999999999   999999999999998543     45788886

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.40  E-value=2.9e-13  Score=133.09  Aligned_cols=146  Identities=19%  Similarity=0.222  Sum_probs=119.8

Q ss_pred             HhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCC------CCCceeeEEEEeeCC
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV------HRNLLRLYGFCTTVT  356 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~g~~~~~~  356 (438)
                      .-..|......|+|-|+.|.+|... .|..||||+++.....  ...=..|+++|.+++      --|.++++..|...+
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M--~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn  507 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM--HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN  507 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH--hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence            3456776777899999999999864 4789999999764322  234568899998885      348899999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC-Ccchhhhh
Q 013682          357 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTIL  435 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~-~~~l~Df~  435 (438)
                      +++||+|-+. -+|.+.|.+.+ ....+.......++.|+.-||..|-..   +|+|.||||.|||+++.- ..|++||+
T Consensus       508 HLClVFE~Ls-lNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  508 HLCLVFEPLS-LNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             eeEEEehhhh-chHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCc
Confidence            9999999775 58999997753 444577888999999999999999998   999999999999999875 45999998


Q ss_pred             h
Q 013682          436 R  436 (438)
Q Consensus       436 ~  436 (438)
                      .
T Consensus       583 S  583 (752)
T KOG0670|consen  583 S  583 (752)
T ss_pred             c
Confidence            5

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.34  E-value=2.2e-13  Score=124.29  Aligned_cols=138  Identities=25%  Similarity=0.406  Sum_probs=114.9

Q ss_pred             CCccccccceEEEEEEeCCCCEEEEEEcccc-ccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCCC
Q 013682          291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEE-RTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS  369 (438)
Q Consensus       291 ~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs  369 (438)
                      ...|.+...|+.|+|+|+.+ .+++|+++.. .+....++|.+|.-.++.+.||||..++|.|.++....++..||+.|+
T Consensus       195 ~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            34578889999999999754 4555776532 233344579999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchh
Q 013682          370 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  432 (438)
Q Consensus       370 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~  432 (438)
                      |+..|++...  ..++..++.++|.++|+|++|||+. .|-|..-.|.++.|++|+|.+++|+
T Consensus       274 lynvlhe~t~--vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris  333 (448)
T KOG0195|consen  274 LYNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS  333 (448)
T ss_pred             HHHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee
Confidence            9999987543  3478889999999999999999997 5556667899999999999998874

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.27  E-value=7.1e-12  Score=129.20  Aligned_cols=138  Identities=22%  Similarity=0.239  Sum_probs=90.2

Q ss_pred             CCCCCCCccccccceEEEEEEeCC-CCEEEEEEccccccc---------------------c------------------
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTS---------------------G------------------  325 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~~-~~~vAvK~l~~~~~~---------------------~------------------  325 (438)
                      ++|+. +.+|+|++|.||+|++++ |+.||||+.+.....                     .                  
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45665 789999999999999977 999999998643100                     0                  


Q ss_pred             chHHHHHHHHHHhcC----CCCCceeeEEEEee-CCeeEEEEecCCCCCHHHH--hhccCCCCCCCCHHHHHHHHHHHH-
Q 013682          326 GELQFQTEVKIISMA----VHRNLLRLYGFCTT-VTEKLLVYPYMTNGSVASR--LRERQSSLPPLDWPTRKKIALGSA-  397 (438)
Q Consensus       326 ~~~~~~~E~~~l~~l----~H~niv~l~g~~~~-~~~~~lv~e~~~~gsL~~~--l~~~~~~~~~l~~~~~~~i~~~ia-  397 (438)
                      .+.++.+|+..+.++    .+.+.+.+-.++.+ ....++||||++|+++.+.  +....     .+.   ..++...+ 
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g-----~d~---~~la~~~v~  270 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG-----TDM---KLLAERGVE  270 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC-----CCH---HHHHHHHHH
Confidence            011355566555544    24555554455443 4567899999999999764  22211     111   11221111 


Q ss_pred             HHHHHHhcCCCCCceecCCCCCCeeeCCCC----Ccchhhhh
Q 013682          398 RGLSYLHEHCDPKIIHRDVKAANILLDEDA----DQSSKTIL  435 (438)
Q Consensus       398 ~gL~yLH~~~~~~ivHrDLK~~NILld~~~----~~~l~Df~  435 (438)
                      .-+.-++..   +++|+|+||.||+++.++    ...+.||+
T Consensus       271 ~~~~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFG  309 (537)
T PRK04750        271 VFFTQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFG  309 (537)
T ss_pred             HHHHHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecc
Confidence            112223445   999999999999999988    88999996

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.24  E-value=1.8e-13  Score=117.08  Aligned_cols=128  Identities=28%  Similarity=0.372  Sum_probs=99.0

Q ss_pred             ecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCccceeeeecCCCccccccchhhccCCCCCeeccc--------
Q 013682           32 ARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLALG--------  103 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~--------  103 (438)
                      ...|..|++|++++|++..||..++.+.++|+|...-|...             .+|...|.++.|++|++.        
T Consensus        52 ia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-------------~lprgfgs~p~levldltynnl~e~~  118 (264)
T KOG0617|consen   52 IAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-------------ILPRGFGSFPALEVLDLTYNNLNENS  118 (264)
T ss_pred             HHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-------------cCccccCCCchhhhhhcccccccccc
Confidence            45677788888888888888888888888887766555443             477777777777777642        


Q ss_pred             ------cccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCCCC
Q 013682          104 ------NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNG  174 (438)
Q Consensus       104 ------~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~~  174 (438)
                            .+..|+.|.|++|.|. .+|+.+|++++||.|.+..|.|- .+|.+++.+++|+.|.+.+|+++-.+|+.+
T Consensus       119 lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~vlppel~  193 (264)
T KOG0617|consen  119 LPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVLPPELA  193 (264)
T ss_pred             CCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeeecChhhh
Confidence                  1345677788888887 88888888888888888888887 678888888888888888888887777643

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.23  E-value=2.2e-11  Score=107.50  Aligned_cols=126  Identities=20%  Similarity=0.179  Sum_probs=91.4

Q ss_pred             CccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCce-eeEEEEeeCCeeEEEEecCCCCCH
Q 013682          292 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL-RLYGFCTTVTEKLLVYPYMTNGSV  370 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv~e~~~~gsL  370 (438)
                      +.++.|.++.||+++.. ++.|++|.......  ....+..|+..+..+.+.+++ +++.+.  ....++||||+++.++
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            56789999999999875 67899998754321  223567889888888665554 444433  3345899999999887


Q ss_pred             HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          371 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC--DPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       371 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ...  .       .   ....++.+++++++.||+..  ...++|+|++|.||+++ ++..++.||-
T Consensus        79 ~~~--~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~  132 (170)
T cd05151          79 LTE--D-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWE  132 (170)
T ss_pred             ccc--c-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecc
Confidence            532  0       0   11335678999999999983  22369999999999999 5678899985

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.22  E-value=7.7e-13  Score=132.70  Aligned_cols=66  Identities=24%  Similarity=0.236  Sum_probs=55.1

Q ss_pred             eeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc------------ceeeeecCCCccccccchhhccCCCCCeec
Q 013682           35 FTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF------------VYLISDLGNAALSGELAPELGQLKNLELLA  101 (438)
Q Consensus        35 ~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~------------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~  101 (438)
                      +.-|++||+|.|.+.+.|..+-+-.++=+|.+|.|.+            .|..+|||+|++.- +|+.+..|.+|+.|.
T Consensus       102 l~dLt~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~-LPPQ~RRL~~LqtL~  179 (1255)
T KOG0444|consen  102 LKDLTILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEM-LPPQIRRLSMLQTLK  179 (1255)
T ss_pred             cccceeeecchhhhhhcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhh-cCHHHHHHhhhhhhh
Confidence            4456689999999999999999999999999998865            37778999999985 899888777777764

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.21  E-value=6.3e-13  Score=127.26  Aligned_cols=155  Identities=28%  Similarity=0.301  Sum_probs=126.8

Q ss_pred             eecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCccc-----------eeeeecCCCccccccchhhccCCCCCe
Q 013682           31 CARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFV-----------YLISDLGNAALSGELAPELGQLKNLEL   99 (438)
Q Consensus        31 ~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~~-----------~~~~~l~~n~l~g~ip~~l~~l~~L~~   99 (438)
                      ..+.+..++-|+..+|+..++|.+++.+.++..++..+|...           +.-+|...|-+. .+|++++.|.+|..
T Consensus       132 ~i~~~~~l~dl~~~~N~i~slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~  210 (565)
T KOG0472|consen  132 SIGRLLDLEDLDATNNQISSLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLEL  210 (565)
T ss_pred             hHHHHhhhhhhhccccccccCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHH
Confidence            344555667777777778888888777777777777666542           444566666665 59999999988887


Q ss_pred             ec-----------cccccCCCEEEccCCcccccCchhhc-cccccceeccccccccCCCchhhccCCCCCeEeccCCCCC
Q 013682          100 LA-----------LGNLIKLKSLDLYSNLFNGTIPDTLA-NLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS  167 (438)
Q Consensus       100 l~-----------l~~l~~L~~l~ls~N~l~g~iP~~~~-~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~  167 (438)
                      |+           |+.|..|.++.++.|+++ .+|.+.+ ++.++..|||..|++. ++|.++.-+.+|+.||+|+|.++
T Consensus       211 LyL~~Nki~~lPef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is  288 (565)
T KOG0472|consen  211 LYLRRNKIRFLPEFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS  288 (565)
T ss_pred             HHhhhcccccCCCCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc
Confidence            75           467888999999999998 8898887 8999999999999998 78999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccccc
Q 013682          168 GPVPDNGSFSQFTPISFENNLN  189 (438)
Q Consensus       168 g~ip~~~~~~~~~~~~~~~N~~  189 (438)
                      +.+++.+.+ ++..+...|||.
T Consensus       289 ~Lp~sLgnl-hL~~L~leGNPl  309 (565)
T KOG0472|consen  289 SLPYSLGNL-HLKFLALEGNPL  309 (565)
T ss_pred             cCCcccccc-eeeehhhcCCch
Confidence            999988777 888889999983

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.18  E-value=2.9e-12  Score=128.61  Aligned_cols=153  Identities=30%  Similarity=0.353  Sum_probs=118.7

Q ss_pred             cceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc-------------ceeeeecCCCccccccchhhccCCCCCe
Q 013682           33 RGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF-------------VYLISDLGNAALSGELAPELGQLKNLEL   99 (438)
Q Consensus        33 ~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~-------------~~~~~~l~~n~l~g~ip~~l~~l~~L~~   99 (438)
                      ..+..||.|.++.|.+..+++.++.|+.||.+..-+|..             .|+++|||+|++. ++|..+-.-+++-+
T Consensus        52 ~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iV  130 (1255)
T KOG0444|consen   52 SRLQKLEHLSMAHNQLISVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIV  130 (1255)
T ss_pred             HHHhhhhhhhhhhhhhHhhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEE
Confidence            445678888999999999999999999999888876653             3888899999998 59999999999888


Q ss_pred             eccc-------------cccCCCEEEccCCcccccCchhhccccccceeccccccccC----------------------
Q 013682          100 LALG-------------NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSG----------------------  144 (438)
Q Consensus       100 l~l~-------------~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g----------------------  144 (438)
                      |+++             ++..|-.||||+|++. .+|+++..+..|++|+||+|.|.-                      
T Consensus       131 LNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqR  209 (1255)
T KOG0444|consen  131 LNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQR  209 (1255)
T ss_pred             EEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccc
Confidence            8764             3556778899999998 899999999999999999998732                      


Q ss_pred             ---CCchhhccCCCCCeEeccCCCCCCCCCCC-CCCCccccccccccc
Q 013682          145 ---LIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNL  188 (438)
Q Consensus       145 ---~~P~~l~~~~~L~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~N~  188 (438)
                         .+|+++-.+.+|..+|+|.|++.- +|+. ..+.++..+.+++|.
T Consensus       210 Tl~N~Ptsld~l~NL~dvDlS~N~Lp~-vPecly~l~~LrrLNLS~N~  256 (1255)
T KOG0444|consen  210 TLDNIPTSLDDLHNLRDVDLSENNLPI-VPECLYKLRNLRRLNLSGNK  256 (1255)
T ss_pred             hhhcCCCchhhhhhhhhccccccCCCc-chHHHhhhhhhheeccCcCc
Confidence               257777778888888888888763 3432 234445555555553

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.15  E-value=1.5e-12  Score=111.46  Aligned_cols=139  Identities=24%  Similarity=0.381  Sum_probs=96.8

Q ss_pred             eeehhHHHHHHHhhhhhhhhhhcchheeecccCCccceeeeecCCCccccccchhhccCCCCCeec------------cc
Q 013682           36 TLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLA------------LG  103 (438)
Q Consensus        36 ~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~------------l~  103 (438)
                      +.++.|++|.|.++-.|-.+..+.++.+|.++.|...             ++|.+|++|+.|..|+            ||
T Consensus        33 s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie-------------~lp~~issl~klr~lnvgmnrl~~lprgfg   99 (264)
T KOG0617|consen   33 SNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIE-------------ELPTSISSLPKLRILNVGMNRLNILPRGFG   99 (264)
T ss_pred             hhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhh-------------hcChhhhhchhhhheecchhhhhcCccccC
Confidence            3445677777777777777777777777766666665             6888888777777764            45


Q ss_pred             cccCCCEEEccCCcccc-cCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCCCCCCCccccc
Q 013682          104 NLIKLKSLDLYSNLFNG-TIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPI  182 (438)
Q Consensus       104 ~l~~L~~l~ls~N~l~g-~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~  182 (438)
                      .++.|..|||+.|+++- .+|..|-.|+.|..|+|+.|.|. .+|..++++++|+.|.+..|++-..+-+.+.+.++..+
T Consensus       100 s~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrel  178 (264)
T KOG0617|consen  100 SFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLREL  178 (264)
T ss_pred             CCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHH
Confidence            66777777777777752 36777777777777777777776 56777777777777777777766444444556666666


Q ss_pred             cccccc
Q 013682          183 SFENNL  188 (438)
Q Consensus       183 ~~~~N~  188 (438)
                      ..+||.
T Consensus       179 hiqgnr  184 (264)
T KOG0617|consen  179 HIQGNR  184 (264)
T ss_pred             hcccce
Confidence            666665

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.15  E-value=1.7e-11  Score=134.51  Aligned_cols=81  Identities=11%  Similarity=0.050  Sum_probs=64.6

Q ss_pred             CCC-CCceeeEEEEe-------eCCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 013682          340 AVH-RNLLRLYGFCT-------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI  411 (438)
Q Consensus       340 l~H-~niv~l~g~~~-------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  411 (438)
                      ++| +||+++++++.       ..+..+.++||+ +++|.++++...   ..+++.++..++.||++||+|||++   +|
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---gI  101 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQ---GI  101 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            345 57778888762       234566778887 569999997532   3489999999999999999999999   99


Q ss_pred             eecCCCCCCeeeCCCC
Q 013682          412 IHRDVKAANILLDEDA  427 (438)
Q Consensus       412 vHrDLK~~NILld~~~  427 (438)
                      +||||||+|||++..+
T Consensus       102 vHrDlKP~NiLl~~~~  117 (793)
T PLN00181        102 VVHNVRPSCFVMSSFN  117 (793)
T ss_pred             eeccCCchhEEEcccC
Confidence            9999999999995433

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.11  E-value=4.1e-10  Score=103.66  Aligned_cols=139  Identities=17%  Similarity=0.217  Sum_probs=103.5

Q ss_pred             CccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCC--CceeeEEEEeeC---CeeEEEEecCC
Q 013682          292 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR--NLLRLYGFCTTV---TEKLLVYPYMT  366 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~---~~~~lv~e~~~  366 (438)
                      +.++.|.++.||+++..+|+.+++|.............+..|++++..+.+.  ++.+++.+....   +..+++|||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            5689999999999988766889999875433222334688999999988763  456677766553   25689999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 013682          367 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC---------------------------------------  407 (438)
Q Consensus       367 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------  407 (438)
                      +.++.+.+..     ..++..+...++.++++++.+||+..                                       
T Consensus        84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9887665421     13667778888888888888888631                                       


Q ss_pred             --------------CCCceecCCCCCCeeeCC--CCCcchhhhh
Q 013682          408 --------------DPKIIHRDVKAANILLDE--DADQSSKTIL  435 (438)
Q Consensus       408 --------------~~~ivHrDLK~~NILld~--~~~~~l~Df~  435 (438)
                                    ...++|+|+++.||++++  ++...+.||-
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e  202 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWE  202 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecc
Confidence                          235799999999999998  5556788874

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PLN03150 hypothetical protein; Provisional

Probab=99.10  E-value=4.9e-11  Score=126.66  Aligned_cols=112  Identities=31%  Similarity=0.424  Sum_probs=88.9

Q ss_pred             ehhHHHHHHHhh-hhhhhhhhcchheeecccCCccceeeeecCCCccccccchhhccCCCCCeeccccccCCCEEEccCC
Q 013682           38 LVTLKAVLQECE-QLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSN  116 (438)
Q Consensus        38 ~~~l~~~~~~~~-~l~~~~~~~~~~~~l~~~~n~~~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~~l~~L~~l~ls~N  116 (438)
                      ++.|++++|.+. .+|..++.+.            .|..|+|++|.++|.+|..++++++           |+.|+|++|
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~------------~L~~L~Ls~N~l~g~iP~~~~~l~~-----------L~~LdLs~N  476 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLR------------HLQSINLSGNSIRGNIPPSLGSITS-----------LEVLDLSYN  476 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCC------------CCCEEECCCCcccCcCChHHhCCCC-----------CCEEECCCC
Confidence            455666666664 4555555444            4555678888899999998877765           566899999


Q ss_pred             cccccCchhhccccccceeccccccccCCCchhhccC-CCCCeEeccCCCCCCCCCC
Q 013682          117 LFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTI-TSLNILDLSNNRLSGPVPD  172 (438)
Q Consensus       117 ~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~-~~L~~l~ls~N~l~g~ip~  172 (438)
                      +++|.+|+.++++++|+.|+|++|+++|.+|..++.. .++..+++++|...+.+|.
T Consensus       477 ~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~  533 (623)
T PLN03150        477 SFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG  533 (623)
T ss_pred             CCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCCC
Confidence            9999999999999999999999999999999999874 4678899999976655553

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.10  E-value=2e-11  Score=123.52  Aligned_cols=139  Identities=24%  Similarity=0.249  Sum_probs=112.7

Q ss_pred             ccccccceEEEEEEe----CCCCEEEEEEccccccccc-hHHHHHHHHHHhcCC-CCCceeeEEEEeeCCeeEEEEecCC
Q 013682          293 ILGRGGFGKVYKGRL----ADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPYMT  366 (438)
Q Consensus       293 ~LG~G~fG~Vy~~~~----~~~~~vAvK~l~~~~~~~~-~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~  366 (438)
                      ++|+|+||.|+.++.    ..+..+|+|.++....... ......|..++...+ ||.+|++.-.+..+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999987642    3477899998865432211 113455667777776 9999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhhcC
Q 013682          367 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRRL  438 (438)
Q Consensus       367 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~~~  438 (438)
                      +|++...+.+..    .++......+....|.|++++|..   +|+|||+|++||++|.+|.+++.||.-|+
T Consensus        81 gg~lft~l~~~~----~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglsk  145 (612)
T KOG0603|consen   81 GGDLFTRLSKEV----MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSK  145 (612)
T ss_pred             cchhhhccccCC----chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhh
Confidence            999988876543    256667777778899999999999   99999999999999999999999998763

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.08  E-value=3.6e-11  Score=126.25  Aligned_cols=140  Identities=21%  Similarity=0.244  Sum_probs=105.5

Q ss_pred             CCCCccccccceEEEEEEeC-CCCEEEEEEccccc-cccchH----HHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          289 SNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER-TSGGEL----QFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       289 ~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~----~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ...+++|.|++|.|+..... ..+..+.|.++... ......    .+..|..+-..++|||++..+..+.+.....-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            34678999999977777542 34444444432110 111111    2556777778899999987776666655555569


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||+++ +|...+....    .+...++..+..|+..|+.|+|+.   +|.|||+|++|++++.+|..+|+||+-
T Consensus       401 E~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~  466 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGA  466 (601)
T ss_pred             hcccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCc
Confidence            99999 9999987642    367788999999999999999999   999999999999999999999999973

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.07  E-value=2.1e-11  Score=129.57  Aligned_cols=140  Identities=25%  Similarity=0.251  Sum_probs=112.5

Q ss_pred             CCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHH---HHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          287 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQF---QTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~---~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      ++...+.||++.|=+|.+|+.+.|. |.||++-+.........|   .+|+. ...++|||.+++.-+-......|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            4566788999999999999987775 889987543323233333   34444 566799999998877777778889999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |..+ +|++.+..+    +-+...+..-|+.|+..|+.-+|..   +|+|+|||.+|||+..-..+.++||+.
T Consensus       102 yvkh-nLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAs  166 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFAS  166 (1431)
T ss_pred             HHhh-hhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccc
Confidence            9865 888887654    2366778888999999999999999   999999999999999999999999974

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.06  E-value=7.8e-10  Score=99.65  Aligned_cols=134  Identities=14%  Similarity=0.165  Sum_probs=93.8

Q ss_pred             CccccccceEEEEEEeCC-------CCEEEEEEcccccc----------cc----------c-hHH----HHHHHHHHhc
Q 013682          292 NILGRGGFGKVYKGRLAD-------GKLVAVKRLKEERT----------SG----------G-ELQ----FQTEVKIISM  339 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~-------~~~vAvK~l~~~~~----------~~----------~-~~~----~~~E~~~l~~  339 (438)
                      ..||.|-=+.||.|...+       +..+|||+.+....          .+          . ...    .++|...|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468899999999997543       47899998753210          00          0 111    2378888887


Q ss_pred             CCC--CCceeeEEEEeeCCeeEEEEecCCCCCHHH-HhhccCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCceecC
Q 013682          340 AVH--RNLLRLYGFCTTVTEKLLVYPYMTNGSVAS-RLRERQSSLPPLDWPTRKKIALGSARGLSYL-HEHCDPKIIHRD  415 (438)
Q Consensus       340 l~H--~niv~l~g~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrD  415 (438)
                      +..  -++.+++++    ...++||||+.+..+.. .+++.     .++..+...+..+++.+|.++ |..   ++||+|
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD  150 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD  150 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            753  355555553    56789999997654422 23221     244455667788999999999 777   999999


Q ss_pred             CCCCCeeeCCCCCcchhhhhhcC
Q 013682          416 VKAANILLDEDADQSSKTILRRL  438 (438)
Q Consensus       416 LK~~NILld~~~~~~l~Df~~~~  438 (438)
                      |++.|||++ ++.+.++||.+.+
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qav  172 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQSV  172 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCce
Confidence            999999997 4779999998753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.05  E-value=1.6e-11  Score=122.69  Aligned_cols=166  Identities=27%  Similarity=0.242  Sum_probs=115.2

Q ss_pred             eeceEEeeeeecceeeehhHHHHHHHhhhhhhh-hhhcchheeecccCCccc----------------------------
Q 013682           22 RVGIICLGICARGFTLLVTLKAVLQECEQLHLL-ISFLIFIRVLQSSSNLFV----------------------------   72 (438)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~l~~~-~~~~~~~~~l~~~~n~~~----------------------------   72 (438)
                      ||+-+-++ |..+|.+|.+|.++.|.+++||.- |.+|.+|+.|++..|.+.                            
T Consensus       184 ~It~l~~~-~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~D  262 (873)
T KOG4194|consen  184 RITTLETG-HFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDD  262 (873)
T ss_pred             cccccccc-cccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccC
Confidence            44444333 677888999999999999999987 677999999988887643                            


Q ss_pred             --------eeeeecCCCccccccchhhccCCCCCeeccc-------------cccCCCEEEccCCcccccCchhhccccc
Q 013682           73 --------YLISDLGNAALSGELAPELGQLKNLELLALG-------------NLIKLKSLDLYSNLFNGTIPDTLANLKQ  131 (438)
Q Consensus        73 --------~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~-------------~l~~L~~l~ls~N~l~g~iP~~~~~l~~  131 (438)
                              +..++|+.|++..-=-..+..|+.|+.|+++             -+++|++|+|++|+++---|.+|..|.+
T Consensus       263 G~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~  342 (873)
T KOG4194|consen  263 GAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQ  342 (873)
T ss_pred             cceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHH
Confidence                    3335566666654333456677777777643             3677888888888888444457777777


Q ss_pred             cceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCCC----CCCCccccccccccc
Q 013682          132 LKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN----GSFSQFTPISFENNL  188 (438)
Q Consensus       132 L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~----~~~~~~~~~~~~~N~  188 (438)
                      |+.|+|++|.++..--..+..+.+|+.|||++|.+++.|-+.    ..++.+..+.+.||.
T Consensus       343 Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNq  403 (873)
T KOG4194|consen  343 LEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQ  403 (873)
T ss_pred             hhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCce
Confidence            777877777777555556777888888888888887777653    123344445555553

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.02  E-value=2.3e-10  Score=109.92  Aligned_cols=87  Identities=25%  Similarity=0.314  Sum_probs=66.6

Q ss_pred             CCCCCceeeEEEEeeC---------------------------CeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHH
Q 013682          340 AVHRNLLRLYGFCTTV---------------------------TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI  392 (438)
Q Consensus       340 l~H~niv~l~g~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i  392 (438)
                      .+|||||++.++|.+.                           ...|+||.-++ -+|.+++....     .+...+..|
T Consensus       273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-----~s~r~~~~~  346 (598)
T KOG4158|consen  273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-----RSYRTGRVI  346 (598)
T ss_pred             CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-----CchHHHHHH
Confidence            4699999999887541                           23577777664 37888886543     455567778


Q ss_pred             HHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC--C--Ccchhhhh
Q 013682          393 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED--A--DQSSKTIL  435 (438)
Q Consensus       393 ~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~--~--~~~l~Df~  435 (438)
                      ..|+.+|..|||.+   +|.|||+|++|||+.-|  +  ...++||+
T Consensus       347 laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFG  390 (598)
T KOG4158|consen  347 LAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFG  390 (598)
T ss_pred             HHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccc
Confidence            88999999999999   99999999999999633  3  23678885

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=98.98  E-value=1.7e-09  Score=102.79  Aligned_cols=142  Identities=23%  Similarity=0.340  Sum_probs=88.5

Q ss_pred             CCCccccccceEEEEEEeC-CCCEEEEEEccccc--cccchHHHHHHHHHHhcCCC----------CCceeeEEEEe---
Q 013682          290 NKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVH----------RNLLRLYGFCT---  353 (438)
Q Consensus       290 ~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H----------~niv~l~g~~~---  353 (438)
                      ..+.||.|+|+.||.++.. +++.+|+|++....  .....+++.+|.-....+.+          -.++..++...   
T Consensus        16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~   95 (288)
T PF14531_consen   16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG   95 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred             EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence            3578999999999999985 58999999874322  22334467777655544332          12222222221   


Q ss_pred             ------eC--C------eeEEEEecCCCCCHHHHhh---ccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCC
Q 013682          354 ------TV--T------EKLLVYPYMTNGSVASRLR---ERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV  416 (438)
Q Consensus       354 ------~~--~------~~~lv~e~~~~gsL~~~l~---~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDL  416 (438)
                            ..  .      ..+++|+-+ .+||.+.+.   ........+....++.+..|+.+.+++||+.   +++|+||
T Consensus        96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi  171 (288)
T PF14531_consen   96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDI  171 (288)
T ss_dssp             S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-
T ss_pred             CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEeccc
Confidence                  11  1      235677766 468877654   2222112233445667778999999999999   9999999


Q ss_pred             CCCCeeeCCCCCcchhhhh
Q 013682          417 KAANILLDEDADQSSKTIL  435 (438)
Q Consensus       417 K~~NILld~~~~~~l~Df~  435 (438)
                      ||+|++++.+|.+.++||-
T Consensus       172 ~~~nfll~~~G~v~Lg~F~  190 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFS  190 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GG
T ss_pred             ceeeEEEcCCCCEEEcChH
Confidence            9999999999999999995

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.91  E-value=1.2e-10  Score=122.11  Aligned_cols=156  Identities=30%  Similarity=0.350  Sum_probs=123.8

Q ss_pred             eecceeeehhHHHHHHHhhhhhhhhhh--cchheeecccCCc------------cceeeeecCCCccccccchhhccCCC
Q 013682           31 CARGFTLLVTLKAVLQECEQLHLLISF--LIFIRVLQSSSNL------------FVYLISDLGNAALSGELAPELGQLKN   96 (438)
Q Consensus        31 ~~~~~~~~~~l~~~~~~~~~l~~~~~~--~~~~~~l~~~~n~------------~~~~~~~l~~n~l~g~ip~~l~~l~~   96 (438)
                      ..+++++|++|++-.|++.++|+.+-.  ...++.|..+.|.            ..|+.+++.+|.|+-..-+.+-..++
T Consensus       305 ~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~h  384 (1081)
T KOG0618|consen  305 FLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKH  384 (1081)
T ss_pred             cccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccc
Confidence            456788888888888888888886311  1113444433332            24777889999999988889999999


Q ss_pred             CCeecc-------------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccC
Q 013682           97 LELLAL-------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSN  163 (438)
Q Consensus        97 L~~l~l-------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~  163 (438)
                      |++|++             .++..|+.|+||+|+++ .||+.+.++..|++|...+|++. ..| ++.++++|+.+|+|.
T Consensus       385 LKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~  461 (1081)
T KOG0618|consen  385 LKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSC  461 (1081)
T ss_pred             eeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEeccc
Confidence            999875             34677999999999998 99999999999999999999998 667 899999999999999


Q ss_pred             CCCCC-CCCCCCCCCcccccccccccc
Q 013682          164 NRLSG-PVPDNGSFSQFTPISFENNLN  189 (438)
Q Consensus       164 N~l~g-~ip~~~~~~~~~~~~~~~N~~  189 (438)
                      |+|+. .+|.....+++..+++.||..
T Consensus       462 N~L~~~~l~~~~p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  462 NNLSEVTLPEALPSPNLKYLDLSGNTR  488 (1081)
T ss_pred             chhhhhhhhhhCCCcccceeeccCCcc
Confidence            99974 455544446788888999873

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=98.90  E-value=3.6e-11  Score=115.39  Aligned_cols=142  Identities=28%  Similarity=0.396  Sum_probs=85.7

Q ss_pred             ecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCccceeeeecCCCccccccchhhccCCCCCeec----------
Q 013682           32 ARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLA----------  101 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~----------  101 (438)
                      .++|.++.+|+...|++.+||..++.+..++.+..++|.            ++ ++|++++++.+|..++          
T Consensus        64 l~nL~~l~vl~~~~n~l~~lp~aig~l~~l~~l~vs~n~------------ls-~lp~~i~s~~~l~~l~~s~n~~~el~  130 (565)
T KOG0472|consen   64 LKNLACLTVLNVHDNKLSQLPAAIGELEALKSLNVSHNK------------LS-ELPEQIGSLISLVKLDCSSNELKELP  130 (565)
T ss_pred             hhcccceeEEEeccchhhhCCHHHHHHHHHHHhhcccch------------Hh-hccHHHhhhhhhhhhhccccceeecC
Confidence            455666666666666666666666666666666655554            33 4566666555555543          


Q ss_pred             --cccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCCCCCCCcc
Q 013682          102 --LGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQF  179 (438)
Q Consensus       102 --l~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~~~~~~~  179 (438)
                        ++.+..|..++.++|+++ ++|++++++.++..+++.+|++....| ..-++++|+.+|+-.|.++.-+|+.+.+..+
T Consensus       131 ~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~-~~i~m~~L~~ld~~~N~L~tlP~~lg~l~~L  208 (565)
T KOG0472|consen  131 DSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPE-NHIAMKRLKHLDCNSNLLETLPPELGGLESL  208 (565)
T ss_pred             chHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCH-HHHHHHHHHhcccchhhhhcCChhhcchhhh
Confidence              233445566667777776 677777777777777777777764433 3333777777777777766555555555555


Q ss_pred             ccccccccc
Q 013682          180 TPISFENNL  188 (438)
Q Consensus       180 ~~~~~~~N~  188 (438)
                      ..+++.-|.
T Consensus       209 ~~LyL~~Nk  217 (565)
T KOG0472|consen  209 ELLYLRRNK  217 (565)
T ss_pred             HHHHhhhcc
Confidence            555544443

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=98.87  E-value=9.9e-10  Score=117.46  Aligned_cols=128  Identities=23%  Similarity=0.193  Sum_probs=63.4

Q ss_pred             eeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc--------ceeeeecCCCccccccchhhccCCC-----------
Q 013682           36 TLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF--------VYLISDLGNAALSGELAPELGQLKN-----------   96 (438)
Q Consensus        36 ~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~--------~~~~~~l~~n~l~g~ip~~l~~l~~-----------   96 (438)
                      +.|+.|++++|.+..+|....   .++.|.+++|.+        .|..|+|++|++++ +|....+++.           
T Consensus       302 ~~L~~LdLS~N~L~~Lp~lp~---~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls~-LP~lp~~L~~L~Ls~N~L~~L  377 (788)
T PRK15387        302 PGLQELSVSDNQLASLPALPS---ELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSL  377 (788)
T ss_pred             cccceeECCCCccccCCCCcc---cccccccccCccccccccccccceEecCCCccCC-CCCCCcccceehhhccccccC
Confidence            456666777776666665432   233444444433        25566677777664 5543222222           


Q ss_pred             ------CCeeccc---------cccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEec
Q 013682           97 ------LELLALG---------NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDL  161 (438)
Q Consensus        97 ------L~~l~l~---------~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~l  161 (438)
                            |+.|+++         .+++|+.|++++|+|+ .+|..+   .+|+.|++++|+++ .+|..+.++++|+.+++
T Consensus       378 P~l~~~L~~LdLs~N~Lt~LP~l~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdL  452 (788)
T PRK15387        378 PALPSGLKELIVSGNRLTSLPVLPSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNL  452 (788)
T ss_pred             cccccccceEEecCCcccCCCCcccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEEC
Confidence                  2222211         0123444444444444 344322   23445555555555 45555666666666666


Q ss_pred             cCCCCCCCCCC
Q 013682          162 SNNRLSGPVPD  172 (438)
Q Consensus       162 s~N~l~g~ip~  172 (438)
                      ++|.|+|.+|.
T Consensus       453 s~N~Ls~~~~~  463 (788)
T PRK15387        453 EGNPLSERTLQ  463 (788)
T ss_pred             CCCCCCchHHH
Confidence            66666655543

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=98.87  E-value=4.9e-10  Score=112.23  Aligned_cols=141  Identities=23%  Similarity=0.220  Sum_probs=109.9

Q ss_pred             eecceeeehhHHHHHHHhhhhhhh-hhhcchheeecccCCcc------------ceeeeecCCCccccccchhhcc-CCC
Q 013682           31 CARGFTLLVTLKAVLQECEQLHLL-ISFLIFIRVLQSSSNLF------------VYLISDLGNAALSGELAPELGQ-LKN   96 (438)
Q Consensus        31 ~~~~~~~~~~l~~~~~~~~~l~~~-~~~~~~~~~l~~~~n~~------------~~~~~~l~~n~l~g~ip~~l~~-l~~   96 (438)
                      .++-+..|++||+|.|.++.+|.. +..-.+++.|.+++|.+            +|+.+.|++|+++. +|....+ |++
T Consensus       144 ~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNritt-Lp~r~Fk~L~~  222 (873)
T KOG4194|consen  144 ELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITT-LPQRSFKRLPK  222 (873)
T ss_pred             HHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccc-cCHHHhhhcch
Confidence            455567889999999999999887 67778888999988865            48888999999995 8877666 999


Q ss_pred             CCeecc-------------c------------------------cccCCCEEEccCCcccccCchhhccccccceecccc
Q 013682           97 LELLAL-------------G------------------------NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN  139 (438)
Q Consensus        97 L~~l~l-------------~------------------------~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~  139 (438)
                      |+.|++             .                        .|.++++|+|+.|+++--=-..+-+|+.|+.|+||.
T Consensus       223 L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~  302 (873)
T KOG4194|consen  223 LESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSY  302 (873)
T ss_pred             hhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccch
Confidence            988753             1                        245667777888877733334556788888888888


Q ss_pred             ccccCCCchhhccCCCCCeEeccCCCCCCCCCC
Q 013682          140 NSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD  172 (438)
Q Consensus       140 N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~  172 (438)
                      |......+.++..+++|+.||||+|+++..-|.
T Consensus       303 NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~  335 (873)
T KOG4194|consen  303 NAIQRIHIDSWSFTQKLKELDLSSNRITRLDEG  335 (873)
T ss_pred             hhhheeecchhhhcccceeEeccccccccCChh
Confidence            888877888888888888888888888865553

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.78  E-value=5.4e-08  Score=92.43  Aligned_cols=137  Identities=16%  Similarity=0.102  Sum_probs=93.7

Q ss_pred             cccccceEEEEEEeCCCCEEEEEEccccccc----------cchHHHHHHHHHHhcCCCCCc--eeeEEEEee-----CC
Q 013682          294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTS----------GGELQFQTEVKIISMAVHRNL--LRLYGFCTT-----VT  356 (438)
Q Consensus       294 LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~----------~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~-----~~  356 (438)
                      +-+.....|++.++ +|+.|.||+.......          .....+.+|...+.++...+|  ..++++...     ..
T Consensus        30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~  108 (268)
T PRK15123         30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR  108 (268)
T ss_pred             EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence            33333345667766 5778999976432210          111247788888877743333  344445433     23


Q ss_pred             eeEEEEecCCCC-CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC-------CCC
Q 013682          357 EKLLVYPYMTNG-SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-------DAD  428 (438)
Q Consensus       357 ~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~-------~~~  428 (438)
                      ..++|+|++++- +|.+++.....  .+.+......++.+++..+.-||..   +|+|+|++++|||++.       ++.
T Consensus       109 ~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        109 TSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             eeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence            578999999986 89888864321  1245567778999999999999999   9999999999999985       467


Q ss_pred             cchhhhhh
Q 013682          429 QSSKTILR  436 (438)
Q Consensus       429 ~~l~Df~~  436 (438)
                      +.++||-+
T Consensus       184 ~~LIDl~r  191 (268)
T PRK15123        184 LSVIDLHR  191 (268)
T ss_pred             EEEEECCc
Confidence            78888854

>PLN03210 Resistant to P

Probab=98.78  E-value=7.9e-09  Score=117.48  Aligned_cols=153  Identities=20%  Similarity=0.175  Sum_probs=110.5

Q ss_pred             eeeehhHHHHHHHhhhhhhhhhhcchheeecccCC-----------ccceeeeecCCCccccccchhhccCCCCCeeccc
Q 013682           35 FTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSN-----------LFVYLISDLGNAALSGELAPELGQLKNLELLALG  103 (438)
Q Consensus        35 ~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n-----------~~~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~  103 (438)
                      +..|+.|++..+.+..|+..+..+++|+.|+++.+           +..|..++|++|.....+|..++++++|+.|++.
T Consensus       610 ~~~L~~L~L~~s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~  689 (1153)
T PLN03210        610 PENLVKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMS  689 (1153)
T ss_pred             ccCCcEEECcCccccccccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeCC
Confidence            45677888888999999888888888998888754           2457788888887777888888888888877653


Q ss_pred             c------------ccCCCEE---------------------EccCCcccccCchhh------------------------
Q 013682          104 N------------LIKLKSL---------------------DLYSNLFNGTIPDTL------------------------  126 (438)
Q Consensus       104 ~------------l~~L~~l---------------------~ls~N~l~g~iP~~~------------------------  126 (438)
                      +            +++|+.|                     ++++|.+. .+|..+                        
T Consensus       690 ~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~  768 (1153)
T PLN03210        690 RCENLEILPTGINLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKLWERVQP  768 (1153)
T ss_pred             CCCCcCccCCcCCCCCCCEEeCCCCCCccccccccCCcCeeecCCCccc-cccccccccccccccccccchhhccccccc
Confidence            2            2334444                     44445543 455432                        


Q ss_pred             ------ccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCCCCCCCccccccccccc
Q 013682          127 ------ANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL  188 (438)
Q Consensus       127 ------~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~N~  188 (438)
                            ...++|+.|++++|...+.+|.+++++++|+.|++++|..-+.+|....++.+..+.++++.
T Consensus       769 l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~  836 (1153)
T PLN03210        769 LTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGCS  836 (1153)
T ss_pred             cchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCCC
Confidence                  11246778888888888889999999999999999988766678876656666666666543

syringae 6; Provisional

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.73  E-value=5.9e-09  Score=111.98  Aligned_cols=99  Identities=26%  Similarity=0.289  Sum_probs=61.8

Q ss_pred             eehhHHHHHHHhhhhhhhhhhcchheeecccCCccc---------eeeeecCCCccccccchhhccCCCCCeecccc---
Q 013682           37 LLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFV---------YLISDLGNAALSGELAPELGQLKNLELLALGN---  104 (438)
Q Consensus        37 ~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~~---------~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~~---  104 (438)
                      .+++|+++.|.++.||..+.  .+|+.|++++|.++         +..++|++|.+. .+|..+.  ++|+.|+++.   
T Consensus       200 ~L~~L~Ls~N~LtsLP~~l~--~nL~~L~Ls~N~LtsLP~~l~~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L  274 (754)
T PRK15370        200 QITTLILDNNELKSLPENLQ--GNIKTLYANSNQLTSIPATLPDTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKI  274 (754)
T ss_pred             CCcEEEecCCCCCcCChhhc--cCCCEEECCCCccccCChhhhccccEEECcCCccC-cCChhHh--CCCCEEECcCCcc
Confidence            46677888888888887654  47777777777543         556777777777 5776654  3566665431   


Q ss_pred             -------ccCCCEEEccCCcccccCchhhccccccceecccccccc
Q 013682          105 -------LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLS  143 (438)
Q Consensus       105 -------l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~  143 (438)
                             +.+|+.|++++|+|+ .+|..+.  ++|+.|++++|+++
T Consensus       275 ~~LP~~l~~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt  317 (754)
T PRK15370        275 SCLPENLPEELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLT  317 (754)
T ss_pred             CccccccCCCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccc
Confidence                   235777777777776 4555432  23444444444444

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.72  E-value=1.1e-07  Score=83.57  Aligned_cols=128  Identities=19%  Similarity=0.227  Sum_probs=92.7

Q ss_pred             CccccccceEEEEEEeCCCCEEEEEEccccccccc-------hHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          292 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG-------ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      ..+++|+=+.+|.+.+. |..+.+|.=........       ...-.+|+.++.+++--.|....=+..+++...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999874 44466664322211111       12456789999888755555445555677888899999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++..|.+.+...           +..++..+-.-+.-||..   +|+|+||.++||.+.++. +.+.||+
T Consensus        81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfG  136 (204)
T COG3642          81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFG  136 (204)
T ss_pred             eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECC
Confidence            9998888888653           244566666677789999   999999999999999765 8888885

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.69  E-value=1.8e-09  Score=113.35  Aligned_cols=82  Identities=28%  Similarity=0.462  Sum_probs=69.5

Q ss_pred             cccCCCEEEccCCcccccCch-hhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCCCCCCCccccc
Q 013682          104 NLIKLKSLDLYSNLFNGTIPD-TLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPI  182 (438)
Q Consensus       104 ~l~~L~~l~ls~N~l~g~iP~-~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~  182 (438)
                      +...|+.|+|++|+++ ++|+ .+.++..|+.|+||+|.|+ .+|..+..+..|++|...+|++. ..|+..+++++..+
T Consensus       381 ~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fPe~~~l~qL~~l  457 (1081)
T KOG0618|consen  381 NFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFPELAQLPQLKVL  457 (1081)
T ss_pred             cccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-echhhhhcCcceEE
Confidence            3567999999999997 8886 5688999999999999998 88999999999999999999988 45677777888777


Q ss_pred             cccccc
Q 013682          183 SFENNL  188 (438)
Q Consensus       183 ~~~~N~  188 (438)
                      +.+.|.
T Consensus       458 DlS~N~  463 (1081)
T KOG0618|consen  458 DLSCNN  463 (1081)
T ss_pred             ecccch
Confidence            776663

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.69  E-value=5.4e-08  Score=87.33  Aligned_cols=123  Identities=21%  Similarity=0.275  Sum_probs=78.0

Q ss_pred             EEEEEEeCCCCEEEEEEcccccc------------cc--------c-----hHHHHHHHHHHhcCCCC--CceeeEEEEe
Q 013682          301 KVYKGRLADGKLVAVKRLKEERT------------SG--------G-----ELQFQTEVKIISMAVHR--NLLRLYGFCT  353 (438)
Q Consensus       301 ~Vy~~~~~~~~~vAvK~l~~~~~------------~~--------~-----~~~~~~E~~~l~~l~H~--niv~l~g~~~  353 (438)
                      .||.|...++..+|+|..+....            ..        .     .....+|.+.|.++...  ++.+++.+  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            48999988899999998753211            00        0     11367899999998766  45555543  


Q ss_pred             eCCeeEEEEecCC--CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCceecCCCCCCeeeCCCCCcc
Q 013682          354 TVTEKLLVYPYMT--NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY-LHEHCDPKIIHRDVKAANILLDEDADQS  430 (438)
Q Consensus       354 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~ivHrDLK~~NILld~~~~~~  430 (438)
                        ....+||||++  +..+.. +.+..     ++......+..++...+.. +|..   +|+|+||.+.||+++++ .+.
T Consensus        79 --~~~~ivME~I~~~G~~~~~-l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPR-LKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGC-HHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred             --eCCEEEEEecCCCccchhh-HHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence              24579999998  544433 33221     1123455667777775555 4677   99999999999999987 999


Q ss_pred             hhhhhhc
Q 013682          431 SKTILRR  437 (438)
Q Consensus       431 l~Df~~~  437 (438)
                      +.||.+.
T Consensus       147 iIDf~qa  153 (188)
T PF01163_consen  147 IIDFGQA  153 (188)
T ss_dssp             E--GTTE
T ss_pred             EEecCcc
Confidence            9999874

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.69  E-value=1e-08  Score=74.51  Aligned_cols=60  Identities=43%  Similarity=0.687  Sum_probs=54.0

Q ss_pred             cCCCEEEccCCcccccCc-hhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCC
Q 013682          106 IKLKSLDLYSNLFNGTIP-DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL  166 (438)
Q Consensus       106 ~~L~~l~ls~N~l~g~iP-~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l  166 (438)
                      ++|+.|++++|+++ .+| ..|..+++|++|++++|+++...|..+..+++|+.|++++|++
T Consensus         1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            46889999999999 555 6889999999999999999977778999999999999999975

...

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.69  E-value=2.1e-07  Score=81.40  Aligned_cols=140  Identities=14%  Similarity=0.177  Sum_probs=97.0

Q ss_pred             CCCccccccceEEEEEEeCCCCEEEEEEcccccccc-------chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          290 NKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG-------GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       290 ~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ....+-||+=+.|+++.+. |+...||.-.......       ...+..+|+..+.+++--.|....=++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            3467889999999999984 6676777432211111       1224678898888776555544444555666678999


Q ss_pred             ecCCC-CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC---cchhhhh
Q 013682          363 PYMTN-GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD---QSSKTIL  435 (438)
Q Consensus       363 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~---~~l~Df~  435 (438)
                      ||+++ .++.+++.......  ..-......+..|-+.+.-||..   +|+|+||..+||++.++++   +.+.||+
T Consensus        90 E~~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfg  161 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFG  161 (229)
T ss_pred             EeccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeec
Confidence            99986 36777777643221  12222257788888899999999   9999999999999987764   4678886

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.68  E-value=6.6e-09  Score=111.61  Aligned_cols=121  Identities=24%  Similarity=0.330  Sum_probs=64.3

Q ss_pred             eehhHHHHHHHhhhhhhhhhhcchheeecccCCcc---------ceeeeecCCCccccccchhhccCCCCCeecccc---
Q 013682           37 LLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF---------VYLISDLGNAALSGELAPELGQLKNLELLALGN---  104 (438)
Q Consensus        37 ~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~---------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~~---  104 (438)
                      .|++|+++.|.++.+|..+.  ..++.|++++|.+         .|..|+|++|+++. +|..+.  ++|+.|++++   
T Consensus       221 nL~~L~Ls~N~LtsLP~~l~--~~L~~L~Ls~N~L~~LP~~l~s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~L  295 (754)
T PRK15370        221 NIKTLYANSNQLTSIPATLP--DTIQEMELSINRITELPERLPSALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSI  295 (754)
T ss_pred             CCCEEECCCCccccCChhhh--ccccEEECcCCccCcCChhHhCCCCEEECcCCccCc-cccccC--CCCcEEECCCCcc
Confidence            45666666666666665432  2455555555543         24445555555553 554443  2444443321   


Q ss_pred             ----------------------------ccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCC
Q 013682          105 ----------------------------LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSL  156 (438)
Q Consensus       105 ----------------------------l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L  156 (438)
                                                  +++|+.|++++|.++ .+|..+.  ++|+.|++++|+++ .+|..+.  ++|
T Consensus       296 t~LP~~lp~sL~~L~Ls~N~Lt~LP~~l~~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L  369 (754)
T PRK15370        296 RTLPAHLPSGITHLNVQSNSLTALPETLPPGLKTLEAGENALT-SLPASLP--PELQVLDVSKNQIT-VLPETLP--PTI  369 (754)
T ss_pred             ccCcccchhhHHHHHhcCCccccCCccccccceeccccCCccc-cCChhhc--CcccEEECCCCCCC-cCChhhc--CCc
Confidence                                        234555555555555 3555442  45666666666665 3454442  456


Q ss_pred             CeEeccCCCCCC
Q 013682          157 NILDLSNNRLSG  168 (438)
Q Consensus       157 ~~l~ls~N~l~g  168 (438)
                      +.|++++|+|+.
T Consensus       370 ~~LdLs~N~Lt~  381 (754)
T PRK15370        370 TTLDVSRNALTN  381 (754)
T ss_pred             CEEECCCCcCCC
Confidence            666666666663

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.67  E-value=2e-09  Score=107.63  Aligned_cols=149  Identities=26%  Similarity=0.287  Sum_probs=78.3

Q ss_pred             eeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc-----------ceeeeecCCCccccccchhhccCCCCCeec--
Q 013682           35 FTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF-----------VYLISDLGNAALSGELAPELGQLKNLELLA--  101 (438)
Q Consensus        35 ~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~-----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~--  101 (438)
                      ++--.+.|++.|.++.+|..+..+..+..+.+.+|-+           .++.+||+.|+++ .+|..+|.|+ |++|-  
T Consensus        74 ltdt~~aDlsrNR~~elp~~~~~f~~Le~liLy~n~~r~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~s  151 (722)
T KOG0532|consen   74 LTDTVFADLSRNRFSELPEEACAFVSLESLILYHNCIRTIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVS  151 (722)
T ss_pred             ccchhhhhccccccccCchHHHHHHHHHHHHHHhccceecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEe
Confidence            3444556667777777776665555555555554433           3555566666666 3666666554 33321  


Q ss_pred             ----------cccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCC
Q 013682          102 ----------LGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP  171 (438)
Q Consensus       102 ----------l~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip  171 (438)
                                ++....|..||.+.|.+. .+|++++.+.+|..|.+..|++. .+|.++. .-.|..||+|+|+++.-+-
T Consensus       152 NNkl~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~-~LpLi~lDfScNkis~iPv  228 (722)
T KOG0532|consen  152 NNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELC-SLPLIRLDFSCNKISYLPV  228 (722)
T ss_pred             cCccccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHh-CCceeeeecccCceeecch
Confidence                      233344555555555555 55555555555555555555554 3445554 2335555555555553222


Q ss_pred             CCCCCCccccccccccc
Q 013682          172 DNGSFSQFTPISFENNL  188 (438)
Q Consensus       172 ~~~~~~~~~~~~~~~N~  188 (438)
                      ....+.++..+.+++|+
T Consensus       229 ~fr~m~~Lq~l~LenNP  245 (722)
T KOG0532|consen  229 DFRKMRHLQVLQLENNP  245 (722)
T ss_pred             hhhhhhhheeeeeccCC
Confidence            33344444444555554

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=98.66  E-value=1.6e-08  Score=108.42  Aligned_cols=92  Identities=24%  Similarity=0.303  Sum_probs=47.7

Q ss_pred             eeeeecCCCccccccchhhccCCCCCee--cccc----ccCCCEEEccCCcccccCchhhcc-----------------c
Q 013682           73 YLISDLGNAALSGELAPELGQLKNLELL--ALGN----LIKLKSLDLYSNLFNGTIPDTLAN-----------------L  129 (438)
Q Consensus        73 ~~~~~l~~n~l~g~ip~~l~~l~~L~~l--~l~~----l~~L~~l~ls~N~l~g~iP~~~~~-----------------l  129 (438)
                      |..|+|++|.+++ +|....++..|..-  .+..    +.+|+.|+|++|+|+ .+|....+                 .
T Consensus       304 L~~LdLS~N~L~~-Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls-~LP~lp~~L~~L~Ls~N~L~~LP~l~  381 (788)
T PRK15387        304 LQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALP  381 (788)
T ss_pred             cceeECCCCcccc-CCCCcccccccccccCccccccccccccceEecCCCccC-CCCCCCcccceehhhccccccCcccc
Confidence            6667777777775 55432222222110  0111    124666666666665 34432211                 1


Q ss_pred             cccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCC
Q 013682          130 KQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP  171 (438)
Q Consensus       130 ~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip  171 (438)
                      .+|+.|++++|++++ +|...   ++|+.|++++|.+++ +|
T Consensus       382 ~~L~~LdLs~N~Lt~-LP~l~---s~L~~LdLS~N~Lss-IP  418 (788)
T PRK15387        382 SGLKELIVSGNRLTS-LPVLP---SELKELMVSGNRLTS-LP  418 (788)
T ss_pred             cccceEEecCCcccC-CCCcc---cCCCEEEccCCcCCC-CC
Confidence            346667777777763 44332   456667777777664 44

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=98.59  E-value=6.3e-08  Score=98.01  Aligned_cols=93  Identities=24%  Similarity=0.334  Sum_probs=84.6

Q ss_pred             HhcCCCCCceeeEEEEeeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCc-eecC
Q 013682          337 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI-IHRD  415 (438)
Q Consensus       337 l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i-vHrD  415 (438)
                      |+.+.|.|+.+++|.+..+...+.|.+|+..|+|.+.+....   ..++|.-...+..+++.||+|+|..   +| .|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~---~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED---IKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc---cCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence            356789999999999999999999999999999999998732   3489999999999999999999987   55 9999


Q ss_pred             CCCCCeeeCCCCCcchhhhh
Q 013682          416 VKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       416 LK~~NILld~~~~~~l~Df~  435 (438)
                      ++++|+++|.....|++||+
T Consensus        75 l~s~nClvd~~w~lklt~~G   94 (484)
T KOG1023|consen   75 LKSSNCLVDSRWVLKLTDFG   94 (484)
T ss_pred             eccccceeeeeEEEEechhh
Confidence            99999999999999999996

>PLN03210 Resistant to P

Probab=98.59  E-value=6.1e-08  Score=110.29  Aligned_cols=145  Identities=21%  Similarity=0.198  Sum_probs=103.4

Q ss_pred             eehhHHHHHHHhhhhhhhhhhcchheeecccCC-------------------ccceeeeecCCCccccccchhhccCCCC
Q 013682           37 LLVTLKAVLQECEQLHLLISFLIFIRVLQSSSN-------------------LFVYLISDLGNAALSGELAPELGQLKNL   97 (438)
Q Consensus        37 ~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n-------------------~~~~~~~~l~~n~l~g~ip~~l~~l~~L   97 (438)
                      .|+.|+++.|.+.++|..+ .+.+++.|.+..+                   ...|..++|++|...+++|..+++|++|
T Consensus       726 nL~~L~L~~n~i~~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L  804 (1153)
T PLN03210        726 NISWLDLDETAIEEFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKL  804 (1153)
T ss_pred             CcCeeecCCCccccccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCC
Confidence            4556666677777777654 3455555554431                   1357788999999889999999999999


Q ss_pred             Ceecccc------------ccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccC-C
Q 013682           98 ELLALGN------------LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSN-N  164 (438)
Q Consensus        98 ~~l~l~~------------l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~-N  164 (438)
                      +.|++.+            +++|+.|++++|..-..+|..   .++|+.|+|++|.++ .+|.++..+++|+.|++++ |
T Consensus       805 ~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~  880 (1153)
T PLN03210        805 EHLEIENCINLETLPTGINLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCN  880 (1153)
T ss_pred             CEEECCCCCCcCeeCCCCCccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCC
Confidence            9998764            456888899887655567754   367889999999998 6799999999999999987 5


Q ss_pred             CCCCCCCCCCCCCccccccccc
Q 013682          165 RLSGPVPDNGSFSQFTPISFEN  186 (438)
Q Consensus       165 ~l~g~ip~~~~~~~~~~~~~~~  186 (438)
                      ++.+-.+....++.+..+.+.+
T Consensus       881 ~L~~l~~~~~~L~~L~~L~l~~  902 (1153)
T PLN03210        881 NLQRVSLNISKLKHLETVDFSD  902 (1153)
T ss_pred             CcCccCcccccccCCCeeecCC
Confidence            6665333334445555555544

syringae 6; Provisional

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.57  E-value=8.4e-09  Score=103.33  Aligned_cols=119  Identities=24%  Similarity=0.308  Sum_probs=75.5

Q ss_pred             EeeeeecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCccc-----------eeeeecCCCccccccchhhccCC
Q 013682           27 CLGICARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFV-----------YLISDLGNAALSGELAPELGQLK   95 (438)
Q Consensus        27 ~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~~-----------~~~~~l~~n~l~g~ip~~l~~l~   95 (438)
                      |..++..+|+.|..||++.|.++.||..+-.| .|++|-.++|..+           +..+|.+.|.+- .+|+.++.+.
T Consensus       112 ~ip~~i~~L~~lt~l~ls~NqlS~lp~~lC~l-pLkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~  189 (722)
T KOG0532|consen  112 TIPEAICNLEALTFLDLSSNQLSHLPDGLCDL-PLKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLT  189 (722)
T ss_pred             ecchhhhhhhHHHHhhhccchhhcCChhhhcC-cceeEEEecCccccCCcccccchhHHHhhhhhhhhh-hchHHhhhHH
Confidence            44577788999999999999999999987544 4777777777654           233344455554 2566666665


Q ss_pred             CCCeecc------------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhh
Q 013682           96 NLELLAL------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSL  150 (438)
Q Consensus        96 ~L~~l~l------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l  150 (438)
                      +|..|.+            ..+ .|..||+|+|+++ .||-.|.+|+.|++|-|.+|.|+.+ |..+
T Consensus       190 slr~l~vrRn~l~~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSP-PAqI  253 (722)
T KOG0532|consen  190 SLRDLNVRRNHLEDLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSP-PAQI  253 (722)
T ss_pred             HHHHHHHhhhhhhhCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCC-hHHH
Confidence            5555432            111 2556666666665 6666666666666666666666633 4444

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.49  E-value=4e-07  Score=93.58  Aligned_cols=116  Identities=19%  Similarity=0.196  Sum_probs=93.1

Q ss_pred             eCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCH
Q 013682          307 LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDW  386 (438)
Q Consensus       307 ~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~  386 (438)
                      ..++.+|.|...+.... .......+.+..++.++||||++++..+...+..|+|+|-+..  |..++.+.       .-
T Consensus        34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~l-------~~  103 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKEL-------GK  103 (690)
T ss_pred             eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHHh-------HH
Confidence            45688899988765433 1223466778889999999999999999999999999998864  66666543       22


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhh
Q 013682          387 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  434 (438)
Q Consensus       387 ~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df  434 (438)
                      ......+.||+.||.|||+.|  +++|+++--..|++++.|+-++++|
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggl  149 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGL  149 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeee
Confidence            344556789999999999765  8999999999999999999999887

>PRK09902 hypothetical protein; Provisional

Probab=98.48  E-value=1.7e-06  Score=78.36  Aligned_cols=135  Identities=19%  Similarity=0.187  Sum_probs=96.6

Q ss_pred             ccccceEEEEEEeCCCCEEEEEEccccc--c---ccchHHHHHHHHHHhcCCCCC--ceeeEEEEe-e----CCeeEEEE
Q 013682          295 GRGGFGKVYKGRLADGKLVAVKRLKEER--T---SGGELQFQTEVKIISMAVHRN--LLRLYGFCT-T----VTEKLLVY  362 (438)
Q Consensus       295 G~G~fG~Vy~~~~~~~~~vAvK~l~~~~--~---~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~-~----~~~~~lv~  362 (438)
                      |+||-+.|++-.+. |+.+=+|+-....  +   +-+...|.+|...+..+...+  +.+.. ++. .    .-..+||+
T Consensus        27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence            66788888887764 4468888754211  1   335567999999988775433  33443 222 1    12357999


Q ss_pred             ecCCC-CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC--cchhhhhh
Q 013682          363 PYMTN-GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD--QSSKTILR  436 (438)
Q Consensus       363 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~--~~l~Df~~  436 (438)
                      |-+.+ -||.+++.+..  ..+.+......+..+++..+.-||+.   ++.|+|+.++||+++.+++  +.+.||=+
T Consensus       105 e~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk  176 (216)
T PRK09902        105 EDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEK  176 (216)
T ss_pred             EeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence            97764 48988886542  22356677789999999999999999   9999999999999986666  88888743

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.46  E-value=8.6e-08  Score=97.22  Aligned_cols=146  Identities=18%  Similarity=0.194  Sum_probs=111.8

Q ss_pred             HHhCCCCCCCccccccceEEEEEEeC--CCCEEEEEEccccccccc-hHHHHHHHHHHhcC-CCCCceeeEEEEeeCCee
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRLA--DGKLVAVKRLKEERTSGG-ELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEK  358 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~~--~~~~vAvK~l~~~~~~~~-~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  358 (438)
                      ..+.+|.....||.|.|+.|++...+  ++..|++|.+.+...... ...-..|+-+...+ .|.++++....+.+.+..
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            33457888899999999999987643  577899998765432221 22234455554444 599999988888888888


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC-CCcchhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTIL  435 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~-~~~~l~Df~  435 (438)
                      ++--||+++++......-.    ..++....+++..|++.++.++|+.   .++|+|+||+||++..+ +..+++||+
T Consensus       342 ~ip~e~~~~~s~~l~~~~~----~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~  412 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTS----QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFG  412 (524)
T ss_pred             cCchhhhcCcchhhhhHHH----HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccc
Confidence            9999999999876555221    1266777888999999999999987   99999999999999987 777888875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=98.46  E-value=4.5e-08  Score=103.09  Aligned_cols=144  Identities=22%  Similarity=0.286  Sum_probs=110.6

Q ss_pred             CCCCCCccccccceEEEEEEeC--CCCEEEEEEcccccc-ccchHHHHHHHHHHhcCC-CCCceeeEEEEeeCCeeEEEE
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA--DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~--~~~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~  362 (438)
                      .|...+.||+|+|+.|-.....  ....+|+|.+..... .........|..+-..+. |+|++++++.....+..++.+
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            4556677999999998877643  345678877654321 111223344666666665 999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCceecCCCCCCeeeCCCC-Ccchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH-EHCDPKIIHRDVKAANILLDEDA-DQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivHrDLK~~NILld~~~-~~~l~Df~  435 (438)
                      ||..++++.+.+...  .....+...+-.+..|+..++.|+| ..   ++.|||+||+|.+++..+ ..+++||.
T Consensus       101 ~~s~g~~~f~~i~~~--~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~  170 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHP--DSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFG  170 (601)
T ss_pred             CcccccccccccccC--CccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCch
Confidence            999999998887321  1113455677888999999999999 77   999999999999999999 89999996

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.42  E-value=1.1e-06  Score=80.54  Aligned_cols=101  Identities=19%  Similarity=0.216  Sum_probs=77.4

Q ss_pred             HHHHHHHHHhcCCCC--CceeeEEEEeeC----CeeEEEEecCCCC-CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHH
Q 013682          329 QFQTEVKIISMAVHR--NLLRLYGFCTTV----TEKLLVYPYMTNG-SVASRLRERQSSLPPLDWPTRKKIALGSARGLS  401 (438)
Q Consensus       329 ~~~~E~~~l~~l~H~--niv~l~g~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~  401 (438)
                      ...+|...+..+...  ...+.+++....    ...++++|++++. +|.+++.....    .+......++.+++..++
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARLIA  132 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHHHH
Confidence            577788777666433  344556665542    2358999999984 79998876322    455677889999999999


Q ss_pred             HHhcCCCCCceecCCCCCCeeeCCCC---Ccchhhhhh
Q 013682          402 YLHEHCDPKIIHRDVKAANILLDEDA---DQSSKTILR  436 (438)
Q Consensus       402 yLH~~~~~~ivHrDLK~~NILld~~~---~~~l~Df~~  436 (438)
                      -||..   +|+|+|+++.|||++.+.   +..+.||-+
T Consensus       133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~  167 (206)
T PF06293_consen  133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDR  167 (206)
T ss_pred             HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchh
Confidence            99999   999999999999999887   788888853

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=98.38  E-value=1.3e-07  Score=92.13  Aligned_cols=156  Identities=24%  Similarity=0.246  Sum_probs=107.9

Q ss_pred             cceeeehhHHHHHHHhh-hhhhhhhhcch---heeecccCCcc-----------------ceeeeecCCCccccc----c
Q 013682           33 RGFTLLVTLKAVLQECE-QLHLLISFLIF---IRVLQSSSNLF-----------------VYLISDLGNAALSGE----L   87 (438)
Q Consensus        33 ~~~~~~~~l~~~~~~~~-~l~~~~~~~~~---~~~l~~~~n~~-----------------~~~~~~l~~n~l~g~----i   87 (438)
                      ..++.|+.|+++.+.+. ..+..+..+..   ++.|+++.|.+                 .+..++|++|.+++.    +
T Consensus        78 ~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~  157 (319)
T cd00116          78 TKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEAL  157 (319)
T ss_pred             HhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHH
Confidence            44668888888888776 34555555555   88888877643                 457889999999853    4


Q ss_pred             chhhccCCCCCeeccc-----------------cccCCCEEEccCCccccc----CchhhccccccceeccccccccCCC
Q 013682           88 APELGQLKNLELLALG-----------------NLIKLKSLDLYSNLFNGT----IPDTLANLKQLKYLRLNNNSLSGLI  146 (438)
Q Consensus        88 p~~l~~l~~L~~l~l~-----------------~l~~L~~l~ls~N~l~g~----iP~~~~~l~~L~~l~ls~N~l~g~~  146 (438)
                      +..+..+++|+.|+++                 .+++|++|++++|.+++.    ++..+..+++|+.|++++|++++..
T Consensus       158 ~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~  237 (319)
T cd00116         158 AKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAG  237 (319)
T ss_pred             HHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHH
Confidence            4456677788888652                 234899999999998743    4556677889999999999998644


Q ss_pred             chhhcc-----CCCCCeEeccCCCCCC--C--CCC-CCCCCccccccccccc
Q 013682          147 PTSLTT-----ITSLNILDLSNNRLSG--P--VPD-NGSFSQFTPISFENNL  188 (438)
Q Consensus       147 P~~l~~-----~~~L~~l~ls~N~l~g--~--ip~-~~~~~~~~~~~~~~N~  188 (438)
                      +..+..     .+.|+.|++++|.++.  .  ++. ...++.+..+.+++|.
T Consensus       238 ~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~  289 (319)
T cd00116         238 AAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNK  289 (319)
T ss_pred             HHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCC
Confidence            444432     3789999999999872  1  111 1122456666666664

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.37  E-value=1.3e-06  Score=81.17  Aligned_cols=133  Identities=23%  Similarity=0.226  Sum_probs=89.0

Q ss_pred             CCCCccccccceEEEEEEeCCCCEEEEEEccccccc----------------c-----chHHHHHHHHHHhcCCCC--Cc
Q 013682          289 SNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS----------------G-----GELQFQTEVKIISMAVHR--NL  345 (438)
Q Consensus       289 ~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~----------------~-----~~~~~~~E~~~l~~l~H~--ni  345 (438)
                      .+...||.|-=+.||.|..+.|.++|||.=+...++                .     .....++|.+.|.++...  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            345789999999999999988999999964321110                0     112367788888888644  45


Q ss_pred             eeeEEEEeeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC
Q 013682          346 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE  425 (438)
Q Consensus       346 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~  425 (438)
                      .+.++    -+...+||||+++-.|... +        ++....-.+...|.+-+.-.-..   ||||+|+.+-||++++
T Consensus       174 P~P~~----~nRHaVvMe~ieG~eL~~~-r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~  237 (304)
T COG0478         174 PKPIA----WNRHAVVMEYIEGVELYRL-R--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCccc----cccceeeeehcccceeecc-c--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence            55543    3456899999998655422 1        11122223333333333333345   8999999999999999


Q ss_pred             CCCcchhhhhhc
Q 013682          426 DADQSSKTILRR  437 (438)
Q Consensus       426 ~~~~~l~Df~~~  437 (438)
                      ||+..+.||-+-
T Consensus       238 dg~~~vIDwPQ~  249 (304)
T COG0478         238 DGDIVVIDWPQA  249 (304)
T ss_pred             CCCEEEEeCccc
Confidence            999999999653

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=98.36  E-value=1.5e-07  Score=91.67  Aligned_cols=97  Identities=31%  Similarity=0.372  Sum_probs=57.8

Q ss_pred             ceeeeecCCCccccccchhhccCCC---CCeecc-----------------ccc-cCCCEEEccCCccccc----Cchhh
Q 013682           72 VYLISDLGNAALSGELAPELGQLKN---LELLAL-----------------GNL-IKLKSLDLYSNLFNGT----IPDTL  126 (438)
Q Consensus        72 ~~~~~~l~~n~l~g~ip~~l~~l~~---L~~l~l-----------------~~l-~~L~~l~ls~N~l~g~----iP~~~  126 (438)
                      .+..++|++|.+.+..+..+..+.+   |+.|++                 ..+ ++|+.|++++|.+++.    ++..+
T Consensus        82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~  161 (319)
T cd00116          82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL  161 (319)
T ss_pred             ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence            3444555555555444444444444   555543                 123 5677777777777743    33445


Q ss_pred             ccccccceeccccccccCC----CchhhccCCCCCeEeccCCCCCC
Q 013682          127 ANLKQLKYLRLNNNSLSGL----IPTSLTTITSLNILDLSNNRLSG  168 (438)
Q Consensus       127 ~~l~~L~~l~ls~N~l~g~----~P~~l~~~~~L~~l~ls~N~l~g  168 (438)
                      ..+..|++|++++|.+++.    ++..+..+++|+.|++++|.+++
T Consensus       162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~  207 (319)
T cd00116         162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTD  207 (319)
T ss_pred             HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccCh
Confidence            5566777777777777742    33445556677777777777764

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.32  E-value=5e-07  Score=79.92  Aligned_cols=56  Identities=39%  Similarity=0.538  Sum_probs=13.4

Q ss_pred             CCEEEccCCcccccCchhhccccccceeccccccccCCCchhh-ccCCCCCeEeccCCCC
Q 013682          108 LKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSL-TTITSLNILDLSNNRL  166 (438)
Q Consensus       108 L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l-~~~~~L~~l~ls~N~l  166 (438)
                      |+.|+|++|.++ .++ .+..++.|+.|++++|+++ .++..+ ..+++|+.|++++|++
T Consensus        44 L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I  100 (175)
T PF14580_consen   44 LEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKI  100 (175)
T ss_dssp             --EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS--
T ss_pred             CCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcC
Confidence            344444455444 332 2444444455555555544 222222 2344455555555444

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=98.32  E-value=2.7e-07  Score=93.01  Aligned_cols=132  Identities=35%  Similarity=0.429  Sum_probs=72.6

Q ss_pred             eehhHHHHHHHhhhhhhhhhhcchheeecccCCccc-----------eeeeecCCCccccccchhhccCCCCCeecc---
Q 013682           37 LLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFV-----------YLISDLGNAALSGELAPELGQLKNLELLAL---  102 (438)
Q Consensus        37 ~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~~-----------~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l---  102 (438)
                      .|+.|+++.|.+.++|..+..++.++.|+++.|...           +..+++++|+++ .+|..+..+.+|+.+.+   
T Consensus       141 nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N  219 (394)
T COG4886         141 NLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNN  219 (394)
T ss_pred             hcccccccccchhhhhhhhhccccccccccCCchhhhhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCC
Confidence            566667777777777666666666666666665432           344555555555 36655544444444432   


Q ss_pred             ---------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCC
Q 013682          103 ---------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD  172 (438)
Q Consensus       103 ---------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~  172 (438)
                               +++.++..+.+.+|++. .+|..++.++.+++|++++|+++ .++. ++.+.+|+.+++++|.+...+|.
T Consensus       220 ~~~~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~  295 (394)
T COG4886         220 SIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPL  295 (394)
T ss_pred             cceecchhhhhcccccccccCCceee-eccchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchh
Confidence                     22344444555555554 44555555555555555555555 3333 55555555555555555554443

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.30  E-value=1e-07  Score=88.80  Aligned_cols=103  Identities=28%  Similarity=0.290  Sum_probs=69.5

Q ss_pred             eehhHHHHHHHhhhhhhhhhhcchheeecccCCccceeeeecCCCccccccchhhccCCCCCeeccccccCCCEEEccCC
Q 013682           37 LLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSN  116 (438)
Q Consensus        37 ~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~~l~~L~~l~ls~N  116 (438)
                      +|++||+|.|.+++.-.+.-.++++++|++|+|.+.             .+-. +..           +++|+.||||+|
T Consensus       285 ~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~-------------~v~n-La~-----------L~~L~~LDLS~N  339 (490)
T KOG1259|consen  285 ELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIR-------------TVQN-LAE-----------LPQLQLLDLSGN  339 (490)
T ss_pred             hhhhccccccchhhhhhhhhhccceeEEecccccee-------------eehh-hhh-----------cccceEeecccc
Confidence            455899999999999999999999999888888764             1211 222           234566677777


Q ss_pred             cccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCC
Q 013682          117 LFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS  167 (438)
Q Consensus       117 ~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~  167 (438)
                      .++ ++-..-.++.++++|.|+.|.+...  +.+..+.+|..||+++|++.
T Consensus       340 ~Ls-~~~Gwh~KLGNIKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie  387 (490)
T KOG1259|consen  340 LLA-ECVGWHLKLGNIKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIE  387 (490)
T ss_pred             hhH-hhhhhHhhhcCEeeeehhhhhHhhh--hhhHhhhhheeccccccchh
Confidence            765 5555555566666777777766422  34566666777777777654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.25  E-value=3.3e-06  Score=86.95  Aligned_cols=135  Identities=19%  Similarity=0.203  Sum_probs=87.5

Q ss_pred             CccccccceEEEEEEeCCCCEEEEEEcccccc---------------------cc------------------chHHHHH
Q 013682          292 NILGRGGFGKVYKGRLADGKLVAVKRLKEERT---------------------SG------------------GELQFQT  332 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~---------------------~~------------------~~~~~~~  332 (438)
                      +.++.++-|.||+|++++|+.||||+.+....                     ..                  .+.++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            67999999999999999999999999864311                     01                  0012445


Q ss_pred             HHHHHhcC----CCCCceeeEEEEe-eCCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHH-HHHHhcC
Q 013682          333 EVKIISMA----VHRNLLRLYGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG-LSYLHEH  406 (438)
Q Consensus       333 E~~~l~~l----~H~niv~l~g~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~g-L~yLH~~  406 (438)
                      |+..+.++    +...-+++-.+|. -.+...|+|||++|-.+.+.......   ..+   +..++...+++ +..+-..
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~---g~d---~k~ia~~~~~~f~~q~~~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA---GID---RKELAELLVRAFLRQLLRD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc---CCC---HHHHHHHHHHHHHHHHHhc
Confidence            66555443    2233333444444 35678999999999887776322211   133   23333333322 2223334


Q ss_pred             CCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          407 CDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       407 ~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                         +++|.|..|.||+++.++..-+-||+
T Consensus       285 ---gffHaDpHpGNi~v~~~g~i~~lDfG  310 (517)
T COG0661         285 ---GFFHADPHPGNILVRSDGRIVLLDFG  310 (517)
T ss_pred             ---CccccCCCccceEEecCCcEEEEcCc
Confidence               89999999999999999998888885

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.14  E-value=1.2e-06  Score=82.96  Aligned_cols=95  Identities=25%  Similarity=0.383  Sum_probs=79.5

Q ss_pred             HhcCCCCCceeeEEEEeeC-----CeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 013682          337 ISMAVHRNLLRLYGFCTTV-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI  411 (438)
Q Consensus       337 l~~l~H~niv~l~g~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  411 (438)
                      +-.+.|.|||+++.++.+.     ....++.|||..|++.++|++.......+....-.+++-||..||.|||+. .|+|
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Ppi  199 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCcc
Confidence            3455699999999888653     346789999999999999998655555566667788999999999999994 8999


Q ss_pred             eecCCCCCCeeeCCCCCcchh
Q 013682          412 IHRDVKAANILLDEDADQSSK  432 (438)
Q Consensus       412 vHrDLK~~NILld~~~~~~l~  432 (438)
                      +|+.+..+-|.+..++-.+++
T Consensus       200 ihgnlTc~tifiq~ngLIkig  220 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIG  220 (458)
T ss_pred             ccCCcchhheeecCCceEEec
Confidence            999999999999988877765

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.14  E-value=2.7e-05  Score=72.35  Aligned_cols=72  Identities=13%  Similarity=0.123  Sum_probs=51.0

Q ss_pred             CccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCC--ceeeEEEEeeCCeeEEEEecCCCCC
Q 013682          292 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN--LLRLYGFCTTVTEKLLVYPYMTNGS  369 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lv~e~~~~gs  369 (438)
                      ..+|+|..+.||+.   .+..+++|..+...   ......+|.+.+..+..-.  +.+.+++....+...++||+++|.+
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            56899999999984   24456788775422   2235688888888775433  3566777767777789999999863

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.14  E-value=1.8e-06  Score=92.64  Aligned_cols=108  Identities=23%  Similarity=0.347  Sum_probs=74.3

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .++|..++.+..|+||.||..+++ ..+.+|+|.=++.       .+.+-  ++.....|.+|                 
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-------lilRn--ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-------LILRN--ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccc-------hhhhc--cccccCCccee-----------------
Confidence            357888899999999999999876 4667888543221       11111  22333334333                 


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhhc
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRR  437 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~~  437 (438)
                          ||-...+.....    +..        +.+.+++|+|+.   +|+|||+||+|.+|..-|..|+.||...
T Consensus       136 ----gDc~tllk~~g~----lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLs  190 (1205)
T KOG0606|consen  136 ----GDCATLLKNIGP----LPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLS  190 (1205)
T ss_pred             ----chhhhhcccCCC----Ccc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhh
Confidence                555555543221    211        227889999999   9999999999999999999999999864

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=98.11  E-value=7.5e-07  Score=89.81  Aligned_cols=119  Identities=34%  Similarity=0.423  Sum_probs=67.1

Q ss_pred             ceeeehhHHHHHHHhhhhhhhhhhcc-hheeecccCCccceeeeecCCCccccccchhhccCCCCCeeccc---------
Q 013682           34 GFTLLVTLKAVLQECEQLHLLISFLI-FIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLALG---------  103 (438)
Q Consensus        34 ~~~~~~~l~~~~~~~~~l~~~~~~~~-~~~~l~~~~n~~~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~---------  103 (438)
                      +++.+++|++..|...+++.....+. +++.|++++|...             .+|..++++++|+.|+++         
T Consensus       114 ~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~-------------~l~~~~~~l~~L~~L~l~~N~l~~l~~  180 (394)
T COG4886         114 ELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-------------SLPSPLRNLPNLKNLDLSFNDLSDLPK  180 (394)
T ss_pred             cccceeEEecCCcccccCccccccchhhcccccccccchh-------------hhhhhhhccccccccccCCchhhhhhh
Confidence            34555566666666666666665553 5555555554433             455666666666666531         


Q ss_pred             ---cccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCC
Q 013682          104 ---NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS  167 (438)
Q Consensus       104 ---~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~  167 (438)
                         .+++|..|++++|+++ .+|..++.+..|+++++++|+.. .+|..+..+.++..+.+++|++.
T Consensus       181 ~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~  245 (394)
T COG4886         181 LLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE  245 (394)
T ss_pred             hhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee
Confidence               3445666666666665 66665555555666666666432 34445555555555555555544

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.09  E-value=2.8e-06  Score=61.53  Aligned_cols=59  Identities=39%  Similarity=0.612  Sum_probs=46.4

Q ss_pred             eeeeecCCCccccccchhhccCCCCCeeccccccCCCEEEccCCcccccCchhhccccccceeccccccc
Q 013682           73 YLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSL  142 (438)
Q Consensus        73 ~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l  142 (438)
                      +..+++++|+++. +|+..          |..+++|++|++++|+++.--|..|..+++|+.|++++|++
T Consensus         3 L~~L~l~~n~l~~-i~~~~----------f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    3 LESLDLSNNKLTE-IPPDS----------FSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             ESEEEETSSTESE-ECTTT----------TTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcEEECCCCCCCc-cCHHH----------HcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            5667888888884 66533          23445678899999999965567899999999999999985

...

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=98.07  E-value=8.9e-07  Score=85.50  Aligned_cols=90  Identities=19%  Similarity=0.288  Sum_probs=71.4

Q ss_pred             ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCCC-CCCCcccc
Q 013682          103 GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTP  181 (438)
Q Consensus       103 ~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~-~~~~~~~~  181 (438)
                      ..+++|+.|+|++|++++.-+.+|..+..++.|.|..|++.-.--..+.++..|++|+|.+|+++---|-. ..+..+..
T Consensus       271 ~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~  350 (498)
T KOG4237|consen  271 KKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLST  350 (498)
T ss_pred             hhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeee
Confidence            45789999999999999878889999999999999999997555556788999999999999998655421 22334555


Q ss_pred             cccccccccCC
Q 013682          182 ISFENNLNLCG  192 (438)
Q Consensus       182 ~~~~~N~~lcg  192 (438)
                      +.+.+|+..|.
T Consensus       351 l~l~~Np~~Cn  361 (498)
T KOG4237|consen  351 LNLLSNPFNCN  361 (498)
T ss_pred             eehccCcccCc
Confidence            66777877663

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.06  E-value=2.6e-06  Score=75.39  Aligned_cols=82  Identities=34%  Similarity=0.487  Sum_probs=37.1

Q ss_pred             ceeeeecCCCccccccchhhccCCCCCeeccccccCCCEEEccCCcccccCchhh-ccccccceeccccccccCCC-chh
Q 013682           72 VYLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTL-ANLKQLKYLRLNNNSLSGLI-PTS  149 (438)
Q Consensus        72 ~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~~l~~L~~l~ls~N~l~g~iP~~~-~~l~~L~~l~ls~N~l~g~~-P~~  149 (438)
                      .+..++|++|.++. ++            .+..++.|++|++++|+++ .+++.+ ..+++|+.|++++|++...- =..
T Consensus        43 ~L~~L~Ls~N~I~~-l~------------~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~  108 (175)
T PF14580_consen   43 KLEVLDLSNNQITK-LE------------GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDLNELEP  108 (175)
T ss_dssp             T--EEE-TTS--S---T------------T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---SCCCCGG
T ss_pred             CCCEEECCCCCCcc-cc------------CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCChHHhHH
Confidence            35556666666653 22            1234677899999999998 787666 46899999999999997421 145


Q ss_pred             hccCCCCCeEeccCCCCC
Q 013682          150 LTTITSLNILDLSNNRLS  167 (438)
Q Consensus       150 l~~~~~L~~l~ls~N~l~  167 (438)
                      ++.+++|+.|++.+|.++
T Consensus       109 L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen  109 LSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             GGG-TT--EEE-TT-GGG
T ss_pred             HHcCCCcceeeccCCccc
Confidence            778999999999998776

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.04  E-value=4e-06  Score=85.27  Aligned_cols=142  Identities=21%  Similarity=0.103  Sum_probs=106.9

Q ss_pred             CCCCCCcccc--ccceEEEEEEe--C-CCCEEEEEEcccccc-ccchHHHHHHHHHHhcCC-CCCceeeEEEEeeCCeeE
Q 013682          287 GFSNKNILGR--GGFGKVYKGRL--A-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKL  359 (438)
Q Consensus       287 ~~~~~~~LG~--G~fG~Vy~~~~--~-~~~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~  359 (438)
                      .|.....+|.  |.+|.||.+..  + ++..+|+|.-+.... ......-.+|.....+++ |+|.++.+..+.+.+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            3455677899  99999999987  3 578899997433221 112223456666666664 999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCceecCCCCCCeeeCCC-CCcchhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR----GLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTI  434 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivHrDLK~~NILld~~-~~~~l~Df  434 (438)
                      +-+|++. .++.++.+....   .+.......+..+...    |+.++|+.   +++|-|+||.||...++ ...+.+||
T Consensus       195 iqtE~~~-~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeecccc-chhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence            9999986 677777765432   2444555566666666    99999999   99999999999999999 78888888


Q ss_pred             h
Q 013682          435 L  435 (438)
Q Consensus       435 ~  435 (438)
                      .
T Consensus       268 ~  268 (524)
T KOG0601|consen  268 G  268 (524)
T ss_pred             c
Confidence            4

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.04  E-value=8.2e-05  Score=67.40  Aligned_cols=124  Identities=21%  Similarity=0.347  Sum_probs=86.5

Q ss_pred             CCCccccccceEEEEEEeCCCCEEEEEEccccc---------------cccchHHHHHHHHHHhcCC------CCCceee
Q 013682          290 NKNILGRGGFGKVYKGRLADGKLVAVKRLKEER---------------TSGGELQFQTEVKIISMAV------HRNLLRL  348 (438)
Q Consensus       290 ~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~---------------~~~~~~~~~~E~~~l~~l~------H~niv~l  348 (438)
                      ....||+|+.-.||.  +++.....||+.+...               ......+..+|+.-...+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            356799999999985  4444556788876543               0112345667766555444      8899999


Q ss_pred             EEEEeeCCeeEEEEecCCCC------CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCee
Q 013682          349 YGFCTTVTEKLLVYPYMTNG------SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL  422 (438)
Q Consensus       349 ~g~~~~~~~~~lv~e~~~~g------sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NIL  422 (438)
                      +|+.++.....+|+|.+.+.      +|.+++++..     ++.    .+...+-+-..||-+.   +|+.+|++|+||+
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-----~~~----~~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv  150 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-----LTE----ELRQALDEFKRYLLDH---HIVIRDLNPHNIV  150 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-----ccH----HHHHHHHHHHHHHHHc---CCeecCCCcccEE
Confidence            99999999999999987542      6888885432     333    2223333445677777   8999999999999


Q ss_pred             eCCCC
Q 013682          423 LDEDA  427 (438)
Q Consensus       423 ld~~~  427 (438)
                      +..+.
T Consensus       151 ~~~~~  155 (199)
T PF10707_consen  151 VQRRD  155 (199)
T ss_pred             EEecC
Confidence            98654

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.03  E-value=3e-05  Score=77.89  Aligned_cols=128  Identities=16%  Similarity=0.126  Sum_probs=95.0

Q ss_pred             eEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEee----CCeeEEEEecCCC-CCHHHH
Q 013682          300 GKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT----VTEKLLVYPYMTN-GSVASR  373 (438)
Q Consensus       300 G~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~e~~~~-gsL~~~  373 (438)
                      .+.||+.. .||..|..|+++........ ....-++.++++.|+|+|++..++..    +....+||+|.+. ++|.++
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n-k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTN-KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcc-cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            46788875 47999999999554322211 23344677899999999999998873    4467899999986 467766


Q ss_pred             hhccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcch
Q 013682          374 LRERQSS-----------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS  431 (438)
Q Consensus       374 l~~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l  431 (438)
                      .......           ....++.....++.|++.||.++|+.   |..-+-|-+.+||++.+...+|
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIri  434 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRI  434 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEE
Confidence            5432111           12345677889999999999999999   8888999999999998864443

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=97.99  E-value=1.2e-06  Score=72.81  Aligned_cols=111  Identities=17%  Similarity=0.207  Sum_probs=84.2

Q ss_pred             hHHHHHHHhhhhhhhhhhcchheeecccCCccceeeeecCCCccccccchhhccCCCCCeeccccccCCCEEEccCCccc
Q 013682           40 TLKAVLQECEQLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFN  119 (438)
Q Consensus        40 ~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~~l~~L~~l~ls~N~l~  119 (438)
                      .+|+|.+++-++++....+....         .+...+|++|.|- .+|+.+...          ++.++.++|++|.++
T Consensus        31 ~ldLssc~lm~i~davy~l~~~~---------el~~i~ls~N~fk-~fp~kft~k----------f~t~t~lNl~~neis   90 (177)
T KOG4579|consen   31 FLDLSSCQLMYIADAVYMLSKGY---------ELTKISLSDNGFK-KFPKKFTIK----------FPTATTLNLANNEIS   90 (177)
T ss_pred             hcccccchhhHHHHHHHHHhCCc---------eEEEEecccchhh-hCCHHHhhc----------cchhhhhhcchhhhh
Confidence            46777777777777765555432         3455677777776 488776543          234677899999998


Q ss_pred             ccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCCC
Q 013682          120 GTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN  173 (438)
Q Consensus       120 g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~  173 (438)
                       .+|+++..|+.|+.++++.|.+. ..|..+..+.+|..||..+|... +||..
T Consensus        91 -dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~d  141 (177)
T KOG4579|consen   91 -DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVD  141 (177)
T ss_pred             -hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHH
Confidence             99999999999999999999998 55888888999999998887764 45543

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.97  E-value=2.6e-05  Score=80.31  Aligned_cols=135  Identities=17%  Similarity=0.147  Sum_probs=82.1

Q ss_pred             CCccccccceEEEEEEeCCCCEEEEEEcccccccc------------------------------------chHHHHHHH
Q 013682          291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG------------------------------------GELQFQTEV  334 (438)
Q Consensus       291 ~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~------------------------------------~~~~~~~E~  334 (438)
                      .+.||.-+.|.||+|++++|+.||||+-+......                                    .+.+|..|+
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            36799999999999999999999999875432100                                    011355565


Q ss_pred             HHHh----cCCCCC---ceeeEEEEee-CCeeEEEEecCCCCCHHHH--hhccCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 013682          335 KIIS----MAVHRN---LLRLYGFCTT-VTEKLLVYPYMTNGSVASR--LRERQSSLPPLDWPTRKKIALGSARGLSYLH  404 (438)
Q Consensus       335 ~~l~----~l~H~n---iv~l~g~~~~-~~~~~lv~e~~~~gsL~~~--l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH  404 (438)
                      +...    .+.|-+   -|.+-.++.+ .....|+||||+|..+.+.  +++..     ++......-..++..-+-+-|
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g-----i~~~~i~~~l~~~~~~qIf~~  320 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG-----ISPHDILNKLVEAYLEQIFKT  320 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC-----CCHHHHHHHHHHHHHHHHHhc
Confidence            4443    334555   1223333333 4567899999999865443  33332     333333332222221122222


Q ss_pred             cCCCCCceecCCCCCCeeeCC----CCCcchhhhh
Q 013682          405 EHCDPKIIHRDVKAANILLDE----DADQSSKTIL  435 (438)
Q Consensus       405 ~~~~~~ivHrDLK~~NILld~----~~~~~l~Df~  435 (438)
                           |++|+|-.|.||+++.    +++..+-||+
T Consensus       321 -----GffHaDPHPGNilv~~~~~~~~~ivllDhG  350 (538)
T KOG1235|consen  321 -----GFFHADPHPGNILVRPNPEGDEEIVLLDHG  350 (538)
T ss_pred             -----CCccCCCCCCcEEEecCCCCCccEEEEccc
Confidence                 8999999999999994    4566676764

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=97.94  E-value=2.9e-06  Score=83.01  Aligned_cols=52  Identities=15%  Similarity=0.004  Sum_probs=39.3

Q ss_pred             EeeceEEeeeeecceeeehhHHHHHHHhhhhhhh---hhhcchheeecccCCccc
Q 013682           21 CRVGIICLGICARGFTLLVTLKAVLQECEQLHLL---ISFLIFIRVLQSSSNLFV   72 (438)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~l~~~---~~~~~~~~~l~~~~n~~~   72 (438)
                      |+|+++-.--..+.|+.+..||+|.|-+..--..   ...+++|+.|.+++|.+.
T Consensus       131 ~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~  185 (505)
T KOG3207|consen  131 YRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLS  185 (505)
T ss_pred             ccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhccccccccc
Confidence            6676543334788999999999999988776555   577788888888888764

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.94  E-value=2.5e-05  Score=70.33  Aligned_cols=99  Identities=22%  Similarity=0.265  Sum_probs=76.8

Q ss_pred             HHHHHHHhcCCC-CCceeeEEEEeeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 013682          331 QTEVKIISMAVH-RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP  409 (438)
Q Consensus       331 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~  409 (438)
                      ..|.-++..+++ +++.+++|+|    ..+++.||...+++...-.. ......-+|..+.+||.++.+.++++++...-
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            457778888876 6999999999    35789999998766422000 00111358999999999999999999985433


Q ss_pred             CceecCCCCCCeeeCCCCCcchhhh
Q 013682          410 KIIHRDVKAANILLDEDADQSSKTI  434 (438)
Q Consensus       410 ~ivHrDLK~~NILld~~~~~~l~Df  434 (438)
                      .+.-.|++++|+-+++++++++.|.
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDl  106 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDL  106 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEec
Confidence            5777999999999999999999885

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=97.92  E-value=6.8e-06  Score=55.19  Aligned_cols=36  Identities=42%  Similarity=0.646  Sum_probs=24.8

Q ss_pred             CCCEEEccCCcccccCchhhccccccceecccccccc
Q 013682          107 KLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLS  143 (438)
Q Consensus       107 ~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~  143 (438)
                      +|++|++++|+++ .+|+++++|++|+.|++++|+++
T Consensus         2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred             cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence            5677777777776 67777777777777777777766

...

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=97.90  E-value=2.1e-05  Score=69.55  Aligned_cols=52  Identities=33%  Similarity=0.297  Sum_probs=44.7

Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcch
Q 013682          368 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS  431 (438)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l  431 (438)
                      |+|.++++...   ..++|.++..++.|++.||+|||++   +      ||+|||+++++.+++
T Consensus         1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~   52 (176)
T smart00750        1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL   52 (176)
T ss_pred             CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee
Confidence            78999997642   2489999999999999999999998   4      999999999887654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN02876 acyl-CoA dehydrogenase

Probab=97.89  E-value=9e-05  Score=81.79  Aligned_cols=79  Identities=13%  Similarity=0.296  Sum_probs=55.9

Q ss_pred             CCccccccceEEEEEEeCCC---CEEEEEEccccccccchHHHHHHHHHHhcCC-CCCc--eeeEEEEeeC---CeeEEE
Q 013682          291 KNILGRGGFGKVYKGRLADG---KLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNL--LRLYGFCTTV---TEKLLV  361 (438)
Q Consensus       291 ~~~LG~G~fG~Vy~~~~~~~---~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lv  361 (438)
                      .+.++.|.+..+|+....++   ..+++|+............+.+|..++..+. |+++  .+++++|.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            35688999999999877543   3577776543322223346889999999885 6665  7777877654   457899


Q ss_pred             EecCCCCC
Q 013682          362 YPYMTNGS  369 (438)
Q Consensus       362 ~e~~~~gs  369 (438)
                      |||+++..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99998753

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.86  E-value=0.00013  Score=67.38  Aligned_cols=149  Identities=20%  Similarity=0.299  Sum_probs=91.7

Q ss_pred             cHHHHHHHhCCCCCCCccc---cccceEEEEEEeCCCCEEEEEEccccccc--------cchH---------------HH
Q 013682          277 SLRELQVATDGFSNKNILG---RGGFGKVYKGRLADGKLVAVKRLKEERTS--------GGEL---------------QF  330 (438)
Q Consensus       277 ~~~~~~~~~~~~~~~~~LG---~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~--------~~~~---------------~~  330 (438)
                      +.+.+....++..+....|   .|.=+.||+|...++..+|||+++.....        .+..               ..
T Consensus        36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~  115 (268)
T COG1718          36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA  115 (268)
T ss_pred             HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence            3444444445555555545   45556799999878999999998643211        0000               12


Q ss_pred             HHHHHHHhcCC--CCCceeeEEEEeeCCeeEEEEecCCCCC-HHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-C
Q 013682          331 QTEVKIISMAV--HRNLLRLYGFCTTVTEKLLVYPYMTNGS-VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-H  406 (438)
Q Consensus       331 ~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~  406 (438)
                      ..|...|.++.  +-.+.+.+++.    .-.|||||+.... -.-.|.+     .++...++..+..++.+.+.-|-. .
T Consensus       116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~~a  186 (268)
T COG1718         116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYKEA  186 (268)
T ss_pred             HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHHhc
Confidence            34555555543  22233333322    3469999996531 1111222     123333567777788888887776 4


Q ss_pred             CCCCceecCCCCCCeeeCCCCCcchhhhhhcC
Q 013682          407 CDPKIIHRDVKAANILLDEDADQSSKTILRRL  438 (438)
Q Consensus       407 ~~~~ivHrDLK~~NILld~~~~~~l~Df~~~~  438 (438)
                         ++||+||..=|||+. ++++.++|+.+.+
T Consensus       187 ---~LVHgDLSEyNiL~~-~~~p~iID~~QaV  214 (268)
T COG1718         187 ---GLVHGDLSEYNILVH-DGEPYIIDVSQAV  214 (268)
T ss_pred             ---CcccccchhhheEEE-CCeEEEEECcccc
Confidence               899999999999999 8999999998754

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=97.84  E-value=5.1e-06  Score=83.24  Aligned_cols=74  Identities=19%  Similarity=0.232  Sum_probs=64.7

Q ss_pred             eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          357 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ..|+.|+++...+|.+|++.+... ...+|.....++.|++.|++|   +   +.+|||+||.||....+...+|+||+-
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~-e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTG-EERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcc-cccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence            468999999999999999755332 346888999999999999999   5   889999999999999999999999985


Q ss_pred             c
Q 013682          437 R  437 (438)
Q Consensus       437 ~  437 (438)
                      .
T Consensus       403 ~  403 (516)
T KOG1033|consen  403 V  403 (516)
T ss_pred             e
Confidence            3

>PRK10593 hypothetical protein; Provisional

Probab=97.84  E-value=0.00022  Score=69.08  Aligned_cols=77  Identities=14%  Similarity=0.083  Sum_probs=54.7

Q ss_pred             CCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCC---CCceeeEEEEee---CCeeEEEEe
Q 013682          290 NKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH---RNLLRLYGFCTT---VTEKLLVYP  363 (438)
Q Consensus       290 ~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~---~~~~~lv~e  363 (438)
                      ..+.||+|..+.||+....++ .+.+|..+...   ....+..|++.++.+.-   -.+.+++++|..   .+..++|||
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQG-NPMPLMARSFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             eeeecCCccceeEEEEEcCCC-CEEEEEecccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            346799999999999876555 46667643311   12368899999887753   357788887754   356899999


Q ss_pred             cCCCCCH
Q 013682          364 YMTNGSV  370 (438)
Q Consensus       364 ~~~~gsL  370 (438)
                      +++++++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998654

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.79  E-value=0.00019  Score=67.32  Aligned_cols=74  Identities=9%  Similarity=0.069  Sum_probs=50.1

Q ss_pred             cccccc-eEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCC-CCCceeeEEEEeeCCeeEEEEecCCCCCHH
Q 013682          294 LGRGGF-GKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPYMTNGSVA  371 (438)
Q Consensus       294 LG~G~f-G~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~gsL~  371 (438)
                      |-.|.+ ..||+.... +..+.+|......    .....+|++++..+. +--+.+++++....+..++|||+++|.++.
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            445555 689998764 4678888764432    224677888877664 333556777776666789999999987665


Q ss_pred             H
Q 013682          372 S  372 (438)
Q Consensus       372 ~  372 (438)
                      .
T Consensus        81 ~   81 (244)
T cd05150          81 A   81 (244)
T ss_pred             H
Confidence            3

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=97.76  E-value=1.3e-06  Score=90.13  Aligned_cols=140  Identities=29%  Similarity=0.317  Sum_probs=82.7

Q ss_pred             eeceEEeeeeecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCccceeeeecCCCccccccchhhccCCCCCeec
Q 013682           22 RVGIICLGICARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLA  101 (438)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~  101 (438)
                      |+|=||-+--|-.|.   +-+-+.|.+..+-..+-.+..++.|++++|.++             .+. .           
T Consensus       153 cggd~~ns~~Wn~L~---~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~-------------~v~-~-----------  204 (1096)
T KOG1859|consen  153 CGGDISNSPVWNKLA---TASFSYNRLVLMDESLQLLPALESLNLSHNKFT-------------KVD-N-----------  204 (1096)
T ss_pred             hccccccchhhhhHh---hhhcchhhHHhHHHHHHHHHHhhhhccchhhhh-------------hhH-H-----------
Confidence            445555555553332   344556666666666666666666666655554             111 1           


Q ss_pred             cccccCCCEEEccCCcccccCch-hhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCC--CCCCCCCc
Q 013682          102 LGNLIKLKSLDLYSNLFNGTIPD-TLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV--PDNGSFSQ  178 (438)
Q Consensus       102 l~~l~~L~~l~ls~N~l~g~iP~-~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~i--p~~~~~~~  178 (438)
                      +..|+.|++|||+.|++. .+|. +...+. |+.|.+++|-++..  ..+.++.+|..||+|+|-+.+.-  -....+..
T Consensus       205 Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~  280 (1096)
T KOG1859|consen  205 LRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSS  280 (1096)
T ss_pred             HHhcccccccccccchhc-cccccchhhhh-heeeeecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHH
Confidence            133566777888888887 6664 222333 78888888888743  35777888888888888776531  11223344


Q ss_pred             ccccccccccccCCC
Q 013682          179 FTPISFENNLNLCGP  193 (438)
Q Consensus       179 ~~~~~~~~N~~lcg~  193 (438)
                      +..+.+.|||.-|-+
T Consensus       281 L~~L~LeGNPl~c~p  295 (1096)
T KOG1859|consen  281 LIVLWLEGNPLCCAP  295 (1096)
T ss_pred             HHHHhhcCCccccCH
Confidence            455667788765543

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.73  E-value=0.00018  Score=63.08  Aligned_cols=122  Identities=19%  Similarity=0.243  Sum_probs=79.3

Q ss_pred             CCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCce-eeEEEEeeCCeeEEEEecCCCCC
Q 013682          291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL-RLYGFCTTVTEKLLVYPYMTNGS  369 (438)
Q Consensus       291 ~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv~e~~~~gs  369 (438)
                      .+.||+|.+|.||.+.|. +..+|+|+-+.   +.....++.|++++..+.-.++. +++.+-    ..++.|||+.|-.
T Consensus        27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~---ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~   98 (201)
T COG2112          27 EKELAKGTTSVVYLGEWR-GGEVALKVRRR---DSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRP   98 (201)
T ss_pred             hhhhhcccccEEEEeecc-CceEEEEEecC---CcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcc
Confidence            467999999999999996 55889987644   33445789999999988877664 333332    2345599999988


Q ss_pred             HHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCC--CCeeeCCCCCcchhhhh
Q 013682          370 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKA--ANILLDEDADQSSKTIL  435 (438)
Q Consensus       370 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~--~NILld~~~~~~l~Df~  435 (438)
                      |.+.-...       +-.+.    ..++++.--|-..   +|-|..+.-  +||++.+ .++.|.||=
T Consensus        99 L~~~~~~~-------~rk~l----~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~-~~~~iIDFd  151 (201)
T COG2112          99 LGKLEIGG-------DRKHL----LRVLEKAYKLDRL---GIEHGELSRPWKNVLVND-RDVYIIDFD  151 (201)
T ss_pred             hhhhhhcc-------cHHHH----HHHHHHHHHHHHh---ccchhhhcCCceeEEecC-CcEEEEEcc
Confidence            87665421       11122    2333332223333   777777653  5666654 489999984

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=97.71  E-value=2.9e-05  Score=52.11  Aligned_cols=37  Identities=41%  Similarity=0.649  Sum_probs=32.5

Q ss_pred             cccceeccccccccCCCchhhccCCCCCeEeccCCCCC
Q 013682          130 KQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS  167 (438)
Q Consensus       130 ~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~  167 (438)
                      ++|+.|++++|+++ .+|..++++++|+.|++++|+++
T Consensus         1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred             CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence            47899999999999 67888999999999999999987

...

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.70  E-value=0.00014  Score=67.00  Aligned_cols=77  Identities=16%  Similarity=0.213  Sum_probs=52.9

Q ss_pred             CccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCC--CceeeEEEEee---CCeeEEEEecCC
Q 013682          292 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR--NLLRLYGFCTT---VTEKLLVYPYMT  366 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~---~~~~~lv~e~~~  366 (438)
                      +.++.|..+.||+....+ ..+++|.....   .......+|..++..+...  .+.+++.....   ....+++|++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            568899999999999876 68999986443   2234677888887776533  34566654433   234689999999


Q ss_pred             CCCHHH
Q 013682          367 NGSVAS  372 (438)
Q Consensus       367 ~gsL~~  372 (438)
                      +..+..
T Consensus        79 g~~~~~   84 (239)
T PF01636_consen   79 GRPLDD   84 (239)
T ss_dssp             SEEHHH
T ss_pred             cccccc
Confidence            887666

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=97.67  E-value=4.2e-06  Score=69.72  Aligned_cols=101  Identities=22%  Similarity=0.253  Sum_probs=72.6

Q ss_pred             eeeeecCCCccccccchhhccCCCCCeeccccccCCCEEEccCCcccccCchhhccc-cccceeccccccccCCCchhhc
Q 013682           73 YLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANL-KQLKYLRLNNNSLSGLIPTSLT  151 (438)
Q Consensus        73 ~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~~l~~L~~l~ls~N~l~g~iP~~~~~l-~~L~~l~ls~N~l~g~~P~~l~  151 (438)
                      +..+||+++.+- .+|..+..+...+        .|...+|++|.|. ..|+.|... +.+++++|++|.++ .+|.+++
T Consensus        29 ~h~ldLssc~lm-~i~davy~l~~~~--------el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~A   97 (177)
T KOG4579|consen   29 LHFLDLSSCQLM-YIADAVYMLSKGY--------ELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELA   97 (177)
T ss_pred             hhhcccccchhh-HHHHHHHHHhCCc--------eEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHh
Confidence            344556655553 3555544444333        3677899999998 899988765 48999999999998 8899999


Q ss_pred             cCCCCCeEeccCCCCCCCCCCCCCCCccccccc
Q 013682          152 TITSLNILDLSNNRLSGPVPDNGSFSQFTPISF  184 (438)
Q Consensus       152 ~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~  184 (438)
                      .++.|+.+|++.|.+.-.+-....+..+..+..
T Consensus        98 am~aLr~lNl~~N~l~~~p~vi~~L~~l~~Lds  130 (177)
T KOG4579|consen   98 AMPALRSLNLRFNPLNAEPRVIAPLIKLDMLDS  130 (177)
T ss_pred             hhHHhhhcccccCccccchHHHHHHHhHHHhcC
Confidence            999999999999999866544333333333333

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=97.60  E-value=7.7e-06  Score=76.53  Aligned_cols=80  Identities=26%  Similarity=0.378  Sum_probs=61.1

Q ss_pred             ccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCCCCCCCccccccc
Q 013682          105 LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISF  184 (438)
Q Consensus       105 l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~  184 (438)
                      ...|+++|||+|.++ .|.++..-++.++.|++|+|.+. .+ .+++.+++|+.||||+|.++...-+...+.+...+.+
T Consensus       283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v-~nLa~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~L  359 (490)
T KOG1259|consen  283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TV-QNLAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLKL  359 (490)
T ss_pred             Hhhhhhccccccchh-hhhhhhhhccceeEEecccccee-ee-hhhhhcccceEeecccchhHhhhhhHhhhcCEeeeeh
Confidence            456889999999998 89999999999999999999987 33 4588999999999999988765544433333333444


Q ss_pred             ccc
Q 013682          185 ENN  187 (438)
Q Consensus       185 ~~N  187 (438)
                      ++|
T Consensus       360 a~N  362 (490)
T KOG1259|consen  360 AQN  362 (490)
T ss_pred             hhh
Confidence            444

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	438
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-85
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-82
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-25
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-25
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-24
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-24
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-24
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-23
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-12
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-12
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-11
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-11
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-11
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-11
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-11
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-11
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-11
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-11
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-11
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-11
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-11
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-11
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		9e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		9e-11
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		9e-11
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		9e-11
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-10
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-10
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-10
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-10
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-10
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-10
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-10
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-10
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-10
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-10
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-10
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-10
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-10
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-10
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-10
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-10
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-10
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-10
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-10
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-10
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-10
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-10
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-10
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-10
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-10
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-10
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-10
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-10
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-10
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-10
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-10
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-10
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-10
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-10
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		6e-10
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-10
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-09
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-09
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-09
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-09
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-09
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-09
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-09
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-09
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-09
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-09
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-09
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-09
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-09
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-09
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-09
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-09
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-09
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-09
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-09
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-09
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		7e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		9e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-08
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-08
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-08
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-08
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-08
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-08
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-08
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-08
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-08
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-08
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-08
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-08
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-08
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-08
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-08
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-08
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-08
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-08
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-08
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-08
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-08
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-08
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-08
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-08
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-08
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-08
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-08
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-08
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-08
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		6e-08
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-08
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-08
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-08
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-08
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		7e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		7e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		7e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		7e-08
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		7e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		7e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		7e-08
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		7e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-08
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		8e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-08
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		8e-08
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		8e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		8e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		8e-08
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-08
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-08
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		8e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		8e-08
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		8e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		8e-08
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		8e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		8e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		8e-08
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		8e-08
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-08
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		8e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		9e-08
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		9e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		9e-08
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		9e-08
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		9e-08
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		9e-08
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		9e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		9e-08
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-07
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-07
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-07
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-07
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-07
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-07
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-07
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-07
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-07
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-07
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-07
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-07
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-07
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-07
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-07
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-07
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-07
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-07
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-07
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-07
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-07
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-07
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-07
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-07
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-07
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-07
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-07
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-07
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-07
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-07
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-07
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-07
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-07
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-07
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-07
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-07
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-07
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-07
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-07
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-07
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-07
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-07
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-07
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-07
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-07
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-07
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-07
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-07
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-07
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-07
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		6e-07
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		7e-07
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-07
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-07
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		7e-07
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		7e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		7e-07
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		7e-07
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-07
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		7e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-07
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-07
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-07
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-07
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		7e-07
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-07
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		8e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		8e-07
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-07
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		8e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		9e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		9e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-07
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		9e-07
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-07
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-07
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-06
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-06
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-06
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-06
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-06
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-06
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-06
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-06
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-06
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-06
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-06
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-06
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-06
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-06
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-06
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-06
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-06
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-06
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-06
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-06
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-06
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-06
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-06
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-06
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-06
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-06
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-06
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-06
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-06
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-06
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-06
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		2e-06
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-06
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-06
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-06
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-06
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-06
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-06
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		3e-06
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-06
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-06
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-06
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-06
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-06
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-06
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-06
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-06
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-06
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-06
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-06
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-06
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-06
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-06
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-06
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-06
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-06
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		6e-06
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-06
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-06
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-06
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		7e-06
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-06
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		7e-06
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		8e-06
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		8e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		8e-06
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		9e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-05
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-05
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-05
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-05
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-05
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-05
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-05
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-05
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-05
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-05
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-05
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-05
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-05
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-05
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-05
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-05
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-05
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-05
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-05
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-05
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-05
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-05
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-05
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-05
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-05
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-05
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-05
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-05
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-05
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-05
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-05
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-05
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-05
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-05
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-05
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-05
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-05
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-05
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-05
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-05
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-05
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-05
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-05
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-05
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-05
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-05
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-05
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-05
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-05
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-05
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-05
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-05
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-05
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		5e-05
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-05
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-05
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-05
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-05
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-05
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-05
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		6e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		6e-05
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-05
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-05
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-05
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-05
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-05
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-05
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		6e-05
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-05
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-05
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-05
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-05
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		6e-05
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-05
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-05
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-05
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-05
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		6e-05
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-05
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-05
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-05
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		7e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		7e-05
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		7e-05
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		7e-05
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-05
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		7e-05
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		7e-05
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		7e-05
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		7e-05
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		8e-05
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		8e-05
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		8e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		8e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-05
4fie_A	423	Full-Length Human Pak4 Length = 423		8e-05
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-05
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		8e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		9e-05
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-04
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-04
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-04
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-04
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-04
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-04
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-04
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-04
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-04
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-04
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-04
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-04
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-04
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-04
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-04
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-04
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-04
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-04
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-04
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-04
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-04
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-04
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-04
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-04
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-04
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-04
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-04
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-04
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-04
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-04
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-04
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-04
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-04
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-04
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-04
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-04
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-04
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-04
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-04
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-04
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-04
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-04
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-04
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-04
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-04
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-04
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-04
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		6e-04
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-04
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		6e-04
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		7e-04
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		7e-04
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-04
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		8e-04
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-04
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-04
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  311 bits (796), Expect = 5e-85,   Method: Compositional matrix adjust.
 Identities = 147/178 (82%), Positives = 160/178 (89%)
Query: 249 RRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLA 308
           RR +P + FFDVPAE+D E+ LGQLKRFSLRELQVA+D FSNKNILGRGGFGKVYKGRLA
Sbjct: 1   RRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA 60
Query: 309 DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG 368
           DG LVAVKRLKEER  GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NG
Sbjct: 61  DGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 120
Query: 369 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           SVAS LRER  S PPLDWP R++IALGSARGL+YLH+HCDPKIIHRDVKAANILLDE+
Sbjct: 121 SVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE 178

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  303 bits (776), Expect = 1e-82,   Method: Compositional matrix adjust.
 Identities = 144/170 (84%), Positives = 155/170 (91%)
Query: 257 FFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVK 316
           FFDVPAE+D E+ LGQLKRFSLRELQVA+D F NKNILGRGGFGKVYKGRLADG LVAVK
Sbjct: 1   FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVK 60
Query: 317 RLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE 376
           RLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NGSVAS LRE
Sbjct: 61  RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 377 RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           R  S PPLDWP R++IALGSARGL+YLH+HCDPKIIHRDVKAANILLDE+
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE 170

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 68/152 (44%), Positives = 93/152 (61%), Gaps = 4/152 (2%)
Query: 275 RFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEV 334
           R  L +L+ AT+ F +K ++G G FGKVYKG L DG  VA+KR   E +S G  +F+TE+
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-SSQGIEEFETEI 86
Query: 335 KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL 394
           + +S   H +L+ L GFC    E +L+Y YM NG++   L         + W  R +I +
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 395 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           G+ARGL YLH      IIHRDVK+ NILLDE+
Sbjct: 147 GAARGLHYLHTRA---IIHRDVKSINILLDEN 175

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 68/152 (44%), Positives = 93/152 (61%), Gaps = 4/152 (2%)
Query: 275 RFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEV 334
           R  L +L+ AT+ F +K ++G G FGKVYKG L DG  VA+KR   E +S G  +F+TE+
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-SSQGIEEFETEI 86
Query: 335 KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL 394
           + +S   H +L+ L GFC    E +L+Y YM NG++   L         + W  R +I +
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 395 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           G+ARGL YLH      IIHRDVK+ NILLDE+
Sbjct: 147 GAARGLHYLHTRA---IIHRDVKSINILLDEN 175

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 69/168 (41%), Positives = 96/168 (57%), Gaps = 14/168 (8%)
Query: 267 ELQLGQLKRFSLRELQVATDGFSNK------NILGRGGFGKVYKGRLADGKLVAVKRLK- 319
           E+   +   FS  EL+  T+ F  +      N +G GGFG VYKG + +   VAVK+L  
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 320 --EERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER 377
             +  T   + QF  E+K+++   H NL+ L GF +   +  LVY YM NGS+  RL   
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 378 QSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 425
             + PPL W  R KIA G+A G+++LHE+     IHRD+K+ANILLDE
Sbjct: 125 DGT-PPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 69/168 (41%), Positives = 96/168 (57%), Gaps = 14/168 (8%)
Query: 267 ELQLGQLKRFSLRELQVATDGFSNK------NILGRGGFGKVYKGRLADGKLVAVKRLK- 319
           E+   +   FS  EL+  T+ F  +      N +G GGFG VYKG + +   VAVK+L  
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 320 --EERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER 377
             +  T   + QF  E+K+++   H NL+ L GF +   +  LVY YM NGS+  RL   
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 378 QSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 425
             + PPL W  R KIA G+A G+++LHE+     IHRD+K+ANILLDE
Sbjct: 125 DGT-PPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 68/159 (42%), Positives = 93/159 (58%), Gaps = 14/159 (8%)
Query: 276 FSLRELQVATDGFSNK------NILGRGGFGKVYKGRLADGKLVAVKRLK---EERTSGG 326
           FS  EL+  T+ F  +      N +G GGFG VYKG + +   VAVK+L    +  T   
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 67
Query: 327 ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDW 386
           + QF  E+K+++   H NL+ L GF +   +  LVY YM NGS+  RL     + PPL W
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT-PPLSW 126
Query: 387 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 425
             R KIA G+A G+++LHE+     IHRD+K+ANILLDE
Sbjct: 127 HMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 162

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 67/159 (42%), Positives = 90/159 (56%), Gaps = 14/159 (8%)
Query: 276 FSLRELQVATDGFSNK------NILGRGGFGKVYKGRLADGKLVAVKRLK---EERTSGG 326
           FS  EL+  T+ F  +      N  G GGFG VYKG + +   VAVK+L    +  T   
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 64
Query: 327 ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDW 386
           + QF  E+K+ +   H NL+ L GF +   +  LVY Y  NGS+  RL     + PPL W
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGT-PPLSW 123
Query: 387 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 425
             R KIA G+A G+++LHE+     IHRD+K+ANILLDE
Sbjct: 124 HXRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 159

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 80/150 (53%), Gaps = 16/150 (10%)
Query: 294 LGRGGFGKVYKGRLA-DGKLVAVKRL----KEERTSGGE--LQFQTEVKIISMAVHRNLL 346
           +G+GGFG V+KGRL  D  +VA+K L     E  T   E   +FQ EV I+S   H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
           +LYG         +V  ++  G +  RL ++     P+ W  + ++ L  A G+ Y+   
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 407 CDPKIIHRDVKAANIL---LDEDADQSSKT 433
            +P I+HRD+++ NI    LDE+A   +K 
Sbjct: 142 -NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 80/150 (53%), Gaps = 16/150 (10%)
Query: 294 LGRGGFGKVYKGRLA-DGKLVAVKRL----KEERTSGGE--LQFQTEVKIISMAVHRNLL 346
           +G+GGFG V+KGRL  D  +VA+K L     E  T   E   +FQ EV I+S   H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
           +LYG         +V  ++  G +  RL ++     P+ W  + ++ L  A G+ Y+   
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 407 CDPKIIHRDVKAANIL---LDEDADQSSKT 433
            +P I+HRD+++ NI    LDE+A   +K 
Sbjct: 142 -NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 80/150 (53%), Gaps = 16/150 (10%)
Query: 294 LGRGGFGKVYKGRLA-DGKLVAVKRL----KEERTSGGE--LQFQTEVKIISMAVHRNLL 346
           +G+GGFG V+KGRL  D  +VA+K L     E  T   E   +FQ EV I+S   H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
           +LYG         +V  ++  G +  RL ++     P+ W  + ++ L  A G+ Y+   
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 407 CDPKIIHRDVKAANIL---LDEDADQSSKT 433
            +P I+HRD+++ NI    LDE+A   +K 
Sbjct: 142 -NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 79/153 (51%), Gaps = 18/153 (11%)
Query: 291 KNILGRGGFGKVYKGRLADGKLVAVKRLK---EERTSGGELQFQTEVKIISMAVHRNLLR 347
           + I+G GGFGKVY+     G  VAVK  +   +E  S      + E K+ +M  H N++ 
Sbjct: 12  EEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYLH 404
           L G C       LV  +   G +   L  ++  +PP   ++W      A+  ARG++YLH
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNW------AVQIARGMNYLH 122
Query: 405 EHCDPKIIHRDVKAANILL---DEDADQSSKTI 434
           +     IIHRD+K++NIL+    E+ D S+K +
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 293 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 349 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 404
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 168
Query: 405 EHCDPKIIHRDVKAANILLDE 425
                K +HRD+ A N +LDE
Sbjct: 169 --ASKKFVHRDLAARNCMLDE 187

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 293 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 349 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 404
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 148
Query: 405 EHCDPKIIHRDVKAANILLDE 425
                K +HRD+ A N +LDE
Sbjct: 149 --ASKKFVHRDLAARNCMLDE 167

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 293 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 349 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 404
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 167
Query: 405 EHCDPKIIHRDVKAANILLDE 425
                K +HRD+ A N +LDE
Sbjct: 168 --ASKKFVHRDLAARNCMLDE 186

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/133 (34%), Positives = 66/133 (49%), Gaps = 7/133 (5%)
Query: 294 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 352
           +GRG FG+V+ GRL AD  LVAVK  +E      + +F  E +I+    H N++RL G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 412
           T      +V   +  G   + LR   +    L   T  ++   +A G+ YL   C    I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLESKC---CI 235
Query: 413 HRDVKAANILLDE 425
           HRD+ A N L+ E
Sbjct: 236 HRDLAARNCLVTE 248

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/133 (34%), Positives = 66/133 (49%), Gaps = 7/133 (5%)
Query: 294 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 352
           +GRG FG+V+ GRL AD  LVAVK  +E      + +F  E +I+    H N++RL G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 412
           T      +V   +  G   + LR   +    L   T  ++   +A G+ YL   C    I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLESKC---CI 235
Query: 413 HRDVKAANILLDE 425
           HRD+ A N L+ E
Sbjct: 236 HRDLAARNCLVTE 248

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/142 (36%), Positives = 70/142 (49%), Gaps = 17/142 (11%)
Query: 292 NILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
            ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 348 LYGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYL 403
           L G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL 146
Query: 404 HEHCDPKIIHRDVKAANILLDE 425
                 K +HRD+ A N +LDE
Sbjct: 147 ---ASKKFVHRDLAARNCMLDE 165

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/142 (36%), Positives = 70/142 (49%), Gaps = 17/142 (11%)
Query: 292 NILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
            ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 348 LYGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYL 403
           L G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL 147
Query: 404 HEHCDPKIIHRDVKAANILLDE 425
                 K +HRD+ A N +LDE
Sbjct: 148 ---ASKKFVHRDLAARNCMLDE 166

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/142 (36%), Positives = 70/142 (49%), Gaps = 17/142 (11%)
Query: 292 NILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
            ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 348 LYGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYL 403
           L G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL 144
Query: 404 HEHCDPKIIHRDVKAANILLDE 425
                 K +HRD+ A N +LDE
Sbjct: 145 ---ASKKFVHRDLAARNCMLDE 163

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 293 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 349 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 404
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 149
Query: 405 EHCDPKIIHRDVKAANILLDE 425
                K +HRD+ A N +LDE
Sbjct: 150 --ASKKFVHRDLAARNCMLDE 168

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 293 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 349 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 404
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 148
Query: 405 EHCDPKIIHRDVKAANILLDE 425
                K +HRD+ A N +LDE
Sbjct: 149 --ASKKFVHRDLAARNCMLDE 167

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/142 (36%), Positives = 70/142 (49%), Gaps = 17/142 (11%)
Query: 292 NILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
            ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L 
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 348 LYGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYL 403
           L G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL
Sbjct: 88  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL 141
Query: 404 HEHCDPKIIHRDVKAANILLDE 425
                 K +HRD+ A N +LDE
Sbjct: 142 ---ASKKFVHRDLAARNCMLDE 160

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 293 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 349 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 404
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 149
Query: 405 EHCDPKIIHRDVKAANILLDE 425
                K +HRD+ A N +LDE
Sbjct: 150 --ASKKFVHRDLAARNCMLDE 168

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 293 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 349 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 404
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ +L 
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL- 147
Query: 405 EHCDPKIIHRDVKAANILLDE 425
                K +HRD+ A N +LDE
Sbjct: 148 --ASKKFVHRDLAARNCMLDE 166

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 293 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 349 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 404
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ +L 
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL- 154
Query: 405 EHCDPKIIHRDVKAANILLDE 425
                K +HRD+ A N +LDE
Sbjct: 155 --ASKKFVHRDLAARNCMLDE 173

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 67/145 (46%), Gaps = 10/145 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LRLYG+    T   L+  Y   G V   L++    L   D           A 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQK----LSKFDEQRTATYITELAN 124
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL 423
            LSY H     ++IHRD+K  N+LL
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLL 146

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 293 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 349 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 404
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ +L 
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL- 150
Query: 405 EHCDPKIIHRDVKAANILLDE 425
                K +HRD+ A N +LDE
Sbjct: 151 --ASKKFVHRDLAARNCMLDE 169

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 293 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 349 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 404
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ +L 
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL- 150
Query: 405 EHCDPKIIHRDVKAANILLDE 425
                K +HRD+ A N +LDE
Sbjct: 151 --ASKKFVHRDLAARNCMLDE 169

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 293 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 349 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 404
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ +L 
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL- 149
Query: 405 EHCDPKIIHRDVKAANILLDE 425
                K +HRD+ A N +LDE
Sbjct: 150 --ASKKFVHRDLAARNCMLDE 168

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 67/145 (46%), Gaps = 10/145 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LRLYG+    T   L+  Y   G V   L++    L   D           A 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQK----LSKFDEQRTATYITELAN 124
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL 423
            LSY H     ++IHRD+K  N+LL
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLL 146

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 293 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 349 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 404
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ +L 
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL- 149
Query: 405 EHCDPKIIHRDVKAANILLDE 425
                K +HRD+ A N +LDE
Sbjct: 150 --ASKKFVHRDLAARNCMLDE 168

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 69/145 (47%), Gaps = 10/145 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           Q A + F     LG+G FG VY  R  + K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL 423
            LSY H     K+IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKKVIHRDIKPENLLL 141

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 73/160 (45%), Gaps = 31/160 (19%)
Query: 294 LGRGGFGKVYKGRLADG-------KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           +G G FG+V++ R A G        +VAVK LKEE ++  +  FQ E  +++   + N++
Sbjct: 55  IGEGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 347 RLYGFCTTVTEKLLVYPYMTNG--------------------SVASRLRERQSSLPPLDW 386
           +L G C       L++ YM  G                     +++R R      PPL  
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 387 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
             +  IA   A G++YL E    K +HRD+   N L+ E+
Sbjct: 174 AEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGEN 210

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 293 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 349 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 404
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ +L 
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL- 208
Query: 405 EHCDPKIIHRDVKAANILLDE 425
                K +HRD+ A N +LDE
Sbjct: 209 --ASKKFVHRDLAARNCMLDE 227

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 71/143 (49%), Gaps = 11/143 (7%)
Query: 289 SNKNILGRGGFGKVYKGRL--ADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHR 343
           + + ++G G FG+VYKG L  + GK    VA+K LK   T    + F  E  I+    H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           N++RL G  +     +++  YM NG++   LRE+      L       +  G A G+ YL
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQ---LVGMLRGIAAGMKYL 163
Query: 404 HEHCDPKIIHRDVKAANILLDED 426
               +   +HRD+ A NIL++ +
Sbjct: 164 ---ANMNYVHRDLAARNILVNSN 183

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 75/167 (44%), Gaps = 10/167 (5%)
Query: 260 VPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL 318
            P  +  E    + K    ++ Q A + F     LG+G FG VY  R    K + A+K L
Sbjct: 8   APENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL 67
Query: 319 --KEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE 376
              +   +G E Q + EV+I S   H N+LRLYG+    T   L+  Y   G+V   L++
Sbjct: 68  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 127
Query: 377 RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 423
               L   D           A  LSY H     ++IHRD+K  N+LL
Sbjct: 128 ----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLL 167

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/165 (32%), Positives = 78/165 (47%), Gaps = 11/165 (6%)
Query: 263 EDDSELQLG-QLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL-- 318
           E++ E +L  + K    ++ Q A + F     LG+G FG VY  R    K + A+K L  
Sbjct: 1   ENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFK 60
Query: 319 KEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ 378
            +   +G E Q + EV+I S   H N+LRLYG+    T   L+  Y   G+V   L++  
Sbjct: 61  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-- 118
Query: 379 SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 423
             L   D           A  LSY H     ++IHRD+K  N+LL
Sbjct: 119 --LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLL 158

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 75/167 (44%), Gaps = 10/167 (5%)
Query: 260 VPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL 318
            P  +  E    + K    ++ Q A + F     LG+G FG VY  R    K + A+K L
Sbjct: 8   APENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL 67
Query: 319 --KEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE 376
              +   +G E Q + EV+I S   H N+LRLYG+    T   L+  Y   G+V   L++
Sbjct: 68  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 127
Query: 377 RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 423
               L   D           A  LSY H     ++IHRD+K  N+LL
Sbjct: 128 ----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLL 167

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL 423
            LSY H     ++IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLL 141

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 120
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL 423
            LSY H     ++IHRD+K  N+LL
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLL 142

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 120
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL 423
            LSY H     ++IHRD+K  N+LL
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLL 142

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 121
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL 423
            LSY H     ++IHRD+K  N+LL
Sbjct: 122 ALSYCH---SKRVIHRDIKPENLLL 143

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 122
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL 423
            LSY H     ++IHRD+K  N+LL
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLL 144

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL 423
            LSY H     ++IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLL 141

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 122
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL 423
            LSY H     ++IHRD+K  N+LL
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLL 144

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL 423
            LSY H     ++IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLL 141

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 3   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 62
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 63  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 118
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL 423
            LSY H     ++IHRD+K  N+LL
Sbjct: 119 ALSYCH---SKRVIHRDIKPENLLL 140

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 122
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL 423
            LSY H     ++IHRD+K  N+LL
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLL 144

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 121
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL 423
            LSY H     ++IHRD+K  N+LL
Sbjct: 122 ALSYCH---SKRVIHRDIKPENLLL 143

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 124
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL 423
            LSY H     ++IHRD+K  N+LL
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLL 146

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL 423
            LSY H     ++IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLL 141

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 122
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL 423
            LSY H     ++IHRD+K  N+LL
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLL 144

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 122
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL 423
            LSY H     ++IHRD+K  N+LL
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLL 144

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL 423
            LSY H     ++IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLL 141

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 71/136 (52%), Gaps = 4/136 (2%)
Query: 291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVHRNLLRLY 349
           K  +G G FG V++     G  VAVK L E+      + +F  EV I+    H N++   
Sbjct: 42  KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
           G  T      +V  Y++ GS+  RL  +  +   LD   R  +A   A+G++YLH   +P
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSL-YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NP 158
Query: 410 KIIHRDVKAANILLDE 425
            I+HRD+K+ N+L+D+
Sbjct: 159 PIVHRDLKSPNLLVDK 174

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 66/133 (49%), Gaps = 8/133 (6%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           +G G FG V+ G   +   VA+K +KE   S  E  F  E +++    H  L++LYG C 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMS--EDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 413
                 LV+ +M +G ++  LR ++         T   + L    G++YL E C   +IH
Sbjct: 93  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIH 146
Query: 414 RDVKAANILLDED 426
           RD+ A N L+ E+
Sbjct: 147 RDLAARNCLVGEN 159

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 124
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL 423
            LSY H     ++IHRD+K  N+LL
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLL 146

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL 423
            LSY H     ++IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLL 141

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 124
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL 423
            LSY H     ++IHRD+K  N+LL
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLL 146

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 120
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL 423
            LSY H     ++IHRD+K  N+LL
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLL 142

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL 423
            LSY H     ++IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLL 141

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 122
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL 423
            LSY H     ++IHRD+K  N+LL
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLL 144

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 8   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 67
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 123
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL 423
            LSY H     ++IHRD+K  N+LL
Sbjct: 124 ALSYCH---SKRVIHRDIKPENLLL 145

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 1   QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 116
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL 423
            LSY H     ++IHRD+K  N+LL
Sbjct: 117 ALSYCH---SKRVIHRDIKPENLLL 138

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 66/133 (49%), Gaps = 8/133 (6%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           +G G FG V+ G   +   VA+K ++E   S  E  F  E +++    H  L++LYG C 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 413
                 LV+ +M +G ++  LR ++         T   + L    G++YL E C   +IH
Sbjct: 73  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIH 126
Query: 414 RDVKAANILLDED 426
           RD+ A N L+ E+
Sbjct: 127 RDLAARNCLVGEN 139

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 66/133 (49%), Gaps = 8/133 (6%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           +G G FG V+ G   +   VA+K ++E   S  E  F  E +++    H  L++LYG C 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 413
                 LV+ +M +G ++  LR ++         T   + L    G++YL E C   +IH
Sbjct: 76  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIH 129
Query: 414 RDVKAANILLDED 426
           RD+ A N L+ E+
Sbjct: 130 RDLAARNCLVGEN 142

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 66/133 (49%), Gaps = 8/133 (6%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           +G G FG V+ G   +   VA+K ++E   S  E  F  E +++    H  L++LYG C 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 413
                 LV+ +M +G ++  LR ++         T   + L    G++YL E C   +IH
Sbjct: 71  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIH 124
Query: 414 RDVKAANILLDED 426
           RD+ A N L+ E+
Sbjct: 125 RDLAARNCLVGEN 137

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 89/182 (48%), Gaps = 31/182 (17%)
Query: 259 DVPAEDDSELQLGQLKR----FSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLV 313
           D PA    E+ L  L+     F L EL            +G G +G+VYKGR +  G+L 
Sbjct: 5   DSPARSLDEIDLSALRDPAGIFELVEL------------VGNGTYGQVYKGRHVKTGQLA 52
Query: 314 AVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLLRLYGFCTT-----VTEKL-LVYPYMT 366
           A+K +  + T   E + + E+ ++   + HRN+   YG         + ++L LV  +  
Sbjct: 53  AIKVM--DVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCG 110
Query: 367 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            GSV   ++  + +    +W     I     RGLS+LH+H   K+IHRD+K  N+LL E+
Sbjct: 111 AGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH---KVIHRDIKGQNVLLTEN 165
Query: 427 AD 428
           A+
Sbjct: 166 AE 167

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/148 (34%), Positives = 69/148 (46%), Gaps = 23/148 (15%)
Query: 293 ILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKI--ISMAVHRNLLRLYG 350
           ++GRG +G VYKG L D + VAVK      +      F  E  I  + +  H N+ R   
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVF----SFANRQNFINEKNIYRVPLMEHDNIARFIV 74
Query: 351 FCTTVT-----EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH- 404
               VT     E LLV  Y  NGS+   L     SL   DW +  ++A    RGL+YLH 
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSSCRLAHSVTRGLAYLHT 129
Query: 405 -----EHCDPKIIHRDVKAANILLDEDA 427
                +H  P I HRD+ + N+L+  D 
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDG 157

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 71/136 (52%), Gaps = 4/136 (2%)
Query: 291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVHRNLLRLY 349
           K  +G G FG V++     G  VAVK L E+      + +F  EV I+    H N++   
Sbjct: 42  KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
           G  T      +V  Y++ GS+  RL  +  +   LD   R  +A   A+G++YLH   +P
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSL-YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NP 158
Query: 410 KIIHRDVKAANILLDE 425
            I+HR++K+ N+L+D+
Sbjct: 159 PIVHRNLKSPNLLVDK 174

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 69/150 (46%), Gaps = 10/150 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           Q   + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQS 67
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSRFDEQRTATYITELAN 123
Query: 399 GLSYLHEHCDPKIIHRDVKAANILLDEDAD 428
            LSY H     ++IHRD+K  N+LL  + +
Sbjct: 124 ALSYCH---SKRVIHRDIKPENLLLGSNGE 150

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 69/150 (46%), Gaps = 10/150 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           Q   + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQS 67
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSRFDEQRTATYITELAN 123
Query: 399 GLSYLHEHCDPKIIHRDVKAANILLDEDAD 428
            LSY H     ++IHRD+K  N+LL  + +
Sbjct: 124 ALSYCH---SKRVIHRDIKPENLLLGSNGE 150

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 82/193 (42%), Gaps = 41/193 (21%)
Query: 266 SELQLGQLKRFSLRELQVATDGFSN------------------KNI-----LGRGGFGKV 302
           SELQ  + K   LR   + TD   N                  KNI     LG G FG+V
Sbjct: 28  SELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEV 87
Query: 303 YKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT 356
           Y+G+++          VAVK L E  +   EL F  E  IIS   H+N++R  G      
Sbjct: 88  YEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147
Query: 357 EKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 410
            + ++   M  G + S LRE      + SSL  LD      +A   A G  YL E+    
Sbjct: 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQYLEEN---H 201
Query: 411 IIHRDVKAANILL 423
            IHRD+ A N LL
Sbjct: 202 FIHRDIAARNCLL 214

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 82/193 (42%), Gaps = 41/193 (21%)
Query: 266 SELQLGQLKRFSLRELQVATDGFSN------------------KNI-----LGRGGFGKV 302
           SELQ  + K   LR   + TD   N                  KNI     LG G FG+V
Sbjct: 5   SELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEV 64
Query: 303 YKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT 356
           Y+G+++          VAVK L E  +   EL F  E  IIS   H+N++R  G      
Sbjct: 65  YEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 124
Query: 357 EKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 410
            + ++   M  G + S LRE      + SSL  LD      +A   A G  YL E+    
Sbjct: 125 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQYLEEN---H 178
Query: 411 IIHRDVKAANILL 423
            IHRD+ A N LL
Sbjct: 179 FIHRDIAARNCLL 191

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 294 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 401
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 169
Query: 402 YLHEHCDPKIIHRDVKAANILL 423
           YL E+     IHRD+ A N LL
Sbjct: 170 YLEEN---HFIHRDIAARNCLL 188

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           +G G FG V+ G   +   VA+K ++E   S  E  F  E +++    H  L++LYG C 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 413
                 LV  +M +G ++  LR ++         T   + L    G++YL E C   +IH
Sbjct: 74  EQAPICLVTEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 414 RDVKAANILLDED 426
           RD+ A N L+ E+
Sbjct: 128 RDLAARNCLVGEN 140

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 294 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 401
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 154
Query: 402 YLHEHCDPKIIHRDVKAANILL 423
           YL E+     IHRD+ A N LL
Sbjct: 155 YLEEN---HFIHRDIAARNCLL 173

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 63/133 (47%), Gaps = 8/133 (6%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG V  G+      VAVK +KE   S  E +F  E + +    H  L++ YG C+
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 413
                 +V  Y++NG + + LR     L P       ++      G+++L  H   + IH
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHGKGLEP---SQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 414 RDVKAANILLDED 426
           RD+ A N L+D D
Sbjct: 128 RDLAARNCLVDRD 140

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 74/142 (52%), Gaps = 14/142 (9%)
Query: 291 KNILGRGGFGKVYKGRL-ADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           + ++G G FG+V +GRL A GK    VA+K LK   T     +F +E  I+    H N++
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVAS--RLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
           RL G  T     +++  +M NG++ S  RL + Q ++  L       +  G A G+ YL 
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQL-----VGMLRGIASGMRYLA 133
Query: 405 EHCDPKIIHRDVKAANILLDED 426
           E      +HRD+ A NIL++ +
Sbjct: 134 EM---SYVHRDLAARNILVNSN 152

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 74/142 (52%), Gaps = 14/142 (9%)
Query: 291 KNILGRGGFGKVYKGRL-ADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           + ++G G FG+V +GRL A GK    VA+K LK   T     +F +E  I+    H N++
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVAS--RLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
           RL G  T     +++  +M NG++ S  RL + Q ++  L    R     G A G+ YL 
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR-----GIASGMRYLA 135
Query: 405 EHCDPKIIHRDVKAANILLDED 426
           E      +HRD+ A NIL++ +
Sbjct: 136 EM---SYVHRDLAARNILVNSN 154

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 294 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 401
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 169
Query: 402 YLHEHCDPKIIHRDVKAANILL 423
           YL E+     IHRD+ A N LL
Sbjct: 170 YLEEN---HFIHRDIAARNCLL 188

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 294 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 401
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 169
Query: 402 YLHEHCDPKIIHRDVKAANILL 423
           YL E+     IHRD+ A N LL
Sbjct: 170 YLEEN---HFIHRDIAARNCLL 188

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 294 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 401
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 402 YLHEHCDPKIIHRDVKAANILL 423
           YL E+     IHRD+ A N LL
Sbjct: 156 YLEEN---HFIHRDIAARNCLL 174

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 294 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 401
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 402 YLHEHCDPKIIHRDVKAANILL 423
           YL E+     IHRD+ A N LL
Sbjct: 156 YLEEN---HFIHRDIAARNCLL 174

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 294 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 401
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 171
Query: 402 YLHEHCDPKIIHRDVKAANILL 423
           YL E+     IHRD+ A N LL
Sbjct: 172 YLEEN---HFIHRDIAARNCLL 190

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 294 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 401
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 154
Query: 402 YLHEHCDPKIIHRDVKAANILL 423
           YL E+     IHRD+ A N LL
Sbjct: 155 YLEEN---HFIHRDIAARNCLL 173

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 294 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 401
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 146
Query: 402 YLHEHCDPKIIHRDVKAANILL 423
           YL E+     IHRD+ A N LL
Sbjct: 147 YLEEN---HFIHRDIAARNCLL 165

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 67/140 (47%), Gaps = 10/140 (7%)
Query: 291 KNILGRGGFGKVYKGRLA-DGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           + ++G G FG+V  G L   GK    VA+K LK   T      F +E  I+    H N++
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
            L G  T  T  +++  +M NGS+ S LR+       +       +  G A G+ YL   
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI---QLVGMLRGIAAGMKYL--- 151
Query: 407 CDPKIIHRDVKAANILLDED 426
            D   +HRD+ A NIL++ +
Sbjct: 152 ADMNYVHRDLAARNILVNSN 171

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 294 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 401
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 402 YLHEHCDPKIIHRDVKAANILL 423
           YL E+     IHRD+ A N LL
Sbjct: 156 YLEEN---HFIHRDIAARNCLL 174

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 294 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 401
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 161
Query: 402 YLHEHCDPKIIHRDVKAANILL 423
           YL E+     IHRD+ A N LL
Sbjct: 162 YLEEN---HFIHRDIAARNCLL 180

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 74/153 (48%), Gaps = 14/153 (9%)
Query: 271 GQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQF 330
           G L     +E++V       + ++GRG FG V K +    K VA+K+++ E        F
Sbjct: 1   GSLHMIDYKEIEV-------EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKA---F 49
Query: 331 QTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK 390
             E++ +S   H N+++LYG C  +    LV  Y   GS+ + L   +  LP        
Sbjct: 50  IVELRQLSRVNHPNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAM 106
Query: 391 KIALGSARGLSYLHEHCDPKIIHRDVKAANILL 423
              L  ++G++YLH      +IHRD+K  N+LL
Sbjct: 107 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL 139

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 76/170 (44%), Gaps = 36/170 (21%)
Query: 288 FSNKNI-----LGRGGFGKVYK-------GRLADGKLVAVKRLKEERTSGGELQFQTEVK 335
           F  KN+     LG G FGKV K       GR A    VAVK LKE  +        +E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGR-AGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 336 IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP------------P 383
           ++    H ++++LYG C+     LL+  Y   GS+   LRE +   P             
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 384 LDWPTRKKIALGS--------ARGLSYLHEHCDPKIIHRDVKAANILLDE 425
           LD P  + + +G         ++G+ YL E    K++HRD+ A NIL+ E
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAE 185

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 76/170 (44%), Gaps = 36/170 (21%)
Query: 288 FSNKNI-----LGRGGFGKVYK-------GRLADGKLVAVKRLKEERTSGGELQFQTEVK 335
           F  KN+     LG G FGKV K       GR A    VAVK LKE  +        +E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGR-AGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 336 IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP------------P 383
           ++    H ++++LYG C+     LL+  Y   GS+   LRE +   P             
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 384 LDWPTRKKIALGS--------ARGLSYLHEHCDPKIIHRDVKAANILLDE 425
           LD P  + + +G         ++G+ YL E    K++HRD+ A NIL+ E
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAE 185

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 294 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 401
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 181
Query: 402 YLHEHCDPKIIHRDVKAANILL 423
           YL E+     IHRD+ A N LL
Sbjct: 182 YLEEN---HFIHRDIAARNCLL 200

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           +G G FG V+ G   +   VA+K ++E   S  E  F  E +++    H  L++LYG C 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 413
                 LV+ +M +G ++  LR ++         T   + L    G++YL E     +IH
Sbjct: 73  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEE---ASVIH 126
Query: 414 RDVKAANILLDED 426
           RD+ A N L+ E+
Sbjct: 127 RDLAARNCLVGEN 139

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 67/141 (47%), Gaps = 16/141 (11%)
Query: 293 ILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 345
           ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+    H N+
Sbjct: 52  VVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 346 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 405
           +RL G  T     ++V  YM NGS+ S LR+  +    +       +  G A G+ YL  
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYL-- 163
Query: 406 HCDPKIIHRDVKAANILLDED 426
             D   +HRD+ A NIL++ +
Sbjct: 164 -SDMGFVHRDLAARNILINSN 183

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/134 (34%), Positives = 66/134 (49%), Gaps = 10/134 (7%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 352
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 88
Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 412
           +T  +  +V  +    S+   L    +S    +      IA  +ARG+ YLH      II
Sbjct: 89  STAPQLAIVTQWCEGSSLYHHL---HASETKFEMKKLIDIARQTARGMDYLHAKS---II 142
Query: 413 HRDVKAANILLDED 426
           HRD+K+ NI L ED
Sbjct: 143 HRDLKSNNIFLHED 156

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/134 (35%), Positives = 64/134 (47%), Gaps = 10/134 (7%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 352
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 20  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 412
           T    +L +      GS  S      +S    +      IA  +ARG+ YLH      II
Sbjct: 78  TK--PQLAIVTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---II 130
Query: 413 HRDVKAANILLDED 426
           HRD+K+ NI L ED
Sbjct: 131 HRDLKSNNIFLHED 144

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 288 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 340
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 18  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 74
Query: 341 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 400
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +       +  G A G+
Sbjct: 75  DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGM 131
Query: 401 SYLHEHCDPKIIHRDVKAANILLDED 426
            YL    D   +HRD+ A NIL++ +
Sbjct: 132 KYL---SDMGYVHRDLAARNILINSN 154

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 67/141 (47%), Gaps = 16/141 (11%)
Query: 293 ILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 345
           ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+    H N+
Sbjct: 52  VVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 346 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 405
           +RL G  T     ++V  YM NGS+ S LR+  +    +       +  G A G+ YL  
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYL-- 163
Query: 406 HCDPKIIHRDVKAANILLDED 426
             D   +HRD+ A NIL++ +
Sbjct: 164 -SDMGYVHRDLAARNILINSN 183

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 67/141 (47%), Gaps = 16/141 (11%)
Query: 293 ILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 345
           ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+    H N+
Sbjct: 52  VVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 346 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 405
           +RL G  T     ++V  YM NGS+ S LR+  +    +       +  G A G+ YL  
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYL-- 163
Query: 406 HCDPKIIHRDVKAANILLDED 426
             D   +HRD+ A NIL++ +
Sbjct: 164 -SDMGYVHRDLAARNILINSN 183

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 288 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 340
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 35  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 91
Query: 341 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 400
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +       +  G A G+
Sbjct: 92  DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGM 148
Query: 401 SYLHEHCDPKIIHRDVKAANILLDED 426
            YL    D   +HRD+ A NIL++ +
Sbjct: 149 KYL---SDMGYVHRDLAARNILINSN 171

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 67/141 (47%), Gaps = 16/141 (11%)
Query: 293 ILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 345
           ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+    H N+
Sbjct: 52  VVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 346 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 405
           +RL G  T     ++V  YM NGS+ S LR+  +    +       +  G A G+ YL  
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYL-- 163
Query: 406 HCDPKIIHRDVKAANILLDED 426
             D   +HRD+ A NIL++ +
Sbjct: 164 -SDMGYVHRDLAARNILINSN 183

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 67/141 (47%), Gaps = 16/141 (11%)
Query: 293 ILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 345
           ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+    H N+
Sbjct: 52  VVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 346 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 405
           +RL G  T     ++V  YM NGS+ S LR+  +    +       +  G A G+ YL  
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYL-- 163
Query: 406 HCDPKIIHRDVKAANILLDED 426
             D   +HRD+ A NIL++ +
Sbjct: 164 -SDMGYVHRDLAARNILINSN 183

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 67/141 (47%), Gaps = 16/141 (11%)
Query: 293 ILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 345
           ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+    H N+
Sbjct: 52  VVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 346 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 405
           +RL G  T     ++V  YM NGS+ S LR+  +    +       +  G A G+ YL  
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYL-- 163
Query: 406 HCDPKIIHRDVKAANILLDED 426
             D   +HRD+ A NIL++ +
Sbjct: 164 -SDMGYVHRDLAARNILINSN 183

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 288 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 340
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 341 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 400
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +       +  G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGM 160
Query: 401 SYLHEHCDPKIIHRDVKAANILLDED 426
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSN 183

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/134 (35%), Positives = 64/134 (47%), Gaps = 10/134 (7%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 352
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 412
           T    +L +      GS  S      +S    +      IA  +ARG+ YLH      II
Sbjct: 90  TK--PQLAIVTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---II 142
Query: 413 HRDVKAANILLDED 426
           HRD+K+ NI L ED
Sbjct: 143 HRDLKSNNIFLHED 156

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 288 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 340
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 45  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 101
Query: 341 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 400
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +       +  G A G+
Sbjct: 102 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGM 158
Query: 401 SYLHEHCDPKIIHRDVKAANILLDED 426
            YL    D   +HRD+ A NIL++ +
Sbjct: 159 KYL---SDMGYVHRDLAARNILINSN 181

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FGKVYK +  +  ++A  ++ + ++      +  E+ I++   H N+++L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 413
                 ++  +   G+V + + E +    PL     + +   +   L+YLH   D KIIH
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLH---DNKIIH 158
Query: 414 RDVKAANILLDEDAD----------QSSKTILRR 437
           RD+KA NIL   D D          ++++TI RR
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 192

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 72/139 (51%), Gaps = 18/139 (12%)
Query: 293 ILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
           +LG G FG VYKG  + +G+ V    A+K L E       ++F  E  I++   H +L+R
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYLH 404
           L G C + T + LV   M +G +   + E + ++     L+W       +  A+G+ YL 
Sbjct: 82  LLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 134
Query: 405 EHCDPKIIHRDVKAANILL 423
           E    +++HRD+ A N+L+
Sbjct: 135 ER---RLVHRDLAARNVLV 150

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 75/170 (44%), Gaps = 36/170 (21%)
Query: 288 FSNKNI-----LGRGGFGKVYK-------GRLADGKLVAVKRLKEERTSGGELQFQTEVK 335
           F  KN+     LG G FGKV K       GR A    VAVK LKE  +        +E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGR-AGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 336 IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP------------P 383
           ++    H ++++LYG C+     LL+  Y   GS+   LRE +   P             
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 384 LDWPTRKKIALGS--------ARGLSYLHEHCDPKIIHRDVKAANILLDE 425
           LD P  + + +G         ++G+ YL E     ++HRD+ A NIL+ E
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAE 185

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 67/133 (50%), Gaps = 7/133 (5%)
Query: 291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 350
           + ++GRG FG V K +    K VA+K+++ E        F  E++ +S   H N+++LYG
Sbjct: 13  EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKA---FIVELRQLSRVNHPNIVKLYG 68
Query: 351 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 410
            C  +    LV  Y   GS+ + L   +  LP           L  ++G++YLH      
Sbjct: 69  AC--LNPVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 411 IIHRDVKAANILL 423
           +IHRD+K  N+LL
Sbjct: 126 LIHRDLKPPNLLL 138

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 66/135 (48%), Gaps = 6/135 (4%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FGKVYK +  +  ++A  ++ + ++      +  E+ I++   H N+++L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 413
                 ++  +   G+V + + E +    PL     + +   +   L+YLH   D KIIH
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLH---DNKIIH 158
Query: 414 RDVKAANILLDEDAD 428
           RD+KA NIL   D D
Sbjct: 159 RDLKAGNILFTLDGD 173

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 72/140 (51%), Gaps = 18/140 (12%)
Query: 292 NILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
            +LG G FG VYKG  + +G+ V    A+K L E       ++F  E  I++   H +L+
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYL 403
           RL G C + T + LV   M +G +   + E + ++     L+W       +  A+G+ YL
Sbjct: 104 RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYL 156
Query: 404 HEHCDPKIIHRDVKAANILL 423
            E    +++HRD+ A N+L+
Sbjct: 157 EER---RLVHRDLAARNVLV 173

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 66/135 (48%), Gaps = 6/135 (4%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FGKVYK +  +  ++A  ++ + ++      +  E+ I++   H N+++L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 413
                 ++  +   G+V + + E +    PL     + +   +   L+YLH   D KIIH
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLH---DNKIIH 158
Query: 414 RDVKAANILLDEDAD 428
           RD+KA NIL   D D
Sbjct: 159 RDLKAGNILFTLDGD 173

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 68/149 (45%), Gaps = 21/149 (14%)
Query: 294 LGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
           LG G FGKV+           D  LVAVK LKE   S  +  FQ E ++++M  H++++R
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ-DFQREAELLTMLQHQHIVR 84
Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRER----------QSSLP-PLDWPTRKKIALGS 396
            +G CT     L+V+ YM +G +   LR            +   P PL       +A   
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLDE 425
           A G+ YL        +HRD+   N L+ +
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQ 170

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 68/149 (45%), Gaps = 21/149 (14%)
Query: 294 LGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
           LG G FGKV+           D  LVAVK LKE   S  +  FQ E ++++M  H++++R
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ-DFQREAELLTMLQHQHIVR 78
Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRER----------QSSLP-PLDWPTRKKIALGS 396
            +G CT     L+V+ YM +G +   LR            +   P PL       +A   
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLDE 425
           A G+ YL        +HRD+   N L+ +
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQ 164

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 68/149 (45%), Gaps = 21/149 (14%)
Query: 294 LGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
           LG G FGKV+           D  LVAVK LKE   S  +  FQ E ++++M  H++++R
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ-DFQREAELLTMLQHQHIVR 107
Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRER----------QSSLP-PLDWPTRKKIALGS 396
            +G CT     L+V+ YM +G +   LR            +   P PL       +A   
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLDE 425
           A G+ YL        +HRD+   N L+ +
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQ 193

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 14/155 (9%)
Query: 276 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEV 334
            SL + ++     + K+ LG G FG+VY+G      L VAVK LKE+     E  F  E 
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEA 58
Query: 335 KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKI 392
            ++    H NL++L G CT      ++  +MT G++   LRE  RQ             +
Sbjct: 59  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VSAVV 110
Query: 393 ALGSARGLSYLHEHCDPK-IIHRDVKAANILLDED 426
            L  A  +S   E+ + K  IHRD+ A N L+ E+
Sbjct: 111 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN 145

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 80/160 (50%), Gaps = 17/160 (10%)
Query: 280 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 332
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 333 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 389
           E  ++      +++RL G  +     L++   MT G + S LR  + ++   P L  P+ 
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 390 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 138 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 80/160 (50%), Gaps = 17/160 (10%)
Query: 280 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 332
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 9   EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 67
Query: 333 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 389
           E  ++      +++RL G  +     L++   MT G + S LR  + ++   P L  P+ 
Sbjct: 68  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 127
Query: 390 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 128 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 164

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 66/140 (47%), Gaps = 10/140 (7%)
Query: 291 KNILGRGGFGKVYKGRLA-DGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           + ++G G FG+V  G L   GK    VA+K LK   T      F +E  I+    H N++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
            L G  T  T  +++  +M NGS+ S LR+       +       +  G A G+ YL   
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQ---LVGMLRGIAAGMKYL--- 125
Query: 407 CDPKIIHRDVKAANILLDED 426
            D   +HR + A NIL++ +
Sbjct: 126 ADMNYVHRALAARNILVNSN 145

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 66/134 (49%), Gaps = 10/134 (7%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 352
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 72
Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 412
           +T  +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 73  STAPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 126
Query: 413 HRDVKAANILLDED 426
           HRD+K+ NI L ED
Sbjct: 127 HRDLKSNNIFLHED 140

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 80/164 (48%), Gaps = 17/164 (10%)
Query: 276 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGEL 328
           F   E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    +
Sbjct: 6   FVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERI 64
Query: 329 QFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLD 385
           +F  E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L 
Sbjct: 65  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 124
Query: 386 WPTRKK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            P+  K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 125 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 165

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 280 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 332
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 333 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 389
           E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L  P+ 
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 390 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 131 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 167

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 67/142 (47%), Gaps = 9/142 (6%)
Query: 288 FSNKNILGRGGFGKVYKGRLADGK-LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           F+  + +G+G FG+VYKG     K +VA+K +  E         Q E+ ++S      + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
           R +G     T+  ++  Y+  GS    L+       PL+      I     +GL YLH  
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPG-----PLEETYIATILREILKGLDYLHSE 135
Query: 407 CDPKIIHRDVKAANILLDEDAD 428
              + IHRD+KAAN+LL E  D
Sbjct: 136 ---RKIHRDIKAANVLLSEQGD 154

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 75/162 (46%), Gaps = 15/162 (9%)
Query: 271 GQLKRFSLRELQVATDG---FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG 326
           G LK   + EL    D    FS+   +G G FG VY  R + + ++VA+K++        
Sbjct: 36  GSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN 95
Query: 327 ELQFQ---TEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP 383
           E ++Q    EV+ +    H N ++  G         LV  Y   GS +  L   +    P
Sbjct: 96  E-KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK---P 150
Query: 384 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 425
           L       +  G+ +GL+YLH H    +IHRDVKA NILL E
Sbjct: 151 LQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSE 189

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 280 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 332
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 333 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 389
           E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L  P+ 
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 137
Query: 390 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 138 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 280 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 332
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 62
Query: 333 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 389
           E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L  P+ 
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 122
Query: 390 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 123 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 159

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 280 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 332
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 71
Query: 333 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 389
           E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L  P+ 
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 390 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 132 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 168

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 277 SLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVK 335
           SL + ++     + K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 59
Query: 336 IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIA 393
           ++    H NL++L G CT      ++  +MT G++   LRE  RQ             + 
Sbjct: 60  VMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE--------VSAVVL 111
Query: 394 LGSARGLSYLHEHCDPK-IIHRDVKAANILLDED 426
           L  A  +S   E+ + K  IHRD+ A N L+ E+
Sbjct: 112 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN 145

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 71/156 (45%), Gaps = 12/156 (7%)
Query: 277 SLRELQVATDGFSNK--NILGRGGFGKVYKGRL-ADGK---LVAVKRLKEERTSGGELQF 330
           ++RE     D    K   ++G G FG+V  GRL   GK    VA+K LK   T      F
Sbjct: 3   AVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDF 62
Query: 331 QTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK 390
            +E  I+    H N++ L G  T     +++  YM NGS+ + LR+       +      
Sbjct: 63  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI---QLV 119
Query: 391 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            +  G   G+ YL    D   +HRD+ A NIL++ +
Sbjct: 120 GMLRGIGSGMKYLS---DMSYVHRDLAARNILVNSN 152

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 280 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 332
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 41  EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 99
Query: 333 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 389
           E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L  P+ 
Sbjct: 100 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 159
Query: 390 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 160 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 196

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 66/140 (47%), Gaps = 10/140 (7%)
Query: 291 KNILGRGGFGKVYKGRL-ADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           + ++G G FG+V  GRL   GK    VA+K LK   T      F +E  I+    H N++
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
            L G  T     +++  YM NGS+ + LR+       +       +  G   G+ YL   
Sbjct: 94  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI---QLVGMLRGIGSGMKYLS-- 148
Query: 407 CDPKIIHRDVKAANILLDED 426
            D   +HRD+ A NIL++ +
Sbjct: 149 -DMSAVHRDLAARNILVNSN 167

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 66/140 (47%), Gaps = 10/140 (7%)
Query: 291 KNILGRGGFGKVYKGRL-ADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           + ++G G FG+V  GRL   GK    VA+K LK   T      F +E  I+    H N++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
            L G  T     +++  YM NGS+ + LR+       +       +  G   G+ YL   
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI---QLVGMLRGIGSGMKYLS-- 127
Query: 407 CDPKIIHRDVKAANILLDED 426
            D   +HRD+ A NIL++ +
Sbjct: 128 -DMSYVHRDLAARNILVNSN 146

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 280 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 332
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 71
Query: 333 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 389
           E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L  P+ 
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 390 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 132 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 168

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 280 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 332
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 333 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 389
           E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L  P+ 
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 390 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 131 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 167

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 280 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 332
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 333 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 389
           E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L  P+ 
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 390 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 125 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 161

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 74/148 (50%), Gaps = 19/148 (12%)
Query: 294 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 346
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 347 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL-----DWPTRKKIALGS---A 397
            L G CT     L+V   +   G++++ LR +++   P      D+ T + +   S   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 398 RGLSYLHEHCDPKIIHRDVKAANILLDE 425
           +G+ +L      K IHRD+ A NILL E
Sbjct: 155 KGMEFLASR---KXIHRDLAARNILLSE 179

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 65/142 (45%), Gaps = 9/142 (6%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           F+    +G+G FG+V+KG      K+VA+K +  E         Q E+ ++S      + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
           + YG     T+  ++  Y+  GS    L        PLD      I     +GL YLH  
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE 143
Query: 407 CDPKIIHRDVKAANILLDEDAD 428
              K IHRD+KAAN+LL E  +
Sbjct: 144 ---KKIHRDIKAANVLLSEHGE 162

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 87/175 (49%), Gaps = 20/175 (11%)
Query: 258 FDVPAEDDSELQ-LGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKG-RLADGK---- 311
           +D+P  ++   Q  G+    +L  +   T+ F    +LG G FG VYKG  + +G+    
Sbjct: 12  YDIPTTENLYFQGSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKI 70
Query: 312 LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVA 371
            VA+K L+E  +     +   E  +++   + ++ RL G C T T +L+    M  G + 
Sbjct: 71  PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQ-LMPFGCLL 129
Query: 372 SRLRERQSSLPP---LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 423
             +RE + ++     L+W       +  A+G++YL    D +++HRD+ A N+L+
Sbjct: 130 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLV 175

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 277 SLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVK 335
           SL + ++     + K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 59
Query: 336 IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIA 393
           ++    H NL++L G CT      ++  +MT G++   LRE  RQ             + 
Sbjct: 60  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VSAVVL 111
Query: 394 LGSARGLSYLHEHCDPK-IIHRDVKAANILLDED 426
           L  A  +S   E+ + K  IHRD+ A N L+ E+
Sbjct: 112 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN 145

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 73/151 (48%), Gaps = 22/151 (14%)
Query: 287 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 344
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ      I+    H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ------IMRKLDHCN 74
Query: 345 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 396
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 131
Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLDEDA 427
            R L+Y+H      I HRD+K  N+LLD D 
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDT 159

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 73/151 (48%), Gaps = 22/151 (14%)
Query: 287 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 344
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ      I+    H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ------IMRKLDHCN 74
Query: 345 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 396
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 75  IVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 131
Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLDEDA 427
            R L+Y+H      I HRD+K  N+LLD D 
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDT 159

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 73/151 (48%), Gaps = 22/151 (14%)
Query: 287 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 344
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ      I+    H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ------IMRKLDHCN 74
Query: 345 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 396
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 131
Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLDEDA 427
            R L+Y+H      I HRD+K  N+LLD D 
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDT 159

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 352
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 412
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 74  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 126
Query: 413 HRDVKAANILLDED 426
           HRD+K+ NI L ED
Sbjct: 127 HRDLKSNNIFLHED 140

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 73/151 (48%), Gaps = 22/151 (14%)
Query: 287 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 344
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ      I+    H N
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ------IMRKLDHCN 75
Query: 345 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 396
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 76  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 132
Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLDEDA 427
            R L+Y+H      I HRD+K  N+LLD D 
Sbjct: 133 FRSLAYIHSF---GICHRDIKPQNLLLDPDT 160

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 73/151 (48%), Gaps = 22/151 (14%)
Query: 287 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 344
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ      I+    H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ------IMRKLDHCN 74
Query: 345 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 396
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 131
Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLDEDA 427
            R L+Y+H      I HRD+K  N+LLD D 
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDT 159

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 352
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 412
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 74  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 126
Query: 413 HRDVKAANILLDED 426
           HRD+K+ NI L ED
Sbjct: 127 HRDLKSNNIFLHED 140

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 352
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 412
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 79  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 131
Query: 413 HRDVKAANILLDED 426
           HRD+K+ NI L ED
Sbjct: 132 HRDLKSNNIFLHED 145

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 352
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 412
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 79  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 131
Query: 413 HRDVKAANILLDED 426
           HRD+K+ NI L ED
Sbjct: 132 HRDLKSNNIFLHED 145

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 287 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 344
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ      I+    H N
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ------IMRKLDHCN 87
Query: 345 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 396
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 88  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 144
Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 145 FRSLAYIHSF---GICHRDIKPQNLLLDPD 171

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 67/146 (45%), Gaps = 16/146 (10%)
Query: 288 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 340
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 341 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 400
            H N++RL G  T     ++V   M NGS+ S LR+  +    +       +  G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGM 160
Query: 401 SYLHEHCDPKIIHRDVKAANILLDED 426
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGAVHRDLAARNILINSN 183

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 352
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 18  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 412
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 76  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 128
Query: 413 HRDVKAANILLDED 426
           HRD+K+ NI L ED
Sbjct: 129 HRDLKSNNIFLHED 142

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 74/148 (50%), Gaps = 19/148 (12%)
Query: 294 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 346
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 347 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL-----DWPTRKKIALGS---A 397
            L G CT     L+V   +   G++++ LR +++   P      D+ T + +   S   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 398 RGLSYLHEHCDPKIIHRDVKAANILLDE 425
           +G+ +L      K IHRD+ A NILL E
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSE 179

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 67/146 (45%), Gaps = 16/146 (10%)
Query: 288 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 340
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 18  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 74
Query: 341 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 400
            H N++RL G  T     ++V   M NGS+ S LR+  +    +       +  G A G+
Sbjct: 75  DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGM 131
Query: 401 SYLHEHCDPKIIHRDVKAANILLDED 426
            YL    D   +HRD+ A NIL++ +
Sbjct: 132 KYL---SDMGYVHRDLAARNILINSN 154

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 68/142 (47%), Gaps = 12/142 (8%)
Query: 288 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQ---TEVKIISMAVHR 343
           FS+   +G G FG VY  R + + ++VA+K++        E ++Q    EV+ +    H 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKLRHP 75
Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           N ++  G         LV  Y   GS +  L   +    PL       +  G+ +GL+YL
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYL 131
Query: 404 HEHCDPKIIHRDVKAANILLDE 425
           H H    +IHRDVKA NILL E
Sbjct: 132 HSH---NMIHRDVKAGNILLSE 150

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 287 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 344
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ      I+    H N
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ------IMRKLDHCN 93
Query: 345 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 396
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 94  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 150
Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 151 FRSLAYIHSF---GICHRDIKPQNLLLDPD 177

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 399
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 81  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 133
Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           ++YL    D +++HRD+ A N+L+
Sbjct: 134 MNYLE---DRRLVHRDLAARNVLV 154

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 73/151 (48%), Gaps = 22/151 (14%)
Query: 287 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 344
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ      I+    H N
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ------IMRKLDHCN 78
Query: 345 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 396
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 79  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 135
Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLDEDA 427
            R L+Y+H      I HRD+K  N+LLD D 
Sbjct: 136 FRSLAYIHSF---GICHRDIKPQNLLLDPDT 163

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 399
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           ++YL    D +++HRD+ A N+L+
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLV 152

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 287 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 344
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ      I+    H N
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ------IMRKLDHCN 82
Query: 345 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 396
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 83  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 139
Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 140 FRSLAYIHSF---GICHRDIKPQNLLLDPD 166

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 399
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 78  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 130
Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           ++YL    D +++HRD+ A N+L+
Sbjct: 131 MNYLE---DRRLVHRDLAARNVLV 151

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 399
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           ++YL    D +++HRD+ A N+L+
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLV 150

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 399
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 80  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           ++YL    D +++HRD+ A N+L+
Sbjct: 133 MNYLE---DRRLVHRDLAARNVLV 153

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 399
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 78  PHVCRLLGICLTSTVQLIMQ-LMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKG 130
Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           ++YL    D +++HRD+ A N+L+
Sbjct: 131 MNYLE---DRRLVHRDLAARNVLV 151

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 399
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 81  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 133
Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           ++YL    D +++HRD+ A N+L+
Sbjct: 134 MNYLE---DRRLVHRDLAARNVLV 154

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 287 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 344
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ      I+    H N
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ------IMRKLDHCN 86
Query: 345 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 396
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 143
Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 144 FRSLAYIHSF---GICHRDIKPQNLLLDPD 170

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 65/142 (45%), Gaps = 9/142 (6%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           F+    +G+G FG+V+KG      K+VA+K +  E         Q E+ ++S      + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
           + YG     T+  ++  Y+  GS    L        PLD      I     +GL YLH  
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE 123
Query: 407 CDPKIIHRDVKAANILLDEDAD 428
              K IHRD+KAAN+LL E  +
Sbjct: 124 ---KKIHRDIKAANVLLSEHGE 142

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 67/146 (45%), Gaps = 16/146 (10%)
Query: 288 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 340
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 341 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 400
            H N++RL G  T     ++V   M NGS+ S LR+  +    +       +  G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGM 160
Query: 401 SYLHEHCDPKIIHRDVKAANILLDED 426
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSN 183

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 399
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           ++YL    D +++HRD+ A N+L+
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLV 152

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 65/142 (45%), Gaps = 9/142 (6%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           F+    +G+G FG+V+KG      K+VA+K +  E         Q E+ ++S      + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
           + YG     T+  ++  Y+  GS    L        PLD      I     +GL YLH  
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE 138
Query: 407 CDPKIIHRDVKAANILLDEDAD 428
              K IHRD+KAAN+LL E  +
Sbjct: 139 ---KKIHRDIKAANVLLSEHGE 157

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 65/142 (45%), Gaps = 9/142 (6%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           F+    +G+G FG+V+KG      K+VA+K +  E         Q E+ ++S      + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
           + YG     T+  ++  Y+  GS    L        PLD      I     +GL YLH  
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE 123
Query: 407 CDPKIIHRDVKAANILLDEDAD 428
              K IHRD+KAAN+LL E  +
Sbjct: 124 ---KKIHRDIKAANVLLSEHGE 142

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 352
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 36  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 412
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 94  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 146
Query: 413 HRDVKAANILLDED 426
           HRD+K+ NI L ED
Sbjct: 147 HRDLKSNNIFLHED 160

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 399
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 71  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 123
Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           ++YL    D +++HRD+ A N+L+
Sbjct: 124 MNYLE---DRRLVHRDLAARNVLV 144

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 73/151 (48%), Gaps = 22/151 (14%)
Query: 294 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 346
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 347 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPLDWP--------TRKKIALGS- 396
            L G CT     L+V   +   G++++ LR +++   P   P        T + +   S 
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 397 --ARGLSYLHEHCDPKIIHRDVKAANILLDE 425
             A+G+ +L      K IHRD+ A NILL E
Sbjct: 156 QVAKGMEFLASR---KCIHRDLAARNILLSE 183

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 399
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           ++YL    D +++HRD+ A N+L+
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLV 152

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 287 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 344
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ      I+    H N
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ------IMRKLDHCN 79
Query: 345 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 396
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 80  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 136
Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 137 FRSLAYIHSF---GICHRDIKPQNLLLDPD 163

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 287 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 344
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ      I+    H N
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ------IMRKLDHCN 86
Query: 345 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 396
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 143
Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 144 FRSLAYIHSF---GICHRDIKPQNLLLDPD 170

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 291 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 80
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 81  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 132
Query: 408 DPK-IIHRDVKAANILLDED 426
           + K  IHRD+ A N L+ E+
Sbjct: 133 EKKNFIHRDLAARNCLVGEN 152

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 399
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 80  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           ++YL    D +++HRD+ A N+L+
Sbjct: 133 MNYLE---DRRLVHRDLAARNVLV 153

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 399
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 87  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 139
Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           ++YL    D +++HRD+ A N+L+
Sbjct: 140 MNYLE---DRRLVHRDLAARNVLV 160

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 399
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           ++YL    D +++HRD+ A N+L+
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLV 150

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 352
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 43  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 412
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 101 TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 153
Query: 413 HRDVKAANILLDED 426
           HRD+K+ NI L ED
Sbjct: 154 HRDLKSNNIFLHED 167

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 70/139 (50%), Gaps = 18/139 (12%)
Query: 294 LGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 351
           LG G +G VYK      G++VA+K++  E     +LQ    E+ I+      ++++ YG 
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 352 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL---GSARGLSYLHEHCD 408
               T+  +V  Y   GSV+  +R R  +L      T  +IA     + +GL YLH    
Sbjct: 93  YFKNTDLWIVMEYCGAGSVSDIIRLRNKTL------TEDEIATILQSTLKGLEYLHFM-- 144
Query: 409 PKIIHRDVKAANILLDEDA 427
            + IHRD+KA NILL+ + 
Sbjct: 145 -RKIHRDIKAGNILLNTEG 162

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 399
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           ++YL    D +++HRD+ A N+L+
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLV 150

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 399
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 80  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           ++YL    D +++HRD+ A N+L+
Sbjct: 133 MNYLE---DRRLVHRDLAARNVLV 153

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 399
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLITQ-LMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           ++YL    D +++HRD+ A N+L+
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLV 150

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 399
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           ++YL    D +++HRD+ A N+L+
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLV 152

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 83/184 (45%), Gaps = 15/184 (8%)
Query: 247 YWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR 306
           Y++   P   F+   AE  +  + G+  R   RE++ +      + I+G G  G+V  GR
Sbjct: 15  YFQGKLPEPQFY---AEPHTYEEPGRAGRSFTREIEASR--IHIEKIIGSGDSGEVCYGR 69
Query: 307 L-ADGKL---VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY 362
           L   G+    VA+K LK   T      F +E  I+    H N++RL G  T     ++V 
Sbjct: 70  LRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVT 129
Query: 363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL 422
            YM NGS+ + LR        +       +  G   G+ YL    D   +HRD+ A N+L
Sbjct: 130 EYMENGSLDTFLRTHDGQFTIMQL---VGMLRGVGAGMRYL---SDLGYVHRDLAARNVL 183
Query: 423 LDED 426
           +D +
Sbjct: 184 VDSN 187

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 399
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           ++YL    D +++HRD+ A N+L+
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLV 150

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 83/184 (45%), Gaps = 15/184 (8%)
Query: 247 YWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR 306
           Y++   P   F+   AE  +  + G+  R   RE++ +      + I+G G  G+V  GR
Sbjct: 15  YFQGKLPEPQFY---AEPHTYEEPGRAGRSFTREIEASR--IHIEKIIGSGDSGEVCYGR 69
Query: 307 L-ADGKL---VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY 362
           L   G+    VA+K LK   T      F +E  I+    H N++RL G  T     ++V 
Sbjct: 70  LRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVT 129
Query: 363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL 422
            YM NGS+ + LR        +       +  G   G+ YL    D   +HRD+ A N+L
Sbjct: 130 EYMENGSLDTFLRTHDGQFTIMQL---VGMLRGVGAGMRYL---SDLGYVHRDLAARNVL 183
Query: 423 LDED 426
           +D +
Sbjct: 184 VDSN 187

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 352
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 412
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 102 TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 154
Query: 413 HRDVKAANILLDED 426
           HRD+K+ NI L ED
Sbjct: 155 HRDLKSNNIFLHED 168

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 291 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 75
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 127
Query: 408 DPK-IIHRDVKAANILLDED 426
           + K  IHRD+ A N L+ E+
Sbjct: 128 EKKNFIHRDLAARNCLVGEN 147

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 69/140 (49%), Gaps = 18/140 (12%)
Query: 292 NILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
            +LG G FG VYKG  + DG+     VA+K L+E  +     +   E  +++      + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRE---RQSSLPPLDWPTRKKIALGSARGLSYL 403
           RL G C T T + LV   M  G +   +RE   R  S   L+W       +  A+G+SYL
Sbjct: 83  RLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNW------CMQIAKGMSYL 135
Query: 404 HEHCDPKIIHRDVKAANILL 423
               D +++HRD+ A N+L+
Sbjct: 136 E---DVRLVHRDLAARNVLV 152

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 399
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 80  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           ++YL    D +++HRD+ A N+L+
Sbjct: 133 MNYLE---DRRLVHRDLAARNVLV 153

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 64/136 (47%), Gaps = 12/136 (8%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL--GSARGLSYLHEHCDPKI 411
                 ++  YM NG + + LRE +         T++ + +       + YL      + 
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRF-----QTQQLLEMCKDVCEAMEYLE---SKQF 126
Query: 412 IHRDVKAANILLDEDA 427
           +HRD+ A N L+++  
Sbjct: 127 LHRDLAARNCLVNDQG 142

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 280 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 332
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 333 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 389
           E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L  P+ 
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 390 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            K   +A   A G++YL+ +   K +HRD+ A N  + ED
Sbjct: 125 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAED 161

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 291 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 80
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 132
Query: 408 DPK-IIHRDVKAANILLDED 426
           + K  IHRD+ A N L+ E+
Sbjct: 133 EKKNFIHRDLAARNCLVGEN 152

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 399
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 83  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 135
Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           ++YL    D +++HRD+ A N+L+
Sbjct: 136 MNYLE---DRRLVHRDLAARNVLV 156

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 291 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 79
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 80  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 131
Query: 408 DPK-IIHRDVKAANILLDED 426
           + K  IHRD+ A N L+ E+
Sbjct: 132 EKKNFIHRDLAARNCLVGEN 151

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 399
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           ++YL    D +++HRD+ A N+L+
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLV 152

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 291 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 75
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 127
Query: 408 DPK-IIHRDVKAANILLDED 426
           + K  IHRD+ A N L+ E+
Sbjct: 128 EKKNFIHRDLAARNCLVGEN 147

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 287 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 344
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ      I+    H N
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ------IMRKLDHCN 102
Query: 345 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 396
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 103 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 159
Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 160 FRSLAYIHSF---GICHRDIKPQNLLLDPD 186

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 399
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 84  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           ++YL    D +++HRD+ A N+L+
Sbjct: 137 MNYLE---DRRLVHRDLAARNVLV 157

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 352
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 412
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 102 TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 154
Query: 413 HRDVKAANILLDED 426
           HRD+K+ NI L ED
Sbjct: 155 HRDLKSNNIFLHED 168

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 64/134 (47%), Gaps = 12/134 (8%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL--GSARGLSYLHEHCDPKI 411
                 ++  YM NG + + LRE +         T++ + +       + YL      + 
Sbjct: 70  KQRPIFIITEYMANGCLLNYLREMRHRF-----QTQQLLEMCKDVCEAMEYLE---SKQF 121
Query: 412 IHRDVKAANILLDE 425
           +HRD+ A N L+++
Sbjct: 122 LHRDLAARNCLVND 135

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 64/134 (47%), Gaps = 12/134 (8%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL--GSARGLSYLHEHCDPKI 411
                 ++  YM NG + + LRE +         T++ + +       + YL      + 
Sbjct: 74  KQRPIFIITEYMANGCLLNYLREMRHRF-----QTQQLLEMCKDVCEAMEYLE---SKQF 125
Query: 412 IHRDVKAANILLDE 425
           +HRD+ A N L+++
Sbjct: 126 LHRDLAARNCLVND 139

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 399
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 84  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           ++YL    D +++HRD+ A N+L+
Sbjct: 137 MNYLE---DRRLVHRDLAARNVLV 157

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 74/150 (49%), Gaps = 21/150 (14%)
Query: 294 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 346
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 347 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL-------DWPTRKKIALGS-- 396
            L G CT     L+V   +   G++++ LR +++   P        D+ T + +   S  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 397 -ARGLSYLHEHCDPKIIHRDVKAANILLDE 425
            A+G+ +L      K IHRD+ A NILL E
Sbjct: 157 VAKGMEFLASR---KXIHRDLAARNILLSE 183

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 291 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 80
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 132
Query: 408 DPK-IIHRDVKAANILLDED 426
           + K  IHRD+ A N L+ E+
Sbjct: 133 EKKNFIHRDLAARNCLVGEN 152

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 287 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 344
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ      I+    H N
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ------IMRKLDHCN 108
Query: 345 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 396
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 165
Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 166 FRSLAYIHSF---GICHRDIKPQNLLLDPD 192

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 291 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 19  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 76
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 77  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 128
Query: 408 DPK-IIHRDVKAANILLDED 426
           + K  IHRD+ A N L+ E+
Sbjct: 129 EKKNFIHRDLAARNCLVGEN 148

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 291 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 31  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 88
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 89  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 140
Query: 408 DPK-IIHRDVKAANILLDED 426
           + K  IHRD+ A N L+ E+
Sbjct: 141 EKKNFIHRDLAARNCLVGEN 160

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 291 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 19  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 76
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 77  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 128
Query: 408 DPK-IIHRDVKAANILLDED 426
           + K  IHRD+ A N L+ E+
Sbjct: 129 EKKNFIHRDLAARNCLVGEN 148

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 64/136 (47%), Gaps = 12/136 (8%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL--GSARGLSYLHEHCDPKI 411
                 ++  YM NG + + LRE +         T++ + +       + YL      + 
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRF-----QTQQLLEMCKDVCEAMEYLE---SKQF 126
Query: 412 IHRDVKAANILLDEDA 427
           +HRD+ A N L+++  
Sbjct: 127 LHRDLAARNCLVNDQG 142

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 73/149 (48%), Gaps = 22/149 (14%)
Query: 288 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNL 345
           +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ      I+    H N+
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ------IMRKLDHCNI 109
Query: 346 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 397
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQLF 166
Query: 398 RGLSYLHEHCDPKIIHRDVKAANILLDED 426
           R L+Y+H      I HRD+K  N+LLD D
Sbjct: 167 RSLAYIHSF---GICHRDIKPQNLLLDPD 192

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 291 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 75
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYL 127
Query: 408 DPK-IIHRDVKAANILLDED 426
           + K  IHRD+ A N L+ E+
Sbjct: 128 EKKNFIHRDLAARNCLVGEN 147

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 73/149 (48%), Gaps = 22/149 (14%)
Query: 288 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNL 345
           +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ      I+    H N+
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ------IMRKLDHCNI 111
Query: 346 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 397
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQLF 168
Query: 398 RGLSYLHEHCDPKIIHRDVKAANILLDED 426
           R L+Y+H      I HRD+K  N+LLD D
Sbjct: 169 RSLAYIHSF---GICHRDIKPQNLLLDPD 194

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 291 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 77
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 129
Query: 408 DPK-IIHRDVKAANILLDED 426
           + K  IHRD+ A N L+ E+
Sbjct: 130 EKKNFIHRDLAARNCLVGEN 149

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 291 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 75
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYL 127
Query: 408 DPK-IIHRDVKAANILLDED 426
           + K  IHRD+ A N L+ E+
Sbjct: 128 EKKNFIHRDLAARNCLVGEN 147

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 64/136 (47%), Gaps = 12/136 (8%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL--GSARGLSYLHEHCDPKI 411
                 ++  YM NG + + LRE +         T++ + +       + YL      + 
Sbjct: 81  KQRPIFIITEYMANGCLLNYLREMRHRF-----QTQQLLEMCKDVCEAMEYLE---SKQF 132
Query: 412 IHRDVKAANILLDEDA 427
           +HRD+ A N L+++  
Sbjct: 133 LHRDLAARNCLVNDQG 148

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 64/135 (47%), Gaps = 10/135 (7%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK-II 412
                 ++  YM NG + + LRE +          + +  L   + +    E+ + K  +
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRF-------QTQQLLEMCKDVCEAMEYLESKQFL 142
Query: 413 HRDVKAANILLDEDA 427
           HRD+ A N L+++  
Sbjct: 143 HRDLAARNCLVNDQG 157

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 64/135 (47%), Gaps = 10/135 (7%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK-II 412
                 ++  YM NG + + LRE +          + +  L   + +    E+ + K  +
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRF-------QTQQLLEMCKDVCEAMEYLESKQFL 142
Query: 413 HRDVKAANILLDEDA 427
           HRD+ A N L+++  
Sbjct: 143 HRDLAARNCLVNDQG 157

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 291 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 80
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 132
Query: 408 DPK-IIHRDVKAANILLDED 426
           + K  IHRD+ A N L+ E+
Sbjct: 133 EKKNFIHRDLAARNCLVGEN 152

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 291 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 77
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 129
Query: 408 DPK-IIHRDVKAANILLDED 426
           + K  IHRD+ A N L+ E+
Sbjct: 130 EKKNFIHRDLAARNCLVGEN 149

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 73/149 (48%), Gaps = 22/149 (14%)
Query: 288 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNL 345
           +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ      I+    H N+
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ------IMRKLDHCNI 113
Query: 346 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 397
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQLF 170
Query: 398 RGLSYLHEHCDPKIIHRDVKAANILLDED 426
           R L+Y+H      I HRD+K  N+LLD D
Sbjct: 171 RSLAYIHSF---GICHRDIKPQNLLLDPD 196

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 291 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 77
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 129
Query: 408 DPK-IIHRDVKAANILLDED 426
           + K  IHRD+ A N L+ E+
Sbjct: 130 EKKNFIHRDLAARNCLVGEN 149

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 73/149 (48%), Gaps = 22/149 (14%)
Query: 288 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNL 345
           +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ      I+    H N+
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ------IMRKLDHCNI 154
Query: 346 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 397
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQLF 211
Query: 398 RGLSYLHEHCDPKIIHRDVKAANILLDED 426
           R L+Y+H      I HRD+K  N+LLD D
Sbjct: 212 RSLAYIHSF---GICHRDIKPQNLLLDPD 237

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 68/138 (49%), Gaps = 11/138 (7%)
Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 351
           +G+G F KV   R +  GK VAVK + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 352 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 410
             T     LV  Y + G V   L           W  ++K A    R +    ++C  K 
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAH-------GW-MKEKEARAKFRQIVSAVQYCHQKF 126
Query: 411 IIHRDVKAANILLDEDAD 428
           I+HRD+KA N+LLD D +
Sbjct: 127 IVHRDLKAENLLLDADMN 144

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 291 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 75
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYL 127
Query: 408 DPK-IIHRDVKAANILLDED 426
           + K  IHRD+ A N L+ E+
Sbjct: 128 EKKNFIHRDLAARNCLVGEN 147

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 294 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 346
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 347 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 396
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 397 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 425
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 157 FQVAKGMEFLASR---KCIHRDLAARNILLSE 185

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 72/144 (50%), Gaps = 18/144 (12%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 399
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A G
Sbjct: 74  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAEG 126
Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           ++YL    D +++HRD+ A N+L+
Sbjct: 127 MNYLE---DRRLVHRDLAARNVLV 147

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 19/152 (12%)
Query: 291 KNILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLL 346
           ++++G G FG+V K R+    L    A+KR+KE  +      F  E++++  +  H N++
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ------------SSLPPLDWPTRKKIAL 394
            L G C       L   Y  +G++   LR+ +            S+   L        A 
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 395 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
             ARG+ YL +    + IHRD+ A NIL+ E+
Sbjct: 140 DVARGMDYLSQK---QFIHRDLAARNILVGEN 168

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 294 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 346
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 347 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 396
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 397 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 425
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSE 183

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 19/152 (12%)
Query: 291 KNILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLL 346
           ++++G G FG+V K R+    L    A+KR+KE  +      F  E++++  +  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ------------SSLPPLDWPTRKKIAL 394
            L G C       L   Y  +G++   LR+ +            S+   L        A 
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 395 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
             ARG+ YL +    + IHRD+ A NIL+ E+
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGEN 178

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 294 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 346
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 347 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 396
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 397 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 425
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSE 183

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 60/132 (45%), Gaps = 7/132 (5%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG+V+ G   +   VAVK LK    S     F  E  ++    H  L+RLY   T
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ--AFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 413
                 ++  YM  GS+   L+  +     L  P     +   A G++Y+        IH
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERK---NYIH 133
Query: 414 RDVKAANILLDE 425
           RD++AAN+L+ E
Sbjct: 134 RDLRAANVLVSE 145

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 294 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 346
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 347 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 396
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 397 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 425
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSE 183

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 67/149 (44%), Gaps = 12/149 (8%)
Query: 286 DGFSNKNILGRGGFGKVYKGRLADGK-LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 344
           D +  + ++G G    V     A  K  VA+KR+  E+      +   E++ +S   H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWPTRKKIALGSAR 398
           ++  Y       E  LV   ++ GSV   ++      E +S +  LD  T   I      
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV--LDESTIATILREVLE 127
Query: 399 GLSYLHEHCDPKIIHRDVKAANILLDEDA 427
           GL YLH++     IHRDVKA NILL ED 
Sbjct: 128 GLEYLHKNGQ---IHRDVKAGNILLGEDG 153

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 74/163 (45%), Gaps = 15/163 (9%)
Query: 276 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD---GKL---VAVKRLKEERTSGGELQ 329
           F   E +V+ +  +    LG+G FG VY+G   D   G+    VAVK + E  +    ++
Sbjct: 7   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 330 FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPP 383
           F  E  ++      +++RL G  +     L+V   M +G + S LR      E     PP
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 384 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
                  ++A   A G++YL+     K +HRD+ A N ++  D
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 166

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 294 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 346
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 347 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 396
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 397 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 425
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 192 FQVAKGMEFLASR---KCIHRDLAARNILLSE 220

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 291 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 80
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYL 132
Query: 408 DPK-IIHRDVKAANILLDED 426
           + K  IHRD+ A N L+ E+
Sbjct: 133 EKKNFIHRDLAARNCLVGEN 152

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 294 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 346
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 347 RLYGFCTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 396
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 397 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 425
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSE 174

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 74/163 (45%), Gaps = 15/163 (9%)
Query: 276 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD---GKL---VAVKRLKEERTSGGELQ 329
           F   E +V+ +  +    LG+G FG VY+G   D   G+    VAVK + E  +    ++
Sbjct: 4   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 63
Query: 330 FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPP 383
           F  E  ++      +++RL G  +     L+V   M +G + S LR      E     PP
Sbjct: 64  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 123
Query: 384 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
                  ++A   A G++YL+     K +HRD+ A N ++  D
Sbjct: 124 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 163

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 291 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 75
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYL 127
Query: 408 DPK-IIHRDVKAANILLDED 426
           + K  IHRD+ A N L+ E+
Sbjct: 128 EKKNFIHRDLAARNCLVGEN 147

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 72/149 (48%), Gaps = 20/149 (13%)
Query: 287 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 345
            +++  ++G G FG VY+ +L D G+LVA+K++ +     G+     E++I+    H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----GKAFKNRELQIMRKLDHCNI 75
Query: 346 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 397
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVI---YVKLYMYQLF 132
Query: 398 RGLSYLHEHCDPKIIHRDVKAANILLDED 426
           R L+Y+H      I HRD+K  N+LLD D
Sbjct: 133 RSLAYIHSF---GICHRDIKPQNLLLDPD 158

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 294 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 346
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 347 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 396
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 397 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 425
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSE 174

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 67/149 (44%), Gaps = 12/149 (8%)
Query: 286 DGFSNKNILGRGGFGKVYKGRLADGK-LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 344
           D +  + ++G G    V     A  K  VA+KR+  E+      +   E++ +S   H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWPTRKKIALGSAR 398
           ++  Y       E  LV   ++ GSV   ++      E +S +  LD  T   I      
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV--LDESTIATILREVLE 132
Query: 399 GLSYLHEHCDPKIIHRDVKAANILLDEDA 427
           GL YLH++     IHRDVKA NILL ED 
Sbjct: 133 GLEYLHKNGQ---IHRDVKAGNILLGEDG 158

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 74/163 (45%), Gaps = 15/163 (9%)
Query: 276 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD---GKL---VAVKRLKEERTSGGELQ 329
           F   E +V+ +  +    LG+G FG VY+G   D   G+    VAVK + E  +    ++
Sbjct: 7   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 330 FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPP 383
           F  E  ++      +++RL G  +     L+V   M +G + S LR      E     PP
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 384 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
                  ++A   A G++YL+     K +HRD+ A N ++  D
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 166

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 74/163 (45%), Gaps = 15/163 (9%)
Query: 276 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD---GKL---VAVKRLKEERTSGGELQ 329
           F   E +V+ +  +    LG+G FG VY+G   D   G+    VAVK + E  +    ++
Sbjct: 7   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 330 FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPP 383
           F  E  ++      +++RL G  +     L+V   M +G + S LR      E     PP
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 384 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
                  ++A   A G++YL+     K +HRD+ A N ++  D
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 166

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 294 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 346
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 347 RLYGFCTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 396
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 397 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 425
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSE 174

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 65/142 (45%), Gaps = 9/142 (6%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           F+    +G+G FG+V+KG      ++VA+K +  E         Q E+ ++S      + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
           + YG     ++  ++  Y+  GS    LR       P D      +     +GL YLH  
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSE 139
Query: 407 CDPKIIHRDVKAANILLDEDAD 428
              K IHRD+KAAN+LL E  D
Sbjct: 140 ---KKIHRDIKAANVLLSEQGD 158

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 294 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 346
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 347 RLYGFCTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 396
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 397 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 425
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSE 174

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 65/151 (43%), Gaps = 19/151 (12%)
Query: 291 KNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 344
           K  LG G FGKV+           D  LVAVK LK+  +      F  E ++++   H +
Sbjct: 18  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEH 76
Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL-------PPLDWPTRK--KIALG 395
           +++ YG C      ++V+ YM +G +   LR             PP +    +   IA  
Sbjct: 77  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136
Query: 396 SARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            A G+ YL        +HRD+   N L+ E+
Sbjct: 137 IAAGMVYL---ASQHFVHRDLATRNCLVGEN 164

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 15/159 (9%)
Query: 280 ELQVATDGFSNKNILGRGGFGKVYKGRLAD---GKL---VAVKRLKEERTSGGELQFQTE 333
           E +V+ +  +    LG+G FG VY+G   D   G+    VAVK + E  +    ++F  E
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 70
Query: 334 VKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWP 387
             ++      +++RL G  +     L+V   M +G + S LR      E     PP    
Sbjct: 71  ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 130
Query: 388 TRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
              ++A   A G++YL+     K +HRD+ A N ++  D
Sbjct: 131 EMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 166

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 72/150 (48%), Gaps = 20/150 (13%)
Query: 287 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 345
            +++  ++G G FG VY+ +L D G+LVA+K++ +     G+     E++I+    H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----GKAFKNRELQIMRKLDHCNI 75
Query: 346 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 397
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQLF 132
Query: 398 RGLSYLHEHCDPKIIHRDVKAANILLDEDA 427
           R L+Y+H      I HRD+K  N+LLD D 
Sbjct: 133 RSLAYIHSF---GICHRDIKPQNLLLDPDT 159

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 72/149 (48%), Gaps = 20/149 (13%)
Query: 287 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 345
            +++  ++G G FG VY+ +L D G+LVA+K++ +     G+     E++I+    H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----GKAFKNRELQIMRKLDHCNI 75
Query: 346 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 397
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQLF 132
Query: 398 RGLSYLHEHCDPKIIHRDVKAANILLDED 426
           R L+Y+H      I HRD+K  N+LLD D
Sbjct: 133 RSLAYIHSF---GICHRDIKPQNLLLDPD 158

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 71/147 (48%), Gaps = 15/147 (10%)
Query: 292 NILGRGGFGKVYKGRL--ADGK--LVAVKRLKEERTSGGEL-QFQTEVKIISMAVHRNLL 346
            ILG G FG V +G L   DG    VAVK +K + +S  E+ +F +E   +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 347 RLYGFCTTVTEK-----LLVYPYMTNGSVASRLRERQSSLPPLDWP--TRKKIALGSARG 399
           RL G C  ++ +     +++ P+M  G + + L   +    P   P  T  K  +  A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 400 LSYLHEHCDPKIIHRDVKAANILLDED 426
           + YL        +HRD+ A N +L +D
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDD 183

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 294 LGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLR 347
           LG G FG V +G      GK V  AVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           LYG   T   K +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYLESK- 130
Query: 408 DPKIIHRDVKAANILL 423
             + IHRD+ A N+LL
Sbjct: 131 --RFIHRDLAARNLLL 144

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 294 LGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLR 347
           LG G FG V +G      GK V  AVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           LYG   T   K +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYLESK- 130
Query: 408 DPKIIHRDVKAANILL 423
             + IHRD+ A N+LL
Sbjct: 131 --RFIHRDLAARNLLL 144

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 294 LGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLR 347
           LG G FG V +G      GK V  AVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           LYG   T   K +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYLESK- 130
Query: 408 DPKIIHRDVKAANILL 423
             + IHRD+ A N+LL
Sbjct: 131 --RFIHRDLAARNLLL 144

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 294 LGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLR 347
           LG G FG V +G      GK V  AVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           LYG   T   K +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYLESK- 134
Query: 408 DPKIIHRDVKAANILL 423
             + IHRD+ A N+LL
Sbjct: 135 --RFIHRDLAARNLLL 148

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 67/141 (47%), Gaps = 12/141 (8%)
Query: 291 KNILGRGGFGKVYKGRLA-DGKL---VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           + ++G G FG+V  GRL   GK    VA+K LK   T      F  E  I+    H N++
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
            L G  T     ++V  YM NGS+ + L++       +         +G  RG+S   ++
Sbjct: 87  HLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQ-------LVGMLRGISAGMKY 139
Query: 407 -CDPKIIHRDVKAANILLDED 426
             D   +HRD+ A NIL++ +
Sbjct: 140 LSDMGYVHRDLAARNILINSN 160

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 294 LGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLR 347
           LG G FG V +G      GK V  AVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           LYG   T   K +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYLESK- 140
Query: 408 DPKIIHRDVKAANILL 423
             + IHRD+ A N+LL
Sbjct: 141 --RFIHRDLAARNLLL 154

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 294 LGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLR 347
           LG G FG V +G      GK V  AVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           LYG   T   K +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYLESK- 134
Query: 408 DPKIIHRDVKAANILL 423
             + IHRD+ A N+LL
Sbjct: 135 --RFIHRDLAARNLLL 148

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 294 LGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLR 347
           LG G FG V +G      GK V  AVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           LYG   T   K +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYLESK- 140
Query: 408 DPKIIHRDVKAANILL 423
             + IHRD+ A N+LL
Sbjct: 141 --RFIHRDLAARNLLL 154

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 60/132 (45%), Gaps = 7/132 (5%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG+V+ G   +   VAVK LK    S     F  E  ++    H  L+RLY   T
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ--AFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 413
                 ++  +M  GS+   L+  +     L  P     +   A G++Y+        IH
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERK---NYIH 132
Query: 414 RDVKAANILLDE 425
           RD++AAN+L+ E
Sbjct: 133 RDLRAANVLVSE 144

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 351
           +G+G F KV   R +  GK VAVK + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 352 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 410
             T     LV  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR--------MKEKEARAKFRQIVSAVQYCHQKF 133
Query: 411 IIHRDVKAANILLDEDAD 428
           I+HRD+KA N+LLD D +
Sbjct: 134 IVHRDLKAENLLLDADMN 151

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 351
           +G+G F KV   R +  GK VAVK + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 352 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 410
             T     LV  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR--------MKEKEARAKFRQIVSAVQYCHQKF 133
Query: 411 IIHRDVKAANILLDEDAD 428
           I+HRD+KA N+LLD D +
Sbjct: 134 IVHRDLKAENLLLDADMN 151

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 277 SLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVK 335
           S+ + ++     + K+ LG G +G+VY G      L VAVK LKE+     E  F  E  
Sbjct: 23  SMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 80
Query: 336 IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALG 395
           ++    H NL++L G CT      +V  YM  G++   LRE               + L 
Sbjct: 81  VMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNRE------EVTAVVLLY 134
Query: 396 SARGLSYLHEHCDPK-IIHRDVKAANILLDED 426
            A  +S   E+ + K  IHRD+ A N L+ E+
Sbjct: 135 MATQISSAMEYLEKKNFIHRDLAARNCLVGEN 166

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 351
           +G+G F KV   R +  GK VAVK + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 352 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 410
             T     LV  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR--------MKEKEARAKFRQIVSAVQYCHQKF 133
Query: 411 IIHRDVKAANILLDEDAD 428
           I+HRD+KA N+LLD D +
Sbjct: 134 IVHRDLKAENLLLDADMN 151

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           F    +L  G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 399
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 84  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           ++YL    D +++HRD+ A N+L+
Sbjct: 137 MNYLE---DRRLVHRDLAARNVLV 157

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 15/145 (10%)
Query: 294 LGRGGFGKVYKGRLAD---GKL---VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
           LG+G FG VY+G   D   G+    VAVK + E  +    ++F  E  ++      +++R
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWPTRKKIALGSARGLS 401
           L G  +     L+V   M +G + S LR      E     PP       ++A   A G++
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 402 YLHEHCDPKIIHRDVKAANILLDED 426
           YL+     K +HRD+ A N ++  D
Sbjct: 144 YLNAK---KFVHRDLAARNCMVAHD 165

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 72/144 (50%), Gaps = 18/144 (12%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           F    +LG G FG VYKG  + +G+     VA+  L+E  +     +   E  +++   +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 399
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 111 PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 163
Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           ++YL    D +++HRD+ A N+L+
Sbjct: 164 MNYLE---DRRLVHRDLAARNVLV 184

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 280 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 339
           E +V  +       LG G FG+V+ G       VAVK LK+   S     F  E  ++  
Sbjct: 9   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQ 66
Query: 340 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--- 396
             H+ L+RLY   T      ++  YM NGS+   L+           P+  K+ +     
Sbjct: 67  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT----------PSGIKLTINKLLD 115
Query: 397 -----ARGLSYLHEHCDPKIIHRDVKAANILLDE 425
                A G++++ E      IHRD++AANIL+ +
Sbjct: 116 MAAQIAEGMAFIEER---NYIHRDLRAANILVSD 146

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 72/144 (50%), Gaps = 18/144 (12%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           F    +L  G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 399
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           ++YL    D +++HRD+ A N+L+
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLV 150

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 63/133 (47%), Gaps = 10/133 (7%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 352
           +G G FG VYKG+      VAVK LK    +  + Q F+ EV ++    H N+L   G+ 
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101
Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 412
           T      +V  +    S+   L  +++            IA  +A+G+ YLH      II
Sbjct: 102 TK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQ---LIDIARQTAQGMDYLHAK---NII 154
Query: 413 HRDVKAANILLDE 425
           HRD+K+ NI L E
Sbjct: 155 HRDMKSNNIFLHE 167

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 73
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 413
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 74  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 127
Query: 414 RDVKAANILLDE 425
           RD++AANIL+ +
Sbjct: 128 RDLRAANILVSD 139

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 24/140 (17%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 79
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--------ARGLSYLHE 405
                 ++  YM NGS+   L+           P+  K+ +          A G++++ E
Sbjct: 80  Q-EPIYIITEYMENGSLVDFLKT----------PSGIKLTINKLLDMAAQIAEGMAFIEE 128
Query: 406 HCDPKIIHRDVKAANILLDE 425
                 IHRD++AANIL+ +
Sbjct: 129 R---NYIHRDLRAANILVSD 145

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 24/140 (17%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 87
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--------ARGLSYLHE 405
                 ++  YM NGS+   L+           P+  K+ +          A G++++ E
Sbjct: 88  Q-EPIYIITEYMENGSLVDFLKT----------PSGIKLTINKLLDMAAQIAEGMAFIEE 136
Query: 406 HCDPKIIHRDVKAANILLDE 425
                 IHRD++AANIL+ +
Sbjct: 137 R---NYIHRDLRAANILVSD 153

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 24/140 (17%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--------ARGLSYLHE 405
                 ++  YM NGS+   L+           P+  K+ +          A G++++ E
Sbjct: 79  Q-EPIYIITEYMENGSLVDFLKT----------PSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 406 HCDPKIIHRDVKAANILLDE 425
                 IHRD++AANIL+ +
Sbjct: 128 R---NYIHRDLRAANILVSD 144

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 280 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 339
           E +V  +       LG G FG+V+ G       VAVK LK+   S     F  E  ++  
Sbjct: 13  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQ 70
Query: 340 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--- 396
             H+ L+RLY   T      ++  YM NGS+   L+           P+  K+ +     
Sbjct: 71  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT----------PSGIKLTINKLLD 119
Query: 397 -----ARGLSYLHEHCDPKIIHRDVKAANILLDE 425
                A G++++ E      IHRD++AANIL+ +
Sbjct: 120 MAAQIAEGMAFIEER---NYIHRDLRAANILVSD 150

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 280 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 339
           E +V  +       LG G FG+V+ G       VAVK LK+   S     F  E  ++  
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQ 64
Query: 340 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--- 396
             H+ L+RLY   T      ++  YM NGS+   L+           P+  K+ +     
Sbjct: 65  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT----------PSGIKLTINKLLD 113
Query: 397 -----ARGLSYLHEHCDPKIIHRDVKAANILLDE 425
                A G++++ E      IHRD++AANIL+ +
Sbjct: 114 MAAQIAEGMAFIEER---NYIHRDLRAANILVSD 144

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 64/141 (45%), Gaps = 9/141 (6%)
Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRL-KEERTSGGELQ-FQTEVKIISMAVH 342
           + F   N+LG+G F  VY+   +  G  VA+K + K+     G +Q  Q EVKI     H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 402
            ++L LY +        LV     NG +   L+ R   + P      +        G+ Y
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLY 127
Query: 403 LHEHCDPKIIHRDVKAANILL 423
           LH H    I+HRD+  +N+LL
Sbjct: 128 LHSH---GILHRDLTLSNLLL 145

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 280 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 339
           E +V  +       LG G FG+V+ G       VAVK LK+   S     F  E  ++  
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQ 64
Query: 340 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--- 396
             H+ L+RLY   T      ++  YM NGS+   L+           P+  K+ +     
Sbjct: 65  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT----------PSGIKLTINKLLD 113
Query: 397 -----ARGLSYLHEHCDPKIIHRDVKAANILLDE 425
                A G++++ E      IHRD++AANIL+ +
Sbjct: 114 MAAQIAEGMAFIEER---NYIHRDLRAANILVSD 144

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 280 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 339
           E +V  +       LG G FG+V+ G       VAVK LK+   S     F  E  ++  
Sbjct: 13  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQ 70
Query: 340 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--- 396
             H+ L+RLY   T      ++  YM NGS+   L+           P+  K+ +     
Sbjct: 71  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT----------PSGIKLTINKLLD 119
Query: 397 -----ARGLSYLHEHCDPKIIHRDVKAANILLDE 425
                A G++++ E      IHRD++AANIL+ +
Sbjct: 120 MAAQIAEGMAFIEER---NYIHRDLRAANILVSD 150

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 62/145 (42%), Gaps = 10/145 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 338
           +   D F     LG+G FG VY  R    K + A+K L   +    G E Q + E++I S
Sbjct: 11  KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 70
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LR+Y +        L+  +   G +   L++        D           A 
Sbjct: 71  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR----FDEQRSATFMEELAD 126
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL 423
            L Y HE    K+IHRD+K  N+L+
Sbjct: 127 ALHYCHER---KVIHRDIKPENLLM 148

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 65/138 (47%), Gaps = 10/138 (7%)
Query: 291 KNILGRGGFGKVYKGRLA-DGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           + ++G G FG+V  GRL   GK    VA+K LK   T      F  E  I+    H N++
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
            L G  T     ++V  +M NG++ + LR+       +       +  G A G+ YL   
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVI---QLVGMLRGIAAGMRYL--- 161
Query: 407 CDPKIIHRDVKAANILLD 424
            D   +HRD+ A NIL++
Sbjct: 162 ADMGYVHRDLAARNILVN 179

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 280 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 339
           E +V  +       LG G FG+V+ G       VAVK LK+   S     F  E  ++  
Sbjct: 12  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQ 69
Query: 340 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--- 396
             H+ L+RLY   T      ++  YM NGS+   L+           P+  K+ +     
Sbjct: 70  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT----------PSGIKLTINKLLD 118
Query: 397 -----ARGLSYLHEHCDPKIIHRDVKAANILLDE 425
                A G++++ E      IHRD++AANIL+ +
Sbjct: 119 MAAQIAEGMAFIEER---NYIHRDLRAANILVSD 149

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 75/157 (47%), Gaps = 19/157 (12%)
Query: 275 RFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEE---RTSGGELQF 330
           ++SL++ Q+          LG G FG+V+  R   +G+  A+K LK+E   R    E   
Sbjct: 2   KYSLQDFQIL-------RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVE-HT 53
Query: 331 QTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK 390
             E  ++S+  H  ++R++G      +  ++  Y+  G + S LR+ Q   P    P  K
Sbjct: 54  NDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR-FPN---PVAK 109
Query: 391 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA 427
             A      L YLH      II+RD+K  NILLD++ 
Sbjct: 110 FYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNG 143

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 24/140 (17%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 86
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--------ARGLSYLHE 405
                 ++  YM NGS+   L+           P+  K+ +          A G++++ E
Sbjct: 87  Q-EPIYIITEYMENGSLVDFLKT----------PSGIKLTINKLLDMAAQIAEGMAFIEE 135
Query: 406 HCDPKIIHRDVKAANILLDE 425
                 IHRD++AANIL+ +
Sbjct: 136 R---NYIHRDLRAANILVSD 152

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 24/140 (17%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 88
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--------ARGLSYLHE 405
                 ++  YM NGS+   L+           P+  K+ +          A G++++ E
Sbjct: 89  Q-EPIYIITEYMENGSLVDFLKT----------PSGIKLTINKLLDMAAQIAEGMAFIEE 137
Query: 406 HCDPKIIHRDVKAANILLDE 425
                 IHRD++AANIL+ +
Sbjct: 138 R---NYIHRDLRAANILVSD 154

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 72/144 (50%), Gaps = 18/144 (12%)
Query: 288 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           F    +L  G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 399
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 84  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           ++YL    D +++HRD+ A N+L+
Sbjct: 137 MNYLE---DRRLVHRDLAARNVLV 157

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 68/143 (47%), Gaps = 21/143 (14%)
Query: 294 LGRGGFGKVYKGR--LADGKLVAVKRLK-EERTSGGELQFQTEVKII---SMAVHRNLLR 347
           +G G +GKV+K R     G+ VA+KR++ +    G  L    EV ++       H N++R
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 348 LYGFCTTV-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR--KKIALGSARGL 400
           L+  CT       T+  LV+ +     V   L      +P    PT   K +     RGL
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEH-----VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 401 SYLHEHCDPKIIHRDVKAANILL 423
            +LH H   +++HRD+K  NIL+
Sbjct: 134 DFLHSH---RVVHRDLKPQNILV 153

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 70/152 (46%), Gaps = 19/152 (12%)
Query: 291 KNILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLL 346
           ++++G G FG+V K R+    L    A+KR+KE  +      F  E++++  +  H N++
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ------------SSLPPLDWPTRKKIAL 394
            L G C       L   Y  +G++   LR+ +            S+   L        A 
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 395 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
             ARG+ YL +    + IHR++ A NIL+ E+
Sbjct: 147 DVARGMDYLSQK---QFIHRNLAARNILVGEN 175

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 63/145 (43%), Gaps = 10/145 (6%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRLKEER--TSGGELQFQTEVKIIS 338
           +   D F     LG+G FG VY  R    K + A+K L + +    G E Q + E++I S
Sbjct: 10  KFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H N+LR+Y +        L+  +   G +   L++        D           A 
Sbjct: 70  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR----FDEQRSATFMEELAD 125
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL 423
            L Y HE    K+IHRD+K  N+L+
Sbjct: 126 ALHYCHER---KVIHRDIKPENLLM 147

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 68/145 (46%), Gaps = 7/145 (4%)
Query: 284 ATDGFSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           ++  F     LG G +  VYKG     G  VA+K +K +   G       E+ ++    H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP--LDWPTRKKIALGSARGL 400
            N++RLY    T  +  LV+ +M N  +   +  R     P  L+    K       +GL
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 401 SYLHEHCDPKIIHRDVKAANILLDE 425
           ++ HE+   KI+HRD+K  N+L+++
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINK 143

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 351
           +G+G F KV   R +  GK VAV+ + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 352 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 410
             T     LV  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR--------MKEKEARAKFRQIVSAVQYCHQKF 133
Query: 411 IIHRDVKAANILLDEDAD 428
           I+HRD+KA N+LLD D +
Sbjct: 134 IVHRDLKAENLLLDADMN 151

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 65/136 (47%), Gaps = 14/136 (10%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           +G+G FG V  G    G  VAVK +K + T+     F  E  +++   H NL++L G   
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLG--V 67
Query: 354 TVTEK---LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 410
            V EK    +V  YM  GS+   LR R  S+  L      K +L     + YL  +    
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGN---N 122
Query: 411 IIHRDVKAANILLDED 426
            +HRD+ A N+L+ ED
Sbjct: 123 FVHRDLAARNVLVSED 138

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 351
           +G+G F KV   R +  GK VAV+ + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 352 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 410
             T     LV  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR--------MKEKEARAKFRQIVSAVQYCHQKF 133
Query: 411 IIHRDVKAANILLDEDAD 428
           I+HRD+KA N+LLD D +
Sbjct: 134 IVHRDLKAENLLLDADMN 151

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 67/144 (46%), Gaps = 9/144 (6%)
Query: 284 ATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT-EVKIISMAV 341
           + + + N  ++G G +G V K R  D G++VA+K+  E        +    E+K++    
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           H NL+ L   C       LV+ ++ +    + L + +     LD+   +K       G+ 
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDH----TILDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 402 YLHEHCDPKIIHRDVKAANILLDE 425
           + H H    IIHRD+K  NIL+ +
Sbjct: 139 FCHSH---NIIHRDIKPENILVSQ 159

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 63/138 (45%), Gaps = 11/138 (7%)
Query: 294 LGRGGFGKVYKGR--LADGKLVAVKRLK-EERTSGGELQFQTEVKII---SMAVHRNLLR 347
           +G G +GKV+K R     G+ VA+KR++ +    G  L    EV ++       H N++R
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR--KKIALGSARGLSYLHE 405
           L+  CT           +    V   L      +P    PT   K +     RGL +LH 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 406 HCDPKIIHRDVKAANILL 423
           H   +++HRD+K  NIL+
Sbjct: 139 H---RVVHRDLKPQNILV 153

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 283 VATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISM 339
           +  D F +  +LGRGGFG+V+  ++ A GKL A K+L ++R     G      E KI++ 
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 340 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 399
              R ++ L     T T+  LV   M  G +   +       P    P           G
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 400 LSYLHEHCDPKIIHRDVKAANILLDEDAD 428
           L +LH+     II+RD+K  N+LLD+D +
Sbjct: 302 LEHLHQR---NIIYRDLKPENVLLDDDGN 327

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 73/167 (43%), Gaps = 6/167 (3%)
Query: 265 DSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAV--KRLKEE 321
           DS+  L  L+   L    +  D F +  +LGRGGFG+V+  ++ A GKL A      K  
Sbjct: 164 DSKYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL 223
Query: 322 RTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL 381
           +   G      E KI++    R ++ L     T T+  LV   M  G +   +       
Sbjct: 224 KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN 283
Query: 382 PPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 428
           P    P           GL +LH+     II+RD+K  N+LLD+D +
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGN 327

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 294 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 344
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 395
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 396 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 69/145 (47%), Gaps = 12/145 (8%)
Query: 288 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLK----EERTSGGELQFQTEVKIISMAVH 342
           +   + LG G F  VYK R  +  ++VA+K++K     E   G       E+K++    H
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 402
            N++ L       +   LV+ +M    +   +++    L P      K   L + +GL Y
Sbjct: 72  PNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTP---SHIKAYMLMTLQGLEY 127
Query: 403 LHEHCDPKIIHRDVKAANILLDEDA 427
           LH+H    I+HRD+K  N+LLDE+ 
Sbjct: 128 LHQHW---ILHRDLKPNNLLLDENG 149

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 65/136 (47%), Gaps = 14/136 (10%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           +G+G FG V  G    G  VAVK +K + T+     F  E  +++   H NL++L G   
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLG--V 73
Query: 354 TVTEK---LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 410
            V EK    +V  YM  GS+   LR R  S+  L      K +L     + YL  +    
Sbjct: 74  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGN---N 128
Query: 411 IIHRDVKAANILLDED 426
            +HRD+ A N+L+ ED
Sbjct: 129 FVHRDLAARNVLVSED 144

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 68/143 (47%), Gaps = 21/143 (14%)
Query: 294 LGRGGFGKVYKGR--LADGKLVAVKRLK-EERTSGGELQFQTEVKII---SMAVHRNLLR 347
           +G G +GKV+K R     G+ VA+KR++ +    G  L    EV ++       H N++R
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 348 LYGFCTTV-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR--KKIALGSARGL 400
           L+  CT       T+  LV+ +     V   L      +P    PT   K +     RGL
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEH-----VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 401 SYLHEHCDPKIIHRDVKAANILL 423
            +LH H   +++HRD+K  NIL+
Sbjct: 134 DFLHSH---RVVHRDLKPQNILV 153

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 294 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 344
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 395
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 396 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 294 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 344
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 395
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 396 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 294 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 344
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 395
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 396 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 294 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 344
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 395
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 396 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 15/159 (9%)
Query: 280 ELQVATDGFSNKNILGRGGFGKVYKGRLAD---GKL---VAVKRLKEERTSGGELQFQTE 333
           E +V+ +  +    LG+G FG VY+G   D   G+    VAVK + E  +    ++F  E
Sbjct: 12  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 71
Query: 334 VKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWP 387
             ++      +++RL G  +     L+V   M +G + S LR      E     PP    
Sbjct: 72  ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 131
Query: 388 TRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
              ++A   A G++YL+     K +HR++ A N ++  D
Sbjct: 132 EMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHD 167

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 65/136 (47%), Gaps = 14/136 (10%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           +G+G FG V  G    G  VAVK +K + T+     F  E  +++   H NL++L G   
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLG--V 82
Query: 354 TVTEK---LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 410
            V EK    +V  YM  GS+   LR R  S+  L      K +L     + YL  +    
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGN---N 137
Query: 411 IIHRDVKAANILLDED 426
            +HRD+ A N+L+ ED
Sbjct: 138 FVHRDLAARNVLVSED 153

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 15/159 (9%)
Query: 280 ELQVATDGFSNKNILGRGGFGKVYKGRLAD---GKL---VAVKRLKEERTSGGELQFQTE 333
           E +V+ +  +    LG+G FG VY+G   D   G+    VAVK + E  +    ++F  E
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 70
Query: 334 VKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWP 387
             ++      +++RL G  +     L+V   M +G + S LR      E     PP    
Sbjct: 71  ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 130
Query: 388 TRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
              ++A   A G++YL+     K +HR++ A N ++  D
Sbjct: 131 EMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHD 166

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 283 VATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISM 339
           +  D F +  +LGRGGFG+V+  ++ A GKL A K+L ++R     G      E KI++ 
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 340 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 399
              R ++ L     T T+  LV   M  G +   +       P    P           G
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 400 LSYLHEHCDPKIIHRDVKAANILLDEDAD 428
           L +LH+     II+RD+K  N+LLD+D +
Sbjct: 302 LEHLHQR---NIIYRDLKPENVLLDDDGN 327

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 71/148 (47%), Gaps = 9/148 (6%)
Query: 278 LRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKI 336
           L+E  +  +      ++G+G FG+VY GR      VA++ +  ER +  +L+ F+ EV  
Sbjct: 25  LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMA 82
Query: 337 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 396
                H N++   G C +     ++       ++ S +R+ +     LD    ++IA   
Sbjct: 83  YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV---LDVNKTRQIAQEI 139
Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLD 424
            +G+ YLH      I+H+D+K+ N+  D
Sbjct: 140 VKGMGYLHAKG---ILHKDLKSKNVFYD 164

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 66/138 (47%), Gaps = 11/138 (7%)
Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 351
           +G+G F KV   R +  GK VAVK + + + +   LQ    EV+I  +  H N+++L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 352 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 410
             T     LV  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGR--------XKEKEARAKFRQIVSAVQYCHQKF 133
Query: 411 IIHRDVKAANILLDEDAD 428
           I+HRD+KA N+LLD D +
Sbjct: 134 IVHRDLKAENLLLDADXN 151

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 27/148 (18%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 351
           +G+G FG+V++G+   G+ VAVK    +EER+   E +    V    M  H N+L   GF
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTV----MLRHENIL---GF 63
Query: 352 CT-------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
                    T T+  LV  Y  +GS+   L     ++  +      K+AL +A GL++LH
Sbjct: 64  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLH 118
Query: 405 -----EHCDPKIIHRDVKAANILLDEDA 427
                    P I HRD+K+ NIL+ ++ 
Sbjct: 119 MEIVGTQGKPAIAHRDLKSKNILVKKNG 146

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 27/148 (18%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 351
           +G+G FG+V++G+   G+ VAVK    +EER+   E +    V    M  H N+L   GF
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTV----MLRHENIL---GF 62
Query: 352 CT-------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
                    T T+  LV  Y  +GS+   L     ++  +      K+AL +A GL++LH
Sbjct: 63  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLH 117
Query: 405 -----EHCDPKIIHRDVKAANILLDEDA 427
                    P I HRD+K+ NIL+ ++ 
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNG 145

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 294 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 344
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 395
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 396 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 291 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 282
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYL 334
Query: 408 DPK-IIHRDVKAANILLDED 426
           + K  IHR++ A N L+ E+
Sbjct: 335 EKKNFIHRNLAARNCLVGEN 354

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 283 VATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISM 339
           +  D F +  +LGRGGFG+V+  ++ A GKL A K+L ++R     G      E KI++ 
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 340 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 399
              R ++ L     T T+  LV   M  G +   +       P    P           G
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 400 LSYLHEHCDPKIIHRDVKAANILLDEDAD 428
           L +LH+     II+RD+K  N+LLD+D +
Sbjct: 302 LEHLHQR---NIIYRDLKPENVLLDDDGN 327

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 294 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 344
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 395
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 396 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 65/136 (47%), Gaps = 14/136 (10%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           +G+G FG V  G    G  VAVK +K + T+     F  E  +++   H NL++L G   
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLG--V 254
Query: 354 TVTEK---LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 410
            V EK    +V  YM  GS+   LR R  S+  L      K +L     + YL  +    
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGN---N 309
Query: 411 IIHRDVKAANILLDED 426
            +HRD+ A N+L+ ED
Sbjct: 310 FVHRDLAARNVLVSED 325

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 27/148 (18%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 351
           +G+G FG+V++G+   G+ VAVK    +EER+   E +    V    M  H N+L   GF
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTV----MLRHENIL---GF 68
Query: 352 CT-------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
                    T T+  LV  Y  +GS+   L     ++  +      K+AL +A GL++LH
Sbjct: 69  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLH 123
Query: 405 -----EHCDPKIIHRDVKAANILLDEDA 427
                    P I HRD+K+ NIL+ ++ 
Sbjct: 124 MEIVGTQGKPAIAHRDLKSKNILVKKNG 151

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 27/148 (18%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 351
           +G+G FG+V++G+   G+ VAVK    +EER+   E +    V    M  H N+L   GF
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTV----MLRHENIL---GF 65
Query: 352 CT-------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
                    T T+  LV  Y  +GS+   L     ++  +      K+AL +A GL++LH
Sbjct: 66  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLH 120
Query: 405 -----EHCDPKIIHRDVKAANILLDEDA 427
                    P I HRD+K+ NIL+ ++ 
Sbjct: 121 MEIVGTQGKPAIAHRDLKSKNILVKKNG 148

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 27/148 (18%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 351
           +G+G FG+V++G+   G+ VAVK    +EER+   E +    V    M  H N+L   GF
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTV----MLRHENIL---GF 88
Query: 352 CT-------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
                    T T+  LV  Y  +GS+   L     ++  +      K+AL +A GL++LH
Sbjct: 89  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLH 143
Query: 405 -----EHCDPKIIHRDVKAANILLDEDA 427
                    P I HRD+K+ NIL+ ++ 
Sbjct: 144 MEIVGTQGKPAIAHRDLKSKNILVKKNG 171

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 27/148 (18%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 351
           +G+G FG+V++G+   G+ VAVK    +EER+   E +    V    M  H N+L   GF
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTV----MLRHENIL---GF 101
Query: 352 CT-------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
                    T T+  LV  Y  +GS+   L     ++  +      K+AL +A GL++LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLH 156
Query: 405 -----EHCDPKIIHRDVKAANILLDEDA 427
                    P I HRD+K+ NIL+ ++ 
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNG 184

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 294 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 344
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 395
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 396 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 291 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 264 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 321
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 322 GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 373
Query: 408 DPK-IIHRDVKAANILLDED 426
           + K  IHR++ A N L+ E+
Sbjct: 374 EKKNFIHRNLAARNCLVGEN 393

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/142 (26%), Positives = 71/142 (50%), Gaps = 22/142 (15%)
Query: 292 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRL 348
           + LG G FGKV  G+    G  VAVK L  ++    ++  + + E++ + +  H ++++L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 349 YGFCTTVTEKLLVYPYMTNGSV------ASRLRERQSSLPPLDWPTRKKIALGSARGLSY 402
           Y   +T ++  +V  Y++ G +        RL E++S          +++      G+ Y
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES----------RRLFQQILSGVDY 131
Query: 403 LHEHCDPKIIHRDVKAANILLD 424
            H H    ++HRD+K  N+LLD
Sbjct: 132 CHRHM---VVHRDLKPENVLLD 150

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 69
Query: 354 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 70  VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 124
Query: 412 IHRDVKAANILLDED 426
           +HRD++AANIL+ E+
Sbjct: 125 VHRDLRAANILVGEN 139

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKIRHEKLVQLYA--- 80
Query: 354 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 412 IHRDVKAANILLDED 426
           +HRD++AANIL+ E+
Sbjct: 136 VHRDLRAANILVGEN 150

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 71
Query: 354 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 72  VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 126
Query: 412 IHRDVKAANILLDED 426
           +HRD++AANIL+ E+
Sbjct: 127 VHRDLRAANILVGEN 141

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 80
Query: 354 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVIEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 412 IHRDVKAANILLDED 426
           +HRD++AANIL+ E+
Sbjct: 136 VHRDLRAANILVGEN 150

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMS--PEAFLQEAQVMKKLRHEKLVQLYA--- 247
Query: 354 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 248 VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 302
Query: 412 IHRDVKAANILLDED 426
           +HRD++AANIL+ E+
Sbjct: 303 VHRDLRAANILVGEN 317

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 73
Query: 354 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 74  VVSEEPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERM---NY 128
Query: 412 IHRDVKAANILLDED 426
           +HRD++AANIL+ E+
Sbjct: 129 VHRDLRAANILVGEN 143

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 80
Query: 354 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVIEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 412 IHRDVKAANILLDED 426
           +HRD++AANIL+ E+
Sbjct: 136 VHRDLRAANILVGEN 150

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 70
Query: 354 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 71  VVSEEPIXIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERM---NY 125
Query: 412 IHRDVKAANILLDED 426
           +HRD++AANIL+ E+
Sbjct: 126 VHRDLRAANILVGEN 140

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 294 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 344
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 395
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 396 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 80
Query: 354 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 412 IHRDVKAANILLDED 426
           +HRD++AANIL+ E+
Sbjct: 136 VHRDLRAANILVGEN 150

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 246
Query: 354 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 247 VVSEEPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 412 IHRDVKAANILLDED 426
           +HRD++AANIL+ E+
Sbjct: 302 VHRDLRAANILVGEN 316

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 80
Query: 354 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVCEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 412 IHRDVKAANILLDED 426
           +HRD++AANIL+ E+
Sbjct: 136 VHRDLRAANILVGEN 150

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 246
Query: 354 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 247 VVSEEPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 412 IHRDVKAANILLDED 426
           +HRD++AANIL+ E+
Sbjct: 302 VHRDLRAANILVGEN 316

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 64/132 (48%), Gaps = 12/132 (9%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG+V+ G       VA+K LK    S     F  E +I+    H  L++LY    
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPE--SFLEEAQIMKKLKHDKLVQLYA--- 71
Query: 354 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
            V+E+   +V  YM  GS+   L++ +     L  P    +A   A G++Y+        
Sbjct: 72  VVSEEPIYIVTEYMNKGSLLDFLKDGEGRA--LKLPNLVDMAAQVAAGMAYIERM---NY 126
Query: 412 IHRDVKAANILL 423
           IHRD+++ANIL+
Sbjct: 127 IHRDLRSANILV 138

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 294 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 344
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS-----SLPPLDWPTRK-------KI 392
           ++ L G CT      ++  Y + G++   L+ R+      S  P   P  +         
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 186

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 294 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 344
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 395
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 396 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 150 TYQLARGMEYLASQ---KCIHRDLTARNVLVTEN 180

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 74/140 (52%), Gaps = 18/140 (12%)
Query: 292 NILGRGGFGKVYKG-RLADGKLVAVK---RLKEERTSGGELQFQTEVKI-ISMAVHRNLL 346
            +LG G FG V+KG  + +G+ + +    ++ E+++     Q  T+  + I    H +++
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYL 403
           RL G C   + + LV  Y+  GS+   +R+ + +L P   L+W       +  A+G+ YL
Sbjct: 79  RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGMYYL 131
Query: 404 HEHCDPKIIHRDVKAANILL 423
            EH    ++HR++ A N+LL
Sbjct: 132 EEH---GMVHRNLAARNVLL 148

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 294 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 344
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 395
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 396 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 155 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 185

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 294 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 344
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 395
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 396 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 152 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 182

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 74/140 (52%), Gaps = 18/140 (12%)
Query: 292 NILGRGGFGKVYKG-RLADGKLVAVK---RLKEERTSGGELQFQTEVKI-ISMAVHRNLL 346
            +LG G FG V+KG  + +G+ + +    ++ E+++     Q  T+  + I    H +++
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYL 403
           RL G C   + + LV  Y+  GS+   +R+ + +L P   L+W       +  A+G+ YL
Sbjct: 97  RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGMYYL 149
Query: 404 HEHCDPKIIHRDVKAANILL 423
            EH    ++HR++ A N+LL
Sbjct: 150 EEH---GMVHRNLAARNVLL 166

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 67/145 (46%), Gaps = 19/145 (13%)
Query: 294 LGRGGFGKVYKGR-LADGKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 351
           +G+G FG+V+K R    G+ VA+K+ L E    G  +    E+KI+ +  H N++ L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 352 CTTVTEKLLVYPY-MTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR--------GLSY 402
           C T        PY    GS+       +  L  L      K  L   +        GL Y
Sbjct: 85  CRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 139
Query: 403 LHEHCDPKIIHRDVKAANILLDEDA 427
           +H +   KI+HRD+KAAN+L+  D 
Sbjct: 140 IHRN---KILHRDMKAANVLITRDG 161

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 294 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 344
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 395
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 396 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 209 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 239

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 294 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 344
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS-----SLPPLDWPTRK-------KI 392
           ++ L G CT      ++  Y + G++   L+ R+      S  P   P  +         
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 186

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 74
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 413
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 75  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 128
Query: 414 RDVKAANILLDE 425
           R+++AANIL+ +
Sbjct: 129 RNLRAANILVSD 140

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 67/145 (46%), Gaps = 19/145 (13%)
Query: 294 LGRGGFGKVYKGR-LADGKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 351
           +G+G FG+V+K R    G+ VA+K+ L E    G  +    E+KI+ +  H N++ L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 352 CTTVTEKLLVYPY-MTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR--------GLSY 402
           C T        PY    GS+       +  L  L      K  L   +        GL Y
Sbjct: 86  CRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 403 LHEHCDPKIIHRDVKAANILLDEDA 427
           +H +   KI+HRD+KAAN+L+  D 
Sbjct: 141 IHRN---KILHRDMKAANVLITRDG 162

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 294 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 344
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-----QSSLPPLDWPTRK-------KI 392
           ++ L G CT      ++  Y + G++   L+ R     + S  P   P  +         
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 227

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 65/151 (43%), Gaps = 16/151 (10%)
Query: 283 VATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE--LQFQT--EVKII 337
           +AT  +     +G G +G VYK R    G  VA   LK  R   GE  L   T  EV ++
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVA---LKSVRVPNGEEGLPISTVREVALL 57
Query: 338 ---SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWP--TRKKI 392
                  H N++RL   C T      +   +    V   LR      PP   P  T K +
Sbjct: 58  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 117
Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 423
                RGL +LH +C   I+HRD+K  NIL+
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILV 145

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYA--- 329
Query: 354 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 330 VVSEEPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERM---NY 384
Query: 412 IHRDVKAANILLDED 426
           +HRD++AANIL+ E+
Sbjct: 385 VHRDLRAANILVGEN 399

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 66/151 (43%), Gaps = 22/151 (14%)
Query: 291 KNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 344
           K  LG G FGKV+           D  LVAVK LK+  T      FQ E ++++   H +
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEH 78
Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-QSSLPPLDWPTRK-----------KI 392
           +++ YG C      ++V+ YM +G +   LR     ++  +D   R+            I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 423
           A   A G+ YL        +HRD+   N L+
Sbjct: 139 ASQIASGMVYL---ASQHFVHRDLATRNCLV 166

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 65/151 (43%), Gaps = 16/151 (10%)
Query: 283 VATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE--LQFQT--EVKII 337
           +AT  +     +G G +G VYK R    G  VA   LK  R   GE  L   T  EV ++
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVA---LKSVRVPNGEEGLPISTVREVALL 57
Query: 338 ---SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWP--TRKKI 392
                  H N++RL   C T      +   +    V   LR      PP   P  T K +
Sbjct: 58  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 117
Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 423
                RGL +LH +C   I+HRD+K  NIL+
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILV 145

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 65/151 (43%), Gaps = 16/151 (10%)
Query: 283 VATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE--LQFQT--EVKII 337
           +AT  +     +G G +G VYK R    G  VA   LK  R   GE  L   T  EV ++
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVA---LKSVRVPNGEEGLPISTVREVALL 57
Query: 338 ---SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWP--TRKKI 392
                  H N++RL   C T      +   +    V   LR      PP   P  T K +
Sbjct: 58  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 117
Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 423
                RGL +LH +C   I+HRD+K  NIL+
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILV 145

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYA--- 246
Query: 354 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 247 VVSEEPIYIVGEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 412 IHRDVKAANILLDED 426
           +HRD++AANIL+ E+
Sbjct: 302 VHRDLRAANILVGEN 316

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 67/145 (46%), Gaps = 19/145 (13%)
Query: 294 LGRGGFGKVYKGR-LADGKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 351
           +G+G FG+V+K R    G+ VA+K+ L E    G  +    E+KI+ +  H N++ L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 352 CTTVTEKLLVYPY-MTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR--------GLSY 402
           C T        PY    GS+       +  L  L      K  L   +        GL Y
Sbjct: 86  CRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 403 LHEHCDPKIIHRDVKAANILLDEDA 427
           +H +   KI+HRD+KAAN+L+  D 
Sbjct: 141 IHRN---KILHRDMKAANVLITRDG 162

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 294 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 344
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-----QSSLPPLDWPTRK-------KI 392
           ++ L G CT      ++  Y + G++   L+ R     + S  P   P  +         
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 175

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 38/81 (46%)
Query: 112 DLYSNLFNGTIPDTLANLKQLKYLRLNNNXXXXXXXXXXXXXXXXXXXXXXNNRLSGPVP 171
           +L  N  +G+IPD + +L+ L  L L++N                      NN LSGP+P
Sbjct: 659 NLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 718
Query: 172 DNGSFSQFTPISFENNLNLCG 192
           + G F  F P  F NN  LCG
Sbjct: 719 EMGQFETFPPAKFLNNPGLCG 739

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 65/135 (48%), Gaps = 12/135 (8%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 80
Query: 354 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 412 IHRDVKAANILLDED 426
           +HRD+ AANIL+ E+
Sbjct: 136 VHRDLAAANILVGEN 150

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 294 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 344
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-----QSSLPPLDWPTRK-------KI 392
           ++ L G CT      ++  Y + G++   L+ R     + S  P   P  +         
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 179

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 79/175 (45%), Gaps = 29/175 (16%)
Query: 270 LGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRL---ADG---KLVAVKRLKEERT 323
           + Q K+  L+E+ ++   F  +  LG   FGKVYKG L   A G   + VA+K LK++  
Sbjct: 12  INQHKQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE 69
Query: 324 SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL--------- 374
                +F+ E  + +   H N++ L G  T      +++ Y ++G +   L         
Sbjct: 70  GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDV 129
Query: 375 ------RERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 423
                 R  +S+L P   P    +    A G+ YL  H    ++H+D+   N+L+
Sbjct: 130 GSTDDDRTVKSALEP---PDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV 178

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 294 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 344
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-----QSSLPPLDWPTRK-------KI 392
           ++ L G CT      ++  Y + G++   L+ R     + S  P   P  +         
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 178

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 65/140 (46%), Gaps = 12/140 (8%)
Query: 292 NILGRGGFGKVYK-GRLADGKLVAVKRLK--EERTSGGELQFQTEVKIISMAVHRNLLRL 348
            +LG+G FG+  K      G+++ +K L   +E T   +  F  EVK++    H N+L+ 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEET---QRTFLKEVKVMRCLEHPNVLKF 72
Query: 349 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 408
            G          +  Y+  G++   ++   S  P   W  R   A   A G++YLH    
Sbjct: 73  IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYP---WSQRVSFAKDIASGMAYLHSM-- 127
Query: 409 PKIIHRDVKAANILLDEDAD 428
             IIHRD+ + N L+ E+ +
Sbjct: 128 -NIIHRDLNSHNCLVRENKN 146

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 294 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 344
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-----QSSLPPLDWPTRK-------KI 392
           ++ L G CT      ++  Y + G++   L+ R     + S  P   P  +         
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 186

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 38/81 (46%)
Query: 112 DLYSNLFNGTIPDTLANLKQLKYLRLNNNXXXXXXXXXXXXXXXXXXXXXXNNRLSGPVP 171
           +L  N  +G+IPD + +L+ L  L L++N                      NN LSGP+P
Sbjct: 662 NLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721
Query: 172 DNGSFSQFTPISFENNLNLCG 192
           + G F  F P  F NN  LCG
Sbjct: 722 EMGQFETFPPAKFLNNPGLCG 742

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 67/139 (48%), Gaps = 11/139 (7%)
Query: 291 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRL 348
           +  +G+G F KV   R +  G+ VAVK + + + +   LQ    EV+I+ +  H N+++L
Sbjct: 20  QKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 349 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 408
           +    T     LV  Y + G V   L              ++K A    R +    ++C 
Sbjct: 80  FEVIETEKTLYLVMEYASGGEVFDYLVAHGR--------MKEKEARAKFRQIVSAVQYCH 131
Query: 409 PK-IIHRDVKAANILLDED 426
            K I+HRD+KA N+LLD D
Sbjct: 132 QKYIVHRDLKAENLLLDGD 150

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 65/135 (48%), Gaps = 12/135 (8%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 80
Query: 354 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
            V+E+   +V  YM+ G +   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVMEYMSKGCLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 412 IHRDVKAANILLDED 426
           +HRD++AANIL+ E+
Sbjct: 136 VHRDLRAANILVGEN 150

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 70/154 (45%), Gaps = 24/154 (15%)
Query: 294 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 344
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ---------SSLPPLDWPTRKKI--- 392
           ++ L G CT      ++  Y + G++   L+ R+          S  P +  + K +   
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 171

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 351
           +G+G F KV   R +  G+ VA+K + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 352 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 410
             T     L+  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGR--------MKEKEARSKFRQIVSAVQYCHQKR 134
Query: 411 IIHRDVKAANILLDEDAD 428
           I+HRD+KA N+LLD D +
Sbjct: 135 IVHRDLKAENLLLDADMN 152

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FGKVYK +  +   +A  ++ E ++      +  E++I++   H  +++L G   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 413
              +  ++  +   G+V + + E    L     P  + +       L++LH     +IIH
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTE---PQIQVVCRQMLEALNFLHSK---RIIH 132
Query: 414 RDVKAANILLDEDAD 428
           RD+KA N+L+  + D
Sbjct: 133 RDLKAGNVLMTLEGD 147

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 70/154 (45%), Gaps = 24/154 (15%)
Query: 294 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 344
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ---------SSLPPLDWPTRKKI--- 392
           ++ L G CT      ++  Y + G++   L+ R+          S  P +  + K +   
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 186

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 65/135 (48%), Gaps = 12/135 (8%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 80
Query: 354 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
            V+E+   +V  YM+ G +   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVTEYMSKGCLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 412 IHRDVKAANILLDED 426
           +HRD++AANIL+ E+
Sbjct: 136 VHRDLRAANILVGEN 150

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 65/135 (48%), Gaps = 12/135 (8%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 77
Query: 354 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
            V+E+   +V  YM  GS+   L+        L  P    ++   A G++Y+        
Sbjct: 78  VVSEEPIYIVTEYMNKGSLLDFLKGETGKY--LRLPQLVDMSAQIASGMAYVERM---NY 132
Query: 412 IHRDVKAANILLDED 426
           +HRD++AANIL+ E+
Sbjct: 133 VHRDLRAANILVGEN 147

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 351
           +G+G F KV   R +  G+ VA+K + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 352 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 410
             T     L+  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGR--------MKEKEARSKFRQIVSAVQYCHQKR 131
Query: 411 IIHRDVKAANILLDEDAD 428
           I+HRD+KA N+LLD D +
Sbjct: 132 IVHRDLKAENLLLDADMN 149

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 65/142 (45%), Gaps = 19/142 (13%)
Query: 294 LGRGGFGKVY-----KGRLADGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLL 346
           LG G FGKV            G++VAVK LKE    G +L+  +Q E++I+    H +++
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKE--GCGPQLRSGWQREIEILRTLYHEHIV 73
Query: 347 RLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
           +  G C    EK   LV  Y+  GS+   L      L  L        A     G++YLH
Sbjct: 74  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICEGMAYLH 128
Query: 405 EHCDPKIIHRDVKAANILLDED 426
                  IHR + A N+LLD D
Sbjct: 129 AQ---HYIHRALAARNVLLDND 147

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 65/135 (48%), Gaps = 12/135 (8%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 77
Query: 354 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
            V+E+   +V  YM  GS+   L+        L  P    ++   A G++Y+        
Sbjct: 78  VVSEEPIYIVTEYMNKGSLLDFLKGETGKY--LRLPQLVDMSAQIASGMAYVERM---NY 132
Query: 412 IHRDVKAANILLDED 426
           +HRD++AANIL+ E+
Sbjct: 133 VHRDLRAANILVGEN 147

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 65/142 (45%), Gaps = 19/142 (13%)
Query: 294 LGRGGFGKVY-----KGRLADGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLL 346
           LG G FGKV            G++VAVK LKE    G +L+  +Q E++I+    H +++
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKE--GCGPQLRSGWQREIEILRTLYHEHIV 74
Query: 347 RLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
           +  G C    EK   LV  Y+  GS+   L      L  L        A     G++YLH
Sbjct: 75  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICEGMAYLH 129
Query: 405 EHCDPKIIHRDVKAANILLDED 426
                  IHR + A N+LLD D
Sbjct: 130 AQ---HYIHRALAARNVLLDND 148

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 63/140 (45%), Gaps = 24/140 (17%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G  G+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--------ARGLSYLHE 405
                 ++  YM NGS+   L+           P+  K+ +          A G++++ E
Sbjct: 79  Q-EPIYIITEYMENGSLVDFLKT----------PSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 406 HCDPKIIHRDVKAANILLDE 425
                 IHRD++AANIL+ +
Sbjct: 128 R---NYIHRDLRAANILVSD 144

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 70/136 (51%), Gaps = 10/136 (7%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 352
           +G G +G VYK + + G++VA+KR++ +    G       E+ ++    H N++ L    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS-ARGLSYLHEHCDPKI 411
            +     LV+ +M    +   L E ++ L      ++ KI L    RG+++ H+H   +I
Sbjct: 89  HSERCLTLVFEFMEK-DLKKVLDENKTGLQ----DSQIKIYLYQLLRGVAHCHQH---RI 140
Query: 412 IHRDVKAANILLDEDA 427
           +HRD+K  N+L++ D 
Sbjct: 141 LHRDLKPQNLLINSDG 156

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 69/144 (47%), Gaps = 17/144 (11%)
Query: 294 LGRGGFGKVYKGR-LADGKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 351
           +G+G FG+V+K R    G+ VA+K+ L E    G  +    E+KI+ +  H N++ L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 352 CTTVTEKL--------LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           C T             LV+ +  +  +A  L    + L        K++      GL Y+
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEH-DLAGLL---SNVLVKFTLSEIKRVMQMLLNGLYYI 141
Query: 404 HEHCDPKIIHRDVKAANILLDEDA 427
           H +   KI+HRD+KAAN+L+  D 
Sbjct: 142 HRN---KILHRDMKAANVLITRDG 162

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 70/136 (51%), Gaps = 10/136 (7%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 352
           +G G +G VYK + + G++VA+KR++ +    G       E+ ++    H N++ L    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS-ARGLSYLHEHCDPKI 411
            +     LV+ +M    +   L E ++ L      ++ KI L    RG+++ H+H   +I
Sbjct: 89  HSERCLTLVFEFMEK-DLKKVLDENKTGLQ----DSQIKIYLYQLLRGVAHCHQH---RI 140
Query: 412 IHRDVKAANILLDEDA 427
           +HRD+K  N+L++ D 
Sbjct: 141 LHRDLKPQNLLINSDG 156

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FGKVYK +  +   +A  ++ E ++      +  E++I++   H  +++L G   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 413
              +  ++  +   G+V + + E    L     P  + +       L++LH     +IIH
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTE---PQIQVVCRQMLEALNFLHSK---RIIH 140
Query: 414 RDVKAANILLDEDAD 428
           RD+KA N+L+  + D
Sbjct: 141 RDLKAGNVLMTLEGD 155

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 18/155 (11%)
Query: 277 SLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVK 335
            L E     D   ++ +LG+G +G VY GR L++   +A+K +  ER S        E+ 
Sbjct: 13  DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP-ERDSRYSQPLHEEIA 71
Query: 336 IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN---GSVASRLRERQSSLPPLDWPTRKKI 392
           +     H+N+++  G   + +E   +  +M     GS+++ LR +   L        + I
Sbjct: 72  LHKHLKHKNIVQYLG---SFSENGFIKIFMEQVPGGSLSALLRSKWGPLK----DNEQTI 124
Query: 393 ALGSAR---GLSYLHEHCDPKIIHRDVKAANILLD 424
              + +   GL YLH   D +I+HRD+K  N+L++
Sbjct: 125 GFYTKQILEGLKYLH---DNQIVHRDIKGDNVLIN 156

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 72/158 (45%), Gaps = 31/158 (19%)
Query: 293 ILGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNL 345
           +LG G FGKV         +      VAVK LKE+  S       +E+K+++ +  H N+
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 346 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS--SLPPLDWPTRKKI----------- 392
           + L G CT      L++ Y   G + + LR ++   S   +++  +K++           
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 393 ------ALGSARGLSYLH-EHCDPKIIHRDVKAANILL 423
                 A   A+G+ +L  + C    +HRD+ A N+L+
Sbjct: 172 EDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLV 205

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 61/140 (43%), Gaps = 15/140 (10%)
Query: 294 LGRGGFGKVY-----KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           LG G FGKV            G++VAVK LK +        ++ E+ I+    H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 349 YGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
            G C    EK   LV  Y+  GS+   L      L  L        A     G++YLH  
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHSQ 136
Query: 407 CDPKIIHRDVKAANILLDED 426
                IHR++ A N+LLD D
Sbjct: 137 ---HYIHRNLAARNVLLDND 153

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 66/151 (43%), Gaps = 13/151 (8%)
Query: 283 VATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVK--RLKEERTSGGELQFQT--EVKII 337
           +AT  +     +G G +G VYK R    G  VA+K  R+      GG L   T  EV ++
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 338 ---SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWP--TRKKI 392
                  H N++RL   C T      +   +    V   LR      PP   P  T K +
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 423
                RGL +LH +C   I+HRD+K  NIL+
Sbjct: 126 MRQFLRGLDFLHANC---IVHRDLKPENILV 153

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 67/140 (47%), Gaps = 13/140 (9%)
Query: 294 LGRGGFGKVYKGRLA-----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           LG G FGKV   R        G+ VAVK LK E         + E++I+    H N+++ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 349 YGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
            G CT        L+  ++ +GS+   L + ++    ++   + K A+   +G+ YL   
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYLGSR 133
Query: 407 CDPKIIHRDVKAANILLDED 426
              + +HRD+ A N+L++ +
Sbjct: 134 ---QYVHRDLAARNVLVESE 150

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 74/152 (48%), Gaps = 18/152 (11%)
Query: 280 ELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS 338
           E     D   ++ +LG+G +G VY GR L++   +A+K +  ER S        E+ +  
Sbjct: 2   EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP-ERDSRYSQPLHEEIALHK 60
Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTN---GSVASRLRERQSSLPPLDWPTRKKIALG 395
              H+N+++  G   + +E   +  +M     GS+++ LR +   L        + I   
Sbjct: 61  HLKHKNIVQYLG---SFSENGFIKIFMEQVPGGSLSALLRSKWGPLK----DNEQTIGFY 113
Query: 396 SAR---GLSYLHEHCDPKIIHRDVKAANILLD 424
           + +   GL YLH   D +I+HRD+K  N+L++
Sbjct: 114 TKQILEGLKYLH---DNQIVHRDIKGDNVLIN 142

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 61/140 (43%), Gaps = 15/140 (10%)
Query: 294 LGRGGFGKVY-----KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           LG G FGKV            G++VAVK LK +        ++ E+ I+    H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 349 YGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
            G C    EK   LV  Y+  GS+   L      L  L        A     G++YLH  
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHAQ 136
Query: 407 CDPKIIHRDVKAANILLDED 426
                IHR++ A N+LLD D
Sbjct: 137 ---HYIHRNLAARNVLLDND 153

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 78/170 (45%), Gaps = 23/170 (13%)
Query: 265 DSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS 324
           DS L L ++K   +   +V T    +  ++G+G FG VY G   D     ++   +  + 
Sbjct: 4   DSAL-LAEVKDVLIPHERVVT---HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR 59
Query: 325 GGELQ----FQTEVKIISMAVHRNLLRLYGFCTTVTEKL--LVYPYMTNGSVASRLRERQ 378
             E+Q    F  E  ++    H N+L L G      E L  ++ PYM +G +   +R  Q
Sbjct: 60  ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP-PEGLPHVLLPYMCHGDLLQFIRSPQ 118
Query: 379 SSLPPLDWPTRKKI---ALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 425
            +      PT K +    L  ARG+ YL E    K +HRD+ A N +LDE
Sbjct: 119 RN------PTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDE 159

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 67/140 (47%), Gaps = 13/140 (9%)
Query: 294 LGRGGFGKVYKGRLA-----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           LG G FGKV   R        G+ VAVK LK E         + E++I+    H N+++ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 349 YGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
            G CT        L+  ++ +GS+   L + ++    ++   + K A+   +G+ YL   
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYLGSR 145
Query: 407 CDPKIIHRDVKAANILLDED 426
              + +HRD+ A N+L++ +
Sbjct: 146 ---QYVHRDLAARNVLVESE 162

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 59/138 (42%), Gaps = 10/138 (7%)
Query: 286 DGFSNKNILGRGGFGKVYKGRLADGK-LVAVKRL--KEERTSGGELQFQTEVKIISMAVH 342
           D F     LG+G FG VY  R      +VA+K L   +    G E Q + E++I +   H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 402
            N+LRLY +        L+  Y   G +   L++  +     D      I    A  L Y
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCT----FDEQRTATIMEELADALMY 138
Query: 403 LHEHCDPKIIHRDVKAAN 420
            H     K+IHRD+K  N
Sbjct: 139 CH---GKKVIHRDIKPEN 153

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 71/146 (48%), Gaps = 25/146 (17%)
Query: 292 NILGRGGFGKVYKGRLADGKLVAVKRLK-EERTSGGELQFQTEVKIISMA--VHRNLLRL 348
            +  RG FG V+K +L + + VAVK    +++ S     +Q E ++ S+    H N+L+ 
Sbjct: 30  EVKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQS-----WQNEYEVYSLPGMKHENILQF 83
Query: 349 YGF---CTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
            G     T+V   L L+  +   GS++  L+    S     W     IA   ARGL+YLH
Sbjct: 84  IGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVS-----WNELCHIAETMARGLAYLH 138
Query: 405 EHC-------DPKIIHRDVKAANILL 423
           E          P I HRD+K+ N+LL
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLL 164

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 72/144 (50%), Gaps = 11/144 (7%)
Query: 289 SNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
           S   ILG G FG+V+K    A G  +A K +K       E + + E+ +++   H NL++
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE-EVKNEISVMNQLDHANLIQ 150
Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPT-RKKIALGSARGLSYLHEH 406
           LY    +  + +LV  Y+  G +  R+ +   +L  LD     K+I      G+ ++H+ 
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQI----CEGIRHMHQM 206
Query: 407 CDPKIIHRDVKAANIL-LDEDADQ 429
               I+H D+K  NIL ++ DA Q
Sbjct: 207 Y---ILHLDLKPENILCVNRDAKQ 227

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 76/174 (43%), Gaps = 34/174 (19%)
Query: 271 GQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRL---ADG---KLVAVKRLKEERTS 324
           G+LK  SL  ++   +       LG   FGKVYKG L   A G   + VA+K LK++   
Sbjct: 1   GKLKEISLSAVRFMEE-------LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG 53
Query: 325 GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL---------- 374
               +F+ E  + +   H N++ L G  T      +++ Y ++G +   L          
Sbjct: 54  PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVG 113
Query: 375 -----RERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 423
                R  +S+L P   P    +    A G+ YL  H    ++H+D+   N+L+
Sbjct: 114 STDDDRTVKSALEP---PDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV 161

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 22/165 (13%)
Query: 278 LRELQVATDGFSNKNILGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGELQ-FQT 332
           L ++ +    F+   +LG+G FG V + +L   DG  V  AVK LK +  +  +++ F  
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 333 EVKIISMAVHRNLLRLYGFCTTVTEK------LLVYPYMTNGSV-----ASRLRERQSSL 381
           E   +    H ++ +L G       K      +++ P+M +G +     ASR+ E   +L
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 382 PPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           P     T  +  +  A G+ YL        IHRD+ A N +L ED
Sbjct: 135 P---LQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED 173

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 66/143 (46%), Gaps = 16/143 (11%)
Query: 294 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 346
           LG G FGKV +         D  L VAVK LK    +  +    +E+KI+S +  H N++
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRER------QSSLPPLDWPTRKKIALGSARGL 400
            L G CT     L++  Y   G + + LR +      +    PL+       +   A+G+
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 165
Query: 401 SYLHEHCDPKIIHRDVKAANILL 423
           ++L        IHRDV A N+LL
Sbjct: 166 AFL---ASKNCIHRDVAARNVLL 185

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 72/146 (49%), Gaps = 8/146 (5%)
Query: 284 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 341
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           H N+++L     T  +  LV+ ++   S+  +     S+L  +  P  K       +GL+
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 402 YLHEHCDPKIIHRDVKAANILLDEDA 427
           + H H   +++HRD+K  N+L++ + 
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEG 141

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 72/146 (49%), Gaps = 8/146 (5%)
Query: 284 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 341
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           H N+++L     T  +  LV+ ++   S+  +     S+L  +  P  K       +GL+
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 402 YLHEHCDPKIIHRDVKAANILLDEDA 427
           + H H   +++HRD+K  N+L++ + 
Sbjct: 121 FCHSH---RVLHRDLKPENLLINTEG 143

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 60/130 (46%), Gaps = 8/130 (6%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG+V+         VAVK +K    S     F  E  ++    H  L++L+   T
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE--AFLAEANVMKTLQHDKLVKLHAVVT 80
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 413
                 ++  +M  GS+   L+  + S  PL  P     +   A G++++ +      IH
Sbjct: 81  K-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NYIH 134
Query: 414 RDVKAANILL 423
           RD++AANIL+
Sbjct: 135 RDLRAANILV 144

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 72/146 (49%), Gaps = 8/146 (5%)
Query: 284 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 341
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           H N+++L     T  +  LV+ ++   S+  +     S+L  +  P  K       +GL+
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 402 YLHEHCDPKIIHRDVKAANILLDEDA 427
           + H H   +++HRD+K  N+L++ + 
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEG 143

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 66/143 (46%), Gaps = 16/143 (11%)
Query: 294 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 346
           LG G FGKV +         D  L VAVK LK    +  +    +E+KI+S +  H N++
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRER------QSSLPPLDWPTRKKIALGSARGL 400
            L G CT     L++  Y   G + + LR +      +    PL+       +   A+G+
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 173
Query: 401 SYLHEHCDPKIIHRDVKAANILL 423
           ++L        IHRDV A N+LL
Sbjct: 174 AFL---ASKNCIHRDVAARNVLL 193

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 72/146 (49%), Gaps = 8/146 (5%)
Query: 284 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 341
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           H N+++L     T  +  LV+ ++   S+  +     S+L  +  P  K       +GL+
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 402 YLHEHCDPKIIHRDVKAANILLDEDA 427
           + H H   +++HRD+K  N+L++ + 
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEG 142

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 68/149 (45%), Gaps = 22/149 (14%)
Query: 294 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 346
           LG G FGKV +         D  L VAVK LK    +  +    +E+KI+S +  H N++
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ----------SSLPPLDWPTRKKIALGS 396
            L G CT     L++  Y   G + + LR ++          S  P     +R  +   S
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSS 173
Query: 397 --ARGLSYLHEHCDPKIIHRDVKAANILL 423
             A+G+++L        IHRDV A N+LL
Sbjct: 174 QVAQGMAFL---ASKNCIHRDVAARNVLL 199

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/136 (25%), Positives = 68/136 (50%), Gaps = 8/136 (5%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQT-EVKIISMAVHRNLLRLYGFC 352
           +G G +G VYK +   G+  A+K+++ E+   G       E+ I+    H N+++LY   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 412
            T    +LV+ ++ +  +   L   +  L  +   T K   L    G++Y H   D +++
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLDVCEGGLESV---TAKSFLLQLLNGIAYCH---DRRVL 122
Query: 413 HRDVKAANILLDEDAD 428
           HRD+K  N+L++ + +
Sbjct: 123 HRDLKPQNLLINREGE 138

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/136 (25%), Positives = 68/136 (50%), Gaps = 8/136 (5%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQT-EVKIISMAVHRNLLRLYGFC 352
           +G G +G VYK +   G+  A+K+++ E+   G       E+ I+    H N+++LY   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 412
            T    +LV+ ++ +  +   L   +  L  +   T K   L    G++Y H   D +++
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLDVCEGGLESV---TAKSFLLQLLNGIAYCH---DRRVL 122
Query: 413 HRDVKAANILLDEDAD 428
           HRD+K  N+L++ + +
Sbjct: 123 HRDLKPQNLLINREGE 138

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 59/140 (42%), Gaps = 15/140 (10%)
Query: 294 LGRGGFGKVY-----KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           LG G FGKV            G++VAVK LK +        ++ E+ I+    H ++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 349 YGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
            G C         LV  Y+  GS+   L      L  L        A     G++YLH  
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHAQ 153
Query: 407 CDPKIIHRDVKAANILLDED 426
                IHRD+ A N+LLD D
Sbjct: 154 ---HYIHRDLAARNVLLDND 170

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/136 (25%), Positives = 68/136 (50%), Gaps = 8/136 (5%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQT-EVKIISMAVHRNLLRLYGFC 352
           +G G +G VYK +   G+  A+K+++ E+   G       E+ I+    H N+++LY   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 412
            T    +LV+ ++ +  +   L   +  L  +   T K   L    G++Y H   D +++
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLDVCEGGLESV---TAKSFLLQLLNGIAYCH---DRRVL 122
Query: 413 HRDVKAANILLDEDAD 428
           HRD+K  N+L++ + +
Sbjct: 123 HRDLKPQNLLINREGE 138

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 67/146 (45%), Gaps = 23/146 (15%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           +G+G +G+V+ G+   G+ VAVK      T       +TE+    +  H N+L   GF  
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFT--TEEASWFRETEIYQTVLMRHENIL---GFIA 98
Query: 354 -------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
                  + T+  L+  Y  NGS+   L+        LD  +  K+A  S  GL +LH  
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-----LDAKSMLKLAYSSVSGLCHLHTE 153
Query: 407 C-----DPKIIHRDVKAANILLDEDA 427
                  P I HRD+K+ NIL+ ++ 
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNG 179

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 60/130 (46%), Gaps = 8/130 (6%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG+V+         VAVK +K    S     F  E  ++    H  L++L+   T
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE--AFLAEANVMKTLQHDKLVKLHAVVT 247
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 413
                 ++  +M  GS+   L+  + S  PL  P     +   A G++++ +      IH
Sbjct: 248 K-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NYIH 301
Query: 414 RDVKAANILL 423
           RD++AANIL+
Sbjct: 302 RDLRAANILV 311

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 60/130 (46%), Gaps = 8/130 (6%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           LG G FG+V+         VAVK +K    S     F  E  ++    H  L++L+   T
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE--AFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 413
                 ++  +M  GS+   L+  + S  PL  P     +   A G++++ +      IH
Sbjct: 254 K-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NYIH 307
Query: 414 RDVKAANILL 423
           RD++AANIL+
Sbjct: 308 RDLRAANILV 317

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 68/138 (49%), Gaps = 17/138 (12%)
Query: 293 ILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           ILG G FG+VY+G   + K     VAVK  K++ T   + +F +E  I+    H ++++L
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 349 YGFCTTVTEKLLV--YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE- 405
            G        +++  YPY   G +   L   ++SL  L   T    +L   + ++YL   
Sbjct: 75  IGIIEEEPTWIIMELYPY---GELGHYLERNKNSLKVL---TLVLYSLQICKAMAYLESI 128
Query: 406 HCDPKIIHRDVKAANILL 423
           +C    +HRD+   NIL+
Sbjct: 129 NC----VHRDIAVRNILV 142

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 69/148 (46%), Gaps = 22/148 (14%)
Query: 294 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 346
           LG G FGKV +         D  L VAVK LK    +  +    +E+KI+S +  H N++
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLD---------WPTRKKIALGS- 396
            L G CT     L++  Y   G + + LR R+S +   D           TR  +   S 
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLR-RKSRVLETDPAFAIANSTLSTRDLLHFSSQ 172
Query: 397 -ARGLSYLHEHCDPKIIHRDVKAANILL 423
            A+G+++L        IHRDV A N+LL
Sbjct: 173 VAQGMAFL---ASKNCIHRDVAARNVLL 197

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 80/161 (49%), Gaps = 20/161 (12%)
Query: 283 VATDGFSNKNILGRGGFGKVY------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKI 336
           + +D +  + +LG+G FG+V        G+    K+++ +++K++      L+   EV++
Sbjct: 29  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR---EVQL 85
Query: 337 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL--RERQSSLPPLDWPTRKKIAL 394
           +    H N+++LY F        LV    T G +   +  R+R S +         +I  
Sbjct: 86  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA------RIIR 139
Query: 395 GSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL 435
               G++Y+H++   KI+HRD+K  N+LL+  +  ++  I+
Sbjct: 140 QVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRII 177

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 10/134 (7%)
Query: 294 LGRGGFGKVYKGR--LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 351
           LG G +  VYKG+  L D  LVA+K ++ E   G       EV ++    H N++ L+  
Sbjct: 10  LGEGTYATVYKGKSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 352 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
             T     LV+ Y+ +  +   L +  +    ++    K       RGL+Y H     K+
Sbjct: 69  IHTEKSLTLVFEYL-DKDLKQYLDDCGNI---INMHNVKLFLFQLLRGLAYCHRQ---KV 121
Query: 412 IHRDVKAANILLDE 425
           +HRD+K  N+L++E
Sbjct: 122 LHRDLKPQNLLINE 135

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 69/148 (46%), Gaps = 22/148 (14%)
Query: 294 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 346
           LG G FGKV +         D  L VAVK LK    +  +    +E+KI+S +  H N++
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLD---------WPTRKKIALGS- 396
            L G CT     L++  Y   G + + LR R+S +   D           TR  +   S 
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLR-RKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 397 -ARGLSYLHEHCDPKIIHRDVKAANILL 423
            A+G+++L        IHRDV A N+LL
Sbjct: 173 VAQGMAFL---ASKNCIHRDVAARNVLL 197

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 68/138 (49%), Gaps = 17/138 (12%)
Query: 293 ILGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           ILG G FG+VY+G   + K     VAVK  K++ T   + +F +E  I+    H ++++L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 349 YGFCTTVTEKLLV--YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE- 405
            G        +++  YPY   G +   L   ++SL  L   T    +L   + ++YL   
Sbjct: 79  IGIIEEEPTWIIMELYPY---GELGHYLERNKNSLKVL---TLVLYSLQICKAMAYLESI 132
Query: 406 HCDPKIIHRDVKAANILL 423
           +C    +HRD+   NIL+
Sbjct: 133 NC----VHRDIAVRNILV 146

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 343
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GLS+ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLSFC 119
Query: 404 HEHCDPKIIHRDVKAANILLDEDA 427
           H H   +++HRD+K  N+L++ + 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEG 140

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 68/138 (49%), Gaps = 17/138 (12%)
Query: 293 ILGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           ILG G FG+VY+G   + K     VAVK  K++ T   + +F +E  I+    H ++++L
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 349 YGFCTTVTEKLLV--YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE- 405
            G        +++  YPY   G +   L   ++SL  L   T    +L   + ++YL   
Sbjct: 91  IGIIEEEPTWIIMELYPY---GELGHYLERNKNSLKVL---TLVLYSLQICKAMAYLESI 144
Query: 406 HCDPKIIHRDVKAANILL 423
           +C    +HRD+   NIL+
Sbjct: 145 NC----VHRDIAVRNILV 158

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 77/162 (47%), Gaps = 29/162 (17%)
Query: 281 LQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLK--EERTSGGELQFQTEVKII 337
           L+ A+D F    +LG+G FG+V K R A D +  A+K+++  EE+ S       +EV ++
Sbjct: 2   LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS----TILSEVMLL 56
Query: 338 SMAVHRNLLRLYGFC----------TTVTEKLLVY---PYMTNGSVASRLR-ERQSSLPP 383
           +   H+ ++R Y             T V +K  ++    Y  NG++   +  E  +    
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116
Query: 384 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 425
             W   ++I       LSY+H      IIHRD+K  NI +DE
Sbjct: 117 EYWRLFRQIL----EALSYIHSQG---IIHRDLKPMNIFIDE 151

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 75/150 (50%), Gaps = 20/150 (13%)
Query: 283 VATDGFSNKNILGRGGFGKVY------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKI 336
           + +D +  + +LG+G FG+V        G+    K+++ +++K++      L+   EV++
Sbjct: 23  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR---EVQL 79
Query: 337 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL--RERQSSLPPLDWPTRKKIAL 394
           +    H N+++LY F        LV    T G +   +  R+R S +         +I  
Sbjct: 80  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA------ARIIR 133
Query: 395 GSARGLSYLHEHCDPKIIHRDVKAANILLD 424
               G++Y+H++   KI+HRD+K  N+LL+
Sbjct: 134 QVLSGITYMHKN---KIVHRDLKPENLLLE 160

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 77/146 (52%), Gaps = 15/146 (10%)
Query: 294 LGRGGFGKVYKG---RLAD-GKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 345
           LG+G F K++KG    + D G+L    V +K L +   +  E  F+    ++S   H++L
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEA-ASMMSKLSHKHL 74
Query: 346 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 405
           +  YG C    E +LV  ++  GS+ + L++ ++ +  L W  + ++A   A  + +L E
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINIL-W--KLEVAKQLAAAMHFLEE 131
Query: 406 HCDPKIIHRDVKAANILLDEDADQSS 431
           +    +IH +V A NILL  + D+ +
Sbjct: 132 NT---LIHGNVCAKNILLIREEDRKT 154

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEE---RTSGGELQFQTEVKII 337
           ++  D F    +LG+G FGKV   R+ + G L AVK LK++   +    E    TE +I+
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM-TEKRIL 77
Query: 338 SMAVHRNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 396
           S+A +   L     C    ++L  V  ++  G +   +++ +      D    +  A   
Sbjct: 78  SLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR----FDEARARFYAAEI 133
Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLDEDA 427
              L +LH   D  II+RD+K  N+LLD + 
Sbjct: 134 ISALMFLH---DKGIIYRDLKLDNVLLDHEG 161

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 72/149 (48%), Gaps = 12/149 (8%)
Query: 283 VATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMA 340
           V  + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++   
Sbjct: 4   VDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 341 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSAR 398
            H N+++L     T  +  LV+ ++        L++    S+L  +  P  K       +
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 118
Query: 399 GLSYLHEHCDPKIIHRDVKAANILLDEDA 427
           GL++ H H   +++HRD+K  N+L++ + 
Sbjct: 119 GLAFCHSH---RVLHRDLKPQNLLINTEG 144

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/148 (24%), Positives = 72/148 (48%), Gaps = 12/148 (8%)
Query: 284 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 341
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARG 399
           H N+++L     T  +  LV+ ++        L++    S+L  +  P  K       +G
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKDFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 400 LSYLHEHCDPKIIHRDVKAANILLDEDA 427
           L++ H H   +++HRD+K  N+L++ + 
Sbjct: 116 LAFCHSH---RVLHRDLKPENLLINTEG 140

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 284 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 341
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KTFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 402 YLHEHCDPKIIHRDVKAANILLDEDA 427
           + H H   +++HRD+K  N+L++ + 
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEG 143

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 70/143 (48%), Gaps = 19/143 (13%)
Query: 291 KNILGRGGFGKV-----YKGRLADGKLVAVKRLKEE--RTSGGELQFQTEVKIISMAVHR 343
           +  LG G FGKV     YK +    + VA+K +  +  + S   ++ + E+  + +  H 
Sbjct: 14  RETLGEGSFGKVKLATHYKTQ----QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           ++++LY   TT T+ ++V  Y   G +   + E++     +     ++        + Y 
Sbjct: 70  HIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKR----MTEDEGRRFFQQIICAIEYC 124
Query: 404 HEHCDPKIIHRDVKAANILLDED 426
           H H   KI+HRD+K  N+LLD++
Sbjct: 125 HRH---KIVHRDLKPENLLLDDN 144

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 30/160 (18%)
Query: 294 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 352
           +G G  G V    + + GKLVAVK++   +    EL F  EV I+    H N++ +Y   
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 86
Query: 353 TTVTEKLLVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
               E  +V  ++  G++      +R+ E Q +           + L   + LS LH   
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----------AVCLAVLQALSVLHAQG 136
Query: 408 DPKIIHRDVKAANILLDEDA----------DQSSKTILRR 437
              +IHRD+K+ +ILL  D            Q SK + RR
Sbjct: 137 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 173

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 30/160 (18%)
Query: 294 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 352
           +G G  G V    + + GKLVAVK++   +    EL F  EV I+    H N++ +Y   
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 95
Query: 353 TTVTEKLLVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
               E  +V  ++  G++      +R+ E Q +           + L   + LS LH   
Sbjct: 96  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----------AVCLAVLQALSVLHAQG 145
Query: 408 DPKIIHRDVKAANILLDEDA----------DQSSKTILRR 437
              +IHRD+K+ +ILL  D            Q SK + RR
Sbjct: 146 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 182

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 30/160 (18%)
Query: 294 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 352
           +G G  G V    + + GKLVAVK++   +    EL F  EV I+    H N++ +Y   
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 90
Query: 353 TTVTEKLLVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
               E  +V  ++  G++      +R+ E Q +           + L   + LS LH   
Sbjct: 91  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----------AVCLAVLQALSVLHAQG 140
Query: 408 DPKIIHRDVKAANILLDEDA----------DQSSKTILRR 437
              +IHRD+K+ +ILL  D            Q SK + RR
Sbjct: 141 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 177

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 63/136 (46%), Gaps = 14/136 (10%)
Query: 294 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I +M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFY 71
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 410 KIIHRDVKAANILLDE 425
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/148 (24%), Positives = 72/148 (48%), Gaps = 12/148 (8%)
Query: 284 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 341
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARG 399
           H N+++L     T  +  LV+ ++        L++    S+L  +  P  K       +G
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 400 LSYLHEHCDPKIIHRDVKAANILLDEDA 427
           L++ H H   +++HRD+K  N+L++ + 
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEG 140

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 30/160 (18%)
Query: 294 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 352
           +G G  G V    + + GKLVAVK++   +    EL F  EV I+    H N++ +Y   
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 97
Query: 353 TTVTEKLLVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
               E  +V  ++  G++      +R+ E Q +           + L   + LS LH   
Sbjct: 98  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----------AVCLAVLQALSVLHAQG 147
Query: 408 DPKIIHRDVKAANILLDEDA----------DQSSKTILRR 437
              +IHRD+K+ +ILL  D            Q SK + RR
Sbjct: 148 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 184

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 284 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 341
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 402 YLHEHCDPKIIHRDVKAANILLDEDA 427
           + H H   +++HRD+K  N+L++ + 
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEG 140

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 284 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 341
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 402 YLHEHCDPKIIHRDVKAANILLDEDA 427
           + H H   +++HRD+K  N+L++ + 
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEG 140

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 67/151 (44%), Gaps = 28/151 (18%)
Query: 292 NILGRGGFGKVYKGRLADGKLVAVK--RLKEERTSGGELQFQTEVKIISMA--VHRNLLR 347
            I  RG FG V+K +L +   VAVK   L+++++      +Q+E +I S     H NLL+
Sbjct: 21  EIKARGRFGCVWKAQLMN-DFVAVKIFPLQDKQS------WQSEREIFSTPGMKHENLLQ 73
Query: 348 LYGF----CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
                        E  L+  +   GS+   L+        + W     +A   +RGLSYL
Sbjct: 74  FIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGNI-----ITWNELCHVAETMSRGLSYL 128
Query: 404 HEHC--------DPKIIHRDVKAANILLDED 426
           HE           P I HRD K+ N+LL  D
Sbjct: 129 HEDVPWCRGEGHKPSIAHRDFKSKNVLLKSD 159

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/148 (24%), Positives = 72/148 (48%), Gaps = 12/148 (8%)
Query: 284 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 341
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARG 399
           H N+++L     T  +  LV+ ++        L++    S+L  +  P  K       +G
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQG 117
Query: 400 LSYLHEHCDPKIIHRDVKAANILLDEDA 427
           L++ H H   +++HRD+K  N+L++ + 
Sbjct: 118 LAFCHSH---RVLHRDLKPQNLLINTEG 142

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 294 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 70
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 410 KIIHRDVKAANILLDE 425
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 284 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 341
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 402 YLHEHCDPKIIHRDVKAANILLDEDA 427
           + H H   +++HRD+K  N+L++ + 
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEG 140

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 294 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 71
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 410 KIIHRDVKAANILLDE 425
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 20/161 (12%)
Query: 277 SLRELQVATDGFSNKN-------ILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGEL 328
            + EL+    G SN          +GRG F  VYKG   +  + VA   L++ + +  E 
Sbjct: 10  DIEELETKAVGXSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER 69
Query: 329 Q-FQTEVKIISMAVHRNLLRLY-GFCTTVTEK---LLVYPYMTNGSVASRLRE-RQSSLP 382
           Q F+ E + +    H N++R Y  + +TV  K   +LV    T+G++ + L+  +   + 
Sbjct: 70  QRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIK 129
Query: 383 PLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 423
            L    R+ +     +GL +LH    P IIHRD+K  NI +
Sbjct: 130 VLRSWCRQIL-----KGLQFLHTRT-PPIIHRDLKCDNIFI 164

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/148 (24%), Positives = 72/148 (48%), Gaps = 12/148 (8%)
Query: 284 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 341
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARG 399
           H N+++L     T  +  LV+ ++        L++    S+L  +  P  K       +G
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQG 116
Query: 400 LSYLHEHCDPKIIHRDVKAANILLDEDA 427
           L++ H H   +++HRD+K  N+L++ + 
Sbjct: 117 LAFCHSH---RVLHRDLKPENLLINTEG 141

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 294 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 70
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 410 KIIHRDVKAANILLDE 425
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 284 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 341
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 402 YLHEHCDPKIIHRDVKAANILLDEDA 427
           + H H   +++HRD+K  N+L++ + 
Sbjct: 120 FCHSH---RVLHRDLKPENLLINTEG 142

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 284 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 341
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 402 YLHEHCDPKIIHRDVKAANILLDEDA 427
           + H H   +++HRD+K  N+L++ + 
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEG 141

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 284 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 341
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 402 YLHEHCDPKIIHRDVKAANILLDEDA 427
           + H H   +++HRD+K  N+L++ + 
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEG 141

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 284 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 341
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 402 YLHEHCDPKIIHRDVKAANILLDEDA 427
           + H H   +++HRD+K  N+L++ + 
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEG 143

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 284 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 341
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 402 YLHEHCDPKIIHRDVKAANILLDEDA 427
           + H H   +++HRD+K  N+L++ + 
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEG 142

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 65/143 (45%), Gaps = 27/143 (18%)
Query: 294 LGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRLYG 350
           LG G FGKV        G+ VA+K + ++  +  ++Q   + E+  + +  H ++++LY 
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 351 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR--------GLSY 402
              +  E ++V  Y  N      ++             R K++   AR         + Y
Sbjct: 72  VIKSKDEIIMVIEYAGNELFDYIVQ-------------RDKMSEQEARRFFQQIISAVEY 118
Query: 403 LHEHCDPKIIHRDVKAANILLDE 425
            H H   KI+HRD+K  N+LLDE
Sbjct: 119 CHRH---KIVHRDLKPENLLLDE 138

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 284 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 341
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 402 YLHEHCDPKIIHRDVKAANILLDEDA 427
           + H H   +++HRD+K  N+L++ + 
Sbjct: 122 FCHSH---RVLHRDLKPQNLLINTEG 144

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 65/143 (45%), Gaps = 27/143 (18%)
Query: 294 LGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRLYG 350
           LG G FGKV        G+ VA+K + ++  +  ++Q   + E+  + +  H ++++LY 
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 351 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR--------GLSY 402
              +  E ++V  Y  N      ++             R K++   AR         + Y
Sbjct: 76  VIKSKDEIIMVIEYAGNELFDYIVQ-------------RDKMSEQEARRFFQQIISAVEY 122
Query: 403 LHEHCDPKIIHRDVKAANILLDE 425
            H H   KI+HRD+K  N+LLDE
Sbjct: 123 CHRH---KIVHRDLKPENLLLDE 142

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 343
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 404 HEHCDPKIIHRDVKAANILLDEDA 427
           H H   +++HRD+K  N+L++ + 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEG 139

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 343
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 404 HEHCDPKIIHRDVKAANILLDEDA 427
           H H   +++HRD+K  N+L++ + 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEG 139

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 343
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 404 HEHCDPKIIHRDVKAANILLDEDA 427
           H H   +++HRD+K  N+L++ + 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEG 139

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 343
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 404 HEHCDPKIIHRDVKAANILLDEDA 427
           H H   +++HRD+K  N+L++ + 
Sbjct: 127 HSH---RVLHRDLKPQNLLINTEG 147

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 343
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 404 HEHCDPKIIHRDVKAANILLDEDA 427
           H H   +++HRD+K  N+L++ + 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEG 140

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 294 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 410 KIIHRDVKAANILLDE 425
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 343
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 404 HEHCDPKIIHRDVKAANILLDEDA 427
           H H   +++HRD+K  N+L++ + 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEG 139

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 75/150 (50%), Gaps = 20/150 (13%)
Query: 283 VATDGFSNKNILGRGGFGKVY------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKI 336
           + +D +  + +LG+G FG+V        G+    K+++ +++K++      L+   EV++
Sbjct: 46  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR---EVQL 102
Query: 337 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL--RERQSSLPPLDWPTRKKIAL 394
           +    H N+++LY F        LV    T G +   +  R+R S +         +I  
Sbjct: 103 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA------RIIR 156
Query: 395 GSARGLSYLHEHCDPKIIHRDVKAANILLD 424
               G++Y+H++   KI+HRD+K  N+LL+
Sbjct: 157 QVLSGITYMHKN---KIVHRDLKPENLLLE 183

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 284 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 341
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 402 YLHEHCDPKIIHRDVKAANILLDEDA 427
           + H H   +++HRD+K  N+L++ + 
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEG 143

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 77/146 (52%), Gaps = 15/146 (10%)
Query: 294 LGRGGFGKVYKG---RLAD-GKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 345
           LG+G F K++KG    + D G+L    V +K L +   +  E  F+    ++S   H++L
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEA-ASMMSKLSHKHL 74
Query: 346 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 405
           +  YG C    E +LV  ++  GS+ + L++ ++ +  L W  + ++A   A  + +L E
Sbjct: 75  VLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINIL-W--KLEVAKQLAWAMHFLEE 131
Query: 406 HCDPKIIHRDVKAANILLDEDADQSS 431
           +    +IH +V A NILL  + D+ +
Sbjct: 132 NT---LIHGNVCAKNILLIREEDRKT 154

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 343
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 404 HEHCDPKIIHRDVKAANILLDEDA 427
           H H   +++HRD+K  N+L++ + 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEG 140

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/148 (25%), Positives = 72/148 (48%), Gaps = 12/148 (8%)
Query: 284 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 341
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARG 399
           H N+++L     T  +  LV+ +     V   L++    S+L  +  P  K       +G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEH-----VDQDLKKFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 400 LSYLHEHCDPKIIHRDVKAANILLDEDA 427
           L++ H H   +++HRD+K  N+L++ + 
Sbjct: 119 LAFCHSH---RVLHRDLKPQNLLINTEG 143

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 75/150 (50%), Gaps = 20/150 (13%)
Query: 283 VATDGFSNKNILGRGGFGKVY------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKI 336
           + +D +  + +LG+G FG+V        G+    K+++ +++K++      L+   EV++
Sbjct: 47  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR---EVQL 103
Query: 337 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL--RERQSSLPPLDWPTRKKIAL 394
           +    H N+++LY F        LV    T G +   +  R+R S +         +I  
Sbjct: 104 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA------RIIR 157
Query: 395 GSARGLSYLHEHCDPKIIHRDVKAANILLD 424
               G++Y+H++   KI+HRD+K  N+LL+
Sbjct: 158 QVLSGITYMHKN---KIVHRDLKPENLLLE 184

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 65/143 (45%), Gaps = 27/143 (18%)
Query: 294 LGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRLYG 350
           LG G FGKV        G+ VA+K + ++  +  ++Q   + E+  + +  H ++++LY 
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 351 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR--------GLSY 402
              +  E ++V  Y  N      ++             R K++   AR         + Y
Sbjct: 82  VIKSKDEIIMVIEYAGNELFDYIVQ-------------RDKMSEQEARRFFQQIISAVEY 128
Query: 403 LHEHCDPKIIHRDVKAANILLDE 425
            H H   KI+HRD+K  N+LLDE
Sbjct: 129 CHRH---KIVHRDLKPENLLLDE 148

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 343
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 404 HEHCDPKIIHRDVKAANILLDEDA 427
           H H   +++HRD+K  N+L++ + 
Sbjct: 121 HSH---RVLHRDLKPQNLLINTEG 141

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 343
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQDL---KTFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 404 HEHCDPKIIHRDVKAANILLDEDA 427
           H H   +++HRD+K  N+L++ + 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEG 139

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 65/143 (45%), Gaps = 27/143 (18%)
Query: 294 LGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRLYG 350
           LG G FGKV        G+ VA+K + ++  +  ++Q   + E+  + +  H ++++LY 
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 351 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR--------GLSY 402
              +  E ++V  Y  N      ++             R K++   AR         + Y
Sbjct: 81  VIKSKDEIIMVIEYAGNELFDYIVQ-------------RDKMSEQEARRFFQQIISAVEY 127
Query: 403 LHEHCDPKIIHRDVKAANILLDE 425
            H H   KI+HRD+K  N+LLDE
Sbjct: 128 CHRH---KIVHRDLKPENLLLDE 147

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 294 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 410 KIIHRDVKAANILLDE 425
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 294 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 410 KIIHRDVKAANILLDE 425
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 294 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 74
Query: 349 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 403
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 75  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 128
Query: 404 HEHCDPKIIHRDVKAANILLDED 426
                 + IHRD+   NIL++ +
Sbjct: 129 ---GTKRYIHRDLATRNILVENE 148

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 69/143 (48%), Gaps = 11/143 (7%)
Query: 288 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           +  K  LG GGFG V +    D G+ VA+K+ ++E +     ++  E++I+    H N++
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 347 RLYGFCTTVTE------KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 400
                   + +       LL   Y   G +   L + ++     + P R  ++  S+  L
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS-AL 135
Query: 401 SYLHEHCDPKIIHRDVKAANILL 423
            YLHE+   +IIHRD+K  NI+L
Sbjct: 136 RYLHEN---RIIHRDLKPENIVL 155

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 294 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 349 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 403
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 129
Query: 404 HEHCDPKIIHRDVKAANILLDED 426
                 + IHRD+   NIL++ +
Sbjct: 130 ---GTKRYIHRDLATRNILVENE 149

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 294 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           LG+G FG V   R   L D  G++VAVK+L +  T      F+ E++I+    H N+++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 349 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 403
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 130
Query: 404 HEHCDPKIIHRDVKAANILLDED 426
                 + IHRD+   NIL++ +
Sbjct: 131 ---GTKRYIHRDLATRNILVENE 150

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 73/149 (48%), Gaps = 14/149 (9%)
Query: 282 QVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA 340
           Q   +   N   +G G  G+V+K R    G ++AVK++   R SG + + +  +  + + 
Sbjct: 21  QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM---RRSGNKEENKRILMDLDVV 77
Query: 341 VHRN----LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 396
           +  +    +++ +G   T T+  +    M  G+ A +L++R     P+      K+ +  
Sbjct: 78  LKSHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQG--PIPERILGKMTVAI 133
Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLDE 425
            + L YL E     +IHRDVK +NILLDE
Sbjct: 134 VKALYYLKEKHG--VIHRDVKPSNILLDE 160

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 71/146 (48%), Gaps = 12/146 (8%)
Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 343
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLS 401
           N+++L     T  +  LV+ ++        L++    S+L  +  P  K       +GL+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 402 YLHEHCDPKIIHRDVKAANILLDEDA 427
           + H H   +++HRD+K  N+L++ + 
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEG 140

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 294 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 349 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 403
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 148
Query: 404 HEHCDPKIIHRDVKAANILLDED 426
                 + IHRD+   NIL++ +
Sbjct: 149 ---GTKRYIHRDLATRNILVENE 168

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 294 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 349 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 403
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 148
Query: 404 HEHCDPKIIHRDVKAANILLDED 426
                 + IHRD+   NIL++ +
Sbjct: 149 ---GTKRYIHRDLATRNILVENE 168

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 294 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 349 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 403
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 130
Query: 404 HEHCDPKIIHRDVKAANILLDED 426
                 + IHRD+   NIL++ +
Sbjct: 131 ---GTKRYIHRDLATRNILVENE 150

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 294 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 349 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 403
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 135
Query: 404 HEHCDPKIIHRDVKAANILLDED 426
                 + IHRD+   NIL++ +
Sbjct: 136 ---GTKRYIHRDLATRNILVENE 155

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 294 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 410 KIIHRDVKAANILLDE 425
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 69/147 (46%), Gaps = 21/147 (14%)
Query: 287 GFSNKNILGRGGFGKVYKGRLADGKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNL 345
            ++N  ++G G FG V++ +L +   VA+K+ L+++R    ELQ      I+ +  H N+
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQ------IMRIVKHPNV 94
Query: 346 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 397
           + L  F  +  +K        +L Y   T    +    + + ++P L     K       
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML---LIKLYMYQLL 151
Query: 398 RGLSYLHEHCDPKIIHRDVKAANILLD 424
           R L+Y+H      I HRD+K  N+LLD
Sbjct: 152 RSLAYIHSI---GICHRDIKPQNLLLD 175

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 69/143 (48%), Gaps = 11/143 (7%)
Query: 288 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           +  K  LG GGFG V +    D G+ VA+K+ ++E +     ++  E++I+    H N++
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 347 RLYGFCTTVTE------KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 400
                   + +       LL   Y   G +   L + ++     + P R  ++  S+  L
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS-AL 134
Query: 401 SYLHEHCDPKIIHRDVKAANILL 423
            YLHE+   +IIHRD+K  NI+L
Sbjct: 135 RYLHEN---RIIHRDLKPENIVL 154

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 66/136 (48%), Gaps = 17/136 (12%)
Query: 292 NILGRGGFGKVY--KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
            +LG G F +V+  K RL  GKL A+K +K+   +  +   + E+ ++    H N++ L 
Sbjct: 15  EVLGSGAFSEVFLVKQRLT-GKLFALKCIKK-SPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS---YLHEH 406
               + T   LV   ++ G +  R+ ER          T K  +L   + LS   YLHE+
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVY-------TEKDASLVIQQVLSAVKYLHEN 125
Query: 407 CDPKIIHRDVKAANIL 422
               I+HRD+K  N+L
Sbjct: 126 ---GIVHRDLKPENLL 138

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 69/156 (44%), Gaps = 29/156 (18%)
Query: 294 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 346
           LG G FGKV +         D  L VAVK LK    +  +    +E+KI+S +  H N++
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS-----SLPP------LDWPTRKKIALG 395
            L G CT     L++  Y   G + + LR +       SL P      LD    + + L 
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELR 158
Query: 396 S--------ARGLSYLHEHCDPKIIHRDVKAANILL 423
                    A+G+++L        IHRDV A N+LL
Sbjct: 159 DLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLL 191

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 294 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 349 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 403
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 161
Query: 404 HEHCDPKIIHRDVKAANILLDED 426
                 + IHRD+   NIL++ +
Sbjct: 162 ---GTKRYIHRDLATRNILVENE 181

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 77/171 (45%), Gaps = 29/171 (16%)
Query: 270 LGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSG 325
           LG ++    ++ +   D +  +++LG G F +V    LA+ K    LVA+K + +E   G
Sbjct: 2   LGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVI---LAEDKRTQKLVAIKCIAKEALEG 58
Query: 326 GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL------RERQS 379
            E   + E+ ++    H N++ L     +     L+   ++ G +  R+       ER +
Sbjct: 59  KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDA 118
Query: 380 SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL---LDEDA 427
           S          ++       + YLH   D  I+HRD+K  N+L   LDED+
Sbjct: 119 S----------RLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDS 156

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 343
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 404 HEHCDPKIIHRDVKAANILLDEDA 427
           H H   +++HRD+K  N+L++ + 
Sbjct: 127 HSH---RVLHRDLKPQNLLINTEG 147

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 294 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 410 KIIHRDVKAANILLDE 425
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 30/160 (18%)
Query: 294 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 352
           +G G  G V    + + GKLVAVK++   +    EL F  EV I+    H N++ +Y   
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 140
Query: 353 TTVTEKLLVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
               E  +V  ++  G++      +R+ E Q +           + L   + LS LH   
Sbjct: 141 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----------AVCLAVLQALSVLHAQG 190
Query: 408 DPKIIHRDVKAANILLDEDA----------DQSSKTILRR 437
              +IHRD+K+ +ILL  D            Q SK + RR
Sbjct: 191 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 227

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 294 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 349 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 403
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 136
Query: 404 HEHCDPKIIHRDVKAANILLDED 426
                 + IHRD+   NIL++ +
Sbjct: 137 ---GTKRYIHRDLATRNILVENE 156

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 294 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 349 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 403
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 81  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 134
Query: 404 HEHCDPKIIHRDVKAANILLDED 426
                 + IHRD+   NIL++ +
Sbjct: 135 ---GTKRYIHRDLATRNILVENE 154

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 65/144 (45%), Gaps = 16/144 (11%)
Query: 291 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           + +L  GGF  VY+ + +  G+  A+KRL            Q    +  ++ H N+++  
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ-- 90
Query: 350 GFCTTVT----------EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 399
            FC+  +           + L+   +  G +   L++ +S   PL   T  KI   + R 
Sbjct: 91  -FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR-GPLSCDTVLKIFYQTCRA 148
Query: 400 LSYLHEHCDPKIIHRDVKAANILL 423
           + ++H    P IIHRD+K  N+LL
Sbjct: 149 VQHMHRQ-KPPIIHRDLKVENLLL 171

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 294 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           LG+G FG V   R   L D  G++VAVK+L +  T      F+ E++I+    H N+++ 
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 349 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 403
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 137
Query: 404 HEHCDPKIIHRDVKAANILLDED 426
                 + IHRD+   NIL++ +
Sbjct: 138 ---GTKRYIHRDLATRNILVENE 157

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 294 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 349 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 403
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 133
Query: 404 HEHCDPKIIHRDVKAANILLDED 426
                 + IHRD+   NIL++ +
Sbjct: 134 ---GTKRYIHRDLATRNILVENE 153

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 294 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           LG+G FG V   R   L D  G++VAVK+L +  T      F+ E++I+    H N+++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 349 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 403
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 130
Query: 404 HEHCDPKIIHRDVKAANILLDED 426
                 + IHRD+   NIL++ +
Sbjct: 131 ---GTKRYIHRDLATRNILVENE 150

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/142 (25%), Positives = 68/142 (47%), Gaps = 22/142 (15%)
Query: 292 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRL 348
           + LG G FGKV  G     G  VAVK L  ++    ++  + + E++ + +  H ++++L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 349 YGFCTTVTEKLLVYPYMTNGSV------ASRLRERQSSLPPLDWPTRKKIALGSARGLSY 402
           Y   +T T+  +V  Y++ G +        R+ E ++          +++       + Y
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA----------RRLFQQILSAVDY 126
Query: 403 LHEHCDPKIIHRDVKAANILLD 424
            H H    ++HRD+K  N+LLD
Sbjct: 127 CHRHM---VVHRDLKPENVLLD 145

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 294 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 410 KIIHRDVKAANILLDE 425
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/142 (25%), Positives = 68/142 (47%), Gaps = 22/142 (15%)
Query: 292 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRL 348
           + LG G FGKV  G     G  VAVK L  ++    ++  + + E++ + +  H ++++L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 349 YGFCTTVTEKLLVYPYMTNGSV------ASRLRERQSSLPPLDWPTRKKIALGSARGLSY 402
           Y   +T T+  +V  Y++ G +        R+ E ++          +++       + Y
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA----------RRLFQQILSAVDY 126
Query: 403 LHEHCDPKIIHRDVKAANILLD 424
            H H    ++HRD+K  N+LLD
Sbjct: 127 CHRHM---VVHRDLKPENVLLD 145

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 294 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 410 KIIHRDVKAANILLDE 425
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 77/171 (45%), Gaps = 29/171 (16%)
Query: 270 LGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSG 325
           LG ++    ++ +   D +  +++LG G F +V    LA+ K    LVA+K + +E   G
Sbjct: 2   LGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVI---LAEDKRTQKLVAIKCIAKEALEG 58
Query: 326 GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL------RERQS 379
            E   + E+ ++    H N++ L     +     L+   ++ G +  R+       ER +
Sbjct: 59  KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDA 118
Query: 380 SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL---LDEDA 427
           S          ++       + YLH   D  I+HRD+K  N+L   LDED+
Sbjct: 119 S----------RLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDS 156

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 57/123 (46%), Gaps = 19/123 (15%)
Query: 310 GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS 369
           GK VAVK++   +    EL F  EV I+    H N++ +Y       E  +V  ++  G+
Sbjct: 70  GKQVAVKKMDLRKQQRRELLF-NEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGA 128
Query: 370 VA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 424
           +      +R+ E Q +           + L   R LSYLH      +IHRD+K+ +ILL 
Sbjct: 129 LTDIVTHTRMNEEQIA----------TVCLSVLRALSYLHNQ---GVIHRDIKSDSILLT 175
Query: 425 EDA 427
            D 
Sbjct: 176 SDG 178

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 77/171 (45%), Gaps = 29/171 (16%)
Query: 270 LGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSG 325
           LG ++    ++ +   D +  +++LG G F +V    LA+ K    LVA+K + +E   G
Sbjct: 2   LGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVI---LAEDKRTQKLVAIKCIAKEALEG 58
Query: 326 GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL------RERQS 379
            E   + E+ ++    H N++ L     +     L+   ++ G +  R+       ER +
Sbjct: 59  KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDA 118
Query: 380 SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL---LDEDA 427
           S          ++       + YLH   D  I+HRD+K  N+L   LDED+
Sbjct: 119 S----------RLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDS 156

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 67/146 (45%), Gaps = 23/146 (15%)
Query: 294 LGRGGFGKV--YKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 351
           LG GGF  V   +G L DG   A+KR+        E + Q E  +  +  H N+LRL  +
Sbjct: 37  LGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDRE-EAQREADMHRLFNHPNILRLVAY 94
Query: 352 C----TTVTEKLLVYPYMTNGSVAS---RLRERQSSLPPLDWPTRKKIA---LGSARGLS 401
           C        E  L+ P+   G++ +   RL+++ + L      T  +I    LG  RGL 
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFL------TEDQILWLLLGICRGLE 148
Query: 402 YLHEHCDPKIIHRDVKAANILLDEDA 427
            +H        HRD+K  NILL ++ 
Sbjct: 149 AIHA---KGYAHRDLKPTNILLGDEG 171

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 294 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 410 KIIHRDVKAANILLDE 425
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 30/160 (18%)
Query: 294 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 352
           +G G  G V    + + GKLVAVK++   +    EL F  EV I+    H N++ +Y   
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 217
Query: 353 TTVTEKLLVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
               E  +V  ++  G++      +R+ E Q +           + L   + LS LH   
Sbjct: 218 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----------AVCLAVLQALSVLHAQG 267
Query: 408 DPKIIHRDVKAANILLDEDA----------DQSSKTILRR 437
              +IHRD+K+ +ILL  D            Q SK + RR
Sbjct: 268 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 304

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 13/153 (8%)
Query: 280 ELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT--EVKI 336
           ++++  + F    +LG+G FGKV+        +  A+K LK++     +    T  E ++
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 337 ISMAVHRNLLRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL 394
           +S+A     L  + FCT  T++    V  Y+  G +   ++    S    D       A 
Sbjct: 72  LSLAWEHPFLT-HMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAA 126
Query: 395 GSARGLSYLHEHCDPKIIHRDVKAANILLDEDA 427
               GL +LH      I++RD+K  NILLD+D 
Sbjct: 127 EIILGLQFLHSKG---IVYRDLKLDNILLDKDG 156

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 294 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 349 YGFCTTVTEK--LLVYPYMTNGSVASRLR---ERQSSLPPLDWPTRKKIALGSARGLSYL 403
            G C +   +   L+  Y+  GS+   L+   ER   +  L + ++        +G+ YL
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQ------ICKGMEYL 133
Query: 404 HEHCDPKIIHRDVKAANILLDED 426
                 + IHRD+   NIL++ +
Sbjct: 134 ---GTKRYIHRDLATRNILVENE 153

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 294 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 13  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 69
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 70  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 122
Query: 410 KIIHRDVKAANILLDE 425
            I HRD+K  N+LLDE
Sbjct: 123 GITHRDIKPENLLLDE 138

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 294 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 410 KIIHRDVKAANILLDE 425
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 294 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 410 KIIHRDVKAANILLDE 425
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 294 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 410 KIIHRDVKAANILLDE 425
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 294 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 410 KIIHRDVKAANILLDE 425
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 294 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 410 KIIHRDVKAANILLDE 425
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 77/171 (45%), Gaps = 18/171 (10%)
Query: 263 EDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEE 321
           E D   +  Q K   L  + +  + FS   I+GRGGFG+VY  R AD GK+ A+K L ++
Sbjct: 167 ESDKFTRFCQWKNVELN-IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK 225
Query: 322 R--TSGGELQFQTEVKIISMAVHRN----LLRLYGFCTTVTEKL-LVYPYMTNGSVASRL 374
           R     GE     E  ++S+    +    +   Y F T   +KL  +   M  G +   L
Sbjct: 226 RIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHL 283
Query: 375 RERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 425
               S          +  A     GL ++H      +++RD+K ANILLDE
Sbjct: 284 ----SQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDE 327

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 77/171 (45%), Gaps = 18/171 (10%)
Query: 263 EDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEE 321
           E D   +  Q K   L  + +  + FS   I+GRGGFG+VY  R AD GK+ A+K L ++
Sbjct: 167 ESDKFTRFCQWKNVELN-IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK 225
Query: 322 R--TSGGELQFQTEVKIISMAVHRN----LLRLYGFCTTVTEKL-LVYPYMTNGSVASRL 374
           R     GE     E  ++S+    +    +   Y F T   +KL  +   M  G +   L
Sbjct: 226 RIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHL 283
Query: 375 RERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 425
               S          +  A     GL ++H      +++RD+K ANILLDE
Sbjct: 284 ----SQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDE 327

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 294 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 410 KIIHRDVKAANILLDE 425
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 27/148 (18%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 351
           +G+G +G+V++G    G+ VAVK    ++E++   E    TE+    M  H N+L   GF
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE----TELYNTVMLRHENIL---GF 67
Query: 352 CTT-------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
             +        T+  L+  Y   GS+   L+     L  LD  +  +I L  A GL++LH
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLH 122
Query: 405 -----EHCDPKIIHRDVKAANILLDEDA 427
                    P I HRD+K+ NIL+ ++ 
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNG 150

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 77/171 (45%), Gaps = 18/171 (10%)
Query: 263 EDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEE 321
           E D   +  Q K   L  + +  + FS   I+GRGGFG+VY  R AD GK+ A+K L ++
Sbjct: 167 ESDKFTRFCQWKNVELN-IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK 225
Query: 322 R--TSGGELQFQTEVKIISMAVHRN----LLRLYGFCTTVTEKL-LVYPYMTNGSVASRL 374
           R     GE     E  ++S+    +    +   Y F T   +KL  +   M  G +   L
Sbjct: 226 RIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHL 283
Query: 375 RERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 425
               S          +  A     GL ++H      +++RD+K ANILLDE
Sbjct: 284 ----SQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDE 327

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 294 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 410 KIIHRDVKAANILLDE 425
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 27/148 (18%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 351
           +G+G +G+V++G    G+ VAVK    ++E++   E    TE+    M  H N+L   GF
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE----TELYNTVMLRHENIL---GF 67
Query: 352 CTT-------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
             +        T+  L+  Y   GS+   L+     L  LD  +  +I L  A GL++LH
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLH 122
Query: 405 -----EHCDPKIIHRDVKAANILLDEDA 427
                    P I HRD+K+ NIL+ ++ 
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNG 150

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 27/148 (18%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 351
           +G+G +G+V++G    G+ VAVK    ++E++   E    TE+    M  H N+L   GF
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE----TELYNTVMLRHENIL---GF 96
Query: 352 CTT-------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
             +        T+  L+  Y   GS+   L+     L  LD  +  +I L  A GL++LH
Sbjct: 97  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLH 151
Query: 405 -----EHCDPKIIHRDVKAANILLDEDA 427
                    P I HRD+K+ NIL+ ++ 
Sbjct: 152 IEIFGTQGKPAIAHRDLKSKNILVKKNG 179

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 73/144 (50%), Gaps = 27/144 (18%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV--HRNLLRLYGF 351
           +G+G +G+V++G L  G+ VAVK      +S  E  +  E +I +  +  H N+L   GF
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIF----SSRDEQSWFRETEIYNTVLLRHDNIL---GF 67
Query: 352 CTT-------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
             +        T+  L+  Y  +GS+   L +RQ+  P L      ++A+ +A GL++LH
Sbjct: 68  IASDMTSRNSSTQLWLITHYHEHGSLYDFL-QRQTLEPHL----ALRLAVSAACGLAHLH 122
Query: 405 -----EHCDPKIIHRDVKAANILL 423
                    P I HRD K+ N+L+
Sbjct: 123 VEIFGTQGKPAIAHRDFKSRNVLV 146

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 65/130 (50%), Gaps = 7/130 (5%)
Query: 300 GKVYKGRLADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT--VT 356
           G+++KGR   G  + VK LK  + ++     F  E   + +  H N+L + G C +    
Sbjct: 24  GELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 357 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV 416
              L+  +M  GS+ + L E  + +  +D     K AL  ARG+++LH   +P I    +
Sbjct: 83  HPTLITHWMPYGSLYNVLHEGTNFV--VDQSQAVKFALDMARGMAFLHT-LEPLIPRHAL 139
Query: 417 KAANILLDED 426
            + ++++DED
Sbjct: 140 NSRSVMIDED 149

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 77/171 (45%), Gaps = 18/171 (10%)
Query: 263 EDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEE 321
           E D   +  Q K   L  + +  + FS   I+GRGGFG+VY  R AD GK+ A+K L ++
Sbjct: 166 ESDKFTRFCQWKNVELN-IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK 224
Query: 322 R--TSGGELQFQTEVKIISMAVHRN----LLRLYGFCTTVTEKL-LVYPYMTNGSVASRL 374
           R     GE     E  ++S+    +    +   Y F T   +KL  +   M  G +   L
Sbjct: 225 RIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHL 282
Query: 375 RERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 425
               S          +  A     GL ++H      +++RD+K ANILLDE
Sbjct: 283 ----SQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDE 326

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 73/171 (42%), Gaps = 25/171 (14%)
Query: 285 TDGFSNKNILGRGGFGKVYK--GRLADGKLVAVKRLKEERTSGGELQFQTEVK-IISMAV 341
           T  F     +G G FG V+K   RL DG + A+KR K  +   G +  Q  ++ + + AV
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSK--KPLAGSVDEQNALREVYAHAV 62
Query: 342 ---HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H +++R +         L+   Y   GS+A  + E    +        K + L   R
Sbjct: 63  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 122
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL-------------DEDADQSSKTILR 436
           GL Y+H      ++H D+K +NI +             DED   S+K + +
Sbjct: 123 GLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 170

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 73/171 (42%), Gaps = 25/171 (14%)
Query: 285 TDGFSNKNILGRGGFGKVYK--GRLADGKLVAVKRLKEERTSGGELQFQTEVK-IISMAV 341
           T  F     +G G FG V+K   RL DG + A+KR K  +   G +  Q  ++ + + AV
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSK--KPLAGSVDEQNALREVYAHAV 64
Query: 342 ---HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H +++R +         L+   Y   GS+A  + E    +        K + L   R
Sbjct: 65  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL-------------DEDADQSSKTILR 436
           GL Y+H      ++H D+K +NI +             DED   S+K + +
Sbjct: 125 GLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 172

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 73/171 (42%), Gaps = 25/171 (14%)
Query: 285 TDGFSNKNILGRGGFGKVYK--GRLADGKLVAVKRLKEERTSGGELQFQTEVK-IISMAV 341
           T  F     +G G FG V+K   RL DG + A+KR K  +   G +  Q  ++ + + AV
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSK--KPLAGSVDEQNALREVYAHAV 64
Query: 342 ---HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H +++R +         L+   Y   GS+A  + E    +        K + L   R
Sbjct: 65  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL-------------DEDADQSSKTILR 436
           GL Y+H      ++H D+K +NI +             DED   S+K + +
Sbjct: 125 GLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 172

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 73/171 (42%), Gaps = 25/171 (14%)
Query: 285 TDGFSNKNILGRGGFGKVYK--GRLADGKLVAVKRLKEERTSGGELQFQTEVK-IISMAV 341
           T  F     +G G FG V+K   RL DG + A+KR K  +   G +  Q  ++ + + AV
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSK--KPLAGSVDEQNALREVYAHAV 66
Query: 342 ---HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              H +++R +         L+   Y   GS+A  + E    +        K + L   R
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 399 GLSYLHEHCDPKIIHRDVKAANILL-------------DEDADQSSKTILR 436
           GL Y+H      ++H D+K +NI +             DED   S+K + +
Sbjct: 127 GLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 13/153 (8%)
Query: 280 ELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT--EVKI 336
           ++++  + F    +LG+G FGKV+        +  A+K LK++     +    T  E ++
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 337 ISMAVHRNLLRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL 394
           +S+A     L  + FCT  T++    V  Y+  G +   ++    S    D       A 
Sbjct: 71  LSLAWEHPFLT-HMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAA 125
Query: 395 GSARGLSYLHEHCDPKIIHRDVKAANILLDEDA 427
               GL +LH      I++RD+K  NILLD+D 
Sbjct: 126 EIILGLQFLHSK---GIVYRDLKLDNILLDKDG 155

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 66/142 (46%), Gaps = 17/142 (11%)
Query: 293 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV-HRNLLRL 348
           ++GRG + KV   RL    ++ A+K +K+E  +  E     QTE  +   A  H  L+ L
Sbjct: 12  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 71
Query: 349 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR---GLSYLHE 405
           +    T +    V  Y+  G +   + +RQ  LP       +     SA     L+YLHE
Sbjct: 72  HSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLP------EEHARFYSAEISLALNYLHE 124
Query: 406 HCDPKIIHRDVKAANILLDEDA 427
                II+RD+K  N+LLD + 
Sbjct: 125 RG---IIYRDLKLDNVLLDSEG 143

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 66/142 (46%), Gaps = 17/142 (11%)
Query: 293 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV-HRNLLRL 348
           ++GRG + KV   RL    ++ A+K +K+E  +  E     QTE  +   A  H  L+ L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 349 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR---GLSYLHE 405
           +    T +    V  Y+  G +   + +RQ  LP       +     SA     L+YLHE
Sbjct: 76  HSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLP------EEHARFYSAEISLALNYLHE 128
Query: 406 HCDPKIIHRDVKAANILLDEDA 427
                II+RD+K  N+LLD + 
Sbjct: 129 RG---IIYRDLKLDNVLLDSEG 147

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 294 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 349 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 403
            G C +   +   L+  ++  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 133
Query: 404 HEHCDPKIIHRDVKAANILLDED 426
                 + IHRD+   NIL++ +
Sbjct: 134 ---GTKRYIHRDLATRNILVENE 153

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 343
           + F     +G G +G VYK R    G++VA+ +++ +  T G       E+ ++    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 404 HEHCDPKIIHRDVKAANILLDEDA 427
           H H   +++HRD+K  N+L++ + 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEG 140

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 343
           + F     +G G +G VYK R    G++VA+ +++ +  T G       E+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 404 HEHCDPKIIHRDVKAANILLDEDA 427
           H H   +++HRD+K  N+L++ + 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEG 139

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 74/147 (50%), Gaps = 26/147 (17%)
Query: 294 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLL 346
           LG+G FG V   R   L D  G LVAVK+L+    SG + Q  FQ E++I+  A+H + +
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDFQREIQILK-ALHSDFI 70
Query: 347 RLY---GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA---RGL 400
             Y    +     E  LV  Y+ +G +   L+  ++ L         ++ L S+   +G+
Sbjct: 71  VKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARL------DASRLLLYSSQICKGM 124
Query: 401 SYLHEHCDPKIIHRDVKAANILLDEDA 427
            YL      + +HRD+ A NIL++ +A
Sbjct: 125 EYLGSR---RCVHRDLAARNILVESEA 148

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 73/150 (48%), Gaps = 20/150 (13%)
Query: 283 VATDGFSNKNILGRGGFGKVY------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKI 336
           + +D +  + +LG+G FG+V        G+    K+++ +++K++      L+   EV++
Sbjct: 23  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR---EVQL 79
Query: 337 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL--RERQSSLPPLDWPTRKKIAL 394
           +    H N+ +LY F        LV    T G +   +  R+R S +         +I  
Sbjct: 80  LKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA------RIIR 133
Query: 395 GSARGLSYLHEHCDPKIIHRDVKAANILLD 424
               G++Y H++   KI+HRD+K  N+LL+
Sbjct: 134 QVLSGITYXHKN---KIVHRDLKPENLLLE 160

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 66/142 (46%), Gaps = 17/142 (11%)
Query: 293 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV-HRNLLRL 348
           ++GRG + KV   RL    ++ A+K +K+E  +  E     QTE  +   A  H  L+ L
Sbjct: 27  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 86
Query: 349 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR---GLSYLHE 405
           +    T +    V  Y+  G +   + +RQ  LP       +     SA     L+YLHE
Sbjct: 87  HSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLP------EEHARFYSAEISLALNYLHE 139
Query: 406 HCDPKIIHRDVKAANILLDEDA 427
                II+RD+K  N+LLD + 
Sbjct: 140 RG---IIYRDLKLDNVLLDSEG 158

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 294 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 349 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 403
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 131
Query: 404 HEHCDPKIIHRDVKAANILLDED 426
                 + IHR++   NIL++ +
Sbjct: 132 ---GTKRYIHRNLATRNILVENE 151

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 29/162 (17%)
Query: 281 LQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLK--EERTSGGELQFQTEVKII 337
           L+ A+D F    +LG+G FG+V K R A D +  A+K+++  EE+ S       +EV ++
Sbjct: 2   LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS----TILSEVMLL 56
Query: 338 SMAVHRNLLRLYGF----------CTTVTEKLLVY---PYMTNGSVASRLR-ERQSSLPP 383
           +   H+ ++R Y             T V +K  ++    Y  N ++   +  E  +    
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRD 116
Query: 384 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 425
             W   ++I       LSY+H      IIHRD+K  NI +DE
Sbjct: 117 EYWRLFRQIL----EALSYIHSQG---IIHRDLKPMNIFIDE 151

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 294 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 346
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 347 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPP 383
            L G CT     L+V   +   G++++ LR +++   P
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 65/148 (43%), Gaps = 12/148 (8%)
Query: 281 LQVATDGFSNKNILGRGGFGKVY--KGRLADGKLVAVKRLKEER--TSGGELQFQTEVKI 336
            Q  +D +     LG G +G+V   K +L  G   A+K +K+    T+        EV +
Sbjct: 16  FQGLSDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAV 74
Query: 337 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 396
           +    H N+++LY F        LV      G +   +  RQ     +D     K  L  
Sbjct: 75  LKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQK-FSEVDAAVIMKQVLS- 132
Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLD 424
             G +YLH+H    I+HRD+K  N+LL+
Sbjct: 133 --GTTYLHKH---NIVHRDLKPENLLLE 155

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 64/144 (44%), Gaps = 12/144 (8%)
Query: 285 TDGFSNKNILGRGGFGKVY--KGRLADGKLVAVKRLKEER--TSGGELQFQTEVKIISMA 340
           +D +     LG G +G+V   K +L  G   A+K +K+    T+        EV ++   
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 341 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 400
            H N+++LY F        LV      G +   +  RQ     +D     K  L    G 
Sbjct: 62  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQK-FSEVDAAVIMKQVLS---GT 117
Query: 401 SYLHEHCDPKIIHRDVKAANILLD 424
           +YLH+H    I+HRD+K  N+LL+
Sbjct: 118 TYLHKH---NIVHRDLKPENLLLE 138

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 294 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 346
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 347 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPP 383
            L G CT     L+V   +   G++++ LR +++   P
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 127

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 294 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 346
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 28  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 87
Query: 347 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPP 383
            L G CT     L+V   +   G++++ LR +++   P
Sbjct: 88  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 125

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 294 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 346
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 347 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPP 383
            L G CT     L+V   +   G++++ LR +++   P
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 134

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 64/145 (44%), Gaps = 12/145 (8%)
Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERT-SGGELQFQT-EVKIISMAVH 342
           + F    ILG G F  V   R LA  +  A+K L++       ++ + T E  ++S   H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 343 RNLLRLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
              ++LY FC    EKL     Y  NG +   +R+  S     D    +         L 
Sbjct: 97  PFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALE 151
Query: 402 YLHEHCDPKIIHRDVKAANILLDED 426
           YLH      IIHRD+K  NILL+ED
Sbjct: 152 YLH---GKGIIHRDLKPENILLNED 173

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 61/136 (44%), Gaps = 14/136 (10%)
Query: 294 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           LG G  G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAAGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 410 KIIHRDVKAANILLDE 425
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 62/140 (44%), Gaps = 15/140 (10%)
Query: 294 LGRGGFGK-VYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 351
           +G G FGK +      DG+   +K +   R S  E +  + EV +++   H N+++    
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 352 CTTVTEKLLVYPYMTNGSVASRLRERQSSL----PPLDWPTRKKIALGSARGLSYLHEHC 407
                   +V  Y   G +  R+  ++  L      LDW  +  +AL         H H 
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK--------HVH- 142
Query: 408 DPKIIHRDVKAANILLDEDA 427
           D KI+HRD+K+ NI L +D 
Sbjct: 143 DRKILHRDIKSQNIFLTKDG 162

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 60/137 (43%), Gaps = 6/137 (4%)
Query: 294 LGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQF-QTEVKIISMAVHRNLLRLYG- 350
           +G G +G+  K  R +DGK++  K L     +  E Q   +EV ++    H N++R Y  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 351 -FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD- 408
               T T   +V  Y   G +AS + +       LD     ++       L   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 409 -PKIIHRDVKAANILLD 424
              ++HRD+K AN+ LD
Sbjct: 134 GHTVLHRDLKPANVFLD 150

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 61/132 (46%), Gaps = 9/132 (6%)
Query: 294 LGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQ-TEVKIISMAVHRNLLRLYGF 351
           +G G +G V+K R  D G++VA+K+  E        +    E++++    H NL+ L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 352 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
                   LV+ Y  + +V   L   Q  +P       K I   + + +++ H+H     
Sbjct: 71  FRRKRRLHLVFEY-CDHTVLHELDRYQRGVPEH---LVKSITWQTLQAVNFCHKH---NC 123
Query: 412 IHRDVKAANILL 423
           IHRDVK  NIL+
Sbjct: 124 IHRDVKPENILI 135

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 60/137 (43%), Gaps = 6/137 (4%)
Query: 294 LGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQF-QTEVKIISMAVHRNLLRLYG- 350
           +G G +G+  K  R +DGK++  K L     +  E Q   +EV ++    H N++R Y  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 351 -FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD- 408
               T T   +V  Y   G +AS + +       LD     ++       L   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 409 -PKIIHRDVKAANILLD 424
              ++HRD+K AN+ LD
Sbjct: 134 GHTVLHRDLKPANVFLD 150

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 60/137 (43%), Gaps = 6/137 (4%)
Query: 294 LGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQF-QTEVKIISMAVHRNLLRLYG- 350
           +G G +G+  K  R +DGK++  K L     +  E Q   +EV ++    H N++R Y  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 351 -FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD- 408
               T T   +V  Y   G +AS + +       LD     ++       L   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 409 -PKIIHRDVKAANILLD 424
              ++HRD+K AN+ LD
Sbjct: 134 GHTVLHRDLKPANVFLD 150

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 69/152 (45%), Gaps = 26/152 (17%)
Query: 294 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 346
           LG G FGKV +        +D  + VAVK LK            +E+K++S +  H N++
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL------PPL--------DWPTRKKI 392
            L G CT     L++  Y   G + + LR ++ S       P +        D       
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 393 ALGSARGLSYL-HEHCDPKIIHRDVKAANILL 423
           +   A+G+++L  ++C    IHRD+ A NILL
Sbjct: 151 SYQVAKGMAFLASKNC----IHRDLAARNILL 178

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 69/152 (45%), Gaps = 26/152 (17%)
Query: 294 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 346
           LG G FGKV +        +D  + VAVK LK            +E+K++S +  H N++
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL------PPL--------DWPTRKKI 392
            L G CT     L++  Y   G + + LR ++ S       P +        D       
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 393 ALGSARGLSYL-HEHCDPKIIHRDVKAANILL 423
           +   A+G+++L  ++C    IHRD+ A NILL
Sbjct: 167 SYQVAKGMAFLASKNC----IHRDLAARNILL 194

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 66/149 (44%), Gaps = 9/149 (6%)
Query: 288 FSNKNILGRGGFGKVY-KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           F  K  LG G F +V      A GKL AVK + ++   G E   + E+ ++    H N++
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
            L     +     LV   ++ G +  R+ E+       D  T  +  L +   + YLH  
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEK-GFYTEKDASTLIRQVLDA---VYYLHRM 139
Query: 407 CDPKIIHRDVKAANILLDEDADQSSKTIL 435
               I+HRD+K  N+L     D+ SK ++
Sbjct: 140 G---IVHRDLKPENLLY-YSQDEESKIMI 164

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 69/152 (45%), Gaps = 26/152 (17%)
Query: 294 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 346
           LG G FGKV +        +D  + VAVK LK            +E+K++S +  H N++
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL------PPL--------DWPTRKKI 392
            L G CT     L++  Y   G + + LR ++ S       P +        D       
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 393 ALGSARGLSYL-HEHCDPKIIHRDVKAANILL 423
           +   A+G+++L  ++C    IHRD+ A NILL
Sbjct: 169 SYQVAKGMAFLASKNC----IHRDLAARNILL 196

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 66/142 (46%), Gaps = 17/142 (11%)
Query: 293 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV-HRNLLRL 348
           ++GRG + KV   RL    ++ A++ +K+E  +  E     QTE  +   A  H  L+ L
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 349 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR---GLSYLHE 405
           +    T +    V  Y+  G +   + +RQ  LP       +     SA     L+YLHE
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLP------EEHARFYSAEISLALNYLHE 171
Query: 406 HCDPKIIHRDVKAANILLDEDA 427
                II+RD+K  N+LLD + 
Sbjct: 172 RG---IIYRDLKLDNVLLDSEG 190

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 69/152 (45%), Gaps = 26/152 (17%)
Query: 294 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 346
           LG G FGKV +        +D  + VAVK LK            +E+K++S +  H N++
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL------PPL--------DWPTRKKI 392
            L G CT     L++  Y   G + + LR ++ S       P +        D       
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 393 ALGSARGLSYL-HEHCDPKIIHRDVKAANILL 423
           +   A+G+++L  ++C    IHRD+ A NILL
Sbjct: 174 SYQVAKGMAFLASKNC----IHRDLAARNILL 201

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 47/105 (44%), Gaps = 10/105 (9%)
Query: 329 QFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVAS------RLRERQSSLP 382
            F+ E++II+   +   L   G  T   E  ++Y YM N S+         L +  +   
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 383 PLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA 427
           P+     K I        SY+H   +  I HRDVK +NIL+D++ 
Sbjct: 149 PI--QVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNG 189

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 66/151 (43%), Gaps = 24/151 (15%)
Query: 294 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 346
           LG G FGKV +        +D  + VAVK LK            +E+K++S +  H N++
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL------PPL--------DWPTRKKI 392
            L G CT     L++  Y   G + + LR ++ S       P +        D       
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 423
           +   A+G+++L        IHRD+ A NILL
Sbjct: 174 SYQVAKGMAFL---ASKNCIHRDLAARNILL 201

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 7/145 (4%)
Query: 281 LQVATDGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 339
           +++  D F   + LG G  G V+K      G ++A K +  E       Q   E++++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 340 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 399
                ++  YG   +  E  +   +M  GS+   L+ +   +P        K+++   +G
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE---QILGKVSIAVIKG 116
Query: 400 LSYLHEHCDPKIIHRDVKAANILLD 424
           L+YL E    KI+HRDVK +NIL++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVN 139

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 7/145 (4%)
Query: 281 LQVATDGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 339
           +++  D F   + LG G  G V+K      G ++A K +  E       Q   E++++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 340 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 399
                ++  YG   +  E  +   +M  GS+   L+ +   +P        K+++   +G
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE---QILGKVSIAVIKG 116
Query: 400 LSYLHEHCDPKIIHRDVKAANILLD 424
           L+YL E    KI+HRDVK +NIL++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVN 139

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 60/136 (44%), Gaps = 15/136 (11%)
Query: 294 LGRGGFGKVYKGRLADGKLVAVKRL-----KEERTSGGELQFQTEVKIISMAVHRNLLRL 348
           LG G +G+V    L   K+  V+R      K   ++    +   EV ++ +  H N+++L
Sbjct: 45  LGSGAYGEVL---LCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 349 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 408
           Y F        LV      G +   +  R      +D     K  L    G++YLH+H  
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMK-FNEVDAAVIIKQVLS---GVTYLHKH-- 155
Query: 409 PKIIHRDVKAANILLD 424
             I+HRD+K  N+LL+
Sbjct: 156 -NIVHRDLKPENLLLE 170

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 32/151 (21%), Positives = 63/151 (41%), Gaps = 4/151 (2%)
Query: 286 DGFSNKNILGRGGFGKVY-KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 344
           D F  K  LG G FG V+     + G    +K + ++R+     Q + E++++    H N
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
           +++++          +V      G +  R+   Q+    L      ++       L+Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 405 EHCDPKIIHRDVKAANILLDEDADQSSKTIL 435
                 ++H+D+K  NIL  + +  S   I+
Sbjct: 142 SQ---HVVHKDLKPENILFQDTSPHSPIKII 169

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 7/145 (4%)
Query: 281 LQVATDGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 339
           +++  D F   + LG G  G V+K      G ++A K +  E       Q   E++++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 340 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 399
                ++  YG   +  E  +   +M  GS+   L+ +   +P        K+++   +G
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQ---ILGKVSIAVIKG 116
Query: 400 LSYLHEHCDPKIIHRDVKAANILLD 424
           L+YL E    KI+HRDVK +NIL++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVN 139

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 70/155 (45%), Gaps = 29/155 (18%)
Query: 286 DGFSNKNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAV 341
           D +  +++LG G F +V    LA+ K    LVA+K + ++   G E   + E+ ++    
Sbjct: 18  DIYDFRDVLGTGAFSEVI---LAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 74
Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL------RERQSSLPPLDWPTRKKIALG 395
           H N++ L     +     L+   ++ G +  R+       ER +S          ++   
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS----------RLIFQ 124
Query: 396 SARGLSYLHEHCDPKIIHRDVKAANIL---LDEDA 427
               + YLH   D  I+HRD+K  N+L   LDED+
Sbjct: 125 VLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDS 156

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 7/145 (4%)
Query: 281 LQVATDGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 339
           +++  D F   + LG G  G V+K      G ++A K +  E       Q   E++++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 340 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 399
                ++  YG   +  E  +   +M  GS+   L+ +   +P        K+++   +G
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQ---ILGKVSIAVIKG 116
Query: 400 LSYLHEHCDPKIIHRDVKAANILLD 424
           L+YL E    KI+HRDVK +NIL++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVN 139

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	438
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-112
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-79
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-74
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-47
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-41
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	8e-41
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-39
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-39
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	8e-38
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-37
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-35
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-24
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-23
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-22
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-22
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-21
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-19
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-18
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-15
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-12
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-34
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-34
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-34
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-34
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	6e-34
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-26
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-08
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-33
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-33
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	9e-33
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-31
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-29
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-28
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-27
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-27
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-27
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-27
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-27
3pls_A	298	Macrophage-stimulating protein receptor; protein k	6e-27
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-26
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-26
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-26
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-26
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-26
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-26
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-26
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-26
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-26
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-26
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-26
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-26
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	8e-26
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-25
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-25
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-25
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-25
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-25
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-25
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-25
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-25
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-25
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	7e-25
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-25
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	8e-25
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-24
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-24
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-24
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-24
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-24
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-24
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-24
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-24
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-24
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-24
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-24
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-24
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-24
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-24
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	8e-24
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-23
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-23
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-23
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-23
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-23
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-23
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-23
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-23
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-23
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-23
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	7e-23
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-23
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-22
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-22
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-22
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-22
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	8e-22
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	9e-22
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-21
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-21
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-21
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-21
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-21
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-21
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-21
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-20
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-20
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-20
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-20
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-20
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-20
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-20
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-20
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-20
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-20
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-19
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-19
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-19
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-18
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-18
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-18
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-18
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-18
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-17
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-17
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-15
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-13
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-13
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-08
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-07
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-17
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-17
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-14
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-13
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-12
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-10
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-09
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-07
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-17
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-17
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-17
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-16
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-16
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-16
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-14
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-14
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-14
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-12
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-12
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-06
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-16
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-16
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-15
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-15
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-15
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-14
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-14
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-14
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-13
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-13
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-06
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-16
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	8e-16
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-16
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-14
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-13
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-11
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-06
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-06
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-15
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-15
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-15
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-15
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-15
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-15
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-15
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-15
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-15
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-14
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-14
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-14
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-14
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-14
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-14
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-14
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-14
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-11
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-08
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-14
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-14
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-13
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-13
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	9e-13
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-12
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-12
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-11
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-06
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-14
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-14
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-14
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-14
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-14
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-14
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-14
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-14
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-14
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	8e-14
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	8e-14
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	9e-14
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	9e-14
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-13
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-13
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-13
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-13
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-13
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-13
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-13
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-13
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-13
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	8e-13
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	9e-12
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-11
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-08
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-08
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-06
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-13
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-13
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-13
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-13
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-13
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	7e-13
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	7e-13
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	7e-13
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	8e-13
3ork_A	311	Serine/threonine protein kinase; structural genomi	8e-13
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	8e-13
3bhy_A	283	Death-associated protein kinase 3; death associate	9e-13
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-12
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-12
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-12
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-12
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-12
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-12
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-12
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-10
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-09
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-08
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-07
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-05
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-12
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-12
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-11
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-10
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-09
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-07
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-07
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-07
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-04
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-12
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-12
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-12
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-12
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-12
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-12
1o6v_A	466	Internalin A; bacterial infection, extracellular r	9e-12
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-10
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-10
1o6v_A	466	Internalin A; bacterial infection, extracellular r	9e-10
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-07
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-11
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-06
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-12
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-11
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-11
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-11
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-11
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-08
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-07
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-07
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-06
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-11
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-11
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-11
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-11
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-10
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	9e-09
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-08
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-07
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-11
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-11
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-11
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-10
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-07
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	7e-11
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	9e-11
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-10
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-09
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-08
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-08
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	9e-11
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-10
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-10
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-10
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-08
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-06
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	9e-11
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-10
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-09
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-08
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-08
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-07
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-10
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-10
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-08
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-06
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-06
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-05
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-04
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	7e-09
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-08
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-06
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-10
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-10
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-10
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	9e-10
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	9e-10
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-09
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-08
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-06
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-05
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-10
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-10
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	8e-10
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-08
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-08
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-08
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-08
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	6e-04
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-10
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-09
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-07
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-07
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-06
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	9e-06
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-10
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-07
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-06
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-06
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-06
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-06
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-06
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-06
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-10
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-10
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	7e-09
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-07
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	7e-07
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-04
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-10
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-09
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-09
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-08
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-07
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-07
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	6e-06
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	8e-10
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-10
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	8e-10
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-09
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-08
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-07
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-07
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-05
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	9e-10
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-09
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-09
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-09
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-08
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-07
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-07
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	6e-05
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-09
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-08
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-07
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-04
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-09
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-08
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-07
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-07
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-04
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-04
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-09
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-09
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-09
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-08
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-07
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-09
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	6e-09
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-08
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-07
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-04
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	6e-09
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	8e-09
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-08
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-08
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-08
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-07
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-07
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-06
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-08
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-08
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-08
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	8e-05
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-08
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-07
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-04
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-06
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-05
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-08
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-08
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-06
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-05
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-08
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-07
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-07
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-08
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-08
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-07
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-04
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-08
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-07
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-06
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-05
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-08
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	6e-08
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-05
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-05
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-05
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	6e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-06
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-08
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	9e-06
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-05
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-05
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-05
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-04
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	9e-08
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-05
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-07
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-07
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	5e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-06
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-07
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	5e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-04
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	7e-07
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	8e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	8e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	5e-05
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	9e-07
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-06
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-06
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-06
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-06
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-05
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-05
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	3e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	7e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-05
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-05
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-04
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-04
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-04
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	5e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-04
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-04
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	3e-04
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-04
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-04
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-04
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-04
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-04
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	6e-04
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	7e-04
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  332 bits (854), Expect = e-112
 Identities = 145/170 (85%), Positives = 156/170 (91%)

Query: 257 FFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVK 316
           FFDVPAE+D E+ LGQLKRFSLRELQVA+D FSNKNILGRGGFGKVYKGRLADG LVAVK
Sbjct: 1   FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60

Query: 317 RLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE 376
           RLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NGSVAS LRE
Sbjct: 61  RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120

Query: 377 RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           R  S PPLDWP R++IALGSARGL+YLH+HCDPKIIHRDVKAANILLDE+
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE 170

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  247 bits (632), Expect = 2e-79
 Identities = 68/173 (39%), Positives = 94/173 (54%), Gaps = 14/173 (8%)

Query: 263 EDDSELQLGQLKRFSLRELQVATDGFSNK------NILGRGGFGKVYKGRLADGKLVAVK 316
               E+   +   FS  EL+  T+ F  +      N +G GGFG VYKG + +   VAVK
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60

Query: 317 RLKEERTSG---GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASR 373
           +L           + QF  E+K+++   H NL+ L GF +   +  LVY YM NGS+  R
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120

Query: 374 LRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           L     + PPL W  R KIA G+A G+++LHE+     IHRD+K+ANILLDE 
Sbjct: 121 LSCLDGT-PPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEA 169

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  234 bits (599), Expect = 3e-74
 Identities = 71/167 (42%), Positives = 96/167 (57%), Gaps = 6/167 (3%)

Query: 261 PAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKE 320
            A   S L   +  R  L +L+ AT+ F +K ++G G FGKVYKG L DG  VA+KR   
Sbjct: 14  DALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP 73

Query: 321 ERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS 379
           E  S  G  +F+TE++ +S   H +L+ L GFC    E +L+Y YM NG++   L     
Sbjct: 74  E--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL 131

Query: 380 SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
               + W  R +I +G+ARGL YLH      IIHRDVK+ NILLDE+
Sbjct: 132 PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDEN 175

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  164 bits (416), Expect = 3e-47
 Identities = 43/162 (26%), Positives = 65/162 (40%), Gaps = 19/162 (11%)

Query: 276 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVK 335
                L   +       +  RG FG V+K +L   + VAVK    +       Q + EV 
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ--DKQSWQNEYEVY 70

Query: 336 IISMAVHRNLLRLYGFCT----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKK 391
            +    H N+L+  G          +  L+  +   GS++  L+        + W     
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-----VVSWNELCH 125

Query: 392 IALGSARGLSYLHEH-------CDPKIIHRDVKAANILLDED 426
           IA   ARGL+YLHE          P I HRD+K+ N+LL  +
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN 167

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  146 bits (370), Expect = 5e-41
 Identities = 50/184 (27%), Positives = 86/184 (46%), Gaps = 28/184 (15%)

Query: 262 AEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKE 320
           A   SE    +L   +  E++        +  +G+GGFG V+KGR + D  +VA+K L  
Sbjct: 2   AMGGSEFPKSRLPTLADNEIEY-------EKQIGKGGFGLVHKGRLVKDKSVVAIKSLIL 54

Query: 321 ERTSGGEL------QFQTEVKIISMAVHRNLLRLYGFCTT----VTEKLLVYPYMTNGSV 370
             + G         +FQ EV I+S   H N+++LYG        V E      ++  G +
Sbjct: 55  GDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVME------FVPCGDL 108

Query: 371 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS 430
             RL ++     P+ W  + ++ L  A G+ Y+  + +P I+HRD+++ NI L    + +
Sbjct: 109 YHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENA 164

Query: 431 SKTI 434
               
Sbjct: 165 PVCA 168

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  147 bits (372), Expect = 8e-41
 Identities = 50/164 (30%), Positives = 68/164 (41%), Gaps = 23/164 (14%)

Query: 276 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVK 335
            +  E  +  D      ++GRG +G VYKG L D + VAVK             F  E  
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFS----FANRQNFINEKN 57

Query: 336 IISMAV--HRNLLRLYGFCTTV-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPT 388
           I  + +  H N+ R       V      E LLV  Y  NGS+   L          DW +
Sbjct: 58  IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-----TSDWVS 112

Query: 389 RKKIALGSARGLSYLHE------HCDPKIIHRDVKAANILLDED 426
             ++A    RGL+YLH       H  P I HRD+ + N+L+  D
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND 156

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  142 bits (360), Expect = 3e-39
 Identities = 45/143 (31%), Positives = 71/143 (49%), Gaps = 16/143 (11%)

Query: 291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLY 349
           K  +G G FG V++     G  VAVK L E+      +  F  EV I+    H N++   
Sbjct: 42  KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100

Query: 350 GFCTT------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           G  T       VTE      Y++ GS+   L  +  +   LD   R  +A   A+G++YL
Sbjct: 101 GAVTQPPNLSIVTE------YLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYL 153

Query: 404 HEHCDPKIIHRDVKAANILLDED 426
           H + +P I+HR++K+ N+L+D+ 
Sbjct: 154 H-NRNPPIVHRNLKSPNLLVDKK 175

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  141 bits (358), Expect = 5e-39
 Identities = 42/140 (30%), Positives = 66/140 (47%), Gaps = 15/140 (10%)

Query: 291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 350
           + ++GRG FG V K +    K VA+K+++ E        F  E++ +S   H N+++LYG
Sbjct: 13  EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE---RKAFIVELRQLSRVNHPNIVKLYG 68

Query: 351 FCTT----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
            C      V E      Y   GS+ + L   +  LP           L  ++G++YLH  
Sbjct: 69  ACLNPVCLVME------YAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 407 CDPKIIHRDVKAANILLDED 426
               +IHRD+K  N+LL   
Sbjct: 122 QPKALIHRDLKPPNLLLVAG 141

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  137 bits (347), Expect = 8e-38
 Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 21/152 (13%)

Query: 291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEER---TSGGELQFQTEVKIISMAVHRNLLR 347
           + I+G GGFGKVY+     G  VAVK  + +     S      + E K+ +M  H N++ 
Sbjct: 12  EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70

Query: 348 LYGFCTT------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           L G C        V E      +   G +   L  ++     +        A+  ARG++
Sbjct: 71  LRGVCLKEPNLCLVME------FARGGPLNRVLSGKR-----IPPDILVNWAVQIARGMN 119

Query: 402 YLHEHCDPKIIHRDVKAANILLDEDADQSSKT 433
           YLH+     IIHRD+K++NIL+ +  +    +
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLS 151

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  136 bits (346), Expect = 1e-37
 Identities = 38/145 (26%), Positives = 65/145 (44%), Gaps = 19/145 (13%)

Query: 291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLY 349
              L     G+++KGR   G  + VK LK    S  + + F  E   + +  H N+L + 
Sbjct: 15  LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73

Query: 350 GFCTT--------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           G C +        +T       +M  GS+ + L E  +    +D     K AL  ARG++
Sbjct: 74  GACQSPPAPHPTLITH------WMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMA 125

Query: 402 YLHEHCDPKIIHRDVKAANILLDED 426
           +LH   +P I    + + ++++DED
Sbjct: 126 FLH-TLEPLIPRHALNSRSVMIDED 149

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  136 bits (345), Expect = 7e-35
 Identities = 47/174 (27%), Positives = 77/174 (44%), Gaps = 14/174 (8%)

Query: 49  EQLHLLISFLIFIRVLQSSSNLFVYLIS-DLGNAALSGELAPELGQLKNLELL------- 100
           ++ H   + L F  +     N        ++ +    G  +P      ++  L       
Sbjct: 585 KECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNML 644

Query: 101 ------ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTIT 154
                  +G++  L  L+L  N  +G+IPD + +L+ L  L L++N L G IP +++ +T
Sbjct: 645 SGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALT 704

Query: 155 SLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPP 208
            L  +DLSNN LSGP+P+ G F  F P  F NN  LCG    +    +      
Sbjct: 705 MLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAH 758

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  103 bits (260), Expect = 6e-24
 Identities = 43/125 (34%), Positives = 61/125 (48%), Gaps = 14/125 (11%)

Query: 77  DLGNAALSGELAPELGQLKNLELLAL-------------GNLIKLKSLDLYSNLFNGTIP 123
            L N   +G++ P L     L  L L             G+L KL+ L L+ N+  G IP
Sbjct: 400 YLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIP 459

Query: 124 DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPI 182
             L  +K L+ L L+ N L+G IP+ L+  T+LN + LSNNRL+G +P   G       +
Sbjct: 460 QELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAIL 519

Query: 183 SFENN 187
              NN
Sbjct: 520 KLSNN 524

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  103 bits (258), Expect = 1e-23
 Identities = 39/126 (30%), Positives = 54/126 (42%), Gaps = 15/126 (11%)

Query: 77  DLGNAALSGELAPELGQLKNLELLAL-------------GNLIKLKSLDLYSNLFNGTIP 123
            L    L GE+  EL  +K LE L L              N   L  + L +N   G IP
Sbjct: 448 KLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP 507

Query: 124 DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 183
             +  L+ L  L+L+NNS SG IP  L    SL  LDL+ N  +G +P   +  + +   
Sbjct: 508 KWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA--AMFKQSGKI 565

Query: 184 FENNLN 189
             N + 
Sbjct: 566 AANFIA 571

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 99.6 bits (249), Expect = 1e-22
 Identities = 43/134 (32%), Positives = 58/134 (43%), Gaps = 18/134 (13%)

Query: 77  DLGNAALSGELAPELGQLK-NLELLALGN---------------LIKLKSLDLYSNLFNG 120
           DL     SGEL   L  L  +L  L L +                  L+ L L +N F G
Sbjct: 349 DLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTG 408

Query: 121 TIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQF 179
            IP TL+N  +L  L L+ N LSG IP+SL +++ L  L L  N L G +P         
Sbjct: 409 KIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTL 468

Query: 180 TPISFENNLNLCGP 193
             +  + N +L G 
Sbjct: 469 ETLILDFN-DLTGE 481

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 99.2 bits (248), Expect = 2e-22
 Identities = 34/147 (23%), Positives = 61/147 (41%), Gaps = 22/147 (14%)

Query: 61  IRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELL------------ALGNLIKL 108
             +      L  +L   +    +SG++  ++ +  NLE L             LG+   L
Sbjct: 171 WVLSDGCGEL-KHL--AISGNKISGDV--DVSRCVNLEFLDVSSNNFSTGIPFLGDCSAL 225

Query: 109 KSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 168
           + LD+  N  +G     ++   +LK L +++N   G IP     + SL  L L+ N+ +G
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTG 283

Query: 169 PVPDN--GSFSQFTPISFENNLNLCGP 193
            +PD   G+    T +    N +  G 
Sbjct: 284 EIPDFLSGACDTLTGLDLSGN-HFYGA 309

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 96.1 bits (240), Expect = 2e-21
 Identities = 42/171 (24%), Positives = 65/171 (38%), Gaps = 47/171 (27%)

Query: 64  LQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLAL--------------------- 102
           L   S L  +L  D+    LSG+ +  +     L+LL +                     
Sbjct: 219 LGDCSAL-QHL--DISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLS 275

Query: 103 ---------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIP 147
                          G    L  LDL  N F G +P    +   L+ L L++N+ SG +P
Sbjct: 276 LAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELP 335

Query: 148 T-SLTTITSLNILDLSNNRLSGPVPDNGSFSQFTP----ISFENNLNLCGP 193
             +L  +  L +LDLS N  SG +P+  S +  +     +   +N N  GP
Sbjct: 336 MDTLLKMRGLKVLDLSFNEFSGELPE--SLTNLSASLLTLDLSSN-NFSGP 383

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 88.0 bits (219), Expect = 8e-19
 Identities = 27/114 (23%), Positives = 44/114 (38%), Gaps = 20/114 (17%)

Query: 77  DLGNAALSGELAPELGQLKNLELL---------------ALGNLIKLKSLDLYSNLFNGT 121
            L N+ ++G +        +L  L               +LG+   LK L++ SN  +  
Sbjct: 83  FLSNSHINGSV-SGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFP 141

Query: 122 IPDT-LANLKQLKYLRLNNNSLSGLIPTSLTT---ITSLNILDLSNNRLSGPVP 171
              +    L  L+ L L+ NS+SG              L  L +S N++SG V 
Sbjct: 142 GKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD 195

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 87.3 bits (217), Expect = 2e-18
 Identities = 31/127 (24%), Positives = 48/127 (37%), Gaps = 18/127 (14%)

Query: 77  DLGNAALSGELAPELGQLKNLELLAL-------------GNLIKLKSLDLYSNLFNGTIP 123
            L    L+GE+   L    NL  ++L             G L  L  L L +N F+G IP
Sbjct: 472 ILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIP 531

Query: 124 DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPI 182
             L + + L +L LN N  +G IP ++          ++ N ++G       +       
Sbjct: 532 AELGDCRSLIWLDLNTNLFNGTIPAAM----FKQSGKIAANFIAGKRYVYIKNDGMKKEC 587

Query: 183 SFENNLN 189
               NL 
Sbjct: 588 HGAGNLL 594

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 77.3 bits (191), Expect = 3e-15
 Identities = 21/107 (19%), Positives = 33/107 (30%), Gaps = 11/107 (10%)

Query: 77  DLGNAALSGELAPELGQLKNLELL---------ALGNLIKLKSLDLYSNL--FNGTIPDT 125
           DL     +G +   + +                 + N    K      NL  F G   + 
Sbjct: 544 DLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQ 603

Query: 126 LANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD 172
           L  L       + +    G    +     S+  LD+S N LSG +P 
Sbjct: 604 LNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPK 650

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 74.2 bits (183), Expect = 2e-14
 Identities = 28/105 (26%), Positives = 43/105 (40%), Gaps = 14/105 (13%)

Query: 75  ISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKY 134
           +S          ++  L  L  LE           SL L ++  NG++         L  
Sbjct: 57  LSSKPLNVGFSAVSSSLLSLTGLE-----------SLFLSNSHINGSVSG-FKCSASLTS 104

Query: 135 LRLNNNSLSGLIPT--SLTTITSLNILDLSNNRLSGPVPDNGSFS 177
           L L+ NSLSG + T  SL + + L  L++S+N L  P   +G   
Sbjct: 105 LDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLK 149

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 67.6 bits (166), Expect = 3e-12
 Identities = 25/95 (26%), Positives = 40/95 (42%), Gaps = 5/95 (5%)

Query: 103 GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLS 162
             +  +       N+    +  +L +L  L+ L L+N+ ++G +        SL  LDLS
Sbjct: 50  DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLS 108

Query: 163 NNRLSGPVPDNGSFSQFTPISF----ENNLNLCGP 193
            N LSGPV    S    + + F     N L+  G 
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGK 143

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  129 bits (327), Expect = 1e-34
 Identities = 38/143 (26%), Positives = 62/143 (43%), Gaps = 20/143 (13%)

Query: 291 KNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
             +LG+G FG+  K      G+++ +K L        +  F  EVK++    H N+L+  
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE-TQRTFLKEVKVMRCLEHPNVLKFI 73

Query: 350 GFCTT------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           G          +TE      Y+  G++   ++   S      W  R   A   A G++YL
Sbjct: 74  GVLYKDKRLNFITE------YIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYL 124

Query: 404 HEHCDPKIIHRDVKAANILLDED 426
           H      IIHRD+ + N L+ E+
Sbjct: 125 HSM---NIIHRDLNSHNCLVREN 144

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  128 bits (324), Expect = 3e-34
 Identities = 47/139 (33%), Positives = 65/139 (46%), Gaps = 20/139 (14%)

Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 352
           +G G FG VYKG+   G  VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 32  IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 353 T-----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           T      VT+      +    S+   L   +      +      IA  +ARG+ YLH   
Sbjct: 90  TAPQLAIVTQ------WCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK- 139

Query: 408 DPKIIHRDVKAANILLDED 426
              IIHRD+K+ NI L ED
Sbjct: 140 --SIIHRDLKSNNIFLHED 156

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  129 bits (325), Expect = 3e-34
 Identities = 38/143 (26%), Positives = 68/143 (47%), Gaps = 21/143 (14%)

Query: 291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLY 349
             ++G+G FG+VY GR   G+ VA++ +  ER +  +L+ F+ EV       H N++   
Sbjct: 38  GELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95

Query: 350 GFCTT------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           G C +      +T            ++ S +R+ +     LD    ++IA    +G+ YL
Sbjct: 96  GACMSPPHLAIITS------LCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYL 146

Query: 404 HEHCDPKIIHRDVKAANILLDED 426
           H      I+H+D+K+ N+  D  
Sbjct: 147 HAK---GILHKDLKSKNVFYDNG 166

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  128 bits (324), Expect = 6e-34
 Identities = 38/146 (26%), Positives = 61/146 (41%), Gaps = 18/146 (12%)

Query: 68  SNLFVYLISDLGNAALSGELAPELGQLKNLELLAL-------------GNLIKLKSLDLY 114
           S LF  +   +    L+G++ P    L NL  + L             G+    + + L 
Sbjct: 173 SKLFTSM--TISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229

Query: 115 SNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNG 174
            N     +   +   K L  L L NN + G +P  LT +  L+ L++S N L G +P  G
Sbjct: 230 KNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288

Query: 175 SFSQFTPISFENNLNLCGPNTKKPCS 200
           +  +F   ++ NN  LCG      C+
Sbjct: 289 NLQRFDVSAYANNKCLCGSPL-PACT 313

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  107 bits (269), Expect = 2e-26
 Identities = 41/135 (30%), Positives = 62/135 (45%), Gaps = 19/135 (14%)

Query: 77  DLGNAALSGELA--PELGQLKNLELL--------------ALGNLIKLKSLDLYSNLFNG 120
           DL    L         L  L  L  L              A+  L +L  L +     +G
Sbjct: 56  DLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSG 115

Query: 121 TIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQ- 178
            IPD L+ +K L  L  + N+LSG +P S++++ +L  +    NR+SG +PD+ GSFS+ 
Sbjct: 116 AIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL 175

Query: 179 FTPISFENNLNLCGP 193
           FT ++   N  L G 
Sbjct: 176 FTSMTISRN-RLTGK 189

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 54.8 bits (133), Expect = 2e-08
 Identities = 22/88 (25%), Positives = 38/88 (43%), Gaps = 5/88 (5%)

Query: 110 SLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSG--LIPTSLTTITSLNILDLSN-NRL 166
           + D  +  + G + DT     ++  L L+  +L     IP+SL  +  LN L +   N L
Sbjct: 30  TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNL 89

Query: 167 SGPVPDN-GSFSQFTPISFENNLNLCGP 193
            GP+P      +Q   +   +  N+ G 
Sbjct: 90  VGPIPPAIAKLTQLHYLYITHT-NVSGA 116

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  125 bits (316), Expect = 5e-33
 Identities = 39/146 (26%), Positives = 64/146 (43%), Gaps = 21/146 (14%)

Query: 292 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV--HRNLLRLY 349
             +G+G +G+V++G    G+ VAVK          E  +  E ++ +  +  H N+L   
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFI 68

Query: 350 GFCTTVTEK----LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 405
               T         L+  Y   GS+   L+        LD  +  +I L  A GL++LH 
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHI 123

Query: 406 -----HCDPKIIHRDVKAANILLDED 426
                   P I HRD+K+ NIL+ ++
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKN 149

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  125 bits (316), Expect = 9e-33
 Identities = 41/146 (28%), Positives = 65/146 (44%), Gaps = 21/146 (14%)

Query: 292 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV--HRNLLRLY 349
             +G+G +G+V+ G+   G+ VAVK          E  +  E +I    +  H N+L   
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFI 97

Query: 350 GFCT----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 405
                   + T+  L+  Y  NGS+   L+        LD  +  K+A  S  GL +LH 
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHT 152

Query: 406 -----HCDPKIIHRDVKAANILLDED 426
                   P I HRD+K+ NIL+ ++
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKN 178

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  120 bits (303), Expect = 7e-31
 Identities = 42/146 (28%), Positives = 66/146 (45%), Gaps = 21/146 (14%)

Query: 292 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV--HRNLLRLY 349
             +G+G FG+V++G+   G+ VAVK          E  +  E +I    +  H N+L   
Sbjct: 48  ESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFI 102

Query: 350 GFCT----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 405
                   T T+  LV  Y  +GS+   L         +      K+AL +A GL++LH 
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHM 157

Query: 406 -----HCDPKIIHRDVKAANILLDED 426
                   P I HRD+K+ NIL+ ++
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKN 183

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  116 bits (294), Expect = 2e-29
 Identities = 46/143 (32%), Positives = 65/143 (45%), Gaps = 19/143 (13%)

Query: 291 KNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
              +GRG FG+V+ GRL AD  LVAVK  +E      + +F  E +I+    H N++RL 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178

Query: 350 GFCTT------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           G CT       V E       +  G   + LR   + L      T  ++   +A G+ YL
Sbjct: 179 GVCTQKQPIYIVME------LVQGGDFLTFLRTEGARLRV---KTLLQMVGDAAAGMEYL 229

Query: 404 HEHCDPKIIHRDVKAANILLDED 426
                   IHRD+ A N L+ E 
Sbjct: 230 ESK---CCIHRDLAARNCLVTEK 249

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  111 bits (281), Expect = 5e-28
 Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 15/148 (10%)

Query: 291 KNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNL 345
             ILG G FG V +G L         VAVK +K + +S  E++ F +E   +    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 346 LRLYGFCT-----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK--KIALGSAR 398
           +RL G C       + + +++ P+M  G + + L   +    P   P +   K  +  A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 399 GLSYLHEHCDPKIIHRDVKAANILLDED 426
           G+ YL        +HRD+ A N +L +D
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDD 183

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  110 bits (277), Expect = 1e-27
 Identities = 48/140 (34%), Positives = 62/140 (44%), Gaps = 11/140 (7%)

Query: 292 NILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
            ++GRG FG VY G L D        AVK L      G   QF TE  I+    H N+L 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 348 LYGFCTTVTEKLL-VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
           L G C       L V PYM +G + + +R    +    D        L  A+G+ YL   
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKYLASK 147

Query: 407 CDPKIIHRDVKAANILLDED 426
              K +HRD+ A N +LDE 
Sbjct: 148 ---KFVHRDLAARNCMLDEK 164

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  110 bits (277), Expect = 2e-27
 Identities = 38/143 (26%), Positives = 66/143 (46%), Gaps = 13/143 (9%)

Query: 291 KNILGRGGFGKVYKGRLA-----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 345
              LG G FGKV   R        G+ VAVK LK E         + E++I+    H N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 346 LRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           ++  G CT        L+  ++ +GS+   L + ++ +       + K A+   +G+ YL
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL---KQQLKYAVQICKGMDYL 142

Query: 404 HEHCDPKIIHRDVKAANILLDED 426
                 + +HRD+ A N+L++ +
Sbjct: 143 GSR---QYVHRDLAARNVLVESE 162

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  109 bits (275), Expect = 3e-27
 Identities = 42/143 (29%), Positives = 59/143 (41%), Gaps = 15/143 (10%)

Query: 291 KNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 345
              LG G FGKV            G++VAVK LK +        ++ E+ I+    H ++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 346 LRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           ++  G C         LV  Y+  GS+   L      L  L        A     G++YL
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYL 150

Query: 404 HEHCDPKIIHRDVKAANILLDED 426
           H       IHRD+ A N+LLD D
Sbjct: 151 HAQ---HYIHRDLAARNVLLDND 170

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  109 bits (274), Expect = 5e-27
 Identities = 35/145 (24%), Positives = 64/145 (44%), Gaps = 22/145 (15%)

Query: 292 NILGRGGFGKVYKGRLADGKL-----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
            +LG G FG VYKG            VA+K L+E  +     +   E  +++   + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 347 RLYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           RL G C T     +T+       M  G +   +RE + ++            +  A+G++
Sbjct: 81  RLLGICLTSTVQLITQ------LMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 131

Query: 402 YLHEHCDPKIIHRDVKAANILLDED 426
           YL +    +++HRD+ A N+L+   
Sbjct: 132 YLEDR---RLVHRDLAARNVLVKTP 153

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  109 bits (274), Expect = 6e-27
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 15/148 (10%)

Query: 291 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 344
              LG+G FG VY+G             VA+K + E  +    ++F  E  ++      +
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER---QSSLPPLDWPTRK---KIALGSAR 398
           ++RL G  +     L++   MT G + S LR      ++ P L  P+     ++A   A 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 399 GLSYLHEHCDPKIIHRDVKAANILLDED 426
           G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 150 GMAYLNAN---KFVHRDLAARNCMVAED 174

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  108 bits (272), Expect = 6e-27
 Identities = 40/141 (28%), Positives = 57/141 (40%), Gaps = 11/141 (7%)

Query: 291 KNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
             ++G+G FG VY G   D        A+K L           F  E  ++    H N+L
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 347 RLYGFCTTVTE-KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 405
            L G          ++ PYM +G +   +R  Q +             L  ARG+ YL E
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV---KDLISFGLQVARGMEYLAE 142

Query: 406 HCDPKIIHRDVKAANILLDED 426
               K +HRD+ A N +LDE 
Sbjct: 143 Q---KFVHRDLAARNCMLDES 160

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  108 bits (271), Expect = 1e-26
 Identities = 38/149 (25%), Positives = 65/149 (43%), Gaps = 16/149 (10%)

Query: 291 KNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNL 345
             +LG+G FG V + +L         VAVK LK +  +  +++ F  E   +    H ++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 346 LRLYGFCT------TVTEKLLVYPYMTNGSVASRLRERQSSLPP--LDWPTRKKIALGSA 397
            +L G          +   +++ P+M +G + + L   +    P  L   T  +  +  A
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 398 RGLSYLHEHCDPKIIHRDVKAANILLDED 426
            G+ YL        IHRD+ A N +L ED
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAED 173

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  109 bits (273), Expect = 2e-26
 Identities = 47/140 (33%), Positives = 62/140 (44%), Gaps = 11/140 (7%)

Query: 292 NILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
            ++GRG FG VY G L D        AVK L      G   QF TE  I+    H N+L 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 348 LYGFCTTVTEKLL-VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
           L G C       L V PYM +G + + +R    +    D        L  A+G+ +L   
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKFLASK 211

Query: 407 CDPKIIHRDVKAANILLDED 426
              K +HRD+ A N +LDE 
Sbjct: 212 ---KFVHRDLAARNCMLDEK 228

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  106 bits (267), Expect = 2e-26
 Identities = 40/136 (29%), Positives = 64/136 (47%), Gaps = 8/136 (5%)

Query: 291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 350
              +G G FG V+ G   +   VA+K ++E   S  E  F  E +++    H  L++LYG
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYG 70

Query: 351 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 410
            C       LV  +M +G ++  LR ++         T   + L    G++YL E     
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEA---C 124

Query: 411 IIHRDVKAANILLDED 426
           +IHRD+ A N L+ E+
Sbjct: 125 VIHRDLAARNCLVGEN 140

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  106 bits (267), Expect = 2e-26
 Identities = 37/145 (25%), Positives = 61/145 (42%), Gaps = 21/145 (14%)

Query: 291 KNILGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
             ILG G FG+VY+G   + K     VAVK  K++ T   + +F +E  I+    H +++
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 347 RLYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           +L G         + E          G +   L   ++SL      T    +L   + ++
Sbjct: 77  KLIGIIEEEPTWIIME------LYPYGELGHYLERNKNSLKV---LTLVLYSLQICKAMA 127

Query: 402 YLHEHCDPKIIHRDVKAANILLDED 426
           YL        +HRD+   NIL+   
Sbjct: 128 YLESI---NCVHRDIAVRNILVASP 149

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  106 bits (267), Expect = 3e-26
 Identities = 34/143 (23%), Positives = 59/143 (41%), Gaps = 21/143 (14%)

Query: 293 ILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
            +G G FG V++G     +     VA+K  K   +     +F  E   +    H ++++L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 349 YGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
            G  T      + E        T G + S L+ R+ SL      +    A   +  L+YL
Sbjct: 82  IGVITENPVWIIME------LCTLGELRSFLQVRKYSLDL---ASLILYAYQLSTALAYL 132

Query: 404 HEHCDPKIIHRDVKAANILLDED 426
                 + +HRD+ A N+L+  +
Sbjct: 133 ESK---RFVHRDIAARNVLVSSN 152

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  106 bits (267), Expect = 4e-26
 Identities = 36/146 (24%), Positives = 62/146 (42%), Gaps = 22/146 (15%)

Query: 291 KNILGRGGFGKVYKGRLADGKL-----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 345
             +LG G FG V+KG            V +K ++++            +  I    H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 346 LRLYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 400
           +RL G C       VT+      Y+  GS+   +R+ + +L P          +  A+G+
Sbjct: 78  VRLLGLCPGSSLQLVTQ------YLPLGSLLDHVRQHRGALGP---QLLLNWGVQIAKGM 128

Query: 401 SYLHEHCDPKIIHRDVKAANILLDED 426
            YL EH    ++HR++ A N+LL   
Sbjct: 129 YYLEEH---GMVHRNLAARNVLLKSP 151

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  110 bits (275), Expect = 4e-26
 Identities = 52/269 (19%), Positives = 86/269 (31%), Gaps = 31/269 (11%)

Query: 170 VPDNGSFSQFTPISFENNLNLCGPNTK--KPCSGSPPFSPPPPFGPTSSPGRNKSNAAIP 227
           +P+   F     +     L   G      + C  S   +      PT     +       
Sbjct: 223 IPEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQR 282

Query: 228 VGVALGAALLFAVP--VIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVAT 285
               L +      P  +      R        F+ P  D  EL+    K+  L+   +  
Sbjct: 283 RIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKD---KKLFLKRDNLLI 339

Query: 286 DGFSNKNILGRGGFGKVYKGRLADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
                   LG G FG V +G     K    VA+K LK+        +   E +I+    +
Sbjct: 340 A----DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 395

Query: 343 RNLLRLYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 397
             ++RL G C       V E          G +   L  ++  +P        ++    +
Sbjct: 396 PYIVRLIGVCQAEALMLVME------MAGGGPLHKFLVGKREEIPV---SNVAELLHQVS 446

Query: 398 RGLSYLHEHCDPKIIHRDVKAANILLDED 426
            G+ YL E      +HR++ A N+LL   
Sbjct: 447 MGMKYLEEK---NFVHRNLAARNVLLVNR 472

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  106 bits (267), Expect = 5e-26
 Identities = 47/147 (31%), Positives = 63/147 (42%), Gaps = 12/147 (8%)

Query: 291 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 344
              LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER---QSSLPPLDWPTRKKIALGSARGLS 401
           ++R  G       + ++   M  G + S LRE     S    L       +A   A G  
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 402 YLHEHCDPKIIHRDVKAANILLDEDAD 428
           YL E+     IHRD+ A N LL     
Sbjct: 155 YLEEN---HFIHRDIAARNCLLTCPGP 178

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  105 bits (264), Expect = 6e-26
 Identities = 39/136 (28%), Positives = 61/136 (44%), Gaps = 8/136 (5%)

Query: 291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 350
              LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYG 86

Query: 351 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 410
            CT      ++  YM NG + + LRE +            ++       + YL      +
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---Q 140

Query: 411 IIHRDVKAANILLDED 426
            +HRD+ A N L+++ 
Sbjct: 141 FLHRDLAARNCLVNDQ 156

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  105 bits (264), Expect = 6e-26
 Identities = 35/144 (24%), Positives = 55/144 (38%), Gaps = 20/144 (13%)

Query: 291 KNILGRGGFGKVYKGRLADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
              LG G FG V +G     K    VA+K LK+        +   E +I+    +  ++R
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 348 LYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 402
           L G C       V E          G +   L  ++  +P        ++    + G+ Y
Sbjct: 75  LIGVCQAEALMLVME------MAGGGPLHKFLVGKREEIPV---SNVAELLHQVSMGMKY 125

Query: 403 LHEHCDPKIIHRDVKAANILLDED 426
           L E      +HRD+ A N+LL   
Sbjct: 126 LEEK---NFVHRDLAARNVLLVNR 146

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  105 bits (264), Expect = 7e-26
 Identities = 36/143 (25%), Positives = 65/143 (45%), Gaps = 14/143 (9%)

Query: 291 KNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 345
              LG+G FG V   R        G++VAVK+L+   T      F+ E++I+    H N+
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNI 73

Query: 346 LRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           ++  G C +   +   L+  Y+  GS+   L++ +  +         +      +G+ YL
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH---IKLLQYTSQICKGMEYL 130

Query: 404 HEHCDPKIIHRDVKAANILLDED 426
                 + IHRD+   NIL++ +
Sbjct: 131 GTK---RYIHRDLATRNILVENE 150

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  106 bits (266), Expect = 7e-26
 Identities = 36/143 (25%), Positives = 65/143 (45%), Gaps = 14/143 (9%)

Query: 291 KNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 345
              LG+G FG V   R        G++VAVK+L+   T      F+ E++I+    H N+
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNI 104

Query: 346 LRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           ++  G C +   +   L+  Y+  GS+   L++ +  +         +      +G+ YL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH---IKLLQYTSQICKGMEYL 161

Query: 404 HEHCDPKIIHRDVKAANILLDED 426
                 + IHRD+   NIL++ +
Sbjct: 162 GTK---RYIHRDLATRNILVENE 181

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  104 bits (263), Expect = 8e-26
 Identities = 42/136 (30%), Positives = 63/136 (46%), Gaps = 8/136 (5%)

Query: 291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 350
              LG G FG V  G+      VAVK +KE   S  E +F  E + +    H  L++ YG
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYG 70

Query: 351 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 410
            C+      +V  Y++NG + + LR     L P       ++      G+++L  H   +
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEP---SQLLEMCYDVCEGMAFLESH---Q 124

Query: 411 IIHRDVKAANILLDED 426
            IHRD+ A N L+D D
Sbjct: 125 FIHRDLAARNCLVDRD 140

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  104 bits (262), Expect = 1e-25
 Identities = 38/138 (27%), Positives = 64/138 (46%), Gaps = 11/138 (7%)

Query: 293 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVHRNLLRLYG 350
            +GRG F  VYKG        VA   L++ + +  E  +F+ E +++    H N++R Y 
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 351 -FCTTVTEKLLVY---PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
            + +TV  K  +      MT+G++ + L+        +     +       +GL +LH  
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR 148

Query: 407 CDPKIIHRDVKAANILLD 424
             P IIHRD+K  NI + 
Sbjct: 149 -TPPIIHRDLKCDNIFIT 165

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  106 bits (266), Expect = 1e-25
 Identities = 45/147 (30%), Positives = 62/147 (42%), Gaps = 12/147 (8%)

Query: 291 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 344
              LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK---KIALGSARGLS 401
           ++R  G       + ++   M  G + S LRE +                +A   A G  
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 402 YLHEHCDPKIIHRDVKAANILLDEDAD 428
           YL E+     IHRD+ A N LL     
Sbjct: 196 YLEEN---HFIHRDIAARNCLLTCPGP 219

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  104 bits (261), Expect = 2e-25
 Identities = 44/141 (31%), Positives = 63/141 (44%), Gaps = 18/141 (12%)

Query: 291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 350
              LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY 
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVRLYA 75

Query: 351 FCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 405
             T      +TE      YM NGS+   L+        L       +A   A G++++ E
Sbjct: 76  VVTQEPIYIITE------YMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE 127

Query: 406 HCDPKIIHRDVKAANILLDED 426
                 IHRD++AANIL+ + 
Sbjct: 128 R---NYIHRDLRAANILVSDT 145

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  104 bits (261), Expect = 2e-25
 Identities = 52/145 (35%), Positives = 64/145 (44%), Gaps = 23/145 (15%)

Query: 293 ILGRGGFGKVYKGRL--ADGKL--VAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLL 346
            LG G FG V +G      GK   VAVK LK +  S  E    F  EV  +    HRNL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 347 RLYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           RLYG   T     VTE          GS+  RLR+ Q         T  + A+  A G+ 
Sbjct: 85  RLYGVVLTPPMKMVTE------LAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEGMG 135

Query: 402 YLHEHCDPKIIHRDVKAANILLDED 426
           YL      + IHRD+ A N+LL   
Sbjct: 136 YLESK---RFIHRDLAARNLLLATR 157

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  104 bits (261), Expect = 2e-25
 Identities = 34/134 (25%), Positives = 68/134 (50%), Gaps = 8/134 (5%)

Query: 293 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 351
           +LG+G +G VY GR L++   +A+K + E  +   +     E+ +     H+N+++  G 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHKHLKHKNIVQYLGS 87

Query: 352 CTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 410
            +     + ++   +  GS+++ LR +   L   +  T          GL YLH++   +
Sbjct: 88  FSE-NGFIKIFMEQVPGGSLSALLRSKWGPLKDNE-QTIGFYTKQILEGLKYLHDN---Q 142

Query: 411 IIHRDVKAANILLD 424
           I+HRD+K  N+L++
Sbjct: 143 IVHRDIKGDNVLIN 156

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  105 bits (263), Expect = 2e-25
 Identities = 42/140 (30%), Positives = 62/140 (44%), Gaps = 10/140 (7%)

Query: 291 KNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           + I+G G  G+V  GRL         VA+K LK   T      F +E  I+    H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
           RL G  T     ++V  YM NGS+ + LR                +  G   G+ YL + 
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI---MQLVGMLRGVGAGMRYLSDL 170

Query: 407 CDPKIIHRDVKAANILLDED 426
                +HRD+ A N+L+D +
Sbjct: 171 ---GYVHRDLAARNVLVDSN 187

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  104 bits (262), Expect = 2e-25
 Identities = 35/145 (24%), Positives = 64/145 (44%), Gaps = 22/145 (15%)

Query: 292 NILGRGGFGKVYKGRLADGK-----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
            +LG G FG VYKG            VA+K L+E  +     +   E  +++   + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 347 RLYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           RL G C T     +T+       M  G +   +RE + ++            +  A+G++
Sbjct: 81  RLLGICLTSTVQLITQ------LMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 131

Query: 402 YLHEHCDPKIIHRDVKAANILLDED 426
           YL +    +++HRD+ A N+L+   
Sbjct: 132 YLEDR---RLVHRDLAARNVLVKTP 153

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  103 bits (258), Expect = 4e-25
 Identities = 37/149 (24%), Positives = 69/149 (46%), Gaps = 15/149 (10%)

Query: 291 KNILGRGGFGKVYKGRL--------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
              LG+G F K++KG               V +K L +   +  E  F     ++S   H
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE-SFFEAASMMSKLSH 71

Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 402
           ++L+  YG C    E +LV  ++  GS+ + L++ ++ +       + ++A   A  + +
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINI---LWKLEVAKQLAAAMHF 128

Query: 403 LHEHCDPKIIHRDVKAANILLDEDADQSS 431
           L E+    +IH +V A NILL  + D+ +
Sbjct: 129 LEEN---TLIHGNVCAKNILLIREEDRKT 154

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  103 bits (258), Expect = 5e-25
 Identities = 43/137 (31%), Positives = 65/137 (47%), Gaps = 8/137 (5%)

Query: 291 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 75

Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
           G CT      ++  +MT G++   LRE       +       +A   +  + YL +    
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQ--EVSAVVLLYMATQISSAMEYLEKK--- 130

Query: 410 KIIHRDVKAANILLDED 426
             IHRD+ A N L+ E+
Sbjct: 131 NFIHRDLAARNCLVGEN 147

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  103 bits (259), Expect = 7e-25
 Identities = 35/143 (24%), Positives = 62/143 (43%), Gaps = 14/143 (9%)

Query: 291 KNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 345
            + LG+G FG V   R        G LVAVK+L+       +  FQ E++I+       +
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFI 86

Query: 346 LRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           ++  G       +   LV  Y+ +G +   L+  ++ L           +    +G+ YL
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA---SRLLLYSSQICKGMEYL 143

Query: 404 HEHCDPKIIHRDVKAANILLDED 426
                 + +HRD+ A NIL++ +
Sbjct: 144 GSR---RCVHRDLAARNILVESE 163

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  102 bits (256), Expect = 7e-25
 Identities = 44/143 (30%), Positives = 61/143 (42%), Gaps = 22/143 (15%)

Query: 291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 350
              +G+G FG V  G    G  VAVK +K + T      F  E  +++   H NL++L G
Sbjct: 26  LQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLG 81

Query: 351 FCTT-------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
                      VTE      YM  GS+   LR R  S   L      K +L     + YL
Sbjct: 82  VIVEEKGGLYIVTE------YMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYL 133

Query: 404 HEHCDPKIIHRDVKAANILLDED 426
             +     +HRD+ A N+L+ ED
Sbjct: 134 EGN---NFVHRDLAARNVLVSED 153

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  103 bits (258), Expect = 8e-25
 Identities = 42/141 (29%), Positives = 65/141 (46%), Gaps = 11/141 (7%)

Query: 291 KNILGRGGFGKVYKGRLADGK-----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 345
           + ++G G FG+VYKG L          VA+K LK   T    + F  E  I+    H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 346 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 405
           +RL G  +     +++  YM NG++   LRE+              +  G A G+ YL  
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSV---LQLVGMLRGIAAGMKYLAN 165

Query: 406 HCDPKIIHRDVKAANILLDED 426
                 +HRD+ A NIL++ +
Sbjct: 166 M---NYVHRDLAARNILVNSN 183

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  102 bits (256), Expect = 1e-24
 Identities = 35/143 (24%), Positives = 54/143 (37%), Gaps = 22/143 (15%)

Query: 293 ILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRL 348
            LG G FG V KG     K+   VAVK LK E            E  ++    +  ++R+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 349 YGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
            G C       V E          G +   L++ +     +      ++    + G+ YL
Sbjct: 84  IGICEAESWMLVME------MAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYL 133

Query: 404 HEHCDPKIIHRDVKAANILLDED 426
            E      +HRD+ A N+LL   
Sbjct: 134 EES---NFVHRDLAARNVLLVTQ 153

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  102 bits (255), Expect = 1e-24
 Identities = 37/143 (25%), Positives = 60/143 (41%), Gaps = 8/143 (5%)

Query: 288 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIIS-MAVHRN 344
           F     +G G FG V+K     DG + A+KR K     S  E     EV   + +  H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 345 LLRLYGFCTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           ++R +       + +L+   Y   GS+A  + E    +        K + L   RGL Y+
Sbjct: 73  VVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131

Query: 404 HEHCDPKIIHRDVKAANILLDED 426
           H      ++H D+K +NI +   
Sbjct: 132 HSM---SLVHMDIKPSNIFISRT 151

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  101 bits (255), Expect = 1e-24
 Identities = 37/154 (24%), Positives = 64/154 (41%), Gaps = 21/154 (13%)

Query: 291 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 344
              LG   FGKVYKG L           VA+K LK++       +F+ E  + +   H N
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER------------QSSLPPLDWPTRKKI 392
           ++ L G  T      +++ Y ++G +   L  R            ++    L+ P    +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
               A G+ YL  H    ++H+D+   N+L+ + 
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDK 164

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  103 bits (258), Expect = 1e-24
 Identities = 44/140 (31%), Positives = 64/140 (45%), Gaps = 10/140 (7%)

Query: 291 KNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
             ++G G FG+V  GRL         VA+K LK   T      F  E  I+    H N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
           RL G  T     ++V  YM NGS+ S LR+  +            +  G A G+ YL + 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV---IQLVGMLRGIASGMKYLSDM 166

Query: 407 CDPKIIHRDVKAANILLDED 426
                +HRD+ A NIL++ +
Sbjct: 167 ---GYVHRDLAARNILINSN 183

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  104 bits (261), Expect = 1e-24
 Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 18/140 (12%)

Query: 292 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 351
             LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY  
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 352 CT-----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
            +      VTE      YM+ GS+   L+        L  P    +A   A G++Y+   
Sbjct: 248 VSEEPIYIVTE------YMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM 299

Query: 407 CDPKIIHRDVKAANILLDED 426
                +HRD++AANIL+ E+
Sbjct: 300 ---NYVHRDLRAANILVGEN 316

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  105 bits (263), Expect = 1e-24
 Identities = 41/196 (20%), Positives = 74/196 (37%), Gaps = 36/196 (18%)

Query: 240 VPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGF 299
           V V     +      E  + +P+  D E+Q  +++                   +G G F
Sbjct: 359 VSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIEL---------------GRCIGEGQF 403

Query: 300 GKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT- 354
           G V++G     +     VA+K  K   +     +F  E   +    H ++++L G  T  
Sbjct: 404 GDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN 463

Query: 355 ----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 410
               + E        T G + S L+ R+ SL      +    A   +  L+YL      +
Sbjct: 464 PVWIIME------LCTLGELRSFLQVRKFSLDL---ASLILYAYQLSTALAYLESK---R 511

Query: 411 IIHRDVKAANILLDED 426
            +HRD+ A N+L+  +
Sbjct: 512 FVHRDIAARNVLVSSN 527

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  101 bits (255), Expect = 2e-24
 Identities = 40/152 (26%), Positives = 67/152 (44%), Gaps = 19/152 (12%)

Query: 291 KNILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQFQTEVKIISM-AVHRNLL 346
           ++++G G FG+V K R+    L    A+KR+KE  +      F  E++++     H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK------------KIAL 394
            L G C       L   Y  +G++   LR+ +       +                  A 
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 395 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
             ARG+ YL +    + IHRD+ A NIL+ E+
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGEN 178

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  103 bits (259), Expect = 3e-24
 Identities = 44/143 (30%), Positives = 61/143 (42%), Gaps = 22/143 (15%)

Query: 291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 350
              +G+G FG V  G    G  VAVK +K + T      F  E  +++   H NL++L G
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLG 253

Query: 351 FCTT-------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
                      VTE      YM  GS+   LR R  S   L      K +L     + YL
Sbjct: 254 VIVEEKGGLYIVTE------YMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYL 305

Query: 404 HEHCDPKIIHRDVKAANILLDED 426
             +     +HRD+ A N+L+ ED
Sbjct: 306 EGN---NFVHRDLAARNVLVSED 325

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  101 bits (253), Expect = 3e-24
 Identities = 41/154 (26%), Positives = 64/154 (41%), Gaps = 22/154 (14%)

Query: 291 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 344
           K  LG G FGKV+     +        LVAVK LK+  T      FQ E ++++   H +
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEH 78

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER------------QSSLPPLDWPTRKKI 392
           +++ YG C      ++V+ YM +G +   LR              + +   L       I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           A   A G+ YL        +HRD+   N L+  +
Sbjct: 139 ASQIASGMVYLASQ---HFVHRDLATRNCLVGAN 169

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  101 bits (254), Expect = 3e-24
 Identities = 41/153 (26%), Positives = 60/153 (39%), Gaps = 20/153 (13%)

Query: 291 KNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHR 343
              LG G FGKV +              VAVK LK    +  +    +E+KI+S    H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK----------KIA 393
           N++ L G CT     L++  Y   G + + LR +   L                     +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 394 LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
              A+G+++L        IHRDV A N+LL   
Sbjct: 171 SQVAQGMAFLASK---NCIHRDVAARNVLLTNG 200

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  103 bits (258), Expect = 4e-24
 Identities = 39/140 (27%), Positives = 61/140 (43%), Gaps = 18/140 (12%)

Query: 292 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 351
             LG G FG+V+         VAVK +K    S     F  E  ++    H  L++L+  
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKLVKLHAV 251

Query: 352 CTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
            T      +TE      +M  GS+   L+  + S  PL  P     +   A G++++ + 
Sbjct: 252 VTKEPIYIITE------FMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR 303

Query: 407 CDPKIIHRDVKAANILLDED 426
                IHRD++AANIL+   
Sbjct: 304 ---NYIHRDLRAANILVSAS 320

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  100 bits (251), Expect = 5e-24
 Identities = 41/149 (27%), Positives = 64/149 (42%), Gaps = 10/149 (6%)

Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 344
           D +  + ++G G    V         + VA+KR+  E+      +   E++ +S   H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 345 LLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWP-TRKKIAL---GSARG 399
           ++  Y     V ++L LV   ++ GSV   ++   +             IA        G
Sbjct: 75  IVSYYT-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133

Query: 400 LSYLHEHCDPKIIHRDVKAANILLDEDAD 428
           L YLH++     IHRDVKA NILL ED  
Sbjct: 134 LEYLHKN---GQIHRDVKAGNILLGEDGS 159

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  103 bits (258), Expect = 5e-24
 Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 18/140 (12%)

Query: 292 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 351
             LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY  
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 352 CT-----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
            +      VTE      YM+ GS+   L+        L  P    +A   A G++Y+   
Sbjct: 331 VSEEPIYIVTE------YMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM 382

Query: 407 CDPKIIHRDVKAANILLDED 426
                +HRD++AANIL+ E+
Sbjct: 383 ---NYVHRDLRAANILVGEN 399

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  100 bits (250), Expect = 7e-24
 Identities = 48/162 (29%), Positives = 71/162 (43%), Gaps = 21/162 (12%)

Query: 288 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           F+    +G+G FG+V+KG      K+VA+K +  E         Q E+ ++S      + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 347 RLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 405
           + YG       KL ++  Y+  GS    L        PLD      I     +GL YLH 
Sbjct: 84  KYYG-SYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHS 137

Query: 406 HCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 437
               K IHRD+KAAN+LL E  +          Q + T ++R
Sbjct: 138 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  100 bits (250), Expect = 8e-24
 Identities = 44/156 (28%), Positives = 66/156 (42%), Gaps = 23/156 (14%)

Query: 291 KNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHR 343
              LGRG FG+V +            + VAVK LKE  T        +E+KI+     H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91

Query: 344 NLLRLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPLDWPTRK------------ 390
           N++ L G CT     L+V   +   G++++ LR +++   P                   
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 391 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
             +   A+G+ +L      K IHRD+ A NILL E 
Sbjct: 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK 184

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  100 bits (250), Expect = 1e-23
 Identities = 40/157 (25%), Positives = 64/157 (40%), Gaps = 24/157 (15%)

Query: 291 KNILGRGGFGKVYKGRLADGK--------LVAVKRLKEERTSGGELQFQTEVKIISM-AV 341
              LG G FG+V                  VAVK LK++ T        +E++++ M   
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER------------QSSLPPLDWPTR 389
           H+N++ L G CT      ++  Y + G++   LR R            +     + +   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 390 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
                  ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 99.7 bits (249), Expect = 1e-23
 Identities = 44/153 (28%), Positives = 67/153 (43%), Gaps = 21/153 (13%)

Query: 291 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 344
           K  LG G FGKV+     +        LVAVK LKE  +      FQ E ++++M  H++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQH 104

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-----------QSSLPPLDWPTRKKIA 393
           ++R +G CT     L+V+ YM +G +   LR               +  PL       +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 394 LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
              A G+ YL        +HRD+   N L+ + 
Sbjct: 165 SQVAAGMVYLAGL---HFVHRDLATRNCLVGQG 194

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  101 bits (254), Expect = 2e-23
 Identities = 39/136 (28%), Positives = 63/136 (46%), Gaps = 8/136 (5%)

Query: 292 NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 350
           + LG G +G+VY+G        VAVK LKE+       +F  E  ++    H NL++L G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 351 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 410
            CT      ++  +MT G++   LRE       +       +A   +  + YL +     
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQ--EVSAVVLLYMATQISSAMEYLEKK---N 338

Query: 411 IIHRDVKAANILLDED 426
            IHR++ A N L+ E+
Sbjct: 339 FIHRNLAARNCLVGEN 354

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 99.0 bits (247), Expect = 2e-23
 Identities = 40/157 (25%), Positives = 65/157 (41%), Gaps = 17/157 (10%)

Query: 279 RELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRL----KEERTSGGELQFQTE 333
             + +    +     LG GGF  V     L DG   A+KR+    +++R      + Q E
Sbjct: 22  HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE-----EAQRE 76

Query: 334 VKIISMAVHRNLLRLYGFC----TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR 389
             +  +  H N+LRL  +C        E  L+ P+   G++ + +   +     L     
Sbjct: 77  ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI 136

Query: 390 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
             + LG  RGL  +H        HRD+K  NILL ++
Sbjct: 137 LWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDE 170

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  100 bits (250), Expect = 2e-23
 Identities = 40/157 (25%), Positives = 64/157 (40%), Gaps = 24/157 (15%)

Query: 291 KNILGRGGFGKVYKGRLADGK--------LVAVKRLKEERTSGGELQFQTEVKIISM-AV 341
              LG G FG+V                  VAVK LK++ T        +E++++ M   
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER------------QSSLPPLDWPTR 389
           H+N++ L G CT      ++  Y + G++   LR R            +     + +   
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 390 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
                  ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 206 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 239

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 98.5 bits (246), Expect = 2e-23
 Identities = 45/166 (27%), Positives = 78/166 (46%), Gaps = 28/166 (16%)

Query: 288 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNL 345
           +     LG G FGKVYK +    G L A K ++ +  S  EL+ +  E++I++   H  +
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYI 78

Query: 346 LRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL---GSARGLS 401
           ++L G       KL ++  +   G+V + + E    L      T  +I +        L+
Sbjct: 79  VKLLG-AYYHDGKLWIMIEFCPGGAVDAIMLELDRGL------TEPQIQVVCRQMLEALN 131

Query: 402 YLHEHCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 437
           +LH     +IIHRD+KA N+L+  + D          ++ KT+ +R
Sbjct: 132 FLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 174

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =   99 bits (249), Expect = 2e-23
 Identities = 33/149 (22%), Positives = 58/149 (38%), Gaps = 11/149 (7%)

Query: 285 TDGFSNKNILGRG--GFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QTEVKIISMA 340
              +    ++G+G      V   R    G+ V V+R+  E  S   + F Q E+ +  + 
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 341 VHRNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 399
            H N++           +L +V  +M  GS    +         ++      I  G  + 
Sbjct: 84  NHPNIVPYRA-TFIADNELWVVTSFMAYGSAKDLICTHFMD--GMNELAIAYILQGVLKA 140

Query: 400 LSYLHEHCDPKIIHRDVKAANILLDEDAD 428
           L Y+H       +HR VKA++IL+  D  
Sbjct: 141 LDYIHHM---GYVHRSVKASHILISVDGK 166

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 98.8 bits (247), Expect = 2e-23
 Identities = 46/162 (28%), Positives = 64/162 (39%), Gaps = 29/162 (17%)

Query: 291 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 344
              LG G FGKV K      K       VAVK LKE  +        +E  ++    H +
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-----------------QSSLPPLDWP 387
           +++LYG C+     LL+  Y   GS+   LRE                      P     
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 388 TRK---KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           T       A   ++G+ YL E    K++HRD+ A NIL+ E 
Sbjct: 148 TMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEG 186

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 98.5 bits (246), Expect = 4e-23
 Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 29/162 (17%)

Query: 291 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 344
              +G G FG+V++ R           +VAVK LKEE ++  +  FQ E  +++   + N
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER--------------------QSSLPPL 384
           +++L G C       L++ YM  G +   LR                          PPL
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 385 DWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
               +  IA   A G++YL E    K +HRD+   N L+ E+
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGEN 210

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 98.3 bits (245), Expect = 5e-23
 Identities = 38/180 (21%), Positives = 68/180 (37%), Gaps = 14/180 (7%)

Query: 248 WRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR- 306
           W              ED+  + L +  +    E +      +++  +GRG FG+V++ + 
Sbjct: 20  WSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKD 79

Query: 307 LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT 366
              G   AVK+++ E           E+   +      ++ LYG         +    + 
Sbjct: 80  KQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133

Query: 367 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            GS+   +++       L           +  GL YLH     +I+H DVKA N+LL  D
Sbjct: 134 GGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSD 186

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 98.6 bits (246), Expect = 7e-23
 Identities = 41/157 (26%), Positives = 63/157 (40%), Gaps = 24/157 (15%)

Query: 291 KNILGRGGFGKVYKGRLADGK--------LVAVKRLKEERTSGGELQFQTEVKIISM-AV 341
              LG G FG+V                  VAVK LK + T        +E++++ M   
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK----------- 390
           H+N++ L G CT      ++  Y + G++   L+ R+       +               
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 391 -KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
              A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 194 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTED 227

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 97.8 bits (244), Expect = 8e-23
 Identities = 38/162 (23%), Positives = 62/162 (38%), Gaps = 29/162 (17%)

Query: 291 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISM-AVHR 343
             +LG G FGKV                VAVK LKE+  S       +E+K+++    H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS------- 396
           N++ L G CT      L++ Y   G + + LR ++      +     +  L         
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 397 ------------ARGLSYLHEHCDPKIIHRDVKAANILLDED 426
                       A+G+ +L        +HRD+ A N+L+   
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHG 208

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 96.9 bits (242), Expect = 1e-22
 Identities = 42/157 (26%), Positives = 61/157 (38%), Gaps = 24/157 (15%)

Query: 291 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISM-AVHR 343
              LG G FGKV +              VAVK LK            +E+K++S    H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE-RQSSLPPLDWPTRKK----------- 391
           N++ L G CT     L++  Y   G + + LR  R S +     P   +           
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 392 --IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
              +   A+G+++L        IHRD+ A NILL   
Sbjct: 148 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHG 181

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 96.3 bits (240), Expect = 2e-22
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 43/199 (21%)

Query: 266 SELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTS 324
           S+     L    L  L+     F    ++G G +G+VYKGR +  G+L A+K +      
Sbjct: 4   SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--- 60

Query: 325 GGELQ-FQTEVKIIS-MAVHRNLLRLYG-----FCTTVTEKL-LVYPYMTNGSVA----- 371
           G E +  + E+ ++   + HRN+   YG         + ++L LV  +   GSV      
Sbjct: 61  GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN 120

Query: 372 ---SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 428
              + L+E   +           I     RGLS+LH+H   K+IHRD+K  N+LL E+A+
Sbjct: 121 TKGNTLKEEWIAY----------ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAE 167

Query: 429 ----------QSSKTILRR 437
                     Q  +T+ RR
Sbjct: 168 VKLVDFGVSAQLDRTVGRR 186

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 94.1 bits (235), Expect = 5e-22
 Identities = 40/137 (29%), Positives = 62/137 (45%), Gaps = 11/137 (8%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRL-KEE-RTSGGELQFQTEVKIISMAVHRNLLRLYG 350
           LG+G F  VY+   +  G  VA+K + K+    +G   + Q EVKI     H ++L LY 
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 351 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-LGSARGLSYLHEHCDP 409
           +        LV     NG +   L+ R       +   R  +  +    G+ YLH H   
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS--ENEARHFMHQI--ITGMLYLHSH--- 131

Query: 410 KIIHRDVKAANILLDED 426
            I+HRD+  +N+LL  +
Sbjct: 132 GILHRDLTLSNLLLTRN 148

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 94.7 bits (236), Expect = 7e-22
 Identities = 33/156 (21%), Positives = 66/156 (42%), Gaps = 11/156 (7%)

Query: 274 KRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQT 332
           +    + + V    +S    +G GG  KV++      ++ A+K +  E      L  ++ 
Sbjct: 16  ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRN 75

Query: 333 EVKIISMAVHRNL--LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK 390
           E+  ++     +   +RLY +  T     +V     N  + S L++++S    +D   RK
Sbjct: 76  EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS----IDPWERK 130

Query: 391 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
                    +  +H+H    I+H D+K AN L+ + 
Sbjct: 131 SYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG 163

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 94.3 bits (235), Expect = 8e-22
 Identities = 38/156 (24%), Positives = 65/156 (41%), Gaps = 24/156 (15%)

Query: 288 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           F    +LG+G FG+V K R   D +  A+K+++   T        +EV +++   H+ ++
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEKLSTILSEVMLLASLNHQYVV 65

Query: 347 RLYGF------------CTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLD-WPTRKKI 392
           R Y                     L +   Y  NG++   +     +    + W   ++I
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125

Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 428
                  LSY+H      IIHRD+K  NI +DE  +
Sbjct: 126 LEA----LSYIHSQ---GIIHRDLKPMNIFIDESRN 154

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 94.3 bits (235), Expect = 9e-22
 Identities = 30/144 (20%), Positives = 61/144 (42%), Gaps = 6/144 (4%)

Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQF-QTEVKIISMAVH 342
             F  +  +GRG F +VY+   L DG  VA+K+++  +            E+ ++    H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 402
            N+++ Y       E  +V      G ++  ++  +     +   T  K  +     L +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 403 LHEHCDPKIIHRDVKAANILLDED 426
           +H     +++HRD+K AN+ +   
Sbjct: 152 MHSR---RVMHRDIKPANVFITAT 172

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 94.4 bits (235), Expect = 1e-21
 Identities = 32/140 (22%), Positives = 61/140 (43%), Gaps = 15/140 (10%)

Query: 292 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNL--LRL 348
             +G GG  KV++      ++ A+K +  E      L  ++ E+  ++     +   +RL
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 349 YGFCTTVTEKLLVYPYM--TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
           Y +  T      +Y  M   N  + S L++++S    +D   RK         +  +H+H
Sbjct: 75  YDYEITDQY---IYMVMECGNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIHQH 127

Query: 407 CDPKIIHRDVKAANILLDED 426
               I+H D+K AN L+ + 
Sbjct: 128 ---GIVHSDLKPANFLIVDG 144

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 44/187 (23%), Positives = 65/187 (34%), Gaps = 18/187 (9%)

Query: 245 FAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYK 304
           F    + +P    F   A +  +       R      Q     F   + LG G +G+V+K
Sbjct: 20  FQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQS----FQRLSRLGHGSYGEVFK 75

Query: 305 GR-LADGKLVAVKRL-KEERTSGGELQFQTEVKII-SMAVHRNLLRLYGFCTTVTEKLLV 361
            R   DG+L AVKR     R      +   EV     +  H   +RL        E  ++
Sbjct: 76  VRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ---AWEEGGIL 132

Query: 362 YPYMT--NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAA 419
           Y        S+        +SLP             +   L++LH      ++H DVK A
Sbjct: 133 YLQTELCGPSLQQHCEAWGASLPE---AQVWGYLRDTLLALAHLHSQ---GLVHLDVKPA 186

Query: 420 NILLDED 426
           NI L   
Sbjct: 187 NIFLGPR 193

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 30/137 (21%), Positives = 61/137 (44%), Gaps = 11/137 (8%)

Query: 292 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNL--LRL 348
             +G GG  KV++      ++ A+K +  E      L  ++ E+  ++     +   +RL
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 349 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 408
           Y +  T  + + +     N  + S L++++S    +D   RK         +  +H+H  
Sbjct: 122 YDYEIT-DQYIYMVMECGNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIHQH-- 174

Query: 409 PKIIHRDVKAANILLDE 425
             I+H D+K AN L+ +
Sbjct: 175 -GIVHSDLKPANFLIVD 190

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 93.3 bits (232), Expect = 2e-21
 Identities = 33/153 (21%), Positives = 64/153 (41%), Gaps = 7/153 (4%)

Query: 282 QVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMA 340
             +   +   +ILG+G    V++GR    G L A+K                E +++   
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 341 VHRNLLRLYGFCTTVTEKL--LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
            H+N+++L+      T +   L+  +   GS+ + L E  ++   L       +      
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVG 123

Query: 399 GLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 431
           G+++L E+    I+HR++K  NI+     D  S
Sbjct: 124 GMNHLREN---GIVHRNIKPGNIMRVIGEDGQS 153

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 93.2 bits (232), Expect = 2e-21
 Identities = 40/166 (24%), Positives = 73/166 (43%), Gaps = 6/166 (3%)

Query: 266 SELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTS 324
           S    G+LK    +      +   +   +GRG +G V K      G+++AVKR++     
Sbjct: 2   SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 61

Query: 325 GGELQFQTEVKII-SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP- 382
             + Q   ++ ++   +    +++ YG      +  +    M + S     +   S L  
Sbjct: 62  KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDD 120

Query: 383 PLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 428
            +      KI L + + L++L E  + KIIHRD+K +NILLD   +
Sbjct: 121 VIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGN 164

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 92.8 bits (231), Expect = 3e-21
 Identities = 33/154 (21%), Positives = 59/154 (38%), Gaps = 17/154 (11%)

Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 344
             F     LGRGGFG V++ +   D    A+KR++         +   EVK ++   H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 345 LLRLYGF---------CTTVTEKLLVY---PYMTNGSVASRLRERQSSLPPLDWPTRKKI 392
           ++R +               + K+ +Y         ++   +  R +     +      I
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHI 123

Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            L  A  + +LH      ++HRD+K +NI    D
Sbjct: 124 FLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMD 154

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 93.3 bits (232), Expect = 3e-21
 Identities = 56/199 (28%), Positives = 84/199 (42%), Gaps = 32/199 (16%)

Query: 251 TRPHEFFFDVPAEDDSELQ-----------LGQLKRFSLRELQVATD---GFSNKNILGR 296
              H   +D+P  ++   Q            G LK   + EL    D    FS+   +G 
Sbjct: 5   HHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGH 64

Query: 297 GGFGKVYKGR-LADGKLVAVKR--LKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 353
           G FG VY  R + + ++VA+K+     ++++        EV+ +    H N ++  G C 
Sbjct: 65  GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG-CY 123

Query: 354 TVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL---GSARGLSYLHEHCDP 409
                  LV  Y   GS +  L   +  L         +IA    G+ +GL+YLH H   
Sbjct: 124 LREHTAWLVMEYC-LGSASDLLEVHKKPL------QEVEIAAVTHGALQGLAYLHSH--- 173

Query: 410 KIIHRDVKAANILLDEDAD 428
            +IHRDVKA NILL E   
Sbjct: 174 NMIHRDVKAGNILLSEPGL 192

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 36/162 (22%), Positives = 71/162 (43%), Gaps = 22/162 (13%)

Query: 288 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           ++    +G+G  G VY    +A G+ VA++++  ++    EL    E+ ++    + N++
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIV 80

Query: 347 RLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 405
                   V ++L +V  Y+  GS+   + E       +D      +     + L +LH 
Sbjct: 81  NYLD-SYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS 134

Query: 406 HCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 437
           +   ++IHRD+K+ NILL  D            Q +    +R
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 90.7 bits (226), Expect = 1e-20
 Identities = 31/136 (22%), Positives = 56/136 (41%), Gaps = 10/136 (7%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYG 350
           LG+GGF K ++       ++ A K + +          +   E+ I     H++++  +G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 351 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 410
           F        +V       S+    + R+     L  P  +        G  YLH +   +
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---R 135

Query: 411 IIHRDVKAANILLDED 426
           +IHRD+K  N+ L+ED
Sbjct: 136 VIHRDLKLGNLFLNED 151

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 92.2 bits (229), Expect = 1e-20
 Identities = 33/153 (21%), Positives = 64/153 (41%), Gaps = 7/153 (4%)

Query: 282 QVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMA 340
             +   +   +ILG+G    V++GR    G L A+K                E +++   
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 341 VHRNLLRLYGFCTTVTEKL--LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
            H+N+++L+      T +   L+  +   GS+ + L E  ++   L       +      
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVG 123

Query: 399 GLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 431
           G+++L E+    I+HR++K  NI+     D  S
Sbjct: 124 GMNHLREN---GIVHRNIKPGNIMRVIGEDGQS 153

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 45/136 (33%), Positives = 64/136 (47%), Gaps = 10/136 (7%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYG 350
           LG+G FG VY  R      ++A+K L + +   +G E Q + EV+I S   H N+LRLYG
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76

Query: 351 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 410
           +    T   L+  Y   G+V   L++        D           A  LSY H     +
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---R 129

Query: 411 IIHRDVKAANILLDED 426
           +IHRD+K  N+LL   
Sbjct: 130 VIHRDIKPENLLLGSA 145

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 91.3 bits (227), Expect = 2e-20
 Identities = 37/147 (25%), Positives = 65/147 (44%), Gaps = 15/147 (10%)

Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QTEVKIISMAVHR 343
           + +     +G G FGK    +   DG+   +K +   R S  E +  + EV +++   H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP----LDWPTRKKIALGSARG 399
           N+++            +V  Y   G +  R+  ++  L      LDW    +I L     
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV--QICLA---- 137

Query: 400 LSYLHEHCDPKIIHRDVKAANILLDED 426
           L ++H+    KI+HRD+K+ NI L +D
Sbjct: 138 LKHVHDR---KILHRDIKSQNIFLTKD 161

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 32/139 (23%), Positives = 56/139 (40%), Gaps = 16/139 (11%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVK-----RLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
           LG+GGF K ++       ++ A K      L +        +   E+ I     H++++ 
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVVG 105

Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
            +GF        +V       S+    + R+     L  P  +        G  YLH + 
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN- 160

Query: 408 DPKIIHRDVKAANILLDED 426
             ++IHRD+K  N+ L+ED
Sbjct: 161 --RVIHRDLKLGNLFLNED 177

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 90.5 bits (225), Expect = 2e-20
 Identities = 43/167 (25%), Positives = 69/167 (41%), Gaps = 32/167 (19%)

Query: 288 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
             +   +G G  G V   R    G+ VAVK +   +    EL    EV I+    H N++
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL-LFNEVVIMRDYQHFNVV 105

Query: 347 RLYGFCTTVTEKL-LVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGL 400
            +Y     V E+L ++  ++  G++       RL E Q +           +     + L
Sbjct: 106 EMYK-SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT----------VCEAVLQAL 154

Query: 401 SYLHEHCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 437
           +YLH      +IHRD+K+ +ILL  D            Q SK + +R
Sbjct: 155 AYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 198

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 36/156 (23%), Positives = 70/156 (44%), Gaps = 27/156 (17%)

Query: 288 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           F    ++G GGFG+V+K +   DGK   +KR+K         + + EVK ++   H N++
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIV 67

Query: 347 RLYGF-------------CTTVTEKLLVYPYM---TNGSVASRLRERQSSLPPLDWPTRK 390
              G               ++ ++   ++  M     G++   + +R+     LD     
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE--KLDKVLAL 125

Query: 391 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           ++     +G+ Y+H     K+I+RD+K +NI L + 
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT 158

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 89.7 bits (223), Expect = 3e-20
 Identities = 47/166 (28%), Positives = 74/166 (44%), Gaps = 30/166 (18%)

Query: 288 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHRNL 345
           F     LG G +G VYK      G++VA+K++  E        +   E+ I+      ++
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ----EIIKEISIMQQCDSPHV 86

Query: 346 LRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL---GSARGLS 401
           ++ YG        L +V  Y   GSV+  +R R  +L      T  +IA     + +GL 
Sbjct: 87  VKYYG-SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTL------TEDEIATILQSTLKGLE 139

Query: 402 YLHEHCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 437
           YLH     + IHRD+KA NILL+ +            Q + T+ +R
Sbjct: 140 YLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR 182

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 88.1 bits (219), Expect = 8e-20
 Identities = 37/147 (25%), Positives = 61/147 (41%), Gaps = 6/147 (4%)

Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QTEVKIISMAVHR 343
           + +     +G G +G+  K R  +DGK++  K L     +  E Q   +EV ++    H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 344 NLLRLYG-FCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           N++R Y          L +V  Y   G +AS + +       LD     ++       L 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 402 YLHEHCDP--KIIHRDVKAANILLDED 426
             H   D    ++HRD+K AN+ LD  
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGK 152

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 35/150 (23%), Positives = 64/150 (42%), Gaps = 5/150 (3%)

Query: 281 LQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKII-S 338
           ++V  D       LGRG +G V K R +  G+++AVKR++    S  + +   ++ I   
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61

Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
                  +  YG      +  +    M + S+    ++       +      KIA+   +
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120

Query: 399 GLSYLHEHCDPKIIHRDVKAANILLDEDAD 428
            L +LH      +IHRDVK +N+L++    
Sbjct: 121 ALEHLHS--KLSVIHRDVKPSNVLINALGQ 148

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 88.3 bits (219), Expect = 3e-19
 Identities = 32/149 (21%), Positives = 60/149 (40%), Gaps = 12/149 (8%)

Query: 288 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 346
           F  K++LG G  G +    + D + VAVKR+  E  S        EV++      H N++
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVI 81

Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
           R +        + +        ++   + ++  +   L+      +   +  GL++LH  
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLHSL 137

Query: 407 CDPKIIHRDVKAANILLDEDADQSSKTIL 435
               I+HRD+K  NIL+           +
Sbjct: 138 ---NIVHRDLKPHNILISMPNAHGKIKAM 163

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 86.1 bits (214), Expect = 4e-19
 Identities = 39/137 (28%), Positives = 64/137 (46%), Gaps = 12/137 (8%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYG 350
           LG+G FG VY  R   +  ++A+K L + +    G E Q + E++I S   H N+LR+Y 
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 351 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-LGSARGLSYLHEHCDP 409
           +        L+  +   G +   L+ +       +  +   +  L  A  L Y HE    
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQ-KHGRFD--EQRSATFMEELADA--LHYCHER--- 133

Query: 410 KIIHRDVKAANILLDED 426
           K+IHRD+K  N+L+   
Sbjct: 134 KVIHRDIKPENLLMGYK 150

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 86.1 bits (213), Expect = 1e-18
 Identities = 42/176 (23%), Positives = 76/176 (43%), Gaps = 15/176 (8%)

Query: 262 AEDDSELQLGQLKRFSLREL--------QVATDGFSNKNILGRGGFGKVYKGRL-ADGKL 312
            +   EL+L + +R  L           ++  D F   + LG G  G V+K      G +
Sbjct: 1   GKKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLV 60

Query: 313 VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVAS 372
           +A K +  E       Q   E++++       ++  YG   +  E  +   +M  GS+  
Sbjct: 61  MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120

Query: 373 RLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 428
            L++       +      K+++   +GL+YL E    KI+HRDVK +NIL++   +
Sbjct: 121 VLKKAG----RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGE 170

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 87.4 bits (216), Expect = 1e-18
 Identities = 41/150 (27%), Positives = 64/150 (42%), Gaps = 17/150 (11%)

Query: 291 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           K  LG GGFG V +      G+ VA+K+ ++E +     ++  E++I+    H N++   
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78

Query: 350 ------GFCTTVTEKLLVYPYMTNGSVASRL--RERQSSLPPLDWPTRKKIA-LGSARGL 400
                          LL   Y   G +   L   E    L       R  ++ + SA  L
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP--IRTLLSDISSA--L 134

Query: 401 SYLHEHCDPKIIHRDVKAANILLDEDADQS 430
            YLHE+   +IIHRD+K  NI+L     + 
Sbjct: 135 RYLHEN---RIIHRDLKPENIVLQPGPQRL 161

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 36/153 (23%), Positives = 58/153 (37%), Gaps = 23/153 (15%)

Query: 294 LGRGGFGKVYKGRLADGKLVAVKRLK----------------EERTSGGELQFQTEVKII 337
           L +G F K+      D K  A+K+ +                +         F+ E++II
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 338 SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ----SSLPPLDWPTRKKIA 393
           +   +   L   G  T   E  ++Y YM N S+            +    +     K I 
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 394 LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
                  SY+H   +  I HRDVK +NIL+D++
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKN 188

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 85.1 bits (210), Expect = 2e-18
 Identities = 18/165 (10%), Positives = 36/165 (21%), Gaps = 34/165 (20%)

Query: 293 ILGRGGFGKVYKGR-LADGKLVAVK--RLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
            L  G    V+  R +   +  A+K   +  E +     +        +  +  +     
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 350 GFC--------------------------TTVTEKLLVYPYM--TNGSVASRLRERQSSL 381
                                          V   LL+ P        + S L       
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 382 PPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
                     +     R  + L       ++H      N+ +  D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPD 230

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 84.7 bits (210), Expect = 1e-17
 Identities = 24/127 (18%), Positives = 42/127 (33%), Gaps = 15/127 (11%)

Query: 68  SNLFVYLIS-DLGNAALSGELAPELGQLKNLELL-------------ALGNLIKLKSLDL 113
            NL     + DL    L    +        L++L             A  +L  L +L L
Sbjct: 24  DNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLIL 83

Query: 114 YSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN 173
             N          + L  L+ L     +L+ L    +  + +L  L++++N +       
Sbjct: 84  TGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS-FKLP 142

Query: 174 GSFSQFT 180
             FS  T
Sbjct: 143 EYFSNLT 149

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 82.0 bits (203), Expect = 7e-17
 Identities = 28/132 (21%), Positives = 44/132 (33%), Gaps = 17/132 (12%)

Query: 55  ISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELL-------------- 100
           +  +    V  S  NL +YL  D+ +             L +LE+L              
Sbjct: 408 LKQMSEFSVFLSLRNL-IYL--DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464

Query: 101 ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILD 160
               L  L  LDL         P    +L  L+ L +++N+   L       + SL +LD
Sbjct: 465 IFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 524

Query: 161 LSNNRLSGPVPD 172
            S N +      
Sbjct: 525 YSLNHIMTSKKQ 536

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 75.8 bits (187), Expect = 6e-15
 Identities = 21/107 (19%), Positives = 37/107 (34%), Gaps = 15/107 (14%)

Query: 77  DLGNAALSGELAPE-LGQLKNLELL-------------ALGNLIKLKSLDLYSNLFNGTI 122
            +   +      P+   +L+NL  L             A  +L  L+ L++  N F    
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD 510

Query: 123 PDTLANLKQLKYLRLNNNSLSGLIPTSLTTI-TSLNILDLSNNRLSG 168
                 L  L+ L  + N +       L    +SL  L+L+ N  + 
Sbjct: 511 TFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 28/130 (21%), Positives = 52/130 (40%), Gaps = 18/130 (13%)

Query: 77  DLGNAALSGELAPELGQLKNLELL-------------ALGNLIKLKSLDLYSNLFNGT-I 122
            L    +          L +L+ L              +G+L  LK L++  NL     +
Sbjct: 82  ILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKL 141

Query: 123 PDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNI----LDLSNNRLSGPVPDNGSFSQ 178
           P+  +NL  L++L L++N +  +  T L  +  + +    LDLS N ++   P      +
Sbjct: 142 PEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR 201

Query: 179 FTPISFENNL 188
              ++  NN 
Sbjct: 202 LHKLTLRNNF 211

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 70.1 bits (172), Expect = 5e-13
 Identities = 29/115 (25%), Positives = 40/115 (34%), Gaps = 19/115 (16%)

Query: 77  DLGNAALSGELAPELGQLKNLELL--------------ALGNLIKLKSLDLYSNLFNGTI 122
                 L+      +G LK L+ L                 NL  L+ LDL SN      
Sbjct: 106 VAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY 165

Query: 123 PDTLANLKQLKY----LRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN 173
              L  L Q+      L L+ N ++ + P +   I  L+ L L NN  S  V   
Sbjct: 166 CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKT 219

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 55.0 bits (133), Expect = 3e-08
 Identities = 29/136 (21%), Positives = 45/136 (33%), Gaps = 8/136 (5%)

Query: 54  LISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDL 113
           L + L  +      S     +     N          L +L N +      L       L
Sbjct: 277 LFNCLTNVSSFSLVSVTIERVKDFSYNFGWQ-----HL-ELVNCKFGQFPTLKLKSLKRL 330

Query: 114 YSNLFNGTIPDTLANLKQLKYLRLNNNSLS--GLIPTSLTTITSLNILDLSNNRLSGPVP 171
                 G    +  +L  L++L L+ N LS  G    S    TSL  LDLS N +     
Sbjct: 331 TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS 390

Query: 172 DNGSFSQFTPISFENN 187
           +     Q   + F+++
Sbjct: 391 NFLGLEQLEHLDFQHS 406

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 24/145 (16%), Positives = 42/145 (28%), Gaps = 20/145 (13%)

Query: 49  EQLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLALGNLIKL 108
            +L L  +F     +      L    +  L             G L+  +  AL  L  L
Sbjct: 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN-----EGNLEKFDKSALEGLCNL 257

Query: 109 KSLDL---YSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNR 165
              +    Y + +   I D    L  +    L + ++  +   S         L+L N  
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN--FGWQHLELVNC- 314

Query: 166 LSGPVPDNGSFSQFTPISFENNLNL 190
                     F QF  +  ++   L
Sbjct: 315 ---------KFGQFPTLKLKSLKRL 330

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 82.3 bits (203), Expect = 2e-17
 Identities = 24/160 (15%), Positives = 58/160 (36%), Gaps = 11/160 (6%)

Query: 279 RELQVATDGFSNKNILGRGGFGKVYKGR------LADGKLVAVKRLKEERTSGGELQFQT 332
            E Q+ +      ++LG G F +VY+          + +   +K  K        +  Q 
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ- 116

Query: 333 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE-RQSSLPPLDWPTRKK 391
            ++ +  ++    ++ Y         +LV    + G++ + +   + +    +       
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176

Query: 392 IALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 431
            A+     +  +H+    +IIH D+K  N +L     +  
Sbjct: 177 FAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQD 213

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 83.8 bits (207), Expect = 2e-17
 Identities = 19/154 (12%), Positives = 50/154 (32%), Gaps = 9/154 (5%)

Query: 45  LQECEQLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLALGN 104
           L   + L   I+    ++ ++  S + +              ++  + +L  L+++   N
Sbjct: 398 LNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFAN 457

Query: 105 --------LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSL 156
                    +  +  +            + +NLK L  + L N      +P  L  +  L
Sbjct: 458 SPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPEL 517

Query: 157 NILDLSNNRLSGPVPDNGSFSQFTPISFENNLNL 190
             L+++ NR          +++      +    +
Sbjct: 518 QSLNIACNRGISAAQLKADWTRL-ADDEDTGPKI 550

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 73.8 bits (181), Expect = 3e-14
 Identities = 23/153 (15%), Positives = 49/153 (32%), Gaps = 23/153 (15%)

Query: 45  LQECEQLHLL---ISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELL- 100
           L  C  +  L   +  L  ++ L  + N  +       +      LA +      +++  
Sbjct: 498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKAD---WTRLADDEDTGPKIQIFY 554

Query: 101 -------------ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIP 147
                        +L  ++KL  LD   N       +      +L  L+L+ N +  +  
Sbjct: 555 MGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIEEIPE 612

Query: 148 TSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 180
                   +  L  S+N+L   +P+  +     
Sbjct: 613 DFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVY 644

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 70.7 bits (173), Expect = 3e-13
 Identities = 18/155 (11%), Positives = 36/155 (23%), Gaps = 21/155 (13%)

Query: 48  CEQLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSG------------ELAPELGQLK 95
            +           +  +    N    L  D     L                  +     
Sbjct: 717 LKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSS 776

Query: 96  NLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITS 155
            L+   +         D   N      P  +     L  L++ +N +  +          
Sbjct: 777 QLKAFGI-----RHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLT---PQ 828

Query: 156 LNILDLSNNRL-SGPVPDNGSFSQFTPISFENNLN 189
           L ILD+++N   S  V     + +        +  
Sbjct: 829 LYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKT 863

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 13/116 (11%), Positives = 32/116 (27%), Gaps = 26/116 (22%)

Query: 90  ELGQLKNLELLALGN------------------LIKLKSLDLYSNLFNGTIPDTLANLKQ 131
               +  +  +                       I   ++ L  N       +  A    
Sbjct: 639 NAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSP 698

Query: 132 LKYLRLNNNSLSGL-------IPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 180
           +  + L+NN ++ +          +      L  +DL  N+L+  + D+   +   
Sbjct: 699 ISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLP 753

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 60.3 bits (146), Expect = 8e-10
 Identities = 13/73 (17%), Positives = 26/73 (35%)

Query: 101 ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILD 160
            L N  ++  L L      G +PD +  L +LK L    +S +           + ++ +
Sbjct: 318 DLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSE 377

Query: 161 LSNNRLSGPVPDN 173
              +R+       
Sbjct: 378 ERKHRIRMHYKKM 390

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 57.6 bits (139), Expect = 5e-09
 Identities = 22/167 (13%), Positives = 46/167 (27%), Gaps = 49/167 (29%)

Query: 55  ISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLEL--LALGNLIKLKSLD 112
           I  L  ++VL   ++         G+  L+ +++ E      +    + L    +L   D
Sbjct: 343 IGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402

Query: 113 LYSNLFNG----------------------------TIPDTLANLKQLKYLRLNNNSLSG 144
           L  +  N                              I   +  L +L+ +   N+  + 
Sbjct: 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTY 462

Query: 145 L-------------------IPTSLTTITSLNILDLSNNRLSGPVPD 172
                                  S + +  L  ++L N      +PD
Sbjct: 463 DNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPD 509

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 51.4 bits (123), Expect = 4e-07
 Identities = 12/75 (16%), Positives = 26/75 (34%), Gaps = 1/75 (1%)

Query: 116 NLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGS 175
           +++       L N  ++  L L      G +P ++  +T L +L    +  +        
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS-GRLFG 367

Query: 176 FSQFTPISFENNLNL 190
             + TP   E   + 
Sbjct: 368 DEELTPDMSEERKHR 382

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 80.9 bits (200), Expect = 4e-17
 Identities = 35/154 (22%), Positives = 66/154 (42%), Gaps = 8/154 (5%)

Query: 277 SLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVK 335
             +  Q   +   N   +G G  G+V+K R    G ++AVK+++         +   ++ 
Sbjct: 16  GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD 75

Query: 336 IISMAV-HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL 394
           ++  +     +++ +G   T T+  +    M   +   + R +     P+      K+ +
Sbjct: 76  VVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG----PIPERILGKMTV 131

Query: 395 GSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 428
              + L YL E     +IHRDVK +NILLDE   
Sbjct: 132 AIVKALYYLKE--KHGVIHRDVKPSNILLDERGQ 163

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 82.1 bits (203), Expect = 4e-17
 Identities = 37/150 (24%), Positives = 60/150 (40%), Gaps = 12/150 (8%)

Query: 288 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 346
             ++ ILG G  G V       G+ VAVKR+  +           E+K+      H N++
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD----IALMEIKLLTESDDHPNVI 72

Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR---KKIALGSARGLSYL 403
           R Y   TT     +      N ++   +  +  S   L          +    A G+++L
Sbjct: 73  RYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131

Query: 404 HEHCDPKIIHRDVKAANILLDEDADQSSKT 433
           H     KIIHRD+K  NIL+   +  ++  
Sbjct: 132 HSL---KIIHRDLKPQNILVSTSSRFTADQ 158

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 80.6 bits (199), Expect = 6e-17
 Identities = 37/142 (26%), Positives = 62/142 (43%), Gaps = 12/142 (8%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLRLYGF 351
           L  GGF  VY+ + +  G+  A+KRL              EV  +  ++ H N+++    
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLS-NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 352 CTTVTEK-------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
            +   E+        L+   +  G +   L++ +S   PL   T  KI   + R + ++H
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR-GPLSCDTVLKIFYQTCRAVQHMH 153

Query: 405 EHCDPKIIHRDVKAANILLDED 426
               P IIHRD+K  N+LL   
Sbjct: 154 -RQKPPIIHRDLKVENLLLSNQ 174

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 80.5 bits (198), Expect = 1e-16
 Identities = 27/166 (16%), Positives = 51/166 (30%), Gaps = 35/166 (21%)

Query: 293 ILGRGGFGKVYKGR-LADGKLVAVK--RLKEERTSGGELQFQTEVKII------------ 337
           +LG+       +      G+   V      E   S    Q + EV  +            
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 338 ----SMAVHRNLLRLYGFCT-----------TVTEKLLVYPYM--TNGSVASRLRERQSS 380
                     +L++                  V  +  +YP M     +    L    S+
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 381 LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
              L    R ++ L   R L+ LH +    ++H  ++  +I+LD+ 
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQR 247

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 80.9 bits (200), Expect = 2e-16
 Identities = 18/147 (12%), Positives = 48/147 (32%), Gaps = 10/147 (6%)

Query: 51  LHLLISFLIFIRVLQSSSNLFVYLIS-DLGNAALSGELAPELGQLKNLELLALGN----- 104
           +   I+     + ++ SS + +        +  ++  ++  + +L  L    +GN     
Sbjct: 162 IKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVA 220

Query: 105 ---LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDL 161
                  ++ +        T      NLK L  + + N      +PT L  +  + ++++
Sbjct: 221 ENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINV 280

Query: 162 SNNRLSGPVPDNGSFSQFTPISFENNL 188
           + NR          +           +
Sbjct: 281 ACNRGISGEQLKDDWQALADAPVGEKI 307

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 80.5 bits (199), Expect = 2e-16
 Identities = 21/141 (14%), Positives = 48/141 (34%), Gaps = 24/141 (17%)

Query: 51  LHLLISFLIFIRVLQSSSNLFVYLIS-DLGNAALSGELAPELGQLKNLELLAL------- 102
            +    +    +      +    L   ++ N     +L   L  L  ++L+ +       
Sbjct: 228 ENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS 287

Query: 103 --------------GNLIKLKSLDLYSN-LFNGTIPDTLANLKQLKYLRLNNNSLSGLIP 147
                             K++ + +  N L    +  +L  +K+L  L    N L G +P
Sbjct: 288 GEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP 347

Query: 148 TSLTTITSLNILDLSNNRLSG 168
            +  +   L  L+L+ N+++ 
Sbjct: 348 -AFGSEIKLASLNLAYNQITE 367

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 25/168 (14%), Positives = 57/168 (33%), Gaps = 35/168 (20%)

Query: 55  ISFLIFIRVLQSSSNLFVYLISDLGNAA------LSG----ELAPEL-GQLKNLELLAL- 102
           +  +  + +L+   N     +   G+        L+     E+     G  + +E L+  
Sbjct: 326 LQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFA 385

Query: 103 -------------GNLIKLKSLDLYSNLFNG-------TIPDTLANLKQLKYLRLNNNSL 142
                         ++  + ++D   N            +  T      +  + L+NN +
Sbjct: 386 HNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQI 445

Query: 143 SGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNL 190
           S       +T + L+ ++L  N L+  +P N    +    +F+N   L
Sbjct: 446 SKFPKELFSTGSPLSSINLMGNMLTE-IPKNSLKDE--NENFKNTYLL 490

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 73.5 bits (181), Expect = 4e-14
 Identities = 15/130 (11%), Positives = 34/130 (26%), Gaps = 20/130 (15%)

Query: 55  ISFLIFIRVLQSSSNLFVYLISDLGNAALS------------GELAPELGQLKNLELLAL 102
                 +  +    N    L  D     L              +   +      L+   +
Sbjct: 484 FKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGI 543

Query: 103 GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLS 162
            N       D   N      P+ +     L  L++ +N +  +         ++++LD+ 
Sbjct: 544 RN-----QRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKIT---PNISVLDIK 595

Query: 163 NNRLSGPVPD 172
           +N        
Sbjct: 596 DNPNISIDLS 605

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 73.2 bits (180), Expect = 5e-14
 Identities = 24/131 (18%), Positives = 37/131 (28%), Gaps = 21/131 (16%)

Query: 85  GELAPELGQLKNLELL-------------ALGNLIKLKSLDLYSNLFNG-------TIPD 124
             L P   +  N+  +                    L S++L  N+             +
Sbjct: 423 DPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENE 482

Query: 125 TLANLKQLKYLRLNNNSLSGLIPT-SLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 183
              N   L  + L  N L+ L      TT+  L  +DLS N  S       + S      
Sbjct: 483 NFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFG 542

Query: 184 FENNLNLCGPN 194
             N  +  G  
Sbjct: 543 IRNQRDAQGNR 553

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 16/111 (14%), Positives = 30/111 (27%), Gaps = 19/111 (17%)

Query: 77  DLGNAALSGELAPELGQLKNLELL-----------------ALGNLIKLKSLDLYSNLFN 119
            L     SG +   +GQL  LE+L                  +   +  +        + 
Sbjct: 87  SLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQ 146

Query: 120 GTIPDTLANLK--QLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 168
            T  D         L    +N++     I  S         +   +N ++ 
Sbjct: 147 KTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF 197

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 66.2 bits (162), Expect = 7e-12
 Identities = 15/92 (16%), Positives = 32/92 (34%), Gaps = 5/92 (5%)

Query: 102 LGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSG----LIPTSLTTITSLN 157
           L +  ++  L L     +G +PD +  L +L+ L L ++          P  ++   S  
Sbjct: 77  LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136

Query: 158 ILDLSNNRLSGPVPDNGSFSQFTPISFENNLN 189
                         D      F+ +  ++ +N
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLI-KDCIN 167

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 11/75 (14%), Positives = 27/75 (36%), Gaps = 1/75 (1%)

Query: 116 NLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGS 175
           +++      +L +  ++  L L     SG +P ++  +T L +L L ++         G 
Sbjct: 67  DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFG- 125

Query: 176 FSQFTPISFENNLNL 190
               +    +     
Sbjct: 126 PKGISANMSDEQKQK 140

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 27/166 (16%), Positives = 55/166 (33%), Gaps = 35/166 (21%)

Query: 293 ILGRGGFGKVYKGR-LADGKLVAVK--------------RLKEERTSGGELQ-------- 329
           +LG+       +      G+   V               ++KEE      L+        
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 330 -----FQTEVKIISMAVHRNLLRLYGFCTT--VTEKLLVYPYM--TNGSVASRLRERQSS 380
                F     ++     + ++R+        V  +  +YP M     +    L    S+
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 381 LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
              L    R ++ L   R L+ LH +    ++H  ++  +I+LD+ 
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQR 242

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 29/127 (22%), Positives = 42/127 (33%), Gaps = 16/127 (12%)

Query: 68  SNLFVYLIS-DLGNAALSGELAPELGQLKNLELL-------------ALGNLIKLKSLDL 113
            +L   +   +L +  L    A    +   L  L                 L  LK L+L
Sbjct: 21  DDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNL 80

Query: 114 YSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN 173
             N  +     T A    L  L L +NS+  +         +L  LDLS+N LS      
Sbjct: 81  QHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKL-- 138

Query: 174 GSFSQFT 180
           G+  Q  
Sbjct: 139 GTQVQLE 145

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 77.0 bits (190), Expect = 3e-15
 Identities = 32/137 (23%), Positives = 53/137 (38%), Gaps = 25/137 (18%)

Query: 61  IRVLQSSSNLFVYLIS----DLGNAALSGELAPELGQLKNLELL---------------- 100
           ++ + SS + F  L +    DL N  ++      L  L+ LE+L                
Sbjct: 466 LKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANP 525

Query: 101 -----ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITS 155
                 L  L  L  L+L SN F+    +   +L +LK + L  N+L+ L  +      S
Sbjct: 526 GGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVS 585

Query: 156 LNILDLSNNRLSGPVPD 172
           L  L+L  N ++     
Sbjct: 586 LKSLNLQKNLITSVEKK 602

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 76.6 bits (189), Expect = 4e-15
 Identities = 25/119 (21%), Positives = 38/119 (31%), Gaps = 14/119 (11%)

Query: 75  ISDLGNAALSGELAPELGQLKNLELL-------------ALGNLIKLKSLDLYSNLFNGT 121
           ++ L   A  G     L  L +L +L                +L +LK +DL  N  N  
Sbjct: 516 LARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTL 575

Query: 122 IPDTLANLKQLKYLRLNNNSLSGLIPTSLTTI-TSLNILDLSNNRLSGPVPDNGSFSQF 179
                 N   LK L L  N ++ +          +L  LD+  N           F  +
Sbjct: 576 PASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNW 634

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 76.6 bits (189), Expect = 4e-15
 Identities = 28/129 (21%), Positives = 43/129 (33%), Gaps = 16/129 (12%)

Query: 77  DLGNAALSGELAPELGQLKNLELL-------------ALGNLIKLKSLDLYSNLFNGTIP 123
           D+G   +S        +L  L++L                    L  L L SN       
Sbjct: 55  DVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKN 114

Query: 124 DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 183
           +     K L  L L++N LS     +   + +L  L LSNN++     +      F   S
Sbjct: 115 NPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE--ELDIFANSS 172

Query: 184 FENNLNLCG 192
            +  L L  
Sbjct: 173 LK-KLELSS 180

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 19/89 (21%), Positives = 29/89 (32%), Gaps = 1/89 (1%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIP-DTLANLKQLKYLRLNNNSLSGLIPTSLT 151
           ++  +E  A   L  L+ LDL  N     +       L+ +  + L+ N    L   S  
Sbjct: 392 KISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFA 451

Query: 152 TITSLNILDLSNNRLSGPVPDNGSFSQFT 180
            + SL  L L    L         F    
Sbjct: 452 LVPSLQRLMLRRVALKNVDSSPSPFQPLR 480

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 73.9 bits (182), Expect = 3e-14
 Identities = 31/132 (23%), Positives = 47/132 (35%), Gaps = 19/132 (14%)

Query: 77  DLGNAALSGELAPELG---QLKNLELLALGN---------------LIKLKSLDLYSNLF 118
            L N  L   L  +L       ++  L+L N                  L  LDL  N  
Sbjct: 201 FLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNL 260

Query: 119 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQ 178
           N    D+ A L QL+Y  L  N++  L   SL  + ++  L+L  +     +    S  +
Sbjct: 261 NVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLA-SLPK 319

Query: 179 FTPISFENNLNL 190
               SF+    L
Sbjct: 320 IDDFSFQWLKCL 331

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 73.5 bits (181), Expect = 4e-14
 Identities = 21/107 (19%), Positives = 36/107 (33%), Gaps = 2/107 (1%)

Query: 77  DLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLR 136
            L    +    +  L  L N+  L L          +           +   LK L++L 
Sbjct: 278 FLEYNNIQHLFSHSLHGLFNVRYLNLKR--SFTKQSISLASLPKIDDFSFQWLKCLEHLN 335

Query: 137 LNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 183
           + +N + G+     T + +L  L LSN+  S     N +F       
Sbjct: 336 MEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSP 382

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 24/112 (21%), Positives = 43/112 (38%), Gaps = 16/112 (14%)

Query: 77  DLGNAALSGELAPELGQLKNLELL--------------ALGNLIKLKSLDLYSNLFNGTI 122
           +L    +S   +     L +LE+L                  L  +  + L  N +    
Sbjct: 387 NLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLT 446

Query: 123 PDTLANLKQLKYLRLNNNSLSGL--IPTSLTTITSLNILDLSNNRLSGPVPD 172
            ++ A +  L+ L L   +L  +   P+    + +L ILDLSNN ++    D
Sbjct: 447 RNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDD 498

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 70.8 bits (174), Expect = 3e-13
 Identities = 33/114 (28%), Positives = 43/114 (37%), Gaps = 18/114 (15%)

Query: 77  DLGNAALSGELAPELGQLKNLELLALGN---------------LIKLKSLDLYSNLFNGT 121
           DL +  LS        QL+NL+ L L N                  LK L+L SN     
Sbjct: 127 DLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEF 186

Query: 122 IPDTLANLKQLKYLRLNNNSLSGLIPTSLT---TITSLNILDLSNNRLSGPVPD 172
            P     + +L  L LNN  L   +   L      TS+  L LSN++LS     
Sbjct: 187 SPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 50.8 bits (122), Expect = 7e-07
 Identities = 16/65 (24%), Positives = 25/65 (38%), Gaps = 3/65 (4%)

Query: 108 LKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
            +  D         +PD L     +  L L +N L  L   + T  + L  LD+  N +S
Sbjct: 6   HEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62

Query: 168 GPVPD 172
              P+
Sbjct: 63  KLEPE 67

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 21/149 (14%), Positives = 43/149 (28%), Gaps = 27/149 (18%)

Query: 44  VLQECEQLHLL------ISFLIFIRVLQSSSNLFVYLIS----DLGNAALSGELAPELGQ 93
           +L+  E+L +L      ++ L               L      +L +             
Sbjct: 499 MLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKD 558

Query: 94  LKNLELL-------------ALGNLIKLKSLDLYSNLFNGTIPDTLA-NLKQLKYLRLNN 139
           L  L+++                N + LKSL+L  NL             + L  L +  
Sbjct: 559 LFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRF 618

Query: 140 NSLSGLIPTSLTTITSLNILDLSNNRLSG 168
           N       +       +N ++ ++  +  
Sbjct: 619 NPFDCTCESIA---WFVNWINETHTNIPE 644

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 77.7 bits (192), Expect = 4e-16
 Identities = 35/150 (23%), Positives = 55/150 (36%), Gaps = 34/150 (22%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVK---RLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           LG G +GKV +          AVK   + K  R   GE   + E++++    H+N+++L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 350 GFCTTVTEK--LLVYPYMTNGS-------VASRLRERQSSLPPLDWPTRKK----IALGS 396
                  ++   +V  Y   G           R    Q+                I    
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQA---------HGYFCQLID--- 120

Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLDED 426
             GL YLH      I+H+D+K  N+LL   
Sbjct: 121 --GLEYLHSQ---GIVHKDIKPGNLLLTTG 145

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 77.0 bits (190), Expect = 8e-16
 Identities = 31/151 (20%), Positives = 55/151 (36%), Gaps = 34/151 (22%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVK-----RLKEERTSGGELQFQTEVKIISMAVHR--NL 345
           LG GGFG VY G  ++D   VA+K     R+ +        +   EV ++         +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 346 LRLYGFCTTVTEKLLVYPYMTNG-------SVASRLRERQSSLPPLDWPTRKK---IALG 395
           +RL  +       +L+              +    L+E  +         R     +   
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA---------RSFFWQVL-- 159

Query: 396 SARGLSYLHEHCDPKIIHRDVKAANILLDED 426
               + + H      ++HRD+K  NIL+D +
Sbjct: 160 --EAVRHCHNC---GVLHRDIKDENILIDLN 185

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 78.5 bits (194), Expect = 9e-16
 Identities = 23/127 (18%), Positives = 41/127 (32%), Gaps = 15/127 (11%)

Query: 68  SNLFVYLIS-DLGNAALSGELAPELGQLKNLELL-------------ALGNLIKLKSLDL 113
            ++     + DL    L    +        L+ L             A   L  L +L L
Sbjct: 28  DDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLIL 87

Query: 114 YSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN 173
             N      P + + L  L+ L      L+ L    +  + +L  L++++N +       
Sbjct: 88  TGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS-CKLP 146

Query: 174 GSFSQFT 180
             FS  T
Sbjct: 147 AYFSNLT 153

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 30/163 (18%), Positives = 49/163 (30%), Gaps = 25/163 (15%)

Query: 38  LVTLKAVLQECEQLHLL------ISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPEL 91
            + + A     E+L  L      +  +       S   L +YL  D+       +     
Sbjct: 388 AIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKL-LYL--DISYTNTKIDFDGIF 444

Query: 92  GQLKNLELL--------------ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 137
             L +L  L                 N   L  LDL               L +L+ L +
Sbjct: 445 LGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNM 504

Query: 138 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 180
           ++N+L  L  +    + SL+ LD S NR+              
Sbjct: 505 SHNNLLFLDSSHYNQLYSLSTLDCSFNRIET--SKGILQHFPK 545

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 18/99 (18%), Positives = 40/99 (40%), Gaps = 2/99 (2%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGL-IPTSLT 151
            +++    +   L  L++L              +  L  LK L + +N +    +P   +
Sbjct: 91  PIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150

Query: 152 TITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNL 190
            +T+L  +DLS N +     ++  F +  P     +L++
Sbjct: 151 NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNL-SLDM 188

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 62.7 bits (153), Expect = 9e-11
 Identities = 26/128 (20%), Positives = 48/128 (37%), Gaps = 12/128 (9%)

Query: 61  IRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLEL--------LALGNLIKLKSLD 112
           I+ L+     F +    +    L      +L  LK+L L             L  L  LD
Sbjct: 297 IKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLD 356

Query: 113 LYSNLFNGTIPDTLANLK--QLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV 170
           L  N  + +   + ++L    L++L L+ N    ++  +   +  L  LD  ++ L   V
Sbjct: 357 LSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKR-V 414

Query: 171 PDNGSFSQ 178
            +  +F  
Sbjct: 415 TEFSAFLS 422

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 32/140 (22%), Positives = 51/140 (36%), Gaps = 16/140 (11%)

Query: 44  VLQECEQLHLLISFLIFIRVLQSSSNLFVYLIS----DLGNAALSG-ELAPELGQLKNLE 98
           +++    + +    L +          F  L +     L   ++   E  P+  + ++L 
Sbjct: 254 IMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLS 313

Query: 99  L-------LALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLT 151
           +           +L  LKSL L  N   G+I      L  L YL L+ N+LS     S +
Sbjct: 314 IIRCQLKQFPTLDLPFLKSLTLTMN--KGSISFKKVALPSLSYLDLSRNALSFSGCCSYS 371

Query: 152 --TITSLNILDLSNNRLSGP 169
                SL  LDLS N     
Sbjct: 372 DLGTNSLRHLDLSFNGAIIM 391

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 54.3 bits (131), Expect = 4e-08
 Identities = 22/115 (19%), Positives = 37/115 (32%), Gaps = 19/115 (16%)

Query: 77  DLGNAALSGELAPELGQLKNLELL--------------ALGNLIKLKSLDLYSNLFNGTI 122
                 L+   +  +GQL  L+ L                 NL  L  +DL  N      
Sbjct: 110 VAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTIT 169

Query: 123 PDTLANLKQLK----YLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN 173
            + L  L++       L ++ N +  +   +   I  L+ L L  N  S  +   
Sbjct: 170 VNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKT 223

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 20/161 (12%), Positives = 41/161 (25%), Gaps = 34/161 (21%)

Query: 61  IRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELL--------------ALGNLI 106
           ++ L+ +  + + L  D+    +   +  +  Q   L  L               L NL 
Sbjct: 173 LQFLRENPQVNLSL--DMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLA 229

Query: 107 KLKSLDLYSNLFNGTI------PDTLANLKQLKY--LRLNNNSLSGLIPTSLTTITSLNI 158
            L    L    F          P  +  L  +     RL   +           + +++ 
Sbjct: 230 GLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSA 289

Query: 159 LDLSNNRLSGPVPDNGSFS---------QFTPISFENNLNL 190
           + L+   +         F          Q       +   L
Sbjct: 290 MSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFL 330

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 48.9 bits (117), Expect = 3e-06
 Identities = 24/129 (18%), Positives = 41/129 (31%), Gaps = 17/129 (13%)

Query: 63  VLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLALGN-----------LIKLKSL 111
           +++   ++ +             +   +   L N+  ++L               K +SL
Sbjct: 254 IMEGLCDVTIDEFRLTYTN-DFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSL 312

Query: 112 DLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 171
            +              +L  LK L L  N  S  I      + SL+ LDLS N LS    
Sbjct: 313 SIIRCQLKQF---PTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGC 367

Query: 172 DNGSFSQFT 180
            + S     
Sbjct: 368 CSYSDLGTN 376

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 76.1 bits (188), Expect = 1e-15
 Identities = 43/156 (27%), Positives = 66/156 (42%), Gaps = 19/156 (12%)

Query: 284 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QT---EVKI-- 336
           AT  +     +G G +G VYK R    G  VA+K ++     GG      +   EV +  
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 337 -ISMAVHRNLLRLYGFCTTVTEKL-----LVYPYMTNGSVASRLRERQSSLPPLDWPTRK 390
            +    H N++RL   C T          LV+ ++    + + L +     P L   T K
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP--PGLPAETIK 123

Query: 391 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            +     RGL +LH +    I+HRD+K  NIL+   
Sbjct: 124 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSG 156

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 78.0 bits (192), Expect = 1e-15
 Identities = 27/140 (19%), Positives = 52/140 (37%), Gaps = 16/140 (11%)

Query: 294 LGRGGFGKVYKGR--LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 351
           +  GG G +Y       +G+ V +K L     +  +     E + ++  VH ++++++ F
Sbjct: 88  IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147

Query: 352 CTTVTEKLLVYPYM-----TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
                       Y+        S+     +       L         L     LSYLH  
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI 201

Query: 407 CDPKIIHRDVKAANILLDED 426
               +++ D+K  NI+L E+
Sbjct: 202 ---GLVYNDLKPENIMLTEE 218

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 75.7 bits (187), Expect = 1e-15
 Identities = 36/144 (25%), Positives = 57/144 (39%), Gaps = 28/144 (19%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 352
           LG G +G+V         + VAVK +  +R        + E+ I  M  H N+++ YG  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 353 TTVTEKLLVYPYMTNGSV------ASRLRERQSSLPPLDWPTRKK----IALGSARGLSY 402
                + L   Y + G +         + E  +         ++     +A     G+ Y
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA---------QRFFHQLMA-----GVVY 120

Query: 403 LHEHCDPKIIHRDVKAANILLDED 426
           LH      I HRD+K  N+LLDE 
Sbjct: 121 LHGI---GITHRDIKPENLLLDER 141

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 36/144 (25%), Positives = 56/144 (38%), Gaps = 28/144 (19%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 352
           LG G +G+V         + VAVK +  +R        + E+ I  M  H N+++ YG  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 353 TTVTEKLLVYPYMTNG------SVASRLRERQSSLPPLDWPTRKK----IALGSARGLSY 402
                + L   Y + G           + E  +         ++     +A     G+ Y
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA---------QRFFHQLMA-----GVVY 120

Query: 403 LHEHCDPKIIHRDVKAANILLDED 426
           LH      I HRD+K  N+LLDE 
Sbjct: 121 LHGI---GITHRDIKPENLLLDER 141

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 49/267 (18%), Positives = 84/267 (31%), Gaps = 47/267 (17%)

Query: 177 SQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAAL 236
                   +N  N      ++     P  +         S   + S +A  +  A     
Sbjct: 4   HHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLND 63

Query: 237 LFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGR 296
                       +       +F     +D        K F           +  K+++GR
Sbjct: 64  A-----------QPKGTENLYFQSMGPEDELPDWAAAKEF--------YQKYDPKDVIGR 104

Query: 297 GGFGKVYKGR-LADGKLVAVK-------RLKEERTSGGELQFQTEVKII-SMAVHRNLLR 347
           G    V +    A G   AVK       RL  E+        + E  I+  +A H +++ 
Sbjct: 105 GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164

Query: 348 LYGFCTTVTEKLLVYPYMTNGS-----VAS-RLRERQSSLPPLDWPTRKKIALGSARGLS 401
           L     + +   LV+  M  G           L E+++            I       +S
Sbjct: 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR----------SIMRSLLEAVS 214

Query: 402 YLHEHCDPKIIHRDVKAANILLDEDAD 428
           +LH +    I+HRD+K  NILLD++  
Sbjct: 215 FLHAN---NIVHRDLKPENILLDDNMQ 238

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 34/150 (22%), Positives = 53/150 (35%), Gaps = 30/150 (20%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVK-----RLKEERTSGGELQFQTEVKIISM----AVHR 343
           LG+GGFG V+ G  L D   VA+K     R+         +    EV ++        H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNG-------SVASRLRERQSSLPPLDWPTRKKIALGS 396
            ++RL  +  T    +LV              +    L E  S          +      
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS----------RCFFGQV 148

Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLDED 426
              + + H      ++HRD+K  NIL+D  
Sbjct: 149 VAAIQHCHSR---GVVHRDIKDENILIDLR 175

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 74.9 bits (185), Expect = 4e-15
 Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 10/143 (6%)

Query: 286 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVHR 343
           + +     +G G +G VYK + + G++VA+KR++ +    G +      E+ ++    H 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEG-IPSTAIREISLLKELHHP 79

Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           N++ L     +     LV+ +M    +   L E ++ L        K       RG+++ 
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQD---SQIKIYLYQLLRGVAHC 135

Query: 404 HEHCDPKIIHRDVKAANILLDED 426
           H+H   +I+HRD+K  N+L++ D
Sbjct: 136 HQH---RILHRDLKPQNLLINSD 155

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 75.6 bits (186), Expect = 6e-15
 Identities = 36/183 (19%), Positives = 74/183 (40%), Gaps = 20/183 (10%)

Query: 261 PAEDDSELQLGQLKRFSLRELQVATDGFSNK----NILGRGGFGKVYKGR-LADGKLVAV 315
            + +         K++  + +++  D   +       LG G FG V++    A G   A 
Sbjct: 128 VSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAA 187

Query: 316 KRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR 375
           K +     S  E   + E++ +S+  H  L+ L+       E +++Y +M+ G +  ++ 
Sbjct: 188 KFVMTPHESDKE-TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA 246

Query: 376 ERQSSLPPLDWPTRKKIALGSAR----GLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 431
           +  + +   +       A+   R    GL ++HE+     +H D+K  NI+         
Sbjct: 247 DEHNKMSEDE-------AVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNEL 296

Query: 432 KTI 434
           K I
Sbjct: 297 KLI 299

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 74.2 bits (183), Expect = 7e-15
 Identities = 34/147 (23%), Positives = 59/147 (40%), Gaps = 12/147 (8%)

Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVH 342
           D +     LG G +G+VYK       + VA+KR++ E    G +      EV ++    H
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEG-VPGTAIREVSLLKELQH 92

Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 402
           RN++ L           L++ Y       + L++     P +     K        G+++
Sbjct: 93  RNIIELKSVIHHNHRLHLIFEYAE-----NDLKKYMDKNPDVSMRVIKSFLYQLINGVNF 147

Query: 403 LHEHCDPKIIHRDVKAANILLDEDADQ 429
            H     + +HRD+K  N+LL      
Sbjct: 148 CHSR---RCLHRDLKPQNLLLSVSDAS 171

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 73.8 bits (182), Expect = 1e-14
 Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 23/154 (14%)

Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QT---EVKIISMA 340
             +     +G+G FG+V+K R    G+ VA+K++  E    G   F  T   E+KI+ + 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLL 73

Query: 341 VHRNLLRLYGFCTTVTEKL--------LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI 392
            H N++ L   C T             LV+ +  +  +A  L               K++
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTL---SEIKRV 129

Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
                 GL Y+H +   KI+HRD+KAAN+L+  D
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRD 160

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 41/142 (28%), Positives = 69/142 (48%), Gaps = 23/142 (16%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRL-KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 351
           +G+G F KV   R +  G+ VA+K + K +       +   EV+I+ +  H N+++L+  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 352 CTTVTEKLLVYPYMTNGSV------ASRLRERQSSLPPLDWPTRKKIA-LGSARGLSYLH 404
             T     L+  Y + G V        R++E+++         R K   + SA  + Y H
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEA---------RSKFRQIVSA--VQYCH 131

Query: 405 EHCDPKIIHRDVKAANILLDED 426
           +     I+HRD+KA N+LLD D
Sbjct: 132 QKR---IVHRDLKAENLLLDAD 150

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 32/185 (17%), Positives = 50/185 (27%), Gaps = 44/185 (23%)

Query: 291 KNILGRGGFGKVYKGR-LADGKLVAVK----RLKEERTSGGELQFQTEVKIISMAVHRNL 345
           K  +G+G +G V          + A+K        +       + +TEV+++    H N+
Sbjct: 31  KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90

Query: 346 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR------- 398
            RLY          LV      G +  +L                K  +           
Sbjct: 91  ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150

Query: 399 -----------------------------GLSYLHEHCDPKIIHRDVKAANILLDEDADQ 429
                                         L YLH      I HRD+K  N L   +   
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSF 207

Query: 430 SSKTI 434
             K +
Sbjct: 208 EIKLV 212

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 72.9 bits (180), Expect = 1e-14
 Identities = 35/146 (23%), Positives = 72/146 (49%), Gaps = 14/146 (9%)

Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVH 342
           + F     +G G +G VYK R    G++VA+K+++ +  + G +      E+ ++    H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNH 61

Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGL 400
            N+++L     T  +  LV+ ++        L++    S+L  +  P  K       +GL
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116

Query: 401 SYLHEHCDPKIIHRDVKAANILLDED 426
           ++ H H   +++HRD+K  N+L++ +
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTE 139

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 72.5 bits (179), Expect = 2e-14
 Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 10/143 (6%)

Query: 286 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVHR 343
           + +     +G G +G VYK +   G+  A+K+++ E+   G +   T  E+ I+    H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG-IPSTTIREISILKELKHS 60

Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           N+++LY    T    +LV+ ++    +   L   +  L      T K   L    G++Y 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLES---VTAKSFLLQLLNGIAYC 116

Query: 404 HEHCDPKIIHRDVKAANILLDED 426
           H+    +++HRD+K  N+L++ +
Sbjct: 117 HDR---RVLHRDLKPQNLLINRE 136

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 38/188 (20%), Positives = 71/188 (37%), Gaps = 27/188 (14%)

Query: 263 EDDSELQLGQLKRF-------SLRELQVATDGFSNK----NILGRGGFGKVYKGR-LADG 310
            ++SE+ L   +         ++ +  V      ++      LG G  G+V         
Sbjct: 101 NNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTC 160

Query: 311 KLVAVK-------RLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP 363
           K VA++        +   R +   L  +TE++I+    H  ++++  F     +  +V  
Sbjct: 161 KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLE 219

Query: 364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 423
            M  G +  ++   +     L   T K         + YLHE+    IIHRD+K  N+LL
Sbjct: 220 LMEGGELFDKVVGNKR----LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLL 272

Query: 424 DEDADQSS 431
               +   
Sbjct: 273 SSQEEDCL 280

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 35/151 (23%), Positives = 53/151 (35%), Gaps = 34/151 (22%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEER-------TSGGELQFQTEVKIISMAVHRNL 345
           LG G FG V+        K V VK +K+E+             +   E+ I+S   H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 346 LRLYGFCTTVTEKLLVYPYMTNG-------SVASRLRERQSSLPPLDWPTRKK---IALG 395
           +++           LV     +G           RL E  +               +   
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLA---------SYIFRQLV-- 140

Query: 396 SARGLSYLHEHCDPKIIHRDVKAANILLDED 426
               + YL       IIHRD+K  NI++ ED
Sbjct: 141 --SAVGYLRLK---DIIHRDIKDENIVIAED 166

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 21/117 (17%), Positives = 34/117 (29%), Gaps = 15/117 (12%)

Query: 77  DLGNAALSGELAPELGQLKNLELL-------------ALGNLIKLKSLDLYSNLFNGTIP 123
           +     L         +L NL  L                +  +L +L L +N       
Sbjct: 39  EFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAE 98

Query: 124 DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 180
             L+  K LK+L      +S +    L    +L  L L +N +S             
Sbjct: 99  TALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS--IKLPKGFPTE 153

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 19/76 (25%), Positives = 27/76 (35%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
            L  +   AL     LK L       +      L N K L+ L L +N +S +       
Sbjct: 92  PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151

Query: 153 ITSLNILDLSNNRLSG 168
              L +LD  NN +  
Sbjct: 152 TEKLKVLDFQNNAIHY 167

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 69.3 bits (170), Expect = 8e-13
 Identities = 25/120 (20%), Positives = 33/120 (27%), Gaps = 17/120 (14%)

Query: 77  DLGNAALSGELAPELGQLKNLELL--------------ALGNLIKLKSLDLYSNLFN--G 120
            L                 +L  L               L NL  L+ LDL  +      
Sbjct: 307 VLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSD 366

Query: 121 TIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 180
                L NL  L+ L L+ N    L   +      L +LDL+  RL         F    
Sbjct: 367 CCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV-KDAQSPFQNLH 425

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 69.3 bits (170), Expect = 9e-13
 Identities = 23/100 (23%), Positives = 45/100 (45%), Gaps = 2/100 (2%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
            + +++ + L N   L+SL L SN  +          ++LK L   NN++  L    +++
Sbjct: 116 GISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSS 175

Query: 153 ITSLNI--LDLSNNRLSGPVPDNGSFSQFTPISFENNLNL 190
           +       L+L+ N ++G  P     + F  ++F    NL
Sbjct: 176 LQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNL 215

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 29/153 (18%), Positives = 45/153 (29%), Gaps = 9/153 (5%)

Query: 29  GICARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFVYL-ISDLGNAALSGEL 87
           GI    F   V         + L ++   L    +       F  +   D+  A   G  
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252

Query: 88  APEL-------GQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNN 140
              +           N+          L+ LDL +   +  +P  L  L  LK L L+ N
Sbjct: 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSAN 311

Query: 141 SLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN 173
               L   S +   SL  L +  N     +   
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTG 344

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 66.2 bits (162), Expect = 7e-12
 Identities = 30/151 (19%), Positives = 57/151 (37%), Gaps = 26/151 (17%)

Query: 44  VLQECEQLHLL------ISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNL 97
             +EC QL LL      +         Q+   L   L  +L ++ L          L  L
Sbjct: 395 AFKECPQLELLDLAFTRLKVKDAQSPFQNLHLL-KVL--NLSHSLLDISSEQLFDGLPAL 451

Query: 98  ELL----------------ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNS 141
           + L                +L  L +L+ L L     +        +LK + ++ L++N 
Sbjct: 452 QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNR 511

Query: 142 LSGLIPTSLTTITSLNILDLSNNRLSGPVPD 172
           L+     +L+ +  +  L+L++N +S  +P 
Sbjct: 512 LTSSSIEALSHLKGI-YLNLASNHISIILPS 541

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 19/76 (25%), Positives = 39/76 (51%), Gaps = 1/76 (1%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
            L +++  A  +L  +  +DL  N    +  + L++LK + YL L +N +S ++P+ L  
Sbjct: 487 DLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPI 545

Query: 153 ITSLNILDLSNNRLSG 168
           ++    ++L  N L  
Sbjct: 546 LSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 22/130 (16%), Positives = 42/130 (32%), Gaps = 19/130 (14%)

Query: 77  DLGNAALSGELAPELGQLKNLELL-------------ALGNLIKLKSLDLY-SNLFNGTI 122
            LG+  +S    P+    + L++L              + +L +  +L L  +      I
Sbjct: 135 YLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGI 194

Query: 123 PDTLANLKQLKYLRLNNNSLSGLIPTSL--TTITSLNILDLSNNRLSGPVPDNGSFSQFT 180
                +    + L         +I   L  +TI SL +    +            F    
Sbjct: 195 EPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDED--ISPAVFEGLC 252

Query: 181 PISFENNLNL 190
            +S E ++NL
Sbjct: 253 EMSVE-SINL 261

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 42/146 (28%), Positives = 70/146 (47%), Gaps = 12/146 (8%)

Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QT---EVKIISMA 340
             +   + LG G F  VYK R     ++VA+K++K    S  +    +T   E+K++   
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 341 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 400
            H N++ L       +   LV+ +M    +   +++    L P      K   L + +GL
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTP---SHIKAYMLMTLQGL 125

Query: 401 SYLHEHCDPKIIHRDVKAANILLDED 426
            YLH+H    I+HRD+K  N+LLDE+
Sbjct: 126 EYLHQH---WILHRDLKPNNLLLDEN 148

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 72.6 bits (179), Expect = 2e-14
 Identities = 37/142 (26%), Positives = 63/142 (44%), Gaps = 8/142 (5%)

Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 344
           + +   + LG G +  VYKG+      LVA+K ++ E   G       EV ++    H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
           ++ L+    T     LV+ Y+    +   L +  + +        K       RGL+Y H
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINM---HNVKLFLFQLLRGLAYCH 117

Query: 405 EHCDPKIIHRDVKAANILLDED 426
                K++HRD+K  N+L++E 
Sbjct: 118 RQ---KVLHRDLKPQNLLINER 136

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 36/144 (25%), Positives = 64/144 (44%), Gaps = 11/144 (7%)

Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVH 342
           + + N  ++G G +G V K R    G++VA+K+  E       ++     E+K++    H
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM-VKKIAMREIKLLKQLRH 83

Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 402
            NL+ L   C       LV+ ++ + ++   L    + L        +K       G+ +
Sbjct: 84  ENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDY---QVVQKYLFQIINGIGF 139

Query: 403 LHEHCDPKIIHRDVKAANILLDED 426
            H H    IIHRD+K  NIL+ + 
Sbjct: 140 CHSH---NIIHRDIKPENILVSQS 160

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 33/144 (22%), Positives = 61/144 (42%), Gaps = 15/144 (10%)

Query: 294 LGRGGFGKVYKGR---LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 350
           +GRG +G VYK +     D K  A+K+++     G  +    E+ ++    H N++ L  
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELKHPNVISLQK 85

Query: 351 FCTTVTEKL--LVYPYM----TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
              +  ++   L++ Y      +     R  +       L     K +      G+ YLH
Sbjct: 86  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145

Query: 405 EHCDPKIIHRDVKAANILLDEDAD 428
            +    ++HRD+K ANIL+  +  
Sbjct: 146 AN---WVLHRDLKPANILVMGEGP 166

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 72.4 bits (178), Expect = 4e-14
 Identities = 38/144 (26%), Positives = 57/144 (39%), Gaps = 30/144 (20%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 352
           +G G FG     R     +LVAVK +  ER +  +   Q E+       H N++R     
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85

Query: 353 TTVTEKLLVYPYMTNGSV------ASRLRERQSSLPPLDWPTRKK----IALGSARGLSY 402
            T T   ++  Y + G +      A R  E ++         R      ++     G+SY
Sbjct: 86  LTPTHLAIIMEYASGGELYERICNAGRFSEDEA---------RFFFQQLLS-----GVSY 131

Query: 403 LHEHCDPKIIHRDVKAANILLDED 426
            H     +I HRD+K  N LLD  
Sbjct: 132 CHSM---QICHRDLKLENTLLDGS 152

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 72.4 bits (178), Expect = 4e-14
 Identities = 36/183 (19%), Positives = 70/183 (38%), Gaps = 20/183 (10%)

Query: 261 PAEDDSELQLGQLKRFSLRELQVATDGFSNK----NILGRGGFGKVYKGR-LADGKLVAV 315
              D  +      K++  + ++V      +       LG G FG V++    A G++   
Sbjct: 22  KINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVA 81

Query: 316 KRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR 375
           K +            + E+ I++   H  L+ L+       E +L+  +++ G +  R+ 
Sbjct: 82  KFINTPYPLDKY-TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA 140

Query: 376 ERQSSLPPLDWPTRKKIALGSAR----GLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 431
                +   +        +   R    GL ++HEH    I+H D+K  NI+ +     S 
Sbjct: 141 AEDYKMSEAE-------VINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSV 190

Query: 432 KTI 434
           K I
Sbjct: 191 KII 193

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 71.0 bits (175), Expect = 5e-14
 Identities = 29/144 (20%), Positives = 62/144 (43%), Gaps = 11/144 (7%)

Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVH 342
             +     +G G +G V+K +     ++VA+KR++ +    G +      E+ ++    H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG-VPSSALREICLLKELKH 60

Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 402
           +N++RL+    +  +  LV+ +     +          L P      K       +GL +
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDP---EIVKSFLFQLLKGLGF 116

Query: 403 LHEHCDPKIIHRDVKAANILLDED 426
            H      ++HRD+K  N+L++ +
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRN 137

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 72.4 bits (178), Expect = 6e-14
 Identities = 35/153 (22%), Positives = 62/153 (40%), Gaps = 10/153 (6%)

Query: 285 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVH 342
           ++ +     LG G +G+V   R        A+K +++   S         EV ++ +  H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 402
            N+++LY F        LV      G +   +  R       +      I      G++Y
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK----FNEVDAAVIIKQVLSGVTY 151

Query: 403 LHEHCDPKIIHRDVKAANILLDEDADQSS-KTI 434
           LH+H    I+HRD+K  N+LL+     +  K +
Sbjct: 152 LHKH---NIVHRDLKPENLLLESKEKDALIKIV 181

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 71.1 bits (175), Expect = 6e-14
 Identities = 42/148 (28%), Positives = 60/148 (40%), Gaps = 17/148 (11%)

Query: 291 KNILGRGGFGKVYKGR-LADGKLVAVK--------RLKEERTSGGELQFQTEVKII-SMA 340
           K ILGRG    V +       K  AVK            E           EV I+  ++
Sbjct: 22  KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81

Query: 341 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 400
            H N+++L     T T   LV+  M  G +   L E+ +    L     +KI       +
Sbjct: 82  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRALLEVI 137

Query: 401 SYLHEHCDPKIIHRDVKAANILLDEDAD 428
             LH+     I+HRD+K  NILLD+D +
Sbjct: 138 CALHKL---NIVHRDLKPENILLDDDMN 162

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 70.7 bits (174), Expect = 8e-14
 Identities = 31/146 (21%), Positives = 61/146 (41%), Gaps = 5/146 (3%)

Query: 291 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           K  LG G FG V+     + G    +K + ++R+     Q + E++++    H N+++++
Sbjct: 27  KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86

Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
                     +V      G +  R+   Q+    L      ++       L+Y H     
Sbjct: 87  EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ--- 143

Query: 410 KIIHRDVKAANILLDEDADQSS-KTI 434
            ++H+D+K  NIL  + +  S  K I
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKII 169

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 71.6 bits (176), Expect = 8e-14
 Identities = 36/148 (24%), Positives = 66/148 (44%), Gaps = 15/148 (10%)

Query: 288 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
           ++N  ++G G FG V++ +L +   VA+K++ +++          E++I+ +  H N++ 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN-----RELQIMRIVKHPNVVD 96

Query: 348 LYGFCTTVTEKL------LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           L  F  +  +K       LV  Y+   +V    R        +     K       R L+
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155

Query: 402 YLHEHCDPKIIHRDVKAANILLDEDADQ 429
           Y+H      I HRD+K  N+LLD  +  
Sbjct: 156 YIHSI---GICHRDIKPQNLLLDPPSGV 180

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 71.3 bits (175), Expect = 9e-14
 Identities = 41/148 (27%), Positives = 68/148 (45%), Gaps = 8/148 (5%)

Query: 288 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
            S   ILG G FG+V+K    A G  +A K +K       E + + E+ +++   H NL+
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE-EVKNEISVMNQLDHANLI 149

Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
           +LY    +  + +LV  Y+  G +  R+ +   +L  LD     K       G+ ++H+ 
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE---GIRHMHQM 206

Query: 407 CDPKIIHRDVKAANILLDEDADQSSKTI 434
               I+H D+K  NIL      +  K I
Sbjct: 207 ---YILHLDLKPENILCVNRDAKQIKII 231

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 70.7 bits (174), Expect = 9e-14
 Identities = 36/143 (25%), Positives = 63/143 (44%), Gaps = 9/143 (6%)

Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHR 343
           + +     +G G +G V+K R    G++VA+K+  E       +     E++++    H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           NL+ L           LV+ Y  + +V   L   Q  +P       K I   + + +++ 
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPE---HLVKSITWQTLQAVNFC 118

Query: 404 HEHCDPKIIHRDVKAANILLDED 426
           H+H     IHRDVK  NIL+ + 
Sbjct: 119 HKH---NCIHRDVKPENILITKH 138

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 53/186 (28%), Positives = 79/186 (42%), Gaps = 24/186 (12%)

Query: 250 RTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD 309
              P + F D         +  Q K    +   +  D F +  +LGRGGFG+V+  ++  
Sbjct: 155 GQAPFQEFLDSLYFL----RFLQWKWLEAQ--PMGEDWFLDFRVLGRGGFGEVFACQMKA 208

Query: 310 -GKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRL-YGFCTTVTEKL-LVYPY 364
            GKL A K+L ++R     G      E KI++    R ++ L Y F T     L LV   
Sbjct: 209 TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK--TDLCLVMTI 266

Query: 365 MTNGSVASRLRERQSSLPPLDWPTRK----KIALGSARGLSYLHEHCDPKIIHRDVKAAN 420
           M  G +   +       P    P       +I  G    L +LH+     II+RD+K  N
Sbjct: 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEHLHQR---NIIYRDLKPEN 319

Query: 421 ILLDED 426
           +LLD+D
Sbjct: 320 VLLDDD 325

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 69.9 bits (172), Expect = 1e-13
 Identities = 37/146 (25%), Positives = 68/146 (46%), Gaps = 30/146 (20%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRLYG 350
           LG G FGKV  G     G  VAVK L  ++    ++  + + E++ + +  H ++++LY 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 351 FCTTVTEKLLVYPYMTNGSV------ASRLRERQSSLPPLDWPTRKK----IALGSARGL 400
             +T T+  +V  Y++ G +        R+ E ++         R+     ++      +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA---------RRLFQQILS-----AV 124

Query: 401 SYLHEHCDPKIIHRDVKAANILLDED 426
            Y H H    ++HRD+K  N+LLD  
Sbjct: 125 DYCHRH---MVVHRDLKPENVLLDAH 147

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 69.9 bits (172), Expect = 2e-13
 Identities = 39/146 (26%), Positives = 65/146 (44%), Gaps = 7/146 (4%)

Query: 284 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH 342
           ++  F     LG G +  VYKG     G  VA+K +K +   G       E+ ++    H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62

Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTN--GSVASRLRERQSSLPPLDWPTRKKIALGSARGL 400
            N++RLY    T  +  LV+ +M N             +    L+    K       +GL
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTP-RGLELNLVKYFQWQLLQGL 121

Query: 401 SYLHEHCDPKIIHRDVKAANILLDED 426
           ++ HE+   KI+HRD+K  N+L+++ 
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINKR 144

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 35/138 (25%), Positives = 55/138 (39%), Gaps = 14/138 (10%)

Query: 294 LGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRL 348
           LG GG   VY     D  L   VA+K +        E    F+ EV   S   H+N++ +
Sbjct: 19  LGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 349 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 408
                      LV  Y+   +++  +        PL   T          G+ + H+   
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDM-- 130

Query: 409 PKIIHRDVKAANILLDED 426
            +I+HRD+K  NIL+D +
Sbjct: 131 -RIVHRDIKPQNILIDSN 147

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 29/146 (19%), Positives = 54/146 (36%), Gaps = 11/146 (7%)

Query: 291 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL----QFQTEVKIISMAVHRNL 345
             ++G+G F  V +      G+  AVK +   + +          + E  I  M  H ++
Sbjct: 29  CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88

Query: 346 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 405
           + L    ++     +V+ +M    +   + +R  +                   L Y H+
Sbjct: 89  VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148

Query: 406 HCDPKIIHRDVKAANILL---DEDAD 428
           +    IIHRDVK   +LL   +  A 
Sbjct: 149 N---NIIHRDVKPHCVLLASKENSAP 171

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 43/149 (28%), Positives = 70/149 (46%), Gaps = 16/149 (10%)

Query: 288 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           +++  ++G G FG VY+ +L D G+LVA+K++ +++          E++I+    H N++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIV 110

Query: 347 RLYGFCTTVTEKL------LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 400
           RL  F  +  EK       LV  Y+   +V    R    +   L     K       R L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169

Query: 401 SYLHEHCDPKIIHRDVKAANILLDEDADQ 429
           +Y+H      I HRD+K  N+LLD D   
Sbjct: 170 AYIHSF---GICHRDIKPQNLLLDPDTAV 195

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 35/159 (22%), Positives = 67/159 (42%), Gaps = 22/159 (13%)

Query: 285 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVH 342
            + ++   +LG+G FG+V K +     +  AVK + +      +      EV+++    H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWPTRKKIALGS 396
            N+++L+      +   +V    T G +   +       E  ++          +I    
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA----------RIIKQV 130

Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS-KTI 434
             G++Y+H+H    I+HRD+K  NILL+        K I
Sbjct: 131 FSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKII 166

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 69.1 bits (170), Expect = 4e-13
 Identities = 20/90 (22%), Positives = 38/90 (42%), Gaps = 13/90 (14%)

Query: 89  PELGQLKNLELL-----------ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 137
             +  L  L++L            L NL +L SL L +N       + +  L  L  L L
Sbjct: 259 NAVKDLTKLKMLNVGSNQISDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFL 318

Query: 138 NNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
           + N ++ + P  L +++ ++  D +N  + 
Sbjct: 319 SQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 68.3 bits (168), Expect = 7e-13
 Identities = 25/91 (27%), Positives = 40/91 (43%), Gaps = 14/91 (15%)

Query: 89  PELGQLKNLELL-----------ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 137
             L  L NL  L            L NL K+ SL+L +N  N +    L+N+  L YL +
Sbjct: 104 SALQNLTNLRELYLNEDNISDISPLANLTKMYSLNLGANH-NLSDLSPLSNMTGLNYLTV 162

Query: 138 NNNSLSGLIPTSLTTITSLNILDLSNNRLSG 168
             + +  + P  +  +T L  L L+ N++  
Sbjct: 163 TESKVKDVTP--IANLTDLYSLSLNYNQIED 191

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 68.3 bits (168), Expect = 8e-13
 Identities = 29/91 (31%), Positives = 39/91 (42%), Gaps = 13/91 (14%)

Query: 89  PELGQLKNLELL-----------ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 137
             L  L  L  L           A+ +L KLK L++ SN    +    L NL QL  L L
Sbjct: 237 SPLANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSNQI--SDISVLNNLSQLNSLFL 294

Query: 138 NNNSLSGLIPTSLTTITSLNILDLSNNRLSG 168
           NNN L       +  +T+L  L LS N ++ 
Sbjct: 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 64.9 bits (159), Expect = 9e-12
 Identities = 24/91 (26%), Positives = 36/91 (39%), Gaps = 15/91 (16%)

Query: 89  PELGQLKNLELL-----------ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 137
             L  +  L  L            + NL  L SL L  N      P  LA+L  L Y   
Sbjct: 149 SPLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTA 206

Query: 138 NNNSLSGLIPTSLTTITSLNILDLSNNRLSG 168
             N ++ + P  +  +T LN L + NN+++ 
Sbjct: 207 YVNQITDITP--VANMTRLNSLKIGNNKITD 235

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 63.7 bits (156), Expect = 2e-11
 Identities = 22/92 (23%), Positives = 35/92 (38%), Gaps = 16/92 (17%)

Query: 89  PELGQLKNLELL------------ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLR 136
             L  L  +  L             L N+  L  L +  +      P  +ANL  L  L 
Sbjct: 126 SPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLS 183

Query: 137 LNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 168
           LN N +  + P  L ++TSL+      N+++ 
Sbjct: 184 LNYNQIEDISP--LASLTSLHYFTAYVNQITD 213

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 55.2 bits (134), Expect = 1e-08
 Identities = 17/92 (18%), Positives = 31/92 (33%), Gaps = 15/92 (16%)

Query: 91  LGQLKNLELLAL-----------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 139
              L       L             L  +  L +       +I   +  L  L+YL LN 
Sbjct: 18  DADLAEGIRAVLQKASVTDVVTQEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNG 75

Query: 140 NSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 171
           N ++ + P  L+ +  L  L +  N+++    
Sbjct: 76  NQITDISP--LSNLVKLTNLYIGTNKITDISA 105

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 54.5 bits (132), Expect = 2e-08
 Identities = 11/91 (12%), Positives = 34/91 (37%), Gaps = 5/91 (5%)

Query: 98  ELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLN 157
           ++    +L +     L        +      L+ +  L +    ++ +    +  +T+L 
Sbjct: 14  QIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASI--QGIEYLTNLE 69

Query: 158 ILDLSNNRLSGPVPDNGSFSQFTPISFENNL 188
            L+L+ N+++  +    +  + T +    N 
Sbjct: 70  YLNLNGNQITD-ISPLSNLVKLTNLYIGTNK 99

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 49.1 bits (118), Expect = 1e-06
 Identities = 10/80 (12%), Positives = 28/80 (35%), Gaps = 5/80 (6%)

Query: 108 LKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
             +L       N   P   A+L +     L   S++ ++      + S+  L ++  +++
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57

Query: 168 GPVPDNGSFSQFTPISFENN 187
             +      +    ++   N
Sbjct: 58  S-IQGIEYLTNLEYLNLNGN 76

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 68.9 bits (169), Expect = 4e-13
 Identities = 37/155 (23%), Positives = 59/155 (38%), Gaps = 28/155 (18%)

Query: 291 KNILGRGGFGKVYKGR-LADGKLVAVK-------RLKEERTSGGELQFQTEVKIISMAVH 342
              LG G  G+V         K VA+K        +   R +   L  +TE++I+    H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74

Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNG------SVASRLRERQSSLPPLDWPTRKKIALGS 396
             ++++  F     +  +V   M  G          RL+E    L         ++ L  
Sbjct: 75  PCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKL------YFYQMLL-- 125

Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 431
              + YLHE+    IIHRD+K  N+LL    +   
Sbjct: 126 --AVQYLHEN---GIIHRDLKPENVLLSSQEEDCL 155

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 68.4 bits (168), Expect = 4e-13
 Identities = 39/169 (23%), Positives = 60/169 (35%), Gaps = 52/169 (30%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVK-------------------------RLKEERTSGGE 327
           +G+G +G V       D    A+K                              +  G  
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 328 LQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLD 385
            Q   E+ I+    H N+++L        E  L  V+  +  G V             ++
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-------------ME 127

Query: 386 WPTRKKIALGSAR--------GLSYLHEHCDPKIIHRDVKAANILLDED 426
            PT K ++   AR        G+ YLH     KIIHRD+K +N+L+ ED
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGED 173

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 69.7 bits (171), Expect = 5e-13
 Identities = 37/156 (23%), Positives = 72/156 (46%), Gaps = 15/156 (9%)

Query: 285 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE--LQFQTEVKIISMAV 341
           +D +  + +LG+G FG+V   +    G+  AVK + + +            EV+++    
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK--KIALGSARG 399
           H N+++LY F        LV    T G +   +  R+       +      +I      G
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR------FSEVDAARIIRQVLSG 138

Query: 400 LSYLHEHCDPKIIHRDVKAANILLDEDADQSS-KTI 434
           ++Y+H++   KI+HRD+K  N+LL+  +  ++ + I
Sbjct: 139 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRII 171

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 69.4 bits (170), Expect = 5e-13
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 30/146 (20%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYG 350
           LG G FGKV  G+    G  VAVK L  ++  +     + + E++ + +  H ++++LY 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 351 FCTTVTEKLLVYPYMTNGSV------ASRLRERQSSLPPLDWPTRKK----IALGSARGL 400
             +T ++  +V  Y++ G +        RL E++S         R+     ++     G+
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES---------RRLFQQILS-----GV 129

Query: 401 SYLHEHCDPKIIHRDVKAANILLDED 426
            Y H H    ++HRD+K  N+LLD  
Sbjct: 130 DYCHRH---MVVHRDLKPENVLLDAH 152

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 68.4 bits (168), Expect = 6e-13
 Identities = 40/157 (25%), Positives = 67/157 (42%), Gaps = 27/157 (17%)

Query: 286 DGFSNKNILGRGGFGKVYKGR--LADGKLVAVKRLKEERTSGGELQF-QT---EVKI--- 336
             +     +G G +GKV+K R     G+ VA+KR++ +    G      +   EV +   
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG---MPLSTIREVAVLRH 67

Query: 337 ISMAVHRNLLRLYGFCTTVTEKL-----LVYPYMTNGSVASRLRE--RQSSLPPLDWPTR 389
           +    H N++RL+  CT           LV+ ++        L     +   P +   T 
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-----QDLTTYLDKVPEPGVPTETI 122

Query: 390 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           K +     RGL +LH H   +++HRD+K  NIL+   
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSS 156

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 68.1 bits (167), Expect = 7e-13
 Identities = 35/158 (22%), Positives = 64/158 (40%), Gaps = 21/158 (13%)

Query: 285 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVK-----RLKEERTSGGELQFQTEVKIIS 338
            D +     LG G F  V K R  + G   A K     + +  R      + + EV I+ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
             +H N++ L+      T+ +L+   ++ G +   L +++S        + ++      +
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES-------LSEEEAT-SFIK 122

Query: 399 ----GLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK 432
               G++YLH     KI H D+K  NI+L +       
Sbjct: 123 QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPH 157

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 68.5 bits (168), Expect = 7e-13
 Identities = 35/158 (22%), Positives = 64/158 (40%), Gaps = 21/158 (13%)

Query: 285 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVK-----RLKEERTSGGELQFQTEVKIIS 338
            D +     LG G F  V K R  + G   A K     + +  R      + + EV I+ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
             +H N++ L+      T+ +L+   ++ G +   L +++S        + ++      +
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES-------LSEEEAT-SFIK 122

Query: 399 ----GLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK 432
               G++YLH     KI H D+K  NI+L +       
Sbjct: 123 QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPH 157

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 68.0 bits (167), Expect = 7e-13
 Identities = 34/138 (24%), Positives = 53/138 (38%), Gaps = 14/138 (10%)

Query: 294 LGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRL 348
           +GRGG G VY+    D      VA+K + E  +S    +   Q E +        +++ +
Sbjct: 42  VGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99

Query: 349 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 408
           + F     +  +    +    +A+ LR +     PL  P    I       L   H    
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAA-- 153

Query: 409 PKIIHRDVKAANILLDED 426
               HRDVK  NIL+  D
Sbjct: 154 -GATHRDVKPENILVSAD 170

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 67.6 bits (166), Expect = 8e-13
 Identities = 33/151 (21%), Positives = 60/151 (39%), Gaps = 25/151 (16%)

Query: 291 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRL 348
           K  LG+G F  V +      G   A K +  ++ S  + Q  + E +I     H N++RL
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 70

Query: 349 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR--------GL 400
           +      +   LV+  +T G +   +  R+         +        A          +
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFY-------SEAD-----ASHCIQQILESI 118

Query: 401 SYLHEHCDPKIIHRDVKAANILLDEDADQSS 431
           +Y H +    I+HR++K  N+LL   A  ++
Sbjct: 119 AYCHSN---GIVHRNLKPENLLLASKAKGAA 146

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 68.0 bits (167), Expect = 8e-13
 Identities = 34/142 (23%), Positives = 61/142 (42%), Gaps = 18/142 (12%)

Query: 294 LGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRL 348
           LG GG  +V+  R  D +    VAVK L+ +          F+ E +  +   H  ++ +
Sbjct: 20  LGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77

Query: 349 Y--GFCTTVTEKL--LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
           Y  G   T    L  +V  Y+   ++   +        P+      ++   + + L++ H
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSH 133

Query: 405 EHCDPKIIHRDVKAANILLDED 426
           ++    IIHRDVK ANI++   
Sbjct: 134 QN---GIIHRDVKPANIMISAT 152

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 68.5 bits (168), Expect = 8e-13
 Identities = 38/176 (21%), Positives = 70/176 (39%), Gaps = 17/176 (9%)

Query: 261 PAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK 319
            A      Q+G+   F +      +D +  K  LG+G F  V +      G   A K + 
Sbjct: 4   MASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN 63

Query: 320 EERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ 378
            ++ S  + Q  + E +I     H N++RL+      +   LV+  +T G +   +  R+
Sbjct: 64  TKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE 123

Query: 379 SSLPPLDWPTRKKIALGSAR----GLSYLHEHCDPKIIHRDVKAANILLDEDADQS 430
                    +    A    +     ++Y H +    I+HR++K  N+LL   A  +
Sbjct: 124 FY-------SEAD-ASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGA 168

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 67.2 bits (165), Expect = 9e-13
 Identities = 40/160 (25%), Positives = 63/160 (39%), Gaps = 25/160 (15%)

Query: 285 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVK-----RLKEERTSGGELQFQTEVKIIS 338
            D +     LG G F  V K R    GK  A K     RL   R      + + EV I+ 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA----- 393
              H N++ L+      T+ +L+   ++ G +   L E++S        T  +       
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES-------LTEDEATQFLKQ 116

Query: 394 -LGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK 432
            L    G+ YLH     +I H D+K  NI+L +    + +
Sbjct: 117 ILD---GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPR 150

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 50/180 (27%), Positives = 76/180 (42%), Gaps = 14/180 (7%)

Query: 254 HEFFFDVPAED--DSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-G 310
           HE+    P  D  DS      L+   L    V  + F    +LG+GGFG+V   ++   G
Sbjct: 150 HEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATG 209

Query: 311 KLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRL-YGFCTTVTEKL-LVYPYMT 366
           K+ A K+L+++R     GE     E +I+     R ++ L Y + T   + L LV   M 
Sbjct: 210 KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDALCLVLTLMN 267

Query: 367 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            G +   +                  A     GL  LH     +I++RD+K  NILLD+ 
Sbjct: 268 GGDLKFHI--YHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDH 322

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 37/148 (25%), Positives = 62/148 (41%), Gaps = 20/148 (13%)

Query: 291 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRNLLRL 348
           +++LG G   +V     L   +  AVK ++++       +   EV+++     HRN+L L
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS-RVFREVEMLYQCQGHRNVLEL 76

Query: 349 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-----LGSARGLSYL 403
             F        LV+  M  GS+ S + +R+            + +     + SA  L +L
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHF-------NELEASVVVQDVASA--LDFL 127

Query: 404 HEHCDPKIIHRDVKAANILLDEDADQSS 431
           H      I HRD+K  NIL +     S 
Sbjct: 128 HNK---GIAHRDLKPENILCEHPNQVSP 152

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 32/155 (20%), Positives = 65/155 (41%), Gaps = 17/155 (10%)

Query: 285 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR 343
            + +     LGRG FG V++    +  K    K +K       ++  + E+ I+++A HR
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHR 61

Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR----G 399
           N+L L+    ++ E ++++ +++   +  R+      L   +        +         
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNERE-------IVSYVHQVCEA 114

Query: 400 LSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI 434
           L +LH H    I H D++  NI+       + K I
Sbjct: 115 LQFLHSH---NIGHFDIRPENIIYQTRRSSTIKII 146

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 54/183 (29%), Positives = 79/183 (43%), Gaps = 30/183 (16%)

Query: 258 FDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVK 316
           F    E D   +  Q K   L    +  + FS   I+GRGGFG+VY  R AD GK+ A+K
Sbjct: 162 FQKFIESDKFTRFCQWKNVELNI-HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 220

Query: 317 RLKEER--TSGGELQFQTEVKI---ISMAVHRNLLRL-YGFCTTVTEKL-LVYPYMTNGS 369
            L ++R     GE     E  +   +S      ++ + Y F T   +KL  +   M  G 
Sbjct: 221 CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILDLMNGGD 278

Query: 370 VASRL-RERQSSLPPLDWPTRKK-----IALGSARGLSYLHEHCDPKIIHRDVKAANILL 423
           +   L +    S          +     I LG    L ++H      +++RD+K ANILL
Sbjct: 279 LHYHLSQHGVFSEA------DMRFYAAEIILG----LEHMHNR---FVVYRDLKPANILL 325

Query: 424 DED 426
           DE 
Sbjct: 326 DEH 328

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 66.9 bits (164), Expect = 1e-12
 Identities = 33/148 (22%), Positives = 63/148 (42%), Gaps = 19/148 (12%)

Query: 291 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRL 348
             +LG+G FG+V K +     +  AVK + +      +      EV+++    H N+++L
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86

Query: 349 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-----LGSARGLSYL 403
           +      +   +V    T G +   + +R+         +    A     + S   ++Y+
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRF-------SEHDAARIIKQVFSG--ITYM 137

Query: 404 HEHCDPKIIHRDVKAANILLDEDADQSS 431
           H+H    I+HRD+K  NILL+       
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCD 162

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 36/149 (24%), Positives = 63/149 (42%), Gaps = 37/149 (24%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVHRNLLRLYG 350
           LG G FGKV         + VA+K +  +     ++  +   E+  + +  H ++++LY 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 351 FCTTVTEKLLVYPY---------MTNGSVASRLRERQSSLPPLDWPTRKK----IALGSA 397
             TT T+ ++V  Y         +       R+ E +          R+     I     
Sbjct: 77  VITTPTDIVMVIEYAGGELFDYIVEKK----RMTEDEG---------RRFFQQIIC---- 119

Query: 398 RGLSYLHEHCDPKIIHRDVKAANILLDED 426
             + Y H H   KI+HRD+K  N+LLD++
Sbjct: 120 -AIEYCHRH---KIVHRDLKPENLLLDDN 144

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 18/88 (20%), Positives = 36/88 (40%), Gaps = 1/88 (1%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
           +++ +E  A  +L  L +L L  N          + L  L+ L     +L+ L    +  
Sbjct: 63  EIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122

Query: 153 ITSLNILDLSNNRLSGPVPDNGSFSQFT 180
           + +L  L++++N +         FS  T
Sbjct: 123 LKTLKELNVAHNLIQS-FKLPEYFSNLT 149

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 20/91 (21%), Positives = 29/91 (31%), Gaps = 14/91 (15%)

Query: 91  LGQLKNLELL--------------ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLR 136
              L +LE+L                  L  L  LDL         P    +L  L+ L 
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 500

Query: 137 LNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
           + +N L  +       +TSL  + L  N   
Sbjct: 501 MASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 26/102 (25%), Positives = 51/102 (50%), Gaps = 5/102 (4%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSN-LFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLT 151
            L +LE   +G+L  LK L++  N + +  +P+  +NL  L++L L++N +  +  T L 
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170

Query: 152 TITSLNI----LDLSNNRLSGPVPDNGSFSQFTPISFENNLN 189
            +  + +    LDLS N ++   P      +   ++  NN +
Sbjct: 171 VLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFD 212

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 13/78 (16%), Positives = 28/78 (35%), Gaps = 2/78 (2%)

Query: 104 NLIKLKSLDLYSNLFNGTIP-DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLS 162
            L +L+ LD   +            +L+ L YL +++             ++SL +L ++
Sbjct: 394 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA 453

Query: 163 NNRLSGPVPDNGSFSQFT 180
            N           F++  
Sbjct: 454 GNSFQENFL-PDIFTELR 470

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 29/115 (25%), Positives = 40/115 (34%), Gaps = 19/115 (16%)

Query: 77  DLGNAALSGELAPELGQLKNLELL--------------ALGNLIKLKSLDLYSNLFNGTI 122
                 L+      +G LK L+ L                 NL  L+ LDL SN      
Sbjct: 106 VAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY 165

Query: 123 PDTLANLKQLKY----LRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN 173
              L  L Q+      L L+ N ++ + P +   I  L+ L L NN  S  V   
Sbjct: 166 CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKT 219

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 23/90 (25%), Positives = 31/90 (34%), Gaps = 5/90 (5%)

Query: 91  LGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSL 150
           L  +    +         + L+L +  F    P     LK LK L   +N        S 
Sbjct: 289 LVSVTIERVKDFSYNFGWQHLELVNCKFGQ-FPTL--KLKSLKRLTFTSNKGGNAF--SE 343

Query: 151 TTITSLNILDLSNNRLSGPVPDNGSFSQFT 180
             + SL  LDLS N LS     + S    T
Sbjct: 344 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 27/146 (18%), Positives = 59/146 (40%), Gaps = 17/146 (11%)

Query: 291 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRL 348
              LG+G F  V +   +  G+  A   +  ++ S  + Q  + E +I  +  H N++RL
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL 75

Query: 349 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR----GLSYLH 404
           +   +      L++  +T G +   +  R+         +    A    +     + + H
Sbjct: 76  HDSISEEGHHYLIFDLVTGGELFEDIVAREYY-------SEAD-ASHCIQQILEAVLHCH 127

Query: 405 EHCDPKIIHRDVKAANILLDEDADQS 430
           +     ++HR++K  N+LL      +
Sbjct: 128 QM---GVVHRNLKPENLLLASKLKGA 150

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 22/86 (25%), Positives = 37/86 (43%), Gaps = 1/86 (1%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTI-PDTLANLKQLKYLRLNNNSLSGLIPTSLT 151
            ++ +   +   L +L+ L+L S     TI  +   NL  L+ L L ++ +  L P +  
Sbjct: 35  YIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQ 94

Query: 152 TITSLNILDLSNNRLSGPVPDNGSFS 177
            +  L  L L    LS  V  +G F 
Sbjct: 95  GLFHLFELRLYFCGLSDAVLKDGYFR 120

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 21/100 (21%), Positives = 39/100 (39%), Gaps = 5/100 (5%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
            + +L       L  LK L+L  N  N    +    L  L+ L L+ N L  L  ++   
Sbjct: 277 FVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYG 336

Query: 153 ITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCG 192
           +  +  +DL  N ++  +  + +F     +     L+L  
Sbjct: 337 LPKVAYIDLQKNHIA--IIQDQTFKFLEKL---QTLDLRD 371

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 17/75 (22%), Positives = 32/75 (42%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
           ++  +   A   L  L+ L+L  NL           L ++ Y+ L  N ++ +   +   
Sbjct: 301 KINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKF 360

Query: 153 ITSLNILDLSNNRLS 167
           +  L  LDL +N L+
Sbjct: 361 LEKLQTLDLRDNALT 375

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 57.1 bits (138), Expect = 6e-09
 Identities = 37/177 (20%), Positives = 66/177 (37%), Gaps = 35/177 (19%)

Query: 45  LQECEQLHLLISFLIFIRVLQSSSNLFVYL--ISDLGNAALSGEL-------------AP 89
           L++ + L L  + L  I  + S  ++F+    +  L    L+  L               
Sbjct: 361 LEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILY 420

Query: 90  ELGQLKNLELLAL--------------GNLIKLKSLDLYSNLFNGTI-----PDTLANLK 130
            L ++ +L++L L                   L+ L L  N+           D    L 
Sbjct: 421 FLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLS 480

Query: 131 QLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN 187
            L+ L LN+N L+ L P   + +T+L  L L++NRL+  +  N   +    +    N
Sbjct: 481 HLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTV-LSHNDLPANLEILDISRN 536

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 15/65 (23%), Positives = 27/65 (41%), Gaps = 1/65 (1%)

Query: 104 NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLI-PTSLTTITSLNILDLS 162
            L   + L L  N        +   L+QL+ L L +      I   +   + +L ILDL 
Sbjct: 22  VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81

Query: 163 NNRLS 167
           ++++ 
Sbjct: 82  SSKIY 86

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 20/96 (20%), Positives = 35/96 (36%), Gaps = 5/96 (5%)

Query: 97  LELLALGNLIKLKSLDLYSNLFNG-TIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTIT- 154
           L+     NL  L  LDL  N      +  +   L  LK +  ++N +  +    L  +  
Sbjct: 114 LKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQG 173

Query: 155 -SLNILDLSNNRLSGPVPDN--GSFSQFTPISFENN 187
            +L+   L+ N L   V  +     + F  +  E  
Sbjct: 174 KTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEIL 209

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 21/75 (28%), Positives = 33/75 (44%), Gaps = 5/75 (6%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
            L  L       L K+  +DL  N        T   L++L+ L L +N+L     T++  
Sbjct: 325 LLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHF 379

Query: 153 ITSLNILDLSNNRLS 167
           I S+  + LS N+L 
Sbjct: 380 IPSIPDIFLSGNKLV 394

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 17/112 (15%), Positives = 42/112 (37%), Gaps = 5/112 (4%)

Query: 61  IRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLAL---GNLIKLKSLDLYSNL 117
           +  LQ  +  F  L ++   + +S +    +   +N+ L  L   GN   +     +SN 
Sbjct: 168 LEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNA 227

Query: 118 FNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNI--LDLSNNRLS 167
            + +   +L     +       +++      +   +   ++  LDLS+  + 
Sbjct: 228 ISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF 279

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 44.4 bits (105), Expect = 7e-05
 Identities = 32/162 (19%), Positives = 54/162 (33%), Gaps = 10/162 (6%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
            L +L      +L  L+ L L SN       + L     L+ L ++ N L    P     
Sbjct: 491 YLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNPDVF-- 546

Query: 153 ITSLNILDLSNNRLSGPVPDNGSFSQF---TPISFENNLNLCGPNTKKPCSGSPPFS-PP 208
             SL++LD+++N+      +  +F  +   T ++                SG   FS   
Sbjct: 547 -VSLSVLDITHNKFICEC-ELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLST 604

Query: 209 PPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWRR 250
                       K +  I   V L   L+  + V  F  +  
Sbjct: 605 EGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTKFRGFCF 646

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 41.7 bits (98), Expect = 5e-04
 Identities = 8/46 (17%), Positives = 18/46 (39%)

Query: 128 NLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN 173
            L   + L L+ N +  +  +S   +  L +L+L +      +   
Sbjct: 22  VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKE 67

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 66.5 bits (163), Expect = 3e-12
 Identities = 39/160 (24%), Positives = 61/160 (38%), Gaps = 25/160 (15%)

Query: 285 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVK-----RLKEERTSGGELQFQTEVKIIS 338
            D +     LG G F  V K R  + G   A K     R K  R        + EV I+ 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA----- 393
              H N++ L+      T+ +L+   +  G +   L E++S        T ++       
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-------LTEEEATEFLKQ 122

Query: 394 -LGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK 432
            L    G+ YLH     +I H D+K  NI+L +      +
Sbjct: 123 ILN---GVYYLHSL---QIAHFDLKPENIMLLDRNVPKPR 156

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 66.5 bits (163), Expect = 3e-12
 Identities = 29/155 (18%), Positives = 60/155 (38%), Gaps = 24/155 (15%)

Query: 285 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-H 342
           TDG+  K  +G G +    +    A     AVK + + +    E     E++I+     H
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-----EIEILLRYGQH 75

Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-----LGSA 397
            N++ L           +V   M  G +  ++  ++         + ++ +     +   
Sbjct: 76  PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFF-------SEREASAVLFTITKT 128

Query: 398 RGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK 432
             + YLH      ++HRD+K +NIL  +++     
Sbjct: 129 --VEYLHAQ---GVVHRDLKPSNILYVDESGNPES 158

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 65.8 bits (161), Expect = 5e-12
 Identities = 35/151 (23%), Positives = 65/151 (43%), Gaps = 14/151 (9%)

Query: 285 TDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVH 342
            D F  + + G+G FG V  G+    G  VA+K+ +++ R    ELQ    ++ +++  H
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ---IMQDLAVLHH 78

Query: 343 RNLLRLYGFCTTVTEK-------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALG 395
            N+++L  +  T+ E+        +V  Y+   ++    R              K     
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137

Query: 396 SARGLSYLHEHCDPKIIHRDVKAANILLDED 426
             R +  LH      + HRD+K  N+L++E 
Sbjct: 138 LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEA 167

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 66.1 bits (162), Expect = 5e-12
 Identities = 28/93 (30%), Positives = 42/93 (45%), Gaps = 14/93 (15%)

Query: 89  PELGQLKNLELLALGN----------LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN 138
             L  L +L+ L+ GN          L  L+ LD+ SN    +    LA L  L+ L   
Sbjct: 150 SALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKV--SDISVLAKLTNLESLIAT 207

Query: 139 NNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 171
           NN +S + P  L  +T+L+ L L+ N+L     
Sbjct: 208 NNQISDITP--LGILTNLDELSLNGNQLKDIGT 238

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 66.1 bits (162), Expect = 7e-12
 Identities = 27/118 (22%), Positives = 45/118 (38%), Gaps = 15/118 (12%)

Query: 89  PELGQLKNLELL-----------ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 137
             +  LKNL  L            + +L KL+ L  Y+N    +   +LANL  + +L  
Sbjct: 303 SPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSA 360

Query: 138 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNT 195
            +N +S L P  L  +T +  L L++   +    +  +              L  P T
Sbjct: 361 GHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPAT 416

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 65.8 bits (161), Expect = 9e-12
 Identities = 34/110 (30%), Positives = 44/110 (40%), Gaps = 16/110 (14%)

Query: 89  PELGQLKNLELL-----------ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 137
             L +L NLE L            LG L  L  L L  N        TLA+L  L  L L
Sbjct: 193 SVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQL--KDIGTLASLTNLTDLDL 250

Query: 138 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN 187
            NN +S L P  L+ +T L  L L  N++S  +      +  T +    N
Sbjct: 251 ANNQISNLAP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNEN 297

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 60.7 bits (148), Expect = 3e-10
 Identities = 25/87 (28%), Positives = 35/87 (40%), Gaps = 15/87 (17%)

Query: 89  PELGQLKNLELL-----------ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 137
             L  L  L  +            L NL  L  L L++N      P  L NL  L  L L
Sbjct: 84  TPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLEL 141

Query: 138 NNNSLSGLIPTSLTTITSLNILDLSNN 164
           ++N++S +    L+ +TSL  L   N 
Sbjct: 142 SSNTISDISA--LSGLTSLQQLSFGNQ 166

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 59.6 bits (145), Expect = 7e-10
 Identities = 28/94 (29%), Positives = 40/94 (42%), Gaps = 16/94 (17%)

Query: 89  PELGQLKNLELL-----------ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 137
             L  L NL  L            L NL  L  L+L SN  +      L+ L  L+ L  
Sbjct: 106 TPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF 163

Query: 138 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 171
            N  ++ L P  L  +T+L  LD+S+N++S    
Sbjct: 164 GNQ-VTDLKP--LANLTTLERLDISSNKVSDISV 194

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 59.2 bits (144), Expect = 9e-10
 Identities = 18/92 (19%), Positives = 33/92 (35%), Gaps = 15/92 (16%)

Query: 91  LGQLKNLELLALGN-----------LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 139
              L       LG            L ++ +L            D +  L  L  +  +N
Sbjct: 20  DTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRL--GIKSIDGVEYLNNLTQINFSN 77

Query: 140 NSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 171
           N L+ + P  L  +T L  + ++NN+++   P
Sbjct: 78  NQLTDITP--LKNLTKLVDILMNNNQIADITP 107

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 21/110 (19%), Positives = 38/110 (34%), Gaps = 13/110 (11%)

Query: 89  PELGQLKNLELL-----------ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 137
             L  L N+  L            L NL ++  L L    +     +  AN+     ++ 
Sbjct: 347 SSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKN 406

Query: 138 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN 187
              +L  + P +++   S    D++ N  S     + +FSQ   I     
Sbjct: 407 VTGAL--IAPATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTT 454

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 63.4 bits (155), Expect = 6e-12
 Identities = 17/85 (20%), Positives = 33/85 (38%), Gaps = 11/85 (12%)

Query: 91  LGQLKNLELL-----------ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 139
           +    N++ L            +  L  L+ L +            L+ L  L  L +++
Sbjct: 62  IEYAHNIKDLTINNIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISH 121

Query: 140 NSLSGLIPTSLTTITSLNILDLSNN 164
           ++    I T + T+  +N +DLS N
Sbjct: 122 SAHDDSILTKINTLPKVNSIDLSYN 146

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 61.9 bits (151), Expect = 2e-11
 Identities = 22/105 (20%), Positives = 37/105 (35%), Gaps = 16/105 (15%)

Query: 77  DLGNAALSGELAPELGQLKNLELL-------------ALGNLIKLKSLDLYSNLFNGTIP 123
            +    ++ +  P L  L +L LL              +  L K+ S+DL  N     I 
Sbjct: 94  RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI- 152

Query: 124 DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 168
             L  L +LK L +  + +       +     LN L   +  + G
Sbjct: 153 MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 60.0 bits (146), Expect = 1e-10
 Identities = 21/114 (18%), Positives = 45/114 (39%), Gaps = 10/114 (8%)

Query: 68  SNLFVYLISDLGNAALSGELAPELGQLKNLELL--------ALGNLIKLKSLDLYSNLFN 119
           S    YL   LG ++ +     ++  L  + L          +     +K L + +    
Sbjct: 20  STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTGIEYAHNIKDLTINNIHAT 79

Query: 120 GTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN 173
              P  ++ L  L+ LR+    ++     +L+ +TSL +LD+S++     +   
Sbjct: 80  NYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 46.1 bits (110), Expect = 4e-06
 Identities = 12/81 (14%), Positives = 31/81 (38%), Gaps = 14/81 (17%)

Query: 77  DLGNAALSGELAPELGQLKNLELL------------ALGNLIKLKSLDLYSNLFNGTIPD 124
           D+ ++A    +  ++  L  +  +             L  L +LKSL++  +  +     
Sbjct: 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYRG- 176

Query: 125 TLANLKQLKYLRLNNNSLSGL 145
            + +  +L  L   + ++ G 
Sbjct: 177 -IEDFPKLNQLYAFSQTIGGK 196

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 65.3 bits (159), Expect = 8e-12
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 8/102 (7%)

Query: 291 KNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HR 343
              LGRG FG+V +         A  + VAVK LKE  T        +E+KI+     H 
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86

Query: 344 NLLRLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL 384
           N++ L G CT     L+V   +   G++++ LR +++   P 
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 40/156 (25%), Positives = 71/156 (45%), Gaps = 15/156 (9%)

Query: 277 SLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRL-KEERTSGGEL-QFQTE 333
            L+E+++  D F    ++GRG F +V   ++   G++ A+K + K +    GE+  F+ E
Sbjct: 52  RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREE 111

Query: 334 VKIISMAVHRNLLRL-YGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKK 391
             ++     R + +L + F       L LV  Y   G + + L  +     P +   R  
Sbjct: 112 RDVLVNGDRRWITQLHFAFQDE--NYLYLVMEYYVGGDLLTLLS-KFGERIPAEM-ARFY 167

Query: 392 IA-LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           +A +  A  +  +H       +HRD+K  NILLD  
Sbjct: 168 LAEIVMA--IDSVHRL---GYVHRDIKPDNILLDRC 198

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 32/170 (18%), Positives = 61/170 (35%), Gaps = 33/170 (19%)

Query: 285 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK------------EERTSGGELQFQ 331
            + +     LG G +G+V   +        A+K +K             +       +  
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 332 TEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLD 385
            E+ ++    H N+++L+          LV  +   G +  ++       E  ++     
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA----- 149

Query: 386 WPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS-KTI 434
                 I      G+ YLH+H    I+HRD+K  NILL+      + K +
Sbjct: 150 -----NIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIV 191

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 34/148 (22%), Positives = 59/148 (39%), Gaps = 21/148 (14%)

Query: 291 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           +N +GRG +G+V            A K++ +      + +F+ E++I+    H N++RLY
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD-RFKQEIEIMKSLDHPNIIRLY 72

Query: 350 GFCTTVTEKLLVYPYMTNG------SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
                 T+  LV    T G            RE  ++         K +       ++Y 
Sbjct: 73  ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR------IMKDV----LSAVAYC 122

Query: 404 HEHCDPKIIHRDVKAANILLDEDADQSS 431
           H+     + HRD+K  N L   D+  S 
Sbjct: 123 HKL---NVAHRDLKPENFLFLTDSPDSP 147

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 22/88 (25%), Positives = 37/88 (42%), Gaps = 1/88 (1%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
           ++  +    L     L+ L L S+  N    D   +L  L++L L++N LS L  +    
Sbjct: 37  KITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGP 96

Query: 153 ITSLNILDLSNNRLSGPVPDNGSFSQFT 180
           ++SL  L+L  N     +     F   T
Sbjct: 97  LSSLKYLNLMGNPYQT-LGVTSLFPNLT 123

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 22/155 (14%), Positives = 52/155 (33%), Gaps = 5/155 (3%)

Query: 29  GICARGFTLLVTLKAVLQECEQLHLL--ISFLIFIRVLQSSSNLFVYLISDLGNAALSGE 86
                   +      + +   +  +L   SF   +++L+    L      D     L+G 
Sbjct: 210 RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDC---TLNGL 266

Query: 87  LAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLI 146
                 +   +  L     + ++ L +        +    + L+++K + + N+ +  + 
Sbjct: 267 GDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVP 326

Query: 147 PTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTP 181
            +    + SL  LDLS N +      N +     P
Sbjct: 327 CSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWP 361

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 59.7 bits (145), Expect = 7e-10
 Identities = 25/149 (16%), Positives = 45/149 (30%), Gaps = 4/149 (2%)

Query: 35  FTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQL 94
           F  L+ L   + E  ++      L  +     S +  V  +  +    +     P+   L
Sbjct: 240 FNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQF-YL 298

Query: 95  KNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLI---PTSLT 151
                     L K+K + + ++           +LK L++L L+ N +            
Sbjct: 299 FYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKG 358

Query: 152 TITSLNILDLSNNRLSGPVPDNGSFSQFT 180
              SL  L LS N L              
Sbjct: 359 AWPSLQTLVLSQNHLRSMQKTGEILLTLK 387

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 14/102 (13%), Positives = 35/102 (34%), Gaps = 2/102 (1%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
               +  +    L  L  L++ +         +L +++ + +L L+ +  + L+      
Sbjct: 135 TFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADI 194

Query: 153 ITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPN 194
           ++S+  L+L +  L+               S    L   G  
Sbjct: 195 LSSVRYLELRDTNLAR--FQFSPLPVDEVSSPMKKLAFRGSV 234

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 54.0 bits (130), Expect = 5e-08
 Identities = 25/114 (21%), Positives = 48/114 (42%), Gaps = 21/114 (18%)

Query: 93  QLKNLELLA--LGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGL---IP 147
            L++++     L  L  L SLD+  N F+  +PD+    +++++L L++  +  +   IP
Sbjct: 372 HLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIP 430

Query: 148 TSLTT--------------ITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN 187
            +L                +  L  L +S N+L   +PD   F     +    N
Sbjct: 431 QTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLKT-LPDASLFPVLLVMKISRN 483

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 19/60 (31%), Positives = 30/60 (50%)

Query: 108 LKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
           +KSLDL  N         L     L+ L L ++ ++ +   +  ++ SL  LDLS+N LS
Sbjct: 28  MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS 87

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 50.5 bits (121), Expect = 7e-07
 Identities = 19/84 (22%), Positives = 34/84 (40%), Gaps = 11/84 (13%)

Query: 92  GQLKNLELLALGN---------LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSL 142
              + LE+L + N         L +L+ L +  N    T+PD  +    L  ++++ N L
Sbjct: 428 CIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQL 485

Query: 143 SGLIPTSLTTITSLNILDLSNNRL 166
             +       +TSL  + L  N  
Sbjct: 486 KSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 25/134 (18%), Positives = 50/134 (37%), Gaps = 23/134 (17%)

Query: 61  IRVLQSSSNLFVYLIS----DLGNAALSGELAPELGQLKNLELLAL----------GNLI 106
           +R +Q +  + + L +    D+        +       + +  L L              
Sbjct: 373 LRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQ 431

Query: 107 KLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 166
            L+ LD+ +N  + +       L +L+ L ++ N L  L   SL     L ++ +S N+L
Sbjct: 432 TLEVLDVSNNNLD-SFS---LFLPRLQELYISRNKLKTLPDASL--FPVLLVMKISRNQL 485

Query: 167 SGPVPDNGSFSQFT 180
                 +G F + T
Sbjct: 486 K--SVPDGIFDRLT 497

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 40/156 (25%), Positives = 73/156 (46%), Gaps = 15/156 (9%)

Query: 277 SLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRL-KEERTSGGELQ-FQTE 333
            ++++++  + F    ++GRG FG+V   +L +  K+ A+K L K E     E   F+ E
Sbjct: 65  KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124

Query: 334 VKIISMAVHRNLLRL-YGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKK 391
             ++     + +  L Y F       L LV  Y   G + + L + +  LP  +   R  
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDD--NNLYLVMDYYVGGDLLTLLSKFEDRLPE-EM-ARFY 180

Query: 392 IA-LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           +A +  A  +  +H+      +HRD+K  NIL+D +
Sbjct: 181 LAEMVIA--IDSVHQL---HYVHRDIKPDNILMDMN 211

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 16/138 (11%), Positives = 37/138 (26%), Gaps = 16/138 (11%)

Query: 294 LGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRL 348
            G     + ++    D  L   VA+  +  +     ++     +    +S      + R+
Sbjct: 39  HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 349 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 408
                T    L+V  ++  GS+            P       +     A      H    
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSP---VGAIRAMQSLAAAADAAHRA-- 148

Query: 409 PKIIHRDVKAANILLDED 426
             +       + + +  D
Sbjct: 149 -GVALSIDHPSRVRVSID 165

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 62.7 bits (153), Expect = 4e-11
 Identities = 36/149 (24%), Positives = 58/149 (38%), Gaps = 27/149 (18%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHR-NLLRLYG 350
           LGRG F  V +    + G+  A K LK+ R           E+ ++ +A     ++ L+ 
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 351 FCTTVTEKLLVYPYMTNG--------SVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 402
                +E +L+  Y   G         +A  + E             K+I      G+ Y
Sbjct: 97  VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIR------LIKQI----LEGVYY 146

Query: 403 LHEHCDPKIIHRDVKAANILL---DEDAD 428
           LH++    I+H D+K  NILL       D
Sbjct: 147 LHQN---NIVHLDLKPQNILLSSIYPLGD 172

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 62.3 bits (152), Expect = 5e-11
 Identities = 19/75 (25%), Positives = 29/75 (38%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
            L+ L      +L  L  L L+ N  +         L  L  L L+ N ++ + P +   
Sbjct: 140 ALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199

Query: 153 ITSLNILDLSNNRLS 167
           +  L  L L  N LS
Sbjct: 200 LGRLMTLYLFANNLS 214

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 59.2 bits (144), Expect = 4e-10
 Identities = 20/76 (26%), Positives = 34/76 (44%), Gaps = 2/76 (2%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIP-DTLANLKQLKYLRLNNNSLSGLIPTSLT 151
           QL++++      L +L +L L        +       L  L+YL L +N+L  L   +  
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150

Query: 152 TITSLNILDLSNNRLS 167
            + +L  L L  NR+S
Sbjct: 151 DLGNLTHLFLHGNRIS 166

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 55.4 bits (134), Expect = 9e-09
 Identities = 20/72 (27%), Positives = 33/72 (45%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
           ++ ++   A   L  L  L L+ N      P    +L +L  L L  N+LS L   +L  
Sbjct: 164 RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAP 223

Query: 153 ITSLNILDLSNN 164
           + +L  L L++N
Sbjct: 224 LRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 54.2 bits (131), Expect = 2e-08
 Identities = 16/76 (21%), Positives = 31/76 (40%), Gaps = 1/76 (1%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNS-LSGLIPTSLT 151
           ++ ++   +      L  L L+SN+           L  L+ L L++N+ L  + P +  
Sbjct: 43  RISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH 102

Query: 152 TITSLNILDLSNNRLS 167
            +  L+ L L    L 
Sbjct: 103 GLGRLHTLHLDRCGLQ 118

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 50.0 bits (120), Expect = 5e-07
 Identities = 16/70 (22%), Positives = 30/70 (42%), Gaps = 1/70 (1%)

Query: 108 LKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
            + + L+ N  +     +    + L  L L++N L+ +   + T +  L  LDLS+N   
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93

Query: 168 GPVPDNGSFS 177
             V    +F 
Sbjct: 94  RSVDP-ATFH 102

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 62.6 bits (153), Expect = 5e-11
 Identities = 34/148 (22%), Positives = 63/148 (42%), Gaps = 21/148 (14%)

Query: 291 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
             +LG G F +V+  +    GKL A+K +K +  +  +   + E+ ++    H N++ L 
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIK-KSPAFRDSSLENEIAVLKKIKHENIVTLE 72

Query: 350 GFCTTVTEKLLVYPYMTNG------SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
               + T   LV   ++ G             E+ +SL        +++       + YL
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL------VIQQV----LSAVKYL 122

Query: 404 HEHCDPKIIHRDVKAANILLDEDADQSS 431
           HE+    I+HRD+K  N+L     + S 
Sbjct: 123 HEN---GIVHRDLKPENLLYLTPEENSK 147

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 62.6 bits (152), Expect = 5e-11
 Identities = 29/188 (15%), Positives = 60/188 (31%), Gaps = 54/188 (28%)

Query: 293 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG- 350
            +GRGGFG V++ +   D    A+KR++         +   EVK ++   H  ++R +  
Sbjct: 13  CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72

Query: 351 -------------FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 397
                            + ++   +P  +   + +   + +   P     T  ++   S 
Sbjct: 73  WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132

Query: 398 RGLSYLH-EHCDP--------------------------------------KIIHRDVKA 418
           +   Y+  + C                                         ++HRD+K 
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKP 192

Query: 419 ANILLDED 426
           +NI    D
Sbjct: 193 SNIFFTMD 200

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 62.7 bits (153), Expect = 5e-11
 Identities = 30/170 (17%), Positives = 54/170 (31%), Gaps = 18/170 (10%)

Query: 33  RGFTLLVTLKAVLQECEQL-HLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPEL 91
           +G T L     VL + ++  +   +         +S+N  +   +     A +  L  E 
Sbjct: 20  QGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLL--ED 77

Query: 92  GQLKNLELL------------ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 139
                   L                L  L+ + + +      +PDT+     L+ L L  
Sbjct: 78  ATQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLAR 136

Query: 140 NSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNL 188
           N L  L P S+ ++  L  L +        +P+   S           NL
Sbjct: 137 NPLRAL-PASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNL 185

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 60.3 bits (147), Expect = 3e-10
 Identities = 28/125 (22%), Positives = 41/125 (32%), Gaps = 14/125 (11%)

Query: 77  DLGNAALSGELAPELGQLKNLELL------------ALGNLIKLKSLDLYSNLFNGTIPD 124
            L    +   L   +  L+NL+ L            A+ +L KL+ LDL         P 
Sbjct: 189 RLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPP 247

Query: 125 TLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPIS 183
                  LK L L + S    +P  +  +T L  LDL        +P           I 
Sbjct: 248 IFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIIL 307

Query: 184 FENNL 188
              +L
Sbjct: 308 VPPHL 312

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 16/93 (17%), Positives = 27/93 (29%), Gaps = 13/93 (13%)

Query: 77  DLGNAALSGELAPELGQLKNLELLAL-------------GNLIKLKSLDLYSNLFNGTIP 123
           DL          P  G    L+ L L               L +L+ LDL   +    +P
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLP 294

Query: 124 DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSL 156
             +A L     + +  +  + L         + 
Sbjct: 295 SLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 62.8 bits (153), Expect = 7e-11
 Identities = 19/75 (25%), Positives = 39/75 (52%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
            L  +  LA+ +L+ L+ L+L  N  +      L  L +L+ ++L    L+ + P +   
Sbjct: 235 NLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRG 294

Query: 153 ITSLNILDLSNNRLS 167
           +  L +L++S N+L+
Sbjct: 295 LNYLRVLNVSGNQLT 309

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 62.4 bits (152), Expect = 9e-11
 Identities = 26/117 (22%), Positives = 40/117 (34%), Gaps = 19/117 (16%)

Query: 61  IRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLEL----------LALGNLIKLKS 110
            R+L    N     I  L     +         L+ LEL           A  NL  L++
Sbjct: 34  TRLLDLGKNR----IKTLNQDEFAS-----FPHLEELELNENIVSAVEPGAFNNLFNLRT 84

Query: 111 LDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
           L L SN            L  L  L ++ N +  L+      + +L  L++ +N L 
Sbjct: 85  LGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV 141

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 19/75 (25%), Positives = 31/75 (41%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
           +LK + L     L  L  LD+  N     +     +L  LK L + +N L  +   + + 
Sbjct: 91  RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSG 150

Query: 153 ITSLNILDLSNNRLS 167
           + SL  L L    L+
Sbjct: 151 LNSLEQLTLEKCNLT 165

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 16/75 (21%), Positives = 33/75 (44%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
           ++  L      +L  LKSL++  N          + L  L+ L L   +L+ +   +L+ 
Sbjct: 115 KIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSH 174

Query: 153 ITSLNILDLSNNRLS 167
           +  L +L L +  ++
Sbjct: 175 LHGLIVLRLRHLNIN 189

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 14/88 (15%), Positives = 34/88 (38%), Gaps = 2/88 (2%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
            +  +   +   L +LK L++    +  T+         L  L + + +L+ +   ++  
Sbjct: 187 NINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRH 246

Query: 153 ITSLNILDLSNNRLSGPVPDNGSFSQFT 180
           +  L  L+LS N +S    +     +  
Sbjct: 247 LVYLRFLNLSYNPIS--TIEGSMLHELL 272

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 17/75 (22%), Positives = 33/75 (44%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
            +  +E   L  L++L+ + L         P     L  L+ L ++ N L+ L  +   +
Sbjct: 259 PISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHS 318

Query: 153 ITSLNILDLSNNRLS 167
           + +L  L L +N L+
Sbjct: 319 VGNLETLILDSNPLA 333

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 61.9 bits (151), Expect = 9e-11
 Identities = 23/93 (24%), Positives = 31/93 (33%), Gaps = 13/93 (13%)

Query: 86  ELAPELGQLKNLELLALGN-----------LIKLKSLDLYSNLFNGTIPDTLANLKQLKY 134
             A        LE L L               KLK+LDL SN     +     +   + +
Sbjct: 160 NFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTW 218

Query: 135 LRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
           + L NN L   I  +L    +L   DL  N   
Sbjct: 219 ISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH 250

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 60.4 bits (147), Expect = 3e-10
 Identities = 16/64 (25%), Positives = 27/64 (42%)

Query: 104 NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSN 163
           N  + K   +  +     +     +   +K L L+ N LS +    L   T L +L+LS+
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67

Query: 164 NRLS 167
           N L 
Sbjct: 68  NVLY 71

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 21/75 (28%), Positives = 35/75 (46%), Gaps = 2/75 (2%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
            LK        +   +K LDL  N  +      LA   +L+ L L++N L   +   L +
Sbjct: 21  SLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LES 78

Query: 153 ITSLNILDLSNNRLS 167
           +++L  LDL+NN + 
Sbjct: 79  LSTLRTLDLNNNYVQ 93

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 17/100 (17%), Positives = 33/100 (33%), Gaps = 12/100 (12%)

Query: 89  PELGQLKNLELL--------ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNN 140
            +L  L  L  L         L     +++L   +N  +  +    +  +  K + L NN
Sbjct: 74  LDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNIS-RVS--CSRGQGKKNIYLANN 130

Query: 141 SLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 180
            ++ L        + +  LDL  N +   V      +   
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDT-VNFAELAASSD 169

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 26/115 (22%), Positives = 44/115 (38%), Gaps = 21/115 (18%)

Query: 77  DLGNAALSGELAPELGQLKNLELL-----------ALGNLIKLKSLDLYSNLFNGTIPDT 125
           DL    LS   A +L     LELL            L +L  L++LDL +N         
Sbjct: 40  DLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ-----E 94

Query: 126 LANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 180
           L     ++ L   NN++S +  +          + L+NN+++  + D       +
Sbjct: 95  LLVGPSIETLHAANNNISRVSCSRG---QGKKNIYLANNKITM-LRD-LDEGCRS 144

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 12/46 (26%), Positives = 23/46 (50%)

Query: 122 IPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
           I +   N  + K  ++ ++SL   + +   +  ++  LDLS N LS
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS 47

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 62.5 bits (152), Expect = 9e-11
 Identities = 25/101 (24%), Positives = 42/101 (41%), Gaps = 13/101 (12%)

Query: 75  ISDLGNAALSGELAPELGQLKNLELL--------ALGNLIKLKSLDLYSNLFNGTIPDTL 126
           +S +   A  G     L  L+ L L          L  LIKL  LDL  N  +   P + 
Sbjct: 173 LSYISEGAFEG-----LSNLRYLNLAMCNLREIPNLTPLIKLDELDLSGNHLSAIRPGSF 227

Query: 127 ANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
             L  L+ L +  + +  +   +   + SL  ++L++N L+
Sbjct: 228 QGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 17/75 (22%), Positives = 32/75 (42%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
           Q++ +++ +  +L  L+ L L  N            L  L  L L +N L+ +   +   
Sbjct: 75  QIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVY 134

Query: 153 ITSLNILDLSNNRLS 167
           ++ L  L L NN + 
Sbjct: 135 LSKLKELWLRNNPIE 149

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 57.1 bits (138), Expect = 5e-09
 Identities = 23/76 (30%), Positives = 34/76 (44%), Gaps = 1/76 (1%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
            ++ +E+ A   L  L +L+L+ N            L +LK L L NN +  +   +   
Sbjct: 99  HIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNR 158

Query: 153 ITSLNILDLS-NNRLS 167
           I SL  LDL    RLS
Sbjct: 159 IPSLRRLDLGELKRLS 174

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 15/60 (25%), Positives = 33/60 (55%)

Query: 108 LKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
            + L+L+ N       ++  +L+ L+ L+L+ N +  +   +   + +LN L+L +NRL+
Sbjct: 66  TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT 125

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 20/89 (22%), Positives = 34/89 (38%), Gaps = 13/89 (14%)

Query: 89  PELGQLKNLELLALG-------------NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 135
           P L  L  L+ L L               L+ L+ L +  +       +   NL+ L  +
Sbjct: 201 PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEI 260

Query: 136 RLNNNSLSGLIPTSLTTITSLNILDLSNN 164
            L +N+L+ L     T +  L  + L +N
Sbjct: 261 NLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 18/76 (23%), Positives = 30/76 (39%), Gaps = 1/76 (1%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL-NNNSLSGLIPTSLT 151
           +L  +   A   L KLK L L +N            +  L+ L L     LS +   +  
Sbjct: 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFE 182

Query: 152 TITSLNILDLSNNRLS 167
            +++L  L+L+   L 
Sbjct: 183 GLSNLRYLNLAMCNLR 198

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 41/163 (25%), Positives = 66/163 (40%), Gaps = 31/163 (19%)

Query: 277 SLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRL-KEERTSGGELQ-FQTE 333
            +R+L++  + +    ++GRG FG+V   R     K+ A+K L K E     +   F  E
Sbjct: 60  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 119

Query: 334 VKIISMAVHRNLLRL-YGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKK 391
             I++ A    +++L Y F       L +V  YM  G + + +                 
Sbjct: 120 RDIMAFANSPWVVQLFYAFQDD--RYLYMVMEYMPGGDLVNLMS-------------NYD 164

Query: 392 IALGSAR--------GLSYLHEHCDPKIIHRDVKAANILLDED 426
           +    AR         L  +H       IHRDVK  N+LLD+ 
Sbjct: 165 VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKS 204

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 20/89 (22%), Positives = 32/89 (35%), Gaps = 1/89 (1%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIP-DTLANLKQLKYLRLNNNSLSGLIPTSLT 151
            +  L   +   L  L+ L +        I  +T   L  L  L+L+ N    L   +  
Sbjct: 41  SIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFN 100

Query: 152 TITSLNILDLSNNRLSGPVPDNGSFSQFT 180
            + +L +L L+   L G V     F   T
Sbjct: 101 GLANLEVLTLTQCNLDGAVLSGNFFKPLT 129

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 25/91 (27%), Positives = 39/91 (42%), Gaps = 2/91 (2%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
           ++  ++  A   L  L  L+L  N           NL +L+ L L+ N +  L   S   
Sbjct: 310 EINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLG 369

Query: 153 ITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 183
           + +L  L L  N+L   VPD G F + T + 
Sbjct: 370 LPNLKELALDTNQLKS-VPD-GIFDRLTSLQ 398

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 21/72 (29%), Positives = 30/72 (41%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
            L +++     NL KL+ LDL  N        +   L  LK L L+ N L  +       
Sbjct: 334 FLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDR 393

Query: 153 ITSLNILDLSNN 164
           +TSL  + L  N
Sbjct: 394 LTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 47.8 bits (114), Expect = 4e-06
 Identities = 16/78 (20%), Positives = 31/78 (39%), Gaps = 2/78 (2%)

Query: 92  GQLKNLELLALGNLI--KLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTS 149
              K+ +      L    +K+ DL  +     +    ++   L+ L L  N ++ +   +
Sbjct: 259 TNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNA 318

Query: 150 LTTITSLNILDLSNNRLS 167
              +T L  L+LS N L 
Sbjct: 319 FWGLTHLLKLNLSQNFLG 336

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 13/61 (21%), Positives = 28/61 (45%), Gaps = 1/61 (1%)

Query: 108 LKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPT-SLTTITSLNILDLSNNRL 166
           +  +DL  N        + + L+ L++L++   +   +I   +   ++SL IL L  N+ 
Sbjct: 32  VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91

Query: 167 S 167
            
Sbjct: 92  L 92

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 41.7 bits (98), Expect = 4e-04
 Identities = 15/102 (14%), Positives = 30/102 (29%), Gaps = 3/102 (2%)

Query: 93  QLKNLELL--ALGNLIKLKSLDLYSNLFNGTIPDTL-ANLKQLKYLRLNNNSLSGLIPTS 149
            L    L       L  L+ L L  N      P +   N+++   L L  N +  +    
Sbjct: 114 NLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEED 173

Query: 150 LTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLC 191
           L      +   L  + ++    +          +   N ++ 
Sbjct: 174 LLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSIT 215

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 23/98 (23%), Positives = 39/98 (39%), Gaps = 2/98 (2%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
            L  +   A   +  L+ LDL SN  +       ++L+ L+ L L NN +  +   +   
Sbjct: 75  HLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFED 134

Query: 153 ITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNL 190
           +  L  L LS N++S   P          +     L+L
Sbjct: 135 MAQLQKLYLSQNQISR-FPV-ELIKDGNKLPKLMLLDL 170

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 56.0 bits (135), Expect = 7e-09
 Identities = 21/78 (26%), Positives = 35/78 (44%), Gaps = 3/78 (3%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIP---TS 149
            L  L+     +L  L+ L LY+N       +   ++ QL+ L L+ N +S         
Sbjct: 99  HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKD 158

Query: 150 LTTITSLNILDLSNNRLS 167
              +  L +LDLS+N+L 
Sbjct: 159 GNKLPKLMLLDLSSNKLK 176

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 20/68 (29%), Positives = 30/68 (44%), Gaps = 2/68 (2%)

Query: 101 ALGNLIKLKSLDLYSNLFNGTIP-DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNIL 159
               L  L SL L  N  N  I  +    +  L+YL L++N L  L     + + +L +L
Sbjct: 59  TPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVL 117

Query: 160 DLSNNRLS 167
            L NN + 
Sbjct: 118 LLYNNHIV 125

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 47.1 bits (112), Expect = 5e-06
 Identities = 21/80 (26%), Positives = 34/80 (42%), Gaps = 7/80 (8%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIP----DTLANLKQLKYLRLNNNSLSGLIPT 148
            +  ++  A  ++ +L+ L L  N  +   P         L +L  L L++N L  L  T
Sbjct: 123 HIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLT 181

Query: 149 SLTTITSL--NILDLSNNRL 166
            L  + +   N L L NN L
Sbjct: 182 DLQKLPAWVKNGLYLHNNPL 201

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 29/148 (19%), Positives = 60/148 (40%), Gaps = 26/148 (17%)

Query: 291 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLRL 348
              LG G F    K       +  AVK + +      E   Q E+  +     H N+++L
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKL 71

Query: 349 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-----LGSARGLSYL 403
           +          LV   +  G +  R+++++         +  + +     L SA  +S++
Sbjct: 72  HEVFHDQLHTFLVMELLNGGELFERIKKKKHF-------SETEASYIMRKLVSA--VSHM 122

Query: 404 HEHCDPKIIHRDVKAANILL---DEDAD 428
           H+     ++HRD+K  N+L    +++ +
Sbjct: 123 HDV---GVVHRDLKPENLLFTDENDNLE 147

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 16/66 (24%), Positives = 27/66 (40%)

Query: 103 GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLS 162
            N  + K   +  +     +     +   +K L L+ N LS +    L   T L +L+LS
Sbjct: 7   QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66

Query: 163 NNRLSG 168
           +N L  
Sbjct: 67  SNVLYE 72

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 21/75 (28%), Positives = 35/75 (46%), Gaps = 2/75 (2%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
            LK        +   +K LDL  N  +      LA   +L+ L L++N L   +   L +
Sbjct: 21  SLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LES 78

Query: 153 ITSLNILDLSNNRLS 167
           +++L  LDL+NN + 
Sbjct: 79  LSTLRTLDLNNNYVQ 93

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 59.5 bits (144), Expect = 9e-10
 Identities = 22/88 (25%), Positives = 30/88 (34%), Gaps = 13/88 (14%)

Query: 91  LGQLKNLELLALGN-----------LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 139
                 LE L L               KLK+LDL SN     +     +   + ++ L N
Sbjct: 165 AASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRN 223

Query: 140 NSLSGLIPTSLTTITSLNILDLSNNRLS 167
           N L   I  +L    +L   DL  N   
Sbjct: 224 NKLVL-IEKALRFSQNLEHFDLRGNGFH 250

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 59.5 bits (144), Expect = 9e-10
 Identities = 17/100 (17%), Positives = 30/100 (30%), Gaps = 12/100 (12%)

Query: 89  PELGQLKNLELL--------ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNN 140
            +L  L  L  L         L     +++L   +N  +          K +    L NN
Sbjct: 74  LDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNI---YLANN 130

Query: 141 SLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 180
            ++ L        + +  LDL  N +   V      +   
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDT-VNFAELAASSD 169

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 56.8 bits (137), Expect = 7e-09
 Identities = 19/76 (25%), Positives = 34/76 (44%), Gaps = 3/76 (3%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNG-TIPDTLANLKQLKYLRLNNNSLSGLIPTSLT 151
           ++  L  L  G   +++ LDL  N  +     +  A+   L++L L  N +  +      
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV--KGQV 188

Query: 152 TITSLNILDLSNNRLS 167
               L  LDLS+N+L+
Sbjct: 189 VFAKLKTLDLSSNKLA 204

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 26/115 (22%), Positives = 44/115 (38%), Gaps = 21/115 (18%)

Query: 77  DLGNAALSGELAPELGQLKNLELL-----------ALGNLIKLKSLDLYSNLFNGTIPDT 125
           DL    LS   A +L     LELL            L +L  L++LDL +N         
Sbjct: 40  DLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ-----E 94

Query: 126 LANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 180
           L     ++ L   NN++S +  +          + L+NN+++  + D       +
Sbjct: 95  LLVGPSIETLHAANNNISRVSCSRG---QGKKNIYLANNKITM-LRD-LDEGCRS 144

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 47.9 bits (114), Expect = 4e-06
 Identities = 14/69 (20%), Positives = 26/69 (37%), Gaps = 10/69 (14%)

Query: 122 IPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTP 181
           I +   N  + K  ++ ++SL   + +   +  ++  LDLS N L          SQ + 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPL----------SQISA 51

Query: 182 ISFENNLNL 190
                   L
Sbjct: 52  ADLAPFTKL 60

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 43.7 bits (103), Expect = 8e-05
 Identities = 12/125 (9%), Positives = 30/125 (24%), Gaps = 5/125 (4%)

Query: 47  ECEQLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLALGNLI 106
            C  L    S    ++ +   +   +   ++      +          ++L       LI
Sbjct: 250 HCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT-LGHYGAYCCEDLPAPFADRLI 308

Query: 107 KLKSLDLY----SNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLS 162
            LK  +             +     N  + + +         +I        +   L+  
Sbjct: 309 ALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQK 368

Query: 163 NNRLS 167
              L 
Sbjct: 369 KKALD 373

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 36/153 (23%), Positives = 60/153 (39%), Gaps = 29/153 (18%)

Query: 291 KNILGRGGFGKVYKGR-LADGKLVAVKRL-KEERTSGGELQFQTEVKIISMAV-HRNLLR 347
           K +LG G  GKV +      G+  A+K L    +        + EV     A    +++ 
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVC 86

Query: 348 LYGFCTTVTEK----LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-----LGSAR 398
           +      +       L++   M  G + SR++ER          T ++ A     +G+A 
Sbjct: 87  ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQ-----AFTEREAAEIMRDIGTA- 140

Query: 399 GLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 431
            + +LH H    I HRDVK  N+L       + 
Sbjct: 141 -IQFLHSH---NIAHRDVKPENLLYTSKEKDAV 169

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 27/101 (26%), Positives = 43/101 (42%), Gaps = 13/101 (12%)

Query: 75  ISDLGNAALSGELAPELGQLKNLEL--------LALGNLIKLKSLDLYSNLFNGTIPDTL 126
           +  +   A  G     L  LK L L          L  L+ L+ L++  N F    P + 
Sbjct: 184 LEYISEGAFEG-----LFNLKYLNLGMCNIKDMPNLTPLVGLEELEMSGNHFPEIRPGSF 238

Query: 127 ANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
             L  LK L + N+ +S +   +   + SL  L+L++N LS
Sbjct: 239 HGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 59.8 bits (145), Expect = 8e-10
 Identities = 16/75 (21%), Positives = 29/75 (38%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
            ++ ++     +L  L+ L L  N            L  L  L L +N L+ +   +   
Sbjct: 86  NIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEY 145

Query: 153 ITSLNILDLSNNRLS 167
           ++ L  L L NN + 
Sbjct: 146 LSKLRELWLRNNPIE 160

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 19/76 (25%), Positives = 33/76 (43%), Gaps = 1/76 (1%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
            ++ +E+ A   L  L +L+L+ N            L +L+ L L NN +  +   +   
Sbjct: 110 SIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNR 169

Query: 153 ITSLNILDLS-NNRLS 167
           + SL  LDL    +L 
Sbjct: 170 VPSLMRLDLGELKKLE 185

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 23/89 (25%), Positives = 33/89 (37%), Gaps = 13/89 (14%)

Query: 89  PELGQLKNLELL-------------ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 135
           P L  L  LE L             +   L  LK L + ++  +    +    L  L  L
Sbjct: 212 PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVEL 271

Query: 136 RLNNNSLSGLIPTSLTTITSLNILDLSNN 164
            L +N+LS L     T +  L  L L +N
Sbjct: 272 NLAHNNLSSLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 15/76 (19%), Positives = 25/76 (32%), Gaps = 1/76 (1%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL-NNNSLSGLIPTSLT 151
            L  +   A   L KL+ L L +N            +  L  L L     L  +   +  
Sbjct: 134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFE 193

Query: 152 TITSLNILDLSNNRLS 167
            + +L  L+L    + 
Sbjct: 194 GLFNLKYLNLGMCNIK 209

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 18/60 (30%), Positives = 30/60 (50%)

Query: 108 LKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
            + L+L  N       DT  +L  L+ L+L  NS+  +   +   + SLN L+L +N L+
Sbjct: 77  TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT 136

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 40.9 bits (96), Expect = 6e-04
 Identities = 14/50 (28%), Positives = 21/50 (42%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSL 142
           Q+  +E  A   L  L  L+L  N  +    D    L+ L  L L++N  
Sbjct: 253 QVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 25/97 (25%), Positives = 44/97 (45%), Gaps = 1/97 (1%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
           ++  +    L   + L++L L SN  N    D+ ++L  L++L L+ N LS L  +    
Sbjct: 63  RITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKP 122

Query: 153 ITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLN 189
           ++SL  L+L  N     + +   FS  T +      N
Sbjct: 123 LSSLTFLNLLGNPYKT-LGETSLFSHLTKLQILRVGN 158

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 57.1 bits (138), Expect = 4e-09
 Identities = 14/98 (14%), Positives = 38/98 (38%), Gaps = 5/98 (5%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
               ++      L  L+ L++ ++      P +L +++ + +L L+      L+   +  
Sbjct: 161 TFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDV 220

Query: 153 ITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNL 190
            +S+  L+L +  L         FS+ +     + +  
Sbjct: 221 TSSVECLELRDTDLDTF-----HFSELSTGETNSLIKK 253

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 21/60 (35%), Positives = 31/60 (51%)

Query: 108 LKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
           +KSLDL +N         L     L+ L L +N ++ +   S +++ SL  LDLS N LS
Sbjct: 54  VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS 113

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 49.7 bits (119), Expect = 8e-07
 Identities = 14/103 (13%), Positives = 35/103 (33%), Gaps = 8/103 (7%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
            L++ E  +L ++  +  L L+       +   +     ++ L L +  L     + L+T
Sbjct: 185 DLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST 244

Query: 153 I--------TSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN 187
                     +   + +++  L   +      S    + F  N
Sbjct: 245 GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRN 287

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 13/74 (17%), Positives = 25/74 (33%), Gaps = 1/74 (1%)

Query: 91  LGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSL 150
             +L   E  +L      +++ +        +   L  +  L  L  + N L  +     
Sbjct: 239 FSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIF 297

Query: 151 TTITSLNILDLSNN 164
             +TSL  + L  N
Sbjct: 298 DRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 46.7 bits (111), Expect = 9e-06
 Identities = 20/96 (20%), Positives = 38/96 (39%), Gaps = 11/96 (11%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGT--------IPDTLANLKQLKYLRLNNNSLSG 144
           Q   L  + +     ++ L+L     +            ++L      + +++ + SL  
Sbjct: 209 QHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ 268

Query: 145 LIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 180
            +   L  I+ L  L+ S N+L   VPD G F + T
Sbjct: 269 -VMKLLNQISGLLELEFSRNQLKS-VPD-GIFDRLT 301

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 60.6 bits (147), Expect = 4e-10
 Identities = 20/88 (22%), Positives = 34/88 (38%), Gaps = 4/88 (4%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
            +  L    + +L KL+ L +  N             ++L+YL L++N L  +       
Sbjct: 32  YISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCHPT-- 89

Query: 153 ITSLNILDLSNNRLSGPVPDNGSFSQFT 180
             +L  LDLS N     +P    F   +
Sbjct: 90  -VNLKHLDLSFNAFDA-LPICKEFGNMS 115

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 21/107 (19%), Positives = 37/107 (34%), Gaps = 9/107 (8%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSL-T 151
           +++ L++       +L+ LDL  N     I         LK+L L+ N+   L       
Sbjct: 56  RIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFG 112

Query: 152 TITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKP 198
            ++ L  L LS   L        S      ++    L + G    + 
Sbjct: 113 NMSQLKFLGLSTTHLE-----KSSVLPIAHLNISKVLLVLGETYGEK 154

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 19/85 (22%), Positives = 36/85 (42%), Gaps = 5/85 (5%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDT---LANLKQLKYLRLNNNSLSGLIPTS 149
            L +      G+L +L++L L  N     +         +K L+ L ++ NS+S      
Sbjct: 335 LLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKG 393

Query: 150 L-TTITSLNILDLSNNRLSGPVPDN 173
             +   SL  L++S+N L+  +   
Sbjct: 394 DCSWTKSLLSLNMSSNILTDTIFRC 418

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 14/60 (23%), Positives = 28/60 (46%)

Query: 108 LKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
              L++  N  +      + +L +L+ L +++N +  L  +       L  LDLS+N+L 
Sbjct: 23  TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 47.9 bits (114), Expect = 4e-06
 Identities = 23/112 (20%), Positives = 35/112 (31%), Gaps = 14/112 (12%)

Query: 93  QLKNLELLALGN----------LIKLKSLDLYSNLFNGTIPDT--LANLKQLKYLRLNNN 140
             + LE L L +           + LK LDL  N F+  +P      N+ QLK+L L+  
Sbjct: 67  FNQELEYLDLSHNKLVKISCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTT 125

Query: 141 SLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCG 192
            L       +  +    +L +          D      F   S         
Sbjct: 126 HLEKSSVLPIAHLNISKVLLVLGETYG-EKEDPEGLQDFNTESLHIVFPTNK 176

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 47.9 bits (114), Expect = 4e-06
 Identities = 11/88 (12%), Positives = 25/88 (28%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
                +         +   +   +          + +    +L  +NN L+  +  +   
Sbjct: 287 VFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGH 346

Query: 153 ITSLNILDLSNNRLSGPVPDNGSFSQFT 180
           +T L  L L  N+L          +Q  
Sbjct: 347 LTELETLILQMNQLKELSKIAEMTTQMK 374

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 47.6 bits (113), Expect = 5e-06
 Identities = 25/117 (21%), Positives = 47/117 (40%), Gaps = 17/117 (14%)

Query: 64  LQSSSNLFVYLIS----DLGNAALSGELAPEL-GQLKNLELLALGN-----------LIK 107
           L   + +   + S    D+   ++S +         K+L  L + +             +
Sbjct: 363 LSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR 422

Query: 108 LKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNN 164
           +K LDL+SN    +IP  +  L+ L+ L + +N L  +       +TSL  + L  N
Sbjct: 423 IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 47.6 bits (113), Expect = 5e-06
 Identities = 26/112 (23%), Positives = 44/112 (39%), Gaps = 26/112 (23%)

Query: 93  QLKNLELLA--LGNLIKLKSLDLYSNLFNGTIPD-TLANLKQLKYLRLNNNSLSGLIPTS 149
           QLK L  +A     +  L+ LD+  N  +        +  K L  L +++N L+  I   
Sbjct: 359 QLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRC 418

Query: 150 LTT---------------------ITSLNILDLSNNRLSGPVPDNGSFSQFT 180
           L                       + +L  L++++N+L   VPD G F + T
Sbjct: 419 LPPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLKS-VPD-GIFDRLT 468

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 59.3 bits (144), Expect = 5e-10
 Identities = 20/76 (26%), Positives = 34/76 (44%), Gaps = 1/76 (1%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTI-PDTLANLKQLKYLRLNNNSLSGLIPTSLT 151
             +         L  L+ L +  N F     PD    L+ L +L L+   L  L PT+  
Sbjct: 137 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 196

Query: 152 TITSLNILDLSNNRLS 167
           +++SL +L++S+N   
Sbjct: 197 SLSSLQVLNMSHNNFF 212

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 59.3 bits (144), Expect = 5e-10
 Identities = 21/87 (24%), Positives = 36/87 (41%), Gaps = 4/87 (4%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNL--FNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSL 150
           +L++L       L +L  L L SN   F G    +      LKYL L+ N +   + ++ 
Sbjct: 39  KLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNF 97

Query: 151 TTITSLNILDLSNNRLSGPVPDNGSFS 177
             +  L  LD  ++ L   + +   F 
Sbjct: 98  LGLEQLEHLDFQHSNLKQ-MSEFSVFL 123

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 55.8 bits (135), Expect = 7e-09
 Identities = 19/76 (25%), Positives = 31/76 (40%), Gaps = 1/76 (1%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
           QL+ L   A  +L  L+ L++  N F          L  L+ L  + N +       L  
Sbjct: 186 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 245

Query: 153 I-TSLNILDLSNNRLS 167
             +SL  L+L+ N  +
Sbjct: 246 FPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 16/94 (17%), Positives = 33/94 (35%), Gaps = 12/94 (12%)

Query: 91  LGQLKNLEL---------LALGNLIKLKSLDLYSNLFNGTIPD--TLANLKQLKYLRLNN 139
              LK L+L              L +L+ LD   +     + +     +L+ L YL +++
Sbjct: 77  TTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISH 135

Query: 140 NSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN 173
                        ++SL +L ++ N        +
Sbjct: 136 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 169

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 49.6 bits (119), Expect = 7e-07
 Identities = 22/62 (35%), Positives = 26/62 (41%), Gaps = 2/62 (3%)

Query: 108 LKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLS--GLIPTSLTTITSLNILDLSNNR 165
              L+L SN            L QL  L L++N LS  G    S    TSL  LDLS N 
Sbjct: 30  ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89

Query: 166 LS 167
           + 
Sbjct: 90  VI 91

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 16/69 (23%), Positives = 24/69 (34%), Gaps = 3/69 (4%)

Query: 109 KSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 168
             +   S     ++P  +        L L +N L  L       +T L  L LS+N LS 
Sbjct: 10  TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66

Query: 169 PVPDNGSFS 177
               + S  
Sbjct: 67  KGCCSQSDF 75

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 59.6 bits (145), Expect = 5e-10
 Identities = 22/75 (29%), Positives = 35/75 (46%), Gaps = 1/75 (1%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
           ++  ++  +L  L  L  L L  N  +     +LAN   L+ L LNNN L   +P  L  
Sbjct: 203 KITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261

Query: 153 ITSLNILDLSNNRLS 167
              + ++ L NN +S
Sbjct: 262 HKYIQVVYLHNNNIS 276

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 56.5 bits (137), Expect = 4e-09
 Identities = 22/84 (26%), Positives = 32/84 (38%), Gaps = 10/84 (11%)

Query: 94  LKNLELLALGN----------LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLS 143
           +K L  + + +             L  L L  N        +L  L  L  L L+ NS+S
Sbjct: 170 MKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 229

Query: 144 GLIPTSLTTITSLNILDLSNNRLS 167
            +   SL     L  L L+NN+L 
Sbjct: 230 AVDNGSLANTPHLRELHLNNNKLV 253

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 56.5 bits (137), Expect = 5e-09
 Identities = 19/85 (22%), Positives = 41/85 (48%), Gaps = 3/85 (3%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
           ++  +   A   L+KL+ L L  N     +P+ +   K L+ LR++ N ++ +  +    
Sbjct: 87  KISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNG 143

Query: 153 ITSLNILDLSNNRLSGPVPDNGSFS 177
           +  + +++L  N L     +NG+F 
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQ 168

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 20/94 (21%), Positives = 40/94 (42%), Gaps = 7/94 (7%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGL------I 146
            +  ++  +L N   L+ L L +N     +P  LA+ K ++ + L+NN++S +       
Sbjct: 227 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 285

Query: 147 PTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 180
           P   T   S + + L +N +        +F    
Sbjct: 286 PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 319

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 17/77 (22%), Positives = 38/77 (49%), Gaps = 5/77 (6%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSN-LFNGTIPD-TLANLKQLKYLRLNNNSLSGLIPTSL 150
           ++  +       L ++  ++L +N L +  I +     +K+L Y+R+ + +++  IP  L
Sbjct: 132 EITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL 190

Query: 151 TTITSLNILDLSNNRLS 167
               SL  L L  N+++
Sbjct: 191 --PPSLTELHLDGNKIT 205

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 20/60 (33%), Positives = 26/60 (43%)

Query: 108 LKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
              LDL +N           NLK L  L L NN +S + P +   +  L  L LS N+L 
Sbjct: 54  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 46.9 bits (112), Expect = 6e-06
 Identities = 16/109 (14%), Positives = 36/109 (33%), Gaps = 24/109 (22%)

Query: 75  ISDLGNAALSGELAPELGQLKNLEL---------LALGNLIKLKSLDLYSNLFNGTIPDT 125
           IS + N +L+         L+ L L           L +   ++ + L++N  +  I   
Sbjct: 228 ISAVDNGSLAN-----TPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS-AIGSN 281

Query: 126 -------LANLKQLKYLRLNNNSL--SGLIPTSLTTITSLNILDLSNNR 165
                           + L +N +    + P++   +     + L N +
Sbjct: 282 DFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 59.2 bits (144), Expect = 5e-10
 Identities = 47/174 (27%), Positives = 67/174 (38%), Gaps = 20/174 (11%)

Query: 261 PAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRL- 318
            AE        Q  +   +  +   + F    ILG G F  V   R  A  +  A+K L 
Sbjct: 5   AAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE 64

Query: 319 KEERTSGGELQF-QTEVKIISMAVHRNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRE 376
           K       ++ +   E  ++S   H   ++LY       EKL     Y  NG +   +R+
Sbjct: 65  KRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLYFGLSYAKNGELLKYIRK 123

Query: 377 RQSSLPPLDWPTRK----KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
             S     D    +    +I       L YLH      IIHRD+K  NILL+ED
Sbjct: 124 IGS----FDETCTRFYTAEIVSA----LEYLHGK---GIIHRDLKPENILLNED 166

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 59.1 bits (142), Expect = 8e-10
 Identities = 33/196 (16%), Positives = 53/196 (27%), Gaps = 45/196 (22%)

Query: 271 GQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVK--RLKEERTSGGEL 328
            Q          + T+       +G G FG+V++   AD   VA+K   ++      G  
Sbjct: 6   SQKGPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSH 63

Query: 329 Q-----FQTEVKI---------ISMAVHRNLLRLYGF--CTTVTEKLLVYPYM----TNG 368
           Q        E+ I                  + L            LL+  +     T G
Sbjct: 64  QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123

Query: 369 SVASRLRERQSSLPPL-------------------DWPTRKKIALGSARGLSYLHEHCDP 409
           S   R    +     +                      T K I       L+        
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL-- 181

Query: 410 KIIHRDVKAANILLDE 425
           +  HRD+   N+LL +
Sbjct: 182 RFEHRDLHWGNVLLKK 197

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 59.4 bits (144), Expect = 8e-10
 Identities = 38/195 (19%), Positives = 68/195 (34%), Gaps = 29/195 (14%)

Query: 249 RRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-L 307
               PH      P       Q        +++  +  D      +LG G  GKV +    
Sbjct: 25  TPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNK 84

Query: 308 ADGKLVAVKRL-KEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEK----LLV 361
              +  A+K L    +        + EV++   A    +++R+      +       L+V
Sbjct: 85  RTQEKFALKMLQDCPK-------ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 137

Query: 362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-----LGSARGLSYLHEHCDPKIIHRDV 416
              +  G + SR+++R          T ++ +     +G A  + YLH      I HRDV
Sbjct: 138 MECLDGGELFSRIQDRGDQ-----AFTEREASEIMKSIGEA--IQYLHSI---NIAHRDV 187

Query: 417 KAANILLDEDADQSS 431
           K  N+L       + 
Sbjct: 188 KPENLLYTSKRPNAI 202

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 59.3 bits (144), Expect = 8e-10
 Identities = 21/75 (28%), Positives = 33/75 (44%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
            ++ L      N+  L  L L  N  +        N  +L  L ++NN+L  +   +   
Sbjct: 104 AIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQA 163

Query: 153 ITSLNILDLSNNRLS 167
            TSL  L LS+NRL+
Sbjct: 164 TTSLQNLQLSSNRLT 178

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 19/75 (25%), Positives = 28/75 (37%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
           Q++ ++  A      ++ L +  N      P    N+  L  L L  N LS L       
Sbjct: 80  QIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHN 139

Query: 153 ITSLNILDLSNNRLS 167
              L  L +SNN L 
Sbjct: 140 TPKLTTLSMSNNNLE 154

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 9/64 (14%), Positives = 24/64 (37%)

Query: 104 NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSN 163
            L   K +   ++         L + +Q++ L LN+  +  +   +     ++  L +  
Sbjct: 43  TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 102

Query: 164 NRLS 167
           N + 
Sbjct: 103 NAIR 106

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 22/102 (21%), Positives = 38/102 (37%), Gaps = 18/102 (17%)

Query: 75  ISDLGNAALSGELAPELGQLKNLEL---------LALGNLIKLKSLDLYSNLFNGTIPDT 125
           +  +            + +L+ L +         L    +  LK LDL  N     +   
Sbjct: 260 LEKIMYHPFVK-----MQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERN 313

Query: 126 LANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
                +L+ L L++NS+  L    L+T  +L  L LS+N   
Sbjct: 314 QPQFDRLENLYLDHNSIVTL---KLSTHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 21/88 (23%), Positives = 31/88 (35%), Gaps = 12/88 (13%)

Query: 90  ELGQLKNLELLALGN----------LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 139
            L     +E L   +           ++L  L L  N    T    L N   L  + L+ 
Sbjct: 200 TLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSY 257

Query: 140 NSLSGLIPTSLTTITSLNILDLSNNRLS 167
           N L  ++      +  L  L +SNNRL 
Sbjct: 258 NELEKIMYHPFVKMQRLERLYISNNRLV 285

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 8/68 (11%), Positives = 23/68 (33%)

Query: 100 LALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNIL 159
             L        + +     +         L   K +   N+++  L    L +   + +L
Sbjct: 15  SNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELL 74

Query: 160 DLSNNRLS 167
           +L++ ++ 
Sbjct: 75  NLNDLQIE 82

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 59.8 bits (144), Expect = 9e-10
 Identities = 35/168 (20%), Positives = 63/168 (37%), Gaps = 23/168 (13%)

Query: 38  LVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNL 97
           L+T+  +++  + L      L +   L++   +    + DL +  L      ++      
Sbjct: 385 LLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVR 444

Query: 98  ELL----------ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIP 147
            L            L  L+ +  LDL  N     +P  LA L+ L+ L+ ++N+L  +  
Sbjct: 445 VLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-- 501

Query: 148 TSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL---NLCG 192
             +  +  L  L L NNRL          +   P+     L   NL G
Sbjct: 502 DGVANLPRLQELLLCNNRLQ-------QSAAIQPLVSCPRLVLLNLQG 542

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 38/146 (26%), Positives = 67/146 (45%), Gaps = 19/146 (13%)

Query: 291 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 349
           ++ LGRG    VY+ +     K  A+K LK    +  +   +TE+ ++    H N+++L 
Sbjct: 58  ESELGRGATSIVYRCKQKGTQKPYALKVLK---KTVDKKIVRTEIGVLLRLSHPNIIKLK 114

Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR----GLSYLHE 405
               T TE  LV   +T G +  R+ E+          + +  A  + +     ++YLHE
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYY-------SERD-AADAVKQILEAVAYLHE 166

Query: 406 HCDPKIIHRDVKAANILLDEDADQSS 431
           +    I+HRD+K  N+L    A  + 
Sbjct: 167 N---GIVHRDLKPENLLYATPAPDAP 189

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 19/75 (25%), Positives = 28/75 (37%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
           Q++ ++  A      ++ L +  N      P    N+  L  L L  N LS L       
Sbjct: 86  QIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHN 145

Query: 153 ITSLNILDLSNNRLS 167
              L  L +SNN L 
Sbjct: 146 TPKLTTLSMSNNNLE 160

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 23/95 (24%), Positives = 36/95 (37%), Gaps = 2/95 (2%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
            ++ L      N+  L  L L  N  +        N  +L  L ++NN+L  +   +   
Sbjct: 110 AIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQA 169

Query: 153 ITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN 187
            TSL  L LS+NRL+  V            +   N
Sbjct: 170 TTSLQNLQLSSNRLTH-VDL-SLIPSLFHANVSYN 202

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 9/64 (14%), Positives = 24/64 (37%)

Query: 104 NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSN 163
            L   K +   ++         L + +Q++ L LN+  +  +   +     ++  L +  
Sbjct: 49  TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 108

Query: 164 NRLS 167
           N + 
Sbjct: 109 NAIR 112

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 25/104 (24%), Positives = 41/104 (39%), Gaps = 18/104 (17%)

Query: 77  DLGNAALSGELAPE-LGQLKNLELLAL------------GNLIKLKSLDLYSNLFNGTIP 123
           DL    L  ++      +++ LE L +              +  LK LDL  N     + 
Sbjct: 260 DLSYNELE-KIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVE 317

Query: 124 DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
                  +L+ L L++NS+  L    L+T  +L  L LS+N   
Sbjct: 318 RNQPQFDRLENLYLDHNSIVTL---KLSTHHTLKNLTLSHNDWD 358

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 19/86 (22%), Positives = 31/86 (36%), Gaps = 9/86 (10%)

Query: 89  PELGQLKNLEL-------LALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNS 141
                ++ L+        +     ++L  L L  N    T    L N   L  + L+ N 
Sbjct: 208 AIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNE 265

Query: 142 LSGLIPTSLTTITSLNILDLSNNRLS 167
           L  ++      +  L  L +SNNRL 
Sbjct: 266 LEKIMYHPFVKMQRLERLYISNNRLV 291

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 44.1 bits (104), Expect = 6e-05
 Identities = 8/66 (12%), Positives = 23/66 (34%)

Query: 102 LGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDL 161
           L        + +     +         L   K +   N+++  L    L +   + +L+L
Sbjct: 23  LQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNL 82

Query: 162 SNNRLS 167
           ++ ++ 
Sbjct: 83  NDLQIE 88

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 59.0 bits (142), Expect = 1e-09
 Identities = 28/88 (31%), Positives = 40/88 (45%), Gaps = 15/88 (17%)

Query: 91  LGQLKNLELL-----------ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 139
           L  LK L+ L            L +L +L+SL L +N    T    L+ L +L  L L +
Sbjct: 105 LKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNN--KITDITVLSRLTKLDTLSLED 162

Query: 140 NSLSGLIPTSLTTITSLNILDLSNNRLS 167
           N +S +    L  +T L  L LS N +S
Sbjct: 163 NQISDI--VPLAGLTKLQNLYLSKNHIS 188

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 55.9 bits (134), Expect = 1e-08
 Identities = 32/143 (22%), Positives = 51/143 (35%), Gaps = 34/143 (23%)

Query: 43  AVLQECEQLHL---LISFLIFIRVLQSSSNLFVY--LISDLGNAALSGELAPELGQLKNL 97
               E  + +L    ++  +    L S   +      I  +            +  L N+
Sbjct: 18  DAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQG----------IQYLPNV 67

Query: 98  ELL-----------ALGNLIKLKSLDLYSNLFNGTIPD--TLANLKQLKYLRLNNNSLSG 144
             L            L NL  L  L L  N     I D  +L +LK+LK L L +N +S 
Sbjct: 68  TKLFLNGNKLTDIKPLTNLKNLGWLFLDEN----KIKDLSSLKDLKKLKSLSLEHNGISD 123

Query: 145 LIPTSLTTITSLNILDLSNNRLS 167
           +    L  +  L  L L NN+++
Sbjct: 124 I--NGLVHLPQLESLYLGNNKIT 144

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 29/120 (24%), Positives = 45/120 (37%), Gaps = 15/120 (12%)

Query: 91  LGQLKNLELL-----------ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 139
           L  L  LE L            L  L KL +L L  N  +  I   LA L +L+ L L+ 
Sbjct: 127 LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSK 184

Query: 140 NSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPC 199
           N +S L    L  + +L++L+L +        ++ S           + +L  P      
Sbjct: 185 NHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDD 242

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 41.6 bits (97), Expect = 4e-04
 Identities = 7/60 (11%), Positives = 19/60 (31%), Gaps = 4/60 (6%)

Query: 108 LKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
           +      S       PD      +     L   S++  +      + S++ +  +N+ + 
Sbjct: 1   MGETITVSTPIKQIFPD--DAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 38/172 (22%), Positives = 59/172 (34%), Gaps = 29/172 (16%)

Query: 38  LVTLKAVLQECEQLHL----------LISFLIFIRVLQSSSNLFVYLISDLGNAALSG-- 85
           L +L  +    E L            L   L  + V  ++      L   L    +S   
Sbjct: 83  LSSLPELPPHLESLVASCNSLTELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQ 142

Query: 86  -ELAPELGQLKNLELLALGN---------LIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 135
            E  PEL     L+++ + N            L+ +   +N     +P+ L NL  L  +
Sbjct: 143 LEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLE-ELPE-LQNLPFLTAI 200

Query: 136 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN 187
             +NNSL  L         SL  +   NN L    P+  +    T I  +NN
Sbjct: 201 YADNNSLKKLPDL----PLSLESIVAGNNILEEL-PELQNLPFLTTIYADNN 247

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 22/88 (25%), Positives = 34/88 (38%), Gaps = 12/88 (13%)

Query: 89  PELGQLKNLELLALGN---------LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 139
           PEL  L  L  +   N          + L+S+   +N+        L NL  L  +  +N
Sbjct: 189 PELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNIL--EELPELQNLPFLTTIYADN 246

Query: 140 NSLSGLIPTSLTTITSLNILDLSNNRLS 167
           N L  L P    ++ +LN+ D     L 
Sbjct: 247 NLLKTL-PDLPPSLEALNVRDNYLTDLP 273

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 29/140 (20%), Positives = 47/140 (33%), Gaps = 37/140 (26%)

Query: 50  QLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLALGN----- 104
            L  L    + +  + + +N+   L              PEL  L  L  +   N     
Sbjct: 206 SLKKLPDLPLSLESIVAGNNILEEL--------------PELQNLPFLTTIYADNNLLKT 251

Query: 105 ----LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIP------------T 148
                  L++L++  N     +P+   +L  L       + LS L P             
Sbjct: 252 LPDLPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIR 310

Query: 149 SL-TTITSLNILDLSNNRLS 167
           SL     SL  L++SNN+L 
Sbjct: 311 SLCDLPPSLEELNVSNNKLI 330

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 50.4 bits (121), Expect = 7e-07
 Identities = 15/87 (17%), Positives = 30/87 (34%), Gaps = 9/87 (10%)

Query: 86  ELAPELGQLKNLE----LLALGNLI-KLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNN 140
           E       +++L     L  +  L   LK L + +N      PD     + ++ LR+N+ 
Sbjct: 371 EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPD---IPESVEDLRMNSE 426

Query: 141 SLSGLIPTSLTTITSLNILDLSNNRLS 167
            +      +  T   L      ++   
Sbjct: 427 RVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 27/133 (20%), Positives = 45/133 (33%), Gaps = 31/133 (23%)

Query: 77  DLGNAALSGELAPELGQLKNLELLALGNLI----------------------KLKSLDLY 114
               +       P  G+ + + +  L + +                       L+SL   
Sbjct: 40  YNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPELPPHLESLVAS 99

Query: 115 SNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNG 174
            N     +P+   +LK L     N  +LS L P        L  L +SNN+L   +P+  
Sbjct: 100 CNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLEK-LPELQ 150

Query: 175 SFSQFTPISFENN 187
           + S    I  +NN
Sbjct: 151 NSSFLKIIDVDNN 163

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 41.5 bits (98), Expect = 4e-04
 Identities = 16/81 (19%), Positives = 22/81 (27%), Gaps = 17/81 (20%)

Query: 100 LALGNLIKLKSLDLYSNLFNGTIPDTLANL-------------KQLKYLRLNNNSLSGLI 146
           +   N+          + +    P                   +Q   L LNN  LS L 
Sbjct: 28  VEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSL- 86

Query: 147 PTSLTTITSLNILDLSNNRLS 167
           P        L  L  S N L+
Sbjct: 87  PEL---PPHLESLVASCNSLT 104

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 40.7 bits (96), Expect = 7e-04
 Identities = 34/190 (17%), Positives = 56/190 (29%), Gaps = 46/190 (24%)

Query: 38  LVTLKAVLQECEQLHL-------LISFLIFIRVLQSSSNLFVYLISDLGN---AALSG-- 85
           L  L  + Q    L +       L      +  L +SSN    L     +     +S   
Sbjct: 269 LTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNK 328

Query: 86  --ELAPELGQLKNLELLALGNLIK--------LKSLDLYSNLFNGTIPDTLANLKQ---- 131
             EL     +L+ L      N +         LK L +  N      PD   +++     
Sbjct: 329 LIELPALPPRLERLIAS--FNHLAEVPELPQNLKQLHVEYNPLR-EFPDIPESVEDLRMN 385

Query: 132 ------------LKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQF 179
                       LK L +  N L    P       S+  L +++ R+  P       +  
Sbjct: 386 SHLAEVPELPQNLKQLHVETNPLREF-PDI---PESVEDLRMNSERVVDPYEFAHETTDK 441

Query: 180 TPI-SFENNL 188
                FE++ 
Sbjct: 442 LEDDVFEHHH 451

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 57.6 bits (140), Expect = 2e-09
 Identities = 43/146 (29%), Positives = 67/146 (45%), Gaps = 28/146 (19%)

Query: 294 LGRGGFGKVY----KGRLADGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRL 348
           LG+G FGKV+           +L A+K LK+        ++ + E  I+    H  +++L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 349 -YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IALGSARGL 400
            Y F T    KL L+  ++  G + +RL +E   +          K     +AL     L
Sbjct: 92  HYAFQTE--GKLYLILDFLRGGDLFTRLSKEVMFTEE------DVKFYLAELALA----L 139

Query: 401 SYLHEHCDPKIIHRDVKAANILLDED 426
            +LH      II+RD+K  NILLDE+
Sbjct: 140 DHLHSL---GIIYRDLKPENILLDEE 162

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 57.7 bits (140), Expect = 3e-09
 Identities = 41/140 (29%), Positives = 63/140 (45%), Gaps = 18/140 (12%)

Query: 294 LGRGGFGKVYKGRLAD-GKLVAVKRL-KEERTSGGELQF-QTEVKIISMAVHRNLLRL-Y 349
           +G+G FGKV   +  D  K+ A+K + K++     E++    E++I+    H  L+ L Y
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82

Query: 350 GFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKKIA-LGSARGLSYLHEH 406
            F     E + +V   +  G +   L +             +  I  L  A  L YL   
Sbjct: 83  SFQDE--EDMFMVVDLLLGGDLRYHLQQNVHFKEET----VKLFICELVMA--LDYLQNQ 134

Query: 407 CDPKIIHRDVKAANILLDED 426
              +IIHRD+K  NILLDE 
Sbjct: 135 ---RIIHRDMKPDNILLDEH 151

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 56.9 bits (138), Expect = 3e-09
 Identities = 33/152 (21%), Positives = 61/152 (40%), Gaps = 27/152 (17%)

Query: 291 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRL 348
             +LG G  GKV +       +  A+K L++        + + EV++   A    +++R+
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRI 76

Query: 349 YGFCTTVTEK----LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-----LGSARG 399
                 +       L+V   +  G + SR+++R          T ++ +     +G A  
Sbjct: 77  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-----AFTEREASEIMKSIGEA-- 129

Query: 400 LSYLHEHCDPKIIHRDVKAANILLDEDADQSS 431
           + YLH      I HRDVK  N+L       + 
Sbjct: 130 IQYLHSI---NIAHRDVKPENLLYTSKRPNAI 158

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 24/90 (26%), Positives = 38/90 (42%), Gaps = 15/90 (16%)

Query: 89  PELGQLKNLELL-----------ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 137
             +  L++++ L            L  L  L+ L L  N      P  LA L  L+YL +
Sbjct: 101 SAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSI 158

Query: 138 NNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
            N  +S L P  L  ++ L  L   +N++S
Sbjct: 159 GNAQVSDLTP--LANLSKLTTLKADDNKIS 186

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 32/129 (24%), Positives = 48/129 (37%), Gaps = 27/129 (20%)

Query: 89  PELGQLKNLELL-----------ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 137
             L  L NL+ L            L NL KL +L    N  +  I   LA+L  L  + L
Sbjct: 145 SPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHL 202

Query: 138 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP------------DNGSFSQFTPISFE 185
            NN +S + P  L   ++L I+ L+N  ++                   S +   P +  
Sbjct: 203 KNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATIS 260

Query: 186 NNLNLCGPN 194
           +N     PN
Sbjct: 261 DNGTYASPN 269

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 20/102 (19%), Positives = 38/102 (37%), Gaps = 17/102 (16%)

Query: 77  DLGNAALSGELAPELGQLKNLELL-----------ALGNLIKLKSLDLYSNLFNGTIPDT 125
             G + ++         L  +  L            +  L  L  L+L  N      P  
Sbjct: 25  AAGKSNVTDT--VTQADLDGITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQITDLAP-- 80

Query: 126 LANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
           L NL ++  L L+ N L  +    +  + S+  LDL++ +++
Sbjct: 81  LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQIT 120

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 56.6 bits (137), Expect = 5e-09
 Identities = 23/104 (22%), Positives = 42/104 (40%), Gaps = 10/104 (9%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTS--- 149
           Q++ +E  +L  L  L+ L L +N  +  +P  L +LK L+ + L+ N+++ +       
Sbjct: 228 QIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCP 286

Query: 150 ---LTTITSLNILDLSNNRLSGPVPDNGSFS---QFTPISFENN 187
                     N + L NN +        +F        I F N 
Sbjct: 287 VGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 56.2 bits (136), Expect = 6e-09
 Identities = 18/85 (21%), Positives = 37/85 (43%), Gaps = 3/85 (3%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
           ++  +   A   L KL+ L +  N     IP  L     L  LR+++N +  +     + 
Sbjct: 89  KISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSG 145

Query: 153 ITSLNILDLSNNRLSGPVPDNGSFS 177
           + ++N +++  N L     + G+F 
Sbjct: 146 LRNMNCIEMGGNPLENSGFEPGAFD 170

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 19/72 (26%), Positives = 29/72 (40%)

Query: 96  NLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITS 155
            L  +       L  L L  N       + L    +L  L L +N +  +   SL+ + +
Sbjct: 183 KLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPT 242

Query: 156 LNILDLSNNRLS 167
           L  L L NN+LS
Sbjct: 243 LRELHLDNNKLS 254

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 50.4 bits (121), Expect = 5e-07
 Identities = 17/60 (28%), Positives = 26/60 (43%)

Query: 108 LKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
              LDL +N  +    D    L+ L  L L NN +S +   + + +  L  L +S N L 
Sbjct: 56  TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV 115

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 19/109 (17%), Positives = 35/109 (32%), Gaps = 24/109 (22%)

Query: 75  ISDLGNAALSGELAPELGQLKNLEL---------LALGNLIKLKSLDLYSNLFNGTIPDT 125
           I  + N +LS      L  L+ L L           L +L  L+ + L++N     +   
Sbjct: 229 IRMIENGSLSF-----LPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNIT-KVGVN 282

Query: 126 -------LANLKQLKYLRLNNNSLS--GLIPTSLTTITSLNILDLSNNR 165
                           + L NN +    + P +   +T    +   N +
Sbjct: 283 DFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 56.5 bits (137), Expect = 6e-09
 Identities = 45/151 (29%), Positives = 62/151 (41%), Gaps = 39/151 (25%)

Query: 294 LGRGGFGKVYKGRL-ADGKLVAVKRLK---------EERTSGGELQFQTEVKIISMAV-H 342
           +G+G FGKV   R  A+    AVK L+         E+          +E  ++   V H
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHI-------MSERNVLLKNVKH 98

Query: 343 RNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IALG 395
             L+ L+ F     +KL  V  Y+  G +   L RER    P      R +     IA  
Sbjct: 99  PFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP------RARFYAAEIASA 151

Query: 396 SARGLSYLHEHCDPKIIHRDVKAANILLDED 426
               L YLH      I++RD+K  NILLD  
Sbjct: 152 ----LGYLHSL---NIVYRDLKPENILLDSQ 175

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 56.3 bits (136), Expect = 8e-09
 Identities = 49/226 (21%), Positives = 80/226 (35%), Gaps = 53/226 (23%)

Query: 241 PVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKN-------- 292
            +I    W       F  + P E +      Q     L++   A   F + +        
Sbjct: 73  FIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAE 132

Query: 293 ----------------------ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQ 329
                                 +LG+G FGKV   +    G+  A+K LK+E     +  
Sbjct: 133 EMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEV 192

Query: 330 FQT--EVKIISMAVHRNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLD 385
             T  E +++  + H  L  L  +     ++L  V  Y   G +   L RER  S     
Sbjct: 193 AHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED--- 248

Query: 386 WPTRKK-----IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
              R +     I       L YLH   +  +++RD+K  N++LD+D
Sbjct: 249 ---RARFYGAEIVSA----LDYLHSEKN--VVYRDLKLENLMLDKD 285

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 36/148 (24%), Positives = 61/148 (41%), Gaps = 18/148 (12%)

Query: 286 DGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRL-KEERTSGGELQ-FQTEVKIISMAVH 342
           D F     LG G FG+V   +  + G   A+K L K++     +++    E +I+     
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK----KIALGSAR 398
             L++L       +   +V  Y+  G + S LR           P  +    +I L    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLT--- 153

Query: 399 GLSYLHEHCDPKIIHRDVKAANILLDED 426
              YLH      +I+RD+K  N+L+D+ 
Sbjct: 154 -FEYLHSL---DLIYRDLKPENLLIDQQ 177

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 29/188 (15%), Positives = 64/188 (34%), Gaps = 48/188 (25%)

Query: 281 LQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT-EVKIIS 338
           L+ ++  +S    LG G FG V +    + GK  A+K++ ++       +++  E+ I+ 
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMK 55

Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR--------- 389
           +  H N+++L  +  T  ++    P   +       +    +                  
Sbjct: 56  VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115

Query: 390 ---------KKIALGSA-------------------RGLSYLHEHCDPKIIHRDVKAANI 421
                     K+                        R + ++H      I HRD+K  N+
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNL 172

Query: 422 LLDEDADQ 429
           L++   + 
Sbjct: 173 LVNSKDNT 180

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 55.3 bits (134), Expect = 1e-08
 Identities = 45/163 (27%), Positives = 68/163 (41%), Gaps = 40/163 (24%)

Query: 282 QVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKE---------ERTSGGELQFQ 331
           +V  + F    +LG+G FGKV   R  A G+  A+K L++           T        
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-------V 53

Query: 332 TEVKIISMAVHRNLLRL-YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPT 388
           TE +++    H  L  L Y F T   ++L  V  Y   G +   L RER  +        
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTH--DRLCFVMEYANGGELFFHLSRERVFTEE------ 105

Query: 389 RKK-----IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           R +     I       L YLH      +++RD+K  N++LD+D
Sbjct: 106 RARFYGAEIVSA----LEYLHSR---DVVYRDIKLENLMLDKD 141

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 55.2 bits (134), Expect = 1e-08
 Identities = 42/155 (27%), Positives = 66/155 (42%), Gaps = 44/155 (28%)

Query: 294 LGRGGFGKVYKGRLA----DGKLVAVKRLKE----------ERTSGGELQFQTEVKIISM 339
           LG+GG+GKV++ R       GK+ A+K LK+            T       + E  I+  
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-------KAERNILEE 77

Query: 340 AVHRNLLRL-YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK----- 391
             H  ++ L Y F T    KL L+  Y++ G +  +L RE                    
Sbjct: 78  VKHPFIVDLIYAFQTG--GKLYLILEYLSGGELFMQLEREGIFMED------TACFYLAE 129

Query: 392 IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           I++     L +LH+     II+RD+K  NI+L+  
Sbjct: 130 ISMA----LGHLHQK---GIIYRDLKPENIMLNHQ 157

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 31/187 (16%), Positives = 58/187 (31%), Gaps = 25/187 (13%)

Query: 55  ISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLY 114
           +S L  +  L       + +  DL +         +    + ++ L + +  +L  LD  
Sbjct: 250 VSTLSKLTTLHCIQTDLLEI--DLTHNTQLIYF--QAEGCRKIKELDVTHNTQLYLLDCQ 305

Query: 115 SNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNG 174
           +      +   L+   +L YL LNN  L+ L    ++  T L  L   N  +       G
Sbjct: 306 AAGIT-ELD--LSQNPKLVYLYLNNTELTEL---DVSHNTKLKSLSCVNAHIQD-FSSVG 358

Query: 175 ----------SFSQFTPISFE----NNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRN 220
                     +  Q   +  E    N+L +          G+P    P   G        
Sbjct: 359 KIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNT 418

Query: 221 KSNAAIP 227
            +   + 
Sbjct: 419 ITWENLS 425

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 53.2 bits (128), Expect = 7e-08
 Identities = 18/78 (23%), Positives = 33/78 (42%), Gaps = 6/78 (7%)

Query: 90  ELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTS 149
           +    K +  L +    +L +LD   N     +   ++  K L  L  + N+++ L    
Sbjct: 154 DCHLNKKITKLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITKL---D 207

Query: 150 LTTITSLNILDLSNNRLS 167
           L     L  LD S+N+L+
Sbjct: 208 LNQNIQLTFLDCSSNKLT 225

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 14/72 (19%), Positives = 28/72 (38%), Gaps = 5/72 (6%)

Query: 96  NLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITS 155
            L  + + +  +L  LD + N         +    QL  L  + N ++ L    ++    
Sbjct: 138 TLTEIDVSHNTQLTELDCHLN--KKITKLDVTPQTQLTTLDCSFNKITEL---DVSQNKL 192

Query: 156 LNILDLSNNRLS 167
           LN L+   N ++
Sbjct: 193 LNRLNCDTNNIT 204

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 50.1 bits (120), Expect = 8e-07
 Identities = 28/140 (20%), Positives = 50/140 (35%), Gaps = 24/140 (17%)

Query: 68  SNLFVYLISDLGNAALSGELAPELGQLKNL--------ELLALGNLIKLKSLDLYSNLFN 119
            N    + +     A       +L  L +L        ++  +  L  L  L   SN   
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLTKLICTSNNIT 77

Query: 120 GTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNG----- 174
            T+   L+    L YL  ++N L+ L    +T +T L  L+   N+L+  +  +      
Sbjct: 78  -TLD--LSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLT-KLDVSQNPLLT 130

Query: 175 ----SFSQFTPISFENNLNL 190
               + +  T I   +N  L
Sbjct: 131 YLNCARNTLTEIDVSHNTQL 150

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 46.6 bits (111), Expect = 9e-06
 Identities = 19/118 (16%), Positives = 28/118 (23%), Gaps = 21/118 (17%)

Query: 90  ELGQLKNLELLAL----------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 139
           +L Q   L  L              L +L   D   N     +  +   L +L  L    
Sbjct: 207 DLNQNIQLTFLDCSSNKLTEIDVTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQ 263

Query: 140 NSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNG-------SFSQFTPISFENNLNL 190
             L  +  T  T +                V  N          +  T +    N  L
Sbjct: 264 TDLLEIDLTHNTQLIYFQAEGC-RKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKL 320

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 18/88 (20%), Positives = 36/88 (40%), Gaps = 1/88 (1%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
           +++ +E  A  +L  L +L L  N          + L  L+ L     +L+ L    +  
Sbjct: 63  EIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122

Query: 153 ITSLNILDLSNNRLSGPVPDNGSFSQFT 180
           + +L  L++++N +         FS  T
Sbjct: 123 LKTLKELNVAHNLIQS-FKLPEYFSNLT 149

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 19/76 (25%), Positives = 32/76 (42%), Gaps = 2/76 (2%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPD-TLANLKQLKYLRLNNNSLSGLIPTSLT 151
            L++L   +  +  +L+ LDL       TI D    +L  L  L L  N +  L   + +
Sbjct: 39  PLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFS 97

Query: 152 TITSLNILDLSNNRLS 167
            ++SL  L      L+
Sbjct: 98  GLSSLQKLVAVETNLA 113

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 53.1 bits (128), Expect = 6e-08
 Identities = 23/80 (28%), Positives = 44/80 (55%), Gaps = 5/80 (6%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSN-LFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLT 151
            L +LE   +G+L  LK L++  N + +  +P+  +NL  L++L L++N +  +  T L 
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170

Query: 152 TITSLNI----LDLSNNRLS 167
            +  + +    LDLS N ++
Sbjct: 171 VLHQMPLLNLSLDLSLNPMN 190

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 43.0 bits (102), Expect = 8e-05
 Identities = 20/76 (26%), Positives = 33/76 (43%), Gaps = 5/76 (6%)

Query: 93  QLKNLELLALGNLIKLK----SLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPT 148
           +++++    L  L ++     SLDL  N  N   P     + +LK L L+ N L  +   
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKELALDTNQLKSVPDG 218

Query: 149 SLTTITSLNILDLSNN 164
               +TSL  + L  N
Sbjct: 219 IFDRLTSLQKIWLHTN 234

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 54.2 bits (131), Expect = 2e-08
 Identities = 16/87 (18%), Positives = 36/87 (41%), Gaps = 3/87 (3%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIP-DTLANLKQLKYLRL-NNNSLSGLIPTSL 150
            L+ +   A  NL  +  + +  ++    +   +  NL ++ ++ + N  +L+ + P +L
Sbjct: 42  HLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL 101

Query: 151 TTITSLNILDLSNNRLSGPVPDNGSFS 177
             +  L  L + N  L    PD     
Sbjct: 102 KELPLLKFLGIFNTGLKM-FPDLTKVY 127

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 50.0 bits (120), Expect = 4e-07
 Identities = 23/99 (23%), Positives = 41/99 (41%), Gaps = 3/99 (3%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIP-DTLANLKQLKYLRLNNNSLSGLIP-TSL 150
            L+ LE  +  NL K+  +++ +      I  D L  L  LK+L + N  L      T +
Sbjct: 67  TLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKV 126

Query: 151 TTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLN 189
            +     IL++++N     +P N +F      +    L 
Sbjct: 127 YSTDIFFILEITDNPYMTSIPVN-AFQGLCNETLTLKLY 164

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 41.1 bits (97), Expect = 3e-04
 Identities = 20/101 (19%), Positives = 41/101 (40%), Gaps = 6/101 (5%)

Query: 93  QLKNLELLALGNLIK-LKSLDLYSNLFNGTIPDTLANLKQLKYLRL-NNNSLSGLIPTSL 150
            + ++ + A   L     +L LY+N F  ++     N  +L  + L  N  L+ +   + 
Sbjct: 142 YMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAF 200

Query: 151 TTITS-LNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNL 190
             + S  ++LD+S   ++  +P  G       +   N   L
Sbjct: 201 GGVYSGPSLLDVSQTSVTA-LPSKG-LEHLKELIARNTWTL 239

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 54.8 bits (133), Expect = 2e-08
 Identities = 43/160 (26%), Positives = 70/160 (43%), Gaps = 34/160 (21%)

Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLK---------EERTSGGELQFQ 331
           + +   F     LG G FG+V+  R    G+  A+K LK          E T        
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT-------N 54

Query: 332 TEVKIISMAVHRNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRK 390
            E  ++S+  H  ++R++G      +++ ++  Y+  G + S LR+ Q        P  K
Sbjct: 55  DERLMLSIVTHPFIIRMWGTFQD-AQQIFMIMDYIEGGELFSLLRKSQR----FPNPVAK 109

Query: 391 ----KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
               ++ L     L YLH      II+RD+K  NILLD++
Sbjct: 110 FYAAEVCLA----LEYLHSK---DIIYRDLKPENILLDKN 142

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 53.5 bits (129), Expect = 2e-08
 Identities = 20/91 (21%), Positives = 41/91 (45%), Gaps = 2/91 (2%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
           ++ ++E  A      +  + L SN            L+ LK L L +N ++ +   S   
Sbjct: 68  KITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIG 127

Query: 153 ITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 183
           ++S+ +L L +N+++  V   G+F     +S
Sbjct: 128 LSSVRLLSLYDNQIT-TVAP-GAFDTLHSLS 156

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 47.3 bits (113), Expect = 2e-06
 Identities = 21/72 (29%), Positives = 37/72 (51%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
           +L+N++      L  LK+L L SN       D+   L  ++ L L +N ++ + P +  T
Sbjct: 92  RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDT 151

Query: 153 ITSLNILDLSNN 164
           + SL+ L+L  N
Sbjct: 152 LHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 43.9 bits (104), Expect = 3e-05
 Identities = 14/60 (23%), Positives = 27/60 (45%), Gaps = 1/60 (1%)

Query: 109 KSLDLYSNLFNGTIPD-TLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
             L L +N F           L QL+ +  +NN ++ +   +    + +N + L++NRL 
Sbjct: 35  AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 54.5 bits (132), Expect = 2e-08
 Identities = 43/152 (28%), Positives = 61/152 (40%), Gaps = 41/152 (26%)

Query: 294 LGRGGFGKVYKGRL-ADGKLVAVKRLK---------EERTSGGELQFQTEVKIISMAV-H 342
           LG+G FGKV+        +  A+K LK          E T         E +++S+A  H
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT-------MVEKRVLSLAWEH 77

Query: 343 RNLLRL-YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IAL 394
             L  +   F T   E L  V  Y+  G +   +    +  L       R       I L
Sbjct: 78  PFLTHMFCTFQTK--ENLFFVMEYLNGGDLMYHIQSCHKFDLS------RATFYAAEIIL 129

Query: 395 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           G    L +LH      I++RD+K  NILLD+D
Sbjct: 130 G----LQFLHSK---GIVYRDLKLDNILLDKD 154

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 53.5 bits (129), Expect = 3e-08
 Identities = 24/87 (27%), Positives = 37/87 (42%), Gaps = 14/87 (16%)

Query: 91  LGQLKNLELLALGN----------LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNN 140
           L  L  LE L++               L  L L +N       D+L +LK L+ L + NN
Sbjct: 81  LKDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDNN--ELRDTDSLIHLKNLEILSIRNN 138

Query: 141 SLSGLIPTSLTTITSLNILDLSNNRLS 167
            L  +    L  ++ L +LDL  N ++
Sbjct: 139 KLKSI--VMLGFLSKLEVLDLHGNEIT 163

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 47.7 bits (114), Expect = 3e-06
 Identities = 20/88 (22%), Positives = 30/88 (34%), Gaps = 16/88 (18%)

Query: 91  LGQLKNLELL-----------ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 139
             +L  ++              +     LK L L  N    +    L +L +L+ L +N 
Sbjct: 37  QKELSGVQNFNGDNSNIQSLAGMQFFTNLKELHLSHN--QISDLSPLKDLTKLEELSVNR 94

Query: 140 NSLSGLIPTSLTTITSLNILDLSNNRLS 167
           N L  L          L+ L L NN L 
Sbjct: 95  NRLKNLNGIPSAC---LSRLFLDNNELR 119

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 27/113 (23%), Positives = 42/113 (37%), Gaps = 16/113 (14%)

Query: 91  LGQLKNLELL-----------ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 139
           L  LKNLE+L            LG L KL+ LDL+ N    T    L  LK++ ++ L  
Sbjct: 124 LIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGN--EITNTGGLTRLKKVNWIDLTG 181

Query: 140 NSLSGLIPTSLTTITSLNILDLSNNRLSGPVP--DNGSFSQFTPISFENNLNL 190
                        +   N +   + R   P    + GS+     + +E  +  
Sbjct: 182 QKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGC-VLWELPVYT 233

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 54.5 bits (131), Expect = 4e-08
 Identities = 25/120 (20%), Positives = 42/120 (35%), Gaps = 10/120 (8%)

Query: 77  DLGNAALSGELAPELGQLKNLELL-----ALGNLI-KLKSLDLYSNLFNGTIPDTLANLK 130
            +    L+  L     +LK L +      +L  L   L SL +Y N     +P++L +L 
Sbjct: 227 IVSGNRLT-SLPVLPSELKELMVSGNRLTSLPMLPSGLLSLSVYRNQLT-RLPESLIHLS 284

Query: 131 QLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNL 190
               + L  N LS     +L  ITS      S   +   +    +  +   +       L
Sbjct: 285 SETTVNLEGNPLSERTLQALREITSAP--GYSGPIIRFDMAGASAPRETRALHLAAADWL 342

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 23/111 (20%), Positives = 38/111 (34%), Gaps = 23/111 (20%)

Query: 77  DLGNAALSGELAPELGQLKNLELL-----ALGNLI-KLKSLDLYSNLFNGTIPDTLANLK 130
            + +  L+  L     +L  L        +L  L   L+ L +  N    ++P   + L 
Sbjct: 147 SVSDNQLA-SLPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLA-SLPTLPSELY 204

Query: 131 QLKYLRLNNNSLSGLIPTSLTT--------------ITSLNILDLSNNRLS 167
           +L        SL  L P+ L                 + L  L +S NRL+
Sbjct: 205 KLWAYNNRLTSLPAL-PSGLKELIVSGNRLTSLPVLPSELKELMVSGNRLT 254

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 20/114 (17%), Positives = 41/114 (35%), Gaps = 28/114 (24%)

Query: 77  DLGNAALSGELAPELGQLKNLELLALGN---------LIKLKSLDLYSNLFNGTIPDTLA 127
           ++G + L+  L   L    ++  L + +           +L++L++  N    ++P    
Sbjct: 46  NVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPALPPELRTLEVSGNQLT-SLPVLPP 101

Query: 128 NLKQLKYLRLNNNSLSGLIPTSLTT--------------ITSLNILDLSNNRLS 167
            L +L         L  L P+ L                   L  L +S+N+L+
Sbjct: 102 GLLELSIFSNPLTHLPAL-PSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLA 154

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 53.2 bits (128), Expect = 4e-08
 Identities = 22/75 (29%), Positives = 32/75 (42%), Gaps = 3/75 (4%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
           +L  L+    G L  L +LDL  N    ++P     L  L  L ++ N L+ L   +L  
Sbjct: 66  ELTKLQ--VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRG 122

Query: 153 ITSLNILDLSNNRLS 167
           +  L  L L  N L 
Sbjct: 123 LGELQELYLKGNELK 137

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 53.2 bits (128), Expect = 4e-08
 Identities = 25/75 (33%), Positives = 36/75 (48%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
           +L +L L AL  L +L+ L L  N      P  L    +L+ L L NN+L+ L    L  
Sbjct: 111 RLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNG 170

Query: 153 ITSLNILDLSNNRLS 167
           + +L+ L L  N L 
Sbjct: 171 LENLDTLLLQENSLY 185

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 27/91 (29%), Positives = 32/91 (35%), Gaps = 12/91 (13%)

Query: 89  PELGQLKNLELLALG------------NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLR 136
              G L  L  L L              L  L  LD+  N         L  L +L+ L 
Sbjct: 71  QVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130

Query: 137 LNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
           L  N L  L P  LT    L  L L+NN L+
Sbjct: 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 19/60 (31%), Positives = 25/60 (41%), Gaps = 2/60 (3%)

Query: 108 LKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
              L L  NL       TL    +L  L L+   L+ L      T+  L  LDLS+N+L 
Sbjct: 33  TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLGTLDLSHNQLQ 90

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 53.4 bits (128), Expect = 4e-08
 Identities = 20/92 (21%), Positives = 26/92 (28%), Gaps = 8/92 (8%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTI-------PDTLANLKQLKYLRLNNNSLSGL 145
              N     +     L +LDL  N   G         P     L+ L        + SG+
Sbjct: 160 HSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGV 219

Query: 146 IPTSLTTITSLNILDLSNNRLSGPVPDNGSFS 177
                     L  LDLS+N L        S  
Sbjct: 220 CSALAAARVQLQGLDLSHNSLRD-AAGAPSCD 250

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 50.3 bits (120), Expect = 5e-07
 Identities = 22/90 (24%), Positives = 31/90 (34%), Gaps = 5/90 (5%)

Query: 90  ELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTL-ANLKQLKYLRLNNNSLSGLIPT 148
            +     +        ++L+ LDL  N               QL  L L+   L  + P 
Sbjct: 212 GMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQV-PK 270

Query: 149 SLTTITSLNILDLSNNRLSGPVPDNGSFSQ 178
            L     L++LDLS NRL    P      Q
Sbjct: 271 GLP--AKLSVLDLSYNRLDR-NPSPDELPQ 297

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 21/81 (25%), Positives = 30/81 (37%), Gaps = 4/81 (4%)

Query: 91  LGQLKNLELLALGNLIKLKSLDLYSNLFN---GTIPDTLANLKQLKYLRLNNNSLSGLIP 147
           LG+   +  L       L+ L L +       G      A   QL+ L L++NSL     
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245

Query: 148 TSLTTI-TSLNILDLSNNRLS 167
                  + LN L+LS   L 
Sbjct: 246 APSCDWPSQLNSLNLSFTGLK 266

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 43.7 bits (103), Expect = 6e-05
 Identities = 22/110 (20%), Positives = 36/110 (32%), Gaps = 5/110 (4%)

Query: 79  GNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLA---NLKQLKYL 135
           G  +L   L     +    +   +   + LK L + +      I         +  L+ L
Sbjct: 41  GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100

Query: 136 RLNNNSLSGLIPTSLT--TITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 183
            L N  ++G  P  L   T   LNIL+L N   +          Q+    
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPG 150

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 54.3 bits (130), Expect = 5e-08
 Identities = 35/145 (24%), Positives = 64/145 (44%), Gaps = 25/145 (17%)

Query: 293 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEER-TSGGELQF-QTEVKIISMAV-HRNLLRL 348
           +LG+G FGKV         +L AVK LK++      +++    E +++++      L +L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407

Query: 349 YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IALGSARGLS 401
           +  C    ++L  V  Y+  G +   + +  +   P              IA+G    L 
Sbjct: 408 H-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP------HAVFYAAEIAIG----LF 456

Query: 402 YLHEHCDPKIIHRDVKAANILLDED 426
           +L       II+RD+K  N++LD +
Sbjct: 457 FLQSK---GIIYRDLKLDNVMLDSE 478

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 53.3 bits (128), Expect = 6e-08
 Identities = 17/77 (22%), Positives = 36/77 (46%), Gaps = 2/77 (2%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIP-DTLANLKQLKYLRL-NNNSLSGLIPTSL 150
           +L+ ++  A      L+ +++  N     I  D  +NL +L  +R+   N+L  + P + 
Sbjct: 41  KLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAF 100

Query: 151 TTITSLNILDLSNNRLS 167
             + +L  L +SN  + 
Sbjct: 101 QNLPNLQYLLISNTGIK 117

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 18/99 (18%), Positives = 32/99 (32%), Gaps = 3/99 (3%)

Query: 93  QLKNLELLALGNL-IKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLT 151
            +  +E  +   L  +   L L  N             +  +    +NN+L  L      
Sbjct: 140 NIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFH 199

Query: 152 TITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNL 190
             +   ILD+S  R+   +P  G       +   +  NL
Sbjct: 200 GASGPVILDISRTRIH-SLPSYG-LENLKKLRARSTYNL 236

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 20/96 (20%), Positives = 34/96 (35%), Gaps = 11/96 (11%)

Query: 94  LKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTI 153
           L  L  + +     L  ++          P+   NL  L+YL ++N  +  L        
Sbjct: 78  LPKLHEIRIEKANNLLYIN----------PEAFQNLPNLQYLLISNTGIKHLPDVHKIHS 127

Query: 154 TSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLN 189
               +LD+ +N     +  N SF   +  S    LN
Sbjct: 128 LQKVLLDIQDNINIHTIERN-SFVGLSFESVILWLN 162

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 44.4 bits (105), Expect = 4e-05
 Identities = 11/99 (11%), Positives = 23/99 (23%), Gaps = 3/99 (3%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
            ++ +   A       +     +N       D          L ++   +  L    L  
Sbjct: 165 GIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 224

Query: 153 ITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLC 191
           +  L      N +    +P           S     + C
Sbjct: 225 LKKLRARSTYNLKK---LPTLEKLVALMEASLTYPSHCC 260

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 45/197 (22%), Positives = 80/197 (40%), Gaps = 37/197 (18%)

Query: 253 PHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKN------------ILGRGGFG 300
            H   +D+P  ++   Q          +  + T      +            ++GRG + 
Sbjct: 7   HHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYA 66

Query: 301 KVYKGRLAD-GKLVAVKRLKEER-TSGGELQF-QTEVKIISMAV-HRNLLRLYGFCTTVT 356
           KV   RL    ++ A++ +K+E      ++ + QTE  +   A  H  L+ L+  C    
Sbjct: 67  KVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTE 125

Query: 357 EKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IALGSARGLSYLHEHCDP 409
            +L  V  Y+  G +   + R+R+            +     I+L     L+YLHE    
Sbjct: 126 SRLFFVIEYVNGGDLMFHMQRQRKLPEE------HARFYSAEISLA----LNYLHER--- 172

Query: 410 KIIHRDVKAANILLDED 426
            II+RD+K  N+LLD +
Sbjct: 173 GIIYRDLKLDNVLLDSE 189

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 52.0 bits (125), Expect = 6e-08
 Identities = 20/75 (26%), Positives = 36/75 (48%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
            +K +   A     KL+ +DL +N  +   PD    L+ L  L L  N ++ L  +    
Sbjct: 43  TIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEG 102

Query: 153 ITSLNILDLSNNRLS 167
           + SL +L L+ N+++
Sbjct: 103 LFSLQLLLLNANKIN 117

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 50.4 bits (121), Expect = 2e-07
 Identities = 27/91 (29%), Positives = 39/91 (42%), Gaps = 2/91 (2%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
           Q+  L   A   L  L SL LY N            L  L+ L LN N ++ L   +   
Sbjct: 67  QISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQD 126

Query: 153 ITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 183
           + +LN+L L +N+L   +   G+FS    I 
Sbjct: 127 LHNLNLLSLYDNKLQT-IAK-GTFSPLRAIQ 155

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 47.3 bits (113), Expect = 2e-06
 Identities = 16/72 (22%), Positives = 30/72 (41%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
           ++  L       L  L+ L L +N  N    D   +L  L  L L +N L  +   + + 
Sbjct: 91  KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSP 150

Query: 153 ITSLNILDLSNN 164
           + ++  + L+ N
Sbjct: 151 LRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 46.2 bits (110), Expect = 5e-06
 Identities = 17/59 (28%), Positives = 29/59 (49%)

Query: 109 KSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
             + L  N      P   +  K+L+ + L+NN +S L P +   + SLN L L  N+++
Sbjct: 35  TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT 93

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 53.7 bits (129), Expect = 6e-08
 Identities = 21/88 (23%), Positives = 34/88 (38%), Gaps = 4/88 (4%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
            +  L +  +  L +L+ L L  N             + L+YL +++N L  +    +  
Sbjct: 63  SISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCCPM-- 120

Query: 153 ITSLNILDLSNNRLSGPVPDNGSFSQFT 180
             SL  LDLS N     +P    F   T
Sbjct: 121 -ASLRHLDLSFNDFDV-LPVCKEFGNLT 146

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 46.8 bits (111), Expect = 9e-06
 Identities = 18/83 (21%), Positives = 34/83 (40%), Gaps = 2/83 (2%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTS--L 150
               + ++   +      L+   N+F  ++    + LK+L+ L L  N L      +   
Sbjct: 340 DTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMT 399

Query: 151 TTITSLNILDLSNNRLSGPVPDN 173
             ++SL  LD+S N L+    D 
Sbjct: 400 KNMSSLETLDVSLNSLNSHAYDR 422

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 17/103 (16%), Positives = 33/103 (32%), Gaps = 4/103 (3%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSL-T 151
           ++++L+         L+ LD+  N     I      +  L++L L+ N    L       
Sbjct: 87  RIRSLDFHVFLFNQDLEYLDVSHNRL-QNISC--CPMASLRHLDLSFNDFDVLPVCKEFG 143

Query: 152 TITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPN 194
            +T L  L LS  +         +    + I  +         
Sbjct: 144 NLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGG 186

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 23/74 (31%), Positives = 42/74 (56%), Gaps = 5/74 (6%)

Query: 107 KLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 166
            +  L+L SN+  G++   L    ++K L L+NN +  + P  +T + +L  L++++N+L
Sbjct: 429 SILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSI-PKDVTHLQALQELNVASNQL 485

Query: 167 SGPVPDNGSFSQFT 180
              VPD G F + T
Sbjct: 486 KS-VPD-GVFDRLT 497

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 18/95 (18%), Positives = 35/95 (36%), Gaps = 11/95 (11%)

Query: 91  LGQLKNLEL-------LALGNLIKLKSLDLYSNLFNGTIPDT--LANLKQLKYLRLNNNS 141
              L+ L++       ++   +  L+ LDL  N F+  +P      NL +L +L L+   
Sbjct: 99  NQDLEYLDVSHNRLQNISCCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAK 157

Query: 142 LSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSF 176
              L    +  +  L+ + L          +  S 
Sbjct: 158 FRQLDLLPVAHL-HLSCILLDLVSYHIKGGETESL 191

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 18/58 (31%), Positives = 32/58 (55%), Gaps = 1/58 (1%)

Query: 107 KLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNN 164
           K+K LDL++N    +IP  + +L+ L+ L + +N L  +       +TSL  + L +N
Sbjct: 451 KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 52.6 bits (127), Expect = 9e-08
 Identities = 37/151 (24%), Positives = 61/151 (40%), Gaps = 39/151 (25%)

Query: 294 LGRGGFGKVYKGRLAD-GKLVAVKRLKE---------ERTSGGELQFQTEVKIISMAV-H 342
           LG+G FGKV         +L AVK LK+         E T         E +++++    
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT-------MVEKRVLALPGKP 80

Query: 343 RNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IALG 395
             L +L+  C    ++L  V  Y+  G +   + +  +   P              IA+G
Sbjct: 81  PFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP------HAVFYAAEIAIG 133

Query: 396 SARGLSYLHEHCDPKIIHRDVKAANILLDED 426
               L +L       II+RD+K  N++LD +
Sbjct: 134 ----LFFLQSK---GIIYRDLKLDNVMLDSE 157

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 52.6 bits (127), Expect = 1e-07
 Identities = 44/151 (29%), Positives = 68/151 (45%), Gaps = 39/151 (25%)

Query: 294 LGRGGFGKVYKGRLAD-GKLVAVKRLKE---------ERTSGGELQFQTEVKIISMAV-H 342
           LG+G FGKV   R+ + G L AVK LK+         E T        TE +I+S+A  H
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECT-------MTEKRILSLARNH 83

Query: 343 RNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IALG 395
             L +L+  C    ++L  V  ++  G +   + + R+          R +     I   
Sbjct: 84  PFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA------RARFYAAEIISA 136

Query: 396 SARGLSYLHEHCDPKIIHRDVKAANILLDED 426
               L +LH+     II+RD+K  N+LLD +
Sbjct: 137 ----LMFLHDK---GIIYRDLKLDNVLLDHE 160

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.4 bits (125), Expect = 1e-07
 Identities = 16/70 (22%), Positives = 27/70 (38%), Gaps = 1/70 (1%)

Query: 99  LLALGNLIKLKSLDLYSNLFNGTIPD-TLANLKQLKYLRLNNNSLSGLIPTSLTTITSLN 157
           L  L     L  L + +      +    L  L +L+ L +  + L  + P +      L+
Sbjct: 24  LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83

Query: 158 ILDLSNNRLS 167
            L+LS N L 
Sbjct: 84  RLNLSFNALE 93

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 22/89 (24%), Positives = 33/89 (37%), Gaps = 12/89 (13%)

Query: 89  PELGQLKNLELL-----------ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 137
           P    L  L +             L  L +L++L +  +      PD      +L  L L
Sbjct: 28  PGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87

Query: 138 NNNSLSGLIPTSLTTITSLNILDLSNNRL 166
           + N+L  L   ++    SL  L LS N L
Sbjct: 88  SFNALESLSWKTVQG-LSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 44.3 bits (104), Expect = 5e-05
 Identities = 10/48 (20%), Positives = 15/48 (31%), Gaps = 1/48 (2%)

Query: 121 TIPDTLANLKQLKYLRL-NNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
                L   + L  L + N   L  L    L  +  L  L +  + L 
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 45/156 (28%), Positives = 66/156 (42%), Gaps = 45/156 (28%)

Query: 294 LGRGGFGKVY---KGRLAD-GKLVAVKRLK----------EERTSGGELQFQTEVKIISM 339
           LG G +GKV+   K    D GKL A+K LK           E T       +TE +++  
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT-------RTERQVLEH 114

Query: 340 AVHRN-LLRL-YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK---- 391
                 L+ L Y F T    KL L+  Y+  G + + L +  + +          +    
Sbjct: 115 IRQSPFLVTLHYAFQTE--TKLHLILDYINGGELFTHLSQRERFTEH------EVQIYVG 166

Query: 392 -IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
            I L     L +LH+     II+RD+K  NILLD +
Sbjct: 167 EIVLA----LEHLHKL---GIIYRDIKLENILLDSN 195

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 51.8 bits (125), Expect = 2e-07
 Identities = 41/145 (28%), Positives = 68/145 (46%), Gaps = 25/145 (17%)

Query: 293 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEER-TSGGELQF-QTEVKIISMAV-HRNLLRL 348
           ++GRG + KV   RL    ++ A+K +K+E      ++ + QTE  +   A  H  L+ L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75

Query: 349 YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IALGSARGLS 401
           +  C     +L  V  Y+  G +   + R+R+            +     I+L     L+
Sbjct: 76  H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE------HARFYSAEISLA----LN 124

Query: 402 YLHEHCDPKIIHRDVKAANILLDED 426
           YLHE     II+RD+K  N+LLD +
Sbjct: 125 YLHER---GIIYRDLKLDNVLLDSE 146

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 34/169 (20%), Positives = 64/169 (37%), Gaps = 42/169 (24%)

Query: 285 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQT---------EV 334
              ++ +  +  G +G V  G  ++G  VA+KR+    + G  +              E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 335 KIISMAVHRNLLRLYG-FCTTVTEKL----LVYPYMTNGSVASRLRERQSSLPP------ 383
           ++++   H N+L L   F       +    LV   M    +A  + +++  + P      
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYF 139

Query: 384 ----LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 428
               L              GL  LH   +  ++HRD+   NILL ++ D
Sbjct: 140 MYHIL-------------LGLHVLH---EAGVVHRDLHPGNILLADNND 172

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 36/158 (22%), Positives = 63/158 (39%), Gaps = 33/158 (20%)

Query: 293 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR------NL 345
           ++G+G FG+V K       + VA+K ++ E+      Q   E++I+     +      N+
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF--HRQAAEEIRILEHLRKQDKDNTMNV 161

Query: 346 LRLYGF-------CTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGS 396
           + +          C    E L           +  L E  +++       P  +K A   
Sbjct: 162 IHMLENFTFRNHICM-TFELL-----------SMNLYELIKKNKFQGFSLPLVRKFAHSI 209

Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI 434
            + L  LH++   +IIH D+K  NILL +      K I
Sbjct: 210 LQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVI 244

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 48.8 bits (117), Expect = 5e-07
 Identities = 24/76 (31%), Positives = 38/76 (50%), Gaps = 2/76 (2%)

Query: 101 ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILD 160
            L N   L  +DL +N  +     + +N+ QL  L L+ N L  + P +   + SL +L 
Sbjct: 49  ELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLS 108

Query: 161 LSNNRLSGPVPDNGSF 176
           L  N +S  VP+ G+F
Sbjct: 109 LHGNDISV-VPE-GAF 122

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 46.9 bits (112), Expect = 3e-06
 Identities = 23/59 (38%), Positives = 30/59 (50%), Gaps = 1/59 (1%)

Query: 109 KSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
             L L  N F   +P  L+N K L  + L+NN +S L   S + +T L  L LS NRL 
Sbjct: 34  TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR 91

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 50.1 bits (120), Expect = 5e-07
 Identities = 26/90 (28%), Positives = 39/90 (43%), Gaps = 19/90 (21%)

Query: 91  LGQLKNLELL-----------ALGNLIKLKSLDLYSNLFNGTIPD--TLANLKQLKYLRL 137
           +  L N+  L            L NL  L  L L  N     + D  +L +LK+LK L L
Sbjct: 64  IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENK----VKDLSSLKDLKKLKSLSL 119

Query: 138 NNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
            +N +S +    L  +  L  L L NN+++
Sbjct: 120 EHNGISDING--LVHLPQLESLYLGNNKIT 147

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 23/100 (23%), Positives = 37/100 (37%), Gaps = 15/100 (15%)

Query: 91  LGQLKNLELL-----------ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 139
           L +L  L+ L            L  L KL++L L  N  + +    LA LK L  L L +
Sbjct: 152 LSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKN--HISDLRALAGLKNLDVLELFS 209

Query: 140 NSLSGLIPTSLTTITSLNILDLSNNRLSGPVP--DNGSFS 177
                      + +   N +  ++  L  P    D+G + 
Sbjct: 210 QECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYE 249

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 48.5 bits (116), Expect = 5e-07
 Identities = 22/94 (23%), Positives = 34/94 (36%), Gaps = 14/94 (14%)

Query: 86  ELAPELGQLKNLELLAL-GNLI-----------KLKSLDLYSNLFNGTIPDTLANLKQLK 133
           E A +         L L G  I           +  ++D   N     + D    L++LK
Sbjct: 10  EQAAQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLK 67

Query: 134 YLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
            L +NNN +  +       +  L  L L+NN L 
Sbjct: 68  TLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 40.0 bits (94), Expect = 4e-04
 Identities = 20/83 (24%), Positives = 30/83 (36%), Gaps = 12/83 (14%)

Query: 94  LKNLELLALGN-----------LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSL 142
           L   + +   +           L +LK+L + +N            L  L  L L NNSL
Sbjct: 41  LDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL 100

Query: 143 SGL-IPTSLTTITSLNILDLSNN 164
             L     L ++ SL  L +  N
Sbjct: 101 VELGDLDPLASLKSLTYLCILRN 123

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 28/132 (21%), Positives = 48/132 (36%), Gaps = 24/132 (18%)

Query: 52  HLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGEL------APELGQLKNLELLALGNL 105
           +  +S   F   +  +   +          AL GE         +   +     L L  L
Sbjct: 10  NFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRL 69

Query: 106 I----------KLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITS 155
                      ++  L++  N    ++P+  A+L+   YL   +N LS L P       S
Sbjct: 70  NLSSLPDNLPPQITVLEITQNAL-ISLPELPASLE---YLDACDNRLSTL-PEL---PAS 121

Query: 156 LNILDLSNNRLS 167
           L  LD+ NN+L+
Sbjct: 122 LKHLDVDNNQLT 133

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 50.4 bits (120), Expect = 8e-07
 Identities = 23/153 (15%), Positives = 54/153 (35%), Gaps = 17/153 (11%)

Query: 77  DLGNAALSGELAPELGQLKNLELLALGNLI--------KLKSLDLYSNLFNGTIPDTLAN 128
           +  N  L+  L      L+ L +    N +         L++LD+ +NL   ++P     
Sbjct: 146 NADNNQLT-MLPELPTSLEVLSVR--NNQLTFLPELPESLEALDVSTNLLE-SLPAVPVR 201

Query: 129 LKQLK----YLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISF 184
               +    + R   N ++ + P ++ ++     + L +N LS  + ++ S     P   
Sbjct: 202 NHHSEETEIFFRCRENRITHI-PENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYH 260

Query: 185 ENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSP 217
              +     + ++     P       + P +  
Sbjct: 261 GPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQ 293

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 48.5 bits (116), Expect = 8e-07
 Identities = 22/88 (25%), Positives = 40/88 (45%), Gaps = 14/88 (15%)

Query: 91  LGQLKNLELLALGN-----------LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 139
           L  LK  + LAL             +  L+ L L  NL    I +  A    L+ L ++ 
Sbjct: 44  LSTLKACKHLALSTNNIEKISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISY 102

Query: 140 NSLSGLIPTSLTTITSLNILDLSNNRLS 167
           N ++ L  + +  + +L +L +SNN+++
Sbjct: 103 NQIASL--SGIEKLVNLRVLYMSNNKIT 128

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 43.1 bits (102), Expect = 5e-05
 Identities = 17/77 (22%), Positives = 37/77 (48%), Gaps = 5/77 (6%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNG--TIPDTLANLKQLKYLRLNNNSLSGLIPTSL 150
            ++  E        + + ++L+  +      +  TL+ LK  K+L L+ N++  +  +SL
Sbjct: 10  AIRIFEERKSVVATEAEKVELH-GMIPPIEKMDATLSTLKACKHLALSTNNIEKI--SSL 66

Query: 151 TTITSLNILDLSNNRLS 167
           + + +L IL L  N + 
Sbjct: 67  SGMENLRILSLGRNLIK 83

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 49.6 bits (119), Expect = 9e-07
 Identities = 33/142 (23%), Positives = 65/142 (45%), Gaps = 28/142 (19%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLK---EERTSGGELQFQTEVKII-SMAVHRNLLRL 348
           LGRG + +V++   + + + V VK LK   +++        + E+KI+ ++    N++ L
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI-------KREIKILENLRGGPNIITL 96

Query: 349 YGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI--ALGSARGLSYLH 404
                    +   LV+ ++ N    +  ++   +L   D   R  +   L   + L Y H
Sbjct: 97  ADIVKDPVSRTPALVFEHVNN----TDFKQLYQTLTDYD--IRFYMYEIL---KALDYCH 147

Query: 405 EHCDPKIIHRDVKAANILLDED 426
                 I+HRDVK  N+++D +
Sbjct: 148 SM---GIMHRDVKPHNVMIDHE 166

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 31/168 (18%), Positives = 60/168 (35%), Gaps = 39/168 (23%)

Query: 293 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISM-----------A 340
            LG G F  V+  + + +   VA+K ++ ++        + E+K++              
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE--AAEDEIKLLQRVNDADNTKEDSM 83

Query: 341 VHRNLLRLY------GFCTT----VTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPT 388
              ++L+L       G        V E L              L    ++     +    
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVL-----------GENLLALIKKYEHRGIPLIY 132

Query: 389 RKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR 436
            K+I+     GL Y+H  C   IIH D+K  N+L++      +   ++
Sbjct: 133 VKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIK 178

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 22/76 (28%), Positives = 31/76 (40%), Gaps = 2/76 (2%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIP-DTLANLKQLKYLRLNNNSLSGLIPTSLT 151
           +L+ L       L  L++L +  N     +P      L  L  LRL+ N L  L P    
Sbjct: 72  KLQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFD 130

Query: 152 TITSLNILDLSNNRLS 167
           ++T L  L L  N L 
Sbjct: 131 SLTKLTYLSLGYNELQ 146

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 47.3 bits (113), Expect = 3e-06
 Identities = 21/75 (28%), Positives = 30/75 (40%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
           +L +L   A   L KL+ L L  N            LK L+ L + +N L  L       
Sbjct: 48  KLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQ 107

Query: 153 ITSLNILDLSNNRLS 167
           + +L  L L  N+L 
Sbjct: 108 LVNLAELRLDRNQLK 122

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 24/75 (32%), Positives = 32/75 (42%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
           +L+ L +     L+ L  L L  N      P    +L +L YL L  N L  L       
Sbjct: 96  KLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDK 155

Query: 153 ITSLNILDLSNNRLS 167
           +TSL  L L NN+L 
Sbjct: 156 LTSLKELRLYNNQLK 170

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 27/76 (35%), Positives = 36/76 (47%), Gaps = 2/76 (2%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTL-ANLKQLKYLRLNNNSLSGLIPTSLT 151
           QLK+L      +L KL  L L  N    ++P  +   L  LK LRL NN L  +   +  
Sbjct: 120 QLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFD 178

Query: 152 TITSLNILDLSNNRLS 167
            +T L  L L NN+L 
Sbjct: 179 KLTELKTLKLDNNQLK 194

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 18/60 (30%), Positives = 28/60 (46%)

Query: 108 LKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
            K LDL SN  +         L +L+ L LN+N L  L       + +L  L +++N+L 
Sbjct: 39  TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ 98

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 29/169 (17%), Positives = 61/169 (36%), Gaps = 51/169 (30%)

Query: 285 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EV 334
            D +  ++++G G +G V +     + ++VA+K++           F+          E+
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV--------FEDLIDCKRILREI 103

Query: 335 KIISMAVHRNLLRLYGFCTTVTEKL-----LVYPYMTNGSVASRLRERQSSLPPLDWPTR 389
            I++   H +++++         +      +V                 S    L    R
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA------------DSDFKKL---FR 148

Query: 390 KKIALGSA----------RGLSYLHEHCDPKIIHRDVKAANILLDEDAD 428
             + L              G+ Y+H      I+HRD+K AN L+++D  
Sbjct: 149 TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCS 194

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 46.3 bits (110), Expect = 3e-06
 Identities = 19/89 (21%), Positives = 36/89 (40%), Gaps = 13/89 (14%)

Query: 90  ELGQLKNLELLALGN-----------LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN 138
               ++ L L    +            + L+ L L +     ++ + L  L +LK L L+
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79

Query: 139 NNSLSGLIPTSLTTITSLNILDLSNNRLS 167
            N + G +      + +L  L+LS N+L 
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 48.0 bits (113), Expect = 3e-06
 Identities = 14/76 (18%), Positives = 28/76 (36%), Gaps = 7/76 (9%)

Query: 99  LLALGNLIKLKSLDLYSNLFNGTIPDTLAN---LKQLKYLRLNNNSLSG----LIPTSLT 151
           L +      LK L +        + +       L QL+ + ++   L+     L+   + 
Sbjct: 245 LFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVD 304

Query: 152 TITSLNILDLSNNRLS 167
            I  L  +++  N LS
Sbjct: 305 KIKHLKFINMKYNYLS 320

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 47.8 bits (114), Expect = 4e-06
 Identities = 35/159 (22%), Positives = 64/159 (40%), Gaps = 31/159 (19%)

Query: 292 NILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISM------AVHRN 344
           +++G+G FG+V K     + + VA+K +K ++      Q Q EV+++ +       +   
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF--LNQAQIEVRLLELMNKHDTEMKYY 117

Query: 345 LLRLYGF-------CTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALG 395
           ++ L          C  V E L           +  L +  R ++   +     +K A  
Sbjct: 118 IVHLKRHFMFRNHLCL-VFEML-----------SYNLYDLLRNTNFRGVSLNLTRKFAQQ 165

Query: 396 SARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI 434
               L +L    +  IIH D+K  NILL      + K +
Sbjct: 166 MCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV 203

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.4 bits (108), Expect = 4e-06
 Identities = 17/66 (25%), Positives = 31/66 (46%), Gaps = 2/66 (3%)

Query: 102 LGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDL 161
                +L+ L   +     +I + L  L +LK L L++N +SG +        +L  L+L
Sbjct: 38  TDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95

Query: 162 SNNRLS 167
           S N++ 
Sbjct: 96  SGNKIK 101

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 46.6 bits (111), Expect = 7e-06
 Identities = 36/153 (23%), Positives = 52/153 (33%), Gaps = 34/153 (22%)

Query: 294 LGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKI---------ISMAVHR 343
           +G GGFG +Y        +  A   +K E    G L    E+K          I   + R
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS--ELKFYQRVAKKDCIKKWIER 102

Query: 344 NLLRLYGF-----CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK-------K 391
             L   G            K   Y +M    V  RL      L  +             +
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFM----VMERL---GIDLQKISGQNGTFKKSTVLQ 155

Query: 392 IALGSARGLSYLHEHCDPKIIHRDVKAANILLD 424
           + +     L Y+HE+     +H D+KAAN+LL 
Sbjct: 156 LGIRMLDVLEYIHENE---YVHGDIKAANLLLG 185

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.2 bits (111), Expect = 1e-05
 Identities = 62/508 (12%), Positives = 133/508 (26%), Gaps = 193/508 (37%)

Query: 37  LLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKN 96
             + L+  L E                L+ + N+ +  +   G   ++ ++         
Sbjct: 136 PYLKLRQALLE----------------LRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCK 179

Query: 97  LEL----LALGNLIKLKS-LDLYSNLFNGTIPDTLANLKQLKYLRLNNNS----LSGLI- 146
           ++     L L N    ++ L++   L     P+  +       ++L  +S    L  L+ 
Sbjct: 180 MDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLK 239

Query: 147 ----PTSL--------------------TTITS--LNILDLSNNRLSGPVPDNGSFSQFT 180
                  L                      +T+    + D  +   +  +  +      T
Sbjct: 240 SKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLT 299

Query: 181 PISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAV 240
           P   +   +L            P                 +     P  +++ A  +   
Sbjct: 300 P---DEVKSLLLKYLDCRPQDLPR----------------EVLTTNPRRLSIIAESI-RD 339

Query: 241 PVIGFAYWRRTR----------------PHEF---FFD---------VPA---------- 262
            +  +  W+                   P E+   F           +P           
Sbjct: 340 GLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDV 399

Query: 263 -EDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEE 321
            + D  + + +L ++SL                                     K+ KE 
Sbjct: 400 IKSDVMVVVNKLHKYSL-----------------------------------VEKQPKES 424

Query: 322 RTSGGELQFQTEVKIISM-AVHRNLLRLY----GFCTTVTEKLLV--YPY------MTNG 368
             S   +  + +VK+ +  A+HR+++  Y     F +       +  Y Y      + N 
Sbjct: 425 TISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKN- 483

Query: 369 SVASRLRERQSSLPP----LDWPTRKKIALGSARGLS---------------YLHEHCDP 409
                  ER +          +  +K     +A   S               Y+ ++ DP
Sbjct: 484 ---IEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDN-DP 539

Query: 410 KIIHRDVKA---------ANILLDEDAD 428
           K   R V A          N++  +  D
Sbjct: 540 K-YERLVNAILDFLPKIEENLICSKYTD 566

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.4 bits (109), Expect = 2e-05
 Identities = 34/201 (16%), Positives = 66/201 (32%), Gaps = 66/201 (32%)

Query: 245 FAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNIL--GRGGFGK- 301
           FA +  +R   +           L+L    R +L EL+        KN+L  G  G GK 
Sbjct: 126 FAKYNVSRLQPY-----------LKL----RQALLELR------PAKNVLIDGVLGSGKT 164

Query: 302 VYKGRLADGKLVAVKRLKEERTSGGEL------QFQTEVKIISMAVHRNLLRLYGFCTTV 355
                +A   L      K +     ++         +   ++ M     L +L       
Sbjct: 165 W----VA---LDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEM-----LQKLL------ 206

Query: 356 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRD 415
               +   + +    +S ++ R  S+         +  L   R L     + +  ++  +
Sbjct: 207 --YQIDPNWTSRSDHSSNIKLRIHSI---------QAEL---RRLLKSKPYENCLLVLLN 252

Query: 416 VKAANILLDEDA-DQSSKTIL 435
           V+ A      +A + S K +L
Sbjct: 253 VQNAKAW---NAFNLSCKILL 270

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 44.6 bits (106), Expect = 2e-05
 Identities = 22/85 (25%), Positives = 36/85 (42%), Gaps = 3/85 (3%)

Query: 93  QLKNLELLAL-GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLT 151
           +L  +    L G L  L  L+L  N   G  P+       ++ L+L  N +  +      
Sbjct: 40  ELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFL 99

Query: 152 TITSLNILDLSNNRLSGPVPDNGSF 176
            +  L  L+L +N++S  V   GSF
Sbjct: 100 GLHQLKTLNLYDNQISC-VMP-GSF 122

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 30/146 (20%), Positives = 57/146 (39%), Gaps = 18/146 (12%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH-RNLLRLYGF 351
           +G G FG +++G  L + + VA+K    E       Q + E +   +      +  +Y F
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 74

Query: 352 CTTVTEKLLVYPYMTNGSVASRLRE---RQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 408
                  +LV   +  G     L +   R+ S+      T    A      +  +HE   
Sbjct: 75  GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSV-----KTVAMAAKQMLARVQSIHEKS- 126

Query: 409 PKIIHRDVKAANILLDEDADQSSKTI 434
             +++RD+K  N L+     +++  I
Sbjct: 127 --LVYRDIKPDNFLIGRPNSKNANMI 150

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 22/74 (29%), Positives = 29/74 (39%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
            L  L       L KL  L+L  N           +L +L  L L NN L+ L       
Sbjct: 46  GLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDH 105

Query: 153 ITSLNILDLSNNRL 166
           +T L+ L L  N+L
Sbjct: 106 LTQLDKLYLGGNQL 119

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 29/96 (30%), Positives = 40/96 (41%), Gaps = 1/96 (1%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
           QL +L L    +L +L  L L  N            L +LK LRLN N L  +   +   
Sbjct: 94  QLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDK 153

Query: 153 ITSLNILDLSNNRL-SGPVPDNGSFSQFTPISFENN 187
           +T+L  L LS N+L S P        +   I+   N
Sbjct: 154 LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 27/98 (27%), Positives = 40/98 (40%), Gaps = 5/98 (5%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
           QL+ L      +L +L +L L +N           +L QL  L L  N L  L       
Sbjct: 70  QLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDR 129

Query: 153 ITSLNILDLSNNRLSGPVPDNGSF---SQFTPISFENN 187
           +T L  L L+ N+L   +P  G+F   +    +S   N
Sbjct: 130 LTKLKELRLNTNQLQS-IPA-GAFDKLTNLQTLSLSTN 165

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 19/59 (32%), Positives = 27/59 (45%)

Query: 109 KSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
           + LDL S         T   L +L +L L+ N L  L       +T L  L L+NN+L+
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA 96

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 23/87 (26%), Positives = 36/87 (41%), Gaps = 10/87 (11%)

Query: 89  PELGQLKNLELL-----ALG---NLIKLKSLDLYSNLFNGTIPDTL-ANLKQLKYLRLNN 139
             L  ++ L L       +     L  L  L L  N    ++P+ +   L  LK L L  
Sbjct: 60  QYLPNVRYLALGGNKLHDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVE 118

Query: 140 NSLSGLIPTSLTTITSLNILDLSNNRL 166
           N L  L       +T+L  L+L++N+L
Sbjct: 119 NQLQSLPDGVFDKLTNLTYLNLAHNQL 145

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 30/152 (19%), Positives = 57/152 (37%), Gaps = 32/152 (21%)

Query: 293 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISM-----AVHRNLL 346
            +G G FG+V   + + + K  AVK ++  +        + E  I+         + N++
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY--TRSAKIEADILKKIQNDDINNNNIV 99

Query: 347 RLYGF-------CTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSA 397
           + +G        C  + E L              L E   +++         K   +   
Sbjct: 100 KYHGKFMYYDHMCL-IFEPL-----------GPSLYEIITRNNYNGFHIEDIKLYCIEIL 147

Query: 398 RGLSYLHEHCDPKIIHRDVKAANILLDEDADQ 429
           + L+YL +     + H D+K  NILLD+   +
Sbjct: 148 KALNYLRKM---SLTHTDLKPENILLDDPYFE 176

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 33/156 (21%), Positives = 59/156 (37%), Gaps = 37/156 (23%)

Query: 294 LGRGGFGKVYKGRLADGKLVAVKR---LKEERTSGGELQFQTEVKI---------ISMAV 341
           +G+GGFG +Y   +   + V       +K E +  G L    E+K          I   +
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFT--ELKFYQRAAKPEQIQKWI 100

Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR----ERQ-SSLPPL-DWPTRK----- 390
               L+  G           +    +       R    +R  S L  + +   ++     
Sbjct: 101 RTRKLKYLGVPK-------YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKT 153

Query: 391 --KIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 424
             +++L     L Y+HEH     +H D+KA+N+LL+
Sbjct: 154 VLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 38/169 (22%), Positives = 60/169 (35%), Gaps = 51/169 (30%)

Query: 285 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EV 334
            D +  K+++GRG +G VY        K VA+K++           F+          E+
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM--------FEDLIDCKRILREI 76

Query: 335 KIISMAVHRNLLRLYGFCTTVTEKL-----LVYPYMTNGSVASRLRERQSSLPPLDWPTR 389
            I++      ++RLY               +V                 S L  L    +
Sbjct: 77  TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA------------DSDLKKL---FK 121

Query: 390 KKIALGSA----------RGLSYLHEHCDPKIIHRDVKAANILLDEDAD 428
             I L              G +++HE     IIHRD+K AN LL++D  
Sbjct: 122 TPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCS 167

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 28/122 (22%), Positives = 43/122 (35%), Gaps = 21/122 (17%)

Query: 62  RVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGT 121
             + S  +L +   SD+    +  E+   L  L    L AL    KL ++ L  N F  T
Sbjct: 54  ENIASKKDLEIAEFSDIFTGRVKDEIPEALRLL----LQALLKCPKLHTVRLSDNAFGPT 109

Query: 122 ----IPDTLANLKQLKYLRLNNNSLS-------------GLIPTSLTTITSLNILDLSNN 164
               + D L+    L++L L+NN L                +         L  +    N
Sbjct: 110 AQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN 169

Query: 165 RL 166
           RL
Sbjct: 170 RL 171

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 40.7 bits (96), Expect = 3e-04
 Identities = 27/98 (27%), Positives = 36/98 (36%), Gaps = 5/98 (5%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
           +L++L       L +L  L L  N            L +L  L L+ N L  L       
Sbjct: 39  KLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDK 98

Query: 153 ITSLNILDLSNNRLSGPVPDNGSF---SQFTPISFENN 187
           +T L  L L  N+L   VPD G F   +    I    N
Sbjct: 99  LTQLKELALDTNQLKS-VPD-GIFDRLTSLQKIWLHTN 134

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 40.8 bits (96), Expect = 3e-04
 Identities = 24/81 (29%), Positives = 29/81 (35%)

Query: 86  ELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGL 145
            L  E   LK+L       L  L  L L  N            L  L YL L+ N L  L
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSL 91

Query: 146 IPTSLTTITSLNILDLSNNRL 166
                  +T L  L L+ N+L
Sbjct: 92  PNGVFDKLTQLKELALNTNQL 112

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 34/140 (24%), Positives = 49/140 (35%), Gaps = 12/140 (8%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLLRLYGF 351
           +G G FG +Y G  +A G+ VA+K    E       Q   E KI   M     +  +   
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 73

Query: 352 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
                  ++V   +  G     L    S    L   T   +A      + Y+H       
Sbjct: 74  GAEGDYNVMVMELL--GPSLEDLFNFCSRKFSL--KTVLLLADQMISRIEYIHSKN---F 126

Query: 412 IHRDVKAANILLDEDADQSS 431
           IHRDVK  N L+      + 
Sbjct: 127 IHRDVKPDNFLMGLGKKGNL 146

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 34/146 (23%), Positives = 58/146 (39%), Gaps = 18/146 (12%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH-RNLLRLYGF 351
           +G G FG++  G+ L   + VA+K    E       Q   E +          + ++Y F
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 73

Query: 352 CTTVTEKLLVYPYMTNG-SVAS--RLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 408
                   +V   +  G S+     L +R  SL      T   IA+     + Y+H    
Sbjct: 74  GPCGKYNAMVLELL--GPSLEDLFDLCDRTFSL-----KTVLMIAIQLISRMEYVHSKN- 125

Query: 409 PKIIHRDVKAANILLDEDADQSSKTI 434
             +I+RDVK  N L+    +++ + I
Sbjct: 126 --LIYRDVKPENFLIGRPGNKTQQVI 149

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 40.8 bits (96), Expect = 4e-04
 Identities = 34/123 (27%), Positives = 46/123 (37%), Gaps = 32/123 (26%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSN----LFNGTIPDTLANLK------------------ 130
           Q+  LE     +LI LK L L SN    L  G + D+L  L                   
Sbjct: 51  QITKLEPGVFDSLINLKELYLGSNQLGALPVG-VFDSLTQLTVLDLGTNQLTVLPSAVFD 109

Query: 131 ---QLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSF---SQFTPISF 184
               LK L +  N L+  +P  +  +T L  L L  N+L   +P  G+F   S  T    
Sbjct: 110 RLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKS-IPH-GAFDRLSSLTHAYL 166

Query: 185 ENN 187
             N
Sbjct: 167 FGN 169

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 41.1 bits (97), Expect = 4e-04
 Identities = 31/162 (19%), Positives = 60/162 (37%), Gaps = 38/162 (23%)

Query: 285 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EV 334
              + +   +G G +G V        G+ VA+K+L           FQ+         E+
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--------PFQSEIFAKRAYREL 74

Query: 335 KIISMAVHRNLLRLY------GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDW 386
            ++    H N++ L              +  LV P+M      + L++            
Sbjct: 75  LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGL----KFSE 125

Query: 387 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 428
              + +     +GL Y+H      ++HRD+K  N+ ++ED +
Sbjct: 126 EKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCE 164

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 32/159 (20%), Positives = 55/159 (34%), Gaps = 38/159 (23%)

Query: 288 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EVKII 337
           + N   +G G  G V         + VA+K+L           FQ          E+ ++
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR--------PFQNQTHAKRAYRELVLM 78

Query: 338 SMAVHRNLLRLY------GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTR 389
               H+N++ L              +  +V   M      + L +  +      LD    
Sbjct: 79  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-----ANLCQVIQM----ELDHERM 129

Query: 390 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 428
             +      G+ +LH      IIHRD+K +NI++  D  
Sbjct: 130 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 165

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 28/155 (18%), Positives = 52/155 (33%), Gaps = 34/155 (21%)

Query: 293 ILGRGGFGKVYKG--RLADGKLVAVKRLKEERTSGGELQFQTEVKIISM------AVHRN 344
            LG G FGKV +          VA+K ++           + E+ ++             
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKY--REAARLEINVLKKIKEKDKENKFL 83

Query: 345 LLRLYGF-------CTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALG 395
            + +  +       C    E L                E  ++++  P   P  + +A  
Sbjct: 84  CVLMSDWFNFHGHMCI-AFELL-----------GKNTFEFLKENNFQPYPLPHVRHMAYQ 131

Query: 396 SARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS 430
               L +LHE+   ++ H D+K  NIL      ++
Sbjct: 132 LCHALRFLHEN---QLTHTDLKPENILFVNSEFET 163

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 30/139 (21%), Positives = 49/139 (35%), Gaps = 12/139 (8%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLLRLYGF 351
           +G G FG++Y G  +   + VA+K    E       Q   E KI   +     +  +  F
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKIYRILQGGTGIPNVRWF 71

Query: 352 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
                  +LV   +  G     L    S    L   T   +A      + ++H       
Sbjct: 72  GVEGDYNVLVMDLL--GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKS---F 124

Query: 412 IHRDVKAANILLDEDADQS 430
           +HRD+K  N L+      +
Sbjct: 125 LHRDIKPDNFLMGLGRRAN 143

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 41.4 bits (97), Expect = 5e-04
 Identities = 33/161 (20%), Positives = 54/161 (33%), Gaps = 36/161 (22%)

Query: 285 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EV 334
              + N   +G G  G V         + VA+K+L           FQ          E+
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR--------PFQNQTHAKRAYREL 112

Query: 335 KIISMAVHRNLLRLY------GFCTTVTEKLLVYPYM-TNGSVASRLRERQSSLPPLDWP 387
            ++    H+N++ L              +  LV   M  N     ++         LD  
Sbjct: 113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--------ELDHE 164

Query: 388 TRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 428
               +      G+ +LH      IIHRD+K +NI++  D  
Sbjct: 165 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 202

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 40.7 bits (96), Expect = 6e-04
 Identities = 29/115 (25%), Positives = 47/115 (40%), Gaps = 24/115 (20%)

Query: 76  SDLGNAALSGELAPELGQLKNLEL--------------LALGNLIKLKSLDLYSNLFNG- 120
            +L +A  + EL P L Q + + L               AL     L  L+L SN     
Sbjct: 13  EELSDARWA-ELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDV 71

Query: 121 ---TIPDTLANLK-QLKYLRLNNNSLS----GLIPTSLTTITSLNILDLSNNRLS 167
               +   L     +++ L L N  L+    G++ ++L T+ +L  L LS+N L 
Sbjct: 72  GVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 126

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 40.7 bits (96), Expect = 7e-04
 Identities = 26/134 (19%), Positives = 48/134 (35%), Gaps = 28/134 (20%)

Query: 62  RVLQSSSNL-FVYL----ISDLGNAALSGELAPELGQLKNLEL--------------LAL 102
             L++   L  ++L    + D G   L   L     +L+ L+L                L
Sbjct: 107 STLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVL 166

Query: 103 GNLIKLKSLDLYSNLFNGT----IPDTLANLK-QLKYLRLNNNSLS----GLIPTSLTTI 153
                 K L + +N  N      +   L +   QL+ L+L +  ++      +   + + 
Sbjct: 167 RAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASK 226

Query: 154 TSLNILDLSNNRLS 167
            SL  L L +N+L 
Sbjct: 227 ASLRELALGSNKLG 240

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 40.4 bits (95), Expect = 7e-04
 Identities = 36/157 (22%), Positives = 64/157 (40%), Gaps = 33/157 (21%)

Query: 288 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EVKII 337
           + +   +G G +G V        G  VA+K+L           FQ+         E++++
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--------PFQSELFAKRAYRELRLL 78

Query: 338 SMAVHRNLLRLY------GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKK 391
               H N++ L             T+  LV P+M  G+   +L + +     L     + 
Sbjct: 79  KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE----KLGEDRIQF 132

Query: 392 IALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 428
           +     +GL Y+H      IIHRD+K  N+ ++ED +
Sbjct: 133 LVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCE 166

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 40.7 bits (95), Expect = 8e-04
 Identities = 36/150 (24%), Positives = 57/150 (38%), Gaps = 34/150 (22%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKI---ISMAV-----HRN 344
           LG G F  V+    +   K VA+K +K             E+++   +  +         
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD--EIRLLKSVRNSDPNDPNREM 102

Query: 345 LLRLYG-----------FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA 393
           +++L              C       +V+  +  G    +   + S+   L  P  KKI 
Sbjct: 103 VVQLLDDFKISGVNGTHIC-------MVFEVL--GHHLLKWIIK-SNYQGLPLPCVKKII 152

Query: 394 LGSARGLSYLHEHCDPKIIHRDVKAANILL 423
               +GL YLH  C  +IIH D+K  NILL
Sbjct: 153 QQVLQGLDYLHTKC--RIIHTDIKPENILL 180

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	438
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	99.98
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.98
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	99.97
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	99.97
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.97
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.97
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	99.97
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.97
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.97
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.97
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.97
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.97
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.96
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.96
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.95
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.95
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.94
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.94
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.93
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.93
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.93
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.93
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.93
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.93
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.93
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.93
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.93
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.93
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.93
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.93
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.93
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.93
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.93
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.93
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.93
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.93
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.93
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.93
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.93
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.93
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.93
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.92
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.92
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.92
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.92
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.92
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.92
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.92
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.92
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.92
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.92
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.92
3niz_A	311	Rhodanese family protein; structural genomics, str	99.92
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.92
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.92
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.92
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.92
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.92
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.92
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.92
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.92
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.92
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.92
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.92
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.92
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.92
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.92
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.92
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.92
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.92
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.92
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.92
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.92
3uqc_A	286	Probable conserved transmembrane protein; structur	99.92
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.92
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.92
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.92
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.92
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.92
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.92
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.92
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.92
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.91
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.91
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.91
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.91
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.91
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.91
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.91
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.91
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.91
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.91
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.91
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.91
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.91
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.91
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.91
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.91
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.91
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.91
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.91
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.91
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.91
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.91
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.91
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.91
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.91
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.91
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.91
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.91
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.91
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.91
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.91
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.91
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.91
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.91
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.91
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.91
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.91
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.91
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.91
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.91
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.91
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.91
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.91
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.91
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.91
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.91
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.91
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.91
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.91
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.91
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.91
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.91
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.91
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.91
3bhy_A	283	Death-associated protein kinase 3; death associate	99.91
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.91
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.91
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.91
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.9
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.9
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.9
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.9
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.9
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.9
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.9
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.9
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.9
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.9
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.9
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.9
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.9
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.9
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.9
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.9
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.9
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.9
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.9
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.9
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.9
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.9
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.9
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.9
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.9
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.9
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.9
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.9
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.9
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.9
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.9
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.9
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.9
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.9
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.9
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.9
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.9
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.9
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.9
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.9
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.9
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.9
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.9
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.9
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.9
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.9
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.9
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.9
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.9
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.9
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.9
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.9
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.9
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.89
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.89
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.89
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.89
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.89
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.89
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.89
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.89
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.89
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.89
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.89
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.89
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.89
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.89
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.89
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.89
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.89
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.89
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.89
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.89
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.89
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.88
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.88
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.88
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.88
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.88
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.88
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.88
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.88
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.88
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.88
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.88
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.88
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.88
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.88
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.88
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.87
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.87
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.87
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.87
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.87
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.87
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.87
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.87
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.87
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.86
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.86
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.86
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.86
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.86
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.85
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.85
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.85
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.85
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.83
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.83
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.8
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.77
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.77
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.71
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.7
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.67
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.66
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.64
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.62
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.59
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.57
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.57
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.57
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.54
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.54
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.53
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.53
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.53
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.53
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.52
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.52
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.52
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.48
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.48
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.47
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.46
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.46
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.46
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.45
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.45
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.44
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.44
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.44
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.44
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.43
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.43
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.43
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.43
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.43
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.43
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.42
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.42
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.42
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.41
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.41
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.41
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.41
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.41
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.41
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.41
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.4
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.39
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.39
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.39
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.38
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.38
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.38
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.38
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.37
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.36
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.36
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.36
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.36
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.35
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.35
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.35
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.35
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.35
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.35
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.34
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.34
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.34
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.33
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.33
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.33
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.33
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.33
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.32
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.32
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.31
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.31
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.31
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.31
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.31
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.31
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.3
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.3
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.29
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.29
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.29
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.29
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.28
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.28
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.28
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.27
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.26
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.26
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.26
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.26
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.25
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.24
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.24
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.24
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.24
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.23
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.23
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.23
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.22
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.22
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.21
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.21
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.21
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.2
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.18
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.18
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.17
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.16
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.15
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.14
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.14
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.13
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.12
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.11
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.1
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.09
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.07
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.04
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.02
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.01
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.01
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.01
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	98.97
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	98.96
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	98.96
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	98.95
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	98.94
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	98.92
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	98.86
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	98.79
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.58
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.47
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.44
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	98.43
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.37
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.26
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.23
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.22
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.15
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.14
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.12
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	98.12
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.1
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.1
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.97
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.97
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	97.9
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	97.88
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.83
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	97.79
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	97.78
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.78
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.78
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.67
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.26
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	97.02
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	96.92
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.67
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.66
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.61
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.49
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	96.37
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.34
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.31
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	95.9
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	95.78
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	95.75
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	95.45
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	95.38
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	94.43
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	94.28
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	93.49
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.82
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	90.43
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	90.31
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	89.92
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	88.89
3mes_A	424	Choline kinase; malaria, structural genomics, stru	88.71
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	85.43
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	83.18
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	80.11

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=7.2e-34  Score=274.85  Aligned_cols=146  Identities=25%  Similarity=0.405  Sum_probs=127.7

Q ss_pred             CCCCCCccccccceEEEEEEeC------CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      +++..+.||+|+||+||+|++.      +++.||||+++.........+|.+|+.++++++|||||+++|+|.+.+..++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            3455678999999999999873      3678999999765544555689999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC
Q 013682          361 VYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  428 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~  428 (438)
                      |||||++|+|.++|+....            ....++|.++..|+.|||+||+|||++   +||||||||+|||+|++++
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence            9999999999999975421            123589999999999999999999999   9999999999999999999


Q ss_pred             cchhhhh
Q 013682          429 QSSKTIL  435 (438)
Q Consensus       429 ~~l~Df~  435 (438)
                      +||+||+
T Consensus       184 ~Ki~DFG  190 (308)
T 4gt4_A          184 VKISDLG  190 (308)
T ss_dssp             EEECCSC
T ss_pred             EEECCcc
Confidence            9999997

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5.7e-34  Score=274.45  Aligned_cols=146  Identities=28%  Similarity=0.467  Sum_probs=126.9

Q ss_pred             CCCCCCCccccccceEEEEEEeC------CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  359 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  359 (438)
                      ++|...+.||+|+||+||+|++.      ++..||||+++.. ......+|.+|+.++++++|||||+++|+|.+.+..+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            45677789999999999999864      3678999999754 2333457999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcc
Q 013682          360 LVYPYMTNGSVASRLRERQ---------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  430 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~  430 (438)
                      +|||||++|+|.++++...         .....++|.++..++.|||+||+|||++   +||||||||+|||+|+++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence            9999999999999998642         2234699999999999999999999999   999999999999999999999


Q ss_pred             hhhhh
Q 013682          431 SKTIL  435 (438)
Q Consensus       431 l~Df~  435 (438)
                      |+||+
T Consensus       169 i~DFG  173 (299)
T 4asz_A          169 IGDFG  173 (299)
T ss_dssp             ECCCS
T ss_pred             ECCcc
Confidence            99997

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2e-33  Score=274.24  Aligned_cols=146  Identities=31%  Similarity=0.483  Sum_probs=128.3

Q ss_pred             CCCCCCCccccccceEEEEEEeC------CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  359 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  359 (438)
                      ++|...+.||+|+||+||+|++.      +++.||||+++.. ......+|.+|+.+|++++|||||+++|+|.+.+..+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            34566788999999999999874      3678999999753 2333457999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC
Q 013682          360 LVYPYMTNGSVASRLRERQS-----------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  428 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~  428 (438)
                      +|||||++|+|.++++....           ...+++|.+++.|+.|||+||+|||++   +||||||||+|||+|+++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence            99999999999999986432           123589999999999999999999998   9999999999999999999


Q ss_pred             cchhhhh
Q 013682          429 QSSKTIL  435 (438)
Q Consensus       429 ~~l~Df~  435 (438)
                      +||+||+
T Consensus       197 ~Ki~DFG  203 (329)
T 4aoj_A          197 VKIGDFG  203 (329)
T ss_dssp             EEECCCC
T ss_pred             EEEcccc
Confidence            9999997

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=99.98  E-value=1.3e-32  Score=269.34  Aligned_cols=145  Identities=21%  Similarity=0.316  Sum_probs=124.0

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      ++|+..+.||+|+||+||+|+.. +|+.||||+++..... .....+.+|+.+++.++|||||++++++.+.+..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            57888899999999999999874 6899999999654322 233479999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||++|+|.+++.....  ..+++.++..++.||+.||+|||++   +||||||||+|||+++++.+||+||+
T Consensus       104 y~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFG  170 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFG  170 (350)
T ss_dssp             CCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTT
T ss_pred             CCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccc
Confidence            9999999999976432  3478899999999999999999999   99999999999999999999999997

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=99.98  E-value=1.2e-32  Score=265.65  Aligned_cols=144  Identities=29%  Similarity=0.423  Sum_probs=125.7

Q ss_pred             HHhCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      +..+++...+.||+|+||+||+|++.+  .||||+++..... .....|.+|+.++++++|||||+++|+|.+ +..++|
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV  109 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV  109 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence            344677778899999999999999753  5999998754322 233579999999999999999999998864 568999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||||++|+|.++++...   ..++|.++..|+.|||.||+|||++   +||||||||+|||+|+++.+||+||+
T Consensus       110 mEy~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFG  177 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFG  177 (307)
T ss_dssp             EECCSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCS
T ss_pred             EEcCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeecc
Confidence            99999999999997643   2489999999999999999999998   99999999999999999999999997

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=99.97  E-value=1.8e-32  Score=264.20  Aligned_cols=143  Identities=26%  Similarity=0.337  Sum_probs=129.9

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccc--cccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|+..+.||+|+||+||+|+.. +++.||||+++...  .......+.+|+.+++.++|||||++++++.+.+..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46888899999999999999874 68999999996532  2233457899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++|+|.+++++..    .+++.++..++.|++.||+|||++   +|+||||||+|||+++++.+||+||+
T Consensus       112 Ey~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFG  177 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG  177 (311)
T ss_dssp             CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcC
Confidence            9999999999998753    489999999999999999999999   99999999999999999999999997

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=99.97  E-value=3.8e-32  Score=265.64  Aligned_cols=141  Identities=25%  Similarity=0.354  Sum_probs=128.2

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      +.|+..+.||+|+||+||+|+.. +|+.||||+++... ......+.+|+.+|+.++|||||++++++.+.+..|+||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            45777889999999999999975 69999999996543 23344689999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |++|+|.+++...     .+++.++..++.|++.||+|||++   +||||||||+|||+++++.+||+||+
T Consensus       153 ~~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFG  215 (346)
T 4fih_A          153 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFG  215 (346)
T ss_dssp             CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             CCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCc
Confidence            9999999999753     389999999999999999999999   99999999999999999999999997

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.97  E-value=4.5e-32  Score=262.21  Aligned_cols=141  Identities=28%  Similarity=0.389  Sum_probs=120.4

Q ss_pred             CCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCC----eeEEEE
Q 013682          287 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT----EKLLVY  362 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lv~  362 (438)
                      +|.+.+.||+|+||+||+|++ +|+.||||+++...  .....++.|+..+..++|||||+++|+|.+++    ..++||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            355668899999999999998 58899999986432  11223445666667889999999999998754    579999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH-----CDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |||++|+|.++++..     .++|.++.+++.|+|.||+|||++     +.++||||||||+|||+|+++++||+||+
T Consensus        81 Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG  153 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             cCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence            999999999999864     389999999999999999999986     35799999999999999999999999997

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.97  E-value=9.4e-32  Score=259.15  Aligned_cols=146  Identities=21%  Similarity=0.319  Sum_probs=124.2

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCC--------
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT--------  356 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--------  356 (438)
                      ++|+..+.||+|+||+||+|+.. +++.||||+++..........+.+|+.+++.++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            35788899999999999999974 689999999865433333457899999999999999999999987644        


Q ss_pred             ----eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchh
Q 013682          357 ----EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  432 (438)
Q Consensus       357 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~  432 (438)
                          ..|+||||+++|+|.+++.... .....++..+..++.|++.||+|||++   +||||||||+|||++.++.+||+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence                3689999999999999998653 223456778899999999999999999   99999999999999999999999


Q ss_pred             hhh
Q 013682          433 TIL  435 (438)
Q Consensus       433 Df~  435 (438)
                      ||+
T Consensus       161 DFG  163 (299)
T 4g31_A          161 DFG  163 (299)
T ss_dssp             CCC
T ss_pred             cCc
Confidence            997

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=99.97  E-value=2.1e-31  Score=266.79  Aligned_cols=141  Identities=25%  Similarity=0.354  Sum_probs=128.6

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      +.|+..+.||+|+||+||+|+.. +|+.||||+++... ......+.+|+.+|+.++|||||++++++.+.+..|+||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT-CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            45888899999999999999975 68999999996543 23344689999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |++|+|.++++..     .+++.++..++.||+.||+|||++   +||||||||+|||++.++.+||+||+
T Consensus       230 ~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFG  292 (423)
T 4fie_A          230 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFG  292 (423)
T ss_dssp             CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCT
T ss_pred             CCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCc
Confidence            9999999999754     389999999999999999999999   99999999999999999999999997

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.97  E-value=2.1e-31  Score=254.99  Aligned_cols=142  Identities=25%  Similarity=0.390  Sum_probs=121.8

Q ss_pred             CCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEee----CCeeEEEE
Q 013682          289 SNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT----VTEKLLVY  362 (438)
Q Consensus       289 ~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~  362 (438)
                      +..+.||+|+||+||+|++. +++.||+|.+...... .....|.+|+.+++.++|||||++++++.+    .+..++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            34567999999999999975 6889999998654322 223469999999999999999999999865    34579999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC-CCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~-~~~~~l~Df~  435 (438)
                      |||++|+|.+++++..    .+++..+..++.||+.||+|||++ .++||||||||+|||+++ ++.+||+||+
T Consensus       109 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFG  177 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTT
T ss_pred             eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCc
Confidence            9999999999998653    489999999999999999999998 234999999999999985 7999999997

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.97  E-value=2.4e-31  Score=252.61  Aligned_cols=142  Identities=24%  Similarity=0.408  Sum_probs=123.7

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|+..+.||+|+||+||+|+.. +++.||||+++....  ......+.+|+.+++.++|||||++++++.+.+..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            67999999999999999999874 689999999865432  223457999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+ +|+|.+++.+..    .+++.++..++.|++.||+|||++   +|+||||||+|||+++++.+||+||+
T Consensus        93 Ey~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFG  157 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFG  157 (275)
T ss_dssp             ECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSS
T ss_pred             eCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecC
Confidence            999 689999997653    489999999999999999999999   99999999999999999999999997

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.97  E-value=1.9e-31  Score=259.88  Aligned_cols=137  Identities=24%  Similarity=0.288  Sum_probs=123.7

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      +.|...+.||+|+||+||+|+.. +|+.||||+++...      ...+|+.+++.++|||||++++++.+.+..|+||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~------~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV------FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT------CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH------hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            45666788999999999999974 68999999996432      235799999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC-Ccchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~-~~~l~Df~  435 (438)
                      |++|+|.++++...    .+++.++..++.|++.||+|||++   +||||||||+|||++.++ .+||+||+
T Consensus       132 ~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFG  196 (336)
T 4g3f_A          132 LEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFG  196 (336)
T ss_dssp             CTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCT
T ss_pred             cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCC
Confidence            99999999998753    489999999999999999999999   999999999999999998 59999997

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.97  E-value=5.9e-32  Score=266.09  Aligned_cols=157  Identities=27%  Similarity=0.364  Sum_probs=133.9

Q ss_pred             cHHHHHHHhCCCCCCCccccccceEEEEEEeCC------CCEEEEEEccccccccchHHHHHHHHHHhcCCC-CCceeeE
Q 013682          277 SLRELQVATDGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVH-RNLLRLY  349 (438)
Q Consensus       277 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~------~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~  349 (438)
                      ...++++..++|+..+.||+|+||+||+|++..      ++.||||.++..........|.+|+.++..++| ||||+++
T Consensus        55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            345566777889999999999999999998632      357999999765444445579999999999965 8999999


Q ss_pred             EEEeeC-CeeEEEEecCCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCC
Q 013682          350 GFCTTV-TEKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV  416 (438)
Q Consensus       350 g~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDL  416 (438)
                      |+|.++ +..++|||||++|+|.++|+....            ....++|.++..++.|||+||+|||++   +||||||
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDL  211 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL  211 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCcc
Confidence            999765 568999999999999999986422            123589999999999999999999999   9999999


Q ss_pred             CCCCeeeCCCCCcchhhhhh
Q 013682          417 KAANILLDEDADQSSKTILR  436 (438)
Q Consensus       417 K~~NILld~~~~~~l~Df~~  436 (438)
                      ||+|||+++++.+||+||+=
T Consensus       212 K~~NILl~~~~~vKi~DFGl  231 (353)
T 4ase_A          212 AARNILLSEKNVVKICDFGL  231 (353)
T ss_dssp             SGGGEEECGGGCEEECCCGG
T ss_pred             CccceeeCCCCCEEECcchh
Confidence            99999999999999999973

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.97  E-value=5.6e-32  Score=260.42  Aligned_cols=143  Identities=27%  Similarity=0.317  Sum_probs=122.8

Q ss_pred             CCCCCCCccccccceEEEEEEeC----CCCEEEEEEcccccc-ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~----~~~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      ++|+..+.||+|+||+||+|+..    +++.||||+++.... ......+.+|+.+++.++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            46888899999999999999852    467999999965432 2223368899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |||||++|+|.+++++..    .+++.++..++.|++.||+|||++   +|+||||||+|||+++++.+||+||+
T Consensus       104 vmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFG  171 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFG  171 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSE
T ss_pred             EEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccc
Confidence            999999999999998753    489999999999999999999999   99999999999999999999999997

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.96  E-value=2.5e-29  Score=244.73  Aligned_cols=176  Identities=80%  Similarity=1.230  Sum_probs=150.1

Q ss_pred             CCCCchhhhcCccccccHHHHHHHhCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcC
Q 013682          261 PAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMA  340 (438)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l  340 (438)
                      +.+.++....++.+.++..++....++|+..+.||+|+||.||+|+..+++.||||+++..........+.+|+.+++.+
T Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l   84 (326)
T 3uim_A            5 PAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMA   84 (326)
T ss_dssp             ----------CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTC
T ss_pred             CcccCcccccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhc
Confidence            34444555567778899999999999999999999999999999998789999999997655444444799999999999


Q ss_pred             CCCCceeeEEEEeeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCC
Q 013682          341 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN  420 (438)
Q Consensus       341 ~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~N  420 (438)
                      +||||+++++++...+..++||||+++|+|.++++........++|..+..++.|++.||+|||+++.++|+||||||+|
T Consensus        85 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~N  164 (326)
T 3uim_A           85 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAAN  164 (326)
T ss_dssp             CCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGG
T ss_pred             cCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhh
Confidence            99999999999999999999999999999999998876555679999999999999999999999888899999999999


Q ss_pred             eeeCCCCCcchhhhhh
Q 013682          421 ILLDEDADQSSKTILR  436 (438)
Q Consensus       421 ILld~~~~~~l~Df~~  436 (438)
                      ||+++++.++|+||.-
T Consensus       165 il~~~~~~~kl~Dfg~  180 (326)
T 3uim_A          165 ILLDEEFEAVVGDFGL  180 (326)
T ss_dssp             EEECTTCCEEECCCSS
T ss_pred             EEECCCCCEEeccCcc
Confidence            9999999999999974

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.96  E-value=4.7e-29  Score=249.40  Aligned_cols=142  Identities=23%  Similarity=0.395  Sum_probs=124.5

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc-chHHHHHHHHHHhcCCCCCceeeEEEEeeC------Ce
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTV------TE  357 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~  357 (438)
                      ++|+..+.||+|+||+||+|+.. +|+.||||+++...... ....+.+|+.+|+.++|||||++++++...      +.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            56888899999999999999874 69999999996543222 234688999999999999999999987643      56


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      .|+|||||+ |+|.+++....    .+++.++..++.|++.||+|||++   +||||||||+|||++.++.+|++||+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~----~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFG  203 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ----PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFG  203 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEeCCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecc
Confidence            899999996 78999997643    489999999999999999999999   99999999999999999999999997

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.95  E-value=2.5e-28  Score=255.60  Aligned_cols=144  Identities=28%  Similarity=0.370  Sum_probs=125.7

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHH---HHHHHHhcCCCCCceeeEEEEeeCCee
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQ---TEVKIISMAVHRNLLRLYGFCTTVTEK  358 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~---~E~~~l~~l~H~niv~l~g~~~~~~~~  358 (438)
                      .++|+..++||+|+||+||+|+.. +|+.||||+++....  ........   +++.+++.++|||||++++++.+.+..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            467999999999999999999975 689999999964321  12222233   345677788999999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+||||++||+|.+++....    .+++..+..++.||+.||+|||++   +||||||||+|||+|.+|.+||+||+
T Consensus       268 ylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFG  337 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLG  337 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccc
Confidence            99999999999999998753    489999999999999999999999   99999999999999999999999997

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.95  E-value=2.6e-28  Score=241.20  Aligned_cols=139  Identities=20%  Similarity=0.345  Sum_probs=124.3

Q ss_pred             HhCCCCCCCccccccceEEEEEEeC----CCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEeeCCee
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEK  358 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~----~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  358 (438)
                      ..+.|+..+.||+|+||+||+|+.+    +++.||+|.+...   ....++.+|+.++..+ +|||||++++++.+.+..
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~---~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT---SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT---SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc---cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            4578999999999999999999752    4678999988543   2344688999999988 699999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC-CCcchhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTIL  435 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~-~~~~l~Df~  435 (438)
                      ++||||+++|+|.++++       .+++.++..++.|++.||+|||++   +|+||||||+|||++.+ +.+||+||+
T Consensus        96 ~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFG  163 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFG  163 (361)
T ss_dssp             EEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence            99999999999999984       278999999999999999999999   99999999999999987 789999997

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.94  E-value=1.9e-27  Score=248.76  Aligned_cols=144  Identities=19%  Similarity=0.326  Sum_probs=128.0

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .++|+..+.||+|+||+||+|+.. +|+.||+|.++.... .....+.+|+.+|+.++|||||++++++.+.+..++|||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E  234 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  234 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch-hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            357888999999999999999874 689999999865322 223468899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC--CCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED--ADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~--~~~~l~Df~  435 (438)
                      ||++|+|.+++.+...   .+++.++..++.||+.||+|||++   +|+||||||+|||++.+  +.+||+||+
T Consensus       235 ~~~gg~L~~~i~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG  302 (573)
T 3uto_A          235 FMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG  302 (573)
T ss_dssp             CCCCCBHHHHHTCTTS---CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred             ecCCCcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeecc
Confidence            9999999999975432   489999999999999999999999   99999999999999865  789999997

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.94  E-value=4.3e-27  Score=228.61  Aligned_cols=153  Identities=43%  Similarity=0.710  Sum_probs=136.3

Q ss_pred             HHHHHhCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeE
Q 013682          280 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  359 (438)
Q Consensus       280 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  359 (438)
                      ++...+++|+..+.||+|+||.||+|++.+++.||||++.... ......+.+|+.+++.++||||+++++++...+..+
T Consensus        33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  111 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI  111 (321)
T ss_dssp             CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred             HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            3345678899999999999999999998889999999986542 233457899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      +||||+++|+|.+++.........++|.++..++.|++.||+|||++   +|+||||||+||++++++.++++||.-
T Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence            99999999999999976544444689999999999999999999999   999999999999999999999999973

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.93  E-value=2.3e-26  Score=223.55  Aligned_cols=148  Identities=21%  Similarity=0.308  Sum_probs=127.3

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCC-------
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-------  356 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-------  356 (438)
                      .++|+..+.||+|+||.||+|+.. +++.||||+++..........+.+|+.+++.++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            346778899999999999999985 789999999975444444557999999999999999999999986543       


Q ss_pred             --------------------------------------------------eeEEEEecCCCCCHHHHhhccCCCCCCCCH
Q 013682          357 --------------------------------------------------EKLLVYPYMTNGSVASRLRERQSSLPPLDW  386 (438)
Q Consensus       357 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~  386 (438)
                                                                        ..++||||+++|+|.+++..... ....++
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~  163 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH  163 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence                                                              27899999999999999987532 334677


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          387 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       387 ~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+||+-
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~  210 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGL  210 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCc
Confidence            78999999999999999999   999999999999999999999999974

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.93  E-value=1.1e-26  Score=235.28  Aligned_cols=152  Identities=20%  Similarity=0.280  Sum_probs=133.7

Q ss_pred             HHHHHHHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEee
Q 013682          278 LRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTT  354 (438)
Q Consensus       278 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~  354 (438)
                      +.+.....++|+..+.||+|+||+||+|+.. +++.||+|+++....  ......+.+|+.++..++||||++++++|.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            4455566789999999999999999999986 478999999865321  2222358999999999999999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhh
Q 013682          355 VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  434 (438)
Q Consensus       355 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df  434 (438)
                      .+..++||||+++|+|.++++...   ..+++..+..++.|++.||+|||+.   +|+||||||+|||+|.++.++|+||
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence            999999999999999999997632   2489999999999999999999999   9999999999999999999999999


Q ss_pred             h
Q 013682          435 L  435 (438)
Q Consensus       435 ~  435 (438)
                      +
T Consensus       220 G  220 (437)
T 4aw2_A          220 G  220 (437)
T ss_dssp             T
T ss_pred             h
Confidence            7

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.93  E-value=2e-26  Score=229.11  Aligned_cols=146  Identities=31%  Similarity=0.428  Sum_probs=128.3

Q ss_pred             hCCCCCCCccccccceEEEEEEeC----CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~----~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      .++|+..+.||+|+||.||+|+..    ++..||||.++..........|.+|+.+++.++||||+++++++...+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357888999999999999999864    4678999999765433344579999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||||+++|+|.++++...   ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||.-
T Consensus       124 v~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~  193 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGL  193 (373)
T ss_dssp             EEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred             EEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcc
Confidence            999999999999997643   2489999999999999999999999   999999999999999999999999963

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.93  E-value=2e-26  Score=228.86  Aligned_cols=148  Identities=28%  Similarity=0.441  Sum_probs=129.3

Q ss_pred             hCCCCCCCccccccceEEEEEEeC--------CCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEeeC
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA--------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  355 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~--------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  355 (438)
                      .++|...+.||+|+||.||+|++.        ++..||||.++..........+.+|+.++..+ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            456778899999999999999852        34579999997654333445789999999999 899999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee
Q 013682          356 TEKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  423 (438)
Q Consensus       356 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILl  423 (438)
                      +..++||||+++|+|.++++....            ....+++.++..++.|++.||+|||++   +|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence            999999999999999999987532            123479999999999999999999999   99999999999999


Q ss_pred             CCCCCcchhhhh
Q 013682          424 DEDADQSSKTIL  435 (438)
Q Consensus       424 d~~~~~~l~Df~  435 (438)
                      +.++.++|+||+
T Consensus       237 ~~~~~~kl~DFG  248 (370)
T 2psq_A          237 TENNVMKIADFG  248 (370)
T ss_dssp             CTTCCEEECCCS
T ss_pred             CCCCCEEEcccc
Confidence            999999999996

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.93  E-value=3.3e-26  Score=223.58  Aligned_cols=144  Identities=24%  Similarity=0.388  Sum_probs=129.4

Q ss_pred             hCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      .++|...+.||+|+||.||+|+. .+++.||||+++..... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            45788889999999999999997 57899999998654322 22346889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++|+|.+++....    .+++.++..++.|++.||+|||++   +|+||||||+|||++.+++++|+||+
T Consensus        94 e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG  159 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFG  159 (328)
T ss_dssp             CCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTT
T ss_pred             ECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeecc
Confidence            9999999999997653    389999999999999999999999   99999999999999999999999997

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.93  E-value=1.3e-26  Score=230.65  Aligned_cols=146  Identities=30%  Similarity=0.447  Sum_probs=129.8

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .++|...+.||+|+||.||+|++. +++.||||.++..........|.+|+.+++.++||||+++++++...+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            456777889999999999999985 6889999998754333333468899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |+++|+|.++++....   .+++.++..++.|++.||+|||++   +|+||||||+|||+++++.++|+||+-
T Consensus       193 ~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~  259 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGM  259 (377)
T ss_dssp             CCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             cCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCC
Confidence            9999999999986432   478999999999999999999999   999999999999999999999999973

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.93  E-value=2.7e-26  Score=223.78  Aligned_cols=145  Identities=29%  Similarity=0.394  Sum_probs=128.4

Q ss_pred             CCCCCCCccccccceEEEEEEeC----CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~----~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      ++|...+.||+|+||.||+|++.    .+..||||.++..........+.+|+.+++.++||||+++++++...+..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            45777789999999999999974    34469999997654444455799999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |||+++|+|.++++...   ..+++.++..++.|++.||+|||+.   +|+||||||+|||+++++.++|+||.-
T Consensus       129 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~  197 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGL  197 (325)
T ss_dssp             EECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred             eeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCc
Confidence            99999999999997543   2489999999999999999999999   999999999999999999999999973

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.93  E-value=1.2e-25  Score=216.28  Aligned_cols=142  Identities=22%  Similarity=0.351  Sum_probs=128.9

Q ss_pred             hCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .++|+..+.||+|+||.||+|+. .+++.||||.+.... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc-ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            45788999999999999999986 468999999986543 2334568999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+++|+|.+++...     .+++.++..++.|++.||+|||++   +|+||||||+|||++.++.++|+||.
T Consensus        98 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg  161 (297)
T 3fxz_A           98 YLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG  161 (297)
T ss_dssp             CCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             CCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCC
Confidence            99999999999764     388999999999999999999999   99999999999999999999999997

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.93  E-value=6.9e-26  Score=218.89  Aligned_cols=144  Identities=25%  Similarity=0.432  Sum_probs=128.6

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      ++|...+.||+|+||.||+|+.. +++.||+|.+... .......+.+|+.++..++||||+++++++.+.+..++||||
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            45777889999999999999975 6889999988543 223345799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      +++|+|.++++....   .++|.++..++.|++.||+|||+.   +|+||||||+|||+++++.++|+||.-
T Consensus        89 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~  154 (310)
T 3s95_A           89 IKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGL  154 (310)
T ss_dssp             CTTCBHHHHHHHCCT---TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTT
T ss_pred             cCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeeccc
Confidence            999999999987432   489999999999999999999999   999999999999999999999999974

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.93  E-value=2.2e-26  Score=231.44  Aligned_cols=150  Identities=23%  Similarity=0.308  Sum_probs=132.1

Q ss_pred             HHHHHHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccc--cccchHHHHHHHHHHhcCCCCCceeeEEEEeeC
Q 013682          279 RELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV  355 (438)
Q Consensus       279 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  355 (438)
                      .++....++|...+.||+|+||+||+|+.. +++.||+|+++...  .......+.+|+.++..++|||||++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            344556678999999999999999999975 58899999986532  122233588999999999999999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          356 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       356 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +..++||||+++|+|.++++..     .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+||+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG  213 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG  213 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccc
Confidence            9999999999999999999764     378999999999999999999999   99999999999999999999999997


Q ss_pred             h
Q 013682          436 R  436 (438)
Q Consensus       436 ~  436 (438)
                      -
T Consensus       214 ~  214 (410)
T 3v8s_A          214 T  214 (410)
T ss_dssp             T
T ss_pred             e
Confidence            3

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.93  E-value=5.4e-26  Score=222.88  Aligned_cols=144  Identities=24%  Similarity=0.326  Sum_probs=129.2

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccc--cccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      .++|+..+.||+|+||+||+|+.. +++.||+|+++...  .......+.+|+.++..++||||+++++++...+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            356788899999999999999875 68999999996542  233445688999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |||+++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+||+
T Consensus        84 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG  150 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFG  150 (337)
T ss_dssp             EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeecc
Confidence            99999999999997653    389999999999999999999999   99999999999999999999999996

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.93  E-value=2.5e-26  Score=224.80  Aligned_cols=151  Identities=29%  Similarity=0.472  Sum_probs=132.1

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEeC------CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeC
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV  355 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  355 (438)
                      ....++|...+.||+|+||.||+|+..      +++.||||.++..........+.+|+.+++.++||||+++++++...
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            345678888999999999999999874      34789999997654333345799999999999999999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecC
Q 013682          356 TEKLLVYPYMTNGSVASRLRERQSS--------------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRD  415 (438)
Q Consensus       356 ~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD  415 (438)
                      +..++||||+++|+|.++++.....                    ...+++.++..++.|++.||+|||++   +|+|||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~D  199 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRD  199 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            9999999999999999999874321                    14689999999999999999999999   999999


Q ss_pred             CCCCCeeeCCCCCcchhhhh
Q 013682          416 VKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       416 LK~~NILld~~~~~~l~Df~  435 (438)
                      |||+|||+++++.++++||.
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg  219 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFG  219 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCS
T ss_pred             CCcceEEECCCCeEEEeecC
Confidence            99999999999999999996

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.93  E-value=2.4e-25  Score=214.57  Aligned_cols=159  Identities=42%  Similarity=0.692  Sum_probs=140.0

Q ss_pred             ccccccHHHHHHHhCCCCCC------CccccccceEEEEEEeCCCCEEEEEEcccccc---ccchHHHHHHHHHHhcCCC
Q 013682          272 QLKRFSLRELQVATDGFSNK------NILGRGGFGKVYKGRLADGKLVAVKRLKEERT---SGGELQFQTEVKIISMAVH  342 (438)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~------~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~---~~~~~~~~~E~~~l~~l~H  342 (438)
                      ....+++.++..++++|...      +.||+|+||.||+|+. +++.||||.+.....   ......+.+|+.+++.++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            34578899999999998877      8899999999999987 578999999865321   1223468999999999999


Q ss_pred             CCceeeEEEEeeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCee
Q 013682          343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL  422 (438)
Q Consensus       343 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NIL  422 (438)
                      |||+++++++...+..+++|||+++|+|.+++..... ...++|..+..++.|++.||+|||++   +|+||||||+||+
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil  165 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL  165 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence            9999999999999999999999999999999975422 23589999999999999999999999   9999999999999


Q ss_pred             eCCCCCcchhhhh
Q 013682          423 LDEDADQSSKTIL  435 (438)
Q Consensus       423 ld~~~~~~l~Df~  435 (438)
                      +++++.++++||.
T Consensus       166 i~~~~~~kl~Dfg  178 (307)
T 2nru_A          166 LDEAFTAKISDFG  178 (307)
T ss_dssp             ECTTCCEEECCCT
T ss_pred             EcCCCcEEEeecc
Confidence            9999999999997

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.93  E-value=2.5e-26  Score=231.10  Aligned_cols=154  Identities=21%  Similarity=0.271  Sum_probs=134.5

Q ss_pred             cHHHHHHHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEe
Q 013682          277 SLRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCT  353 (438)
Q Consensus       277 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~  353 (438)
                      .+++.....++|+..+.||+|+||+||+|+.. +++.||||+++....  ......+.+|..++..++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            34555566788999999999999999999975 689999999864321  122235889999999999999999999999


Q ss_pred             eCCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhh
Q 013682          354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKT  433 (438)
Q Consensus       354 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~D  433 (438)
                      +.+..++||||+++|+|.++++....   .+++..+..++.|++.||+|||++   +|+||||||+|||+|.++.++|+|
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D  205 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKFGE---RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD  205 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence            99999999999999999999986432   489999999999999999999999   999999999999999999999999


Q ss_pred             hhh
Q 013682          434 ILR  436 (438)
Q Consensus       434 f~~  436 (438)
                      |+-
T Consensus       206 FGl  208 (412)
T 2vd5_A          206 FGS  208 (412)
T ss_dssp             CTT
T ss_pred             chh
Confidence            973

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.93  E-value=6.1e-26  Score=223.92  Aligned_cols=146  Identities=29%  Similarity=0.417  Sum_probs=128.3

Q ss_pred             HHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccc--cccchHHHHHHHHHHhcC-CCCCceeeEEEEeeCCee
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEK  358 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  358 (438)
                      ...++|+..+.||+|+||+||+|+.. +++.||||+++...  .......+.+|..++..+ +||||+++++++.+.+..
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            44678999999999999999999975 58999999986542  223344678899999887 799999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++||||+++|+|.+++....    .+++.++..++.|++.||+|||++   +|+||||||+|||++.++.++|+||+
T Consensus       100 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG  169 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFG  169 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccc
Confidence            99999999999999998753    389999999999999999999999   99999999999999999999999997

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.93  E-value=4.4e-26  Score=222.13  Aligned_cols=145  Identities=25%  Similarity=0.368  Sum_probs=126.9

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .++|+..+.||+|+||.||+|+.. +++.||||+++..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            357888899999999999999875 6899999998654433334568999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |+++|+|.+++....    .+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||.-
T Consensus        86 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~  151 (323)
T 3tki_A           86 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL  151 (323)
T ss_dssp             CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeec
Confidence            999999999886542    489999999999999999999999   999999999999999999999999973

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.93  E-value=1.6e-25  Score=217.97  Aligned_cols=152  Identities=22%  Similarity=0.296  Sum_probs=132.3

Q ss_pred             cccHHHHHHHhCC----------CCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCC
Q 013682          275 RFSLRELQVATDG----------FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR  343 (438)
Q Consensus       275 ~~~~~~~~~~~~~----------~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~  343 (438)
                      .++.+++..+++.          |+..+.||+|+||.||+|+.. +|+.||||+++... ......+.+|+.+++.++||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCCT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCC
Confidence            4556666655543          455578999999999999975 69999999986543 33445789999999999999


Q ss_pred             CceeeEEEEeeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee
Q 013682          344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  423 (438)
Q Consensus       344 niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILl  423 (438)
                      ||+++++++...+..++||||+++|+|.+++...     .+++..+..++.|++.||+|||+.   +|+||||||+|||+
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll  174 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL  174 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEE
Confidence            9999999999999999999999999999998643     489999999999999999999999   99999999999999


Q ss_pred             CCCCCcchhhhh
Q 013682          424 DEDADQSSKTIL  435 (438)
Q Consensus       424 d~~~~~~l~Df~  435 (438)
                      +.++.++++||.
T Consensus       175 ~~~~~~kl~Dfg  186 (321)
T 2c30_A          175 TLDGRVKLSDFG  186 (321)
T ss_dssp             CTTCCEEECCCT
T ss_pred             CCCCcEEEeeee
Confidence            999999999997

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.93  E-value=1.1e-25  Score=218.85  Aligned_cols=145  Identities=29%  Similarity=0.406  Sum_probs=129.1

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      .++|+..+.||+|+||+||+|+.. +++.||+|+++....  ......+.+|+.+++.++||||+++++++.+....++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            356788899999999999999975 689999999865421  23344688999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |||+++|+|.++++...    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+||.-
T Consensus        85 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~  152 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGF  152 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             EeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCc
Confidence            99999999999998643    389999999999999999999999   999999999999999999999999963

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.93  E-value=5.5e-26  Score=225.40  Aligned_cols=149  Identities=31%  Similarity=0.401  Sum_probs=129.0

Q ss_pred             hCCCCCCCccccccceEEEEEEeC------CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCee
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  358 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  358 (438)
                      .++|...+.||+|+||.||+|++.      +++.||||+++..........+.+|+.+++.++|||||++++++......
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            456777899999999999999853      35689999997654444455789999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC---Ccchh
Q 013682          359 LLVYPYMTNGSVASRLRERQS---SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSK  432 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~---~~~l~  432 (438)
                      ++||||+++|+|.++++....   ....+++.++..++.|++.||+|||++   +|+||||||+|||++.++   .++|+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence            999999999999999987542   223589999999999999999999999   999999999999999655   49999


Q ss_pred             hhhh
Q 013682          433 TILR  436 (438)
Q Consensus       433 Df~~  436 (438)
                      ||+-
T Consensus       227 DFG~  230 (367)
T 3l9p_A          227 DFGM  230 (367)
T ss_dssp             CCHH
T ss_pred             CCcc
Confidence            9963

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.93  E-value=1.3e-25  Score=212.31  Aligned_cols=144  Identities=27%  Similarity=0.422  Sum_probs=129.5

Q ss_pred             hCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      .++|+..+.||+|+||.||+|++.+++.||+|+++...  ....++.+|+.++..++||||+++++++.+.+..++||||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   86 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc--cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence            35677788999999999999999888899999997543  2345799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      +++|+|.+++....   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++||.-
T Consensus        87 ~~~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~  152 (269)
T 4hcu_A           87 MEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGM  152 (269)
T ss_dssp             CTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTG
T ss_pred             CCCCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccc
Confidence            99999999997643   2489999999999999999999999   999999999999999999999999963

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.93  E-value=9.2e-26  Score=221.94  Aligned_cols=147  Identities=25%  Similarity=0.410  Sum_probs=128.7

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccc--cccchHHHHHHHHHHhcC-CCCCceeeEEEEeeCCe
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTE  357 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  357 (438)
                      ....++|...+.||+|+||.||+|+.. +++.||+|+++...  .......+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            455678999999999999999999975 68899999996542  123344678888888866 89999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      .++||||+++|+|.++++...    .+++.++..++.|++.||+|||++   +|+||||||+|||++.++.++|+||+
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG  163 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFG  163 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeECh
Confidence            999999999999999998643    389999999999999999999999   99999999999999999999999997

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.93  E-value=1.8e-25  Score=214.77  Aligned_cols=145  Identities=22%  Similarity=0.287  Sum_probs=128.7

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc--chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      .++|+..+.||+|+||.||+|+.. +++.||+|.+.......  ....+.+|+..+..++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            356788899999999999999864 68899999985433222  234689999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |||+++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++++||.-
T Consensus        90 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~  157 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGI  157 (294)
T ss_dssp             EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSS
T ss_pred             EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCC
Confidence            99999999999997653    489999999999999999999999   999999999999999999999999963

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.92  E-value=2.7e-26  Score=226.14  Aligned_cols=157  Identities=28%  Similarity=0.380  Sum_probs=133.3

Q ss_pred             cHHHHHHHhCCCCCCCccccccceEEEEEEe------CCCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeE
Q 013682          277 SLRELQVATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLY  349 (438)
Q Consensus       277 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~------~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~  349 (438)
                      ...++....++|...+.||+|+||.||+|++      .+++.||||+++..........+.+|+.++..+ +||||++++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            3445566778899999999999999999974      245789999997654333445799999999999 799999999


Q ss_pred             EEEeeCCe-eEEEEecCCCCCHHHHhhccCCC------------------------------------------------
Q 013682          350 GFCTTVTE-KLLVYPYMTNGSVASRLRERQSS------------------------------------------------  380 (438)
Q Consensus       350 g~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------  380 (438)
                      +++...+. .++||||+++|+|.++++.....                                                
T Consensus        93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (359)
T 3vhe_A           93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS  172 (359)
T ss_dssp             EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred             eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence            99987654 89999999999999999865321                                                


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          381 --------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       381 --------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                                    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+||.-
T Consensus       173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~  239 (359)
T 3vhe_A          173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGL  239 (359)
T ss_dssp             -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGG
T ss_pred             cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccc
Confidence                          11288999999999999999999999   999999999999999999999999974

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.92  E-value=1.3e-25  Score=224.73  Aligned_cols=146  Identities=25%  Similarity=0.343  Sum_probs=127.7

Q ss_pred             HhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc--chHHHHHHHHHHhcC-CCCCceeeEEEEeeCCeeE
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKL  359 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  359 (438)
                      ..++|+..+.||+|+||+||+|+.. +++.||+|+++......  ....+.+|..++..+ +|||||++++++.+.+..+
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            3457888899999999999999975 57899999997543222  223578899888776 8999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      +||||+++|+|..++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+||+-
T Consensus       130 lV~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGl  199 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGM  199 (396)
T ss_dssp             EEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecce
Confidence            9999999999999998653    389999999999999999999999   999999999999999999999999973

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.92  E-value=1.9e-25  Score=219.65  Aligned_cols=144  Identities=26%  Similarity=0.351  Sum_probs=127.4

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc--chHHHHHHHHHHhcC-CCCCceeeEEEEeeCCeeEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv  361 (438)
                      ++|+..+.||+|+||.||+|+.. +++.||+|+++......  ....+.+|..++..+ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            46777899999999999999975 58899999997543222  223578899999887 899999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |||+++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+||+-
T Consensus        89 ~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~  156 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGM  156 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGG
T ss_pred             EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccc
Confidence            99999999999997653    389999999999999999999999   999999999999999999999999973

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.92  E-value=2.5e-25  Score=216.05  Aligned_cols=148  Identities=26%  Similarity=0.429  Sum_probs=116.3

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .++|+..+.||+|+||.||+|+.. +++.||+|.++..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            457888899999999999999874 6899999998755444444578899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          364 YMTNGSVASRLRERQ--SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |++ |+|.+++....  .....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||.-
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  154 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGL  154 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSS
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCcc
Confidence            998 69999887542  1123488999999999999999999999   999999999999999999999999963

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.92  E-value=3e-25  Score=219.56  Aligned_cols=145  Identities=24%  Similarity=0.319  Sum_probs=128.4

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc-----chHHHHHHHHHHhcCCCCCceeeEEEEeeCCee
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-----GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  358 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  358 (438)
                      .+.|...+.||+|+||.||+|+.. +++.||+|.++......     ....+.+|+.++..++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            456888899999999999999975 68999999986543221     235689999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC----Ccchhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA----DQSSKTI  434 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~----~~~l~Df  434 (438)
                      ++||||+++|+|.+++....    .+++.++..++.|++.||+|||++   +|+||||||+|||+++++    .++|+||
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            99999999999999997542    489999999999999999999999   999999999999999877    7899999


Q ss_pred             hh
Q 013682          435 LR  436 (438)
Q Consensus       435 ~~  436 (438)
                      +-
T Consensus       164 G~  165 (361)
T 2yab_A          164 GL  165 (361)
T ss_dssp             SS
T ss_pred             CC
Confidence            63

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.92  E-value=1.4e-25  Score=223.57  Aligned_cols=145  Identities=25%  Similarity=0.334  Sum_probs=129.3

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccc--cccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      .++|...+.||+|+||.||+|+.. +++.||+|.++...  .......+.+|+.++..++|||||++++++.+.+..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            356788899999999999999875 58899999986432  223345788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |||+.+|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||+-
T Consensus        94 ~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~  161 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNV----HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNI  161 (384)
T ss_dssp             ECCCTTEEHHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccce
Confidence            99999999999997643    489999999999999999999999   999999999999999999999999973

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.92  E-value=1.6e-25  Score=218.43  Aligned_cols=144  Identities=25%  Similarity=0.333  Sum_probs=122.9

Q ss_pred             hCCCCCCCccccccceEEEEEEe----CCCCEEEEEEcccccc---ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRL----ADGKLVAVKRLKEERT---SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  357 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~----~~~~~vAvK~l~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  357 (438)
                      .++|+..+.||+|+||.||+|+.    .+++.||+|+++....   ......+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            45688889999999999999986    3688999999975432   1223357889999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      .++||||+++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+||.
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg  166 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFG  166 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCS
T ss_pred             EEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCC
Confidence            999999999999999997653    378999999999999999999999   99999999999999999999999997

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.92  E-value=2.1e-25  Score=219.77  Aligned_cols=144  Identities=24%  Similarity=0.301  Sum_probs=129.1

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccc--cccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|+..+.||+|+||.||+|+.. +++.||+|+++...  .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            56788899999999999999975 68999999986532  2233456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||+++|+|.++++...    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+||.-
T Consensus       121 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~  187 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGF  187 (350)
T ss_dssp             ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEccccc
Confidence            9999999999998653    389999999999999999999999   999999999999999999999999973

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.92  E-value=2.3e-25  Score=210.48  Aligned_cols=144  Identities=28%  Similarity=0.417  Sum_probs=129.5

Q ss_pred             hCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      .++|+..+.||+|+||.||+|+..++..||+|.++...  ....++.+|+.++..++||||+++++++......++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT--BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC--CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            45677789999999999999999888899999996543  2345789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      +++++|.++++....   .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.++++||.-
T Consensus        85 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~  150 (268)
T 3sxs_A           85 ISNGCLLNYLRSHGK---GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGM  150 (268)
T ss_dssp             CTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTC
T ss_pred             cCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCcc
Confidence            999999999976432   489999999999999999999999   999999999999999999999999963

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.92  E-value=1.2e-25  Score=221.56  Aligned_cols=148  Identities=20%  Similarity=0.252  Sum_probs=127.7

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc----ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT----SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      +.|+..+.||+|+||.||+|+.. +++.||||+++....    ......+.+|+.++..++||||+++++++...+..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            45778899999999999999874 689999999854321    1134578999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC---cchhhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD---QSSKTILR  436 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~---~~l~Df~~  436 (438)
                      ||||+++|+|.+.+.........+++..+..++.|++.||+|||++   +|+||||||+|||++.+++   ++++||.-
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999988875433334589999999999999999999999   9999999999999987665   89999963

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.92  E-value=2.6e-25  Score=211.81  Aligned_cols=145  Identities=26%  Similarity=0.409  Sum_probs=127.2

Q ss_pred             HhCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      ..++|+..+.||+|+||.||+|++.++..||+|+++...  ....++.+|+.++..++||||+++++++...+..++|||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   99 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   99 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC--CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence            345677789999999999999999888899999997543  234578999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |+++|+|.+++.....   .+++.++..++.|++.||+|||++   +|+||||||+||++++++.++++||.-
T Consensus       100 ~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~  166 (283)
T 3gen_A          100 YMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGL  166 (283)
T ss_dssp             CCTTCBHHHHHHCGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTG
T ss_pred             ccCCCcHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccc
Confidence            9999999999976322   489999999999999999999999   999999999999999999999999964

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.92  E-value=2.4e-25  Score=215.57  Aligned_cols=145  Identities=24%  Similarity=0.407  Sum_probs=125.9

Q ss_pred             hCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccc-hHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .++|+..+.||+|+||.||+|+..+++.||+|+++....... ...+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            466888899999999999999998899999999875433322 3468899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |++ |+|.+.+....   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||.-
T Consensus       100 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~  165 (311)
T 3niz_A          100 FME-KDLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGL  165 (311)
T ss_dssp             CCS-EEHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CCC-CCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcC
Confidence            998 48888887543   2489999999999999999999999   999999999999999999999999973

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.92  E-value=5.3e-26  Score=220.13  Aligned_cols=149  Identities=28%  Similarity=0.407  Sum_probs=129.7

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEeCCCCEEEEEEcccccccc-chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      ....++|+..+.||+|+||.||+|+. +++.||||+++...... ....+.+|+.+++.++||||+++++++...+..++
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI  111 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred             cCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence            34456788889999999999999987 57899999986543222 23468899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeeeCCCCCcchhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK--IIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||||+++|+|.+++..... ...+++..+..++.|++.||+|||++   +  |+||||||+|||+++++.++|+||.
T Consensus       112 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg  184 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFG  184 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred             EEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCC
Confidence            9999999999999976421 12388999999999999999999998   7  9999999999999999999999996

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.92  E-value=1.7e-25  Score=223.01  Aligned_cols=149  Identities=29%  Similarity=0.403  Sum_probs=129.7

Q ss_pred             hCCCCCCCccccccceEEEEEEeC--------CCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEeeC
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA--------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  355 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~--------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  355 (438)
                      .++|...+.||+|+||.||+|+..        ++..||||+++..........+.+|+++++.+ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            456777899999999999999852        23579999997654444445789999999999 999999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee
Q 013682          356 TEKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  423 (438)
Q Consensus       356 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILl  423 (438)
                      +..++||||+++|+|.+++.....            ....+++.++..++.|++.||+|||+.   +|+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence            999999999999999999987542            123589999999999999999999999   99999999999999


Q ss_pred             CCCCCcchhhhhh
Q 013682          424 DEDADQSSKTILR  436 (438)
Q Consensus       424 d~~~~~~l~Df~~  436 (438)
                      ++++.++|+||.-
T Consensus       225 ~~~~~~kL~DFG~  237 (382)
T 3tt0_A          225 TEDNVMKIADFGL  237 (382)
T ss_dssp             CTTCCEEECSCSC
T ss_pred             cCCCcEEEcccCc
Confidence            9999999999963

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.92  E-value=2.9e-25  Score=212.35  Aligned_cols=144  Identities=24%  Similarity=0.426  Sum_probs=127.2

Q ss_pred             CCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      ++|+..+.||+|+||.||+|+..+++.||+|+++..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            467778999999999999999877999999998654322 2234688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      +++ +|.+++....   ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++++||.-
T Consensus        82 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~  146 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL  146 (288)
T ss_dssp             CSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             cCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECcc
Confidence            985 9999887643   2488999999999999999999999   999999999999999999999999973

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.92  E-value=1.3e-25  Score=216.92  Aligned_cols=150  Identities=30%  Similarity=0.424  Sum_probs=129.8

Q ss_pred             HhCCCCCCCccccccceEEEEEEe------CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCe
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  357 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~------~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  357 (438)
                      ..++|...+.||+|+||.||+|+.      .+++.||||.++..........+.+|+.+++.++||||+++++++...+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            345677789999999999999985      23578999999765433344578999999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCC
Q 013682          358 KLLVYPYMTNGSVASRLRERQS--------------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVK  417 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK  417 (438)
                      .++||||+++|+|.+++.....                    ....+++.++..++.|++.||+|||++   +|+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccc
Confidence            9999999999999999987532                    112478999999999999999999999   99999999


Q ss_pred             CCCeeeCCCCCcchhhhhh
Q 013682          418 AANILLDEDADQSSKTILR  436 (438)
Q Consensus       418 ~~NILld~~~~~~l~Df~~  436 (438)
                      |+||++++++.++++||.-
T Consensus       178 p~NIli~~~~~~kl~Dfg~  196 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGL  196 (314)
T ss_dssp             GGGEEEETTTEEEECCCTT
T ss_pred             hheEEEcCCCCEEEccccc
Confidence            9999999999999999963

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.92  E-value=3.4e-25  Score=215.01  Aligned_cols=147  Identities=22%  Similarity=0.313  Sum_probs=128.7

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCC--eeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT--EKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv~  362 (438)
                      ++|...+.||+|+||.||+|+.. +++.||||+++..........+.+|+.+++.++||||+++++++....  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            45777899999999999999975 589999999976554455567889999999999999999999988755  679999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee----CCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL----DEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILl----d~~~~~~l~Df~~  436 (438)
                      ||+++|+|.+++..... ...+++.++..++.|++.||+|||+.   +|+||||||+|||+    +.++.++|+||.-
T Consensus        89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             ECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             eCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            99999999999986532 22489999999999999999999999   99999999999999    7888899999963

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.92  E-value=4.8e-25  Score=220.07  Aligned_cols=147  Identities=22%  Similarity=0.298  Sum_probs=130.0

Q ss_pred             hCCCCCCCccccc--cceEEEEEEeC-CCCEEEEEEccccccccc-hHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          285 TDGFSNKNILGRG--GFGKVYKGRLA-DGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       285 ~~~~~~~~~LG~G--~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      .++|+..+.||+|  +||.||+|+.. +++.||||+++....... ...+.+|+.+++.++|||||++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            3467788999999  99999999975 689999999975433222 3468889999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||||+++|+|.+++.....  ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++++||..
T Consensus       104 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~  174 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRS  174 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGG
T ss_pred             EEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccccc
Confidence            9999999999999987532  2489999999999999999999999   999999999999999999999999953

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.92  E-value=2.9e-25  Score=219.07  Aligned_cols=146  Identities=24%  Similarity=0.318  Sum_probs=128.8

Q ss_pred             HHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccc--cccchHHHHHHHHHHhcC-CCCCceeeEEEEeeCCee
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEK  358 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  358 (438)
                      ...++|+..+.||+|+||+||+|+.. +++.||+|+++...  .......+..|..++..+ +||||+++++++.+.+..
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            44578888999999999999999985 47899999986542  223344688899999887 899999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++||||+++|+|.++++...    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+||+
T Consensus        97 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG  166 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFG  166 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCC
Confidence            99999999999999998653    389999999999999999999999   99999999999999999999999997

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=5.4e-25  Score=214.26  Aligned_cols=144  Identities=21%  Similarity=0.316  Sum_probs=127.7

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .++|...+.||+|+||.||+|+.. +++.||+|.++..  ......+.+|+.++..++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            356788899999999999999875 5889999998643  2233468899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC--CCCcchhhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE--DADQSSKTILR  436 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~--~~~~~l~Df~~  436 (438)
                      |+++|+|.+++....   ..+++.++..++.|++.||+|||++   +|+||||||+|||++.  ++.++++||.-
T Consensus        82 ~~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~  150 (321)
T 1tki_A           82 FISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQ  150 (321)
T ss_dssp             CCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred             eCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCC
Confidence            999999999997542   2489999999999999999999999   9999999999999997  78999999974

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.92  E-value=2e-25  Score=227.62  Aligned_cols=147  Identities=22%  Similarity=0.363  Sum_probs=129.4

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      ++..++|...+.||+|+||.||+|.+.++..||||.++...  .....|.+|+.+++.++|||||++++++. .+..++|
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv  260 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII  260 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence            34456777889999999999999999888899999997542  34557999999999999999999999986 6678999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |||+++|+|.++++....  ..+++.++..++.|++.||+|||++   +|+||||||+|||+++++.++|+||+-
T Consensus       261 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~  330 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGL  330 (454)
T ss_dssp             ECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred             EeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCC
Confidence            999999999999975421  2378899999999999999999999   999999999999999999999999963

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.92  E-value=2.3e-25  Score=229.54  Aligned_cols=145  Identities=28%  Similarity=0.399  Sum_probs=129.8

Q ss_pred             HhCCCCCCCccccccceEEEEEEeCC-CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~~-~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ..++|...+.||+|+||.||+|++.. +..||||.++...  .....|.+|+.+++.++|||||+++++|...+..++||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  295 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT  295 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence            34567778899999999999999864 7899999997542  23557999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++|+|.++++....  ..+++..+..++.|++.||+|||++   +|+||||||+|||+++++.++|+||+
T Consensus       296 E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG  363 (495)
T 1opk_A          296 EFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFG  363 (495)
T ss_dssp             ECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTT
T ss_pred             EccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecc
Confidence            99999999999986432  3489999999999999999999999   99999999999999999999999996

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.92  E-value=2.6e-25  Score=212.40  Aligned_cols=148  Identities=20%  Similarity=0.304  Sum_probs=129.8

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      ++|...+.||+|+||.||+|+.. ++..||+|.+...........+.+|+.+++.++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            45777899999999999999874 68899999987665555556799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC---CCCCcchhhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD---EDADQSSKTILR  436 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld---~~~~~~l~Df~~  436 (438)
                      +++|+|.+.+.........+++..+..++.|++.||+|||+.   +|+||||||+||+++   .++.++|+||.-
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~  173 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGL  173 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence            999999999865432234589999999999999999999999   999999999999994   457899999963

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=1.5e-25  Score=219.59  Aligned_cols=152  Identities=26%  Similarity=0.407  Sum_probs=128.4

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEe------CCCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEee
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  354 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~------~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  354 (438)
                      +...++|...+.||+|+||.||+|+.      .++..||||.++..........+.+|+.++..+ +||||+++++++..
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            34456788889999999999999985      235689999997654444445799999999999 89999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHhhccCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecC
Q 013682          355 VTEKLLVYPYMTNGSVASRLRERQSS-------------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRD  415 (438)
Q Consensus       355 ~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD  415 (438)
                      .+..++||||+++|+|.+++......                   ...+++..+..++.|++.||+|||++   +|+|||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~D  197 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD  197 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence            99999999999999999999865321                   12478999999999999999999999   999999


Q ss_pred             CCCCCeeeCCCCCcchhhhhh
Q 013682          416 VKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       416 LK~~NILld~~~~~~l~Df~~  436 (438)
                      |||+|||++.++.++|+||.-
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~  218 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGL  218 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGG
T ss_pred             CChhhEEEcCCCcEEeCCCcc
Confidence            999999999999999999974

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.92  E-value=5.6e-25  Score=210.65  Aligned_cols=144  Identities=20%  Similarity=0.386  Sum_probs=125.2

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccc-hHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      ++|+..+.||+|+||.||+|+.. +++.||+|+++....... ...+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46777899999999999999975 688999999865443332 3468899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |+++ ++.+.+....   ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+||.-
T Consensus        82 ~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~  147 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL  147 (292)
T ss_dssp             CCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence            9985 6666665432   2489999999999999999999999   999999999999999999999999963

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.92  E-value=5.2e-25  Score=224.32  Aligned_cols=143  Identities=28%  Similarity=0.434  Sum_probs=127.1

Q ss_pred             HhCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCC-eeEEEE
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-EKLLVY  362 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~  362 (438)
                      ..++|+..+.||+|+||.||+|++. ++.||||.++...   ....|.+|+.+++.++|||||++++++...+ ..++||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~  266 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT  266 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence            3456777889999999999999985 7799999997542   3457999999999999999999999987765 789999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++|+|.++++....  ..+++..+..++.|++.||+|||++   +|+||||||+|||+++++.++|+||+
T Consensus       267 e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG  334 (450)
T 1k9a_A          267 EYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFG  334 (450)
T ss_dssp             ECCTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCC
Confidence            99999999999987532  2378999999999999999999999   99999999999999999999999996

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.92  E-value=1.9e-25  Score=217.37  Aligned_cols=144  Identities=30%  Similarity=0.411  Sum_probs=124.7

Q ss_pred             hCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCe----eEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE----KLL  360 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----~~l  360 (438)
                      .++|+..+.||+|+||.||+|++. ++.||||+++...  .....+.+|+.++..++|||||++++++.....    .++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            456788899999999999999985 7899999986532  223356778999999999999999999987543    699


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-------CCCCceecCCCCCCeeeCCCCCcchhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH-------CDPKIIHRDVKAANILLDEDADQSSKT  433 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------~~~~ivHrDLK~~NILld~~~~~~l~D  433 (438)
                      ||||+++|+|.++++..     .++|..+..++.|++.||+|||+.       +.++|+||||||+|||+++++.++|+|
T Consensus       100 v~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D  174 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD  174 (322)
T ss_dssp             EEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred             EEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence            99999999999999764     389999999999999999999986       244899999999999999999999999


Q ss_pred             hhh
Q 013682          434 ILR  436 (438)
Q Consensus       434 f~~  436 (438)
                      |.-
T Consensus       175 Fg~  177 (322)
T 3soc_A          175 FGL  177 (322)
T ss_dssp             CTT
T ss_pred             CCc
Confidence            974

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.92  E-value=6.1e-25  Score=214.26  Aligned_cols=144  Identities=26%  Similarity=0.323  Sum_probs=127.4

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc-----chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-----GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  359 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  359 (438)
                      +.|...+.||+|+||.||+|+.. +++.||+|.++......     ....+.+|+.++..++||||+++++++......+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45777889999999999999975 68899999986543221     2456899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC----Ccchhhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA----DQSSKTIL  435 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~----~~~l~Df~  435 (438)
                      +||||+++|+|.+++....    .+++.++..++.|++.||+|||+.   +|+||||||+|||+++++    .++|+||.
T Consensus        91 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSS----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEcCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            9999999999999997542    489999999999999999999999   999999999999999887    79999996


Q ss_pred             h
Q 013682          436 R  436 (438)
Q Consensus       436 ~  436 (438)
                      -
T Consensus       164 ~  164 (326)
T 2y0a_A          164 L  164 (326)
T ss_dssp             T
T ss_pred             C
Confidence            3

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.92  E-value=3.5e-25  Score=219.14  Aligned_cols=147  Identities=16%  Similarity=0.240  Sum_probs=126.3

Q ss_pred             HHhCCCCCCCccccccceEEEEEE------eCCCCEEEEEEccccccccchHHHHHHHHHHhcCC---CCCceeeEEEEe
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGR------LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV---HRNLLRLYGFCT  353 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~------~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~  353 (438)
                      ...++|...+.||+|+||.||+|.      ..+++.||||+++..    ...++.+|+..+..++   |+||+++++++.
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            345678888999999999999994      346889999998643    3346788888888877   999999999999


Q ss_pred             eCCeeEEEEecCCCCCHHHHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC-------
Q 013682          354 TVTEKLLVYPYMTNGSVASRLRERQS-SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-------  425 (438)
Q Consensus       354 ~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~-------  425 (438)
                      ..+..++||||+++|+|.+++..... ....++|..+..++.|++.||+|||++   +|+||||||+|||++.       
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC--
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccc
Confidence            99999999999999999999975322 233589999999999999999999999   9999999999999998       


Q ss_pred             ----CCCcchhhhhh
Q 013682          426 ----DADQSSKTILR  436 (438)
Q Consensus       426 ----~~~~~l~Df~~  436 (438)
                          ++.++|+||+-
T Consensus       215 ~~~~~~~~kl~DFG~  229 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQ  229 (365)
T ss_dssp             ----CTTEEECCCTT
T ss_pred             cccccCCEEEeeCch
Confidence                89999999974

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.92  E-value=4.1e-25  Score=216.53  Aligned_cols=143  Identities=24%  Similarity=0.420  Sum_probs=127.2

Q ss_pred             hCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccc--cccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      .++|...+.||+|+||.||+|+. .+++.||+|+++...  .......+.+|+.+++.++||||+++++++...+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            35678889999999999999997 568999999986432  122334789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |||+ +|+|.+++....    .+++.++..++.|++.||+|||+.   +|+||||||+|||+++++.++|+||+
T Consensus        88 ~E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG  153 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFG  153 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSS
T ss_pred             EECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEec
Confidence            9999 789999887653    389999999999999999999999   99999999999999999999999997

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.92  E-value=3.1e-25  Score=213.09  Aligned_cols=143  Identities=25%  Similarity=0.368  Sum_probs=120.8

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-------------------------cchHHHHHHHHHHh
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-------------------------GGELQFQTEVKIIS  338 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-------------------------~~~~~~~~E~~~l~  338 (438)
                      .++|...+.||+|+||.||+|+.. +++.||||+++.....                         .....+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            467888899999999999999874 6889999998643211                         11236889999999


Q ss_pred             cCCCCCceeeEEEEee--CCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCC
Q 013682          339 MAVHRNLLRLYGFCTT--VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV  416 (438)
Q Consensus       339 ~l~H~niv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDL  416 (438)
                      .++||||+++++++..  .+..++||||+++++|.+++..     ..+++.++..++.|++.||+|||++   +|+||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl  163 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI  163 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence            9999999999999986  5678999999999998775432     2589999999999999999999999   9999999


Q ss_pred             CCCCeeeCCCCCcchhhhh
Q 013682          417 KAANILLDEDADQSSKTIL  435 (438)
Q Consensus       417 K~~NILld~~~~~~l~Df~  435 (438)
                      ||+|||++.++.++|+||.
T Consensus       164 kp~Nil~~~~~~~kl~Dfg  182 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFG  182 (298)
T ss_dssp             CGGGEEECTTSCEEECCCT
T ss_pred             CHHHEEECCCCCEEEecCC
Confidence            9999999999999999997

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.92  E-value=4.9e-25  Score=215.35  Aligned_cols=150  Identities=27%  Similarity=0.437  Sum_probs=129.0

Q ss_pred             HhCCCCCCCccccccceEEEEEEeC--------CCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEee
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLA--------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  354 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~--------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  354 (438)
                      ..++|...+.||+|+||.||+|+..        ++..||||+++..........+.+|+.++..+ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3467888899999999999999863        46789999997654333445789999999999 89999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHhhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCee
Q 013682          355 VTEKLLVYPYMTNGSVASRLRERQSS------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL  422 (438)
Q Consensus       355 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NIL  422 (438)
                      .+..++||||+++|+|.+++......            ...+++.++..++.|++.||+|||+.   +|+||||||+||+
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence            99999999999999999999865321            12488999999999999999999999   9999999999999


Q ss_pred             eCCCCCcchhhhhh
Q 013682          423 LDEDADQSSKTILR  436 (438)
Q Consensus       423 ld~~~~~~l~Df~~  436 (438)
                      ++.++.++++||.-
T Consensus       190 l~~~~~~kL~Dfg~  203 (334)
T 2pvf_A          190 VTENNVMKIADFGL  203 (334)
T ss_dssp             ECTTCCEEECCCTT
T ss_pred             EcCCCCEEEccccc
Confidence            99999999999963

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.92  E-value=5.7e-25  Score=210.59  Aligned_cols=140  Identities=10%  Similarity=-0.016  Sum_probs=123.0

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccc--hHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|+..+.||+|+||.||+|+.. +++.||||.++.......  ...+.+|+..+..++||||+++++++...+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            56788899999999999999975 589999999976543222  246899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  434 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df  434 (438)
                      ||+++++|.++++..      ....+...++.|++.||+|||++   +|+||||||+|||+++++.++++++
T Consensus       111 e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~  173 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYP  173 (286)
T ss_dssp             ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSC
T ss_pred             EecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEec
Confidence            999999999998542      34567889999999999999999   9999999999999999999998765

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.92  E-value=5.3e-25  Score=211.52  Aligned_cols=144  Identities=26%  Similarity=0.430  Sum_probs=124.1

Q ss_pred             CCCCCCccccccceEEEEEEe-----CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeC--CeeE
Q 013682          287 GFSNKNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKL  359 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~-----~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~  359 (438)
                      .|+..+.||+|+||.||+|++     .+++.||+|+++..........+.+|+.++..++||||+++++++...  ...+
T Consensus        22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  101 (302)
T 4e5w_A           22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK  101 (302)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred             hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence            466678999999999999984     357899999997655444556799999999999999999999999876  6689


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      +||||+++|+|.+++.....   .+++.++..++.|++.||+|||++   +|+||||||+||+++.++.++++||.-
T Consensus       102 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~  172 (302)
T 4e5w_A          102 LIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL  172 (302)
T ss_dssp             EEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             EEEEeCCCCcHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccc
Confidence            99999999999999965432   489999999999999999999999   999999999999999999999999973

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.92  E-value=6.5e-25  Score=217.29  Aligned_cols=145  Identities=22%  Similarity=0.301  Sum_probs=127.3

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      .++|...+.||+|+||.||+|... +++.||+|.++..... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            456888899999999999999875 6889999998654322 22346889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC---Ccchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~---~~~l~Df~~  436 (438)
                      ||+++|+|.+.+....    .+++.++..++.|++.||+|||++   +|+||||||+|||++.++   .++|+||+-
T Consensus       108 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~  177 (362)
T 2bdw_A          108 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGL  177 (362)
T ss_dssp             CCCCSCBHHHHHTTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence            9999999999987542    489999999999999999999999   999999999999998764   489999973

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.92  E-value=3.3e-25  Score=213.91  Aligned_cols=151  Identities=28%  Similarity=0.379  Sum_probs=130.8

Q ss_pred             HHhCCCCCCCccccccceEEEEEEe------CCCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEeeC
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  355 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~------~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  355 (438)
                      ...++|...+.||+|+||.||+|++      .+++.||||.++..........+.+|+.++..+ +||||+++++++...
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            3445678889999999999999985      246789999997554333345789999999999 999999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCe
Q 013682          356 TEKLLVYPYMTNGSVASRLRERQSS--------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANI  421 (438)
Q Consensus       356 ~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NI  421 (438)
                      +..++||||+++|+|.+++......              ...+++.++..++.|++.||+|||++   +|+||||||+||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni  176 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI  176 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceE
Confidence            9999999999999999999875321              12489999999999999999999999   999999999999


Q ss_pred             eeCCCCCcchhhhhh
Q 013682          422 LLDEDADQSSKTILR  436 (438)
Q Consensus       422 Lld~~~~~~l~Df~~  436 (438)
                      ++++++.++++||.-
T Consensus       177 l~~~~~~~kl~Dfg~  191 (313)
T 1t46_A          177 LLTHGRITKICDFGL  191 (313)
T ss_dssp             EEETTTEEEECCCGG
T ss_pred             EEcCCCCEEEccccc
Confidence            999999999999974

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.92  E-value=2.4e-25  Score=226.44  Aligned_cols=144  Identities=24%  Similarity=0.316  Sum_probs=120.4

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccc--cccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      .++|+..+.||+|+||.||+|+.. +++.||||+++...  .......+.+|+.+++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            456888899999999999999874 68999999986542  222334678899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |||+++|+|.+++....    .+++..+..++.|++.||+|||+ .   +|+||||||+|||++.++.++|+||+
T Consensus       227 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG  294 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFG  294 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCC
T ss_pred             EeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCC
Confidence            99999999999997653    48999999999999999999998 7   99999999999999999999999997

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.92  E-value=2.3e-25  Score=215.49  Aligned_cols=144  Identities=24%  Similarity=0.358  Sum_probs=126.2

Q ss_pred             hCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccc--hHHHHHHHHHHhcCCCCCceeeEEEEeeCCe----
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTTVTE----  357 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----  357 (438)
                      .++|+..+.||+|+||.||+|+. .+++.||||+++.......  ...+.+|+.++..++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            45688889999999999999996 5688999999976433222  2368899999999999999999999876543    


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      .++||||+++|+|.++++...    .+++.++..++.|++.||+|||++   +|+||||||+|||++.++.++|+||.
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  161 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFG  161 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCS
T ss_pred             cEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeecc
Confidence            399999999999999997653    489999999999999999999999   99999999999999999999999996

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.92  E-value=5.5e-25  Score=209.24  Aligned_cols=149  Identities=25%  Similarity=0.370  Sum_probs=126.8

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcC-CCCCceeeEEEEeeCCeeEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv  361 (438)
                      .++|+..+.||+|+||.||+|+.. +++.||+|.++..... .....+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            456788899999999999999975 6899999998754322 2344688899999888 999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC--------------
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA--------------  427 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~--------------  427 (438)
                      |||+++|+|.+++.........+++.++..++.|++.||+|||++   +|+||||||+|||++.++              
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            999999999999986532223589999999999999999999999   999999999999999544              


Q ss_pred             -----Ccchhhhhh
Q 013682          428 -----DQSSKTILR  436 (438)
Q Consensus       428 -----~~~l~Df~~  436 (438)
                           .++++||..
T Consensus       167 ~~~~~~~kl~Dfg~  180 (289)
T 1x8b_A          167 ASNKVMFKIGDLGH  180 (289)
T ss_dssp             ---CCCEEECCCTT
T ss_pred             cCCceEEEEccccc
Confidence                 789999963

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.92  E-value=7.8e-25  Score=227.04  Aligned_cols=149  Identities=30%  Similarity=0.419  Sum_probs=132.0

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      .++|...+.||+|+||.||+|+.. +++.||+|+++....  ......+.+|+.++..++||||+++++++.+.+..++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            356888889999999999999975 689999999865432  23345688999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |||+++|+|.+++.........+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+||+-
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGl  335 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGL  335 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecce
Confidence            999999999999987544445689999999999999999999999   999999999999999999999999973

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.92  E-value=2.3e-25  Score=216.11  Aligned_cols=154  Identities=27%  Similarity=0.420  Sum_probs=132.3

Q ss_pred             HHHHHhCCCCCCCccccccceEEEEEEeC------CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEe
Q 013682          280 ELQVATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT  353 (438)
Q Consensus       280 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~  353 (438)
                      +++...++|...+.||+|+||.||+|++.      +++.||+|.++..........+.+|+.+++.++||||+++++++.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            34455677888899999999999999754      367899999975443333446899999999999999999999999


Q ss_pred             eCCeeEEEEecCCCCCHHHHhhccC------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC
Q 013682          354 TVTEKLLVYPYMTNGSVASRLRERQ------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  427 (438)
Q Consensus       354 ~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~  427 (438)
                      ..+..++||||+++|+|.++++...      .....+++..+..++.|++.||+|||++   +|+||||||+||+++.++
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCC
Confidence            9999999999999999999987532      1123478999999999999999999999   999999999999999999


Q ss_pred             Ccchhhhhh
Q 013682          428 DQSSKTILR  436 (438)
Q Consensus       428 ~~~l~Df~~  436 (438)
                      .++++||.-
T Consensus       176 ~~kl~Dfg~  184 (322)
T 1p4o_A          176 TVKIGDFGM  184 (322)
T ss_dssp             CEEECCTTC
T ss_pred             eEEECcCcc
Confidence            999999963

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.91  E-value=7.4e-25  Score=216.78  Aligned_cols=142  Identities=24%  Similarity=0.274  Sum_probs=127.1

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .++|...+.||+|+||.||+++.. +++.||||+++...  .....+.+|+..++.++||||+++++++.+.+..++|||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA--AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST--TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc--cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            356888899999999999999975 68999999986532  223468899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC--cchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD--QSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~--~~l~Df~  435 (438)
                      |+++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.  ++|+||+
T Consensus        97 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg  163 (361)
T 3uc3_A           97 YASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFG  163 (361)
T ss_dssp             CCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCC
T ss_pred             eCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecC
Confidence            999999999997643    389999999999999999999999   9999999999999998776  8999996

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.91  E-value=5e-25  Score=214.80  Aligned_cols=144  Identities=26%  Similarity=0.465  Sum_probs=120.7

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCC----EEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~----~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      ++|+..+.||+|+||.||+|++. +++    .||+|.++..........+.+|+.+++.++||||++++++|.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            45777899999999999999864 343    468888865544455568999999999999999999999998754 789


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ++||+++|+|.++++....   .+++..+..++.|++.||+|||++   +|+||||||+|||+++++.++|+||+-
T Consensus        94 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~  163 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGL  163 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTT---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred             EEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcc
Confidence            9999999999999987532   489999999999999999999999   999999999999999999999999973

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.91  E-value=8.7e-25  Score=227.51  Aligned_cols=148  Identities=26%  Similarity=0.354  Sum_probs=130.6

Q ss_pred             HhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccc--cccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      ..++|...+.||+|+||.||+|+.. +++.||+|+++...  .......+.+|+.++..++|||||++++++.+.+..++
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            3456888899999999999999975 68999999986532  22334568899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||||+++|+|.+++.....  ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.++|+||+-
T Consensus       262 VmEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGl  332 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGL  332 (576)
T ss_dssp             EECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEeccc
Confidence            9999999999999976432  2489999999999999999999999   999999999999999999999999973

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.91  E-value=6.5e-25  Score=207.09  Aligned_cols=147  Identities=26%  Similarity=0.374  Sum_probs=126.3

Q ss_pred             hCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeC--CeeEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLLV  361 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv  361 (438)
                      .++|...+.||+|+||.||+|++. ++.||||+++..... .....+.+|+.+++.++||||+++++++...  +..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            356777899999999999999985 889999998754322 2234689999999999999999999999887  778999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |||+++|+|.++++....  ..+++.++..++.|++.||+|||++ .++|+||||||+||++++++.++++||.
T Consensus        88 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~~  158 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMAD  158 (271)
T ss_dssp             EECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGGG
T ss_pred             ecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEecc
Confidence            999999999999986432  3589999999999999999999998 1229999999999999999999888764

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.91  E-value=2.1e-25  Score=213.88  Aligned_cols=145  Identities=25%  Similarity=0.427  Sum_probs=125.7

Q ss_pred             hCCCCCCCccccccceEEEEEEe-----CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEee--CCe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTE  357 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~-----~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~  357 (438)
                      .++|+..+.||+|+||.||+|++     .+++.||||+++... ......+.+|+.++..++||||+++++++..  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            35677789999999999999985     257899999986532 2233478999999999999999999999865  355


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      .++||||+++|+|.+++.....   .+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.++++||.-
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~  160 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL  160 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHCGG---GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred             eEEEEEeCCCCCHHHHHHhccc---ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence            8999999999999999986532   489999999999999999999999   999999999999999999999999963

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.91  E-value=7.6e-25  Score=224.17  Aligned_cols=144  Identities=25%  Similarity=0.430  Sum_probs=128.9

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      .++|...+.||+|+||.||+|+.. +|+.||||+++....  .+....+.+|+.+++.++||||+++++++...+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            356788899999999999999975 789999999865321  22344689999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |||+++|+|.+++....    .+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||+
T Consensus        95 ~E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG  161 (476)
T 2y94_A           95 MEYVSGGELFDYICKNG----RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFG  161 (476)
T ss_dssp             EECCSSEEHHHHTTSSS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCS
T ss_pred             EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEecc
Confidence            99999999999997542    489999999999999999999999   99999999999999999999999996

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.91  E-value=4.6e-25  Score=219.21  Aligned_cols=144  Identities=26%  Similarity=0.345  Sum_probs=119.5

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc--cchHHHHHHHHH-HhcCCCCCceeeEEEEeeCCeeEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKI-ISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      .++|+..+.||+|+||+||+|+.. +++.||+|+++.....  .....+.+|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            356778899999999999999975 5889999999654322  222346667665 577899999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||||+++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+||+
T Consensus       117 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG  184 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFG  184 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCc
Confidence            999999999999998653    378999999999999999999999   99999999999999999999999996

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.91  E-value=2.7e-25  Score=215.83  Aligned_cols=152  Identities=26%  Similarity=0.377  Sum_probs=121.1

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEeCC-C---CEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCC
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRLAD-G---KLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT  356 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-~---~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  356 (438)
                      ....++|+..+.||+|+||.||+|+... +   ..||||.++..... .....+.+|+.+++.++||||+++++++....
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            3445678889999999999999998753 3   27999999754322 23457999999999999999999999998766


Q ss_pred             ee------EEEEecCCCCCHHHHhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC
Q 013682          357 EK------LLVYPYMTNGSVASRLRERQS--SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  428 (438)
Q Consensus       357 ~~------~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~  428 (438)
                      ..      +++|||+++|+|.+++.....  ....+++.++..++.|++.||+|||++   +|+||||||+|||+++++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCC
Confidence            55      899999999999999875421  222589999999999999999999999   9999999999999999999


Q ss_pred             cchhhhhh
Q 013682          429 QSSKTILR  436 (438)
Q Consensus       429 ~~l~Df~~  436 (438)
                      ++++||.-
T Consensus       176 ~kl~Dfg~  183 (323)
T 3qup_A          176 VCVADFGL  183 (323)
T ss_dssp             EEECCCCC
T ss_pred             EEEeeccc
Confidence            99999973

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.91  E-value=5.1e-25  Score=209.77  Aligned_cols=146  Identities=23%  Similarity=0.302  Sum_probs=124.0

Q ss_pred             HhCCCCCCCccccccceEEEEEEeCC----CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeE
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  359 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~~----~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  359 (438)
                      ..++|+..+.||+|+||.||+|+...    +..||+|.++..........+.+|+..++.++||||+++++++. .+..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            34567778999999999999998742    45799999875433333457899999999999999999999984 56789


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      +||||+++|+|.+++....   ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++++||.-
T Consensus        92 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~  162 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL  162 (281)
T ss_dssp             EEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---
T ss_pred             EEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccc
Confidence            9999999999999997643   2489999999999999999999999   999999999999999999999999973

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.91  E-value=1e-24  Score=205.51  Aligned_cols=144  Identities=27%  Similarity=0.417  Sum_probs=129.3

Q ss_pred             hCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      .++|+..+.||+|+||.||+|+..+++.||+|.++....  ....+.+|+.++..++||||+++++++...+..+++|||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF   84 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence            346777889999999999999988888999999975432  345789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      +++++|.++++....   .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++++||.-
T Consensus        85 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~  150 (267)
T 3t9t_A           85 MEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGM  150 (267)
T ss_dssp             CTTCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTG
T ss_pred             CCCCcHHHHHhhCcc---cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccc
Confidence            999999999986532   478999999999999999999999   999999999999999999999999963

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.91  E-value=1e-24  Score=212.36  Aligned_cols=148  Identities=29%  Similarity=0.477  Sum_probs=126.7

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCE--EEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEeeCCeeEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKL--VAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~--vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  360 (438)
                      .++|+..+.||+|+||.||+|+.. ++..  +|+|.++..........+.+|+.++.++ +||||+++++++...+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            356788899999999999999864 4554  5999987544444455799999999999 89999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC
Q 013682          361 VYPYMTNGSVASRLRERQ------------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  428 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~  428 (438)
                      ||||+++|+|.+++....            .....+++.++..++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence            999999999999998653            1223589999999999999999999999   9999999999999999999


Q ss_pred             cchhhhh
Q 013682          429 QSSKTIL  435 (438)
Q Consensus       429 ~~l~Df~  435 (438)
                      ++++||.
T Consensus       181 ~kL~Dfg  187 (327)
T 1fvr_A          181 AKIADFG  187 (327)
T ss_dssp             EEECCTT
T ss_pred             EEEcccC
Confidence            9999996

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.91  E-value=4.3e-25  Score=225.04  Aligned_cols=146  Identities=27%  Similarity=0.417  Sum_probs=128.2

Q ss_pred             HHhCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      +..++|...+.||+|+||.||+|.+.++..||||.++...  .....|.+|+.+++.++||||+++++++.+ +..++||
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~  257 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT  257 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence            3455677788999999999999999877889999997543  234579999999999999999999999876 6789999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||+++|+|.++++....  ..+++.++..++.|++.||+|||++   +|+||||||+|||+++++.++|+||+-
T Consensus       258 e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~  326 (452)
T 1fmk_A          258 EYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGL  326 (452)
T ss_dssp             CCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred             hhhcCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCcc
Confidence            99999999999975321  2488999999999999999999999   999999999999999999999999963

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.91  E-value=1.2e-24  Score=208.86  Aligned_cols=139  Identities=28%  Similarity=0.400  Sum_probs=119.2

Q ss_pred             hCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhc--CCCCCceeeEEEEeeC----Cee
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM--AVHRNLLRLYGFCTTV----TEK  358 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~----~~~  358 (438)
                      .++|+..+.||+|+||.||+|++ +++.||||+++..    ....+.+|.+++..  ++||||+++++++...    ...
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            45788889999999999999998 6889999998543    23345666666655  8999999999987653    457


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCceecCCCCCCeeeCCCCCcc
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH--------EHCDPKIIHRDVKAANILLDEDADQS  430 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivHrDLK~~NILld~~~~~~  430 (438)
                      ++||||+++|+|.++++..     .+++..+..++.|++.||+|||        +.   +|+||||||+|||++.++.++
T Consensus        82 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             EEEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEE
T ss_pred             EEehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEE
Confidence            8999999999999999643     4899999999999999999999        66   999999999999999999999


Q ss_pred             hhhhhh
Q 013682          431 SKTILR  436 (438)
Q Consensus       431 l~Df~~  436 (438)
                      |+||.-
T Consensus       154 l~Dfg~  159 (301)
T 3q4u_A          154 IADLGL  159 (301)
T ss_dssp             ECCCTT
T ss_pred             EeeCCC
Confidence            999973

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.91  E-value=8.5e-25  Score=211.69  Aligned_cols=145  Identities=23%  Similarity=0.203  Sum_probs=122.5

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhc-CCCCCceeeEEEEeeCCeeEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISM-AVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      .++|+..+.||+|+||+||+|+.. +++.||||++...... .....+..|+..+.. .+||||++++++|.+.+..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            356888899999999999999985 6899999987653222 122345555555544 4899999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |||+ +++|.+++....   ..++|..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||+-
T Consensus       136 ~e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~  203 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGL  203 (311)
T ss_dssp             EECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTT
T ss_pred             Eecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEcccee
Confidence            9999 679999887653   2489999999999999999999999   999999999999999999999999973

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.91  E-value=8.7e-25  Score=207.83  Aligned_cols=145  Identities=32%  Similarity=0.476  Sum_probs=128.5

Q ss_pred             HhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      ..++|+..+.||+|+||.||+|+.. +++.||+|.+.....  ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3456888899999999999999875 577999999854321  2234468899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++||.
T Consensus        87 v~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg  154 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG  154 (279)
T ss_dssp             EECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCC
T ss_pred             EEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEecc
Confidence            999999999999997653    389999999999999999999999   99999999999999999999999996

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.91  E-value=1e-24  Score=218.44  Aligned_cols=147  Identities=22%  Similarity=0.313  Sum_probs=128.4

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCC--eeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT--EKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv~  362 (438)
                      +.|...+.||+|+||.||+|+.. +++.||||+++..........+.+|+.+++.++||||+++++++...+  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            45777889999999999999975 589999999976554445567889999999999999999999998755  679999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee----CCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL----DEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILl----d~~~~~~l~Df~~  436 (438)
                      ||+++|+|.+++..... ...+++..+..++.|++.||+|||+.   +|+||||||+|||+    +.++.++|+||+-
T Consensus        89 e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             CCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             ecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            99999999999976432 22389999999999999999999999   99999999999999    7788899999974

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.91  E-value=1.6e-25  Score=218.49  Aligned_cols=153  Identities=27%  Similarity=0.368  Sum_probs=131.2

Q ss_pred             HHHHhCCCCCCCccccccceEEEEEEeCC-C-----CEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEe
Q 013682          281 LQVATDGFSNKNILGRGGFGKVYKGRLAD-G-----KLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCT  353 (438)
Q Consensus       281 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-~-----~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~  353 (438)
                      .+...++|...+.||+|+||.||+|.... +     ..||+|.++..........+.+|+.++..+ +||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            34556788889999999999999998642 2     479999997654333445789999999999 8999999999999


Q ss_pred             eCCeeEEEEecCCCCCHHHHhhccCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee
Q 013682          354 TVTEKLLVYPYMTNGSVASRLRERQS----------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  423 (438)
Q Consensus       354 ~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILl  423 (438)
                      ..+..++||||+++|+|.+++.....          ....+++..+..++.|++.||+|||++   +|+||||||+|||+
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLL  197 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEE
Confidence            99999999999999999999875321          123478999999999999999999999   99999999999999


Q ss_pred             CCCCCcchhhhhh
Q 013682          424 DEDADQSSKTILR  436 (438)
Q Consensus       424 d~~~~~~l~Df~~  436 (438)
                      ++++.++|+||.-
T Consensus       198 ~~~~~~kl~Dfg~  210 (333)
T 2i1m_A          198 TNGHVAKIGDFGL  210 (333)
T ss_dssp             EGGGEEEBCCCGG
T ss_pred             CCCCeEEECcccc
Confidence            9999999999974

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.91  E-value=2.2e-24  Score=209.40  Aligned_cols=141  Identities=28%  Similarity=0.423  Sum_probs=124.8

Q ss_pred             CCCCCccccccceEEEEEEeC-----CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeC--CeeEE
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLL  360 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-----~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l  360 (438)
                      |+..+.||+|+||.||++.+.     +++.||||+++..........+.+|+.+++.++||||+++++++...  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            367789999999999998753     57889999997654333445789999999999999999999999874  56899


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||||+++|+|.+++...     .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.++|+||.-
T Consensus       113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~  180 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGL  180 (318)
T ss_dssp             EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccc
Confidence            99999999999999764     289999999999999999999999   999999999999999999999999974

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.91  E-value=1e-24  Score=206.61  Aligned_cols=145  Identities=25%  Similarity=0.367  Sum_probs=129.5

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .++|+..+.||+|+||.||+|+.. +++.||+|.++..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            356778899999999999999975 6889999998655444444578999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |+++++|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++++||.-
T Consensus        86 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~  151 (276)
T 2yex_A           86 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL  151 (276)
T ss_dssp             CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             ecCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCC
Confidence            99999999988653    2489999999999999999999999   999999999999999999999999973

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.91  E-value=3.9e-24  Score=206.88  Aligned_cols=142  Identities=25%  Similarity=0.337  Sum_probs=124.6

Q ss_pred             CCCCC-CCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhc-CCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSN-KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~-~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      +.|.. .+.||+|+||.||+|+.. +++.||||+++... ......+.+|+.++.+ .+||||+++++++.+.+..++||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            45665 378999999999999864 68999999986542 3344578999999988 47999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC---cchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD---QSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~---~~l~Df~  435 (438)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.   ++++||.
T Consensus        91 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg  159 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFD  159 (316)
T ss_dssp             ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred             EcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence            9999999999998653    389999999999999999999999   9999999999999998876   8999995

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.91  E-value=1.7e-24  Score=208.90  Aligned_cols=144  Identities=23%  Similarity=0.340  Sum_probs=127.3

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccc-hHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      ++|+..+.||+|+||.||+|+.. +++.||+|++........ ...+.+|+.++..++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            56778899999999999999975 589999999865432222 3468899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |+++++|.++++...    .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++++||.-
T Consensus        83 ~~~~~~l~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~  148 (311)
T 4agu_A           83 YCDHTVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGF  148 (311)
T ss_dssp             CCSEEHHHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             eCCCchHHHHHhhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCC
Confidence            999999998876543    389999999999999999999999   999999999999999999999999974

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=7.4e-25  Score=216.25  Aligned_cols=144  Identities=27%  Similarity=0.328  Sum_probs=127.1

Q ss_pred             hCCCCCCCccccccceEEEEEEe----CCCCEEEEEEcccccc---ccchHHHHHHHHHHhcC-CCCCceeeEEEEeeCC
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRL----ADGKLVAVKRLKEERT---SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVT  356 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~----~~~~~vAvK~l~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  356 (438)
                      .++|...+.||+|+||.||+|+.    .+++.||||+++....   ......+.+|+.++..+ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            35678889999999999999987    3688999999875421   22334577899999998 6999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          357 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ..++||||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||.
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG  204 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG  204 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             eEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCC
Confidence            9999999999999999998653    389999999999999999999999   99999999999999999999999996

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=1.1e-24  Score=212.91  Aligned_cols=145  Identities=29%  Similarity=0.453  Sum_probs=126.8

Q ss_pred             CCCCCCCccccccceEEEEEEeCC-----CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLAD-----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~~-----~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      ++|...+.||+|+||.||+|+...     +..||||.++..........+.+|+.++..++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            456667899999999999998642     236999999765433334578999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||||+++|+|.++++...   ..+++.++..++.|++.||+|||++   +|+||||||+||++++++.++++||.-
T Consensus       124 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~  193 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGL  193 (333)
T ss_dssp             EEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             EEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCc
Confidence            999999999999997643   2489999999999999999999999   999999999999999999999999963

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.91  E-value=1.2e-24  Score=220.96  Aligned_cols=146  Identities=18%  Similarity=0.258  Sum_probs=126.4

Q ss_pred             HhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      ..++|+..+.||+|+||.||+|... +++.||+|.++..... .....+.+|+.+++.++|||||++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            3456888899999999999999864 6889999998654322 2234689999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC---CCCCcchhhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD---EDADQSSKTILR  436 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld---~~~~~~l~Df~~  436 (438)
                      |||+++|+|.+.+....    .+++.++..++.|++.||+|||++   +|+||||||+|||++   +++.++|+||+-
T Consensus        89 ~E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~  159 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGL  159 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred             EEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCce
Confidence            99999999999988653    389999999999999999999999   999999999999999   457899999973

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.91  E-value=1.6e-24  Score=213.44  Aligned_cols=141  Identities=28%  Similarity=0.359  Sum_probs=120.6

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .+.|...+.||+|+||.||+|+.. +++.||||+++...   ....+.+|+.++..++||||+++++++...+..++|||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            456888899999999999999985 57899999986532   23468899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC---CCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~---~~~~~l~Df~  435 (438)
                      |+++|+|.+++....    .+++.++..++.|++.||+|||+.   +|+||||||+|||++.   ++.++|+||.
T Consensus       129 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg  196 (349)
T 2w4o_A          129 LVTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFG  196 (349)
T ss_dssp             CCCSCBHHHHHTTCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC
T ss_pred             eCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCc
Confidence            999999999997642    489999999999999999999999   9999999999999975   8899999996

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.91  E-value=3.9e-25  Score=213.65  Aligned_cols=157  Identities=28%  Similarity=0.381  Sum_probs=132.4

Q ss_pred             cHHHHHHHhCCCCCCCccccccceEEEEEEe------CCCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeE
Q 013682          277 SLRELQVATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLY  349 (438)
Q Consensus       277 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~------~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~  349 (438)
                      ...++....++|...+.||+|+||.||+|++      .+++.||||.++..........+.+|+.++..+ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3344555667899999999999999999974      246789999997654333445789999999999 799999999


Q ss_pred             EEEeeCC-eeEEEEecCCCCCHHHHhhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCC
Q 013682          350 GFCTTVT-EKLLVYPYMTNGSVASRLRERQSS------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV  416 (438)
Q Consensus       350 g~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDL  416 (438)
                      +++...+ ..+++|||+++|+|.+++......            ...+++..+..++.|++.||+|||++   +|+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccC
Confidence            9988755 489999999999999999875431            12278999999999999999999999   9999999


Q ss_pred             CCCCeeeCCCCCcchhhhhh
Q 013682          417 KAANILLDEDADQSSKTILR  436 (438)
Q Consensus       417 K~~NILld~~~~~~l~Df~~  436 (438)
                      ||+||+++.++.++++||.-
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~  194 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGL  194 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGG
T ss_pred             ccceEEECCCCCEEECCCcc
Confidence            99999999999999999974

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.91  E-value=8e-25  Score=213.13  Aligned_cols=144  Identities=25%  Similarity=0.409  Sum_probs=123.2

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCE----EEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~----vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      ++|+..+.||+|+||.||+|++. +++.    ||+|.+...........+.+|+.+++.++||||+++++++. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            46777889999999999999864 4443    78888755433333446889999999999999999999886 466899


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||||+++|+|.+++....   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||+-
T Consensus        92 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~  161 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGV  161 (325)
T ss_dssp             EEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSG
T ss_pred             EEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCc
Confidence            999999999999997642   2478899999999999999999999   999999999999999999999999974

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.91  E-value=2.4e-24  Score=204.49  Aligned_cols=145  Identities=28%  Similarity=0.456  Sum_probs=128.7

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|...+.||+|+||.||+|+. .+++.||+|.++....  ......+.+|+.++..++||||+++++++...+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            4677889999999999999987 4689999999864322  223357899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||+++++|.+++....   ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++++||.-
T Consensus        91 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~  158 (278)
T 3cok_A           91 EMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGL  158 (278)
T ss_dssp             ECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTT
T ss_pred             ecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecc
Confidence            9999999999997642   2489999999999999999999999   999999999999999999999999963

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.91  E-value=8.8e-25  Score=208.62  Aligned_cols=145  Identities=26%  Similarity=0.389  Sum_probs=126.1

Q ss_pred             hCCCCCCCccccccceEEEEEEeCC-C-------CEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCC
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLAD-G-------KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT  356 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~~-~-------~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  356 (438)
                      .++|...+.||+|+||.||+|+... +       ..||+|.++... ......+.+|+.+++.++||||+++++++...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            3467778899999999999998642 3       479999986542 233457999999999999999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC--------
Q 013682          357 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD--------  428 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~--------  428 (438)
                      ..++||||+++|+|.+++.....   .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.        
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~  159 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF  159 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred             CCEEEEECCCCCCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence            99999999999999999986432   378999999999999999999999   9999999999999999987        


Q ss_pred             cchhhhhh
Q 013682          429 QSSKTILR  436 (438)
Q Consensus       429 ~~l~Df~~  436 (438)
                      ++++||.-
T Consensus       160 ~kl~Dfg~  167 (289)
T 4fvq_A          160 IKLSDPGI  167 (289)
T ss_dssp             EEECCCCS
T ss_pred             eeeccCcc
Confidence            89999863

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.91  E-value=8.1e-25  Score=213.07  Aligned_cols=144  Identities=26%  Similarity=0.432  Sum_probs=124.1

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      ++|...+.||+|+||.||+|+.. +++.||+|+++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            46777899999999999999975 68899999986544333333466899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ++ |+|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||.-
T Consensus        82 ~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~  146 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGN---IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGL  146 (324)
T ss_dssp             CS-EEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSE
T ss_pred             cc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcc
Confidence            98 599998876532   488999999999999999999999   999999999999999999999999963

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.91  E-value=1.2e-24  Score=221.86  Aligned_cols=143  Identities=20%  Similarity=0.304  Sum_probs=115.5

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeC-----Cee
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TEK  358 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~  358 (438)
                      ++|...+.||+|+||+||+|+.. +++.||||++...... .....+.+|+.++..++|||||++++++...     ...
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            57888899999999999999864 6899999998653222 2234688999999999999999999998543     568


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ++||||+. |+|.++++...    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||+-
T Consensus       133 ~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGl  202 (458)
T 3rp9_A          133 YVVLEIAD-SDFKKLFRTPV----YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGL  202 (458)
T ss_dssp             EEEECCCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEeccc-cchhhhcccCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeeccccc
Confidence            99999984 79999987643    489999999999999999999999   999999999999999999999999973

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.91  E-value=6.9e-25  Score=228.13  Aligned_cols=147  Identities=27%  Similarity=0.418  Sum_probs=129.0

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      ++..++|+..+.||+|+||.||+|++.++..||||+++...  .....|.+|+.+++.++|||||++++++.+ +..++|
T Consensus       263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv  339 (535)
T 2h8h_A          263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  339 (535)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence            34456677788999999999999999877889999997543  234579999999999999999999999876 678999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |||+++|+|.++++....  ..+++.++..++.|++.||+|||++   +|+||||||+|||+++++.++|+||.-
T Consensus       340 ~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~  409 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGL  409 (535)
T ss_dssp             ECCCTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred             eehhcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccccc
Confidence            999999999999975321  2488999999999999999999999   999999999999999999999999963

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.91  E-value=2.7e-24  Score=204.07  Aligned_cols=143  Identities=22%  Similarity=0.319  Sum_probs=127.7

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      ++|...+.||+|+||.||+|+.. ++..||+|.++.... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            45777899999999999999975 577999999865432 3345799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee---CCCCCcchhhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTILR  436 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILl---d~~~~~~l~Df~~  436 (438)
                      +++++|.+++....    .+++.++..++.|++.||+|||++   +|+||||||+||++   +.++.++++||.-
T Consensus        88 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~  155 (277)
T 3f3z_A           88 CTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGL  155 (277)
T ss_dssp             CCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEeccc
Confidence            99999999987653    389999999999999999999999   99999999999999   7889999999973

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.91  E-value=2.5e-24  Score=214.97  Aligned_cols=145  Identities=20%  Similarity=0.300  Sum_probs=126.9

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .+.|+..+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.++..++||||+++++++.+....++|||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            356888899999999999999875 688999999865322 223468999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC--CCCcchhhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE--DADQSSKTILR  436 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~--~~~~~l~Df~~  436 (438)
                      |+++|+|.+++....   ..+++.++..++.|++.||+|||++   +|+||||||+|||++.  ++.++|+||+-
T Consensus       129 ~~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~  197 (387)
T 1kob_A          129 FLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGL  197 (387)
T ss_dssp             CCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred             cCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEeccc
Confidence            999999999987542   2489999999999999999999999   9999999999999985  46799999973

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.91  E-value=2.3e-24  Score=209.47  Aligned_cols=145  Identities=24%  Similarity=0.326  Sum_probs=128.1

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc-----chHHHHHHHHHHhcCCCCCceeeEEEEeeCCee
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-----GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  358 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  358 (438)
                      .+.|...+.||+|+||.||+|+.. +++.||+|.++......     ....+.+|+.++..++||||+++++++...+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            345778899999999999999975 68899999986543221     245689999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC----Ccchhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA----DQSSKTI  434 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~----~~~l~Df  434 (438)
                      ++||||+++++|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+||++++++    .++++||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCS----CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            99999999999999997642    488999999999999999999999   999999999999999988    7999999


Q ss_pred             hh
Q 013682          435 LR  436 (438)
Q Consensus       435 ~~  436 (438)
                      .-
T Consensus       164 g~  165 (321)
T 2a2a_A          164 GL  165 (321)
T ss_dssp             TT
T ss_pred             cc
Confidence            63

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.91  E-value=4.9e-26  Score=222.66  Aligned_cols=143  Identities=20%  Similarity=0.217  Sum_probs=118.7

Q ss_pred             hCCCCCCCccccccceEEEEEEeCCCCEEEEEEcccccc-------ccchHHHHHHHHHHhcCC---------CCCceee
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERT-------SGGELQFQTEVKIISMAV---------HRNLLRL  348 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~-------~~~~~~~~~E~~~l~~l~---------H~niv~l  348 (438)
                      .++|+..+.||+|+||+||+|+. +++.||||+++....       ......+.+|+.+++.++         |||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35577789999999999999998 689999999975432       122356889999888775         8888888


Q ss_pred             EEEEe------------------------------eCCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHH
Q 013682          349 YGFCT------------------------------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR  398 (438)
Q Consensus       349 ~g~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~  398 (438)
                      .+++.                              ..+..++||||+++|++.+.+.+     ..+++.++..++.|++.
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence            77643                              26789999999999977666643     23799999999999999


Q ss_pred             HHHHHh-cCCCCCceecCCCCCCeeeCCCC--------------------Ccchhhhhh
Q 013682          399 GLSYLH-EHCDPKIIHRDVKAANILLDEDA--------------------DQSSKTILR  436 (438)
Q Consensus       399 gL~yLH-~~~~~~ivHrDLK~~NILld~~~--------------------~~~l~Df~~  436 (438)
                      ||+||| +.   +|+||||||+|||++.++                    .+||+||+-
T Consensus       173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~  228 (336)
T 2vuw_A          173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTL  228 (336)
T ss_dssp             HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTT
T ss_pred             HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccc
Confidence            999999 88   999999999999999987                    899999973

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.91  E-value=7.1e-25  Score=208.29  Aligned_cols=145  Identities=28%  Similarity=0.411  Sum_probs=126.9

Q ss_pred             HhCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      ..++|+..+.||+|+||.||+|+..+++.||+|.++...  .....+.+|+.+++.++||||+++++++. .+..++|||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   87 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE   87 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence            345677889999999999999998888899999986542  23457999999999999999999999986 456899999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |+++++|.+++.....  ..+++.++..++.|++.||+|||++   +|+||||||+||++++++.++++||.-
T Consensus        88 ~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~  155 (279)
T 1qpc_A           88 YMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGL  155 (279)
T ss_dssp             CCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             cCCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcc
Confidence            9999999999875321  1488999999999999999999999   999999999999999999999999964

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=1e-24  Score=216.84  Aligned_cols=143  Identities=32%  Similarity=0.462  Sum_probs=121.7

Q ss_pred             CCCCCccccccceEEEEEEeC--C--CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEee-CCeeEEEE
Q 013682          288 FSNKNILGRGGFGKVYKGRLA--D--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTEKLLVY  362 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~--~--~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~  362 (438)
                      |...+.||+|+||.||+|++.  +  +..||||.++..........+.+|+.+++.++||||+++++++.. .+..++||
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~  170 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  170 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence            445678999999999999863  2  236899998754433444579999999999999999999998765 45789999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||+++|+|.++++...   ..+++.++..++.|++.||+|||++   +|+||||||+|||+++++.++|+||.-
T Consensus       171 e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~  238 (373)
T 3c1x_A          171 PYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGL  238 (373)
T ss_dssp             ECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred             ECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccc
Confidence            9999999999997643   2478999999999999999999999   999999999999999999999999963

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.91  E-value=1.4e-24  Score=214.25  Aligned_cols=145  Identities=26%  Similarity=0.346  Sum_probs=129.0

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .++|...+.||+|+||.||+|+.. +++.||+|+++..........+.+|+.++..++||||+++++++...+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            356888899999999999999975 6889999998765333334578999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+++|+|.+++....    .+++..+..++.|++.||+|||+.+  +|+||||||+|||++.++.++|+||.
T Consensus       112 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg  177 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFG  177 (360)
T ss_dssp             CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred             CCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECC
Confidence            999999999998753    3889999999999999999999831  79999999999999999999999996

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.91  E-value=1.6e-24  Score=228.78  Aligned_cols=137  Identities=23%  Similarity=0.345  Sum_probs=122.1

Q ss_pred             ccccccceEEEEEEeC---CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCCC
Q 013682          293 ILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS  369 (438)
Q Consensus       293 ~LG~G~fG~Vy~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs  369 (438)
                      .||+|+||.||+|.+.   ++..||||+++..........+.+|+.+++.++|||||+++++|.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            6999999999999863   4567999999765444455689999999999999999999999976 56899999999999


Q ss_pred             HHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          370 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       370 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |.+++....   ..+++.++..++.|++.||+|||++   +|+||||||+|||+++++.++|+||+-
T Consensus       422 L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGl  482 (613)
T 2ozo_A          422 LHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGL  482 (613)
T ss_dssp             HHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCST
T ss_pred             HHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccC
Confidence            999997542   3489999999999999999999999   999999999999999999999999973

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.91  E-value=4.5e-24  Score=205.37  Aligned_cols=143  Identities=31%  Similarity=0.455  Sum_probs=129.1

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      +.|...+.||+|+||.||+|+.. +++.||+|.++..........+.+|+.++..++||||+++++++......++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            45777889999999999999864 68899999987654444556799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      +++++|.+++...     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++||.-
T Consensus       102 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~  165 (303)
T 3a7i_A          102 LGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGV  165 (303)
T ss_dssp             CTTEEHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeeccc
Confidence            9999999998642     489999999999999999999999   999999999999999999999999963

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.91  E-value=1.1e-24  Score=213.42  Aligned_cols=146  Identities=25%  Similarity=0.298  Sum_probs=128.1

Q ss_pred             HhCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccc-------cchHHHHHHHHHHhcCCCCCceeeEEEEeeC
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-------GGELQFQTEVKIISMAVHRNLLRLYGFCTTV  355 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  355 (438)
                      ..++|...+.||+|+||.||+|+. .+++.||||.++.....       .....+.+|+.+++.++||||+++++++...
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            345788889999999999999986 46889999998654321       1223578899999999999999999999999


Q ss_pred             CeeEEEEecCCCC-CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhh
Q 013682          356 TEKLLVYPYMTNG-SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  434 (438)
Q Consensus       356 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df  434 (438)
                      +..++||||+..| +|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||+++++.++|+||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence            9999999999877 9999987643    489999999999999999999999   9999999999999999999999999


Q ss_pred             hh
Q 013682          435 LR  436 (438)
Q Consensus       435 ~~  436 (438)
                      .-
T Consensus       175 g~  176 (335)
T 3dls_A          175 GS  176 (335)
T ss_dssp             TT
T ss_pred             cc
Confidence            73

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.91  E-value=1.2e-24  Score=210.56  Aligned_cols=147  Identities=26%  Similarity=0.369  Sum_probs=125.9

Q ss_pred             hCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEee----CCeeE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT----VTEKL  359 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~  359 (438)
                      .++|+..+.||+|+||.||+++. .+++.||||++.... ......+.+|+.+++.++||||+++++++..    ....+
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            45688889999999999999997 578999999885432 2234468999999999999999999999873    34678


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +||||+++|+|.+++.........+++.++..++.|++.||+|||++   +|+||||||+||+++.++.++++||.
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg  179 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLG  179 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecC
Confidence            99999999999999987433344689999999999999999999999   99999999999999999999999997

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.91  E-value=4.6e-25  Score=210.43  Aligned_cols=147  Identities=28%  Similarity=0.394  Sum_probs=130.4

Q ss_pred             HHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      ...++|+..+.||+|+||.||+|+.. ++..||+|.++..  ......+.+|+.+++.++||||+++++++...+..++|
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v   87 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   87 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC--STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence            34567788899999999999999975 4889999998653  22345789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |||+++++|.+++.....  ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++++||.-
T Consensus        88 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~  157 (288)
T 3kfa_A           88 TEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGL  157 (288)
T ss_dssp             EECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred             EEcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCcc
Confidence            999999999999986432  3489999999999999999999999   999999999999999999999999963

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.91  E-value=3.4e-24  Score=211.56  Aligned_cols=153  Identities=22%  Similarity=0.334  Sum_probs=132.2

Q ss_pred             cHHHHHHHhCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccc----------hHHHHHHHHHHhcCCCCCce
Q 013682          277 SLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG----------ELQFQTEVKIISMAVHRNLL  346 (438)
Q Consensus       277 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~----------~~~~~~E~~~l~~l~H~niv  346 (438)
                      ...++....++|...+.||+|+||.||+|...+++.||||++........          ...+.+|+.++..++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            45677788899999999999999999999988899999999865432211          14689999999999999999


Q ss_pred             eeEEEEeeC-----CeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCe
Q 013682          347 RLYGFCTTV-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANI  421 (438)
Q Consensus       347 ~l~g~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NI  421 (438)
                      ++++++...     ...++||||++ |+|.+.+....   ..+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI  165 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI  165 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence            999998542     35799999998 68888887543   2489999999999999999999999   999999999999


Q ss_pred             eeCCCCCcchhhhhh
Q 013682          422 LLDEDADQSSKTILR  436 (438)
Q Consensus       422 Lld~~~~~~l~Df~~  436 (438)
                      |++.++.++|+||.-
T Consensus       166 l~~~~~~~kl~Dfg~  180 (362)
T 3pg1_A          166 LLADNNDITICDFNL  180 (362)
T ss_dssp             EECTTCCEEECCTTC
T ss_pred             EEcCCCCEEEEecCc
Confidence            999999999999964

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.91  E-value=2.1e-24  Score=207.00  Aligned_cols=144  Identities=33%  Similarity=0.455  Sum_probs=123.6

Q ss_pred             CCCCCCccccccceEEEEEEeCC----CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEee-CCeeEEE
Q 013682          287 GFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTEKLLV  361 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~~----~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv  361 (438)
                      .|+..+.||+|+||.||+|+..+    ...||+|.++..........+.+|+.+++.++||||+++++++.. .+..+++
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  105 (298)
T 3f66_A           26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  105 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence            46677899999999999998642    236899998764433344578999999999999999999998654 5678999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |||+++|+|.++++...   ..+++.++..++.|++.||+|||++   +|+||||||+||++++++.++++||.-
T Consensus       106 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~  174 (298)
T 3f66_A          106 LPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGL  174 (298)
T ss_dssp             EECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGG
T ss_pred             EeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccc
Confidence            99999999999997643   2478999999999999999999999   999999999999999999999999974

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.91  E-value=3.9e-24  Score=204.86  Aligned_cols=144  Identities=22%  Similarity=0.325  Sum_probs=127.6

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc--cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|...+.||+|+||.||+|+.. +++.||+|.+......  .....+.+|+.+++.++||||+++++++...+..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            45777889999999999999975 5789999998654322  22346889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||+++++|.+++....    .+++.++..++.|++.||+|||+.   +|+||||||+||++++++.++++||.-
T Consensus        95 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~  161 (294)
T 2rku_A           95 ELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGL  161 (294)
T ss_dssp             ECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccC
Confidence            9999999999887643    489999999999999999999999   999999999999999999999999963

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.91  E-value=1.5e-24  Score=208.11  Aligned_cols=151  Identities=28%  Similarity=0.376  Sum_probs=115.9

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      ....++|...+.||+|+||.||+|+.. +++.||||.++..........+.+|+..+..++||||+++++++...+..++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            455678999999999999999999864 6889999998654433344568899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhcc----CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          361 VYPYMTNGSVASRLRER----QSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||||+++++|.+++...    ......+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++++||.
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  166 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG  166 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence            99999999999998742    11223589999999999999999999999   99999999999999999999999996

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.91  E-value=5.2e-24  Score=203.18  Aligned_cols=144  Identities=31%  Similarity=0.577  Sum_probs=123.8

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccch------HHHHHHHHHHhcCCCCCceeeEEEEeeCCe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGE------LQFQTEVKIISMAVHRNLLRLYGFCTTVTE  357 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  357 (438)
                      .++|+..+.||+|+||.||+|+.. +++.||+|.+.........      ..+.+|+.++..++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            356777899999999999999974 6899999998654332221      46899999999999999999999986654 


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeeeCCCCC-----cc
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK--IIHRDVKAANILLDEDAD-----QS  430 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDLK~~NILld~~~~-----~~  430 (438)
                       ++||||+++|+|.+.+....   ..+++..+..++.|++.||+|||++   +  |+||||||+|||++.+++     ++
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k  169 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK  169 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred             -eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence             79999999999999887643   2589999999999999999999998   7  999999999999998886     89


Q ss_pred             hhhhhh
Q 013682          431 SKTILR  436 (438)
Q Consensus       431 l~Df~~  436 (438)
                      ++||.-
T Consensus       170 l~Dfg~  175 (287)
T 4f0f_A          170 VADFGL  175 (287)
T ss_dssp             ECCCTT
T ss_pred             eCCCCc
Confidence            999963

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=1.9e-24  Score=207.05  Aligned_cols=143  Identities=27%  Similarity=0.381  Sum_probs=123.2

Q ss_pred             CCCCCccccccceEEEEEEeC-CC---CEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCee-EEEE
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-DG---KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK-LLVY  362 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-~~---~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lv~  362 (438)
                      |...+.||+|+||.||+|++. ++   ..||+|.++..........+.+|+.+++.++||||+++++++.+.+.. +++|
T Consensus        23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  102 (298)
T 3pls_A           23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL  102 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence            444578999999999999863 22   379999987544333445789999999999999999999999876665 9999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||+.+|+|.++++...   ..+++.++..++.|++.||+|||++   +|+||||||+||++++++.++++||.-
T Consensus       103 e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~  170 (298)
T 3pls_A          103 PYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGL  170 (298)
T ss_dssp             CCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTS
T ss_pred             ecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCC
Confidence            9999999999997643   2478999999999999999999999   999999999999999999999999973

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.91  E-value=3.4e-24  Score=203.13  Aligned_cols=145  Identities=23%  Similarity=0.393  Sum_probs=129.3

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccc--cccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      .++|...+.||+|+||.||+|+.. +++.||||.++...  .......+.+|+..++.++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            456788899999999999999975 68999999986532  223345789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |||+++++|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++||.-
T Consensus        90 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~  157 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGL  157 (276)
T ss_dssp             EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCG
T ss_pred             EeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccc
Confidence            99999999999997653    388999999999999999999999   999999999999999999999999963

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.91  E-value=4.1e-24  Score=203.34  Aligned_cols=144  Identities=26%  Similarity=0.349  Sum_probs=127.4

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc-----chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-----GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  359 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  359 (438)
                      ++|...+.||+|+||.||+|+.. +++.||+|.++......     ....+.+|+.+++.++||||+++++++...+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            45777889999999999999975 68999999986543221     2457899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC----Ccchhhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA----DQSSKTIL  435 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~----~~~l~Df~  435 (438)
                      +||||+++++|.+++....    .+++.++..++.|++.||+|||+.   +|+||||||+||++++++    .++++||.
T Consensus        85 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            9999999999999997643    489999999999999999999999   999999999999999887    79999996


Q ss_pred             h
Q 013682          436 R  436 (438)
Q Consensus       436 ~  436 (438)
                      -
T Consensus       158 ~  158 (283)
T 3bhy_A          158 I  158 (283)
T ss_dssp             T
T ss_pred             c
Confidence            3

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.91  E-value=4.5e-24  Score=203.12  Aligned_cols=145  Identities=22%  Similarity=0.302  Sum_probs=127.6

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      .++|+..+.||+|+||.||+|... +++.||+|+++..... .....+.+|+.++..++||||+++++++...+..+++|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            467888899999999999999875 5889999998654322 22346889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC---cchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD---QSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~---~~l~Df~~  436 (438)
                      ||+++++|.+.+....    .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.   ++++||.-
T Consensus        85 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~  154 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGL  154 (284)
T ss_dssp             CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             ecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence            9999999999887653    389999999999999999999999   9999999999999987765   89999963

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.91  E-value=6.3e-24  Score=207.02  Aligned_cols=135  Identities=20%  Similarity=0.314  Sum_probs=119.8

Q ss_pred             CCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCC-CCCceeeEEEEeeCCeeEEEEecCCCC
Q 013682          291 KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPYMTNG  368 (438)
Q Consensus       291 ~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~g  368 (438)
                      .+.||+|+||.||+|+.. +++.||||+++..    ....+.+|+..+..+. ||||+++++++.+....++||||+++|
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~   91 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG   91 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence            478999999999999975 6899999998542    2346789999999997 999999999999999999999999999


Q ss_pred             CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC---Ccchhhhhh
Q 013682          369 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSKTILR  436 (438)
Q Consensus       369 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~---~~~l~Df~~  436 (438)
                      +|.+++....    .+++.++..++.|++.||+|||++   +|+||||||+|||++.++   .++|+||.-
T Consensus        92 ~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~  155 (325)
T 3kn6_A           92 ELFERIKKKK----HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGF  155 (325)
T ss_dssp             BHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTT
T ss_pred             cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEecccc
Confidence            9999998753    489999999999999999999999   999999999999998766   789999963

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.91  E-value=4.2e-24  Score=209.00  Aligned_cols=144  Identities=22%  Similarity=0.325  Sum_probs=127.5

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc--cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|...+.||+|+||.||+++.. +++.||+|.+......  .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            45677789999999999999975 5789999998654322  22346889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||+++++|.+++....    .+++.++..++.|++.||+|||++   +|+||||||+||+++.++.++|+||.-
T Consensus       121 e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~  187 (335)
T 2owb_A          121 ELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGL  187 (335)
T ss_dssp             CCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             ecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccC
Confidence            9999999999987643    489999999999999999999999   999999999999999999999999963

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.90  E-value=1e-24  Score=213.59  Aligned_cols=151  Identities=21%  Similarity=0.248  Sum_probs=126.2

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccc----cccchHHHHHHHHHHhcCCCCCceeeEEEEeeCC
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER----TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT  356 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  356 (438)
                      ....++|...+.||+|+||.||+|+.. +++.||+|+++...    .......+.+|+.+++.++||||+++++++.+.+
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            445567888999999999999999874 68899999986532    2233457899999999999999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhccCCC------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 013682          357 EKLLVYPYMTNGSVASRLRERQSS------------------------------------LPPLDWPTRKKIALGSARGL  400 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~ia~gL  400 (438)
                      ..++||||+++|+|.+++......                                    ...+++..+..++.|++.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            999999999999999998631100                                    11235667788999999999


Q ss_pred             HHHhcCCCCCceecCCCCCCeeeCCCC--Ccchhhhh
Q 013682          401 SYLHEHCDPKIIHRDVKAANILLDEDA--DQSSKTIL  435 (438)
Q Consensus       401 ~yLH~~~~~~ivHrDLK~~NILld~~~--~~~l~Df~  435 (438)
                      +|||+.   +|+||||||+|||++.++  .++|+||.
T Consensus       182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg  215 (345)
T 3hko_A          182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFG  215 (345)
T ss_dssp             HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCT
T ss_pred             HHHHHC---CccccCCChhhEEEecCCCceEEEeecc
Confidence            999999   999999999999998776  89999996

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.90  E-value=4.9e-24  Score=206.07  Aligned_cols=144  Identities=23%  Similarity=0.305  Sum_probs=129.1

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccc--hHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      .++|...+.||+|+||.||+|+.. +++.||+|.++.....+.  ...+.+|+.++..++||||+++++++...+..+++
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            467888899999999999999975 688999999875433222  24688999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |||+++++|.+++....    .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.++++||.
T Consensus       113 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg  179 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFG  179 (309)
T ss_dssp             EECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCC
T ss_pred             EEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCc
Confidence            99999999999998653    489999999999999999999999   99999999999999999999999996

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.90  E-value=1.7e-24  Score=205.63  Aligned_cols=148  Identities=23%  Similarity=0.329  Sum_probs=127.0

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEee--CCeeEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEKLLV  361 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv  361 (438)
                      ++|+..+.||+|+||.||+|+.. +++.||+|.++..... .....+.+|+.+++.++||||+++++++..  ....++|
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   85 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   85 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence            46777899999999999999875 6899999998654322 223468999999999999999999998754  5678999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----ceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK-----IIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-----ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |||+++|+|.+++.........+++..+..++.|++.||+|||+.   +     |+||||||+||++++++.++++||.-
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~  162 (279)
T 2w5a_A           86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  162 (279)
T ss_dssp             EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred             EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence            999999999999986543344589999999999999999999998   6     99999999999999999999999963

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.90  E-value=4.5e-24  Score=206.04  Aligned_cols=148  Identities=20%  Similarity=0.295  Sum_probs=126.3

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccc--cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|...+.||+|+||.||+|+. .+++.||+|+++.....  .....+.+|+.+++.++||||+++++++...+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            4677789999999999999986 46899999998653222  22346889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||+++|+|.+++.........+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++||.-
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~  182 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGL  182 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccc
Confidence            99999999999875332334589999999999999999999999   999999999999999999999999963

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.90  E-value=3.9e-24  Score=203.80  Aligned_cols=144  Identities=28%  Similarity=0.444  Sum_probs=128.2

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      .++|...+.||+|+||.||+|+.. +++.||+|.+.....  ......+.+|+.++..++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            356778899999999999999975 578999999864321  22345789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++||.
T Consensus        93 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg  159 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFG  159 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             EEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEeccc
Confidence            99999999999998653    388999999999999999999999   99999999999999999999999996

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=3e-24  Score=205.05  Aligned_cols=143  Identities=23%  Similarity=0.334  Sum_probs=123.6

Q ss_pred             CCCCCC-ccccccceEEEEEEeC---CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          287 GFSNKN-ILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       287 ~~~~~~-~LG~G~fG~Vy~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      +|...+ .||+|+||.||+|.+.   ++..||||.++..........+.+|+.++..++||||+++++++ ..+..++||
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~   88 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM   88 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred             HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence            344444 8999999999999863   57789999997654333445789999999999999999999999 556789999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||+++++|.+++....   ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++++||.-
T Consensus        89 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~  156 (287)
T 1u59_A           89 EMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGL  156 (287)
T ss_dssp             ECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred             EeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccc
Confidence            9999999999997542   2489999999999999999999999   999999999999999999999999963

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.90  E-value=3.2e-24  Score=228.70  Aligned_cols=146  Identities=24%  Similarity=0.318  Sum_probs=128.5

Q ss_pred             HHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccc--cccchHHHHHHHHHHhcC-CCCCceeeEEEEeeCCee
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEK  358 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  358 (438)
                      ...++|+..+.||+|+||+||+|+.. +++.||||+++...  .......+..|..++..+ +||||+++++++.+.+..
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            34567888899999999999999975 58899999997532  223344678899999887 799999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++||||+++|+|.++++...    .+++..+..++.|++.||+|||++   +|+||||||+|||+|.++.++|+||+
T Consensus       418 ~lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFG  487 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFG  487 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCT
T ss_pred             EEEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecc
Confidence            99999999999999998753    389999999999999999999999   99999999999999999999999997

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.90  E-value=3.1e-24  Score=209.26  Aligned_cols=142  Identities=19%  Similarity=0.243  Sum_probs=125.3

Q ss_pred             hCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEeeCCeeEEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      .++|...+.||+|+||.||+|+. .+++.||||.++...   ....+.+|+.++..+ +||||+++++++...+..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS---RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC---SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            35688889999999999999996 468899999986432   223588999999999 9999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC-----cchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD-----QSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~-----~~l~Df~~  436 (438)
                      ||+ +++|.+++....   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.     ++|+||.-
T Consensus        85 e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~  156 (330)
T 2izr_A           85 ELL-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL  156 (330)
T ss_dssp             ECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred             EeC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence            999 999999998642   2589999999999999999999999   9999999999999999887     99999974

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.90  E-value=3.4e-24  Score=216.27  Aligned_cols=146  Identities=23%  Similarity=0.332  Sum_probs=123.4

Q ss_pred             HHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc-------ccchHHHHHHHHHHhcCCCCCceeeEEEEee
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-------SGGELQFQTEVKIISMAVHRNLLRLYGFCTT  354 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~  354 (438)
                      ...++|...+.||+|+||.||+|... +++.||||+++....       ......+.+|+.+++.++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            45678999999999999999999874 688999999865321       111225889999999999999999999975 


Q ss_pred             CCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC---Ccch
Q 013682          355 VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSS  431 (438)
Q Consensus       355 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~---~~~l  431 (438)
                      .+..++||||+++|+|.+++....    .+++.++..++.|++.||+|||++   +|+||||||+|||++.++   .++|
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             cCceEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence            456899999999999998886542    489999999999999999999999   999999999999997654   4999


Q ss_pred             hhhhh
Q 013682          432 KTILR  436 (438)
Q Consensus       432 ~Df~~  436 (438)
                      +||.-
T Consensus       284 ~DFG~  288 (419)
T 3i6u_A          284 TDFGH  288 (419)
T ss_dssp             CCSST
T ss_pred             eeccc
Confidence            99973

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.90  E-value=3.4e-24  Score=211.00  Aligned_cols=143  Identities=31%  Similarity=0.438  Sum_probs=124.7

Q ss_pred             CCCCCCccccccceEEEEEEe-CCCCEEEEEEcccccccc--chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          287 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .|...+.||+|+||.||+|+. .+++.||||+++......  ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus        55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  134 (348)
T 1u5q_A           55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME  134 (348)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence            467778999999999999986 578899999986432221  22468899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |+. |++.+.+....   ..+++.++..++.|++.||+|||++   +|+||||||+|||+++++.++|+||+-
T Consensus       135 ~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~  200 (348)
T 1u5q_A          135 YCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGS  200 (348)
T ss_dssp             CCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred             cCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccC
Confidence            997 68888876543   2489999999999999999999999   999999999999999999999999963

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.90  E-value=2.5e-24  Score=212.36  Aligned_cols=154  Identities=19%  Similarity=0.259  Sum_probs=131.9

Q ss_pred             cccHHHHHHHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCC-----CCCceee
Q 013682          275 RFSLRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-----HRNLLRL  348 (438)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l  348 (438)
                      .+++++.....++|...+.||+|+||.||+|+.. +++.||||+++...  .....+..|+.++..++     ||||+++
T Consensus        24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--KYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH--HHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch--hhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            3445555566788999999999999999999974 68899999986422  22345778999998886     9999999


Q ss_pred             EEEEeeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC---
Q 013682          349 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---  425 (438)
Q Consensus       349 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~---  425 (438)
                      ++++...+..++||||+ +++|.+++.....  ..+++.++..++.|++.||+|||++   +|+||||||+|||+++   
T Consensus       102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~  175 (360)
T 3llt_A          102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYF  175 (360)
T ss_dssp             EEEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTC
T ss_pred             cceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccc
Confidence            99999999999999999 8999999986532  2489999999999999999999999   9999999999999986   


Q ss_pred             ----------------------CCCcchhhhhh
Q 013682          426 ----------------------DADQSSKTILR  436 (438)
Q Consensus       426 ----------------------~~~~~l~Df~~  436 (438)
                                            ++.++|+||+-
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~  208 (360)
T 3llt_A          176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC  208 (360)
T ss_dssp             CEEEEEEECTTTCCEEEEEEESCCCEEECCCTT
T ss_pred             cccccchhcccccccccccccCCCCEEEEeccC
Confidence                                  78899999974

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.90  E-value=3.6e-24  Score=208.49  Aligned_cols=149  Identities=31%  Similarity=0.402  Sum_probs=125.7

Q ss_pred             HhCCCCCCCccccccceEEEEEEeC------CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCe
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  357 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  357 (438)
                      ..++|...+.||+|+||.||+|++.      +++.||||.++..........+.+|+.+++.++||||+++++++.....
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            3467888899999999999999842      4678999999754433444578999999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhccCCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC---CCcch
Q 013682          358 KLLVYPYMTNGSVASRLRERQSS---LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED---ADQSS  431 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~---~~~~l  431 (438)
                      .++||||+++|+|.+++......   ...+++.++..++.|++.||+|||+.   +|+||||||+|||++.+   ..+++
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence            99999999999999999875421   13489999999999999999999999   99999999999999954   45899


Q ss_pred             hhhh
Q 013682          432 KTIL  435 (438)
Q Consensus       432 ~Df~  435 (438)
                      +||.
T Consensus       185 ~Dfg  188 (327)
T 2yfx_A          185 GDFG  188 (327)
T ss_dssp             CCCH
T ss_pred             Cccc
Confidence            9996

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.90  E-value=4e-24  Score=202.07  Aligned_cols=146  Identities=29%  Similarity=0.426  Sum_probs=121.4

Q ss_pred             hCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccc---cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS---GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      .++|+..+.||+|+||.||+|++. ++.||||+++.....   .....+.+|+.+++.++||||+++++++...+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            456778899999999999999974 789999998654322   2234688999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC--------CCCcchhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE--------DADQSSKT  433 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~--------~~~~~l~D  433 (438)
                      |||+++++|.+++...     .+++..+..++.|++.||+|||++...+|+||||||+||+++.        ++.++++|
T Consensus        85 ~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            9999999999998643     4899999999999999999999983233999999999999996        67799999


Q ss_pred             hhh
Q 013682          434 ILR  436 (438)
Q Consensus       434 f~~  436 (438)
                      |.-
T Consensus       160 fg~  162 (271)
T 3dtc_A          160 FGL  162 (271)
T ss_dssp             CCC
T ss_pred             CCc
Confidence            963

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.90  E-value=4.1e-24  Score=216.56  Aligned_cols=144  Identities=25%  Similarity=0.329  Sum_probs=125.8

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeC-----Ce
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TE  357 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~  357 (438)
                      .++|...+.||+|+||.||+|+.. +++.||||+++..... .....+.+|+.+++.++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            457888899999999999999874 5889999999654222 2234689999999999999999999998775     56


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      .++||||+. |+|.++++...    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||+-
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGl  175 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI----FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGL  175 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEecCC-cCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCC
Confidence            899999987 59999997642    489999999999999999999999   999999999999999999999999973

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.90  E-value=3.7e-24  Score=212.69  Aligned_cols=138  Identities=24%  Similarity=0.344  Sum_probs=117.2

Q ss_pred             CCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCCCC
Q 013682          291 KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS  369 (438)
Q Consensus       291 ~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs  369 (438)
                      .+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|+.++..++||||+++++++...+..++||||+++|+
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            467999999999999874 689999999865422 234478999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee--CCCCCcchhhhh
Q 013682          370 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL--DEDADQSSKTIL  435 (438)
Q Consensus       370 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILl--d~~~~~~l~Df~  435 (438)
                      |.+++....   ..+++..+..++.|++.||+|||+.   +|+||||||+|||+  ++++.++|+||.
T Consensus       173 L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG  234 (373)
T 2x4f_A          173 LFDRIIDES---YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFG  234 (373)
T ss_dssp             EHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCS
T ss_pred             HHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCC
Confidence            999887542   2488999999999999999999999   99999999999999  667889999996

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.90  E-value=1.9e-24  Score=208.98  Aligned_cols=152  Identities=26%  Similarity=0.422  Sum_probs=123.4

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEeC----CCCEEEEEEcccccccc-chHHHHHHHHHHhcCCCCCceeeEEEEeeCC
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVT  356 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~----~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  356 (438)
                      ....++|...+.||+|+||.||+|+..    +++.||+|.++...... ....+.+|+.+++.++||||+++++++...+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            445567888899999999999999763    24589999987543222 2346899999999999999999999998755


Q ss_pred             e-----eEEEEecCCCCCHHHHhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCc
Q 013682          357 E-----KLLVYPYMTNGSVASRLRERQ--SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  429 (438)
Q Consensus       357 ~-----~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~  429 (438)
                      .     .+++|||+++|+|.+++....  .....+++..+..++.|++.||.|||++   +|+||||||+||++++++.+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcE
Confidence            3     499999999999999986432  2234589999999999999999999999   99999999999999999999


Q ss_pred             chhhhhh
Q 013682          430 SSKTILR  436 (438)
Q Consensus       430 ~l~Df~~  436 (438)
                      +++||.-
T Consensus       187 kl~Dfg~  193 (313)
T 3brb_A          187 CVADFGL  193 (313)
T ss_dssp             EECSCSC
T ss_pred             EEeecCc
Confidence            9999973

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.90  E-value=4.2e-24  Score=208.40  Aligned_cols=145  Identities=26%  Similarity=0.461  Sum_probs=125.9

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCC----EEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  359 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~----~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  359 (438)
                      .++|+..+.||+|+||.||+|++. +++    .||+|.++..........+.+|+.+++.++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            356888899999999999999864 444    357887765544455668999999999999999999999998754 78


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      +++||+++|+|.+++.....   .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+||.-
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~  163 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGL  163 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred             EEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcc
Confidence            99999999999999987532   489999999999999999999999   999999999999999999999999973

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.90  E-value=8.5e-24  Score=218.38  Aligned_cols=144  Identities=22%  Similarity=0.361  Sum_probs=124.3

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc------------cchHHHHHHHHHHhcCCCCCceeeEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS------------GGELQFQTEVKIISMAVHRNLLRLYGF  351 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~------------~~~~~~~~E~~~l~~l~H~niv~l~g~  351 (438)
                      .++|...+.||+|+||.||+|+.. +++.||+|+++.....            .....+.+|+.+++.++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            456888899999999999999975 5789999998654321            223468899999999999999999999


Q ss_pred             EeeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC---C
Q 013682          352 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---D  428 (438)
Q Consensus       352 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~---~  428 (438)
                      +.+....++||||+++|+|.+.+....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++   .
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence            999999999999999999999987653    389999999999999999999999   999999999999999876   6


Q ss_pred             cchhhhh
Q 013682          429 QSSKTIL  435 (438)
Q Consensus       429 ~~l~Df~  435 (438)
                      ++|+||+
T Consensus       188 ~kl~Dfg  194 (504)
T 3q5i_A          188 IKIVDFG  194 (504)
T ss_dssp             EEECCCT
T ss_pred             EEEEECC
Confidence            8999996

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.90  E-value=6.1e-24  Score=204.07  Aligned_cols=144  Identities=25%  Similarity=0.401  Sum_probs=126.3

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .+.|+..+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++..++||||+++++++...+..++|||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            456778899999999999999985 58899999986542 3344578999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+++++|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++||.
T Consensus        97 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  162 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFG  162 (302)
T ss_dssp             CCTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCH
T ss_pred             eCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECC
Confidence            9999999999876432   489999999999999999999999   99999999999999999999999996

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.90  E-value=1.8e-23  Score=199.96  Aligned_cols=146  Identities=23%  Similarity=0.353  Sum_probs=125.7

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      ++|.....||+|+||.||+|+. .+++.||||.++... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  100 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ  100 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence            3455567899999999999996 468899999986542 23345789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC-CCCcchhhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTILR  436 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~-~~~~~l~Df~~  436 (438)
                      +++++|.+++..... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++. ++.++++||.-
T Consensus       101 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~  169 (295)
T 2clq_A          101 VPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGT  169 (295)
T ss_dssp             CSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTT
T ss_pred             CCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeeccc
Confidence            999999999987532 23467889999999999999999999   9999999999999998 89999999963

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.90  E-value=6.6e-24  Score=211.81  Aligned_cols=144  Identities=23%  Similarity=0.380  Sum_probs=117.2

Q ss_pred             HHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCC-CCCceeeEEEEeeCC--e
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAV-HRNLLRLYGFCTTVT--E  357 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~  357 (438)
                      ...++|+..+.||+|+||.||+|... +++.||||++...... .....+.+|+.++..+. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            34578888999999999999999864 6899999998643222 22346789999999997 999999999997644  6


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      .++||||++ |+|.+.++..     .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||+
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG  154 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFG  154 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCc
Confidence            899999998 6899998763     388999999999999999999999   99999999999999999999999997

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.90  E-value=5.3e-24  Score=207.77  Aligned_cols=144  Identities=25%  Similarity=0.412  Sum_probs=126.3

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc-chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      ++|+..+.||+|+||.||+|+.. +++.||||++....... ....+.+|+.++..++||||+++++++...+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            45777889999999999999975 58999999986543222 23357899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |+++++|..+.....    .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+||.-
T Consensus       105 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~  170 (331)
T 4aaa_A          105 FVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF  170 (331)
T ss_dssp             CCSEEHHHHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             cCCcchHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCC
Confidence            999999988765432    389999999999999999999999   999999999999999999999999973

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=1.2e-23  Score=204.97  Aligned_cols=145  Identities=28%  Similarity=0.405  Sum_probs=123.1

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhc--CCCCCceeeEEEEeeC----
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM--AVHRNLLRLYGFCTTV----  355 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~----  355 (438)
                      ....++|+..+.||+|+||.||+|+.. ++.||||++...    ....+.+|.+++..  ++||||+++++++...    
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            344567999999999999999999985 889999998542    22345555555554  4899999999999887    


Q ss_pred             CeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCceecCCCCCCeeeCCCCCcc
Q 013682          356 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC-----DPKIIHRDVKAANILLDEDADQS  430 (438)
Q Consensus       356 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDLK~~NILld~~~~~~  430 (438)
                      ...++||||+++|+|.++++..     .+++..+..++.|++.||+|||+.+     .++|+||||||+|||++.++.++
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence            6789999999999999999764     3899999999999999999999862     45899999999999999999999


Q ss_pred             hhhhhh
Q 013682          431 SKTILR  436 (438)
Q Consensus       431 l~Df~~  436 (438)
                      |+||.-
T Consensus       183 l~Dfg~  188 (337)
T 3mdy_A          183 IADLGL  188 (337)
T ss_dssp             ECCCTT
T ss_pred             EEeCCC
Confidence            999974

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.90  E-value=5e-24  Score=207.93  Aligned_cols=146  Identities=22%  Similarity=0.341  Sum_probs=122.8

Q ss_pred             HHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc-chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      ...++|...+.||+|+||.||+|+.. +++.||||+++...... ....+.+|+.+++.++||||+++++++...+..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            34567888899999999999999864 68899999996543322 23357899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC-----CCCCcchhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-----EDADQSSKTIL  435 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld-----~~~~~~l~Df~  435 (438)
                      ||||++ |+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++     +++.++|+||.
T Consensus       111 v~e~~~-~~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          111 IFEYAE-NDLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             EEECCS-EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             EEecCC-CCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            999998 59999997653    389999999999999999999999   999999999999994     44559999997


Q ss_pred             h
Q 013682          436 R  436 (438)
Q Consensus       436 ~  436 (438)
                      -
T Consensus       183 ~  183 (329)
T 3gbz_A          183 L  183 (329)
T ss_dssp             H
T ss_pred             C
Confidence            3

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.90  E-value=1.1e-23  Score=203.14  Aligned_cols=148  Identities=28%  Similarity=0.433  Sum_probs=122.1

Q ss_pred             HHhCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccc----cchHHHHHHHHHHhcCC---CCCceeeEEEEee
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS----GGELQFQTEVKIISMAV---HRNLLRLYGFCTT  354 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~----~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~  354 (438)
                      ...++|+..+.||+|+||.||+|+. .+++.||||+++.....    .....+.+|+.+++.++   ||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            3467899999999999999999996 46899999998643211    11235778887777664   9999999999987


Q ss_pred             CC-----eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCc
Q 013682          355 VT-----EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  429 (438)
Q Consensus       355 ~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~  429 (438)
                      ..     ..+++|||+. |+|.+++.....  ..+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~  159 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV  159 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence            55     4789999997 699999986532  2489999999999999999999999   99999999999999999999


Q ss_pred             chhhhhh
Q 013682          430 SSKTILR  436 (438)
Q Consensus       430 ~l~Df~~  436 (438)
                      +|+||.-
T Consensus       160 kl~Dfg~  166 (308)
T 3g33_A          160 KLADFGL  166 (308)
T ss_dssp             EECSCSC
T ss_pred             EEeeCcc
Confidence            9999973

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.90  E-value=2.8e-24  Score=210.72  Aligned_cols=146  Identities=25%  Similarity=0.347  Sum_probs=128.6

Q ss_pred             hCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccch----------------HHHHHHHHHHhcCCCCCceee
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGE----------------LQFQTEVKIISMAVHRNLLRL  348 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~----------------~~~~~E~~~l~~l~H~niv~l  348 (438)
                      .++|...+.||+|+||.||+|+. +++.||+|.++........                ..+.+|+.++..++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46788889999999999999998 8999999998654322111                579999999999999999999


Q ss_pred             EEEEeeCCeeEEEEecCCCCCHHHH------hhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceecCCCCCCe
Q 013682          349 YGFCTTVTEKLLVYPYMTNGSVASR------LRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANI  421 (438)
Q Consensus       349 ~g~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDLK~~NI  421 (438)
                      ++++...+..++||||+++|+|.++      +...  ....+++..+..++.|++.||+|||+ .   +|+||||||+||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni  183 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI  183 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence            9999999999999999999999988      5432  13458999999999999999999998 8   999999999999


Q ss_pred             eeCCCCCcchhhhhh
Q 013682          422 LLDEDADQSSKTILR  436 (438)
Q Consensus       422 Lld~~~~~~l~Df~~  436 (438)
                      +++.++.++++||.-
T Consensus       184 l~~~~~~~kl~dfg~  198 (348)
T 2pml_X          184 LMDKNGRVKLSDFGE  198 (348)
T ss_dssp             EECTTSCEEECCCTT
T ss_pred             EEcCCCcEEEecccc
Confidence            999999999999974

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.90  E-value=3.7e-24  Score=203.68  Aligned_cols=146  Identities=24%  Similarity=0.338  Sum_probs=125.7

Q ss_pred             HhCCCCCCCccccccceEEEEEEeCC----CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeE
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  359 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~~----~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  359 (438)
                      ..++|...+.||+|+||.||+|++.+    +..||+|.++..........+.+|+.+++.++||||+++++++.+ +..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            34567788999999999999998632    346999998765433345579999999999999999999999865 4578


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      +||||+++++|.+++....   ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++++||.-
T Consensus        89 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~  159 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGL  159 (281)
T ss_dssp             EEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred             EEEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCC
Confidence            9999999999999997643   2488999999999999999999999   999999999999999999999999963

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.90  E-value=4.1e-24  Score=208.11  Aligned_cols=144  Identities=26%  Similarity=0.387  Sum_probs=125.4

Q ss_pred             CCCCCCCccccccceEEEEEEe-----CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEee--CCee
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEK  358 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-----~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~  358 (438)
                      ++|+..+.||+|+||.||+|++     .+++.||||+++... ......+.+|+.+++.++||||+++++++..  ....
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            4677788999999999999984     357899999986542 2233468999999999999999999999874  5568


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ++||||+++++|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++++||.-
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~  173 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGL  173 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred             EEEEeecCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccc
Confidence            899999999999999976432   389999999999999999999999   999999999999999999999999974

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.90  E-value=7e-24  Score=224.62  Aligned_cols=136  Identities=26%  Similarity=0.361  Sum_probs=120.0

Q ss_pred             CccccccceEEEEEEeC---CCCEEEEEEcccccccc-chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCC
Q 013682          292 NILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  367 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~---~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  367 (438)
                      +.||+|+||.||+|.+.   .++.||||+++...... ....+.+|+.++..++|||||++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            46999999999999653   46789999997654332 24579999999999999999999999864 568899999999


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          368 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+|.++++...    .+++.++..++.||+.||+|||++   +|+||||||+|||+++++.++|+||+
T Consensus       454 g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFG  514 (635)
T 4fl3_A          454 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFG  514 (635)
T ss_dssp             EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTT
T ss_pred             CCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcC
Confidence            99999997643    489999999999999999999999   99999999999999999999999997

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.90  E-value=1.2e-23  Score=208.50  Aligned_cols=148  Identities=23%  Similarity=0.314  Sum_probs=129.8

Q ss_pred             HHHHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccc-------hHHHHHHHHHHhcC-CCCCceeeEEE
Q 013682          281 LQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG-------ELQFQTEVKIISMA-VHRNLLRLYGF  351 (438)
Q Consensus       281 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~-------~~~~~~E~~~l~~l-~H~niv~l~g~  351 (438)
                      .....++|...+.||+|+||.||+|+.. +|+.||||+++.......       ...+.+|+.++..+ +||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            3445567888899999999999999985 689999999865432111       23578899999998 79999999999


Q ss_pred             EeeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcch
Q 013682          352 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS  431 (438)
Q Consensus       352 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l  431 (438)
                      +......++||||+++++|.+++....    .+++..+..++.|++.||.|||+.   +|+||||||+|||+++++.+++
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl  241 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRL  241 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence            999999999999999999999998643    489999999999999999999999   9999999999999999999999


Q ss_pred             hhhh
Q 013682          432 KTIL  435 (438)
Q Consensus       432 ~Df~  435 (438)
                      +||+
T Consensus       242 ~DfG  245 (365)
T 2y7j_A          242 SDFG  245 (365)
T ss_dssp             CCCT
T ss_pred             EecC
Confidence            9997

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.90  E-value=9e-24  Score=216.99  Aligned_cols=144  Identities=26%  Similarity=0.438  Sum_probs=127.6

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      .++|...+.||+|+||.||+|+.. +++.||||++.....  ......+.+|+.+++.++||||+++++++...+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            345777899999999999999975 689999999864432  23345789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee---CCCCCcchhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTIL  435 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILl---d~~~~~~l~Df~  435 (438)
                      |||+.+|+|.+.+....    .+++..+..++.|++.||+|||++   +|+||||||+|||+   +.++.++|+||+
T Consensus       105 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  174 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFG  174 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred             EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence            99999999999987643    489999999999999999999999   99999999999999   467889999996

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.90  E-value=1.1e-23  Score=201.91  Aligned_cols=144  Identities=22%  Similarity=0.443  Sum_probs=124.4

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      ++|+..+.||+|+||.||+|+.. +++.||||.++..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (299)
T 2r3i_A            3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence            56778899999999999999975 6899999998654322 223468899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+. |+|.+++.....  ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++++||.
T Consensus        83 ~~~-~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg  148 (299)
T 2r3i_A           83 FLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFG  148 (299)
T ss_dssp             CCS-EEHHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECSTT
T ss_pred             ccc-CCHHHHHHhhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHeEEcCCCCEEECcch
Confidence            998 699999876532  2478999999999999999999999   99999999999999999999999996

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.90  E-value=3e-24  Score=205.49  Aligned_cols=144  Identities=24%  Similarity=0.343  Sum_probs=122.4

Q ss_pred             hCCCCCCC-ccccccceEEEEEEe---CCCCEEEEEEccccccccc-hHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeE
Q 013682          285 TDGFSNKN-ILGRGGFGKVYKGRL---ADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  359 (438)
Q Consensus       285 ~~~~~~~~-~LG~G~fG~Vy~~~~---~~~~~vAvK~l~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  359 (438)
                      .++|...+ .||+|+||.||+|.+   .+++.||||.++....... ...+.+|+.+++.++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            34566666 899999999999964   2467899999975433222 34789999999999999999999999 667789


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      +||||+++++|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++||.-
T Consensus        94 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~  163 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGL  163 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             EEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCc
Confidence            9999999999999998643    389999999999999999999999   999999999999999999999999963

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=7.3e-24  Score=208.19  Aligned_cols=146  Identities=27%  Similarity=0.411  Sum_probs=121.4

Q ss_pred             HhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc----chHHHHHHHHHHhcCCCCCceeeEEEEeeCCee
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG----GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  358 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  358 (438)
                      ..++|...+.||+|+||.||+|+.. +++.||||.++......    ....+.+|+.++..++||||+++++++...+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            3467888999999999999999975 58999999986532211    123688999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ++||||+++ +|.+.+....   ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+||.-
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGL  158 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred             EEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccc
Confidence            999999986 8888887543   2478889999999999999999999   999999999999999999999999974

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.90  E-value=5.5e-24  Score=212.09  Aligned_cols=146  Identities=21%  Similarity=0.291  Sum_probs=120.2

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeC-----
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----  355 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----  355 (438)
                      +...++|...+.||+|+||.||+|+. .+++.||||++.....     ...+|+.+++.++|||||++++++...     
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            34567888899999999999999986 4789999999854321     234799999999999999999998543     


Q ss_pred             ---------------------------------CeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHH
Q 013682          356 ---------------------------------TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY  402 (438)
Q Consensus       356 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~y  402 (438)
                                                       ...++||||++ |+|.+.+.........+++..+..++.|++.||+|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                             33789999998 58888776532233458999999999999999999


Q ss_pred             HhcCCCCCceecCCCCCCeeeC-CCCCcchhhhhh
Q 013682          403 LHEHCDPKIIHRDVKAANILLD-EDADQSSKTILR  436 (438)
Q Consensus       403 LH~~~~~~ivHrDLK~~NILld-~~~~~~l~Df~~  436 (438)
                      ||+.   +|+||||||+|||++ .++.++|+||.-
T Consensus       157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~  188 (383)
T 3eb0_A          157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGS  188 (383)
T ss_dssp             HHTT---TEECSCCCGGGEEEETTTTEEEECCCTT
T ss_pred             HHHC---cCccCccCHHHEEEcCCCCcEEEEECCC
Confidence            9999   999999999999998 678999999974

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.90  E-value=4.8e-24  Score=202.65  Aligned_cols=141  Identities=25%  Similarity=0.433  Sum_probs=124.1

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEee---------
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT---------  354 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~---------  354 (438)
                      .++|+..+.||+|+||.||+|+.. +++.||+|.++...     ..+.+|+.++..++||||+++++++..         
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            456788899999999999999985 78999999986432     357899999999999999999998864         


Q ss_pred             -------CCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC
Q 013682          355 -------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  427 (438)
Q Consensus       355 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~  427 (438)
                             ....++||||+++|+|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCC
Confidence                   3457899999999999999976422  3489999999999999999999999   999999999999999999


Q ss_pred             Ccchhhhh
Q 013682          428 DQSSKTIL  435 (438)
Q Consensus       428 ~~~l~Df~  435 (438)
                      .++++||.
T Consensus       160 ~~kl~Dfg  167 (284)
T 2a19_B          160 QVKIGDFG  167 (284)
T ss_dssp             EEEECCCT
T ss_pred             CEEECcch
Confidence            99999997

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.90  E-value=6.7e-24  Score=208.40  Aligned_cols=140  Identities=19%  Similarity=0.287  Sum_probs=121.1

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEeeCCeeEEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      .++|+..+.||+|+||.||+|+.. +++.||||.++....     ...+|++++.++ +||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            456888899999999999999875 688999999865321     245678878776 7999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC-C---Ccchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-A---DQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~-~---~~~l~Df~~  436 (438)
                      ||+++|+|.+++....    .+++.++..++.|++.||+|||++   +|+||||||+|||+.++ +   .++++||.-
T Consensus        96 E~~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~  166 (342)
T 2qr7_A           96 ELMKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGF  166 (342)
T ss_dssp             CCCCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred             eCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence            9999999999997643    489999999999999999999999   99999999999998543 3   489999973

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.90  E-value=1.6e-23  Score=200.27  Aligned_cols=142  Identities=25%  Similarity=0.374  Sum_probs=122.5

Q ss_pred             CCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEee----CCeeEEE
Q 013682          288 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT----VTEKLLV  361 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv  361 (438)
                      |...+.||+|+||.||+|... ++..||+|.++..... .....+.+|+.+++.++||||+++++++..    ....++|
T Consensus        28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  107 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence            555678999999999999874 6789999998654322 223468999999999999999999999875    3457899


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeeeC-CCCCcchhhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK--IIHRDVKAANILLD-EDADQSSKTILR  436 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDLK~~NILld-~~~~~~l~Df~~  436 (438)
                      |||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +  |+||||||+||+++ +++.++++||.-
T Consensus       108 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~  178 (290)
T 1t4h_A          108 TELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL  178 (290)
T ss_dssp             EECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             EEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence            99999999999998643    388999999999999999999998   6  99999999999998 789999999973

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.90  E-value=6.7e-24  Score=203.27  Aligned_cols=143  Identities=24%  Similarity=0.403  Sum_probs=124.6

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEee---------
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT---------  354 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~---------  354 (438)
                      .++|+..+.||+|+||.||+|+.. +++.||||.++..  ......+.+|+.+++.++||||+++++++.+         
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            346778899999999999999974 6899999998542  2233468899999999999999999998865         


Q ss_pred             ----CCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcc
Q 013682          355 ----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  430 (438)
Q Consensus       355 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~  430 (438)
                          ....++||||+++|+|.+++....   ..+++.....++.|++.||+|||++   +|+||||||+||+++.++.++
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence                346789999999999999998643   2467889999999999999999999   999999999999999999999


Q ss_pred             hhhhh
Q 013682          431 SKTIL  435 (438)
Q Consensus       431 l~Df~  435 (438)
                      ++||.
T Consensus       157 l~dfg  161 (303)
T 1zy4_A          157 IGDFG  161 (303)
T ss_dssp             ECCCC
T ss_pred             EeeCc
Confidence            99996

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.90  E-value=5.2e-24  Score=205.77  Aligned_cols=144  Identities=29%  Similarity=0.467  Sum_probs=122.5

Q ss_pred             CCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecC
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      ++|+..+.||+|+||.||+|++. ++.||||.++..   .....+.+|+.+++.++||||+++++++.  +..++||||+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~   81 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA   81 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence            45667789999999999999985 788999998542   23457899999999999999999999876  4579999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC-cchhhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD-QSSKTILR  436 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~-~~l~Df~~  436 (438)
                      ++|+|.+++.... ....+++..+..++.|+++||+|||+.+..+|+||||||+|||+++++. ++++||.-
T Consensus        82 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~  152 (307)
T 2eva_A           82 EGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT  152 (307)
T ss_dssp             TTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred             CCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence            9999999998643 2234788999999999999999999943238999999999999998887 79999963

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.90  E-value=1.1e-23  Score=202.92  Aligned_cols=143  Identities=24%  Similarity=0.387  Sum_probs=125.2

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      ++|...+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|+.++..++||||+++++++...+..++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            45777899999999999999975 689999999875432 2234688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee---CCCCCcchhhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTILR  436 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILl---d~~~~~~l~Df~~  436 (438)
                      +++++|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+||++   ++++.++++||.-
T Consensus        88 ~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~  155 (304)
T 2jam_A           88 VSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGL  155 (304)
T ss_dssp             CCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCST
T ss_pred             CCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCc
Confidence            99999999987653    388999999999999999999999   99999999999999   7889999999973

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.90  E-value=6.7e-24  Score=202.42  Aligned_cols=149  Identities=22%  Similarity=0.248  Sum_probs=121.6

Q ss_pred             hCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchH-HHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~-~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      .++|+..+.||+|+||.||+|+. .+++.||+|+++......... .+.++...++.++||||+++++++...+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            45678889999999999999997 468899999997543332222 3445555688899999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||++ |+|.+++.........+++..+..++.|++.||+|||+++  +|+||||||+||+++.++.++++||.-
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGI  156 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCC
Confidence            9997 5888877653233345899999999999999999999842  899999999999999999999999963

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.90  E-value=8.9e-24  Score=205.24  Aligned_cols=144  Identities=24%  Similarity=0.346  Sum_probs=121.5

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc-------ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCC
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-------SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT  356 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  356 (438)
                      .++|...+.||+|+||.||+|+.. +++.||||.++....       ......+.+|+.++..++||||+++++++....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            456888899999999999999875 578999999864321       112235889999999999999999999987654


Q ss_pred             eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC---cchhh
Q 013682          357 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD---QSSKT  433 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~---~~l~D  433 (438)
                       .++||||+++|+|.+++....    .+++.....++.|++.||+|||++   +|+||||||+|||++.+++   ++|+|
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             -eEEEEecCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence             899999999999999886542    489999999999999999999999   9999999999999997765   99999


Q ss_pred             hhh
Q 013682          434 ILR  436 (438)
Q Consensus       434 f~~  436 (438)
                      |.-
T Consensus       161 fg~  163 (322)
T 2ycf_A          161 FGH  163 (322)
T ss_dssp             CTT
T ss_pred             Ccc
Confidence            973

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.90  E-value=1.3e-23  Score=216.54  Aligned_cols=143  Identities=24%  Similarity=0.385  Sum_probs=121.7

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc-ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      +.|+..+.||+|+||.||+|+.. ++..||+|+++.... ......+.+|+.+++.++|||||++++++......++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            35777899999999999999975 688999999865432 2234578999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC---CCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED---ADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~---~~~~l~Df~  435 (438)
                      |+++|+|.+.+....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.+   +.++|+||+
T Consensus       117 ~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG  184 (494)
T 3lij_A          117 CYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFG  184 (494)
T ss_dssp             CCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECC
Confidence            999999999887653    389999999999999999999999   99999999999999874   448999997

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.90  E-value=7.4e-24  Score=202.63  Aligned_cols=144  Identities=30%  Similarity=0.460  Sum_probs=123.1

Q ss_pred             HHhCCCCCCCccccccceEEEEEEeCCCCEEEEEEcccccccc-chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      +..++|+..+.||+|+||.||+|+..  ..||+|.++...... ....+.+|+.+++.++||||+++++++ ..+..++|
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv   97 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV   97 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence            34567888899999999999999864  359999987543322 234689999999999999999999965 55668999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |||+++++|.+++....   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.++++||.
T Consensus        98 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg  165 (289)
T 3og7_A           98 TQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFG  165 (289)
T ss_dssp             EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred             EEecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccce
Confidence            99999999999996543   3489999999999999999999999   99999999999999999999999996

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.90  E-value=1.2e-23  Score=201.56  Aligned_cols=146  Identities=28%  Similarity=0.296  Sum_probs=128.0

Q ss_pred             HhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc--------cchHHHHHHHHHHhcCC-CCCceeeEEEEe
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--------GGELQFQTEVKIISMAV-HRNLLRLYGFCT  353 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--------~~~~~~~~E~~~l~~l~-H~niv~l~g~~~  353 (438)
                      ..++|...+.||+|+||.||+|+.. +++.||||.++.....        .....+.+|+.++.++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3567888899999999999999975 6889999998643211        11235789999999995 999999999999


Q ss_pred             eCCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhh
Q 013682          354 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKT  433 (438)
Q Consensus       354 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~D  433 (438)
                      .....++||||+++++|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++|
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence            9999999999999999999998643    489999999999999999999999   999999999999999999999999


Q ss_pred             hhh
Q 013682          434 ILR  436 (438)
Q Consensus       434 f~~  436 (438)
                      |.-
T Consensus       168 fg~  170 (298)
T 1phk_A          168 FGF  170 (298)
T ss_dssp             CTT
T ss_pred             ccc
Confidence            963

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.90  E-value=7e-24  Score=208.09  Aligned_cols=142  Identities=22%  Similarity=0.277  Sum_probs=124.4

Q ss_pred             hCCCCCCCccccccceEEEEEEeCCCCEEEEEEcccccccc-chHHHHHHHHHHhcCCC--CCceeeEEEEeeCCeeEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVH--RNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lv  361 (438)
                      .+.|+..+.||+|+||.||+|...+++.||||+++...... ....+.+|+.++..++|  |||+++++++......++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            34577889999999999999998889999999986543222 23468999999999986  9999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      || +.+|+|.+++....    .+++.++..++.|++.||+|||++   +|+||||||+|||++ ++.++|+||+
T Consensus        88 ~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG  152 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFG  152 (343)
T ss_dssp             EC-CCSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred             Ee-CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecc
Confidence            99 56789999998753    489999999999999999999999   999999999999997 6789999996

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=6.8e-24  Score=210.35  Aligned_cols=143  Identities=23%  Similarity=0.348  Sum_probs=117.9

Q ss_pred             hCCCCCCCccccccceEEEEEEe-CCCCEEEEEEcccccccc-chHHHHHHHHHHhcCCCCCceeeEEEEeeCC------
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVT------  356 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  356 (438)
                      .++|...+.||+|+||.||+|.. .+++.||||++....... ....+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            35677789999999999999987 468999999985532221 2346889999999999999999999997653      


Q ss_pred             eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          357 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ..++||||+ +++|.++++..     .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+||+-
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence            459999999 78999998763     388999999999999999999999   999999999999999999999999973

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.90  E-value=2.3e-23  Score=203.63  Aligned_cols=142  Identities=27%  Similarity=0.395  Sum_probs=125.3

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhc--CCCCCceeeEEEEeeCC---
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM--AVHRNLLRLYGFCTTVT---  356 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~---  356 (438)
                      ....++|...+.||+|+||.||+|+. +++.||||.++..    ....+.+|++++..  ++||||+++++++....   
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~  112 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW  112 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence            44567899999999999999999998 5889999998543    23467788888876  78999999999998875   


Q ss_pred             -eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCceecCCCCCCeeeCCCC
Q 013682          357 -EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH--------EHCDPKIIHRDVKAANILLDEDA  427 (438)
Q Consensus       357 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivHrDLK~~NILld~~~  427 (438)
                       ..++||||+++|+|.+++...     .+++.++..++.|++.||+|||        +.   +|+||||||+|||++.++
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~  184 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNG  184 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTS
T ss_pred             ceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCC
Confidence             789999999999999999763     3899999999999999999999        66   999999999999999999


Q ss_pred             Ccchhhhhh
Q 013682          428 DQSSKTILR  436 (438)
Q Consensus       428 ~~~l~Df~~  436 (438)
                      .++|+||.-
T Consensus       185 ~~kL~Dfg~  193 (342)
T 1b6c_B          185 TCCIADLGL  193 (342)
T ss_dssp             CEEECCCTT
T ss_pred             CEEEEECCC
Confidence            999999963

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.90  E-value=1.1e-23  Score=211.29  Aligned_cols=140  Identities=23%  Similarity=0.283  Sum_probs=118.3

Q ss_pred             CCCCCC-CccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHH-hcCCCCCceeeEEEEee----CCee
Q 013682          286 DGFSNK-NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLRLYGFCTT----VTEK  358 (438)
Q Consensus       286 ~~~~~~-~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~~  358 (438)
                      ++|... +.||+|+||+||+|... +++.||||+++..      ..+.+|+.++ ...+||||+++++++..    ....
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            345444 68999999999999875 6889999998532      3567888876 45689999999999875    5568


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC---CCCcchhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTIL  435 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~---~~~~~l~Df~  435 (438)
                      ++||||+++|+|.+++....  ...+++.++..++.|++.||+|||+.   +|+||||||+|||++.   ++.++|+||+
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence            99999999999999998643  23489999999999999999999999   9999999999999998   7889999997


Q ss_pred             h
Q 013682          436 R  436 (438)
Q Consensus       436 ~  436 (438)
                      -
T Consensus       210 ~  210 (400)
T 1nxk_A          210 F  210 (400)
T ss_dssp             T
T ss_pred             c
Confidence            3

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.90  E-value=1.4e-23  Score=206.44  Aligned_cols=143  Identities=28%  Similarity=0.452  Sum_probs=123.7

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEcccccccc-chHHHHHHHHHHhcCCCCCceeeEEEEeeC--------
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTV--------  355 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------  355 (438)
                      ++|+..+.||+|+||.||+|+. .+++.||||++....... ....+.+|+.++..++||||+++++++...        
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            4677889999999999999997 468999999986543322 234688999999999999999999999873        


Q ss_pred             CeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          356 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       356 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +..++||||+++ ++.+.+.....   .+++.++..++.|++.||+|||++   +|+||||||+|||++.++.++|+||+
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccCC-CHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence            468999999985 78777765432   489999999999999999999999   99999999999999999999999997

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.90  E-value=8.7e-24  Score=217.31  Aligned_cols=144  Identities=24%  Similarity=0.409  Sum_probs=127.2

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc-ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      .++|...+.||+|+||.||+|+.. +++.||||+++.... ......+.+|+.+++.++||||+++++++......++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            346888899999999999999975 689999999864332 234457899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC---CCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD---EDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld---~~~~~~l~Df~  435 (438)
                      ||+++|+|.+.+....    .+++..+..++.|++.||+|||++   +|+||||||+|||++   .++.++|+||+
T Consensus       101 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  169 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFG  169 (486)
T ss_dssp             CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred             EcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECC
Confidence            9999999999887653    389999999999999999999999   999999999999995   45679999996

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.89  E-value=7.6e-24  Score=216.46  Aligned_cols=141  Identities=23%  Similarity=0.293  Sum_probs=121.0

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeC------C
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV------T  356 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~  356 (438)
                      .++|+..+.||+|+||.||+|+.. +++.||||++...... .....+.+|+.+++.++|||||++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            467888899999999999999864 6889999998654222 2234688999999999999999999999654      3


Q ss_pred             eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          357 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ..++||||+++ ++.+.+..      .+++.++..++.|++.||+|||++   +|+||||||+|||++.++.++|+||+
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG  209 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  209 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEE
Confidence            56999999986 46666643      278999999999999999999999   99999999999999999999999996

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.89  E-value=1.1e-23  Score=205.17  Aligned_cols=144  Identities=26%  Similarity=0.439  Sum_probs=124.6

Q ss_pred             CCCCCCCccccccceEEEEEEe-----CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCC--ee
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT--EK  358 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-----~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~  358 (438)
                      ++|+..+.||+|+||.||+|++     .+++.||||+++.. .......+.+|+.+++.++||||+++++++...+  ..
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            4567778999999999999984     35789999998653 2233447899999999999999999999987644  67


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ++||||+++++|.+++.....   .+++.++..++.|++.||+|||+.   +|+||||||+||++++++.++++||.-
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~  191 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL  191 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTT---SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             EEEEECCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence            999999999999999987532   489999999999999999999999   999999999999999999999999963

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.89  E-value=1.7e-24  Score=215.29  Aligned_cols=147  Identities=16%  Similarity=0.185  Sum_probs=118.4

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEcccccc--ccchHHHHHHH---HHHhcCCCCCceeeE-------EEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEV---KIISMAVHRNLLRLY-------GFC  352 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~--~~~~~~~~~E~---~~l~~l~H~niv~l~-------g~~  352 (438)
                      ++|...+.||+|+||.||+|+. .+++.||||+++....  ......+.+|+   ..++.++|||||+++       +++
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~  152 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  152 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred             ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence            4577788999999999999996 4689999999864322  22335788999   455666899999998       666


Q ss_pred             eeCCe-----------------eEEEEecCCCCCHHHHhhccCCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCce
Q 013682          353 TTVTE-----------------KLLVYPYMTNGSVASRLRERQSS---LPPLDWPTRKKIALGSARGLSYLHEHCDPKII  412 (438)
Q Consensus       353 ~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv  412 (438)
                      ...+.                 .+++|||+ +|+|.+++......   ...++|..+..++.|++.||+|||++   +|+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv  228 (377)
T 3byv_A          153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV  228 (377)
T ss_dssp             ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence            55432                 78999999 68999999864211   11244688889999999999999999   999


Q ss_pred             ecCCCCCCeeeCCCCCcchhhhhh
Q 013682          413 HRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       413 HrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||||||+|||++.++.++|+||+-
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG~  252 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFEH  252 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGG
T ss_pred             cCCCCHHHEEEcCCCCEEEEechh
Confidence            999999999999999999999973

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.89  E-value=1.1e-23  Score=206.80  Aligned_cols=143  Identities=22%  Similarity=0.357  Sum_probs=125.0

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeC-----Cee
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TEK  358 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~  358 (438)
                      .++|...+.||+|+||.||+|+.. +++.||||.++..........+.+|+.+++.++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            457888899999999999999975 68899999996543333344688999999999999999999988754     678


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      +++|||+. |+|.+++...     .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+||.-
T Consensus        90 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGL  158 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence            99999997 6999988763     389999999999999999999999   999999999999999999999999973

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.89  E-value=3e-23  Score=199.47  Aligned_cols=146  Identities=23%  Similarity=0.326  Sum_probs=123.4

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc---ccchHHHHHHHHHHhcCCCCCceeeEEEEe--eCCee
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT---SGGELQFQTEVKIISMAVHRNLLRLYGFCT--TVTEK  358 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~  358 (438)
                      .++|...+.||+|+||.||+|... +++.||+|.++....   ......+.+|+.+++.++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            467899999999999999999974 688999999865421   223457899999999999999999999984  45578


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ++||||++++ +.+.+.....  ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++++||.-
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~  155 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGV  155 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccc
Confidence            9999999976 7777765432  3589999999999999999999999   999999999999999999999999963

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.89  E-value=2.3e-23  Score=201.29  Aligned_cols=144  Identities=29%  Similarity=0.442  Sum_probs=123.4

Q ss_pred             HhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ..++|+..+.||+|+||.||+|... +++.||+|.++..   .....+.+|+.++..++||||+++++++...+..++||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE---SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT---SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch---HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            4567888899999999999999875 5899999998653   23347899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||+++++|.+++....   ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++++||.-
T Consensus       104 e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~  171 (314)
T 3com_A          104 EYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGV  171 (314)
T ss_dssp             ECCTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             ecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeeccc
Confidence            9999999999987432   2489999999999999999999999   999999999999999999999999963

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.89  E-value=1.4e-23  Score=207.64  Aligned_cols=143  Identities=21%  Similarity=0.290  Sum_probs=124.8

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeC-----Cee
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TEK  358 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~  358 (438)
                      .++|+..+.||+|+||.||+|+.. +++.||||+++..........+.+|+.++..++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            356888899999999999999874 68899999987543333335789999999999999999999999765     368


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ++||||+. |+|.+++...     .+++.++..++.|++.||+|||++   +|+||||||+|||++.++.++|+||.-
T Consensus       106 ~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~  174 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL  174 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcc
Confidence            99999998 5999998763     389999999999999999999999   999999999999999999999999974

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.89  E-value=6.9e-24  Score=206.07  Aligned_cols=148  Identities=30%  Similarity=0.452  Sum_probs=128.8

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEee-----
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT-----  354 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-----  354 (438)
                      ....++|+..+.||+|+||.||+|+. .+++.||||+++..  ......+.+|+.++..+ +||||+++++++..     
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC--cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            34567788889999999999999997 46889999998643  23345789999999998 79999999999977     


Q ss_pred             -CCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhh
Q 013682          355 -VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKT  433 (438)
Q Consensus       355 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~D  433 (438)
                       .+..++||||+++|+|.+++....  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++|
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~D  172 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD  172 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECC
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEee
Confidence             467899999999999999998642  12488999999999999999999999   999999999999999999999999


Q ss_pred             hhh
Q 013682          434 ILR  436 (438)
Q Consensus       434 f~~  436 (438)
                      |.-
T Consensus       173 fg~  175 (326)
T 2x7f_A          173 FGV  175 (326)
T ss_dssp             CTT
T ss_pred             CcC
Confidence            963

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.89  E-value=7.2e-24  Score=209.68  Aligned_cols=146  Identities=16%  Similarity=0.209  Sum_probs=119.3

Q ss_pred             HhCCCCCCCccccccceEEEEEEeCC------CCEEEEEEcccccccc----------chHHHHHHHHHHhcCCCCCcee
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSG----------GELQFQTEVKIISMAVHRNLLR  347 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~~------~~~vAvK~l~~~~~~~----------~~~~~~~E~~~l~~l~H~niv~  347 (438)
                      ..++|...+.||+|+||.||+|.+.+      ++.||||.++......          ....+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34578888999999999999998754      4789999985432110          0112445566777889999999


Q ss_pred             eEEEEeeC----CeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee
Q 013682          348 LYGFCTTV----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  423 (438)
Q Consensus       348 l~g~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILl  423 (438)
                      +++++...    ...++||||+ +++|.+++....   ..+++.++..++.|++.||+|||++   +|+||||||+|||+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill  185 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL  185 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence            99998764    4479999999 999999997642   2489999999999999999999999   99999999999999


Q ss_pred             C--CCCCcchhhhhh
Q 013682          424 D--EDADQSSKTILR  436 (438)
Q Consensus       424 d--~~~~~~l~Df~~  436 (438)
                      +  +++.++|+||+-
T Consensus       186 ~~~~~~~~kl~DFG~  200 (364)
T 3op5_A          186 NYKNPDQVYLVDYGL  200 (364)
T ss_dssp             ESSCTTCEEECCCTT
T ss_pred             ecCCCCeEEEEECCc
Confidence            9  889999999973

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.89  E-value=2.9e-23  Score=202.05  Aligned_cols=137  Identities=23%  Similarity=0.303  Sum_probs=122.2

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCC-CCCceeeEEEEee--CCeeEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTT--VTEKLLV  361 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lv  361 (438)
                      ++|+..+.||+|+||.||+|+. .+++.||||+++..    ....+.+|+.++..++ ||||+++++++..  ....++|
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            5677889999999999999986 46899999998642    3457899999999997 9999999999987  5678999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC-Ccchhhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTILR  436 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~-~~~l~Df~~  436 (438)
                      |||+++++|.++++.       +++.++..++.|++.||+|||++   +|+||||||+|||++.++ .++|+||.-
T Consensus       112 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~  177 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL  177 (330)
T ss_dssp             EECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence            999999999998853       78899999999999999999999   999999999999999777 899999973

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.89  E-value=4.2e-23  Score=197.70  Aligned_cols=142  Identities=18%  Similarity=0.211  Sum_probs=125.2

Q ss_pred             hCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEeeCCeeEEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      .++|...+.||+|+||.||+|+. .+++.||||.++...   ....+.+|+..+..+ +|+|++++++++......++||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC---ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            45688889999999999999996 568999999985432   223588999999998 7999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC-----cchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD-----QSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~-----~~l~Df~~  436 (438)
                      ||+ +++|.+++....   ..+++.++..++.|++.||+|||++   +|+||||||+|||++.++.     ++++||.-
T Consensus        86 e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~  157 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  157 (298)
T ss_dssp             ECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             Eec-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence            999 999999998643   2489999999999999999999999   9999999999999988876     99999973

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.89  E-value=2.4e-23  Score=203.12  Aligned_cols=143  Identities=33%  Similarity=0.500  Sum_probs=117.9

Q ss_pred             HhCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHH--HhcCCCCCceeeEEEEee-----CC
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKI--ISMAVHRNLLRLYGFCTT-----VT  356 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~-----~~  356 (438)
                      ..++|+..+.||+|+||.||+|+. +++.||||+++...    ...+..|.++  +..++||||+++++.+..     ..
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   85 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM   85 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence            346788889999999999999987 68899999985432    2234444444  456899999999986643     23


Q ss_pred             eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------CCCceecCCCCCCeeeCCCCCcc
Q 013682          357 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC------DPKIIHRDVKAANILLDEDADQS  430 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivHrDLK~~NILld~~~~~~  430 (438)
                      ..++||||+++|+|.+++....     .++..+..++.|++.||+|||+.+      .++|+||||||+|||++.++.++
T Consensus        86 ~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           86 EYLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             eEEEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence            5689999999999999997643     588999999999999999999873      34899999999999999999999


Q ss_pred             hhhhhh
Q 013682          431 SKTILR  436 (438)
Q Consensus       431 l~Df~~  436 (438)
                      |+||.-
T Consensus       161 L~DFG~  166 (336)
T 3g2f_A          161 ISDFGL  166 (336)
T ss_dssp             ECCCTT
T ss_pred             Eeeccc
Confidence            999974

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.89  E-value=3.5e-23  Score=199.05  Aligned_cols=140  Identities=23%  Similarity=0.293  Sum_probs=120.7

Q ss_pred             CCCCCC-CccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHH-hcCCCCCceeeEEEEee----CCee
Q 013682          286 DGFSNK-NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLRLYGFCTT----VTEK  358 (438)
Q Consensus       286 ~~~~~~-~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~~  358 (438)
                      ++|... +.||+|+||.||+|.. .+++.||+|.++..      ..+.+|+..+ +..+||||+++++++..    ....
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            445555 7799999999999987 46889999998532      3577888877 66799999999999877    6678


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC---CCCcchhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTIL  435 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~---~~~~~l~Df~  435 (438)
                      ++||||+++|+|.+++.....  ..+++..+..++.|++.||+|||++   +|+||||||+||+++.   ++.++++||.
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence            999999999999999987532  3589999999999999999999999   9999999999999998   7889999996


Q ss_pred             h
Q 013682          436 R  436 (438)
Q Consensus       436 ~  436 (438)
                      -
T Consensus       166 ~  166 (299)
T 3m2w_A          166 F  166 (299)
T ss_dssp             T
T ss_pred             c
Confidence            3

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.89  E-value=8e-24  Score=201.05  Aligned_cols=142  Identities=28%  Similarity=0.438  Sum_probs=123.1

Q ss_pred             hCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeC-CeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV-TEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lv~e  363 (438)
                      .++|+..+.||+|+||.||+|+.. ++.||||.++..   .....+.+|+.++..++||||+++++++.+. +..++|||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch---hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            456777899999999999999884 789999998643   2345789999999999999999999997654 46899999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+++|+|.+++.....  ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++++||.
T Consensus        96 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg  162 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFG  162 (278)
T ss_dssp             CCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred             cCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecc
Confidence            9999999999976421  1278899999999999999999999   99999999999999999999999996

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.89  E-value=2.4e-23  Score=208.10  Aligned_cols=141  Identities=22%  Similarity=0.275  Sum_probs=123.5

Q ss_pred             CCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccc-cchHHHHHHHHHHhcCC--CCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAV--HRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lv~  362 (438)
                      +.|...+.||+|+||.||+|...+++.||||+++..... .....+.+|+.++..++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            347888999999999999999877999999998654322 22346899999999996  599999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      | +.+++|.+++....    .+++.++..++.|++.||+|||++   +|+||||||+|||++ ++.++|+||+
T Consensus       136 E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG  199 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFG  199 (390)
T ss_dssp             E-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCS
T ss_pred             e-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecC
Confidence            9 56889999998753    478999999999999999999999   999999999999996 5889999996

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.89  E-value=2.2e-23  Score=203.10  Aligned_cols=150  Identities=22%  Similarity=0.270  Sum_probs=128.0

Q ss_pred             HHHhCCCCCC-CccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCC-CCCceeeEEEEeeCCe
Q 013682          282 QVATDGFSNK-NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTE  357 (438)
Q Consensus       282 ~~~~~~~~~~-~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~  357 (438)
                      +...+.|... +.||+|+||.||+|+.. +++.||+|+++..... .....+.+|+.++..+. ||||+++++++...+.
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            4444556655 78999999999999875 6899999998754332 23457899999999884 6999999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC---CCCcchhhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTI  434 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~---~~~~~l~Df  434 (438)
                      .++||||+++|+|.+++....  ...+++.++..++.|++.||+|||++   +|+||||||+|||++.   ++.++|+||
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Df  178 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDF  178 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred             EEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeC
Confidence            999999999999999886532  23589999999999999999999999   9999999999999998   789999999


Q ss_pred             hh
Q 013682          435 LR  436 (438)
Q Consensus       435 ~~  436 (438)
                      .-
T Consensus       179 g~  180 (327)
T 3lm5_A          179 GM  180 (327)
T ss_dssp             GG
T ss_pred             cc
Confidence            74

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.89  E-value=3.1e-23  Score=205.74  Aligned_cols=142  Identities=22%  Similarity=0.281  Sum_probs=122.6

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCC------
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT------  356 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  356 (438)
                      .++|...+.||+|+||.||+|... +++.||||+++..... .....+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            357888899999999999999864 6889999998653222 22346889999999999999999999997654      


Q ss_pred             eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          357 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ..++||||++ |+|.+.+..      .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+||+-
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             ceEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence            6799999997 478888753      278999999999999999999999   999999999999999999999999963

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.89  E-value=5.7e-23  Score=196.17  Aligned_cols=147  Identities=23%  Similarity=0.378  Sum_probs=128.8

Q ss_pred             HHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc-ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      ...++|+..+.||+|+||.||+|+.. +++.||+|+++.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            34467888999999999999999975 688999999865432 2334578999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC---Ccchhhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSKTILR  436 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~---~~~l~Df~~  436 (438)
                      +|||+++++|.+.+....    .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++   .++++||.-
T Consensus        99 v~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           99 VGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCc
Confidence            999999999999887643    389999999999999999999999   999999999999997644   699999963

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.89  E-value=1.3e-23  Score=224.76  Aligned_cols=142  Identities=20%  Similarity=0.332  Sum_probs=121.5

Q ss_pred             hCCCCCCCccccccceEEEEEEeC--CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCe-----
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA--DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE-----  357 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~--~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----  357 (438)
                      .++|...+.||+|+||.||+|...  +++.||||.+...........+.+|+.++..++|||||++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            367888899999999999999874  5889999998654333334468899999999999999999999987665     


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      .++||||+++++|.+++..      .++|.++..++.|++.||+|||++   +|+||||||+|||++++ .++|+||+-
T Consensus       159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence            6999999999999887643      489999999999999999999999   99999999999999986 899999973

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.89  E-value=2.1e-23  Score=221.79  Aligned_cols=148  Identities=22%  Similarity=0.309  Sum_probs=127.1

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEeCC----CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCe
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  357 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~----~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  357 (438)
                      ....++|...+.||+|+||.||+|.+..    +..||+|.++..........+.+|+.+++.++||||+++++++. .+.
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~  464 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP  464 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence            3344567778899999999999998742    45799999875433333457999999999999999999999984 466


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      .++||||+++|+|.++++...   ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+||+-
T Consensus       465 ~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~  537 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL  537 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred             eEEEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCC
Confidence            899999999999999998643   2489999999999999999999999   999999999999999999999999973

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.89  E-value=4.5e-23  Score=200.19  Aligned_cols=147  Identities=29%  Similarity=0.481  Sum_probs=123.5

Q ss_pred             HhCCCCCCCccccccceEEEEEEe--CCCCEEEEEEcccccccc-chHHHHHHHHHHhcC---CCCCceeeEEEEe----
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRL--ADGKLVAVKRLKEERTSG-GELQFQTEVKIISMA---VHRNLLRLYGFCT----  353 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~--~~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l---~H~niv~l~g~~~----  353 (438)
                      ..++|+..+.||+|+||.||+|+.  .+++.||+|+++...... ....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            346788889999999999999997  357899999986543222 223577788777665   8999999999987    


Q ss_pred             -eCCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchh
Q 013682          354 -TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  432 (438)
Q Consensus       354 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~  432 (438)
                       .....++||||+. |+|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence             4566899999998 699999986532  2489999999999999999999999   99999999999999999999999


Q ss_pred             hhhh
Q 013682          433 TILR  436 (438)
Q Consensus       433 Df~~  436 (438)
                      ||.-
T Consensus       163 Dfg~  166 (326)
T 1blx_A          163 DFGL  166 (326)
T ss_dssp             SCCS
T ss_pred             cCcc
Confidence            9963

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.88  E-value=1e-23  Score=204.03  Aligned_cols=147  Identities=24%  Similarity=0.444  Sum_probs=126.3

Q ss_pred             HHHHHhCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCee
Q 013682          280 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  358 (438)
Q Consensus       280 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  358 (438)
                      +.....++|+..+.||+|+||.||+|+..+  .||+|.++..... .....+.+|+.++..++||||+++++++...+..
T Consensus        27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (319)
T 2y4i_B           27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL  104 (319)
T ss_dssp             GSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred             cccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence            334556788899999999999999999753  4999998654322 2234678899999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++|||+++++|.+++....   ..+++.++..++.|++.||+|||++   +|+||||||+||+++ ++.++++||.
T Consensus       105 ~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg  174 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFG  174 (319)
T ss_dssp             EEECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCS
T ss_pred             EEEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecC
Confidence            99999999999999997643   2488999999999999999999999   999999999999998 6899999997

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.88  E-value=6.9e-23  Score=201.78  Aligned_cols=151  Identities=21%  Similarity=0.274  Sum_probs=113.9

Q ss_pred             HHHHHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCe-
Q 013682          280 ELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE-  357 (438)
Q Consensus       280 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-  357 (438)
                      +.....++|+..+.||+|+||.||+|+.. +++.||||++....  .....+.+|+..+..++||||+++++++..... 
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT--TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc--cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            34567789999999999999999999974 68999999885432  222356778888888999999999999976443 


Q ss_pred             ------eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHh--cCCCCCceecCCCCCCeeeCC-CCC
Q 013682          358 ------KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH--EHCDPKIIHRDVKAANILLDE-DAD  428 (438)
Q Consensus       358 ------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivHrDLK~~NILld~-~~~  428 (438)
                            .++||||+++ ++...+.........+++..+..++.|++.|++|||  +.   +|+||||||+|||++. ++.
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence                  7899999986 555555442223345889999999999999999999  77   9999999999999997 899


Q ss_pred             cchhhhhh
Q 013682          429 QSSKTILR  436 (438)
Q Consensus       429 ~~l~Df~~  436 (438)
                      ++|+||+-
T Consensus       171 ~kl~Dfg~  178 (360)
T 3e3p_A          171 LKLCDFGS  178 (360)
T ss_dssp             EEECCCTT
T ss_pred             EEEeeCCC
Confidence            99999973

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.88  E-value=2.3e-23  Score=206.56  Aligned_cols=143  Identities=24%  Similarity=0.344  Sum_probs=113.9

Q ss_pred             hCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeC------C
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV------T  356 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~  356 (438)
                      .++|+..+.||+|+||.||+|.. .+++.||||+++..... .....+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            36788889999999999999986 46889999998653222 2234688999999999999999999998754      5


Q ss_pred             eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          357 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ..++++||+ +++|.++++..     .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||+-
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             CCEEEEECC-CEECC-----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred             eEEEEeccc-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence            679999999 68998887642     489999999999999999999999   999999999999999999999999973

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.88  E-value=4.9e-23  Score=204.35  Aligned_cols=141  Identities=21%  Similarity=0.347  Sum_probs=122.6

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc-chHHHHHHHHHHhcCCCCCceeeEEEEeeCCee-----
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK-----  358 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-----  358 (438)
                      ++|...+.||+|+||.||+|+.. +++.||||+++...... ....+.+|+.+++.++||||+++++++...+..     
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            56777889999999999999874 68899999986543222 234688999999999999999999999876654     


Q ss_pred             -EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          359 -LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       359 -~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                       ++||||+. ++|.+.+..      .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+||.-
T Consensus       122 ~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             EEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence             99999998 688887743      289999999999999999999999   999999999999999999999999973

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.88  E-value=4.1e-23  Score=199.49  Aligned_cols=141  Identities=26%  Similarity=0.370  Sum_probs=116.2

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEe-----------
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT-----------  353 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-----------  353 (438)
                      ++|...+.||+|+||.||+|+.. +++.||+|+++... ......+.+|+.+++.++||||+++++++.           
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            56778899999999999999975 58899999986432 223346889999999999999999999874           


Q ss_pred             ---eCCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC-CCCCc
Q 013682          354 ---TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-EDADQ  429 (438)
Q Consensus       354 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld-~~~~~  429 (438)
                         .....++||||++ |+|.+++...     .+++..+..++.|++.||+|||++   +|+||||||+||+++ +++.+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG-----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC-----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeE
Confidence               3467899999998 6999998642     488999999999999999999999   999999999999997 56789


Q ss_pred             chhhhhh
Q 013682          430 SSKTILR  436 (438)
Q Consensus       430 ~l~Df~~  436 (438)
                      +++||.-
T Consensus       161 kl~Dfg~  167 (320)
T 2i6l_A          161 KIGDFGL  167 (320)
T ss_dssp             EECCCTT
T ss_pred             EEccCcc
Confidence            9999973

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.88  E-value=3e-23  Score=201.94  Aligned_cols=145  Identities=26%  Similarity=0.363  Sum_probs=121.9

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCC-CCCceeeEEEEe--------eC
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCT--------TV  355 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~--------~~  355 (438)
                      .+|...+.||+|+||.||+|+.. +++.||||++.... ......+.+|+..+..+. ||||+++++++.        ..
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            46777899999999999999974 68999999885432 223346889999999996 999999999984        23


Q ss_pred             CeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeeeCCCCCcchhh
Q 013682          356 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK--IIHRDVKAANILLDEDADQSSKT  433 (438)
Q Consensus       356 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDLK~~NILld~~~~~~l~D  433 (438)
                      ...+++|||+. |+|.+++..... ...+++.++..++.|++.||+|||+.   +  |+||||||+|||++.++.++|+|
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence            44789999996 799998875322 22489999999999999999999998   6  99999999999999999999999


Q ss_pred             hhh
Q 013682          434 ILR  436 (438)
Q Consensus       434 f~~  436 (438)
                      |.-
T Consensus       182 fg~  184 (337)
T 3ll6_A          182 FGS  184 (337)
T ss_dssp             CTT
T ss_pred             Ccc
Confidence            964

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.88  E-value=2.7e-23  Score=198.35  Aligned_cols=143  Identities=34%  Similarity=0.433  Sum_probs=116.0

Q ss_pred             CCCCCCCccccccceEEEEEEeC--CCC--EEEEEEccccccc--cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA--DGK--LVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  359 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~--~~~--~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  359 (438)
                      ++|+..+.||+|+||.||+|++.  +++  .||||.++.....  .....+.+|+.++..++||||+++++++.... .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            46777889999999999999863  333  6899998654322  22347899999999999999999999987754 88


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +||||+++|+|.+++....   ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++++||.
T Consensus        97 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg  166 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFG  166 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             eeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccc
Confidence            9999999999999998643   2478999999999999999999999   99999999999999999999999996

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.88  E-value=4.3e-23  Score=208.23  Aligned_cols=141  Identities=29%  Similarity=0.424  Sum_probs=115.2

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeC----C--eeE
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV----T--EKL  359 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----~--~~~  359 (438)
                      +|...+.||+|+||.||+|+.. +++.||||++....     ..+.+|+.+++.++|||||++++++...    +  ..+
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            4667789999999999999985 58999999985432     1245799999999999999999988542    2  356


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC-CCcchhhhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTILR  436 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~-~~~~l~Df~~  436 (438)
                      +||||+++ ++.+.++........+++..+..++.|++.||+|||++   +|+||||||+|||++.+ +.+||+||+-
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchh
Confidence            89999985 66666654222233589999999999999999999999   99999999999999966 5679999973

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.88  E-value=2.5e-23  Score=204.26  Aligned_cols=143  Identities=18%  Similarity=0.175  Sum_probs=116.5

Q ss_pred             CCCCCCCccccccceEEEEEEeC----CCCEEEEEEcccccccc----------chHHHHHHHHHHhcCCCCCceeeEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSG----------GELQFQTEVKIISMAVHRNLLRLYGF  351 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~----~~~~vAvK~l~~~~~~~----------~~~~~~~E~~~l~~l~H~niv~l~g~  351 (438)
                      ++|...+.||+|+||.||+|+..    ++..||+|.+.......          ....+.+|+..+..++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            46777899999999999999975    46789999986432110          11246778888999999999999999


Q ss_pred             Eee----CCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC
Q 013682          352 CTT----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  427 (438)
Q Consensus       352 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~  427 (438)
                      +..    ....++||||+ +++|.+++....    .+++.++..++.|++.||+|||++   +|+||||||+|||++.++
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence            988    67789999999 999999997653    489999999999999999999999   999999999999999887


Q ss_pred             --Ccchhhhhh
Q 013682          428 --DQSSKTILR  436 (438)
Q Consensus       428 --~~~l~Df~~  436 (438)
                        .++|+||.-
T Consensus       189 ~~~~kL~Dfg~  199 (345)
T 2v62_A          189 PDQVYLADYGL  199 (345)
T ss_dssp             TTSEEECCCTT
T ss_pred             CCcEEEEeCCC
Confidence              999999973

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.88  E-value=3.1e-23  Score=205.67  Aligned_cols=142  Identities=11%  Similarity=0.007  Sum_probs=105.1

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc--cchHHHHHHHH---HHhcCCCCCceeeE-------EEEe
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVK---IISMAVHRNLLRLY-------GFCT  353 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~~E~~---~l~~l~H~niv~l~-------g~~~  353 (438)
                      .|...+.||+|+||.||+|+.. +++.||||+++.....  .....+.+|+.   .+.. +||||++++       +++.
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhee
Confidence            4677789999999999999975 6889999999764321  22335777854   5555 799988755       4444


Q ss_pred             eC-----------------CeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCC
Q 013682          354 TV-----------------TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR------KKIALGSARGLSYLHEHCDPK  410 (438)
Q Consensus       354 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~  410 (438)
                      ..                 ...++||||++ |+|.+++.....   .+.+..+      ..++.|++.||+|||++   +
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~  214 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSK---G  214 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence            33                 33799999999 899999986422   2345555      78889999999999999   9


Q ss_pred             ceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          411 IIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       411 ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |+||||||+|||++.++.++|+||+-
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~  240 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSA  240 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGG
T ss_pred             CccCcCCHHHEEECCCCCEEEEecce
Confidence            99999999999999999999999974

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.88  E-value=6e-23  Score=202.07  Aligned_cols=141  Identities=21%  Similarity=0.342  Sum_probs=121.5

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc-chHHHHHHHHHHhcCCCCCceeeEEEEeeCCe------
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTE------  357 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------  357 (438)
                      ++|...+.||+|+||.||+|+.. +|+.||||.++...... ....+.+|+.+++.++||||+++++++.....      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            56777899999999999999874 68899999986543222 23468899999999999999999999987654      


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      .++||||+. |+|.+.+..      .+++..+..++.|++.||+|||++   +|+||||||+||++++++.++++||.-
T Consensus       104 ~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             CEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             EEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence            499999998 688776642      389999999999999999999999   999999999999999999999999963

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.88  E-value=2.4e-23  Score=201.05  Aligned_cols=148  Identities=23%  Similarity=0.352  Sum_probs=118.9

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEe-CCCCEEEEEEcccccccc-----chHHHHHHHHHHhcC----CCCCceeeEEE
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-----GELQFQTEVKIISMA----VHRNLLRLYGF  351 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~-----~~~~~~~E~~~l~~l----~H~niv~l~g~  351 (438)
                      +...++|...+.||+|+||.||+|+. .+++.||||.++......     ....+.+|+.++..+    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            44567899999999999999999986 468899999986543211     122466788888887    89999999999


Q ss_pred             EeeCCeeEEEEec-CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC-CCCCc
Q 013682          352 CTTVTEKLLVYPY-MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-EDADQ  429 (438)
Q Consensus       352 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld-~~~~~  429 (438)
                      +...+..+++||| +.+++|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+||+++ +++.+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence            9999999999999 78999999998753    389999999999999999999999   999999999999999 78999


Q ss_pred             chhhhhh
Q 013682          430 SSKTILR  436 (438)
Q Consensus       430 ~l~Df~~  436 (438)
                      +++||.-
T Consensus       180 kl~dfg~  186 (312)
T 2iwi_A          180 KLIDFGS  186 (312)
T ss_dssp             EECCCSS
T ss_pred             EEEEcch
Confidence            9999963

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.88  E-value=2.7e-23  Score=204.51  Aligned_cols=139  Identities=19%  Similarity=0.223  Sum_probs=120.4

Q ss_pred             CCCCCCCccccccceEEEEEEeCC---------CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCcee---------
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLAD---------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR---------  347 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~~---------~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~---------  347 (438)
                      ++|...+.||+|+||.||+|+...         ++.||+|.++..      ..+.+|+.++..++||||++         
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            567888999999999999998753         789999998543      25889999999999999988         


Q ss_pred             ------eEEEEee-CCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCC
Q 013682          348 ------LYGFCTT-VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN  420 (438)
Q Consensus       348 ------l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~N  420 (438)
                            +++++.. ....++||||+ +++|.+++....  ...+++.++..++.|++.||+|||++   +|+||||||+|
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N  189 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN  189 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence                  6777766 67889999999 999999998642  13489999999999999999999999   99999999999


Q ss_pred             eeeCCCC--Ccchhhhhh
Q 013682          421 ILLDEDA--DQSSKTILR  436 (438)
Q Consensus       421 ILld~~~--~~~l~Df~~  436 (438)
                      ||++.++  .++|+||.-
T Consensus       190 Il~~~~~~~~~kl~Dfg~  207 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGF  207 (352)
T ss_dssp             EEEETTEEEEEEECCGGG
T ss_pred             EEEcCCCCceEEEecCcc
Confidence            9999998  899999974

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.88  E-value=1.2e-22  Score=205.45  Aligned_cols=144  Identities=21%  Similarity=0.295  Sum_probs=123.0

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcC------CCCCceeeEEEEeeCCe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA------VHRNLLRLYGFCTTVTE  357 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~g~~~~~~~  357 (438)
                      ..+|+..+.||+|+||.||+|+.. +++.||||+++...  .....+.+|+.++..+      +|+||+++++++...+.
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            346788899999999999999875 58899999996532  2233577788777765      67899999999999999


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC--cchhhhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD--QSSKTIL  435 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~--~~l~Df~  435 (438)
                      .++||||+. ++|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.  ++|+||+
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             EEEEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence            999999996 699999887532  2489999999999999999999999   9999999999999999987  8999997


Q ss_pred             h
Q 013682          436 R  436 (438)
Q Consensus       436 ~  436 (438)
                      -
T Consensus       248 ~  248 (429)
T 3kvw_A          248 S  248 (429)
T ss_dssp             T
T ss_pred             c
Confidence            4

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.88  E-value=9.1e-23  Score=204.76  Aligned_cols=142  Identities=23%  Similarity=0.335  Sum_probs=112.4

Q ss_pred             CCC-CCccccccceEEEEEEeC---CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEee--CCeeEEE
Q 013682          288 FSN-KNILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEKLLV  361 (438)
Q Consensus       288 ~~~-~~~LG~G~fG~Vy~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv  361 (438)
                      |.. .+.||+|+||.||+|++.   +++.||||+++...   ....+.+|+.+++.++|||||++++++..  ....++|
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS---CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC---CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            443 468999999999999965   47889999996432   23468899999999999999999999954  6778999


Q ss_pred             EecCCCCCHHHHhhccC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee----CCCCCcchh
Q 013682          362 YPYMTNGSVASRLRERQ-----SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL----DEDADQSSK  432 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILl----d~~~~~~l~  432 (438)
                      |||+. |+|.+.+....     .....+++..+..++.|++.||+|||+.   +|+||||||+|||+    ++++.++|+
T Consensus        99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            99997 58887776321     1122489999999999999999999999   99999999999999    777899999


Q ss_pred             hhhh
Q 013682          433 TILR  436 (438)
Q Consensus       433 Df~~  436 (438)
                      ||+-
T Consensus       175 Dfg~  178 (405)
T 3rgf_A          175 DMGF  178 (405)
T ss_dssp             CTTC
T ss_pred             ECCC
Confidence            9973

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.87  E-value=7.9e-23  Score=204.59  Aligned_cols=141  Identities=25%  Similarity=0.387  Sum_probs=115.1

Q ss_pred             CCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCe------eEE
Q 013682          287 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE------KLL  360 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~l  360 (438)
                      +|...+.||+|+||.||+|+...+..||+|++.....     ...+|+.+++.++||||+++++++.....      .++
T Consensus        41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            5777899999999999999987766799998754321     23479999999999999999999865433      789


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC-CCCCcchhhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-EDADQSSKTILR  436 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld-~~~~~~l~Df~~  436 (438)
                      ||||++++ +.+.+.........+++..+..++.|++.||+|||++   +|+||||||+|||++ .++.++|+||+-
T Consensus       116 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          116 VLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGS  188 (394)
T ss_dssp             EEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence            99999875 4443332111223589999999999999999999999   999999999999999 789999999974

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.87  E-value=5.4e-23  Score=199.76  Aligned_cols=148  Identities=22%  Similarity=0.337  Sum_probs=127.0

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEe-CCCCEEEEEEcccccccc-----chHHHHHHHHHHhcCC--CCCceeeEEEEe
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-----GELQFQTEVKIISMAV--HRNLLRLYGFCT  353 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~-----~~~~~~~E~~~l~~l~--H~niv~l~g~~~  353 (438)
                      ....++|+..+.||+|+||.||+|+. .+++.||||.++......     ....+.+|+.++..++  ||||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            33456788889999999999999986 468899999986543221     2235778999999886  599999999999


Q ss_pred             eCCeeEEEEecCCC-CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC-CCCCcch
Q 013682          354 TVTEKLLVYPYMTN-GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-EDADQSS  431 (438)
Q Consensus       354 ~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld-~~~~~~l  431 (438)
                      ..+..+++|||+.+ ++|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++ +++.++|
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL  191 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKL  191 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEE
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEE
Confidence            99999999999986 89999998643    488999999999999999999999   999999999999999 7799999


Q ss_pred             hhhhh
Q 013682          432 KTILR  436 (438)
Q Consensus       432 ~Df~~  436 (438)
                      +||.-
T Consensus       192 ~Dfg~  196 (320)
T 3a99_A          192 IDFGS  196 (320)
T ss_dssp             CCCTT
T ss_pred             eeCcc
Confidence            99973

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.87  E-value=2.8e-22  Score=191.62  Aligned_cols=143  Identities=22%  Similarity=0.262  Sum_probs=119.2

Q ss_pred             HhCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEE-eeCCeeEEE
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC-TTVTEKLLV  361 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lv  361 (438)
                      ..++|+..+.||+|+||.||+|+. .+++.||||.+.....   ...+.+|+.++..++|++++..++.+ ...+..++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            346788899999999999999996 5688999998654322   23588999999999998887777665 557778999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee---CCCCCcchhhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTILR  436 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILl---d~~~~~~l~Df~~  436 (438)
                      |||+ +++|.+++.....   .+++.++..++.|++.||+|||++   +|+||||||+|||+   ++++.++|+||.-
T Consensus        84 ~e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~  154 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGL  154 (296)
T ss_dssp             EECC-CCBHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred             EEcc-CCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence            9999 9999999975432   489999999999999999999999   99999999999999   7889999999974

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.87  E-value=1.2e-22  Score=212.23  Aligned_cols=132  Identities=15%  Similarity=0.132  Sum_probs=104.4

Q ss_pred             cccccceEEEEEE-eCCCCEEEEEEccccccc---------cchHHHHHHHHHHhcC-CCCCceeeEEEEeeCCeeEEEE
Q 013682          294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTS---------GGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       294 LG~G~fG~Vy~~~-~~~~~~vAvK~l~~~~~~---------~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      .+.|++|.++.++ .-.|+.+|||.+......         ....+|.+|+++|+++ .|+||++++++++++...||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4566777666554 235888999998653211         1123699999999999 7999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||++|++|.+.++...    +++.   .+|+.||+.||+|+|++   +||||||||+|||+++++.+||+||+
T Consensus       322 Eyv~G~~L~d~i~~~~----~l~~---~~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFG  384 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE----EIDR---EKILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFG  384 (569)
T ss_dssp             ECCCSEEHHHHHHTTC----CCCH---HHHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCT
T ss_pred             ecCCCCcHHHHHHhCC----CCCH---HHHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecc
Confidence            9999999999998653    3554   35889999999999999   99999999999999999999999997

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.87  E-value=4.5e-22  Score=190.29  Aligned_cols=142  Identities=22%  Similarity=0.261  Sum_probs=121.5

Q ss_pred             hCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEE-eeCCeeEEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC-TTVTEKLLVY  362 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lv~  362 (438)
                      .++|...+.||+|+||.||+|+. .+++.||||++....   ....+.+|+.++..++|++++..++.+ ...+..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS---SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc---chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            45788889999999999999996 578999999985432   223689999999999998877766665 5567789999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee---CCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILl---d~~~~~~l~Df~~  436 (438)
                      ||+ +++|.+++.....   .+++.++..++.|++.||+|||++   +|+||||||+|||+   ++++.++|+||.-
T Consensus        85 e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  154 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGL  154 (296)
T ss_dssp             ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred             Eec-CCCHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence            999 8999999975432   489999999999999999999999   99999999999999   4788999999973

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.87  E-value=2e-22  Score=196.06  Aligned_cols=149  Identities=23%  Similarity=0.316  Sum_probs=122.3

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHH-HHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVK-IISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      .++|...+.||+|+||.||+|... +++.||||+++.........++..|+. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            467788899999999999999974 688999999975433333335556665 778889999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQ-SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||+++ +|.+++.... .....+++..+..++.|++.||.|||+.  ++|+||||||+||+++.++.++|+||.-
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~  172 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGI  172 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCC
Confidence            99985 7877775311 1123589999999999999999999984  2799999999999999999999999973

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.87  E-value=4.7e-22  Score=194.58  Aligned_cols=142  Identities=23%  Similarity=0.271  Sum_probs=115.9

Q ss_pred             hCCCCCC-CccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEee----CCee
Q 013682          285 TDGFSNK-NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT----VTEK  358 (438)
Q Consensus       285 ~~~~~~~-~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~  358 (438)
                      .++|... +.||+|+||.||+|+.. +++.||||++...     .....+....+..+.||||+++++++..    ....
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            4567764 56999999999999975 6899999998542     1122233334667899999999999876    4457


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC---CCcchhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED---ADQSSKTIL  435 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~---~~~~l~Df~  435 (438)
                      ++||||+++|+|.+++.....  ..+++.++..++.|++.||+|||++   +|+||||||+|||++.+   +.++|+||.
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence            899999999999999986532  3589999999999999999999999   99999999999999864   459999996


Q ss_pred             h
Q 013682          436 R  436 (438)
Q Consensus       436 ~  436 (438)
                      -
T Consensus       177 ~  177 (336)
T 3fhr_A          177 F  177 (336)
T ss_dssp             T
T ss_pred             c
Confidence            3

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.87  E-value=2.7e-22  Score=195.18  Aligned_cols=144  Identities=22%  Similarity=0.312  Sum_probs=123.1

Q ss_pred             hCCCCCCCccccccceEEEEEEe--CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCC------CceeeEEEEeeCC
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRL--ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR------NLLRLYGFCTTVT  356 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~--~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~------niv~l~g~~~~~~  356 (438)
                      .++|+..+.||+|+||.||+|..  .+++.||||+++...  .....+.+|+.++..++|+      +++++++++...+
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            45788889999999999999986  357899999986432  2234678899888877665      4999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC-----------
Q 013682          357 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-----------  425 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~-----------  425 (438)
                      ..++||||+ +++|.+++.....  ..+++..+..++.|++.||+|||++   +|+||||||+|||++.           
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred             cEEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcc
Confidence            999999999 8899999976532  3588999999999999999999999   9999999999999998           


Q ss_pred             --------CCCcchhhhhh
Q 013682          426 --------DADQSSKTILR  436 (438)
Q Consensus       426 --------~~~~~l~Df~~  436 (438)
                              ++.++++||.-
T Consensus       165 ~~~~~~~~~~~~kl~Dfg~  183 (339)
T 1z57_A          165 KRDERTLINPDIKVVDFGS  183 (339)
T ss_dssp             -CEEEEESCCCEEECCCSS
T ss_pred             ccccccccCCCceEeeCcc
Confidence                    66799999963

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.87  E-value=1.9e-22  Score=195.00  Aligned_cols=144  Identities=21%  Similarity=0.256  Sum_probs=124.8

Q ss_pred             HhCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccc-cchHHHHHHHHHHhcCC--CCCceeeEEEEeeCCeeEE
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAV--HRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~l  360 (438)
                      ..++|...+.||+|+||.||+|+..+++.||||.++..... .....+.+|+.++..++  ||||+++++++...+..++
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            34567888999999999999999888999999998654322 22346899999999987  5999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      +|| +.+++|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||+++ +.++++||.-
T Consensus       106 v~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~  172 (313)
T 3cek_A          106 VME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGI  172 (313)
T ss_dssp             EEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred             EEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccc
Confidence            999 66889999998653    488999999999999999999999   9999999999999964 8899999963

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.86  E-value=9.2e-23  Score=214.75  Aligned_cols=148  Identities=25%  Similarity=0.346  Sum_probs=125.3

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEee------CCe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT------VTE  357 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~  357 (438)
                      .++|...+.||+|+||.||+|... +++.||||+++..........+.+|+.++..++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            367999999999999999999874 6889999998765433344578999999999999999999998765      567


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC---cchhhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD---QSSKTI  434 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~---~~l~Df  434 (438)
                      .++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.   ++++||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence            7999999999999999986432 23488899999999999999999999   9999999999999998775   789999


Q ss_pred             hh
Q 013682          435 LR  436 (438)
Q Consensus       435 ~~  436 (438)
                      .-
T Consensus       169 G~  170 (676)
T 3qa8_A          169 GY  170 (676)
T ss_dssp             CC
T ss_pred             cc
Confidence            63

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.86  E-value=3.1e-22  Score=199.38  Aligned_cols=136  Identities=25%  Similarity=0.356  Sum_probs=112.2

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCC--------CCCceeeEEEEe--
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV--------HRNLLRLYGFCT--  353 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~g~~~--  353 (438)
                      .++|...+.||+|+||.||+|+.. +++.||||+++..  ......+.+|+.++..++        |+||+++++++.  
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            357888899999999999999864 6889999998643  222346889999998875        788999999987  


Q ss_pred             --eCCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC
Q 013682          354 --TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  427 (438)
Q Consensus       354 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~  427 (438)
                        .....++||||+ ++++.+.+.....  ..+++..+..++.|++.||+|||+++  +|+||||||+|||++.++
T Consensus       114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~  184 (397)
T 1wak_A          114 GVNGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             ETTEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCH
T ss_pred             CCCCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccc
Confidence              455789999999 5667666655422  34899999999999999999999853  799999999999999875

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.86  E-value=1.2e-21  Score=200.79  Aligned_cols=142  Identities=20%  Similarity=0.232  Sum_probs=120.9

Q ss_pred             hCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCC-CceeeEEEEeeCCeeEEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR-NLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lv~  362 (438)
                      .++|...+.||+|+||.||+|+. .+++.||||+++....   ..++.+|+.++..++|+ ++..+..++...+..++||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            46788899999999999999996 4689999998754322   23588999999999874 5556666667788889999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee---CCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILl---d~~~~~~l~Df~~  436 (438)
                      ||+ +++|.+++.....   .+++.++..++.|++.||+|||++   +|+||||||+|||+   ++++.++|+||.-
T Consensus        83 e~~-g~sL~~ll~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGl  152 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGL  152 (483)
T ss_dssp             ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred             ECC-CCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCc
Confidence            999 9999999975432   489999999999999999999999   99999999999999   5889999999974

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.86  E-value=4.7e-22  Score=192.15  Aligned_cols=145  Identities=24%  Similarity=0.353  Sum_probs=113.3

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchH-HHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~-~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      .++|+..+.||+|+||.||+|+.. +++.||||.++......... .+.++..++..++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            456777889999999999999975 68999999986543322222 3445556788889999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||+ ++.+........   ..+++..+..++.|++.||+|||+ .   +|+||||||+||+++.++.++|+||.-
T Consensus       104 e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~  171 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGI  171 (318)
T ss_dssp             CCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             ecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCC
Confidence            999 455555544322   248899999999999999999998 5   899999999999999999999999963

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.86  E-value=3.2e-22  Score=202.69  Aligned_cols=139  Identities=25%  Similarity=0.222  Sum_probs=111.8

Q ss_pred             CCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEeeCCeeEEEEecCCC
Q 013682          289 SNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  367 (438)
Q Consensus       289 ~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~  367 (438)
                      ...+.||+|+||+||.+...+|+.||||++...    ....+.+|+.++..+ +|||||++++++.+.+..++||||+. 
T Consensus        18 ~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-   92 (434)
T 2rio_A           18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-   92 (434)
T ss_dssp             EEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred             eccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence            345789999999998766667999999998543    223578899999875 89999999999999999999999996 


Q ss_pred             CCHHHHhhccCCCCCC---CCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC-------------CCcch
Q 013682          368 GSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-------------ADQSS  431 (438)
Q Consensus       368 gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~-------------~~~~l  431 (438)
                      |+|.+++.........   .++..+..++.|++.||+|||++   +|+||||||+|||++.+             +.++|
T Consensus        93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL  169 (434)
T 2rio_A           93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI  169 (434)
T ss_dssp             EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred             CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence            6999999865322111   13334678999999999999999   99999999999999754             47899


Q ss_pred             hhhh
Q 013682          432 KTIL  435 (438)
Q Consensus       432 ~Df~  435 (438)
                      +||+
T Consensus       170 ~DFG  173 (434)
T 2rio_A          170 SDFG  173 (434)
T ss_dssp             CCCT
T ss_pred             cccc
Confidence            9996

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.85  E-value=7.4e-22  Score=199.91  Aligned_cols=139  Identities=22%  Similarity=0.278  Sum_probs=114.4

Q ss_pred             CCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      .+|...+.||+|+||.||.....+++.||||++.....    ..+.+|+.++..+ +|||||++++++.+....++||||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            35777789999999986655455789999999864321    2367899999988 799999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC---CC--Ccchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DA--DQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~---~~--~~~l~Df~  435 (438)
                      +. |+|.+++.....   ...+..+..++.|++.||+|||++   +|+||||||+|||++.   ++  .++|+||+
T Consensus       100 ~~-g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG  168 (432)
T 3p23_A          100 CA-ATLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFG  168 (432)
T ss_dssp             CS-EEHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred             CC-CCHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence            96 699999986543   234456678999999999999999   9999999999999953   23  46699997

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.85  E-value=3.1e-22  Score=216.91  Aligned_cols=169  Identities=31%  Similarity=0.496  Sum_probs=133.9

Q ss_pred             ecceeeehhHHHHHHHhh-hhhhhhhhcchheeecccCCccc------------eeeeecCCCccccccchhhcc-----
Q 013682           32 ARGFTLLVTLKAVLQECE-QLHLLISFLIFIRVLQSSSNLFV------------YLISDLGNAALSGELAPELGQ-----   93 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~-~l~~~~~~~~~~~~l~~~~n~~~------------~~~~~l~~n~l~g~ip~~l~~-----   93 (438)
                      +.+++.|++|+++.|.+. .+|..++.+.+++.|++++|.+.            |..++|++|.++|.+|..+++     
T Consensus       486 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~  565 (768)
T 3rgz_A          486 LSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKI  565 (768)
T ss_dssp             GGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCB
T ss_pred             HhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchh
Confidence            556666777777777766 56667777777777777766543            666777777777777765543     


Q ss_pred             -----------------------------------------------------------------CCCCCeec-------
Q 013682           94 -----------------------------------------------------------------LKNLELLA-------  101 (438)
Q Consensus        94 -----------------------------------------------------------------l~~L~~l~-------  101 (438)
                                                                                       +++|+.|+       
T Consensus       566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~  645 (768)
T 3rgz_A          566 AANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLS  645 (768)
T ss_dssp             CCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCB
T ss_pred             hhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCccc
Confidence                                                                             34455554       


Q ss_pred             ------cccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCCCCC
Q 013682          102 ------LGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGS  175 (438)
Q Consensus       102 ------l~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~~~  175 (438)
                            ++++++|+.|+|++|+++|.||++++++++|+.|||++|+++|.+|..++.+++|+.||+|+|+++|.||..++
T Consensus       646 g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~  725 (768)
T 3rgz_A          646 GYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQ  725 (768)
T ss_dssp             SCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSS
T ss_pred             ccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchh
Confidence                  34577888999999999999999999999999999999999999999999999999999999999999999988


Q ss_pred             CCcccccccccccccCCCCCCCCCCC
Q 013682          176 FSQFTPISFENNLNLCGPNTKKPCSG  201 (438)
Q Consensus       176 ~~~~~~~~~~~N~~lcg~~~~~~C~~  201 (438)
                      +..+...+|.||+.+||++.. +|..
T Consensus       726 ~~~~~~~~~~gN~~Lcg~~l~-~C~~  750 (768)
T 3rgz_A          726 FETFPPAKFLNNPGLCGYPLP-RCDP  750 (768)
T ss_dssp             GGGSCGGGGCSCTEEESTTSC-CCCS
T ss_pred             hccCCHHHhcCCchhcCCCCc-CCCC
Confidence            999999999999999998765 7854

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.85  E-value=1.7e-21  Score=190.92  Aligned_cols=144  Identities=19%  Similarity=0.297  Sum_probs=121.3

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CC-CEEEEEEccccccccchHHHHHHHHHHhcCCCCC------ceeeEEEEeeCC
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DG-KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN------LLRLYGFCTTVT  356 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~-~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~  356 (438)
                      .++|...+.||+|+||.||+|... ++ +.||+|+++...  .....+.+|+.++..++|++      ++.+.+++...+
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~   95 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG--KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG   95 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc--cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence            457888899999999999999874 34 689999986432  22346788999998887766      899999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee-------------
Q 013682          357 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL-------------  423 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILl-------------  423 (438)
                      ..++||||+ ++++.+.+.....  ..+++.++..++.|++.||+|||++   +|+||||||+|||+             
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             eEEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccc
Confidence            999999999 6677777766432  3489999999999999999999999   99999999999999             


Q ss_pred             ------CCCCCcchhhhhh
Q 013682          424 ------DEDADQSSKTILR  436 (438)
Q Consensus       424 ------d~~~~~~l~Df~~  436 (438)
                            +.++.++|+||.-
T Consensus       170 ~~~~~~~~~~~~kl~Dfg~  188 (355)
T 2eu9_A          170 SCEEKSVKNTSIRVADFGS  188 (355)
T ss_dssp             CCCEEEESCCCEEECCCTT
T ss_pred             cccccccCCCcEEEeecCc
Confidence                  5678999999973

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.85  E-value=2.2e-21  Score=193.11  Aligned_cols=147  Identities=23%  Similarity=0.296  Sum_probs=121.8

Q ss_pred             HhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCC-CC-----CceeeEEEEeeCC
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HR-----NLLRLYGFCTTVT  356 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~g~~~~~~  356 (438)
                      ..++|...+.||+|+||.||+|+.. +++.||||+++...  ....++.+|+.++..++ |+     +++++++++...+
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            4578888899999999999999875 68899999996432  22335778888887775 44     4999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC--CCCCcchhhh
Q 013682          357 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD--EDADQSSKTI  434 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld--~~~~~~l~Df  434 (438)
                      ..++||||+. |+|.+++.....  ..+++..+..++.|++.||+|||++ ..+|+||||||+|||++  .++.++|+||
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             ceEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            9999999996 599999987532  2489999999999999999999953 23899999999999995  4678999999


Q ss_pred             hh
Q 013682          435 LR  436 (438)
Q Consensus       435 ~~  436 (438)
                      +-
T Consensus       206 G~  207 (382)
T 2vx3_A          206 GS  207 (382)
T ss_dssp             TT
T ss_pred             cC
Confidence            74

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=1.2e-21  Score=187.09  Aligned_cols=136  Identities=12%  Similarity=0.049  Sum_probs=108.3

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEeCCCCEEEEEEcccccccc-----------------chHHHHHHHHHHhcCCCCC
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG-----------------GELQFQTEVKIISMAVHRN  344 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~-----------------~~~~~~~E~~~l~~l~H~n  344 (438)
                      ......|...+.||+|+||.||+|+..+++.||+|.++......                 ....+.+|+.+++.++  |
T Consensus        86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~  163 (282)
T 1zar_A           86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G  163 (282)
T ss_dssp             HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred             HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence            33444566678999999999999999778999999986432211                 1335889999999998  4


Q ss_pred             ceeeEEEEeeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC
Q 013682          345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD  424 (438)
Q Consensus       345 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld  424 (438)
                       +++.+++.. +..++||||+++|+|.+ +..          .....++.|++.||+|||+.   +|+||||||+|||++
T Consensus       164 -~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~  227 (282)
T 1zar_A          164 -LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS  227 (282)
T ss_dssp             -SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred             -CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE
Confidence             666665543 55699999999999987 421          12457999999999999999   999999999999999


Q ss_pred             CCCCcchhhhhh
Q 013682          425 EDADQSSKTILR  436 (438)
Q Consensus       425 ~~~~~~l~Df~~  436 (438)
                       ++.++|+||+.
T Consensus       228 -~~~vkl~DFG~  238 (282)
T 1zar_A          228 -EEGIWIIDFPQ  238 (282)
T ss_dssp             -TTEEEECCCTT
T ss_pred             -CCcEEEEECCC
Confidence             99999999974

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.83  E-value=2.6e-21  Score=191.23  Aligned_cols=144  Identities=19%  Similarity=0.319  Sum_probs=120.1

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCC-----------CCCceeeEEEEe
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-----------HRNLLRLYGFCT  353 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~  353 (438)
                      ++|...+.||+|+||.||+|+. .+++.||||+++...  .....+.+|+.++..++           ||||+++++++.
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            5678889999999999999997 468899999986432  22346788998888776           899999999987


Q ss_pred             eCC----eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC-----
Q 013682          354 TVT----EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-----  424 (438)
Q Consensus       354 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld-----  424 (438)
                      ..+    ..+++|||+ +++|.+++.....  ..+++..+..++.|++.||+|||+++  +|+||||||+|||++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCC
Confidence            654    678999999 8999999986432  24889999999999999999999842  799999999999994     


Q ss_pred             -CCCCcchhhhhh
Q 013682          425 -EDADQSSKTILR  436 (438)
Q Consensus       425 -~~~~~~l~Df~~  436 (438)
                       .++.++|+||.-
T Consensus       172 ~~~~~~kl~Dfg~  184 (373)
T 1q8y_A          172 ENLIQIKIADLGN  184 (373)
T ss_dssp             TTEEEEEECCCTT
T ss_pred             cCcceEEEccccc
Confidence             445789999973

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.83  E-value=6.1e-21  Score=198.26  Aligned_cols=129  Identities=15%  Similarity=0.231  Sum_probs=102.5

Q ss_pred             CCCccccccceEEEEEEeCCCCEEEEEEcccccccc-------chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          290 NKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG-------GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       290 ~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ..+.||+|+||.||+|++ .++.+|+|+........       ....+.+|+.++++++||||+++..++...+..++||
T Consensus       340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            356899999999999965 47789999864322111       1234799999999999999997777777778889999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||+++++|.+++..            +..++.|+++||+|||++   +|+||||||+|||+++  .++|+||.-
T Consensus       419 E~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGl  475 (540)
T 3en9_A          419 SYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGL  475 (540)
T ss_dssp             ECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTT
T ss_pred             ECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECcc
Confidence            99999999999865            357899999999999999   9999999999999999  999999974

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.80  E-value=3.7e-20  Score=186.31  Aligned_cols=146  Identities=16%  Similarity=0.185  Sum_probs=108.0

Q ss_pred             CCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccc--cchHHHHHHHHHHhcCCC-CCcee---------eEEE--
Q 013682          287 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVH-RNLLR---------LYGF--  351 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~H-~niv~---------l~g~--  351 (438)
                      .|...+.||+|+||.||+|++ .+++.||||+++.....  .....+.+|+.++..++| +|...         ....  
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            355668899999999999996 46899999998733222  224578999999999987 32111         1111  


Q ss_pred             ----------Eee-----CCeeEEEEecCCCCCHHHHhhcc---CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcee
Q 013682          352 ----------CTT-----VTEKLLVYPYMTNGSVASRLRER---QSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH  413 (438)
Q Consensus       352 ----------~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH  413 (438)
                                +..     ....+++|+++ +++|.++++..   ......++|..+..++.|++.||+|||++   +|+|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiH  234 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH  234 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence                      111     12346667655 68999888521   12223478889999999999999999999   9999


Q ss_pred             cCCCCCCeeeCCCCCcchhhhhh
Q 013682          414 RDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       414 rDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |||||+|||++.++.++|+||+-
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~  257 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEH  257 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGG
T ss_pred             CCcccceEEEecCCeEEEEeccc
Confidence            99999999999999999999974

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.77  E-value=1.1e-19  Score=175.98  Aligned_cols=164  Identities=26%  Similarity=0.407  Sum_probs=114.1

Q ss_pred             cceeeehhHHHHHHHhh-hhhhhhhhcchheeecccCCcc-------------ceeeeecCCCccccccchhhccCCCCC
Q 013682           33 RGFTLLVTLKAVLQECE-QLHLLISFLIFIRVLQSSSNLF-------------VYLISDLGNAALSGELAPELGQLKNLE   98 (438)
Q Consensus        33 ~~~~~~~~l~~~~~~~~-~l~~~~~~~~~~~~l~~~~n~~-------------~~~~~~l~~n~l~g~ip~~l~~l~~L~   98 (438)
                      .+++.|++|+++.|.+. .+|..++.+.+++.|+++.|.+             .+..++|++|.++|.+|..++.++ |+
T Consensus       122 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~  200 (313)
T 1ogq_A          122 SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LA  200 (313)
T ss_dssp             GGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CS
T ss_pred             hCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-cc
Confidence            34444444444444444 3444445555555555444432             234445555555555555555544 55


Q ss_pred             eecc-------------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCC
Q 013682           99 LLAL-------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNR  165 (438)
Q Consensus        99 ~l~l-------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~  165 (438)
                      .|++             +.+++|+.|+|++|.+++.+|. ++.+++|++|++++|+++|.+|..+..+++|+.|++++|+
T Consensus       201 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~  279 (313)
T 1ogq_A          201 FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN  279 (313)
T ss_dssp             EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSE
T ss_pred             EEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCc
Confidence            4432             3466788888888888766555 7888899999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCcccccccccccccCCCCCCCCC
Q 013682          166 LSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPC  199 (438)
Q Consensus       166 l~g~ip~~~~~~~~~~~~~~~N~~lcg~~~~~~C  199 (438)
                      ++|.+|....++.+..+.+.+|+.+||.+.. .|
T Consensus       280 l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~-~C  312 (313)
T 1ogq_A          280 LCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC  312 (313)
T ss_dssp             EEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred             ccccCCCCccccccChHHhcCCCCccCCCCC-CC
Confidence            9999999888888999999999999987543 45

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.77  E-value=2.6e-19  Score=168.61  Aligned_cols=133  Identities=17%  Similarity=0.182  Sum_probs=101.5

Q ss_pred             CCCCCccccccceEEEEEEe-CCCCE--EEEEEcccccccc-----------------------chHHHHHHHHHHhcCC
Q 013682          288 FSNKNILGRGGFGKVYKGRL-ADGKL--VAVKRLKEERTSG-----------------------GELQFQTEVKIISMAV  341 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~-~~~~~--vAvK~l~~~~~~~-----------------------~~~~~~~E~~~l~~l~  341 (438)
                      |...+.||+|+||.||+|.. .+|+.  ||||+++......                       ....+.+|+..+..++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            45668899999999999997 67888  9999875431110                       0125788999999998


Q ss_pred             CCCc--eeeEEEEeeCCeeEEEEecCCC-C----CHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCcee
Q 013682          342 HRNL--LRLYGFCTTVTEKLLVYPYMTN-G----SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH-EHCDPKIIH  413 (438)
Q Consensus       342 H~ni--v~l~g~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH  413 (438)
                      |+++  ..++..    ...++||||+.+ |    +|.+....       .++..+..++.|++.|+.||| +.   +|+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH  194 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH  194 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence            8864  333332    356899999942 4    66665432       224467889999999999999 88   9999


Q ss_pred             cCCCCCCeeeCCCCCcchhhhhh
Q 013682          414 RDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       414 rDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |||||+|||+++  .++++||+.
T Consensus       195 rDlkp~NILl~~--~~~liDFG~  215 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQ  215 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTT
T ss_pred             CCCCHHHEEEcC--cEEEEECcc
Confidence            999999999998  899999975

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.71  E-value=4.8e-18  Score=184.02  Aligned_cols=157  Identities=30%  Similarity=0.423  Sum_probs=123.5

Q ss_pred             ecceeeehhHHHHHHHhh-hhhhhhhhcchheeecccCCccc------------eeeeecCCCccccccchhhccCCCCC
Q 013682           32 ARGFTLLVTLKAVLQECE-QLHLLISFLIFIRVLQSSSNLFV------------YLISDLGNAALSGELAPELGQLKNLE   98 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~-~l~~~~~~~~~~~~l~~~~n~~~------------~~~~~l~~n~l~g~ip~~l~~l~~L~   98 (438)
                      +.+++.|++|+++.|.+. .+|..+..+++++.|+++.|.+.            |..++|++|.++|.+|..++++++|+
T Consensus       462 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~  541 (768)
T 3rgz_A          462 LMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLI  541 (768)
T ss_dssp             GGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCC
T ss_pred             HcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCC
Confidence            445666667777777766 56777777777777777776542            66778888888888888888888887


Q ss_pred             eeccc---------------------------------------------------------------------------
Q 013682           99 LLALG---------------------------------------------------------------------------  103 (438)
Q Consensus        99 ~l~l~---------------------------------------------------------------------------  103 (438)
                      .|+++                                                                           
T Consensus       542 ~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~  621 (768)
T 3rgz_A          542 WLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYG  621 (768)
T ss_dssp             EEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEE
T ss_pred             EEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceec
Confidence            77542                                                                           


Q ss_pred             --------cccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCCC-C
Q 013682          104 --------NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-G  174 (438)
Q Consensus       104 --------~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~-~  174 (438)
                              .+++|+.|||++|+++|.+|.+++++++|+.|+|++|+++|.+|..++++++|+.||||+|+++|.||.. .
T Consensus       622 g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~  701 (768)
T 3rgz_A          622 GHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMS  701 (768)
T ss_dssp             EECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGG
T ss_pred             ccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHh
Confidence                    1245788999999999999999999999999999999999999999999999999999999999999965 3


Q ss_pred             CCCccccccccccc
Q 013682          175 SFSQFTPISFENNL  188 (438)
Q Consensus       175 ~~~~~~~~~~~~N~  188 (438)
                      .++.+..+++++|.
T Consensus       702 ~l~~L~~L~ls~N~  715 (768)
T 3rgz_A          702 ALTMLTEIDLSNNN  715 (768)
T ss_dssp             GCCCCSEEECCSSE
T ss_pred             CCCCCCEEECcCCc
Confidence            45566777777774

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.70  E-value=1.3e-18  Score=171.47  Aligned_cols=135  Identities=16%  Similarity=0.119  Sum_probs=94.9

Q ss_pred             CCCCCccccccceEEEEEEeCCCCEEEEEEccccccc-------------cchHHH--------HHHHHHHhcCCCCCce
Q 013682          288 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-------------GGELQF--------QTEVKIISMAVHRNLL  346 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~-------------~~~~~~--------~~E~~~l~~l~H~niv  346 (438)
                      |.+.+.||+|+||.||+|...+|+.||||+++.....             ......        .+|...+.++.+..+.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            7778899999999999999888999999987643211             001112        3355555555444332


Q ss_pred             eeEEEEeeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC
Q 013682          347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED  426 (438)
Q Consensus       347 ~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~  426 (438)
                      ...-+..  ...++||||+++++|.+...          ......++.|++.++.|||+.   +||||||||.|||++++
T Consensus       177 vp~p~~~--~~~~LVME~i~G~~L~~l~~----------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~d  241 (397)
T 4gyi_A          177 VPEPIAQ--SRHTIVMSLVDALPMRQVSS----------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREE  241 (397)
T ss_dssp             CCCEEEE--ETTEEEEECCSCEEGGGCCC----------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEE
T ss_pred             CCeeeec--cCceEEEEecCCccHhhhcc----------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCC
Confidence            1111111  12479999999888754321          123456789999999999998   99999999999999988


Q ss_pred             CC----------cchhhhhhc
Q 013682          427 AD----------QSSKTILRR  437 (438)
Q Consensus       427 ~~----------~~l~Df~~~  437 (438)
                      ++          +.|+||-+.
T Consensus       242 gd~~d~~~~~~~~~iID~~Q~  262 (397)
T 4gyi_A          242 KDAEDPSSITLTPIIIXFPQM  262 (397)
T ss_dssp             ECSSCTTSEEEEEEECCCTTC
T ss_pred             CCcccccccccceEEEEeCCc
Confidence            74          678998764

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.67  E-value=1.8e-17  Score=161.54  Aligned_cols=158  Identities=19%  Similarity=0.164  Sum_probs=121.3

Q ss_pred             eecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc-----------ceeeeecCCCccccccchhhcc------
Q 013682           31 CARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF-----------VYLISDLGNAALSGELAPELGQ------   93 (438)
Q Consensus        31 ~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~-----------~~~~~~l~~n~l~g~ip~~l~~------   93 (438)
                      .+.+++.|++|+++.|.+..+|..++.+.+|+.|+++.|.+           .|..++|++|++.|.+|..++.      
T Consensus        99 ~l~~l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~  178 (328)
T 4fcg_A           99 QAFRLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGE  178 (328)
T ss_dssp             CGGGGTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCCCCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCC
T ss_pred             hhhhCCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccccCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhh
Confidence            35567788888888888888888888888888888877754           3667788888888888887765      


Q ss_pred             ---CCCCCeecc------------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCe
Q 013682           94 ---LKNLELLAL------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNI  158 (438)
Q Consensus        94 ---l~~L~~l~l------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~  158 (438)
                         +++|+.|++            +.+++|+.|+|++|.++ .+|+.++++++|+.|++++|++.+.+|..++.+++|+.
T Consensus       179 ~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~  257 (328)
T 4fcg_A          179 HQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKR  257 (328)
T ss_dssp             EEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCE
T ss_pred             hccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCE
Confidence               788877753            45677888888888887 57777888888888888888888888888888888888


Q ss_pred             EeccCCCCCCCCCCC-CCCCcccccccccccc
Q 013682          159 LDLSNNRLSGPVPDN-GSFSQFTPISFENNLN  189 (438)
Q Consensus       159 l~ls~N~l~g~ip~~-~~~~~~~~~~~~~N~~  189 (438)
                      |++++|++.+.+|.. ..++.+..+++.+|..
T Consensus       258 L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~  289 (328)
T 4fcg_A          258 LILKDCSNLLTLPLDIHRLTQLEKLDLRGCVN  289 (328)
T ss_dssp             EECTTCTTCCBCCTTGGGCTTCCEEECTTCTT
T ss_pred             EECCCCCchhhcchhhhcCCCCCEEeCCCCCc
Confidence            888888888888854 3455566666766653

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.66  E-value=1.4e-18  Score=178.62  Aligned_cols=152  Identities=24%  Similarity=0.155  Sum_probs=110.3

Q ss_pred             eecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCccc-------eeeeecCCCccccccchhhccCCCCCeecc-
Q 013682           31 CARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFV-------YLISDLGNAALSGELAPELGQLKNLELLAL-  102 (438)
Q Consensus        31 ~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~~-------~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l-  102 (438)
                      .+.+++.|++|+++.|.++..+. ++.+.+|+.|++++|.++       +..++|++|.+++..+.   .+++|+.|++ 
T Consensus        53 ~~~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~  128 (487)
T 3oja_A           53 DLAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCS---RGQGKKNIYLA  128 (487)
T ss_dssp             GGTTCTTCCEEECTTSCCEEEEE-CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCEEEC---CCSSCEEEECC
T ss_pred             HHhCCCCCCEEEeeCCCCCCCcc-cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCCCcc---ccCCCCEEECC
Confidence            35677888888888888877665 788888888888887653       56677777777764443   3456666643 


Q ss_pred             ------------ccccCCCEEEccCCcccccCchhhc-cccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCC
Q 013682          103 ------------GNLIKLKSLDLYSNLFNGTIPDTLA-NLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGP  169 (438)
Q Consensus       103 ------------~~l~~L~~l~ls~N~l~g~iP~~~~-~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~  169 (438)
                                  +.+++|+.|+|++|.+++.+|..+. .+++|+.|+|++|.+++. |. ...+++|+.|+|++|.+++.
T Consensus       129 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~  206 (487)
T 3oja_A          129 NNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFM  206 (487)
T ss_dssp             SSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEE
T ss_pred             CCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCCC
Confidence                        4467788888888888887787776 688888888888888765 32 34578888888888888887


Q ss_pred             CCCCCCCCccccccccccc
Q 013682          170 VPDNGSFSQFTPISFENNL  188 (438)
Q Consensus       170 ip~~~~~~~~~~~~~~~N~  188 (438)
                      +|....++.+..+++++|.
T Consensus       207 ~~~~~~l~~L~~L~Ls~N~  225 (487)
T 3oja_A          207 GPEFQSAAGVTWISLRNNK  225 (487)
T ss_dssp             CGGGGGGTTCSEEECTTSC
T ss_pred             CHhHcCCCCccEEEecCCc
Confidence            6665555666666776664

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.64  E-value=5.6e-17  Score=158.00  Aligned_cols=152  Identities=21%  Similarity=0.239  Sum_probs=133.5

Q ss_pred             eeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc-----------ceeeeecCCCccccccchhhccCCCCCeeccc
Q 013682           35 FTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF-----------VYLISDLGNAALSGELAPELGQLKNLELLALG  103 (438)
Q Consensus        35 ~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~-----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~  103 (438)
                      ++.++.|+++.|.+.++|..++.+.+++.|+++.|.+           .|..++|++|.++ .+|..++++++|+.|+++
T Consensus        80 ~~~l~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~  158 (328)
T 4fcg_A           80 QPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIR  158 (328)
T ss_dssp             STTCCEEEEESSCCSSCCSCGGGGTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEE
T ss_pred             ccceeEEEccCCCchhcChhhhhCCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECC
Confidence            3567788999999999999999999999999988764           4788999999999 799999999999999753


Q ss_pred             c----------------------ccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEec
Q 013682          104 N----------------------LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDL  161 (438)
Q Consensus       104 ~----------------------l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~l  161 (438)
                      +                      +++|+.|+|++|.++ .+|..++++++|+.|++++|++++ +|..+..+++|+.|++
T Consensus       159 ~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~L  236 (328)
T 4fcg_A          159 ACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDL  236 (328)
T ss_dssp             EETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEEC
T ss_pred             CCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEEC
Confidence            2                      789999999999998 999999999999999999999995 6778999999999999


Q ss_pred             cCCCCCCCCCCC-CCCCcccccccccccc
Q 013682          162 SNNRLSGPVPDN-GSFSQFTPISFENNLN  189 (438)
Q Consensus       162 s~N~l~g~ip~~-~~~~~~~~~~~~~N~~  189 (438)
                      ++|++.+.+|.. ..++.+..+.+.+|..
T Consensus       237 s~n~~~~~~p~~~~~l~~L~~L~L~~n~~  265 (328)
T 4fcg_A          237 RGCTALRNYPPIFGGRAPLKRLILKDCSN  265 (328)
T ss_dssp             TTCTTCCBCCCCTTCCCCCCEEECTTCTT
T ss_pred             cCCcchhhhHHHhcCCCCCCEEECCCCCc
Confidence            999999999974 4566777777777653

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.62  E-value=9e-17  Score=155.46  Aligned_cols=151  Identities=23%  Similarity=0.316  Sum_probs=113.5

Q ss_pred             eehhHHHHHHHhh---hhhhhhhhcchheeecccC-Ccc------------ceeeeecCCCccccccchhhccCCCCCee
Q 013682           37 LLVTLKAVLQECE---QLHLLISFLIFIRVLQSSS-NLF------------VYLISDLGNAALSGELAPELGQLKNLELL  100 (438)
Q Consensus        37 ~~~~l~~~~~~~~---~l~~~~~~~~~~~~l~~~~-n~~------------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l  100 (438)
                      .++.|+++.+.++   .+|..++.+.+++.|++++ |.+            .|..++|++|.++|.+|..++++++|+.|
T Consensus        51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L  130 (313)
T 1ogq_A           51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence            4566777777777   4788888888888888773 432            37778888888888888888888888887


Q ss_pred             cc-------------ccccCCCEEEccCCcccccCchhhcccc-ccceeccccccccCCCchhhccCCCCCeEeccCCCC
Q 013682          101 AL-------------GNLIKLKSLDLYSNLFNGTIPDTLANLK-QLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL  166 (438)
Q Consensus       101 ~l-------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~-~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l  166 (438)
                      ++             +.+++|++|++++|.++|.+|..+++++ .|+.|++++|+++|.+|..+..++ |+.|++++|.+
T Consensus       131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l  209 (313)
T 1ogq_A          131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML  209 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEE
T ss_pred             eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcc
Confidence            64             3467788888888888888888888887 788888888888888888887776 88888888888


Q ss_pred             CCCCCCC-CCCCccccccccccc
Q 013682          167 SGPVPDN-GSFSQFTPISFENNL  188 (438)
Q Consensus       167 ~g~ip~~-~~~~~~~~~~~~~N~  188 (438)
                      ++.+|.. ..++.+..+.+++|.
T Consensus       210 ~~~~~~~~~~l~~L~~L~L~~N~  232 (313)
T 1ogq_A          210 EGDASVLFGSDKNTQKIHLAKNS  232 (313)
T ss_dssp             EECCGGGCCTTSCCSEEECCSSE
T ss_pred             cCcCCHHHhcCCCCCEEECCCCc
Confidence            7776643 334555566666654

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.59  E-value=1.4e-15  Score=143.95  Aligned_cols=160  Identities=21%  Similarity=0.212  Sum_probs=119.3

Q ss_pred             eecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc----------ceeeeecCCCccccccchhhccCCCCCee
Q 013682           31 CARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF----------VYLISDLGNAALSGELAPELGQLKNLELL  100 (438)
Q Consensus        31 ~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l  100 (438)
                      ....++.|+.|+++.+.+..++. +..+.+++.|+++.|.+          .|..++|++|.+++..|..++.+++|+.|
T Consensus        36 ~~~~l~~L~~L~l~~~~i~~~~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  114 (272)
T 3rfs_A           36 TQNELNSIDQIIANNSDIKSVQG-IQYLPNVRYLALGGNKLHDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKEL  114 (272)
T ss_dssp             CHHHHTTCCEEECTTSCCCCCTT-GGGCTTCCEEECTTSCCCCCGGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred             ccccccceeeeeeCCCCcccccc-cccCCCCcEEECCCCCCCCchhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEE
Confidence            34556666667777777776664 66677777777776643          47778888888887555557888888887


Q ss_pred             cc-------------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCC
Q 013682          101 AL-------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS  167 (438)
Q Consensus       101 ~l-------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~  167 (438)
                      ++             +.+++|++|++++|++++..|..++.+++|+.|++++|++++..|..+..+++|+.|++++|.++
T Consensus       115 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  194 (272)
T 3rfs_A          115 VLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLK  194 (272)
T ss_dssp             ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred             ECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCC
Confidence            53             45678888888888888655666788888888999988888777777788888888999888888


Q ss_pred             CCCCCC-CCCCcccccccccccccC
Q 013682          168 GPVPDN-GSFSQFTPISFENNLNLC  191 (438)
Q Consensus       168 g~ip~~-~~~~~~~~~~~~~N~~lc  191 (438)
                      +.+|.. ..++.+..+.+.+|+..|
T Consensus       195 ~~~~~~~~~l~~L~~L~l~~N~~~~  219 (272)
T 3rfs_A          195 SVPDGVFDRLTSLQYIWLHDNPWDC  219 (272)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             ccCHHHHhCCcCCCEEEccCCCccc
Confidence            877653 456677777777776544

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.57  E-value=2.6e-15  Score=140.28  Aligned_cols=151  Identities=23%  Similarity=0.215  Sum_probs=110.2

Q ss_pred             hhHHHHHHHhhhhhhhhhhcchheeecccCCc------------cceeeeecCCCccccccchhhccCCCCCeecc----
Q 013682           39 VTLKAVLQECEQLHLLISFLIFIRVLQSSSNL------------FVYLISDLGNAALSGELAPELGQLKNLELLAL----  102 (438)
Q Consensus        39 ~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~------------~~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l----  102 (438)
                      ++++.+.+.++++|..+.  ..++.|+++.|.            ..|..++|++|.+++..|..+..+++|+.|++    
T Consensus        17 ~~l~~~~~~l~~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~   94 (251)
T 3m19_A           17 KEVDCQGKSLDSVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ   94 (251)
T ss_dssp             TEEECTTCCCSSCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             eEEecCCCCccccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCc
Confidence            345556666777776554  455666665543            34677788888888766666788888888764    


Q ss_pred             ---------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCC-
Q 013682          103 ---------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-  172 (438)
Q Consensus       103 ---------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~-  172 (438)
                               +.+++|+.|+|++|++++..|..|+.+++|+.|+|++|++++..|..+..+++|+.|++++|++++.+|. 
T Consensus        95 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  174 (251)
T 3m19_A           95 LASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGA  174 (251)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred             ccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHH
Confidence                     4567888899999998855455578888999999999999877666788888999999999998877664 


Q ss_pred             CCCCCcccccccccccccC
Q 013682          173 NGSFSQFTPISFENNLNLC  191 (438)
Q Consensus       173 ~~~~~~~~~~~~~~N~~lc  191 (438)
                      ...++.+..+.+.+|+.-|
T Consensus       175 ~~~l~~L~~L~l~~N~~~c  193 (251)
T 3m19_A          175 FDRLGKLQTITLFGNQFDC  193 (251)
T ss_dssp             TTTCTTCCEEECCSCCBCT
T ss_pred             HhCCCCCCEEEeeCCceeC
Confidence            3345667777777776544

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.57  E-value=1.2e-15  Score=146.67  Aligned_cols=138  Identities=20%  Similarity=0.210  Sum_probs=65.4

Q ss_pred             ceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc-------------ceeeeecCCCccccccchhhccCCCCCee
Q 013682           34 GFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF-------------VYLISDLGNAALSGELAPELGQLKNLELL  100 (438)
Q Consensus        34 ~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~-------------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l  100 (438)
                      +++.|++|+++.|.+..+|..+..+.+++.|++++|.+             .|..+++++|.+++..|..+..+++|+.|
T Consensus        76 ~~~~L~~L~Ls~n~i~~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  155 (306)
T 2z66_A           76 GTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL  155 (306)
T ss_dssp             SCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEE
T ss_pred             cccccCEEECCCCccccChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEE
Confidence            34444444444444444444444444444444443321             23444455555544444444444554444


Q ss_pred             cc--------------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCC
Q 013682          101 AL--------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL  166 (438)
Q Consensus       101 ~l--------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l  166 (438)
                      ++              +.+++|+.|++++|.+++..|..++++++|+.|++++|++++..+..+..+++|+.|++++|.+
T Consensus       156 ~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  235 (306)
T 2z66_A          156 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI  235 (306)
T ss_dssp             ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCC
T ss_pred             ECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCC
Confidence            32              2234455555555555444444455555555555555555544444444555555555555555


Q ss_pred             CCCCC
Q 013682          167 SGPVP  171 (438)
Q Consensus       167 ~g~ip  171 (438)
                      ++.+|
T Consensus       236 ~~~~~  240 (306)
T 2z66_A          236 MTSKK  240 (306)
T ss_dssp             CBCSS
T ss_pred             cccCH
Confidence            54444

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.57  E-value=7.8e-16  Score=146.48  Aligned_cols=152  Identities=21%  Similarity=0.199  Sum_probs=88.5

Q ss_pred             eeehhHHHHHHHhhhhhh-hhhhcchheeecccCCcc------------ceeeeecCCCc-cccccchhhccCCCCCeec
Q 013682           36 TLLVTLKAVLQECEQLHL-LISFLIFIRVLQSSSNLF------------VYLISDLGNAA-LSGELAPELGQLKNLELLA  101 (438)
Q Consensus        36 ~~~~~l~~~~~~~~~l~~-~~~~~~~~~~l~~~~n~~------------~~~~~~l~~n~-l~g~ip~~l~~l~~L~~l~  101 (438)
                      +.|++|+++.|.++.++. .+..+.+++.|+++.|.+            .|..++|++|. +++..|..+..+++|+.|+
T Consensus        32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~  111 (285)
T 1ozn_A           32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH  111 (285)
T ss_dssp             TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred             CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence            345666666666666663 356666666666665532            25556666665 4443355566666666664


Q ss_pred             c-------------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCC
Q 013682          102 L-------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG  168 (438)
Q Consensus       102 l-------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g  168 (438)
                      +             +.+++|++|++++|.+++..|..++++++|+.|++++|++++..+..+..+++|+.|++++|.+++
T Consensus       112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  191 (285)
T 1ozn_A          112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH  191 (285)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred             CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccc
Confidence            3             335566666666666664444446666666666666666665544456666666666666666666


Q ss_pred             CCCCC-CCCCcccccccccc
Q 013682          169 PVPDN-GSFSQFTPISFENN  187 (438)
Q Consensus       169 ~ip~~-~~~~~~~~~~~~~N  187 (438)
                      .+|.. ..++.+..+++++|
T Consensus       192 ~~~~~~~~l~~L~~L~l~~n  211 (285)
T 1ozn_A          192 VHPHAFRDLGRLMTLYLFAN  211 (285)
T ss_dssp             ECTTTTTTCTTCCEEECCSS
T ss_pred             cCHhHccCcccccEeeCCCC
Confidence            55532 23344455555554

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.54  E-value=1.7e-15  Score=159.35  Aligned_cols=159  Identities=20%  Similarity=0.173  Sum_probs=85.4

Q ss_pred             ecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCc-------------cceeeeecCCCccccccchhhccCCCCC
Q 013682           32 ARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNL-------------FVYLISDLGNAALSGELAPELGQLKNLE   98 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~-------------~~~~~~~l~~n~l~g~ip~~l~~l~~L~   98 (438)
                      +.+++.|++|+++.|.+..+|..+..+.+++.|++++|.             ..|..+++++|.+++.+|..++.+++|+
T Consensus       372 ~~~~~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  451 (606)
T 3vq2_A          372 DLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLN  451 (606)
T ss_dssp             HHCCSCCCEEECCSCSEEEECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCC
T ss_pred             hccCCcccEeECCCCccccchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCC
Confidence            344445555555555555555455555555555554432             1244555555555555555555555555


Q ss_pred             eecc--------------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCC
Q 013682           99 LLAL--------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNN  164 (438)
Q Consensus        99 ~l~l--------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N  164 (438)
                      .|++              +.+++|+.|++++|++++..|..++++++|+.|++++|++++.+|..+..+++|+.|++++|
T Consensus       452 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N  531 (606)
T 3vq2_A          452 TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFN  531 (606)
T ss_dssp             EEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTS
T ss_pred             EEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCC
Confidence            5542              23455666666666666555555666666666666666666555666666666666666666


Q ss_pred             CCCCCCCCC-CCCC-cccccccccccccC
Q 013682          165 RLSGPVPDN-GSFS-QFTPISFENNLNLC  191 (438)
Q Consensus       165 ~l~g~ip~~-~~~~-~~~~~~~~~N~~lc  191 (438)
                      +++ .+|.. ..++ .+..+++.+|+..|
T Consensus       532 ~l~-~~p~~~~~l~~~L~~l~l~~N~~~c  559 (606)
T 3vq2_A          532 RIE-TSKGILQHFPKSLAFFNLTNNSVAC  559 (606)
T ss_dssp             CCC-CEESCGGGSCTTCCEEECCSCCCCC
T ss_pred             cCc-ccCHhHhhhcccCcEEEccCCCccc
Confidence            665 33332 2222 24445555555444

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.54  E-value=8.7e-15  Score=139.98  Aligned_cols=155  Identities=21%  Similarity=0.127  Sum_probs=89.7

Q ss_pred             eeehhHHHHHHHhhhhh-hhhhhcchheeecccCCcc----------ceeeeecCCCccccccchhhccCCCCCeecc--
Q 013682           36 TLLVTLKAVLQECEQLH-LLISFLIFIRVLQSSSNLF----------VYLISDLGNAALSGELAPELGQLKNLELLAL--  102 (438)
Q Consensus        36 ~~~~~l~~~~~~~~~l~-~~~~~~~~~~~l~~~~n~~----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l--  102 (438)
                      +.+++|+++.|.++.++ ..+..+.+++.|+++.|.+          .|..++|++|.++ .+|..+..+++|+.|++  
T Consensus        31 ~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~  109 (290)
T 1p9a_G           31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSF  109 (290)
T ss_dssp             TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCS
T ss_pred             CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCCCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCC
Confidence            34556666666666664 3466666666666665543          3556666777666 46666666666666542  


Q ss_pred             -----------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCC
Q 013682          103 -----------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP  171 (438)
Q Consensus       103 -----------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip  171 (438)
                                 +.+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|++++|+++.-.+
T Consensus       110 N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~  189 (290)
T 1p9a_G          110 NRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPK  189 (290)
T ss_dssp             SCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             CcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccCh
Confidence                       335566666666666664444445666666666666666664444445566666666666666663222


Q ss_pred             CCCCCCcccccccccccccC
Q 013682          172 DNGSFSQFTPISFENNLNLC  191 (438)
Q Consensus       172 ~~~~~~~~~~~~~~~N~~lc  191 (438)
                      .......+..+.+.+|+..|
T Consensus       190 ~~~~~~~L~~l~L~~Np~~C  209 (290)
T 1p9a_G          190 GFFGSHLLPFAFLHGNPWLC  209 (290)
T ss_dssp             TTTTTCCCSEEECCSCCBCC
T ss_pred             hhcccccCCeEEeCCCCccC
Confidence            22233344445555555444

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.53  E-value=1.4e-15  Score=161.23  Aligned_cols=117  Identities=22%  Similarity=0.370  Sum_probs=93.8

Q ss_pred             cceeeeecCCCccccc-----------------cchhhc--cCCCCCeecc-------------ccccCCCEEEccCCc-
Q 013682           71 FVYLISDLGNAALSGE-----------------LAPELG--QLKNLELLAL-------------GNLIKLKSLDLYSNL-  117 (438)
Q Consensus        71 ~~~~~~~l~~n~l~g~-----------------ip~~l~--~l~~L~~l~l-------------~~l~~L~~l~ls~N~-  117 (438)
                      ..|..++|++|.++|.                 +|.+++  ++++|+.|++             +++++|++|++++|+ 
T Consensus       206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~  285 (636)
T 4eco_A          206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG  285 (636)
T ss_dssp             TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTT
T ss_pred             cCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCC
Confidence            3577788888888886                 888888  8888888863             457788899999998 


Q ss_pred             ccc-cCchhhccc------cccceeccccccccCCCch--hhccCCCCCeEeccCCCCCCCCCCCCCCCccccccccccc
Q 013682          118 FNG-TIPDTLANL------KQLKYLRLNNNSLSGLIPT--SLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL  188 (438)
Q Consensus       118 l~g-~iP~~~~~l------~~L~~l~ls~N~l~g~~P~--~l~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~N~  188 (438)
                      ++| .+|..++++      ++|+.|++++|+++ .+|.  .++.+++|+.|++++|.++|.+|....++.+..+.+++|.
T Consensus       286 l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~~~l~~L~~L~L~~N~  364 (636)
T 4eco_A          286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQ  364 (636)
T ss_dssp             SCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECCCCEEEEEESEEECCSSE
T ss_pred             CccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchhhhCCCCCCCEEECCCCc
Confidence            888 888888887      88999999999988 7888  8889999999999999999888844444555555555553

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.53  E-value=8e-15  Score=148.58  Aligned_cols=119  Identities=24%  Similarity=0.297  Sum_probs=64.6

Q ss_pred             eeeeecCCCccccccchhhccCCCCCeecc-------------ccccCCCEEEccCCcccccCchhhccccccceecccc
Q 013682           73 YLISDLGNAALSGELAPELGQLKNLELLAL-------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN  139 (438)
Q Consensus        73 ~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l-------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~  139 (438)
                      +..+++++|.+++.+|..++.+++|+.|++             +.+++|+.|+|++|.+++..|..++++++|+.|+|++
T Consensus       277 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  356 (455)
T 3v47_A          277 VKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSY  356 (455)
T ss_dssp             CCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCS
T ss_pred             ceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCC
Confidence            444445555555545555555555555542             2345566666666666544555556666666666666


Q ss_pred             ccccCCCchhhccCCCCCeEeccCCCCCCCCCCC-CCCCcccccccccccccC
Q 013682          140 NSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNLNLC  191 (438)
Q Consensus       140 N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~N~~lc  191 (438)
                      |++++..|..+..+++|+.|++++|++++.++.. ..++.+..+++++|+.-|
T Consensus       357 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  409 (455)
T 3v47_A          357 NHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  409 (455)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             CcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCccc
Confidence            6665555555666666666666666665543332 234445555555555433

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.53  E-value=7.6e-15  Score=138.86  Aligned_cols=140  Identities=23%  Similarity=0.196  Sum_probs=123.5

Q ss_pred             ecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc------------ceeeeecCCCccccccchhhccCCCCCe
Q 013682           32 ARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF------------VYLISDLGNAALSGELAPELGQLKNLEL   99 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~------------~~~~~~l~~n~l~g~ip~~l~~l~~L~~   99 (438)
                      +++++.|++|+++.|.+..++ .++.+.+++.|+++.|.+            .|..++|++|.+++..|..++.+++|+.
T Consensus        59 l~~l~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  137 (272)
T 3rfs_A           59 IQYLPNVRYLALGGNKLHDIS-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTY  137 (272)
T ss_dssp             GGGCTTCCEEECTTSCCCCCG-GGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred             cccCCCCcEEECCCCCCCCch-hhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCE
Confidence            567888999999999999986 688899999999987753            4888999999999866666899999999


Q ss_pred             ecc-------------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCC
Q 013682          100 LAL-------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL  166 (438)
Q Consensus       100 l~l-------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l  166 (438)
                      |++             +.+++|+.|++++|++++..|..++.+++|+.|++++|++++..|..+..+++|+.|++++|.+
T Consensus       138 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~  217 (272)
T 3rfs_A          138 LNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPW  217 (272)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred             EECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCc
Confidence            864             4578999999999999976677789999999999999999998888899999999999999999


Q ss_pred             CCCCCC
Q 013682          167 SGPVPD  172 (438)
Q Consensus       167 ~g~ip~  172 (438)
                      .|..|.
T Consensus       218 ~~~~~~  223 (272)
T 3rfs_A          218 DCTCPG  223 (272)
T ss_dssp             CCCTTT
T ss_pred             cccCcH
Confidence            998874

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.53  E-value=1.7e-15  Score=146.34  Aligned_cols=141  Identities=21%  Similarity=0.117  Sum_probs=66.4

Q ss_pred             cceeeehhHHHHHHHhhhhhhhhhhc-----chheeecccCCccceeeeecCCCccccccchhhccCCCCCeecc-----
Q 013682           33 RGFTLLVTLKAVLQECEQLHLLISFL-----IFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLAL-----  102 (438)
Q Consensus        33 ~~~~~~~~l~~~~~~~~~l~~~~~~~-----~~~~~l~~~~n~~~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l-----  102 (438)
                      .+++.|++|+++.|.++.+|..++.+     .+++.            ++|++|.+++..|..++.+++|+.|++     
T Consensus       118 ~~l~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~~L~~------------L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  185 (312)
T 1wwl_A          118 ATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKV------------LSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE  185 (312)
T ss_dssp             CCSCCCSEEEEESCBCSSSSSHHHHHHTTCCTTCCE------------EEEESCSCCCCCTTTCCCCSSCCEEECCSCTT
T ss_pred             hcCCCccEEEccCCCCcchhHHHHHHHHhhcCCCcE------------EEeeCCCCccchHHHhccCCCCCEEECCCCCc
Confidence            44455555555555555444444444     44444            455555555444445555555555432     


Q ss_pred             ------------ccccCCCEEEccCCcccc--cCc-hhhccccccceeccccccccCCCc-hhhccCCCCCeEeccCCCC
Q 013682          103 ------------GNLIKLKSLDLYSNLFNG--TIP-DTLANLKQLKYLRLNNNSLSGLIP-TSLTTITSLNILDLSNNRL  166 (438)
Q Consensus       103 ------------~~l~~L~~l~ls~N~l~g--~iP-~~~~~l~~L~~l~ls~N~l~g~~P-~~l~~~~~L~~l~ls~N~l  166 (438)
                                  +.+++|++|+|++|++++  .+| ..+.++++|+.|++++|++++.+| ..+..+++|+.|++++|.+
T Consensus       186 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l  265 (312)
T 1wwl_A          186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL  265 (312)
T ss_dssp             CHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCC
T ss_pred             CcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCcc
Confidence                        233445555555555541  122 122344555555555555555443 2334445555555555555


Q ss_pred             CCCCCCCCCCCcccccccccc
Q 013682          167 SGPVPDNGSFSQFTPISFENN  187 (438)
Q Consensus       167 ~g~ip~~~~~~~~~~~~~~~N  187 (438)
                      + .+|.... +.+..+++++|
T Consensus       266 ~-~ip~~~~-~~L~~L~Ls~N  284 (312)
T 1wwl_A          266 K-QVPKGLP-AKLSVLDLSYN  284 (312)
T ss_dssp             S-SCCSSCC-SEEEEEECCSS
T ss_pred             C-hhhhhcc-CCceEEECCCC
Confidence            5 4444322 33444444444

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.52  E-value=5.6e-15  Score=150.03  Aligned_cols=88  Identities=25%  Similarity=0.342  Sum_probs=65.6

Q ss_pred             ccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCCC-CCCCcccccc
Q 013682          105 LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPIS  183 (438)
Q Consensus       105 l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~-~~~~~~~~~~  183 (438)
                      +++|+.|+|++|.+++..|..|.++++|+.|++++|++++..|..+..+++|+.|+|++|++++.++.. ..++.+..++
T Consensus       217 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  296 (452)
T 3zyi_A          217 LVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELH  296 (452)
T ss_dssp             CTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEE
T ss_pred             cccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEE
Confidence            345667777777777666777888888888888888888777788888888888888888888665543 3456667777


Q ss_pred             cccccccCC
Q 013682          184 FENNLNLCG  192 (438)
Q Consensus       184 ~~~N~~lcg  192 (438)
                      +.+|+.-|.
T Consensus       297 L~~Np~~Cd  305 (452)
T 3zyi_A          297 LHHNPWNCD  305 (452)
T ss_dssp             CCSSCEECS
T ss_pred             ccCCCcCCC
Confidence            888876664

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.52  E-value=1.2e-14  Score=137.39  Aligned_cols=154  Identities=25%  Similarity=0.212  Sum_probs=89.9

Q ss_pred             ehhHHHHHHHhhhhhh-hhhhcchheeecccCCc------------cceeeeecCCCccccccchhhccCCCCCeecc--
Q 013682           38 LVTLKAVLQECEQLHL-LISFLIFIRVLQSSSNL------------FVYLISDLGNAALSGELAPELGQLKNLELLAL--  102 (438)
Q Consensus        38 ~~~l~~~~~~~~~l~~-~~~~~~~~~~l~~~~n~------------~~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l--  102 (438)
                      +++|+++.|.++.++. .++.+.+++.|++++|.            ..|..++|++|.+++..+..+..+++|+.|++  
T Consensus        39 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~  118 (270)
T 2o6q_A           39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDR  118 (270)
T ss_dssp             CSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCS
T ss_pred             CCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCC
Confidence            5666666666666664 46666666666665553            23556666666666533334456666666643  


Q ss_pred             -----------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCC
Q 013682          103 -----------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP  171 (438)
Q Consensus       103 -----------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip  171 (438)
                                 +.+++|+.|+|++|.+++..+..|+.+++|+.|++++|++++..|..+..+++|+.|++++|.+++..+
T Consensus       119 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  198 (270)
T 2o6q_A          119 NQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPE  198 (270)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             CccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCH
Confidence                       345566666666666663333346666666666666666665555556666666666666666665443


Q ss_pred             C-CCCCCcccccccccccccC
Q 013682          172 D-NGSFSQFTPISFENNLNLC  191 (438)
Q Consensus       172 ~-~~~~~~~~~~~~~~N~~lc  191 (438)
                      . ...++.+..+.+.+|+.-|
T Consensus       199 ~~~~~l~~L~~L~l~~N~~~c  219 (270)
T 2o6q_A          199 GAFDSLEKLKMLQLQENPWDC  219 (270)
T ss_dssp             TTTTTCTTCCEEECCSSCBCC
T ss_pred             HHhccccCCCEEEecCCCeeC
Confidence            3 1234445555566665433

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.52  E-value=5.9e-15  Score=149.39  Aligned_cols=161  Identities=20%  Similarity=0.215  Sum_probs=110.2

Q ss_pred             ecceeeehhHHHHHHHhhhhh-hhhhhcchheeecccCCcc------------ceeeeecCCCccccccchhhc------
Q 013682           32 ARGFTLLVTLKAVLQECEQLH-LLISFLIFIRVLQSSSNLF------------VYLISDLGNAALSGELAPELG------   92 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l~-~~~~~~~~~~~l~~~~n~~------------~~~~~~l~~n~l~g~ip~~l~------   92 (438)
                      +.+++.|++|+++.|.+..++ ..+..+.+|+.|++++|.+            .|..++|++|.+++..+..+.      
T Consensus        84 ~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~  163 (440)
T 3zyj_A           84 FKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLR  163 (440)
T ss_dssp             TSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCC
T ss_pred             hhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccC
Confidence            455666666666666666665 3466666666666665532            255566666666543233344      


Q ss_pred             -------------------cCCCCCeecc-----------ccccCCCEEEccCCcccccCchhhccccccceeccccccc
Q 013682           93 -------------------QLKNLELLAL-----------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSL  142 (438)
Q Consensus        93 -------------------~l~~L~~l~l-----------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l  142 (438)
                                         .+++|+.|++           ..+++|+.|+|++|.+++..|..|.++++|+.|+|++|++
T Consensus       164 ~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l  243 (440)
T 3zyj_A          164 RLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI  243 (440)
T ss_dssp             EEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCCCCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             EeCCCCCCCcceeCcchhhcccccCeecCCCCcCccccccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCce
Confidence                               4445554443           2345777888888888877788888888888888888888


Q ss_pred             cCCCchhhccCCCCCeEeccCCCCCCCCCCC-CCCCcccccccccccccCC
Q 013682          143 SGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNLNLCG  192 (438)
Q Consensus       143 ~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~N~~lcg  192 (438)
                      ++..|..+..+++|+.|+|++|++++..+.. ..++.+..+++.+|+..|.
T Consensus       244 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd  294 (440)
T 3zyj_A          244 QVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN  294 (440)
T ss_dssp             CEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECS
T ss_pred             eEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCC
Confidence            8888888888888999999999888766543 3456677778888887664

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.48  E-value=3.3e-15  Score=158.40  Aligned_cols=156  Identities=18%  Similarity=0.218  Sum_probs=135.4

Q ss_pred             eeecceeeehhHHHHHHHhhh------------------hhhhhh--hcchheeecccCCc------------cceeeee
Q 013682           30 ICARGFTLLVTLKAVLQECEQ------------------LHLLIS--FLIFIRVLQSSSNL------------FVYLISD   77 (438)
Q Consensus        30 ~~~~~~~~~~~l~~~~~~~~~------------------l~~~~~--~~~~~~~l~~~~n~------------~~~~~~~   77 (438)
                      -.+++++.|++|+++.|.++.                  +|..++  .+.+|+.|+++.|.            ..|..++
T Consensus       200 ~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~  279 (636)
T 4eco_A          200 KAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLIN  279 (636)
T ss_dssp             GGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEE
T ss_pred             HHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEE
Confidence            348899999999999999999                  999999  99999999998774            3588899


Q ss_pred             cCCCc-ccc-ccchhhccC------CCCCeecc--------------ccccCCCEEEccCCcccccCchhhcccccccee
Q 013682           78 LGNAA-LSG-ELAPELGQL------KNLELLAL--------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL  135 (438)
Q Consensus        78 l~~n~-l~g-~ip~~l~~l------~~L~~l~l--------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l  135 (438)
                      |++|+ ++| .+|..++++      ++|+.|++              +++++|+.|++++|+++|.+| .++++++|+.|
T Consensus       280 Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L  358 (636)
T 4eco_A          280 VACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASL  358 (636)
T ss_dssp             CTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEE
T ss_pred             CcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEE
Confidence            99998 999 999999987      89998854              456789999999999999999 99999999999


Q ss_pred             ccccccccCCCchhhccCCC-CCeEeccCCCCCCCCCCCCCC---Cccccccccccc
Q 013682          136 RLNNNSLSGLIPTSLTTITS-LNILDLSNNRLSGPVPDNGSF---SQFTPISFENNL  188 (438)
Q Consensus       136 ~ls~N~l~g~~P~~l~~~~~-L~~l~ls~N~l~g~ip~~~~~---~~~~~~~~~~N~  188 (438)
                      ++++|+++ .+|..+..+++ |+.|++++|.++ .+|.....   ..+..+.+++|.
T Consensus       359 ~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~  413 (636)
T 4eco_A          359 NLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNE  413 (636)
T ss_dssp             ECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSC
T ss_pred             ECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCc
Confidence            99999999 88999999999 999999999999 77764322   246666776664

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.48  E-value=1.5e-14  Score=136.99  Aligned_cols=164  Identities=20%  Similarity=0.230  Sum_probs=127.0

Q ss_pred             eEEeeeeeccee-----eehhHHHHHHHhhhhhh-hhhhcchheeecccCCcc------------ceeeeecCCCccccc
Q 013682           25 IICLGICARGFT-----LLVTLKAVLQECEQLHL-LISFLIFIRVLQSSSNLF------------VYLISDLGNAALSGE   86 (438)
Q Consensus        25 ~~~~~~~~~~~~-----~~~~l~~~~~~~~~l~~-~~~~~~~~~~l~~~~n~~------------~~~~~~l~~n~l~g~   86 (438)
                      +-|.+.....+.     .|++|+++.|.+++++. .+..+.+++.|++++|.+            .|..++|++|.+++.
T Consensus        12 ~~c~~~~l~~ip~~l~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~   91 (276)
T 2z62_A           12 YQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL   91 (276)
T ss_dssp             EECTTSCCSSCCSSSCTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEE
T ss_pred             EEecCCCccccCCCCCCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCcc
Confidence            345554444333     48889999999999887 688889999999887743            477889999999987


Q ss_pred             cchhhccCCCCCeecc-------------ccccCCCEEEccCCcccc-cCchhhccccccceeccccccccCCCchhhcc
Q 013682           87 LAPELGQLKNLELLAL-------------GNLIKLKSLDLYSNLFNG-TIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT  152 (438)
Q Consensus        87 ip~~l~~l~~L~~l~l-------------~~l~~L~~l~ls~N~l~g-~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~  152 (438)
                      .|..+..+++|+.|++             +.+++|+.|++++|.+++ .+|..++++++|+.|++++|++++..|..+..
T Consensus        92 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  171 (276)
T 2z62_A           92 ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV  171 (276)
T ss_dssp             CTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHH
T ss_pred             ChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhh
Confidence            7778888999988853             456789999999999975 47889999999999999999998877777777


Q ss_pred             CCCCC----eEeccCCCCCCCCCCCCCCCccccccccccc
Q 013682          153 ITSLN----ILDLSNNRLSGPVPDNGSFSQFTPISFENNL  188 (438)
Q Consensus       153 ~~~L~----~l~ls~N~l~g~ip~~~~~~~~~~~~~~~N~  188 (438)
                      +++|+    .+++++|.+++..|.......+..+++++|.
T Consensus       172 l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~  211 (276)
T 2z62_A          172 LHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQ  211 (276)
T ss_dssp             HHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSC
T ss_pred             hhhccccceeeecCCCcccccCccccCCCcccEEECCCCc
Confidence            77666    7888888888766655444456666666664

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.47  E-value=4.4e-14  Score=131.91  Aligned_cols=137  Identities=20%  Similarity=0.176  Sum_probs=118.6

Q ss_pred             eeehhHHHHHHHhhhhhhh-hhhcchheeecccCCcc------------ceeeeecCCCccccccchhhccCCCCCeecc
Q 013682           36 TLLVTLKAVLQECEQLHLL-ISFLIFIRVLQSSSNLF------------VYLISDLGNAALSGELAPELGQLKNLELLAL  102 (438)
Q Consensus        36 ~~~~~l~~~~~~~~~l~~~-~~~~~~~~~l~~~~n~~------------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l  102 (438)
                      +.+++|+++.|.+..++.. ++.+.+++.|++++|.+            .|..++|++|.+++..|..+..+++|+.|++
T Consensus        35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  114 (251)
T 3m19_A           35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL  114 (251)
T ss_dssp             TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence            3578899999999998774 88999999999987754            4888999999999755567789999999864


Q ss_pred             -------------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCC
Q 013682          103 -------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGP  169 (438)
Q Consensus       103 -------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~  169 (438)
                                   +.+++|+.|+|++|++++..|..|+.+++|+.|+|++|++++..|..+..+++|+.|++++|.+++.
T Consensus       115 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             CCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence                         4578999999999999955555899999999999999999988888999999999999999999987


Q ss_pred             CCC
Q 013682          170 VPD  172 (438)
Q Consensus       170 ip~  172 (438)
                      .+.
T Consensus       195 ~~~  197 (251)
T 3m19_A          195 RCE  197 (251)
T ss_dssp             STT
T ss_pred             ccc
Confidence            554

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.46  E-value=1.2e-14  Score=152.84  Aligned_cols=158  Identities=20%  Similarity=0.179  Sum_probs=76.3

Q ss_pred             ecceeeehhHHHHHHHhhhh-hhhhhhcchheeecccCCcc-------------ceeeeecCCCccccccchhhccCCCC
Q 013682           32 ARGFTLLVTLKAVLQECEQL-HLLISFLIFIRVLQSSSNLF-------------VYLISDLGNAALSGELAPELGQLKNL   97 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l-~~~~~~~~~~~~l~~~~n~~-------------~~~~~~l~~n~l~g~ip~~l~~l~~L   97 (438)
                      +++++.|++|+++.|.+..+ |..+..+.+++.|+++.|.+             .|..+++++|.+++..|..++.+++|
T Consensus       372 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  451 (606)
T 3t6q_A          372 LRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPAL  451 (606)
T ss_dssp             TTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTC
T ss_pred             cccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCC
Confidence            44444444444444444443 23344444444444443321             24444555555555444445555555


Q ss_pred             Ceecc----------------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEec
Q 013682           98 ELLAL----------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDL  161 (438)
Q Consensus        98 ~~l~l----------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~l  161 (438)
                      +.|++                +.+++|+.|++++|++++..|..|+++++|+.|+|++|++++..|..+.++++| .|++
T Consensus       452 ~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L  530 (606)
T 3t6q_A          452 QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNL  530 (606)
T ss_dssp             CEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEEC
T ss_pred             CEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEEC
Confidence            55432                123445555555555554445555555555555555555555555555555555 5555


Q ss_pred             cCCCCCCCCCCC-CCCCccccccccccccc
Q 013682          162 SNNRLSGPVPDN-GSFSQFTPISFENNLNL  190 (438)
Q Consensus       162 s~N~l~g~ip~~-~~~~~~~~~~~~~N~~l  190 (438)
                      ++|++++.+|.. ..++.+..+++.+|+..
T Consensus       531 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  560 (606)
T 3t6q_A          531 ASNHISIILPSLLPILSQQRTINLRQNPLD  560 (606)
T ss_dssp             CSSCCCCCCGGGHHHHHTSSEEECTTCCEE
T ss_pred             cCCcccccCHhhcccCCCCCEEeCCCCCcc
Confidence            555555544432 12233444445555433

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.46  E-value=2e-14  Score=156.50  Aligned_cols=116  Identities=22%  Similarity=0.324  Sum_probs=83.7

Q ss_pred             cceeeeecCCCcccc-----------------ccchhhc--cCCCCCeecc-------------ccccCCCEEEccCCc-
Q 013682           71 FVYLISDLGNAALSG-----------------ELAPELG--QLKNLELLAL-------------GNLIKLKSLDLYSNL-  117 (438)
Q Consensus        71 ~~~~~~~l~~n~l~g-----------------~ip~~l~--~l~~L~~l~l-------------~~l~~L~~l~ls~N~-  117 (438)
                      ..|..|+|++|.++|                 .+|.+++  ++++|+.|++             +++++|+.|+|++|+ 
T Consensus       448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~  527 (876)
T 4ecn_A          448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG  527 (876)
T ss_dssp             TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTT
T ss_pred             CCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCC
Confidence            346667777777777                 3777777  7777777753             346677788888887 


Q ss_pred             ccc-cCchhhcccc-------ccceeccccccccCCCch--hhccCCCCCeEeccCCCCCCCCCCCCCCCcccccccccc
Q 013682          118 FNG-TIPDTLANLK-------QLKYLRLNNNSLSGLIPT--SLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN  187 (438)
Q Consensus       118 l~g-~iP~~~~~l~-------~L~~l~ls~N~l~g~~P~--~l~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~N  187 (438)
                      ++| .+|..+++++       +|+.|+|++|+++ .+|.  .++.+++|+.|++++|.++ .+|....++.+..+.+++|
T Consensus       528 lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L~~L~Ls~N  605 (876)
T 4ecn_A          528 ISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDYN  605 (876)
T ss_dssp             SCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEESEEECCSS
T ss_pred             cccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcceEEECcCC
Confidence            777 7777777776       7788888888877 7777  7777888888888888777 7775555556666666665


Q ss_pred             c
Q 013682          188 L  188 (438)
Q Consensus       188 ~  188 (438)
                      .
T Consensus       606 ~  606 (876)
T 4ecn_A          606 Q  606 (876)
T ss_dssp             C
T ss_pred             c
Confidence            4

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.46  E-value=1.8e-14  Score=138.29  Aligned_cols=152  Identities=22%  Similarity=0.251  Sum_probs=118.9

Q ss_pred             eeehhHHHHHHHhhhhhhh-hhhcchheeecccCCcc--------------ceeeeecCCCccccccchhhccCCCCCee
Q 013682           36 TLLVTLKAVLQECEQLHLL-ISFLIFIRVLQSSSNLF--------------VYLISDLGNAALSGELAPELGQLKNLELL  100 (438)
Q Consensus        36 ~~~~~l~~~~~~~~~l~~~-~~~~~~~~~l~~~~n~~--------------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l  100 (438)
                      +.|++|+++.|.+.++|.. +..+.+++.|+++.|.+              .|..++|++|.+++ +|..+..+++|+.|
T Consensus        28 ~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L  106 (306)
T 2z66_A           28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHL  106 (306)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEEE-EEEEEETCTTCCEE
T ss_pred             CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCcccc-ChhhcCCCCCCCEE
Confidence            4677888888888888876 68888899998888764              36678888888885 88888888888888


Q ss_pred             cc--------------ccccCCCEEEccCCcccccCchhhccccccceeccccccccC-CCchhhccCCCCCeEeccCCC
Q 013682          101 AL--------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSG-LIPTSLTTITSLNILDLSNNR  165 (438)
Q Consensus       101 ~l--------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g-~~P~~l~~~~~L~~l~ls~N~  165 (438)
                      ++              ..+++|++|++++|.+.+..|..++.+++|++|++++|.+++ .+|..+..+++|+.|++++|.
T Consensus       107 ~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~  186 (306)
T 2z66_A          107 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ  186 (306)
T ss_dssp             ECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSC
T ss_pred             ECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCC
Confidence            64              345678888888888887778888888888888888888876 567788888888888888888


Q ss_pred             CCCCCCCC-CCCCccccccccccc
Q 013682          166 LSGPVPDN-GSFSQFTPISFENNL  188 (438)
Q Consensus       166 l~g~ip~~-~~~~~~~~~~~~~N~  188 (438)
                      +++..|.. ..++.+..+.+++|.
T Consensus       187 l~~~~~~~~~~l~~L~~L~L~~N~  210 (306)
T 2z66_A          187 LEQLSPTAFNSLSSLQVLNMSHNN  210 (306)
T ss_dssp             CCEECTTTTTTCTTCCEEECTTSC
T ss_pred             cCCcCHHHhcCCCCCCEEECCCCc
Confidence            88776643 345566666666664

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.45  E-value=5.9e-14  Score=136.30  Aligned_cols=155  Identities=22%  Similarity=0.227  Sum_probs=94.9

Q ss_pred             ecceeeehhHHHHHHHhhhh-hhhhhhcchheeecccCCcc---------ceeeeecCCCccccccchhhccCCCCCeec
Q 013682           32 ARGFTLLVTLKAVLQECEQL-HLLISFLIFIRVLQSSSNLF---------VYLISDLGNAALSGELAPELGQLKNLELLA  101 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l-~~~~~~~~~~~~l~~~~n~~---------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~  101 (438)
                      +.+++.|++|+++.|.+..+ |..++.+.+++.|+++.|.+         .+..+++++|.+++..|..+..+++|+.|+
T Consensus        72 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  151 (330)
T 1xku_A           72 FKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE  151 (330)
T ss_dssp             TTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEE
T ss_pred             hccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCccChhhcccccEEECCCCcccccCHhHhcCCccccEEE
Confidence            56778888888888888887 67788888888888887754         366677777777765555566666666654


Q ss_pred             c---------------ccccC---------------------CCEEEccCCcccccCchhhccccccceeccccccccCC
Q 013682          102 L---------------GNLIK---------------------LKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGL  145 (438)
Q Consensus       102 l---------------~~l~~---------------------L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~  145 (438)
                      +               +.+++                     |+.|++++|.+++..|..++.+++|+.|++++|++++.
T Consensus       152 l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~  231 (330)
T 1xku_A          152 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV  231 (330)
T ss_dssp             CCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEE
T ss_pred             CCCCcCCccCcChhhccCCCCcCEEECCCCccccCCccccccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCcee
Confidence            3               12334                     45555555555544455555555666666666665555


Q ss_pred             CchhhccCCCCCeEeccCCCCCCCCCC-CCCCCcccccccccc
Q 013682          146 IPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFENN  187 (438)
Q Consensus       146 ~P~~l~~~~~L~~l~ls~N~l~g~ip~-~~~~~~~~~~~~~~N  187 (438)
                      .|..+..+++|+.|++++|.++ .+|. ...++.+..+.+.+|
T Consensus       232 ~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N  273 (330)
T 1xku_A          232 DNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN  273 (330)
T ss_dssp             CTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSS
T ss_pred             ChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCC
Confidence            5555555556666666666555 3332 223344444444444

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.45  E-value=6.9e-14  Score=133.69  Aligned_cols=153  Identities=24%  Similarity=0.246  Sum_probs=89.2

Q ss_pred             ecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc------------ceeeeecCCCccccccchhhccCCCCCe
Q 013682           32 ARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF------------VYLISDLGNAALSGELAPELGQLKNLEL   99 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~------------~~~~~~l~~n~l~g~ip~~l~~l~~L~~   99 (438)
                      .++++.+++++.+.+.++++|..+.  ..++.|+++.|.+            .|..++|++|.+++ +|.. +.+++|+.
T Consensus         6 ~~~l~~l~~l~~~~~~l~~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~-~~l~~L~~   81 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVLGT   81 (290)
T ss_dssp             EECSTTCCEEECTTSCCSSCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC-SCCTTCCE
T ss_pred             ccccCCccEEECCCCCCCcCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC-CCCCcCCE
Confidence            5677778888888888888887654  4566666655543            24555666666664 4433 55555655


Q ss_pred             ecc------------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCC
Q 013682          100 LAL------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS  167 (438)
Q Consensus       100 l~l------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~  167 (438)
                      |++            ..+++|++|++++|++++..|..|+.+++|++|+|++|++++..|..+..+++|+.|++++|+++
T Consensus        82 L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  161 (290)
T 1p9a_G           82 LDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT  161 (290)
T ss_dssp             EECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred             EECCCCcCCcCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCC
Confidence            543            23455666666666665433455666666666666666666554555556666666666666665


Q ss_pred             CCCCCC-CCCCccccccccccc
Q 013682          168 GPVPDN-GSFSQFTPISFENNL  188 (438)
Q Consensus       168 g~ip~~-~~~~~~~~~~~~~N~  188 (438)
                      +..+.. ..++.+..+.+++|.
T Consensus       162 ~l~~~~~~~l~~L~~L~L~~N~  183 (290)
T 1p9a_G          162 ELPAGLLNGLENLDTLLLQENS  183 (290)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSC
T ss_pred             ccCHHHhcCcCCCCEEECCCCc
Confidence            433322 223444445555543

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.44  E-value=1e-14  Score=138.71  Aligned_cols=161  Identities=20%  Similarity=0.169  Sum_probs=139.7

Q ss_pred             ecceeeehhHHHHHHHhhhh-hhhhhhcchheeecccCCc-------------cceeeeecCCCccccccchhhccCCCC
Q 013682           32 ARGFTLLVTLKAVLQECEQL-HLLISFLIFIRVLQSSSNL-------------FVYLISDLGNAALSGELAPELGQLKNL   97 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l-~~~~~~~~~~~~l~~~~n~-------------~~~~~~~l~~n~l~g~ip~~l~~l~~L   97 (438)
                      +.+++.|++|+++.|.+..+ +..+..+.+++.|+++.|.             ..|..++|++|.+++..|..+..+++|
T Consensus        52 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  131 (285)
T 1ozn_A           52 FRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL  131 (285)
T ss_dssp             TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTC
T ss_pred             cccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCC
Confidence            67888999999999999998 6779999999999999884             247889999999999778889999999


Q ss_pred             Ceecc-------------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCC
Q 013682           98 ELLAL-------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNN  164 (438)
Q Consensus        98 ~~l~l-------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N  164 (438)
                      +.|++             +.+++|+.|++++|++++..+..++.+++|+.|++++|++++..|..+..+++|+.|++++|
T Consensus       132 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  211 (285)
T 1ozn_A          132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN  211 (285)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             CEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCC
Confidence            99864             45789999999999999555557999999999999999999999999999999999999999


Q ss_pred             CCCCCCCC-CCCCCcccccccccccccCC
Q 013682          165 RLSGPVPD-NGSFSQFTPISFENNLNLCG  192 (438)
Q Consensus       165 ~l~g~ip~-~~~~~~~~~~~~~~N~~lcg  192 (438)
                      .+++.+|. ...++.+..+++.+|+..|.
T Consensus       212 ~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  240 (285)
T 1ozn_A          212 NLSALPTEALAPLRALQYLRLNDNPWVCD  240 (285)
T ss_dssp             CCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred             cCCcCCHHHcccCcccCEEeccCCCccCC
Confidence            99986654 34566777888889987664

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.44  E-value=3.3e-14  Score=144.06  Aligned_cols=81  Identities=19%  Similarity=0.246  Sum_probs=40.3

Q ss_pred             CCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCCC-CCCCcccccccc
Q 013682          107 KLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFE  185 (438)
Q Consensus       107 ~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~  185 (438)
                      +|+.|++++|.+++.+|..++++++|+.|++++|++++..|..+..+++|+.|++++|.+++.+|.. ..++.+..++++
T Consensus       276 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  355 (455)
T 3v47_A          276 GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLS  355 (455)
T ss_dssp             CCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECC
T ss_pred             CceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECC
Confidence            4555555555555555555555555555555555555555555555555555555555554443322 223334444444


Q ss_pred             cc
Q 013682          186 NN  187 (438)
Q Consensus       186 ~N  187 (438)
                      +|
T Consensus       356 ~N  357 (455)
T 3v47_A          356 YN  357 (455)
T ss_dssp             SS
T ss_pred             CC
Confidence            44

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.44  E-value=2.6e-14  Score=128.46  Aligned_cols=145  Identities=15%  Similarity=0.156  Sum_probs=98.1

Q ss_pred             eeecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc----------ceeeeecCCCccccccchhhccCCCCCe
Q 013682           30 ICARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF----------VYLISDLGNAALSGELAPELGQLKNLEL   99 (438)
Q Consensus        30 ~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~   99 (438)
                      |..+.++.|+.|+++.|.+.++| .+..+.+++.|++++|..          .|..+++++|.+++..|..+        
T Consensus        38 i~~~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~~n~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l--------  108 (197)
T 4ezg_A           38 ITEAQMNSLTYITLANINVTDLT-GIEYAHNIKDLTINNIHATNYNPISGLSNLERLRIMGKDVTSDKIPNL--------  108 (197)
T ss_dssp             CBHHHHHTCCEEEEESSCCSCCT-TGGGCTTCSEEEEESCCCSCCGGGTTCTTCCEEEEECTTCBGGGSCCC--------
T ss_pred             CChhhcCCccEEeccCCCccChH-HHhcCCCCCEEEccCCCCCcchhhhcCCCCCEEEeECCccCcccChhh--------
Confidence            44566777777777777777777 566677777766665532          24444444444444444333        


Q ss_pred             eccccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCCCCCCCcc
Q 013682          100 LALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQF  179 (438)
Q Consensus       100 l~l~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~~~~~~~  179 (438)
                         +.+++|++|++++|.+++..|..++.+++|+.|++++|++.+.+| .+..+++|+.|++++|.+++ +|....++.+
T Consensus       109 ---~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~-~~~l~~l~~L  183 (197)
T 4ezg_A          109 ---SGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD-YRGIEDFPKL  183 (197)
T ss_dssp             ---TTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC-CTTGGGCSSC
T ss_pred             ---cCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcC-hHHhccCCCC
Confidence               334567778888888887788888888888888888887444666 68888888888888888876 3444455666


Q ss_pred             ccccccccc
Q 013682          180 TPISFENNL  188 (438)
Q Consensus       180 ~~~~~~~N~  188 (438)
                      ..+++.+|.
T Consensus       184 ~~L~l~~N~  192 (197)
T 4ezg_A          184 NQLYAFSQT  192 (197)
T ss_dssp             CEEEECBC-
T ss_pred             CEEEeeCcc
Confidence            667776664

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.44  E-value=4.5e-13  Score=122.66  Aligned_cols=138  Identities=18%  Similarity=0.223  Sum_probs=104.3

Q ss_pred             hHHHHHHHhhhhhhhhhhcchheeecccCCccceeeeecCCCccccccch-hhccCCCCCeecc-------------ccc
Q 013682           40 TLKAVLQECEQLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAP-ELGQLKNLELLAL-------------GNL  105 (438)
Q Consensus        40 ~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~~~~~~~l~~n~l~g~ip~-~l~~l~~L~~l~l-------------~~l  105 (438)
                      +++++.|.++++|..+...              +..++|++|.+++..|. .+..+++|+.|++             +.+
T Consensus        15 ~l~~s~n~l~~iP~~~~~~--------------~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l   80 (220)
T 2v70_A           15 TVDCSNQKLNKIPEHIPQY--------------TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGA   80 (220)
T ss_dssp             EEECCSSCCSSCCSCCCTT--------------CSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred             EeEeCCCCcccCccCCCCC--------------CCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCC
Confidence            5566677777777654221              23566777777764343 3677777777753             456


Q ss_pred             cCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCCC-CCCCccccccc
Q 013682          106 IKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISF  184 (438)
Q Consensus       106 ~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~-~~~~~~~~~~~  184 (438)
                      ++|+.|+|++|.+++..|..|+.+++|++|+|++|++++..|..+..+++|+.|++++|++++.+|.. ..++.+..+.+
T Consensus        81 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  160 (220)
T 2v70_A           81 SGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNL  160 (220)
T ss_dssp             TTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEe
Confidence            78899999999999777778999999999999999999888999999999999999999999887754 34566777778


Q ss_pred             ccccccC
Q 013682          185 ENNLNLC  191 (438)
Q Consensus       185 ~~N~~lc  191 (438)
                      ++|+.-|
T Consensus       161 ~~N~l~c  167 (220)
T 2v70_A          161 LANPFNC  167 (220)
T ss_dssp             CSCCEEC
T ss_pred             cCcCCcC
Confidence            8887555

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.43  E-value=6.1e-14  Score=146.38  Aligned_cols=139  Identities=21%  Similarity=0.258  Sum_probs=97.4

Q ss_pred             ceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc------------------------------------------
Q 013682           34 GFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF------------------------------------------   71 (438)
Q Consensus        34 ~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~------------------------------------------   71 (438)
                      ..+.|++|+++.|.+..||..++.+.+|+.|++++|..                                          
T Consensus       347 ~~~~L~~L~Ls~n~L~~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~L~  426 (567)
T 1dce_A          347 TDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLR  426 (567)
T ss_dssp             TTTTSSSCCCCHHHHHHHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHHHH
T ss_pred             cCccceeccCChhhHHhhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccchhh
Confidence            46678899999999999999999998888888755531                                          


Q ss_pred             ---------------ceeeeecCCCccccccchhhccCCCCCeeccccccCCCEEEccCCcccccCchhhccccccceec
Q 013682           72 ---------------VYLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLR  136 (438)
Q Consensus        72 ---------------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~  136 (438)
                                     .+..++|++|.+++ +|. +           +.+++|+.|+|++|+++ .+|..++++++|+.|+
T Consensus       427 ~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~-----------~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~  492 (567)
T 1dce_A          427 SKFLLENSVLKMEYADVRVLHLAHKDLTV-LCH-L-----------EQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQ  492 (567)
T ss_dssp             HHHHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-G-----------GGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEE
T ss_pred             hhhhhcccccccCccCceEEEecCCCCCC-CcC-c-----------cccccCcEeecCccccc-ccchhhhcCCCCCEEE
Confidence                           01224444444443 332 3           34556777788888877 7788888888888888


Q ss_pred             cccccccCCCchhhccCCCCCeEeccCCCCCCCC-CC-CCCCCccccccccccc
Q 013682          137 LNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV-PD-NGSFSQFTPISFENNL  188 (438)
Q Consensus       137 ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~i-p~-~~~~~~~~~~~~~~N~  188 (438)
                      |++|++++ +| .++.+++|+.|+|++|++++.+ |. ...++.+..+++++|+
T Consensus       493 Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~  544 (567)
T 1dce_A          493 ASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNS  544 (567)
T ss_dssp             CCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSG
T ss_pred             CCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCc
Confidence            88888875 56 7777888888888888887774 43 3445566666676665

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.43  E-value=6.5e-14  Score=141.69  Aligned_cols=145  Identities=28%  Similarity=0.287  Sum_probs=96.4

Q ss_pred             eEEeeeeecce-----eeehhHHHHHHHhhhhh-hhhhhcchheeecccCCcc------------ceeeeecCCCccccc
Q 013682           25 IICLGICARGF-----TLLVTLKAVLQECEQLH-LLISFLIFIRVLQSSSNLF------------VYLISDLGNAALSGE   86 (438)
Q Consensus        25 ~~~~~~~~~~~-----~~~~~l~~~~~~~~~l~-~~~~~~~~~~~l~~~~n~~------------~~~~~~l~~n~l~g~   86 (438)
                      +.|.+-.++.+     +.+++|+++.|.+..++ ..+..+.+|+.|+++.|.+            .|..|+|++|.+++-
T Consensus        48 v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~  127 (440)
T 3zyj_A           48 VICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTI  127 (440)
T ss_dssp             EECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSC
T ss_pred             EEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCee
Confidence            45555444333     45788999999999987 5689999999999988753            488899999999974


Q ss_pred             cchhhccCCCCCeecc-------------ccccCCCEEEccCCcccccCch-hhccccccceeccccccccCCCchhhcc
Q 013682           87 LAPELGQLKNLELLAL-------------GNLIKLKSLDLYSNLFNGTIPD-TLANLKQLKYLRLNNNSLSGLIPTSLTT  152 (438)
Q Consensus        87 ip~~l~~l~~L~~l~l-------------~~l~~L~~l~ls~N~l~g~iP~-~~~~l~~L~~l~ls~N~l~g~~P~~l~~  152 (438)
                      .+..+..+++|+.|++             ..+++|+.|+|++|+..+.+|+ .|.++++|+.|++++|+++ .+| .+..
T Consensus       128 ~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~  205 (440)
T 3zyj_A          128 PNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTP  205 (440)
T ss_dssp             CTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTT
T ss_pred             CHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCC
Confidence            4456899999999864             3355666666666433334443 4555665655555555555 333 2455


Q ss_pred             CCCCCeEeccCCCCCCCCC
Q 013682          153 ITSLNILDLSNNRLSGPVP  171 (438)
Q Consensus       153 ~~~L~~l~ls~N~l~g~ip  171 (438)
                      +++|+.|++++|.+++..|
T Consensus       206 l~~L~~L~Ls~N~l~~~~~  224 (440)
T 3zyj_A          206 LIKLDELDLSGNHLSAIRP  224 (440)
T ss_dssp             CSSCCEEECTTSCCCEECT
T ss_pred             CcccCEEECCCCccCccCh
Confidence            5555555555555554433

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.43  E-value=5.1e-14  Score=129.03  Aligned_cols=123  Identities=22%  Similarity=0.249  Sum_probs=96.3

Q ss_pred             eehhHHHHHHHhhhhhh--hhhhcchheeecccCCccceeeeecCCCccccccchhhccCCCCCeecc------------
Q 013682           37 LLVTLKAVLQECEQLHL--LISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLAL------------  102 (438)
Q Consensus        37 ~~~~l~~~~~~~~~l~~--~~~~~~~~~~l~~~~n~~~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l------------  102 (438)
                      .+++|+++.|.++.++.  .+..+.+++.|+++.|            .+++..|..+..+++|+.|++            
T Consensus        33 ~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N------------~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  100 (220)
T 2v70_A           33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNN------------KITDIEEGAFEGASGVNEILLTSNRLENVQHKM  100 (220)
T ss_dssp             TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSS------------CCCEECTTTTTTCTTCCEEECCSSCCCCCCGGG
T ss_pred             CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCC------------cCCEECHHHhCCCCCCCEEECCCCccCccCHhH
Confidence            45678888888888743  3666666666555544            444433335555666655542            


Q ss_pred             -ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCC
Q 013682          103 -GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP  171 (438)
Q Consensus       103 -~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip  171 (438)
                       +.+++|+.|+|++|++++..|..|+.+++|+.|+|++|++++..|..+..+++|+.|++++|.+++..+
T Consensus       101 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A          101 FKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             GTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             hcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence             456778999999999998889999999999999999999999999999999999999999999998765

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.43  E-value=6.2e-14  Score=145.96  Aligned_cols=159  Identities=21%  Similarity=0.244  Sum_probs=128.7

Q ss_pred             cceeeehhHHHHHHHhhhh---hhhhhhcchheeecccCCcc-----------ceeeeecCCCccccccc-hhhccCCCC
Q 013682           33 RGFTLLVTLKAVLQECEQL---HLLISFLIFIRVLQSSSNLF-----------VYLISDLGNAALSGELA-PELGQLKNL   97 (438)
Q Consensus        33 ~~~~~~~~l~~~~~~~~~l---~~~~~~~~~~~~l~~~~n~~-----------~~~~~~l~~n~l~g~ip-~~l~~l~~L   97 (438)
                      .+++.|++|+++.|.++..   +..+..+.+++.|+++.|.+           .+..+++++|.+++..| ..+.++++|
T Consensus       344 ~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L  423 (570)
T 2z63_A          344 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL  423 (570)
T ss_dssp             CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTC
T ss_pred             ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccccccccCCCCEEEccCCccccccchhhhhcCCCC
Confidence            5677888888888888776   57788888888888887743           47778888898888666 467888888


Q ss_pred             Ceecc-------------ccccCCCEEEccCCccc-ccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccC
Q 013682           98 ELLAL-------------GNLIKLKSLDLYSNLFN-GTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSN  163 (438)
Q Consensus        98 ~~l~l-------------~~l~~L~~l~ls~N~l~-g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~  163 (438)
                      +.|++             +.+++|+.|++++|.++ +.+|..++.+++|+.|++++|++++..|..+..+++|+.|++++
T Consensus       424 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~  503 (570)
T 2z63_A          424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMAS  503 (570)
T ss_dssp             CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCC
Confidence            88864             44778999999999987 67898999999999999999999988888999999999999999


Q ss_pred             CCCCCCCCCC-CCCCcccccccccccccC
Q 013682          164 NRLSGPVPDN-GSFSQFTPISFENNLNLC  191 (438)
Q Consensus       164 N~l~g~ip~~-~~~~~~~~~~~~~N~~lc  191 (438)
                      |++++.+|.. ..++.+..+++.+|+.-|
T Consensus       504 n~l~~~~~~~~~~l~~L~~L~l~~N~~~~  532 (570)
T 2z63_A          504 NQLKSVPDGIFDRLTSLQKIWLHTNPWDC  532 (570)
T ss_dssp             SCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             CcCCCCCHHHhhcccCCcEEEecCCcccC
Confidence            9999877753 455667777788887554

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.43  E-value=1.3e-13  Score=127.16  Aligned_cols=119  Identities=25%  Similarity=0.229  Sum_probs=89.8

Q ss_pred             ceeeeecCCCccccccchhhccCCCCCeecc-------------ccccCCCEEEccCCcccccCchhhccccccceeccc
Q 013682           72 VYLISDLGNAALSGELAPELGQLKNLELLAL-------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  138 (438)
Q Consensus        72 ~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l-------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls  138 (438)
                      .+..++|++|.+++..|..+..+++|+.|++             +.+++|+.|+|++|++++..|..|+.+++|+.|+|+
T Consensus        41 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls  120 (229)
T 3e6j_A           41 NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMC  120 (229)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEecc
Confidence            3455667777777766667777777777753             456788889999999985555667889999999999


Q ss_pred             cccccCCCchhhccCCCCCeEeccCCCCCCCCCC-CCCCCcccccccccccccC
Q 013682          139 NNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFENNLNLC  191 (438)
Q Consensus       139 ~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~-~~~~~~~~~~~~~~N~~lc  191 (438)
                      +|+++ .+|..+..+++|+.|++++|++++..+. ...++.+..+.+.+|+.-|
T Consensus       121 ~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  173 (229)
T 3e6j_A          121 CNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC  173 (229)
T ss_dssp             SSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred             CCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence            99998 7788889999999999999999876554 2345566677777776544

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.43  E-value=5.9e-14  Score=132.79  Aligned_cols=161  Identities=22%  Similarity=0.186  Sum_probs=131.5

Q ss_pred             eecceeeehhHHHHHHHhhhhhh-hhhhcchheeecccCCcc------------ceeeeecCCCccccccchhhccCCCC
Q 013682           31 CARGFTLLVTLKAVLQECEQLHL-LISFLIFIRVLQSSSNLF------------VYLISDLGNAALSGELAPELGQLKNL   97 (438)
Q Consensus        31 ~~~~~~~~~~l~~~~~~~~~l~~-~~~~~~~~~~l~~~~n~~------------~~~~~~l~~n~l~g~ip~~l~~l~~L   97 (438)
                      .+.+++.|++|+++.|.+..++. .+..+.+++.|+++.|.+            .|..+++++|.+++..+..++.+++|
T Consensus        47 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  126 (276)
T 2z62_A           47 SFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL  126 (276)
T ss_dssp             TTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTC
T ss_pred             HhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCC
Confidence            56788899999999999998876 588899999999988753            47788999999998656679999999


Q ss_pred             Ceecc--------------ccccCCCEEEccCCcccccCchhhccccccc----eeccccccccCCCchhhccCCCCCeE
Q 013682           98 ELLAL--------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLK----YLRLNNNSLSGLIPTSLTTITSLNIL  159 (438)
Q Consensus        98 ~~l~l--------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~----~l~ls~N~l~g~~P~~l~~~~~L~~l  159 (438)
                      +.|++              +.+++|+.|++++|++++..|..+..+++|+    .|++++|++++..| ......+|+.|
T Consensus       127 ~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~-~~~~~~~L~~L  205 (276)
T 2z62_A          127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP-GAFKEIRLKEL  205 (276)
T ss_dssp             CEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECT-TSSCSCCEEEE
T ss_pred             CEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCc-cccCCCcccEE
Confidence            98864              3467899999999999977778888888888    89999999996544 44445589999


Q ss_pred             eccCCCCCCCCCCC-CCCCcccccccccccccCC
Q 013682          160 DLSNNRLSGPVPDN-GSFSQFTPISFENNLNLCG  192 (438)
Q Consensus       160 ~ls~N~l~g~ip~~-~~~~~~~~~~~~~N~~lcg  192 (438)
                      ++++|.+++.++.. ..++.+..+.+.+|+.-|.
T Consensus       206 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  239 (276)
T 2z62_A          206 ALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  239 (276)
T ss_dssp             ECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCC
T ss_pred             ECCCCceeecCHhHhcccccccEEEccCCccccc
Confidence            99999999776653 4567777888888876653

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.42  E-value=5.4e-14  Score=153.78  Aligned_cols=69  Identities=29%  Similarity=0.428  Sum_probs=47.5

Q ss_pred             chhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCCCC--------------------CCCccccc
Q 013682          123 PDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNG--------------------SFSQFTPI  182 (438)
Q Consensus       123 P~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~~--------------------~~~~~~~~  182 (438)
                      |..|..+++|+.|+|++|++++.+|..+..+++|+.|+|++|++++.+|...                    .+..+..+
T Consensus       473 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~L~~l  552 (844)
T 3j0a_A          473 WDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVL  552 (844)
T ss_dssp             SSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSCCCSSCCEE
T ss_pred             hhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhhccccEEECCCCcCCCCChhHhCCcCEE
Confidence            3456677778888888888887777777778888888777777776544321                    12344556


Q ss_pred             ccccccccC
Q 013682          183 SFENNLNLC  191 (438)
Q Consensus       183 ~~~~N~~lc  191 (438)
                      ++.+|+..|
T Consensus       553 ~l~~Np~~C  561 (844)
T 3j0a_A          553 DITHNKFIC  561 (844)
T ss_dssp             EEEEECCCC
T ss_pred             EecCCCccc
Confidence            677887777

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.42  E-value=9.8e-14  Score=133.75  Aligned_cols=149  Identities=26%  Similarity=0.352  Sum_probs=82.7

Q ss_pred             ecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc----------ceeeeecCCCccccccchhhccCCCCCeec
Q 013682           32 ARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF----------VYLISDLGNAALSGELAPELGQLKNLELLA  101 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~  101 (438)
                      +..++.|++|+++.|.+..++. +..+.+++.|+++.|.+          .|..++|++|.+++ +|. +..+++|+.|+
T Consensus        59 ~~~l~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~  135 (308)
T 1h6u_A           59 VQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLY  135 (308)
T ss_dssp             GGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCCGGGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEE
T ss_pred             hhccCCCCEEEccCCcCCCChh-HccCCCCCEEEccCCcCCCchhhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEE
Confidence            3445555666666666666665 55666666666655532          35555666666654 443 55566665554


Q ss_pred             c-----------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCC
Q 013682          102 L-----------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV  170 (438)
Q Consensus       102 l-----------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~i  170 (438)
                      +           +.+++|+.|++++|.++ .+|. ++.+++|+.|++++|++++..|  +..+++|+.|++++|.+++..
T Consensus       136 l~~n~l~~~~~l~~l~~L~~L~l~~n~l~-~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~  211 (308)
T 1h6u_A          136 LDLNQITNISPLAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS  211 (308)
T ss_dssp             CCSSCCCCCGGGGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG
T ss_pred             CCCCccCcCccccCCCCccEEEccCCcCC-CChh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc
Confidence            3           23455666666666665 3443 5666666666666666654322  556666666666666665544


Q ss_pred             CCCCCCCccccccccccc
Q 013682          171 PDNGSFSQFTPISFENNL  188 (438)
Q Consensus       171 p~~~~~~~~~~~~~~~N~  188 (438)
                      | ...++.+..+.+.+|+
T Consensus       212 ~-l~~l~~L~~L~l~~N~  228 (308)
T 1h6u_A          212 P-LANTSNLFIVTLTNQT  228 (308)
T ss_dssp             G-GTTCTTCCEEEEEEEE
T ss_pred             c-ccCCCCCCEEEccCCe
Confidence            3 3334445555555554

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.42  E-value=3.7e-14  Score=136.90  Aligned_cols=150  Identities=20%  Similarity=0.143  Sum_probs=114.5

Q ss_pred             ehhHHHHHHHhhh--hhhhhh-------hcchheeecccCCc--------------cceeeeecCCCccccccchhhccC
Q 013682           38 LVTLKAVLQECEQ--LHLLIS-------FLIFIRVLQSSSNL--------------FVYLISDLGNAALSGELAPELGQL   94 (438)
Q Consensus        38 ~~~l~~~~~~~~~--l~~~~~-------~~~~~~~l~~~~n~--------------~~~~~~~l~~n~l~g~ip~~l~~l   94 (438)
                      |++|+++.|.+..  +|..+.       .+.+++.|+++.|.              ..+..++|++|.+++. |..++.+
T Consensus        65 L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l  143 (312)
T 1wwl_A           65 IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAEL  143 (312)
T ss_dssp             HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHH
T ss_pred             HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHH
Confidence            6666666666643  444443       56677777765543              3477789999999986 8888888


Q ss_pred             -----CCCCeecc-------------ccccCCCEEEccCCccccc--Cchhh--ccccccceeccccccccC--CCch-h
Q 013682           95 -----KNLELLAL-------------GNLIKLKSLDLYSNLFNGT--IPDTL--ANLKQLKYLRLNNNSLSG--LIPT-S  149 (438)
Q Consensus        95 -----~~L~~l~l-------------~~l~~L~~l~ls~N~l~g~--iP~~~--~~l~~L~~l~ls~N~l~g--~~P~-~  149 (438)
                           ++|+.|++             +.+++|++|+|++|++.|.  +|+.+  +++++|++|++++|++++  .+|. .
T Consensus       144 ~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  223 (312)
T 1wwl_A          144 QQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSAL  223 (312)
T ss_dssp             HTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHH
T ss_pred             HHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHH
Confidence                 89999863             5688999999999999876  45566  899999999999999984  2333 3


Q ss_pred             hccCCCCCeEeccCCCCCCCCCC--CCCCCccccccccccc
Q 013682          150 LTTITSLNILDLSNNRLSGPVPD--NGSFSQFTPISFENNL  188 (438)
Q Consensus       150 l~~~~~L~~l~ls~N~l~g~ip~--~~~~~~~~~~~~~~N~  188 (438)
                      +..+++|+.|++++|.+++.+|.  ...++.+..+.+++|.
T Consensus       224 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~  264 (312)
T 1wwl_A          224 AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG  264 (312)
T ss_dssp             HHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSC
T ss_pred             HhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCc
Confidence            46789999999999999998753  3345677778888775

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.41  E-value=4.8e-14  Score=148.17  Aligned_cols=159  Identities=18%  Similarity=0.145  Sum_probs=130.0

Q ss_pred             eeecceeeehhHHHHHHHhhhh---hhhhhhcchheeecccCCcc-----------ceeeeecCCCccccccc-hhhccC
Q 013682           30 ICARGFTLLVTLKAVLQECEQL---HLLISFLIFIRVLQSSSNLF-----------VYLISDLGNAALSGELA-PELGQL   94 (438)
Q Consensus        30 ~~~~~~~~~~~l~~~~~~~~~l---~~~~~~~~~~~~l~~~~n~~-----------~~~~~~l~~n~l~g~ip-~~l~~l   94 (438)
                      +...+++.|++|+++.|.++.+   +..+..+.+++.|+++.|.+           .+..+++++|.+.+..| ..+..+
T Consensus       344 ~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l  423 (606)
T 3vq2_A          344 FKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSL  423 (606)
T ss_dssp             CCCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEECCCCTTCTTCCEEECTTSEEESTTTTTTTTTC
T ss_pred             hhhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccccchhhccCCCCCCeeECCCCccCCccChhhhhcc
Confidence            3566788888888888888887   77888889999998887743           47778899999998777 678888


Q ss_pred             CCCCeecc-------------ccccCCCEEEccCCccccc-CchhhccccccceeccccccccCCCchhhccCCCCCeEe
Q 013682           95 KNLELLAL-------------GNLIKLKSLDLYSNLFNGT-IPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILD  160 (438)
Q Consensus        95 ~~L~~l~l-------------~~l~~L~~l~ls~N~l~g~-iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~  160 (438)
                      ++|+.|++             +.+++|+.|++++|.+++. +|..++.+++|+.|++++|++++..|..+..+++|+.|+
T Consensus       424 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  503 (606)
T 3vq2_A          424 EKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLN  503 (606)
T ss_dssp             TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             ccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEE
Confidence            99988864             4567899999999999874 788889999999999999999988888899999999999


Q ss_pred             ccCCCCCCCCCCC-CCCCccccccccccc
Q 013682          161 LSNNRLSGPVPDN-GSFSQFTPISFENNL  188 (438)
Q Consensus       161 ls~N~l~g~ip~~-~~~~~~~~~~~~~N~  188 (438)
                      +++|++++.+|.. ..++.+..+++++|.
T Consensus       504 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~  532 (606)
T 3vq2_A          504 MSHNNLLFLDSSHYNQLYSLSTLDCSFNR  532 (606)
T ss_dssp             CCSSCCSCEEGGGTTTCTTCCEEECTTSC
T ss_pred             CCCCcCCCcCHHHccCCCcCCEEECCCCc
Confidence            9999999887753 345667777777775

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.41  E-value=9.9e-14  Score=134.89  Aligned_cols=157  Identities=22%  Similarity=0.247  Sum_probs=101.0

Q ss_pred             eecceeeehhHHHHHHHhhhh-hhhhhhcchheeecccCCcc---------ceeeeecCCCccccccchhhccCCCCCee
Q 013682           31 CARGFTLLVTLKAVLQECEQL-HLLISFLIFIRVLQSSSNLF---------VYLISDLGNAALSGELAPELGQLKNLELL  100 (438)
Q Consensus        31 ~~~~~~~~~~l~~~~~~~~~l-~~~~~~~~~~~~l~~~~n~~---------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l  100 (438)
                      .+.+++.|++|+++.|.++.+ |..++.+.+++.|+++.|.+         .+..+++++|.+++..+..+..+++|+.|
T Consensus        73 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L  152 (332)
T 2ft3_A           73 DFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCI  152 (332)
T ss_dssp             TTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCCSCCSSCCTTCCEEECCSSCCCCCCSGGGSSCSSCCEE
T ss_pred             HhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCCccCccccccCCEEECCCCccCccCHhHhCCCccCCEE
Confidence            356777788888888888877 66688888888888887754         36777888888876434457778888777


Q ss_pred             cccc---------------c--------------------cCCCEEEccCCcccccCchhhccccccceeccccccccCC
Q 013682          101 ALGN---------------L--------------------IKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGL  145 (438)
Q Consensus       101 ~l~~---------------l--------------------~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~  145 (438)
                      +++.               +                    ++|+.|++++|.+++..|..++++++|+.|++++|++++.
T Consensus       153 ~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~  232 (332)
T 2ft3_A          153 EMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMI  232 (332)
T ss_dssp             ECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSSSCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCC
T ss_pred             ECCCCccccCCCCcccccCCccCEEECcCCCCCccCccccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcC
Confidence            5421               1                    2455555555555544455666666666666666666665


Q ss_pred             CchhhccCCCCCeEeccCCCCCCCCCCC-CCCCccccccccccc
Q 013682          146 IPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNL  188 (438)
Q Consensus       146 ~P~~l~~~~~L~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~N~  188 (438)
                      .|..+..+++|+.|++++|.++ .+|.. ..++.+..+++.+|.
T Consensus       233 ~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~  275 (332)
T 2ft3_A          233 ENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNN  275 (332)
T ss_dssp             CTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSC
T ss_pred             ChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCC
Confidence            5556666666666666666666 44432 233444455555553

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.41  E-value=2.9e-14  Score=155.19  Aligned_cols=155  Identities=17%  Similarity=0.186  Sum_probs=116.8

Q ss_pred             eeecceeeehhHHHHHHHhhh------------------hhhhhh--hcchheeecccCCcc------------ceeeee
Q 013682           30 ICARGFTLLVTLKAVLQECEQ------------------LHLLIS--FLIFIRVLQSSSNLF------------VYLISD   77 (438)
Q Consensus        30 ~~~~~~~~~~~l~~~~~~~~~------------------l~~~~~--~~~~~~~l~~~~n~~------------~~~~~~   77 (438)
                      -.+.+++.|++|+++.|.++.                  +|..++  .+.+|+.|+++.|.+            .|..++
T Consensus       442 ~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~  521 (876)
T 4ecn_A          442 KAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLN  521 (876)
T ss_dssp             GGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEE
T ss_pred             HHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEE
Confidence            358899999999999999998                  999987  999999999887742            477888


Q ss_pred             cCCCc-ccc-ccchhhccCC-------CCCeecc--------------ccccCCCEEEccCCcccccCchhhccccccce
Q 013682           78 LGNAA-LSG-ELAPELGQLK-------NLELLAL--------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKY  134 (438)
Q Consensus        78 l~~n~-l~g-~ip~~l~~l~-------~L~~l~l--------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~  134 (438)
                      |++|+ ++| .+|..+++++       +|+.|++              +++++|+.|+|++|+++ .+| .++++++|+.
T Consensus       522 Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~  599 (876)
T 4ecn_A          522 IACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTD  599 (876)
T ss_dssp             CTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESE
T ss_pred             CcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceE
Confidence            88888 888 8888888776       7776643              34566777778877777 777 7777777778


Q ss_pred             eccccccccCCCchhhccCCC-CCeEeccCCCCCCCCCCCCCC---Cccccccccccc
Q 013682          135 LRLNNNSLSGLIPTSLTTITS-LNILDLSNNRLSGPVPDNGSF---SQFTPISFENNL  188 (438)
Q Consensus       135 l~ls~N~l~g~~P~~l~~~~~-L~~l~ls~N~l~g~ip~~~~~---~~~~~~~~~~N~  188 (438)
                      |+|++|+++ .+|..+..+++ |+.|++++|.++ .+|.....   ..+..+.+++|.
T Consensus       600 L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~  655 (876)
T 4ecn_A          600 LKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNK  655 (876)
T ss_dssp             EECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSC
T ss_pred             EECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCc
Confidence            888877777 77777777777 778888877777 56643221   124455555553

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.41  E-value=2e-14  Score=128.79  Aligned_cols=119  Identities=23%  Similarity=0.251  Sum_probs=71.8

Q ss_pred             hhHHHHHHHhhhhhhhhhhcchheeecccCCccceeeeecCCCccccccch-hhccCCCCCeecc-------------cc
Q 013682           39 VTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAP-ELGQLKNLELLAL-------------GN  104 (438)
Q Consensus        39 ~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~~~~~~~l~~n~l~g~ip~-~l~~l~~L~~l~l-------------~~  104 (438)
                      ++++++.+.+.++|..+..              .+..++|++|.+++..|. .++.+++|+.|++             +.
T Consensus        11 ~~l~~s~~~l~~ip~~~~~--------------~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~   76 (192)
T 1w8a_A           11 TTVDCTGRGLKEIPRDIPL--------------HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEG   76 (192)
T ss_dssp             TEEECTTSCCSSCCSCCCT--------------TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTT
T ss_pred             CEEEcCCCCcCcCccCCCC--------------CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCC
Confidence            4556677777777765432              334556666666653222 2555555555432             23


Q ss_pred             ccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCC
Q 013682          105 LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP  171 (438)
Q Consensus       105 l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip  171 (438)
                      +++|++|+|++|++++..|..|+++++|++|+|++|++++.+|..+..+++|+.|++++|.+++..+
T Consensus        77 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  143 (192)
T 1w8a_A           77 ASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             CTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             cccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence            4456666666666665555566666666666666666666666666666666666666666666554

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.41  E-value=7.1e-14  Score=134.70  Aligned_cols=149  Identities=19%  Similarity=0.146  Sum_probs=86.9

Q ss_pred             eehhHHHHHHHhhh-hhhhh--hhcchheeecccCCcc----------------ceeeeecCCCccccccchhhccCCCC
Q 013682           37 LLVTLKAVLQECEQ-LHLLI--SFLIFIRVLQSSSNLF----------------VYLISDLGNAALSGELAPELGQLKNL   97 (438)
Q Consensus        37 ~~~~l~~~~~~~~~-l~~~~--~~~~~~~~l~~~~n~~----------------~~~~~~l~~n~l~g~ip~~l~~l~~L   97 (438)
                      .|+.|+++.|.+.. .|..+  ..+.+++.|+++.|.+                .|..++|++|.+++..|..++.+++|
T Consensus        92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L  171 (310)
T 4glp_A           92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL  171 (310)
T ss_dssp             CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred             ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence            35555555555542 33333  5555555555555432                35556666666666555666666666


Q ss_pred             Ceecc-----------------ccccCCCEEEccCCcccccCch----hhccccccceeccccccccCCCchhhccC---
Q 013682           98 ELLAL-----------------GNLIKLKSLDLYSNLFNGTIPD----TLANLKQLKYLRLNNNSLSGLIPTSLTTI---  153 (438)
Q Consensus        98 ~~l~l-----------------~~l~~L~~l~ls~N~l~g~iP~----~~~~l~~L~~l~ls~N~l~g~~P~~l~~~---  153 (438)
                      +.|++                 +.+++|++|+|++|+++ .+|.    -++++++|++|+|++|++++..|..+..+   
T Consensus       172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~  250 (310)
T 4glp_A          172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWS  250 (310)
T ss_dssp             CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCC
T ss_pred             CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCc
Confidence            66643                 23455667777777765 3333    24566777777777777776666666655   


Q ss_pred             CCCCeEeccCCCCCCCCCCCCCCCccccccccccc
Q 013682          154 TSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL  188 (438)
Q Consensus       154 ~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~N~  188 (438)
                      ++|+.|++++|+++ .+|.... +.+..+++++|.
T Consensus       251 ~~L~~L~Ls~N~l~-~lp~~~~-~~L~~L~Ls~N~  283 (310)
T 4glp_A          251 SALNSLNLSFAGLE-QVPKGLP-AKLRVLDLSSNR  283 (310)
T ss_dssp             TTCCCEECCSSCCC-SCCSCCC-SCCSCEECCSCC
T ss_pred             CcCCEEECCCCCCC-chhhhhc-CCCCEEECCCCc
Confidence            46777777777776 4554432 455555665553

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.41  E-value=7.7e-14  Score=145.26  Aligned_cols=148  Identities=20%  Similarity=0.176  Sum_probs=132.2

Q ss_pred             EEeeeeecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCc-------------cceeeeecCCCccccccchhhc
Q 013682           26 ICLGICARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNL-------------FVYLISDLGNAALSGELAPELG   92 (438)
Q Consensus        26 ~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~-------------~~~~~~~l~~n~l~g~ip~~l~   92 (438)
                      .|..-...+++.|++|+++.|.+..++..+..+.+++.|++++|.             ..|..+++++|.+++..|..+.
T Consensus       363 ~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~  442 (570)
T 2z63_A          363 GCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN  442 (570)
T ss_dssp             EEEEHHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTT
T ss_pred             ccccccccccCccCEEECCCCccccccccccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhh
Confidence            344556778899999999999999999889999999999887764             3478899999999999999999


Q ss_pred             cCCCCCeecc--------------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCe
Q 013682           93 QLKNLELLAL--------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNI  158 (438)
Q Consensus        93 ~l~~L~~l~l--------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~  158 (438)
                      .+++|+.|++              +.+++|+.|++++|++++..|..++++++|+.|++++|++++..|..+.++++|+.
T Consensus       443 ~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  522 (570)
T 2z63_A          443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQK  522 (570)
T ss_dssp             TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred             cCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcE
Confidence            9999999864              34688999999999999888999999999999999999999998888999999999


Q ss_pred             EeccCCCCCCCCCCC
Q 013682          159 LDLSNNRLSGPVPDN  173 (438)
Q Consensus       159 l~ls~N~l~g~ip~~  173 (438)
                      +++++|.++|.+|..
T Consensus       523 L~l~~N~~~~~~~~~  537 (570)
T 2z63_A          523 IWLHTNPWDCSCPRI  537 (570)
T ss_dssp             EECCSSCBCCCTTTT
T ss_pred             EEecCCcccCCCcch
Confidence            999999999999864

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.41  E-value=1.2e-13  Score=145.13  Aligned_cols=158  Identities=20%  Similarity=0.221  Sum_probs=125.1

Q ss_pred             ceeeehhHHHHHHHhhhhhhhhhhcchheeecccCC-------------ccceeeeecCCCccccccchhhccCCCCCee
Q 013682           34 GFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSN-------------LFVYLISDLGNAALSGELAPELGQLKNLELL  100 (438)
Q Consensus        34 ~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n-------------~~~~~~~~l~~n~l~g~ip~~l~~l~~L~~l  100 (438)
                      ++..|+.|+...+....++..+..+..++.++++.|             +..+..++++.|.+.+..|.....+++|+.|
T Consensus       395 ~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L  474 (635)
T 4g8a_A          395 GTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL  474 (635)
T ss_dssp             SCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEE
T ss_pred             hhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhh
Confidence            334444444444444445555566666666665433             3357778999999999888888899999888


Q ss_pred             cc--------------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCC
Q 013682          101 AL--------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL  166 (438)
Q Consensus       101 ~l--------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l  166 (438)
                      ++              +.+++|+.|+|++|++++..|..|+++++|++|+|++|++++..|..+..+++|+.||+++|++
T Consensus       475 ~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l  554 (635)
T 4g8a_A          475 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI  554 (635)
T ss_dssp             ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCC
T ss_pred             hhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcC
Confidence            64              4567899999999999988899999999999999999999999899999999999999999999


Q ss_pred             CCCCCCCCC-C-CcccccccccccccC
Q 013682          167 SGPVPDNGS-F-SQFTPISFENNLNLC  191 (438)
Q Consensus       167 ~g~ip~~~~-~-~~~~~~~~~~N~~lc  191 (438)
                      ++.+|.... + +.+..+++++|+.-|
T Consensus       555 ~~~~~~~l~~l~~~L~~L~L~~Np~~C  581 (635)
T 4g8a_A          555 MTSKKQELQHFPSSLAFLNLTQNDFAC  581 (635)
T ss_dssp             CBCCSSCTTCCCTTCCEEECTTCCBCC
T ss_pred             CCCCHHHHHhhhCcCCEEEeeCCCCcc
Confidence            999887532 3 457778889998776

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.40  E-value=1.8e-13  Score=129.13  Aligned_cols=141  Identities=23%  Similarity=0.250  Sum_probs=122.5

Q ss_pred             eecceeeehhHHHHHHHhhhhhhhh-hhcchheeecccCCcc------------ceeeeecCCCccccccchhhccCCCC
Q 013682           31 CARGFTLLVTLKAVLQECEQLHLLI-SFLIFIRVLQSSSNLF------------VYLISDLGNAALSGELAPELGQLKNL   97 (438)
Q Consensus        31 ~~~~~~~~~~l~~~~~~~~~l~~~~-~~~~~~~~l~~~~n~~------------~~~~~~l~~n~l~g~ip~~l~~l~~L   97 (438)
                      .+.+++.|++|+++.|.++.++..+ ..+.+++.|+++.|.+            .|..++|++|.+++..|..+..+++|
T Consensus        56 ~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  135 (270)
T 2o6q_A           56 AFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKL  135 (270)
T ss_dssp             SSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred             HhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCC
Confidence            3678899999999999999998874 7899999999987653            48889999999998666678999999


Q ss_pred             Ceecc-------------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCC
Q 013682           98 ELLAL-------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNN  164 (438)
Q Consensus        98 ~~l~l-------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N  164 (438)
                      +.|++             +.+++|+.|++++|.+++..|..|.++++|+.|++++|++++..+..+..+++|+.|++++|
T Consensus       136 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  215 (270)
T 2o6q_A          136 TYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN  215 (270)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCC
Confidence            99964             45789999999999999655567999999999999999999877777999999999999999


Q ss_pred             CCCCCCC
Q 013682          165 RLSGPVP  171 (438)
Q Consensus       165 ~l~g~ip  171 (438)
                      .++...+
T Consensus       216 ~~~c~c~  222 (270)
T 2o6q_A          216 PWDCTCN  222 (270)
T ss_dssp             CBCCSSS
T ss_pred             CeeCCCc
Confidence            9987654

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.39  E-value=1.7e-13  Score=125.59  Aligned_cols=136  Identities=20%  Similarity=0.263  Sum_probs=98.3

Q ss_pred             HHHHHHHhhhhhhhhhhcchheeecccCCccceeeeecCCCccccccchhhccCCCCCeecc-------------ccccC
Q 013682           41 LKAVLQECEQLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLAL-------------GNLIK  107 (438)
Q Consensus        41 l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l-------------~~l~~  107 (438)
                      ++.+++.+.++|..+.  ..            +..++|++|.+++..|..+..+++|+.|++             +.+++
T Consensus        16 v~c~~~~l~~iP~~l~--~~------------l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~   81 (220)
T 2v9t_B           16 VDCRGKGLTEIPTNLP--ET------------ITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRS   81 (220)
T ss_dssp             EECTTSCCSSCCSSCC--TT------------CCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSS
T ss_pred             EEcCCCCcCcCCCccC--cC------------CCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcC
Confidence            3444556666665432  23            334455555555433335555666666542             44667


Q ss_pred             CCEEEccCCcccccCch-hhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCC-CCCCCcccccccc
Q 013682          108 LKSLDLYSNLFNGTIPD-TLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFE  185 (438)
Q Consensus       108 L~~l~ls~N~l~g~iP~-~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~-~~~~~~~~~~~~~  185 (438)
                      |++|+|++|+++ .+|+ .|+.+++|+.|+|++|++++..|..+..+++|+.|+|++|.+++..|. ...++.+..+.+.
T Consensus        82 L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  160 (220)
T 2v9t_B           82 LNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLA  160 (220)
T ss_dssp             CCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred             CCEEECCCCcCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeC
Confidence            888999999998 5555 578999999999999999998899999999999999999999987775 3446677778888


Q ss_pred             cccccC
Q 013682          186 NNLNLC  191 (438)
Q Consensus       186 ~N~~lc  191 (438)
                      +|+..|
T Consensus       161 ~N~~~c  166 (220)
T 2v9t_B          161 QNPFIC  166 (220)
T ss_dssp             SSCEEC
T ss_pred             CCCcCC
Confidence            888766

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.39  E-value=1.6e-13  Score=144.12  Aligned_cols=157  Identities=23%  Similarity=0.197  Sum_probs=104.9

Q ss_pred             ecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc------------ceeeeecCCCccccccchh-hccCCCCC
Q 013682           32 ARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF------------VYLISDLGNAALSGELAPE-LGQLKNLE   98 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~------------~~~~~~l~~n~l~g~ip~~-l~~l~~L~   98 (438)
                      +++++.|++|+++.|.++++|..+..+.+++.|+++.|.+            .|..+++++|.+.+.+|.. +..+++|+
T Consensus       274 ~~~l~~L~~L~l~~n~l~~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~  353 (606)
T 3t6q_A          274 FHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLR  353 (606)
T ss_dssp             TTTCTTCSEEECTTSCCSCCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCC
T ss_pred             hccccCCCEEeccCCccCCCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCC
Confidence            4566777777777777777777777777777777766643            3566677777777766654 66777777


Q ss_pred             eecc---------------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchh-hccCCCCCeEecc
Q 013682           99 LLAL---------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTS-LTTITSLNILDLS  162 (438)
Q Consensus        99 ~l~l---------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~-l~~~~~L~~l~ls  162 (438)
                      .|++               +.+++|+.|++++|.+.+..|..++++++|+.|++++|++++..|.. +..+++|+.|+++
T Consensus       354 ~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~  433 (606)
T 3t6q_A          354 ELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLS  433 (606)
T ss_dssp             EEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECT
T ss_pred             EEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECC
Confidence            6643               34566777777777777666677777777777777777777665543 6677777777777


Q ss_pred             CCCCCCCCCCC-CCCCccccccccccc
Q 013682          163 NNRLSGPVPDN-GSFSQFTPISFENNL  188 (438)
Q Consensus       163 ~N~l~g~ip~~-~~~~~~~~~~~~~N~  188 (438)
                      +|.+++.+|.. ..++.+..+.+++|.
T Consensus       434 ~n~l~~~~~~~~~~l~~L~~L~L~~n~  460 (606)
T 3t6q_A          434 HSLLDISSEQLFDGLPALQHLNLQGNH  460 (606)
T ss_dssp             TCCCBTTCTTTTTTCTTCCEEECTTCB
T ss_pred             CCccCCcCHHHHhCCCCCCEEECCCCC
Confidence            77777666643 334555555555554

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.39  E-value=9.6e-14  Score=141.69  Aligned_cols=161  Identities=19%  Similarity=0.197  Sum_probs=104.6

Q ss_pred             ecceeeehhHHHHHHHhhhhhhh-hhhcchheeecccCCcc------------ceeeeecCCCccccccchhhccCCCCC
Q 013682           32 ARGFTLLVTLKAVLQECEQLHLL-ISFLIFIRVLQSSSNLF------------VYLISDLGNAALSGELAPELGQLKNLE   98 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l~~~-~~~~~~~~~l~~~~n~~------------~~~~~~l~~n~l~g~ip~~l~~l~~L~   98 (438)
                      +.+++.|++|+++.|.+..++.. +..+.+++.|+++.|.+            .|..+++++|.+.+.+|+......+|+
T Consensus       148 ~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~  227 (477)
T 2id5_A          148 FSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT  227 (477)
T ss_dssp             STTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCS
T ss_pred             ccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCcccc
Confidence            34445555555555555555433 45555555555544322            345555656555556666555555666


Q ss_pred             eecc-------------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCC
Q 013682           99 LLAL-------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNR  165 (438)
Q Consensus        99 ~l~l-------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~  165 (438)
                      .|++             +.+++|+.|+|++|.+++..|..|.++++|+.|+|++|++++..|..+..+++|+.|++++|.
T Consensus       228 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  307 (477)
T 2id5_A          228 SLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQ  307 (477)
T ss_dssp             EEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSC
T ss_pred             EEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCc
Confidence            5543             346678888888888876666678888888888888888888778888888888888888888


Q ss_pred             CCCCCCCC-CCCCcccccccccccccCC
Q 013682          166 LSGPVPDN-GSFSQFTPISFENNLNLCG  192 (438)
Q Consensus       166 l~g~ip~~-~~~~~~~~~~~~~N~~lcg  192 (438)
                      +++..+.. ..++.+..+.+.+|+..|.
T Consensus       308 l~~~~~~~~~~l~~L~~L~l~~N~l~c~  335 (477)
T 2id5_A          308 LTTLEESVFHSVGNLETLILDSNPLACD  335 (477)
T ss_dssp             CSCCCGGGBSCGGGCCEEECCSSCEECS
T ss_pred             CceeCHhHcCCCcccCEEEccCCCccCc
Confidence            88755532 3445666677778876553

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.38  E-value=8.8e-14  Score=134.54  Aligned_cols=150  Identities=24%  Similarity=0.169  Sum_probs=69.7

Q ss_pred             ecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCccc-------eeeeecCCCccccccchhhccCCCCCeecc--
Q 013682           32 ARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFV-------YLISDLGNAALSGELAPELGQLKNLELLAL--  102 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~~-------~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l--  102 (438)
                      +.+++.|++|+++.|.+...+. +..+.+++.|+++.|.++       +..+++++|.+++..+.   .+++|+.|++  
T Consensus        54 ~~~l~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~Ls~n~l~~l~~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~  129 (317)
T 3o53_A           54 LAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCS---RGQGKKNIYLAN  129 (317)
T ss_dssp             HTTCTTCCEEECTTSCCEEEEE-ETTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCS
T ss_pred             hhCCCcCCEEECCCCcCCcchh-hhhcCCCCEEECcCCccccccCCCCcCEEECCCCccCCcCcc---ccCCCCEEECCC
Confidence            3455555566666665555544 555556666666555432       33344444444432221   1333333322  


Q ss_pred             -----------ccccCCCEEEccCCcccccCchhhc-cccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCC
Q 013682          103 -----------GNLIKLKSLDLYSNLFNGTIPDTLA-NLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV  170 (438)
Q Consensus       103 -----------~~l~~L~~l~ls~N~l~g~iP~~~~-~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~i  170 (438)
                                 +.+++|+.|++++|.+++..|..+. .+++|++|++++|++++. |. ...+++|+.|++++|.+++.+
T Consensus       130 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~  207 (317)
T 3o53_A          130 NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMG  207 (317)
T ss_dssp             SCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEEC
T ss_pred             CCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcch
Confidence                       2244455555555555544444442 445555555555555433 22 223455555555555555443


Q ss_pred             CCCCCCCcccccccccc
Q 013682          171 PDNGSFSQFTPISFENN  187 (438)
Q Consensus       171 p~~~~~~~~~~~~~~~N  187 (438)
                      |....++.+..+++++|
T Consensus       208 ~~~~~l~~L~~L~L~~N  224 (317)
T 3o53_A          208 PEFQSAAGVTWISLRNN  224 (317)
T ss_dssp             GGGGGGTTCSEEECTTS
T ss_pred             hhhcccCcccEEECcCC
Confidence            33333333444444444

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.38  E-value=1.1e-13  Score=142.08  Aligned_cols=148  Identities=18%  Similarity=0.116  Sum_probs=120.6

Q ss_pred             eeeehhHHHHHHHhhhhh-hhhhhcchheeecccCCcc----------ceeeeecCCCccccccchhhccCCCCCeeccc
Q 013682           35 FTLLVTLKAVLQECEQLH-LLISFLIFIRVLQSSSNLF----------VYLISDLGNAALSGELAPELGQLKNLELLALG  103 (438)
Q Consensus        35 ~~~~~~l~~~~~~~~~l~-~~~~~~~~~~~l~~~~n~~----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~  103 (438)
                      ++.|++|++++|.++.++ ..++.+.+|+.|++++|.+          .|..++|++|.+++ +|.    .++|+.|+++
T Consensus        33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~l~~-l~~----~~~L~~L~L~  107 (487)
T 3oja_A           33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQE-LLV----GPSIETLHAA  107 (487)
T ss_dssp             GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEECTTCTTCCEEECCSSEEEE-EEE----CTTCCEEECC
T ss_pred             CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcccccCCCCCEEEecCCcCCC-CCC----CCCcCEEECc
Confidence            346788888888888875 5688888899988888765          37778888888886 443    2777777653


Q ss_pred             ----------cccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhc-cCCCCCeEeccCCCCCCCCCC
Q 013682          104 ----------NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLT-TITSLNILDLSNNRLSGPVPD  172 (438)
Q Consensus       104 ----------~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~-~~~~L~~l~ls~N~l~g~ip~  172 (438)
                                .+++|+.|+|++|.+++..|..++++++|+.|+|++|++++.+|..+. .+++|+.|+|++|.+++..+ 
T Consensus       108 ~N~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~-  186 (487)
T 3oja_A          108 NNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG-  186 (487)
T ss_dssp             SSCCCCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC-
T ss_pred             CCcCCCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc-
Confidence                      367899999999999988899999999999999999999998888886 79999999999999998744 


Q ss_pred             CCCCCccccccccccc
Q 013682          173 NGSFSQFTPISFENNL  188 (438)
Q Consensus       173 ~~~~~~~~~~~~~~N~  188 (438)
                      ...++.+..+++++|.
T Consensus       187 ~~~l~~L~~L~Ls~N~  202 (487)
T 3oja_A          187 QVVFAKLKTLDLSSNK  202 (487)
T ss_dssp             CCCCTTCCEEECCSSC
T ss_pred             cccCCCCCEEECCCCC
Confidence            4456777777777774

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.38  E-value=1.8e-13  Score=143.99  Aligned_cols=65  Identities=22%  Similarity=0.230  Sum_probs=46.1

Q ss_pred             hhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCCCCCCCccccccccccc
Q 013682          124 DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL  188 (438)
Q Consensus       124 ~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~N~  188 (438)
                      +.++.+++|+.|+|++|.+++.+|..++.+++|+.|++++|.+++..+....++.+..+.+++|.
T Consensus       248 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~Ls~N~  312 (597)
T 3oja_B          248 AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNH  312 (597)
T ss_dssp             GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEEECSSSCCTTCCEEECCSSC
T ss_pred             hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCCCcccccCCCCcEEECCCCC
Confidence            45677777788888888887777777888888888888888877744444445666666666664

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.38  E-value=2.2e-13  Score=130.25  Aligned_cols=149  Identities=24%  Similarity=0.287  Sum_probs=113.4

Q ss_pred             ecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc----------ceeeeecCCCccccccchhhccCCCCCeec
Q 013682           32 ARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF----------VYLISDLGNAALSGELAPELGQLKNLELLA  101 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~  101 (438)
                      ...++.|++|+++.|.+..++. +..+.+++.|+++.|.+          .|..++|++|.+++ +| .+..+++|+.|+
T Consensus        42 ~~~l~~L~~L~l~~~~i~~~~~-~~~l~~L~~L~L~~n~l~~~~~l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~  118 (291)
T 1h6t_A           42 QNELNSIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS  118 (291)
T ss_dssp             HHHHHTCCEEECTTSCCCCCTT-GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred             hhhcCcccEEEccCCCcccChh-HhcCCCCCEEEccCCccCCCcccccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEE
Confidence            3456777777888888888865 67788888888877653          36778888888876 44 488888888886


Q ss_pred             c-----------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCC
Q 013682          102 L-----------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV  170 (438)
Q Consensus       102 l-----------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~i  170 (438)
                      +           +.+++|+.|++++|++++ + +.++.+++|+.|++++|++++..|  +..+++|+.|++++|.+++ +
T Consensus       119 L~~n~i~~~~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l  193 (291)
T 1h6t_A          119 LEHNGISDINGLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-L  193 (291)
T ss_dssp             CTTSCCCCCGGGGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-C
T ss_pred             CCCCcCCCChhhcCCCCCCEEEccCCcCCc-c-hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC-C
Confidence            4           456788888888888874 4 578888888899999888886644  8888888899998888876 4


Q ss_pred             CCCCCCCccccccccccc
Q 013682          171 PDNGSFSQFTPISFENNL  188 (438)
Q Consensus       171 p~~~~~~~~~~~~~~~N~  188 (438)
                      |....++.+..+.+.+|+
T Consensus       194 ~~l~~l~~L~~L~l~~n~  211 (291)
T 1h6t_A          194 RALAGLKNLDVLELFSQE  211 (291)
T ss_dssp             GGGTTCTTCSEEEEEEEE
T ss_pred             hhhccCCCCCEEECcCCc
Confidence            555566677777777775

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.37  E-value=1.7e-12  Score=118.77  Aligned_cols=122  Identities=20%  Similarity=0.261  Sum_probs=89.4

Q ss_pred             eeehhHHHHHHHhhhhhh-hhhhcchheeecccCCccceeeeecCCCccccccchhhccCCCCCeecc------------
Q 013682           36 TLLVTLKAVLQECEQLHL-LISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLAL------------  102 (438)
Q Consensus        36 ~~~~~l~~~~~~~~~l~~-~~~~~~~~~~l~~~~n~~~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l------------  102 (438)
                      +.+++|+++.|.++.++. .+..+.+++.            ++|++|.+++..|..+..+++|+.|++            
T Consensus        32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~------------L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~   99 (220)
T 2v9t_B           32 ETITEIRLEQNTIKVIPPGAFSPYKKLRR------------IDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSL   99 (220)
T ss_dssp             TTCCEEECCSSCCCEECTTSSTTCTTCCE------------EECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTT
T ss_pred             cCCCEEECCCCcCCCcCHhHhhCCCCCCE------------EECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhH
Confidence            356777777777777665 3444444444            455555555555666666777766653            


Q ss_pred             -ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCC
Q 013682          103 -GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGP  169 (438)
Q Consensus       103 -~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~  169 (438)
                       +.+++|+.|+|++|++++..|..|+.+++|+.|+|++|++++..|..+..+++|+.|++++|.+...
T Consensus       100 f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~  167 (220)
T 2v9t_B          100 FEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD  167 (220)
T ss_dssp             TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             ccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence             3467788889999998877788888888999999999998887777788888899999998888753

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.36  E-value=4.3e-13  Score=130.90  Aligned_cols=151  Identities=29%  Similarity=0.366  Sum_probs=116.4

Q ss_pred             ecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc----------ceeeeecCCCccccccchhhccCCCCCeec
Q 013682           32 ARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF----------VYLISDLGNAALSGELAPELGQLKNLELLA  101 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~  101 (438)
                      ..+++.|++|+++.|.+..++. +..+..++.|+++.|.+          .+..+++++|.+++ +|+ +..+++|+.|+
T Consensus       173 ~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~  249 (347)
T 4fmz_A          173 IANLTDLYSLSLNYNQIEDISP-LASLTSLHYFTAYVNQITDITPVANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLE  249 (347)
T ss_dssp             GGGCTTCSEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEE
T ss_pred             hccCCCCCEEEccCCccccccc-ccCCCccceeecccCCCCCCchhhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEE
Confidence            5567777778888888777776 77777788877766643          47778888888886 554 88888888886


Q ss_pred             c-----------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCC
Q 013682          102 L-----------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV  170 (438)
Q Consensus       102 l-----------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~i  170 (438)
                      +           +.+++|+.|++++|.++ .+ +.+..+++|+.|++++|++++..|..+..+++|+.|++++|.+++.+
T Consensus       250 l~~n~l~~~~~~~~l~~L~~L~l~~n~l~-~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~  327 (347)
T 4fmz_A          250 IGTNQISDINAVKDLTKLKMLNVGSNQIS-DI-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIR  327 (347)
T ss_dssp             CCSSCCCCCGGGTTCTTCCEEECCSSCCC-CC-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCG
T ss_pred             CCCCccCCChhHhcCCCcCEEEccCCccC-CC-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCcccccc
Confidence            4           34678889999999887 44 45888888999999999998888888888999999999999988877


Q ss_pred             CCCCCCCccccccccccc
Q 013682          171 PDNGSFSQFTPISFENNL  188 (438)
Q Consensus       171 p~~~~~~~~~~~~~~~N~  188 (438)
                      | ...++.+..+++.+|+
T Consensus       328 ~-~~~l~~L~~L~l~~N~  344 (347)
T 4fmz_A          328 P-LASLSKMDSADFANQV  344 (347)
T ss_dssp             G-GGGCTTCSEESSSCC-
T ss_pred             C-hhhhhccceeehhhhc
Confidence            7 4456666677776664

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.36  E-value=5.6e-13  Score=129.37  Aligned_cols=154  Identities=21%  Similarity=0.212  Sum_probs=104.0

Q ss_pred             ecceeeehhHHHHHHHhhhhhhhh----------------------hhcchheeecccCCcc--------------ceee
Q 013682           32 ARGFTLLVTLKAVLQECEQLHLLI----------------------SFLIFIRVLQSSSNLF--------------VYLI   75 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l~~~~----------------------~~~~~~~~l~~~~n~~--------------~~~~   75 (438)
                      +.+++.|++|+++.|.+.++|..+                      ..+.+++.|+++.|.+              .|..
T Consensus        96 ~~~l~~L~~L~Ls~n~l~~l~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~  175 (330)
T 1xku_A           96 FAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSY  175 (330)
T ss_dssp             TTTCTTCCEEECCSSCCSBCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCE
T ss_pred             hcCCCCCCEEECCCCcCCccChhhcccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCE
Confidence            455666777777777666666543                      3444444444443322              2344


Q ss_pred             eecCCCccccccchhhccCCCCCeec-------------cccccCCCEEEccCCcccccCchhhccccccceeccccccc
Q 013682           76 SDLGNAALSGELAPELGQLKNLELLA-------------LGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSL  142 (438)
Q Consensus        76 ~~l~~n~l~g~ip~~l~~l~~L~~l~-------------l~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l  142 (438)
                      +++++|.++. +|..+.  ++|+.|+             ++.+++|+.|++++|.+++..|..++.+++|+.|++++|++
T Consensus       176 L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l  252 (330)
T 1xku_A          176 IRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL  252 (330)
T ss_dssp             EECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCC
T ss_pred             EECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcC
Confidence            4444444443 443332  4444443             24578899999999999987778999999999999999999


Q ss_pred             cCCCchhhccCCCCCeEeccCCCCCCCCCCCC-------CCCcccccccccccc
Q 013682          143 SGLIPTSLTTITSLNILDLSNNRLSGPVPDNG-------SFSQFTPISFENNLN  189 (438)
Q Consensus       143 ~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~~-------~~~~~~~~~~~~N~~  189 (438)
                      + .+|..+..+++|+.|++++|.+++..+...       ....+..+++.+|+.
T Consensus       253 ~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~  305 (330)
T 1xku_A          253 V-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV  305 (330)
T ss_dssp             S-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSS
T ss_pred             c-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcc
Confidence            9 889999999999999999999997655421       123344455666654

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.36  E-value=1.1e-13  Score=142.79  Aligned_cols=158  Identities=19%  Similarity=0.167  Sum_probs=126.0

Q ss_pred             eecceeeehhHHHHHHH-------hhhhhhhhhhcchheeecccCCcc---------------ceeeeecCCCccccccc
Q 013682           31 CARGFTLLVTLKAVLQE-------CEQLHLLISFLIFIRVLQSSSNLF---------------VYLISDLGNAALSGELA   88 (438)
Q Consensus        31 ~~~~~~~~~~l~~~~~~-------~~~l~~~~~~~~~~~~l~~~~n~~---------------~~~~~~l~~n~l~g~ip   88 (438)
                      .+.+++.|+.|+++.|.       +......++.+.+++.|+++.|.+               .+..+++++|.++|.+|
T Consensus       185 ~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p  264 (520)
T 2z7x_B          185 SVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLD  264 (520)
T ss_dssp             CCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCC
T ss_pred             hhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccc
Confidence            45578888888877764       333333678888899988876532               57889999999999999


Q ss_pred             hhh-----ccCCCCCeecc-------------------------------------ccccCCCEEEccCCcccccCchhh
Q 013682           89 PEL-----GQLKNLELLAL-------------------------------------GNLIKLKSLDLYSNLFNGTIPDTL  126 (438)
Q Consensus        89 ~~l-----~~l~~L~~l~l-------------------------------------~~l~~L~~l~ls~N~l~g~iP~~~  126 (438)
                      ..+     +++++|+.+++                                     +.+++|++|++++|++++.+|..+
T Consensus       265 ~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~  344 (520)
T 2z7x_B          265 FRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENC  344 (520)
T ss_dssp             CCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTC
T ss_pred             cchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeECCccChhhhhhh
Confidence            888     66666655432                                     567889999999999998899999


Q ss_pred             ccccccceeccccccccC--CCchhhccCCCCCeEeccCCCCCCCCCCC--CCCCccccccccccc
Q 013682          127 ANLKQLKYLRLNNNSLSG--LIPTSLTTITSLNILDLSNNRLSGPVPDN--GSFSQFTPISFENNL  188 (438)
Q Consensus       127 ~~l~~L~~l~ls~N~l~g--~~P~~l~~~~~L~~l~ls~N~l~g~ip~~--~~~~~~~~~~~~~N~  188 (438)
                      +++++|++|++++|++++  .+|..+..+++|+.|++++|.+++.+|..  ..++.+..+.+++|.
T Consensus       345 ~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~  410 (520)
T 2z7x_B          345 GHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNI  410 (520)
T ss_dssp             CCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSC
T ss_pred             ccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCC
Confidence            999999999999999997  67788999999999999999999977753  344566666776664

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.36  E-value=4e-13  Score=139.38  Aligned_cols=152  Identities=16%  Similarity=0.160  Sum_probs=108.0

Q ss_pred             cceeeehhHHHHHHHhhhh-h---hhhhhcchheeecccCCcc--------------ceeeeecCCCccccccchhhccC
Q 013682           33 RGFTLLVTLKAVLQECEQL-H---LLISFLIFIRVLQSSSNLF--------------VYLISDLGNAALSGELAPELGQL   94 (438)
Q Consensus        33 ~~~~~~~~l~~~~~~~~~l-~---~~~~~~~~~~~l~~~~n~~--------------~~~~~~l~~n~l~g~ip~~l~~l   94 (438)
                      ++++.|++|+++.|.+... |   ..++.+.+++.|++++|.+              .|..++|++|+++ .+|..++.+
T Consensus       331 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~  409 (549)
T 2z81_A          331 QHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWP  409 (549)
T ss_dssp             HHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCC
T ss_pred             hcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhccc
Confidence            3566677777777776653 2   2256667777777776654              3666777777777 477777777


Q ss_pred             CCCCeecccc----------ccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCC
Q 013682           95 KNLELLALGN----------LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNN  164 (438)
Q Consensus        95 ~~L~~l~l~~----------l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N  164 (438)
                      ++|+.|++++          +++|+.|++++|++++. +   +.+++|++|+|++|+++ .+|. ...+++|+.||+++|
T Consensus       410 ~~L~~L~Ls~N~l~~l~~~~~~~L~~L~Ls~N~l~~~-~---~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N  483 (549)
T 2z81_A          410 EKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSF-S---LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRN  483 (549)
T ss_dssp             TTCCEEECTTSCCSCCCTTSCTTCSEEECCSSCCSCC-C---CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSS
T ss_pred             ccccEEECCCCCcccccchhcCCceEEECCCCChhhh-c---ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCC
Confidence            7787776542          24678888888888753 2   46788888888888888 6776 567888888899888


Q ss_pred             CCCCCCCCC-CCCCcccccccccccccC
Q 013682          165 RLSGPVPDN-GSFSQFTPISFENNLNLC  191 (438)
Q Consensus       165 ~l~g~ip~~-~~~~~~~~~~~~~N~~lc  191 (438)
                      ++++.+|.. ..++.+..+++++|+..|
T Consensus       484 ~l~~~~~~~~~~l~~L~~L~l~~N~~~~  511 (549)
T 2z81_A          484 QLKSVPDGIFDRLTSLQKIWLHTNPWDC  511 (549)
T ss_dssp             CCCCCCTTGGGGCTTCCEEECCSSCBCC
T ss_pred             ccCCcCHHHHhcCcccCEEEecCCCccC
Confidence            888877753 455667777777887554

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.35  E-value=3.9e-13  Score=123.81  Aligned_cols=98  Identities=26%  Similarity=0.339  Sum_probs=80.6

Q ss_pred             eeeeecCCCccccccchh-hccCCCCCeecc-------------ccccCCCEEEccCCcccccCchhhccccccceeccc
Q 013682           73 YLISDLGNAALSGELAPE-LGQLKNLELLAL-------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  138 (438)
Q Consensus        73 ~~~~~l~~n~l~g~ip~~-l~~l~~L~~l~l-------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls  138 (438)
                      |..++|++|.+++ +|.. +..+++|+.|++             +.+++|+.|+|++|+++ .+|..++.+++|+.|+|+
T Consensus        66 L~~L~L~~N~l~~-i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~  143 (229)
T 3e6j_A           66 LKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALD  143 (229)
T ss_dssp             CCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECC
T ss_pred             CcEEECCCCCCCC-cChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECC
Confidence            5555666666654 5543 467777777753             45778999999999998 999999999999999999


Q ss_pred             cccccCCCchhhccCCCCCeEeccCCCCCCCCCC
Q 013682          139 NNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD  172 (438)
Q Consensus       139 ~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~  172 (438)
                      +|++++..+..+..+++|+.|++++|.+++..+.
T Consensus       144 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~  177 (229)
T 3e6j_A          144 QNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECRD  177 (229)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBGG
T ss_pred             CCcCCccCHHHHhCCCCCCEEEeeCCCccCCcch
Confidence            9999987777899999999999999999987663

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.35  E-value=3.9e-13  Score=141.20  Aligned_cols=149  Identities=24%  Similarity=0.280  Sum_probs=108.3

Q ss_pred             ecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc----------ceeeeecCCCccccccchhhccCCCCCeec
Q 013682           32 ARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF----------VYLISDLGNAALSGELAPELGQLKNLELLA  101 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~  101 (438)
                      ...|..|+.|+++.|.+..++ .+..+.+|+.|+++.|.+          .|..|+|++|.+++ +| .+..|++|+.|+
T Consensus        39 ~~~L~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~  115 (605)
T 1m9s_A           39 QNELNSIDQIIANNSDIKSVQ-GIQYLPNVTKLFLNGNKLTDIKPLTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLS  115 (605)
T ss_dssp             HHHHTTCCCCBCTTCCCCCCT-TGGGCTTCCEEECTTSCCCCCGGGGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEE
T ss_pred             hhcCCCCCEEECcCCCCCCCh-HHccCCCCCEEEeeCCCCCCChhhccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEE
Confidence            456667777777777777776 467777788887777643          36677788888776 44 677788888776


Q ss_pred             c-----------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCC
Q 013682          102 L-----------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV  170 (438)
Q Consensus       102 l-----------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~i  170 (438)
                      +           +.+++|+.|+|++|.+++ + +.++.+++|+.|+|++|++++..|  +..+++|+.|+|++|.+++. 
T Consensus       116 Ls~N~l~~l~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-  190 (605)
T 1m9s_A          116 LEHNGISDINGLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-  190 (605)
T ss_dssp             CTTSCCCCCGGGGGCTTCSEEECCSSCCCC-C-GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-
T ss_pred             ecCCCCCCCccccCCCccCEEECCCCccCC-c-hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC-
Confidence            4           346778888888888874 3 567888888888888888887655  77888888888888888763 


Q ss_pred             CCCCCCCccccccccccc
Q 013682          171 PDNGSFSQFTPISFENNL  188 (438)
Q Consensus       171 p~~~~~~~~~~~~~~~N~  188 (438)
                      |....++.+..+.+.+|.
T Consensus       191 ~~l~~l~~L~~L~L~~N~  208 (605)
T 1m9s_A          191 RALAGLKNLDVLELFSQE  208 (605)
T ss_dssp             GGGTTCTTCSEEECCSEE
T ss_pred             hHHccCCCCCEEEccCCc
Confidence            555556666666666665

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.35  E-value=2.2e-13  Score=145.16  Aligned_cols=136  Identities=28%  Similarity=0.243  Sum_probs=68.0

Q ss_pred             ecceeeehhHHHHHHHhhh-hh-hhhhhcchheeecccCCcc------------ceeeeecCCCccc--cccchhhccCC
Q 013682           32 ARGFTLLVTLKAVLQECEQ-LH-LLISFLIFIRVLQSSSNLF------------VYLISDLGNAALS--GELAPELGQLK   95 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~-l~-~~~~~~~~~~~l~~~~n~~------------~~~~~~l~~n~l~--g~ip~~l~~l~   95 (438)
                      +.+++.|++|+++.|.+.+ +| ..+..+.+++.|+++.|.+            .+..+++++|.+.  +.+|..++.++
T Consensus       401 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~  480 (680)
T 1ziw_A          401 FSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR  480 (680)
T ss_dssp             TTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCT
T ss_pred             hhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCC
Confidence            4566777777777777653 44 4566667777776666542            2444555555544  34455555555


Q ss_pred             CCCeecc-------------ccccCCCEEEccCCcccccC----c----hhhccccccceeccccccccCCCchhhccCC
Q 013682           96 NLELLAL-------------GNLIKLKSLDLYSNLFNGTI----P----DTLANLKQLKYLRLNNNSLSGLIPTSLTTIT  154 (438)
Q Consensus        96 ~L~~l~l-------------~~l~~L~~l~ls~N~l~g~i----P----~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~  154 (438)
                      +|+.|++             +.+++|++|+|++|++++..    |    ..++++++|+.|+|++|+++...+..+..++
T Consensus       481 ~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~  560 (680)
T 1ziw_A          481 NLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLF  560 (680)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred             CCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHccccc
Confidence            5555432             22344455555555444211    1    1134444444444444444422222344444


Q ss_pred             CCCeEeccCCCCC
Q 013682          155 SLNILDLSNNRLS  167 (438)
Q Consensus       155 ~L~~l~ls~N~l~  167 (438)
                      +|+.|++++|+++
T Consensus       561 ~L~~L~Ls~N~l~  573 (680)
T 1ziw_A          561 ELKIIDLGLNNLN  573 (680)
T ss_dssp             TCCEEECCSSCCC
T ss_pred             CcceeECCCCCCC
Confidence            4444444444444

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.35  E-value=1.1e-13  Score=133.34  Aligned_cols=115  Identities=19%  Similarity=0.143  Sum_probs=61.6

Q ss_pred             eeeeecCCCccccccc----hhhccCCCCCeecc-------------ccccCCCEEEccCCccccc--Cch--hhccccc
Q 013682           73 YLISDLGNAALSGELA----PELGQLKNLELLAL-------------GNLIKLKSLDLYSNLFNGT--IPD--TLANLKQ  131 (438)
Q Consensus        73 ~~~~~l~~n~l~g~ip----~~l~~l~~L~~l~l-------------~~l~~L~~l~ls~N~l~g~--iP~--~~~~l~~  131 (438)
                      +..++|++|.+++..|    ..+..+++|+.|++             +.+++|++|+|++|++.+.  +|.  .++++++
T Consensus       119 L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~  198 (310)
T 4glp_A          119 LSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPA  198 (310)
T ss_dssp             CSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCC
T ss_pred             CCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCC
Confidence            5556666666665444    33345666666542             3455666666666665542  222  2255666


Q ss_pred             cceeccccccccCCCch----hhccCCCCCeEeccCCCCCCCCCCC-CCC---Cccccccccccc
Q 013682          132 LKYLRLNNNSLSGLIPT----SLTTITSLNILDLSNNRLSGPVPDN-GSF---SQFTPISFENNL  188 (438)
Q Consensus       132 L~~l~ls~N~l~g~~P~----~l~~~~~L~~l~ls~N~l~g~ip~~-~~~---~~~~~~~~~~N~  188 (438)
                      |++|+|++|+++ .+|.    .+..+++|+.||+++|.+++.+|.. ..+   +.+..+.+++|.
T Consensus       199 L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~  262 (310)
T 4glp_A          199 IQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAG  262 (310)
T ss_dssp             CCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSC
T ss_pred             CCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCC
Confidence            666666666665 2232    1355666666666666666664432 122   344555555553

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.35  E-value=3.2e-13  Score=142.01  Aligned_cols=152  Identities=22%  Similarity=0.237  Sum_probs=86.7

Q ss_pred             ecceeeehhHHHHHHHhhhhhhh-hhhcchheeecccCCcc------------ceeeeecCCCccccccchhhccCCC--
Q 013682           32 ARGFTLLVTLKAVLQECEQLHLL-ISFLIFIRVLQSSSNLF------------VYLISDLGNAALSGELAPELGQLKN--   96 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l~~~-~~~~~~~~~l~~~~n~~------------~~~~~~l~~n~l~g~ip~~l~~l~~--   96 (438)
                      +++++.|++|+++.|.++.+|.. ++.+.+|+.|+++.|.+            .|..++|++|.+++. |  ++.+++  
T Consensus       119 ~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~--~~~l~~L~  195 (597)
T 3oja_B          119 FQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-D--LSLIPSLF  195 (597)
T ss_dssp             TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC-C--GGGCTTCS
T ss_pred             HcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc-C--hhhhhhhh
Confidence            45666677777777777777665 36666677766665532            255566666666652 2  112222  


Q ss_pred             --------------------------------------CCeec-----------cccccCCCEEEccCCcccccCchhhc
Q 013682           97 --------------------------------------LELLA-----------LGNLIKLKSLDLYSNLFNGTIPDTLA  127 (438)
Q Consensus        97 --------------------------------------L~~l~-----------l~~l~~L~~l~ls~N~l~g~iP~~~~  127 (438)
                                                            |+.|+           ++.+++|+.|+|++|.+++.+|..|+
T Consensus       196 ~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~~~~L~~L~L~~n~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~  275 (597)
T 3oja_B          196 HANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFV  275 (597)
T ss_dssp             EEECCSSCCSEEECCTTCSEEECCSSCCCEEECSCCSCCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCEEESGGGT
T ss_pred             hhhcccCccccccCCchhheeeccCCcccccccccCCCCCEEECCCCCCCCChhhccCCCCCEEECCCCccCCCCHHHhc
Confidence                                                  22222           23455666777777777666666677


Q ss_pred             cccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCCCCCCCcccccccccc
Q 013682          128 NLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN  187 (438)
Q Consensus       128 ~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~N  187 (438)
                      .+++|+.|+|++|++++ +|..+..+++|+.|+|++|.+++.++....++.+..+++.+|
T Consensus       276 ~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~l~~L~~L~L~~N  334 (597)
T 3oja_B          276 KMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHN  334 (597)
T ss_dssp             TCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCCCCGGGHHHHTTCSEEECCSS
T ss_pred             CccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCCccCcccccCCCCCEEECCCC
Confidence            66667667666666664 455555666666666666666632222223334444444444

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.35  E-value=3.6e-13  Score=130.90  Aligned_cols=154  Identities=23%  Similarity=0.207  Sum_probs=108.7

Q ss_pred             ecceeeehhHHHHHHHhhhhhhh----------------------hhhcchheeecccCCcc-------------ceeee
Q 013682           32 ARGFTLLVTLKAVLQECEQLHLL----------------------ISFLIFIRVLQSSSNLF-------------VYLIS   76 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l~~~----------------------~~~~~~~~~l~~~~n~~-------------~~~~~   76 (438)
                      +.+++.|++|+++.|.+.++|..                      +..+.+++.|+++.|.+             .+..+
T Consensus        98 ~~~l~~L~~L~L~~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L  177 (332)
T 2ft3_A           98 FSPLRKLQKLYISKNHLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYL  177 (332)
T ss_dssp             STTCTTCCEEECCSSCCCSCCSSCCTTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCC
T ss_pred             hhCcCCCCEEECCCCcCCccCccccccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEE
Confidence            44555555555555555555443                      45556666666655544             34555


Q ss_pred             ecCCCccccccchhhccCCCCCeec-------------cccccCCCEEEccCCcccccCchhhccccccceecccccccc
Q 013682           77 DLGNAALSGELAPELGQLKNLELLA-------------LGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLS  143 (438)
Q Consensus        77 ~l~~n~l~g~ip~~l~~l~~L~~l~-------------l~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~  143 (438)
                      ++++|.+++ +|..+.  ++|+.|+             ++.+++|+.|++++|++++..|..++.+++|+.|++++|+++
T Consensus       178 ~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  254 (332)
T 2ft3_A          178 RISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS  254 (332)
T ss_dssp             BCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC
T ss_pred             ECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe
Confidence            666666665 665544  5666664             345789999999999999777779999999999999999999


Q ss_pred             CCCchhhccCCCCCeEeccCCCCCCCCCCCCC-------CCcccccccccccc
Q 013682          144 GLIPTSLTTITSLNILDLSNNRLSGPVPDNGS-------FSQFTPISFENNLN  189 (438)
Q Consensus       144 g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~~~-------~~~~~~~~~~~N~~  189 (438)
                       .+|..+..+++|+.|++++|.+++..+....       ...+..+.+.+|+.
T Consensus       255 -~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~  306 (332)
T 2ft3_A          255 -RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPV  306 (332)
T ss_dssp             -BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSS
T ss_pred             -ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcc
Confidence             8899999999999999999999976554211       23344556666654

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.34  E-value=5.8e-13  Score=128.33  Aligned_cols=150  Identities=23%  Similarity=0.334  Sum_probs=113.9

Q ss_pred             eecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc----------ceeeeecCCCccccccchhhccCCCCCee
Q 013682           31 CARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF----------VYLISDLGNAALSGELAPELGQLKNLELL  100 (438)
Q Consensus        31 ~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l  100 (438)
                      ...+|+.|+.|+++++.+..++ .+..+.+++.|+++.|.+          .|..++|++|.+++ +| .+..+++|+.|
T Consensus        36 ~~~~l~~L~~L~l~~~~i~~l~-~~~~l~~L~~L~L~~n~i~~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L  112 (308)
T 1h6u_A           36 TQADLDGITTLSAFGTGVTTIE-GVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKN-VS-AIAGLQSIKTL  112 (308)
T ss_dssp             CHHHHHTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGGGTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEE
T ss_pred             cHHHcCCcCEEEeeCCCccCch-hhhccCCCCEEEccCCcCCCChhHccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEE
Confidence            4456788888889999999988 578889999999887754          47788888888886 44 68888888887


Q ss_pred             cc-----------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCC
Q 013682          101 AL-----------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGP  169 (438)
Q Consensus       101 ~l-----------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~  169 (438)
                      ++           +.+++|+.|++++|.++ .+|. ++.+++|+.|++++|++++. |. +..+++|+.|++++|.+++.
T Consensus       113 ~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~-~~~~-l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~  188 (308)
T 1h6u_A          113 DLTSTQITDVTPLAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDL-TP-LANLSKLTTLKADDNKISDI  188 (308)
T ss_dssp             ECTTSCCCCCGGGTTCTTCCEEECCSSCCC-CCGG-GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC
T ss_pred             ECCCCCCCCchhhcCCCCCCEEECCCCccC-cCcc-ccCCCCccEEEccCCcCCCC-hh-hcCCCCCCEEECCCCccCcC
Confidence            64           45678888888888887 4444 88888888888888888854 43 78888888888888888765


Q ss_pred             CCCCCCCCccccccccccc
Q 013682          170 VPDNGSFSQFTPISFENNL  188 (438)
Q Consensus       170 ip~~~~~~~~~~~~~~~N~  188 (438)
                      .| ...++.+..+.+++|.
T Consensus       189 ~~-l~~l~~L~~L~L~~N~  206 (308)
T 1h6u_A          189 SP-LASLPNLIEVHLKNNQ  206 (308)
T ss_dssp             GG-GGGCTTCCEEECTTSC
T ss_pred             hh-hcCCCCCCEEEccCCc
Confidence            44 4445556666666664

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.34  E-value=4e-13  Score=137.05  Aligned_cols=134  Identities=19%  Similarity=0.174  Sum_probs=81.3

Q ss_pred             eehhHHHHHHHhhhhh-hhhhhcchheeecccCCcc------------ceeeeecCCCccccccch-hhccCCCCCeecc
Q 013682           37 LLVTLKAVLQECEQLH-LLISFLIFIRVLQSSSNLF------------VYLISDLGNAALSGELAP-ELGQLKNLELLAL  102 (438)
Q Consensus        37 ~~~~l~~~~~~~~~l~-~~~~~~~~~~~l~~~~n~~------------~~~~~~l~~n~l~g~ip~-~l~~l~~L~~l~l  102 (438)
                      .+++|+++.|.++.++ ..+..+.+|+.|+++.|.+            .|..++|++|.+++ +|. .+.++++|+.|++
T Consensus        33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L  111 (477)
T 2id5_A           33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDI  111 (477)
T ss_dssp             TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCS-CCTTSSTTCTTCCEEEC
T ss_pred             CCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCc-cCcccccCCCCCCEEEC
Confidence            4556666666666663 4466666666666665532            35566666666664 443 3566666666643


Q ss_pred             -------------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCC
Q 013682          103 -------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGP  169 (438)
Q Consensus       103 -------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~  169 (438)
                                   +.+++|+.|++++|.+++..|..|+++++|+.|++++|++++..+..+..+++|+.|++++|.+++.
T Consensus       112 s~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~  191 (477)
T 2id5_A          112 SENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAI  191 (477)
T ss_dssp             TTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEE
T ss_pred             CCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEe
Confidence                         2355666666666666655566666666666666666666655555566666666666666666554


Q ss_pred             CC
Q 013682          170 VP  171 (438)
Q Consensus       170 ip  171 (438)
                      .+
T Consensus       192 ~~  193 (477)
T 2id5_A          192 RD  193 (477)
T ss_dssp             CT
T ss_pred             Ch
Confidence            43

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.34  E-value=1.6e-12  Score=122.31  Aligned_cols=148  Identities=22%  Similarity=0.245  Sum_probs=117.5

Q ss_pred             ceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc----------ceeeeecCCCccccccchhhccCCCCCeeccc
Q 013682           34 GFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF----------VYLISDLGNAALSGELAPELGQLKNLELLALG  103 (438)
Q Consensus        34 ~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~  103 (438)
                      ++..++.++++.+.+++++ .+..+.+++.|+++.|.+          .+..++|++|.+++ +|+ +..+++|+.|+++
T Consensus        17 ~l~~l~~l~l~~~~i~~~~-~~~~l~~L~~L~l~~n~i~~l~~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~   93 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDLV-SQKELSGVQNFNGDNSNIQSLAGMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVN   93 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSEE-CHHHHTTCSEEECTTSCCCCCTTGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECC
T ss_pred             HHHHHHHHHhcCCCccccc-chhhcCcCcEEECcCCCcccchHHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECC
Confidence            4555666777777777777 567777777777776643          47778888888887 665 8899999998753


Q ss_pred             c----------ccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCCC
Q 013682          104 N----------LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN  173 (438)
Q Consensus       104 ~----------l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~  173 (438)
                      .          .++|+.|++++|++++ +| .++.+++|+.|++++|++++. | .+..+++|+.|++++|.+++. +..
T Consensus        94 ~N~l~~l~~~~~~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~-~~l  168 (263)
T 1xeu_A           94 RNRLKNLNGIPSACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT-GGL  168 (263)
T ss_dssp             SSCCSCCTTCCCSSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC-TTS
T ss_pred             CCccCCcCccccCcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch-HHh
Confidence            2          1579999999999984 55 699999999999999999965 5 699999999999999999987 555


Q ss_pred             CCCCcccccccccccc
Q 013682          174 GSFSQFTPISFENNLN  189 (438)
Q Consensus       174 ~~~~~~~~~~~~~N~~  189 (438)
                      ..++.+..+++.+|+.
T Consensus       169 ~~l~~L~~L~l~~N~~  184 (263)
T 1xeu_A          169 TRLKKVNWIDLTGQKC  184 (263)
T ss_dssp             TTCCCCCEEEEEEEEE
T ss_pred             ccCCCCCEEeCCCCcc
Confidence            6667777888888864

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.33  E-value=5.5e-13  Score=132.53  Aligned_cols=68  Identities=18%  Similarity=0.165  Sum_probs=35.4

Q ss_pred             cceeeehhHHHHHHHhhhhhh-hhhhcchheeecccCCcc------------ceeeeecCCCccccccchhh-ccCCCCC
Q 013682           33 RGFTLLVTLKAVLQECEQLHL-LISFLIFIRVLQSSSNLF------------VYLISDLGNAALSGELAPEL-GQLKNLE   98 (438)
Q Consensus        33 ~~~~~~~~l~~~~~~~~~l~~-~~~~~~~~~~l~~~~n~~------------~~~~~~l~~n~l~g~ip~~l-~~l~~L~   98 (438)
                      ++++.|++|+++.|.+..++. .++.+.+++.|+++.|.+            .|..++|++|.++. +|..+ .++++|+
T Consensus        66 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~l~~L~  144 (390)
T 3o6n_A           66 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLT  144 (390)
T ss_dssp             HHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCC
T ss_pred             cccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCc-CCHHHhcCCCCCc
Confidence            445556666666666555553 455555555555554432            24455555555552 44442 4555555


Q ss_pred             eec
Q 013682           99 LLA  101 (438)
Q Consensus        99 ~l~  101 (438)
                      .|+
T Consensus       145 ~L~  147 (390)
T 3o6n_A          145 TLS  147 (390)
T ss_dssp             EEE
T ss_pred             EEE
Confidence            553

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.33  E-value=1.4e-13  Score=134.90  Aligned_cols=138  Identities=17%  Similarity=0.150  Sum_probs=105.5

Q ss_pred             eecceeeehhHHHHHHHhhhhh-hhhhhcchheeecccCCcc------------ceeeeecCCCccccccch--hhccCC
Q 013682           31 CARGFTLLVTLKAVLQECEQLH-LLISFLIFIRVLQSSSNLF------------VYLISDLGNAALSGELAP--ELGQLK   95 (438)
Q Consensus        31 ~~~~~~~~~~l~~~~~~~~~l~-~~~~~~~~~~~l~~~~n~~------------~~~~~~l~~n~l~g~ip~--~l~~l~   95 (438)
                      .+.+++.|++|+++.|.++.++ ..++.+.+++.|+++.|.+            .|..++|++|.+++ +|.  .+..++
T Consensus        71 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~~l~  149 (353)
T 2z80_A           71 DLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLT  149 (353)
T ss_dssp             TTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSS-SCSSCSCTTCT
T ss_pred             HhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcc-cCchhhhccCC
Confidence            3678888999999999999885 4588899999999987753            47888999999985 776  688899


Q ss_pred             CCCeecc--------------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchh-hccCCCCCeEe
Q 013682           96 NLELLAL--------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTS-LTTITSLNILD  160 (438)
Q Consensus        96 ~L~~l~l--------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~-l~~~~~L~~l~  160 (438)
                      +|+.|++              +.+++|+.|++++|.+++..|..++++++|+.|++++|+++. +|.. +..+++|+.|+
T Consensus       150 ~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~-~~~~~~~~~~~L~~L~  228 (353)
T 2z80_A          150 KLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL-LLEIFVDVTSSVECLE  228 (353)
T ss_dssp             TCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTT-HHHHHHHHTTTEEEEE
T ss_pred             CCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCcccc-chhhhhhhcccccEEE
Confidence            9988864              346678889999999988888888888888888887777753 3433 33466666666


Q ss_pred             ccCCCCCCCC
Q 013682          161 LSNNRLSGPV  170 (438)
Q Consensus       161 ls~N~l~g~i  170 (438)
                      +++|.+++..
T Consensus       229 L~~n~l~~~~  238 (353)
T 2z80_A          229 LRDTDLDTFH  238 (353)
T ss_dssp             EESCBCTTCC
T ss_pred             CCCCcccccc
Confidence            6666666543

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.33  E-value=2.1e-12  Score=115.56  Aligned_cols=115  Identities=21%  Similarity=0.365  Sum_probs=94.6

Q ss_pred             eeeecCCCccccccchhhccCCCCCeec--------------cccccCCCEEEccCCcccccCchhhccccccceecccc
Q 013682           74 LISDLGNAALSGELAPELGQLKNLELLA--------------LGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN  139 (438)
Q Consensus        74 ~~~~l~~n~l~g~ip~~l~~l~~L~~l~--------------l~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~  139 (438)
                      ..+++++|+++ .+|..+..  +|+.|+              ++.+++|+.|+|++|++++..|..|+++++|++|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            34677777774 58877654  666664              45678899999999999988899999999999999999


Q ss_pred             ccccCCCchhhccCCCCCeEeccCCCCCCCCCCC-CCCCcccccccccccccC
Q 013682          140 NSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNLNLC  191 (438)
Q Consensus       140 N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~N~~lc  191 (438)
                      |++++..|..+..+++|+.|++++|++++.+|.. ..++.+..+.+++|+.-|
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  140 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC  140 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence            9999988888999999999999999999988864 345667777888887544

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.33  E-value=6.5e-12  Score=113.54  Aligned_cols=119  Identities=26%  Similarity=0.272  Sum_probs=72.1

Q ss_pred             eeeeecCCCccccccchhhccCCCCCeecc-------------ccccCCCEEEccCCcccccCchhhccccccceecccc
Q 013682           73 YLISDLGNAALSGELAPELGQLKNLELLAL-------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN  139 (438)
Q Consensus        73 ~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l-------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~  139 (438)
                      +..++|++|.+++..+..+..+++|+.|++             +.+++|++|++++|++++..|..++++++|++|++++
T Consensus        30 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~  109 (208)
T 2o6s_A           30 TTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNT  109 (208)
T ss_dssp             CSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCC
Confidence            344455555555422233455555555542             3455677777777777744444567777777777777


Q ss_pred             ccccCCCchhhccCCCCCeEeccCCCCCCCCCC-CCCCCcccccccccccccC
Q 013682          140 NSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFENNLNLC  191 (438)
Q Consensus       140 N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~-~~~~~~~~~~~~~~N~~lc  191 (438)
                      |++++..|..+..+++|+.|++++|.+++..+. ...++.+..+.+.+|+..|
T Consensus       110 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~  162 (208)
T 2o6s_A          110 NQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC  162 (208)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC
T ss_pred             CcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec
Confidence            777766555667777777777777777765554 2345556666666665443

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.33  E-value=1.1e-12  Score=135.31  Aligned_cols=152  Identities=21%  Similarity=0.279  Sum_probs=101.3

Q ss_pred             cceeeehhHHHHHHHhhhhh-hhhhhc---chheeecccCC----------ccceeeeecCCCccccccchhhccCCCCC
Q 013682           33 RGFTLLVTLKAVLQECEQLH-LLISFL---IFIRVLQSSSN----------LFVYLISDLGNAALSGELAPELGQLKNLE   98 (438)
Q Consensus        33 ~~~~~~~~l~~~~~~~~~l~-~~~~~~---~~~~~l~~~~n----------~~~~~~~~l~~n~l~g~ip~~l~~l~~L~   98 (438)
                      ++++.|+.++++.|.+ ++| ..+..+   .+++.|+++.|          ...+..++|++|.+++.+|..++++++|+
T Consensus       273 ~~l~~L~~l~l~~n~~-~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~  351 (520)
T 2z7x_B          273 TSLKALSIHQVVSDVF-GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELE  351 (520)
T ss_dssp             CCCCEEEEEEEEECCC-CSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCC
T ss_pred             ccCceeEeccccccce-ecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeECCccChhhhhhhccCCCCC
Confidence            6777777777777766 666 334333   34555555433          34577788888888888888888888888


Q ss_pred             eecc---------------ccccCCCEEEccCCcccccCchh-hccccccceeccccccccCCCchhhccCCCCCeEecc
Q 013682           99 LLAL---------------GNLIKLKSLDLYSNLFNGTIPDT-LANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLS  162 (438)
Q Consensus        99 ~l~l---------------~~l~~L~~l~ls~N~l~g~iP~~-~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls  162 (438)
                      .|++               +.+++|+.|++++|.+++.+|.. +..+++|+.|++++|++++.+|..+.  ++|+.|+++
T Consensus       352 ~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls  429 (520)
T 2z7x_B          352 TLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLH  429 (520)
T ss_dssp             EEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECC
T ss_pred             EEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECC
Confidence            8753               34677888888888888667764 67777777777777777766665554  567777777


Q ss_pred             CCCCCCCCCC-CCCCCccccccccccc
Q 013682          163 NNRLSGPVPD-NGSFSQFTPISFENNL  188 (438)
Q Consensus       163 ~N~l~g~ip~-~~~~~~~~~~~~~~N~  188 (438)
                      +|+++ .+|. ...++.+..++..+|.
T Consensus       430 ~N~l~-~ip~~~~~l~~L~~L~L~~N~  455 (520)
T 2z7x_B          430 SNKIK-SIPKQVVKLEALQELNVASNQ  455 (520)
T ss_dssp             SSCCC-CCCGGGGGCTTCCEEECCSSC
T ss_pred             CCccc-ccchhhhcCCCCCEEECCCCc
Confidence            77776 4553 2344455555555553

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.32  E-value=2.5e-12  Score=112.17  Aligned_cols=118  Identities=25%  Similarity=0.233  Sum_probs=94.2

Q ss_pred             cceeeeecCCCccc-cccchhhccCCCCCeecc-----------ccccCCCEEEccCCcccccCchhhccccccceeccc
Q 013682           71 FVYLISDLGNAALS-GELAPELGQLKNLELLAL-----------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  138 (438)
Q Consensus        71 ~~~~~~~l~~n~l~-g~ip~~l~~l~~L~~l~l-----------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls  138 (438)
                      ..+..++|++|.++ |.+|..+..+++|+.|++           +.+++|++|++++|++++.+|..++++++|+.|+++
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  103 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLS  103 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCCSSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECB
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCChhhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEecc
Confidence            34666778888887 778888888888888763           457789999999999997789888889999999999


Q ss_pred             cccccCCC-chhhccCCCCCeEeccCCCCCCCCC----CCCCCCccccccccccc
Q 013682          139 NNSLSGLI-PTSLTTITSLNILDLSNNRLSGPVP----DNGSFSQFTPISFENNL  188 (438)
Q Consensus       139 ~N~l~g~~-P~~l~~~~~L~~l~ls~N~l~g~ip----~~~~~~~~~~~~~~~N~  188 (438)
                      +|++++.. +..+..+++|+.|++++|.+++..+    ....++.+..++..+|.
T Consensus       104 ~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~  158 (168)
T 2ell_A          104 GNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRE  158 (168)
T ss_dssp             SSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETT
T ss_pred             CCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCC
Confidence            99998642 2788999999999999999997766    33455666666666664

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.32  E-value=2.4e-13  Score=125.78  Aligned_cols=151  Identities=19%  Similarity=0.154  Sum_probs=108.7

Q ss_pred             eehhHHHHHHHhhhhhh-hhhhcchheeecccCCc-c------------ceeeeecCC-CccccccchhhccCCCCCeec
Q 013682           37 LLVTLKAVLQECEQLHL-LISFLIFIRVLQSSSNL-F------------VYLISDLGN-AALSGELAPELGQLKNLELLA  101 (438)
Q Consensus        37 ~~~~l~~~~~~~~~l~~-~~~~~~~~~~l~~~~n~-~------------~~~~~~l~~-n~l~g~ip~~l~~l~~L~~l~  101 (438)
                      .|++|+++.|.++.+|. .+..+.+++.|+++.|. +            .|..++|++ |.+++--|..+..+++|+.|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            57778888888888877 57788888888887773 2            366778887 888864445677888888886


Q ss_pred             c-----------ccccCCC---EEEccCC-cccccCchhhccccccc-eeccccccccCCCchhhccCCCCCeEeccCCC
Q 013682          102 L-----------GNLIKLK---SLDLYSN-LFNGTIPDTLANLKQLK-YLRLNNNSLSGLIPTSLTTITSLNILDLSNNR  165 (438)
Q Consensus       102 l-----------~~l~~L~---~l~ls~N-~l~g~iP~~~~~l~~L~-~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~  165 (438)
                      +           +.+++|+   .|++++| ++++..|..|+++++|+ .|++++|+++ .+|......++|+.|++++|.
T Consensus       112 l~~n~l~~lp~~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~  190 (239)
T 2xwt_C          112 IFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNK  190 (239)
T ss_dssp             EEEECCCSCCCCTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCT
T ss_pred             CCCCCCccccccccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCC
Confidence            4           3455666   8888888 88754445688888888 8888888888 566655444788888888884


Q ss_pred             -CCCCCCCC-CCC-Cccccccccccc
Q 013682          166 -LSGPVPDN-GSF-SQFTPISFENNL  188 (438)
Q Consensus       166 -l~g~ip~~-~~~-~~~~~~~~~~N~  188 (438)
                       +++..|.. ..+ +.+..+++++|.
T Consensus       191 ~l~~i~~~~~~~l~~~L~~L~l~~N~  216 (239)
T 2xwt_C          191 YLTVIDKDAFGGVYSGPSLLDVSQTS  216 (239)
T ss_dssp             TCCEECTTTTTTCSBCCSEEECTTCC
T ss_pred             CcccCCHHHhhccccCCcEEECCCCc
Confidence             77544432 234 566666666664

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.31  E-value=7.7e-13  Score=134.58  Aligned_cols=131  Identities=21%  Similarity=0.175  Sum_probs=86.3

Q ss_pred             eecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc---------ceeeeecCCCccccccchhhccCCCCCeec
Q 013682           31 CARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF---------VYLISDLGNAALSGELAPELGQLKNLELLA  101 (438)
Q Consensus        31 ~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~---------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~  101 (438)
                      .+++++.|++|+++.|.++.+|  ++.+.+++.|+++.|.+         .|..+++++|...|.+  .++.+++|+.|+
T Consensus       101 ~~~~l~~L~~L~L~~N~l~~l~--~~~l~~L~~L~l~~N~l~~l~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~  176 (457)
T 3bz5_A          101 DVTPLTKLTYLNCDTNKLTKLD--VSQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLD  176 (457)
T ss_dssp             CCTTCTTCCEEECCSSCCSCCC--CTTCTTCCEEECTTSCCSCCCCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEE
T ss_pred             ecCCCCcCCEEECCCCcCCeec--CCCCCcCCEEECCCCccceeccccCCcCCEEECCCCCccccc--ccccCCcCCEEE
Confidence            3667777777777777777765  67777777777766654         3556666666666655  356666666665


Q ss_pred             c----------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCC
Q 013682          102 L----------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP  171 (438)
Q Consensus       102 l----------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip  171 (438)
                      +          +.+++|+.|++++|++++ +  .++.+++|+.|++++|++++ +|  +..+++|+.|++++|.+++..+
T Consensus       177 ls~n~l~~l~l~~l~~L~~L~l~~N~l~~-~--~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~  250 (457)
T 3bz5_A          177 CSFNKITELDVSQNKLLNRLNCDTNNITK-L--DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDV  250 (457)
T ss_dssp             CCSSCCCCCCCTTCTTCCEEECCSSCCSC-C--CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCC
T ss_pred             CCCCccceeccccCCCCCEEECcCCcCCe-e--ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCH
Confidence            3          345667777777777764 3  36667777777777777765 45  6666777777777777766543

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.31  E-value=7e-13  Score=131.76  Aligned_cols=153  Identities=22%  Similarity=0.231  Sum_probs=105.1

Q ss_pred             ecceeeehhHHHHHHHhhhhhhh-hhhcchheeecccCCcc------------ceeeeecCCCccccccchhhccCC---
Q 013682           32 ARGFTLLVTLKAVLQECEQLHLL-ISFLIFIRVLQSSSNLF------------VYLISDLGNAALSGELAPELGQLK---   95 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l~~~-~~~~~~~~~l~~~~n~~------------~~~~~~l~~n~l~g~ip~~l~~l~---   95 (438)
                      +++++.|++|+++.|.+..+|.. ++.+.+++.|+++.|.+            .|..+++++|.+++. +  +..++   
T Consensus       113 ~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~--~~~l~~L~  189 (390)
T 3o6n_A          113 FQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-D--LSLIPSLF  189 (390)
T ss_dssp             TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC-C--GGGCTTCS
T ss_pred             hcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc-c--cccccccc
Confidence            45667777777777777777766 36677777777766543            356666777766652 2  22222   


Q ss_pred             -------------------------------------CCCeec-----------cccccCCCEEEccCCcccccCchhhc
Q 013682           96 -------------------------------------NLELLA-----------LGNLIKLKSLDLYSNLFNGTIPDTLA  127 (438)
Q Consensus        96 -------------------------------------~L~~l~-----------l~~l~~L~~l~ls~N~l~g~iP~~~~  127 (438)
                                                           +|+.|+           ++.+++|+.|++++|.+++..|..++
T Consensus       190 ~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~n~l~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~  269 (390)
T 3o6n_A          190 HANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFV  269 (390)
T ss_dssp             EEECCSSCCSEEECCSSCSEEECCSSCCCEEECCCCSSCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCEEESGGGT
T ss_pred             eeecccccccccCCCCcceEEECCCCeeeeccccccccccEEECCCCCCcccHHHcCCCCccEEECCCCcCCCcChhHcc
Confidence                                                 333332           23467888888888888877788888


Q ss_pred             cccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCCCCCCCccccccccccc
Q 013682          128 NLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL  188 (438)
Q Consensus       128 ~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~N~  188 (438)
                      ++++|+.|++++|++++ +|..+..+++|+.|++++|++++..+....++.+..+++.+|.
T Consensus       270 ~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~N~  329 (390)
T 3o6n_A          270 KMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNS  329 (390)
T ss_dssp             TCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCCCCGGGHHHHTTCSEEECCSSC
T ss_pred             ccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcceecCccccccCcCCEEECCCCc
Confidence            88888888888888875 5777778888888888888888544443345566666666664

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.31  E-value=1.2e-13  Score=135.40  Aligned_cols=159  Identities=19%  Similarity=0.225  Sum_probs=118.5

Q ss_pred             ecceeeehhHHHHHHHhhhhhhh-hhhcchheeecccCCcc-------------ceeeeecCCCc-cccccchhhccCCC
Q 013682           32 ARGFTLLVTLKAVLQECEQLHLL-ISFLIFIRVLQSSSNLF-------------VYLISDLGNAA-LSGELAPELGQLKN   96 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l~~~-~~~~~~~~~l~~~~n~~-------------~~~~~~l~~n~-l~g~ip~~l~~l~~   96 (438)
                      +++++.|++|+++.|.++.++.. +..+.+++.|++++|.+             .|..+++++|. +++..|..++.+++
T Consensus        96 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~  175 (353)
T 2z80_A           96 FSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTF  175 (353)
T ss_dssp             TTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCE
T ss_pred             cCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCC
Confidence            56778888888888888888877 78888888888877632             36667888774 55544567888888


Q ss_pred             CCeecc-------------ccccCCCEEEccCCcccccCchhh-ccccccceeccccccccCC-----------------
Q 013682           97 LELLAL-------------GNLIKLKSLDLYSNLFNGTIPDTL-ANLKQLKYLRLNNNSLSGL-----------------  145 (438)
Q Consensus        97 L~~l~l-------------~~l~~L~~l~ls~N~l~g~iP~~~-~~l~~L~~l~ls~N~l~g~-----------------  145 (438)
                      |+.|++             +.+++|+.|++++|.++ .+|..+ +.+++|+.|++++|++++.                 
T Consensus       176 L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l  254 (353)
T 2z80_A          176 LEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKF  254 (353)
T ss_dssp             EEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEE
T ss_pred             CCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCccccccccccccccccchhhcc
Confidence            887753             44667888888888885 566543 4578888888888888763                 


Q ss_pred             --------------CchhhccCCCCCeEeccCCCCCCCCCCC--CCCCcccccccccccccCC
Q 013682          146 --------------IPTSLTTITSLNILDLSNNRLSGPVPDN--GSFSQFTPISFENNLNLCG  192 (438)
Q Consensus       146 --------------~P~~l~~~~~L~~l~ls~N~l~g~ip~~--~~~~~~~~~~~~~N~~lcg  192 (438)
                                    +|..+..+++|+.|++++|+++ .+|..  ..++.+..+++.+|+..|.
T Consensus       255 ~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~  316 (353)
T 2z80_A          255 TFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS  316 (353)
T ss_dssp             EEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             ccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCc
Confidence                          4566788899999999999998 55653  4567777888888876654

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.31  E-value=1.2e-12  Score=111.82  Aligned_cols=100  Identities=26%  Similarity=0.283  Sum_probs=80.4

Q ss_pred             ceeeeecCCCccc-cccchhhccCCCCCeecc-----------ccccCCCEEEccCCcccccCchhhccccccceecccc
Q 013682           72 VYLISDLGNAALS-GELAPELGQLKNLELLAL-----------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN  139 (438)
Q Consensus        72 ~~~~~~l~~n~l~-g~ip~~l~~l~~L~~l~l-----------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~  139 (438)
                      .+..+++++|.++ |.+|..++.+++|+.|++           +.+++|++|++++|.+++.+|..++.+++|++|++++
T Consensus        18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~   97 (149)
T 2je0_A           18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSG   97 (149)
T ss_dssp             GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCCTTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTT
T ss_pred             cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCchhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCC
Confidence            4566777777777 677777777777777753           4567889999999999877888888899999999999


Q ss_pred             ccccCC-CchhhccCCCCCeEeccCCCCCCCCC
Q 013682          140 NSLSGL-IPTSLTTITSLNILDLSNNRLSGPVP  171 (438)
Q Consensus       140 N~l~g~-~P~~l~~~~~L~~l~ls~N~l~g~ip  171 (438)
                      |++++. .|..+..+++|+.|++++|.+++..+
T Consensus        98 N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  130 (149)
T 2je0_A           98 NKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND  130 (149)
T ss_dssp             SCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred             CcCCChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence            999863 45788999999999999999887655

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.31  E-value=1.1e-12  Score=135.92  Aligned_cols=137  Identities=21%  Similarity=0.288  Sum_probs=119.4

Q ss_pred             eecceeeehhHHHHHHHhhhhhh---hhhhcchheeecccCCcc-----------ceeeeecCCCccccccchhhccCCC
Q 013682           31 CARGFTLLVTLKAVLQECEQLHL---LISFLIFIRVLQSSSNLF-----------VYLISDLGNAALSGELAPELGQLKN   96 (438)
Q Consensus        31 ~~~~~~~~~~l~~~~~~~~~l~~---~~~~~~~~~~l~~~~n~~-----------~~~~~~l~~n~l~g~ip~~l~~l~~   96 (438)
                      ++++++.|++|+++.|.++.++.   .++.+.+++.|++++|.+           .|..++|++|.+++ +|..+.  ++
T Consensus       356 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~~--~~  432 (549)
T 2z81_A          356 CKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRV-VKTCIP--QT  432 (549)
T ss_dssp             CTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCCCCSCCCCCTTCCEEECTTSCCSC-CCTTSC--TT
T ss_pred             hhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCccCChhhcccccccEEECCCCCccc-ccchhc--CC
Confidence            36788899999999999999874   489999999999998854           47788999999985 666553  57


Q ss_pred             CCeeccc---------cccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCC
Q 013682           97 LELLALG---------NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS  167 (438)
Q Consensus        97 L~~l~l~---------~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~  167 (438)
                      |+.|+++         .+++|++|+|++|+++ .+|+ .+.+++|+.|+|++|++++.+|..+..+++|+.|++++|.++
T Consensus       433 L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  510 (549)
T 2z81_A          433 LEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD  510 (549)
T ss_dssp             CSEEECCSSCCSCCCCCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBC
T ss_pred             ceEEECCCCChhhhcccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCcc
Confidence            8888763         5789999999999998 8997 578999999999999999999999999999999999999999


Q ss_pred             CCCCC
Q 013682          168 GPVPD  172 (438)
Q Consensus       168 g~ip~  172 (438)
                      +..|.
T Consensus       511 ~~~~~  515 (549)
T 2z81_A          511 CSCPR  515 (549)
T ss_dssp             CCHHH
T ss_pred             CCCcc
Confidence            98873

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.31  E-value=1.2e-12  Score=117.33  Aligned_cols=126  Identities=21%  Similarity=0.241  Sum_probs=95.9

Q ss_pred             hHHHHHHHhhhhhhhhhhcchheeecccCCccceeeeecCCCccccccchhhccCCCCCeeccccccCCCEEEccCCccc
Q 013682           40 TLKAVLQECEQLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFN  119 (438)
Q Consensus        40 ~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~~l~~L~~l~ls~N~l~  119 (438)
                      +++.+.+.+.++|..+.  .            .+..++|++|.++ .+|..+..++           +|+.|+|++|.++
T Consensus        14 ~l~~~~~~l~~ip~~~~--~------------~l~~L~L~~n~i~-~ip~~~~~l~-----------~L~~L~Ls~N~i~   67 (193)
T 2wfh_A           14 VVRCSNKGLKVLPKGIP--R------------DVTELYLDGNQFT-LVPKELSNYK-----------HLTLIDLSNNRIS   67 (193)
T ss_dssp             EEECTTSCCSSCCSCCC--T------------TCCEEECCSSCCC-SCCGGGGGCT-----------TCCEEECCSSCCC
T ss_pred             EEEcCCCCCCcCCCCCC--C------------CCCEEECCCCcCc-hhHHHhhccc-----------CCCEEECCCCcCC
Confidence            45566677777775432  1            3456777777776 5786555444           5677899999999


Q ss_pred             ccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCC-CCCCCcccccccccccccC
Q 013682          120 GTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFENNLNLC  191 (438)
Q Consensus       120 g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~-~~~~~~~~~~~~~~N~~lc  191 (438)
                      +..|..|.++++|+.|+|++|++++..|..+..+++|+.|+|++|.+++..+. ...++.+..+.+.+|+..|
T Consensus        68 ~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A           68 TLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC  140 (193)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             EeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence            76677899999999999999999988888899999999999999999965553 3356677778888887665

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.30  E-value=5.6e-12  Score=128.10  Aligned_cols=147  Identities=22%  Similarity=0.190  Sum_probs=112.6

Q ss_pred             eecceeeehhHHHHHHHhh-hhhhhhhhcchh-------------eeecccCCcc--------ceeeeecCCCccccccc
Q 013682           31 CARGFTLLVTLKAVLQECE-QLHLLISFLIFI-------------RVLQSSSNLF--------VYLISDLGNAALSGELA   88 (438)
Q Consensus        31 ~~~~~~~~~~l~~~~~~~~-~l~~~~~~~~~~-------------~~l~~~~n~~--------~~~~~~l~~n~l~g~ip   88 (438)
                      .+++++.|++|+++.|.+. .+|..++.+..+             +.|++++|.+        .+..+++++|.+++ +|
T Consensus        29 ~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~~~~~L~~L~l~~n~l~~-lp  107 (454)
T 1jl5_A           29 EAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPELPPHLESLVASCNSLTE-LP  107 (454)
T ss_dssp             -----CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCSCCTTCSEEECCSSCCSS-CC
T ss_pred             hHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCCCcCCCCEEEccCCcCCc-cc
Confidence            4789999999999999987 789988888876             7788877753        47889999999998 88


Q ss_pred             hhhccCCCCCeecccc--------c-cCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeE
Q 013682           89 PELGQLKNLELLALGN--------L-IKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNIL  159 (438)
Q Consensus        89 ~~l~~l~~L~~l~l~~--------l-~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l  159 (438)
                      ..   +++|+.|+++.        . ++|++|++++|++++ +| +++++++|++|++++|++++ +|..+   .+|+.|
T Consensus       108 ~~---~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L  178 (454)
T 1jl5_A          108 EL---PQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFI  178 (454)
T ss_dssp             CC---CTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEE
T ss_pred             cc---cCCCcEEECCCCccCcccCCCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEE
Confidence            64   36777776532        2 589999999999985 88 59999999999999999986 66543   478888


Q ss_pred             eccCCCCCCCCCCCCCCCccccccccccc
Q 013682          160 DLSNNRLSGPVPDNGSFSQFTPISFENNL  188 (438)
Q Consensus       160 ~ls~N~l~g~ip~~~~~~~~~~~~~~~N~  188 (438)
                      ++++|.+++ +|+...++.+..+.+++|.
T Consensus       179 ~L~~n~l~~-l~~~~~l~~L~~L~l~~N~  206 (454)
T 1jl5_A          179 AAGNNQLEE-LPELQNLPFLTAIYADNNS  206 (454)
T ss_dssp             ECCSSCCSS-CCCCTTCTTCCEEECCSSC
T ss_pred             ECcCCcCCc-CccccCCCCCCEEECCCCc
Confidence            888888887 6665566666666666664

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.30  E-value=7.9e-13  Score=127.78  Aligned_cols=149  Identities=17%  Similarity=0.123  Sum_probs=109.8

Q ss_pred             ceeeehhHHHHHHHhhhhh-hhhhhcchheeecccCCcc----------ceeeeecCCCccccccchhhccCCCCCeecc
Q 013682           34 GFTLLVTLKAVLQECEQLH-LLISFLIFIRVLQSSSNLF----------VYLISDLGNAALSGELAPELGQLKNLELLAL  102 (438)
Q Consensus        34 ~~~~~~~l~~~~~~~~~l~-~~~~~~~~~~~l~~~~n~~----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l  102 (438)
                      .++.|++|+++.|.+..++ ..+..+.+++.|+++.|.+          .|..++|++|.+++ +|    .+++|+.|++
T Consensus        32 ~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~-l~----~~~~L~~L~l  106 (317)
T 3o53_A           32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQE-LL----VGPSIETLHA  106 (317)
T ss_dssp             TGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEEETTCTTCCEEECCSSEEEE-EE----ECTTCCEEEC
T ss_pred             cCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchhhhhcCCCCEEECcCCcccc-cc----CCCCcCEEEC
Confidence            3456778888888888776 4678888888888877754          36677777777775 43    2366666654


Q ss_pred             c----------cccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhc-cCCCCCeEeccCCCCCCCCC
Q 013682          103 G----------NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLT-TITSLNILDLSNNRLSGPVP  171 (438)
Q Consensus       103 ~----------~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~-~~~~L~~l~ls~N~l~g~ip  171 (438)
                      +          .+++|+.|++++|++++..|..++.+++|+.|++++|++++..|..+. .+++|+.|++++|.+++. |
T Consensus       107 ~~n~l~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~  185 (317)
T 3o53_A          107 ANNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K  185 (317)
T ss_dssp             CSSCCSEEEECCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E
T ss_pred             CCCccCCcCccccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c
Confidence            2          356788888888888876677888888999999999998887777764 688899999999988865 4


Q ss_pred             CCCCCCccccccccccc
Q 013682          172 DNGSFSQFTPISFENNL  188 (438)
Q Consensus       172 ~~~~~~~~~~~~~~~N~  188 (438)
                      ....++.+..+++++|.
T Consensus       186 ~~~~l~~L~~L~Ls~N~  202 (317)
T 3o53_A          186 GQVVFAKLKTLDLSSNK  202 (317)
T ss_dssp             CCCCCTTCCEEECCSSC
T ss_pred             cccccccCCEEECCCCc
Confidence            44446666677776664

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.29  E-value=5.4e-13  Score=139.13  Aligned_cols=58  Identities=17%  Similarity=0.088  Sum_probs=38.7

Q ss_pred             ceeeehhHHHHHHHhhhhh--hhhhhcchheeecccCCccc---------e--eeeecCCCcc--ccccchhh
Q 013682           34 GFTLLVTLKAVLQECEQLH--LLISFLIFIRVLQSSSNLFV---------Y--LISDLGNAAL--SGELAPEL   91 (438)
Q Consensus        34 ~~~~~~~l~~~~~~~~~l~--~~~~~~~~~~~l~~~~n~~~---------~--~~~~l~~n~l--~g~ip~~l   91 (438)
                      +++.|++|+++.|.+..++  ..++.+.+++.|+++.|.+.         +  ..++|++|.+  ++..|..+
T Consensus       119 ~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l  191 (562)
T 3a79_B          119 PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESL  191 (562)
T ss_dssp             CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTTGGGTTSCEEEEEEEESSCCCCSSSCCEE
T ss_pred             ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccCchhhhhhceeeEEEeecccccccccCcccc
Confidence            6777888888888888765  67788888888877776532         2  5556666655  44444433

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.29  E-value=1.9e-12  Score=131.36  Aligned_cols=150  Identities=21%  Similarity=0.194  Sum_probs=94.9

Q ss_pred             eehhHHHHHHHhhhh-hhhhhhcchheeecccCCcc------------ceeeeecCCCccccccchhhccCCCCCeec--
Q 013682           37 LLVTLKAVLQECEQL-HLLISFLIFIRVLQSSSNLF------------VYLISDLGNAALSGELAPELGQLKNLELLA--  101 (438)
Q Consensus        37 ~~~~l~~~~~~~~~l-~~~~~~~~~~~~l~~~~n~~------------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~--  101 (438)
                      .+++|+++.|.+..+ +..+..+.+|+.|+++.|.+            .|..++|++|.+++..+..+..+++|+.|+  
T Consensus        76 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  155 (452)
T 3zyi_A           76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLR  155 (452)
T ss_dssp             TCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECC
T ss_pred             CccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECC
Confidence            456666667766666 34466666666666665532            355556666666542223344555555543  


Q ss_pred             ----------------------c--------------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCC
Q 013682          102 ----------------------L--------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGL  145 (438)
Q Consensus       102 ----------------------l--------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~  145 (438)
                                            +              +.+++|+.|+|++|+++ .+| .+..+++|+.|+|++|++++.
T Consensus       156 ~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~  233 (452)
T 3zyi_A          156 NNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEI  233 (452)
T ss_dssp             SCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS-SCC-CCTTCTTCCEEECTTSCCSEE
T ss_pred             CCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccc-ccc-cccccccccEEECcCCcCccc
Confidence                                  2              23456677777777776 444 466777777778888888777


Q ss_pred             CchhhccCCCCCeEeccCCCCCCCCCCC-CCCCccccccccccc
Q 013682          146 IPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNL  188 (438)
Q Consensus       146 ~P~~l~~~~~L~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~N~  188 (438)
                      .|..+..+++|+.|++++|++++..|.. ..++.+..+++++|.
T Consensus       234 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  277 (452)
T 3zyi_A          234 RPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNN  277 (452)
T ss_dssp             CGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             CcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCc
Confidence            7778888888888888888887766643 334556666666664

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.29  E-value=7.9e-13  Score=130.24  Aligned_cols=151  Identities=22%  Similarity=0.218  Sum_probs=106.2

Q ss_pred             hHHHHHHHhhhhhhhhhhcchheeecccCCc-------------cceeeeecCCCccccccchhhccCCCCCeecc----
Q 013682           40 TLKAVLQECEQLHLLISFLIFIRVLQSSSNL-------------FVYLISDLGNAALSGELAPELGQLKNLELLAL----  102 (438)
Q Consensus        40 ~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~-------------~~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l----  102 (438)
                      +++.+.+.+.++|..+..  .++.|+++.|.             ..|..|+|++|++++..|..+..+++|+.|++    
T Consensus        22 ~l~c~~~~l~~iP~~~~~--~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~   99 (361)
T 2xot_A           22 ILSCSKQQLPNVPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNH   99 (361)
T ss_dssp             EEECCSSCCSSCCSSCCT--TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             EEEeCCCCcCccCccCCC--CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCc
Confidence            445555666666665432  34556655543             34677888888888755567888888888864    


Q ss_pred             ---------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhh---ccCCCCCeEeccCCCCCCCC
Q 013682          103 ---------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSL---TTITSLNILDLSNNRLSGPV  170 (438)
Q Consensus       103 ---------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l---~~~~~L~~l~ls~N~l~g~i  170 (438)
                               +.+++|+.|+|++|++++..|..|+++++|+.|+|++|++++..+..+   ..+++|+.|||++|++++..
T Consensus       100 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~  179 (361)
T 2xot_A          100 LHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLP  179 (361)
T ss_dssp             CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCC
T ss_pred             CCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccC
Confidence                     457889999999999997778899999999999999999996544444   57899999999999998644


Q ss_pred             CCC-CCCCc--ccccccccccccCC
Q 013682          171 PDN-GSFSQ--FTPISFENNLNLCG  192 (438)
Q Consensus       171 p~~-~~~~~--~~~~~~~~N~~lcg  192 (438)
                      +.. ..++.  +..+.+.+|+..|.
T Consensus       180 ~~~~~~l~~~~l~~l~l~~N~~~C~  204 (361)
T 2xot_A          180 LTDLQKLPAWVKNGLYLHNNPLECD  204 (361)
T ss_dssp             HHHHHHSCHHHHTTEECCSSCEECC
T ss_pred             HHHhhhccHhhcceEEecCCCccCC
Confidence            321 11121  23456777776653

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.29  E-value=1.8e-12  Score=117.20  Aligned_cols=123  Identities=26%  Similarity=0.263  Sum_probs=90.5

Q ss_pred             eehhHHHHHHHhhhhhhh-hhhcchheeecccCCccceeeeecCCCccccccch-hhccCCCCCeecc------------
Q 013682           37 LLVTLKAVLQECEQLHLL-ISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAP-ELGQLKNLELLAL------------  102 (438)
Q Consensus        37 ~~~~l~~~~~~~~~l~~~-~~~~~~~~~l~~~~n~~~~~~~~l~~n~l~g~ip~-~l~~l~~L~~l~l------------  102 (438)
                      .|++|+++.|.++.++.. ++.+.+            |..++|++|.+++ +|. .+..+++|+.|++            
T Consensus        29 ~l~~L~l~~n~l~~~~~~~~~~l~~------------L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~   95 (208)
T 2o6s_A           29 QTTYLDLETNSLKSLPNGVFDELTS------------LTQLYLGGNKLQS-LPNGVFNKLTSLTYLNLSTNQLQSLPNGV   95 (208)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTT------------CSEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred             CCcEEEcCCCccCcCChhhhccccc------------CcEEECCCCccCc-cChhhcCCCCCcCEEECCCCcCCccCHhH
Confidence            455666666666555543 334444            4455556666664 443 3466777777653            


Q ss_pred             -ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCC
Q 013682          103 -GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD  172 (438)
Q Consensus       103 -~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~  172 (438)
                       +.+++|++|++++|++++..|..++++++|+.|++++|++++..+..+..+++|+.|++++|.+.+..|.
T Consensus        96 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  166 (208)
T 2o6s_A           96 FDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG  166 (208)
T ss_dssp             TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTTT
T ss_pred             hcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCCC
Confidence             4567899999999999965566689999999999999999987777789999999999999999887764

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.28  E-value=2e-12  Score=131.45  Aligned_cols=144  Identities=20%  Similarity=0.218  Sum_probs=84.5

Q ss_pred             ecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc---------ceeeeecCCCccccccchhhccCCCCCeecc
Q 013682           32 ARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF---------VYLISDLGNAALSGELAPELGQLKNLELLAL  102 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~---------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l  102 (438)
                      +.+++.|++|+++.|.++.++  ++.+.+++.|+++.|.+         .|..+++++|.+++ +|  ++.+++|+.|++
T Consensus        81 ~~~l~~L~~L~Ls~N~l~~~~--~~~l~~L~~L~L~~N~l~~l~~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l  155 (457)
T 3bz5_A           81 LSQNTNLTYLACDSNKLTNLD--VTPLTKLTYLNCDTNKLTKLDVSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDC  155 (457)
T ss_dssp             CTTCTTCSEEECCSSCCSCCC--CTTCTTCCEEECCSSCCSCCCCTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEEC
T ss_pred             cccCCCCCEEECcCCCCceee--cCCCCcCCEEECCCCcCCeecCCCCCcCCEEECCCCccce-ec--cccCCcCCEEEC
Confidence            344444444444444444443  44455555555544432         24445555555554 32  455555555542


Q ss_pred             -----------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCC
Q 013682          103 -----------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP  171 (438)
Q Consensus       103 -----------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip  171 (438)
                                 +.+++|+.|++++|++++ +|  ++.+++|+.|++++|++++.   .++.+++|+.|++++|++++ +|
T Consensus       156 ~~n~~~~~~~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip  228 (457)
T 3bz5_A          156 HLNKKITKLDVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID  228 (457)
T ss_dssp             TTCSCCCCCCCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC
T ss_pred             CCCCcccccccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC
Confidence                       234567777777777764 55  66777777777777777754   37777788888888888877 55


Q ss_pred             CCCCCCccccccccccc
Q 013682          172 DNGSFSQFTPISFENNL  188 (438)
Q Consensus       172 ~~~~~~~~~~~~~~~N~  188 (438)
                       ...++.+..+.+++|.
T Consensus       229 -~~~l~~L~~L~l~~N~  244 (457)
T 3bz5_A          229 -VTPLTQLTYFDCSVNP  244 (457)
T ss_dssp             -CTTCTTCSEEECCSSC
T ss_pred             -ccccCCCCEEEeeCCc
Confidence             4455666666666664

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.28  E-value=2.7e-12  Score=137.82  Aligned_cols=100  Identities=25%  Similarity=0.353  Sum_probs=73.9

Q ss_pred             ccceeeeecCCCccccccchhhccCCCCCeecc------------ccccCCCEEEccCCcccccCchhhccccccceecc
Q 013682           70 LFVYLISDLGNAALSGELAPELGQLKNLELLAL------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  137 (438)
Q Consensus        70 ~~~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~l  137 (438)
                      +..|..|+|++|.+. .+|..++.+++|+.|++            +++++|+.|+|++|+|+ .+|.+|++|++|++|+|
T Consensus       223 l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L  300 (727)
T 4b8c_D          223 DQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLTELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYF  300 (727)
T ss_dssp             CCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCSCCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEEC
T ss_pred             CCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCcccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEEC
Confidence            344555666666666 56766667777666653            34667778888888887 78888888888888888


Q ss_pred             ccccccCCCchhhccCCCCCeEeccCCCCCCCCCC
Q 013682          138 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD  172 (438)
Q Consensus       138 s~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~  172 (438)
                      ++|.++ .+|..++.+++|+.|+|++|.|+|.+|.
T Consensus       301 ~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~  334 (727)
T 4b8c_D          301 FDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLK  334 (727)
T ss_dssp             CSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHH
T ss_pred             CCCCCC-ccChhhhcCCCccEEeCCCCccCCCChH
Confidence            888886 6777788888888888888888877775

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.28  E-value=1.2e-12  Score=137.60  Aligned_cols=134  Identities=18%  Similarity=0.157  Sum_probs=76.6

Q ss_pred             Eeeeeecce-----eeehhHHHHHHHhhhhhh-hhhhcchheeecccCCcc------------ceeeeecCCCccccccc
Q 013682           27 CLGICARGF-----TLLVTLKAVLQECEQLHL-LISFLIFIRVLQSSSNLF------------VYLISDLGNAALSGELA   88 (438)
Q Consensus        27 ~~~~~~~~~-----~~~~~l~~~~~~~~~l~~-~~~~~~~~~~l~~~~n~~------------~~~~~~l~~n~l~g~ip   88 (438)
                      |.+..+...     +++++||++.|.++.+|. .|+.+++|+.|++++|.+            .|..|+|++|++++--|
T Consensus        38 c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~  117 (635)
T 4g8a_A           38 CMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLAL  117 (635)
T ss_dssp             CTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECG
T ss_pred             CCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCH
Confidence            555444433     257888888888888874 578888888877776643            24555555555554222


Q ss_pred             hhhccCCCCCeeccccccCCCEEEccCCcccccCchhhccccccceeccccccccC-CCchhhccCCCCCeEeccCCCCC
Q 013682           89 PELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSG-LIPTSLTTITSLNILDLSNNRLS  167 (438)
Q Consensus        89 ~~l~~l~~L~~l~l~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g-~~P~~l~~~~~L~~l~ls~N~l~  167 (438)
                      ..+..|+           +|++|+|++|++++..|..|+++++|++|++++|++++ .+|..++.+++|+.|++++|+++
T Consensus       118 ~~f~~L~-----------~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~  186 (635)
T 4g8a_A          118 GAFSGLS-----------SLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ  186 (635)
T ss_dssp             GGGTTCT-----------TCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred             HHhcCCC-----------CCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccc
Confidence            2344444           45555555555553333345555555555555555543 34555555555555555555555


Q ss_pred             CCCC
Q 013682          168 GPVP  171 (438)
Q Consensus       168 g~ip  171 (438)
                      +..|
T Consensus       187 ~~~~  190 (635)
T 4g8a_A          187 SIYC  190 (635)
T ss_dssp             EECG
T ss_pred             cccc
Confidence            4433

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.27  E-value=3.2e-12  Score=133.29  Aligned_cols=141  Identities=23%  Similarity=0.275  Sum_probs=70.4

Q ss_pred             cceeeehhHHHHHHHhhh-hhhhhhhcchheeecccCCccceeeeecCCCcccc--ccchhhccCCCCCeecc-------
Q 013682           33 RGFTLLVTLKAVLQECEQ-LHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSG--ELAPELGQLKNLELLAL-------  102 (438)
Q Consensus        33 ~~~~~~~~l~~~~~~~~~-l~~~~~~~~~~~~l~~~~n~~~~~~~~l~~n~l~g--~ip~~l~~l~~L~~l~l-------  102 (438)
                      ++++.|++|+++.|.++. .|..++.+.+++.|+++.            |.+++  .+|..++.+++|+.|++       
T Consensus       350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~------------N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~  417 (562)
T 3a79_B          350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQR------------NGLKNFFKVALMTKNMSSLETLDVSLNSLNS  417 (562)
T ss_dssp             SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCS------------SCCCBTTHHHHTTTTCTTCCEEECTTSCCBS
T ss_pred             cCCCCceEEECCCCccccchhhhhcccCCCCEEECCC------------CCcCCcccchhhhcCCCCCCEEECCCCcCCC
Confidence            455566666666665555 444455555555544444            33333  22333444444444432       


Q ss_pred             -------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCC--C
Q 013682          103 -------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD--N  173 (438)
Q Consensus       103 -------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~--~  173 (438)
                             ..+++|+.|++++|++++.+|..+.  ++|+.|++++|+++ .+|..+..+++|+.|++++|++++ +|.  .
T Consensus       418 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~  493 (562)
T 3a79_B          418 HAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVF  493 (562)
T ss_dssp             CCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC-CCTTST
T ss_pred             ccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC-CCHHHH
Confidence                   1234455555555555555554443  45555566666555 455555555566666666666553 333  2


Q ss_pred             CCCCcccccccccccc
Q 013682          174 GSFSQFTPISFENNLN  189 (438)
Q Consensus       174 ~~~~~~~~~~~~~N~~  189 (438)
                      ..++.+..+++++|+.
T Consensus       494 ~~l~~L~~L~l~~N~~  509 (562)
T 3a79_B          494 DRLTSLQYIWLHDNPW  509 (562)
T ss_dssp             TTCTTCCCEECCSCCB
T ss_pred             hcCCCCCEEEecCCCc
Confidence            2334444445555543

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.26  E-value=3.1e-12  Score=136.26  Aligned_cols=158  Identities=21%  Similarity=0.227  Sum_probs=126.4

Q ss_pred             eecceeeehhHHHHHHHhhhhhhh-hhhcchheeecccCCc----------------cceeeeecCCCccccccchhhcc
Q 013682           31 CARGFTLLVTLKAVLQECEQLHLL-ISFLIFIRVLQSSSNL----------------FVYLISDLGNAALSGELAPELGQ   93 (438)
Q Consensus        31 ~~~~~~~~~~l~~~~~~~~~l~~~-~~~~~~~~~l~~~~n~----------------~~~~~~~l~~n~l~g~ip~~l~~   93 (438)
                      .+++++.|++|+++.|.+..++.. +..+.+++.|+++.|.                ..+..+++++|.+++..|..+..
T Consensus       324 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~  403 (680)
T 1ziw_A          324 SFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSW  403 (680)
T ss_dssp             TTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTT
T ss_pred             hcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhC
Confidence            345677888888888888877544 7888999999988874                25778899999999988888999


Q ss_pred             CCCCCeecc--------------ccccCCCEEEccCCcccccCchhhccccccceecccccccc--CCCchhhccCCCCC
Q 013682           94 LKNLELLAL--------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLS--GLIPTSLTTITSLN  157 (438)
Q Consensus        94 l~~L~~l~l--------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~--g~~P~~l~~~~~L~  157 (438)
                      +++|+.|++              +.+++|++|++++|++.+..|..|+.+++|+.|++++|.++  +.+|..+..+++|+
T Consensus       404 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~  483 (680)
T 1ziw_A          404 LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT  483 (680)
T ss_dssp             CTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCC
T ss_pred             CCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCC
Confidence            999998864              34678899999999998777888888888888888888887  56788888888899


Q ss_pred             eEeccCCCCCCCCCCC-CCCCccccccccccc
Q 013682          158 ILDLSNNRLSGPVPDN-GSFSQFTPISFENNL  188 (438)
Q Consensus       158 ~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~N~  188 (438)
                      .|++++|++++.+|.. ..++.+..+++++|.
T Consensus       484 ~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~  515 (680)
T 1ziw_A          484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNN  515 (680)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEECCCCCCCcCChhhhccccccCEEeCCCCC
Confidence            9999999888766642 345666667776664

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.26  E-value=1.5e-11  Score=115.11  Aligned_cols=142  Identities=12%  Similarity=0.033  Sum_probs=108.4

Q ss_pred             HHhCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCC-CCCceeeEEEEeeCCeeEEE
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv  361 (438)
                      ...++|......+.|+++.||+.... ++.+++|..+.... .....+.+|+.+++.+. |..+.++++++...+..++|
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            34467777777888888999999854 67899999864321 22236889999998874 67788899999888899999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC----------------------------------  407 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------  407 (438)
                      |||++|.++.+.+..         ......++.+++++++.||+..                                  
T Consensus        89 ~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           89 MSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             EEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            999999998776321         1223477889999999999810                                  


Q ss_pred             ----------------------CCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          408 ----------------------DPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       408 ----------------------~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                                            .+.++|+|++|.|||++++....+.||-
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe  209 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLG  209 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCT
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEch
Confidence                                  1458999999999999876555688875

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.26  E-value=2.4e-12  Score=140.78  Aligned_cols=85  Identities=21%  Similarity=0.297  Sum_probs=56.4

Q ss_pred             cccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCC-CCCCCccccc
Q 013682          104 NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPI  182 (438)
Q Consensus       104 ~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~-~~~~~~~~~~  182 (438)
                      .+++|+.|+|++|++++..|..|+.+++|+.|+|++|++++..|..+..+++|+.|++++|.+++..|. ...++.+..+
T Consensus       288 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  367 (844)
T 3j0a_A          288 TLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTL  367 (844)
T ss_dssp             SCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEE
T ss_pred             cCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEE
Confidence            355666777777777666666677777777777777777766677777777777777777777655543 2334556666


Q ss_pred             cccccc
Q 013682          183 SFENNL  188 (438)
Q Consensus       183 ~~~~N~  188 (438)
                      .+++|.
T Consensus       368 ~Ls~N~  373 (844)
T 3j0a_A          368 DLRDNA  373 (844)
T ss_dssp             EEETCC
T ss_pred             ECCCCC
Confidence            666664

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.26  E-value=9.2e-13  Score=141.50  Aligned_cols=122  Identities=26%  Similarity=0.298  Sum_probs=96.7

Q ss_pred             hhhhhhhcchheeecccCCcc-----------ceeeeecCCCccccccchhhccCCCCCeecc------------ccccC
Q 013682           51 LHLLISFLIFIRVLQSSSNLF-----------VYLISDLGNAALSGELAPELGQLKNLELLAL------------GNLIK  107 (438)
Q Consensus        51 l~~~~~~~~~~~~l~~~~n~~-----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l------------~~l~~  107 (438)
                      .+..+..+..|+.|+++.|.+           .|..|+|++|.++ .+|..++.|++|+.|++            +++++
T Consensus       216 ~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~  294 (727)
T 4b8c_D          216 PKDSKYDDQLWHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQ  294 (727)
T ss_dssp             ------CCCCCCEEECTTSCCSCCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTT
T ss_pred             ChhhhccCCCCcEEECCCCCCCCCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCC
Confidence            345566777777777776643           3667788888888 79999999999998864            45788


Q ss_pred             CCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCC-CCeEeccCCCCCCCCCCCC
Q 013682          108 LKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITS-LNILDLSNNRLSGPVPDNG  174 (438)
Q Consensus       108 L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~-L~~l~ls~N~l~g~ip~~~  174 (438)
                      |+.|+|++|.|+ .+|.+|+++++|+.|+|++|+++|.+|..+..+.. +..++|++|.++|.+|...
T Consensus       295 L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l  361 (727)
T 4b8c_D          295 LKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHER  361 (727)
T ss_dssp             CSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-
T ss_pred             CCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcccc
Confidence            999999999997 99999999999999999999999999998876543 2347899999999999753

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.25  E-value=4e-12  Score=133.48  Aligned_cols=134  Identities=24%  Similarity=0.258  Sum_probs=117.9

Q ss_pred             eecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc----------ceeeeecCCCccccccchhhccCCCCCee
Q 013682           31 CARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF----------VYLISDLGNAALSGELAPELGQLKNLELL  100 (438)
Q Consensus        31 ~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l  100 (438)
                      .+++++.|+.|+++.|.+..++. +..+.+|+.|+++.|.+          .|..|+|++|.+++ + +.+..|++|+.|
T Consensus        60 ~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~l~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L  136 (605)
T 1m9s_A           60 GIQYLPNVTKLFLNGNKLTDIKP-LTNLKNLGWLFLDENKIKDLSSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESL  136 (605)
T ss_dssp             TGGGCTTCCEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCCCCTTSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEE
T ss_pred             HHccCCCCCEEEeeCCCCCCChh-hccCCCCCEEECcCCCCCCChhhccCCCCCEEEecCCCCCC-C-ccccCCCccCEE
Confidence            36788999999999999999998 89999999999988864          48889999999997 4 469999999999


Q ss_pred             cc-----------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCC
Q 013682          101 AL-----------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGP  169 (438)
Q Consensus       101 ~l-----------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~  169 (438)
                      ++           +.+++|+.|+|++|.+++..|  ++.+++|+.|+|++|++++. | .+..+++|+.|+|++|.+++.
T Consensus       137 ~Ls~N~l~~l~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~L~~N~l~~~  212 (605)
T 1m9s_A          137 YLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNK  212 (605)
T ss_dssp             ECCSSCCCCCGGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEECCSEEEECC
T ss_pred             ECCCCccCCchhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEccCCcCcCC
Confidence            75           457899999999999996555  99999999999999999964 4 699999999999999999875


Q ss_pred             CC
Q 013682          170 VP  171 (438)
Q Consensus       170 ip  171 (438)
                      ..
T Consensus       213 p~  214 (605)
T 1m9s_A          213 PI  214 (605)
T ss_dssp             CC
T ss_pred             cc
Confidence            43

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.24  E-value=4.5e-12  Score=129.05  Aligned_cols=148  Identities=27%  Similarity=0.336  Sum_probs=89.2

Q ss_pred             ecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc----------ceeeeecCCCccccccchhhccCCCCCeec
Q 013682           32 ARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF----------VYLISDLGNAALSGELAPELGQLKNLELLA  101 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~  101 (438)
                      +.+++.|++|+++.|.+..++. ++.+.+++.|++++|.+          .|..+++++|.+++..|  +..+++|+.|+
T Consensus       195 l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~  271 (466)
T 1o6v_A          195 LAKLTNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELK  271 (466)
T ss_dssp             GGGCTTCSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEE
T ss_pred             hccCCCCCEEEecCCccccccc-ccccCCCCEEECCCCCcccchhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEE
Confidence            4566677777777777766655 56667777777666543          36666777777766333  66666666665


Q ss_pred             c-----------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCC
Q 013682          102 L-----------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV  170 (438)
Q Consensus       102 l-----------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~i  170 (438)
                      +           +.+++|+.|++++|++++ +|+ ++.+++|+.|++++|++++..|  +..+++|+.|++++|.+++. 
T Consensus       272 l~~n~l~~~~~~~~l~~L~~L~L~~n~l~~-~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-  346 (466)
T 1o6v_A          272 LGANQISNISPLAGLTALTNLELNENQLED-ISP-ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV-  346 (466)
T ss_dssp             CCSSCCCCCGGGTTCTTCSEEECCSSCCSC-CGG-GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-
T ss_pred             CCCCccCccccccCCCccCeEEcCCCcccC-chh-hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc-
Confidence            3           235566666666666663 332 5666666666666666665544  55666666666666666653 


Q ss_pred             CCCCCCCcccccccccc
Q 013682          171 PDNGSFSQFTPISFENN  187 (438)
Q Consensus       171 p~~~~~~~~~~~~~~~N  187 (438)
                      |....++.+..+++.+|
T Consensus       347 ~~l~~l~~L~~L~l~~n  363 (466)
T 1o6v_A          347 SSLANLTNINWLSAGHN  363 (466)
T ss_dssp             GGGTTCTTCCEEECCSS
T ss_pred             hhhccCCCCCEEeCCCC
Confidence            33334444444555444

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.24  E-value=2.8e-12  Score=122.52  Aligned_cols=131  Identities=24%  Similarity=0.252  Sum_probs=115.1

Q ss_pred             ecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc----------ceeeeecCCCccccccchhhccCCCCCeec
Q 013682           32 ARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF----------VYLISDLGNAALSGELAPELGQLKNLELLA  101 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~  101 (438)
                      ++.++.|++|+++.|.++.++. ++.+.+++.|+++.|.+          .|..++|++|.+++ + +.+..+++|+.|+
T Consensus        64 ~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~  140 (291)
T 1h6t_A           64 IQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLY  140 (291)
T ss_dssp             GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCGGGGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEE
T ss_pred             HhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCCChhhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEE
Confidence            5678899999999999999998 99999999999988764          48889999999997 4 5789999999997


Q ss_pred             c-----------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCC
Q 013682          102 L-----------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGP  169 (438)
Q Consensus       102 l-----------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~  169 (438)
                      +           +.+++|+.|++++|.+++ +|+ ++.+++|+.|++++|++++ +| .+..+++|+.|++++|.++..
T Consensus       141 l~~n~l~~~~~l~~l~~L~~L~L~~N~l~~-~~~-l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~~  215 (291)
T 1h6t_A          141 LGNNKITDITVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNK  215 (291)
T ss_dssp             CCSSCCCCCGGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEECC
T ss_pred             ccCCcCCcchhhccCCCCCEEEccCCcccc-chh-hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccCC
Confidence            5           457899999999999985 454 9999999999999999986 45 499999999999999998863

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.24  E-value=3.3e-13  Score=133.99  Aligned_cols=136  Identities=21%  Similarity=0.173  Sum_probs=78.0

Q ss_pred             cceeeehhHHHHHHHhhh-----hhhhhhhcchheeecccCCcc-------------------------ceeeeecCCCc
Q 013682           33 RGFTLLVTLKAVLQECEQ-----LHLLISFLIFIRVLQSSSNLF-------------------------VYLISDLGNAA   82 (438)
Q Consensus        33 ~~~~~~~~l~~~~~~~~~-----l~~~~~~~~~~~~l~~~~n~~-------------------------~~~~~~l~~n~   82 (438)
                      .+++.|++|+++.|.+..     ++..+..+++++.|+++.|.+                         .|..++|++|.
T Consensus        91 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~  170 (386)
T 2ca6_A           91 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR  170 (386)
T ss_dssp             TTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSC
T ss_pred             hhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCC
Confidence            345555566666665555     555566666666666665532                         45556666666


Q ss_pred             cc-cccc---hhhccCCCCCeecc------------------ccccCCCEEEccCCccc----ccCchhhccccccceec
Q 013682           83 LS-GELA---PELGQLKNLELLAL------------------GNLIKLKSLDLYSNLFN----GTIPDTLANLKQLKYLR  136 (438)
Q Consensus        83 l~-g~ip---~~l~~l~~L~~l~l------------------~~l~~L~~l~ls~N~l~----g~iP~~~~~l~~L~~l~  136 (438)
                      ++ +.+|   ..+..+++|+.|++                  ..+++|+.|+|++|.++    +.+|..+..+++|+.|+
T Consensus       171 l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~  250 (386)
T 2ca6_A          171 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELG  250 (386)
T ss_dssp             CTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEE
T ss_pred             CCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEE
Confidence            65 3344   34555566665543                  13445666666666664    45566666666666666


Q ss_pred             cccccccCC----Cchhhcc--CCCCCeEeccCCCCCC
Q 013682          137 LNNNSLSGL----IPTSLTT--ITSLNILDLSNNRLSG  168 (438)
Q Consensus       137 ls~N~l~g~----~P~~l~~--~~~L~~l~ls~N~l~g  168 (438)
                      |++|++++.    +|..+..  +++|+.|++++|.+++
T Consensus       251 L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~  288 (386)
T 2ca6_A          251 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL  288 (386)
T ss_dssp             CTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred             CCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCH
Confidence            666666544    4445532  6666666666666665

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.24  E-value=2.1e-12  Score=112.64  Aligned_cols=126  Identities=19%  Similarity=0.157  Sum_probs=95.5

Q ss_pred             ecceeeehhHHHHHHHhh--hhhhhhhhcchheeecccCCcc----------ceeeeecCCCccccccchhhccCCCCCe
Q 013682           32 ARGFTLLVTLKAVLQECE--QLHLLISFLIFIRVLQSSSNLF----------VYLISDLGNAALSGELAPELGQLKNLEL   99 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~--~l~~~~~~~~~~~~l~~~~n~~----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~   99 (438)
                      ....+.|++|+++.|.+.  .+|..+..+.+++.|+++.|.+          .|..++|++|.+++.+|..+..      
T Consensus        20 ~~~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~------   93 (168)
T 2ell_A           20 NRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPKLPKLKKLELSENRIFGGLDMLAEK------   93 (168)
T ss_dssp             TSCTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCCSSCCCCSSCCEEEEESCCCCSCCCHHHHH------
T ss_pred             cCCcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCChhhhccCCCCCEEECcCCcCchHHHHHHhh------
Confidence            344566778888888887  7887777777777777666643          3555566666666554444433      


Q ss_pred             eccccccCCCEEEccCCcccccCc--hhhccccccceeccccccccCCCc---hhhccCCCCCeEeccCCCCCCC
Q 013682          100 LALGNLIKLKSLDLYSNLFNGTIP--DTLANLKQLKYLRLNNNSLSGLIP---TSLTTITSLNILDLSNNRLSGP  169 (438)
Q Consensus       100 l~l~~l~~L~~l~ls~N~l~g~iP--~~~~~l~~L~~l~ls~N~l~g~~P---~~l~~~~~L~~l~ls~N~l~g~  169 (438)
                           +++|+.|++++|.++ .+|  ..++.+++|+.|++++|++++..+   ..+..+++|+.|++++|.++..
T Consensus        94 -----l~~L~~L~Ls~N~l~-~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~  162 (168)
T 2ell_A           94 -----LPNLTHLNLSGNKLK-DISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEA  162 (168)
T ss_dssp             -----CTTCCEEECBSSSCC-SSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred             -----CCCCCEEeccCCccC-cchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhc
Confidence                 456788999999998 555  789999999999999999997755   4899999999999999987643

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.23  E-value=6.2e-13  Score=113.66  Aligned_cols=123  Identities=20%  Similarity=0.147  Sum_probs=93.3

Q ss_pred             eeecceeeehhHHHHHHHhh--hhhhhhhhcchheeecccCCcc----------ceeeeecCCCccccccchhhccCCCC
Q 013682           30 ICARGFTLLVTLKAVLQECE--QLHLLISFLIFIRVLQSSSNLF----------VYLISDLGNAALSGELAPELGQLKNL   97 (438)
Q Consensus        30 ~~~~~~~~~~~l~~~~~~~~--~l~~~~~~~~~~~~l~~~~n~~----------~~~~~~l~~n~l~g~ip~~l~~l~~L   97 (438)
                      +....++.|++|+++.|.+.  .+|..+..+.+++.|+++.|.+          .|..++|++|.+++.+|..++.    
T Consensus        11 ~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~----   86 (149)
T 2je0_A           11 LRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPKLNKLKKLELSDNRVSGGLEVLAEK----   86 (149)
T ss_dssp             HTTCCGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCCTTCCCCTTCCEEECCSSCCCSCTHHHHHH----
T ss_pred             HhcCCCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCchhhhcCCCCCEEECCCCcccchHHHHhhh----
Confidence            33445677778888888887  7887777777777777766543          3555666666666655554443    


Q ss_pred             CeeccccccCCCEEEccCCccccc-CchhhccccccceeccccccccCCCc---hhhccCCCCCeEeccC
Q 013682           98 ELLALGNLIKLKSLDLYSNLFNGT-IPDTLANLKQLKYLRLNNNSLSGLIP---TSLTTITSLNILDLSN  163 (438)
Q Consensus        98 ~~l~l~~l~~L~~l~ls~N~l~g~-iP~~~~~l~~L~~l~ls~N~l~g~~P---~~l~~~~~L~~l~ls~  163 (438)
                             +++|++|++++|.+++. .|..++.+++|+.|++++|++++..+   ..+..+++|+.||+++
T Consensus        87 -------l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           87 -------CPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             -------CTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             -------CCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence                   45678899999999852 45899999999999999999998766   5799999999999874

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.23  E-value=1e-11  Score=111.45  Aligned_cols=117  Identities=17%  Similarity=0.243  Sum_probs=98.9

Q ss_pred             ccceeeeecCCCccccccchhhccCCCCCeecc-----------ccccCCCEEEccCCcccccCchhhccccccceeccc
Q 013682           70 LFVYLISDLGNAALSGELAPELGQLKNLELLAL-----------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  138 (438)
Q Consensus        70 ~~~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l-----------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls  138 (438)
                      ...+..+++++|.++ .+| .+..+++|+.|++           +.+++|++|++++|.+++..|..++.+++|+.|+++
T Consensus        43 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls  120 (197)
T 4ezg_A           43 MNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS  120 (197)
T ss_dssp             HHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSCCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred             cCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCcchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence            345667788888887 578 7889999998864           557899999999999998899999999999999999


Q ss_pred             cccccCCCchhhccCCCCCeEeccCCCCCCCCCCCCCCCccccccccccc
Q 013682          139 NNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL  188 (438)
Q Consensus       139 ~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~N~  188 (438)
                      +|++++..|..++.+++|+.|++++|.+.+.+|....++.+..+.+++|.
T Consensus       121 ~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~~n~  170 (197)
T 4ezg_A          121 HSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDG  170 (197)
T ss_dssp             SSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECTTBC
T ss_pred             CCccCcHhHHHHhhCCCCCEEEccCCCCccccHhhcCCCCCCEEECCCCC
Confidence            99999988999999999999999999855566765566677777777764

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.23  E-value=2.5e-12  Score=133.84  Aligned_cols=137  Identities=20%  Similarity=0.256  Sum_probs=68.9

Q ss_pred             eeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc--------ceeeeecCCCccccccchhhccCCCCCeecccc---
Q 013682           36 TLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF--------VYLISDLGNAALSGELAPELGQLKNLELLALGN---  104 (438)
Q Consensus        36 ~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~--------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~~---  104 (438)
                      +.|++|+++.|.++.+|   +.+.+++.|++++|.+        .|..++|++|.+++ +|.   .+++|+.|++++   
T Consensus        80 ~~L~~L~Ls~N~l~~ip---~~l~~L~~L~Ls~N~l~~ip~l~~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l  152 (571)
T 3cvr_A           80 PQITVLEITQNALISLP---ELPASLEYLDACDNRLSTLPELPASLKHLDVDNNQLTM-LPE---LPALLEYINADNNQL  152 (571)
T ss_dssp             TTCSEEECCSSCCSCCC---CCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCC
T ss_pred             CCCCEEECcCCCCcccc---cccCCCCEEEccCCCCCCcchhhcCCCEEECCCCcCCC-CCC---cCccccEEeCCCCcc
Confidence            34555555555555555   3455555666555543        34555666666655 555   455555555422   


Q ss_pred             ------ccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCC-------CeEeccCCCCCCCCC
Q 013682          105 ------LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSL-------NILDLSNNRLSGPVP  171 (438)
Q Consensus       105 ------l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L-------~~l~ls~N~l~g~ip  171 (438)
                            +++|+.|+|++|++++ +|. |+  ++|+.|+|++|+++ .+|. +..  +|       +.|+|++|.++. +|
T Consensus       153 ~~lp~~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~-lp  223 (571)
T 3cvr_A          153 TMLPELPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRITH-IP  223 (571)
T ss_dssp             SCCCCCCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCCC-CC
T ss_pred             CcCCCcCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCccee-cC
Confidence                  2355556666665553 555 44  55555555555555 4444 332  44       555555555553 33


Q ss_pred             C-CCCCCccccccccccc
Q 013682          172 D-NGSFSQFTPISFENNL  188 (438)
Q Consensus       172 ~-~~~~~~~~~~~~~~N~  188 (438)
                      . ...++.+..+++.+|+
T Consensus       224 ~~l~~l~~L~~L~L~~N~  241 (571)
T 3cvr_A          224 ENILSLDPTCTIILEDNP  241 (571)
T ss_dssp             GGGGGSCTTEEEECCSSS
T ss_pred             HHHhcCCCCCEEEeeCCc
Confidence            2 2223344444444443

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.22  E-value=8.4e-12  Score=127.04  Aligned_cols=150  Identities=27%  Similarity=0.343  Sum_probs=126.8

Q ss_pred             eecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc----------ceeeeecCCCccccccchhhccCCCCCee
Q 013682           31 CARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF----------VYLISDLGNAALSGELAPELGQLKNLELL  100 (438)
Q Consensus        31 ~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l  100 (438)
                      .+.+++.|++|+++.|.+..++. +..+.+++.|+++.|.+          .|..+++++|.+++ + +.+..+++|+.|
T Consensus       172 ~~~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L  248 (466)
T 1o6v_A          172 PLANLTTLERLDISSNKVSDISV-LAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD-I-GTLASLTNLTDL  248 (466)
T ss_dssp             GGTTCTTCCEEECCSSCCCCCGG-GGGCTTCSEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEE
T ss_pred             hhccCCCCCEEECcCCcCCCChh-hccCCCCCEEEecCCcccccccccccCCCCEEECCCCCccc-c-hhhhcCCCCCEE
Confidence            37788999999999999999865 78899999999988754          47889999999987 4 468899999998


Q ss_pred             cc-----------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCC
Q 013682          101 AL-----------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGP  169 (438)
Q Consensus       101 ~l-----------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~  169 (438)
                      ++           +.+++|+.|++++|.+++ +|+ ++.+++|+.|++++|++++..|  +..+++|+.|++++|.+++.
T Consensus       249 ~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~  324 (466)
T 1o6v_A          249 DLANNQISNLAPLSGLTKLTELKLGANQISN-ISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDI  324 (466)
T ss_dssp             ECCSSCCCCCGGGTTCTTCSEEECCSSCCCC-CGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCC
T ss_pred             ECCCCccccchhhhcCCCCCEEECCCCccCc-ccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCc
Confidence            75           457889999999999985 555 8999999999999999997654  88999999999999999998


Q ss_pred             CCCCCCCCccccccccccc
Q 013682          170 VPDNGSFSQFTPISFENNL  188 (438)
Q Consensus       170 ip~~~~~~~~~~~~~~~N~  188 (438)
                      .| ...++.+..+.+.+|.
T Consensus       325 ~~-~~~l~~L~~L~l~~n~  342 (466)
T 1o6v_A          325 SP-VSSLTKLQRLFFYNNK  342 (466)
T ss_dssp             GG-GGGCTTCCEEECCSSC
T ss_pred             hh-hccCccCCEeECCCCc
Confidence            77 4456677777777774

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.22  E-value=3.5e-12  Score=120.05  Aligned_cols=131  Identities=20%  Similarity=0.229  Sum_probs=107.8

Q ss_pred             ecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc----------ceeeeecCCCccccccchhhccCCCCCeec
Q 013682           32 ARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF----------VYLISDLGNAALSGELAPELGQLKNLELLA  101 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~  101 (438)
                      ..+++.|++|+++.|.+++++ .+..+.+++.|++++|.+          .|..++|++|.+++ +|....  ++|+.|+
T Consensus        37 ~~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~L~~N~i~~~~~l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~  112 (263)
T 1xeu_A           37 QKELSGVQNFNGDNSNIQSLA-GMQFFTNLKELHLSHNQISDLSPLKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLF  112 (263)
T ss_dssp             HHHHTTCSEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGGGTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEE
T ss_pred             hhhcCcCcEEECcCCCcccch-HHhhCCCCCEEECCCCccCCChhhccCCCCCEEECCCCccCC-cCcccc--CcccEEE
Confidence            456777888888888888888 677888888888887754          37778888888886 664333  7787775


Q ss_pred             c-----------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCC
Q 013682          102 L-----------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV  170 (438)
Q Consensus       102 l-----------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~i  170 (438)
                      +           +.+++|+.|++++|+++ .+| .++.+++|+.|++++|++++.  ..+..+++|+.|++++|.+++..
T Consensus       113 L~~N~l~~~~~l~~l~~L~~L~Ls~N~i~-~~~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~~  188 (263)
T 1xeu_A          113 LDNNELRDTDSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNEP  188 (263)
T ss_dssp             CCSSCCSBSGGGTTCTTCCEEECTTSCCC-BCG-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECCC
T ss_pred             ccCCccCCChhhcCcccccEEECCCCcCC-CCh-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCCc
Confidence            4           46788999999999998 456 799999999999999999976  67999999999999999998763

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.21  E-value=3.8e-11  Score=105.21  Aligned_cols=89  Identities=22%  Similarity=0.228  Sum_probs=56.1

Q ss_pred             ceeeeecCCCccccccchhhccCCCCCeeccccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhc
Q 013682           72 VYLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLT  151 (438)
Q Consensus        72 ~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~  151 (438)
                      .+..++|++|.+++..|..+..++           +|++|+|++|++++..|..|+.+++|+.|+|++|++++..|..+.
T Consensus        31 ~l~~L~L~~N~i~~~~~~~~~~l~-----------~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~   99 (170)
T 3g39_A           31 TTQVLYLYDNQITKLEPGVFDRLT-----------QLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFD   99 (170)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCT-----------TCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred             CCcEEEcCCCcCCccChhhhcCcc-----------cCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhc
Confidence            345566666666664444443333           455567777777644444556777777777777777765555677


Q ss_pred             cCCCCCeEeccCCCCCCCCC
Q 013682          152 TITSLNILDLSNNRLSGPVP  171 (438)
Q Consensus       152 ~~~~L~~l~ls~N~l~g~ip  171 (438)
                      .+++|+.|++++|.+++..+
T Consensus       100 ~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A          100 NLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             TCTTCCEEECCSSCBCTTBG
T ss_pred             CCCCCCEEEeCCCCCCCCch
Confidence            77777777777777766554

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.21  E-value=3.2e-11  Score=106.12  Aligned_cols=107  Identities=21%  Similarity=0.207  Sum_probs=58.2

Q ss_pred             ceeeeecCCCccccccchhhccCCCCCeeccccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhc
Q 013682           72 VYLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLT  151 (438)
Q Consensus        72 ~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~  151 (438)
                      .+..+++++|.+++..|..+..+++           |++|++++|++++..|..++.+++|+.|++++|++++..|..+.
T Consensus        29 ~l~~L~l~~n~l~~~~~~~~~~l~~-----------L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~   97 (177)
T 2o6r_A           29 SATRLELESNKLQSLPHGVFDKLTQ-----------LTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFD   97 (177)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTT-----------CSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred             CCcEEEeCCCcccEeCHHHhcCccc-----------ccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhh
Confidence            3566777778777533333455554           45555666666533333455566666666666666655444555


Q ss_pred             cCCCCCeEeccCCCCCCCCCCC-CCCCcccccccccccc
Q 013682          152 TITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNLN  189 (438)
Q Consensus       152 ~~~~L~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~N~~  189 (438)
                      .+++|+.|++++|++++.++.. ..++.+..+.+.+|+.
T Consensus        98 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~  136 (177)
T 2o6r_A           98 KLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW  136 (177)
T ss_dssp             TCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred             CCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCe
Confidence            5666666666666665443332 2344445555555543

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.21  E-value=4.2e-11  Score=105.36  Aligned_cols=83  Identities=25%  Similarity=0.288  Sum_probs=50.8

Q ss_pred             CCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCC-CCCCCcccccccc
Q 013682          107 KLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFE  185 (438)
Q Consensus       107 ~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~-~~~~~~~~~~~~~  185 (438)
                      +|+.|+|++|++++..|..|+++++|++|+|++|++++..|..+..+++|+.|+|++|++++.+|. ...++.+..+.+.
T Consensus        34 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~  113 (174)
T 2r9u_A           34 DKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLY  113 (174)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECC
T ss_pred             CCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeC
Confidence            455666666666655566666666666666666666655444456666666666666666654443 3344555555666


Q ss_pred             cccc
Q 013682          186 NNLN  189 (438)
Q Consensus       186 ~N~~  189 (438)
                      +|+.
T Consensus       114 ~N~~  117 (174)
T 2r9u_A          114 NNPW  117 (174)
T ss_dssp             SSCB
T ss_pred             CCCc
Confidence            6653

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.20  E-value=2.6e-12  Score=133.78  Aligned_cols=128  Identities=21%  Similarity=0.279  Sum_probs=110.5

Q ss_pred             cceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCccc--------eeeeecCCCccccccchhhccCCCCCeecccc
Q 013682           33 RGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFV--------YLISDLGNAALSGELAPELGQLKNLELLALGN  104 (438)
Q Consensus        33 ~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~~--------~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~~  104 (438)
                      +.++.|++|+++.|.++.+|. +..  +++.|++++|.++        |..++|++|.+++ +|.   .+++|+.|++++
T Consensus        97 ~~l~~L~~L~Ls~N~l~~ip~-l~~--~L~~L~Ls~N~l~~lp~~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~  169 (571)
T 3cvr_A           97 ELPASLEYLDACDNRLSTLPE-LPA--SLKHLDVDNNQLTMLPELPALLEYINADNNQLTM-LPE---LPTSLEVLSVRN  169 (571)
T ss_dssp             CCCTTCCEEECCSSCCSCCCC-CCT--TCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCS
T ss_pred             cccCCCCEEEccCCCCCCcch-hhc--CCCEEECCCCcCCCCCCcCccccEEeCCCCccCc-CCC---cCCCcCEEECCC
Confidence            567889999999999999999 655  8999999998764        7889999999998 887   678899887643


Q ss_pred             c---------cCCCEEEccCCcccccCchhhcccccc-------ceeccccccccCCCchhhccCCCCCeEeccCCCCCC
Q 013682          105 L---------IKLKSLDLYSNLFNGTIPDTLANLKQL-------KYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG  168 (438)
Q Consensus       105 l---------~~L~~l~ls~N~l~g~iP~~~~~l~~L-------~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g  168 (438)
                      .         ++|+.|+|++|+|+ .+|. +..  +|       +.|+|++|+++ .+|..+..+++|+.|++++|.++|
T Consensus       170 N~L~~lp~l~~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~  244 (571)
T 3cvr_A          170 NQLTFLPELPESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSS  244 (571)
T ss_dssp             SCCSCCCCCCTTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCH
T ss_pred             CCCCCcchhhCCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCC
Confidence            2         48999999999998 8998 765  77       99999999999 689999999999999999999999


Q ss_pred             CCCC
Q 013682          169 PVPD  172 (438)
Q Consensus       169 ~ip~  172 (438)
                      .+|.
T Consensus       245 ~~p~  248 (571)
T 3cvr_A          245 RIRE  248 (571)
T ss_dssp             HHHH
T ss_pred             cCHH
Confidence            8885

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.18  E-value=4.1e-11  Score=117.92  Aligned_cols=116  Identities=25%  Similarity=0.231  Sum_probs=94.7

Q ss_pred             eeeeecCCCccccccchhhc-cCCCCCeecc-------------ccccCCCEEEccCCcccccCchhhccccccceeccc
Q 013682           73 YLISDLGNAALSGELAPELG-QLKNLELLAL-------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  138 (438)
Q Consensus        73 ~~~~~l~~n~l~g~ip~~l~-~l~~L~~l~l-------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls  138 (438)
                      +..|+|++|++++..+..+. .+++|+.|++             +.+++|+.|+|++|++++..|..|.++++|+.|+|+
T Consensus        41 l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  120 (361)
T 2xot_A           41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY  120 (361)
T ss_dssp             CSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECC
Confidence            67899999999985555555 8999999864             457889999999999996666689999999999999


Q ss_pred             cccccCCCchhhccCCCCCeEeccCCCCCCCCCCC----CCCCccccccccccc
Q 013682          139 NNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN----GSFSQFTPISFENNL  188 (438)
Q Consensus       139 ~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~----~~~~~~~~~~~~~N~  188 (438)
                      +|++++..|..+..+++|+.|+|++|++++..+..    ..++.+..+++++|.
T Consensus       121 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~  174 (361)
T 2xot_A          121 NNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNK  174 (361)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSC
T ss_pred             CCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCC
Confidence            99999888999999999999999999999744432    235666667777764

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.18  E-value=1.3e-11  Score=125.33  Aligned_cols=141  Identities=26%  Similarity=0.287  Sum_probs=106.9

Q ss_pred             eeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc--------ceeeeecCCCccccccchhhccCCCCCeecccc---
Q 013682           36 TLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF--------VYLISDLGNAALSGELAPELGQLKNLELLALGN---  104 (438)
Q Consensus        36 ~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~--------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~~---  104 (438)
                      +.|++|+++.|.++.+|..   ..+++.|+++.|.+        .+..+++++|.+++ +| +++++++|+.|+++.   
T Consensus        91 ~~L~~L~l~~n~l~~lp~~---~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l  165 (454)
T 1jl5_A           91 PHLESLVASCNSLTELPEL---PQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSL  165 (454)
T ss_dssp             TTCSEEECCSSCCSSCCCC---CTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCC
T ss_pred             CCCCEEEccCCcCCccccc---cCCCcEEECCCCccCcccCCCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcC
Confidence            4566777777777777754   36778888877753        47888999999997 88 699999999998642   


Q ss_pred             ------ccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCCCCCCCc
Q 013682          105 ------LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQ  178 (438)
Q Consensus       105 ------l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~~~~~~  178 (438)
                            +.+|++|++++|++++ +| +++++++|+.|++++|++++ +|...   ++|+.|++++|.++ .+|+...++.
T Consensus       166 ~~lp~~~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~~~~l~~  238 (454)
T 1jl5_A          166 KKLPDLPPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELPELQNLPF  238 (454)
T ss_dssp             SCCCCCCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCCCCTTCTT
T ss_pred             cccCCCcccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-cccccCCCCC
Confidence                  3579999999999985 77 68999999999999999886 45432   47778888888777 6676555666


Q ss_pred             cccccccccc
Q 013682          179 FTPISFENNL  188 (438)
Q Consensus       179 ~~~~~~~~N~  188 (438)
                      +..+.+++|.
T Consensus       239 L~~L~l~~N~  248 (454)
T 1jl5_A          239 LTTIYADNNL  248 (454)
T ss_dssp             CCEEECCSSC
T ss_pred             CCEEECCCCc
Confidence            6666666664

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.17  E-value=1.2e-10  Score=102.39  Aligned_cols=121  Identities=21%  Similarity=0.205  Sum_probs=89.7

Q ss_pred             hhHHHHHHHhhhhhhhhhhcchheeecccCCcc------------ceeeeecCCCccccccchhhccCCCCCeecccccc
Q 013682           39 VTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF------------VYLISDLGNAALSGELAPELGQLKNLELLALGNLI  106 (438)
Q Consensus        39 ~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~------------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~~l~  106 (438)
                      +.++.+.+.+.++|..+.  ..++.|++++|.+            .|..++|++|.+++ +|+..          ++.++
T Consensus        10 ~~l~~~~~~l~~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~----------~~~l~   76 (177)
T 2o6r_A           10 TEIRCNSKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGV----------FDKLT   76 (177)
T ss_dssp             TEEECCSSCCSSCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC-CCTTT----------TTTCT
T ss_pred             CEEEecCCCCccCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceE-eChhH----------ccCCC
Confidence            566677788888886543  6788888877643            47778888888875 44331          23445


Q ss_pred             CCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCC
Q 013682          107 KLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD  172 (438)
Q Consensus       107 ~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~  172 (438)
                      +|+.|++++|++++..|..++++++|+.|++++|++++..+..+..+++|+.|++++|.+++..|.
T Consensus        77 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  142 (177)
T 2o6r_A           77 KLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  142 (177)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             ccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence            567788888988855556678888999999999999866555668888899999999988887763

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.16  E-value=9e-12  Score=111.61  Aligned_cols=112  Identities=21%  Similarity=0.217  Sum_probs=89.1

Q ss_pred             eeehhHHHHHHHhhhhhhhhhhcchheeecccCCccceeeeecCCCccccccchhhccCCCCCeeccccccCCCEEEccC
Q 013682           36 TLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYS  115 (438)
Q Consensus        36 ~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~~l~~L~~l~ls~  115 (438)
                      ..|++|+++.|.++.+|..+..+.+++.|+            |++|.+++..|..+           +.+++|+.|+|++
T Consensus        31 ~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~------------Ls~N~i~~i~~~~f-----------~~l~~L~~L~Ls~   87 (193)
T 2wfh_A           31 RDVTELYLDGNQFTLVPKELSNYKHLTLID------------LSNNRISTLSNQSF-----------SNMTQLLTLILSY   87 (193)
T ss_dssp             TTCCEEECCSSCCCSCCGGGGGCTTCCEEE------------CCSSCCCCCCTTTT-----------TTCTTCCEEECCS
T ss_pred             CCCCEEECCCCcCchhHHHhhcccCCCEEE------------CCCCcCCEeCHhHc-----------cCCCCCCEEECCC
Confidence            467888999999999988777776666655            55555554333334           3455678899999


Q ss_pred             CcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCC
Q 013682          116 NLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV  170 (438)
Q Consensus       116 N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~i  170 (438)
                      |++++..|..|+.+++|+.|+|++|++++..+..+..+++|+.|++++|.+.+..
T Consensus        88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c  142 (193)
T 2wfh_A           88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC  142 (193)
T ss_dssp             SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred             CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence            9999777788999999999999999999776677999999999999999987643

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.15  E-value=3.2e-11  Score=117.56  Aligned_cols=150  Identities=25%  Similarity=0.361  Sum_probs=111.8

Q ss_pred             ecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc----------ceeeeecCCCccccccchhhccCCCCCeec
Q 013682           32 ARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF----------VYLISDLGNAALSGELAPELGQLKNLELLA  101 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~  101 (438)
                      +++++.|++|+++.|.+..++ .+..+.+++.|+++.|.+          .+..+++++|...+.++. +..+++|+.|+
T Consensus        84 ~~~l~~L~~L~L~~n~i~~~~-~~~~l~~L~~L~l~~n~i~~~~~~~~l~~L~~L~l~~n~~~~~~~~-~~~l~~L~~L~  161 (347)
T 4fmz_A           84 LSNLVKLTNLYIGTNKITDIS-ALQNLTNLRELYLNEDNISDISPLANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLT  161 (347)
T ss_dssp             GTTCTTCCEEECCSSCCCCCG-GGTTCTTCSEEECTTSCCCCCGGGTTCTTCCEEECTTCTTCCCCGG-GTTCTTCCEEE
T ss_pred             hhcCCcCCEEEccCCcccCch-HHcCCCcCCEEECcCCcccCchhhccCCceeEEECCCCCCcccccc-hhhCCCCcEEE
Confidence            678888888888888888886 478888888888877754          367788888876665544 88888888886


Q ss_pred             c-----------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCC
Q 013682          102 L-----------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV  170 (438)
Q Consensus       102 l-----------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~i  170 (438)
                      +           +.+++|+.|++++|.+. .+|. +..+++|+.+++++|.+++..|  +..+++|+.|++++|.+++..
T Consensus       162 l~~~~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~  237 (347)
T 4fmz_A          162 VTESKVKDVTPIANLTDLYSLSLNYNQIE-DISP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLS  237 (347)
T ss_dssp             CCSSCCCCCGGGGGCTTCSEEECTTSCCC-CCGG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCG
T ss_pred             ecCCCcCCchhhccCCCCCEEEccCCccc-cccc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCc
Confidence            4           45678888888888887 5555 7788888888888888875544  777888888888888887655


Q ss_pred             CCCCCCCccccccccccc
Q 013682          171 PDNGSFSQFTPISFENNL  188 (438)
Q Consensus       171 p~~~~~~~~~~~~~~~N~  188 (438)
                      | ...++.+..+.+.+|.
T Consensus       238 ~-~~~l~~L~~L~l~~n~  254 (347)
T 4fmz_A          238 P-LANLSQLTWLEIGTNQ  254 (347)
T ss_dssp             G-GTTCTTCCEEECCSSC
T ss_pred             c-hhcCCCCCEEECCCCc
Confidence            4 4445556666666653

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.14  E-value=9.7e-11  Score=102.57  Aligned_cols=104  Identities=26%  Similarity=0.322  Sum_probs=87.4

Q ss_pred             eeecCCCccccccchhhccCCCCCeeccccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCC
Q 013682           75 ISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTIT  154 (438)
Q Consensus        75 ~~~l~~n~l~g~ip~~l~~l~~L~~l~l~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~  154 (438)
                      .+++++|.++. +|..+.             ++|+.|+|++|++++..|..|+++++|++|+|++|++++..|..+..++
T Consensus        13 ~l~~s~n~l~~-ip~~~~-------------~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~   78 (170)
T 3g39_A           13 TVDCSGKSLAS-VPTGIP-------------TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLT   78 (170)
T ss_dssp             EEECTTSCCSS-CCSCCC-------------TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCT
T ss_pred             EEEeCCCCcCc-cCccCC-------------CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCC
Confidence            46777777775 886542             4678899999999977789999999999999999999988777789999


Q ss_pred             CCCeEeccCCCCCCCCCC-CCCCCcccccccccccccCC
Q 013682          155 SLNILDLSNNRLSGPVPD-NGSFSQFTPISFENNLNLCG  192 (438)
Q Consensus       155 ~L~~l~ls~N~l~g~ip~-~~~~~~~~~~~~~~N~~lcg  192 (438)
                      +|+.|+|++|++++..|. ...++.+..+++.+|+.-|.
T Consensus        79 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~  117 (170)
T 3g39_A           79 QLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCA  117 (170)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred             CCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence            999999999999987775 45677788888999986664

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.14  E-value=7.3e-12  Score=115.75  Aligned_cols=114  Identities=15%  Similarity=0.183  Sum_probs=74.8

Q ss_pred             ceeeeecCCCc-cccccchhhccCCCCCeeccc--------------cccCCCEEEccCCcccccCchhhccccccc---
Q 013682           72 VYLISDLGNAA-LSGELAPELGQLKNLELLALG--------------NLIKLKSLDLYSNLFNGTIPDTLANLKQLK---  133 (438)
Q Consensus        72 ~~~~~~l~~n~-l~g~ip~~l~~l~~L~~l~l~--------------~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~---  133 (438)
                      .+..++|++|. +++--|..+..+++|+.|+++              ++++|+.|++++|.+++ +|+ ++.+++|+   
T Consensus        56 ~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~  133 (239)
T 2xwt_C           56 NISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFF  133 (239)
T ss_dssp             TCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEE
T ss_pred             CCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-ccccccccccc
Confidence            46677777776 654223356777777776542              35667777777777773 676 77777776   


Q ss_pred             eeccccc-cccCCCchhhccCCCCC-eEeccCCCCCCCCCCC-CCCCccccccccccc
Q 013682          134 YLRLNNN-SLSGLIPTSLTTITSLN-ILDLSNNRLSGPVPDN-GSFSQFTPISFENNL  188 (438)
Q Consensus       134 ~l~ls~N-~l~g~~P~~l~~~~~L~-~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~N~  188 (438)
                      .|++++| ++++..|..+..+++|+ .|++++|.++ .+|.. ...+.+..+.+.+|.
T Consensus       134 ~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~  190 (239)
T 2xwt_C          134 ILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNK  190 (239)
T ss_dssp             EEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCT
T ss_pred             EEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCC
Confidence            7778777 77766556677777777 7888777777 55543 122345555666663

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.13  E-value=1.5e-11  Score=119.31  Aligned_cols=133  Identities=17%  Similarity=0.110  Sum_probs=81.6

Q ss_pred             cceeeehhHHHHHHHhhh--hhhhhhhcchheeecccCCcc------------ceeeeecCCC-ccccc-cchhhccCCC
Q 013682           33 RGFTLLVTLKAVLQECEQ--LHLLISFLIFIRVLQSSSNLF------------VYLISDLGNA-ALSGE-LAPELGQLKN   96 (438)
Q Consensus        33 ~~~~~~~~l~~~~~~~~~--l~~~~~~~~~~~~l~~~~n~~------------~~~~~~l~~n-~l~g~-ip~~l~~l~~   96 (438)
                      .+++.|++|+++.|.+..  ++..+..+.+++.|+++.|.+            .|..++|++| .+++. +|..+..+++
T Consensus        90 ~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~  169 (336)
T 2ast_B           90 FSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR  169 (336)
T ss_dssp             CCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTT
T ss_pred             ccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCC
Confidence            356777777777776654  666677777777777666543            2556666666 45542 5555666666


Q ss_pred             CCeeccc---------------ccc-CCCEEEccCC--ccc-ccCchhhccccccceecccccc-ccCCCchhhccCCCC
Q 013682           97 LELLALG---------------NLI-KLKSLDLYSN--LFN-GTIPDTLANLKQLKYLRLNNNS-LSGLIPTSLTTITSL  156 (438)
Q Consensus        97 L~~l~l~---------------~l~-~L~~l~ls~N--~l~-g~iP~~~~~l~~L~~l~ls~N~-l~g~~P~~l~~~~~L  156 (438)
                      |+.|+++               .++ +|+.|++++|  .++ +.+|..++++++|+.|++++|. +++..+..+..+++|
T Consensus       170 L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L  249 (336)
T 2ast_B          170 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL  249 (336)
T ss_dssp             CCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred             CCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCC
Confidence            6666542               234 6666666666  343 3456666666666666666666 555555566666666


Q ss_pred             CeEeccCCC
Q 013682          157 NILDLSNNR  165 (438)
Q Consensus       157 ~~l~ls~N~  165 (438)
                      +.|++++|.
T Consensus       250 ~~L~l~~~~  258 (336)
T 2ast_B          250 QHLSLSRCY  258 (336)
T ss_dssp             CEEECTTCT
T ss_pred             CEeeCCCCC
Confidence            666666664

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.12  E-value=3.7e-12  Score=126.37  Aligned_cols=157  Identities=19%  Similarity=0.191  Sum_probs=109.7

Q ss_pred             ecceeeehhHHHHHHHhhh-----hhhhhhhcchheeecccCC----------------------ccceeeeecCCCccc
Q 013682           32 ARGFTLLVTLKAVLQECEQ-----LHLLISFLIFIRVLQSSSN----------------------LFVYLISDLGNAALS   84 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~-----l~~~~~~~~~~~~l~~~~n----------------------~~~~~~~~l~~n~l~   84 (438)
                      ++.++.|++|++++|.++.     ++..+..+++++.|+++.|                      ...|..++|++|.++
T Consensus        28 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~  107 (386)
T 2ca6_A           28 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG  107 (386)
T ss_dssp             HHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCC
T ss_pred             HhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCC
Confidence            4456667777777776655     4444667778888877654                      245778888888888


Q ss_pred             c----ccchhhccCCCCCeecccc-----------------c---------cCCCEEEccCCccc-ccCc---hhhcccc
Q 013682           85 G----ELAPELGQLKNLELLALGN-----------------L---------IKLKSLDLYSNLFN-GTIP---DTLANLK  130 (438)
Q Consensus        85 g----~ip~~l~~l~~L~~l~l~~-----------------l---------~~L~~l~ls~N~l~-g~iP---~~~~~l~  130 (438)
                      +    .+|..+.++++|+.|++++                 +         ++|++|+|++|+++ +.+|   ..+..++
T Consensus       108 ~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~  187 (386)
T 2ca6_A          108 PTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR  187 (386)
T ss_dssp             TTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCT
T ss_pred             HHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCC
Confidence            7    5788888888888887532                 2         68888888888887 4556   4677788


Q ss_pred             ccceecccccccc--C---CCchhhccCCCCCeEeccCCCCC----CCCCCC-CCCCccccccccccc
Q 013682          131 QLKYLRLNNNSLS--G---LIPTSLTTITSLNILDLSNNRLS----GPVPDN-GSFSQFTPISFENNL  188 (438)
Q Consensus       131 ~L~~l~ls~N~l~--g---~~P~~l~~~~~L~~l~ls~N~l~----g~ip~~-~~~~~~~~~~~~~N~  188 (438)
                      +|+.|++++|+++  |   .+|..+..+++|+.|++++|.++    +.+|.. ..++.+..+.+++|.
T Consensus       188 ~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~  255 (386)
T 2ca6_A          188 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCL  255 (386)
T ss_dssp             TCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCC
T ss_pred             CcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCC
Confidence            8888888888887  3   34547778888888888888885    444432 223445555555553

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.11  E-value=1.3e-10  Score=113.29  Aligned_cols=61  Identities=26%  Similarity=0.297  Sum_probs=30.8

Q ss_pred             CCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCC
Q 013682          107 KLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG  168 (438)
Q Consensus       107 ~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g  168 (438)
                      +|+.|+|++|+|++..|..|+++++|+.|+|++|+|++..|..+..++ |+.|+|++|.+..
T Consensus        57 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c  117 (347)
T 2ifg_A           57 ELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHC  117 (347)
T ss_dssp             CCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred             CCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence            344455555555554455555555555555555555543333333333 5555555555543

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.10  E-value=6.9e-11  Score=110.00  Aligned_cols=126  Identities=14%  Similarity=0.048  Sum_probs=92.8

Q ss_pred             ccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCC--ceeeEEEEeeCCeeEEEEecCCCCCHHH
Q 013682          295 GRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN--LLRLYGFCTTVTEKLLVYPYMTNGSVAS  372 (438)
Q Consensus       295 G~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lv~e~~~~gsL~~  372 (438)
                      +.|..+.||+....+|+.+++|.....    ....+.+|+.+++.+.+.+  +.+++++....+..+++|||+++.++. 
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence            355668999998777788999986542    2235788999888886544  456888887777889999999998873 


Q ss_pred             HhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------------
Q 013682          373 RLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC---------------------------------------------  407 (438)
Q Consensus       373 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------------  407 (438)
                       ...       .+   ...++.+++..+..||+..                                             
T Consensus       104 -~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (264)
T 1nd4_A          104 -SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  172 (264)
T ss_dssp             -TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             -cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence             211       11   2356777888888888742                                             


Q ss_pred             ----------CCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          408 ----------DPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       408 ----------~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                                .+.++|+|++|.||+++++....+.||-.
T Consensus       173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~  211 (264)
T 1nd4_A          173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGR  211 (264)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTT
T ss_pred             HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchh
Confidence                      11399999999999998776566889853

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.09  E-value=1.8e-10  Score=120.17  Aligned_cols=127  Identities=24%  Similarity=0.270  Sum_probs=100.1

Q ss_pred             cceeeehhHH-HHHHHhhhhhhh------hhhc--chheeecccCCcc----------ceeeeecCCCccccccchhhcc
Q 013682           33 RGFTLLVTLK-AVLQECEQLHLL------ISFL--IFIRVLQSSSNLF----------VYLISDLGNAALSGELAPELGQ   93 (438)
Q Consensus        33 ~~~~~~~~l~-~~~~~~~~l~~~------~~~~--~~~~~l~~~~n~~----------~~~~~~l~~n~l~g~ip~~l~~   93 (438)
                      ++|+.|+.|+ ++.|.+.+|+..      +..+  ..++.|++++|.+          .|..|+|++|.++ .+|..++.
T Consensus       406 ~~l~~L~~L~~l~~n~~~~L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~lp~~~~l~~L~~L~Ls~N~l~-~lp~~~~~  484 (567)
T 1dce_A          406 QYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLR-ALPPALAA  484 (567)
T ss_dssp             HHHHHHHHHCGGGHHHHHHHHHHHHHHHHHHHHHHTTCSEEECTTSCCSSCCCGGGGTTCCEEECCSSCCC-CCCGGGGG
T ss_pred             HHHHhcccCcchhhcccchhhhhhhhcccccccCccCceEEEecCCCCCCCcCccccccCcEeecCccccc-ccchhhhc
Confidence            4556666665 455555555442      1111  1467788887754          4888999999999 79988876


Q ss_pred             CCCCCeeccccccCCCEEEccCCcccccCchhhccccccceeccccccccCCC-chhhccCCCCCeEeccCCCCCCCCCC
Q 013682           94 LKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLI-PTSLTTITSLNILDLSNNRLSGPVPD  172 (438)
Q Consensus        94 l~~L~~l~l~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~-P~~l~~~~~L~~l~ls~N~l~g~ip~  172 (438)
                      |++           |+.|+|++|++++ +| .++++++|+.|+|++|++++.+ |..++.+++|+.|++++|.+++.+|.
T Consensus       485 l~~-----------L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~  551 (567)
T 1dce_A          485 LRC-----------LEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI  551 (567)
T ss_dssp             CTT-----------CCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred             CCC-----------CCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence            664           5678999999995 88 8999999999999999999887 99999999999999999999998875


Q ss_pred             C
Q 013682          173 N  173 (438)
Q Consensus       173 ~  173 (438)
                      .
T Consensus       552 ~  552 (567)
T 1dce_A          552 Q  552 (567)
T ss_dssp             T
T ss_pred             H
Confidence            4

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.09  E-value=2.3e-11  Score=107.01  Aligned_cols=128  Identities=20%  Similarity=0.133  Sum_probs=80.9

Q ss_pred             cceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCccceeeeecCCCccccccchhhccCCCCCeeccccccCCCEEE
Q 013682           33 RGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLD  112 (438)
Q Consensus        33 ~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~~l~~L~~l~  112 (438)
                      .+.+.|++|++++|.++.++.......+            +..++|++|.+++ + ..           ++.+++|++|+
T Consensus        16 ~~~~~L~~L~l~~n~l~~i~~~~~~~~~------------L~~L~Ls~N~l~~-~-~~-----------l~~l~~L~~L~   70 (176)
T 1a9n_A           16 TNAVRDRELDLRGYKIPVIENLGATLDQ------------FDAIDFSDNEIRK-L-DG-----------FPLLRRLKTLL   70 (176)
T ss_dssp             ECTTSCEEEECTTSCCCSCCCGGGGTTC------------CSEEECCSSCCCE-E-CC-----------CCCCSSCCEEE
T ss_pred             CCcCCceEEEeeCCCCchhHHhhhcCCC------------CCEEECCCCCCCc-c-cc-----------cccCCCCCEEE
Confidence            3455556666666666655432221113            3344455555544 2 12           34556788889


Q ss_pred             ccCCcccccCchh-hccccccceeccccccccCCCch--hhccCCCCCeEeccCCCCCCCCCC-----CCCCCccccccc
Q 013682          113 LYSNLFNGTIPDT-LANLKQLKYLRLNNNSLSGLIPT--SLTTITSLNILDLSNNRLSGPVPD-----NGSFSQFTPISF  184 (438)
Q Consensus       113 ls~N~l~g~iP~~-~~~l~~L~~l~ls~N~l~g~~P~--~l~~~~~L~~l~ls~N~l~g~ip~-----~~~~~~~~~~~~  184 (438)
                      +++|.++ .+|+. ++.+++|+.|++++|+++ .+|.  .+..+++|+.|++++|.++. +|.     ...++.+..++.
T Consensus        71 Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~  147 (176)
T 1a9n_A           71 VNNNRIC-RIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDF  147 (176)
T ss_dssp             CCSSCCC-EECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETT
T ss_pred             CCCCccc-ccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCC
Confidence            9999998 45544 488899999999999985 5676  78888999999999998874 443     233455555555


Q ss_pred             cccc
Q 013682          185 ENNL  188 (438)
Q Consensus       185 ~~N~  188 (438)
                      .+|.
T Consensus       148 ~~n~  151 (176)
T 1a9n_A          148 QKVK  151 (176)
T ss_dssp             EECC
T ss_pred             CcCC
Confidence            5553

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.07  E-value=3e-10  Score=99.88  Aligned_cols=109  Identities=20%  Similarity=0.163  Sum_probs=83.1

Q ss_pred             hhHHHHHHHhhhhhhhhhhcchheeecccCCccceeeeecCCCccccccchhhccCCCCCeeccccccCCCEEEccCCcc
Q 013682           39 VTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLF  118 (438)
Q Consensus        39 ~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~~l~~L~~l~ls~N~l  118 (438)
                      +++++++|.+.++|..+.              ..+..++|++|.+++..|..+..+           ++|+.|+|++|+|
T Consensus        15 ~~l~~~~n~l~~iP~~~~--------------~~L~~L~Ls~N~l~~~~~~~~~~l-----------~~L~~L~Ls~N~l   69 (174)
T 2r9u_A           15 TLVNCQNIRLASVPAGIP--------------TDKQRLWLNNNQITKLEPGVFDHL-----------VNLQQLYFNSNKL   69 (174)
T ss_dssp             SEEECCSSCCSSCCSCCC--------------TTCSEEECCSSCCCCCCTTTTTTC-----------TTCCEEECCSSCC
T ss_pred             cEEEeCCCCCCccCCCcC--------------CCCcEEEeCCCCccccCHHHhcCC-----------cCCCEEECCCCCC
Confidence            355666777777776432              234567788888887556555544           4567799999999


Q ss_pred             cccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCC
Q 013682          119 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD  172 (438)
Q Consensus       119 ~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~  172 (438)
                      ++..|..|+++++|+.|+|++|++++..|..+..+++|+.|++++|.++...+.
T Consensus        70 ~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~  123 (174)
T 2r9u_A           70 TAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDCECRD  123 (174)
T ss_dssp             CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCTTBGG
T ss_pred             CccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCccccccc
Confidence            954444579999999999999999977666799999999999999999876553

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.04  E-value=1.2e-11  Score=120.01  Aligned_cols=93  Identities=22%  Similarity=0.248  Sum_probs=48.3

Q ss_pred             ceeeeecCCCccccc-cchhhccCCCCCeecc-------------ccccCCCEEEccCC-ccccc-Cchhhcccccccee
Q 013682           72 VYLISDLGNAALSGE-LAPELGQLKNLELLAL-------------GNLIKLKSLDLYSN-LFNGT-IPDTLANLKQLKYL  135 (438)
Q Consensus        72 ~~~~~~l~~n~l~g~-ip~~l~~l~~L~~l~l-------------~~l~~L~~l~ls~N-~l~g~-iP~~~~~l~~L~~l  135 (438)
                      .+..++|++|.+++. +|..+..+++|+.|++             +.+++|+.|++++| .+++. +|..++++++|++|
T Consensus        94 ~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L  173 (336)
T 2ast_B           94 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL  173 (336)
T ss_dssp             CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEE
T ss_pred             CCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEE
Confidence            355555555555544 5555555555555543             23445555555555 44432 44445555555555


Q ss_pred             ccccc-cccCC-CchhhccCC-CCCeEeccCC
Q 013682          136 RLNNN-SLSGL-IPTSLTTIT-SLNILDLSNN  164 (438)
Q Consensus       136 ~ls~N-~l~g~-~P~~l~~~~-~L~~l~ls~N  164 (438)
                      ++++| .+++. +|..+..++ +|+.|++++|
T Consensus       174 ~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~  205 (336)
T 2ast_B          174 NLSWCFDFTEKHVQVAVAHVSETITQLNLSGY  205 (336)
T ss_dssp             ECCCCTTCCHHHHHHHHHHSCTTCCEEECCSC
T ss_pred             cCCCCCCcChHHHHHHHHhcccCCCEEEeCCC
Confidence            55555 55432 344455555 5555555555

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.02  E-value=4.6e-10  Score=110.15  Aligned_cols=138  Identities=12%  Similarity=0.202  Sum_probs=100.4

Q ss_pred             CCccccccceEEEEEEeCCCCEEEEEEcc--ccccccchHHHHHHHHHHhcCC--CCCceeeEEEEeeC---CeeEEEEe
Q 013682          291 KNILGRGGFGKVYKGRLADGKLVAVKRLK--EERTSGGELQFQTEVKIISMAV--HRNLLRLYGFCTTV---TEKLLVYP  363 (438)
Q Consensus       291 ~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~--~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lv~e  363 (438)
                      .+.++.|.++.||+.... +..+++|+..  ..........+.+|..+++.+.  +..+.+++.++.+.   +..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            467899999999999875 4578888765  3221122346889999998886  45578888888765   44799999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC------------------------------------  407 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------  407 (438)
                      |+++..+.+.      ....++..++..++.++++.|+.||+..                                    
T Consensus       122 ~v~G~~l~~~------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          122 FVSGRVLWDQ------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             CCCCBCCCCT------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             ecCCeecCCC------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            9998776431      1123677888899999999999999731                                    


Q ss_pred             -------------------CCCceecCCCCCCeeeCCCCC--cchhhhh
Q 013682          408 -------------------DPKIIHRDVKAANILLDEDAD--QSSKTIL  435 (438)
Q Consensus       408 -------------------~~~ivHrDLK~~NILld~~~~--~~l~Df~  435 (438)
                                         .+.++|+|+++.|||+++++.  ..+.||-
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe  244 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWE  244 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCT
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcc
Confidence                               257999999999999998764  4678874

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.01  E-value=1.2e-10  Score=122.54  Aligned_cols=34  Identities=29%  Similarity=0.405  Sum_probs=15.1

Q ss_pred             cccceeccccccccCCCchhhccCCCCCeEeccCCCCC
Q 013682          130 KQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS  167 (438)
Q Consensus       130 ~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~  167 (438)
                      ++|+.|++++|+++ .+|.   .+++|+.|++++|+++
T Consensus       241 ~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~  274 (622)
T 3g06_A          241 SELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT  274 (622)
T ss_dssp             TTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC
T ss_pred             CcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC
Confidence            34444444444444 2333   3344555555555554

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.01  E-value=6.7e-11  Score=124.48  Aligned_cols=63  Identities=27%  Similarity=0.309  Sum_probs=55.9

Q ss_pred             ccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCC
Q 013682          105 LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD  172 (438)
Q Consensus       105 l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~  172 (438)
                      +++|+.|+|++|+++ .+|.   .+++|+.|+|++|+++ .+|..+..+++|+.|++++|.++|.+|.
T Consensus       240 l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~  302 (622)
T 3g06_A          240 PSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ  302 (622)
T ss_dssp             CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHH
T ss_pred             CCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHH
Confidence            567888888888887 6777   5788999999999999 7899999999999999999999988775

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.01  E-value=3.9e-10  Score=99.07  Aligned_cols=106  Identities=25%  Similarity=0.249  Sum_probs=81.7

Q ss_pred             CccceeeeecCCCccccccchhhccCCCCCeeccccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCch
Q 013682           69 NLFVYLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPT  148 (438)
Q Consensus        69 n~~~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~  148 (438)
                      |...+..+++++|.++. +|. +..+          .++|++|++++|.+++ + +.++.+++|++|++++|++++..|.
T Consensus        17 ~~~~L~~L~l~~n~l~~-i~~-~~~~----------~~~L~~L~Ls~N~l~~-~-~~l~~l~~L~~L~Ls~N~l~~~~~~   82 (176)
T 1a9n_A           17 NAVRDRELDLRGYKIPV-IEN-LGAT----------LDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEG   82 (176)
T ss_dssp             CTTSCEEEECTTSCCCS-CCC-GGGG----------TTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSC
T ss_pred             CcCCceEEEeeCCCCch-hHH-hhhc----------CCCCCEEECCCCCCCc-c-cccccCCCCCEEECCCCcccccCcc
Confidence            45567788888888884 542 3222          2368889999999985 4 6899999999999999999976555


Q ss_pred             hhccCCCCCeEeccCCCCCCCCCC---CCCCCcccccccccccc
Q 013682          149 SLTTITSLNILDLSNNRLSGPVPD---NGSFSQFTPISFENNLN  189 (438)
Q Consensus       149 ~l~~~~~L~~l~ls~N~l~g~ip~---~~~~~~~~~~~~~~N~~  189 (438)
                      .+..+++|+.|++++|.++. +|.   ...++.+..+.+.+|+.
T Consensus        83 ~~~~l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i  125 (176)
T 1a9n_A           83 LDQALPDLTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPV  125 (176)
T ss_dssp             HHHHCTTCCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGG
T ss_pred             hhhcCCCCCEEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCC
Confidence            56999999999999999954 553   34556677778888864

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=98.97  E-value=1e-10  Score=115.08  Aligned_cols=134  Identities=24%  Similarity=0.189  Sum_probs=86.3

Q ss_pred             eeeehhHHHHHHHhhhhh-----hhhhhcc-hheeecccCCcc-----------------ceeeeecCCCccccccchhh
Q 013682           35 FTLLVTLKAVLQECEQLH-----LLISFLI-FIRVLQSSSNLF-----------------VYLISDLGNAALSGELAPEL   91 (438)
Q Consensus        35 ~~~~~~l~~~~~~~~~l~-----~~~~~~~-~~~~l~~~~n~~-----------------~~~~~~l~~n~l~g~ip~~l   91 (438)
                      .+.|++|+++.|.++..+     ..+..+. +++.|+++.|.+                 .+..++|++|.+++..+..+
T Consensus        21 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l  100 (362)
T 3goz_A           21 PHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDEL  100 (362)
T ss_dssp             CTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHH
T ss_pred             CCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHH
Confidence            344777888888887776     3456666 677777777643                 36667777777777666655


Q ss_pred             ccC-----CCCCeecccc------------------ccCCCEEEccCCccccc----Cchhhcccc-ccceecccccccc
Q 013682           92 GQL-----KNLELLALGN------------------LIKLKSLDLYSNLFNGT----IPDTLANLK-QLKYLRLNNNSLS  143 (438)
Q Consensus        92 ~~l-----~~L~~l~l~~------------------l~~L~~l~ls~N~l~g~----iP~~~~~l~-~L~~l~ls~N~l~  143 (438)
                      +..     ++|+.|+++.                  +++|++|+|++|.+++.    ++..+..++ +|+.|+|++|+++
T Consensus       101 ~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~  180 (362)
T 3goz_A          101 VKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA  180 (362)
T ss_dssp             HHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGG
T ss_pred             HHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCc
Confidence            544     6777765421                  24677777777777643    333444444 6777777777777


Q ss_pred             CCCchhhcc----C-CCCCeEeccCCCCCC
Q 013682          144 GLIPTSLTT----I-TSLNILDLSNNRLSG  168 (438)
Q Consensus       144 g~~P~~l~~----~-~~L~~l~ls~N~l~g  168 (438)
                      +..+..++.    + ++|+.||+++|.+++
T Consensus       181 ~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~  210 (362)
T 3goz_A          181 SKNCAELAKFLASIPASVTSLDLSANLLGL  210 (362)
T ss_dssp             GSCHHHHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred             hhhHHHHHHHHHhCCCCCCEEECCCCCCCh
Confidence            666654443    3 477777777777665

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=98.96  E-value=8.6e-11  Score=115.58  Aligned_cols=157  Identities=18%  Similarity=0.208  Sum_probs=119.7

Q ss_pred             eccee-eehhHHHHHHHhhhh-hhhhhhc-----chheeecccCCcc-----------------ceeeeecCCCcccccc
Q 013682           32 ARGFT-LLVTLKAVLQECEQL-HLLISFL-----IFIRVLQSSSNLF-----------------VYLISDLGNAALSGEL   87 (438)
Q Consensus        32 ~~~~~-~~~~l~~~~~~~~~l-~~~~~~~-----~~~~~l~~~~n~~-----------------~~~~~~l~~n~l~g~i   87 (438)
                      +++++ .|++|+++.|.++.. +..+..+     .+++.|+++.|.+                 .+..++|++|.+++..
T Consensus        46 l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~  125 (362)
T 3goz_A           46 FANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKS  125 (362)
T ss_dssp             HHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSC
T ss_pred             HHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHH
Confidence            45666 789999999998886 4445554     8999999998863                 5888999999999876


Q ss_pred             chhhcc-----CCCCCeecccc-----------------c-cCCCEEEccCCcccccCchhhccc-----cccceecccc
Q 013682           88 APELGQ-----LKNLELLALGN-----------------L-IKLKSLDLYSNLFNGTIPDTLANL-----KQLKYLRLNN  139 (438)
Q Consensus        88 p~~l~~-----l~~L~~l~l~~-----------------l-~~L~~l~ls~N~l~g~iP~~~~~l-----~~L~~l~ls~  139 (438)
                      +..+++     .++|+.|+++.                 + ++|+.|+|++|++++..|..++..     ++|+.|||++
T Consensus       126 ~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~  205 (362)
T 3goz_A          126 SSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSA  205 (362)
T ss_dssp             HHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTT
T ss_pred             HHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCC
Confidence            666554     36899987632                 3 389999999999998777766654     6999999999


Q ss_pred             ccccCC----Cchhhcc-CCCCCeEeccCCCCCCCCCC-----CCCCCccccccccccc
Q 013682          140 NSLSGL----IPTSLTT-ITSLNILDLSNNRLSGPVPD-----NGSFSQFTPISFENNL  188 (438)
Q Consensus       140 N~l~g~----~P~~l~~-~~~L~~l~ls~N~l~g~ip~-----~~~~~~~~~~~~~~N~  188 (438)
                      |++++.    +|..+.. .++|+.||+++|.+++..+.     ...++.+..+.+++|.
T Consensus       206 N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~  264 (362)
T 3goz_A          206 NLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDI  264 (362)
T ss_dssp             SCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHH
T ss_pred             CCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCC
Confidence            999873    5666666 45999999999999876542     1234556666666664

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=98.96  E-value=6.5e-10  Score=108.39  Aligned_cols=104  Identities=19%  Similarity=0.163  Sum_probs=85.0

Q ss_pred             eecCCC-ccccccchhhccCCCCCeeccccccCCCEEEccC-CcccccCchhhccccccceeccccccccCCCchhhccC
Q 013682           76 SDLGNA-ALSGELAPELGQLKNLELLALGNLIKLKSLDLYS-NLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTI  153 (438)
Q Consensus        76 ~~l~~n-~l~g~ip~~l~~l~~L~~l~l~~l~~L~~l~ls~-N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~  153 (438)
                      ++++++ ++++ ||. +..++           +|+.|+|++ |+|++..|..|+++++|+.|+|++|+|++..|..|.++
T Consensus        13 v~~~~~n~l~~-ip~-l~~~~-----------~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l   79 (347)
T 2ifg_A           13 LRCTRDGALDS-LHH-LPGAE-----------NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFT   79 (347)
T ss_dssp             EECCSSCCCTT-TTT-SCSCS-----------CCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSC
T ss_pred             EEcCCCCCCCc-cCC-CCCCC-----------CeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCC
Confidence            466666 7775 887 65554           567789996 99997777899999999999999999999999999999


Q ss_pred             CCCCeEeccCCCCCCCCCCCCCCCcccccccccccccCC
Q 013682          154 TSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCG  192 (438)
Q Consensus       154 ~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~N~~lcg  192 (438)
                      ++|+.|||++|+|++.+|.......+..+.+.+|+.-|.
T Consensus        80 ~~L~~L~l~~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~  118 (347)
T 2ifg_A           80 PRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCS  118 (347)
T ss_dssp             SCCCEEECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred             cCCCEEeCCCCccceeCHHHcccCCceEEEeeCCCccCC
Confidence            999999999999998776554433477777888876653

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=98.95  E-value=4.2e-11  Score=121.23  Aligned_cols=152  Identities=21%  Similarity=0.155  Sum_probs=108.4

Q ss_pred             eeehhHHHHHHHhhh-----hhhhhhhcchheeecccCCc-----------------cceeeeecCCCccccc----cch
Q 013682           36 TLLVTLKAVLQECEQ-----LHLLISFLIFIRVLQSSSNL-----------------FVYLISDLGNAALSGE----LAP   89 (438)
Q Consensus        36 ~~~~~l~~~~~~~~~-----l~~~~~~~~~~~~l~~~~n~-----------------~~~~~~~l~~n~l~g~----ip~   89 (438)
                      +.|++|+++.|.++.     ++..+..+.+++.|+++.|.                 ..+..++|++|.+++.    +|.
T Consensus       199 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~  278 (461)
T 1z7x_W          199 CQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCR  278 (461)
T ss_dssp             CCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred             CCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHH
Confidence            466677777776665     56777778888888887764                 3477788888888865    677


Q ss_pred             hhccCCCCCeecccc------------------ccCCCEEEccCCccccc----CchhhccccccceeccccccccCCCc
Q 013682           90 ELGQLKNLELLALGN------------------LIKLKSLDLYSNLFNGT----IPDTLANLKQLKYLRLNNNSLSGLIP  147 (438)
Q Consensus        90 ~l~~l~~L~~l~l~~------------------l~~L~~l~ls~N~l~g~----iP~~~~~l~~L~~l~ls~N~l~g~~P  147 (438)
                      .+.++++|+.|+++.                  .++|+.|++++|.+++.    +|..+..+++|+.|++++|++++..+
T Consensus       279 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~  358 (461)
T 1z7x_W          279 VLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGV  358 (461)
T ss_dssp             HHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHH
T ss_pred             HHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccH
Confidence            788888888887532                  25788888888888765    56777778888888888888876655


Q ss_pred             hhhcc-----CCCCCeEeccCCCCCC----CCCCC-CCCCcccccccccc
Q 013682          148 TSLTT-----ITSLNILDLSNNRLSG----PVPDN-GSFSQFTPISFENN  187 (438)
Q Consensus       148 ~~l~~-----~~~L~~l~ls~N~l~g----~ip~~-~~~~~~~~~~~~~N  187 (438)
                      ..+..     .++|+.|++++|.+++    .+|.. ...+.+..+++.+|
T Consensus       359 ~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N  408 (461)
T 1z7x_W          359 RELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNN  408 (461)
T ss_dssp             HHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSS
T ss_pred             HHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCC
Confidence            55543     6688888888888875    44432 12344555555555

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=98.94  E-value=3.5e-10  Score=110.66  Aligned_cols=146  Identities=20%  Similarity=0.145  Sum_probs=105.1

Q ss_pred             eeehhHHHHHHHhhhhhh-hhhhcchheeecccCCcc-c-------------eeeeecCCCccccccchhhccCCCCCee
Q 013682           36 TLLVTLKAVLQECEQLHL-LISFLIFIRVLQSSSNLF-V-------------YLISDLGNAALSGELAPELGQLKNLELL  100 (438)
Q Consensus        36 ~~~~~l~~~~~~~~~l~~-~~~~~~~~~~l~~~~n~~-~-------------~~~~~l~~n~l~g~ip~~l~~l~~L~~l  100 (438)
                      +.+++|+++.|.++.+|. .|+.+++|+.|++++|.+ .             +..+.++.|++++--|..+..+++|+.|
T Consensus        30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L  109 (350)
T 4ay9_X           30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL  109 (350)
T ss_dssp             TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEE
T ss_pred             CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccc
Confidence            467889999999999996 489999999999988864 1             1234566788887556667888888887


Q ss_pred             ccc--------------------------------------c-ccCCCEEEccCCcccccCchhhccccccceecccccc
Q 013682          101 ALG--------------------------------------N-LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNS  141 (438)
Q Consensus       101 ~l~--------------------------------------~-l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~  141 (438)
                      +++                                      . ...++.|+|++|+++ .||+.+...++|+.+++++|+
T Consensus       110 ~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n  188 (350)
T 4ay9_X          110 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNN  188 (350)
T ss_dssp             EEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCT
T ss_pred             cccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCC
Confidence            521                                      1 134778888888887 788777777888888887544


Q ss_pred             ccCCCch-hhccCCCCCeEeccCCCCCCCCCCCCCCCccccccc
Q 013682          142 LSGLIPT-SLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISF  184 (438)
Q Consensus       142 l~g~~P~-~l~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~  184 (438)
                      .-+.+|. .+..+++|+.||+++|+++.- |.. .+..+..+..
T Consensus       189 ~l~~i~~~~f~~l~~L~~LdLs~N~l~~l-p~~-~~~~L~~L~~  230 (350)
T 4ay9_X          189 NLEELPNDVFHGASGPVILDISRTRIHSL-PSY-GLENLKKLRA  230 (350)
T ss_dssp             TCCCCCTTTTTTEECCSEEECTTSCCCCC-CSS-SCTTCCEEEC
T ss_pred             cccCCCHHHhccCcccchhhcCCCCcCcc-Chh-hhccchHhhh
Confidence            3345554 578889999999999988854 432 2444444443

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=98.92  E-value=3.7e-11  Score=107.78  Aligned_cols=110  Identities=23%  Similarity=0.354  Sum_probs=64.3

Q ss_pred             eecCCCccccccch------hhccCCCCCeecc-----------ccccCCCEEEccCCcccccCchhhccccccceeccc
Q 013682           76 SDLGNAALSGELAP------ELGQLKNLELLAL-----------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  138 (438)
Q Consensus        76 ~~l~~n~l~g~ip~------~l~~l~~L~~l~l-----------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls  138 (438)
                      ++++.+.++|.+|.      .++.+++|+.|++           +.+++|++|++++|.++ .+|..++.+++|+.|+++
T Consensus        23 l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l~~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~  101 (198)
T 1ds9_A           23 TEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWIS  101 (198)
T ss_dssp             TTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESCCCCHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEE
T ss_pred             cchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCccccccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECc
Confidence            34444555555444      5555666655543           23456666777777776 666666666777777777


Q ss_pred             cccccCCCchhhccCCCCCeEeccCCCCCCCCC--CCCCCCccccccccccc
Q 013682          139 NNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP--DNGSFSQFTPISFENNL  188 (438)
Q Consensus       139 ~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip--~~~~~~~~~~~~~~~N~  188 (438)
                      +|++++ +| .+..+++|+.|++++|++++..+  ....++.+..+.+.+|+
T Consensus       102 ~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~  151 (198)
T 1ds9_A          102 YNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNP  151 (198)
T ss_dssp             EEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCH
T ss_pred             CCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCc
Confidence            777764 34 56666677777777776664221  22334445555555554

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=98.86  E-value=6.8e-11  Score=106.07  Aligned_cols=96  Identities=22%  Similarity=0.293  Sum_probs=75.4

Q ss_pred             eeeeecCCCccccccchhhccCCCCCeeccc------------cccCCCEEEccCCcccccCchhhccccccceeccccc
Q 013682           73 YLISDLGNAALSGELAPELGQLKNLELLALG------------NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNN  140 (438)
Q Consensus        73 ~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~------------~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N  140 (438)
                      +..++|++|.+++ +| .+..+++|+.|+++            .+++|++|++++|++++ +| .++.+++|+.|++++|
T Consensus        50 L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N  125 (198)
T 1ds9_A           50 CKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNN  125 (198)
T ss_dssp             CSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEE
T ss_pred             CCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCC
Confidence            3344455555554 66 77777777777642            34679999999999984 66 7999999999999999


Q ss_pred             cccCCCc-hhhccCCCCCeEeccCCCCCCCCCC
Q 013682          141 SLSGLIP-TSLTTITSLNILDLSNNRLSGPVPD  172 (438)
Q Consensus       141 ~l~g~~P-~~l~~~~~L~~l~ls~N~l~g~ip~  172 (438)
                      ++++..+ ..+..+++|+.|++++|.+++.+|.
T Consensus       126 ~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~  158 (198)
T 1ds9_A          126 KITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE  158 (198)
T ss_dssp             ECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred             cCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence            9985422 4789999999999999999988775

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=98.79  E-value=5.8e-10  Score=112.74  Aligned_cols=137  Identities=23%  Similarity=0.098  Sum_probs=97.9

Q ss_pred             cceeeehhHHHHHHHhhhh------hhhhhhcchheeecccCCcc----------------ceeeeecCCCccccccchh
Q 013682           33 RGFTLLVTLKAVLQECEQL------HLLISFLIFIRVLQSSSNLF----------------VYLISDLGNAALSGELAPE   90 (438)
Q Consensus        33 ~~~~~~~~l~~~~~~~~~l------~~~~~~~~~~~~l~~~~n~~----------------~~~~~~l~~n~l~g~ip~~   90 (438)
                      ++++.|++|+++.|.+...      +.....+.+++.|+++.|.+                .+..++|++|.+++..+..
T Consensus       224 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~  303 (461)
T 1z7x_W          224 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL  303 (461)
T ss_dssp             HHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHH
T ss_pred             HhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHH
Confidence            3456666666666655543      22233466677777666532                3666777777776655555


Q ss_pred             hccC-----CCCCeeccc-----------------cccCCCEEEccCCcccccCchhhcc-----ccccceecccccccc
Q 013682           91 LGQL-----KNLELLALG-----------------NLIKLKSLDLYSNLFNGTIPDTLAN-----LKQLKYLRLNNNSLS  143 (438)
Q Consensus        91 l~~l-----~~L~~l~l~-----------------~l~~L~~l~ls~N~l~g~iP~~~~~-----l~~L~~l~ls~N~l~  143 (438)
                      +...     ++|+.|+++                 .+++|+.|++++|.+++..+..+.+     .++|+.|++++|+++
T Consensus       304 l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~  383 (461)
T 1z7x_W          304 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS  383 (461)
T ss_dssp             HHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred             HHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCC
Confidence            5433     567776542                 3478999999999998776666654     679999999999998


Q ss_pred             C----CCchhhccCCCCCeEeccCCCCCCC
Q 013682          144 G----LIPTSLTTITSLNILDLSNNRLSGP  169 (438)
Q Consensus       144 g----~~P~~l~~~~~L~~l~ls~N~l~g~  169 (438)
                      +    .+|..+..+++|+.|++++|++++.
T Consensus       384 ~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~  413 (461)
T 1z7x_W          384 DSSCSSLAATLLANHSLRELDLSNNCLGDA  413 (461)
T ss_dssp             HHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred             hhhHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence            6    7899999999999999999998753

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.58  E-value=8.9e-09  Score=101.62  Aligned_cols=97  Identities=18%  Similarity=0.164  Sum_probs=63.2

Q ss_pred             ceeeeecCCCccccccchhhc-cCCCCCeeccc------------------cccCCCEEEccCCcccc----cCchhhcc
Q 013682           72 VYLISDLGNAALSGELAPELG-QLKNLELLALG------------------NLIKLKSLDLYSNLFNG----TIPDTLAN  128 (438)
Q Consensus        72 ~~~~~~l~~n~l~g~ip~~l~-~l~~L~~l~l~------------------~l~~L~~l~ls~N~l~g----~iP~~~~~  128 (438)
                      .+..++|++|.++..-...+. .+++|+.|+++                  ..++|+.|+|++|.++.    .++..+..
T Consensus       102 ~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~  181 (372)
T 3un9_A          102 ALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAG  181 (372)
T ss_dssp             CEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHT
T ss_pred             CceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhc
Confidence            466677777777654333333 34566666542                  23568888888888763    24555567


Q ss_pred             ccccceeccccccccCC----CchhhccCCCCCeEeccCCCCCC
Q 013682          129 LKQLKYLRLNNNSLSGL----IPTSLTTITSLNILDLSNNRLSG  168 (438)
Q Consensus       129 l~~L~~l~ls~N~l~g~----~P~~l~~~~~L~~l~ls~N~l~g  168 (438)
                      +++|++|+|++|+++..    ++..+..+++|+.|||++|.++.
T Consensus       182 ~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~  225 (372)
T 3un9_A          182 NTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGD  225 (372)
T ss_dssp             CSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCH
T ss_pred             CCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCH
Confidence            77788888888887642    34556677788888888887764

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=98.43  E-value=2.1e-07  Score=90.77  Aligned_cols=92  Identities=10%  Similarity=-0.005  Sum_probs=49.8

Q ss_pred             HHHHhhhhhhhhhhcchheeecccCCcc------------ceeeeecCCCccccccchh-hccCCCCCeec---------
Q 013682           44 VLQECEQLHLLISFLIFIRVLQSSSNLF------------VYLISDLGNAALSGELAPE-LGQLKNLELLA---------  101 (438)
Q Consensus        44 ~~~~~~~l~~~~~~~~~~~~l~~~~n~~------------~~~~~~l~~n~l~g~ip~~-l~~l~~L~~l~---------  101 (438)
                      +.++++++|..+.  .+++.|++++|.+            .|..++|++|.+.+.+|.. +.+++++..+.         
T Consensus        17 ~~~~Lt~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~   94 (350)
T 4ay9_X           17 QESKVTEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLY   94 (350)
T ss_dssp             ESTTCCSCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCE
T ss_pred             cCCCCCccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccc
Confidence            4556677776552  3455555555432            3666777777776666653 34555554321         


Q ss_pred             -----cccccCCCEEEccCCcccccCchhhccccccceecc
Q 013682          102 -----LGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  137 (438)
Q Consensus       102 -----l~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~l  137 (438)
                           |+.+++|+.|++++|++.+..+..+....++..+++
T Consensus        95 l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l  135 (350)
T 4ay9_X           95 INPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDI  135 (350)
T ss_dssp             ECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEE
T ss_pred             cCchhhhhccccccccccccccccCCchhhcccchhhhhhh
Confidence                 345666667777766666333333333333344444

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.37  E-value=4e-07  Score=86.95  Aligned_cols=132  Identities=20%  Similarity=0.147  Sum_probs=90.5

Q ss_pred             CCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCC-CCC--ceeeEEEEeeCC---eeEEEEec
Q 013682          291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRN--LLRLYGFCTTVT---EKLLVYPY  364 (438)
Q Consensus       291 ~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~g~~~~~~---~~~lv~e~  364 (438)
                      .+.++.|.+..||+..    ..+++|..+..   .....+.+|++.+..+. +..  +.+++......+   ..|+|||+
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            4568999999999853    45888875432   22346889999998763 333  334444433322   34789999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH--------------------------------------  406 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------  406 (438)
                      ++|.++......      .++..++..++.+++..++.||+.                                      
T Consensus        98 i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           98 IKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             CCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             cCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            999887653322      256677778888888888888851                                      


Q ss_pred             -----------------CCCCceecCCCCCCeeeCCC--CCcchhhhh
Q 013682          407 -----------------CDPKIIHRDVKAANILLDED--ADQSSKTIL  435 (438)
Q Consensus       407 -----------------~~~~ivHrDLK~~NILld~~--~~~~l~Df~  435 (438)
                                       ..+.++|+|++|.||+++++  ....+.||-
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~  219 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFG  219 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCT
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCC
Confidence                             12458999999999999984  446788874

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.26  E-value=1.9e-07  Score=97.28  Aligned_cols=127  Identities=20%  Similarity=0.109  Sum_probs=76.3

Q ss_pred             ceeeehhHHHHHHHhhh-----hhhhhhhcchheeecccCCcc----------------ceeeeecCCCccccccchhhc
Q 013682           34 GFTLLVTLKAVLQECEQ-----LHLLISFLIFIRVLQSSSNLF----------------VYLISDLGNAALSGELAPELG   92 (438)
Q Consensus        34 ~~~~~~~l~~~~~~~~~-----l~~~~~~~~~~~~l~~~~n~~----------------~~~~~~l~~n~l~g~ip~~l~   92 (438)
                      +++.|++|+++.|.+..     ++..+..+.+|+.|+++.|.+                .|..++|++|.+.+ +|..+.
T Consensus       162 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~  240 (592)
T 3ogk_B          162 HCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFK  240 (592)
T ss_dssp             HCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHH
T ss_pred             hCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHh
Confidence            45566666666665332     344455566666666655443                26666777777665 666667


Q ss_pred             cCCCCCeeccc----------------cccCCCEEEccCCcccccCchhhccccccceeccccccccCCCc-hhhccCCC
Q 013682           93 QLKNLELLALG----------------NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIP-TSLTTITS  155 (438)
Q Consensus        93 ~l~~L~~l~l~----------------~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P-~~l~~~~~  155 (438)
                      .+++|+.|+++                .+++|+.++++++.. +.+|..+..+++|+.|++++|.+++..+ ..+..+++
T Consensus       241 ~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~  319 (592)
T 3ogk_B          241 AAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPN  319 (592)
T ss_dssp             HCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTT
T ss_pred             hhhHHHhhcccccccccchHHHHHHhhccccccccCccccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcC
Confidence            77777666542                345566666666432 3666666677777777777777654333 23456666


Q ss_pred             CCeEecc
Q 013682          156 LNILDLS  162 (438)
Q Consensus       156 L~~l~ls  162 (438)
                      |+.|+++
T Consensus       320 L~~L~L~  326 (592)
T 3ogk_B          320 LEVLETR  326 (592)
T ss_dssp             CCEEEEE
T ss_pred             CCEEecc
Confidence            7666666

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.23  E-value=1.1e-07  Score=99.16  Aligned_cols=37  Identities=14%  Similarity=0.024  Sum_probs=20.5

Q ss_pred             cceeeehhHHHHHHHhh-----hhhhhhhhcchheeecccCC
Q 013682           33 RGFTLLVTLKAVLQECE-----QLHLLISFLIFIRVLQSSSN   69 (438)
Q Consensus        33 ~~~~~~~~l~~~~~~~~-----~l~~~~~~~~~~~~l~~~~n   69 (438)
                      .+++.|++|+++.|.++     .++..+..+++|+.|+++.|
T Consensus       189 ~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~  230 (592)
T 3ogk_B          189 QHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDF  230 (592)
T ss_dssp             HHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSC
T ss_pred             hcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCc
Confidence            44556666666655553     44444555556666655544

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.22  E-value=8.3e-07  Score=83.06  Aligned_cols=68  Identities=29%  Similarity=0.348  Sum_probs=57.7

Q ss_pred             ccccCCCEEEccCCcccc--cCchhhccccccceeccccccccCCCchhhccCC--CCCeEeccCCCCCCCCCC
Q 013682          103 GNLIKLKSLDLYSNLFNG--TIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTIT--SLNILDLSNNRLSGPVPD  172 (438)
Q Consensus       103 ~~l~~L~~l~ls~N~l~g--~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~--~L~~l~ls~N~l~g~ip~  172 (438)
                      .++++|+.|+|++|++++  .+|..++.+++|+.|+|++|++++.  ..+..+.  +|+.|+|++|.+++.+|+
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~  238 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRD  238 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSS
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCc
Confidence            356678999999999997  6778889999999999999999975  3455555  899999999999988774

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.15  E-value=8.9e-06  Score=75.83  Aligned_cols=131  Identities=18%  Similarity=0.103  Sum_probs=89.1

Q ss_pred             ccccccce-EEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCC-CCCceeeEEEEeeCCeeEEEEecCCCCC
Q 013682          293 ILGRGGFG-KVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPYMTNGS  369 (438)
Q Consensus       293 ~LG~G~fG-~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~gs  369 (438)
                      .+..|..| .||+.... ++..+.+|+-+..    ....+.+|...++.+. +--+.++++++...+..++|||++++.+
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            34556665 68987764 4567888875432    2346788998887664 3346678888888899999999999988


Q ss_pred             HHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 013682          370 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH-------------------------------------------  406 (438)
Q Consensus       370 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------------------------------------------  406 (438)
                      +.+.....        ......++.+++..|.-||+.                                           
T Consensus       107 ~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (272)
T 4gkh_A          107 AFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ  178 (272)
T ss_dssp             HHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred             ccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence            76654321        112334555566666666642                                           


Q ss_pred             ------------CCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          407 ------------CDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       407 ------------~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                                  ..+.++|+|+.+.|||+++++..-|.||-
T Consensus       179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe  219 (272)
T 4gkh_A          179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVG  219 (272)
T ss_dssp             HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCT
T ss_pred             HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECc
Confidence                        01237999999999999987666677763

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.14  E-value=9.2e-06  Score=77.61  Aligned_cols=132  Identities=14%  Similarity=0.123  Sum_probs=85.2

Q ss_pred             CCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCC---CceeeEEEEe-eCCeeEEEEecCC
Q 013682          291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR---NLLRLYGFCT-TVTEKLLVYPYMT  366 (438)
Q Consensus       291 ~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lv~e~~~  366 (438)
                      .+.++.|....||+.    +..+++|.-+.   ......+.+|++++..+.+.   .+.+.+.++. ..+..+++|||++
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            356788888899987    45678887422   12234688999999988653   2456666664 3455789999999


Q ss_pred             CCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 013682          367 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH----------------------------------------  406 (438)
Q Consensus       367 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------  406 (438)
                      |.++.+....      .++..+...++.++++.|+.||+.                                        
T Consensus        97 G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~  170 (306)
T 3tdw_A           97 GQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD  170 (306)
T ss_dssp             SEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred             CeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence            9877653211      123334444444444444444432                                        


Q ss_pred             -----------------CCCCceecCCCCCCeeeCC---CCCc-chhhhh
Q 013682          407 -----------------CDPKIIHRDVKAANILLDE---DADQ-SSKTIL  435 (438)
Q Consensus       407 -----------------~~~~ivHrDLK~~NILld~---~~~~-~l~Df~  435 (438)
                                       ..+.++|+|+++.||++++   ++.. .+.||-
T Consensus       171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~  220 (306)
T 3tdw_A          171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFG  220 (306)
T ss_dssp             HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCT
T ss_pred             HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehh
Confidence                             2345799999999999997   3543 678874

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.12  E-value=9e-07  Score=86.78  Aligned_cols=65  Identities=18%  Similarity=0.315  Sum_probs=37.0

Q ss_pred             cccCCCEEEccC--Cccccc-----Cchhh--ccccccceeccccccccCCCchhhc---cCCCCCeEeccCCCCCC
Q 013682          104 NLIKLKSLDLYS--NLFNGT-----IPDTL--ANLKQLKYLRLNNNSLSGLIPTSLT---TITSLNILDLSNNRLSG  168 (438)
Q Consensus       104 ~l~~L~~l~ls~--N~l~g~-----iP~~~--~~l~~L~~l~ls~N~l~g~~P~~l~---~~~~L~~l~ls~N~l~g  168 (438)
                      .+++|+.|+|+.  |...|.     +.+.+  +.+++|+.|+|++|.++...+..+.   .+++|+.|||+.|.+++
T Consensus       217 ~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d  293 (362)
T 2ra8_A          217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTD  293 (362)
T ss_dssp             BCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBH
T ss_pred             cCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCCh
Confidence            466777777653  222111     11112  2456777777777777654444443   36677777777777765

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=98.12  E-value=1.3e-07  Score=98.58  Aligned_cols=60  Identities=18%  Similarity=0.256  Sum_probs=27.8

Q ss_pred             CCCEEEccCCcccccCchhhcc-ccccceeccccccccCCCchhh-ccCCCCCeEeccCCCCC
Q 013682          107 KLKSLDLYSNLFNGTIPDTLAN-LKQLKYLRLNNNSLSGLIPTSL-TTITSLNILDLSNNRLS  167 (438)
Q Consensus       107 ~L~~l~ls~N~l~g~iP~~~~~-l~~L~~l~ls~N~l~g~~P~~l-~~~~~L~~l~ls~N~l~  167 (438)
                      +|+.|++++ ++++..+..++. +++|+.|+|++|.+++..+..+ ..+++|+.|++++|.++
T Consensus       433 ~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~  494 (594)
T 2p1m_B          433 DLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFG  494 (594)
T ss_dssp             TCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCC
T ss_pred             CccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCc
Confidence            344444433 333333333333 4555555555555544333333 34555555555555553

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.10  E-value=2.3e-06  Score=79.99  Aligned_cols=78  Identities=26%  Similarity=0.283  Sum_probs=60.8

Q ss_pred             ccceeeeecCCCcccc--ccchhhccCCCCCeeccccccCCCEEEccCCcccccCchhhcccc--ccceeccccccccCC
Q 013682           70 LFVYLISDLGNAALSG--ELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLK--QLKYLRLNNNSLSGL  145 (438)
Q Consensus        70 ~~~~~~~~l~~n~l~g--~ip~~l~~l~~L~~l~l~~l~~L~~l~ls~N~l~g~iP~~~~~l~--~L~~l~ls~N~l~g~  145 (438)
                      +..|..|+|++|++++  .+|..+..+           ++|+.|+|++|++++.  +++..+.  +|+.|+|++|.+++.
T Consensus       169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l-----------~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~  235 (267)
T 3rw6_A          169 IPELLSLNLSNNRLYRLDDMSSIVQKA-----------PNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDT  235 (267)
T ss_dssp             CTTCCEEECTTSCCCCCGGGTTHHHHS-----------TTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGG
T ss_pred             CCCCCEEECCCCCCCCCccchhHHhhC-----------CCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccc
Confidence            4568888899998887  455555444           4677799999999854  4566666  899999999999988


Q ss_pred             Cch-------hhccCCCCCeEe
Q 013682          146 IPT-------SLTTITSLNILD  160 (438)
Q Consensus       146 ~P~-------~l~~~~~L~~l~  160 (438)
                      +|.       .+..+++|+.||
T Consensus       236 ~~~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          236 FRDQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             CSSHHHHHHHHHHHCTTCCEES
T ss_pred             cCcchhHHHHHHHHCcccCeEC
Confidence            773       467899999886

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.10  E-value=1.4e-06  Score=85.73  Aligned_cols=109  Identities=19%  Similarity=0.167  Sum_probs=67.2

Q ss_pred             chheeecccCCcc-------------ceeeeecCCCccccccchhhc-----cCCCCCeeccc-----------------
Q 013682           59 IFIRVLQSSSNLF-------------VYLISDLGNAALSGELAPELG-----QLKNLELLALG-----------------  103 (438)
Q Consensus        59 ~~~~~l~~~~n~~-------------~~~~~~l~~n~l~g~ip~~l~-----~l~~L~~l~l~-----------------  103 (438)
                      ..++.|+++.|.+             .+..++|++|.++..-...++     ..++|+.|+++                 
T Consensus       101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~  180 (372)
T 3un9_A          101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA  180 (372)
T ss_dssp             SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred             CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence            4666777776654             256677777777654444432     34566666542                 


Q ss_pred             cccCCCEEEccCCccccc----CchhhccccccceeccccccccCC----CchhhccCCCCCeEeccCCCCC
Q 013682          104 NLIKLKSLDLYSNLFNGT----IPDTLANLKQLKYLRLNNNSLSGL----IPTSLTTITSLNILDLSNNRLS  167 (438)
Q Consensus       104 ~l~~L~~l~ls~N~l~g~----iP~~~~~l~~L~~l~ls~N~l~g~----~P~~l~~~~~L~~l~ls~N~l~  167 (438)
                      .+++|++|+|++|.++..    ++..+...++|+.|+|++|+++..    ++..+..+++|+.|||++|.++
T Consensus       181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~  252 (372)
T 3un9_A          181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS  252 (372)
T ss_dssp             TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCC
T ss_pred             cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCC
Confidence            245677777777776532    355566666777777777777642    3344455677777777777665

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.97  E-value=8e-06  Score=79.52  Aligned_cols=80  Identities=8%  Similarity=-0.019  Sum_probs=53.1

Q ss_pred             Ccc-ccccceEEEEEEeC-------CCCEEEEEEcccccc--ccchHHHHHHHHHHhcCC-C--CCceeeEEEEeeC---
Q 013682          292 NIL-GRGGFGKVYKGRLA-------DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAV-H--RNLLRLYGFCTTV---  355 (438)
Q Consensus       292 ~~L-G~G~fG~Vy~~~~~-------~~~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~---  355 (438)
                      +.| +.|....+|+....       +++.+++|.-.....  ......+.+|+.++..+. +  -.+.++++++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            456 78888999988754       256788887643220  101235788888887764 2  3466777777654   


Q ss_pred             CeeEEEEecCCCCCHH
Q 013682          356 TEKLLVYPYMTNGSVA  371 (438)
Q Consensus       356 ~~~~lv~e~~~~gsL~  371 (438)
                      +..+++|||+++..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3468999999886543

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=97.90  E-value=3.3e-06  Score=81.43  Aligned_cols=57  Identities=32%  Similarity=0.384  Sum_probs=33.0

Q ss_pred             ccCCCEEEccCCcccccCch-hhccccccceeccccccccCCCchhhccCCCCC-eEeccC
Q 013682          105 LIKLKSLDLYSNLFNGTIPD-TLANLKQLKYLRLNNNSLSGLIPTSLTTITSLN-ILDLSN  163 (438)
Q Consensus       105 l~~L~~l~ls~N~l~g~iP~-~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~-~l~ls~  163 (438)
                      +++|+.++|++|+++ .||+ .|.++++|+.+++++| ++..-+..|.+|++|+ .+++++
T Consensus       225 ~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~  283 (329)
T 3sb4_A          225 MPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA  283 (329)
T ss_dssp             CTTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT
T ss_pred             cCCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc
Confidence            456666666666665 4443 4566666666666665 4433344556666666 666655

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=97.88  E-value=1.2e-06  Score=91.18  Aligned_cols=35  Identities=11%  Similarity=0.020  Sum_probs=17.2

Q ss_pred             eeeehhHHHHHH-Hhhh--hhhhhhhcchheeecccCC
Q 013682           35 FTLLVTLKAVLQ-ECEQ--LHLLISFLIFIRVLQSSSN   69 (438)
Q Consensus        35 ~~~~~~l~~~~~-~~~~--l~~~~~~~~~~~~l~~~~n   69 (438)
                      ++.|++|+++.+ .++.  ++..+..+.+|+.|+++.|
T Consensus       129 ~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~  166 (594)
T 2p1m_B          129 FKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRES  166 (594)
T ss_dssp             CTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTC
T ss_pred             CCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCC
Confidence            445555554443 2222  4444455556666665544

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.83  E-value=6.9e-05  Score=70.63  Aligned_cols=77  Identities=17%  Similarity=0.232  Sum_probs=53.8

Q ss_pred             CCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCC---CceeeEEEEeeCCeeEEEEec
Q 013682          288 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR---NLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       288 ~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~~~~~lv~e~  364 (438)
                      ....+.+|.|..+.||+.+..||+.|.+|+-.... ......|.+|++.|+.+.-.   .+.+++++    +..+++|||
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~   91 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW   91 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence            34456789999999999999999999999865432 22223578999988877422   23444443    234789999


Q ss_pred             CCCCC
Q 013682          365 MTNGS  369 (438)
Q Consensus       365 ~~~gs  369 (438)
                      ++++.
T Consensus        92 l~~~~   96 (288)
T 3f7w_A           92 VDERP   96 (288)
T ss_dssp             CCCCC
T ss_pred             ecccC
Confidence            98764

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=97.79  E-value=1.2e-05  Score=77.45  Aligned_cols=72  Identities=19%  Similarity=0.242  Sum_probs=60.0

Q ss_pred             CCCCCeecc-------------ccccCCCEEEccCCcccccCc-hhhccccccc-eeccccccccCCCchhhccCCCCCe
Q 013682           94 LKNLELLAL-------------GNLIKLKSLDLYSNLFNGTIP-DTLANLKQLK-YLRLNNNSLSGLIPTSLTTITSLNI  158 (438)
Q Consensus        94 l~~L~~l~l-------------~~l~~L~~l~ls~N~l~g~iP-~~~~~l~~L~-~l~ls~N~l~g~~P~~l~~~~~L~~  158 (438)
                      +++|+.+++             .+|.+|+.++|++| +. .|+ ..|.++++|+ .+++++ +++..-+..|.+|++|+.
T Consensus       225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~  301 (329)
T 3sb4_A          225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRY  301 (329)
T ss_dssp             CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEE
T ss_pred             cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCE
Confidence            677777754             56889999999998 76 555 5799999999 999998 777555789999999999


Q ss_pred             EeccCCCCCC
Q 013682          159 LDLSNNRLSG  168 (438)
Q Consensus       159 l~ls~N~l~g  168 (438)
                      +++++|.++.
T Consensus       302 l~l~~n~i~~  311 (329)
T 3sb4_A          302 VLATGDKITT  311 (329)
T ss_dssp             EEECSSCCCE
T ss_pred             EEeCCCccCc
Confidence            9999998874

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=97.78  E-value=1.3e-05  Score=70.57  Aligned_cols=62  Identities=26%  Similarity=0.316  Sum_probs=38.3

Q ss_pred             cCCCEEEccCCccccc----Cchhhccccccceecc--ccccccCC----CchhhccCCCCCeEeccCCCCC
Q 013682          106 IKLKSLDLYSNLFNGT----IPDTLANLKQLKYLRL--NNNSLSGL----IPTSLTTITSLNILDLSNNRLS  167 (438)
Q Consensus       106 ~~L~~l~ls~N~l~g~----iP~~~~~l~~L~~l~l--s~N~l~g~----~P~~l~~~~~L~~l~ls~N~l~  167 (438)
                      ++|++|+|++|.++..    +...+...+.|+.|+|  ++|.++..    +...+...++|+.|++++|.+.
T Consensus        93 ~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A           93 NTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             SSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             CCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            4566777777777643    4555666667777777  66776533    2334455567777777776653

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.78  E-value=5.6e-05  Score=72.65  Aligned_cols=139  Identities=16%  Similarity=0.203  Sum_probs=75.2

Q ss_pred             CccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcC-----CCCCceeeE-E--EEeeCCeeEEEEe
Q 013682          292 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-----VHRNLLRLY-G--FCTTVTEKLLVYP  363 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~-g--~~~~~~~~~lv~e  363 (438)
                      +.++.|..+.||+....++ .+++|+....     ......|...+..+     ..|.++.-. |  +....+..+++||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC-----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC-----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            3465577889999987554 5889987542     12333444444433     234444311 1  1124566789999


Q ss_pred             cCCCCCHH--------------HHhhccCC----C-C-----CCCCHHHHH-----------------------------
Q 013682          364 YMTNGSVA--------------SRLRERQS----S-L-----PPLDWPTRK-----------------------------  390 (438)
Q Consensus       364 ~~~~gsL~--------------~~l~~~~~----~-~-----~~l~~~~~~-----------------------------  390 (438)
                      |++|..+.              ..++....    . .     ..-.|....                             
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986431              11221100    0 0     012343211                             


Q ss_pred             --HHHHHHHHHHHHHhc----------CCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          391 --KIALGSARGLSYLHE----------HCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       391 --~i~~~ia~gL~yLH~----------~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                        .+...+..++++|+.          ...+.++|+|+++.|||+++++.+.+.||-.
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~  249 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDT  249 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTT
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhh
Confidence              011123346667763          1245899999999999998888888998853

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.78  E-value=7.2e-05  Score=73.95  Aligned_cols=76  Identities=11%  Similarity=0.031  Sum_probs=48.3

Q ss_pred             CCccccccceEEEEEEeC-CCCEEEEEEcccccc------ccchHHHHHHHHHHhcCCC--CCc-eeeEEEEeeCCeeEE
Q 013682          291 KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT------SGGELQFQTEVKIISMAVH--RNL-LRLYGFCTTVTEKLL  360 (438)
Q Consensus       291 ~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~------~~~~~~~~~E~~~l~~l~H--~ni-v~l~g~~~~~~~~~l  360 (438)
                      .+.+|.|.++.||++... +++.++||.......      ......+..|.+.+..+..  |.. .+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            357899999999999754 467899998643211      1122346778888876632  333 355543  3455689


Q ss_pred             EEecCCCC
Q 013682          361 VYPYMTNG  368 (438)
Q Consensus       361 v~e~~~~g  368 (438)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.67  E-value=0.00012  Score=70.02  Aligned_cols=138  Identities=16%  Similarity=0.167  Sum_probs=89.6

Q ss_pred             CCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCC---CCCceeeEEEEeeCCeeEEEEecCCC
Q 013682          291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV---HRNLLRLYGFCTTVTEKLLVYPYMTN  367 (438)
Q Consensus       291 ~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv~e~~~~  367 (438)
                      .+.++.|.+..+|+... ++..+++|.....    ....+.+|.+.++.+.   ...+.+++.++...+..++||||+++
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            45689999999999886 4667888976432    2346888988887764   35677888888877889999999998


Q ss_pred             CCHH-----------HHhhccCC-CC-----------------CCCCHHHHH---HHHHH----------------HH-H
Q 013682          368 GSVA-----------SRLRERQS-SL-----------------PPLDWPTRK---KIALG----------------SA-R  398 (438)
Q Consensus       368 gsL~-----------~~l~~~~~-~~-----------------~~l~~~~~~---~i~~~----------------ia-~  398 (438)
                      ..+.           ..++.... ..                 -.-+|.+..   ++..+                +. .
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            7531           12222211 00                 012465432   11111                11 1


Q ss_pred             HHHHHhc-CCCCCceecCCCCCCeeeCCCCCcchhhh
Q 013682          399 GLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTI  434 (438)
Q Consensus       399 gL~yLH~-~~~~~ivHrDLK~~NILld~~~~~~l~Df  434 (438)
                      ....|.. ...|.++|+|+.+.|+++++++ +.+.|+
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~  231 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNP  231 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcC
Confidence            1233432 3367899999999999999887 777775

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.26  E-value=0.00094  Score=66.44  Aligned_cols=74  Identities=14%  Similarity=0.093  Sum_probs=45.0

Q ss_pred             CCccccccceEEEEEEeCCCCEEEEEEccccc---cc-----cchHHHHHHHHHHh-cCCCCCceeeEEEEeeCCeeEEE
Q 013682          291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEER---TS-----GGELQFQTEVKIIS-MAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       291 ~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~---~~-----~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      .+.+|.|..+.||+... +++.++||......   ..     .....++.|+..+. ...+..+.+++.+.  .+..++|
T Consensus        39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv  115 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG  115 (420)
T ss_dssp             EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred             EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence            45689999999999975 46789999532211   01     12223444544332 22234556666654  5667999


Q ss_pred             EecC-CC
Q 013682          362 YPYM-TN  367 (438)
Q Consensus       362 ~e~~-~~  367 (438)
                      |||+ ++
T Consensus       116 ~e~l~~g  122 (420)
T 2pyw_A          116 MRYLEPP  122 (420)
T ss_dssp             ECCCCTT
T ss_pred             EeecCCc
Confidence            9999 76

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=97.02  E-value=0.00034  Score=61.38  Aligned_cols=92  Identities=20%  Similarity=0.158  Sum_probs=63.7

Q ss_pred             ccceeeeecCCC-ccccccchhhccCCCCCeeccccccCCCEEEccCCccccc----CchhhccccccceeccccccccC
Q 013682           70 LFVYLISDLGNA-ALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGT----IPDTLANLKQLKYLRLNNNSLSG  144 (438)
Q Consensus        70 ~~~~~~~~l~~n-~l~g~ip~~l~~l~~L~~l~l~~l~~L~~l~ls~N~l~g~----iP~~~~~l~~L~~l~ls~N~l~g  144 (438)
                      ...+..++|++| .++..--..++..       +...++|++|+|++|.+...    +...+...+.|++|+|++|+++.
T Consensus        35 ~~~L~~L~L~~n~~i~~~g~~~l~~~-------L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~  107 (185)
T 1io0_A           35 DPDLEEVNLNNIMNIPVPTLKACAEA-------LKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG  107 (185)
T ss_dssp             CTTCCEEECTTCTTCCHHHHHHHHHH-------HTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred             CCCCCEEEecCCCCCCHHHHHHHHHH-------HHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence            345666777777 6664322222211       12345678899999998743    45556667889999999999975


Q ss_pred             C----CchhhccCCCCCeEec--cCCCCCC
Q 013682          145 L----IPTSLTTITSLNILDL--SNNRLSG  168 (438)
Q Consensus       145 ~----~P~~l~~~~~L~~l~l--s~N~l~g  168 (438)
                      .    +...+...++|+.|++  ++|.++.
T Consensus       108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~  137 (185)
T 1io0_A          108 SGILALVEALQSNTSLIELRIDNQSQPLGN  137 (185)
T ss_dssp             HHHHHHHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred             HHHHHHHHHHHhCCCceEEEecCCCCCCCH
Confidence            3    4567788889999999  7888763

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=96.92  E-value=0.00036  Score=68.15  Aligned_cols=81  Identities=20%  Similarity=0.237  Sum_probs=38.9

Q ss_pred             cchhhccCCCCCeeccc-c---------ccCCCEEEccCCcccccCchhhc--cccccceecccc--ccccCC-----Cc
Q 013682           87 LAPELGQLKNLELLALG-N---------LIKLKSLDLYSNLFNGTIPDTLA--NLKQLKYLRLNN--NSLSGL-----IP  147 (438)
Q Consensus        87 ip~~l~~l~~L~~l~l~-~---------l~~L~~l~ls~N~l~g~iP~~~~--~l~~L~~l~ls~--N~l~g~-----~P  147 (438)
                      ++.-+..+++|+.|.+. +         +++|+.|+|..+.++......++  .+++|+.|+|+.  |...|.     +.
T Consensus       164 L~~ll~~~P~L~~L~L~g~~~l~l~~~~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~  243 (362)
T 2ra8_A          164 LSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFR  243 (362)
T ss_dssp             CHHHHHTCTTCCEEEEECCBTCBCCSCBCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTG
T ss_pred             HHHHHhcCCCCcEEEEeCCCCceeccccCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHH
Confidence            44444555555555441 1         34566666666555433333333  456666666642  222111     01


Q ss_pred             hhh--ccCCCCCeEeccCCCCC
Q 013682          148 TSL--TTITSLNILDLSNNRLS  167 (438)
Q Consensus       148 ~~l--~~~~~L~~l~ls~N~l~  167 (438)
                      ..+  ..+++|+.|++++|.++
T Consensus       244 ~~l~~~~~p~Lr~L~L~~~~i~  265 (362)
T 2ra8_A          244 PLFSKDRFPNLKWLGIVDAEEQ  265 (362)
T ss_dssp             GGSCTTTCTTCCEEEEESCTTH
T ss_pred             HHHhcCCCCCcCEEeCCCCCCc
Confidence            111  23566666666666654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.67  E-value=0.0037  Score=59.03  Aligned_cols=69  Identities=9%  Similarity=0.011  Sum_probs=41.7

Q ss_pred             CCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCc-eeeEEEEeeCCeeEEEEecC-CCC
Q 013682          291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL-LRLYGFCTTVTEKLLVYPYM-TNG  368 (438)
Q Consensus       291 ~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e~~-~~g  368 (438)
                      .+.|+.|....+|+.     +.+.+|+..... . ......+|...+..+....+ .++++.  ..+.-++++||+ ++.
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~-~-~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGT-E-EYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCc-c-ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence            577888999999998     457888764321 1 11234567777765542222 344443  344457899999 543

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.66  E-value=0.0036  Score=59.94  Aligned_cols=76  Identities=12%  Similarity=0.037  Sum_probs=37.5

Q ss_pred             CccccccceE-EEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCC--CCceeeEEEEeeCCeeEEEEecCCCC
Q 013682          292 NILGRGGFGK-VYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH--RNLLRLYGFCTTVTEKLLVYPYMTNG  368 (438)
Q Consensus       292 ~~LG~G~fG~-Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lv~e~~~~g  368 (438)
                      +.++.|+... +|+....+++.+.+|.......    ..+..|+.++..+..  -.+.+++.+....  -+++||++.+.
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~   97 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDA   97 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSC
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCc
Confidence            4465565554 6677654466777776533210    234456666555432  2345566553322  37899999776


Q ss_pred             CHHHH
Q 013682          369 SVASR  373 (438)
Q Consensus       369 sL~~~  373 (438)
                      .+.+.
T Consensus        98 ~l~~~  102 (333)
T 3csv_A           98 LFTEV  102 (333)
T ss_dssp             BHHHH
T ss_pred             chHHH
Confidence            66543

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.61  E-value=0.0024  Score=60.69  Aligned_cols=154  Identities=8%  Similarity=0.043  Sum_probs=79.2

Q ss_pred             HHHHHHHhCCCCC-----CCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCC--ceeeEE
Q 013682          278 LRELQVATDGFSN-----KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN--LLRLYG  350 (438)
Q Consensus       278 ~~~~~~~~~~~~~-----~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g  350 (438)
                      .+++......|..     .+.++.|....+|+....++ .+++|......   ....+..|..++..+....  +.+++.
T Consensus         9 ~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~---~~~~l~~e~~~l~~L~~~g~~vP~~~~   84 (322)
T 2ppq_A            9 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLPLP   84 (322)
T ss_dssp             HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             HHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC---CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence            3444444444543     23466788889999987655 57788875421   1124556666665543211  222221


Q ss_pred             E------EeeCCeeEEEEecCCCCCHH--------------HHhhccCCC--CC---C---CCHHHHHH-----------
Q 013682          351 F------CTTVTEKLLVYPYMTNGSVA--------------SRLRERQSS--LP---P---LDWPTRKK-----------  391 (438)
Q Consensus       351 ~------~~~~~~~~lv~e~~~~gsL~--------------~~l~~~~~~--~~---~---l~~~~~~~-----------  391 (438)
                      .      ....+..+++|+|++|..+.              ..++.....  ..   .   ..|.....           
T Consensus        85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~  164 (322)
T 2ppq_A           85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  164 (322)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence            1      11235568999999875421              012211000  00   0   12332111           


Q ss_pred             -HHHHHHHHHHHHhcC----CCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          392 -IALGSARGLSYLHEH----CDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       392 -i~~~ia~gL~yLH~~----~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                       +...+...+++++..    ..+.++|+|+.+.|||++++....+.||-
T Consensus       165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~  213 (322)
T 2ppq_A          165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFY  213 (322)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCT
T ss_pred             hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecch
Confidence             011234455555532    23478999999999999987555788884

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.49  E-value=0.0036  Score=51.53  Aligned_cols=57  Identities=21%  Similarity=0.287  Sum_probs=39.9

Q ss_pred             CEEEccCCccc-ccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCC
Q 013682          109 KSLDLYSNLFN-GTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS  167 (438)
Q Consensus       109 ~~l~ls~N~l~-g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~  167 (438)
                      ..++.+++.++ ..+|..+.  .+|+.|+|++|+++...+..+..+++|+.|+|++|.+.
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            35677777774 35665432  35778888888888665666777888888888888664

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=96.37  E-value=0.0015  Score=64.71  Aligned_cols=55  Identities=13%  Similarity=0.184  Sum_probs=30.5

Q ss_pred             CCCEEEccCCcccccC-chhhccccccceecccccccc-----CCCchhhccCCCCCeEeccC
Q 013682          107 KLKSLDLYSNLFNGTI-PDTLANLKQLKYLRLNNNSLS-----GLIPTSLTTITSLNILDLSN  163 (438)
Q Consensus       107 ~L~~l~ls~N~l~g~i-P~~~~~l~~L~~l~ls~N~l~-----g~~P~~l~~~~~L~~l~ls~  163 (438)
                      +|+.+.+. |.++ .| +..|.++++|+.+++.+|.+.     ..-+..+..|++|+.+++.+
T Consensus       249 ~L~~i~lp-~~i~-~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~  309 (401)
T 4fdw_A          249 GITTVKLP-NGVT-NIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE  309 (401)
T ss_dssp             CCSEEEEE-TTCC-EECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT
T ss_pred             CccEEEeC-CCcc-EEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC
Confidence            45555552 3343 33 345666667777776666554     12234566666666666653

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.34  E-value=0.016  Score=55.06  Aligned_cols=74  Identities=19%  Similarity=0.117  Sum_probs=45.8

Q ss_pred             CccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCC--CceeeEEE-----EeeCCeeEEEEec
Q 013682          292 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR--NLLRLYGF-----CTTVTEKLLVYPY  364 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~-----~~~~~~~~lv~e~  364 (438)
                      ..++ |....||+....+|+.+++|..+...  .....+..|...+..+...  .+.+++..     ....+..+++|||
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~--~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC--CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            3466 77789999877667789999875321  1233566777776655321  23334332     1224456789999


Q ss_pred             CCCC
Q 013682          365 MTNG  368 (438)
Q Consensus       365 ~~~g  368 (438)
                      +++.
T Consensus       109 i~G~  112 (328)
T 1zyl_A          109 VGGR  112 (328)
T ss_dssp             CCCE
T ss_pred             cCCC
Confidence            9874

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.31  E-value=0.0056  Score=61.11  Aligned_cols=70  Identities=19%  Similarity=0.262  Sum_probs=46.1

Q ss_pred             CccccccceEEEEEEeCC--------CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCc-eeeEEEEeeCCeeEEEE
Q 013682          292 NILGRGGFGKVYKGRLAD--------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL-LRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~--------~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~  362 (438)
                      +.|+.|....+|+....+        ++.+.+|+....   .....+.+|..++..+...++ .++++.+.  +  .+|+
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~  151 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE  151 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence            457778889999998753        467888887331   111345678888877643333 56666553  2  3899


Q ss_pred             ecCCCC
Q 013682          363 PYMTNG  368 (438)
Q Consensus       363 e~~~~g  368 (438)
                      ||+++.
T Consensus       152 e~l~G~  157 (429)
T 1nw1_A          152 EYIPSR  157 (429)
T ss_dssp             CCCCEE
T ss_pred             EEeCCc
Confidence            999863

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=95.90  E-value=0.021  Score=57.39  Aligned_cols=71  Identities=17%  Similarity=0.177  Sum_probs=45.0

Q ss_pred             CccccccceEEEEEEeCC-CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCc-eeeEEEEeeCCeeEEEEecCCCC
Q 013682          292 NILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL-LRLYGFCTTVTEKLLVYPYMTNG  368 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~-~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e~~~~g  368 (438)
                      +.|+.|-...+|+....+ +..+.+|+.... . ....+..+|..++..+...++ .++++.+.  +  .+||||+++.
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~-~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~  186 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPK-T-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY  186 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC--C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCC-h-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence            457778888999998764 467888876332 1 111123678888887765444 46676662  2  3599999864

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=95.78  E-value=0.01  Score=57.65  Aligned_cols=71  Identities=7%  Similarity=0.008  Sum_probs=41.0

Q ss_pred             CccccccceEEEEEEeCC---------CCEEEEEEccccccccchHHHHHHHHHHhcCCCCC-ceeeEEEEeeCCeeEEE
Q 013682          292 NILGRGGFGKVYKGRLAD---------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN-LLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~---------~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lv  361 (438)
                      +.++.|....+|+....+         ++.+.+|+......  ...+...|..++..+...+ ..++++..  .  -+++
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            456778888999998753         26788887643211  1113467777777664333 34566543  2  3789


Q ss_pred             EecCCCC
Q 013682          362 YPYMTNG  368 (438)
Q Consensus       362 ~e~~~~g  368 (438)
                      |||+++.
T Consensus       113 ~e~i~G~  119 (369)
T 3c5i_A          113 EEWLYGD  119 (369)
T ss_dssp             EECCCSE
T ss_pred             EEEecCC
Confidence            9999874

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=95.75  E-value=0.012  Score=48.37  Aligned_cols=55  Identities=24%  Similarity=0.363  Sum_probs=41.6

Q ss_pred             eeecCCCccc-cccchhhccCCCCCeeccccccCCCEEEccCCcccccCc-hhhccccccceecccccccc
Q 013682           75 ISDLGNAALS-GELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIP-DTLANLKQLKYLRLNNNSLS  143 (438)
Q Consensus        75 ~~~l~~n~l~-g~ip~~l~~l~~L~~l~l~~l~~L~~l~ls~N~l~g~iP-~~~~~l~~L~~l~ls~N~l~  143 (438)
                      ..+-+++.|+ ..+|..+             ..+|+.|+|++|+|+ .+| ..|..+++|+.|+|++|.+.
T Consensus        12 ~v~Cs~~~L~~~~vP~~l-------------p~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAF-------------PVDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCC-------------CTTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCC-------------CcCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence            3466667776 3467432             346889999999999 665 46788999999999999874

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=95.45  E-value=0.0082  Score=52.02  Aligned_cols=85  Identities=13%  Similarity=0.098  Sum_probs=53.6

Q ss_pred             ccceeeeecCCCccccccchhhccCCCCCeeccccccCCCEEEccCCc-ccccCchhhccc----cccceecccccc-cc
Q 013682           70 LFVYLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNL-FNGTIPDTLANL----KQLKYLRLNNNS-LS  143 (438)
Q Consensus        70 ~~~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~~l~~L~~l~ls~N~-l~g~iP~~~~~l----~~L~~l~ls~N~-l~  143 (438)
                      .+.+..+||+++.++-.--..+.           .+++|+.|+|+++. ++..-=..++.+    ++|+.|+|+++. ++
T Consensus        60 ~~~L~~LDLs~~~Itd~GL~~L~-----------~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~IT  128 (176)
T 3e4g_A           60 KYKIQAIDATDSCIMSIGFDHME-----------GLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVT  128 (176)
T ss_dssp             CCCEEEEEEESCCCCGGGGGGGT-----------TCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCC
T ss_pred             CceEeEEeCcCCCccHHHHHHhc-----------CCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCC
Confidence            35678888888776543223333           44556666666663 443322344443    479999999875 65


Q ss_pred             CCCchhhccCCCCCeEeccCCC
Q 013682          144 GLIPTSLTTITSLNILDLSNNR  165 (438)
Q Consensus       144 g~~P~~l~~~~~L~~l~ls~N~  165 (438)
                      ..-=..++++++|+.|++++..
T Consensus       129 D~Gl~~L~~~~~L~~L~L~~c~  150 (176)
T 3e4g_A          129 DKGIIALHHFRNLKYLFLSDLP  150 (176)
T ss_dssp             HHHHHHGGGCTTCCEEEEESCT
T ss_pred             HHHHHHHhcCCCCCEEECCCCC
Confidence            3323457788999999998753

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=95.38  E-value=0.04  Score=53.85  Aligned_cols=137  Identities=14%  Similarity=0.157  Sum_probs=74.6

Q ss_pred             CccccccceEEEEEEeCC--------CCEEEEEEccccccccchHHHHHHHHHHhcCCCCC-ceeeEEEEeeCCeeEEEE
Q 013682          292 NILGRGGFGKVYKGRLAD--------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN-LLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~--------~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lv~  362 (438)
                      +.+..|-...+|+....+        ++.+.+|+... . ........+|..+++.+.-.. ..++++.+..    .+||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-I-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-c-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            456667788899988742        46788887522 1 123345678988887664222 3556665543    3999


Q ss_pred             ecCCCCCHH--------------HH---hhccCCC-CCCCC--HHHHHHHHHHHH-------------------HHHHHH
Q 013682          363 PYMTNGSVA--------------SR---LRERQSS-LPPLD--WPTRKKIALGSA-------------------RGLSYL  403 (438)
Q Consensus       363 e~~~~gsL~--------------~~---l~~~~~~-~~~l~--~~~~~~i~~~ia-------------------~gL~yL  403 (438)
                      ||+++..+.              +.   ++..... .....  |.+..++..++.                   ..++.|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            999875432              11   1111110 11122  344444443321                   122333


Q ss_pred             ----hcC-CCCCceecCCCCCCeeeCCC----CCcchhhh
Q 013682          404 ----HEH-CDPKIIHRDVKAANILLDED----ADQSSKTI  434 (438)
Q Consensus       404 ----H~~-~~~~ivHrDLK~~NILld~~----~~~~l~Df  434 (438)
                          ... ....++|+|+.+.||+++++    +.+.+.||
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDw  249 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDF  249 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCC
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEec
Confidence                221 23468999999999999877    57788886

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=94.43  E-value=0.12  Score=49.49  Aligned_cols=28  Identities=18%  Similarity=0.215  Sum_probs=24.1

Q ss_pred             CCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          408 DPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       408 ~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      .+.++|+|+.+.||++++++.+.+.||-
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e  232 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWD  232 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCS
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECC
Confidence            3479999999999999988888888873

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=94.28  E-value=0.17  Score=49.74  Aligned_cols=91  Identities=13%  Similarity=0.197  Sum_probs=56.2

Q ss_pred             ceeeeecCCCccccccchhhccCCCCCeec------------cccccCCCEEEccCCcccccCch-hhccccccceeccc
Q 013682           72 VYLISDLGNAALSGELAPELGQLKNLELLA------------LGNLIKLKSLDLYSNLFNGTIPD-TLANLKQLKYLRLN  138 (438)
Q Consensus        72 ~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~------------l~~l~~L~~l~ls~N~l~g~iP~-~~~~l~~L~~l~ls  138 (438)
                      .|..++|++|.++- ||.....+.+|+.+.            |.+|.+|+.+++..| ++ .|+. .|.+ .+|+.+.+ 
T Consensus       181 ~L~~l~l~~n~l~~-I~~~aF~~~~L~~l~lp~~l~~I~~~aF~~~~~L~~l~l~~~-l~-~I~~~aF~~-~~L~~i~l-  255 (401)
T 4fdw_A          181 NLKKADLSKTKITK-LPASTFVYAGIEEVLLPVTLKEIGSQAFLKTSQLKTIEIPEN-VS-TIGQEAFRE-SGITTVKL-  255 (401)
T ss_dssp             TCCEEECTTSCCSE-ECTTTTTTCCCSEEECCTTCCEECTTTTTTCTTCCCEECCTT-CC-EECTTTTTT-CCCSEEEE-
T ss_pred             cCCeeecCCCcceE-echhhEeecccCEEEeCCchheehhhHhhCCCCCCEEecCCC-cc-Ccccccccc-CCccEEEe-
Confidence            35556666666553 555555555555553            345667777777764 44 4443 4444 66777777 


Q ss_pred             cccccCCCchhhccCCCCCeEeccCCCCC
Q 013682          139 NNSLSGLIPTSLTTITSLNILDLSNNRLS  167 (438)
Q Consensus       139 ~N~l~g~~P~~l~~~~~L~~l~ls~N~l~  167 (438)
                      .|.++..-+..+..|++|+.+++.+|.+.
T Consensus       256 p~~i~~I~~~aF~~c~~L~~l~l~~~~~~  284 (401)
T 4fdw_A          256 PNGVTNIASRAFYYCPELAEVTTYGSTFN  284 (401)
T ss_dssp             ETTCCEECTTTTTTCTTCCEEEEESSCCC
T ss_pred             CCCccEEChhHhhCCCCCCEEEeCCcccc
Confidence            34455444567788888888888887765

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=93.49  E-value=0.066  Score=47.16  Aligned_cols=90  Identities=14%  Similarity=0.117  Sum_probs=51.4

Q ss_pred             CCccceeeeecCCC-ccccccchhhccCCCCCeeccccccCCCEEEccCCccccc----Cchhhccccccceeccccccc
Q 013682           68 SNLFVYLISDLGNA-ALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGT----IPDTLANLKQLKYLRLNNNSL  142 (438)
Q Consensus        68 ~n~~~~~~~~l~~n-~l~g~ip~~l~~l~~L~~l~l~~l~~L~~l~ls~N~l~g~----iP~~~~~l~~L~~l~ls~N~l  142 (438)
                      .|..+|..++|++| .+..+--..++..       +..-+.|+.|+|++|.+...    |-+.+..-+.|+.|+|++|++
T Consensus        38 ~~n~~L~~L~L~~nn~igd~ga~~la~a-------L~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~I  110 (197)
T 1pgv_A           38 EDDTDLKEVNINNMKRVSKERIRSLIEA-------ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFL  110 (197)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHH-------HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBC
T ss_pred             hcCCCccEEECCCCCCCCHHHHHHHHHH-------HhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcC
Confidence            34556777888875 5543211112111       11223577788888877632    333444556788888888887


Q ss_pred             cCC----CchhhccCCCCCeEeccCC
Q 013682          143 SGL----IPTSLTTITSLNILDLSNN  164 (438)
Q Consensus       143 ~g~----~P~~l~~~~~L~~l~ls~N  164 (438)
                      +..    +-..+..-+.|+.|+|++|
T Consensus       111 g~~Ga~ala~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A          111 TPELLARLLRSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             CHHHHHHHHHHTTTTCCCSEEECCCC
T ss_pred             CHHHHHHHHHHHhhCCceeEEECCCC
Confidence            632    2223445566888888765

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=90.43  E-value=0.082  Score=45.68  Aligned_cols=61  Identities=13%  Similarity=0.191  Sum_probs=44.9

Q ss_pred             CCCEEEccCCcccccCchhhccccccceecccccc-ccCCCchhhccC----CCCCeEeccCCC-CC
Q 013682          107 KLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNS-LSGLIPTSLTTI----TSLNILDLSNNR-LS  167 (438)
Q Consensus       107 ~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~-l~g~~P~~l~~~----~~L~~l~ls~N~-l~  167 (438)
                      +|+.||++++.++..=-..+..+++|+.|+|+++. ++..-=..++.+    ++|+.|+|+++. +|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~IT  128 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVT  128 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCC
Confidence            57889999998875544567889999999999985 653322345553    479999999874 54

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=90.31  E-value=0.11  Score=45.63  Aligned_cols=66  Identities=20%  Similarity=0.291  Sum_probs=49.9

Q ss_pred             ccccCCCEEEccCC-cccc----cCchhhccccccceeccccccccCC----CchhhccCCCCCeEeccCCCCCC
Q 013682          103 GNLIKLKSLDLYSN-LFNG----TIPDTLANLKQLKYLRLNNNSLSGL----IPTSLTTITSLNILDLSNNRLSG  168 (438)
Q Consensus       103 ~~l~~L~~l~ls~N-~l~g----~iP~~~~~l~~L~~l~ls~N~l~g~----~P~~l~~~~~L~~l~ls~N~l~g  168 (438)
                      .+-+.|++|+|++| .+..    .+-+.+..-+.|+.|+|++|++...    +-..+..-+.|+.|+|+.|.++.
T Consensus        38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~  112 (197)
T 1pgv_A           38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP  112 (197)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred             hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence            34467899999986 7652    2445666678899999999999732    34456678899999999999873

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=89.92  E-value=0.036  Score=55.73  Aligned_cols=62  Identities=6%  Similarity=-0.007  Sum_probs=18.1

Q ss_pred             CCCccccccceEEEEEEeCC-CCEEEE------EEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEee
Q 013682          290 NKNILGRGGFGKVYKGRLAD-GKLVAV------KRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT  354 (438)
Q Consensus       290 ~~~~LG~G~fG~Vy~~~~~~-~~~vAv------K~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~  354 (438)
                      ..+.+|   ||.||+|.+.. ..+|||      |..+....+ +....|.+|+.++...+|||+++.+++...
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            345666   99999999854 467888      776543322 222368889999999999999999887643

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=88.89  E-value=1.1  Score=43.58  Aligned_cols=60  Identities=23%  Similarity=0.405  Sum_probs=32.9

Q ss_pred             cccccCCCEEEccCCcccccCc-hhhccccccceeccccccccCCCchhhccCCCCCeEeccCC
Q 013682          102 LGNLIKLKSLDLYSNLFNGTIP-DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNN  164 (438)
Q Consensus       102 l~~l~~L~~l~ls~N~l~g~iP-~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N  164 (438)
                      |.+|.+|+.+++..+ ++ .|. ..|.++++|+.+.+..+ ++..-..++.+|++|+.+++++|
T Consensus       307 F~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~  367 (394)
T 4gt6_A          307 FAGCISLKSIDIPEG-IT-QILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGS  367 (394)
T ss_dssp             TTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSC
T ss_pred             ecCCCCcCEEEeCCc-cc-EehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCc
Confidence            345566666666543 33 333 35666666666666543 44222345666666666666554

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=88.71  E-value=0.73  Score=45.54  Aligned_cols=72  Identities=6%  Similarity=0.045  Sum_probs=44.6

Q ss_pred             CccccccceEEEEEEeCC--------CCEEEEEEccccccccchHHHHHHHHHHhcCCCCC-ceeeEEEEeeCCeeEEEE
Q 013682          292 NILGRGGFGKVYKGRLAD--------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN-LLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~--------~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lv~  362 (438)
                      +.+..|-...+|+....+        ++.+.+|+.... + ....+..+|..+++.+.-.. ..++++.+  .  -++||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~-t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~  149 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH-V-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE  149 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC-C--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC-c-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence            446667788999998753        577888875332 2 11223467887777664222 34555533  2  37899


Q ss_pred             ecCCCCC
Q 013682          363 PYMTNGS  369 (438)
Q Consensus       363 e~~~~gs  369 (438)
                      ||+++..
T Consensus       150 efI~G~~  156 (424)
T 3mes_A          150 EFIDGEP  156 (424)
T ss_dssp             ECCCSEE
T ss_pred             EEeCCcc
Confidence            9999854

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=85.43  E-value=1.5  Score=42.07  Aligned_cols=61  Identities=23%  Similarity=0.390  Sum_probs=37.7

Q ss_pred             cccccCCCEEEccCCcccccCc-hhhccccccceeccccccccCCCchhhccCCCCCeEeccCC
Q 013682          102 LGNLIKLKSLDLYSNLFNGTIP-DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNN  164 (438)
Q Consensus       102 l~~l~~L~~l~ls~N~l~g~iP-~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N  164 (438)
                      +.++.+|+.+.+..+ +. .++ ..|.++++|+.+.+.++.++..-+..+.+|.+|+.+++.++
T Consensus       259 F~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~  320 (379)
T 4h09_A          259 LQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA  320 (379)
T ss_dssp             TTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT
T ss_pred             cceeehhcccccccc-ce-eccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc
Confidence            345666777766543 33 343 35667777777777776666443456677777777776543

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=83.18  E-value=1.4  Score=42.69  Aligned_cols=71  Identities=14%  Similarity=0.246  Sum_probs=46.4

Q ss_pred             hccCCCCCeec------------cccccCCCEEEccCCcccccCc-hhhccccccceeccccccccCCCchhhccCCCCC
Q 013682           91 LGQLKNLELLA------------LGNLIKLKSLDLYSNLFNGTIP-DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLN  157 (438)
Q Consensus        91 l~~l~~L~~l~------------l~~l~~L~~l~ls~N~l~g~iP-~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~  157 (438)
                      ...|.+|+.+.            |.+|.+|+.+.+..+ ++ .|+ ..|.++++|+.+++.+|...   -..+..+.+|+
T Consensus       307 F~~c~~L~~i~lp~~v~~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~~~~---~~~~~~~~~L~  381 (394)
T 4gt6_A          307 FAGCISLKSIDIPEGITQILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNCTALNNIEYSGSRSQ---WNAISTDSGLQ  381 (394)
T ss_dssp             TTTCTTCCEEECCTTCCEECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTCTTCCEEEESSCHHH---HHTCBCCCCC-
T ss_pred             ecCCCCcCEEEeCCcccEehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCCCCCCEEEECCceee---hhhhhccCCCC
Confidence            34567776664            567899999999765 66 665 58999999999999988654   24677888999


Q ss_pred             eEeccCCCC
Q 013682          158 ILDLSNNRL  166 (438)
Q Consensus       158 ~l~ls~N~l  166 (438)
                      .+.+..|.+
T Consensus       382 ~i~i~~~~~  390 (394)
T 4gt6_A          382 NLPVAPGSI  390 (394)
T ss_dssp             ---------
T ss_pred             EEEeCCCCE
Confidence            888776654

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=80.11  E-value=4.1  Score=36.15  Aligned_cols=80  Identities=10%  Similarity=0.015  Sum_probs=57.2

Q ss_pred             CCCCCceeeEEEEeeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCceecCCCC
Q 013682          340 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS-YLHEHCDPKIIHRDVKA  418 (438)
Q Consensus       340 l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~-yLH~~~~~~ivHrDLK~  418 (438)
                      ..||++  -...-.+++...+.++--+++.-...++.       ++...+++++..++.... +++..     +|--+.|
T Consensus        47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-------~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P  112 (219)
T 4ano_A           47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-------TTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCP  112 (219)
T ss_dssp             GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-------SCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCG
T ss_pred             ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-------cCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeC
Confidence            368887  33344566777777776555543444433       577899999999888776 66654     7888999


Q ss_pred             CCeeeCCCCCcchhh
Q 013682          419 ANILLDEDADQSSKT  433 (438)
Q Consensus       419 ~NILld~~~~~~l~D  433 (438)
                      +|+++|.++.+++.-
T Consensus       113 ~NL~f~~~~~p~i~h  127 (219)
T 4ano_A          113 ENLMFNRALEPFFLH  127 (219)
T ss_dssp             GGEEECTTCCEEESC
T ss_pred             ceEEEeCCCcEEEEE
Confidence            999999999988753

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	438
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-39
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-36
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-36
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	8e-36
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-35
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-35
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-35
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-34
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-34
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-34
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-34
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-34
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-34
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-34
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-33
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-33
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-33
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-33
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-33
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-33
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-32
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-32
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-31
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-31
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-31
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-31
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-31
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-30
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-30
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-30
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-29
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-29
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-29
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	9e-29
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-28
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-28
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-28
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-28
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-28
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	8e-28
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-27
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	9e-27
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-26
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-26
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-26
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-26
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-26
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	7e-26
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-25
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	8e-25
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-24
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-23
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-23
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	9e-23
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-22
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-22
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-22
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-21
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-21
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-21
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-20
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-18
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-17
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-16
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-12
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	7e-07
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-11
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-11
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	6e-06
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-06
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	9e-05
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	9e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.003
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-07
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-06
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-04
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	0.003
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-06
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	5e-06
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	2e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	7e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.003
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	8e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	4e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-04
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-04
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	0.001
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	9e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.002
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.002
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	0.003

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 7e-39
 Identities = 37/147 (25%), Positives = 67/147 (45%), Gaps = 7/147 (4%)

Query: 281 LQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISM 339
           +++  D F   + LG G  G V+K      G ++A K +  E       Q   E++++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 340 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 399
                ++  YG   +  E  +   +M  GS+   L++       +      K+++   +G
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKG 116

Query: 400 LSYLHEHCDPKIIHRDVKAANILLDED 426
           L+YL E    KI+HRDVK +NIL++  
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSR 141

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  134 bits (337), Expect = 1e-36
 Identities = 44/164 (26%), Positives = 70/164 (42%), Gaps = 19/164 (11%)

Query: 276 FSLRELQVATDGFSNK---------NILGRGGFGKVYKGRLA----DGKLVAVKRLKEER 322
           F+  +   A   F+ +          ++G G FG+V  G L         VA+K LK   
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 323 TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP 382
           T      F +E  I+    H N++ L G  T  T  +++  +M NGS+ S LR+      
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND---G 123

Query: 383 PLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
                    +  G A G+ YL +      +HRD+ A NIL++ +
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSN 164

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 2e-36
 Identities = 42/140 (30%), Positives = 63/140 (45%), Gaps = 8/140 (5%)

Query: 286 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 345
           +       LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRL 70

Query: 346 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 405
           +RLY   T      ++  YM NGS+   L+        L       +A   A G++++ E
Sbjct: 71  VRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE 127

Query: 406 HCDPKIIHRDVKAANILLDE 425
                 IHRD++AANIL+ +
Sbjct: 128 RN---YIHRDLRAANILVSD 144

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 8e-36
 Identities = 37/152 (24%), Positives = 62/152 (40%), Gaps = 11/152 (7%)

Query: 279 RELQVATDGFSNKNI-LGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEV 334
           ++L +  D     +I LG G FG V +G          VA+K LK+        +   E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 335 KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL 394
           +I+    +  ++RL G C      +LV      G +   L  ++  +P        ++  
Sbjct: 61  QIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIP---VSNVAELLH 116

Query: 395 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
             + G+ YL E      +HRD+ A N+LL   
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNR 145

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 1e-35
 Identities = 43/162 (26%), Positives = 64/162 (39%), Gaps = 24/162 (14%)

Query: 286 DGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIIS- 338
           +  S    LG G FGKV +              VAVK LK            +E+K++S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP--------------PL 384
           +  H N++ L G CT     L++  Y   G + + LR ++ S                 L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 385 DWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           D       +   A+G+++L        IHRD+ A NILL   
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHG 181

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 2e-35
 Identities = 44/140 (31%), Positives = 66/140 (47%), Gaps = 10/140 (7%)

Query: 288 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLL 346
            +    +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L
Sbjct: 10  ITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
              G+ T   +  +V  +    S+   L   ++     +      IA  +A+G+ YLH  
Sbjct: 68  LFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK 123

Query: 407 CDPKIIHRDVKAANILLDED 426
               IIHRD+K+ NI L ED
Sbjct: 124 S---IIHRDLKSNNIFLHED 140

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 3e-35
 Identities = 43/140 (30%), Positives = 62/140 (44%), Gaps = 10/140 (7%)

Query: 288 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
                 +G+G FG V  G    G  VAVK +K + T+     F  E  +++   H NL++
Sbjct: 9   LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQ 64

Query: 348 LYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
           L G        L +V  YM  GS+   LR R  S   L      K +L     + YL  +
Sbjct: 65  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEGN 122

Query: 407 CDPKIIHRDVKAANILLDED 426
                +HRD+ A N+L+ ED
Sbjct: 123 ---NFVHRDLAARNVLVSED 139

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 1e-34
 Identities = 37/147 (25%), Positives = 60/147 (40%), Gaps = 6/147 (4%)

Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHR 343
           + +     +G G +G+  K R  +DGK++  K L     +  E Q   +EV ++    H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 344 NLLRLYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           N++R Y      T   L  V  Y   G +AS + +       LD     ++       L 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 402 YLHEH--CDPKIIHRDVKAANILLDED 426
             H        ++HRD+K AN+ LD  
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGK 150

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  128 bits (322), Expect = 2e-34
 Identities = 46/176 (26%), Positives = 73/176 (41%), Gaps = 29/176 (16%)

Query: 277 SLRELQVATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQF 330
            L  L+   +       +G G FG+V++ R           +VAVK LKEE ++  +  F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 331 QTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL--------- 381
           Q E  +++   + N+++L G C       L++ YM  G +   LR               
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 382 -----------PPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
                      PPL    +  IA   A G++YL E    K +HRD+   N L+ E+
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGEN 176

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 2e-34
 Identities = 36/142 (25%), Positives = 58/142 (40%), Gaps = 8/142 (5%)

Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 344
           + +     LG G +G+V         + VAVK +  +R        + E+ I  M  H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
           +++ YG       + L   Y + G +  R+         +  P  ++       G+ YLH
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLH 120

Query: 405 EHCDPKIIHRDVKAANILLDED 426
                 I HRD+K  N+LLDE 
Sbjct: 121 GIG---ITHRDIKPENLLLDER 139

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  127 bits (321), Expect = 3e-34
 Identities = 42/145 (28%), Positives = 63/145 (43%), Gaps = 10/145 (6%)

Query: 285 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV 341
              FS+   +G G FG VY  R + + ++VA+K++        E       EV+ +    
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           H N ++  G         LV  Y    +       ++    PL       +  G+ +GL+
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLA 129

Query: 402 YLHEHCDPKIIHRDVKAANILLDED 426
           YLH H    +IHRDVKA NILL E 
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEP 151

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 3e-34
 Identities = 39/160 (24%), Positives = 62/160 (38%), Gaps = 29/160 (18%)

Query: 293 ILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNL 345
           +LG G FGKV                VAVK LKE+  S       +E+K+++    H N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 346 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP-------------------PLDW 386
           + L G CT      L++ Y   G + + LR ++                        L +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 387 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
                 A   A+G+ +L        +HRD+ A N+L+   
Sbjct: 164 EDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHG 200

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 4e-34
 Identities = 41/139 (29%), Positives = 67/139 (48%), Gaps = 8/139 (5%)

Query: 288 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
            +    +G G FG V+ G   +   VA+K ++E   S  E  F  E +++    H  L++
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQ 64

Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           LYG C       LV+ +M +G ++  LR ++         T   + L    G++YL E C
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC 121

Query: 408 DPKIIHRDVKAANILLDED 426
              +IHRD+ A N L+ E+
Sbjct: 122 ---VIHRDLAARNCLVGEN 137

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  126 bits (317), Expect = 7e-34
 Identities = 42/154 (27%), Positives = 69/154 (44%), Gaps = 8/154 (5%)

Query: 274 KRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT 332
              +  + ++     + K+ LG G +G+VY+G        VAVK LKE+     E  F  
Sbjct: 5   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLK 62

Query: 333 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI 392
           E  ++    H NL++L G CT      ++  +MT G++   LRE       +       +
Sbjct: 63  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYM 120

Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           A   +  + YL +      IHRD+ A N L+ E+
Sbjct: 121 ATQISSAMEYLEKK---NFIHRDLAARNCLVGEN 151

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 1e-33
 Identities = 39/139 (28%), Positives = 61/139 (43%), Gaps = 8/139 (5%)

Query: 288 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 347
            +    LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQ 63

Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           LYG CT      ++  YM NG + + LRE +            ++       + YL    
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESKQ 120

Query: 408 DPKIIHRDVKAANILLDED 426
               +HRD+ A N L+++ 
Sbjct: 121 ---FLHRDLAARNCLVNDQ 136

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 2e-33
 Identities = 41/145 (28%), Positives = 65/145 (44%), Gaps = 17/145 (11%)

Query: 291 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 350
           +  +G+G FG+V++G+   G+ VAVK              + E+    M  H N+L    
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIA 64

Query: 351 FCT----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
                  T T+  LV  Y  +GS+   L         +      K+AL +A GL++LH  
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHME 119

Query: 407 C-----DPKIIHRDVKAANILLDED 426
                  P I HRD+K+ NIL+ ++
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKN 144

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (311), Expect = 5e-33
 Identities = 40/143 (27%), Positives = 65/143 (45%), Gaps = 8/143 (5%)

Query: 285 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR 343
            D +     LG G FGKVYK +      L A K +  +     E  +  E+ I++   H 
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-DYMVEIDILASCDHP 69

Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           N+++L           ++  +   G+V + + E +    PL     + +   +   L+YL
Sbjct: 70  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYL 126

Query: 404 HEHCDPKIIHRDVKAANILLDED 426
           H++   KIIHRD+KA NIL   D
Sbjct: 127 HDN---KIIHRDLKAGNILFTLD 146

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 5e-33
 Identities = 38/142 (26%), Positives = 65/142 (45%), Gaps = 11/142 (7%)

Query: 291 KNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRL 348
              +GRG F  VYKG   +    VA   L++ + +  E Q F+ E +++    H N++R 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 349 YGFCTTVTEK----LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
           Y    +  +     +LV   MT+G++ + L+  +     +     +       +GL +LH
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLH 129

Query: 405 EHCDPKIIHRDVKAANILLDED 426
               P IIHRD+K  NI +   
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGP 150

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 5e-33
 Identities = 46/156 (29%), Positives = 72/156 (46%), Gaps = 17/156 (10%)

Query: 274 KRFSLRELQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER--TSGGELQF 330
           ++++L + ++          LG+G FG VY  R      ++A+K L + +   +G E Q 
Sbjct: 1   RQWALEDFEI-------GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53

Query: 331 QTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK 390
           + EV+I S   H N+LRLYG+    T   L+  Y   G+V   L++        D     
Sbjct: 54  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL----SKFDEQRTA 109

Query: 391 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
                 A  LSY H     ++IHRD+K  N+LL   
Sbjct: 110 TYITELANALSYCHSK---RVIHRDIKPENLLLGSA 142

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 8e-33
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 19/157 (12%)

Query: 286 DGFSNKNILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQFQTEVKIIS-MAV 341
           +    ++++G G FG+V K R+    L    A+KR+KE  +      F  E++++  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ------------SSLPPLDWPTR 389
           H N++ L G C       L   Y  +G++   LR+ +            S+   L     
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 390 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
              A   ARG+ YL +    + IHRD+ A NIL+ E+
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 163

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 1e-32
 Identities = 42/150 (28%), Positives = 68/150 (45%), Gaps = 11/150 (7%)

Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLADG-----KLVAVKRLKEERTSGGELQFQTEVKI 336
           ++     + + ++G G FG+VYKG L          VA+K LK   T    + F  E  I
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62

Query: 337 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 396
           +    H N++RL G  +     +++  YM NG++   LRE+              +  G 
Sbjct: 63  MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGI 119

Query: 397 ARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           A G+ YL        +HRD+ A NIL++ +
Sbjct: 120 AAGMKYLANMN---YVHRDLAARNILVNSN 146

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 3e-32
 Identities = 40/141 (28%), Positives = 65/141 (46%), Gaps = 8/141 (5%)

Query: 286 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 345
           +    +  LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKL 74

Query: 346 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 405
           ++LY   +      +V  YM+ GS+   L+        L  P    +A   A G++Y+  
Sbjct: 75  VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER 131

Query: 406 HCDPKIIHRDVKAANILLDED 426
                 +HRD++AANIL+ E+
Sbjct: 132 MN---YVHRDLRAANILVGEN 149

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 2e-31
 Identities = 45/141 (31%), Positives = 59/141 (41%), Gaps = 11/141 (7%)

Query: 291 KNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
             ++GRG FG VY G L D        AVK L      G   QF TE  I+    H N+L
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 347 RLYGFCTTV-TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 405
            L G C       L+V PYM +G + + +R                  L  A+G   +  
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKG---MKF 145

Query: 406 HCDPKIIHRDVKAANILLDED 426
               K +HRD+ A N +LDE 
Sbjct: 146 LASKKFVHRDLAARNCMLDEK 166

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 2e-31
 Identities = 35/139 (25%), Positives = 55/139 (39%), Gaps = 12/139 (8%)

Query: 292 NILGRGGFGKVYKGRLAD---GKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVHRNLLR 347
             LG G FG V KG        K VAVK LK E        +   E  ++    +  ++R
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           + G C      +LV      G +   L++ +     +      ++    + G+ YL E  
Sbjct: 73  MIGICEA-ESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES- 126

Query: 408 DPKIIHRDVKAANILLDED 426
               +HRD+ A N+LL   
Sbjct: 127 --NFVHRDLAARNVLLVTQ 143

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 2e-31
 Identities = 42/159 (26%), Positives = 71/159 (44%), Gaps = 15/159 (9%)

Query: 280 ELQVATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTE 333
           E +VA +  +    LG+G FG VY+G             VA+K + E  +    ++F  E
Sbjct: 14  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73

Query: 334 VKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWP 387
             ++      +++RL G  +     L++   MT G + S LR           L P    
Sbjct: 74  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133

Query: 388 TRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
              ++A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 134 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 169

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  120 bits (301), Expect = 4e-31
 Identities = 31/144 (21%), Positives = 61/144 (42%), Gaps = 8/144 (5%)

Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 344
           D +     LG G FG V++    A G   A K +     S  E   + E++ +S+  H  
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-TVRKEIQTMSVLRHPT 84

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
           L+ L+       E +++Y +M+ G +  ++ +  +    +      +      +GL ++H
Sbjct: 85  LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMH 141

Query: 405 EHCDPKIIHRDVKAANILLDEDAD 428
           E+     +H D+K  NI+      
Sbjct: 142 ENN---YVHLDLKPENIMFTTKRS 162

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  119 bits (300), Expect = 6e-31
 Identities = 33/150 (22%), Positives = 60/150 (40%), Gaps = 8/150 (5%)

Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 344
           D +     LG G FG V++    A G++   K +            + E+ I++   H  
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPK 87

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
           L+ L+       E +L+  +++ G +  R+         +           +  GL ++H
Sbjct: 88  LINLHDAFEDKYEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMH 144

Query: 405 EHCDPKIIHRDVKAANILLDEDADQSSKTI 434
           EH    I+H D+K  NI+ +     S K I
Sbjct: 145 EH---SIVHLDIKPENIMCETKKASSVKII 171

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 3e-30
 Identities = 32/143 (22%), Positives = 63/143 (44%), Gaps = 10/143 (6%)

Query: 285 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR 343
              ++    +G+G  G VY    +A G+ VA++++  ++    E     E+ ++    + 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNP 77

Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           N++          E  +V  Y+  GS+   + E       +D      +     + L +L
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFL 132

Query: 404 HEHCDPKIIHRDVKAANILLDED 426
           H +   ++IHRD+K+ NILL  D
Sbjct: 133 HSN---QVIHRDIKSDNILLGMD 152

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 6e-30
 Identities = 43/162 (26%), Positives = 64/162 (39%), Gaps = 24/162 (14%)

Query: 286 DGFSNKNILGRGGFGKVYKGRL--------ADGKLVAVKRLKEERTSGGELQFQTEVKII 337
           D       LG G FG+V                  VAVK LK + T        +E++++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 338 SMAV-HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER------------QSSLPPL 384
            M   H+N++ L G CT      ++  Y + G++   L+ R             +    L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 385 DWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
                   A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTED 171

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  117 bits (293), Expect = 7e-30
 Identities = 40/146 (27%), Positives = 66/146 (45%), Gaps = 13/146 (8%)

Query: 286 DGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGE-----LQFQTEVKIISM 339
           + FS   I+GRGGFG+VY  R AD GK+ A+K L ++R    +     L  +  + ++S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 340 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 399
                ++ +     T  +   +   M  G +   L +             +  A     G
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILG 119

Query: 400 LSYLHEHCDPKIIHRDVKAANILLDE 425
           L ++H      +++RD+K ANILLDE
Sbjct: 120 LEHMHNRF---VVYRDLKPANILLDE 142

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 2e-29
 Identities = 33/137 (24%), Positives = 57/137 (41%), Gaps = 11/137 (8%)

Query: 293 ILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 348
            +G G FG V++G           VA+K  K   +     +F  E   +    H ++++L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 349 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 408
            G  T      ++    T G + S L+ R+     LD  +    A   +  L+YL     
Sbjct: 74  IGVITE-NPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK-- 127

Query: 409 PKIIHRDVKAANILLDE 425
            + +HRD+ A N+L+  
Sbjct: 128 -RFVHRDIAARNVLVSS 143

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 4e-29
 Identities = 39/144 (27%), Positives = 54/144 (37%), Gaps = 10/144 (6%)

Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVH 342
           + F    ILG G F  V   R LA  +  A+K L++              E  ++S   H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 402
              ++LY       +      Y  NG     L +    +   D    +         L Y
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALEY 123

Query: 403 LHEHCDPKIIHRDVKAANILLDED 426
           LH      IIHRD+K  NILL+ED
Sbjct: 124 LHGKG---IIHRDLKPENILLNED 144

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 5e-29
 Identities = 29/143 (20%), Positives = 58/143 (40%), Gaps = 5/143 (3%)

Query: 285 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR 343
              ++N + +G G +G V       +   VA+K++          +   E+KI+    H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           N++ +       T + +   Y+    + + L +   +   L             RGL Y+
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYI 125

Query: 404 HEHCDPKIIHRDVKAANILLDED 426
           H      ++HRD+K +N+LL+  
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTT 145

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  112 bits (280), Expect = 9e-29
 Identities = 42/151 (27%), Positives = 61/151 (40%), Gaps = 17/151 (11%)

Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK--------EERTSGGELQFQTEVKI 336
           + +  K ILGRG    V +       K  AVK +          E           EV I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 337 IS-MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALG 395
           +  ++ H N+++L     T T   LV+  M  G +   L E+      L     +KI   
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRA 118

Query: 396 SARGLSYLHEHCDPKIIHRDVKAANILLDED 426
               +  LH+     I+HRD+K  NILLD+D
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDD 146

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 1e-28
 Identities = 48/139 (34%), Positives = 60/139 (43%), Gaps = 13/139 (9%)

Query: 294 LGRGGFGKVYKGRL----ADGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLR 347
           LG G FG V +G           VAVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 348 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 407
           LYG   T     +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 76  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESKR 131

Query: 408 DPKIIHRDVKAANILLDED 426
               IHRD+ A N+LL   
Sbjct: 132 ---FIHRDLAARNLLLATR 147

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 2e-28
 Identities = 33/142 (23%), Positives = 64/142 (45%), Gaps = 9/142 (6%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 352
           LGRG FG V++    +  K    K +K + T   ++  + E+ I+++A HRN+L L+   
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLHESF 70

Query: 353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 412
            ++ E ++++ +++   +  R+         L+              L +LH H    I 
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIG 124

Query: 413 HRDVKAANILLDEDADQSSKTI 434
           H D++  NI+       + K I
Sbjct: 125 HFDIRPENIIYQTRRSSTIKII 146

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 2e-28
 Identities = 46/161 (28%), Positives = 69/161 (42%), Gaps = 23/161 (14%)

Query: 286 DGFSNKNILGRGGFGKVYKGR------LADGKLVAVKRLKEERTSGGELQFQTEVKIISM 339
           D       LGRG FG+V +         A  + VAVK LKE  T        +E+KI+  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 340 AVHR-NLLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPP------------LD 385
             H  N++ L G CT     L ++  +   G++++ LR +++   P            L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 386 WPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
                  +   A+G+ +L      K IHRD+ A NILL E 
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK 170

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  111 bits (278), Expect = 3e-28
 Identities = 31/151 (20%), Positives = 64/151 (42%), Gaps = 8/151 (5%)

Query: 279 RELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKII 337
           ++ +   D +  +++LG G F +V         KLVA+K + ++   G E   + E+ ++
Sbjct: 2   KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61

Query: 338 SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 397
               H N++ L     +     L+   ++ G +  R+ E+             ++     
Sbjct: 62  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQVL 117

Query: 398 RGLSYLHEHCDPKIIHRDVKAANILLDEDAD 428
             + YLH+     I+HRD+K  N+L     +
Sbjct: 118 DAVKYLHDLG---IVHRDLKPENLLYYSLDE 145

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 4e-28
 Identities = 38/148 (25%), Positives = 70/148 (47%), Gaps = 13/148 (8%)

Query: 284 ATDGFSNKNILGRGGFGKVYKGR-LADGKL----VAVKRLKEERTSGGELQFQTEVKIIS 338
            T+ F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++
Sbjct: 8   ETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66

Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
              + ++ RL G C T +   L+   M  G +   +RE +     +         +  A+
Sbjct: 67  SVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAK 122

Query: 399 GLSYLHEHCDPKIIHRDVKAANILLDED 426
           G++YL +    +++HRD+ A N+L+   
Sbjct: 123 GMNYLEDR---RLVHRDLAARNVLVKTP 147

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 8e-28
 Identities = 42/146 (28%), Positives = 68/146 (46%), Gaps = 16/146 (10%)

Query: 288 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 346
           +++  ++G G FG VY+ +L D G+LVA+K++ +++          E++I+    H N++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 76

Query: 347 RLYGFCTTVTEK------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 400
           RL  F  +  EK       LV  Y+         R    +   L     K       R L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 401 SYLHEHCDPKIIHRDVKAANILLDED 426
           +Y+H      I HRD+K  N+LLD D
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPD 158

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 2e-27
 Identities = 40/143 (27%), Positives = 63/143 (44%), Gaps = 11/143 (7%)

Query: 292 NILGRGGFGKVYKGR--LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV---HRNL 345
             +G G +GKV+K R     G+ VA+KR++ +    G  L    EV ++       H N+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 346 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYL 403
           +RL+  CT           +    V   L     +   P +   T K +     RGL +L
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 404 HEHCDPKIIHRDVKAANILLDED 426
           H H   +++HRD+K  NIL+   
Sbjct: 133 HSH---RVVHRDLKPQNILVTSS 152

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  107 bits (268), Expect = 9e-27
 Identities = 40/154 (25%), Positives = 66/154 (42%), Gaps = 17/154 (11%)

Query: 276 FSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL--QFQT 332
           +SL++ Q+          LG G FG+V+  R   +G+  A+K LK+E     +       
Sbjct: 1   YSLQDFQI-------LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND 53

Query: 333 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI 392
           E  ++S+  H  ++R++G      +  ++  Y+        L            P  K  
Sbjct: 54  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFY 109

Query: 393 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           A      L YLH      II+RD+K  NILLD++
Sbjct: 110 AAEVCLALEYLHSKD---IIYRDLKPENILLDKN 140

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  106 bits (264), Expect = 2e-26
 Identities = 33/136 (24%), Positives = 63/136 (46%), Gaps = 8/136 (5%)

Query: 292 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYG 350
             +G G +G VYK +   G+  A+K+++ E+   G       E+ I+    H N+++LY 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 351 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 410
              T    +LV+ ++                  L+  T K   L    G++Y H+    +
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHDR---R 120

Query: 411 IIHRDVKAANILLDED 426
           ++HRD+K  N+L++ +
Sbjct: 121 VLHRDLKPQNLLINRE 136

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 3e-26
 Identities = 31/144 (21%), Positives = 56/144 (38%), Gaps = 17/144 (11%)

Query: 293 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYG 350
           +LG G  GKV +       +  A+K L++        + + EV++   A    +++R+  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRIVD 72

Query: 351 FCTTVTEK----LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
               +       L+V   +  G + SR+++R             +I       + YLH  
Sbjct: 73  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI 130

Query: 407 CDPKIIHRDVKAANILLDEDADQS 430
               I HRDVK  N+L       +
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNA 151

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  106 bits (265), Expect = 4e-26
 Identities = 38/168 (22%), Positives = 65/168 (38%), Gaps = 11/168 (6%)

Query: 263 EDDSELQLGQLKRFSLRELQVAT-DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKE 320
           E  ++ +   LK++       A  D F     LG G FG+V   +    G   A+K L +
Sbjct: 17  EFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76

Query: 321 ERTSGGEL--QFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ 378
           ++    +       E +I+       L++L       +   +V  Y+  G + S LR   
Sbjct: 77  QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG 136

Query: 379 SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
                   P  +  A        YLH      +I+RD+K  N+L+D+ 
Sbjct: 137 ----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQ 177

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 5e-26
 Identities = 35/143 (24%), Positives = 68/143 (47%), Gaps = 8/143 (5%)

Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 343
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 344 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 403
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118

Query: 404 HEHCDPKIIHRDVKAANILLDED 426
           H H    ++HRD+K  N+L++ +
Sbjct: 119 HSHR---VLHRDLKPQNLLINTE 138

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 5e-26
 Identities = 37/145 (25%), Positives = 61/145 (42%), Gaps = 11/145 (7%)

Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV- 341
           + F    +LG+G FGKV+        +  A+K LK++     +       E +++S+A  
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 342 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           H  L  ++    T      V  Y+  G +   ++         D       A     GL 
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQ 117

Query: 402 YLHEHCDPKIIHRDVKAANILLDED 426
           +LH      I++RD+K  NILLD+D
Sbjct: 118 FLHSK---GIVYRDLKLDNILLDKD 139

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  104 bits (259), Expect = 7e-26
 Identities = 38/148 (25%), Positives = 68/148 (45%), Gaps = 14/148 (9%)

Query: 285 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEE--RTSGGELQFQTEVKIISMAV 341
           +D +    ILG GG  +V+  R L   + VAVK L+ +  R     L+F+ E +  +   
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 342 HRNLLRLYGFCTTVTEKL----LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 397
           H  ++ +Y      T       +V  Y+   +    LR+   +  P+      ++   + 
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVT----LRDIVHTEGPMTPKRAIEVIADAC 121

Query: 398 RGLSYLHEHCDPKIIHRDVKAANILLDE 425
           + L++ H++    IIHRDVK ANI++  
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISA 146

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 2e-25
 Identities = 41/140 (29%), Positives = 64/140 (45%), Gaps = 12/140 (8%)

Query: 292 NILGRGGFGKVYKGR-LADGKLVAVKRLK----EERTSGGELQFQTEVKIISMAVHRNLL 346
           + LG G F  VYK R     ++VA+K++K     E   G       E+K++    H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 347 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 406
            L       +   LV+ +M            + +   L     K   L + +GL YLH+H
Sbjct: 64  GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119

Query: 407 CDPKIIHRDVKAANILLDED 426
               I+HRD+K  N+LLDE+
Sbjct: 120 W---ILHRDLKPNNLLLDEN 136

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 8e-25
 Identities = 38/163 (23%), Positives = 65/163 (39%), Gaps = 21/163 (12%)

Query: 276 FSLRELQVATDGFSNK----NILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL-Q 329
           F  +E+                +G G +G V        G  VA+K+L     S     +
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 330 FQTEVKIISMAVHRNLLRLYGFCTT------VTEKLLVYPYMTNGSVASRLRERQSSLPP 383
              E++++    H N++ L    T        T+  LV P+M  G+   +L + +     
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE----K 117

Query: 384 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
           L     + +     +GL Y+H      IIHRD+K  N+ ++ED
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNED 157

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  100 bits (250), Expect = 2e-24
 Identities = 33/148 (22%), Positives = 53/148 (35%), Gaps = 11/148 (7%)

Query: 280 ELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS 338
           EL+V  + +     +G G FG +Y G  +A G+ VA+K    +       Q   E KI  
Sbjct: 2   ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYK 57

Query: 339 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 398
           M      +    +C    +  ++   +   S+                 T   +A     
Sbjct: 58  MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS---RKFSLKTVLLLADQMIS 114

Query: 399 GLSYLHEHCDPKIIHRDVKAANILLDED 426
            + Y+H       IHRDVK  N L+   
Sbjct: 115 RIEYIHSK---NFIHRDVKPDNFLMGLG 139

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.9 bits (243), Expect = 1e-23
 Identities = 36/153 (23%), Positives = 57/153 (37%), Gaps = 13/153 (8%)

Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL-----QFQTEVKIISM 339
           D +     LG G F  V K R  + G   A K +K+ RT            + EV I+  
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 340 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 399
             H N++ L+      T+ +L+   +  G     L +  +    L      +       G
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILNG 125

Query: 400 LSYLHEHCDPKIIHRDVKAANILLDEDADQSSK 432
           + YLH      I H D+K  NI+L +      +
Sbjct: 126 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPR 155

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.5 bits (242), Expect = 4e-23
 Identities = 36/147 (24%), Positives = 58/147 (39%), Gaps = 10/147 (6%)

Query: 283 VATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL--QFQTEVKIISM 339
           V  + F    +LG+G FGKV   R  A G+  A+K L++E     +      TE +++  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 340 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 399
             H  L  L     T      V  Y   G +   L   +           +      A  
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYG---AEI 114

Query: 400 LSYLHEHCDPKIIHRDVKAANILLDED 426
           +S L       +++RD+K  N++LD+D
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKD 141

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 95.6 bits (237), Expect = 9e-23
 Identities = 26/143 (18%), Positives = 51/143 (35%), Gaps = 12/143 (8%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL-RLYGF 351
           +G G FG +++G  L + + VA+K       +    Q + E +   +      +  +Y F
Sbjct: 13  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP---QLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 352 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 411
                  +LV   +      S               T    A      +  +HE     +
Sbjct: 70  GQEGLHNVLVIDLLGP----SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SL 122

Query: 412 IHRDVKAANILLDEDADQSSKTI 434
           ++RD+K  N L+     +++  I
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMI 145

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 96.1 bits (238), Expect = 1e-22
 Identities = 31/145 (21%), Positives = 59/145 (40%), Gaps = 18/145 (12%)

Query: 286 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHR 343
           D +     LGRG + +V++   + + + V VK LK  +      + + E+KI+  +    
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK----KIKREIKILENLRGGP 90

Query: 344 NLLRLYGFCTTVTEKL--LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 401
           N++ L         +   LV+ ++ N       +        L     +       + L 
Sbjct: 91  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALD 143

Query: 402 YLHEHCDPKIIHRDVKAANILLDED 426
           Y H      I+HRDVK  N+++D +
Sbjct: 144 YCHSMG---IMHRDVKPHNVMIDHE 165

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.8 bits (235), Expect = 1e-22
 Identities = 30/142 (21%), Positives = 56/142 (39%), Gaps = 14/142 (9%)

Query: 293 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE-----LQFQTEVKIISM--AVHRN 344
           +LG GGFG VY G  ++D   VA+K ++++R S         +   EV ++    +    
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 345 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
           ++RL  +       +L+                +     L     +         + + H
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCH 127

Query: 405 EHCDPKIIHRDVKAANILLDED 426
                 ++HRD+K  NIL+D +
Sbjct: 128 NC---GVLHRDIKDENILIDLN 146

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.2 bits (233), Expect = 3e-22
 Identities = 38/149 (25%), Positives = 65/149 (43%), Gaps = 17/149 (11%)

Query: 288 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRL-KEERTSGGELQFQTEVKIISMAVHRNL 345
           +     +G+G FG+V+K R    G+ VA+K++  E    G  +    E+KI+ +  H N+
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 346 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 397
           + L   C T             LV+ +  +           + L        K++     
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDL----AGLLSNVLVKFTLSEIKRVM---Q 124

Query: 398 RGLSYLHEHCDPKIIHRDVKAANILLDED 426
             L+ L+     KI+HRD+KAAN+L+  D
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITRD 153

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 89.1 bits (220), Expect = 2e-21
 Identities = 24/143 (16%), Positives = 41/143 (28%), Gaps = 19/143 (13%)

Query: 292 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTS---------GGELQFQTEVKIISMAVH 342
            ++G G    V+           VK  K   TS          G+L F       +    
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 402
           R L +L G             Y   G+           L  +      ++       ++ 
Sbjct: 66  RALQKLQGLAV-------PKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118

Query: 403 LHEHCDPKIIHRDVKAANILLDE 425
            +      I+H D+   N+L+ E
Sbjct: 119 FYHRG---IVHGDLSQYNVLVSE 138

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.6 bits (226), Expect = 2e-21
 Identities = 29/137 (21%), Positives = 60/137 (43%), Gaps = 9/137 (6%)

Query: 292 NILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHRNLLRLY 349
             +G G +G V+K +     ++VA+KR++ ++   G       E+ ++    H+N++RL+
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 350 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 409
               +  +  LV+ +          +   S    LD    K       + L  L      
Sbjct: 68  DVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFL---FQLLKGLGFCHSR 120

Query: 410 KIIHRDVKAANILLDED 426
            ++HRD+K  N+L++ +
Sbjct: 121 NVLHRDLKPQNLLINRN 137

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.1 bits (225), Expect = 5e-21
 Identities = 39/153 (25%), Positives = 64/153 (41%), Gaps = 15/153 (9%)

Query: 282 QVATDGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGEL---QFQTEV 334
           +V  + F    +LG G +GKV+  R       GKL A+K LK+             +TE 
Sbjct: 20  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79

Query: 335 KIISMAVHR-NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA 393
           +++        L+ L+    T T+  L+  Y+  G + + L +R+            +I 
Sbjct: 80  QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI- 138

Query: 394 LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 426
                 +  L       II+RD+K  NILLD +
Sbjct: 139 ------VLALEHLHKLGIIYRDIKLENILLDSN 165

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.2 bits (220), Expect = 3e-20
 Identities = 31/143 (21%), Positives = 53/143 (37%), Gaps = 5/143 (3%)

Query: 285 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVH 342
            + + N + +G G +G V        G  VAVK+L     S     +   E++++    H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 343 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 402
            N++ L    T                +             L     + +     RGL Y
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 403 LHEHCDPKIIHRDVKAANILLDE 425
           +H      IIHRD+K +N+ ++E
Sbjct: 137 IHSAD---IIHRDLKPSNLAVNE 156

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.2 bits (207), Expect = 2e-18
 Identities = 30/142 (21%), Positives = 50/142 (35%), Gaps = 18/142 (12%)

Query: 293 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVHRNLLRLYG 350
            +G G  G V         + VA+K+L     +     +   E+ ++    H+N++ L  
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 351 FCTT------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 404
             T         +  LV   M          E        D      +      G+ +LH
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHERMSYLLYQMLCGIKHLH 136

Query: 405 EHCDPKIIHRDVKAANILLDED 426
                 IIHRD+K +NI++  D
Sbjct: 137 SAG---IIHRDLKPSNIVVKSD 155

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 80.5 bits (197), Expect = 3e-17
 Identities = 27/146 (18%), Positives = 53/146 (36%), Gaps = 17/146 (11%)

Query: 294 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 352
           LG G F  V+  + + +   VA+K ++ ++        + E+K++      +  +     
Sbjct: 21  LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY--TEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 353 TTVTEKLLVYPY------------MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 400
                KLL +                          ++     +     K+I+     GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 401 SYLHEHCDPKIIHRDVKAANILLDED 426
            Y+H  C   IIH D+K  N+L++  
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIV 162

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 76.7 bits (187), Expect = 4e-16
 Identities = 22/64 (34%), Positives = 34/64 (53%), Gaps = 1/64 (1%)

Query: 137 LNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTK 196
           L NN + G +P  LT +  L+ L++S N L G +P  G+  +F   ++ NN  LCG    
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS-PL 309

Query: 197 KPCS 200
             C+
Sbjct: 310 PACT 313

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 64.8 bits (156), Expect = 3e-12
 Identities = 20/62 (32%), Positives = 31/62 (50%), Gaps = 3/62 (4%)

Query: 112 DLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL--SGP 169
           DL +N   GT+P  L  LK L  L ++ N+L G IP     +   ++   +NN+     P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308

Query: 170 VP 171
           +P
Sbjct: 309 LP 310

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 48.6 bits (114), Expect = 7e-07
 Identities = 22/69 (31%), Positives = 27/69 (39%), Gaps = 13/69 (18%)

Query: 77  DLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLR 136
           DL N  + G L   L QLK L            SL++  N   G IP    NL++     
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFL-----------HSLNVSFNNLCGEIPQ-GGNLQRFDVSA 297

Query: 137 L-NNNSLSG 144
             NN  L G
Sbjct: 298 YANNKCLCG 306

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 63.1 bits (152), Expect = 2e-11
 Identities = 18/67 (26%), Positives = 34/67 (50%), Gaps = 4/67 (5%)

Query: 98  ELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLN 157
           ++  + +L KL+ L   +N    +   +LANL  + +L   +N +S L P  L  +T + 
Sbjct: 321 DISPVSSLTKLQRLFFANNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRIT 376

Query: 158 ILDLSNN 164
            L L++ 
Sbjct: 377 QLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 61.9 bits (149), Expect = 4e-11
 Identities = 23/84 (27%), Positives = 42/84 (50%), Gaps = 5/84 (5%)

Query: 104 NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSN 163
           NL  L  L LY N  +   P  +++L +L+ L   NN +S    +SL  +T++N L   +
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGH 360

Query: 164 NRLSGPVPDNGSFSQFTPISFENN 187
           N++S   P   + ++ T +   + 
Sbjct: 361 NQISDLTPL-ANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.8 bits (107), Expect = 6e-06
 Identities = 27/81 (33%), Positives = 34/81 (41%), Gaps = 4/81 (4%)

Query: 107 KLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 166
            L  L L  N        TLA+L  L  L L NN +S L P  L+ +T L  L L  N++
Sbjct: 220 NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI 275

Query: 167 SGPVPDNGSFSQFTPISFENN 187
           S   P  G  +       EN 
Sbjct: 276 SNISPLAGLTALTNLELNENQ 296

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.8 bits (107), Expect = 7e-06
 Identities = 12/68 (17%), Positives = 28/68 (41%), Gaps = 4/68 (5%)

Query: 104 NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSN 163
            L +     L       T+  +  +L Q+  L+ +   +  +    +  + +L  ++ SN
Sbjct: 20  ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75

Query: 164 NRLSGPVP 171
           N+L+   P
Sbjct: 76  NQLTDITP 83

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.9 bits (97), Expect = 9e-05
 Identities = 18/84 (21%), Positives = 38/84 (45%), Gaps = 4/84 (4%)

Query: 81  AALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNN 140
            AL+ ++   LG+    + ++  +L ++ +L            D +  L  L  +  +NN
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRL--GIKSIDGVEYLNNLTQINFSNN 76

Query: 141 SLSGLIPTSLTTITSLNILDLSNN 164
            L+ + P  L  +T L  + ++NN
Sbjct: 77  QLTDITP--LKNLTKLVDILMNNN 98

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 2e-04
 Identities = 18/94 (19%), Positives = 26/94 (27%), Gaps = 25/94 (26%)

Query: 57  FLIFIRVLQSSSNLFVYLIS----------DLGNAALSGELAPELGQLKNLELLALGNLI 106
            L  +  L    N    +               N  +S      L  L N+         
Sbjct: 305 NLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD--VSSLANLTNIN-------- 354

Query: 107 KLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNN 140
               L    N  +   P  LANL ++  L LN+ 
Sbjct: 355 ---WLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.9 bits (135), Expect = 2e-09
 Identities = 20/99 (20%), Positives = 38/99 (38%), Gaps = 5/99 (5%)

Query: 106 IKLKSLDLYSNLFNGT-IPDTLANLKQLKYLRLNNNSLSG----LIPTSLTTITSLNILD 160
           + ++SLD+     +     + L  L+Q + +RL++  L+      I ++L    +L  L+
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 161 LSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPC 199
           L +N L             TP      L+L         
Sbjct: 62  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAG 100

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.6 bits (116), Expect = 5e-07
 Identities = 17/78 (21%), Positives = 25/78 (32%), Gaps = 9/78 (11%)

Query: 104 NLIKLKSLDLYSNLFNGT----IPDTLANLKQLKYLRLNNNSLSGLIPTSLTTI-----T 154
               L+ L L     + +    +  TL     L+ L L+NN L       L         
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 155 SLNILDLSNNRLSGPVPD 172
            L  L L +   S  + D
Sbjct: 427 LLEQLVLYDIYWSEEMED 444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (107), Expect = 6e-06
 Identities = 17/92 (18%), Positives = 27/92 (29%), Gaps = 16/92 (17%)

Query: 77  DLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLA-----NLKQ 131
            L +  +S      L          L     L+ LDL +N         L          
Sbjct: 375 WLADCDVSDSSCSSLAA-------TLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427

Query: 132 LKYLRLNNNSLSGLIPTSLTTI----TSLNIL 159
           L+ L L +   S  +   L  +     SL ++
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 2e-05
 Identities = 19/97 (19%), Positives = 27/97 (27%), Gaps = 19/97 (19%)

Query: 77  DLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNG----TIPDTLANLKQL 132
           D+    LS     EL          L  L + + + L            I   L     L
Sbjct: 8   DIQCEELSDARWAEL----------LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPAL 57

Query: 133 KYLRLNNNSLSGLIPTSL-----TTITSLNILDLSNN 164
             L L +N L  +    +     T    +  L L N 
Sbjct: 58  AELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 51.2 bits (121), Expect = 5e-08
 Identities = 22/62 (35%), Positives = 32/62 (51%), Gaps = 4/62 (6%)

Query: 102 LGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDL 161
           L NL KL +L    N  +   P  LA+L  L  + L NN +S + P  L   ++L I+ L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

Query: 162 SN 163
           +N
Sbjct: 225 TN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 1e-04
 Identities = 12/42 (28%), Positives = 19/42 (45%), Gaps = 2/42 (4%)

Query: 98  ELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 139
           ++  L +L  L  + L +N  +   P  LAN   L  + L N
Sbjct: 187 DISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 2e-04
 Identities = 10/63 (15%), Positives = 25/63 (39%), Gaps = 4/63 (6%)

Query: 104 NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSN 163
            L     +    +    T+  T A+L  +  L      ++ +    +  + +L  L+L +
Sbjct: 17  ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 164 NRL 166
           N++
Sbjct: 73  NQI 75

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.5 bits (88), Expect = 9e-04
 Identities = 16/54 (29%), Positives = 29/54 (53%), Gaps = 2/54 (3%)

Query: 118 FNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 171
              +    LANL +L  L+ ++N +S + P  L ++ +L  + L NN++S   P
Sbjct: 161 AQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP 212

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 36.5 bits (83), Expect = 0.003
 Identities = 7/82 (8%), Positives = 23/82 (28%), Gaps = 5/82 (6%)

Query: 119 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQ 178
           N   PD    L     +    ++++  +  +   +  +  L      ++  +      + 
Sbjct: 10  NVIFPD--PALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IEGVQYLNN 64

Query: 179 FTPISFENNLNLCGPNTKKPCS 200
              +  ++N        K    
Sbjct: 65  LIGLELKDNQITDLAPLKNLTK 86

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 50.8 bits (120), Expect = 1e-07
 Identities = 21/84 (25%), Positives = 29/84 (34%)

Query: 108 LKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 167
              LDL +N           NLK L  L L NN +S + P +   +  L  L LS N+L 
Sbjct: 33  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92

Query: 168 GPVPDNGSFSQFTPISFENNLNLC 191
                     Q   +       + 
Sbjct: 93  ELPEKMPKTLQELRVHENEITKVR 116

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 47.7 bits (112), Expect = 1e-06
 Identities = 17/74 (22%), Positives = 32/74 (43%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
           ++  ++     NL  L +L L +N  +   P   A L +L+ L L+ N L  L      T
Sbjct: 42  KITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKT 101

Query: 153 ITSLNILDLSNNRL 166
           +  L + +    ++
Sbjct: 102 LQELRVHENEITKV 115

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 39.3 bits (90), Expect = 6e-04
 Identities = 31/181 (17%), Positives = 56/181 (30%), Gaps = 1/181 (0%)

Query: 12  RSYKILTIVCRVGIICLGICARGFTLLVTLKAVLQECEQLHLLISFLI-FIRVLQSSSNL 70
           ++ K L  +  +      I    F  LV L+ +     QL  L   +   ++ L+   N 
Sbjct: 52  KNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENE 111

Query: 71  FVYLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLK 130
              +   + N      +            +  G    +K L                   
Sbjct: 112 ITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPP 171

Query: 131 QLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNL 190
            L  L L+ N ++ +   SL  + +L  L LS N +S     + + +        NN  L
Sbjct: 172 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 231

Query: 191 C 191
            
Sbjct: 232 V 232

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 36.9 bits (84), Expect = 0.003
 Identities = 29/185 (15%), Positives = 65/185 (35%), Gaps = 9/185 (4%)

Query: 1   MLKLMLCIFLSRSYKILTIVCRVGIICLGICARGFTLLVTLKAV-LQECEQLHLLISFLI 59
           + K+   +F   +  I+  +    +   GI    F  +  L  + + +     +      
Sbjct: 112 ITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPP 171

Query: 60  FIRVLQSSSNLFVYLISD-LGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLF 118
            +  L    N    + +  L       +L      +  ++  +L N   L+ L   +N  
Sbjct: 172 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH-LNNNK 230

Query: 119 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTS------LTTITSLNILDLSNNRLSGPVPD 172
              +P  LA+ K ++ + L+NN++S +           T   S + + L +N +      
Sbjct: 231 LVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ 290

Query: 173 NGSFS 177
             +F 
Sbjct: 291 PSTFR 295

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.1 bits (110), Expect = 2e-06
 Identities = 15/80 (18%), Positives = 26/80 (32%), Gaps = 9/80 (11%)

Query: 93  QLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 152
              N           L+ L++ +N     +P     L+    L  + N L+ +       
Sbjct: 271 ASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLAEVPEL---- 322

Query: 153 ITSLNILDLSNNRLSGPVPD 172
             +L  L +  N L    PD
Sbjct: 323 PQNLKQLHVEYNPLRE-FPD 341

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.3 bits (105), Expect = 5e-06
 Identities = 8/53 (15%), Positives = 14/53 (26%), Gaps = 1/53 (1%)

Query: 114 YSNLFNGTIP-DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNR 165
             N     +P D          L ++   +  L    L  +  L      N +
Sbjct: 184 SDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.7 bits (101), Expect = 2e-05
 Identities = 8/41 (19%), Positives = 12/41 (29%)

Query: 101 ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNS 141
                     LD+     +      L NLK+L+     N  
Sbjct: 196 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.6 bits (99), Expect = 2e-05
 Identities = 18/108 (16%), Positives = 33/108 (30%), Gaps = 3/108 (2%)

Query: 98  ELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLN 157
           +     N ++ + LDL        I +  A L Q   +  ++N +  L       +  L 
Sbjct: 10  QAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLK 66

Query: 158 ILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPF 205
            L ++NNR+                    N +L       P +     
Sbjct: 67  TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSL 114

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 42.2 bits (97), Expect = 7e-05
 Identities = 13/92 (14%), Positives = 31/92 (33%), Gaps = 6/92 (6%)

Query: 106 IKLKSLDLYSNLFNG--TIPDTLANLKQLKYLRLNNNSLSG----LIPTSLTTITSLNIL 159
           I+ KSL L +       ++   L     +K + L+ N++       +  ++ +   L I 
Sbjct: 5   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64

Query: 160 DLSNNRLSGPVPDNGSFSQFTPISFENNLNLC 191
           + S+        +     +    +      L 
Sbjct: 65  EFSDIFTGRVKDEIPEALRLLLQALLKCPKLH 96

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 41.0 bits (94), Expect = 2e-04
 Identities = 15/70 (21%), Positives = 24/70 (34%), Gaps = 6/70 (8%)

Query: 92  GQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLA-----NLKQLKYLRLNNNSLSGLI 146
           G    ++  +    I L++L L  N        TL       +  L +L LN N  S   
Sbjct: 259 GAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE- 317

Query: 147 PTSLTTITSL 156
              +  I  +
Sbjct: 318 DDVVDEIREV 327

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 37.2 bits (84), Expect = 0.003
 Identities = 15/66 (22%), Positives = 24/66 (36%), Gaps = 11/66 (16%)

Query: 113 LYSNLFNGTIPDTLAN------LKQLKYLRLNNNSLSGLIPTSLTTI-----TSLNILDL 161
           L   L +      + +         L+ LRL  N +      +L T+       L  L+L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309

Query: 162 SNNRLS 167
           + NR S
Sbjct: 310 NGNRFS 315

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.1 bits (95), Expect = 8e-05
 Identities = 9/65 (13%), Positives = 24/65 (36%), Gaps = 4/65 (6%)

Query: 104 NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSN 163
              +    +L        +  T   L  +  +  NN+ +  +    +  + ++  L L+ 
Sbjct: 22  AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 164 NRLSG 168
           N+L+ 
Sbjct: 78  NKLTD 82

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.2 bits (90), Expect = 4e-04
 Identities = 13/38 (34%), Positives = 24/38 (63%), Gaps = 2/38 (5%)

Query: 126 LANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSN 163
           LA L +L+ L L+ N +S L   +L  + +L++L+L +
Sbjct: 174 LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFS 209

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 39.7 bits (92), Expect = 1e-04
 Identities = 23/94 (24%), Positives = 30/94 (31%), Gaps = 24/94 (25%)

Query: 98  ELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQL----------------------KYL 135
            L  L  L+ +  LDL  N      P  LA L+ L                      + L
Sbjct: 12  VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGVANLPRLQEL 70

Query: 136 RLNNNSLSGL-IPTSLTTITSLNILDLSNNRLSG 168
            L NN L        L +   L +L+L  N L  
Sbjct: 71  LLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.9 bits (94), Expect = 2e-04
 Identities = 13/66 (19%), Positives = 24/66 (36%), Gaps = 4/66 (6%)

Query: 103 GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLS 162
             L  L+ L L  N +             L+  R +++ +   +P  L      ++  L+
Sbjct: 222 APLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQRLA---GRDLKRLA 277

Query: 163 NNRLSG 168
            N L G
Sbjct: 278 ANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.3 bits (87), Expect = 0.001
 Identities = 19/66 (28%), Positives = 30/66 (45%)

Query: 107 KLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 166
            L+ L L  N       DT  +L  L +L L+ N +S +   +   + SL+ L L  NR+
Sbjct: 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189

Query: 167 SGPVPD 172
           +   P 
Sbjct: 190 AHVHPH 195

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.5 bits (88), Expect = 9e-04
 Identities = 12/63 (19%), Positives = 19/63 (30%), Gaps = 3/63 (4%)

Query: 103 GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLS 162
             +     ++         +P  L   K    L L+ N L      +L   T L  L+L 
Sbjct: 7   SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 163 NNR 165
              
Sbjct: 64  RAE 66

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.7 bits (84), Expect = 0.002
 Identities = 21/105 (20%), Positives = 33/105 (31%), Gaps = 14/105 (13%)

Query: 89  PELGQLKNLELLALGN------------LIKLKSLDLYSNLFNGT--IPDTLANLKQLKY 134
           P+L       +L   +            + +L SL+L +N       +   +     LK 
Sbjct: 36  PDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKI 95

Query: 135 LRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQF 179
           L L+ N L             L  L L  N LS    D  ++   
Sbjct: 96  LNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISA 140

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.0 bits (84), Expect = 0.002
 Identities = 11/65 (16%), Positives = 27/65 (41%), Gaps = 4/65 (6%)

Query: 104 NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSN 163
            L +     L       T+  +  +L Q+  L+ +   +  +    +  + +L  ++ SN
Sbjct: 16  ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 71

Query: 164 NRLSG 168
           N+L+ 
Sbjct: 72  NQLTD 76

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.0 bits (84), Expect = 0.003
 Identities = 16/101 (15%), Positives = 39/101 (38%), Gaps = 5/101 (4%)

Query: 95  KNLELLALGNLIK--LKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSG-LIPTSLT 151
           KNL     G L+   + +     +  +  + +  +  + ++++ L+N+ +    +   L+
Sbjct: 10  KNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLHGILS 68

Query: 152 TITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNLNLC 191
             + L  L L   RLS P+ +     S    ++        
Sbjct: 69  QCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFS 109

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	438
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.97
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.97
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.97
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.97
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.97
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.97
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.97
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.97
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.97
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.97
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.97
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.97
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.97
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.96
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.96
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.96
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.96
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.96
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.96
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.96
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.96
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.96
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.96
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.96
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.96
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.96
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.96
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.96
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.96
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.96
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.96
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.95
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.95
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.95
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.95
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.95
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.95
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.95
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.95
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.95
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.95
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.95
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.95
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.95
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.95
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.95
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.94
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.94
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.94
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.94
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.93
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.93
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.93
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.93
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.93
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.93
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.93
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.92
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.91
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.9
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.84
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.81
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.8
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.54
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.44
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.34
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.33
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.23
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.23
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.21
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.19
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.15
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.1
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.1
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.1
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.08
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.06
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.04
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.01
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.92
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	98.87
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	98.87
d2ifga3	156	High affinity nerve growth factor receptor, N-term	98.79
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	98.79
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	98.78
d2ifga3	156	High affinity nerve growth factor receptor, N-term	98.69
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	98.66
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	98.65
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	98.59
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.51
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.19
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.19
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	98.16
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	97.83
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	97.82
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.79
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	97.77
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	97.73
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	97.71
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	97.66
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	97.49
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	97.4
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.3
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.45
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	96.29
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	94.69
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	93.99
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	92.92
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	91.92
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	86.26

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.6e-32  Score=258.70  Aligned_cols=144  Identities=25%  Similarity=0.376  Sum_probs=127.3

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .++|+..+.||+|+||+||+|+.. +++.||||+++.....+....+.+|+.++++++|||||++++++.+.+..++|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            357888899999999999999974 6899999998654433344579999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+++|+|.+++....    .+++.++..++.|++.||+|||++   +|+||||||+|||+++++.+||+||+
T Consensus        84 y~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG  148 (271)
T d1nvra_          84 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFG  148 (271)
T ss_dssp             CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCT
T ss_pred             ccCCCcHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccch
Confidence            999999999986542    489999999999999999999999   99999999999999999999999997

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=8.9e-33  Score=262.79  Aligned_cols=148  Identities=28%  Similarity=0.392  Sum_probs=132.0

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      ++..++|+..+.||+|+||+||+|++. +++.||||+++...  ....+|.+|+.+++.++|||||+++|+|.+.+..++
T Consensus        13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence            344567888899999999999999975 58899999987542  334579999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||||+++|+|.+++.....  ..++|..+..++.|+|.||+|||++   +|+||||||+|||+|+++.+||+||+-
T Consensus        91 v~E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~  161 (287)
T d1opja_          91 ITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGL  161 (287)
T ss_dssp             EEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred             EeecccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccc
Confidence            9999999999999976432  3589999999999999999999999   999999999999999999999999973

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.4e-32  Score=253.68  Aligned_cols=142  Identities=27%  Similarity=0.436  Sum_probs=129.4

Q ss_pred             CCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecC
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      ++|+..+.||+|+||.||+|++.+++.||||+++..  .....+|.+|+.+++.++|||||+++|+|...+..++||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC--cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            467778899999999999999988889999999753  233457999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++|+|.+++....   ..++|..+..++.|+|.||+|||++   +|+||||||+|||+|+++.+||+||+
T Consensus        83 ~~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFG  146 (263)
T d1sm2a_          83 EHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFG  146 (263)
T ss_dssp             TTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC
T ss_pred             CCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccc
Confidence            9999999987643   3489999999999999999999999   99999999999999999999999997

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=5.4e-32  Score=258.84  Aligned_cols=144  Identities=29%  Similarity=0.443  Sum_probs=126.1

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CC---CEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DG---KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~---~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      ++|+..+.||+|+||+||+|++. ++   ..||||.++..........|.+|+.++++++|||||+++|+|...+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            45666789999999999999875 23   368999987654444455799999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |||+++|+|.+++.....   .++|.++..++.|||+||+|||++   +|+||||||+|||+|.++.+||+||+
T Consensus       106 ~Ey~~~g~L~~~~~~~~~---~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG  173 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFG  173 (299)
T ss_dssp             EECCTTEEHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             EEecCCCcceeeeccccC---CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcc
Confidence            999999999998876432   489999999999999999999999   99999999999999999999999997

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.9e-32  Score=256.37  Aligned_cols=145  Identities=29%  Similarity=0.420  Sum_probs=127.4

Q ss_pred             HhCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      ..++|+..+.||+|+||+||+|++++++.||||+++..  ......|.+|+.++++++|||||+++|++.+ +..++|||
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E   87 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG--SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE   87 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC--cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence            34567778899999999999999988889999999653  2334579999999999999999999998754 56799999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |+++|+|.+++.....  ..++|.++..++.|||+||+|||++   +|+||||||+|||+|+++.+||+||+-
T Consensus        88 y~~~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGl  155 (272)
T d1qpca_          88 YMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGL  155 (272)
T ss_dssp             CCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             eCCCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccc
Confidence            9999999998765422  2489999999999999999999999   999999999999999999999999973

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8.6e-32  Score=254.44  Aligned_cols=143  Identities=29%  Similarity=0.434  Sum_probs=125.8

Q ss_pred             HhCCCCCCCccccccceEEEEEEeCCCCEEEEEEcccccc-ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ..++|+..+.||+|+||+||+|++.  ..||||+++.... ......|.+|+.++++++|||||+++|++.+ +..++||
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~   82 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT   82 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence            4567888999999999999999874  3699999975433 2334579999999999999999999998754 5689999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++|+|.++++....   .++|.++..++.|+|+||+|||++   +||||||||+|||+|+++.+||+||+
T Consensus        83 Ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFG  149 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFG  149 (276)
T ss_dssp             ECCCEEEHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCC
T ss_pred             ecCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEcccc
Confidence            99999999999976432   489999999999999999999999   99999999999999999999999997

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.1e-31  Score=250.44  Aligned_cols=142  Identities=22%  Similarity=0.343  Sum_probs=128.8

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++... ......+.+|+.+++.++|||||++++++.+.+..++||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc-ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            4699999999999999999986 468999999986543 23345799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      +++|+|.+++.+.     .+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+|++||+-
T Consensus        99 ~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~  162 (293)
T d1yhwa1          99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF  162 (293)
T ss_dssp             CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             cCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchh
Confidence            9999999988653     389999999999999999999999   999999999999999999999999973

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.9e-31  Score=248.96  Aligned_cols=144  Identities=32%  Similarity=0.477  Sum_probs=129.6

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccc--cccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|+..+.||+|+||+||+|+.. +++.||+|+++...  .......+.+|+.+++.++|||||++++++.+.+..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            56888899999999999999975 68899999986432  2233457899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||+++|+|.+++....    .+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+|++||+-
T Consensus        86 Ey~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~  152 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGW  152 (263)
T ss_dssp             ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCS
T ss_pred             eecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccce
Confidence            9999999999998653    389999999999999999999999   999999999999999999999999974

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.1e-31  Score=259.45  Aligned_cols=144  Identities=26%  Similarity=0.364  Sum_probs=130.5

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .++|+..+.||+|+||+||+|+.. +|+.||+|+++..........+.+|+.+++.++|||||+++++|.+.+..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            567888899999999999999974 6899999999765444444578999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+++|+|.+++.+..    .+++..+..++.|++.||.|||+ +   +|+||||||+|||+++++.+||+||+
T Consensus        85 y~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFG  150 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFG  150 (322)
T ss_dssp             CCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred             cCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCC
Confidence            999999999998653    38999999999999999999996 5   79999999999999999999999997

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.3e-31  Score=251.85  Aligned_cols=143  Identities=28%  Similarity=0.411  Sum_probs=128.6

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      +.|+..+.||+|+||+||+|+.. +++.||||+++... ......+.+|+.+++.++|||||++++++.+.+..++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            45777889999999999999974 68899999986542 33345789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++|+|.+++.+...   .+++.++..++.|++.||+|||++   +|+||||||+|||++.++++||+||+
T Consensus        91 ~~~g~L~~~~~~~~~---~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG  155 (288)
T d2jfla1          91 CAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFG  155 (288)
T ss_dssp             CTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEech
Confidence            999999999875432   489999999999999999999999   99999999999999999999999997

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.9e-31  Score=245.74  Aligned_cols=142  Identities=27%  Similarity=0.423  Sum_probs=130.1

Q ss_pred             CCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecC
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      ++|+..+.||+|+||+||+|++++++.||||.++...  ....+|.+|+.++++++|||||+++|+|.+.+..++||||+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~--~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS--SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc--CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            5788899999999999999999888899999997543  33457999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++|++..++.....   .+++..+.+++.|+|+||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        82 ~~g~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG  145 (258)
T d1k2pa_          82 ANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFG  145 (258)
T ss_dssp             TTEEHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCS
T ss_pred             CCCcHHHhhhcccc---CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcch
Confidence            99999999776433   478999999999999999999999   99999999999999999999999996

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.6e-31  Score=251.69  Aligned_cols=151  Identities=23%  Similarity=0.320  Sum_probs=121.4

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEee--CCeeEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEKLLV  361 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv  361 (438)
                      ++|+..+.||+|+||+||+|+.. +|+.||||.++..... .....+.+|+.++++++|||||++++++.+  .+..++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            56888899999999999999874 6899999998654322 223468999999999999999999999865  4568999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC--DPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |||+++|+|.+++.+.......+++..+..++.|++.||+|||++.  ..+|+||||||+|||+++++.+||+||+-
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~  160 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  160 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence            9999999999998754333345899999999999999999999862  12499999999999999999999999973

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.8e-31  Score=249.24  Aligned_cols=145  Identities=29%  Similarity=0.466  Sum_probs=128.2

Q ss_pred             hCCCCCCCccccccceEEEEEEeCC-C----CEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLAD-G----KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  359 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~~-~----~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  359 (438)
                      .+.|+..++||+|+||+||+|.+++ +    ..||||+++.........+|.+|+.+++.++|||||+++|++.+.+..+
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            3457778999999999999998753 2    3799999976544444457999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++|||+.+|++.+.+.....   .++|.++..++.|+|.||+|||++   +|+||||||+|||+|.++.+||+||+
T Consensus        86 ~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG  155 (283)
T d1mqba_          86 IITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFG  155 (283)
T ss_dssp             EEEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             EEEEecccCcchhhhhcccc---cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccc
Confidence            99999999999998876532   489999999999999999999999   99999999999999999999999997

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.9e-31  Score=249.71  Aligned_cols=142  Identities=24%  Similarity=0.358  Sum_probs=122.9

Q ss_pred             CCCCCCc-cccccceEEEEEEeC---CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          287 GFSNKNI-LGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       287 ~~~~~~~-LG~G~fG~Vy~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      +|...+. ||+|+||+||+|.++   ++..||||+++..........|.+|+.++++++|||||+++|+|.+ +..++||
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvm   87 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM   87 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEE
Confidence            4444553 999999999999864   3457999999765444444579999999999999999999999865 5689999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++|+|.+++....   ..+++.++..++.|+|.||+|||++   +|+||||||+|||++.++.+||+||+
T Consensus        88 E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFG  154 (285)
T d1u59a_          88 EMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFG  154 (285)
T ss_dssp             ECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCT
T ss_pred             EeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccch
Confidence            9999999999986543   2489999999999999999999999   99999999999999999999999997

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.2e-30  Score=247.94  Aligned_cols=144  Identities=26%  Similarity=0.334  Sum_probs=129.6

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccc--cccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|+..+.||+|+||+||+|+.. +++.||||+++...  .......+.+|+.++++++|||||++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            46888899999999999999974 68999999986432  2333457899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||+++++.++++||+-
T Consensus        88 Ey~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~  154 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGT  154 (288)
T ss_dssp             CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             EccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEeccccc
Confidence            9999999999987653    389999999999999999999999   999999999999999999999999973

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=1.3e-30  Score=250.23  Aligned_cols=143  Identities=29%  Similarity=0.400  Sum_probs=126.4

Q ss_pred             CCCCCCccccccceEEEEEEe-CCCCEEEEEEcccccccc--chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          287 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .|+..+.||+|+||+||+|+. .+++.||||+++......  ....+.+|+.+++.++|||||++++++.+.+..++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            377788999999999999986 468899999986543222  23468999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |+++|++..++....    .+++.++..++.|++.||+|||++   +|+||||||+|||+++++.+||+||+-
T Consensus        96 ~~~~g~l~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~  161 (309)
T d1u5ra_          96 YCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGS  161 (309)
T ss_dssp             CCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred             ecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeeccc
Confidence            999999987665542    489999999999999999999999   999999999999999999999999974

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.3e-31  Score=250.59  Aligned_cols=143  Identities=27%  Similarity=0.418  Sum_probs=127.5

Q ss_pred             hCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      .++|+..+.||+|+||+||+|++++++.||||+++...  .....|.+|+.++++++|||||+++|+|. .++.++||||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey   92 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY   92 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEe
Confidence            45688889999999999999999888889999996542  33457999999999999999999999985 4668999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +++|+|..++.....  ..++|.+++.++.|||.||+|||++   +|+||||||+|||+|+++++||+||+
T Consensus        93 ~~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfG  158 (285)
T d1fmka3          93 MSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFG  158 (285)
T ss_dssp             CTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             cCCCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccc
Confidence            999999998876422  2489999999999999999999999   99999999999999999999999997

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.9e-30  Score=251.00  Aligned_cols=150  Identities=27%  Similarity=0.409  Sum_probs=126.5

Q ss_pred             HhCCCCCCCccccccceEEEEEEeCC-C-----CEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEeeCC
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLAD-G-----KLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVT  356 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~~-~-----~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  356 (438)
                      ..++|+..+.||+|+||+||+|++.. +     ..||||.+...........+.+|+.++.++ +|||||++++++.+.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            44678888999999999999998642 2     369999987654444455799999999887 8999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhccCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCC
Q 013682          357 EKLLVYPYMTNGSVASRLRERQSS-------------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVK  417 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK  417 (438)
                      ..++||||+++|+|.++++.....                   ...++|..+..++.|++.||+|||++   +|||||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlK  191 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA  191 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCc
Confidence            999999999999999999865321                   23589999999999999999999999   99999999


Q ss_pred             CCCeeeCCCCCcchhhhhh
Q 013682          418 AANILLDEDADQSSKTILR  436 (438)
Q Consensus       418 ~~NILld~~~~~~l~Df~~  436 (438)
                      |+|||++.++.+||+||+-
T Consensus       192 p~Nill~~~~~~Kl~DFGl  210 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGL  210 (325)
T ss_dssp             GGGEEEETTTEEEECCCGG
T ss_pred             hhccccccCCeEEEeeccc
Confidence            9999999999999999974

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=1.1e-30  Score=249.98  Aligned_cols=154  Identities=29%  Similarity=0.468  Sum_probs=134.5

Q ss_pred             HHHHHHhCCCCCCCccccccceEEEEEEeC------CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEE
Q 013682          279 RELQVATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC  352 (438)
Q Consensus       279 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~  352 (438)
                      .+++...++|+..+.||+|+||+||+|++.      +++.||||+++.....+...+|.+|+.+++.++||||++++++|
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            344556788999999999999999999863      35689999997654444455799999999999999999999999


Q ss_pred             eeCCeeEEEEecCCCCCHHHHhhccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCce
Q 013682          353 TTVTEKLLVYPYMTNGSVASRLRERQS--------------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKII  412 (438)
Q Consensus       353 ~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv  412 (438)
                      ...+..+++|||+++|+|.++++....                    ....++|..++.++.|+|.||+|||++   +||
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iv  162 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV  162 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeE
Confidence            999999999999999999999975321                    123489999999999999999999999   999


Q ss_pred             ecCCCCCCeeeCCCCCcchhhhh
Q 013682          413 HRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       413 HrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||||||+|||+|.++++||+||+
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFG  185 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFG  185 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCS
T ss_pred             eeEEcccceEECCCCcEEEccch
Confidence            99999999999999999999997

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.5e-30  Score=244.43  Aligned_cols=136  Identities=26%  Similarity=0.360  Sum_probs=117.8

Q ss_pred             CccccccceEEEEEEeCC---CCEEEEEEcccccccc-chHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecCCC
Q 013682          292 NILGRGGFGKVYKGRLAD---GKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  367 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~---~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  367 (438)
                      +.||+|+||+||+|.+++   ++.||||+++...... ....|.+|+.++++++|||||+++|+|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            469999999999998642   4689999997543332 23479999999999999999999999865 567899999999


Q ss_pred             CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          368 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       368 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      |+|.++++...    .++|.++..++.|||.||+|||++   +|+||||||+|||++.++.++++||+
T Consensus        92 g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFG  152 (277)
T d1xbba_          92 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFG  152 (277)
T ss_dssp             EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             CcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchh
Confidence            99999998653    489999999999999999999999   99999999999999999999999997

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=2.6e-30  Score=247.90  Aligned_cols=144  Identities=23%  Similarity=0.368  Sum_probs=123.0

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .+.|+..+.||+|+||+||+|+.. +++.||||+++..........+.+|+.+++.++|||||++++++.+.+..++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            456888899999999999999975 6899999999765444444568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC---CCCCcchhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD---EDADQSSKTIL  435 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld---~~~~~~l~Df~  435 (438)
                      |+++|+|.+++....    .+++.++..++.|++.||+|||++   +|+||||||+|||+.   +++.+|++||+
T Consensus        88 ~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG  155 (307)
T d1a06a_          88 LVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFG  155 (307)
T ss_dssp             CCCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-
T ss_pred             ccCCCcHHHhhhccc----CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccc
Confidence            999999999997643    489999999999999999999999   999999999999995   57889999997

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=8.2e-30  Score=242.96  Aligned_cols=145  Identities=26%  Similarity=0.306  Sum_probs=128.5

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-----cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCee
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-----GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  358 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  358 (438)
                      .+.|+..+.||+|+||+||+|+.. +|+.||||+++.....     .....+.+|+.+++.++|||||++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            356888899999999999999974 6899999998643321     1245799999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC----cchhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD----QSSKTI  434 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~----~~l~Df  434 (438)
                      ++||||+++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.    ++++||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence            99999999999999998753    489999999999999999999999   9999999999999998874    899999


Q ss_pred             hh
Q 013682          435 LR  436 (438)
Q Consensus       435 ~~  436 (438)
                      +-
T Consensus       162 G~  163 (293)
T d1jksa_         162 GL  163 (293)
T ss_dssp             TT
T ss_pred             hh
Confidence            73

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=6.1e-30  Score=240.81  Aligned_cols=143  Identities=25%  Similarity=0.383  Sum_probs=121.5

Q ss_pred             CCCCccccccceEEEEEEeC-CCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEee----CCeeEEEE
Q 013682          289 SNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT----VTEKLLVY  362 (438)
Q Consensus       289 ~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~  362 (438)
                      +..+.||+|+||+||+|+.. +++.||+|.++..... .....+.+|++++++++|||||++++++.+    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            34467999999999999975 6889999998654322 233468999999999999999999999865    34578999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC-CCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-EDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld-~~~~~~l~Df~~  436 (438)
                      ||+++|+|.+++....    .+++.++..++.|++.||+|||++ .++|+||||||+|||++ +++.+||+||+-
T Consensus        92 E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl  161 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGL  161 (270)
T ss_dssp             ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             eCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence            9999999999998653    489999999999999999999998 22399999999999997 478999999974

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.96  E-value=6.6e-30  Score=241.46  Aligned_cols=144  Identities=28%  Similarity=0.312  Sum_probs=128.5

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccc--------hHHHHHHHHHHhcCC-CCCceeeEEEEeeC
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGG--------ELQFQTEVKIISMAV-HRNLLRLYGFCTTV  355 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~--------~~~~~~E~~~l~~l~-H~niv~l~g~~~~~  355 (438)
                      ++|+..+.||+|+||+||+|+. .+++.||||+++.......        ...+.+|+.++++++ |||||++++++.+.
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            5788889999999999999987 4689999999865432211        125889999999997 99999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          356 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       356 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +..++||||+++|+|.++++...    .+++.++..++.||+.||+|||++   +|+||||||+|||+++++.+||+||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence            99999999999999999998653    489999999999999999999999   99999999999999999999999997


Q ss_pred             h
Q 013682          436 R  436 (438)
Q Consensus       436 ~  436 (438)
                      -
T Consensus       156 ~  156 (277)
T d1phka_         156 F  156 (277)
T ss_dssp             T
T ss_pred             h
Confidence            4

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=6.4e-30  Score=248.01  Aligned_cols=145  Identities=25%  Similarity=0.325  Sum_probs=130.8

Q ss_pred             hCCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccc--cccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      .++|+..+.||+|+||+||+|+. .+++.||||+++...  .......+.+|+.+++.++|||||++++++.+.+..++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            45788899999999999999997 479999999996532  233445789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |||+++|+|.++++...    .+++..+..++.|++.||+|||++   +|+||||||+|||+|++|.+||+||+-
T Consensus        84 ~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~  151 (337)
T d1o6la_          84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGL  151 (337)
T ss_dssp             EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             eeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccc
Confidence            99999999999998754    388999999999999999999999   999999999999999999999999974

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.96  E-value=8.7e-30  Score=245.16  Aligned_cols=144  Identities=29%  Similarity=0.411  Sum_probs=129.0

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccc--cccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|+..+.||+|+||+||+|+.. +|+.||||+++...  .......+.+|+.+++.++|||||++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            56888899999999999999974 68999999986532  2233457899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||+++|++...+....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||+-
T Consensus        84 E~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~  150 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGF  150 (316)
T ss_dssp             CCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             eecCCccccccccccc----cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCcc
Confidence            9999999999987754    378889999999999999999999   999999999999999999999999973

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.96  E-value=1.1e-29  Score=247.68  Aligned_cols=145  Identities=19%  Similarity=0.315  Sum_probs=127.9

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .++|+..+.||+|+||+||+|+.. +|+.||||+++.... .....+.+|+.+++.++|||||++++++.+.+..++|||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE  103 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  103 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch-hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            357888899999999999999974 689999999865432 223468999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC--CCCcchhhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE--DADQSSKTILR  436 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~--~~~~~l~Df~~  436 (438)
                      |+++|+|.+++.+..   ..+++.++..++.||+.||+|||++   +||||||||+|||++.  ++.+||+||+-
T Consensus       104 ~~~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~  172 (350)
T d1koaa2         104 FMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGL  172 (350)
T ss_dssp             CCCSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred             cCCCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecch
Confidence            999999999986543   2489999999999999999999999   9999999999999964  57899999973

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.96  E-value=1.2e-29  Score=247.59  Aligned_cols=143  Identities=21%  Similarity=0.323  Sum_probs=127.2

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++.... .....+.+|+.+++.++|||||++++++.+.+..++||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            5688889999999999999987 4799999999865422 2234688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC--CCCCcchhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD--EDADQSSKTIL  435 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld--~~~~~~l~Df~  435 (438)
                      +++|+|.+.+....   ..+++.++..++.||+.||+|||++   +|+||||||+|||++  .++.++|+||+
T Consensus       108 ~~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFG  174 (352)
T d1koba_         108 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG  174 (352)
T ss_dssp             CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred             CCCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecc
Confidence            99999998876543   2489999999999999999999999   999999999999998  56889999997

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.7e-29  Score=242.64  Aligned_cols=148  Identities=29%  Similarity=0.473  Sum_probs=126.8

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCC--EEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEeeCCeeEE
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGK--LVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~--~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  360 (438)
                      .++|+..+.||+|+||+||+|++. ++.  .||||+++.....+..+.|.+|+.+++++ +|||||+++|+|.+.+..++
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i   88 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   88 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence            367788899999999999999875 343  57888886554444555799999999998 79999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC
Q 013682          361 VYPYMTNGSVASRLRERQ------------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  428 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~  428 (438)
                      ||||+++|+|.++++...            .....++|.++..++.|||.||.|+|+.   +|+||||||+|||++.++.
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV  165 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCc
Confidence            999999999999997541            2234689999999999999999999999   9999999999999999999


Q ss_pred             cchhhhh
Q 013682          429 QSSKTIL  435 (438)
Q Consensus       429 ~~l~Df~  435 (438)
                      +||+||+
T Consensus       166 ~kl~DfG  172 (309)
T d1fvra_         166 AKIADFG  172 (309)
T ss_dssp             EEECCTT
T ss_pred             eEEcccc
Confidence            9999997

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=6.3e-30  Score=241.28  Aligned_cols=146  Identities=23%  Similarity=0.305  Sum_probs=125.0

Q ss_pred             HhCCCCCCCccccccceEEEEEEeCC----CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeE
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  359 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~~----~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  359 (438)
                      ..++|+..+.||+|+||+||+|++..    +..||||.++..........|.+|+.++++++|||||+++|++. .+..+
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~   83 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   83 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence            34678888999999999999998742    34689999866544444557999999999999999999999985 56789


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      +||||+++|++.+++.....   .+++.++..++.|+++||+|||++   +|+||||||+||++++++.+|++||+-
T Consensus        84 iv~E~~~~g~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~  154 (273)
T d1mp8a_          84 IIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL  154 (273)
T ss_dssp             EEEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---
T ss_pred             EEEEeccCCcHHhhhhccCC---CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchh
Confidence            99999999999998776432   489999999999999999999999   999999999999999999999999973

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.3e-29  Score=240.85  Aligned_cols=144  Identities=21%  Similarity=0.311  Sum_probs=127.1

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      .++|...+.||+|+||+||+|... +++.||||.++...  .....+.+|+.+++.++|||||++++++.+.+..|+|||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            356888899999999999999875 68899999996542  223468899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC--CCcchhhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED--ADQSSKTILR  436 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~--~~~~l~Df~~  436 (438)
                      |+++|+|.+++....   ..+++.++..++.|++.||+|||++   +|+||||||+|||++.+  ..++++||+-
T Consensus        82 ~~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~  150 (321)
T d1tkia_          82 FISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQ  150 (321)
T ss_dssp             CCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred             cCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccch
Confidence            999999999997643   2489999999999999999999999   99999999999999865  4778999974

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=7.8e-30  Score=244.79  Aligned_cols=151  Identities=27%  Similarity=0.425  Sum_probs=130.6

Q ss_pred             HHHhCCCCCCCccccccceEEEEEEeC------CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeC
Q 013682          282 QVATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV  355 (438)
Q Consensus       282 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  355 (438)
                      ++..++|+..+.||+|+||.||+|.+.      +++.||||+++..........|.+|+.++++++|||||+++|+|...
T Consensus        16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~   95 (308)
T d1p4oa_          16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   95 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence            344567788899999999999999863      25689999997554333444689999999999999999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhccC------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCc
Q 013682          356 TEKLLVYPYMTNGSVASRLRERQ------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  429 (438)
Q Consensus       356 ~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~  429 (438)
                      +..++||||+++|+|.+++....      .....++|..+..++.|+|+||.|||++   +|+||||||+|||+|+++++
T Consensus        96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~  172 (308)
T d1p4oa_          96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV  172 (308)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred             CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceE
Confidence            99999999999999999887531      2223578999999999999999999999   99999999999999999999


Q ss_pred             chhhhh
Q 013682          430 SSKTIL  435 (438)
Q Consensus       430 ~l~Df~  435 (438)
                      ||+||+
T Consensus       173 Kl~DFG  178 (308)
T d1p4oa_         173 KIGDFG  178 (308)
T ss_dssp             EECCTT
T ss_pred             EEeecc
Confidence            999997

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=4.2e-29  Score=240.63  Aligned_cols=143  Identities=26%  Similarity=0.467  Sum_probs=122.7

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCC----EEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  360 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~----~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  360 (438)
                      ++|+..+.||+|+||+||+|++. +|+    .||+|.++........++|.+|+.++++++|||||+++|+|.+. ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            35888899999999999999874 343    68999987655555566899999999999999999999999764 5678


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++||+.+|+|.+.+.....   .++|..+..++.|||.||+|||++   +|+||||||+|||++.++.+||+||+
T Consensus        88 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFG  156 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFG  156 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCS
T ss_pred             EEEeccCCccccccccccc---CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccc
Confidence            8999999999998876532   489999999999999999999999   99999999999999999999999996

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.95  E-value=4.9e-29  Score=235.57  Aligned_cols=144  Identities=24%  Similarity=0.329  Sum_probs=127.0

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccc--hHHHHHHHHHHhcCCCCCceeeEEEEeeCCe----e
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTTVTE----K  358 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----~  358 (438)
                      ++|+..+.||+|+||+||+|+. .+++.||||+++.....+.  ...+.+|+.+++.++|||||++++++...+.    .
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            5688889999999999999986 4789999999976443322  3468999999999999999999999876543    7


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |+||||+++|+|.+++....    .+++.++..++.|++.||+|||++   +|+||||||+|||++.++..+++||..
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~  157 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGI  157 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTT
T ss_pred             EEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhh
Confidence            89999999999999887653    489999999999999999999999   999999999999999999999999874

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.95  E-value=4.9e-29  Score=236.64  Aligned_cols=144  Identities=23%  Similarity=0.383  Sum_probs=128.1

Q ss_pred             CCCCCCCccccccceEEEEEEeCCCCEEEEEEcccccc-ccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEec
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  364 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  364 (438)
                      ++|+..+.||+|+||+||+|+.++++.||||+++.... ......+.+|+.+++.++|||||++++++...+..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            57888899999999999999998899999999965432 22345799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          365 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       365 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      +.++.+..+.+..    ..+++.++..++.|++.||+|||+.   +||||||||+|||++.++.++++||+-
T Consensus        82 ~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~  146 (286)
T d1ob3a_          82 LDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL  146 (286)
T ss_dssp             CSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             ehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEeccccc
Confidence            9887776665543    2489999999999999999999999   999999999999999999999999974

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=6.3e-29  Score=237.32  Aligned_cols=145  Identities=23%  Similarity=0.450  Sum_probs=123.4

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      |+|+..+.||+|+||+||+|+. .+++.||||+++..... .....+.+|+.+++.++|||||++++++.+.+..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            6788889999999999999997 56899999999654322 224578999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |+.++ +.+.+....  ...+++.++..++.|++.||+|||++   +||||||||+|||++.++..+++||+-
T Consensus        82 ~~~~~-~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~  148 (298)
T d1gz8a_          82 FLHQD-LKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL  148 (298)
T ss_dssp             CCSEE-HHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred             ecCCc-hhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCc
Confidence            99764 444544332  23489999999999999999999999   999999999999999999999999973

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.95  E-value=6.5e-29  Score=242.30  Aligned_cols=144  Identities=24%  Similarity=0.301  Sum_probs=129.6

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccc--cccchHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  362 (438)
                      ++|+..+.||+|+||+||+|+.. +|+.||||+++...  .......+.+|+.+++.++|||||++++++......++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            56888899999999999999974 69999999986432  2233456899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ||+.+|+|.+++....    .+++.++..++.|++.||.|||++   +||||||||+|||++.++.+||+||+-
T Consensus       121 e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~  187 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGF  187 (350)
T ss_dssp             ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeecee
Confidence            9999999999997754    389999999999999999999999   999999999999999999999999973

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.2e-28  Score=236.76  Aligned_cols=139  Identities=33%  Similarity=0.491  Sum_probs=121.2

Q ss_pred             CCccccccceEEEEEEeCC----CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEee-CCeeEEEEecC
Q 013682          291 KNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTEKLLVYPYM  365 (438)
Q Consensus       291 ~~~LG~G~fG~Vy~~~~~~----~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e~~  365 (438)
                      .++||+|+||+||+|++.+    ...||||+++.........+|.+|++++++++|||||+++|++.+ +...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            3679999999999999743    236899999754333344579999999999999999999999876 45789999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ++|+|.++++....   ..++.+++.++.|+|.||.|+|+.   +|+||||||+|||+|+++.+||+||+
T Consensus       112 ~~g~l~~~~~~~~~---~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG  175 (311)
T d1r0pa_         112 KHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFG  175 (311)
T ss_dssp             TTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSG
T ss_pred             ecCchhhhhccccc---cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEeccc
Confidence            99999999876432   478899999999999999999999   99999999999999999999999997

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.7e-29  Score=236.66  Aligned_cols=143  Identities=28%  Similarity=0.430  Sum_probs=123.7

Q ss_pred             hCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEee-CCeeEEEEe
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTEKLLVYP  363 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e  363 (438)
                      .++|+..+.||+|+||.||+|+++ |+.||||+++..   ...+.|.+|++++++++|||||+++|+|.+ .+..++|||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e   81 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   81 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence            345677789999999999999984 778999999653   234579999999999999999999999865 456899999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |+++|+|.++++....  ..++|..++.++.|||.||+|||+.   +|+||||||+|||++.++.++++||.-
T Consensus        82 y~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~  149 (262)
T d1byga_          82 YMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL  149 (262)
T ss_dssp             CCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred             ccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeeccccc
Confidence            9999999999976421  2479999999999999999999998   999999999999999999999999963

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=8.1e-29  Score=238.73  Aligned_cols=144  Identities=25%  Similarity=0.388  Sum_probs=126.5

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccc--cccchHHHHHHHHHHh-cCCCCCceeeEEEEeeCCeeEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIIS-MAVHRNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lv  361 (438)
                      ++|...+.||+|+||+||+|+.. +++.||||+++...  .......+..|..++. .++|||||++++++.+.+..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57888899999999999999975 68999999996432  2233345667776654 68999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      |||+++|+|.++++...    .+++.++..++.||+.||+|||++   +|+||||||+|||+++++.++++||+-
T Consensus        82 mEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~  149 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGM  149 (320)
T ss_dssp             EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccch
Confidence            99999999999998754    378999999999999999999999   999999999999999999999999974

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.4e-29  Score=240.68  Aligned_cols=151  Identities=28%  Similarity=0.371  Sum_probs=130.8

Q ss_pred             HHhCCCCCCCccccccceEEEEEEeC------CCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEeeC
Q 013682          283 VATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  355 (438)
Q Consensus       283 ~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  355 (438)
                      +..++|+..+.||+|+||.||+|++.      +++.||||+++..........|.+|+.+++++ +|||||+++|+|.+.
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            34567778899999999999999852      35689999997654444445789999999998 699999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHhhccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCe
Q 013682          356 TEKLLVYPYMTNGSVASRLRERQS--------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANI  421 (438)
Q Consensus       356 ~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NI  421 (438)
                      +..+++|||+++|+|.++++....              ....+++.++..++.|||.||+|||++   +||||||||+||
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI  176 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI  176 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccc
Confidence            999999999999999999986532              123589999999999999999999999   999999999999


Q ss_pred             eeCCCCCcchhhhhh
Q 013682          422 LLDEDADQSSKTILR  436 (438)
Q Consensus       422 Lld~~~~~~l~Df~~  436 (438)
                      +++.++.++++||+-
T Consensus       177 l~~~~~~~ki~DfG~  191 (311)
T d1t46a_         177 LLTHGRITKICDFGL  191 (311)
T ss_dssp             EEETTTEEEECCCGG
T ss_pred             cccccCcccccccch
Confidence            999999999999975

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.95  E-value=7.8e-29  Score=242.99  Aligned_cols=145  Identities=28%  Similarity=0.365  Sum_probs=125.4

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccc--ccchHHHHH---HHHHHhcCCCCCceeeEEEEeeCCee
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQT---EVKIISMAVHRNLLRLYGFCTTVTEK  358 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~~---E~~~l~~l~H~niv~l~g~~~~~~~~  358 (438)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++.....  ......+.+   |+.+++.++|||||++++++.+.+..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            467888999999999999999975 689999999854321  122223444   46677888999999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ++||||+++|+|.+++....    .+++.++..++.||+.||+|||++   +||||||||+|||+++++.+||+||+-
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGl  153 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGL  153 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTT
T ss_pred             EEEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeece
Confidence            99999999999999998753    378999999999999999999999   999999999999999999999999973

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=4.1e-29  Score=238.69  Aligned_cols=153  Identities=28%  Similarity=0.383  Sum_probs=122.7

Q ss_pred             HHHHHhCCCCCCCccccccceEEEEEEeC------CCCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEE
Q 013682          280 ELQVATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFC  352 (438)
Q Consensus       280 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~  352 (438)
                      ++++..++|+..+.||+|+||+||+|++.      +++.||||+++..........+.+|...+.++ +|+|||.+++++
T Consensus         7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~   86 (299)
T d1ywna1           7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC   86 (299)
T ss_dssp             HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence            33455678888999999999999999863      24689999997654444445677787777665 789999999998


Q ss_pred             eeC-CeeEEEEecCCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCC
Q 013682          353 TTV-TEKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAA  419 (438)
Q Consensus       353 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~  419 (438)
                      ... ...++||||+++|+|.++++....            ....++|.++..++.|||+||+|||++   +||||||||+
T Consensus        87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~  163 (299)
T d1ywna1          87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR  163 (299)
T ss_dssp             CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred             ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCcc
Confidence            765 458999999999999999976432            123488999999999999999999999   9999999999


Q ss_pred             CeeeCCCCCcchhhhh
Q 013682          420 NILLDEDADQSSKTIL  435 (438)
Q Consensus       420 NILld~~~~~~l~Df~  435 (438)
                      |||+++++.+||+||+
T Consensus       164 NILl~~~~~~Kl~DFG  179 (299)
T d1ywna1         164 NILLSEKNVVKICDFG  179 (299)
T ss_dssp             GEEECGGGCEEECC--
T ss_pred             ceeECCCCcEEEccCc
Confidence            9999999999999997

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=8.4e-29  Score=236.54  Aligned_cols=150  Identities=29%  Similarity=0.401  Sum_probs=124.4

Q ss_pred             HhCCCCCCCccccccceEEEEEEeCC--------CCEEEEEEccccccccchHHHHHHHHHHhcC-CCCCceeeEEEEee
Q 013682          284 ATDGFSNKNILGRGGFGKVYKGRLAD--------GKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  354 (438)
Q Consensus       284 ~~~~~~~~~~LG~G~fG~Vy~~~~~~--------~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  354 (438)
                      ..++|...+.||+|+||.||+|+...        +..||||+++.........++.+|+..+.++ +|||||+++++|.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            45677788999999999999998521        2479999997655444455788898888877 89999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCee
Q 013682          355 VTEKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL  422 (438)
Q Consensus       355 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NIL  422 (438)
                      ++..++||||+++|+|.++++....            ....+++.++..++.|+|.||+|||++   +||||||||+|||
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiL  167 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL  167 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccccee
Confidence            9999999999999999999986532            124589999999999999999999999   9999999999999


Q ss_pred             eCCCCCcchhhhhh
Q 013682          423 LDEDADQSSKTILR  436 (438)
Q Consensus       423 ld~~~~~~l~Df~~  436 (438)
                      ++.++.+|++||.-
T Consensus       168 l~~~~~~kl~dfg~  181 (299)
T d1fgka_         168 VTEDNVMKIADFGL  181 (299)
T ss_dssp             ECTTCCEEECSTTC
T ss_pred             ecCCCCeEeccchh
Confidence            99999999999963

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.3e-28  Score=235.67  Aligned_cols=141  Identities=28%  Similarity=0.389  Sum_probs=118.0

Q ss_pred             CCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCC----eeEEEE
Q 013682          287 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT----EKLLVY  362 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lv~  362 (438)
                      +|...+.||+|+||.||+|++ +|+.||||+++...  .....++.|+..+..++|||||+++++|.+.+    ..++||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            355568899999999999997 58899999986432  11112344555566789999999999998754    578999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          363 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH-----CDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       363 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ||+++|+|.+++++.     .++|.++..++.|+|.||+|+|+.     ..++|+||||||+|||+|+++.+||+||+
T Consensus        81 Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG  153 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             ecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence            999999999999864     389999999999999999999974     24599999999999999999999999997

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.3e-28  Score=235.14  Aligned_cols=139  Identities=29%  Similarity=0.389  Sum_probs=118.2

Q ss_pred             CCccccccceEEEEEEeC-CCCEEEEEEccccccccc----hHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEecC
Q 013682          291 KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG----ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  365 (438)
Q Consensus       291 ~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~----~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  365 (438)
                      .++||+|+||+||+|+.. +|+.||||+++.......    ...+.+|+.+++.++|||||++++++...+..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            467999999999999974 689999999865432211    236889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          366 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       366 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      .++++.......    ..+++.++..++.|++.||+|||++   +|+||||||+|||+++++.+||+||+-
T Consensus        83 ~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~  146 (299)
T d1ua2a_          83 ETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGL  146 (299)
T ss_dssp             SEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred             cchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCcc
Confidence            988776655432    2478889999999999999999999   999999999999999999999999984

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=9.7e-29  Score=232.98  Aligned_cols=143  Identities=34%  Similarity=0.424  Sum_probs=115.6

Q ss_pred             CCCCCCCccccccceEEEEEEeC--CC--CEEEEEEccccccccc--hHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA--DG--KLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  359 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~--~~--~~vAvK~l~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  359 (438)
                      ++|+..+.||+|+||.||+|++.  ++  ..||||+++.......  ..+|.+|+.++++++|||||+++|+|.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            45777889999999999999863  23  3789999875433222  3479999999999999999999999965 4678


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      +||||+++|++.+.+.....   .+++..+..++.|+|.||.|||++   +|+||||||+|||++.++++|++||+
T Consensus        87 lv~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfG  156 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFG  156 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             eeeeeecCcchhhhhhcccC---CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccch
Confidence            99999999999988876432   489999999999999999999998   99999999999999999999999996

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.6e-27  Score=226.39  Aligned_cols=144  Identities=20%  Similarity=0.351  Sum_probs=128.4

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccc-hHHHHHHHHHHhcCCCCCceeeEEEEeeCCeeEEEEe
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  363 (438)
                      ++|+..+.||+|+||+||+|+. .+++.||||+++....... ...+.+|+.+++.++|||||++++++......++++|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            4678889999999999999997 4688999999965443322 3578999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ++.++++..+++...    .+++..+..++.|++.||+|||++   +|+||||||+|||++.+++++++||+-
T Consensus        82 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~  147 (292)
T d1unla_          82 FCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL  147 (292)
T ss_dssp             CCSEEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             ecccccccccccccc----ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecch
Confidence            999999888776543    478999999999999999999999   999999999999999999999999975

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.4e-27  Score=232.55  Aligned_cols=143  Identities=20%  Similarity=0.293  Sum_probs=120.2

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeCC----eeEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT----EKLL  360 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~l  360 (438)
                      ++|...+.||+|+||+||+|+. .+++.||||+++..........+.+|+.+|+.++|||||++++++....    ..++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            4678889999999999999986 5799999999975433333447899999999999999999999997643    2345


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          361 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       361 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ++||+.+|+|.+++...     .+++..+..++.|++.||+|||++   +||||||||+|||+++++.++|+||+-
T Consensus        88 l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~  155 (345)
T d1pmea_          88 LVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL  155 (345)
T ss_dssp             EEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCc
Confidence            56667799999999754     389999999999999999999999   999999999999999999999999973

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.1e-27  Score=225.88  Aligned_cols=144  Identities=22%  Similarity=0.347  Sum_probs=123.7

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEcccccccc-----chHHHHHHHHHHhcCC--CCCceeeEEEEeeCCe
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-----GELQFQTEVKIISMAV--HRNLLRLYGFCTTVTE  357 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~-----~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~  357 (438)
                      ++|+..+.||+|+||+||+|+. .+++.||||+++.....+     ....+.+|+.++++++  |||||++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            4688889999999999999997 478999999986543221     1224778999999886  8999999999999999


Q ss_pred             eEEEEecCCC-CCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC-CCcchhhhh
Q 013682          358 KLLVYPYMTN-GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTIL  435 (438)
Q Consensus       358 ~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~-~~~~l~Df~  435 (438)
                      .++||||+.+ +++.++++...    .+++.++..++.|++.||+|||++   +|+||||||+|||++.+ +.++++||+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence            9999999986 57888877643    389999999999999999999999   99999999999999955 789999997


Q ss_pred             h
Q 013682          436 R  436 (438)
Q Consensus       436 ~  436 (438)
                      -
T Consensus       157 ~  157 (273)
T d1xwsa_         157 S  157 (273)
T ss_dssp             T
T ss_pred             c
Confidence            4

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.1e-27  Score=230.25  Aligned_cols=140  Identities=23%  Similarity=0.292  Sum_probs=119.3

Q ss_pred             hCCCCCC-CccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHh-cCCCCCceeeEEEEee----CCe
Q 013682          285 TDGFSNK-NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLLRLYGFCTT----VTE  357 (438)
Q Consensus       285 ~~~~~~~-~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~----~~~  357 (438)
                      .++|... +.||+|+||+||+|+. .+++.||||+++..      ..+.+|+.++. ..+|||||++++++.+    ...
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence            3567765 4699999999999987 46899999998532      35788998865 4589999999999875    356


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC---CCCcchhhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTI  434 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~---~~~~~l~Df  434 (438)
                      .++|||||++|+|.+++.....  ..+++.++..++.|++.||+|||++   +|+||||||+|||+++   ++.+|++||
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             EEEEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccc
Confidence            7999999999999999986432  3589999999999999999999999   9999999999999986   456899999


Q ss_pred             h
Q 013682          435 L  435 (438)
Q Consensus       435 ~  435 (438)
                      +
T Consensus       159 G  159 (335)
T d2ozaa1         159 G  159 (335)
T ss_dssp             T
T ss_pred             c
Confidence            7

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=5.4e-27  Score=228.88  Aligned_cols=141  Identities=28%  Similarity=0.411  Sum_probs=115.4

Q ss_pred             CCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeEEEEeeC------CeeE
Q 013682          287 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV------TEKL  359 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~  359 (438)
                      +|+..++||+|+||+||+|+.. +++.||||+++....     ...+|+.++++++|||||++++++...      ...+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            4666788999999999999975 689999999865321     235799999999999999999998643      3468


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC-Ccchhhhhh
Q 013682          360 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTILR  436 (438)
Q Consensus       360 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~-~~~l~Df~~  436 (438)
                      +||||++++.+ +.+.........+++.++..++.|++.||+|||++   +|+||||||+|||++.++ .+||+||+-
T Consensus        96 lv~Ey~~~~~~-~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~  169 (350)
T d1q5ka_          96 LVLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS  169 (350)
T ss_dssp             EEEECCSEEHH-HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred             EEEeccCCccH-HHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccc
Confidence            99999986643 33332212234589999999999999999999999   999999999999999875 889999973

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=8.4e-27  Score=227.11  Aligned_cols=143  Identities=23%  Similarity=0.350  Sum_probs=117.6

Q ss_pred             hCCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc-chHHHHHHHHHHhcCCCCCceeeEEEEeeCC------
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVT------  356 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  356 (438)
                      .++|+..+.||+|+||+||+|+.. +|+.||||+++...... ....+.+|+.+|+.++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            457888899999999999999974 69999999997543222 2346889999999999999999999997654      


Q ss_pred             eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          357 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ..++||||+ +.+|....+..     .+++..+..++.|++.||+|||++   +|+||||||+|||++.++..+++||+-
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence            469999999 56777776543     389999999999999999999999   999999999999999999999999974

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.93  E-value=1.5e-26  Score=223.65  Aligned_cols=137  Identities=23%  Similarity=0.301  Sum_probs=119.6

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCC-CCCceeeEEEEeeC--CeeEEE
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTV--TEKLLV  361 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lv  361 (438)
                      ++|+..+.||+|+||+||+|+. .+++.||||+++..    ....+.+|+.++..++ ||||+++++++...  ...++|
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            5788889999999999999997 46899999998642    2346889999999985 99999999998753  568999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC-Ccchhhhhh
Q 013682          362 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTILR  436 (438)
Q Consensus       362 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~-~~~l~Df~~  436 (438)
                      |||+.+++|....+       .+++.++..++.||+.||+|||++   +|+||||||+|||++.++ .++++||+-
T Consensus       111 ~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~  176 (328)
T d3bqca1         111 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL  176 (328)
T ss_dssp             EECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred             EeecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccc
Confidence            99999999876532       388999999999999999999999   999999999999999765 589999984

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.1e-26  Score=223.89  Aligned_cols=144  Identities=27%  Similarity=0.330  Sum_probs=126.7

Q ss_pred             hCCCCCCCccccccceEEEEEEeC----CCCEEEEEEcccccc---ccchHHHHHHHHHHhcCCC-CCceeeEEEEeeCC
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERT---SGGELQFQTEVKIISMAVH-RNLLRLYGFCTTVT  356 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~~----~~~~vAvK~l~~~~~---~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~  356 (438)
                      .++|+..+.||+|+||+||+|+..    +|+.||||.++....   ......+.+|+.++++++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            366888999999999999999852    478999999865421   2233468899999999976 89999999999999


Q ss_pred             eeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          357 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       357 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ..+++|||+.+|+|.+++.....    +.......++.|++.|++|+|+.   +|+||||||+|||+|.++.++|+||+
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~~~----~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG  174 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG  174 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             ceeeeeecccccHHHHHHHhccc----ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeecc
Confidence            99999999999999999987643    67788899999999999999999   99999999999999999999999996

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=2.3e-26  Score=221.32  Aligned_cols=144  Identities=27%  Similarity=0.423  Sum_probs=119.7

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccc-cchHHHHHHHHHHhcCCCCCceeeEEEEee--------C
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT--------V  355 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~  355 (438)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++..... .....+.+|+.+++.++|||++++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            5678889999999999999997 47899999998654332 234578999999999999999999999865        3


Q ss_pred             CeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          356 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       356 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                      ...+++|||+.++.+.......    ..++......++.|++.||.|||++   +|+||||||+|||++.++.++++||+
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence            4578999999987766554332    2478899999999999999999999   99999999999999999999999997


Q ss_pred             h
Q 013682          436 R  436 (438)
Q Consensus       436 ~  436 (438)
                      -
T Consensus       163 ~  163 (318)
T d3blha1         163 L  163 (318)
T ss_dssp             T
T ss_pred             e
Confidence            3

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.8e-26  Score=224.81  Aligned_cols=144  Identities=22%  Similarity=0.322  Sum_probs=123.0

Q ss_pred             hCCCCCCCccccccceEEEEEEe-CCCCEEEEEEcccccccc-chHHHHHHHHHHhcCCCCCceeeEEEEeeC-----Ce
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TE  357 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~  357 (438)
                      .++|+..+.||+|+||+||+|+. .+|+.||||+++...... ....+.+|+.+++.++|||+|++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            46788889999999999999986 479999999997543222 234688999999999999999999998643     34


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      .++++||+.+|+|.++++..     .+++.++..++.|++.||+|||++   +|+||||||+|||++.++..+++||.-
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~  167 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL  167 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred             eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccch
Confidence            46778888999999998643     389999999999999999999999   999999999999999999999999964

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=2.4e-26  Score=219.80  Aligned_cols=146  Identities=27%  Similarity=0.458  Sum_probs=118.7

Q ss_pred             hCCCCCCCccccccceEEEEEEe-CC-CCEEEEEEcccccccc-chHHHHHHHHHHhcC---CCCCceeeEEEEee----
Q 013682          285 TDGFSNKNILGRGGFGKVYKGRL-AD-GKLVAVKRLKEERTSG-GELQFQTEVKIISMA---VHRNLLRLYGFCTT----  354 (438)
Q Consensus       285 ~~~~~~~~~LG~G~fG~Vy~~~~-~~-~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l---~H~niv~l~g~~~~----  354 (438)
                      .++|+..+.||+|+||+||+|+. .+ ++.||||+++...... ....+.+|+.+++.+   +|||||+++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46788889999999999999987 34 6679999986543322 233567788776654   89999999999864    


Q ss_pred             -CCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhh
Q 013682          355 -VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKT  433 (438)
Q Consensus       355 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~D  433 (438)
                       ....+++|||+.++++........   ..+++.....++.|++.||+|||++   +|+||||||+|||+++++.++++|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence             345789999999887654443322   3488999999999999999999999   999999999999999999999999


Q ss_pred             hhh
Q 013682          434 ILR  436 (438)
Q Consensus       434 f~~  436 (438)
                      |.-
T Consensus       160 fg~  162 (305)
T d1blxa_         160 FGL  162 (305)
T ss_dssp             CCS
T ss_pred             hhh
Confidence            963

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.6e-25  Score=218.78  Aligned_cols=141  Identities=23%  Similarity=0.284  Sum_probs=118.3

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEcccccccc-chHHHHHHHHHHhcCCCCCceeeEEEEee------CCe
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTT------VTE  357 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~  357 (438)
                      ++|+..+.||+|+||+||+|+.. +|+.||||+++...... ....+.+|+.+++.++|||||++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            56888899999999999999975 69999999997543322 23368899999999999999999999964      367


Q ss_pred             eEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          358 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       358 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      .++||||+.++. .+.+..      .+++..+..++.|++.||+|||++   +|+||||||+|||++.++..+++||..
T Consensus        97 ~~iv~Ey~~~~l-~~~~~~------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~  165 (355)
T d2b1pa1          97 VYLVMELMDANL-CQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_dssp             EEEEEECCSEEH-HHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             eEEEEeccchHH-HHhhhc------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhh
Confidence            899999997654 444432      378999999999999999999999   999999999999999999999999963

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.91  E-value=9.7e-25  Score=207.49  Aligned_cols=141  Identities=18%  Similarity=0.217  Sum_probs=121.7

Q ss_pred             CCCCCCCccccccceEEEEEEeC-CCCEEEEEEccccccccchHHHHHHHHHHhcCCC-CCceeeEEEEeeCCeeEEEEe
Q 013682          286 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH-RNLLRLYGFCTTVTEKLLVYP  363 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e  363 (438)
                      ++|+..+.||+|+||+||+|+.. +++.||||+++....   ...+.+|++.+..++| +|++.+++++......++|||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            46888899999999999999974 688999998754322   2357888999988875 899999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC-----CCCcchhhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-----DADQSSKTILR  436 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~-----~~~~~l~Df~~  436 (438)
                      |+ +|+|.++++....   .+++.++..++.|++.||+|||++   +|+||||||+|||++.     ++.++++||+-
T Consensus        82 ~~-~~~l~~~~~~~~~---~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~  152 (293)
T d1csna_          82 LL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  152 (293)
T ss_dssp             CC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             ec-CCCHHHHHHhhcc---chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccce
Confidence            98 6899998876432   489999999999999999999999   9999999999999975     56789999974

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.90  E-value=2.6e-24  Score=204.97  Aligned_cols=141  Identities=21%  Similarity=0.201  Sum_probs=114.8

Q ss_pred             CCCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCceeeE-EEEeeCCeeEEEEe
Q 013682          286 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY-GFCTTVTEKLLVYP  363 (438)
Q Consensus       286 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~-g~~~~~~~~~lv~e  363 (438)
                      ++|+..+.||+|+||+||+|+. .+++.||||+++...   ...++.+|+++++.++|+|+|..+ ++..+.+..++|||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT---TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc---cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            4588889999999999999987 468899999876432   223588999999999877765554 55567788899999


Q ss_pred             cCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC---CCCcchhhhhh
Q 013682          364 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTILR  436 (438)
Q Consensus       364 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~---~~~~~l~Df~~  436 (438)
                      |+. |++...+....   ..+++..+..++.|++.||+|||++   +|+||||||+|||++.   +..++++||+-
T Consensus        84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~  152 (299)
T d1ckia_          84 LLG-PSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGL  152 (299)
T ss_dssp             CCC-CBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSS
T ss_pred             EcC-Cchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCc
Confidence            994 56666665432   2489999999999999999999999   9999999999999764   45689999974

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.84  E-value=1.3e-21  Score=173.67  Aligned_cols=128  Identities=13%  Similarity=0.112  Sum_probs=99.9

Q ss_pred             CCCccccccceEEEEEEeCCCCEEEEEEccccccc----c-------------chHHHHHHHHHHhcCCCCCceeeEEEE
Q 013682          290 NKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS----G-------------GELQFQTEVKIISMAVHRNLLRLYGFC  352 (438)
Q Consensus       290 ~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~----~-------------~~~~~~~E~~~l~~l~H~niv~l~g~~  352 (438)
                      ..+.||+|+||.||+|+..+|+.||||+++.....    .             ......+|...+..+.|++++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            35789999999999999888999999987532111    0             011345688889999999999887653


Q ss_pred             eeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCcchh
Q 013682          353 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  432 (438)
Q Consensus       353 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLK~~NILld~~~~~~l~  432 (438)
                          ..+++|||+++..+.+           +++.....++.|++.|++|||++   +|+||||||+|||+++++ ++++
T Consensus        84 ----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~~-~~li  144 (191)
T d1zara2          84 ----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEEG-IWII  144 (191)
T ss_dssp             ----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETTE-EEEC
T ss_pred             ----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCCC-EEEE
Confidence                2379999999865432           33345678899999999999999   999999999999999654 8889


Q ss_pred             hhhh
Q 013682          433 TILR  436 (438)
Q Consensus       433 Df~~  436 (438)
                      ||+.
T Consensus       145 DFG~  148 (191)
T d1zara2         145 DFPQ  148 (191)
T ss_dssp             CCTT
T ss_pred             ECCC
Confidence            9984

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.81  E-value=8.6e-21  Score=185.00  Aligned_cols=145  Identities=19%  Similarity=0.250  Sum_probs=111.4

Q ss_pred             CCCCCCccccccceEEEEEEe-CCCCEEEEEEccccccccchHHHHHHHHHHhcCC-----------CCCceeeEEEEee
Q 013682          287 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-----------HRNLLRLYGFCTT  354 (438)
Q Consensus       287 ~~~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~  354 (438)
                      +|+..+.||+|+||+||+|+. .+|+.||||+++....  ....+.+|+.+++.++           |+|||++++++..
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~--~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc--chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            478889999999999999997 4789999999975421  1235778888877664           5789999988764


Q ss_pred             --CCeeEEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceecCCCCCCeeeCCCCC---
Q 013682          355 --VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDAD---  428 (438)
Q Consensus       355 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDLK~~NILld~~~~---  428 (438)
                        ....+++|+++..+......... .....+++..+..++.|++.||+|||+ .   +|+||||||+|||++.++.   
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTT
T ss_pred             ccccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccc
Confidence              45566777776655433332222 123357889999999999999999998 6   8999999999999987654   


Q ss_pred             ---cchhhhhhc
Q 013682          429 ---QSSKTILRR  437 (438)
Q Consensus       429 ---~~l~Df~~~  437 (438)
                         ++++||+..
T Consensus       168 ~~~~kl~dfg~s  179 (362)
T d1q8ya_         168 LIQIKIADLGNA  179 (362)
T ss_dssp             EEEEEECCCTTC
T ss_pred             cceeeEeecccc
Confidence               789999753

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.80  E-value=7.8e-21  Score=181.52  Aligned_cols=168  Identities=26%  Similarity=0.354  Sum_probs=137.8

Q ss_pred             eeecceeeehhHHHHH-HHhh-hhhhhhhhcchheeecccCCccc------------eeeeecCCCccccccchhhccCC
Q 013682           30 ICARGFTLLVTLKAVL-QECE-QLHLLISFLIFIRVLQSSSNLFV------------YLISDLGNAALSGELAPELGQLK   95 (438)
Q Consensus        30 ~~~~~~~~~~~l~~~~-~~~~-~l~~~~~~~~~~~~l~~~~n~~~------------~~~~~l~~n~l~g~ip~~l~~l~   95 (438)
                      -.+.+|+.|++|+++. |.+. ++|..++.+++|+.|++++|.+.            +..++++.|.+.+.+|.++++++
T Consensus        70 ~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~  149 (313)
T d1ogqa_          70 SSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLP  149 (313)
T ss_dssp             GGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCT
T ss_pred             hHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCc
Confidence            3678899999999986 7777 79999999999999999887542            55566666666666666666666


Q ss_pred             CCCeec-------------------------------------------------------------cccccCCCEEEcc
Q 013682           96 NLELLA-------------------------------------------------------------LGNLIKLKSLDLY  114 (438)
Q Consensus        96 ~L~~l~-------------------------------------------------------------l~~l~~L~~l~ls  114 (438)
                      +|+.++                                                             ++.+++++.++++
T Consensus       150 ~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~  229 (313)
T d1ogqa_         150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLA  229 (313)
T ss_dssp             TCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECC
T ss_pred             ccceeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            665542                                                             1235678888999


Q ss_pred             CCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCCCCCCCcccccccccccccCCCC
Q 013682          115 SNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPN  194 (438)
Q Consensus       115 ~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~N~~lcg~~  194 (438)
                      +|.+++.+| +++.+++|+.|+|++|+++|.+|.+++++++|+.|||++|+|+|.+|+...++.+..+++.||+.+||.|
T Consensus       230 ~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p  308 (313)
T d1ogqa_         230 KNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP  308 (313)
T ss_dssp             SSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred             ccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCC
Confidence            999887654 6888999999999999999999999999999999999999999999998888889999999999999975


Q ss_pred             CCCCC
Q 013682          195 TKKPC  199 (438)
Q Consensus       195 ~~~~C  199 (438)
                      .+ .|
T Consensus       309 lp-~c  312 (313)
T d1ogqa_         309 LP-AC  312 (313)
T ss_dssp             SS-CC
T ss_pred             CC-CC
Confidence            43 45

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.54  E-value=3.8e-15  Score=138.29  Aligned_cols=155  Identities=23%  Similarity=0.184  Sum_probs=133.0

Q ss_pred             eeehhHHHHHHHhhhhhh-hhhhcchheeecccCCcc----------ceeeeecCCCccccccchhhccCCCCCeecc--
Q 013682           36 TLLVTLKAVLQECEQLHL-LISFLIFIRVLQSSSNLF----------VYLISDLGNAALSGELAPELGQLKNLELLAL--  102 (438)
Q Consensus        36 ~~~~~l~~~~~~~~~l~~-~~~~~~~~~~l~~~~n~~----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l--  102 (438)
                      +.+++|+++.|.++.+|. .+..+.+|+.|++++|.+          .|..++|++|++++ +|..+..+++|+.|++  
T Consensus        31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~  109 (266)
T d1p9ag_          31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSF  109 (266)
T ss_dssp             TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECCS
T ss_pred             cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccc
Confidence            468899999999999985 589999999999998865          37788999999996 7888999999999875  


Q ss_pred             -----------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCC
Q 013682          103 -----------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP  171 (438)
Q Consensus       103 -----------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip  171 (438)
                                 ..+.+++.|++++|.+++..|..+..++.++.+++++|++++..|..+..+++|+.|||++|+++ .+|
T Consensus       110 ~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp  188 (266)
T d1p9ag_         110 NRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIP  188 (266)
T ss_dssp             SCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCC
T ss_pred             cccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccC
Confidence                       34678999999999999555667788999999999999999888888999999999999999999 677


Q ss_pred             CC-CCCCcccccccccccccCC
Q 013682          172 DN-GSFSQFTPISFENNLNLCG  192 (438)
Q Consensus       172 ~~-~~~~~~~~~~~~~N~~lcg  192 (438)
                      .. .....+..+.+.||+-.|.
T Consensus       189 ~~~~~~~~L~~L~L~~Np~~Cd  210 (266)
T d1p9ag_         189 KGFFGSHLLPFAFLHGNPWLCN  210 (266)
T ss_dssp             TTTTTTCCCSEEECCSCCBCCS
T ss_pred             hhHCCCCCCCEEEecCCCCCCC
Confidence            54 4456677888899987663

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.44  E-value=7.9e-15  Score=139.19  Aligned_cols=124  Identities=25%  Similarity=0.460  Sum_probs=95.5

Q ss_pred             ehhHHHHHHHhh---hhhhhhhhcchheeecccCCccceeeeecCC-CccccccchhhccCCCCCeecc-----------
Q 013682           38 LVTLKAVLQECE---QLHLLISFLIFIRVLQSSSNLFVYLISDLGN-AALSGELAPELGQLKNLELLAL-----------  102 (438)
Q Consensus        38 ~~~l~~~~~~~~---~l~~~~~~~~~~~~l~~~~n~~~~~~~~l~~-n~l~g~ip~~l~~l~~L~~l~l-----------  102 (438)
                      ++.|+++++.++   .+|..++.++.|+.            ++|++ |.++|.+|+++++|++|+.|++           
T Consensus        52 v~~L~L~~~~l~g~~~lp~~l~~L~~L~~------------L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~  119 (313)
T d1ogqa_          52 VNNLDLSGLNLPKPYPIPSSLANLPYLNF------------LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD  119 (313)
T ss_dssp             EEEEEEECCCCSSCEECCGGGGGCTTCSE------------EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCG
T ss_pred             EEEEECCCCCCCCCCCCChHHhcCccccc------------cccccccccccccccccccccccchhhhccccccccccc
Confidence            556777777666   46666666665555            45554 7788999999999999988864           


Q ss_pred             --ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCC-CeEeccCCCCCCCCCCC
Q 013682          103 --GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSL-NILDLSNNRLSGPVPDN  173 (438)
Q Consensus       103 --~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L-~~l~ls~N~l~g~ip~~  173 (438)
                        ..+.+|+.+++++|.+.+.+|.++++++.++.+++++|.++|.+|..+..+..+ +.+++++|+++|..|..
T Consensus       120 ~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~  193 (313)
T d1ogqa_         120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT  193 (313)
T ss_dssp             GGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGG
T ss_pred             cccchhhhcccccccccccccCchhhccCcccceeecccccccccccccccccccccccccccccccccccccc
Confidence              345678888888888888888888888888888888888888888888887775 77888888888877754

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.34  E-value=1.9e-13  Score=127.68  Aligned_cols=153  Identities=22%  Similarity=0.191  Sum_probs=111.4

Q ss_pred             eeehhHHHHHHHhhhhhh-hhhhcchheeecccCCccc------------eeeeec-CCCccccccchhhccCCCCCeec
Q 013682           36 TLLVTLKAVLQECEQLHL-LISFLIFIRVLQSSSNLFV------------YLISDL-GNAALSGELAPELGQLKNLELLA  101 (438)
Q Consensus        36 ~~~~~l~~~~~~~~~l~~-~~~~~~~~~~l~~~~n~~~------------~~~~~l-~~n~l~g~ip~~l~~l~~L~~l~  101 (438)
                      +++++|+++.|.++.+|. .+..+..++.|+++.|.+.            +..++. ..|.++.--|..+.++++|+.|+
T Consensus        32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~  111 (284)
T d1ozna_          32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH  111 (284)
T ss_dssp             TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEe
Confidence            345889999999999996 4899999999999988653            333333 35556554467788899999886


Q ss_pred             c-------------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCC
Q 013682          102 L-------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG  168 (438)
Q Consensus       102 l-------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g  168 (438)
                      +             +.+.+|+.+++++|++++..|..|..+++|+.|++++|++++..|..+.++++|+.+++++|++++
T Consensus       112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~  191 (284)
T d1ozna_         112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH  191 (284)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred             cCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccc
Confidence            4             335678888888888874445667778888888888888887777777888888888888888887


Q ss_pred             CCCCC-CCCCccccccccccc
Q 013682          169 PVPDN-GSFSQFTPISFENNL  188 (438)
Q Consensus       169 ~ip~~-~~~~~~~~~~~~~N~  188 (438)
                      ..|.. ..++.+..++..+|.
T Consensus       192 i~~~~f~~l~~L~~L~l~~N~  212 (284)
T d1ozna_         192 VHPHAFRDLGRLMTLYLFANN  212 (284)
T ss_dssp             ECTTTTTTCTTCCEEECCSSC
T ss_pred             cChhHhhhhhhcccccccccc
Confidence            66653 233445555555554

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.33  E-value=3.3e-13  Score=124.98  Aligned_cols=136  Identities=25%  Similarity=0.190  Sum_probs=119.5

Q ss_pred             eecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc-----------ceeeeecCCCccccccchhhccCCCCCe
Q 013682           31 CARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF-----------VYLISDLGNAALSGELAPELGQLKNLEL   99 (438)
Q Consensus        31 ~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~-----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~   99 (438)
                      .+.+++.|++|+++.|.++.+|. ++.+.+|+.|+++.|.+           .+..+++++|.+.+..+.....+.++..
T Consensus        50 ~f~~l~~L~~L~L~~N~l~~l~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~  128 (266)
T d1p9ag_          50 TLMPYTRLTQLNLDRAELTKLQV-DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQE  128 (266)
T ss_dssp             GGTTCTTCCEEECTTSCCCEEEC-CSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCE
T ss_pred             Hhhcccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccceeecccccccccccc
Confidence            36789999999999999999985 57899999999998864           4788899999999866777788888888


Q ss_pred             ecc-------------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCC
Q 013682          100 LAL-------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL  166 (438)
Q Consensus       100 l~l-------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l  166 (438)
                      |.+             ..+++|+.+++++|++++..|..|+.+++|+.|+|++|+++ .+|.++..+++|+.|+|++|.+
T Consensus       129 L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~  207 (266)
T d1p9ag_         129 LYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW  207 (266)
T ss_dssp             EECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred             ccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCC
Confidence            864             34678999999999999777788999999999999999999 8899999999999999999987


Q ss_pred             CC
Q 013682          167 SG  168 (438)
Q Consensus       167 ~g  168 (438)
                      ..
T Consensus       208 ~C  209 (266)
T d1p9ag_         208 LC  209 (266)
T ss_dssp             CC
T ss_pred             CC
Confidence            64

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.23  E-value=8.8e-12  Score=109.36  Aligned_cols=125  Identities=18%  Similarity=0.279  Sum_probs=72.0

Q ss_pred             hHHHHHHHhhhhhhhhhhcchheeecccCCccceeeeecCCCccccccchh-hccCCCCCeeccccccCCCEEEccCCcc
Q 013682           40 TLKAVLQECEQLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPE-LGQLKNLELLALGNLIKLKSLDLYSNLF  118 (438)
Q Consensus        40 ~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~~~~~~~l~~n~l~g~ip~~-l~~l~~L~~l~l~~l~~L~~l~ls~N~l  118 (438)
                      +++.+++.++++|..+.              ..++.|+|++|.+++.++.. +..++           +|+.|+|++|++
T Consensus        12 ~v~Cs~~~L~~iP~~lp--------------~~l~~L~Ls~N~i~~~~~~~~f~~l~-----------~L~~L~L~~N~i   66 (192)
T d1w8aa_          12 TVDCTGRGLKEIPRDIP--------------LHTTELLLNDNELGRISSDGLFGRLP-----------HLVKLELKRNQL   66 (192)
T ss_dssp             EEECTTSCCSSCCSCCC--------------TTCSEEECCSCCCCSBCCSCSGGGCT-----------TCCEEECCSSCC
T ss_pred             EEEEeCCCcCccCCCCC--------------CCCCEEEeCCCCCcccccccccCCCc-----------eEeeeecccccc
Confidence            44556666777775432              13456788888887655433 34444           455566666666


Q ss_pred             cccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCCC-CCCCcccccccccccc
Q 013682          119 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNLN  189 (438)
Q Consensus       119 ~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~N~~  189 (438)
                      .+..|..+..+++|++|+|++|++++..|..|.++++|+.|+|++|++++..|.. ..++.+..+.+.+|+.
T Consensus        67 ~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~  138 (192)
T d1w8aa_          67 TGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF  138 (192)
T ss_dssp             CCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCB
T ss_pred             ccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccc
Confidence            6555566666666666666666666555555666666666666666666544432 2334444445555543

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.23  E-value=5.7e-13  Score=117.19  Aligned_cols=113  Identities=22%  Similarity=0.227  Sum_probs=85.9

Q ss_pred             eeehhHHHHHHHhhhhh--hhhhhcchheeecccCCccceeeeecCCCccccccchhhccCCCCCeeccccccCCCEEEc
Q 013682           36 TLLVTLKAVLQECEQLH--LLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDL  113 (438)
Q Consensus        36 ~~~~~l~~~~~~~~~l~--~~~~~~~~~~~l~~~~n~~~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~~l~~L~~l~l  113 (438)
                      +.+++|+++.|.+++..  ..+..+.+|+            .|+|++|.+.+..+..+..+           ++|+.|+|
T Consensus        29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~------------~L~L~~N~i~~~~~~~~~~~-----------~~L~~L~L   85 (192)
T d1w8aa_          29 LHTTELLLNDNELGRISSDGLFGRLPHLV------------KLELKRNQLTGIEPNAFEGA-----------SHIQELQL   85 (192)
T ss_dssp             TTCSEEECCSCCCCSBCCSCSGGGCTTCC------------EEECCSSCCCCBCTTTTTTC-----------TTCCEEEC
T ss_pred             CCCCEEEeCCCCCcccccccccCCCceEe------------eeeccccccccccccccccc-----------cccceeee
Confidence            46778888888886532  2345555544            45566666665445444444           45677999


Q ss_pred             cCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCC
Q 013682          114 YSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP  171 (438)
Q Consensus       114 s~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip  171 (438)
                      ++|++++-.|..|.++++|++|+|++|++++..|..+..+++|+.++|++|.+.+..+
T Consensus        86 s~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~  143 (192)
T d1w8aa_          86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             CSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             ccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence            9999996667789999999999999999998888899999999999999999886544

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.21  E-value=3.8e-12  Score=113.41  Aligned_cols=143  Identities=24%  Similarity=0.263  Sum_probs=98.4

Q ss_pred             cceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc----------ceeeeecCCCccccccchhhccCCCCCeecc
Q 013682           33 RGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF----------VYLISDLGNAALSGELAPELGQLKNLELLAL  102 (438)
Q Consensus        33 ~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l  102 (438)
                      +.+.+|+.|+++.+.+..++. +..+++++.|+++.|.+          .|..+++++|.+++ +| .++.+++|+.|++
T Consensus        43 ~~L~~L~~L~l~~~~i~~l~~-l~~l~~L~~L~L~~n~i~~l~~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l  119 (210)
T d1h6ta2          43 NELNSIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL  119 (210)
T ss_dssp             HHHHTCCEEECTTSCCCCCTT-GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred             HHhcCccEEECcCCCCCCchh-HhhCCCCCEEeCCCccccCccccccCccccccccccccccc-cc-ccccccccccccc
Confidence            345666667777777777664 56677777777766643          36667777787775 65 5777888887754


Q ss_pred             -----------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCC
Q 013682          103 -----------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP  171 (438)
Q Consensus       103 -----------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip  171 (438)
                                 ..++++++++++.|.+++  +..++.+++|+.+++++|++++. + .+.++++|+.|++++|+++. +|
T Consensus       120 ~~~~~~~~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~-l~  194 (210)
T d1h6ta2         120 EHNGISDINGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISD-LR  194 (210)
T ss_dssp             TTSCCCCCGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCB-CG
T ss_pred             ccccccccccccccccccccccccccccc--ccccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCCC-Ch
Confidence                       345678888888888863  34577788888888888888753 3 37788888888888888863 55


Q ss_pred             CCCCCCcccccc
Q 013682          172 DNGSFSQFTPIS  183 (438)
Q Consensus       172 ~~~~~~~~~~~~  183 (438)
                      ....++.+..++
T Consensus       195 ~l~~l~~L~~L~  206 (210)
T d1h6ta2         195 ALAGLKNLDVLE  206 (210)
T ss_dssp             GGTTCTTCSEEE
T ss_pred             hhcCCCCCCEEE
Confidence            433444444433

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.19  E-value=6e-12  Score=111.10  Aligned_cols=128  Identities=27%  Similarity=0.389  Sum_probs=65.1

Q ss_pred             cceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc----------ceeeeecCCCccccccchhhccCCCCCeecc
Q 013682           33 RGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF----------VYLISDLGNAALSGELAPELGQLKNLELLAL  102 (438)
Q Consensus        33 ~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l  102 (438)
                      ..+..++.|+++.+.+.++++ +..+++++.|++++|.+          .|..+++++|.+.. +| .+..+++|+.|++
T Consensus        37 ~~l~~l~~L~l~~~~i~~l~~-l~~l~nL~~L~Ls~N~l~~~~~l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l  113 (199)
T d2omxa2          37 TDLDQVTTLQADRLGIKSIDG-VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTL  113 (199)
T ss_dssp             HHHTTCCEEECTTSCCCCCTT-GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEEC
T ss_pred             HHhcCCCEEECCCCCCCCccc-cccCCCcCcCccccccccCcccccCCccccccccccccccc-cc-ccccccccccccc
Confidence            445556666666666666643 45566666665555433          24444444444442 33 2444555544432


Q ss_pred             -----------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCC
Q 013682          103 -----------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS  167 (438)
Q Consensus       103 -----------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~  167 (438)
                                 ..+++|+.|++++|++. .+| .+..+++|+.|++++|++++. | .++++++|+.|++++|+++
T Consensus       114 ~~~~~~~~~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~  185 (199)
T d2omxa2         114 FNNQITDIDPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVS  185 (199)
T ss_dssp             CSSCCCCCGGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC
T ss_pred             cccccccccccchhhhhHHhhhhhhhhc-ccc-cccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCC
Confidence                       23445555555555554 232 345555555555555555532 2 2455555555555555554

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.15  E-value=7.6e-12  Score=101.81  Aligned_cols=81  Identities=27%  Similarity=0.411  Sum_probs=52.0

Q ss_pred             ccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCC--CCCCCCccccc
Q 013682          105 LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP--DNGSFSQFTPI  182 (438)
Q Consensus       105 l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip--~~~~~~~~~~~  182 (438)
                      +++|++|++++|.++ .+|++++.+++|+.|++++|++++ +| .++.+++|+.+++++|+++...+  ....++.+..+
T Consensus        19 l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L   95 (124)
T d1dcea3          19 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL   95 (124)
T ss_dssp             GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEE
T ss_pred             CCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCccCCCCCchhhcCCCCCCEE
Confidence            334566777777776 677777777777777777777763 34 37777777777777777764321  12233455556


Q ss_pred             cccccc
Q 013682          183 SFENNL  188 (438)
Q Consensus       183 ~~~~N~  188 (438)
                      ++.+|+
T Consensus        96 ~l~~N~  101 (124)
T d1dcea3          96 NLQGNS  101 (124)
T ss_dssp             ECTTSG
T ss_pred             ECCCCc
Confidence            666664

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.10  E-value=7.3e-11  Score=109.71  Aligned_cols=161  Identities=19%  Similarity=0.166  Sum_probs=123.9

Q ss_pred             eecceeeehhHHHHHHHhhhhhhhh-hhcchheeecc-------------cCCccceeeeecCCCccccccchhhccCCC
Q 013682           31 CARGFTLLVTLKAVLQECEQLHLLI-SFLIFIRVLQS-------------SSNLFVYLISDLGNAALSGELAPELGQLKN   96 (438)
Q Consensus        31 ~~~~~~~~~~l~~~~~~~~~l~~~~-~~~~~~~~l~~-------------~~n~~~~~~~~l~~n~l~g~ip~~l~~l~~   96 (438)
                      .+++++.|++|++++|.+..++... ..+..++.+..             ..++..|..+++++|.+.+..+.....+++
T Consensus        51 ~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~  130 (284)
T d1ozna_          51 SFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA  130 (284)
T ss_dssp             TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTT
T ss_pred             HhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcc
Confidence            3678888889998888888776663 33444444332             223445788888888887755666777788


Q ss_pred             CCeecc-------------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccC
Q 013682           97 LELLAL-------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSN  163 (438)
Q Consensus        97 L~~l~l-------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~  163 (438)
                      |+.+++             ..+++|+.|++++|++++..|..|.++++|+.+++++|++++..|..+..+++|+.||+++
T Consensus       131 L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~  210 (284)
T d1ozna_         131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA  210 (284)
T ss_dssp             CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             cchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccc
Confidence            877753             4567899999999999977778889999999999999999998899999999999999999


Q ss_pred             CCCCCCCCCC-CCCCcccccccccccccC
Q 013682          164 NRLSGPVPDN-GSFSQFTPISFENNLNLC  191 (438)
Q Consensus       164 N~l~g~ip~~-~~~~~~~~~~~~~N~~lc  191 (438)
                      |.+++.+|.. .....+..+.+++|+..|
T Consensus       211 N~i~~~~~~~~~~~~~L~~L~l~~N~l~C  239 (284)
T d1ozna_         211 NNLSALPTEALAPLRALQYLRLNDNPWVC  239 (284)
T ss_dssp             SCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred             cccccccccccccccccCEEEecCCCCCC
Confidence            9999876643 345667778888888766

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.10  E-value=1e-10  Score=95.00  Aligned_cols=86  Identities=30%  Similarity=0.388  Sum_probs=67.9

Q ss_pred             ccceeeeecCCCccccccchhhccCCCCCeeccccccCCCEEEccCCcccccCchhhccccccceeccccccccCCC-ch
Q 013682           70 LFVYLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLI-PT  148 (438)
Q Consensus        70 ~~~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~-P~  148 (438)
                      +..+..+++++|.++. +|+.++.++           +|+.|++++|.++ .+| .++++++|+.|++++|+++... +.
T Consensus        19 l~~L~~L~ls~N~l~~-lp~~~~~l~-----------~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~~~~~~~   84 (124)
T d1dcea3          19 LLLVTHLDLSHNRLRA-LPPALAALR-----------CLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQ   84 (124)
T ss_dssp             GTTCCEEECCSSCCCC-CCGGGGGCT-----------TCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCCSSSTTG
T ss_pred             CCCCCEEECCCCccCc-chhhhhhhh-----------ccccccccccccc-ccC-ccccccccCeEECCCCccCCCCCch
Confidence            3446677777777763 666665554           5677899999998 676 5999999999999999998543 25


Q ss_pred             hhccCCCCCeEeccCCCCCCC
Q 013682          149 SLTTITSLNILDLSNNRLSGP  169 (438)
Q Consensus       149 ~l~~~~~L~~l~ls~N~l~g~  169 (438)
                      .+..+++|+.+++++|.++..
T Consensus        85 ~l~~~~~L~~L~l~~N~i~~~  105 (124)
T d1dcea3          85 PLVSCPRLVLLNLQGNSLCQE  105 (124)
T ss_dssp             GGGGCTTCCEEECTTSGGGGS
T ss_pred             hhcCCCCCCEEECCCCcCCcC
Confidence            789999999999999998753

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.10  E-value=2.6e-11  Score=109.05  Aligned_cols=130  Identities=22%  Similarity=0.325  Sum_probs=83.8

Q ss_pred             ecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCccc----------eeeeecCCCccccccchhhccCCCCCeec
Q 013682           32 ARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLFV----------YLISDLGNAALSGELAPELGQLKNLELLA  101 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~~----------~~~~~l~~n~l~g~ip~~l~~l~~L~~l~  101 (438)
                      ...|+.|+.|++.++.+++++ .+..+++|+.|+++.|.++          +..+++++|.++. ++ .+..+++|+.+.
T Consensus        37 ~~~l~~L~~L~l~~~~i~~l~-~l~~l~~L~~L~ls~n~i~~~~~l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l~  113 (227)
T d1h6ua2          37 QADLDGITTLSAFGTGVTTIE-GVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLD  113 (227)
T ss_dssp             HHHHHTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGGGTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEE
T ss_pred             HHHcCCcCEEECCCCCCCcch-hHhcCCCCcEeecCCceeeccccccccccccccccccccccc-cc-cccccccccccc
Confidence            356677777788888888885 4788888888888877543          5556777777763 54 467777777764


Q ss_pred             c---------------------------------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCch
Q 013682          102 L---------------------------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPT  148 (438)
Q Consensus       102 l---------------------------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~  148 (438)
                      +                                 ..+++|+.|++++|.+. .++ .++++++|+.|++++|++++ +| 
T Consensus       114 l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~Ls~n~l~~-l~-  189 (227)
T d1h6ua2         114 LTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVS-DLT-PLANLSKLTTLKADDNKISD-IS-  189 (227)
T ss_dssp             CTTSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCTTCCEEECCSSCCCC-CG-
T ss_pred             cccccccccchhccccchhhhhchhhhhchhhhhccccccccccccccccc-cch-hhcccccceecccCCCccCC-Ch-
Confidence            3                                 22445666666666654 222 25666666666666666654 33 


Q ss_pred             hhccCCCCCeEeccCCCCCC
Q 013682          149 SLTTITSLNILDLSNNRLSG  168 (438)
Q Consensus       149 ~l~~~~~L~~l~ls~N~l~g  168 (438)
                      .++++++|+.|++++|++++
T Consensus       190 ~l~~l~~L~~L~Ls~N~lt~  209 (227)
T d1h6ua2         190 PLASLPNLIEVHLKNNQISD  209 (227)
T ss_dssp             GGGGCTTCCEEECTTSCCCB
T ss_pred             hhcCCCCCCEEECcCCcCCC
Confidence            25666666666666666654

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.08  E-value=3.8e-11  Score=115.79  Aligned_cols=148  Identities=24%  Similarity=0.327  Sum_probs=102.2

Q ss_pred             ecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc----------ceeeeecCCCccccccchhhccCCCCCeec
Q 013682           32 ARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF----------VYLISDLGNAALSGELAPELGQLKNLELLA  101 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~  101 (438)
                      +...+.|++|++++|.++.++ .+..+.+++.|+++.|.+          .+..+++++|.+++ ++ .+..++.++.+.
T Consensus       215 ~~~~~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~l~~n~l~~~~~~~~~~~L~~L~l~~~~l~~-~~-~~~~~~~l~~l~  291 (384)
T d2omza2         215 LGILTNLDELSLNGNQLKDIG-TLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISN-IS-PLAGLTALTNLE  291 (384)
T ss_dssp             GGGCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEE
T ss_pred             ccccCCCCEEECCCCCCCCcc-hhhcccccchhccccCccCCCCcccccccCCEeeccCcccCC-CC-cccccccccccc
Confidence            444555666666666666665 355666667766665543          25556677777665 33 244555555543


Q ss_pred             -----------cccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCC
Q 013682          102 -----------LGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV  170 (438)
Q Consensus       102 -----------l~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~i  170 (438)
                                 +..+++++.|++++|++++ +++ +..+++|++|++++|++++ +| .++++++|+.|++++|++++.+
T Consensus       292 ~~~n~l~~~~~~~~~~~l~~L~ls~n~l~~-l~~-l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~  367 (384)
T d2omza2         292 LNENQLEDISPISNLKNLTYLTLYFNNISD-ISP-VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLT  367 (384)
T ss_dssp             CCSSCCSCCGGGGGCTTCSEEECCSSCCSC-CGG-GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCG
T ss_pred             ccccccccccccchhcccCeEECCCCCCCC-Ccc-cccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCCh
Confidence                       2446788999999999984 443 8889999999999999984 45 6899999999999999999766


Q ss_pred             CCCCCCCcccccccccc
Q 013682          171 PDNGSFSQFTPISFENN  187 (438)
Q Consensus       171 p~~~~~~~~~~~~~~~N  187 (438)
                      | ...++.+..+..++|
T Consensus       368 ~-l~~l~~L~~L~L~~N  383 (384)
T d2omza2         368 P-LANLTRITQLGLNDQ  383 (384)
T ss_dssp             G-GTTCTTCSEEECCCE
T ss_pred             h-hccCCCCCEeeCCCC
Confidence            5 445566666666655

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.06  E-value=4.1e-11  Score=106.56  Aligned_cols=125  Identities=25%  Similarity=0.260  Sum_probs=105.5

Q ss_pred             ecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc----------ceeeeecCCCccccccchhhccCCCCCeec
Q 013682           32 ARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF----------VYLISDLGNAALSGELAPELGQLKNLELLA  101 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~  101 (438)
                      ++.|+.|++|++++|.++.++. ++.+.+++.|+++.|.+          .+..+++++|.+.. + ..+..+++++.++
T Consensus        64 l~~l~~L~~L~L~~n~i~~l~~-~~~l~~L~~L~l~~n~i~~l~~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~  140 (210)
T d1h6ta2          64 IQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLY  140 (210)
T ss_dssp             GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCGGGGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEE
T ss_pred             HhhCCCCCEEeCCCccccCccc-cccCccccccccccccccccccccccccccccccccccccc-c-ccccccccccccc
Confidence            5778999999999999999885 68899999999988764          36778888888864 4 4688888888875


Q ss_pred             c-----------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccC
Q 013682          102 L-----------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSN  163 (438)
Q Consensus       102 l-----------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~  163 (438)
                      +           +.+++|+.+++++|+++ .+|+ ++++++|+.|+|++|+++ .+| .+..+++|+.|+|++
T Consensus       141 ~~~n~l~~~~~~~~l~~L~~l~l~~n~l~-~i~~-l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         141 LGNNKITDITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             CCSSCCCCCGGGGGCTTCSEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred             ccccccccccccccccccccccccccccc-cccc-ccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEEccC
Confidence            3           45789999999999998 5654 899999999999999998 466 599999999999975

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.04  E-value=1e-10  Score=109.72  Aligned_cols=83  Identities=29%  Similarity=0.295  Sum_probs=68.0

Q ss_pred             ccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCC-CCCCCcccccc
Q 013682          105 LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPIS  183 (438)
Q Consensus       105 l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~-~~~~~~~~~~~  183 (438)
                      +++|+.|++++|...+..|..+.+++.++.|++++|++++..|..+..+++|+.|+|++|.++. +|+ ...++.+..++
T Consensus       170 ~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~-lp~~l~~l~~L~~L~  248 (305)
T d1xkua_         170 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVY  248 (305)
T ss_dssp             CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS-CCTTTTTCSSCCEEE
T ss_pred             CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccc-cccccccccCCCEEE
Confidence            4567888888888888888888889999999999999998888888999999999999999884 454 34567777777


Q ss_pred             ccccc
Q 013682          184 FENNL  188 (438)
Q Consensus       184 ~~~N~  188 (438)
                      +++|.
T Consensus       249 Ls~N~  253 (305)
T d1xkua_         249 LHNNN  253 (305)
T ss_dssp             CCSSC
T ss_pred             CCCCc
Confidence            77774

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.01  E-value=8.3e-11  Score=113.34  Aligned_cols=127  Identities=27%  Similarity=0.377  Sum_probs=106.5

Q ss_pred             eecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc----------ceeeeecCCCccccccchhhccCCCCCee
Q 013682           31 CARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF----------VYLISDLGNAALSGELAPELGQLKNLELL  100 (438)
Q Consensus        31 ~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l  100 (438)
                      .+++++.|+.|+++.|.++.++. ++.+.+++.|+++.|.+          .+..++++.|.+++ + ..+..+++++.|
T Consensus       236 ~l~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L  312 (384)
T d2omza2         236 TLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLED-I-SPISNLKNLTYL  312 (384)
T ss_dssp             GGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSC-C-GGGGGCTTCSEE
T ss_pred             hhhcccccchhccccCccCCCCc-ccccccCCEeeccCcccCCCCcccccccccccccccccccc-c-cccchhcccCeE
Confidence            46788888999999999998875 77788999998877643          35667888899887 3 457888888877


Q ss_pred             cc-----------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCC
Q 013682          101 AL-----------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNN  164 (438)
Q Consensus       101 ~l-----------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N  164 (438)
                      ++           +.+++|+.|++++|+++ .+| .++++++|++|++++|++++..|  +.++++|+.|++++|
T Consensus       313 ~ls~n~l~~l~~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         313 TLYFNNISDISPVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             ECCSSCCSCCGGGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             ECCCCCCCCCcccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            53           56889999999999998 566 69999999999999999997655  899999999999988

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.92  E-value=3.7e-10  Score=99.31  Aligned_cols=121  Identities=24%  Similarity=0.280  Sum_probs=101.2

Q ss_pred             ecceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc----------ceeeeecCCCccccccchhhccCCCCCeec
Q 013682           32 ARGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF----------VYLISDLGNAALSGELAPELGQLKNLELLA  101 (438)
Q Consensus        32 ~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~----------~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~  101 (438)
                      ++.|+.|++|++++|.++.++. ++.+++++.|+++.|..          .+..+++++|.... + ..+..+++|+.|+
T Consensus        58 l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~~~~~l~~l~~L~~L~l~~~~~~~-~-~~~~~l~~L~~L~  134 (199)
T d2omxa2          58 VEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITD-I-DPLKNLTNLNRLE  134 (199)
T ss_dssp             GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEE
T ss_pred             cccCCCcCcCccccccccCccc-ccCCccccccccccccccccccccccccccccccccccccc-c-cccchhhhhHHhh
Confidence            4678899999999999999886 88999999999988754          36778899888876 3 3478899999886


Q ss_pred             c-----------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeE
Q 013682          102 L-----------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNIL  159 (438)
Q Consensus       102 l-----------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l  159 (438)
                      +           ..+++|+.|++++|+++ .+| .++++++|++|++++|+++. +| .++++++|+.|
T Consensus       135 l~~n~l~~~~~l~~~~~L~~L~l~~n~l~-~l~-~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         135 LSSNTISDISALSGLTSLQQLNFSSNQVT-DLK-PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL  199 (199)
T ss_dssp             CCSSCCCCCGGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred             hhhhhhccccccccccccccccccccccc-CCc-cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence            4           45788999999999998 455 48999999999999999985 55 58899998875

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.87  E-value=2.7e-10  Score=96.91  Aligned_cols=64  Identities=30%  Similarity=0.306  Sum_probs=53.3

Q ss_pred             ccccCCCEEEccCCcccccCch-hhccccccceeccccccccCCCc--hhhccCCCCCeEeccCCCCCC
Q 013682          103 GNLIKLKSLDLYSNLFNGTIPD-TLANLKQLKYLRLNNNSLSGLIP--TSLTTITSLNILDLSNNRLSG  168 (438)
Q Consensus       103 ~~l~~L~~l~ls~N~l~g~iP~-~~~~l~~L~~l~ls~N~l~g~~P--~~l~~~~~L~~l~ls~N~l~g  168 (438)
                      +.+++|++|++++|+++ .+|+ .+..+++|+.|++++|+++. ++  ..+..+++|+.+++++|.++.
T Consensus        60 ~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~  126 (162)
T d1a9na_          60 PLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTN  126 (162)
T ss_dssp             CCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred             ccCcchhhhhccccccc-CCCccccccccccccceeccccccc-cccccccccccccchhhcCCCcccc
Confidence            45678899999999998 5555 45789999999999999984 34  468899999999999998864

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.87  E-value=2e-09  Score=91.30  Aligned_cols=107  Identities=21%  Similarity=0.175  Sum_probs=80.1

Q ss_pred             CCccceeeeecCCCccccccchhhccCCCCCeeccccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCc
Q 013682           68 SNLFVYLISDLGNAALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIP  147 (438)
Q Consensus        68 ~n~~~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P  147 (438)
                      .|...+..++|++|+++. +|.....           +++|+.|+|++|.++ .++ .+..+++|++|++++|+++...|
T Consensus        15 ~n~~~lr~L~L~~n~I~~-i~~~~~~-----------l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~   80 (162)
T d1a9na_          15 TNAVRDRELDLRGYKIPV-IENLGAT-----------LDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGE   80 (162)
T ss_dssp             ECTTSCEEEECTTSCCCS-CCCGGGG-----------TTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECS
T ss_pred             cCcCcCcEEECCCCCCCc-cCccccc-----------cccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCc
Confidence            355556677888888774 6643333           445778999999998 775 58999999999999999996655


Q ss_pred             hhhccCCCCCeEeccCCCCCCC--CCCCCCCCccccccccccc
Q 013682          148 TSLTTITSLNILDLSNNRLSGP--VPDNGSFSQFTPISFENNL  188 (438)
Q Consensus       148 ~~l~~~~~L~~l~ls~N~l~g~--ip~~~~~~~~~~~~~~~N~  188 (438)
                      ..+..+++|+.|++++|+++..  +.....++.+..+.+.+|+
T Consensus        81 ~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~  123 (162)
T d1a9na_          81 GLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNP  123 (162)
T ss_dssp             CHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSG
T ss_pred             cccccccccccceeccccccccccccccccccccchhhcCCCc
Confidence            5667899999999999999752  2223345667777777775

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.79  E-value=8.1e-09  Score=86.92  Aligned_cols=83  Identities=18%  Similarity=0.130  Sum_probs=41.5

Q ss_pred             CCEEEccCC-cccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCCCCCCCccccccccc
Q 013682          108 LKSLDLYSN-LFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFEN  186 (438)
Q Consensus       108 L~~l~ls~N-~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~  186 (438)
                      |+.|++++| .++..-+++|.++++|+.|++++|+++...|..+..+++|+.|+|++|+++.-.+.......+..+.+.+
T Consensus        33 l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~~l~~L~L~~  112 (156)
T d2ifga3          33 LTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSG  112 (156)
T ss_dssp             CSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEECCS
T ss_pred             cCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhccccccccccCC
Confidence            444555443 2542223445556666666666666655545555566666666666666653322222222344445555


Q ss_pred             cccc
Q 013682          187 NLNL  190 (438)
Q Consensus       187 N~~l  190 (438)
                      |+.-
T Consensus       113 Np~~  116 (156)
T d2ifga3         113 NPLH  116 (156)
T ss_dssp             SCCC
T ss_pred             Cccc
Confidence            5443

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.79  E-value=1.2e-08  Score=95.26  Aligned_cols=112  Identities=25%  Similarity=0.320  Sum_probs=85.0

Q ss_pred             ceeeeecCCCccccccchhhccCCCCCeecc-------------ccccCCCEEEccCCcccccCchhhccccccceeccc
Q 013682           72 VYLISDLGNAALSGELAPELGQLKNLELLAL-------------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  138 (438)
Q Consensus        72 ~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l-------------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls  138 (438)
                      .+..+++++|.++. +|..+  +++|+.|++             ..++.++.|++++|.+++..|..+.++++|++|+|+
T Consensus       151 ~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~  227 (305)
T d1xkua_         151 KLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN  227 (305)
T ss_dssp             TCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECC
T ss_pred             ccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecc
Confidence            35667777777763 66543  466666653             456778999999999997778899999999999999


Q ss_pred             cccccCCCchhhccCCCCCeEeccCCCCCCCCCCCC--------CCCccccccccccc
Q 013682          139 NNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNG--------SFSQFTPISFENNL  188 (438)
Q Consensus       139 ~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~~--------~~~~~~~~~~~~N~  188 (438)
                      +|+++ .+|.++..+++|+.|++++|+++. ++...        ....+..+.+.+|+
T Consensus       228 ~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~-i~~~~f~~~~~~~~~~~L~~L~L~~N~  283 (305)
T d1xkua_         228 NNKLV-KVPGGLADHKYIQVVYLHNNNISA-IGSNDFCPPGYNTKKASYSGVSLFSNP  283 (305)
T ss_dssp             SSCCS-SCCTTTTTCSSCCEEECCSSCCCC-CCTTSSSCSSCCTTSCCCSEEECCSSS
T ss_pred             ccccc-ccccccccccCCCEEECCCCccCc-cChhhccCcchhcccCCCCEEECCCCc
Confidence            99998 679999999999999999999984 44321        12334455566665

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.78  E-value=1.8e-09  Score=96.63  Aligned_cols=124  Identities=28%  Similarity=0.314  Sum_probs=84.4

Q ss_pred             cceeeehhHHHHHHHhhhhhhhhhhcchheeecccCCcc----------ceeee----------------------ecCC
Q 013682           33 RGFTLLVTLKAVLQECEQLHLLISFLIFIRVLQSSSNLF----------VYLIS----------------------DLGN   80 (438)
Q Consensus        33 ~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~l~~~~n~~----------~~~~~----------------------~l~~   80 (438)
                      +.++.|++|+++.|.+..++. +..+.+++.+..+.|..          .+..+                      .+++
T Consensus        60 ~~l~~L~~L~ls~n~i~~~~~-l~~l~~l~~l~~~~n~~~~i~~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~  138 (227)
T d1h6ua2          60 QYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDL  138 (227)
T ss_dssp             GGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCCGGGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCS
T ss_pred             hcCCCCcEeecCCceeecccc-ccccccccccccccccccccccccccccccccccccccccccchhccccchhhhhchh
Confidence            455555566666665555543 44445555554444322          13333                      3444


Q ss_pred             CccccccchhhccCCCCCeec-----------cccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchh
Q 013682           81 AALSGELAPELGQLKNLELLA-----------LGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTS  149 (438)
Q Consensus        81 n~l~g~ip~~l~~l~~L~~l~-----------l~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~  149 (438)
                      +.+...  ..+..+++|+.|+           ++++++|+.|+|++|+++ .+|+ ++++++|++|+|++|++++ +| .
T Consensus       139 ~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~~l~~l~~L~~L~Ls~n~l~-~l~~-l~~l~~L~~L~Ls~N~lt~-i~-~  212 (227)
T d1h6ua2         139 NQITNI--SPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISD-VS-P  212 (227)
T ss_dssp             SCCCCC--GGGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC-CCGG-GGGCTTCCEEECTTSCCCB-CG-G
T ss_pred             hhhchh--hhhccccccccccccccccccchhhcccccceecccCCCccC-CChh-hcCCCCCCEEECcCCcCCC-Cc-c
Confidence            444332  2366777888775           456889999999999998 5664 8999999999999999995 45 3


Q ss_pred             hccCCCCCeEeccC
Q 013682          150 LTTITSLNILDLSN  163 (438)
Q Consensus       150 l~~~~~L~~l~ls~  163 (438)
                      +.++++|+.|++++
T Consensus       213 l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         213 LANTSNLFIVTLTN  226 (227)
T ss_dssp             GTTCTTCCEEEEEE
T ss_pred             cccCCCCCEEEeeC
Confidence            89999999999985

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.69  E-value=2.8e-09  Score=89.86  Aligned_cols=66  Identities=27%  Similarity=0.232  Sum_probs=55.2

Q ss_pred             cccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCC
Q 013682          102 LGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG  168 (438)
Q Consensus       102 l~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g  168 (438)
                      |.++++|+.|+|++|+++..-|..|..+++|++|+|++|+++ .+|..+....+|+.|+|++|.+..
T Consensus        52 f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~C  117 (156)
T d2ifga3          52 LRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHC  117 (156)
T ss_dssp             SCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCCC
T ss_pred             hccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhccccccccccCCCcccC
Confidence            455667888999999999555778999999999999999999 556665556689999999998863

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=98.66  E-value=7.6e-11  Score=103.86  Aligned_cols=107  Identities=24%  Similarity=0.325  Sum_probs=75.6

Q ss_pred             hhhhhhhhcchheeecccCCccceeeeecCCCccccccchhhccCCCCCeeccc------------cccCCCEEEccCCc
Q 013682           50 QLHLLISFLIFIRVLQSSSNLFVYLISDLGNAALSGELAPELGQLKNLELLALG------------NLIKLKSLDLYSNL  117 (438)
Q Consensus        50 ~l~~~~~~~~~~~~l~~~~n~~~~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~------------~l~~L~~l~ls~N~  117 (438)
                      .++..++.+.+++.|+++.|.+.             .++ .+..|++|+.|+++            .+++|++|++++|+
T Consensus        39 ~l~~sl~~L~~L~~L~Ls~n~I~-------------~i~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~  104 (198)
T d1m9la_          39 KMDATLSTLKACKHLALSTNNIE-------------KIS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQ  104 (198)
T ss_dssp             CCHHHHHHTTTCCEEECSEEEES-------------CCC-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEE
T ss_pred             hhhhHHhcccccceeECcccCCC-------------Ccc-cccCCccccChhhccccccccccccccccccccccccccc
Confidence            34445555555555555544332             343 35566666666542            23568999999999


Q ss_pred             ccccCchhhccccccceeccccccccCCCc--hhhccCCCCCeEeccCCCCCCCCCCC
Q 013682          118 FNGTIPDTLANLKQLKYLRLNNNSLSGLIP--TSLTTITSLNILDLSNNRLSGPVPDN  173 (438)
Q Consensus       118 l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P--~~l~~~~~L~~l~ls~N~l~g~ip~~  173 (438)
                      ++ .++ .+.++++|+.|++++|+++.. +  ..+..+++|+.|++++|.++...+..
T Consensus       105 i~-~l~-~~~~l~~L~~L~L~~N~i~~~-~~~~~l~~l~~L~~L~L~~N~l~~~~~~~  159 (198)
T d1m9la_         105 IA-SLS-GIEKLVNLRVLYMSNNKITNW-GEIDKLAALDKLEDLLLAGNPLYNDYKEN  159 (198)
T ss_dssp             CC-CHH-HHHHHHHSSEEEESEEECCCH-HHHHHHTTTTTCSEEEECSSHHHHHHCTT
T ss_pred             cc-ccc-cccccccccccccccchhccc-cccccccCCCccceeecCCCccccCcccc
Confidence            98 554 588999999999999999843 4  46899999999999999887665543

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=98.65  E-value=7.1e-10  Score=97.46  Aligned_cols=101  Identities=22%  Similarity=0.340  Sum_probs=82.7

Q ss_pred             ccchhhccCCCCCeecc-----------ccccCCCEEEccCCcccccCchhhccccccceeccccccccCCCchhhccCC
Q 013682           86 ELAPELGQLKNLELLAL-----------GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTIT  154 (438)
Q Consensus        86 ~ip~~l~~l~~L~~l~l-----------~~l~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~  154 (438)
                      .+|..+.++++|+.|++           +.+++|+.|+|++|.++ .+|..+..+++|+.|++++|+++. + +.+..++
T Consensus        39 ~l~~sl~~L~~L~~L~Ls~n~I~~i~~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~  115 (198)
T d1m9la_          39 KMDATLSTLKACKHLALSTNNIEKISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLV  115 (198)
T ss_dssp             CCHHHHHHTTTCCEEECSEEEESCCCCHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHH
T ss_pred             hhhhHHhcccccceeECcccCCCCcccccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccccc
Confidence            46778999999999875           45789999999999997 888877888899999999999984 3 4588999


Q ss_pred             CCCeEeccCCCCCCC--CCCCCCCCcccccccccccc
Q 013682          155 SLNILDLSNNRLSGP--VPDNGSFSQFTPISFENNLN  189 (438)
Q Consensus       155 ~L~~l~ls~N~l~g~--ip~~~~~~~~~~~~~~~N~~  189 (438)
                      +|+.|++++|+++..  +.....++.+..+.+.+|+.
T Consensus       116 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l  152 (198)
T d1m9la_         116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPL  152 (198)
T ss_dssp             HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHH
T ss_pred             cccccccccchhccccccccccCCCccceeecCCCcc
Confidence            999999999999753  22334567778888888863

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.59  E-value=2.6e-08  Score=89.44  Aligned_cols=144  Identities=21%  Similarity=0.164  Sum_probs=101.3

Q ss_pred             eeehhHHHHHHHhhhhhhh-hhhcchheeecccCCccc-------------eeeeec-CCCccccccchhhccCCCCCee
Q 013682           36 TLLVTLKAVLQECEQLHLL-ISFLIFIRVLQSSSNLFV-------------YLISDL-GNAALSGELAPELGQLKNLELL  100 (438)
Q Consensus        36 ~~~~~l~~~~~~~~~l~~~-~~~~~~~~~l~~~~n~~~-------------~~~~~l-~~n~l~g~ip~~l~~l~~L~~l  100 (438)
                      +.+++|++++|.++.+|.. |..+.+++.|+++.|...             +..+++ ..|.+....|..+..+++|+.+
T Consensus        29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l  108 (242)
T d1xwdc1          29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL  108 (242)
T ss_dssp             SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred             CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence            4688899999999999874 789999999999888542             233343 3567776666667888888877


Q ss_pred             cc--------------------------------------ccc-cCCCEEEccCCcccccCchhhcccccccee-ccccc
Q 013682          101 AL--------------------------------------GNL-IKLKSLDLYSNLFNGTIPDTLANLKQLKYL-RLNNN  140 (438)
Q Consensus       101 ~l--------------------------------------~~l-~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l-~ls~N  140 (438)
                      ++                                      ..+ ..++.+++++|+++ .++....+.++++.+ ++++|
T Consensus       109 ~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n  187 (242)
T d1xwdc1         109 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNN  187 (242)
T ss_dssp             EEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCT
T ss_pred             ccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc-ccccccccchhhhcccccccc
Confidence            42                                      112 35777889999887 666666566665544 67888


Q ss_pred             cccCCCchhhccCCCCCeEeccCCCCCCCCCCCCCCCccccc
Q 013682          141 SLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPI  182 (438)
Q Consensus       141 ~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~  182 (438)
                      +++...+..+..+++|+.|++++|+++ .+|.. .+..+..+
T Consensus       188 ~l~~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~~-~~~~l~~L  227 (242)
T d1xwdc1         188 NLEELPNDVFHGASGPVILDISRTRIH-SLPSY-GLENLKKL  227 (242)
T ss_dssp             TCCCCCTTTTTTSCCCSEEECTTSCCC-CCCSS-SCTTCCEE
T ss_pred             ccccccHHHhcCCCCCCEEECCCCcCC-ccCHH-HHcCCccc
Confidence            888443445788999999999999998 45542 33444333

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.51  E-value=2.8e-08  Score=93.61  Aligned_cols=53  Identities=28%  Similarity=0.290  Sum_probs=42.0

Q ss_pred             ccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCCCCCCCCccccccccccc
Q 013682          129 LKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL  188 (438)
Q Consensus       129 l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~N~  188 (438)
                      +++|++|+|++|+++ .+|..   +++|+.|++++|+++ .+|..  ...+..+++++|+
T Consensus       283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~--~~~L~~L~L~~N~  335 (353)
T d1jl5a_         283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL--PQNLKQLHVEYNP  335 (353)
T ss_dssp             CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC--CTTCCEEECCSSC
T ss_pred             CCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc--cCCCCEEECcCCc
Confidence            368999999999998 67754   578999999999998 57754  3456677788886

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.19  E-value=4.4e-06  Score=75.26  Aligned_cols=145  Identities=13%  Similarity=0.067  Sum_probs=91.1

Q ss_pred             HHHHHhCCCCCCCccccccceEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCC-CCCceeeEEEEeeCCee
Q 013682          280 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEK  358 (438)
Q Consensus       280 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~  358 (438)
                      ++....+.|...+..+-++...||+... +++.+.+|+..... ......+.+|...+..+. +--+.+++.+...++..
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~-~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRY-KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGG-TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCc-ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            3344445554444333334468998875 45567788765432 222235778888876553 43456777888888889


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------
Q 013682          359 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC-------------------------------  407 (438)
Q Consensus       359 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------  407 (438)
                      ++||+++++.++.+.....      -   ....++.++++.++.||+..                               
T Consensus        86 ~lv~~~l~G~~~~~~~~~~------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDE------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTC------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred             EEEEEeccccccccccccc------c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence            9999999998776544221      1   12334455555566666421                               


Q ss_pred             -------------------------CCCceecCCCCCCeeeCCCCCcchhhhh
Q 013682          408 -------------------------DPKIIHRDVKAANILLDEDADQSSKTIL  435 (438)
Q Consensus       408 -------------------------~~~ivHrDLK~~NILld~~~~~~l~Df~  435 (438)
                                               .+.++|+|+.|.|||+++++..-+.||-
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe  209 (263)
T d1j7la_         157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLG  209 (263)
T ss_dssp             GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCT
T ss_pred             cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeech
Confidence                                     1137899999999999987666688873

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.19  E-value=4.3e-07  Score=85.18  Aligned_cols=70  Identities=30%  Similarity=0.323  Sum_probs=44.3

Q ss_pred             eeeeecCCCccccccchhhccCCCCCeec-----cccc-cCCCEEEccCCcccccCchhhccccccceeccccccccCC
Q 013682           73 YLISDLGNAALSGELAPELGQLKNLELLA-----LGNL-IKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGL  145 (438)
Q Consensus        73 ~~~~~l~~n~l~g~ip~~l~~l~~L~~l~-----l~~l-~~L~~l~ls~N~l~g~iP~~~~~l~~L~~l~ls~N~l~g~  145 (438)
                      +..|+|++|+++ ++|..+++|+.|...+     +..+ +.|++|++++|.++ .+|+ ++.++.|+.|++++|.+++.
T Consensus        60 L~~L~Ls~N~l~-~lp~~~~~L~~L~l~~n~l~~l~~lp~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~  135 (353)
T d1jl5a_          60 LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL  135 (353)
T ss_dssp             CSEEECCSSCCS-SCCCCCTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSCC
T ss_pred             CCEEECCCCCCc-ccccchhhhhhhhhhhcccchhhhhccccccccccccccc-cccc-hhhhccceeecccccccccc
Confidence            455666666666 6786655554443322     1222 35778888888876 6764 57777888888877777643

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.16  E-value=4.1e-07  Score=83.86  Aligned_cols=135  Identities=16%  Similarity=0.086  Sum_probs=88.3

Q ss_pred             ceeeehhHHHHHHHhh--hhhhhhhhcchheeecccCCc------------cceeeeecCCC-ccccc-cchhhccCCCC
Q 013682           34 GFTLLVTLKAVLQECE--QLHLLISFLIFIRVLQSSSNL------------FVYLISDLGNA-ALSGE-LAPELGQLKNL   97 (438)
Q Consensus        34 ~~~~~~~l~~~~~~~~--~l~~~~~~~~~~~~l~~~~n~------------~~~~~~~l~~n-~l~g~-ip~~l~~l~~L   97 (438)
                      ....|++||++++.+.  .++..+..+.+++.|.+.++.            ..|..++|+++ .++.. +..-...+++|
T Consensus        44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L  123 (284)
T d2astb2          44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL  123 (284)
T ss_dssp             CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTC
T ss_pred             cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhc
Confidence            3456777888776653  366777888888888876653            24777788773 45432 33334567778


Q ss_pred             Ceecccc----------------ccCCCEEEccCC--ccccc-Cchhhccccccceeccccc-cccCCCchhhccCCCCC
Q 013682           98 ELLALGN----------------LIKLKSLDLYSN--LFNGT-IPDTLANLKQLKYLRLNNN-SLSGLIPTSLTTITSLN  157 (438)
Q Consensus        98 ~~l~l~~----------------l~~L~~l~ls~N--~l~g~-iP~~~~~l~~L~~l~ls~N-~l~g~~P~~l~~~~~L~  157 (438)
                      +.|+++.                +++|+.|++++.  .++.. ++.-+.++++|+.|++++| .+++..+..+.++++|+
T Consensus       124 ~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~  203 (284)
T d2astb2         124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ  203 (284)
T ss_dssp             CEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCC
T ss_pred             cccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCC
Confidence            7776532                346777777753  33322 3333456788888888875 47767777888888888


Q ss_pred             eEeccC-CCCCC
Q 013682          158 ILDLSN-NRLSG  168 (438)
Q Consensus       158 ~l~ls~-N~l~g  168 (438)
                      .|++++ +.++.
T Consensus       204 ~L~L~~C~~i~~  215 (284)
T d2astb2         204 HLSLSRCYDIIP  215 (284)
T ss_dssp             EEECTTCTTCCG
T ss_pred             EEECCCCCCCCh
Confidence            888887 45554

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=97.83  E-value=1.6e-06  Score=81.85  Aligned_cols=121  Identities=20%  Similarity=0.183  Sum_probs=81.2

Q ss_pred             hhhhhhhhhhcchheeecccCCcc----------------ceeeeecCCCccccccchh-------------hccCCCCC
Q 013682           48 CEQLHLLISFLIFIRVLQSSSNLF----------------VYLISDLGNAALSGELAPE-------------LGQLKNLE   98 (438)
Q Consensus        48 ~~~l~~~~~~~~~~~~l~~~~n~~----------------~~~~~~l~~n~l~g~ip~~-------------l~~l~~L~   98 (438)
                      +..+-..+....+++.|++++|.+                .+..+++++|.++..-...             ....+.|+
T Consensus        82 ~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~  161 (344)
T d2ca6a1          82 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLR  161 (344)
T ss_dssp             HHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCC
T ss_pred             HHHHHHHHhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccc
Confidence            334455566677788888877753                3667788888765321111             12345555


Q ss_pred             eecc-----------------ccccCCCEEEccCCccccc-----CchhhccccccceeccccccccCC----Cchhhcc
Q 013682           99 LLAL-----------------GNLIKLKSLDLYSNLFNGT-----IPDTLANLKQLKYLRLNNNSLSGL----IPTSLTT  152 (438)
Q Consensus        99 ~l~l-----------------~~l~~L~~l~ls~N~l~g~-----iP~~~~~l~~L~~l~ls~N~l~g~----~P~~l~~  152 (438)
                      .+.+                 ..++.|+.|+|++|.++..     +...+..+++|+.|+|++|+++..    +...+..
T Consensus       162 ~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~  241 (344)
T d2ca6a1         162 SIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS  241 (344)
T ss_dssp             EEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGG
T ss_pred             eeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccc
Confidence            5543                 2356788999999988632     344567788899999999987632    4456678


Q ss_pred             CCCCCeEeccCCCCCC
Q 013682          153 ITSLNILDLSNNRLSG  168 (438)
Q Consensus       153 ~~~L~~l~ls~N~l~g  168 (438)
                      +++|+.|++++|.+++
T Consensus       242 ~~~L~~L~Ls~n~i~~  257 (344)
T d2ca6a1         242 WPNLRELGLNDCLLSA  257 (344)
T ss_dssp             CTTCCEEECTTCCCCH
T ss_pred             cccchhhhhhcCccCc
Confidence            8899999999998865

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.82  E-value=4.8e-06  Score=69.78  Aligned_cols=69  Identities=26%  Similarity=0.227  Sum_probs=52.3

Q ss_pred             ccccCCCEEEccCCccccc--CchhhccccccceeccccccccCCCchhhccCCCCCeEeccCCCCCCCCC
Q 013682          103 GNLIKLKSLDLYSNLFNGT--IPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP  171 (438)
Q Consensus       103 ~~l~~L~~l~ls~N~l~g~--iP~~~~~l~~L~~l~ls~N~l~g~~P~~l~~~~~L~~l~ls~N~l~g~ip  171 (438)
                      ..+++|++|+|++|+++.-  ++..+..+++|+.|+|++|.++..-+-......+|+.+++++|.++....
T Consensus        62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~  132 (162)
T d1koha1          62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR  132 (162)
T ss_dssp             HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred             HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcc
Confidence            4578899999999999832  34567889999999999999985433234455678999999999886554

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.79  E-value=1.9e-05  Score=70.60  Aligned_cols=74  Identities=12%  Similarity=0.022  Sum_probs=50.8

Q ss_pred             ccccccc-eEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCC--CCCceeeEEEEeeCCeeEEEEecCCCCC
Q 013682          293 ILGRGGF-GKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV--HRNLLRLYGFCTTVTEKLLVYPYMTNGS  369 (438)
Q Consensus       293 ~LG~G~f-G~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lv~e~~~~gs  369 (438)
                      .+..|.. +.||+....++..+.+|.-+...    ...+.+|+..++.+.  .-.+.+++.+..+.+..+++|||+++.+
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            3445554 57999988777778888764331    224677777776553  3335677888788888899999998754


Q ss_pred             H
Q 013682          370 V  370 (438)
Q Consensus       370 L  370 (438)
                      +
T Consensus        93 ~   93 (255)
T d1nd4a_          93 L   93 (255)
T ss_dssp             T
T ss_pred             c
Confidence            3

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.77  E-value=1.2e-05  Score=73.74  Aligned_cols=96  Identities=24%  Similarity=0.249  Sum_probs=47.2

Q ss_pred             eeeeecCCCccccccchhhccCCCCCeeccc---------------cccCCCEEEccCC-ccccc-Cchhhcc-ccccce
Q 013682           73 YLISDLGNAALSGELAPELGQLKNLELLALG---------------NLIKLKSLDLYSN-LFNGT-IPDTLAN-LKQLKY  134 (438)
Q Consensus        73 ~~~~~l~~n~l~g~ip~~l~~l~~L~~l~l~---------------~l~~L~~l~ls~N-~l~g~-iP~~~~~-l~~L~~  134 (438)
                      +..++|+++.++...+..++++++|+.|+++               ++++|+.|+++++ +++.. ++..+.. .+.|+.
T Consensus        73 L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~  152 (284)
T d2astb2          73 LQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQ  152 (284)
T ss_dssp             CSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCE
T ss_pred             cccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccch
Confidence            5555666666665556666666666666542               2455666666553 33211 2222322 245666


Q ss_pred             eccccc--cccCC-CchhhccCCCCCeEeccCC-CCCC
Q 013682          135 LRLNNN--SLSGL-IPTSLTTITSLNILDLSNN-RLSG  168 (438)
Q Consensus       135 l~ls~N--~l~g~-~P~~l~~~~~L~~l~ls~N-~l~g  168 (438)
                      |++++.  .++.. +......+++|+.|++++| .+++
T Consensus       153 L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd  190 (284)
T d2astb2         153 LNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKN  190 (284)
T ss_dssp             EECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCG
T ss_pred             hhhcccccccccccccccccccccccccccccccCCCc
Confidence            666542  22211 2223345666666666654 3443

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.73  E-value=1.8e-05  Score=70.20  Aligned_cols=94  Identities=18%  Similarity=0.246  Sum_probs=54.7

Q ss_pred             eeeeecCCCccccccch-hhccCCCCCeecc--------------ccccCCCEEEcc-CCcccccCchhhccccccceec
Q 013682           73 YLISDLGNAALSGELAP-ELGQLKNLELLAL--------------GNLIKLKSLDLY-SNLFNGTIPDTLANLKQLKYLR  136 (438)
Q Consensus        73 ~~~~~l~~n~l~g~ip~-~l~~l~~L~~l~l--------------~~l~~L~~l~ls-~N~l~g~iP~~~~~l~~L~~l~  136 (438)
                      ++.++|++|.++. +|. .+.++++|+.|++              ..+++++.+++. .|++....|..|.++++|+.++
T Consensus        31 l~~L~Ls~n~i~~-l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~  109 (242)
T d1xwdc1          31 AIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL  109 (242)
T ss_dssp             CSEEEEESCCCCE-ECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred             CCEEECcCCcCCc-cChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence            3456666666654 554 3566777777653              234566666654 4566655566677777788888


Q ss_pred             cccccccCCCc-hhhccCCCCCeEeccCCCCC
Q 013682          137 LNNNSLSGLIP-TSLTTITSLNILDLSNNRLS  167 (438)
Q Consensus       137 ls~N~l~g~~P-~~l~~~~~L~~l~ls~N~l~  167 (438)
                      +++|++....+ ..+..+..+..+..+++.+.
T Consensus       110 l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~  141 (242)
T d1xwdc1         110 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH  141 (242)
T ss_dssp             EESCCCCSCCCCTTTCBSSCEEEEEESCTTCC
T ss_pred             cchhhhcccccccccccccccccccccccccc
Confidence            87777764322 12333444444444554443

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=97.71  E-value=3.3e-06  Score=79.50  Aligned_cols=97  Identities=22%  Similarity=0.231  Sum_probs=74.0

Q ss_pred             ceeeeecCCCccccc----cchhhccCCCCCeeccc--------------------------cccCCCEEEccCCccccc
Q 013682           72 VYLISDLGNAALSGE----LAPELGQLKNLELLALG--------------------------NLIKLKSLDLYSNLFNGT  121 (438)
Q Consensus        72 ~~~~~~l~~n~l~g~----ip~~l~~l~~L~~l~l~--------------------------~l~~L~~l~ls~N~l~g~  121 (438)
                      .+..++|++|.++..    +...+..+++|+.|++.                          ..+.|+.+++++|.++..
T Consensus        94 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~  173 (344)
T d2ca6a1          94 KLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENG  173 (344)
T ss_dssp             TCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGG
T ss_pred             CcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeeccccccccc
Confidence            477899999998764    55566678899988753                          245789999999988632


Q ss_pred             ----CchhhccccccceeccccccccCC-----CchhhccCCCCCeEeccCCCCCC
Q 013682          122 ----IPDTLANLKQLKYLRLNNNSLSGL-----IPTSLTTITSLNILDLSNNRLSG  168 (438)
Q Consensus       122 ----iP~~~~~l~~L~~l~ls~N~l~g~-----~P~~l~~~~~L~~l~ls~N~l~g  168 (438)
                          +...+...+.|+.|++++|+++..     +...+..+++|+.|++++|.++.
T Consensus       174 ~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~  229 (344)
T d2ca6a1         174 SMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTH  229 (344)
T ss_dssp             GHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHH
T ss_pred             ccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccc
Confidence                444566788999999999998632     33456788999999999998753

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.66  E-value=1.3e-05  Score=67.03  Aligned_cols=56  Identities=27%  Similarity=0.216  Sum_probs=42.7

Q ss_pred             cccCCCEEEccCCcccccCch-hhccccccceeccccccccCCCch-------hhccCCCCCeEe
Q 013682          104 NLIKLKSLDLYSNLFNGTIPD-TLANLKQLKYLRLNNNSLSGLIPT-------SLTTITSLNILD  160 (438)
Q Consensus       104 ~l~~L~~l~ls~N~l~g~iP~-~~~~l~~L~~l~ls~N~l~g~~P~-------~l~~~~~L~~l~  160 (438)
                      .+++|+.|+|++|.++ .+++ .+.....|+.|++++|+++.....       .+..+++|+.||
T Consensus        89 ~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD  152 (162)
T d1koha1          89 KAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD  152 (162)
T ss_dssp             HSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred             hCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence            3456777899999998 6665 444556799999999999876543       356789999886

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.49  E-value=1.5e-05  Score=76.91  Aligned_cols=65  Identities=29%  Similarity=0.374  Sum_probs=46.7

Q ss_pred             cccCCCEEEccCCccccc----Cchhhcc-ccccceeccccccccCC----CchhhccCCCCCeEeccCCCCCC
Q 013682          104 NLIKLKSLDLYSNLFNGT----IPDTLAN-LKQLKYLRLNNNSLSGL----IPTSLTTITSLNILDLSNNRLSG  168 (438)
Q Consensus       104 ~l~~L~~l~ls~N~l~g~----iP~~~~~-l~~L~~l~ls~N~l~g~----~P~~l~~~~~L~~l~ls~N~l~g  168 (438)
                      .+++|++|||++|.++..    +...+.. ..+|+.|+|++|+++..    ++..+..+++|+.|++++|.++.
T Consensus        53 ~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~  126 (460)
T d1z7xw1          53 VNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD  126 (460)
T ss_dssp             TCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred             cCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence            456788899999988521    2222222 34799999999998754    45667788999999999998753

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.40  E-value=3.9e-05  Score=73.82  Aligned_cols=97  Identities=27%  Similarity=0.185  Sum_probs=64.9

Q ss_pred             ceeeeecCCCccccccchhhc-----cCCCCCeeccc-----------------cccCCCEEEccCCccccc----Cchh
Q 013682           72 VYLISDLGNAALSGELAPELG-----QLKNLELLALG-----------------NLIKLKSLDLYSNLFNGT----IPDT  125 (438)
Q Consensus        72 ~~~~~~l~~n~l~g~ip~~l~-----~l~~L~~l~l~-----------------~l~~L~~l~ls~N~l~g~----iP~~  125 (438)
                      .+..+++++|.++..-...++     ....|+.+.++                 ...+|++|+|++|+++.+    ++..
T Consensus       284 ~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~  363 (460)
T d1z7xw1         284 SLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQG  363 (460)
T ss_dssp             TCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHH
T ss_pred             cccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhh
Confidence            356667777777643333222     22345555432                 245789999999998643    4555


Q ss_pred             hc-cccccceeccccccccCC----CchhhccCCCCCeEeccCCCCCC
Q 013682          126 LA-NLKQLKYLRLNNNSLSGL----IPTSLTTITSLNILDLSNNRLSG  168 (438)
Q Consensus       126 ~~-~l~~L~~l~ls~N~l~g~----~P~~l~~~~~L~~l~ls~N~l~g  168 (438)
                      +. ..+.|++|+|++|+++..    ++..+..+++|+.||+++|.++.
T Consensus       364 l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~  411 (460)
T d1z7xw1         364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD  411 (460)
T ss_dssp             HTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred             hhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence            54 356799999999998742    45567778999999999998864

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.30  E-value=0.00032  Score=66.95  Aligned_cols=76  Identities=11%  Similarity=0.041  Sum_probs=46.1

Q ss_pred             CccccccceEEEEEEeCC-CCEEEEEEccccc------cccchHHHHHHHHHHhcCC-C--CCceeeEEEEeeCCeeEEE
Q 013682          292 NILGRGGFGKVYKGRLAD-GKLVAVKRLKEER------TSGGELQFQTEVKIISMAV-H--RNLLRLYGFCTTVTEKLLV  361 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~-~~~vAvK~l~~~~------~~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~lv  361 (438)
                      +.+|.|....||+....+ ++.+.||.-....      ......+...|.+.+..+. +  ..+.+++.+  +++..+++
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            458999999999998654 6789999643211      1111223456777776442 2  334555544  45567899


Q ss_pred             EecCCCCC
Q 013682          362 YPYMTNGS  369 (438)
Q Consensus       362 ~e~~~~gs  369 (438)
                      ||++.+..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997653

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.45  E-value=0.0023  Score=58.95  Aligned_cols=67  Identities=18%  Similarity=0.134  Sum_probs=42.3

Q ss_pred             eEEEEEEeCCCCEEEEEEccccccccchHHHHHHHHHHhcCCCCCc--eeeE-----EEEeeCCeeEEEEecCCCC
Q 013682          300 GKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL--LRLY-----GFCTTVTEKLLVYPYMTNG  368 (438)
Q Consensus       300 G~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~-----g~~~~~~~~~lv~e~~~~g  368 (438)
                      -.||+.+..+|+.|++|+.+....  ...++.+|...+..+....+  +..+     ......+..+.+++|++|.
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            479999998899999998765422  23457778877765542222  1111     1123355678899998763

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=96.29  E-value=0.0023  Score=52.90  Aligned_cols=93  Identities=17%  Similarity=0.145  Sum_probs=48.1

Q ss_pred             CCccceeeeecCCC-ccccccchhhccCCCCCeeccccccCCCEEEccCCccccc----Cchhhccccccceeccccccc
Q 013682           68 SNLFVYLISDLGNA-ALSGELAPELGQLKNLELLALGNLIKLKSLDLYSNLFNGT----IPDTLANLKQLKYLRLNNNSL  142 (438)
Q Consensus        68 ~n~~~~~~~~l~~n-~l~g~ip~~l~~l~~L~~l~l~~l~~L~~l~ls~N~l~g~----iP~~~~~l~~L~~l~ls~N~l  142 (438)
                      .|...+..++|+++ .++...-..+..       .+...+.|+.|+|++|.+...    +...+...+.|+.|+|++|.+
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~-------~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i   84 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIE-------AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFL   84 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHH-------HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBC
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHH-------HHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhc
Confidence            34556666777653 343321111111       112334466667777766522    223344456677777777776


Q ss_pred             cCC----CchhhccCCCCCeEeccCCCCC
Q 013682          143 SGL----IPTSLTTITSLNILDLSNNRLS  167 (438)
Q Consensus       143 ~g~----~P~~l~~~~~L~~l~ls~N~l~  167 (438)
                      +..    +-..+...++|+.|++++|...
T Consensus        85 ~~~g~~~l~~aL~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          85 TPELLARLLRSTLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             CHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred             chHHHHHHHHHHHhCCcCCEEECCCCcCC
Confidence            532    1123455666777777766543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=94.69  E-value=0.038  Score=51.86  Aligned_cols=70  Identities=19%  Similarity=0.263  Sum_probs=44.7

Q ss_pred             CccccccceEEEEEEeCC--------CCEEEEEEccccccccchHHHHHHHHHHhcCCCCCc-eeeEEEEeeCCeeEEEE
Q 013682          292 NILGRGGFGKVYKGRLAD--------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL-LRLYGFCTTVTEKLLVY  362 (438)
Q Consensus       292 ~~LG~G~fG~Vy~~~~~~--------~~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~  362 (438)
                      +.|+-|-.-.+|+....+        ++.|.+++. ..  ........+|..+++.+.-.++ .++++++.    -++|+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~-g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~  120 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVY-FN--PETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLE  120 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEE-CS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEec-CC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEE
Confidence            457777788999998653        234655554 22  2233356688888877653344 47777764    26899


Q ss_pred             ecCCCC
Q 013682          363 PYMTNG  368 (438)
Q Consensus       363 e~~~~g  368 (438)
                      ||+++.
T Consensus       121 efi~g~  126 (395)
T d1nw1a_         121 EYIPSR  126 (395)
T ss_dssp             CCCCEE
T ss_pred             EEeccc
Confidence            999864

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=93.99  E-value=0.017  Score=47.44  Aligned_cols=66  Identities=20%  Similarity=0.283  Sum_probs=49.0

Q ss_pred             ccccCCCEEEccCC-ccccc----CchhhccccccceeccccccccCC----CchhhccCCCCCeEeccCCCCCC
Q 013682          103 GNLIKLKSLDLYSN-LFNGT----IPDTLANLKQLKYLRLNNNSLSGL----IPTSLTTITSLNILDLSNNRLSG  168 (438)
Q Consensus       103 ~~l~~L~~l~ls~N-~l~g~----iP~~~~~l~~L~~l~ls~N~l~g~----~P~~l~~~~~L~~l~ls~N~l~g  168 (438)
                      .+.++|+.|+|+++ .++..    +-..+...+.|+.|+|++|.+...    +...+...+.|+.|++++|.++.
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~   86 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP   86 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcch
Confidence            34578999999974 45422    334566778899999999999732    33456678899999999999874

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=92.92  E-value=0.044  Score=44.57  Aligned_cols=16  Identities=19%  Similarity=-0.014  Sum_probs=8.1

Q ss_pred             CccceeeeecCC-Cccc
Q 013682           69 NLFVYLISDLGN-AALS   84 (438)
Q Consensus        69 n~~~~~~~~l~~-n~l~   84 (438)
                      |...+..++|++ +.++
T Consensus        15 ~~~~L~~L~L~~~~~i~   31 (166)
T d1io0a_          15 NDPDLEEVNLNNIMNIP   31 (166)
T ss_dssp             TCTTCCEEECTTCTTCC
T ss_pred             cCCCCcEEEcCCCCCCC
Confidence            344555566665 3343

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=91.92  E-value=0.38  Score=42.81  Aligned_cols=29  Identities=17%  Similarity=0.171  Sum_probs=24.7

Q ss_pred             CCCceecCCCCCCeeeCCCCCcchhhhhh
Q 013682          408 DPKIIHRDVKAANILLDEDADQSSKTILR  436 (438)
Q Consensus       408 ~~~ivHrDLK~~NILld~~~~~~l~Df~~  436 (438)
                      ..++||+|+.+.||+++++...-+.||-+
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~  210 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYF  210 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTT
T ss_pred             ccccccCCcchhhhhcccccceeEecccc
Confidence            34799999999999999887778889864

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=86.26  E-value=0.16  Score=40.96  Aligned_cols=64  Identities=16%  Similarity=0.157  Sum_probs=40.4

Q ss_pred             cccCCCEEEccC-Cccccc----CchhhccccccceeccccccccCCC----chhhccCCCCCeEeccCCCCC
Q 013682          104 NLIKLKSLDLYS-NLFNGT----IPDTLANLKQLKYLRLNNNSLSGLI----PTSLTTITSLNILDLSNNRLS  167 (438)
Q Consensus       104 ~l~~L~~l~ls~-N~l~g~----iP~~~~~l~~L~~l~ls~N~l~g~~----P~~l~~~~~L~~l~ls~N~l~  167 (438)
                      +.++|+.|+|++ |.++..    +-..+...+.|++|++++|+++..-    -..+...++++.+++++|.++
T Consensus        15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~   87 (166)
T d1io0a_          15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS   87 (166)
T ss_dssp             TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred             cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence            445677777776 445421    2234456777888888888776331    123455778888888877765